PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zaar, M; Herzig, MC; Fedyk, CG; Montgomery, RK; Prat, N; Parida, BK; Hinojosa-Laborde, C; Muniz, GW; Shade, RE; Bauer, C; Delacruz, W; Bynum, JA; Convertino, VA; Cap, AP; Pidcoke, HF; Goswami, N; Goswami, N; Goswami, N				Zaar, Morten; Herzig, Maryanne C.; Fedyk, Chriselda G.; Montgomery, Robbie K.; Prat, Nicolas; Parida, Bijaya K.; Hinojosa-Laborde, Carmen; Muniz, Gary W.; Shade, Robert E.; Bauer, Cassondra; Delacruz, Wilfred; Bynum, James A.; Convertino, Victor A.; Cap, Andrew P.; Pidcoke, Heather F.; Goswami, Nandu; Goswami, Nandu; Goswami, Nandu			Similar hemostatic responses to hypovolemia induced by hemorrhage and lower body negative pressure reveal a hyperfibrinolytic subset of non-human primates	PLOS ONE			English	Article							BLOOD-LOSS; FIBRINOLYSIS SHUTDOWN; AGGREGOMETRY; ACTIVATION; MODEL	Background To study central hypovolemia in humans, lower body negative pressure (LBNP) is a recognized alternative to blood removal (HEM). While LBNP mimics the cardiovascular responses of HEM in baboons, similarities in hemostatic responses to LBNP and HEM remain unknown in this species. Methods Thirteen anesthetized baboons were exposed to progressive hypovolemia by HEM and, four weeks later, by LBNP. Hemostatic activity was evaluated by plasma markers, thromboelastography (TEG), flow cytometry, and platelet aggregometry at baseline (BL), during and after hypovolemia. Results BL values were indistinguishable for most parameters although platelet count, maximal clot strength (MA), protein C, thrombin anti-thrombin complex (TAT), thrombin activatable fibrinolysis inhibitor (TAFI) activity significantly differed between HEM and LBNP. Central hypovolemia induced by either method activated coagulation; TEG R-time decreased and MA increased during and after hypovolemia compared to BL. Platelets displayed activation by flow cytometry; platelet count and functional aggregometry were unchanged. TAFI activity and protein, Factors V and VIII, vWF, Proteins C and S all demonstrated hemodilution during HEM and hemoconcentration during LBNP, whereas tissue plasminogen activator (tPA), plasmin/anti-plasmin complex, and plasminogen activator inhibitor-1 did not. Fibrinolysis (TEG LY30) was unchanged by either method; however, at BL, fibrinolysis varied greatly. Post-hoc analysis separated baboons into low-lysis (LY30 <2%) or high-lysis (LY30 >2%) whose fibrinolytic state matched at both HEM and LBNP BL. In high-lysis, BL tPA and LY30 correlated strongly (r = 0.95;P<0.001), but this was absent in low-lysis. In low-lysis, BL TAFI activity and tPA correlated (r = 0.88;P<0.050), but this was absent in high-lysis. Conclusions Central hypovolemia induced by either LBNP or HEM resulted in activation of coagulation; thus, LBNP is an adjunct to study hemorrhage-induced pro-coagulation in baboons. Furthermore, this study revealed a subset of baboons with baseline hyperfibrinolysis, which was strongly coupled to tPA and uncoupled from TAFI activity.	[Zaar, Morten; Hinojosa-Laborde, Carmen; Muniz, Gary W.; Delacruz, Wilfred; Convertino, Victor A.] US Army, Inst Surg Res, Ctr Human Integrat Physiol, Ft Sam Houston, TX 78234 USA; [Herzig, Maryanne C.; Fedyk, Chriselda G.; Montgomery, Robbie K.; Prat, Nicolas; Parida, Bijaya K.; Bynum, James A.; Cap, Andrew P.; Pidcoke, Heather F.] US Army, Inst Surg Res, Coagulat & Blood Res, Ft Sam Houston, TX 78234 USA; [Prat, Nicolas] French Armed Forces Biomed Res Inst IRBA, Bretigny Sur Orge, France; [Shade, Robert E.; Bauer, Cassondra] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX USA; [Bauer, Cassondra] Charles River Labs, Ashland, OH USA; [Delacruz, Wilfred] San Antonio Mil Med Ctr, Hematol Oncol, Ft Sam Houston, TX USA; [Pidcoke, Heather F.] Colorado State Univ, Translat Med Inst, Ft Collins, CO 80523 USA	Texas Biomedical Research Institute; San Antonio Military Medical Center; Colorado State University	Herzig, MC (corresponding author), US Army, Inst Surg Res, Coagulat & Blood Res, Ft Sam Houston, TX 78234 USA.	maryanne.c.herzig.ctr@mail.mil	Cap, Andrew Peter/GQZ-4426-2022; Goswami, Nandu/B-4021-2011	Convertino, Victor/0000-0001-9246-0554; Shade, Robert/0000-0002-2979-5279	United States Army, Medical Research and Development Command	United States Army, Medical Research and Development Command	This study was funded by the United States Army, Medical Research and Development Command. Charles Rivers Laboratories provided support in the form of salary for author CB during the editing of this manuscript but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors have no other specific funding to declare.	Bagot CN, 2008, BRIT J HAEMATOL, V143, P180, DOI 10.1111/j.1365-2141.2008.07323.x; Barcroft H, 1944, LANCET, V1, P489; Chapman MP, 2016, J TRAUMA ACUTE CARE, V80, P16, DOI 10.1097/TA.0000000000000885; Colic L, 2018, EUR NEUROPSYCHOPHARM, V28, P701, DOI 10.1016/j.euroneuro.2018.03.014; Cooke WH, 2004, J APPL PHYSIOL, V96, P1249, DOI 10.1152/japplphysiol.01155.2003; Cvirn G, 2019, J APPL PHYSIOL, V126, P1214, DOI 10.1152/japplphysiol.00940.2018; Cvirn G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042221; Dugan G, 2015, PLATELETS, V26, P730, DOI 10.3109/09537104.2014.988694; Goswami N, 2019, PHYSIOL REV, V99, P807, DOI 10.1152/physrev.00006.2018; HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X; Hinojosa-Laborde C, 2016, AM J PHYSIOL-REG I, V310, pR1154, DOI 10.1152/ajpregu.00304.2015; Hinojosa-Laborde C, 2014, J APPL PHYSIOL, V116, P406, DOI 10.1152/japplphysiol.00640.2013; Johnson BD, 2014, J APPL PHYSIOL, V117, P131, DOI 10.1152/japplphysiol.00070.2014; Moore HB, 2017, J TRAUMA ACUTE CARE, V83, P1014, DOI 10.1097/TA.0000000000001718; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Rickards CA, 2015, J APPL PHYSIOL, V119, P677, DOI 10.1152/japplphysiol.00127.2015; Ruttmann TG, 2003, ANAESTH INTENS CARE, V31, P40, DOI 10.1177/0310057X0303100107; Toth O, 2006, THROMB HAEMOSTASIS, V96, P781, DOI 10.1160/TH06-05-0242; van Helmond N, 2016, EXP PHYSIOL, V101, P1265, DOI 10.1113/EP085952; van Helmond N, 2015, AM J PHYSIOL-HEART C, V309, pH1591, DOI 10.1152/ajpheart.00435.2015; von Kanel R, 2000, EUR J HAEMATOL, V65, P357, DOI 10.1034/j.1600-0609.2000.065006357.x; Zaar M, 2009, CLIN PHYSIOL FUNCT I, V29, P427, DOI 10.1111/j.1475-097X.2009.00890.x; Zaar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116174; Zaar M, 2014, BLOOD COAGUL FIBRIN, V25, P592, DOI 10.1097/MBC.0000000000000114	24	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234844	10.1371/journal.pone.0234844	http://dx.doi.org/10.1371/journal.pone.0234844			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579572	gold, Green Published			2022-12-27	WOS:000545646600021
J	Pezzali, JG; Suprabha-Raj, A; Siliveru, K; Aldrich, CG				Pezzali, Julia Guazzelli; Suprabha-Raj, Anu; Siliveru, Kaliramesh; Aldrich, Charles Gregory			Characterization of white and red sorghum flour and their potential use for production of extrudate crisps	PLOS ONE			English	Article							PHYSICAL-PROPERTIES; EXTRUSION; STARCH; FRACTIONS; SNACKS; BREAD	In the human food industry, the wheat-free market sales have increased over the years due to awareness of wheat gluten allergy and celiac disease. Sorghum is a gluten-free grain with great potential to address shortcomings in this market. The aim of this study was to evaluate the milling process and flour quality of one white and one red sorghum varieties and evaluate extrusion as a potential process to produce sorghum crisps. The white and red sorghum grains were milled into flour in three production cycles. Flour quality was evaluated by determination of nutritional composition, pasting, and thermal profile. Extrusion processing of white and red sorghum flour was performed, and macrostructure of final product was evaluated. The white and red sorghum used in this study yielded similar flour content (P > 0.05). Chemical analyses revealed a higher protein and lower starch content for white sorghum than red sorghum flour (P < 0.05); however, their pasting properties did not differ. Initial and peak gelatinization temperatures were higher (P < 0.05) for red sorghum compared to white sorghum flour. Regarding particle size, white sorghum flour presented lower d10 and d50 compared to the red sorghum flour (P < 0.05). However, these differences did not impact the extrusion conditions, and white and red sorghum crisps had similar macrostructure characteristics. In conclusion, although differences in nutritional, thermal, and particle size properties were observed between the sorghum flours used in this study, changes in extrusion parameters were not needed in order to produce sorghum crisps with similar characteristics.	[Pezzali, Julia Guazzelli; Suprabha-Raj, Anu; Siliveru, Kaliramesh; Aldrich, Charles Gregory] Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA; [Pezzali, Julia Guazzelli] Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada	Kansas State University; University of Guelph	Aldrich, CG (corresponding author), Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA.	aldrich4@ksu.edu			Kansas Department of Agriculture through the U.S. Department of Agriculture Federal State Marketing Improvement Program [PP35176]	Kansas Department of Agriculture through the U.S. Department of Agriculture Federal State Marketing Improvement Program	This research was funded by the Kansas Department of Agriculture through the U.S. Department of Agriculture Federal State Marketing Improvement Program, grant number PP35176. CGA received the award/funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.ams.usda.gov/services/grants/fsmip.	Al-Rabadi GJ, 2012, J CEREAL SCI, V56, P396, DOI 10.1016/j.jcs.2012.04.009; Alvarenga IC, 2018, J CEREAL SCI, V82, P121, DOI 10.1016/j.jcs.2018.05.013; Anton AA, 2009, FOOD CHEM, V113, P989, DOI 10.1016/j.foodchem.2008.08.050; Arbex PM, 2018, J FUNCT FOODS, V42, P346, DOI 10.1016/j.jff.2018.01.010; Baik BK, 2004, CEREAL CHEM, V81, P94, DOI 10.1094/CCHEM.2004.81.1.94; Bisharat GI, 2013, FOOD RES INT, V53, P1, DOI 10.1016/j.foodres.2013.03.043; Boudries N, 2009, CARBOHYD POLYM, V78, P475, DOI 10.1016/j.carbpol.2009.05.010; Ding QB, 2005, J FOOD ENG, V66, P283, DOI 10.1016/j.jfoodeng.2004.03.019; Duizer LM, 2006, J TEXTURE STUD, V37, P1, DOI 10.1111/j.1745-4603.2006.00035.x; Frederick EJ, 2009, THESIS; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b; Kim YS, 1999, CEREAL CHEM, V76, P957, DOI 10.1094/CCHEM.1999.76.6.957; Liang X, 2003, J FOOD SCI, V68, P832, DOI 10.1111/j.1365-2621.2003.tb08251.x; Liu LM, 2012, J CEREAL SCI, V55, P31, DOI 10.1016/j.jcs.2011.09.007; Liu Y, 2000, J FOOD SCI, V65, P1253, DOI 10.1111/j.1365-2621.2000.tb10274.x; Martin JM, 2007, CROP SCI, V47, P497, DOI 10.2135/cropsci2006.05.0342; Palavecino PM, 2016, STARCH-STARKE, V68, P1055, DOI 10.1002/star.201600111; McCallum L, 2013, FOODBORNE PATHOG DIS, V10, P159, DOI 10.1089/fpd.2012.1282; Mesquita CD, 2013, FOOD SCI TECH-BRAZIL, V33, P404, DOI 10.1590/S0101-20612013005000073; MORAD MM, 1984, J FOOD SCI, V49, P1070, DOI 10.1111/j.1365-2621.1984.tb10394.x; Moraes EA, 2015, FOOD CHEM, V180, P116, DOI 10.1016/j.foodchem.2015.02.023; Saad M, 2011, J FOOD ENG, V102, P293, DOI 10.1016/j.jfoodeng.2010.08.020; Schober TJ, 2005, CEREAL CHEM, V82, P394, DOI 10.1094/CC-82-0394; Shibanuma Y, 1996, CARBOHYD POLYM, V29, P253, DOI 10.1016/0144-8617(96)00026-4; Smith J, 2011, PROC FOOD SCI, V1, P1573, DOI 10.1016/j.profoo.2011.09.233; Trappey EF, 2015, FOOD SCI TECHNOL INT, V21, P188, DOI 10.1177/1082013214523632; Verlinden A, 2006, CRIT REV FOOD SCI, V46, P259, DOI 10.1080/10408390591001117; Wieser H, 2008, CEREAL CHEM, V85, P1, DOI 10.1094/CCHEM-85-1-0001; Winger M, 2014, J FOOD QUALITY, V37, P95, DOI 10.1111/jfq.12080	30	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234940	10.1371/journal.pone.0234940	http://dx.doi.org/10.1371/journal.pone.0234940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574219	gold, Green Published			2022-12-27	WOS:000544972400053
J	Marx-Blumel, L; Marx, C; Weise, F; Frey, J; Perner, B; Schlingloff, G; Lindig, N; Hampl, J; Sonnemann, J; Brauer, D; Voigt, A; Singh, S; Beck, B; Jager, UM; Wang, ZQ; Beck, JF; Schober, A				Marx-Bluemel, L.; Marx, C.; Weise, F.; Frey, J.; Perner, B.; Schlingloff, G.; Lindig, N.; Hampl, J.; Sonnemann, J.; Brauer, D.; Voigt, A.; Singh, S.; Beck, B.; Jaeger, Ute-Maria; Wang, Z. Q.; Beck, J. F.; Schober, A.			Biomimetic reconstruction of the hematopoietic stem cell niche forin vitroamplification of human hematopoietic stem cells	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; EXPANSION; BIOMATERIALS; DIFFERENTIATION; FIBRONECTIN; GENERATION; CULTURE	Hematopoietic stem cell transplantation is successfully applied since the late 1950s; however, its efficacy still needs to be increased. A promising strategy is to transplant high numbers of pluripotent hematopoietic stem cells (HSCs). Therefore, an improvedex vivoculture system that supports proliferation and maintains HSC pluripotency would override possible limitations in cell numbers gained from donors. To model the natural HSC nichein vitro, we optimized the HSC medium composition with a panel of cytokines and valproic acid and used an artificial 3D bone marrow-like scaffold made of polydimethylsiloxane (PDMS). This 3D scaffold offered a suitable platform to amplify human HSCsin vitroand, simultaneously, to support their viability, multipotency and ability for self-renewal. Silicon oxide-covering of PDMS structures further improved amplification of CD34+ cells, although the conservation of naive HSCs was better on non-covered 3D PDMS. Finally, we found that HSC cultivated on non-covered 3D PDMS generated most pluripotent colonies within colony forming unit assays. In conclusion, by combining biological and biotechnological approaches, we optimizedin vitroHSCs culture conditions, resulting in improved amplification, multipotency maintenance and vitality of HSCs.	[Marx-Bluemel, L.; Frey, J.; Lindig, N.; Voigt, A.; Beck, B.; Jaeger, Ute-Maria; Beck, J. F.] Jena Univ Hosp, Dept Paediat Haematol & Oncol, Childrens Clin, Jena, Germany; [Marx-Bluemel, L.; Frey, J.; Lindig, N.; Sonnemann, J.; Voigt, A.; Beck, B.; Jaeger, Ute-Maria] Jena Univ Hosp, Res Ctr Lobeda, Jena, Germany; [Marx, C.; Perner, B.; Wang, Z. Q.] Fritz Lipmann Inst FLI, Leibniz Inst Aging, Jena, Germany; [Weise, F.; Schlingloff, G.; Hampl, J.; Brauer, D.; Singh, S.; Schober, A.] Ilmenau Univ Technol, Inst Micro & Nanotechnol MacroNano, Nanobiosyst Technol, Ilmenau, Germany; [Wang, Z. Q.] Friedrich Schiller Univ Jena, Fac Biol Sci, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Technische Universitat Ilmenau; Friedrich Schiller University of Jena	Marx-Blumel, L (corresponding author), Jena Univ Hosp, Dept Paediat Haematol & Oncol, Childrens Clin, Jena, Germany.; Marx-Blumel, L (corresponding author), Jena Univ Hosp, Res Ctr Lobeda, Jena, Germany.	lisa.marx-bluemel@med.uni-jena.de	Marx, Christian/AAJ-5813-2021; Sonnemann, Jürgen/H-9116-2019	Marx, Christian/0000-0003-2240-8261; Sonnemann, Jürgen/0000-0003-2993-9161; Marx-Blumel, Lisa/0000-0002-9360-6559; Singh, Sukhdeep/0000-0001-6871-4294	German Federal Ministry of Education and Research (BMBF) [03VP00592]; German Jose Carreras Leukaemia Foundation [DJCLS R 13/18]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Jose Carreras Leukaemia Foundation	This project was funded by the German Federal Ministry of Education and Research (BMBF) 03VP00592 and the German Jose ' Carreras Leukaemia Foundation DJCLS R 13/18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Chaurasia P, 2014, J CLIN INVEST, V124, P2378, DOI 10.1172/JCI70313; Chen BJ, 2004, BLOOD, V103, P4344, DOI 10.1182/blood-2003-07-2534; Dahlberg A, 2014, LEUKEMIA, V28, P2097, DOI 10.1038/leu.2014.181; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; De Felice LD, 2005, CANCER RES, V65, P1505, DOI 10.1158/0008-5472.CAN-04-3063; Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Feng Q, 2006, J BIOMED MATER RES A, V78A, P781, DOI 10.1002/jbm.a.30829; Frisch BJ, 2014, METHODS MOL BIOL, V1130, P315, DOI 10.1007/978-1-62703-989-5_24; Hashimoto Y, 2011, BIOMATERIALS, V32, P7060, DOI 10.1016/j.biomaterials.2011.06.008; Islami M, 2018, ARTIF CELL NANOMED B, V46, P1025, DOI 10.1080/21691401.2017.1358733; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298; Laurenti E, 2018, NATURE, V553, P418, DOI 10.1038/nature25022; Li Y, 2001, J HEMATOTH STEM CELL, V10, P355, DOI 10.1089/152581601750288966; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Moraes C, 2009, BIOMATERIALS, V30, P5241, DOI 10.1016/j.biomaterials.2009.05.066; Niederwieser D, 2016, BONE MARROW TRANSPL, V51, P778, DOI 10.1038/bmt.2016.18; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Prewitz M, 2012, MACROMOL RAPID COMM, V33, P1420, DOI 10.1002/marc.201200382; Sagar BMM, 2006, BIOCHEM BIOPH RES CO, V350, P1000, DOI 10.1016/j.bbrc.2006.09.140; Sahin AO, 2012, CELL ADHES MIGR, V6, P39, DOI 10.4161/cam.18975; Schmidt M, 2009, PROCEDIA CHEM, V1, P1523, DOI 10.1016/j.proche.2009.07.380; Steigert J, 2007, J MICROMECH MICROENG, V17, P333, DOI 10.1088/0960-1317/17/2/020; Wagner JE, 2016, CELL STEM CELL, V18, P144, DOI 10.1016/j.stem.2015.10.004; Walasek MA, 2012, ANN NY ACAD SCI, V1266, P138, DOI 10.1111/j.1749-6632.2012.06549.x; Wilkinson AC, 2019, NATURE, V571, DOI 10.1038/s41586-019-1395-9; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	32	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234638	10.1371/journal.pone.0234638	http://dx.doi.org/10.1371/journal.pone.0234638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569325	Green Published, gold			2022-12-27	WOS:000543547900005
J	Ready, E; Habecker, P; Abadie, R; Khan, B; Dombrowski, K				Ready, Elspeth; Habecker, Patrick; Abadie, Roberto; Khan, Bilal; Dombrowski, Kirk			Competing forces of withdrawal and disease avoidance in the risk networks of people who inject drugs	PLOS ONE			English	Article							NEEDLE-SHARING BEHAVIOR; HEPATITIS-C VIRUS; HIV RISK; EVERYDAY VIOLENCE; UNITED-STATES; USERS; INFECTION; EQUIPMENT; DETERMINANTS; PREDICTORS	We analyze a network of needle-sharing ties among 117 people who inject drugs (PWID) in rural Puerto Rico, using exponential random graph modeling to examine whether network members engage in partner restriction to lower their risk of contracting HIV or hepatitis C (HCV), or in informed altruism to prevent others from contracting these infections. Although sharing of used syringes is a significant risk factor for transmission of these diseases among PWID, we find limited evidence for partner restriction or informed altruism in the network of reported needle-sharing ties. We find however that sharing of needles is strongly reciprocal, and individuals with higher injection frequency are more likely to have injected with a used needle. Drawing on our ethnographic work, we discuss how the network structures we observe may relate to a decision-making rationale focused on avoiding withdrawal sickness, which leads to risk-taking behaviors in this poor, rural context where economic considerations often lead PWID to cooperate in the acquisition and use of drugs.	[Ready, Elspeth] Max Planck Inst Evolutionary Anthropol, Dept Human Behav Ecol & Culture, Leipzig, Germany; [Ready, Elspeth] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Habecker, Patrick; Abadie, Roberto; Khan, Bilal] Univ Nebraska, Dept Sociol, Lincoln, NE 68588 USA; [Dombrowski, Kirk] Univ Vermont, VP Res Admin Off, Burlington, VT USA	Max Planck Society; State University System of Florida; University of Florida; University of Nebraska System; University of Nebraska Lincoln; University of Vermont	Ready, E (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Behav Ecol & Culture, Leipzig, Germany.; Ready, E (corresponding author), Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA.	elspeth_ready@eva.mpg.de		Habecker, Patrick/0000-0003-4435-1593	National Science Foundation [1443985, 1638618]; National Institutes of Health [R01DA037117]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported in part by a grant from the National Science Foundation (www.nsf.gov) program for Enhancing Access to Radio Spectrum, grant numbers 1443985 and 1638618 (KD and BK), and in part by a grant from the National Institutes of Health (www.nih.gov) grant number R01DA037117 (KD and BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie R, 2018, INT J DRUG POLICY, V51, P121, DOI 10.1016/j.drugpo.2017.06.011; Abadie R, 2016, HARM REDUCT J, V13, DOI 10.1186/s12954-016-0099-9; Bailey SL, 2007, DRUG ALCOHOL DEPEN, V91, pS18, DOI 10.1016/j.drugalcdep.2007.02.014; BARNARD MA, 1993, ADDICTION, V88, P805, DOI 10.1111/j.1360-0443.1993.tb02094.x; Betts KS, 2016, ADDICTION, V111, P1214, DOI 10.1111/add.13339; Bourgois P, 1998, SUBST USE MISUSE, V33, P2323, DOI 10.3109/10826089809056260; Bourgois P, 2004, HUM ORGAN, V63, P253, DOI 10.17730/humo.63.3.h1phxbhrb7m4mlv0; CDC, 2010, HIV SURV REP 2010; CDC, 2016, VIR HEP SURV US 2016; Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366; Colon-Lopez V, 2013, P R HEALTH SCI J, V32, P8; CURTIS R, 1995, SOC NETWORKS, V17, P229, DOI 10.1016/0378-8733(95)00264-O; Davey-Rothwell MA, 2007, J URBAN HEALTH, V84, P691, DOI 10.1007/s11524-007-9215-1; Friedman S.R., 1998, INT J DRUG POLICY, V9, P461, DOI [10.1016/S0955-3959(98)00062-0., DOI 10.1016/S0955-3959(98)00062-0]; Friedman SR, 2011, SUBST USE MISUSE, V46, P307, DOI 10.3109/10826084.2011.523316; Friedman SR, 1997, AM J PUBLIC HEALTH, V87, P1289, DOI 10.2105/AJPH.87.8.1289; GIBSON DR, 1993, INT J ADDICT, V28, P973, DOI 10.3109/10826089309062177; Handcock MS, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P229; Holtzman D, 2009, PREV MED, V49, P68, DOI 10.1016/j.ypmed.2009.04.014; Hunter DR, 2007, SOC NETWORKS, V29, P216, DOI 10.1016/j.socnet.2006.08.005; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Jarlais DCD, 2004, JAIDS-J ACQ IMM DEF, V35, P158, DOI 10.1097/00126334-200402010-00010; KLOVDAHL AS, 1994, SOC SCI MED, V38, P79, DOI 10.1016/0277-9536(94)90302-6; Krumpal I, 2013, QUAL QUANT, V47, P2025, DOI 10.1007/s11135-011-9640-9; Latkin C, 1996, J ACQ IMMUN DEF SYND, V13, P273, DOI 10.1097/00042560-199611010-00010; LATKIN C, 1995, SOC NETWORKS, V17, P219, DOI 10.1016/0378-8733(95)00263-N; Latkin CA, 2008, JAIDS-J ACQ IMM DEF, V49, P447, DOI 10.1097/QAI.0b013e31818a6546; Lee W, 2015, AIDS BEHAV, V19, P1415, DOI 10.1007/s10461-014-0930-9; LOXLEY W, 1995, AIDS CARE, V7, P337, DOI 10.1080/09540129550126551; Lundgren LM, 2005, AIDS EDUC PREV, V17, P525, DOI 10.1521/aeap.2005.17.6.525; MacRae R, 2000, AIDS CARE, V12, P505, DOI 10.1080/09540120050123909; MAGURA S, 1989, AM J PUBLIC HEALTH, V79, P459, DOI 10.2105/AJPH.79.4.459; Mandell W, 1999, AM J DRUG ALCOHOL AB, V25, P117, DOI 10.1081/ADA-100101849; MANDELL W, 1994, AM J PUBLIC HEALTH, V84, P920, DOI 10.2105/AJPH.84.6.920; Metsch LR, 2007, JAIDS-J ACQ IMM DEF, V46, pS72, DOI 10.1097/QAI.0b013e3181576818; Mizuno Y, 2011, J URBAN HEALTH, V88, P1031, DOI 10.1007/s11524-011-9578-1; NEAIGUS A, 1994, SOC SCI MED, V38, P67, DOI 10.1016/0277-9536(94)90301-8; Norman Lisa R, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P260, DOI 10.1177/1545109710393310; Perez CM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-76; R Core Team, 2018, R LANG ENV STAT MPUT; Smith BD, 2013, J INFECT DIS, V208, P1934, DOI 10.1093/infdis/jit520; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Strathdee SA, 1997, ADDICTION, V92, P1339, DOI 10.1046/j.1360-0443.1997.9210133910.x; Strathdee SA, 2015, NEW ENGL J MED, V373, P397, DOI 10.1056/NEJMp1507252; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sutter A., 1966, ISSUES CRIMINOL, V196, P177; Tassiopoulos K, 2013, ADDICT SCI CLIN PRAC, V8, DOI 10.1186/1940-0640-8-20; Unger JB, 2006, ADDICT BEHAV, V31, P1607, DOI 10.1016/j.addbeh.2005.12.007; Valente TW, 2001, AM J PUBLIC HEALTH, V91, P406, DOI 10.2105/AJPH.91.3.406; Verdery AM, 2017, JAIDS-J ACQ IMM DEF, V76, P26, DOI 10.1097/QAI.0000000000001485; Vlahov D, 2001, AIDS, V15, P2311, DOI 10.1097/00002030-200111230-00013; Voon P, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0050-5; Wagner KD, 2011, ADDICT BEHAV, V36, P835, DOI 10.1016/j.addbeh.2011.03.014; Wood E, 2002, AIDS, V16, P941, DOI 10.1097/00002030-200204120-00021; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	55	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235124	10.1371/journal.pone.0235124	http://dx.doi.org/10.1371/journal.pone.0235124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569332	Green Published, gold			2022-12-27	WOS:000543547900009
J	Xu, X; Li, JY				Xu, Xu; Li, Jiayin			Concreteness/abstractness ratings for two-character Chinese words in MELD-SCH	PLOS ONE			English	Article							CONTEXT AVAILABILITY; ALZHEIMERS-DISEASE; ABSTRACT WORDS; CONCRETENESS; NORMS; FREQUENCY; COMPREHENSION; IMAGEABILITY; ACQUISITION; VARIABLES	The concreteness-abstractness continuum is considered a primary dimension in the representation of semantic networks. Its theoretical importance and clinical significance are widely acknowledged. To assist and enhance future research, this study collected and evaluated concreteness/abstractness ratings for 9,877 two-character Chinese words retrieved from the MEga study of Lexical Decision in Simplified CHinese (MELD-SCH, Tsang et al, 2018). The ratings were validated through comparisons with previous rating studies on concreteness and imageability of smaller word samples. Relations of word concreteness with word frequency, age-of-acquisition, and efficiency of lexical processing were also examined. These ratings provide an additional dimension of information to two-character words in the database MELD-SCH, permitting not only more comprehensive research on the Chinese language, but also cross-language investigation of the concreteness effect between Chinese and other languages such as English and Dutch where a large database of concreteness ratings is also available.	[Xu, Xu; Li, Jiayin] Shanghai Jiao Tong Univ, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xu, X (corresponding author), Shanghai Jiao Tong Univ, Shanghai, Peoples R China.	xu2xu3@gmail.com			Shanghai Jiao Tong University [220414005, 117114003/031]	Shanghai Jiao Tong University	This study is supported by research grants (Grant No. 220414005 and Grant No. 117114003/031) awarded to XX by Shanghai Jiao Tong University (www.sjtu.edu.cn).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyahya RSW, 2018, NEUROIMAGE-CLIN, V17, P811, DOI 10.1016/j.nicl.2017.12.009; Barber HA, 2010, BRAIN RES, V1332, P65, DOI 10.1016/j.brainres.2010.03.014; Bocanegra Y, 2017, BRAIN LANG, V168, P37, DOI 10.1016/j.bandl.2017.01.005; Bonin P, 2018, BEHAV RES METHODS, V50, P2366, DOI 10.3758/s13428-018-1014-y; Brysbaert M, 2016, J EXP PSYCHOL HUMAN, V42, P441, DOI 10.1037/xhp0000159; Brysbaert M, 2014, BEHAV RES METHODS, V46, P904, DOI 10.3758/s13428-013-0403-5; Brysbaert M, 2014, ACTA PSYCHOL, V150, P80, DOI 10.1016/j.actpsy.2014.04.010; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; CARROLL JB, 1973, Q J EXP PSYCHOL, V25, P85, DOI 10.1080/14640747308400325; Catricala E, 2014, NEUROPSYCHOLOGIA, V64, P271, DOI 10.1016/j.neuropsychologia.2014.09.041; Coso B, 2019, Q J EXP PSYCHOL, V72, P2302, DOI 10.1177/1747021819834226; Craik FIM, 2002, MEMORY, V10, P305, DOI 10.1080/09658210244000135; GERNSBACHER MA, 1984, J EXP PSYCHOL GEN, V113, P256, DOI 10.1037/0096-3445.113.2.256; Giffard B, 2015, CORTEX, V69, P201, DOI 10.1016/j.cortex.2015.05.020; Guasch M, 2016, BEHAV RES METHODS, V48, P1358, DOI 10.3758/s13428-015-0684-y; Hoffman P, 2010, J NEUROSCI, V30, P15450, DOI 10.1523/JNEUROSCI.3783-10.2010; Imbir KK, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01081; Joubert S, 2017, BRAIN LANG, V170, P93, DOI 10.1016/j.bandl.2017.04.004; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171394; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Kuperman V, 2012, BEHAV RES METHODS, V44, P978, DOI 10.3758/s13428-012-0210-4; Lahl O, 2009, BEHAV RES METHODS, V41, P13, DOI 10.3758/BRM.41.1.13; Lakoff G., 1980, METAPHORS WE LIVE; Lakoff George., 1999, PHILOS FLESH EMBODIE; Law SP, 2017, J NEUROLINGUIST, V44, P223, DOI 10.1016/j.jneuroling.2017.07.001; Liu YY, 2007, BEHAV RES METHODS, V39, P192, DOI 10.3758/BF03193147; Lv S., 1984, 800 WORDS MODERN CHI; McEnery A., 2004, LREC, P1175; Montefinese M, 2014, BEHAV RES METHODS, V46, P887, DOI 10.3758/s13428-013-0405-3; Moseley RL, 2014, BRAIN LANG, V132, P28, DOI 10.1016/j.bandl.2014.03.001; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Paivio, 1986, MENTAL REPRESENTATIO; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; Papagno C, 2013, BRAIN SCI, V3, P1229, DOI 10.3390/brainsci3031229; Pollock L, 2018, BEHAV RES METHODS, V50, P1198, DOI 10.3758/s13428-017-0938-y; Riccardi N, 2019, CORTEX, V120, P131, DOI 10.1016/j.cortex.2019.05.013; Rice CA, 2019, MEM COGNITION, V47, P1297, DOI 10.3758/s13421-019-00934-4; Samson D, 2004, BRAIN LANG, V91, P252, DOI 10.1016/j.bandl.2004.03.001; SCHWANENFLUGEL PJ, 1983, J EXP PSYCHOL LEARN, V9, P82, DOI 10.1037/0278-7393.9.1.82; SCHWANENFLUGEL PJ, 1992, MEM COGNITION, V20, P96, DOI 10.3758/BF03208259; Smirnova D, 2017, PSYCHIAT RES, V257, P203, DOI 10.1016/j.psychres.2017.07.044; Soares AP, 2017, BEHAV RES METHODS, V49, P1065, DOI 10.3758/s13428-016-0767-4; The Lancet Planetary Health, 2017, LANCET PLANET HLTH, V1, pe209; Tsang YK, 2018, BEHAV RES METHODS, V50, P1763, DOI 10.3758/s13428-017-0944-0; Wang RM, 2020, BEHAV RES METHODS, V52, P82, DOI 10.3758/s13428-019-01206-4; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; Wiemer-Hastings K, 2005, COGNITIVE SCI, V29, P719, DOI 10.1207/s15516709cog0000_33; Xu J., 2017, TEXT RECENT CHINESE; Xu X., AGE ACQUISITION RATI; Xu X, 2016, COGN PROCESS, V17, P175, DOI 10.1007/s10339-015-0747-0; Yao Z, 2017, BEHAV RES METHODS, V49, P1374, DOI 10.3758/s13428-016-0793-2; Zhang Q, 2006, BRAIN LANG, V96, P59, DOI 10.1016/j.bandl.2005.04.004	54	11	11	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0232133	10.1371/journal.pone.0232133	http://dx.doi.org/10.1371/journal.pone.0232133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569306	gold, Green Published			2022-12-27	WOS:000543547900013
J	Skidmore, T; Roe, E				Skidmore, Tess; Roe, Emma			A semi-structured questionnaire survey of laboratory animal rehoming practice across 41 UK animal research facilities	PLOS ONE			English	Article							QUALITY-OF-LIFE; ADOPTION SUCCESS; SHELTERS; STRESS; OWNER; CATS; DOGS	If a laboratory animal survives an experiment without lasting compromised welfare, its future must be negotiated. Rehoming may be a consideration. This paper reports on research findings that provide an indication of the uptake of animal rehoming by UK facilities and the associated moral, ethical, practical and regulatory considerations that inform decisions to rehome or not. This research addresses a widely acknowledged gap in the literature to understand both the numbers, and types of animals rehomed from UK research facilities, as well as the main motivations for engaging in the practice, and the barriers for those facilities not currently rehoming. From the similar to 160 UK research facilities in the UK, 41 facilities completed the questionnaire, giving a response rate of approximately 25%. Results suggest rehoming occurs routinely, yet the numbers are small; just 2322 animals are known to have been rehomed between 2015-2017. At least 1 in 10 facilities are rehoming. There exists a clear preference for the rehoming of some species (mainly cats, dogs and horses) over others (rodents, agricultural animals and primates). Indeed, although 94.15% of species kept in laboratories are rodents, they make up under a fifth (19.14%) of all animals known to be rehomed between 2015-2017. The primary motivation for rehoming is to boost staff morale and promote a positive ethical profile for the facility. Barriers include concern for the animal's welfare following rehoming, high scientific demand for animals that leaves few to be rehomed, and, finally, certain animals (mainly those genetically modified) are simply unsuited to rehoming. The findings of this research will support facilities choosing to rehome, as well as those that are not currently engaging in the practice. By promoting the practice, the benefits to rehoming in terms of improving laboratory animal's quality of life, helping facility staff to overcome the moral stress of killing, and addressing public concern regarding the fate of laboratory animals, can be attained. It is only once an understanding of rehoming from the perspective of UK research facilities has been ascertained, that appropriate policy and support can be provided.	[Skidmore, Tess; Roe, Emma] Univ Southampton, Sch Geog & Environm Sci, Southampton, Hants, England	University of Southampton	Skidmore, T (corresponding author), Univ Southampton, Sch Geog & Environm Sci, Southampton, Hants, England.	t.a.skidmore@soton.ac.uk		Skidmore, Tess/0000-0001-8816-4082	Wellcome Trust [205393/D/16/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	T.S and E.R 205393/D/16/Z Wellcome Trust https://wellcome.ac.uk/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, NCCN PRACT GUIDEL, V2017, P1, DOI DOI 10.1155/2017/2683789; [Anonymous], 1987, AM LAW I PUBLISHERS, V1-2, P115; Association L.A.S., 2002, LASA GUID REH LAB DO; Bayne Kathryn, 2002, ILAR J, V43, P4; Birke L., 2007, SACRIFICE SCI EXPT T; Bono G, 2005, VET RES COMMUN, V29, P165, DOI 10.1007/s11259-005-0033-1; Carbone L, 2003, LAB ANIMAL, V32, P37, DOI 10.1038/laban1003-37; Clark J. L., 2014, Humanimalia: A Journal of Human/Animal Interface Studies, V6, P88; Davis R., 2013, UNDERSTANDING VOLUNT; DiGangi Brian A., 2006, Journal of Applied Animal Welfare Science, V9, P143, DOI 10.1207/s15327604jaws0902_4; Doring D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181303; Doring D, 2017, ALTEX-ALTERN ANIM EX, V34, P133, DOI 10.14573/altex.1608171; F.A.W.C. Farm Animal Welfare in Great Britain, 2009, FARM ANIMAL WELFARE, P1; Fleury E., 2017, ANIMAL STUDIES J, V6, P30; Franco NH, 2016, END OF ANIMAL LIFE: A START FOR ETHICAL DEBATE: ETHICAL AND SOCIETAL CONSIDERATIONS ON KILLING ANIMALS, P187, DOI 10.3920/978-90-8686-808-7_12; Harms CA, 2007, J AM ASSOC LAB ANIM, V46, P50; Home Office, 2016, ANN STAT SCI PROCEDU, P1; Home Office, 2017, ANN STAT SCI PROCEDU, P1; Home Office, 2015, ANN STAT SCI PROC LI, P1, DOI DOI 10.1016/J.FSIGEN.2013.09.005; Howard VJ, 2015, J ORGAN BEHAV MANAGE, V35, P296, DOI 10.1080/01608061.2015.1093052; Hua J, 2013, AM QUART, V65, P619; Kerwin Amy M., 2006, Journal of Applied Animal Welfare Science, V9, P337, DOI 10.1207/s15327604jaws0904_9; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kue J., 2011, EUTHANASIA GOOD DEAT; Luescher AU, 2009, APPL ANIM BEHAV SCI, V117, P63, DOI 10.1016/j.applanim.2008.11.001; Marchant-Forde JN, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00016; Marinelli L, 2007, APPL ANIM BEHAV SCI, V108, P143, DOI 10.1016/j.applanim.2006.11.018; McAndrew R., 2016, LAB PRIMATES THEIR L; McMillan FD, 2000, J AM VET MED ASSOC, V216, P1904, DOI 10.2460/javma.2000.216.1904; Mellor DJ, 2016, ANIMALS, V6, DOI 10.3390/ani6030021; Mondelli Francesca, 2004, Journal of Applied Animal Welfare Science, V7, P253, DOI 10.1207/s15327604jaws0704_3; Novak MA, 2013, APPL ANIM BEHAV SCI, V143, P135, DOI 10.1016/j.applanim.2012.10.012; Patronek GJ, 1996, J AM VET MED ASSOC, V209, P582; Pirrone F, 2015, J VET BEHAV, V10, P295, DOI 10.1016/j.jveb.2015.03.004; Prescott M.J., 2006, LAB PRIMATE NEWSL, V45, P5; Protopopova A, 2012, APPL ANIM BEHAV SCI, V142, P61, DOI 10.1016/j.applanim.2012.09.009; Quigley M, 2007, J MED ETHICS, V33, P655, DOI 10.1136/jme.2007.020784; Roberts M., 2018, BSAVA MANUAL CANINE, P314; Rogelberg SG, 2010, NONPROFIT MANAG LEAD, V20, P423, DOI 10.1002/nml.20003; Rohlf V, 2005, SOC ANIM, V13, P201, DOI 10.1163/1568530054927753; Seelig D, 1999, LAB PRIMATE NEWSL, V38, P1; Sinski J., 2016, COMPANION ANIMALS EV, P73; Towner S, 2010, BIOSCI HORIZ, V3, P96, DOI [10.1093/biohorizons/hzq011, DOI 10.1093/BIOHORIZONS/HZQ011, DOI 10.1093/BI0H0RIZ0NS/HZQ0]; Weary DM, 2019, ANIM WELFARE, V28, P33, DOI 10.7120/09627286.28.1.033; Weiss Emily, 2012, Animals (Basel), V2, P144, DOI 10.3390/ani2020144; Wolfensohn S., 2010, The UFAW handbook on the care and management of laboratory and other research animals, P219, DOI 10.1002/9781444318777.ch17; Yeates J, 2009, J SMALL ANIM PRACT, V50, P274, DOI 10.1111/j.1748-5827.2009.00755.x	47	5	5	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234922	10.1371/journal.pone.0234922	http://dx.doi.org/10.1371/journal.pone.0234922			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559221	Green Published, gold			2022-12-27	WOS:000543261600028
J	Al-Hanawi, MK; Almubark, S; Qattan, AMN; Cenkier, A; Kosycarz, EA				Al-Hanawi, Mohammed Khaled; Almubark, Sarh; Qattan, Ameerah M. N.; Cenkier, Agnieszka; Kosycarz, Ewa Agnieszka			Barriers to the implementation of public-private partnerships in the healthcare sector in the Kingdom of Saudi Arabia	PLOS ONE			English	Article							HOSPITAL SERVICES; PROJECTS; FINANCE; CONTRACTS	Background Saudi Arabia is considering increasing the role of the private sector's participation in financing and delivering healthcare services through the adoption of Public-Private Partnerships (PPPs). However, the adoption and successful implementation of PPPs in the Saudi healthcare sector requires careful attention to overcome potential obstacles. Objectives This study investigates and identifies potential barriers to the successful implementation of PPPs in the Saudi healthcare sector. Methods A pre-tested interviewer-administered questionnaire was used to collect data from 72 respondents over a two-month period. Respondents were asked to rate the degree of influence of potential key barriers using a five-point Likert scale. The collected data was analysed using descriptive and inferential statistics. Results The evidence showed that the top three barriers, as rated by the respondents, were legal barriers, including delays in receiving approval and permits and law and regulation changes, environmental barriers, including lack of transparency and accountability and technological barriers, including a shortage of professionals qualified to handle PPP projects. Conclusions The barriers identified suggested that the government should ensure that PPPs are implemented in a timely manner to ensure that private sector involvement yields the intended benefits. Furthermore, a stable legal and regulatory framework must be established that is properly and easily enforced to avoid confusing stakeholders with too many changes. It is also important to ensure that transparency and accountability measures are strengthened.	[Al-Hanawi, Mohammed Khaled; Almubark, Sarh; Qattan, Ameerah M. N.] King Abdulaziz Univ, Dept Hlth Serv & Hosp Adm, Fac Econ & Adm, Jeddah, Saudi Arabia; [Cenkier, Agnieszka] SGH Warsaw Sch Econ, Coll Business Adm, Warsaw, Poland; [Kosycarz, Ewa Agnieszka] SGH Warsaw Sch Econ, Coll Socioecon, Warsaw, Poland	King Abdulaziz University; Warsaw School of Economics; Warsaw School of Economics	Al-Hanawi, MK (corresponding author), King Abdulaziz Univ, Dept Hlth Serv & Hosp Adm, Fac Econ & Adm, Jeddah, Saudi Arabia.	mkalhanawi@kau.edu.sa	Qattan, Ameerah/AAU-6538-2020; Al-Hanawi, Mohammed Khaled/AAB-2455-2020	Qattan, Ameerah/0000-0003-3201-547X; Al-Hanawi, Mohammed Khaled/0000-0002-8419-2219	Deanship of Scientific Research (DSR) at King Abdulaziz University [D-163-120-1440]; King Abdulaziz University, Jeddah	Deanship of Scientific Research (DSR) at King Abdulaziz University; King Abdulaziz University, Jeddah	This research was funded by the Deanship of Scientific Research (DSR) at King Abdulaziz University, grant number D-163-120-1440. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; The authors acknowledge, with thanks, the support of the Deanship of Scientific Research at King Abdulaziz University, Jeddah.	Acerete B, 2012, PUBLIC MONEY MANAGE, V32, P311, DOI 10.1080/09540962.2012.691315; Al-Hanawi MK, 2018, APPL HEALTH ECON HEA, V16, P259, DOI 10.1007/s40258-017-0366-2; Al-Hanawi MK, 2018, APPL HEALTH ECON HEA, V16, P55, DOI 10.1007/s40258-017-0353-7; Almalki M., 2011, Eastern Mediterranean Health Journal, V17, P784; [Anonymous], 2019, MONTHLY NEWSLETTER M; Babatunde SO, 2015, ENG CONSTR ARCHIT MA, V22, P669, DOI 10.1108/ECAM-12-2014-0159; Barlow J, 2013, HEALTH AFFAIR, V32, P146, DOI 10.1377/hlthaff.2011.1223; Barlow J, 2009, CALIF MANAGE REV, V51, P126, DOI 10.2307/41166483; Biygautane M, 2017, PUBLIC WORKS MANAG P, V22, P85, DOI 10.1177/1087724X16671719; Boyer E. J., 2015, J STRATEGIC CONTRACT, V1, P129, DOI DOI 10.1177/2055563615592739; Caldwell ND, 2017, J MANAGE STUD, V54, P906, DOI 10.1111/joms.12268; Chan APC, 2010, J MANAGE ENG, V26, P30, DOI 10.1061/(ASCE)0742-597X(2010)26:1(30); Chan D, 2006, FEASIBILITY STUDY IM; Chowdhury A, 2011, CONSTR MANAG ECON, V29, P247, DOI 10.1080/01446193.2010.537354; Clifton C., 2006, International Journal of Project Management, V24, P573, DOI 10.1016/j.ijproman.2006.07.005; Das T.K., 2013, MANAGING PUBLIC PRIV; Elachola H, 2016, LANCET, V387, P827, DOI 10.1016/S0140-6736(16)00203-8; European Commission, 2004, COM327 EUR COMM; European Union, 2013, HLTH EC AN EV PUBL P; Forest JJ., 2006, OIL TERRORISM NEW GU; Garson D., 2009, RELIABILITY ANAL STA; Gibson H, 2008, INT J EDUC MANAG, V22, P74, DOI 10.1108/09513540810844576; Gottwald M, 2016, ARCH PHARM, V349, P692, DOI 10.1002/ardp.201600078; Gunnigan L, 2010, COMP INDIAN PPP CONS; Hellwig M, 2018, SEMIN CANCER BIOL, V49, P1, DOI 10.1016/j.semcancer.2017.11.014; Hodge GA, 2007, PUBLIC ADMIN REV, V67, P545, DOI 10.1111/j.1540-6210.2007.00736.x; Hodge GA, 2010, INTERNATIONAL HANDBOOK ON PUBLIC- PRIVATE PARTNERSHIPS, P3; Holden C, 2009, POLICY STUD-UK, V30, P313, DOI 10.1080/01442870902863885; Hwang BG, 2013, INT J PROJ MANAG, V31, P424, DOI 10.1016/j.ijproman.2012.08.003; Jurong Zheng, 2008, Journal of Purchasing and Supply Management, V14, P43, DOI 10.1016/j.pursup.2008.01.004; Karawajczyk A, 2017, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00075; Khanom N., 2010, INT REV BUSINESS RES, V6, P150; Kivleniece I, 2012, ACAD MANAGE REV, V37, P272, DOI 10.5465/amr.2011.0004; Klijn E. H., 2007, NEW PUBLIC MANAGEMEN, P71; Klijn E.H., 2000, PUBLIC PRIVATE PARTN; Kosycarz EA, 2019, J PUBLIC HEALTH-HEID, V27, P1, DOI 10.1007/s10389-018-0920-x; Kumar R., 2019, RES METHODOLOGY STEP; Kwak YH, 2009, CALIF MANAGE REV, V51, P51, DOI 10.2307/41166480; Li B., 2003, THESIS GLASGOW CALED; Li B, 2005, ENG CONSTR ARCHIT MA, V12, P125, DOI 10.1108/09699980510584485; Lonsdale C, 2007, POLICY POLIT, V35, P683, DOI 10.1332/030557307782453010; Mahalingam A, 2010, J CONSTR ENG M ASCE, V136, P419, DOI 10.1061/(ASCE)CO.1943-7862.0000130; McKee M, 2006, B WORLD HEALTH ORGAN, V84, P890; Miremadi M, 2019, LEADERSH HEALTH SERV, V32, P129, DOI 10.1108/LHS-10-2017-0063; MOH, 2020, RAD PIL PROJ; MOH, 2019, HEALTHC TRANSF STRAT; Moreno PG, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00003; Mouraviev N, 2015, INT J PUBLIC SECT MA, V28, P181, DOI 10.1108/IJPSM-09-2014-0116; Mufti M.H., 2000, HEALTHCARE DEV STRAT; NTP, 2016, VIS 2030 NAT TRANSF; Nunally JC, 1978, PSYCHOMETRIC THEORY; OECD, 2015, CONS CORR SECT LEV I, DOI [10.1787/9789264230781-en, DOI 10.1787/9789264230781-EN]; Osei-Kyei R., 2015, INT J PROJ MANAG, V33, P1335; Pollock AM, 1997, BRIT MED J, V314, P1266, DOI 10.1136/bmj.314.7089.1266; PPP Knowledge Lab, 2020, HEALTH; Reijneveld SA, 2012, EUR J PUBLIC HEALTH, V22, P165, DOI 10.1093/eurpub/ckr187; Roehrich JK, 2014, SOC SCI MED, V113, P110, DOI 10.1016/j.socscimed.2014.03.037; Sadeghi Ahmad, 2016, Electron Physician, V8, P2208, DOI 10.19082/2208; Society for Endocrinology MaDoSAS, 2017, J ENDOCRINOL METAB D, V21, pS1; Tsukada S, 2019, PUBLIC WORKS MANAG P, V24, P284, DOI 10.1177/1087724X18799762; Vaillancourt Rosenau P., 2000, PUBLIC PRIVATE POLIC; Valila T., 2005, EIB PAPERS, V10, P95; Vecchi V, 2017, PUBLIC MONEY MANAGE, V37, P133, DOI 10.1080/09540962.2016.1266173; Walston S, 2008, ANN SAUDI MED, V28, P243; Weththasinghe K., 2016, P 40 AUBEA 2016 RAD, P858; World Bank, 2017, MOB ISL FIN INFR PUB; World Bank, 2017, BENCHM PUBL PRIV PAR; World Health Organization, 2006, COUNTR COOP STRAT WH; Wright S, 2019, PUBLIC PRIVATE PARTN; Yescombe Edward R., 2011, PUBLIC PRIVATE PARTN; Yuan JF, 2009, CONSTR MANAG ECON, V27, P253, DOI 10.1080/01446190902748705; Zikmund W., 2010, BUSINESS RES METHODS, V8th	72	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0233802	10.1371/journal.pone.0233802	http://dx.doi.org/10.1371/journal.pone.0233802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555648	gold, Green Published			2022-12-27	WOS:000543273200053
J	Flack, KD; Hays, HM; Moreland, J				Flack, Kyle D.; Hays, Harry M.; Moreland, Jack			The consequences of exercise-induced weight loss on food reinforcement. A randomized controlled trial	PLOS ONE			English	Article							FAT-FREE MASS; RESTING METABOLIC-RATE; ENERGY-INTAKE; REINFORCING VALUE; POLYMORPHISMS MODERATE; PHYSICAL-ACTIVITY; BODY-COMPOSITION; PUBLIC-HEALTH; OLDER-ADULTS; DIETARY	Background Obesity remains a primary threat to the health of most Americans, with over 66% considered overweight or obese with a body mass index (BMI) of 25 kg/m(2)or greater. A common treatment option many believe to be effective, and therefore turn to, is exercise. However, the amount of weight loss from exercise training is often disappointingly less than expected with greater amounts of exercise not always promoting greater weight loss. Increases in energy intake have been prescribed as the primary reason for this lack of weight loss success with exercise. Research has mostly focused on alterations in hormonal mediators of appetite (e.g.: ghrelin, peptide YY, GLP-1, pancreatic polypeptide, and leptin) that may increase hunger and/or reduce satiety to promote greater energy intake with exercise training. A less understood mechanism that may be working to increase energy intake with exercise is reward-driven feeding, a strong predictor of energy intake and weight status but rarely analyzed in the context of exercise. Design Sedentary men and women (BMI: 25-35 kg/m(2), N = 52) were randomized into parallel aerobic exercise training groups partaking in either two or six exercise sessions/week, or sedentary control for 12 weeks. Methods The reinforcing value of food was measured by an operant responding progressive ratio schedule task (the behavioral choice task) to determine how much work participants were willing to perform for access to a healthy food option relative to a less healthy food option before and after the exercise intervention. Body composition and resting energy expenditure were assessed via DXA and indirect calorimetry, respectively, at baseline and post testing. Results Changes in fat-free mass predicted the change in total amount of operant responding for food (healthy and unhealthy). There were no correlations between changes in the reinforcing value of one type of food (healthy vs unhealthy) to changes in body composition. Conclusion In support of previous work, reductions in fat-free mass resulting from an aerobic exercise intervention aimed at weight loss plays an important role in energy balance regulation by increasing operant responding for food.	[Flack, Kyle D.; Hays, Harry M.; Moreland, Jack] Univ Kentucky, Dept Dietet & Human Nutr, Lexington, KY 40506 USA	University of Kentucky	Flack, KD (corresponding author), Univ Kentucky, Dept Dietet & Human Nutr, Lexington, KY 40506 USA.	Kyle.Flack@uky.edu		Flack, Kyle/0000-0001-7622-4770	NIH National Center for Advancing Translational Sciences [UL1TR001998]	NIH National Center for Advancing Translational Sciences	The project described was supported by the NIH National Center for Advancing Translational Sciences through grant number UL1TR001998. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the staff of the University of Kentucky's Center for Clinical and Translational Science (CCTS), who aided in recruitment and assessments throughout the study. The authors would also like to thank the participants for their time and effort in performing the intervention and willingness to be assessed, and the department of Dietetics and Human Nutrition for funding the present study.	Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Ancel Keys JB, 1950, BIOL HUMAN STARVATIO; Arias-Carrion Oscar, 2014, Int Arch Med, V7, P29, DOI 10.1186/1755-7682-7-29; Beavers KM, 2017, OBESITY, V25, P1823, DOI 10.1002/oby.21977; Bickel WK, 2000, PSYCHOPHARMACOLOGY, V153, P44, DOI 10.1007/s002130000589; Carr KA, 2013, BEHAV NEUROSCI, V127, P387, DOI 10.1037/a0032026; Casperson SL, 2017, APPETITE, V112, P143, DOI 10.1016/j.appet.2017.01.028; Caudwell P, 2013, AM J CLIN NUTR, V97, P7, DOI 10.3945/ajcn.111.029975; Davis C, 2002, COMPR PSYCHIAT, V43, P189, DOI 10.1053/comp.2002.32356; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Dulloo AG, 2006, INT J OBESITY, V30, pS23, DOI 10.1038/sj.ijo.0803516; Dulloo A, 2017, EUR J CLIN NUTR, V71, P353, DOI 10.1038/ejcn.2016.256; Dulloo AG, 1997, AM J CLIN NUTR, V65, P717, DOI 10.1093/ajcn/65.3.717; Epstein LH, 2007, BEHAV NEUROSCI, V121, P877, DOI 10.1037/0735-7044.121.5.877; Epstein LH, 2007, PSYCHOL BULL, V133, P884, DOI 10.1037/0033-2909.133.5.884; Epstein LH, 2015, APPETITE, V91, P226, DOI 10.1016/j.appet.2015.04.050; Epstein LH, 2011, AM J CLIN NUTR, V94, P12, DOI 10.3945/ajcn.110.010314; Epstein LH, 2004, PHYSIOL BEHAV, V81, P511, DOI 10.1016/j.physbeh.2004.02.015; Epstein LH, 2003, PHYSIOL BEHAV, V78, P221, DOI 10.1016/S0031-9384(02)00978-2; Flack K, 2019, BEHAV BRAIN RES, V375, DOI 10.1016/j.bbr.2019.112148; Flack KD, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00265; Flack KD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216355; Flack KD, 2019, J ACAD NUTR DIET, V119, P1099, DOI 10.1016/j.jand.2018.12.016; Hagobian TA, 2009, AM J PHYSIOL-REG I, V296, pR233, DOI 10.1152/ajpregu.90671.2008; Halliday TM, 2014, EAT BEHAV, V15, P379, DOI 10.1016/j.eatbeh.2014.04.004; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Heden TD, 2013, J APPL PHYSIOL, V115, P680, DOI 10.1152/japplphysiol.00515.2013; Hopkins M, 2016, INT J OBESITY, V40, P312, DOI 10.1038/ijo.2015.155; Hulton AT, 2010, INT J SPORTS MED, V31, P463, DOI 10.1055/s-0030-1251992; Huppertz C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/591717; King JA, 2013, APPETITE, V61, P45, DOI 10.1016/j.appet.2012.10.018; King NA, 1997, EUR J CLIN NUTR, V51, P478, DOI 10.1038/sj.ejcn.1600432; KING NA, 1994, EUR J CLIN NUTR, V48, P715; King NA, 2007, OBESITY, V15, P1373, DOI 10.1038/oby.2007.164; King NA, 2009, AM J CLIN NUTR, V90, P921, DOI 10.3945/ajcn.2009.27706; Lett BT, 1996, BEHAV NEUROSCI, V110, P1492, DOI 10.1037/0735-7044.110.6.1492; Lluch A, 1998, EUR J CLIN NUTR, V52, P300, DOI 10.1038/sj.ejcn.1600555; Martins C, 2010, J CLIN ENDOCR METAB, V95, P1609, DOI 10.1210/jc.2009-2082; Mason C, 2015, CLIN ENDOCRINOL, V82, P369, DOI 10.1111/cen.12483; McNeil J, 2015, APPETITE, V84, P264, DOI 10.1016/j.appet.2014.10.018; Miller WC, 1999, MED SCI SPORT EXER, V31, P1129, DOI 10.1097/00005768-199908000-00008; Mullaney L, 2015, J PUBLIC HEALTH-UK, V37, P728, DOI 10.1093/pubmed/fdu086; National Center for Health Statistics (US), 2017, 20171232 NAT CTR HLT; Ogden Cynthia L, 2013, NCHS Data Brief, P1; Panek LM, 2014, APPETITE, V81, P320, DOI 10.1016/j.appet.2014.06.102; Piaggi P, 2015, J CLIN ENDOCR METAB, V100, P3011, DOI 10.1210/jc.2015-2164; Robledo P, 2008, ADDICT BIOL, V13, P213, DOI 10.1111/j.1369-1600.2008.00107.x; Santos I, 2017, OBES REV, V18, P32, DOI 10.1111/obr.12466; Scheid JL, 2014, PHYSIOL BEHAV, V132, P51, DOI 10.1016/j.physbeh.2014.04.029; Schubert MM, 2013, APPETITE, V63, P92, DOI 10.1016/j.appet.2012.12.010; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Suzuki K, 2012, EXP DIABETES RES, DOI 10.1155/2012/824305; Temple JL, 2009, AM J CLIN NUTR, V90, P304, DOI 10.3945/ajcn.2008.27283; Thomas DM, 2012, OBES REV, V13, P835, DOI 10.1111/j.1467-789X.2012.01012.x; Thomas DM, 2015, PREV MED, V81, P357, DOI 10.1016/j.ypmed.2015.10.001; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Weise CM, 2015, HUM BRAIN MAPP, V36, P2406, DOI 10.1002/hbm.22780; Westcott WL, 2012, CURR SPORT MED REP, V11, P209, DOI 10.1249/JSR.0b013e31825dabb8; Westerterp KR, 2017, EUR J CLIN NUTR, V71, P340, DOI 10.1038/ejcn.2016.237; Williams EP, 2015, CURR OBES REP, V4, P363, DOI 10.1007/s13679-015-0169-4; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S	62	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234692	10.1371/journal.pone.0234692	http://dx.doi.org/10.1371/journal.pone.0234692			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555624	Green Published, gold			2022-12-27	WOS:000543273200058
J	Kim, H; Lim, YM; Lee, EJ; Oh, YJ; Kim, KK				Kim, Hyunjin; Lim, Young-Min; Lee, Eun-Jae; Oh, Yeo Jin; Kim, Kwang-Kuk			Clinical and imaging features of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and cysteine-sparing NOTCH3 mutations	PLOS ONE			English	Article							CADASIL MUTATIONS; RATING-SCALE; HYPERINTENSITIES; MRI; AGE	Background Characteristics of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and cysteine-sparing NOTCH3 mutations are relatively unknown. This study compared clinical and imaging characteristics between patients with CADASIL and cysteine-sparing NOTCH3 mutations and those with CADASIL and cysteine-involving NOTCH3 mutations. Methods We retrospectively reviewed medical records of patients with CADASIL admitted to the Asan Medical Center between September 1999 and September 2017. We compared clinical and brain magnetic resonance imaging (MRI) characteristics based on the presence or absence of cysteine-involving NOTCH3 gene mutations. We compared white matter change frequencies and grades in specific spatial regions between the groups according to age-related white matter change (ARWMC) scores. We evaluated the presence, number, and anatomical distributions of cerebral microbleeds according to the microbleed anatomical rating scale. Results We reviewed data from 79 patients (55 cysteine-involving, 24 cysteine-sparing NOTCH3 mutations). Clinical symptoms and signs did not differ significantly between the groups. The white matter change frequency and ARWMC scores (adjusted for age and stroke risk factors) in the anterior temporal lobes were lower in cysteine-sparing patients than in cysteine-involving patients. Frequencies and grades of the other brain region's white matter changes and cerebral microbleeds were similar between the groups. Conclusions Patients with CADASIL and cysteine-sparing NOTCH3 mutations showed less involvement of the anterior temporal lobes in brain MRI than those with CADASIL and cysteine-involving NOTCH3 mutations, although both groups showed similar clinical characteristics.	[Kim, Hyunjin; Lim, Young-Min; Lee, Eun-Jae; Oh, Yeo Jin; Kim, Kwang-Kuk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea	University of Ulsan; Asan Medical Center	Kim, KK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea.	kkkim@amc.seoul.kr		Kim, Hyunjin/0000-0003-0264-4531	Ministry of Science and ICT, South Korea [NRF-2018R1C1B6008884, NRF-2018M3A9E8066249]; Ministry of Health & Welfare, South Korea [HI18C2383]	Ministry of Science and ICT, South Korea; Ministry of Health & Welfare, South Korea	This study was supported by grants from the Ministry of Science and ICT, South Korea (NRF-2018R1C1B6008884, NRF-2018M3A9E8066249) and Ministry of Health & Welfare, South Korea (HI18C2383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Choi JE, 2006, J KOREAN SOC MED, V12, P1; Duering M, 2011, HUM MOL GENET, V20, P3256, DOI 10.1093/hmg/ddr237; Ge W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104533; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kim Y, 2006, NEUROLOGY, V66, P1511, DOI 10.1212/01.wnl.0000216259.99811.50; Lee YC, 2009, J NEUROL, V256, P249, DOI 10.1007/s00415-009-0091-3; Markus HS, 2002, NEUROLOGY, V59, P1134, DOI 10.1212/WNL.59.8.1134; Mazzei R, 2004, NEUROLOGY, V63, P561, DOI 10.1212/01.WNL.0000133399.37716.84; Muino E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091964; O'Sullivan M, 2001, NEUROLOGY, V56, P628, DOI 10.1212/WNL.56.5.628; Opherk C, 2009, HUM MOL GENET, V18, P2761, DOI 10.1093/hmg/ddp211; Rutten JW, 2014, EXPERT REV MOL DIAGN, V14, P593, DOI 10.1586/14737159.2014.922880; Scheid R, 2008, NEUROLOGY, V71, P774, DOI 10.1212/01.wnl.0000324928.44694.f7; Singhal S, 2005, AM J NEURORADIOL, V26, P2481; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; Ueda A, 2015, J NEUROL, V262, P1828, DOI 10.1007/s00415-015-7782-8; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wang ZX, 2011, J NEUROL NEUROSUR PS, V82, P534, DOI 10.1136/jnnp.2010.209247; Wollenweber FA, 2015, STROKE, V46, P786, DOI 10.1161/STROKEAHA.114.007472; Yamamoto Y, 2009, STROKE, V40, P2004, DOI 10.1161/STROKEAHA.108.528299	26	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234797	10.1371/journal.pone.0234797	http://dx.doi.org/10.1371/journal.pone.0234797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555735	Green Published, gold			2022-12-27	WOS:000543273200007
J	Zhang, LW; Kang, K; Jiang, SC; Zhang, YN; Wang, TT; Zhang, J; Sun, L; Yang, YQ; Huang, CC; Jiang, LY; Ding, DG				Zhang, Long-Wa; Kang, Ke; Jiang, Shi-Chang; Zhang, Ya-Nan; Wang, Tian-Tian; Zhang, Jing; Sun, Long; Yang, Yun-Qiu; Huang, Chang-Chun; Jiang, Li-Ya; Ding, De-Gui			Analysis of the Antennal Transcriptome and Insights into Olfactory Genes in Hyphantria cunea (Drury) (vol 11, e0164729, 2016)	PLOS ONE			English	Correction																		Zhang LW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164729	1	0	1	9	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0235200	10.1371/journal.pone.0235200	http://dx.doi.org/10.1371/journal.pone.0235200			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555726	Green Published, gold			2022-12-27	WOS:000543273200019
J	Li, GF; Wang, X; Ren, J				Li Guangfu; Wang Xu; Ren Jia			Multi-packet transmission aero-engine DCS neural network sliding mode control based on multi-kernel LS-SVM packet dropout online compensation	PLOS ONE			English	Article							SENSOR FAULT ESTIMATION; CONTROL-SYSTEMS; TOLERANT CONTROL; STABILITY; DESIGN	In view of the strong nonlinear characteristics of the multi-packet transmission Aero-engine DCS with induced delay and random packet dropout, a neural network PID approach law sliding-mode controller using sliding window strategy and multi-kernel LS-SVM packet dropout online compensation is proposed. Firstly, the time-delay term in the system model is transformed equivalently, to establish the discrete system model of multi-packet transmission without time-delay; furthermore, the construction of multi-kernel function is transformed into kernel function coefficient optimization, and the optimization problem can be solved by the chaos adaptive artificial fish swarm algorithm, then the online predictive compensation will be made for data packet dropout of multi-packet transmission through the sliding window multi-kernel LS-SVM. After that, a sliding-mode controller design method of proportional integral differential approach law based on neural network is proposed. And online adjustment of PID approach law parameters can be achieved by nonlinear mapping of neural network. Finally, Truetime is used to simulate the method. The results shows that when the packet dropout rate is 30% and 60%, the average error of packet dropout prediction of multi-kernel LS-SVM reduces 29.21% and 44.66% compared with that of combined kernel LS-SVM, and the chattering amplitude of the proposed neural network PID approach law sliding-mode controller is decreased compared with other five approach law methods respectively. This controller can ensure a fast response speed, which shows that this method can achieve a better tracking control of the aeroengine network control system.	[Li Guangfu; Wang Xu; Ren Jia] City Univ Macau, Data Sci Inst, Macau, Peoples R China; [Li Guangfu] Shandong Univ Art & Design, Dept Network Informat, Jinan, Shandong, Peoples R China; [Wang Xu] Lingnan Normal Univ, Coll Business, Zhanjiang, Guangdong, Peoples R China; [Ren Jia] Hainan Univ, Coll Informat & Technol, Haikou, Hainan, Peoples R China	City University of Macau; Shandong University of Art & Design; LingNan Normal University; Hainan University	Li, GF (corresponding author), City Univ Macau, Data Sci Inst, Macau, Peoples R China.; Li, GF (corresponding author), Shandong Univ Art & Design, Dept Network Informat, Jinan, Shandong, Peoples R China.	ligf@sdada.edu.cn			International Science and Technology Cooperation Projects of China [2015DFR10510]; National Natural Science Foundation of China and Macau Science and Technology Development Joint Fund (NSFC-FDCT) [6191101101]; National Natural Science Foundation of China [61562018]; Key Science and Technology Projects of Haikou, Hainan Province [2017041]; Hainan Provincial Natural Science Foundation of China [519QN180]; Hainan Provincial Key RD Plan [ZDYF2019014]; National Natural Science Foundation of China and Macau Science and Technology Development Joint Fund [0066/2019/AFJ]; Scientific Research Foundation of Hainan University [KYQD(ZR)1859]	International Science and Technology Cooperation Projects of China; National Natural Science Foundation of China and Macau Science and Technology Development Joint Fund (NSFC-FDCT); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Projects of Haikou, Hainan Province; Hainan Provincial Natural Science Foundation of China; Hainan Provincial Key RD Plan; National Natural Science Foundation of China and Macau Science and Technology Development Joint Fund; Scientific Research Foundation of Hainan University	International Science and Technology Cooperation Projects of China (2015DFR10510), National Natural Science Foundation of China and Macau Science and Technology Development Joint Fund (NSFC-FDCT)(6191101101), National Natural Science Foundation of China (61562018), Key Science and Technology Projects of Haikou, Hainan Province (2017041),Hainan Provincial Natural Science Foundation of China (519QN180), Hainan Provincial Key R&D Plan (ZDYF2019014), National Natural Science Foundation of China and Macau Science and Technology Development Joint Fund (0066/2019/AFJ), the program of and the Scientific Research Foundation of Hainan University (KYQD(ZR)1859) are gratefully acknowledged.	Abdelaziz A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174715; Belaroussi R, 2009, P WORKSH APPL COMP V, P1; Ben Gaid ME, 2006, IEEE T CONTR SYST T, V14, P776, DOI 10.1109/TCST.2006.872504; Chen L, 2017, J NAT GAS SCI ENG, V46, P1, DOI 10.1016/j.jngse.2017.07.009; Chen QC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222365; Cordeschi N, 2015, J SUPERCOMPUT, V71, P448, DOI 10.1007/s11227-014-1305-8; Dong HL, 2012, IEEE T SYST MAN CY B, V42, P365, DOI 10.1109/TSMCB.2011.2163797; Ferreira J, PLOS ONE, V12, pe0174959, DOI 10.1371/journal.pone.0174959; Gao ZW, 2015, IEEE T IND ELECTRON, V62, P3874, DOI 10.1109/TIE.2015.2392720; Huang CZ, 2010, IEEE T IND INFORM, V6, P62, DOI 10.1109/TII.2009.2033589; Jimenez Y, 2014, 2014 IFIP NETWORKING CONFERENCE; Junyan Yu, 2011, International Journal of Systems, Control and Communications, V3, P158, DOI 10.1504/IJSCC.2011.039866; Kang MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155781; Kazempour F, 2013, J PROCESS CONTR, V23, P444, DOI 10.1016/j.jprocont.2012.12.010; Khalgui M, 2010, INFORM SOFTWARE TECH, V52, P1259, DOI 10.1016/j.infsof.2010.06.001; Li D, 2017, 2017 INTERNATIONAL CONFERENCE ON SMART GRID AND ELECTRICAL AUTOMATION (ICSGEA), P24, DOI 10.1109/ICSGEA.2017.14; Li TH, 2018, P IMECHE I, P1, DOI 10.1177/0959651818777678; Liu M, 2013, AUTOMATICA, V49, P1242, DOI 10.1016/j.automatica.2013.01.030; Liu X, 2016, DIABETOL STOFFWECHS, V11, pe0163545, DOI 10.1371/journal.pone.0163545; Luo C, 2019, NEURAL PROCESSING LE; Merrill W, 2010, P 46 AIAA ASME SAE A; Rani RHJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196871; Song YD, 2016, INFORM SCIENCES, V367, P194, DOI 10.1016/j.ins.2016.06.008; Venkat AN, 2008, IEEE T CONTR SYST T, V16, P1192, DOI 10.1109/TCST.2008.919414; Wang JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187152; Wang JF, 2012, APPL MATH COMPUT, V218, P8887, DOI 10.1016/j.amc.2012.02.047; Wang ZH, 2015, INT J ADAPT CONTROL, V29, P242, DOI 10.1002/acs.2469; Wang ZD, 2007, IEEE T SYST MAN CY B, V37, P916, DOI 10.1109/TSMCB.2007.896412; Xiang WM, 2014, NONLINEAR ANAL-HYBRI, V12, P132, DOI 10.1016/j.nahs.2013.11.004; Xiong YY, 2019, SYST CONTROL LETT, V133, DOI 10.1016/j.sysconle.2019.104557; Yang JQ, 2015, INT J CONTROL AUTOM, V13, P1037, DOI 10.1007/s12555-014-0159-4; Yang YF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171246; Yazici V., 2014, ARXIV14017651; Yedavalli RK, 2009, J GUID CONTROL DYNAM, V32, P1544, DOI 10.2514/1.40900; Yu M, 2015, ASIAN J CONTROL, V17, P1415, DOI 10.1002/asjc.1032; Zhai XS, 2013, J AEROSPACE POWER, P1429; Zhang LD, 2020, ASIAN J CONTROL, V22, P788, DOI 10.1002/asjc.1928; Zhang R, IEEE TRANSACTIONS ON, P20191, DOI 10.1109/tii.2019.2896032; Zhang Y, 2011, APPL MATH MODEL, V35, P2253, DOI 10.1016/j.apm.2010.11.038; Zheng BC, 2018, AUTOMATICA, V91, P126, DOI 10.1016/j.automatica.2018.01.007; Zhu XY, 2015, MECH SYST SIGNAL PR, V58-59, P15, DOI 10.1016/j.ymssp.2014.11.011; Zhu YZ, 2020, IEEE T AUTOMAT CONTR, V65, P3714, DOI 10.1109/TAC.2019.2953210; ZHU YZ, 2018, IEEE T SYST MAN CY-S, V48, P2035, DOI DOI 10.1109/TSMC.2017.2723038	43	1	1	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234356	10.1371/journal.pone.0234356	http://dx.doi.org/10.1371/journal.pone.0234356			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555656	Green Published, gold			2022-12-27	WOS:000542759600013
J	Baskaran, L; Ying, XH; Xu, ZR; Al'Aref, SJ; Lee, BNC; Lee, SE; Danad, I; Park, HB; Bathina, R; Baggiano, A; Beltrama, V; Cerci, R; Choi, EY; Choi, JH; Choi, SY; Cole, J; Doh, JH; Ha, SJ; Her, AY; Kepka, C; Kim, JY; Kim, JW; Kim, SW; Kim, W; Lu, Y; Kumar, A; Heo, R; Lee, JH; Sung, JM; Valeti, U; Andreini, D; Pontone, G; Han, D; Villines, TC; Lin, F; Chang, HJ; Min, JMK; Shaw, LJ				Baskaran, Lohendran; Ying, Xiaohan; Xu, Zhuoran; Al'Aref, Subhi J.; Lee, Benjamin C.; Lee, Sang-Eun; Danad, Ibrahim; Park, Hyung-Bok; Bathina, Ravi; Baggiano, Andrea; Beltrama, Virginia; Cerci, Rodrigo; Choi, Eui-Young; Choi, Jung-Hyun; Choi, So-Yeon; Cole, Jason; Doh, Joon-Hyung; Ha, Sang-Jin; Her, Ae-Young; Kepka, Cezary; Kim, Jang-Young; Kim, Jin-Won; Kim, Sang-Wook; Kim, Woong; Lu, Yao; Kumar, Amit; Heo, Ran; Lee, Ji Hyun; Sung, Ji-min; Valeti, Uma; Andreini, Daniele; Pontone, Gianluca; Han, Donghee; Villines, Todd C.; Lin, Fay; Chang, Hyuk-Jae; Min, James K.; Shaw, Leslee J.			Machine learning insight into the role of imaging and clinical variables for the prediction of obstructive coronary artery disease and revascularization: An exploratory analysis of the CONSERVE study	PLOS ONE			English	Article							COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CARDIOVASCULAR NURSES ASSOCIATION; APPROPRIATE USE CRITERIA; ISCHEMIC-HEART-DISEASE; BODY-MASS INDEX; AMERICAN ASSOCIATION; THORACIC-SURGERY; TASK-FORCE; DIAGNOSTIC-ACCURACY; PRACTICE GUIDELINES	Background Machine learning (ML) is able to extract patterns and develop algorithms to construct data-driven models. We use ML models to gain insight into the relative importance of variables to predict obstructive coronary artery disease (CAD) using the Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization (CONSERVE) study, as well as to compare prediction of obstructive CAD to the CAD consortium clinical score (CAD2). We further perform ML analysis to gain insight into the role of imaging and clinical variables for revascularization. Methods For prediction of obstructive CAD, the entire ICA arm of the study, comprising 719 patients was used. For revascularization, 1,028 patients were randomized to invasive coronary angiography (ICA) or coronary computed tomographic angiography (CCTA). Data was randomly split into 80% training 20% test sets for building and validation. Models used extreme gradient boosting (XGBoost). Results Mean age was 60.6 +/- 11.5 years and 64.3% were female. For the prediction of obstructive CAD, the AUC was significantly higher for ML at 0.779 (95% CI: 0.672-0.886) than for CAD2 (0.696 [95% CI: 0.594-0.798]) (P = 0.01). BMI, age, and angina severity were the most important variables. For revascularization, the model obtained an overall area under the receiver-operation curve (AUC) of 0.958 (95% CI = 0.933-0.983). Performance did not differ whether the imaging parameters used were from ICA (AUC 0.947, 95% CI = 0.903-0.990) or CCTA (AUC 0.941, 95% CI = 0.895-0.988) (P = 0.90). The ML model obtained sensitivity and specificity of 89.2% and 92.9%, respectively. Number of vessels with >= 70% stenosis, maximum segment stenosis severity (SSS) and body mass index (BMI) were the most important variables. Exclusion of imaging variables resulted in performance deterioration, with an AUC of 0.705 (95% CI 0.614-0.795) (P <0.0001). Conclusions For obstructive CAD, the ML model outperformed CAD2. BMI is an important variable, although currently not included in most scores. In this ML model, imaging variables were most associated with revascularization. Imaging modality did not influence model performance. Removal of imaging variables reduced model performance.	[Baskaran, Lohendran; Xu, Zhuoran; Al'Aref, Subhi J.; Lee, Benjamin C.; Lin, Fay; Min, James K.; Shaw, Leslee J.] New York Presbyterian Hosp, Dept Radiol, New York, NY 10065 USA; [Baskaran, Lohendran; Xu, Zhuoran; Al'Aref, Subhi J.; Lee, Benjamin C.; Lin, Fay; Min, James K.; Shaw, Leslee J.] Weill Cornell Med, New York, NY 10065 USA; [Baskaran, Lohendran; Ying, Xiaohan; Xu, Zhuoran; Al'Aref, Subhi J.; Lee, Benjamin C.; Lu, Yao; Kumar, Amit; Lee, Ji Hyun; Lin, Fay; Min, James K.; Shaw, Leslee J.] Weill Cornell Med, Dalio Inst Cardiovasc Imaging, New York, NY 10065 USA; [Baskaran, Lohendran] Natl Heart Ctr, Dept Cardiovasc Med, Singapore, Singapore; [Lee, Sang-Eun; Chang, Hyuk-Jae] Yonsei Univ, Severance Cardiovasc Hosp, Integrat Cardiovasc Imaging Ctr, Div Cardiol,Coll Med, Seoul, South Korea; [Danad, Ibrahim] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Park, Hyung-Bok] Seonam Univ, Myongji Hosp, Coll Med, Gyeonggi Do, South Korea; [Bathina, Ravi] CARE Hosp, Hyderabad, India; [Bathina, Ravi] FACTS Fdn, Hyderabad, India; [Baggiano, Andrea; Beltrama, Virginia; Andreini, Daniele; Pontone, Gianluca] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Cerci, Rodrigo] Quanta Diagnost Nucl, Curitiba, Parana, Brazil; [Choi, Eui-Young] Gangnam Severance Hosp, Seoul, South Korea; [Choi, Jung-Hyun] Pusan Natl Univ, Busan, South Korea; [Choi, So-Yeon] Ajou Univ Hosp, Gyeonggi Do, South Korea; [Cole, Jason] Cardiol Associates Mobile, Mobile, AL USA; [Doh, Joon-Hyung] Inje Univ, Ilsan Paik Hosp, Gyeonggi Do, South Korea; [Ha, Sang-Jin] Gangneung Asan Hosp, Gangwon Do, South Korea; [Her, Ae-Young] Kangwon Natl Univ Hosp, Gangwon Do, South Korea; [Kepka, Cezary] Inst Cardiol, Warsaw, Poland; [Kim, Jang-Young] Wonju Severance Hosp, Gangwon Do, South Korea; [Kim, Jin-Won] Korea Univ, Guro Hosp, Seoul, South Korea; [Kim, Sang-Wook] Chung Ang Univ Hosp, Seoul, South Korea; [Kim, Woong] Yeungnam Univ Hosp, Daegu, South Korea; [Heo, Ran] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea; [Lee, Ji Hyun; Sung, Ji-min] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Seoul, South Korea; [Valeti, Uma] Stanford Med, Dept Med, Stanford, CA USA; [Han, Donghee] Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Dept Imaging, Los Angeles, CA 90048 USA; [Villines, Todd C.] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA USA; [Min, James K.] Cleerly Inc, New York, NY USA	NewYork-Presbyterian Hospital; Cornell University; Cornell University; National Heart Centre Singapore; Yonsei University; Yonsei University Health System; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Myongji Hospital; Seonam University; IRCCS Centro Cardiologico Monzino; Yonsei University; Yonsei University Health System; Pusan National University; Ajou University; Ajou University Hospital; Inje University; Kangwon National University; Kangwon National University Hospital; Institute of Cardiology - Poland; Korea University; Korea University Medicine (KU Medicine); Chung Ang University; Chung Ang University Hospital; Yeungnam University; Yeungnam University Hospital; University of Ulsan; Yonsei University; Yonsei University Health System; Cedars Sinai Medical Center; University of Virginia	Baskaran, L (corresponding author), New York Presbyterian Hosp, Dept Radiol, New York, NY 10065 USA.; Baskaran, L (corresponding author), Weill Cornell Med, New York, NY 10065 USA.; Baskaran, L (corresponding author), Weill Cornell Med, Dalio Inst Cardiovasc Imaging, New York, NY 10065 USA.; Baskaran, L (corresponding author), Natl Heart Ctr, Dept Cardiovasc Med, Singapore, Singapore.	lob2008@med.cornell.edu	Baskaran, Lohendran/AAE-8338-2019; Lee, Sang-Eun/AAS-3253-2021; Heo, Ran/AAJ-8471-2021; Danad, Ibrahim/GLT-1585-2022; Andreini, Daniele/ABG-9647-2020; Lin, Fay/AAJ-9453-2021; Villines, Todd/AAJ-3744-2021	Baskaran, Lohendran/0000-0003-0565-7151; Heo, Ran/0000-0002-2675-3612; Chang, Hyuk-Jae/0000-0002-6139-7545; Choi, Eui-Young/0000-0003-3732-0190; Ha, Sang Jin/0000-0003-4275-6538; Ying, Xiaohan/0000-0001-5586-4314	Dalio Institute of Cardiovascular Imaging (New York, NY, USA); Dalio Foundation; National Institutes of Health; GE Healthcare	Dalio Institute of Cardiovascular Imaging (New York, NY, USA); Dalio Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GE Healthcare(General ElectricGE Healthcare)	This study was funded by the Dalio Institute of Cardiovascular Imaging (New York, NY, USA). James K. Min received funding from the Dalio Foundation, National Institutes of Health, and GE Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al'Aref SJ, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011160; Alizadehsani R, 2018, COMPUT METH PROG BIO, V162, P119, DOI 10.1016/j.cmpb.2018.05.009; Alizadehsani R, 2013, COMPUT METH PROG BIO, V111, P52, DOI 10.1016/j.cmpb.2013.03.004; Baskaran L, 2016, J AM COLL CARDIOL, V67, P1571, DOI 10.1016/S0735-1097(16)31572-8; Bittencourt MS, 2016, CIRCULATION, V134, P201, DOI 10.1161/CIRCULATIONAHA.116.023396; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Budoff MJ, 2017, ACAD RADIOL, V24, P22, DOI 10.1016/j.acra.2016.09.008; Chang HJ, 2019, JACC-CARDIOVASC IMAG, V12, P1303, DOI 10.1016/j.jcmg.2018.09.018; Chen T., 2016, KDD16 P 22 ACM, DOI DOI 10.1145/2939672.2939785; Choi S, 2018, JAMA INTERN MED, V178, P1060, DOI 10.1001/jamainternmed.2018.2310; Dewey M, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5441; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Douglas PS, 2011, J AM COLL CARDIOL, V58, P801, DOI 10.1016/j.jacc.2011.05.019; Ferencik M, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.117.006592; Fihn SD, 2014, CIRCULATION, V130, P1749, DOI 10.1161/CIR.0000000000000095; Fihn SD, 2012, CIRCULATION, V126, pE354, DOI 10.1161/CIR.0b013e318277d6a0; Genders TSS, 2018, JACC-CARDIOVASC IMAG, V11, P437, DOI 10.1016/j.jcmg.2017.02.020; Genders TSS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3485; Hastie T., 2009, UNSUPERVISED LEARNIN; HU LH, 2018, J NUCL MED S1, V59; King KM, 2009, AM J MED, V122, P273, DOI 10.1016/j.amjmed.2008.09.036; Lee SE, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.117.007562; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Mohareb MM, 2015, ANN INTERN MED, V162, P549, DOI 10.7326/M14-1889; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Motwani M, 2017, EUR HEART J, V38, P500, DOI 10.1093/eurheartj/ehw188; Nasarian E, 2020, PATTERN RECOGN LETT, V133, P33, DOI 10.1016/j.patrec.2020.02.010; Newby D, 2015, LANCET, V385, P2383, DOI 10.1016/S0140-6736(15)60291-4; Patel MR, 2014, AM HEART J, V167, P846, DOI 10.1016/j.ahj.2014.03.001; Patel MR, 2012, J AM COLL CARDIOL, V59, P1995, DOI [10.1016/j.jacc.2012.03.003, 10.1002/ccd.24467]; Reeh J, 2019, EUR HEART J, V40, P1426, DOI 10.1093/eurheartj/ehy806; Rudzinski PN, 2018, J CARDIOVASC COMPUT, V12, P472, DOI 10.1016/j.jcct.2018.08.004; Shaw LJ, 2012, J AM COLL CARDIOL, V60, P2103, DOI 10.1016/j.jacc.2012.05.062; Skinner JS, 2010, HEART, V96, P974, DOI 10.1136/hrt.2009.190066; Terada T, 2017, CAN J CARDIOL, V33, P822, DOI 10.1016/j.cjca.2016.12.016; Williams MC, 2016, J AM COLL CARDIOL, V67, P1759, DOI 10.1016/j.jacc.2016.02.026	38	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0233791	10.1371/journal.pone.0233791	http://dx.doi.org/10.1371/journal.pone.0233791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584909	Green Published, gold			2022-12-27	WOS:000545747200078
J	Egbe, E; Levy, CW; Tabernero, L				Egbe, Eyong; Levy, Colin W.; Tabernero, Lydia			Computational and structure-guided design of phosphoinositide substrate specificity into the tyrosine specific LMW-PTP enzyme	PLOS ONE			English	Article							WEIGHT PHOSPHOTYROSYL PHOSPHATASE; CRYSTAL-STRUCTURE; TUMOR-SUPPRESSOR; PROTEIN; PTEN; MUTATIONS; CRYSTALLOGRAPHY; ALIGNMENT; FAMILY; DOMAIN	We have used a combination of computational and structure-based redesign of the low molecular weight protein tyrosine phosphatase, LMW-PTP, to create new activity towards phosphoinositide substrates for which the wild-type enzyme had little or no activity. The redesigned enzymes retain catalytic activity despite residue alterations in the active site, and kinetic experiments confirmed specificity for up to four phosphoinositide substrates. Changes in the shape and overall volume of the active site where critical to facilitate access of the new substrates for catalysis. The kinetics data suggest that both the position and the combination of amino acid mutations are important for specificity towards the phosphoinositide substrates. The introduction of basic residues proved essential to establish new interactions with the multiple phosphate groups in the inositol head, thus promoting catalytically productive complexes. The crystallographic structures of the top-ranking designs confirmed the computational predictions and showed that residue substitutions do not alter the overall folding of the phosphatase or the conformation of the active site P-loop. The engineered LMW-PTP mutants with new activities can be useful reagents in investigating cell signalling pathways and offer the potential for therapeutic applications.	[Egbe, Eyong; Levy, Colin W.; Tabernero, Lydia] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester	Tabernero, L (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Acad Hlth Sci Ctr, Manchester, Lancs, England.	Lydia.Tabernero@manchester.ac.uk	Tabernero, Lydia/F-3795-2018	Tabernero, Lydia/0000-0001-8867-455X; Levy, Colin/0000-0002-9724-310X	Medical Research Council [MR/K011049/1]; Commonwealth Scholarship Commission; University of Manchester	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Commonwealth Scholarship Commission; University of Manchester	This study was funded in part by Medical Research Council (MR/K011049/1). EE is a recipient of a studentship from The Commonwealth Scholarship Commission and a Presidents scholarship from the University of Manchester.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alonso A, 2016, FEBS J, V283, P1404, DOI 10.1111/febs.13600; Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; Beresford N, 2007, BIOCHEM J, V406, P13, DOI 10.1042/BJ20070670; Beresford NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-457; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Campeau PM, 2013, AM J HUM GENET, V92, P781, DOI 10.1016/j.ajhg.2013.03.020; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; D'Avanzo N, 2013, J BIOL CHEM, V288, P16726, DOI 10.1074/jbc.M113.452540; Damborsky J, 2014, CURR OPIN CHEM BIOL, V19, P8, DOI 10.1016/j.cbpa.2013.12.003; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; Dyment DA, 2015, NEUROBIOL AGING, V36, p1222 e1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez-Soto P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46731-6; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Nguyen HN, 2014, P NATL ACAD SCI USA, V111, pE2684, DOI 10.1073/pnas.1409433111; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Hussein HA, 2015, NUCLEIC ACIDS RES, V43, pW436, DOI 10.1093/nar/gkv462; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Krebs CE, 2013, HUM MUTAT, V34, P1200, DOI 10.1002/humu.22372; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lavictoire SJ, 2018, MOL THER-METH CLIN D, V9, P12, DOI 10.1016/j.omtm.2017.11.006; Lawlor MW, 2013, HUM MOL GENET, V22, P1525, DOI 10.1093/hmg/ddt003; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Liu Y, 2010, PROG LIPID RES, V49, P201, DOI 10.1016/j.plipres.2009.12.001; Mak WS, 2014, CURR OPIN STRUC BIOL, V27, P87, DOI 10.1016/j.sbi.2014.05.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCrea HJ, 2009, PHYSIOLOGY, V24, P8, DOI 10.1152/physiol.00035.2008; Nivon LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059004; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tabernero L, 2008, FEBS J, V275, P867, DOI 10.1111/j.1742-4658.2008.06251.x; Umeda IO, 2001, EXP EYE RES, V73, P123, DOI 10.1006/exer.2001.1018; Vainio MJ, 2007, J CHEM INF MODEL, V47, P2462, DOI 10.1021/ci6005646; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; WO YYP, 1992, J BIOL CHEM, V267, P10856; Yoo KY, 2015, ACTA CRYSTALLOGR D, V71, P1528, DOI 10.1107/S139900471500927X; Zabell APR, 2006, J BIOL CHEM, V281, P6520, DOI 10.1074/jbc.M506285200; Zhang M, 1997, BIOCHEMISTRY-US, V36, P15, DOI 10.1021/bi961804n; ZHANG ZY, 1994, ADV ENZYMOL RAMB, V68, P1	50	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235133	10.1371/journal.pone.0235133	http://dx.doi.org/10.1371/journal.pone.0235133			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584877	Green Published, gold			2022-12-27	WOS:000545747200019
J	Quyen, PN; Nga, HT; Chaffee, B; Ngu, T; King, JC				Quyen, Phi N.; Nga, Hoang T.; Chaffee, Benjamin; Ngu, Tu; King, Janet C.			Effect of maternal prenatal food supplementation, gestational weight gain, and breast-feeding on infant growth during the first 24 months of life in rural Vietnam	PLOS ONE			English	Article							ENERGY SUPPLEMENTATION; NUTRITION; PREGNANCY; WOMEN; AGE	Growth faltering among children during the first five years of life is a common problem among low and middle-income countries. The purpose of this study was to determine the effect of a nutrient-rich, food-based supplement given to Vietnamese rural women prior to and/or during pregnancy on the growth of their infants during first 24 months of life and to identify maternal and newborn factors associated with the infant's growth. This prospective cohort study included 236 infants born to mothers who had received nutritional advice or a food supplement from pre-conception to term or from mid-gestation to term as part of a prior randomized controlled trial. Infant anthropometry and feeding information were monitored monthly and the infant weight for age Z-score (WAZ), length for age Z-score (LAZ), and weight for length Z-score (WLZ) were assessed at 6, 12, 18, and 24 months of age using mixed-effects regression modeling. Compared to the non-supplemented mothers, infants born to mothers receiving food supplementation from mid-gestation to term had significantly higher WLZ only at 18 months (p = 0.03) and did not differ in other outcomes. Supplementation from pre-conception to term did not affect infant growth at any time point during the first 24 months. In the entire study cohort, maternal height and gestational weight gain were positively associated with the infant's WAZ and LAZ from 6 to 24 months of age. Programs designed to improve gestational weight gain among women performing demanding physical work throughout a reproductive cycle may improve postnatal infant growth.	[Quyen, Phi N.; Nga, Hoang T.; Ngu, Tu] Natl Inst Nutr, Hanoi, Vietnam; [Chaffee, Benjamin] Univ Calif San Francisco, San Francisco, CA 94143 USA; [King, Janet C.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	University of California System; University of California San Francisco; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	King, JC (corresponding author), Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.	jking@chori.org		King, Janet/0000-0002-8484-7940	Nestle Research Foundation; Thrasher Research Fund	Nestle Research Foundation(Nestle SA); Thrasher Research Fund	Nestle Research Foundation and Thrasher Research Fund. TAwards for the research were received by JCK and TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashorn P, 2015, J NUTR, V145, P1345, DOI 10.3945/jn.114.207225; Nguyen BKL, 2013, BRIT J NUTR, V110, pS45, DOI 10.1017/S0007114513002080; Deierlein AL, 2012, PEDIATR OBES, V7, P134, DOI 10.1111/j.2047-6310.2011.00025.x; Devakumar D, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0633-3; Dewey KG, 2016, MATERN CHILD NUTR, V12, P27, DOI 10.1111/mcn.12282; Gibson R, 2005, PRINCIPLES NUTR ASSE; Haider BA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905; Hall AG, 2017, J NUTR, V147, P1200, DOI 10.3945/jn.116.241968; Hambidge K, 2019, AM J CIN NUTR; Hanieh S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-339; Heerman WJ, 2014, ACAD PEDIATR, V14, P463, DOI 10.1016/j.acap.2014.05.005; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P178, DOI 10.1111/j.1365-3016.2012.01308.x; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Khan AI, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-134; KUSIN JA, 1992, LANCET, V340, P623, DOI 10.1016/0140-6736(92)92168-F; Lanou H, 2014, PEDIATRICS, V133, pE1001, DOI 10.1542/peds.2013-2850; LECHTIG A, 1975, AM J CLIN NUTR, V28, P1223, DOI 10.1093/ajcn/28.11.1223; Li C, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0432-8; Nga HT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232197; Roberfroid D, 2012, AM J CLIN NUTR, V95, P916, DOI 10.3945/ajcn.111.029033; Stevens B, 2015, MATERN CHILD NUTR, V11, P415, DOI 10.1111/mcn.12183; Vietnam WB, 2012, WELL DONE NOT YET DO; Villar J, 2016, LANCET, V387, P844, DOI 10.1016/S0140-6736(16)00384-6; Wahlqvist M., 2015, WORLD NUTR, V6, P613; WHO, 2011, WHO ANTHR MACR VERS; Wieringa FT, 2010, EUR J CLIN NUTR, V64, P1072, DOI 10.1038/ejcn.2010.115; World Health Organization, 2006, WHO CHILD GROWTH STA; Young MF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203201; Young MF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170192	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0233671	10.1371/journal.pone.0233671	http://dx.doi.org/10.1371/journal.pone.0233671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584881	gold, Green Published			2022-12-27	WOS:000545747200081
J	Zhan, JW; Wang, SQ; Feng, MS; Wei, X; Yu, J; Yin, XL; Han, T; Zhu, LG				Zhan, Jia-Wen; Wang, Shang-Quan; Feng, Min-Shan; Wei, Xu; Yu, Jie; Yin, Xun-Lu; Han, Tao; Zhu, Li-Guo			Constant compression decreases vascular bud and VEGFA expression in a rabbit vertebral endplate ex vivo culture model	PLOS ONE			English	Article							DEGENERATED INTERVERTEBRAL DISCS; ORGAN-CULTURE; NUCLEUS PULPOSUS; GROWTH-FACTOR; LUMBAR SPINE; IN-VIVO; MOTION SEGMENT; CHONDROCYTES; DISTRACTION; CARTILAGE	of background data The vascular buds in the vertebral endplate (VEP) are the structural foundation of nutrient exchange in the intervertebral disc (IVD). VEGF is closely related to angiogenesis in the endplate and intervertebral disc degeneration (IDD). Objective To investigate the effects of static load on vascular buds and VEGF expression in the VEP and to further clarify the relation between IDD and VEGF. Methods IVD motion segments were harvested from rabbit lumbar spines and cultured under no-loading conditions (controls) or in custom-made apparatuses under a constant compressive load (0.5 MPa) for up to 14 days. Tissue integrity and the number of vascular buds were determined, and the concentrations and expression of Aggrecan, COL2a1, and VEGFA in the VEPs were assessed after 3, 7, and 14 days of culturing and then compared with those of fresh tissues. Results Under the constant compression, the morphological integrity of the VEPs was gradually disrupted, and immunohistochemistry results showed a significant decrease in the levels of Agg and COL2a1. During the static load, the number of vascular buds in the VEPs was gradually reduced from the early stage of culture, and ELISA showed that the constant compressive load caused a significant decrease in the VEGFA and VEGFR2 protein concentrations, which were consistent with the immunohistochemistry results. Western blot and RT-PCR results also showed that the loading state caused a significant decrease in VEGFA expression compared with that of fresh and control samples. Conclusions Constant compression caused degeneration of the VEP as well as a decreased number of vascular buds, thereby accelerating disc degeneration. VEGFA is involved in this process. We anticipate that regulating the expression of VEGFA may improve the condition of the lesions to the vascular buds in the endplates, thus enhancing the nutritional supply function in IVD and providing new therapeutic targets and strategies for the effective prevention and treatment of IDD.	[Zhan, Jia-Wen; Wang, Shang-Quan; Han, Tao] China Acad Chinese Med Sci, Wangjing Hosp, Gen Orthoped Dept, Beijing, Peoples R China; [Zhan, Jia-Wen; Feng, Min-Shan; Yin, Xun-Lu; Han, Tao; Zhu, Li-Guo] China Acad Chinese Med Sci, Wangjing Hosp, Key Lab Beijing Palasy Technol, Beijing, Peoples R China; [Feng, Min-Shan; Yu, Jie; Yin, Xun-Lu; Zhu, Li-Guo] China Acad Chinese Med Sci, Wangjing Hosp, Spine Dept 2, Beijing, Peoples R China; [Wei, Xu] China Acad Chinese Med Sci, Wangjing Hosp, Sci Res Off, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Wang Jing Hospital, CACMS; China Academy of Chinese Medical Sciences; Wang Jing Hospital, CACMS; China Academy of Chinese Medical Sciences; Wang Jing Hospital, CACMS; China Academy of Chinese Medical Sciences; Wang Jing Hospital, CACMS	Zhu, LG (corresponding author), China Acad Chinese Med Sci, Wangjing Hosp, Key Lab Beijing Palasy Technol, Beijing, Peoples R China.; Zhu, LG (corresponding author), China Acad Chinese Med Sci, Wangjing Hosp, Spine Dept 2, Beijing, Peoples R China.	532414151@qq.com			National Natural Fund Project of China [81804120, 81930118]; Standardized construction project of rehabilitation service ability and technical platform of TCM Department of orthopedics in Beijing [110019]; Scientific Research Project of Chinese Academy of Traditional Chinese Medicine?Research on Rehabilitation-related Diagnosis and Treatment Technology of Characteristic Traditional Chinese Medicine [ZZ13-YQ-038]; State General Administration of Physical Education [HXKT2017001]	National Natural Fund Project of China; Standardized construction project of rehabilitation service ability and technical platform of TCM Department of orthopedics in Beijing; Scientific Research Project of Chinese Academy of Traditional Chinese Medicine?Research on Rehabilitation-related Diagnosis and Treatment Technology of Characteristic Traditional Chinese Medicine; State General Administration of Physical Education	JWZ received support from the National Natural Fund Project of China (No.81804120); LGZ received support from the National Natural Fund Project of China (No.81930118), Standardized construction project of rehabilitation service ability and technical platform of TCM Department of orthopedics in Beijing(No.110019), Scientific Research Project of Chinese Academy of Traditional Chinese Medicine?Research on Rehabilitation-related Diagnosis and Treatment Technology of Characteristic Traditional Chinese Medicine ZZ13-YQ-038; SQW received support from the State General Administration of Physical Education (No: HXKT2017001).	Adams MA, 2005, J BIOMECH, V38, P1972, DOI 10.1016/j.jbiomech.2005.03.028; [Anonymous], 2005, BUSINESS STRATEGY RE, V16, P58; Ariga K, 2003, SPINE, V28, P1528, DOI 10.1097/00007632-200307150-00010; Ariga K, 2001, SPINE, V26, P2414, DOI 10.1097/00007632-200111150-00004; Arun R, 2009, SPINE, V34, P2324, DOI 10.1097/BRS.0b013e3181b4df92; Ashina K, BIOCH BIOPHYSICAL RE, V464, P590; Benneker LM, 2005, SPINE, V30, P167, DOI 10.1097/01.brs.0000150833.93248.09; Bian Qin, 2017, [Bone Research, 骨研究], V5, P27; Bluteau G, 2007, BONE, V40, P568, DOI 10.1016/j.bone.2006.09.024; Cao Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43094; Chan SCW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072489; Chan SCW, 2011, SPINE, V36, P2021, DOI 10.1097/BRS.0b013e318203aea5; Chiba K, 1998, SPINE, V23, P1821, DOI 10.1097/00007632-199809010-00002; Curatola AM, RETINAL BLOOD VESSEL, V81, P158; DeLucca JF, 2016, J BIOMECH, V49, P550, DOI 10.1016/j.jbiomech.2016.01.007; Gantenbein B, 2006, SPINE, V31, P2665, DOI 10.1097/01.brs.0000244620.15386.df; Guehring T, SENSITIVITY NOTOCHOR, V19, P113; Guehring T, 2006, SPINE, V31, P1658, DOI 10.1097/01.brs.0000224558.81765.56; Guehring T, 2006, EUR SPINE J, V15, P597, DOI 10.1007/s00586-005-0953-z; Haglund L, 2011, TISSUE ENG PART C-ME, V17, P1011, DOI [10.1089/ten.tec.2011.0025, 10.1089/ten.TEC.2011.0025]; Han IB, 2013, GENET MOL RES, V12, P2294, DOI 10.4238/2013.July.8.10; HANSSON TH, 1987, SPINE, V12, P56, DOI 10.1097/00007632-198701000-00011; Haschtmann D, 2006, SPINE, V31, P2918, DOI 10.1097/01.brs.0000247954.69438.ae; Haschtmann D, 2006, J ORTHOP RES, V24, P1957, DOI 10.1002/jor.20243; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hee HT, 2011, SPINE, V36, P505, DOI 10.1097/BRS.0b013e3181d32410; Jim B, DEV INTACT INTERVERT, V20, P1244; Kaspar D, 2003, J ORTHOP RES, V21, P320, DOI 10.1016/S0736-0266(02)00134-1; KELLER TS, 1989, SPINE, V14, P1012, DOI 10.1097/00007632-198909000-00016; Kim KW, 2003, SPINE, V28, P982, DOI 10.1097/00007632-200305150-00005; Kobayashi S, 2008, J NEUROSURG-SPINE, V9, P96, DOI 10.3171/SPI/2008/9/7/096; Kokubo Y, 2008, J NEUROSURG-SPINE, V9, P285, DOI 10.3171/SPI/2008/9/9/285; Korecki CL, 2007, EUR SPINE J, V16, P1029, DOI 10.1007/s00586-007-0327-9; Kroeber M, 2005, SPINE, V30, P181, DOI 10.1097/01.brs.0000150487.17562.b1; Kroeber MW, 2002, SPINE, V27, P2684, DOI 10.1097/00007632-200212010-00007; Lantieri LA, 1998, PLAST RECONSTR SURG, V101, P392, DOI 10.1097/00006534-199802000-00020; Lao Y, 2018, ORTHOPAEDIC SURG, P10; Lee CR, 2006, SPINE, V31, P515, DOI 10.1097/01.brs.0000201302.59050.72; Lim TH, 2006, SPINE, V31, P1291, DOI 10.1097/01.brs.0000218455.28463.f0; Malonzo C, 2015, J TISSUE ENG REGEN M, V9, pE167, DOI 10.1002/term.1667; Miyamoto T, ARTHRITIS RES THERAP, V12; Nguyen C, 2012, OSTEOPOROSIS INT, V23, pS857, DOI 10.1007/s00198-012-2164-x; Oki S, 1996, SPINE, V21, P174, DOI 10.1097/00007632-199601150-00003; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; Pufe T, 2004, BONE, V35, P543, DOI 10.1016/j.bone.2004.02.026; Risbud MV, 2003, SPINE, V28, P2652, DOI 10.1097/01.BRS.0000099384.58981.C6; Rodriguez AG, 2012, J ORTHOP RES, V30, P280, DOI 10.1002/jor.21513; Rodriguez AG, 2011, SPINE, V36, P512, DOI 10.1097/BRS.0b013e3181f72b94; Roskoski R, 2017, PHARMACOL RES, V120, P116, DOI 10.1016/j.phrs.2017.03.010; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Sabatino AD., 2006, Inflamm Bowel Dis, V10, P573; Salo J, 2008, CLIN EXP RHEUMATOL, V26, P1018; Seol D, 2013, J ORTHOP RES, V31, P838, DOI 10.1002/jor.22285; SERI Quarterly, 2013, SERI Q, V6, P79; Sharma A, 2014, SPINE, V39, P1084, DOI 10.1097/BRS.0000000000000265; Shirazi-Adl A, 2010, J BIOMECH, V43, P1330, DOI 10.1016/j.jbiomech.2010.01.023; Stover JD, 2017, MOL THERAPY J AM SOC; Tarkka T, 2003, J GENE MED, V5, P560, DOI 10.1002/jgm.392; Wang Dong, BUPIVACAINE DECREASE; Wang H, 2008, J PRACTICAL MED; WEIDNER N, 1995, AM J PATHOL, V147, P9; Xu HG, 2005, SPINE, V30, P1973, DOI 10.1097/01.BRS.0000176445.01967.8a; Xu HG, 2012, CHINESE MED J-PEKING, V125, P4055, DOI 10.3760/cma.j.issn.0366-6999.2012.22.026; Xu Hong-Guang, 2012, Zhonghua Yi Xue Za Zhi, V92, P491, DOI 10.3760/cma.j.issn.00376-2491-2012.07.016; Xulu Yin, 2019, CHINESE ACAD TRADITI; Yamaguchi T, 2015, J ORTHOP RES, V33, P270, DOI 10.1002/jor.22759; YASUMA T, 1993, SPINE, V18, P1761, DOI 10.1097/00007632-199310000-00008; Zhan JW, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2481712; Zhu LG, 2016, CHINESE MED J-PEKING, V129, P2338, DOI 10.4103/0366-6999.190666	69	2	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234747	10.1371/journal.pone.0234747	http://dx.doi.org/10.1371/journal.pone.0234747			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584845	Green Published, gold			2022-12-27	WOS:000545747200094
J	Huang, PSB; Chen, CL; Yeung, KT; Hsu, MY; Wan, SW; Lou, SZ				Huang, Paul Sin-Bao; Chen, Chiung-Ling; Yeung, Kwok-Tak; Hsu, Ming-Yi; Wan, Sok-Wa; Lou, Shu-Zon			Effects of different types of sensory signals on reaching performance in persons with chronic schizophrenia	PLOS ONE			English	Article							INDUCED MOVEMENT-DISORDERS; NEUROLOGICAL SOFT SIGNS; REACTION-TIME; SUSTAINED ATTENTION; PARKINSONS-DISEASE; BIPOLAR DISORDER; VIRTUAL-REALITY; MOTOR BEHAVIOR; NAIVE PATIENTS; REHABILITATION	Previous studies have reported movement abnormalities in persons with schizophrenia. This study aimed to examine the differences between persons with chronic schizophrenia and healthy control participants in reaching movement and the effects of sensory signals on reaching performance in persons with chronic schizophrenia. A counter-balanced repeated-measures design was employed. Twenty persons with schizophrenia and 20 age- and gender-matched control participants were recruited in this study. Reaching performance was measured in three types of sensory signal conditions (visual, auditory, and no signal), i.e., two externally triggered and one self-initiated movement were assessed in reaction time/inter-response interval, movement time, peak velocity, percentage of time in which peak velocity occurred, and movement units. The results revealed significant main effects of group in reaction time/inter-response interval (p = 0.003), movement time (p < 0.001), peak velocity (p < 0.001), and movement units (p < 0.001). The persons with chronic schizophrenia demonstrated slower response to signals and in self-initiated movement, increased movement time, and less forceful and less smooth movement compared to healthy control participants when performing the reaching task. The interaction effect between group and signal in reaction time/inter-response interval was also significant (p < 0.001). The inter-response interval for self-initiated reaching was the shortest in healthy controls. Conversely, the inter-response interval for self-initiated reaching was the longest in persons with schizophrenia. The main effect of the signal on movement time was significant (p < 0.001). The movement time of reaching was longer in response to the auditory signal than in response to visual or self-initiated. The differences in percentages of time in which peak velocity occurred between persons with schizophrenia and healthy controls (p > 0.01) and across the three conditions (p > 0.01) were non-significant. Neither duration of illness nor antipsychotic dosage was significantly associated with reaching performance (all p > 0.01). In conclusion, these findings indicate that reaching movement in persons with chronic schizophrenia is slower, less forceful, and less coordinated compared to healthy control participants. In addition, persons with chronic schizophrenia also had shorter inter-response interval for self-initiated movement and shorter movement time in auditory signal condition, independent of duration of illness and antipsychotic dosage.	[Huang, Paul Sin-Bao] Changhua Christian Hosp, Dept Palliat Care, Changhua, Taiwan; [Chen, Chiung-Ling; Yeung, Kwok-Tak; Lou, Shu-Zon] Chung Shan Med Univ, Dept Occupat Therapy, Taichung, Taiwan; [Chen, Chiung-Ling; Yeung, Kwok-Tak; Lou, Shu-Zon] Chung Shan Med Univ Hosp, Occupat Therapy Room, Taichung, Taiwan; [Hsu, Ming-Yi] Chung Shan Med Univ, Dept Nursing, Taichung, Taiwan; [Hsu, Ming-Yi] Chung Shan Med Univ Hosp, Dept Nursing, Taichung, Taiwan; [Wan, Sok-Wa] Long Ching Ctr Fuhong Soc Macau, Macau, Peoples R China	Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Lou, SZ (corresponding author), Chung Shan Med Univ, Dept Occupat Therapy, Taichung, Taiwan.; Lou, SZ (corresponding author), Chung Shan Med Univ Hosp, Occupat Therapy Room, Taichung, Taiwan.	szlou@csmu.edu.tw		Huang, Paul Sin-Bao/0000-0002-4893-393X	Chung Shan Medical University; Changhua Christian Hospital [CSMU-CCH-105-05]	Chung Shan Medical University; Changhua Christian Hospital	SBH and CLC received award to the study. The study was funded by research grants from Chung Shan Medical University (www.csmu.edu.tw) and Changhua Christian Hospital (www.cch.org.tw) (CSMU-CCH-105-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayehu M, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0280-1; Baerwald JP, 2005, ARCH CLIN NEUROPSYCH, V20, P17, DOI 10.1016/j.acn.2004.02.003; Birkett P, 2007, SCHIZOPHR RES, V95, P76, DOI 10.1016/j.schres.2007.05.030; Bombin I, 2005, SCHIZOPHRENIA BULL, V31, P962, DOI 10.1093/schbul/sbi028; Chan RCK, 2008, NEUROSCI BIOBEHAV R, V32, P957, DOI 10.1016/j.neubiorev.2008.01.005; Chan RCK, 2010, SCHIZOPHRENIA BULL, V36, P1089, DOI 10.1093/schbul/sbp011; COLAVITA FB, 1979, PERCEPT PSYCHOPHYS, V25, P345, DOI 10.3758/BF03198814; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; Danivas V, 2013, INDIAN J PSYCHIAT, V55, P207, DOI 10.4103/0019-5545.111475; de Araujo AN, 2012, DRUG HEALTHC PATIENT, V4, P173, DOI 10.2147/DHPS.S37429; Dorgan J.F., 2010, BREAST CANC RES, V12, pR98; Dutschke LL, 2018, SCHIZOPHR RES, V200, P42, DOI 10.1016/j.schres.2017.07.012; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Exner C, 2006, SCHIZOPHR RES, V84, P386, DOI 10.1016/j.schres.2006.03.013; Flashman LA, 1996, AM J PSYCHIAT, V153, P526; Fleck DE, 2001, SCHIZOPHR RES, V52, P251, DOI 10.1016/S0920-9964(01)00170-0; Fleischhacker W, 2000, Encephale, V26 Spec No 1, P12; Flyckt L, 1999, PSYCHIAT RES, V86, P113, DOI 10.1016/S0165-1781(99)00027-X; Fuller R, 1999, J NEUROL NEUROSUR PS, V66, P668, DOI 10.1136/jnnp.66.5.668; Fuller R, 1999, EXP BRAIN RES, V126, P545, DOI 10.1007/s002210050763; GRIFFITH JM, 1994, NEUROPSYCHOBIOLOGY, V29, P179, DOI 10.1159/000119084; HEINRICHS DW, 1988, AM J PSYCHIAT, V145, P11; Henkel V, 2004, PHARMACOPSYCHIATRY, V37, P110, DOI 10.1055/s-2004-818988; Horan WP, 2003, SCHIZOPHR RES, V65, P125, DOI 10.1016/S0920-9964(02)00410-3; Jahn T, 2006, PSYCHIAT RES, V142, P191, DOI 10.1016/j.psychres.2002.12.003; Janno S, 2004, AM J PSYCHIAT, V161, P160, DOI 10.1176/appi.ajp.161.1.160; Karantinos T, 2014, PSYCHIAT RES, V215, P26, DOI 10.1016/j.psychres.2013.10.031; Krieger S, 2001, ACTA PSYCHIAT SCAND, V104, P18, DOI 10.1034/j.1600-0447.2001.104s408018.x; Li CSR, 2002, SCHIZOPHR RES, V55, P115, DOI 10.1016/S0920-9964(01)00203-1; Lin KC, 2007, CLIN REHABIL, V21, P1075, DOI 10.1177/0269215507079843; Lin KC, 2008, AM J OCCUP THER, V62, P456, DOI 10.5014/ajot.62.4.456; Lin KC, 2010, NEUROREHAB NEURAL RE, V24, P42, DOI 10.1177/1545968309345268; Ma HI, 2011, CLIN REHABIL, V25, P892, DOI 10.1177/0269215511406757; Maddox RK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001319; Midorikawa A, 2008, PSYCHIAT RES, V159, P281, DOI 10.1016/j.psychres.2007.04.004; Mitra Sayantanava, 2016, Ind Psychiatry J, V25, P135, DOI 10.4103/ipj.ipj_30_15; Morin L, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00100; Morrens M, 2007, SCHIZOPHRENIA BULL, V33, P1038, DOI 10.1093/schbul/sbl051; Morrens M, 2006, SCHIZOPHR RES, V84, P397, DOI 10.1016/j.schres.2006.01.024; PAPA SM, 1991, MOVEMENT DISORD, V6, P217, DOI 10.1002/mds.870060305; Parksepp M, 2016, NORD J PSYCHIAT, V70, P498, DOI 10.3109/08039488.2016.1164245; Peralta V, 2010, MOVEMENT DISORD, V25, P1068, DOI 10.1002/mds.23050; ROMO R, 1987, EXP BRAIN RES, V67, P656; SCHWARTZ F, 1989, BIOL PSYCHIAT, V25, P540, DOI 10.1016/0006-3223(89)90214-X; Shelton J., 2010, NEUROSCIENCE MED, V1, P30, DOI [10.4236/nm.2010.11004, DOI 10.4236/NM.2010.11004]; Stegmayer K, 2014, PSYCHIAT RES-NEUROIM, V223, P49, DOI 10.1016/j.pscychresns.2014.05.002; Thielman G, 2008, NEUROREHAB NEURAL RE, V22, P697, DOI 10.1177/1545968308315998; TODOR JI, 1985, J MOTOR BEHAV, V17, P355, DOI 10.1080/00222895.1985.10735354; Trivedi J K, 2006, Indian J Psychiatry, V48, P10, DOI 10.4103/0019-5545.31613; Tsuang MT, 1999, ACTA PSYCHIAT SCAND, V99, P2, DOI 10.1111/j.1600-0447.1999.tb05977.x; van den Ameele S, 2015, Tijdschr Psychiatr, V57, P94; Walther S, 2012, NEUROPSYCHOBIOLOGY, V66, P77, DOI 10.1159/000339456; Wang CY, 2011, ARCH PHYS MED REHAB, V92, P1238, DOI 10.1016/j.apmr.2011.03.014; Wang SM, 2018, HONG KONG J OCCUP TH, V31, P22, DOI 10.1177/1569186118759610; Welford A. T., 1980, REACTION TIMES, P73; Wu CY, 2011, NEUROREHAB NEURAL RE, V25, P130, DOI 10.1177/1545968310380686; Wu CY, 2001, STROKE, V32, P70, DOI 10.1161/01.STR.32.1.70; Wulf G, 1998, J MOTOR BEHAV, V30, P169, DOI 10.1080/00222899809601334	58	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234976	10.1371/journal.pone.0234976	http://dx.doi.org/10.1371/journal.pone.0234976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579579	gold, Green Published			2022-12-27	WOS:000545646600040
J	Oda, Y; Miura, T; Mori, G; Sasaki, H; Ito, T; Yoshinari, M; Yajima, Y				Oda, Yukari; Miura, Tadashi; Mori, Gentaro; Sasaki, Hodaka; Ito, Taichi; Yoshinari, Masao; Yajima, Yasutomo			Adhesion of streptococci to titanium and zirconia	PLOS ONE			English	Article							VITRO BIOFILM FORMATION; PERI-IMPLANT MUCOSITIS; BACTERIAL ADHESION; IN-VITRO; SURFACE; STIFFNESS	The purpose of this study was to evaluate the adherence of streptococci to disks of titanium (commercially pure titanium: CpTi) and zirconia (tetragonal zirconia polycrystals: TZP). CpTi and yttria-stabilized TZP disks with a mirror-polished surface were used as specimens. The arithmetic mean surface roughness (Ra and Sa) and the surface wettability of the experimental specimens were measured. For analyzing the outermost layer of the experimental specimens, X-ray photoelectron spectroscopy (XPS) analysis was performed.Streptococcus sanguinis,S.gordonii,S.oralis, andS.mutanswere used as streptococcal bacterial strains. These bacterial cultures were grown for 24 h on CpTi and TZP. The number of bacterial adhesions was estimated using an ATP-bioluminescent assay, and scanning electron microscope (SEM) observation of the adhered bacterial specimens was performed. No significant differences in surface roughness or wettability were found between CpTi and TZP. In XPS analyses, outermost layer of CpTi included Ti0 and Ti4+, and outermost layer of TZP included Zr4+. In the cell adhesion assay, the adherences ofS.sanguinis,S.gordonii, andS.oralisto TZP were significantly lower than those to CpTi (p < 0.05); however, significant difference was not observed forS.mutansamong the specimens. The adherence to CpTi and TZP ofS.mutanswas significantly lower than that ofS.sanguinis,S.gordonii, andS.oralis. These results were confirmed by SEM.S.sanguinis,S.gordonii, andS.oralisadhered less to TZP than to CpTi, but the adherence ofS.mutanswas similar to both surfaces.S.mutanswas less adherent compare with the other streptococci tested in those specimens.	[Oda, Yukari; Mori, Gentaro; Sasaki, Hodaka; Ito, Taichi; Yajima, Yasutomo] Tokyo Dent Coll, Dept Oral & Maxillofacial Implantol, Tokyo, Japan; [Miura, Tadashi; Yoshinari, Masao] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan	Tokyo Dental College; Tokyo Dental College	Oda, Y (corresponding author), Tokyo Dent Coll, Dept Oral & Maxillofacial Implantol, Tokyo, Japan.	takahashiyukari@tdc.ac.jp		Oda, Yukari/0000-0003-3419-9217; Mori, Gentaro/0000-0003-4700-2647				Andreiotelli M, 2009, CLIN IMPLANT DENT R, V11, P158, DOI 10.1111/j.1708-8208.2008.00105.x; Carcuac O, 2013, CLIN ORAL IMPLAN RES, V24, P363, DOI 10.1111/clr.12067; Pita PPC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/159625; CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105; Di Giulio M, 2016, CLIN ORAL IMPLAN RES, V27, P918, DOI 10.1111/clr.12659; do Nascimento C, 2014, CLIN ORAL IMPLAN RES, V25, P337, DOI 10.1111/clr.12093; Handfield M, 2008, J DENT RES, V87, P203, DOI 10.1177/154405910808700302; Hauslich LB, 2013, CLIN ORAL IMPLAN RES, V24, P49, DOI 10.1111/j.1600-0501.2011.02364.x; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kumar PS, 2012, J CLIN PERIODONTOL, V39, P425, DOI 10.1111/j.1600-051X.2012.01856.x; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Lichter JA, 2008, BIOMACROMOLECULES, V9, P1571, DOI 10.1021/bm701430y; Lorenzetti M, 2015, ACS APPL MATER INTER, V7, P1644, DOI 10.1021/am507148n; McNamee CE, 2005, LANGMUIR, V21, P11283, DOI 10.1021/la0517890; Mombelli A, 1994, Periodontol 2000, V4, P74, DOI 10.1111/j.1600-0757.1994.tb00007.x; PONTORIERO R, 1994, CLIN ORAL IMPLAN RES, V5, P254, DOI 10.1034/j.1600-0501.1994.050409.x; Quirynen M, 1996, Int J Oral Maxillofac Implants, V11, P169; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; RIGNEY MP, 1990, J CHROMATOGR, V499, P291, DOI 10.1016/S0021-9673(00)96980-2; Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793; Roehling S, 2017, J PERIODONTOL, V88, P298, DOI 10.1902/jop.2016.160245; Saha N, 2013, BIOMACROMOLECULES, V14, P520, DOI 10.1021/bm301774a; Sanchez MC, 2014, DENT MATER, V30, P1161, DOI 10.1016/j.dental.2014.07.008; Sanz M, 2018, CLIN ORAL IMPLAN RES, V29, P152, DOI 10.1111/clr.13274; Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292; Schwarz F, 2018, J PERIODONTOL, V89, pS267, DOI 10.1002/JPER.16-0350; Schwarz F, 2014, J CLIN PERIODONTOL, V41, P513, DOI 10.1111/jcpe.12240; Shiba T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30997; Song F, 2015, J DENT RES, V94, P1027, DOI 10.1177/0022034515587690; Wei WCJ, 1999, J AM CERAM SOC, V82, P3385; Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234524	10.1371/journal.pone.0234524	http://dx.doi.org/10.1371/journal.pone.0234524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579584	Green Published, gold			2022-12-27	WOS:000545646600020
J	Starns, HD; Fuhlendorf, SD; Elmore, RD; Twidwell, D; Thacker, ET; Hovick, TJ; Luttbeg, B				Starns, Heath D.; Fuhlendorf, Samuel D.; Elmore, Robert D.; Twidwell, Dirac; Thacker, Eric T.; Hovick, Torre J.; Luttbeg, Barney			Effects of pyric herbivory on prairie-chicken (Tympanuchusspp) habitat	PLOS ONE			English	Article							TALLGRASS-PRAIRIE; NESTING ECOLOGY; BROOD HABITAT; FIRE; CONSERVATION; GRASSLAND; HETEROGENEITY; MANAGEMENT; ENCROACHMENT; POPULATIONS	The reduction and simplification of grasslands has led to the decline of numerous species of grassland fauna, particularly grassland-obligate birds. Prairie-chickens (Tympanuchusspp.) are an example of obligate grassland birds that have declined throughout most of their distribution and are species of conservation concern. Pyric herbivory has been suggested as a land management strategy for enhancing prairie-chicken habitat and stabilizing declining population trends. We assessed differences in vegetation structure created by pyric herbivory compared to fire-only treatments to determine whether pyric herbivory increased habitat heterogeneity for prairie-chickens, spatially or temporally. Our study was performed at four sites in the southern Great Plains, all within the current or historic distribution of either lesser (T.pallidicinctus), greater (T.cupido), or Attwater's (T.cupido attwateri) prairie-chickens. Key vegetation characteristics of grass cover and vegetation height in pyric herbivory and fire-only treatments were within the recommended range of values for prairie-chickens during their distinct life history stages. However, patches managed via pyric herbivory provided approximately 5% more forb cover than fire-only treatments for almost 30 months post-fire. Additionally, pyric herbivory extended the length of time bare ground was present after fires. Pyric herbivory also reduced vegetation height and biomass, with mean vegetation height in pyric herbivory treatments lagging behind fire-only treatments by approximately 15 months. Canopy cover in fire-only treatments exceeded levels recommended for prairie-chicken young within 12 months post-fire. However, canopy cover in pyric herbivory treatments never exceeded the maximum recommended levels. Overall, it appears that pyric herbivory improves vegetation characteristics reported as critical to prairie-chicken reproduction. Based on our results, we suggest pyric herbivory as a viable management technique to promote prairie-chicken habitat in the southern Great Plains, while still accommodating livestock production.	[Starns, Heath D.; Fuhlendorf, Samuel D.; Elmore, Robert D.] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA; [Twidwell, Dirac] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Thacker, Eric T.] Utah State Univ, SJ & Jessie E Quinney Coll Nat Resources, Logan, UT 84322 USA; [Hovick, Torre J.] North Dakota State Univ, Sch Nat Resource Sci, Fargo, ND USA; [Luttbeg, Barney] Oklahoma State Univ, Dept Integrat Biol, Stillwater, OK 74078 USA; [Starns, Heath D.] Texas AgriLife Res, Sonora, TX USA	Oklahoma State University System; Oklahoma State University - Stillwater; University of Nebraska System; University of Nebraska Lincoln; Utah System of Higher Education; Utah State University; North Dakota State University Fargo; Oklahoma State University System; Oklahoma State University - Stillwater	Starns, HD (corresponding author), Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA.; Starns, HD (corresponding author), Texas AgriLife Res, Sonora, TX USA.	Heath.Starns@ag.tamu.edu	Fuhlendorf, Samuel/A-2931-2011	Fuhlendorf, Samuel/0000-0002-8726-9402	Joint Fire Science Program [13-1-06-8]	Joint Fire Science Program	This study was funded by the Joint Fire Science Program (www.firescience.gov) grant #13-1-06-8. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Allred BW, 2011, ECOL EVOL, V1, P132, DOI 10.1002/ece3.12; Anderson WR, 2015, INT J WILDLAND FIRE, V24, P443, DOI 10.1071/WF14130; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2015, DABIQ            JUL, V10, P14; Archibald S, 2005, ECOL APPL, V15, P96, DOI 10.1890/03-5210; Bates D., 2013, LME4 LINEAR MIXED EF; Bell LA, 2010, RANGELAND ECOL MANAG, V63, P478, DOI 10.2111/08-245.1; BIDWELL TG, 1990, J RANGE MANAGE, V43, P209, DOI 10.2307/3898674; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Briske DD, 2003, J APPL ECOL, V40, P601, DOI 10.1046/j.1365-2664.2003.00837.x; Carroll JM, 2017, RANGELAND ECOL MANAG, V70, P175, DOI 10.1016/j.rama.2016.08.006; COLLINS SL, 1992, ECOLOGY, V73, P2001, DOI 10.2307/1941450; Daubenmire R., 1968, Advances in Ecological Research, V5, P209, DOI 10.1016/S0065-2504(08)60226-3; Engle DM, 2008, RANGELAND ECOL MANAG, V61, P55, DOI 10.2111/06-149R2.1; Fuhlendorf SD, 2006, ECOL APPL, V16, P1706, DOI 10.1890/1051-0761(2006)016[1706:SHBTBF]2.0.CO;2; Fuhlendorf SD, 2017, RANGELAND ECOL MANAG, V70, P9, DOI 10.1016/j.rama.2016.08.010; Fuhlendorf SD, 2009, CONSERV BIOL, V23, P588, DOI 10.1111/j.1523-1739.2008.01139.x; Fuhlendorf SD, 2004, J APPL ECOL, V41, P604, DOI 10.1111/j.0021-8901.2004.00937.x; Fuhlendorf SD, 2002, LANDSCAPE ECOL, V17, P617, DOI 10.1023/A:1021592817039; Fuhlendorf SD, 2001, BIOSCIENCE, V51, P625, DOI 10.1641/0006-3568(2001)051[0625:RHOREM]2.0.CO;2; Grisham BA, 2014, J WILDLIFE MANAGE, V78, P857, DOI 10.1002/jwmg.716; Hagen CA, 2005, WILDLIFE SOC B, V33, P1080, DOI 10.2193/0091-7648(2005)33[1080:LPBHIS]2.0.CO;2; Hagen CA, 2004, WILDLIFE SOC B, V32, P69, DOI 10.2193/0091-7648(2004)32[69:GFMLPP]2.0.CO;2; Hagen CA, 2013, WILDLIFE SOC B, V37, P750, DOI 10.1002/wsb.313; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hovick TJ, 2015, RANGELAND ECOL MANAG, V68, P186, DOI 10.1016/j.rama.2015.01.009; Hovick TJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00062.1; IUCN, IUCN RED LIST THREAT; Johnson K, 2004, SOUTHWEST NAT, V49, P334, DOI 10.1894/0038-4909(2004)049<0334:HUANSS>2.0.CO;2; Lautenbach JM, 2019, J WILDLIFE MANAGE, V83, P205, DOI 10.1002/jwmg.21582; Lautenbach JM, 2017, RANGELAND ECOL MANAG, V70, P78, DOI 10.1016/j.rama.2016.07.008; Lockwood MA, 2005, RANGELAND ECOL MANAG, V58, P320, DOI 10.2111/1551-5028(2005)58[320:SHROCA]2.0.CO;2; Martin RE, 1992, P C BIOD NW CAL EC C; Matthews TW, 2011, STUD AVIAN BIOL, P179; Mcnew LB, 2015, RANGELAND ECOL MANAG, V68, P298, DOI 10.1016/j.rama.2015.03.009; Morrow ME, 1996, WILDLIFE SOC B, V24, P593; Niemuth ND, 2000, J WILDLIFE MANAGE, V64, P278, DOI 10.2307/3803000; Palmer MW, 2007, CASTANEA, V72, P235, DOI 10.2179/06-29.1; Poiani KA, 2001, CONSERV BIOL, V15, P513, DOI 10.1046/j.1523-1739.2001.015002513.x; Powell AFLA, 2008, J FIELD ORNITHOL, V79, P41, DOI 10.1111/j.1557-9263.2008.00144.x; Rahmig CJ, 2009, CONSERV BIOL, V23, P420, DOI 10.1111/j.1523-1739.2008.01118.x; Ratajczak Z, 2012, ECOLOGY, V93, P697, DOI 10.1890/11-1199.1; Reddy LVK, 2011, J ADV ORAL RES, V2, P17, DOI 10.1177/2229411220110104; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Sauer John R., 2013, North American Fauna, V79, P2, DOI 10.3996/nafa.79.0001; SCHROEDER MA, 1992, WILSON BULL, V104, P273; Silvy NJ, 2004, WILDLIFE SOC B, V32, P16, DOI 10.2193/0091-7648(2004)32[16:TCOTDO]2.0.CO;2; Starns HD, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2578; Svedarsky W.D., 2022, US GEOLOGICAL SURVEY, P1842; U.S. Fish and Wildlife Service, 2010, ATTW PRAIR CHICK REC; van den Bel Martijn, 2015, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V10, P11, DOI 10.1590/1981-81222015000100002	53	3	3	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234983	10.1371/journal.pone.0234983	http://dx.doi.org/10.1371/journal.pone.0234983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574224	Green Published, gold			2022-12-27	WOS:000544972400057
J	Veeroju, S; Mamazhakypov, A; Rai, N; Kojonazarov, B; Nadeau, V; Breuils-Bonnet, S; Li, L; Weissmann, N; Rohrbach, S; Provencher, S; Bonnet, S; Seeger, W; Schermuly, R; Novoyatleva, T				Veeroju, Swathi; Mamazhakypov, Argen; Rai, Nabham; Kojonazarov, Baktybek; Nadeau, Valerie; Breuils-Bonnet, Sandra; Li, Ling; Weissmann, Norbert; Rohrbach, Susanne; Provencher, Steve; Bonnet, Sebastien; Seeger, Werner; Schermuly, Ralph; Novoyatleva, Tatyana			Effect of p53 activation on experimental right ventricular hypertrophy	PLOS ONE			English	Article							RECEPTOR-GAMMA; CARDIAC-HYPERTROPHY; OXIDATIVE STRESS; HEME OXYGENASE-1; CELL-DEATH; PULMONARY; EXPRESSION; APOPTOSIS; CONTRACTILITY; DYSFUNCTION	The leading cause of death in Pulmonary Arterial Hypertension (PAH) is right ventricular (RV) failure. The tumor suppressor p53 has been associated with left ventricular hypertrophy (LVH) and remodeling but its role in RV hypertrophy (RVH) is unclear. The purpose of this study was to determine whether pharmacological activation of p53 by Quinacrine affects RV remodeling and function in the pulmonary artery banding (PAB) model of compensated RVH in mice. The effects of p53 activation on cellular functions were studied in isolated cardiomyocytes, cardiac fibroblasts and endothelial cells (ECs). The expression of p53 was examined both on human RV tissues from patients with compensated and decompensated RVH and in mouse RV tissues early and late after the PAB. As compared to control human RVs, there was no change in p53 expression in compensated RVH, while a marked upregulation was found in decompensated RVH. Similarly, in comparison to SHAM-operated mice, unaltered RV p53 expression 7 days after PAB, was markedly induced 21 days after the PAB. Quinacrine induced p53 accumulation did not further deteriorate RV function at day 7 after PAB. Quinacrine administration did not increase EC death, neither diminished EC number and capillary density in RV tissues. No major impact on the expression of markers of sarcomere organization, fatty acid and mitochondrial metabolism and respiration was noted in Quinacrine-treated PAB mice. p53 accumulation modulated the expression of Heme Oxygenase 1 (HO-1) and Glucose Transporter (Glut1) in mouse RVs and in adult cardiomyocytes. We conclude that early p53 activation in PAB-induced RVH does not cause substantial detrimental effects on right ventricular remodeling and function.	[Veeroju, Swathi; Mamazhakypov, Argen; Rai, Nabham; Kojonazarov, Baktybek; Weissmann, Norbert; Seeger, Werner; Schermuly, Ralph; Novoyatleva, Tatyana] Justus Liebig Univ Giessen, Univ Giessen & Marburg Lung Ctr UGMLC, Excellence Cluster Cardio Pulm Inst CPI, Giessen, Germany; [Veeroju, Swathi; Mamazhakypov, Argen; Rai, Nabham; Kojonazarov, Baktybek; Weissmann, Norbert; Seeger, Werner; Schermuly, Ralph; Novoyatleva, Tatyana] Justus Liebig Univ Giessen, German Ctr Lung Res DZL, Giessen, Germany; [Kojonazarov, Baktybek] Inst Lung Hlth, Giessen, Germany; [Nadeau, Valerie; Breuils-Bonnet, Sandra; Provencher, Steve; Bonnet, Sebastien] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Dept Med, Pulm Hypertens & Vasc Biol Res Grp, Montreal, PQ, Canada; [Li, Ling; Rohrbach, Susanne] Justus Liebig Univ Giessen, Inst Physiol, Giessen, Germany; [Seeger, Werner] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Laval University; Justus Liebig University Giessen; Max Planck Society	Schermuly, R; Novoyatleva, T (corresponding author), Justus Liebig Univ Giessen, Univ Giessen & Marburg Lung Ctr UGMLC, Excellence Cluster Cardio Pulm Inst CPI, Giessen, Germany.; Schermuly, R; Novoyatleva, T (corresponding author), Justus Liebig Univ Giessen, German Ctr Lung Res DZL, Giessen, Germany.	ralph.schermuly@innere.med.uni-giessen.de; tatyana.novovatleva@innere.med.uni-giessen.de	Mamazhakypov, Argen/AAT-7794-2021	Mamazhakypov, Argen/0000-0002-2140-4819; Seeger, Werner/0000-0003-1946-0894	Universities of Giessen and Marburg Lung Centre (UGMLC); ECCPS (Excellence Cluster Cardiopulmonary System); German Research Foundation (DFG) [CRC1213]	Universities of Giessen and Marburg Lung Centre (UGMLC); ECCPS (Excellence Cluster Cardiopulmonary System)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG))	The authors received funding from Universities of Giessen and Marburg Lung Centre (UGMLC), ECCPS (Excellence Cluster Cardiopulmonary System), and the German Research Foundation (DFG) by the CRC1213 (Collaborative Research Center 1213), projects B03 (S.R.), B04 (T.N. and R.T.S.) and CP02 (B.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley SR, 1999, J BIOL CHEM, V274, P5038, DOI 10.1074/jbc.274.8.5038; [Anonymous], 2018, AM J PHYSIOL-CELL PH, V314, pC404; [Anonymous], 2011, AM J PHYSIOL-HEART C, V301, pH287; ARMSTRONG SC, 1991, AM J PATHOL, V138, P545; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Cesselli D, 2001, CIRC RES, V89, P279, DOI 10.1161/hh1501.094115; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Chen YH, 2003, EXP BIOL MED, V228, P447, DOI 10.1177/15353702-0322805-03; Ding GL, 2007, CARDIOVASC RES, V76, P269, DOI 10.1016/j.cardiores.2007.06.027; DOROSHOW JH, 1983, CANCER RES, V43, P4543; Drake JI, 2011, AM J RESP CELL MOL, V45, P1239, DOI 10.1165/rcmb.2010-0412OC; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Fang L, 2001, EMBO J, V20, P1931, DOI 10.1093/emboj/20.8.1931; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gomez-Arroyo J, 2013, CIRC-HEART FAIL, V6, P136, DOI 10.1161/CIRCHEARTFAILURE.111.966127; Gottlieb E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001040; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Hoshida S, 1996, J MOL CELL CARDIOL, V28, P1845, DOI 10.1006/jmcc.1996.0177; Ikeda S, 1999, LIFE SCI, V65, P925, DOI 10.1016/S0024-3205(99)00322-7; Jacquin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131940; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Leri A, 1998, J CLIN INVEST, V101, P1326, DOI 10.1172/JCI316; Lipskaia L, 2010, EXPERT OPIN BIOL TH, V10, P29, DOI 10.1517/14712590903321462; Luitel H, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13146; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Mak TW, 2017, P NATL ACAD SCI USA, V114, P2331, DOI 10.1073/pnas.1621436114; Meyer M, 1999, AM J PHYSIOL-HEART C, V276, pH779, DOI 10.1152/ajpheart.1999.276.3.H779; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Mouraret N, 2013, CIRCULATION, V127, P1664, DOI 10.1161/CIRCULATIONAHA.113.002434; Nam SY, 2011, ONCOGENE, V30, P4476, DOI 10.1038/onc.2011.150; Novoyatleva T, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0325-x; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Onodera Y, 2015, FEBS OPEN BIO, V5, P492, DOI 10.1016/j.fob.2015.06.001; Partovian C, 1998, AM J PHYSIOL-HEART C, V275, pH1948, DOI 10.1152/ajpheart.1998.275.6.H1948; Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0; Potus F, 2015, CIRCULATION, V132, P932, DOI 10.1161/CIRCULATIONAHA.115.016382; Provencher S, 2018, CIRC RES, V122, P1021, DOI 10.1161/CIRCRESAHA.117.312579; Ravi R, 2000, GENE DEV, V14, P34; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sajjad A, 2014, BBA-MOL CELL RES, V1843, P2556, DOI 10.1016/j.bbamcr.2014.06.019; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; SARGENT CA, 1992, J PHARMACOL EXP THER, V262, P1161; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Schmid T, 2004, BIOCHEM J, V380, P289, DOI 10.1042/BJ20031299; Song H, 1999, J HEART LUNG TRANSPL, V18, P744, DOI 10.1016/S1053-2498(98)00039-4; Sutendra G, 2013, J MOL MED, V91, P1315, DOI 10.1007/s00109-013-1059-4; Toth A, 2006, J BIOL CHEM, V281, P3679, DOI 10.1074/jbc.M509630200; Wang WG, 2005, CANCER BIOL THER, V4, P893, DOI 10.4161/cbt.4.8.2134; Yamamoto K, 2001, CIRCULATION, V104, P1670, DOI 10.1161/hc4001.097186; Yeh YH, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0577-y; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Zuckerbraun BS, 2006, J EXP MED, V203, P2109, DOI 10.1084/jem.20052267; Zungu-Edmondson M, 2016, CARDIOVASC RES, V110, P30, DOI 10.1093/cvr/cvw014	59	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234872	10.1371/journal.pone.0234872	http://dx.doi.org/10.1371/journal.pone.0234872			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559203	Green Published, gold			2022-12-27	WOS:000543261600012
J	Pearce, I; Clemens, A; Brent, MH; Lu, L; Gallego-Pinazo, R; Minnelle, AM; Creuzot-Garcher, C; Spital, G; Sakamoto, T; Dunger-Baldauf, C; McAllister, IL				Pearce, Ian; Clemens, Andreas; Brent, Michael H.; Lu, Lin; Gallego-Pinazo, Roberto; Minnelle, Angelo Maria; Creuzot-Garcher, Catherine; Spital, Georg; Sakamoto, Taiji; Dunger-Baldauf, Cornelia; McAllister, Ian L.		LUMINOUS Study Investigators	Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study	PLOS ONE			English	Article							MACULAR EDEMA; SUSTAINED BENEFITS; LASER	Objective To evaluate the effectiveness, safety, and treatment patterns of ranibizumab 0.5 mg in treatment-naive patients with branch retinal vein occlusion (BRVO) enrolled in the LUMINOUS((TM))study. Study design A 5-year, global, prospective, multicenter, observational, open-label study conducted in a clinical practice (real-world) setting at outpatient ophthalmology clinics that recruited 30,138 consenting adult patients from all approved indications for ranibizumab across 42 countries. Patients with BRVO were treated according to the local ranibizumab label of the participating countries. Mean change in visual acuity (VA) in Early Treatment Diabetic Retinopathy Study letters from baseline to Year 1, treatment exposure during Year 1, and adverse events (AEs) over 5 years were assessed. Results Of the 1366 recruited BRVO patients, 405 were treatment-naive at baseline with a mean (standard deviation [SD]) age of 67.9 (12.5) years, 57.5% were female, and 71.8% were White. At Year 1 (n = 189), the mean (SD) VA gain was 11.9 (17.66) letters from a baseline of 49.2 (+/- 20.32) letters with a mean (SD) of 5.0 (2.34) injections. VA gains were higher in patients (n = 83) who received 6-9 injections (13.6 [20.16] letters) than in those who received 2-5 injections (n = 92, 11.7 [15.43] letters), or 1 injection (n = 14, 3.6 [13.72] letters). Patients with baseline VA <23 letters had numerically highest VA gains (n = 20, 31.1 [24.48] letters). Over 5 years, the rate of ocular/non-ocular AEs was 7.4%/9.1% and serious AEs was 0.3%/4.4% in treatment-naive BRVO patients (n = 405). Conclusions One year results from the LUMINOUS real-world study showed a clinically meaningful VA improvement with ranibizumab in treatment-naive patients with BRVO; numerically higher VA gains were achieved in patients who received more injections and those with poor baseline VA. No new safety signals were observed.	[Pearce, Ian] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England; [Pearce, Ian] Univ Liverpool, Dept Eye & Vis Sci, Liverpool, Merseyside, England; [Clemens, Andreas; Dunger-Baldauf, Cornelia] Novartis Pharma AG, Basel, Switzerland; [Clemens, Andreas] Univ Freiburg, Heart Ctr Freiburg Univ, Fac Med, Dept Cardiol & Angiol 1, Freiburg, Germany; [Brent, Michael H.] Univ Toronto, Fac Med, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Lu, Lin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China; [Gallego-Pinazo, Roberto] Oftalvist Clin, Unit Macula, Valencia, Spain; [Minnelle, Angelo Maria] Catholic Univ Sacred Heart Fdn Policlin Univ A Ge, Dept Ophthalmol, Rome, Italy; [Creuzot-Garcher, Catherine] Ctr Hosp Univ, Dept Ophthalmol, Dijon, France; [Spital, Georg] St Franziskus Hosp, Dept Ophthalmol, Munster, Germany; [Sakamoto, Taiji] Kagoshima Univ, Dept Ophthalmol, Kagoshima, Japan; [McAllister, Ian L.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Perth, WA, Australia; [McAllister, Ian L.] Univ Western Australia, Lions Eye Inst, Perth, WA, Australia; [McAllister, Ian L.] Royal Perth Hosp, Dept Ophthalmol, Perth, WA, Australia	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Liverpool; Novartis; Universitats Herzzentrum Freiburg; University of Freiburg; University of Toronto; Sun Yat Sen University; CHU Dijon Bourgogne; St. Franziskus-Hospital; Kagoshima University; University of Western Australia; Lions Eye Institute; University of Western Australia; Royal Perth Hospital; University of Western Australia	Clemens, A (corresponding author), Novartis Pharma AG, Basel, Switzerland.; Clemens, A (corresponding author), Univ Freiburg, Heart Ctr Freiburg Univ, Fac Med, Dept Cardiol & Angiol 1, Freiburg, Germany.	andreas.clemens@novartis.com	minnella, angelo maria/AAQ-6250-2020	minnella, angelo maria/0000-0001-5896-5313; Clemens, Andreas/0000-0001-6192-1557	Novartis Pharma AG, Basel, Switzerland	Novartis Pharma AG, Basel, Switzerland	This study was funded and sponsored by Novartis Pharma AG, Basel, Switzerland and is registered with https://clinicaltrials.gov/(NCT01318941).The sponsor had a role in the study design, conducting the study, data collection, data analysis, data interpretation and manuscript preparation. Additionally, Novartis Pharma AG was responsible for the conduct of the study and oversight of the collection and management of data. The funder also provided support in the form of salaries for authors [A.C and C.D-B].	[Anonymous], 2018, NOVARTIS DATA FILE D; Bandello F, 2018, EUR J OPHTHALMOL, V28, P697, DOI 10.1177/1120672117750058; Brown DM, 2011, OPHTHALMOLOGY, V118, P1594, DOI 10.1016/j.ophtha.2011.02.022; Campochiaro PA, 2014, OPHTHALMOLOGY, V121, P2432, DOI 10.1016/j.ophtha.2014.06.011; Campochiaro PA, 2014, OPHTHALMOLOGY, V121, P209, DOI 10.1016/j.ophtha.2013.08.038; European Medicines Agency, 2016, LUC SUMM PROD CHAR; Food and Drug Administration, 2017, LUC PRESCR INF; Hattenbach LO, 2018, ACTA OPHTHALMOL, V96, pE10, DOI 10.1111/aos.13381; Heier JS, 2012, OPHTHALMOLOGY, V119, P802, DOI 10.1016/j.ophtha.2011.12.005; Holz FG, 2020, RETINA-J RET VIT DIS, V40, P1673, DOI 10.1097/IAE.0000000000002670; Holz FG, 2016, BRIT J OPHTHALMOL, V100, P1623, DOI 10.1136/bjophthalmol-2015-308166; Kim SJ, 2015, J KOREAN MED SCI, V30, P475, DOI 10.3346/jkms.2015.30.4.475; Lunt B, 2019, PROCEEDINGS OF THE 20TH ANNUAL CONFERENCE ON INFORMATION TECHNOLOGY EDUCATION (SIGITE '19), P5, DOI 10.1145/3349266.3351413; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Prunte C, 2016, BRIT J OPHTHALMOL, V100, P787, DOI 10.1136/bjophthalmol-2015-307249; Pulido JS, 2016, OPHTHALMOLOGY, V123, pP209, DOI [10.1016/j.ophtha.2015.10.045, 10.1016/j.ophtha.2015.10.047]; Rezar S, 2015, ACTA OPHTHALMOL, V93, P719, DOI 10.1111/aos.12772; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Sharma S, 2019, OPHTHALMOLOGICA, V241, P24, DOI 10.1159/000488602; Song PG, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010427; Tadayoni R, 2017, OPHTHALMOLOGY, V124, P1778, DOI 10.1016/j.ophtha.2017.06.027; Tadayoni R, 2016, OPHTHALMOLOGY, V123, P1332, DOI 10.1016/j.ophtha.2016.02.030; Tufail A, 2014, OPHTHALMOLOGY, V121, P1092, DOI 10.1016/j.ophtha.2013.11.031; Vaz-Pereira S, 2017, EUR J OPHTHALMOL, V27, P756, DOI 10.5301/ejo.5000943; Ziemssen F, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0401-y	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234739	10.1371/journal.pone.0234739	http://dx.doi.org/10.1371/journal.pone.0234739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555630	gold, Green Published			2022-12-27	WOS:000543273200070
J	Baron, JN; Aznar, MN; Monterubbianesi, M; Martinez-Lopez, B				Baron, Jerome N.; Aznar, Maria N.; Monterubbianesi, Mariela; Martinez-Lopez, Beatriz			Application of network analysis and cluster analysis for better prevention and control of swine diseases in Argentina	PLOS ONE			English	Article							CATTLE MOVEMENTS; CENTRALITY; PATTERNS	Rationale/background Though much smaller than the bovine industry, the porcine sector in Argentina involves a large number of farms and represents a significant economic sector. In recent years Argentina has implemented a national registry of swine movements amongst other measures, in an effort to control and eventually eradicate endemic Aujesky's disease. Such information can prove valuable in assessing the risk of transmission between farms for endemic diseases but also for other diseases at risk of emergence. Methods Shipment data from 2011 to 2016 were analyzed in an effort to define strategic locations and times at which control and surveillance efforts should be focused to provide cost-effective interventions. Social network analysis (SNA) was used to characterize the network as a whole and at the individual farm and market level to help identify important nodes. Spatio-temporal trends of pig movements were also analyzed. Finally, in an attempt to classify farms and markets in different groups based on their SNA metrics, we used factor analysis for mixed data (FAMD) and hierarchical clustering. Results The network involved approximate 136,000 shipments for a total of 6 million pigs. Over 350 markets and 17,800 production units participated in shipments with another 83,500 not participating. Temporal data of shipments and network metrics showed peaks in shipments in September and October. Most shipments where within provinces, with Buenos Aires, Cordoba and Santa Fe concentrating 61% of shipments. Network analysis showed that markets are involved in relatively few shipments but hold strategic positions with much higher betweenness compared to farms. Hierarchical clustering yielded four groups based on SNA metrics and node characteristics which can be broadly described as: 1. small and backyard farms; 2. industrial farms; 3. markets; and 4. a single outlying market with extreme centrality values. Conclusion Characterizing the network structure and spatio-temporal characteristics of Argentine swine shipments provides valuable information that can guide targeted and more cost-effective surveillance and control programs. We located key nodes where efforts should be prioritized. Pig network characteristics and patterns can be used to create dynamic disease transmission models, which can both be used in assessing the impact of emerging diseases and guiding efforts to eradicate endemic ones.	[Baron, Jerome N.; Martinez-Lopez, Beatriz] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Ctr Anim Dis Modeling & Surveillance CADMS, Davis, CA 95616 USA; [Aznar, Maria N.] Inst Nacl Tecnol Agr & NTA, Buenos Aires, DF, Argentina; [Monterubbianesi, Mariela] Serv Nacl Sanidad & Calidad Agroalimentaria Repub, Buenos Aires, DF, Argentina	University of California System; University of California Davis	Baron, JN (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Ctr Anim Dis Modeling & Surveillance CADMS, Davis, CA 95616 USA.	jnbaron@ucdavis.edu	Lopez, Beatriz Martinez/AAE-6692-2021	Baron, Jerome/0000-0002-9036-1218				[Anonymous], 2013, AM J KIDNEY DIS    S, V63, pe1; [Anonymous], MAD NAT EARTH 1 50M; Aznar MN, 2011, PREV VET MED, V98, P119, DOI 10.1016/j.prevetmed.2010.11.004; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Brandes U, 2005, LECT NOTES COMPUT SC, V3418, P7; Buttner K, 2013, PREV VET MED, V110, P418, DOI 10.1016/j.prevetmed.2013.01.008; CSARDI G., 2006, INTERJOURNAL COMPLEX, V1695; Echeverria M G, 1992, Rev Sci Tech, V11, P819; Environmental Systems Research Institute (ESRI), 2017, ARCGIS PROF HELP; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; FRIEDKIN NE, 1984, SOCIOL METHOD RES, V12, P235, DOI 10.1177/0049124184012003001; Gorsich EE, 2016, PREV VET MED, V134, P82, DOI 10.1016/j.prevetmed.2016.09.023; INDEC (Instituto National de Estadistica y Censos), 2010, CENS BIC SER B, V1; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Koschutzki D, 2005, LECT NOTES COMPUT SC, V3418, P16; Kukielka EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178904; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee K, 2017, PREV VET MED, V138, P113, DOI 10.1016/j.prevetmed.2017.02.001; Leon EA, 2006, PREV VET MED, V76, P109, DOI 10.1016/j.prevetmed.2006.04.010; Martinez-Lopez B, 2009, PREV VET MED, V91, P29, DOI 10.1016/j.prevetmed.2009.05.007; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; OIE, WORLD AN HLTH INF DA; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Proctor C.H., 1951, RES METHODS SOCIAL R, P561; R Core Team, 2018, R LANG ENV STAT COMP; Relun A, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00004; Ribbens S, 2004, VET QUART, V26, P146, DOI 10.1080/01652176.2004.9695177; VanderWaal KL, 2016, PREV VET MED, V123, P12, DOI 10.1016/j.prevetmed.2015.12.003; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wint W., 2007, GRIDDED LIVESTOCK WO, pp 131	32	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234489	10.1371/journal.pone.0234489	http://dx.doi.org/10.1371/journal.pone.0234489			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555649	Green Published, gold			2022-12-27	WOS:000542759600021
J	Gogos, BJ; Larkin, P; Haycraft, JAZ; Collier, NF; Robertson, S				Gogos, Benjamin J.; Larkin, Paul; Haycraft, Jade A. Z.; Collier, Neil French; Robertson, Sam			Combine performance, draft position and playing position are poor predictors of player career outcomes in the Australian Football League	PLOS ONE			English	Article							TALENT IDENTIFICATION; DECISION-MAKING; RULES FOOTBALL; LOSS AVERSION; NFL COMBINE	Physical testing-based draft combines are undertaken across various sporting codes to inform talent selection. To determine the explanatory power of the Australian football league (AFL) draft combine, participants drafted between 1999-2016 (n= 1488) were assessed. Testing performance, draft selection order and playing position, AFL matches played, AFL player ranking points and AFL player rating points were collected as career outcomes. Boosted regression tree analysis revealed that position and draft selection order were the most explanatory variables of career outcomes. Linear modelling based on testing results is able to explain 4% of matches played and 3% of in-game performance measures. Each individual combine test explained <2% of the matches played outcome. Draft selection order demonstrated mixed results for career outcomes relative to playing position. For instance, key forwards and draft selection order were observed as a slight negative relationship using the AFL Player Ranking points career outcome measure. These findings indicate that the AFL draft combine is a poor measure for informing talent selection, thus providing minimal utility for the practices investigated in this study.	[Gogos, Benjamin J.; Larkin, Paul; Haycraft, Jade A. Z.; Collier, Neil French; Robertson, Sam] Victoria Univ, Inst Hlth & Sport iHES, Melbourne, Vic, Australia; [Larkin, Paul] Maribyrnong Sports Acad, Melbourne, Vic, Australia	Victoria University	Gogos, BJ (corresponding author), Victoria Univ, Inst Hlth & Sport iHES, Melbourne, Vic, Australia.	benjamin.gogos@live.vu.edu.au	Larkin, Paul/AAV-2213-2020	Robertson, Samuel/0000-0002-8330-0011; Haycraft, Jade/0000-0002-2745-2969; Gogos, Benjamin/0000-0001-7007-1873; Collier, Neil/0000-0003-0115-0564	Natural Science Foundation of China [71704070]; Ministry of Education for the Humanities and Social Sciences Research Young Fund on the West and Borderland Project [17XJC790002]; Guangdong Provincial Natural Science Foundation of China [2017A030313443]; National social science fund [17BJY061]; Major program of National Social Science Fund [18zda004]; Program of Lanzhou University of Finance and Economics [Lzufe2018B-06]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education for the Humanities and Social Sciences Research Young Fund on the West and Borderland Project; Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); National social science fund; Major program of National Social Science Fund; Program of Lanzhou University of Finance and Economics	This work was supported by the Natural Science Foundation of China under Grant [number 71704070]; Ministry of Education for the Humanities and Social Sciences Research Young Fund on the West and Borderland Project [number 17XJC790002]; Guangdong Provincial Natural Science Foundation of China under Grant [number 2017A030313443]; National social science fund [number 17BJY061], Major program of National Social Science Fund [number 18zda004],and Program of Lanzhou University of Finance and Economics under Grant [number Lzufe2018B-06].	Abbott A, 2002, HIGH ABIL STUD, V13, P157, DOI 10.1080/1359813022000048798; Abbott Angela, 2005, Nonlinear Dynamics Psychol Life Sci, V9, P61; AFL, 2019, 2019 NAB AFL DRAFT; AFL, 2018, BROWNL MED HUB; [Anonymous], 2020, AUSTR FOOTBALL LEAGU; Bonney N, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00429; Boxall P, 2007, OXFORD HDB HUMAN RES; Burgess D, 2012, J SCI MED SPORT, V15, P561, DOI 10.1016/j.jsams.2012.01.006; Burke L M, 1985, Br J Sports Med, V19, P100; Burr JF, 2008, J STRENGTH COND RES, V22, P1535, DOI 10.1519/JSC.0b013e318181ac20; Davids K, 2000, J SPORT SCI, V18, P703, DOI 10.1080/02640410050120087; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Gray AJ, 2010, SPORTS MED, V40, P347, DOI 10.2165/11531400-000000000-00000; Groothuis PA, 2009, APPL ECON, V41, P3193, DOI 10.1080/00036840701564459; Hijmans R.J., 2017, CIRCLES, V9, P1, DOI DOI 10.1016/J.JHYDROL.2011.07.022; Jackson K., 2009, SWINBURNE VENTURE MA; Keogh J, 1999, J Sci Med Sport, V2, P125, DOI 10.1016/S1440-2440(99)80192-3; Kiesel A, 2006, PSYCHON B REV, V13, P800, DOI 10.3758/BF03194000; Kuzmits FE, 2008, J STRENGTH COND RES, V22, P1721, DOI 10.1519/JSC.0b013e318185f09d; Massey C, 2013, MANAGE SCI, V59, P1479, DOI 10.1287/mnsc.1120.1657; McGee KJ, 2003, J STRENGTH COND RES, V17, P6; McIntosh S, 2018, INT J SPORTS SCI COA, V13, P1064, DOI 10.1177/1747954118758000; Meil AJ, 2018, PREDICTING SUCCESS U; Morris T, 2000, J SPORT SCI, V18, P715, DOI 10.1080/02640410050120096; Pyne DB, 2005, J SCI MED SPORT, V8, P321, DOI 10.1016/S1440-2440(05)80043-X; R Core Team, 2021, R LANG ENV STAT COMP; Robbins DW, 2010, J STRENGTH COND RES, V24, P2888, DOI 10.1519/JSC.0b013e3181f927cc; Robertson S, 2015, J SCI MED SPORT, V18, P601, DOI 10.1016/j.jsams.2014.07.019; Simonton DK, 1999, PSYCHOL REV, V106, P435, DOI 10.1037/0033-295X.106.3.435; STAW BM, 1995, ADMIN SCI QUART, V40, P474, DOI 10.2307/2393794; Tanner R., 2012, PHYSL TESTS ELITE AT; Teramoto M, 2018, J STRENGTH COND RES, V32, P396, DOI 10.1519/JSC.0000000000001798; Teramoto M, 2016, J STRENGTH COND RES, V30, P1379, DOI 10.1519/JSC.0000000000001202; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Woods CT, 2017, J SPORT SCI, V35, P1879, DOI 10.1080/02640414.2016.1240879; Woods CTE, 2015, J SCI MED SPORT, V18, P225, DOI 10.1016/j.jsams.2014.02.006; Young WB, 2005, J SCI MED SPORT, V8, P333, DOI 10.1016/S1440-2440(05)80044-1	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234400	10.1371/journal.pone.0234400	http://dx.doi.org/10.1371/journal.pone.0234400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555713	gold, Green Accepted, Green Published			2022-12-27	WOS:000542759600024
J	Kapitany, R; Nelson, N; Burdett, ERR; Goldstein, TR				Kapitany, Rohan; Nelson, Nicole; Burdett, Emily R. R.; Goldstein, Thalia R.			The child's pantheon: Children's hierarchical belief structure in real and non-real figures	PLOS ONE			English	Article							SANTA-CLAUS; RITUALIZED BEHAVIOR; INTERNAL STRUCTURE; EASTER-BUNNY; CANDY WITCH; FANTASY; GOD; DISTINCTION; MONSTERS	To what extent do children believe in real, unreal, natural and supernatural figures relative to each other, and to what extent are features of culture responsible for belief? Are some figures, like Santa Claus or an alien, perceived as more real than figures like Princess Elsa or a unicorn? We categorized 13 figures into five a priori categories based on 1) whether children receive direct evidence of the figure's existence, 2) whether children receive indirect evidence of the figure's existence, 3) whether the figure was associated with culture-specific rituals or norms, and 4) whether the figure was explicitly presented as fictional. We anticipated that the categories would be endorsed in the following order: 'Real People' (a person known to the child,The Wiggles), 'Cultural Figures' (Santa Claus,The Easter Bunny,The Tooth Fairy), 'Ambiguous Figures' (Dinosaurs,Aliens), 'Mythical Figures' (unicorns,ghosts,dragons), and 'Fictional Figures' (Spongebob Squarepants,Princess Elsa,Peter Pan). In total, we analysed responses from 176 children (aged 2-11 years) and 56 adults for 'how real' they believed 13 individual figures were (95 children were examined online by their parents, and 81 children were examined by trained research assistants). A cluster analysis, based exclusively on children's 'realness' scores, revealed a structure supporting our hypotheses, and multilevel regressions revealed a sensible hierarchy of endorsement with differing developmental trajectories for each category of figures. We advance the argument that cultural rituals are a special form of testimony that influences children's reality/fantasy distinctions, and that rituals and norms for 'Cultural Figures' are a powerful and under-researched factor in generating and sustaining a child's endorsement for a figure's reality status. All our data and materials are publically available at https://osf.io/wurxy/.	[Kapitany, Rohan] Keele Univ, Sch Psychol, Keele, Staffs, England; [Kapitany, Rohan; Burdett, Emily R. R.] Univ Oxford, Sch Anthropol & Museum Ethnol, Oxford, England; [Nelson, Nicole] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Burdett, Emily R. R.] Univ Nottingham, Nottingham, England; [Goldstein, Thalia R.] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	Keele University; University of Oxford; University of Queensland; University of Nottingham; George Mason University	Kapitany, R (corresponding author), Keele Univ, Sch Psychol, Keele, Staffs, England.; Kapitany, R (corresponding author), Univ Oxford, Sch Anthropol & Museum Ethnol, Oxford, England.	r.f.kapitany@keele.ac.uk	Kapitany, Rohan/N-8437-2018; Nelson, Nicole/P-1078-2014	Kapitany, Rohan/0000-0002-1944-2613; Nelson, Nicole/0000-0001-8299-4798	Horizon 2020 Excellent Science Grant, ERC [694986]	Horizon 2020 Excellent Science Grant, ERC	This research was supported by funding from Horizon 2020 Excellent Science Grant provided by the ERC (Ritual Modes, No. 694986).	ANDERSON CJ, 1994, CHILD PSYCHIAT HUM D, V25, P67, DOI 10.1007/BF02253287; Atkinson QD, 2011, EVOL HUM BEHAV, V32, P50, DOI 10.1016/j.evolhumbehav.2010.09.002; Barrett JL, 2008, J COGN CULT, V8, P149, DOI 10.1163/156770908X289251; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; BLAIR JR, 1980, PSYCHOL REP, V46, P691, DOI 10.2466/pr0.1980.46.3.691; Boerger EA, 2009, BRIT J DEV PSYCHOL, V27, P953, DOI 10.1348/026151008X398557; Boyer P, 2006, BEHAV BRAIN SCI, V29, P595, DOI 10.1017/S0140525X06009332; Bunce L, 2008, BRIT J DEV PSYCHOL, V26, P445, DOI 10.1348/026151007X258733; Bunce L, 2013, DEV PSYCHOL, V49, P1494, DOI 10.1037/a0030608; Canfield CF, 2014, J COGN DEV, V15, P269, DOI 10.1080/15248372.2013.777841; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; FLAVELL JH, 1983, COGNITIVE PSYCHOL, V15, P95, DOI 10.1016/0010-0285(83)90005-1; Formann AK., 1984, LATENT CLASS ANAL EI; Gervais WM, 2010, J COGN CULT, V10, P383, DOI 10.1163/156853710X531249; Goldstein TR, 2016, COGNITIVE DEV, V39, P113, DOI 10.1016/j.cogdev.2016.04.002; GOLOMB C, 1995, DEV PSYCHOL, V31, P800, DOI 10.1037/0012-1649.31.5.800; Harris P.L., 2000, WORK IMAGINATION; Harris PL, 2006, DEVELOPMENTAL SCI, V9, P76, DOI 10.1111/j.1467-7687.2005.00465.x; HARRIS PL, 1991, BRIT J DEV PSYCHOL, V9, P105, DOI 10.1111/j.2044-835X.1991.tb00865.x; Henrich J, 2009, EVOL HUM BEHAV, V30, P244, DOI 10.1016/j.evolhumbehav.2009.03.005; King AC, 2011, J GENET PSYCHOL, V172, P414, DOI 10.1080/00221325.2011.554921; Knight N, 2004, COGNITIVE SCI, V28, P117, DOI 10.1016/j.cogsci.2003.09.002; McCauley RN, 2006, BEHAV BRAIN SCI, V29, P623, DOI 10.1017/S0140525X06009447; Nyhof MA, 2017, BRIT J DEV PSYCHOL, V35, P60, DOI 10.1111/bjdp.12173; Piazza J, 2011, J EXP CHILD PSYCHOL, V109, P311, DOI 10.1016/j.jecp.2011.02.003; PRENTICE NM, 1979, J AM ACAD CHILD PSY, V18, P658, DOI 10.1016/S0002-7138(09)62213-5; PRENTICE NM, 1978, AM J ORTHOPSYCHIAT, V48, P618, DOI 10.1111/j.1939-0025.1978.tb02566.x; Purzycki BG, 2012, COGNITIVE SCI, V36, P846, DOI 10.1111/j.1551-6709.2012.01242.x; REVELLE W, 1979, MULTIVAR BEHAV RES, V14, P57, DOI 10.1207/s15327906mbr1401_4; Robinson EJ, 2008, COGNITIVE DEV, V23, P105, DOI 10.1016/j.cogdev.2007.05.001; Rossano MJ, 2012, PSYCHOL BULL, V138, P529, DOI 10.1037/a0027038; Sarstedt M., 2014, CONCISE GUIDE MARKET; Sharon T, 2004, BRIT J DEV PSYCHOL, V22, P293, DOI 10.1348/026151004323044627; Shtulman A, 2015, COGNITIVE DEV, V34, P51, DOI 10.1016/j.cogdev.2014.12.006; Skolnick D, 2006, COGNITION, V101, pB9, DOI 10.1016/j.cognition.2005.10.001; Tryfos P., 1998, METHODS BUSINESS ANA; van Buuren S, 2011, J STAT SOFTW, V45, P1; Weisberg DS, 2009, DEVELOPMENTAL SCI, V12, P699, DOI 10.1111/j.1467-7687.2009.00819.x; Whitehouse Harvey, 2004, MODES RELIGIOSITY CO; Wigger JB, 2013, INT J PSYCHOL RELIG, V23, P2, DOI 10.1080/10508619.2013.739059; Woolley JD, 2013, CHILD DEV, V84, P1496, DOI 10.1111/cdev.12081; WOOLLEY JD, 1990, CHILD DEV, V61, P946, DOI 10.2307/1130867; Woolley JD, 2004, DEVELOPMENTAL SCI, V7, P456, DOI 10.1111/j.1467-7687.2004.00366.x; Woolley JD, 1997, CHILD DEV, V68, P991, DOI 10.2307/1132282	44	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234142	10.1371/journal.pone.0234142	http://dx.doi.org/10.1371/journal.pone.0234142			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555692	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000542759600058
J	Akoto, C; Chan, CYS; Ravi, K; Zhang, W; Vatish, M; Norris, SA; Hemelaar, J				Akoto, Charlene; Chan, Christina Y. S.; Ravi, Krithi; Zhang, Wei; Vatish, Manu; Norris, Shane A.; Hemelaar, Joris			gamma delta T cell frequencies are altered in HIV positive pregnant South African women and are associated with preterm birth	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PERIPHERAL-BLOOD; MYCOBACTERIUM-TUBERCULOSIS; TH17 CELLS; IFN-GAMMA; RECOGNITION; RECEPTOR; LYMPHOCYTES; INCREASE; OUTCOMES	Background Preterm birth is the leading cause of neonatal and child mortality worldwide. Maternal HIV infection and antiretroviral treatment (ART) increase the rate of preterm birth, but the underlying mechanisms remain unknown, limiting progress in prediction, prevention and treatment. While overall gamma delta T cell levels remain constant, acute HIV infection is associated with a depletion of the V delta 2 subset and an increase in the V delta 1 subset, which do not return to baseline with ART. gamma delta T cells have also been implicated in adverse pregnancy outcomes and we therefore investigated the potential association between maternal HIV infection, peripheral gamma delta T cell frequencies and preterm birth. Methods Study participants were HIV positive (n = 47) and HIV negative (n = 45) women enrolled in a prospective pregnancy cohort study at Chris Hani Baragwanath Academic Hospital in Soweto, South Africa. Women were enrolled in early pregnancy and gestational age was accurately determined by first trimester ultrasound scan. Peripheral blood samples were collected in each trimester and peripheral blood mononuclear cells isolated. Frequencies of gamma delta T cells, V delta 1+ and V delta 2+ gamma delta T cell subsets, and CCR6 chemokine receptor expression were determined by flow cytometry. Results Total gamma delta T cell levels were similar between HIV positive and HIV negative women throughout pregnancy. However, in each trimester maternal HIV infection was associated with reduced levels of the V delta 2+ subset and increased levels of the V delta 1+ subset, leading to a reversal of the V delta 1/V delta 2 ratio. Timing of ART initiation among HIV positive women did not affect levels of gamma delta T cells, the V delta 1+ and V delta 2+ subsets, or the V delta 1/V delta 2 ratio. Importantly, preterm birth was associated with lower total gamma delta T cell levels in early pregnancy and gamma delta T cell frequencies were lowest in HIV positive women who delivered preterm. Moreover, in the first trimester the proportion of V delta 1+ T cells that were CCR6+ was significantly reduced in HIV+ women and women who delivered preterm, resulting in the lowest proportion of CCR6+ V delta 1 T cells in HIV positive women who delivered preterm. Conclusions Our findings suggest that altered gamma delta T cell frequencies may link maternal HIV infection and preterm birth. gamma delta T cell frequencies in early pregnancy may serve as predictive biomarkers to identify women at risk of delivering preterm.	[Akoto, Charlene; Chan, Christina Y. S.; Ravi, Krithi; Zhang, Wei; Vatish, Manu; Norris, Shane A.; Hemelaar, Joris] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Womens & Reprod Hlth, Womens Ctr, Oxford, England; [Norris, Shane A.; Hemelaar, Joris] Univ Witwatersrand, South African Med Res Council, Dev Pathways Hlth Res Unit, Dept Paediat,Sch Clin Med, Johannesburg, South Africa	University of Oxford; South African Medical Research Council; University of Witwatersrand	Hemelaar, J (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Womens & Reprod Hlth, Womens Ctr, Oxford, England.; Hemelaar, J (corresponding author), Univ Witwatersrand, South African Med Res Council, Dev Pathways Hlth Res Unit, Dept Paediat,Sch Clin Med, Johannesburg, South Africa.	joris.hemelaar@wrh.ox.ac.uk	Norris, Shane/C-4664-2014; vatish, manu/AAY-8750-2020	Norris, Shane/0000-0001-7124-3788; vatish, manu/0000-0002-6012-2574; Akoto, Charlene/0000-0003-3355-1688; Hemelaar, Joris/0000-0003-3523-7457	Higher Education Funding Council for England (HEFCE) [0005078]; Oxford University Clinical Academic Graduate School (OUCAGS)	Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Oxford University Clinical Academic Graduate School (OUCAGS)	Grants from the Higher Education Funding Council for England (HEFCE; reference number 0005078) and Oxford University Clinical Academic Graduate School (OUCAGS; no grant number) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2015, CELL IMMUNOL, V296, P31, DOI 10.1016/j.cellimm.2015.04.008; Altincicek B, 2001, J IMMUNOL, V166, P3655, DOI 10.4049/jimmunol.166.6.3655; [Anonymous], 2017, FUEL CELLS B, V2017, P5, DOI [DOI 10.1016/S1464-2859(17)30347-4, 10.1016/S1464-2859(17)30346-2, DOI 10.1016/S1464-2859(17)30346-2]; AUTRAN B, 1989, CLIN EXP IMMUNOL, V75, P206; Barakonyi A, 2002, J IMMUNOL, V168, P2683, DOI 10.4049/jimmunol.168.6.2683; Bonneville M, 2005, MICROBES INFECT, V7, P503, DOI 10.1016/j.micinf.2005.03.004; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Chetty T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192805; Child Trends Databank, 2018, SEXUALLY TRANSMITTED; CHRISTMAS SE, 1993, IMMUNOLOGY, V78, P436; DEMARIA A, 1992, J INFECT DIS, V165, P917, DOI 10.1093/infdis/165.5.917; Dieli F, 2001, J INFECT DIS, V184, P1082, DOI 10.1086/323600; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dudal S, 2006, J IMMUNOL, V177, P5533, DOI 10.4049/jimmunol.177.8.5533; Fan DX, 2011, CLIN IMMUNOL, V141, P284, DOI 10.1016/j.clim.2011.07.008; Fenoglio D, 2009, BLOOD, V113, P6611, DOI 10.1182/blood-2009-01-198028; Fowler MG, 2016, NEW ENGL J MED, V375, P1726, DOI 10.1056/NEJMoa1511691; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Hintz M, 2001, FEBS LETT, V509, P317, DOI 10.1016/S0014-5793(01)03191-X; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jomaa H, 1999, FEMS IMMUNOL MED MIC, V25, P371, DOI 10.1111/j.1574-695X.1999.tb01362.x; KABELITZ D, 1991, J EXP MED, V173, P1331, DOI 10.1084/jem.173.6.1331; Kaminski VD, 2018, MOL BIOL REP, V45, P1565, DOI 10.1007/s11033-018-4268-7; Kourtis AP, 2007, AIDS, V21, P607, DOI 10.1097/QAD.0b013e32802ef2f6; Laggner U, 2011, J IMMUNOL, V187, P2783, DOI 10.4049/jimmunol.1100804; Li Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106064; Lombardelli Letizia, 2016, Clin Mol Allergy, V14, P1, DOI 10.1186/s12948-016-0039-y; Luoma AM, 2013, IMMUNITY, V39, P1032, DOI 10.1016/j.immuni.2013.11.001; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Maeurer MJ, 1996, J EXP MED, V183, P1681, DOI 10.1084/jem.183.4.1681; Malaba TR, 2017, INT J EPIDEMIOL, V46, P1678, DOI 10.1093/ije/dyx136; Mandala WL, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12678; MINCHEVANILSSON L, 1992, J IMMUNOL, V149, P2203; MinchevaNilsson L, 1997, J IMMUNOL, V159, P3266; Mofenson LM, 2016, J INFECT DIS, V213, P1051, DOI 10.1093/infdis/jiv390; Nagaeva O, 2002, AM J REPROD IMMUNOL, V48, P9, DOI 10.1034/j.1600-0897.2002.01131.x; Ness-Schwickerath KJ, 2010, J IMMUNOL, V184, P7268, DOI 10.4049/jimmunol.1000600; Nielsen MM, 2017, NAT REV IMMUNOL, V17, P733, DOI 10.1038/nri.2017.101; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Oo YH, 2012, J HEPATOL, V57, P1044, DOI 10.1016/j.jhep.2012.07.008; Pintye J, 2017, J INFECT DIS, V216, P1561, DOI 10.1093/infdis/jix542; Poles MA, 2003, J VIROL, V77, P10456, DOI 10.1128/JVI.77.19.10456-10467.2003; Polgar B, 1999, AM J REPROD IMMUNOL, V41, P239; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Ribot JC, 2014, J IMMUNOL, V192, P2237, DOI 10.4049/jimmunol.1303119; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Rossol R, 1998, BRIT J HAEMATOL, V100, P728, DOI 10.1046/j.1365-2141.1998.00630.x; Saifi B, 2014, REPROD BIOMED ONLINE, V29, P481, DOI 10.1016/j.rbmo.2014.06.008; Santosa WB, 2019, AIDS, V33, P1623, DOI 10.1097/QAD.0000000000002222; SCHONDELMAIER S, 1993, IMMUNOL LETT, V38, P121, DOI 10.1016/0165-2478(93)90176-3; Strbo N, 2016, AM J REPROD IMMUNOL, V75, P134, DOI 10.1111/aji.12458; Szekeres-Bartho J, 2001, SEMIN IMMUNOL, V13, P229, DOI 10.1006/smim.2000.0318; Talukdar A, 2018, CYTOKINE, V102, P117, DOI 10.1016/j.cyto.2017.07.018; Terzieva A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030687; Tham M, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0925-1; Todaro M, 2009, J IMMUNOL, V182, P7287, DOI 10.4049/jimmunol.0804288; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; UNICEF, 2018, EL MOTH CHILD TRANSM; Uthman OA, 2017, LANCET HIV, V4, pE21, DOI 10.1016/S2352-3018(16)30195-3; Wallace M, 1997, MOL MED, V3, P60, DOI 10.1007/BF03401668; Wedi COO, 2016, LANCET HIV, V3, pE33, DOI 10.1016/S2352-3018(15)00207-6; WHO, 2017, WHO GLOB HLTH OBS GH; Wu HX, 2014, CELL MOL IMMUNOL, V11, P253, DOI 10.1038/cmi.2013.67; Zhang XX, 2015, GENET MOL RES, V14, P9145, DOI 10.4238/2015.August.7.24	69	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235162	10.1371/journal.pone.0235162	http://dx.doi.org/10.1371/journal.pone.0235162			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584913	Green Published, gold			2022-12-27	WOS:000545747200062
J	Balachandra, S; Rogers, JH; Ruangtragool, L; Radin, E; Musuka, G; Oboho, I; Paulin, H; Parekh, B; Birhanu, S; Takarinda, KC; Hakim, A; Apollo, T				Balachandra, S.; Rogers, J. H.; Ruangtragool, L.; Radin, E.; Musuka, G.; Oboho, I.; Paulin, H.; Parekh, B.; Birhanu, S.; Takarinda, K. C.; Hakim, A.; Apollo, T.			Concurrent advanced HIV disease and viral load suppression in a high-burden setting: Findings from the 2015-6 ZIMPHIA survey	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TRENDS; CARE; PREVALENCE; COUNTRIES	Background As Zimbabwe approaches epidemic control of HIV, programs now prioritize viral load over CD4 monitoring, making it difficult to identify persons living with HIV (PLHIV) suffering from advanced disease (AD). We present an analysis of cross-sectional ZIMPHIA data, highlighting PLHIV with AD and concurrent viral load suppression (VLS). Methods ZIMPHIA collected blood specimens for HIV testing from 22,501 consenting adults (ages 15 years and older); 3,466 PLHIV had CD4 and VL results. Household HIV testing used the national serial algorithm, and those testing positive then received point-of-care CD4 enumeration with subsequent VL testing. We used logistic regression analysis to explore factors associated with concurrent AD and VLS (<1000 copies/mL). All analyses were weighted to account for complex survey design. Results Of the 3,466 PLHIV in the survey with CD4 and VL results, 17% were found to have AD (CD4<200cells/mm(3)). Of all AD patients, 30% had VLS. Concurrent AD and VLS was associated with male sex (aOR 2.45 95%CI 1.61-3.72), older age (35-49 years [aOR 2.46 95%CI 1.03-5.91] and 50+ years [aOR 4.82 95%CI 2.02-11.46] vs 15-24 years), and ART duration (<6 months [aOR 0.46 95%CI 0.29-0.76] and 6-24 months [aOR 2.07 95%CI 1.35-3.17] vs more than 2 years). The relationship between sex and AD is driven by age with significant associations among men aged 25-34, (aOR 3.37 95%CI 1.35-8.41), 35-49 (aOR 5.13 95%CI 2.16-12.18), and 50+ (aOR 12.56 95%CI 4.82-32.72) versus men aged 15-24. Conclusions The percentage of PLHIV with AD and VLS illustrates the conundrum of decreased support for CD4 monitoring, as these patients may not receive appropriate clinical services for advanced HIV disease. In high-prevalence settings such as Zimbabwe, CD4 monitoring support warrants further consideration to differentiate care appropriately for the most vulnerable PLHIV. Males may need to be prioritized, given their over-representation in this sub-population.	[Balachandra, S.; Rogers, J. H.] US Centers Dis Control & Prevent, Div Global HIV & TB, Harare, Zimbabwe; [Ruangtragool, L.] US Centers Dis Control & Prevent, Harare, Zimbabwe; [Radin, E.] ICAP New York, New York, NY USA; [Musuka, G.] ICAP Zimbabwe, Avondale, PA, Zimbabwe; [Oboho, I.; Paulin, H.; Parekh, B.; Birhanu, S.; Hakim, A.] US Ctr Dis & Prevent, Div Global HIV & TB, Atlanta, GA USA; [Takarinda, K. C.; Apollo, T.] Minist Hlth & Child Care, Harare, Zimbabwe		Balachandra, S (corresponding author), US Centers Dis Control & Prevent, Div Global HIV & TB, Harare, Zimbabwe.	ymx1@cdc.gov		Musuka, Godfrey/0000-0001-9077-4429	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [U2GGH001226]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	ZIMPHIA 2015-2016 was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) to ICAP at Columbia University under the terms of cooperative agreement #U2GGH001226. The funder provided support in the form of salaries for authors (CDCSB, JR, LR, IO, HP, BP, SBi, AH; ICAP-ER, GM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2019, LIF EXP BIRTH; [Anonymous], 2012, ART OUTC PEOPL LIV H; [Anonymous], 2019, ZIMB POP BAS HIV IMP; [Anonymous], 2019, UNAIDS COUNTR FACT S; Asmelash A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-331; Auld AF, 2017, MMWR-MORBID MORTAL W, V66, P558, DOI 10.15585/mmwr.mm6621a3; Burrage A, 2018, MMWR-MORBID MORTAL W, V67, P552, DOI 10.15585/mmwr.mm6719a4; Carmona S, 2018, CLIN INFECT DIS, V66, pS111, DOI 10.1093/cid/ciy045; Davies MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081037; Fomundam HN, 2017, SAMJ S AFR MED J, V107, P1058, DOI [10.7196/SAMJ.2017.v107i12.12358, 10.7196/samj.2017.v107i12.12358]; Ford N, 2018, CLIN INFECT DIS, V66, pS106, DOI 10.1093/cid/cix1139; Ford N, 2017, CURR OPIN HIV AIDS, V12, P123, DOI 10.1097/COH.0000000000000348; Hallfors DD, 2016, SAHARA J-J SOC ASP H, V13, P178, DOI 10.1080/17290376.2016.1245627; Kroeze S, 2018, AIDS, V32, P1043, DOI [10.1097/QAD.0000000000001801, 10.1097/qad.0000000000001801]; Kujawski SA, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx156; Martin T, 2017, S AFR J HIV MED, V18, DOI 10.4102/sajhivmed.v18i1.717; Merci Nyiramana Marie, 2017, Pan Afr Med J, V26, P14, DOI 10.11604/pamj.2017.26.14.10488; Ministry of Health and Child Care, 2017, PROGR DAT; Mutimura E, 2015, AIDS, V29, P67, DOI 10.1097/QAD.0000000000000520; Nanzigu S, 2013, HIV AIDS-RES PALLIAT, V5, P309, DOI 10.2147/HIV.S50614; Nyika H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3044-7; Ousley J, 2018, CLIN INFECT DIS, V66, pS126, DOI 10.1093/cid/ciy103; Post FA, 2018, CLIN INFECT DIS, V66, pS132, DOI 10.1093/cid/cix1141; Reynolds SJ, 2014, AIDS PATIENT CARE ST, V28, P575, DOI 10.1089/apc.2014.0086; Siika A, 2018, CLIN INFECT DIS, V66, pS140, DOI 10.1093/cid/cix1142; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Takuva S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18651; WHO, GUID START ANT THER; World Health Organization, GUID MAN ADV HIV DIS	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0230205	10.1371/journal.pone.0230205	http://dx.doi.org/10.1371/journal.pone.0230205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584821	Green Published, gold			2022-12-27	WOS:000545747200076
J	Gross, NT; Wang, JM; Fiandalo, MV; Gomez, EC; Watts, A; Godoy, AS; Smith, GJ; Wu, Y				Gross, Nelson T.; Wang, Jianmin; Fiandalo, Michael V.; Cortes Gomez, Eduardo; Watts, Anica; Godoy, Alejandro S.; Smith, Gary J.; Wu, Yue			Recapitulation of prostate tissue cell type-specific transcriptomes by anin vivoprimary prostate tissue xenograft model	PLOS ONE			English	Article							PATIENT-DERIVED XENOGRAFTS; ANDROGEN RECEPTOR; EXPRESSION ANALYSIS; CANCER CELLS; TRANSPORT; COACTIVATOR; INHIBITION; MRP4/ABCC4; VARIANTS; PROSTEIN	Studies of the normal functions and diseases of the prostate requestin vivomodels that maintain the tissue architecture and the multiple-cell type compartments of human origin in order to recapitulate reliably the interactions of different cell types. Cell type-specific transcriptomes are critical to reveal the roles of each cell type in the functions and diseases of the prostate. A primary prostate tissue xenograft model was developed using fresh human prostate tissue specimens transplanted onto male mice that were castrated surgically and implanted with a device to maintain circulating testosterone levels comparable to adult human males. Endothelial cells and epithelial cells were isolated from 7 fresh human prostate tissue specimens and from primary tissue xenografts established from 9 fresh human prostate tissue specimens, using antibody-conjugated magnetic beads specific to human CD31 and human EpCAM, respectively. Transcriptomes of endothelial, epithelial and stromal cell fractions were obtained using RNA-Seq. Global and function-specific gene expression profiles were compared in inter-cell type and inter-tissue type manners. Gene expression profiles in the individual cell types isolated from xenografts were similar to those of cells isolated from fresh tissue, demonstrating the value of the primary tissue xenograft model for studies of the inter-relationships between prostatic cell types and the role of such inter-relationships in organ development, disease progression, and response to drug treatments.	[Gross, Nelson T.; Fiandalo, Michael V.; Watts, Anica; Godoy, Alejandro S.; Smith, Gary J.; Wu, Yue] Roswell Park Comprehens Canc Ctr, Dept Urol, Buffalo, NY USA; [Wang, Jianmin; Cortes Gomez, Eduardo] Roswell Park Comprehens Canc Ctr, Dept Biostat & Bioinformat, Buffalo, NY USA; [Godoy, Alejandro S.] Pontificial Univ Catolica Chile, Dept Physiol, Santiago, Chile; [Godoy, Alejandro S.] Univ San Sebastian, Ctr Biol Celular & Biomed CEBICEM, Santiago, Chile	Universidad San Sebastian	Wu, Y (corresponding author), Roswell Park Comprehens Canc Ctr, Dept Urol, Buffalo, NY USA.	yue.wu@roswellpark.org	Cortes, Eduardo/AAW-8005-2021; wang, jian/GVS-0711-2022; Godoy, Alejandro/GPS-4942-2022	Fiandalo, Michael/0000-0002-3558-2712	National Cancer Institute [1R01CA193829-01A1, P30CA16056]; Roswell Park Alliance Foundation [U24CA232979]; National Center grant for Research Resources [S10OD019977]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Roswell Park Alliance Foundation; National Center grant for Research Resources	This work was supported by grant 1R01CA193829-01A1 (to G.J.S. and Y.W.) from the National Cancer Institute, two awards from the Roswell Park Alliance Foundation (to Y.W.), U24CA232979 (to J.W.) from the National Cancer Institute, and National Cancer Institute grant P30CA16056 and National Center grant for Research Resources S10OD019977 involving the use of Roswell Park Comprehensive Cancer Center's Shared Resources.	[Anonymous], 2014, HUELLAS PAPEL, V2, P15; [Anonymous], 2002, AM J PHYSIOL-HEART C, V282, pH2011; [Anonymous], 2001, GENOME RES, V11, P1156; [Anonymous], 2012, EMPEDOCLES EUROPEAN, V4, P183; Auchus RJ, 2004, TRENDS ENDOCRIN MET, V15, P432, DOI 10.1016/j.tem.2004.09.004; Beck FWJ, 2004, PROSTATE, V58, P374, DOI 10.1002/pros.10344; Belandia B, 2005, MOL CELL BIOL, V25, P1425, DOI 10.1128/MCB.25.4.1425-1436.2005; Bennett N, 2009, IUBMB LIFE, V61, P961, DOI [10.1002/IUB.244, 10.1002/iub.244]; Brennen WN, 2018, PROSTATE, V78, P646, DOI 10.1002/pros.23510; Centenera MM, 2013, NAT REV UROL, V10, P483, DOI 10.1038/nrurol.2013.126; Cho E, 2014, ENDOCRINOLOGY, V155, P4124, DOI 10.1210/en.2014-1337; Choi SYC, 2014, ADV DRUG DELIVER REV, V79-80, P222, DOI 10.1016/j.addr.2014.09.009; Cunningham David, 2015, J Biol Methods, V2; Davies AH, 2018, MOL CELL ENDOCRINOL, V462, P17, DOI 10.1016/j.mce.2017.03.013; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Ellem SJ, 2014, ADV DRUG DELIVER REV, V79-80, P214, DOI 10.1016/j.addr.2014.04.008; Elsnerova K, 2017, J CANCER, V8, P3598, DOI 10.7150/jca.20766; Elsnerova K, 2016, ONCOL REP, V35, P2159, DOI 10.3892/or.2016.4599; Esgueva R, 2010, MODERN PATHOL, V23, P539, DOI 10.1038/modpathol.2009.193; Fiandalo MV, 2019, ASIAN J UROL, V6, P50, DOI 10.1016/j.ajur.2018.09.002; Fiandalo MV, 2018, PROSTATE, V78, P213, DOI 10.1002/pros.23459; Froesch BA, 1998, J BIOL CHEM, V273, P11660, DOI 10.1074/jbc.273.19.11660; Gao L, 2018, PATHOL RES PRACT, V214, P732, DOI 10.1016/j.prp.2018.03.002; Godoy A, 2008, ENDOCRINOLOGY, V149, P2959, DOI 10.1210/en.2007-1078; Godoy A, 2011, AM J PHYSIOL-ENDOC M, V300, pE263, DOI 10.1152/ajpendo.00210.2010; Gregg JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-165; Hatanaka T, 2000, BBA-BIOMEMBRANES, V1467, P1, DOI 10.1016/S0005-2736(00)00252-2; Henry GH, 2018, CELL REP, V25, P3530, DOI 10.1016/j.celrep.2018.11.086; Ho LL, 2008, PROSTATE, V68, P1421, DOI 10.1002/pros.20809; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Januchowski R, 2014, BIOMED PHARMACOTHER, V68, P447, DOI 10.1016/j.biopha.2014.02.002; Januchowski R, 2013, BIOMED PHARMACOTHER, V67, P240, DOI 10.1016/j.biopha.2012.11.011; Karlou M, 2010, NAT REV UROL, V7, P494, DOI 10.1038/nrurol.2010.134; Karvonen U, 2006, EXP CELL RES, V312, P3165, DOI 10.1016/j.yexcr.2006.06.018; Kim S, 2015, GENE, V556, P199, DOI 10.1016/j.gene.2014.11.059; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kronig M, 2015, ONCOTARGET, V6, P1302; Krupski T, 2001, GROWTH FACTORS, V18, P287, DOI 10.3109/08977190109029117; LIU W, 1995, BBA-BIOMEMBRANES, V1235, P461, DOI 10.1016/0005-2736(95)80036-F; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu ML, 2001, J BIOL CHEM, V276, P13442, DOI 10.1074/jbc.M006598200; McGrath MJ, 2013, CANCER RES, V73, P5066, DOI 10.1158/0008-5472.CAN-12-4520; McLean DT, 2017, DIFFERENTIATION, V97, P23, DOI 10.1016/j.diff.2017.08.005; Miyajima N, 2008, CANCER RES, V68, P3486, DOI 10.1158/0008-5472.CAN-07-6059; Montecinos VP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029623; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Mostaghel EA, 2013, TRANSL ANDROL UROL, V2, P212, DOI 10.3978/j.issn.2223-4683.2013.09.16; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Nakanishi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16738-y; Nieuweboer AJM, 2014, CANCER RES, V74, P3137, DOI 10.1158/0008-5472.CAN-13-3634; Obaidat A, 2012, ANNU REV PHARMACOL, V52, P135, DOI 10.1146/annurev-pharmtox-010510-100556; Perner S, 2013, INT J CANCER, V132, P807, DOI 10.1002/ijc.27733; Puca L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04495-z; Risbridger GP, 2016, HORM CANCER-US, V7, P236, DOI 10.1007/s12672-016-0266-1; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; RSA, 2000, TELLING STORIES AM H, VX, P415; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sebastian K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083257; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Singh CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep36772; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Stuchbery R, 2017, NAT REV UROL, V14, P49, DOI 10.1038/nrurol.2016.221; Sun DL, 2013, PROSTATE, V73, P287, DOI 10.1002/pros.22568; Tai WY, 2013, MOL PHARMACEUT, V10, P477, DOI 10.1021/mp300364k; Taylor RA, 2008, CURR CANCER DRUG TAR, V8, P490, DOI 10.2174/156800908785699351; Tchernitchko D, 2017, J AM SOC NEPHROL, V28, P1924, DOI 10.1681/ASN.2016080918; Than BLN, 2016, ONCOGENE, V35, P4191, DOI 10.1038/onc.2015.483; Toivanen R, 2017, DEVELOPMENT, V144, P1382, DOI 10.1242/dev.148270; Torres-Estay V, 2015, J ENDOCRINOL, V224, pR131, DOI 10.1530/JOE-14-0611; van de Steeg E, 2013, CLIN CANCER RES, V19, P821, DOI 10.1158/1078-0432.CCR-12-2080; van Weerden WM, 2009, BRIT J CANCER, V100, P13, DOI 10.1038/sj.bjc.6604822; Verma S, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00235; Walker MG, 1999, GENOME RES, V9, P1198, DOI 10.1101/gr.9.12.1198; Wang SQ, 2017, NAT REV UROL, V14, P401, DOI 10.1038/nrurol.2017.65; White MA, 2018, ENDOCR-RELAT CANCER, V25, P453, DOI 10.1530/ERC-17-0051; Wilson JD, 2011, ENDOCRIN METAB CLIN, V40, P577, DOI 10.1016/j.ecl.2011.05.003; Wright JL, 2011, CANCER EPIDEM BIOMAR, V20, P619, DOI 10.1158/1055-9965.EPI-10-1023; Wu Y, 2019, MOL CELL ENDOCRINOL, V486, P79, DOI 10.1016/j.mce.2019.02.018; Xu JC, 2001, CANCER RES, V61, P1563; Yang J, 2009, ENDOCR-RELAT CANCER, V16, P139, DOI 10.1677/ERC-08-0150; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886; Zhang DX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10798; Zhu Q, 2017, NEOPLASMA, V64, P709, DOI 10.4149/neo_2017_508; Zhu QL, 2015, INT J CLIN EXP PATHO, V8, P9175	86	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0233899	10.1371/journal.pone.0233899	http://dx.doi.org/10.1371/journal.pone.0233899			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584883	Green Published, gold			2022-12-27	WOS:000545747200093
J	Hoque, S; Chen, BJ; Schoen, MW; Carson, KR; Keller, J; Witherspoon, BJ; Knopf, KB; Yang, YT; Schooley, B; Nabhan, C; Sartor, O; Yarnold, PR; Ray, P; Bobolts, L; Hrushesky, WJ; Dickson, M; Bennett, CL				Hoque, Shamia; Chen, Brian J.; Schoen, Martin W.; Carson, Kenneth R.; Keller, Jesse; Witherspoon, Bartlett J.; Knopf, Kevin B.; Yang, Y. Tony; Schooley, Benjamin; Nabhan, Chadi; Sartor, Oliver; Yarnold, Paul R.; Ray, Paul; Bobolts, Laura; Hrushesky, William J.; Dickson, Michael; Bennett, Charles L.			End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia	PLOS ONE			English	Article							DOUBLE-BLIND; PEDIATRIC SUICIDALITY; DARBEPOETIN-ALPHA; CLINICAL-PRACTICE; PRACTICE PATTERNS; HEMOGLOBIN LEVELS; PHASE-III; IMPACT; FDA; SAFETY	Erythropoisis stimulating agent (ESA) use was addressed in Food and Drug Administration (FDA) Oncology Drug Advisory Committee (ODAC) meetings between 2004 and 2008. FDA safety-focused regulatory actions occurred in 2007 and 2008. In 2007, black box warnings advised of early death and venous thromboembolism (VTE) risks with ESAs in oncology. In 2010, a Risk Evaluation Strategies (REMS) was initiated, with cancer patient consent that mortality and VTE risks were noted with ESAs. We report warnings and REMS impacts on ESA utilization among Veterans Administration (VA) cancer patients with chemotherapy-induced anemia (CIA). Data were from Veterans Affairs database (2003-2012). Epoetin and darbepoetin use were primary outcomes. Segmented linear regression was used to estimate changes in ESA use levels and trends, clinical appropriateness, and adverse events (VTEs) among chemotherapy-treated cancer patients. To estimate changes in level of drug prescription rate after policy actions, model-specific indicator variables as covariates based on specific actions were included. ESA use fell by 95% and 90% from 2005, for epoetin and darbepoetin, from 22% and 11%, respectively, to 1% and 1%, respectively, among cancer patients with CIA, respectively (p<0.01). Following REMS in 2010, mean hematocrit levels at ESA initiation decreased from 30% to 21% (p<0.01). Black box warnings preceded decreased ESA use among VA cancer patients with CIA. REMS was followed by reduced hematocrit levels at ESA initiation. Our findings contrast with privately- insured and Medicaid insured cancer patient data on chemotherapy-induced anemia where ESA use decreased to 3% to 7% by 2010-2012. By 2012, the era of ESA administration to VA to cancer patients had ended but the warnings remain relevant and significant. In 2019, oncology/hematology national guidelines (ASCO/ASH) recommend that cancer patients with chemotherapy-induced anemia should receive ESAs or red blood cell transfusions after risk-benefit evaluation.	[Hoque, Shamia] Univ South Carolina, Dept Civil & Environm Engn, Coll Engn & Comp, Columbia, SC 29208 USA; [Chen, Brian J.] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Schoen, Martin W.] St Louis Univ, Sch Med, Dept Med, St Louis, MO 63104 USA; [Carson, Kenneth R.; Keller, Jesse; Hrushesky, William J.] Washington Univ, Sch Med, St Louis, MO USA; [Carson, Kenneth R.; Keller, Jesse; Hrushesky, William J.] St Louis VA Med Ctr, St Louis, MO USA; [Witherspoon, Bartlett J.; Yarnold, Paul R.; Hrushesky, William J.] Med Univ South Carolina, Charleston, SC 29425 USA; [Knopf, Kevin B.; Nabhan, Chadi; Yarnold, Paul R.; Ray, Paul; Hrushesky, William J.; Dickson, Michael; Bennett, Charles L.] Univ South Carolina, Coll Pharm, Columbia, SC 29208 USA; [Yang, Y. Tony] George Washington Univ, Washington, DC USA; [Schooley, Benjamin] Univ South Carolina, Coll Engn & Comp, Dept Integrated Informat Technol, Columbia, SC 29208 USA; [Sartor, Oliver] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Bobolts, Laura] Oncol Analyt, Plantation, FL USA; [Bobolts, Laura] Nova Southeastern Univ, Coll Pharm, Ft Lauderdale, FL 33314 USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; Saint Louis University; Washington University (WUSTL); Medical University of South Carolina; University of South Carolina System; University of South Carolina Columbia; George Washington University; University of South Carolina System; University of South Carolina Columbia; Tulane University; Nova Southeastern University	Hoque, S (corresponding author), Univ South Carolina, Dept Civil & Environm Engn, Coll Engn & Comp, Columbia, SC 29208 USA.	hoques@cec.sc.edu	Schoen, Martin W./H-5425-2019	Schoen, Martin W./0000-0001-6388-5553; Yarnold, Paul/0000-0002-1648-739X; Chen, Brian/0000-0001-6384-1673; Hrushesky, William/0000-0002-0955-3192	National Cancer Institute [1R01CA102713-01]; Centers for Economic Excellence program of the state of South Carolina; Doris Levkoff Meddin Center for Medication Safety; American Cancer Society [IRG-13-043-01]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Economic Excellence program of the state of South Carolina; Doris Levkoff Meddin Center for Medication Safety; American Cancer Society(American Cancer Society)	This manuscript was supported by funding from a grant from the National Cancer Institute (1R01CA102713-01) the Centers for Economic Excellence program of the state of South Carolina and the Doris Levkoff Meddin Center for Medication Safety and a grant from the American Cancer Society (IRG-13-043-01). No author has any pharmaceutical or industry-related conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder, Oncology Analytics provided support in the form of salary for author LB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of LB is articulated in the 'author contributions' section.	American Medical Association, 2010, 2010 ANN M, P402; [Anonymous], 2017, DRUG SAFETY, DOI [DOI 10.1310/hpj4505-389, DOI 10.1007/s40264-017-0538-x]; BAKER DD, 2010, HOSP PHARM, V45, P348, DOI DOI 10.1310/hpj4505-348; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Bian J, 2017, J CLIN ONCOL, V35, P1945, DOI 10.1200/JCO.2017.72.6273; Bohlius J, 2006, COCHRANE DATABASE SY, V3, P2006; Bohlius J, 2006, JNCI-J NATL CANCER I, V98, P708, DOI 10.1093/jnci/djj189; Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Bowen ME, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.009; Center for Drug Evaluation and Research, 2012, GUID DRUG SAF INF FD; Desai VCA, 2012, ALZHEIMERS DEMENT, V8, P453, DOI 10.1016/j.jalz.2011.08.004; Dorsey ER, 2010, ARCH INTERN MED, V170, P96, DOI 10.1001/archinternmed.2009.456; Dusetzina SB, 2012, MED CARE, V50, P466, DOI 10.1097/MLR.0b013e318245a160; Ehrenpreis ED, 2012, AM J GASTROENTEROL, V107, P501, DOI 10.1038/ajg.2011.449; ESA APPRISE, WHAT IS ESA APPRISE; Faden LB, 2008, FOOD DRUG LAW J, V63, P683; Food and Drug Administration, 2014, PREV ADV DRUG REACT; Goldfrank LR, 2002, GOLDFRANKS TOXICOLOG; Goldman SA, 2004, DRUG SAFETY, V27, P519, DOI 10.2165/00002018-200427080-00005; Hedenus M, 2003, BRIT J HAEMATOL, V122, P394, DOI 10.1046/j.1365-2141.2003.04448.x; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Hershman DL, 2009, JNCI-J NATL CANCER I, V101, P1633, DOI 10.1093/jnci/djp387; Johnson C, 2016, WASHINGTON POST; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kurian BT, 2007, ARCH PEDIAT ADOL MED, V161, P690, DOI 10.1001/archpedi.161.7.690; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; Libby AM, 2009, ARCH GEN PSYCHIAT, V66, P633, DOI 10.1001/archgenpsychiatry.2009.46; Lineberry TW, 2007, MAYO CLIN PROC, V82, P518, DOI 10.4065/82.4.518; Lu CY, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3596; Nemeroff CB, 2007, ARCH GEN PSYCHIAT, V64, P466, DOI 10.1001/archpsyc.64.4.466; Noxon V, 2016, J ONCOLOGY PRACTICE, V019364, P2017; Noxon V, 2017, J ONCOL PRACT, V13, P387, DOI 10.1200/JOP.2016.019364; Overgaard J, 2007, EJC SUPPL, V5, P7, DOI 10.1016/S1359-6349(07)70099-X; Piening S, 2012, DRUG SAFETY, V35, P373, DOI 10.2165/11599100-000000000-00000; Qato DM, 2011, JAMA-J AM MED ASSOC, V306, P1595, DOI 10.1001/jama.2011.1457; Reeves David J, 2011, P T, V36, P423; Rizzo JD, 2008, J CLIN ONCOL, V26, P132, DOI 10.1200/JCO.2007.14.3396; Schoen MW, 2020, INT J CANCER, V146, P2829, DOI 10.1002/ijc.32917; Singh AK, 2010, CLIN J AM SOC NEPHRO, V5, P1355, DOI 10.2215/CJN.03560410; Smith RE, 2008, J CLIN ONCOL, V26, P1040, DOI 10.1200/JCO.2007.14.2885; Stewart KA, 2009, PHARMACOEPIDEM DR S, V18, P1048, DOI 10.1002/pds.1819; Tarlov E, 2012, SUPPORT CARE CANCER, V20, P1649, DOI 10.1007/s00520-011-1255-0; Thomas G, 2008, GYNECOL ONCOL, V108, P317, DOI 10.1016/j.ygyno.2007.10.011; Valluri S, 2010, MED CARE, V48, P947, DOI 10.1097/MLR.0b013e3181ef9d2b; Valuck RJ, 2007, AM J PSYCHIAT, V164, P1198, DOI 10.1176/appi.ajp.2007.07010007; Weatherby LB, 2002, CLIN PHARMACOL THER, V72, P735, DOI 10.1067/mcp.2002.129503; Weatherby LB, 2001, PHARMACOEPIDEM DR S, V10, P211, DOI 10.1002/pds.592; Weaver J, 2009, DERMATOL THER, V22, P204, DOI 10.1111/j.1529-8019.2009.01233.x; Weir MA, 2012, J ONCOL PRACT, V8, P179, DOI 10.1200/JOP.2011.000287; Werble C, 2017, PRESCRIPTION DRUG B; Whoriskey P, 2012, WASHINGTON POST; Wilkinson JJ, 2004, PHARMACOTHERAPY, V24, P978, DOI 10.1592/phco.24.11.978.36136; Wilson A, 2011, FOOD DRUG LAW J, V66, P569; Wright JR, 2007, J CLIN ONCOL, V25, P1027, DOI 10.1200/JCO.2006.07.1514	55	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234541	10.1371/journal.pone.0234541	http://dx.doi.org/10.1371/journal.pone.0234541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584835	Green Published, gold			2022-12-27	WOS:000545747200059
J	Huang, KX; Luo, XZ; Zheng, Z				Huang, Kuixian; Luo, Xingzhang; Zheng, Zheng			Modeling solute transport in karst fissure dual porosity system and application: A case study in an arsenic contamination site	PLOS ONE			English	Article							FLOW	Fractures and fracture networks are key conduits for migration of hydrothermal fluids, water and contaminants in groundwater systems Modeling is widely used to understand the environmental risk associated with migration of pollutant for different hydrogeological conditions. In this paper, we proposed a conceptual and mathematical model of flow and transport phenomena in fractured rock systems, and applied in a arsenic contaminate site as a case study. The groundwater flow model and arsenic migration model in fissure-matrix dual system were established. The results show that the velocity of groundwater is positively correlated with inlet pressure, but not with the porosity of the fracture. When the velocity of groundwater is relatively high, arsenic is transported along with the current in a finger-like manner. The distribution of arsenic concentration on the fracture surface is heterogeneous and the phenomenon of diffusion from the fracture to the matrix is not obvious. Indeed, when the velocity of groundwater is relatively small, the arsenic moves forward slowly, the concentration distribution on the crack surface is relatively uniform, and the diffusion phenomenon from the crack to the matrix is more significant.	[Huang, Kuixian; Luo, Xingzhang; Zheng, Zheng] Fudan Univ, Dept Environm Sci & Engn, Shanghai, Peoples R China	Fudan University	Zheng, Z (corresponding author), Fudan Univ, Dept Environm Sci & Engn, Shanghai, Peoples R China.	elsevier_eest@163.com						Anderson CR, 2004, CURR MICROBIOL, V48, P341, DOI 10.1007/s00284-003-4205-3; Berkowitz B, 2002, ADV WATER RESOUR, V25, P861, DOI 10.1016/S0309-1708(02)00042-8; Cao C, 2019, J HYDROL, V579, DOI 10.1016/j.jhydrol.2019.124142; Cao HL, 2018, J HYDROL, V560, P318, DOI 10.1016/j.jhydrol.2018.03.007; Cheng jianmei, 1998, HYDROGEOLOGY ENG GEO, V04, P52; De Smedt F, 2011, TRANSPORT POROUS MED, V88, P479, DOI 10.1007/s11242-011-9750-9; Einsiedl F, 2005, J HYDROL, V312, P312, DOI 10.1016/j.jhydrol.2005.03.031; Einsiedl F, 2006, ENVIRON SCI TECHNOL, V40, P6697, DOI 10.1021/es061129x; Fatima S, 2018, ENVIRON EARTH SCI, V77, DOI 10.1007/s12665-018-7542-z; [贾永锋 Jia Yongfeng], 2013, [地球科学进展, Advance in Earth Sciences], V28, P51; Kumar M, 2019, ISOT ENVIRON HEALT S, V55, P254, DOI 10.1080/10256016.2019.1600515; Li R, 2018, ENVIRON GEOCHEM HLTH, V40, P1585, DOI 10.1007/s10653-018-0073-4; Medici G, 2019, J CONTAM HYDROL, V222, P1, DOI 10.1016/j.jconhyd.2019.02.001; Medici G, 2019, ENVIRON SCI POLLUT R, V26, P24863, DOI 10.1007/s11356-019-05525-z; Peng XD, 2018, ENG GEOL, V243, P10, DOI 10.1016/j.enggeo.2018.06.007; Qian JZ, 2007, J HYDROL, V339, P206, DOI 10.1016/j.jhydrol.2007.03.015; Shamsudduha M, 2019, SUST WAT RESOUR MAN, V5, P1073, DOI 10.1007/s40899-018-0275-z; Singh SK, 2018, J ENVIRON MANAGE, V211, P125, DOI 10.1016/j.jenvman.2018.01.044; Trippetta F, 2019, J PETROL SCI ENG, V177, P849, DOI 10.1016/j.petrol.2019.03.002; Trippetta F, 2020, MAR PETROL GEOL, V111, P350, DOI 10.1016/j.marpetgeo.2019.08.035; WYLLIE J., 1937, Canadian Public Health Journal, V28, P128; Yang HJ, 2016, SCI TOTAL ENVIRON, V569, P212, DOI 10.1016/j.scitotenv.2016.06.122; Ying SC, 2017, ENVIRON SCI TECHNOL, V51, P8926, DOI 10.1021/acs.est.7b01121	23	0	0	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234998	10.1371/journal.pone.0234998	http://dx.doi.org/10.1371/journal.pone.0234998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584869	gold, Green Published			2022-12-27	WOS:000545747200065
J	Stockhoff, L; Schultalbers, M; Tergast, TL; Hinrichs, JB; Gerbel, S; Meine, TC; Manns, MP; Simon, N; Cornberg, M; Meyer, BC; Maasoumy, B				Stockhoff, Lena; Schultalbers, Marie; Tergast, Tammo L.; Hinrichs, Jan B.; Gerbel, Svetlana; Meine, Timo C.; Manns, Michael P.; Simon, Nicolas; Cornberg, Markus; Meyer, Bernhard C.; Maasoumy, Benjamin			Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites	PLOS ONE			English	Article							PARACENTESIS PLUS ALBUMIN; EARLY MORTALITY; HEPATORENAL-SYNDROME; PREDICTING SURVIVAL; OLDER AGE; CREATION; TIPS; COMPLICATIONS; IMPACT; SCORE	Background & aims The management of patients with refractory ascites (RA) is challenging, particularly at higher age. Transjugular intrahepatic portosystemic shunt (TIPS) is an established treatment for RA, but safety data in elderly patients are rare. Our aim was to evaluate the safety and feasibility of TIPS in elderly patients with RA. Methods Overall, 160 consecutive cirrhotic patients receiving a TIPS for RA at Hannover Medical School between 2012 and 2018 were considered for this retrospective analysis. Periinterventional complications such as acute-on-chronic liver failure (ACLF) as well as survival were compared between patients Results A number of 53 out of the 160 patients were >= 65 years (33%). Periinterventional course in those >= 65 years appeared to be slightly more complicated than in <65 years as reflected by a significantly longer hospital stay (p = 0.030) and more ACLF-episodes (21% vs. 9%; p = 0.044). 28-day mortality was similar between both groups (p = 0.350), whereas survival of the younger patients was significantly higher at 90 days (p = 0.029) and numerically higher at 1 year (p = 0.171). In the multivariate analysis age >= 65 years remained an independent predictor for 90-day mortality (HR: 2.58; p = 0.028), while it was not associated with 28-day and 1-year survival. Importantly, after matching for potential confounders 1-year survival was similar in elderly patients if treated with TIPS or paracentesis (p = 0.419). Conclusions TIPS placement in elderly patients with RA appears to be slightly more complicated compared to younger individuals, but overall feasible and at least not inferior to paracentesis.	[Stockhoff, Lena; Schultalbers, Marie; Tergast, Tammo L.; Manns, Michael P.; Cornberg, Markus; Maasoumy, Benjamin] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Hinrichs, Jan B.; Meine, Timo C.; Meyer, Bernhard C.] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany; [Gerbel, Svetlana; Simon, Nicolas] Hannover Med Sch, Ctr Informat Management ZIMt, Hannover, Germany; [Manns, Michael P.; Cornberg, Markus; Maasoumy, Benjamin] CRC Hannover, CIIM, Hannover, Germany; [Manns, Michael P.; Cornberg, Markus; Maasoumy, Benjamin] DZIF, German Ctr Infect Res, Partner Site Hannover Braunschweig, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; German Center for Infection Research	Maasoumy, B (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.; Maasoumy, B (corresponding author), CRC Hannover, CIIM, Hannover, Germany.; Maasoumy, B (corresponding author), DZIF, German Ctr Infect Res, Partner Site Hannover Braunschweig, Hannover, Germany.	maasoumy.benjamin@mh-hannover.de		Schultalbers, Marie/0000-0002-2539-2093; Hinrichs, Jan/0000-0002-0135-7082; Stockhoff, Lena/0000-0002-8453-8603	'KlinStrucMed' program - 'Else Kroner-Fresenius-Stiftung'; 'Clinician Scientist' program ('Junge Akademie') of Hannover Medical School	'KlinStrucMed' program - 'Else Kroner-Fresenius-Stiftung'; 'Clinician Scientist' program ('Junge Akademie') of Hannover Medical School	LS, MS and TLT were supported by the 'KlinStrucMed' program funded by the 'Else Kroner-Fresenius-Stiftung'. BM and JBH were supported by the 'Clinician Scientist' program ('Junge Akademie') of Hannover Medical School. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Angeli P, 2015, J HEPATOL, V62, P968, DOI 10.1016/j.jhep.2014.12.029; Angermayr B, 2003, GUT, V52, P879, DOI 10.1136/gut.52.6.879; [Anonymous], 2019, LANCET DIGITAL HLTH; Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; Bowers J, 2010, RITOOLS RANDOMIZATIO, V2; Bucsics T, 2018, LIVER INT, V38, P1036, DOI 10.1111/liv.13615; Carrier P, 2019, WORLD J HEPATOL, V11, P663, DOI 10.4254/wjh.v11.i9.663; Durand F, 2019, J HEPATOL, V70, P745, DOI 10.1016/j.jhep.2018.12.009; Gaba RC, 2013, J VASC INTERV RADIOL, V24, P411, DOI 10.1016/j.jvir.2012.10.026; Gerbes AL, 2011, Z GASTROENTEROL, V49, P749, DOI 10.1055/s-0031-1273405; Gerbes AL, 2019, Z GASTROENTEROL, V57, P611, DOI 10.1055/a-0873-4658; Gines P, 2002, GASTROENTEROLOGY, V123, P1839, DOI 10.1053/gast.2002.37073; Harrod-Kim P, 2006, J VASC INTERV RADIOL, V17, P1605, DOI 10.1097/01.RVI.0000240651.38289.4B; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Iacus SM, 2009, J STAT SOFTW, V30, P1; Keswani RN, 2004, LIVER TRANSPLANT, V10, P957, DOI 10.1002/lt.20155; Lebrec D, 1996, J HEPATOL, V25, P135, DOI 10.1016/S0168-8278(96)80065-1; Luca A, 2007, LIVER TRANSPLANT, V13, P1174, DOI 10.1002/lt.21197; Marquardt S, 2015, CARDIOVASC INTER RAD, V38, P903, DOI 10.1007/s00270-014-1035-6; Meine TC, 2020, ABDOMINAL RADIOLOGY; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Narahara Y, 2011, J GASTROENTEROL, V46, P78, DOI 10.1007/s00535-010-0282-9; Pan JJ, 2008, J VASC INTERV RADIOL, V19, P1576, DOI 10.1016/j.jvir.2008.07.021; Parsons L, 2001, REDUCING BIAS PROPEN; Parvinian A, 2013, J VASC INTERV RADIOL, V24, P941, DOI 10.1016/j.jvir.2013.03.018; Rajan DK, 2002, J VASC INTERV RADIOL, V13, P155, DOI 10.1016/S1051-0443(07)61932-0; Rossle M, 2010, GUT, V59, P988, DOI 10.1136/gut.2009.193227; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Saad N, 2016, ANN HEPATOL, V15, P215, DOI 10.5604/16652681.1193716; Salerno F, 2004, HEPATOLOGY, V40, P629, DOI 10.1002/hep.20364; SALERNO F, 1993, AM J GASTROENTEROL, V88, P514; Salerno F, 2007, GASTROENTEROLOGY, V133, P825, DOI 10.1053/j.gastro.2007.06.020; Schultalbers M, 2020, UNITED EUR GASTROENT, V8, P567, DOI 10.1177/2050640620913732; Suraweera D, 2017, J CLIN GASTROENTEROL, V51, P360, DOI 10.1097/MCG.0000000000000541; Syed MI, 2012, WORLD J HEPATOL, V4, P35, DOI 10.4254/wjh.v4.i2.35; Tan HK, 2015, J GASTROEN HEPATOL, V30, P389, DOI 10.1111/jgh.12725; Tergast TL, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0053-0; Tergast TL, 2018, LIVER INT, V38, P1602, DOI 10.1111/liv.13862; Thoemmes F, 2012, 1201 ARXIV, V1201; Tripathi D, 2020, GUT; Vizzutti F, 2020, INTERNAL EMERGENCY M; Yang ZP, 2010, J GASTROEN HEPATOL, V25, P1718, DOI 10.1111/j.1440-1746.2010.06400.x; 2018, J HEPATOL, V69, P406	44	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235199	10.1371/journal.pone.0235199	http://dx.doi.org/10.1371/journal.pone.0235199			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584874	Green Published, gold			2022-12-27	WOS:000545747200051
J	Hogekamp, L; Hogekamp, SH; Stahl, MR				Hogekamp, Lola; Hogekamp, Stefan H.; Stahl, Mario R.			Experimental setup and image processing method for automatic enumeration of bacterial colonies on agar plates	PLOS ONE			English	Article							COUNT	Automated colony counting methods have long been known in Microbiology. Numerous methods for automated image analysis have been described and a wide range of commercial products exists. Known advantages are saving cost by reducing enumeration time, automatic documentation, reproducibility, and operator independence. Still, even today the realization of all advantages of automated image analysis makes it necessary to either invest in an expensive, high performance commercial system, or to acquire expert knowledge in image processing. This is a considerable obstacle for many laboratories, and the reason why manual colony counting is still done frequently. This article describes an easy to apply automatic colony counting system-including suggestions for sample preparation-that can be put into operation with basic knowledge of image processing and low budget.	[Hogekamp, Lola; Stahl, Mario R.] Max Rubner Inst, Inst Lebensmittel & Bioverfahrenstech, Karlsruhe, Germany; [Hogekamp, Stefan H.] PALAS GmbH, Karlsruhe, Germany		Stahl, MR (corresponding author), Max Rubner Inst, Inst Lebensmittel & Bioverfahrenstech, Karlsruhe, Germany.	mario.stahl@mri.bund.de		Stahl, Mario/0000-0003-3034-9740	Max Rubner Institut	Max Rubner Institut	The authors received no specific funding for this work. The purchase of equipment for this study was funded by Max Rubner Institut. Author SH received support in the form of salary from the private, commercial company PALAS GmbH (https://www.palas.de/en/).PALAS GmbH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section	[Anonymous], 101925 DIN; Barber PR, 2001, PHYS MED BIOL, V46, P63, DOI 10.1088/0031-9155/46/1/305; Basler, 2016, DG001468 BASL; Breed RS, 1916, J BACTERIOL, V1, P321, DOI 10.1128/JB.1.3.321-331.1916; Brugger SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033695; Chengcui Zhang, 2008, 2008 IEEE International Conference on Sensor Networks, Ubiquitous, and Trustworthy Computing (SUTC '08), P233; Chiang PJ, 2015, J MICROBIOL METH, V108, P74, DOI 10.1016/j.mimet.2014.11.009; Clarke ML, 2010, CYTOM PART A, V77A, P790, DOI 10.1002/cyto.a.20864; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Hwang JC, 2010, NISTS INTEGRATED COL; Marotz J, 2001, COMPUT METH PROG BIO, V66, P183, DOI 10.1016/S0169-2607(00)00128-0; Mutterer J, 2012, IMAGEJ MACROLANGUAGE; Putman M, 2005, J IMMUNOL METHODS, V302, P99, DOI 10.1016/j.jim.2005.05.003; Sethi P., 2012, INT J COMPUTER APPL, V49, P21; Sutton S., 2011, J VALID TECHNOL, V17, P42; Yadav S., 2012, IRACST ENG SCI TECHN, V2, P42; Young LM, 2018, LETT APPL MICROBIOL, V66, P188, DOI 10.1111/lam.12851; Zhang C, 2007, ICSC 2007: INTERNATIONAL CONFERENCE ON SEMANTIC COMPUTING, PROCEEDINGS, P581, DOI 10.1109/ICSC.2007.20	18	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0232869	10.1371/journal.pone.0232869	http://dx.doi.org/10.1371/journal.pone.0232869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579562	Green Published, gold			2022-12-27	WOS:000545646600037
J	Schwenke, D; Fjaellingsdal, TG; Bleichner, MG; Grage, T; Scherbaum, S				Schwenke, Diana; Goregliad Fjaellingsdal, Tatiana; Bleichner, Martin G.; Grage, Tobias; Scherbaum, Stefan			An approach to social flexibility: Congruency effects during spontaneous word-by-word interaction	PLOS ONE			English	Article							TURN-TAKING; EXECUTIVE CONTROL; TASK; INFORMATION; INCREASES; ENDS	Cognitive flexibility is the ability to switch between different concepts or to adapt goal-directed behavior in a changing environment. Although, cognitive research on this ability has long been focused on the individual mind, it is becoming increasingly clear that cognitive flexibility plays a central role in our social life. This is particularly evident in turn-taking in verbal conversation, where cognitive flexibility of the individual becomes part of social flexibility in the dyadic interaction. In this work, we introduce a model that reveals different parameters that explain how people flexibly handle unexpected events in verbal conversation. In order to study hypotheses derived from the model, we use a novel experimental approach in which thirty pairs of participants engaged in a word-by-word interaction by taking turns in generating sentences word by word. Similar to well established individual cognitive tasks, participants needed to adapt their behavior in order to respond to their co-actor's last utterance. With our experimental approach we could manipulate the interaction between participants: Either both participants had to construct a sentence with a common target word (congruent condition) or with distinct target words (incongruent condition). We further studied the relation between the interactive Word-by-Word task measures and classical individual-centered, cognitive tasks, namely the Number-Letter task, the Stop-Signal task, and the GoNogo task. In the Word-by-Word task, we found that participants had faster response times in congruent compared to incongruent trials, which replicates the primary findings of standard cognitive tasks measuring cognitive flexibility. Further, we found a significant correlation between the performance in the Word-by-Word task and the Stop-Signal task indicating that participants with a high cognitive flexibility in the Word-by-Word task also showed high inhibition control.	[Schwenke, Diana; Grage, Tobias; Scherbaum, Stefan] Tech Univ Dresden, Dept Psychol, Dresden, Germany; [Goregliad Fjaellingsdal, Tatiana] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Bleichner, Martin G.] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Oldenburg, Germany	Technische Universitat Dresden; University of Lubeck; Carl von Ossietzky Universitat Oldenburg	Schwenke, D (corresponding author), Tech Univ Dresden, Dept Psychol, Dresden, Germany.	diana.schwenke@tu-dresden.de	Bleichner, Martin G/AAA-1383-2021; Bleichner, Martin G/AAV-2585-2021	Bleichner, Martin G/0000-0001-6933-9238; Bleichner, Martin G/0000-0001-6933-9238; , Tatiana/0000-0002-1698-3529	Volkswagen Foundation [89426]; Open Access Funding by the Publication Fund of the TU Dresden	Volkswagen Foundation(Volkswagen); Open Access Funding by the Publication Fund of the TU Dresden	This project was funded by Volkswagen Foundation grant 89426 (recipient: Stefan Scherbaum) and the Open Access Funding by the Publication Fund of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; Atmaca S, 2008, SOC NEUROSCI-UK, V3, P410, DOI 10.1080/17470910801900908; Bogels S, 2015, J PHONETICS, V52, P46, DOI 10.1016/j.wocn.2015.04.004; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; Colzato LS, 2010, ZYGON, V45, P2; Congdon E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00037; Corps RE, 2019, LANG COGN NEUROSCI, V34, P615, DOI 10.1080/23273798.2018.1552008; Corps RE, 2018, DISCOURSE PROCESS, V55, P230, DOI 10.1080/0163853X.2017.1330031; De Jaegher H, 2010, TRENDS COGN SCI, V14, P441, DOI 10.1016/j.tics.2010.06.009; Dreisbach G, 2004, J EXP PSYCHOL LEARN, V30, P343, DOI 10.1037/0278-7393.30.2.343; Dshemuchadse M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01244; Dudarev V, 2016, COGNITION, V146, P223, DOI 10.1016/j.cognition.2015.10.001; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Eskenazi T, 2013, Q J EXP PSYCHOL, V66, P1026, DOI 10.1080/17470218.2012.725058; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fjaellingsdal TG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62155-z; Garrod S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00751; Goregliad Fjaellingsdal T, 2020, PLOS ONE, V15, P1; Gruber O, 2004, ACTA PSYCHOL, V115, P105, DOI 10.1016/j.actpsy.2003.12.003; He X, 2011, EXP BRAIN RES, V211, P429, DOI 10.1007/s00221-011-2698-8; Himberg T, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00797; Hommel B, 2011, COGNITION, V120, P177, DOI 10.1016/j.cognition.2011.04.003; Hommel B, 2009, PSYCHOL RES-PSYCH FO, V73, P512, DOI 10.1007/s00426-009-0234-2; Johnstone Keith, 1999, IMPRO STORYTELLERS T; Johnstone Keith, 1987, IMPRO IMPROVISATION; Kuhlen AK, 2017, COGNITION, V166, P94, DOI 10.1016/j.cognition.2017.05.024; Levelt CC, 2009, LANG ACQUIS, V9223, P12; Levinson SC, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00731; Loehr JD, 2013, J COGNITIVE NEUROSCI, V25, P1049, DOI 10.1162/jocn_a_00388; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Naber M, 2013, P NATL ACAD SCI USA, V110, P20046, DOI 10.1073/pnas.1305996110; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pfeiffer UJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00022; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Rubinstein JS, 2001, J EXP PSYCHOL HUMAN, V27, P763, DOI 10.1037//0096-1523.27.4.763; Schmitz L, 2018, COGNITION, V181, P65, DOI 10.1016/j.cognition.2018.08.008; Sebanz N, 2005, J EXP PSYCHOL HUMAN, V31, P1234, DOI 10.1037/0096-1523.31.6.1234; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Shteynberg G, 2015, PERSPECT PSYCHOL SCI, V10, P579, DOI 10.1177/1745691615589104; Shteynberg G, 2014, J EXP PSYCHOL GEN, V143, P123, DOI 10.1037/a0031549; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Stivers T, 2009, P NATL ACAD SCI USA, V106, P10587, DOI 10.1073/pnas.0903616106; Van Berkum J. J. A., 2012, CAMBRIDGE HDB PSYCHO, P589, DOI DOI 10.1017/CBO9781139029377.040; Vesper C., 2017, FRONT PSYCHOL, V7, P1, DOI DOI 10.3389/FPSYG.2017.00001; Vesper C, 2016, COGNITION, V153, P118, DOI 10.1016/j.cognition.2016.05.002; Vesper C, 2014, EXP BRAIN RES, V232, P2945, DOI 10.1007/s00221-014-3982-1; Vesper C, 2013, J EXP PSYCHOL HUMAN, V39, P48, DOI 10.1037/a0028066; Wenke D, 2011, REV PHILOS PSYCHOL, V2, P147, DOI 10.1007/s13164-011-0057-0; Wolff M, 2016, J EXP PSYCHOL GEN, V145, P1635, DOI 10.1037/xge0000229	54	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235083	10.1371/journal.pone.0235083	http://dx.doi.org/10.1371/journal.pone.0235083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579618	Green Published, gold			2022-12-27	WOS:000545646600004
J	Theilmann, W; Rosenholm, M; Hampel, P; Loscher, W; Rantamaki, T				Theilmann, Wiebke; Rosenholm, Marko; Hampel, Philip; Loescher, Wolfgang; Rantamaki, Tomi			Lack of antidepressant effects of burst-suppressing isoflurane anesthesia in adult male Wistar outbred rats subjected to chronic mild stress	PLOS ONE			English	Article							TRKB NEUROTROPHIN RECEPTOR; RESISTANT MAJOR DEPRESSION; ELECTROCONVULSIVE-THERAPY; MESSENGER-RNAS; AMPA RECEPTOR; BRAIN; BDNF; EXPRESSION; KETAMINE; ACTIVATION	Post-ictal emergence of slow wave EEG (electroencephalogram) activity and burst-suppression has been associated with the therapeutic effects of the electroconvulsive therapy (ECT), indicating that mere "cerebral silence" may elicit antidepressant actions. Indeed, brief exposures to burst-suppressing anesthesia has been reported to elicit antidepressant effects in a subset of patients, and produce behavioral and molecular alterations, such as increased expression of brain-derived neurotrophic factor (BDNF), connected with antidepressant responses in rodents. Here, we have further tested the cerebral silence hypothesis by determining whether repeated exposures to isoflurane anesthesia reduce depressive-like symptoms or influence BDNF expression in male Wistar outbred rats (Crl:WI(Han)) subjected to chronic mild stress (CMS), a model which is responsive to repeated electroconvulsive shocks (ECS, a model of ECT). Stress-susceptible, stress-resilient, and unstressed rats were exposed to 5 doses of isoflurane over a 15-day time period, with administrations occurring every third day. Isoflurane dosing is known to reliably produce rapid EEG burst-suppression (4% induction, 2% maintenance; 15 min). Antidepressant and anxiolytic effects of isoflurane were assessed after the first, third, and fifth drug exposure by measuring sucrose consumption, as well as performance on the open field and the elevated plus maze tasks. Tissue samples from the medial prefrontal cortex and hippocampus were collected, and levels of BDNF (brain-derived neurotrophic factor) protein were assessed. We find that isoflurane anesthesia had no impact on the behavior of stress-resilient or anhedonic rats in selected tests; findings which were consistent-perhaps inherently related-with unchanged levels of BDNF.	[Theilmann, Wiebke; Hampel, Philip; Loescher, Wolfgang] Univ Vet Med Hannover, Dept Pharmacol Toxicol & Pharm, Hannover, Germany; [Rosenholm, Marko; Rantamaki, Tomi] Univ Helsinki, Div Pharmacol & Pharmacotherapy, Drug Res Program, Fac Pharm,Lab Neurotherapeut, Helsinki, Finland; [Rosenholm, Marko; Rantamaki, Tomi] Univ Helsinki, SleepWell Res Program, Fac Med, Helsinki, Finland	University of Veterinary Medicine Hannover, Foundation; University of Helsinki; University of Helsinki	Rantamaki, T (corresponding author), Univ Helsinki, Div Pharmacol & Pharmacotherapy, Drug Res Program, Fac Pharm,Lab Neurotherapeut, Helsinki, Finland.; Rantamaki, T (corresponding author), Univ Helsinki, SleepWell Res Program, Fac Med, Helsinki, Finland.	tomi.rantamaki@helsinki.fi	Löscher, Wolfgang/G-9824-2016	Löscher, Wolfgang/0000-0002-9648-8973; Rosenholm, Marko/0000-0002-5437-8282; Hampel, Philip/0000-0002-5391-555X; Rantamaki, Tomi/0000-0002-0052-1434	Academy of Finland [276333, 305195, 312664]; Finnish Cultural Foundation; Finnish Pharmaceutical Society	Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Pharmaceutical Society	This work has been supported by the Academy of Finland (T.R.) [www.aka.fi; grants 276333, 305195, 312664], the Finnish Cultural Foundation (M.R.) [www.skr.fi] and the Finnish Pharmaceutical Society (M.R.) [www.pro.tsv.fi/finpharmsociety]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah CG, 2018, NEUROPSYCHOPHARMACOL, V43, P2154, DOI 10.1038/s41386-018-0136-3; Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Altar CA, 2003, BIOL PSYCHIAT, V54, P703, DOI 10.1016/S0006-3223(03)00073-8; [Anonymous], 2019, MONTHLY NEWSLETTER M; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Bath KG, 2012, NEUROPSYCHOPHARMACOL, V37, P1297, DOI 10.1038/npp.2011.318; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039346; Brown PL, 2018, INT J NEUROPSYCHOPH, V21, P777, DOI 10.1093/ijnp/pyy029; CARL C, 1988, PHARMACOPSYCHIATRY, V21, P432, DOI 10.1055/s-2007-1017040; Carney S, 2003, LANCET, V361, P799; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Christensen T, 2011, NEUROSCIENCE, V196, P66, DOI 10.1016/j.neuroscience.2011.08.024; Cornwell BR, 2012, BIOL PSYCHIAT, V72, P555, DOI 10.1016/j.biopsych.2012.03.029; Costi D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007084.pub2; Duman RS, 1998, J ECT, V14, P181; ENGELHARDT W, 1993, EUR J ANAESTH, V10, P113; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; Ferron JF, 2009, J NEUROSCI, V29, P9850, DOI 10.1523/JNEUROSCI.5176-08.2009; FILE SE, 1993, BEHAV BRAIN RES, V58, P199, DOI 10.1016/0166-4328(93)90103-W; Folkerts H, 1996, EUR ARCH PSY CLIN N, V246, P155, DOI 10.1007/BF02189117; Garcia-Toro M, 2004, J ECT, V20, P53, DOI 10.1097/00124509-200403000-00015; Garcia-Toro M, 2001, J ECT, V17, P284, DOI 10.1097/00124509-200112000-00009; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; GREENBERG LB, 1987, CONVULSIVE THER, V3, P269; Guo ZG, 2019, J MOL NEUROSCI, V69, P546, DOI 10.1007/s12031-019-01380-2; Hall C., 1932, U CALIF PUBL PSYCHOL, V6, P1; Hansen HH, 2007, CELL MOL NEUROBIOL, V27, P585, DOI 10.1007/s10571-007-9145-1; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Jacobsen JPR, 2004, BRAIN RES, V1024, P183, DOI 10.1016/j.brainres.2004.07.065; Kellner CH, 2012, AM J PSYCHIAT, V169, P1238, DOI 10.1176/appi.ajp.2012.12050648; Kenny JD, 2016, ANESTH ANALG, V123, P1210, DOI 10.1213/ANE.0000000000001234; Kohtala S, 2019, MOL NEUROBIOL, V56, P4163, DOI 10.1007/s12035-018-1364-6; Koike H, 2014, BEHAV BRAIN RES, V271, P111, DOI 10.1016/j.bbr.2014.05.065; Koike H, 2011, BEHAV BRAIN RES, V224, P107, DOI 10.1016/j.bbr.2011.05.035; Kroeger D, 2007, J NEUROSCI, V27, P10597, DOI 10.1523/JNEUROSCI.3440-07.2007; KRYSTAL AD, 1995, J NEUROPSYCH CLIN N, V7, P295; LANGER G, 1995, NEUROPSYCHOBIOLOGY, V31, P182, DOI 10.1159/000119190; LANGER G, 1985, NEUROPSYCHOBIOLOGY, V14, P118, DOI 10.1159/000118216; Leikas JV, 2017, J NEUROCHEM, V142, P456, DOI 10.1111/jnc.14066; Lisanby SH, 2007, NEW ENGL J MED, V357, P1939, DOI 10.1056/NEJMct075234; Liu RJ, 2012, BIOL PSYCHIAT, V71, P996, DOI 10.1016/j.biopsych.2011.09.030; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McCarthy Michelle M, 2008, J Neurosci, V28, P13488, DOI 10.1523/JNEUROSCI.3536-08.2008; Mickey BJ, 2018, INT J NEUROPSYCHOPH, V21, P1079, DOI 10.1093/ijnp/pyy085; Moghaddam B, 1997, J NEUROSCI, V17, P2921; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Nagele P, 2015, BIOL PSYCHIAT, V78, P10, DOI 10.1016/j.biopsych.2014.11.016; Neyazi A, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-017-0077-3; NIBUYA M, 1995, J NEUROSCI, V15, P7539; NOBLER MS, 1993, BIOL PSYCHIAT, V34, P321, DOI 10.1016/0006-3223(93)90089-V; Ou MC, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2019.100760; Ozer AB, 2015, EUR REV MED PHARMACO, V19, P3886; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Perera TD, 2004, NEUROPSYCHOPHARMACOL, V29, P813, DOI 10.1038/sj.npp.1300377; Purdon PL, 2015, ANESTHESIOLOGY, V123, P937, DOI 10.1097/ALN.0000000000000841; Rantamaki T, 2007, NEUROPSYCHOPHARMACOL, V32, P2152, DOI 10.1038/sj.npp.1301345; Rantamaki T, 2020, PHARMACOL REV, V72, P439, DOI 10.1124/pr.119.018697; Rantamaki T, 2016, PROG NEURO-PSYCHOPH, V64, P285, DOI 10.1016/j.pnpbp.2015.06.001; Rantamaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068722; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Saarelainen T, 2003, J NEUROSCI, V23, P349; Sackeim HA, 1996, ARCH GEN PSYCHIAT, V53, P814; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; Smith MA, 1997, NEUROREPORT, V8, P1829, DOI 10.1097/00001756-199705260-00008; Tadler SC, 2018, CURR OPIN ANESTHESIO, V31, P439, DOI 10.1097/ACO.0000000000000617; Taylor SM, 2008, J ECT, V24, P160, DOI 10.1097/YCT.0b013e3181571ad0; Theilmann W, 2019, NEUROSCI LETT, V694, P29, DOI 10.1016/j.neulet.2018.11.018; Theilmann W, 2016, BRAIN RES, V1642, P505, DOI 10.1016/j.brainres.2016.04.041; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Vanicek T, 2019, ACTA PSYCHIAT SCAND, V140, P426, DOI 10.1111/acps.13080; Vanicek T, 2019, BRAIN STIMUL, V12, P1041, DOI 10.1016/j.brs.2019.02.015; Voss LJ, 2008, ANESTH ANALG, V107, P1689, DOI 10.1213/ane.0b013e3181852595; Vutskits L, 2008, NEUROCHEM RES, V33, P1325, DOI 10.1007/s11064-007-9586-4; Wang JY, 2018, J MOL NEUROSCI, V64, P346, DOI 10.1007/s12031-018-1029-y; Wang XB, 2011, PSYCHIAT RES, V185, P248, DOI 10.1016/j.psychres.2010.04.046; Weeks HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069809; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; YLIHANKALA A, 1993, ELECTROEN CLIN NEURO, V87, P215, DOI 10.1016/0013-4694(93)90021-M; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; Zetterstrom TSC, 1998, MOL BRAIN RES, V57, P106, DOI 10.1016/S0169-328X(98)00077-1; Zhang F, 2014, EXP THER MED, V8, P471, DOI 10.3892/etm.2014.1769; Zhang SS, 2019, PSYCHOPHARMACOLOGY, V236, P3301, DOI 10.1007/s00213-019-05287-z	86	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235046	10.1371/journal.pone.0235046	http://dx.doi.org/10.1371/journal.pone.0235046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579566	Green Published, gold			2022-12-27	WOS:000545646600018
J	Yin, BZ; Fang, JC; Zhang, JS; Zhang, LM; Xu, C; Xu, HY; Shao, J; Xia, GJ				Yin, Bao-zhen; Fang, Jia-chen; Zhang, Jia-su; Zhang, Luo-meng; Xu, Chang; Xu, Hong-yan; Shao, Jing; Xia, Guang-jun			Correlations between single nucleotide polymorphisms in FABP4 and meat quality and lipid metabolism gene expression in Yanbian yellow cattle	PLOS ONE			English	Article							CONSTRUCTION; ASSOCIATION	FABP4is a candidate gene for carcass and meat quality traits in livestock and poultry. However, the effects ofFABP4have not been examined in the Yanbian yellow cattle, an economically important local cattle breed in China. In this study, we characterized single nucleotide polymorphisms (SNPs) inFABP4in this cattle breed and their associations with meat quality traits. Six SNPs (referred to as SNP1-6) were identified inFABP4by direct sequencing and polymerase chain reaction-restriction fragment length polymorphism. The six SNPs were significantly correlated with meat quality traits. In particular, the GG and GA genotypes of SNP1 were significantly associated with water and fat contents and GG and AA genotypes of SNP1 were significantly associated with protein contents (P< 0.05). The fat content and marbling in heterozygous individuals at SNP2-6 were significantly higher than those in wild-type or mutant individuals (P< 0.05), while protein content was significantly higher in wild-type and mutant individuals than in heterozygous individuals (P< 0.05). A gene expression analysis indicated that the lipid metabolism-related genesFABP4,PPAR gamma,ANGPTL4, andLPLshow similar expression patterns with respect toFABP4genotypes, with the highest levels in wild-type individuals and the lowest levels in mutants. In conclusion,FABP4SNPs can be used for marker-assisted selection in Yanbian yellow cattle breeding.	[Yin, Bao-zhen; Zhang, Jia-su; Zhang, Luo-meng; Xu, Chang; Xu, Hong-yan; Shao, Jing; Xia, Guang-jun] Yanbian Univ, Coll Agr, Yanji, Jilin, Peoples R China; [Fang, Jia-chen] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan	Yanbian University; Hirosaki University	Xia, GJ (corresponding author), Yanbian Univ, Coll Agr, Yanji, Jilin, Peoples R China.	ybuac@ybu.edu.cn			Key scientific and technological projects of Jilin Provincial Science and technology development plan [20160204017NY]; scientific and technological projects of the 13th five year plan of Jilin Provincial Department of Education [JJKH20180903KJ]	Key scientific and technological projects of Jilin Provincial Science and technology development plan; scientific and technological projects of the 13th five year plan of Jilin Provincial Department of Education	The research was supported by Key scientific and technological projects of Jilin Provincial Science and technology development plan (20160204017NY); scientific and technological projects of the 13th five year plan of Jilin Provincial Department of Education (JJKH20180903KJ).(http://kjt.jl.gov.cn/http://jyt.jl.gov.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, PENSIONS INVESTMENTS, V46, P1; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Cho S, 2008, BMB REP, V41, P29, DOI 10.5483/BMBRep.2008.41.1.029; Damon M, 2006, J ANIM SCI, V84, P1083, DOI 10.2527/2006.8451083x; Dijk W, 2018, J CLIN LIPIDOL, V12, P773, DOI 10.1016/j.jacl.2018.02.006; Hoashi S, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-84; Jiang J, 2012, ISOLATION IDENTIFICA; Lee SH, 2010, ANIM GENET, V41, P442, DOI 10.1111/j.1365-2052.2010.02024.x; Li N, 2013, EXPRESSION 4 LIPID M; Li X.L., 2017, HEILONGJIANG ANIMAL, P106; Li Yuan, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P726; Luo Gui-Fen, 2006, Yichuan, V28, P39; Ma Y, 2009, J CHINESE CATTLE SCI, V35, P36; Michal J. J., 2010, ANIMAL GENETICS, V37, P400; NEI M, 1974, GENETICS, V76, P379; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shin SC, 2012, MOL BIOL REP, V39, P5323, DOI 10.1007/s11033-011-1331-z; Tan X, 2014, EFFECT FABP4 FATTY A; Tian WanNian, 2017, Chinese Journal of Animal Science, V53, P40; Wang D, 2016, RICE, V9, DOI 10.1186/s12284-016-0133-2; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang S.H., 2008, MOL MECH CASTRATION; Wang X.M., 2018, HEILONGJIANG ANIMAL; Wang X.M., 2018, HEILONGJIANG ANIMAL; Wang YW, 2017, PROCEEDINGS OF THE ASME FLUIDS ENGINEERING DIVISION SUMMER MEETING, 2017, VOL 2; Warnke I, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-30; Xu Ruixia, 2015, Yichuan, V37, P174, DOI 10.16288/j.yczz.14-369; Yan C., 2004, CHINA CATTLE SCI, V30, P5; Yan W, 2018, CHINA AGR SCI TECHNO, V20, P40; Yang L., 2018, FRONTIERS MECH ENG, P1; Yu H.W., 2017, SNP DETECTION FABP3; Zhang L., 2007, FEED ANAL FEED QUALI	34	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234328	10.1371/journal.pone.0234328	http://dx.doi.org/10.1371/journal.pone.0234328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579617	gold, Green Published			2022-12-27	WOS:000545646600027
J	Berry, MJ; Miller, GD; Kim-Shapiro, DB; Fletcher, MS; Jones, CG; Gauthier, ZD; Collins, SL; Basu, S; Heinrich, TM				Berry, Michael J.; Miller, Gary D.; Kim-Shapiro, Daniel B.; Fletcher, Macie S.; Jones, Caleb G.; Gauthier, Zachary D.; Collins, Summer L.; Basu, Swati; Heinrich, Timothy M.			A randomized controlled trial of nitrate supplementation in well-trained middle and older-aged adults	PLOS ONE			English	Article							DIETARY NITRATE; BLOOD-PRESSURE; INORGANIC NITRATE; BEETROOT JUICE; EXERCISE PERFORMANCE; ENDURANCE PERFORMANCE; HEART-FAILURE; NITRIC-OXIDE; EFFICIENCY; TOLERANCE	Purpose Nitrate (NO3-), through its conversion to nitrite (NO2-) and nitric oxide, has been shown to increase exercise tolerance in healthy younger adults and older diseased patients. Nitrate's effect in well-trained middle to older-aged adults has not been studied. Therefore, the purpose of this investigation was to examine the effects of a NO(3)(-)rich beverage on submaximal constant work rate exercise time in well-trained middle to older-aged adults. Methods This was a randomized controlled cross-over trial with 15 well-trained middle to older-aged adults, 41-64 year-old, who received one of two treatments (NO(3)(-)rich beverage then placebo or placebo then NO(3)(-)rich beverage), after which an exercise test at 75 percent of the subject's maximal work rate was completed. Results The NO(3)(-)rich beverage increased plasma NO(3)(-)and NO(2)(-)levels by 260 mu M and 0.47 mu M, respectively (p<0.001). Exercise time was not significantly different (p = 0.31) between the NO(3)(-)rich versus placebo conditions (1130 +/- 151 vs 1060 +/- 132 sec, respectively). Changes in exercise time between the two conditions ranged from a 55% improvement to a 40% decrease with the NO(3)(-)rich beverage. Oxygen consumption and rating of perceived exertion were not significantly different between the two conditions. Conclusion In middle to older-aged well-trained adults, NO(3)(-)supplementation has non-significant, albeit highly variable, effects on exercise tolerance.	[Berry, Michael J.; Miller, Gary D.; Fletcher, Macie S.; Jones, Caleb G.; Gauthier, Zachary D.; Collins, Summer L.; Heinrich, Timothy M.] Wake Forest Univ, Hlth & Exercise Dept, Winston Salem, NC 27101 USA; [Kim-Shapiro, Daniel B.; Basu, Swati] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University	Berry, MJ (corresponding author), Wake Forest Univ, Hlth & Exercise Dept, Winston Salem, NC 27101 USA.	berry@wfu.edu	Kim-Shapiro, Daniel/HGA-2682-2022	Collins, Summer/0000-0002-7286-9851; Berry, Michael/0000-0002-5798-1861	Isagenix International LLC, Gilbert, AZ	Isagenix International LLC, Gilbert, AZ	Funding: This work was supported by a grant from Isagenix International LLC, Gilbert, AZ awarded to MJB. The funding source had no involvement with the study design, data collection, data analysis and interpretation or the decision to submit this work for publication.	Bailey SJ, 2017, NITRIC OXIDE-BIOL CH, V63, P13, DOI 10.1016/j.niox.2016.12.008; Bailey SJ, 2015, J APPL PHYSIOL, V118, P1396, DOI 10.1152/japplphysiol.01141.2014; Bailey SJ, 2010, J APPL PHYSIOL, V109, P135, DOI 10.1152/japplphysiol.00046.2010; Bailey SJ, 2009, J APPL PHYSIOL, V107, P1144, DOI 10.1152/japplphysiol.00722.2009; Berry MJ, 2015, NITRIC OXIDE-BIOL CH, V48, P22, DOI 10.1016/j.niox.2014.10.007; Bescos R, 2012, MED SCI SPORT EXER, V44, P2400, DOI 10.1249/MSS.0b013e3182687e5c; Boorsma RK, 2014, MED SCI SPORT EXER, V46, P2326, DOI 10.1249/MSS.0000000000000364; Cermak NM, 2012, INT J SPORT NUTR EXE, V22, P470, DOI 10.1123/ijsnem.22.6.470; Cermak NM, 2012, INT J SPORT NUTR EXE, V22, P64, DOI 10.1123/ijsnem.22.1.64; Christensen PM, 2013, SCAND J MED SCI SPOR, V23, pe21, DOI 10.1111/sms.12005; Coggan AR, 2018, J CARD FAIL, V24, P65, DOI 10.1016/j.cardfail.2017.09.004; Delp MD, 2008, J PHYSIOL-LONDON, V586, P1161, DOI 10.1113/jphysiol.2007.147686; Dokun AO, 2013, AM J PHYSIOL-HEART C, V304, pH1085; DUNCAN C, 1995, NAT MED, V1, P546, DOI 10.1038/nm0695-546; Eggebeen J, 2016, JACC-HEART FAIL, V4, P428, DOI 10.1016/j.jchf.2015.12.013; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365, DOI DOI 10.1016/J.JACR.2018.09.023; Fraga C, 2017, CLIN PHYSIOL FUNCT I, V37, P17, DOI 10.1111/cpf.12261; Hernandez A, 2012, J PHYSIOL-LONDON, V590, P3575, DOI 10.1113/jphysiol.2012.232777; Hoon MW, 2014, INT J SPORT PHYSIOL, V9, P615, DOI [10.1123/IJSPP.2013-0207, 10.1123/ijspp.2013-0207]; James PE, 2015, NITRIC OXIDE-BIOL CH, V48, P44, DOI 10.1016/j.niox.2015.04.006; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; Jones AM, 2018, ANNU REV NUTR, V38, P303, DOI 10.1146/annurev-nutr-082117-051622; Jonvik KL, 2017, INT J SPORT NUTR EXE, V27, P148, DOI 10.1123/ijsnem.2016-0239; Kaminsky LA, 2015, MAYO CLIN PROC, V90, P1515, DOI 10.1016/j.mayocp.2015.07.026; Kelly J, 2013, MED SCI SPORT EXER, V45, P1798, DOI 10.1249/MSS.0b013e31828e885c; Kenjale AA, 2011, J APPL PHYSIOL, V110, P1582, DOI 10.1152/japplphysiol.00071.2011; Lankhaar JAC, 2014, RES Q EXERCISE SPORT, V85, P365, DOI 10.1080/02701367.2014.930405; Lansley KE, 2011, MED SCI SPORT EXER, V43, P1125, DOI 10.1249/MSS.0b013e31821597b4; Larsen FJ, 2014, AM J CLIN NUTR, V99, P843, DOI 10.3945/ajcn.113.079491; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Larsen FJ, 2006, NEW ENGL J MED, V355, P2792, DOI 10.1056/NEJMc062800; Lundberg JO, 2004, FREE RADICAL BIO MED, V37, P395, DOI 10.1016/j.freeradbiomed.2004.04.027; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; McConell GK, 2007, AM J PHYSIOL-REG I, V293, pR821, DOI 10.1152/ajpregu.00796.2006; Miller GD, 2012, NUTR RES, V32, P160, DOI 10.1016/j.nutres.2012.02.002; Montesanto A, 2013, BIOGERONTOLOGY, V14, P177, DOI 10.1007/s10522-013-9421-z; Oggioni C, 2018, INT J FOOD SCI NUTR, V69, P74, DOI 10.1080/09637486.2017.1328666; Porcelli S, 2015, MED SCI SPORT EXER, V47, P1643, DOI 10.1249/MSS.0000000000000577; Presley TD, 2011, NITRIC OXIDE-BIOL CH, V24, P34, DOI 10.1016/j.niox.2010.10.002; RECKELHOFF JF, 1994, LIFE SCI, V55, P1895, DOI 10.1016/0024-3205(94)00521-4; Rokkedal-Lausch T, 2019, NITRIC OXIDE-BIOL CH, V85, P44, DOI 10.1016/j.niox.2019.01.011; Shepherd AI, 2015, NITRIC OXIDE-BIOL CH, V48, P31, DOI 10.1016/j.niox.2015.01.002; Siervo M, 2016, NUTR RES, V36, P1361, DOI 10.1016/j.nutres.2016.11.004; Skripnikova E., 2017, AM J PHYSIOL-REG I, V312, pR412; Sonetti DA, 2001, RESP PHYSIOL, V127, P185, DOI 10.1016/S0034-5687(01)00250-X; Sverdlov AL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000973; van Loon AJM, 1998, BRIT J CANCER, V78, P129, DOI 10.1038/bjc.1998.454; Whitfield J, 2017, MED SCI SPORT EXER, V49, P2016, DOI 10.1249/MSS.0000000000001321; Wilkerson DP, 2012, EUR J APPL PHYSIOL, V112, P4127, DOI 10.1007/s00421-012-2397-6	49	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235047	10.1371/journal.pone.0235047	http://dx.doi.org/10.1371/journal.pone.0235047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574223	Green Published, gold			2022-12-27	WOS:000544972400019
J	Anil, KC; Basel, PL; Singh, S				Anil, K. C.; Basel, Prem Lal; Singh, Sarswoti			Low birth weight and its associated risk factors: Health facility-based case-control study	PLOS ONE			English	Article							PREGNANCY; INFANTS; WOOD	Background Low birth weight is a preventable public health problem. It is an important determinant of child survival and development, as well as long-term consequences like the onset of non-communicable disease in the life course. A large number of mortality and morbidity can be prevented by addressing the factors associated with low birth weight. The main objective of this study was to identify associated risk factors of low birth weight. Methodology A health facility-based unmatched case-control study was carried out from July 2018 to March 2019 among the mothers who delivered in health facilities of Dang district of Nepal from 17(th)August to 16(th)November 2018. The total sample size for the study was 369; 123 cases and 246 controls. Cases and controls were randomly selected independent of the exposure status in the ratio of 1:2. Information regarding exposure status was assessed through interviews and medical records. Mothers who delivered outside Dang districts were excluded from the study. Ethical clearance was obtained from the Institutional Review Committee (IRC) of the Institute of Medicine, Tribhuvan University and written consent was taken from each participant after explaining the objectives of the study. Results Multivariate logistic regression found that having the kitchen in the same living house (AOR 2.7, CI: 1.5-4.8), iron intake less than 180 tablets (AOR 3.2, CI: 1.7-5.7), maternal weight gain during second and third trimester less than 6.53 kg (AOR 2.6, CI: 1.5-4.7), co-morbidity during pregnancy (AOR 2.4, CI: 1.3-4.5), preterm birth (AOR 2.9, CI: 1.4-6.1) were the risk factors associated with low birth weight. Conclusion Having the kitchen in the same living house, iron intake less than 180 tablets during pregnancy, maternal weight gain less than 6.53 kg during the second and third trimester, co-morbidity during pregnancy and preterm birth were the risk factors associated with low birth weight.	[Anil, K. C.] Hlth Fdn Nepal, Patan, Nepal; [Basel, Prem Lal; Singh, Sarswoti] Tribhuvan Univ Teaching Hosp, Dept Community Med & Publ Hlth, Kathmandu, Nepal	Tribhuvan University; Institute of Medicine (IoM) - Nepal	Anil, KC (corresponding author), Hlth Fdn Nepal, Patan, Nepal.	kcanil707@gmail.com						African Development, 2015, AFRICAN DEV, V2, P45; Agbozo F, 2016, MIDWIFERY, V40, P200, DOI 10.1016/j.midw.2016.06.016; Al Hazzani F, 2011, ANN SAUDI MED, V31, P581, DOI 10.4103/0256-4947.87093; de Oliveira BFA, 2011, CAD SAUDE PUBLICA, V27, P1678, DOI [10.1590/S0102-311X2011000900003, 10.1590/S0102-311X2011000900016]; Ammari M, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2002846; [Anonymous], 2017, OCUL SURF, V15, P169; Atessahin E, 2015, IRAN J PUBLIC HEALTH, V44, P1299; Beard JL, 2004, MICRONUTRIENT DEFICI; Bhaskar RK, 2015, INT J PEDIAT, V2015, DOI 10.1155/2015/807373; Bondevik GT, 2001, ACTA OBSTET GYN SCAN, V80, P402, DOI 10.1034/j.1600-0412.2001.080005402.x; Boy E, 2002, ENVIRON HEALTH PERSP, V110, P109, DOI 10.1289/ehp.02110109; Chang HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131976; Coffey D, 2015, P NATL ACAD SCI USA, V112, P3302, DOI 10.1073/pnas.1416964112; Cutland CL, 2017, VACCINE, V35, P6492, DOI 10.1016/j.vaccine.2017.01.049; Fan RG, 2013, CLINICS, V68, P915, DOI 10.6061/clinics/2013(07)05; Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013; Gebremedhin M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0658-1; Hassoune Samira, 2015, Pan Afr Med J, V20, P303, DOI 10.11604/pamj.2015.20.303.2659; Hosain GMM, 2006, J TROP PEDIATRICS, V52, P87, DOI 10.1093/tropej/fmi066; Kadam Yugantara Ramesh, 2013, Indian J Community Med, V38, P212, DOI 10.4103/0970-0218.120155; Karuna Laxmi Shakya NS, 2015, INT J CLIN BIOMEDICA, V1, P8; Lambers DS, 1996, SEMIN PERINATOL, V20, P115, DOI 10.1016/S0146-0005(96)80079-6; Mathewson KJ, 2017, PSYCHOL BULL, V143, P347, DOI 10.1037/bul0000091; Ministry of Health Nepal; New ERA; ICF, 2017, NEP DEM HLTH SURV 20; Muchemi OM, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.108.4831; Negrato CA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-49; Osman NB, 2001, J TROP PEDIATRICS, V47, P30, DOI 10.1093/tropej/47.1.30; Shakya K L, 2015, J Nepal Health Res Counc, V13, P121; Sharma D, 2016, CLIN MED INSIGHTS-PE, V10, P67, DOI 10.4137/CMPed.S40070; Sharma SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123962; Sicuri E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028744; UNICEF WHO, 2004, LOW BIRTH WEIGHT COU; Washam C, 2008, ENVIRON HEALTH PERSP, V116, pA173, DOI 10.1289/ehp.116-a173a; WHO/UNICEF, 2014, GLOB NUTR TARG 2025, DOI [10.1057/9781137477699_6, DOI 10.1057/9781137477699_6]; World Health Organization, 2016, INT STAT CLASS DIS R, V10th; Yadav D K, 2011, J Nepal Health Res Counc, V9, P159	36	19	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234907	10.1371/journal.pone.0234907	http://dx.doi.org/10.1371/journal.pone.0234907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569281	gold, Green Published			2022-12-27	WOS:000543547900002
J	Dalhammar, K; Malmstrom, M; Schelin, M; Falkenback, D; Kristensson, J				Dalhammar, Karin; Malmstrom, Marlene; Schelin, Maria; Falkenback, Dan; Kristensson, Jimmie			The impact of initial treatment strategy and survival time on quality of end-of-life care among patients with oesophageal and gastric cancer: A population-based cohort study	PLOS ONE			English	Article							PALLIATIVE CARE; DEATH; REGISTER; AGGRESSIVENESS; CHEMOTHERAPY; SURGERY	Background Oesophageal and gastric cancer are highly lethal malignancies with a 5-year survival rate of 15-29%. More knowledge is needed about the quality of end-of-life care in order to understand the burden of the illness and the ability of the current health care system to deliver timely and appropriate end-of-life care. The aim of this study was to describe the impact of initial treatment strategy and survival time on the quality of end-of-life care among patients with oesophageal and gastric cancer. Methods This register-based cohort study included patients who died from oesophageal and gastric cancer in Sweden during 2014-2016. Through linking data from the National Register for Esophageal and Gastric Cancer, the National Cause of Death Register, and the Swedish Register of Palliative Care, 2156 individuals were included. Associations between initial treatment strategy and survival time and end-of-life care quality indicators were investigated. Adjusted risk ratios (RRs) with 95% confidence intervals were calculated using modified Poisson regression. Results Patients with a survival of <= 3 months and 4-7 months had higher RRs for hospital death compared to patients with a survival >= 17 months. Patients with a survival of <= 3 months also had a lower RR for end-of-life information and bereavement support compared to patients with a survival >= 17 months, while the risks of pain assessment and oral assessment were not associated with survival time. Compared to patients with curative treatment, patients with no tumour-directed treatment had a lower RR for pain assessment. No significant differences were shown between the treatment groups regarding hospital death, end-of-life information, oral health assessment, and bereavement support. Conclusions Short survival time is associated with several indicators of low quality end-of-life care among patients with oesophageal and gastric cancer, suggesting that a proactive palliative care approach is imperative to ensure quality end-of-life care.	[Dalhammar, Karin; Malmstrom, Marlene; Schelin, Maria; Kristensson, Jimmie] Lund Univ, Inst Palliat Care, Lund, Sweden; [Dalhammar, Karin; Malmstrom, Marlene; Kristensson, Jimmie] Lund Univ, Dept Hlth Sci, Fac Med, Lund, Sweden; [Schelin, Maria; Falkenback, Dan] Lund Univ, Dept Clin Sci, Fac Med, Lund, Sweden; [Falkenback, Dan] Skane Univ Hosp, Dept Surg, Lund, Sweden	Lund University; Lund University; Lund University; Lund University; Skane University Hospital	Dalhammar, K (corresponding author), Lund Univ, Inst Palliat Care, Lund, Sweden.; Dalhammar, K (corresponding author), Lund Univ, Dept Hlth Sci, Fac Med, Lund, Sweden.	Karin.dalhammar@med.lu.se		Malmstrom, Marlene/0000-0001-9575-0311	ALF (Swedish NHS) [ALF 2018:0092]; Sjoberg Foundation [Sjoberg F2019/210]	ALF (Swedish NHS); Sjoberg Foundation	This work was supported by the ALF (governmental founding from the Swedish NHS; grant number ALF 2018:0092; URL:https://www.med.lu.se/intramed/styrning_organisation/ekonomi_alf/alf) and the Sjoberg Foundation (grant number Sjoberg F2019/210; URL: https://sjobergstiftelsen.se) awarded to JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accordino MK, 2017, BREAST CANCER RES TR, V166, P549, DOI 10.1007/s10549-017-4420-4; Addington-Hall JM, 2009, PALLIATIVE MED, V23, P190, DOI 10.1177/0269216309102525; American Society of Clinical Oncology, 2019, QUAL ONC PRACT IN; [Anonymous], 2017, STATISTIKDATABAS DOD; Bergquist H, 2007, DIS ESOPHAGUS, V20, P523, DOI 10.1111/j.1442-2050.2007.00741.x; Bischoff KE, 2013, J AM GERIATR SOC, V61, P209, DOI 10.1111/jgs.12105; Blazeby JM, 2000, CANCER, V88, P1781; Boxer MM, 2011, CANCER-AM CANCER SOC, V117, P5112, DOI 10.1002/cncr.26149; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; British Geriatrics Society, 2010, PALL END LIF CAR OLD; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; Brooks GA, 2017, J PALLIAT MED, V20, P42, DOI 10.1089/jpm.2016.0231; Brooks GA, 2014, J CLIN ONCOL, V32, P496, DOI 10.1200/JCO.2013.52.4330; ECOG-ACRIN Cancer Research Group, EC PERF STAT; Ethier JL, 2018, J PALLIAT CARE, V33, P125, DOI 10.1177/0825859718762287; Gani F, 2018, J PALLIAT MED, V21, P428, DOI 10.1089/jpm.2017.0295; Gieniusz M, 2018, AM J HOSP PALLIAT ME, V35, P21, DOI 10.1177/1049909116682470; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Hong JH, 2013, CANCER RES TREAT, V45, P270, DOI 10.4143/crt.2013.45.4.270; Hunt RW, 2018, J PALLIAT CARE; Janah A, 2019, CLIN EPIDEMIOL, V11, P443, DOI 10.2147/CLEP.S198499; Janmaat VT, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004063.pub4; Johnson PC, 2019, J ONCOL PRACT, V15, pE420, DOI 10.1200/JOP.18.00595; Kauppila JH, 2020, ANN SURG, V271, P311, DOI 10.1097/SLA.0000000000002972; Kelly M, 2018, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-018-0285-5; Kempf E, 2017, EUR J CANCER, V79, P31, DOI 10.1016/j.ejca.2017.03.029; Kross EK, 2014, CHEST, V145, P313, DOI 10.1378/chest.13-1351; Lee SS, 2014, INT J SURG, V12, P700, DOI 10.1016/j.ijsu.2014.05.067; Linder G, 2016, BRIT J SURG, V103, P1326, DOI 10.1002/bjs.10234; Lundstrom S, 2012, PALLIATIVE MED, V26, P313, DOI 10.1177/0269216311414758; Malmstrom M, 2013, INT J NURS STUD, V50, P44, DOI 10.1016/j.ijnurstu.2012.08.011; Martinsson L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186804; Merchant SJ, 2017, J PALLIAT CARE, V32, P92, DOI 10.1177/0825859717738464; Mokadem I, 2019, GASTRIC CANCER, V22, P1263, DOI 10.1007/s10120-019-00956-6; Morrison RS, 2013, CURR OPIN SUPPORT PA, V7, P201, DOI 10.1097/SPC.0b013e32836103e5; Olmsted CL, 2014, JAMA SURG, V149, P1169, DOI 10.1001/jamasurg.2014.2101; Prater LC, 2019, AM J HOSP PALLIAT ME, V36, P1089, DOI 10.1177/1049909119848987; Regionala Cancercentrum i Samverkan, 2016, NAT VARDPR PALL VARD; Rouvelas I, 2005, LANCET ONCOL, V6, P864, DOI 10.1016/S1470-2045(05)70347-8; Sheffield KM, 2011, CANCER-AM CANCER SOC, V117, P5003, DOI 10.1002/cncr.26115; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sohda M, 2017, ANN THORAC CARDIOVAS, V23, P1, DOI 10.5761/atcs.ra.16-00162; Svenska Palliativregistret, 2017, RSRAPP SVENSK PALL V; Task Force on Surgical Palliative care, 2005, Bull Am Coll Surg, V90, P34; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Van den Block L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-69; Wagner AD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub4; Wang SM, 2014, AM J MANAG CARE, V20, pE353; Whitney RL, 2019, J ONCOL PRACT, V15, P37, DOI 10.1200/JOP.18.00254; Whitney RL, 2017, J CLIN ONCOL, V35, P3610, DOI 10.1200/JCO.2017.72.4963; WHO | WHO Definition of Palliative Care, 2018, WHO DEF PALL CAR; Wright AA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1219; Wu CC, 2016, ONCOLOGIST, V21, P771, DOI 10.1634/theoncologist.2015-0445; Yamashita K, 2017, WORLD J SURG, V41, P2337, DOI 10.1007/s00268-017-4024-5; Ziegler LE, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018284	56	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235045	10.1371/journal.pone.0235045	http://dx.doi.org/10.1371/journal.pone.0235045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569329	gold, Green Published			2022-12-27	WOS:000543547900006
J	Geissler, KH; Lubin, B; Ericson, KMM				Geissler, Kimberley H.; Lubin, Benjamin; Ericson, Keith M. Marzilli			The association between patient sharing network structure and healthcare costs	PLOS ONE			English	Article							PHYSICIAN SOCIAL NETWORKS; COORDINATION; COHESION	Study question While physician relationships (measured through shared patients) are associated with clinical and utilization outcomes, the extent to which this is driven by local or global network characteristics is not well established. The objective of this research is to examine the association between local and global network statistics with total medical spending and utilization. Data source Data used are the 2011 Massachusetts All Payer Claims Database. Study design The association between network statistics and total medical spending and utilization (using standardized prices) is estimated using multivariate regression analysis controlling for patient demographics and health status. Data collection We limit the sample to continuously enrolled commercially insured patients in Massachusetts in 2011. Principal findings Mean patient age was 45 years, and 56.3% of patients were female. 73.4% were covered by a health maintenance organization. Average number of visits was 5.43, with average total medical spending of $4,911 and total medical utilization of $4,252. Spending was lower for patients treated by physicians with higher degree (p<0.001), eigenvector centrality (p<0.001), clustering coefficient (p<0.001), and measures reflecting the normalized degree (p<0.001) and eigenvector centrality (p<0.001) of specialists connected to a patient's PCP. Spending was higher for patients treated by physicians with higher normalized degree, which accounts for physician specialty and patient panel size (p<0.001). Results were similar for utilization outcomes, although magnitudes differed indicating patients may see different priced physicians. Conclusions Generally, higher values of network statistics reflecting local connectivity adjusted for physician characteristics are associated with increased costs and utilization, while higher values of network statistics reflecting global connectivity are associated with decreased costs and utilization. As changes in the financing and delivery system advance through policy changes and healthcare consolidation, future research should examine mechanisms through which this structure impacts outcomes and potential policy responses to determine ways to reduce costs while maintaining quality and coordination of care. What this study adds It is unknown whether local and global measures of physician network connectivity associated with spending and utilization for commercially insured patients? In this social network analysis, we found generally higher values of network statistics reflecting local connectivity are associated with increased costs and utilization, while higher values of network statistics reflecting global connectivity are associated with decreased costs and utilization. Understanding how to influence local and global physician network characteristics may be important for reducing costs while maintaining quality.	[Geissler, Kimberley H.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Hlth Promot & Policy, Amherst, MA 01003 USA; [Lubin, Benjamin; Ericson, Keith M. Marzilli] Boston Univ, Questrom Sch Business, Informat Syst, Boston, MA 02215 USA; [Ericson, Keith M. Marzilli] Univ Southern Calif, Keck Sch Med, Gehr Ctr Hlth Syst Sci, Los Angeles, CA 90007 USA	University of Massachusetts System; University of Massachusetts Amherst; Boston University; University of Southern California	Geissler, KH (corresponding author), Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Hlth Promot & Policy, Amherst, MA 01003 USA.	kgeissler@umass.edu			National Institute for Health Care Management (NIHCM)	National Institute for Health Care Management (NIHCM)	This research was supported by a research grant from the National Institute for Health Care Management (NIHCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha L., 2019, TEAM FORMATION PERFO; Altalib HH, 2017, EPILEPSY BEHAV, V73, P31, DOI 10.1016/j.yebeh.2017.05.026; An CK, 2018, STAT MED, V37, P847, DOI 10.1002/sim.7565; Bae SH, 2015, NURS OUTLOOK, V63, P566, DOI 10.1016/j.outlook.2015.05.006; Barnett ML, 2019, J GEN INTERN MED, V34, P1952, DOI 10.1007/s11606-019-05264-4; Barnett ML, 2012, ARCH INTERN MED, V172, P163, DOI 10.1001/archinternmed.2011.722; Barnett ML, 2012, MED CARE, V50, P152, DOI 10.1097/MLR.0b013e31822dcef7; Barnett ML, 2011, HEALTH SERV RES, V46, P1592, DOI 10.1111/j.1475-6773.2011.01262.x; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Brunson JC, 2018, J AM MED INFORM ASSN, V25, P210, DOI 10.1093/jamia/ocx052; Center for Health Information and Analysis, 2013, ALL PAYER CLAIMS DAT; Cooper Z, 2019, Q J ECON, V134, P51, DOI 10.1093/qje/qjy020; Craig SV, 2018, NATL BUREAU EC RES W; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; De Choudhury M, 2010, P 19 INT C WORLD WID; DuGoff EH, 2018, MED CARE RES REV, V75, P586, DOI 10.1177/1077558717697016; DuGoff EH, 2018, TRANSL BEHAV MED, V8, P598, DOI 10.1093/tbm/ibx015; Ericson K., 2019, AM J HEALTH ECON, V4, P454; GALBRAITH JR, 1974, INTERFACES, V4, P28, DOI 10.1287/inte.4.3.28; Geissler K., 2019, ASS INSURANCE PLAN C; Geissler KH, 2020, PSYCHIAT SERV, V71, P389, DOI 10.1176/appi.ps.201900004; Geissler KH, 2020, HEALTH SERV RES, V55, P94, DOI 10.1111/1475-6773.13244; Geissler KH, 2020, MED CARE RES REV, V77, P165, DOI 10.1177/1077558718769403; Geissler KH, 2016, MED CARE, V54, P350, DOI 10.1097/MLR.0000000000000488; Ghomrawi HMK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193014; Hollingsworth JM, 2016, CIRC-CARDIOVASC QUAL, V9, P641, DOI 10.1161/CIRCOUTCOMES.116.002714; Hollingsworth JM, 2015, MED CARE, V53, P160, DOI 10.1097/MLR.0000000000000291; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Kilian Reinhold, 2002, J Ment Health Policy Econ, V5, P21; Kuo YF, 2019, MED CARE, V57, P905, DOI 10.1097/MLR.0000000000001201; Landon BE, 2018, JAMA INTERN MED, V178, P66, DOI 10.1001/jamainternmed.2017.5034; Landon BE, 2013, MED CARE, V51, P715, DOI 10.1097/MLR.0b013e3182977991; Landon BE, 2012, JAMA-J AM MED ASSOC, V308, P265, DOI 10.1001/jama.2012.7615; Mandl KD, 2014, J GEN INTERN MED, V29, P1499, DOI 10.1007/s11606-014-2964-0; Massachusetts Health Connector, 2014, COMM MASS NOT BEN PA; McClellan M, 2010, HEALTH AFFAIR, V29, P982, DOI 10.1377/hlthaff.2010.0194; Milstein A, 2009, HEALTH AFFAIR, V28, P1317, DOI 10.1377/hlthaff.28.5.1317; Ong MS, 2016, J GEN INTERN MED, V31, P164, DOI 10.1007/s11606-015-3470-8; OREILLY CA, 1982, ACAD MANAGE J, V25, P756, DOI 10.2307/256097; Pollack CE, 2013, J GEN INTERN MED, V28, P459, DOI 10.1007/s11606-012-2104-7; Pollack CE, 2012, HEALTH SERV RES, V47, P380, DOI 10.1111/j.1475-6773.2011.01331.x; Rathi VK, 2019, JAMA-J AM MED ASSOC, V321, P1157, DOI 10.1001/jama.2019.1295; Reagans R, 2003, ADMIN SCI QUART, V48, P240, DOI 10.2307/3556658; Seifert RW., 2018, WHAT KNOW ACOS INTRO; Shi YR, 2019, MED CARE, V57, P460, DOI 10.1097/MLR.0000000000001123; Shoham DA, 2015, J BURN CARE RES, V36, P551, DOI 10.1097/BCR.0000000000000218; Trogdon JG, 2019, J GEN INTERN MED, V34, P2014, DOI 10.1007/s11606-019-04978-9; Tushman M.L., 1978, ACAD MANAGE REV, V3, P613, DOI [10.5465/amr.1978.4305791, DOI 10.2307/257550]	48	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234990	10.1371/journal.pone.0234990	http://dx.doi.org/10.1371/journal.pone.0234990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569294	gold, Green Published			2022-12-27	WOS:000543547900007
J	Debnath, T; Nakamoto, T				Debnath, Tanoy; Nakamoto, Takamichi			Predicting human odor perception represented by continuous values from mass spectra of essential oils resembling chemical mixtures	PLOS ONE			English	Article							DIMENSIONALITY; FEATURES	There have been recent advances in predicting odor characteristics using molecular structure parameters of chemicals. Although the molecular structure parameters are available for each chemical, they cannot be used for chemical mixtures. This study will elucidate a computational method of predicting human odor perception from the mass spectra of chemical mixtures such as essential oils. Furthermore, a method for obtaining similarity among odor descriptors has been proposed although the dataset contains binary values only. When the database indicates a set of odor descriptors for one sample, only binary data are available and the correlation between the similar descriptors disappears. Thus, the prediction performance degrades for not considering the similarity among the odor descriptors. Since mass spectra dataset is highly dimensional, we use auto-encoder to learn the compressed representation from the mass spectra of essential oils in its bottleneck hidden layer and then accomplishes the hierarchical clustering to create odor descriptor groups with similar odor impressions using a matrix of continuous value-based correlation coefficient as well as natural language processing. This work will help to expatiate the process of overcoming binary value problem and find out the similarity among odor descriptors using machine learning with natural language semantic representation of words. To overcome the problem of disproportionate ratio of positive and negative class for both the continuous value-based correlation coefficient and word similarity based models, we use Synthetic Minority Oversampling Technique (SMOTE). This model allows us to predict human odor perception through computer simulations by forming odor descriptors group. Accordingly, this study demonstrates the feasibility of ensembling machine learning with natural language processing and SMOTE approach for predicting odor descriptor group from mass spectra of essential oils.	[Debnath, Tanoy; Nakamoto, Takamichi] Tokyo Inst Technol, Dept Informat & Commun Engn, Yokohama, Kanagawa, Japan; [Nakamoto, Takamichi] Tokyo Inst Technol, Lab Future Interdisciplinary Res Sci & Technol, Yokohama, Kanagawa, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Nakamoto, T (corresponding author), Tokyo Inst Technol, Dept Informat & Commun Engn, Yokohama, Kanagawa, Japan.; Nakamoto, T (corresponding author), Tokyo Inst Technol, Lab Future Interdisciplinary Res Sci & Technol, Yokohama, Kanagawa, Japan.	nakamoto@mn.ee.titech.ac.jp		Nakamoto, Takamichi/0000-0002-0599-226X; Debnath, Tanoy/0000-0002-2624-8923				Bojanowski P., 2017, T ASSOC COMPUT LING, V5, P135, DOI [https://doi.org/10.1162/tacl_a_00051, 10.1162/tacl_a_00051]; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Debnath T., 2019, IEEE 2019 IEEE INT S, P1, DOI [DOI 10.1109/ISOEN.2019.8823226, 10.1109/ISOEN.2019.8823226]; Goodfellow I., 2016, DEEP LEARNING, DOI DOI 10.4258/HIR.2016.22.4.351; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Keller A, 2017, SCIENCE, V355, P820, DOI 10.1126/science.aal2014; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; Nakamoto T, 2013, IEEE SENS J, V13, P4305, DOI 10.1109/JSEN.2013.2267728; Nakamoto T, 2012, IEEE SENS J, V12, P3225, DOI 10.1109/JSEN.2012.2190506; Nakashizuka T, 2016, ECOL RES MONOGR, P1, DOI 10.1007/978-4-431-55954-2_1; Nozaki Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208962; Nozaki Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157030; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Shang L, 2017, ANAL CHEM, V89, P11999, DOI 10.1021/acs.analchem.7b02389; Shang L, 2018, SENSOR ACTUAT B-CHEM, V255, P508, DOI 10.1016/j.snb.2017.08.024; Torgo L., DATA MINING R LEARNI; TRUNK GV, 1979, IEEE T PATTERN ANAL, V1, P306, DOI 10.1109/TPAMI.1979.4766926	18	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234688	10.1371/journal.pone.0234688	http://dx.doi.org/10.1371/journal.pone.0234688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559255	gold, Green Published			2022-12-27	WOS:000543261600024
J	Bhatia, SM; Streilein, RD; Hall, RP				Bhatia, Sravya M.; Streilein, Robert D.; Hall, Russell P.			Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab	PLOS ONE			English	Article							FOLIACEUS FOGO SELVAGEM; THYROID AUTOIMMUNITY; ANTI-DESMOGLEIN; VULGARIS; DISEASE; ANTIBODIES; PREVALENCE; ADHESION; MICROARRAY; CELLS	Introduction Autoantibodies (autoAbs) against desmoglein-1 (DSG1) and desmoglein-3 (DSG3) have conventionally been studied and well accepted in the pathogenesis of pemphigus vulgaris (PV) and foliaceus (PF). Recent studies have suggested that non-DSG autoAbs may contribute to the pathogenesis of pemphigus, including autoAbs directed at acetylcholine receptors (AChR) and thyroid peroxidase (TPO). The purpose of this study is to retrospectively analyze PV and PF patient sera to better understand the relationship between anti-AChR and -TPO Abs to disease activity and DSG reactivity between patients treated with prednisone and steroid sparing agents (SSA; n = 22) or prednisone and rituximab (n = 21). Methods Patients were evaluated at 2 time points, T1 and T2, for disease activity using the Pemphigus Disease Area Index (PDAI), and sera were tested for the presence of TPO, DSG1, DSG3, muscarinic (M3) and nicotinic (n) AChR IgG autoAbs, as well as antibodies against Varicella Zoster Virus (VZV) by ELISA. Results Disease activity significantly decreased in patients from T1 to T2 (p < .0001). A significant difference was seen in IgG anti-DSG1 (p < .0001) and anti-DSG3 (p = .0049) levels when T1 was compared to T2 in both treatment groups. A significant increase was found between pemphigus patients and normal subjects with nAChR (p < .0001) at T1 but not with m3AChR, TPO or VZV Abs. No significant difference was seen between T1 and T2 values in patients with pemphigus for the non-desmoglein Abs TPO (p = .7559), M3AChR (p = .9003), nAChR (p = .5143) or VZV (p = .2454). These findings demonstrate that although an increase in IgG anti-nAChR autoAbs was found in PV and PF subjects, these Abs did not decrease with treatment. No other non-DSG Abs were increased or significantly changed over time in patients with pemphigus. This suggests that anti -AChR and -TPO Abs may not play a direct role in the pathogenesis of most patients with pemphigus, but does not rule out a role for non-DSG auto antibodies in distinct subsets of pemphigus patient.	[Bhatia, Sravya M.] Duke Univ, Sch Med, Durham, NC USA; [Streilein, Robert D.; Hall, Russell P.] Duke Univ, Sch Med, Dept Dermatol, Durham, NC 27708 USA; [Hall, Russell P.] Duke Univ, Med Ctr, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Hall, RP (corresponding author), Duke Univ, Sch Med, Dept Dermatol, Durham, NC 27708 USA.; Hall, RP (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.	Russell.Hall@dm.duke.edu						Abasq C, 2009, ARCH DERMATOL, V145, P529, DOI 10.1001/archdermatol.2009.9; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; AMAGAI M, 1995, J INVEST DERMATOL, V104, P146, DOI 10.1111/1523-1747.ep12613668; [Anonymous], 2012, NAT BIOTECHNOL, V30, P78; [Anonymous], 2013, J THORAC DIS S2, V5, pS168; Ansar A, 2009, J EUR ACAD DERMATOL, V23, P719, DOI 10.1111/j.1468-3083.2009.03172.x; Boulard C, 2016, BRIT J DERMATOL, V175, P142, DOI 10.1111/bjd.14405; Brown F, 2018, INFORM RES, V23; Chams-Davatchi C, 2005, INT J DERMATOL, V44, P470, DOI 10.1111/j.1365-4632.2004.02501.x; Chernyavsky A, 2015, INT IMMUNOPHARMACOL, V29, P76, DOI 10.1016/j.intimp.2015.04.046; Daneshpazhooh M, 2010, J AM ACAD DERMATOL, V62, P349, DOI 10.1016/j.jaad.2009.05.024; Desmet C, 2013, ENVIRON SCI-PROC IMP, V15, P1876, DOI 10.1039/c3em00296a; Di Zenzo G, 2012, J CLIN INVEST, V122, P3781, DOI 10.1172/JCI64413; DIAZ LA, 1989, J INVEST DERMATOL, V92, P4, DOI 10.1111/1523-1747.ep13070394; EYRE RW, 1987, J EXP MED, V165, P1719, DOI 10.1084/jem.165.6.1719; Feliciani C, 2007, INT J IMMUNOPATH PH, V20, P289, DOI 10.1177/039463200702000209; FRIEDMAN H, 1995, J AM ACAD DERMATOL, V32, P949, DOI 10.1016/0190-9622(95)91330-0; Grando SA, 2012, AUTOIMMUNITY, V45, P7, DOI 10.3109/08916934.2011.606444; Hans G, 1996, J INVEST DERMATOL, V107, P68, DOI 10.1111/1523-1747.ep12298213; Jahn-Schmid B, 2003, CLIN EXP ALLERGY, V33, P1443, DOI 10.1046/j.1365-2222.2003.01784.x; Kalantari-Dehaghi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057587; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Lakshmi MJD, 2017, J AM ACAD DERMATOL, V76, P895, DOI 10.1016/j.jaad.2016.11.039; Lin MS, 1997, J CLIN INVEST, V99, P31, DOI 10.1172/JCI119130; Marchenko S, 2010, J BIOL CHEM, V285, P3695, DOI 10.1074/jbc.M109.081570; Mihai S, 2007, J CELL MOL MED, V11, P462, DOI 10.1111/j.1582-4934.2007.00033.x; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Nguyen VT, 2000, J CLIN INVEST, V106, P1467, DOI 10.1172/JCI10305; Nguyen VT, 1998, ARCH DERMATOL, V134, P971, DOI 10.1001/archderm.134.8.971; Pitoia F, 2005, MEDICINA-BUENOS AIRE, V65, P307; Quan C, 2015, J NEUROIMMUNOL, V282, P45, DOI 10.1016/j.jneuroim.2015.03.016; Robbins AC, 2007, J AM ACAD DERMATOL, V56, pS82, DOI 10.1016/j.jaad.2006.10.956; ROCK B, 1990, J CLIN INVEST, V85, P296, DOI 10.1172/JCI114426; Rosenbach M, 2009, J INVEST DERMATOL, V129, P2404, DOI 10.1038/jid.2009.72; RUOCCO V, 1982, ARCH DERMATOL RES, V274, P123, DOI 10.1007/BF00510366; Ruocco V, 2013, CLIN DERMATOL, V31, P374, DOI 10.1016/j.clindermatol.2013.01.004; Sajda T, 2016, P NATL ACAD SCI USA, V113, P1859, DOI 10.1073/pnas.1525448113; Seiffert-Sinha K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00625; Sinha AA, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00218; Spindler V, 2018, J INVEST DERMATOL, V138, P32, DOI 10.1016/j.jid.2017.06.022; STANLEY JR, 1989, J CLIN INVEST, V83, P1443, DOI 10.1172/JCI114036; Tirado-Sanchez Andres, 2012, Dermatol Online J, V18, P14; Van P., 2009, J STAT MECH THEORY E, V2009, pP0254; VIGNALE R, 1993, INT J DERMATOL, V32, P307, DOI 10.1111/j.1365-4362.1993.tb04276.x; Warren SJP, 2000, NEW ENGL J MED, V343, P23, DOI 10.1056/NEJM200007063430104	45	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0233957	10.1371/journal.pone.0233957	http://dx.doi.org/10.1371/journal.pone.0233957			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555697	Green Published, gold			2022-12-27	WOS:000543273200030
J	Grzywa, TM; Klicka, K; Paskal, W; Dudkiewicz, J; Wejman, J; Pyzlak, M; Wlodarski, PK				Grzywa, Tomasz M.; Klicka, Klaudia; Paskal, Wiktor; Dudkiewicz, Julia; Wejman, Jaroslaw; Pyzlak, Michal; Wlodarski, Pawel K.			miR-410-3p is induced by vemurafenib via ER stress and contributes to resistance to BRAF inhibitor in melanoma	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TARGET; CELLS; DOWNSTREAM; SURVIVAL; CLUSTER	Despite significant development of melanoma therapies, death rates remain high. MicroRNAs, controlling posttranscriptionally gene expression, play role in development of resistance to BRAF inhibitors. The aim of the study was to assess the role of miR-410-3p in response to vemurafenib-BRAF inhibitor. FFPE tissue samples of 12 primary nodular melanomas were analyzed. With the use of Laser Capture Microdissection, parts of tumor, transient tissue, and adjacent healthy tissue were separated. In vitro experiments were conducted on human melanoma cell lines A375, G361, and SK-MEL1. IC50s of vemurafenib were determined using MTT method. Cells were transfected with miR-410-3p mimic, anti-miR-410-3p and their non-targeting controls. ER stress was induced by thapsigargin. Expression of isolated RNA was determined using qRT-PCR. We have found miR-410-3p is downregulated in melanoma tissues. Its expression is induced by vemurafenib in melanoma cells. Upregulation of miR-410-3p level increased melanoma cells resistance to vemurafenib, while its inhibition led to the decrease of resistance. Induction of ER stress increased the level of miR-410-3p. miR-410-3p upregulated the expression of AXL in vitro and correlated with markers of invasive phenotype in starBase. The study shows a novel mechanism of melanoma resistance. miR-410-3p is induced by vemurafenib in melanoma cells via ER stress. It drives switching to the invasive phenotype that leads to the response and resistance to BRAF inhibition.	[Grzywa, Tomasz M.; Klicka, Klaudia; Paskal, Wiktor; Dudkiewicz, Julia; Wlodarski, Pawel K.] Med Univ Warsaw, Lab Ctr Preclin Res, Dept Methodol, Warsaw, Poland; [Grzywa, Tomasz M.] Med Univ Warsaw, Dept Immunol, Warsaw, Poland; [Wejman, Jaroslaw; Pyzlak, Michal] Med Ctr Postgrad Educ, Dept Pathol, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Centre of Postgraduate Medical Education - Poland	Paskal, W (corresponding author), Med Univ Warsaw, Lab Ctr Preclin Res, Dept Methodol, Warsaw, Poland.	wiktor.paskal@wum.edu.pl	Grzywa, Tomasz M./AAU-7668-2020; Wejman, Jarosław/AAV-7974-2020; Paskal, Wiktor/ABF-3337-2021	Grzywa, Tomasz M./0000-0002-1809-248X; Wejman, Jarosław/0000-0003-0659-7322; Klicka, Klaudia/0000-0002-3650-5401; Paskal, Wiktor/0000-0003-3051-5446	Medical University of Warsaw [1M15/NM5/18]; Polish Ministry of Science and Higher Education [0075/DIA/2017/46]	Medical University of Warsaw; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was funded by a grant from the Medical University of Warsaw 1M15/NM5/18 (TMG) (www.wum.edu.pl) and from the Polish Ministry of Science and Higher Education 0075/DIA/2017/46 (WP) (www.mnisw.gov.pl The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; [Anonymous], 2011, NUCLEIC ACIDS RES, V39, pD214; [Anonymous], 2002, MOD THEOL, V18, P333; [Anonymous], 2015, CANC DISCOV, V5, pOF2; Arozarena I, 2019, NAT REV CANCER, V19, P377, DOI 10.1038/s41568-019-0154-4; Ascierto ML, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00152; Atkinson V, 2017, INTERN MED J, V47, P1114, DOI 10.1111/imj.13574; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Beck D, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003057; Chapman PB, 2017, ANN ONCOL, V28, P2581, DOI 10.1093/annonc/mdx339; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Clark AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151515; Corella D, 2014, AM J CLIN NUTR, V100, P719, DOI 10.3945/ajcn.113.076992; Couts KL, 2013, ONCOGENE, V32, P1959, DOI 10.1038/onc.2012.209; Cubillos-Ruiz JR, 2016, CLIN CANCER RES, V22, P2121, DOI 10.1158/1078-0432.CCR-15-1570; Diaz-Martinez Marta, 2018, Oncotarget, V9, P35374, DOI 10.18632/oncotarget.26244; Diaz-Martinez M, 2018, CANCER RES, V78, P1017, DOI 10.1158/0008-5472.CAN-17-1318; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Fattore L, 2019, CELL DEATH DIFFER, V26, P1267, DOI 10.1038/s41418-018-0205-5; Fattore L, 2017, ONCOTARGET, V8, P22262, DOI 10.18632/oncotarget.14763; Fattore L, 2016, P NATL ACAD SCI USA, V113, pE5005, DOI 10.1073/pnas.1607753113; Grzywa TM, 2019, ENDOCRINE, V65, P646, DOI 10.1007/s12020-019-01960-7; Grzywa TM, 2017, TRANSL ONCOL, V10, P956, DOI 10.1016/j.tranon.2017.09.007; Guy GP, 2015, MMWR-MORBID MORTAL W, V64, P591; Hachey SJ, 2016, EXP DERMATOL, V25, P497, DOI 10.1111/exd.13002; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Kato M, 2016, ENDOPLASMIC RETICULU; Kemper K, 2014, CANCER RES, V74, P5937, DOI 10.1158/0008-5472.CAN-14-1174; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim A, 2016, EXPERT OPIN DRUG DIS, V11, P907, DOI 10.1080/17460441.2016.1201057; Kozar I, 2019, BBA-REV CANCER, V1871, P313, DOI 10.1016/j.bbcan.2019.02.002; Li FZ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00031; Liu SM, 2014, ONCOTARGET, V5, P9444, DOI 10.18632/oncotarget.2452; Ma XH, 2014, J CLIN INVEST, V124, P1406, DOI 10.1172/JCI70454; Manzano JL, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.07; McArthur GA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00161; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; NCBI Resource Coordinators, 2013, NUCLEIC ACIDS RES, V42, pD7; Restivo G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01573-6; Ross CL, 2018, J CELL PHYSIOL, V233, P5133, DOI 10.1002/jcp.26395; Sahoo A, 2019, J INVEST DERMATOL, V139, P167, DOI 10.1016/j.jid.2018.06.189; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Shiah SG, 2014, CANCER RES, V74, P7560, DOI 10.1158/0008-5472.CAN-14-0978; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Stark MS, 2015, ONCOTARGET, V6, P17753, DOI 10.18632/oncotarget.3924; Sun XY, 2016, ONCOTARGET, V7, P53558, DOI 10.18632/oncotarget.10669; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vergani E, 2016, ONCOTARGET, V7, P4428, DOI 10.18632/oncotarget.6599; Wen R, 2018, J CELL BIOCHEM, V119, P8737, DOI 10.1002/jcb.27251; Wong NW, 2018, BIOINFORMATICS, V34, P713, DOI 10.1093/bioinformatics/btx627; Xiong J, 2017, ONCOTARGET, V8, P6555, DOI 10.18632/oncotarget.14149; Yarza R, 2016, FRONT PHARMACOL, V6, DOI [10.3389/fphys.2015.00321, 10.3389/fphar.2015.00321]	55	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234707	10.1371/journal.pone.0234707	http://dx.doi.org/10.1371/journal.pone.0234707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555626	Green Published, gold			2022-12-27	WOS:000542759600003
J	Khalifa, MM; Abdel-Rahman, SM; Bakir, HY; Othman, RA; El-Mokhtar, MA				Khalifa, Mervat M.; Abdel-Rahman, Salma M.; Bakir, Hanaa Y.; Othman, Ragaa A.; El-Mokhtar, Mohamed A.			Comparison of the diagnostic performance of microscopic examination, Copro-ELISA, and Copro-PCR in the diagnosis ofCapillaria philippinensis infections	PLOS ONE			English	Article							HUMAN INTESTINAL CAPILLARIASIS; LINKED-IMMUNOSORBENT-ASSAY; COPROANTIGEN; ANTIGEN; EGYPT	Intestinal capillariasis is a parasitic zoonosis caused by the tiny nematode parasiteCapillaria philippinensis. It is a major health problem that may lead to death if not diagnosed and treated appropriately. The difficulties in the diagnosis ofC.philippinensishighlight the importance of developing accurate, sensitive, and specific methods for early diagnosis. This study aimed to detect the presence ofC.philippinensisinfection among 42 clinically suspected patients with certain criteria that are highly suggestive of capillariasis and to compare the diagnostic yield of microscopy, copro-ELISA, and PCR for the detection of copro-DNA. Sociodemographic characteristics and clinical data were also described for the infected group. Out of 42 patients, 10 were microscopically positive, 40 samples were positive by copro-ELISA, nested PCR detected 35 positive cases, with total detection rates of 23.8%, 95.2%, and 83.3% using direct microscopic examination, copro-ELISA, and PCR, respectively. The majority of positive cases were females, middle-aged people, and people from rural areas. The real number of cases infected withC.philippinensismay far exceed those estimated using microscopy. The diagnosis by copro-ELISA for the detection ofC.philippinensiscoproantigen and by nested PCR to identify parasite DNA revealed a higher number of positive cases. Using ELISA for the detection of coproantigen is a sensitive test that identifies the infection, yet it is not specific. Copro-DNA offers a satisfactory sensitive and specific method for the detection of infection in clinically suspected patients. The most susceptible individuals toC.philippinensisinfection are females, middle-aged people, and people of low social standards. Intestinal capillariasis needs to be considered in patients who present with symptoms of chronic diarrhea and hypoalbuminemia because if these cases are left undiagnosed and untreated, they may suffer from lethal complications.	[Khalifa, Mervat M.; Abdel-Rahman, Salma M.; Bakir, Hanaa Y.; Othman, Ragaa A.] Assiut Univ, Dept Med Parasitol, Fac Med, Assiut, Egypt; [El-Mokhtar, Mohamed A.] Assiut Univ, Dept Med Microbiol & Immunol, Assiut, Egypt	Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University	Othman, RA (corresponding author), Assiut Univ, Dept Med Parasitol, Fac Med, Assiut, Egypt.	ragaa_othman@yahoo.com		El-Mokhtar, Mohamed A./0000-0003-1943-8419				Abdel-Rahman SM, 1998, AM J VET RES, V59, P533; Amin FM, 2011, THESIS; [Anonymous], 2016, PECIA, V17, P93; [Anonymous], 2016, DIAGNOSTIC MED PARAS; Attia RAH, 2012, AM J TROP MED HYG, V86, P126, DOI 10.4269/ajtmh.2012.11-0321; Austin DN, 1999, EUR J GASTROEN HEPAT, V11, P935, DOI 10.1097/00042737-199908000-00023; Bair MJ, 2004, WORLD J GASTROENTERO, V10, P2391; Chidambaram Meenachi, 2017, Trop Parasitol, V7, P111, DOI 10.4103/tp.TP_26_17; Chitwood MB, 1968, P 1 INT C PAR ROM IT, V2, P797; CROSS JH, 1992, CLIN MICROBIOL REV, V5, P120, DOI 10.1128/CMR.5.2.120-129.1992; Cross JH, 1983, HUMAN ECOLOGY INFECT; El Dib Nadia A., 2004, Journal of the Egyptian Society of Parasitology, V34, P97; El-Dib NA, 2015, EXP PARASITOL, V154, P127, DOI 10.1016/j.exppara.2015.04.011; El-Dib Nadia A., 2002, Journal of the Egyptian Society of Parasitology, V32, P145; Fraser A, 1997, J HELMINTHOL, V71, P103, DOI 10.1017/S0022149X00015753; Intapan PM, 2017, PARASITOL RES, V116, P2443, DOI 10.1007/s00436-017-5546-3; Intapan PM, 2010, SE ASIAN J TROP MED, V41, P298; Intapan PM, 2006, PARASITOL RES, V98, P227, DOI 10.1007/s00436-005-0070-2; LANGLEY RJ, 1989, AM J TROP MED HYG, V41, P472, DOI 10.4269/ajtmh.1989.41.472; Limsrivilai J, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0207-9; Lin Y.-L., 1990, Journal of the Formosan Medical Association, V89, P49; Lu LH, 2006, AM J TROP MED HYG, V74, P810, DOI 10.4269/ajtmh.2006.74.810; Methanitikorn R, 2003, REV I MED TROP S PAU, V45; O'Connell EM, 2016, AM J TROP MED HYG, V95, P508, DOI 10.4269/ajtmh.16-0266; Saichua P, 2008, WORLD J GASTROENTERO, V14, P506, DOI 10.3748/wjg.14.506; Soukhathammavong P, 2008, AM J TROP MED HYG, V79, P735; Sykes AM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000955; Szollosi E, 2008, J PARASITOL, V94, P562, DOI 10.1645/GE-1286.1; Thewjitcharoen Y, 2012, ASIAN BIOMED, V6, P781, DOI 10.5372/1905-7415.0605.123; Verweij JJ, 2014, CLIN MICROBIOL REV, V27, P371, DOI 10.1128/CMR.00122-13; YOUSSEF FG, 1989, AM J TROP MED HYG, V40, P195, DOI 10.4269/ajtmh.1989.40.195; 2019, CAN J KIDNEY HLTH DI, V6, P1	32	4	4	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234746	10.1371/journal.pone.0234746	http://dx.doi.org/10.1371/journal.pone.0234746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555632	Green Published, gold			2022-12-27	WOS:000542759600055
J	Choe, SA; Yoon, NH; Yoo, S; Kim, H				Choe, Seung-Ah; Yoon, Nan-He; Yoo, Seunghyun; Kim, Hyekyeong			Gender-differences in predictors for time to metabolic syndrome resolution: A secondary analysis of a randomized controlled trial study	PLOS ONE			English	Article							LIFE-STYLE; PREVALENCE; OBESITY; INTERVENTION	Understanding gender differences in health-related behaviors and their impacts is a crucial aspect of effective primary care. We studied gender-based differences in predictors of metabolic syndrome (MetS) resolution among newly diagnosed MetS patients. This study was a secondary analysis of a prospective clinical trial study comprising of 637 middle-aged and older adults (226 men and 411 women) who underwent a regular health checkup and were newly diagnosed with MetS at 16 different health clinics of 14 metropolitan cities and provinces. We conducted Cox proportional hazard analysis to estimate cumulative probability of MetS resolution within a 12-month observation period. Among the 637 patients, 47.6% of participants achieved MetS resolution. The resolution rate was similar among men and women (44.7% and 49.1%, respectively, P = 0.320). Low household income (Hazard ratio = 2.62, 95% confidence interval: 1.13-6.08) and current employment (2.29, 1.26-4.13) were associated with a higher cumulative probability of MetS resolution in men than in women. For women, however, longer sleeping hours (1.18, 1.04-1.34) and living with a partner (1.58, 1.06-2.35) were positive predictors of MetS resolution. Being overweight (0.63, 0.44-0.89) was associated with lower cumulative probability of MetS resolution in women than in men. The factors associated with cumulative probability of MetS resolution within the 12-month follow-up were different between men and women. These findings facilitate further exploration on gender-based differences in risk factors for less optimal improvements in MetS.	[Choe, Seung-Ah] CHA Univ, Sch Med, Dept Obstet & Gynecol, Pocheon Si, Gyunggi Do, South Korea; [Yoon, Nan-He] Hanyang Cyber Univ, Dept Hlth Adm, Seoul, South Korea; [Yoo, Seunghyun] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Publ Hlth Sci, Seoul, South Korea; [Yoo, Seunghyun] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Kim, Hyekyeong] Ewha Womans Univ, Dept Hlth Convergence, Seoul, South Korea	Pochon Cha University; Seoul National University (SNU); Seoul National University (SNU); Ewha Womans University	Yoo, S (corresponding author), Seoul Natl Univ, Grad Sch Publ Hlth, Dept Publ Hlth Sci, Seoul, South Korea.; Yoo, S (corresponding author), Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea.	syoo@snu.ac.kr			National Research Foundation of Korea [NRF-2010-0004016]	National Research Foundation of Korea(National Research Foundation of Korea)	HK and SY received a research grant (NRF-2010-0004016) from the National Research Foundation of Korea (URL: http://nrf.re.kr).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, SOC SURG AL TRACT AN; Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Batsis JA, 2008, MAYO CLIN PROC, V83, P897, DOI 10.4065/83.8.897; Bird C., 2008, EFFECTS CONSTRAINED; Choe SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196719; Dalle Grave R, 2010, DIABET METAB SYND OB, V3, P373, DOI 10.2147/DMSOTT.S13860; EU, 2016, FAZ, P1, DOI DOI 10.5194/ACP16-150752016; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gurka MJ, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003609; Han TS, 2002, DIABETES CARE, V25, P2016, DOI 10.2337/diacare.25.11.2016; Liao CM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102178; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Montano Diego, 2017, Rev Diabet Stud, V14, P279, DOI 10.1900/RDS.2017.14.279; Morales DD, 2008, DIABETES VASC DIS RE, V5, P36, DOI 10.3132/dvdr.2008.007; Oh Sang Woo, 2017, Korean Journal of Helicobacter Upper Gastrointestinal Research, V17, P62, DOI 10.7704/kjhugr.2017.17.2.62; Orchard TJ, 2005, ANN INTERN MED, V142, P611, DOI 10.7326/0003-4819-142-8-200504190-00009; Pan L., 2009, Morbidity and Mortality Weekly Report, V58, P740; Ranasinghe P, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4041-1; Rochlani Y, 2015, CARDIOVASC DRUG THER, V29, P329, DOI 10.1007/s10557-015-6593-6; Sarris J, 2015, ASIA-PAC PSYCHIAT, V7, P345, DOI 10.1111/appy.12212; Simonsen SE, 2015, EVAL PROGRAM PLANN, V51, P8, DOI 10.1016/j.evalprogplan.2014.12.003; Thomas SL, 2008, HEALTH EXPECT, V11, P321, DOI 10.1111/j.1369-7625.2008.00490.x; Troxel WM, 2005, ARCH INTERN MED, V165, P1022, DOI 10.1001/archinte.165.9.1022; Villamizar N, 2011, J OBES, V2011, DOI 10.1155/2011/790683; Wadden TA, 2012, CIRCULATION, V125, P1157, DOI 10.1161/CIRCULATIONAHA.111.039453; Whisman MA, 2010, J FAM PSYCHOL, V24, P367, DOI 10.1037/a0019547; Yeh CJ, 2011, ASIA PAC J CLIN NUTR, V20, P292; Yoo S, 2013, PSYCHOL HEALTH MED, V18, P47, DOI 10.1080/13548506.2012.672751; Yoon NH, 2015, J KOREAN MED SCI, V30, P1092, DOI 10.3346/jkms.2015.30.8.1092	32	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234035	10.1371/journal.pone.0234035	http://dx.doi.org/10.1371/journal.pone.0234035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584834	Green Published, gold			2022-12-27	WOS:000545747200012
J	Wagner, B; Latimer, J; Adams, E; Olson, HC; Symons, M; Mazzucchelli, TG; Jirikowic, T; Watkins, R; Cross, D; Carapetis, J; Boulton, J; Wright, E; McRae, T; Carter, M; Fitzpatrick, JP				Wagner, Bree; Latimer, Jane; Adams, Emma; Carmichael Olson, Heather; Symons, Martyn; Mazzucchelli, Trevor G.; Jirikowic, Tracy; Watkins, Rochelle; Cross, Donna; Carapetis, Jonathan; Boulton, John; Wright, Edie; McRae, Tracy; Carter, Maureen; Fitzpatrick, James P.			School-based intervention to address self-regulation and executive functioning in children attending primary schools in remote Australian Aboriginal communities	PLOS ONE			English	Article							ALCOHOL SPECTRUM DISORDER; EFFORTFUL CONTROL; ALERT PROGRAM; BEHAVIOR; PROMOTION; SKILLS; MODEL; RISK; FASD	Executive functioning and self-regulation influence a range of outcomes across the life course including physical and mental health, educational success, and employment. Children prenatally exposed to alcohol or early life trauma (ELT) are at higher risk of impairment of these skills and may require intervention to address self-regulation deficits. Researchers partnered with the local Aboriginal health organization and schools to develop and pilot a manualized version of the Alert Program (R) in the Fitzroy Valley, north Western Australia, a region with documented high rates of fetal alcohol spectrum disorder and ELT. This self-controlled cluster randomized trial evaluated the effect of an 8-week Alert Program (R) intervention on children's executive functioning and self-regulation skills. Following parent or caregiver consent (referred to hereafter as parent), 271 students were enrolled in the study. This reflects a 75% participation rate and indicates the strong community support that exists for the study. Teachers from 26 primary school classrooms across eight Fitzroy Valley schools received training to deliver eight, one-hour Alert Program (R) lessons over eight-weeks to students. Student outcomes were measured by parent and teacher ratings of children's behavioral, emotional, and cognitive regulation. The mean number of lessons attended by children was 4.2. Although no significant improvements to children's executive functioning skills or behavior were detected via the teacher-rated measures as hypothesized, statistically significant improvements were noted on parent-rated measures of executive functioning and behavior. The effectiveness of future self-regulation programs may be enhanced through multimodal delivery through home, school and community based settings to maximize children's exposure to the intervention. Despite mixed findings of effect, this study was an important first step in adapting and evaluating the Alert Program (R) for use in remote Australian Aboriginal community schools, where access to self-regulation interventions is limited.	[Wagner, Bree; Adams, Emma; McRae, Tracy; Fitzpatrick, James P.] Univ Western Australia, Telethon Kids Inst, Alcohol & Pregnancy & Fetal Alcohol Spectrum Diso, Perth, WA, Australia; [Latimer, Jane] Univ Sydney, Sydney Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia; [Carmichael Olson, Heather] Seattle Childrens Res Inst, Seattle, WA USA; [Carmichael Olson, Heather] Univ Washington, Sch Med, Seattle, WA USA; [Symons, Martyn; Watkins, Rochelle] Natl Hlth & Med Res Council, FASD Res Australia Ctr Res Excellence, Perth, WA, Australia; [Symons, Martyn; Cross, Donna; Carapetis, Jonathan] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Mazzucchelli, Trevor G.] Curtin Univ, Sch Psychol, Child & Family Res Grp, Perth, WA, Australia; [Mazzucchelli, Trevor G.] Curtin Univ, Sch Psychol, Brain Behav & Mental Hlth Res Grp, Perth, WA, Australia; [Jirikowic, Tracy] Univ Washington, Sch Med, Dept Rehabil Med, Div Occupat Therapy, Seattle, WA 98195 USA; [Cross, Donna] Univ Western Australia, Telethon Kids Inst, Hlth Promot & Educ Res Team, Perth, WA, Australia; [Cross, Donna] Univ Western Australia, Telethon Kids Inst, CoLab Collaborate Kids, Perth, WA, Australia; [Carapetis, Jonathan] Perth Childrens Hosp, Perth, WA, Australia; [Boulton, John] Univ Newcastle, Newcastle, NSW, Australia; [Wright, Edie] Western Australian Dept Educ Kimberley Educ Reg, Broome, WA, Australia; [Carter, Maureen] Nindilingarri Cultural Hlth Serv, Fitzroy Crossing, WA, Australia	Telethon Kids Institute; University of Western Australia; University of Sydney; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Telethon Kids Institute; University of Western Australia; Curtin University; Curtin University; University of Washington; University of Washington Seattle; Telethon Kids Institute; University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Newcastle	Wagner, B (corresponding author), Univ Western Australia, Telethon Kids Inst, Alcohol & Pregnancy & Fetal Alcohol Spectrum Diso, Perth, WA, Australia.	bree.wagner@telethonkids.org.au	Adams, Emma/AGZ-7490-2022; Carapetis, Jonathan/H-8933-2014	Adams, Emma/0000-0002-6295-9714; Symons, Martyn/0000-0003-1875-0427; Wagner, Bree/0000-0002-1202-9172; Cross, Donna/0000-0001-6217-5058; Watkins, Rochelle/0000-0002-1372-4089; Carapetis, Jonathan/0000-0002-1182-9792	National Health and Medical Research Council [1086145]; Australian Government Research Training Program (RTP) Scholarship; National Health and Medical Research Council FASD Research Australia Centre of Research Excellence [1110341]; National Health and Medical Research Council Research Fellowship [1119339]; 100 Women	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); National Health and Medical Research Council FASD Research Australia Centre of Research Excellence(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); 100 Women	This project was funded by the National Health and Medical Research Council project grant (1086145) https://nhmrc.gov.au/.BW is supported by an Australian Government Research Training Program (RTP) Scholarship https://www.education.gov.au/research-training-program.MS received support through the National Health and Medical Research Council FASD Research Australia Centre of Research Excellence (1110341). DC is supported by a National Health and Medical Research Council Research Fellowship (1119339). Community researcher training was supported by a philanthropic grant from 100 Women https://100women.org.au/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, EUR HEART J S, V17, pD2; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2010, MARULU LILILWAN PROJ; [Anonymous], MIA MIA ABORIGINAL C; [Anonymous], AUSTR CURR ASS REP A; [Anonymous], INTRO DOES YOUR ENGI; [Anonymous], 2005, SOCIAL EMOTIONAL WEL; Ardila A., 1996, J SOC EVOL SYST, V19, P237, DOI [10.1016/S1061-7361(96)90034-X, DOI 10.1016/S1061-7361(96)90034-X, 10.1016/S1061-7361(96)90034-X.23, DOI 10.1016/S1061-7361(96)90034-X.23]; Barkley RA., 2012, EXECUTIVE FUNCTIONS; Barnes Karin J, 2008, Phys Occup Ther Pediatr, V28, P369, DOI 10.1080/01942630802307127; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackwell AL, 2014, J OCC THER SCH EARLY, V7, P204, DOI 10.1080/19411243.2014.966013; Blair C, 2008, DEV PSYCHOPATHOL, V20, P899, DOI 10.1017/S0954579408000436; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Blair C, 2010, CHILD DEV PERSPECT, V4, P181, DOI 10.1111/j.1750-8606.2010.00145.x; Bower C, 2017, J PAEDIATR CHILD H, V53, P1021, DOI 10.1111/jpc.13625; Bridgett DJ, 2013, EMOTION, V13, P47, DOI 10.1037/a0029536; Coffin J., 2007, ABORIGINAL ISLANDER, V31, P22; Diamond A., 2016, EXECUTIVE FUNCTION P, P11, DOI [10.1037/14797-002, DOI 10.1037/14797-002, 10.13140/RG.2.1.2644.6483, DOI 10.13140/RG.2.1.2644.6483]; Dingwall KM, 2010, AUST NZ J PSYCHIAT, V44, P20, DOI 10.3109/00048670903393670; Dossetor PJ, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0947-0; Eyberg S.M., 1999, EYBERG CHILD BEHAV I; Fitzpatrick JP, 2017, AUST NZ J PUBL HEAL, V41, P467, DOI 10.1111/1753-6405.12689; Fitzpatrick JP, 2017, RES DEV DISABIL, V65, P114, DOI 10.1016/j.ridd.2017.04.001; Gill K, 2018, J OCC THER SCH EARLY, V11, P212, DOI 10.1080/19411243.2018.1432445; Gioia GA IP, 2015, BRIEF2 BEHAV RATING; Gooda M, 2010, ABORIGINAL TORRES ST, V2010; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Kearney CA, 2008, EDUC PSYCHOL REV, V20, P257, DOI 10.1007/s10648-008-9078-3; Kimberley Workforce Development Alliance, 2013, KIMB WORKF DEV PLAN; Kodituwakku PW, 1995, ALCOHOL CLIN EXP RES, V19, P1558, DOI 10.1111/j.1530-0277.1995.tb01024.x; Mac Cobb S, 2014, EMOT BEHAV DIFFIC, V19, P410, DOI 10.1080/13632752.2014.903593; Malbin D., 2002, TRYING DIFFERENTLY R; Mason BA, 2014, PSYCHOL SCHOOLS, V51, P1017, DOI 10.1002/pits.21800; Mattson SN, 2011, NEUROPSYCHOL REV, V21, P81, DOI 10.1007/s11065-011-9167-9; Mc Loughlin F, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0517-1; McClelland M., 2018, HDB LIFE COURSE HLTH, P275, DOI [DOI 10.1007/978-3-319-47143-3_12, 10.1007/978-3-319-47143-3_12]; McClelland MM, 2012, CHILD DEV PERSPECT, V6, P136, DOI 10.1111/j.1750-8606.2011.00191.x; McIntosh K, 2013, EXCEPT CHILDREN, V79, P293; McShane G, 2001, AUST NZ J PSYCHIAT, V35, P822, DOI 10.1046/j.1440-1614.2001.00955.x; Miyake A, 2016, INT J PSYCHOL, V51, P1032; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Morphy F, 2010, POPULATION PEOPLE PL; Nash K, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010007; Nash K, 2015, CHILD NEUROPSYCHOL, V21, P191, DOI 10.1080/09297049.2014.889110; Nigg JT, 2017, J CHILD PSYCHOL PSYC, V58, P361, DOI 10.1111/jcpp.12675; Portilla XA, 2014, CHILD DEV, V85, P1915, DOI 10.1111/cdev.12259; Rai JK, 2017, CHILD NEUROPSYCHOL, V23, P713, DOI 10.1080/09297049.2016.1191628; Rasmussen C, 2006, CHILD NEUROPSYCHOL, V12, P453, DOI 10.1080/09297040600646854; Snyder HR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00328; Soh DW, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00108; Soh DW, 2015, FRONT HUM NEUROSCI, P9, DOI [10.3389/fnhum.2015.00009, DOI 10.3389/FNHUM.2015.00009]; Sulik MJ, 2015, CHILD DEV, V86, P1588, DOI 10.1111/cdev.12386; Townsend C, 2018, AUST HEALTH REV, V42, P227, DOI 10.1071/AH16229; Ursache A, 2012, CHILD DEV PERSPECT, V6, P122, DOI 10.1111/j.1750-8606.2011.00209.x; Wagner B, 2019, AUST J EDUC, V63, P98, DOI 10.1177/0004944119826206; Wagner B, 2017, AUST OCCUP THER J, V64, P243, DOI 10.1111/1440-1630.12352; Wells AM, 2012, AM J OCCUP THER, V66, P24, DOI 10.5014/ajot.2012.002691; Western Australian Department of Education, SCH ON LIN DIR PUBL; Williams M.S., 1996, DOES YOUR ENGINE RUN; Zhou Q, 2012, CHILD DEV PERSPECT, V6, P112, DOI 10.1111/j.1750-8606.2011.00176.x	63	12	12	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234895	10.1371/journal.pone.0234895	http://dx.doi.org/10.1371/journal.pone.0234895			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579567	gold, Green Published			2022-12-27	WOS:000545646600048
J	Yogendrakumar, V; Lun, RD; Khan, F; Salottolo, K; Lacut, K; Graham, C; Dennis, M; Hutton, B; Wells, PS; Fergusson, D; Dowlatshahi, D				Yogendrakumar, Vignan; Lun, Ronda; Khan, Faizan; Salottolo, Kristin; Lacut, Karine; Graham, Catriona; Dennis, Martin; Hutton, Brian; Wells, Philip S.; Fergusson, Dean; Dowlatshahi, Dar			Venous thromboembolism prevention in intracerebral hemorrhage: A systematic review and network meta-analysis	PLOS ONE			English	Review							DEEP-VEIN THROMBOSIS; INTERMITTENT PNEUMATIC COMPRESSION; PULMONARY-EMBOLISM; HEPARIN-THERAPY; HIGH-RISK; PROPHYLAXIS; GUIDELINES; MANAGEMENT; SAFETY	Introduction To summarize and compare the effectiveness of pharmacological thromboprophylaxis to pneumatic compression devices (PCD) for the prevention of venous thromboembolism in patients with acute intracerebral hemorrhage. Methods MEDLINE, PUBMED, EMBASE, and CENTRAL were systematically searched to identify randomized and non-randomized studies that compared each intervention directly to each other or against a common control (hydration, anti-platelet agents, stockings) in adults with acute spontaneous intracerebral hemorrhage. Two investigators independently screened the studies, extracted data, and appraised risk of bias. Studies with a high risk of bias were excluded from our final analysis. The primary outcome was the occurrence of venous thromboembolism (proximal deep vein thrombosis or pulmonary embolism) in the first 30 days. Results 8,739 articles were screened; four articles, all randomized control trials, met eligibility criteria. Bayesian network meta-analysis was performed to calculate risk estimates using both fixed and random effects analyses. 607 patients were included in the network analysis. PCD were associated with a significant decrease in venous thromboembolism compared to control (OR: 0.43, 95% Credible Limits [CrI]: 0.23-0.80). We did not find evidence of statistically significant differences between pharmacological thromboprophylaxis and control (OR: 0.93, 95% CrI: 0.19-4.37) or between PCD and pharmacological thromboprophylaxis (OR: 0.47, 95% CrI: 0.09-2.54). Conclusion PCDs are superior to control interventions, but meaningful comparisons with pharmacotherapy are not possible due to a lack of data. This requires further exploration via large pragmatic clinical trials	[Yogendrakumar, Vignan; Lun, Ronda; Dowlatshahi, Dar] Univ Ottawa, Div Neurol, Dept Med, Ottawa, ON, Canada; [Khan, Faizan; Hutton, Brian; Fergusson, Dean] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Salottolo, Kristin] St Anthony Hosp, Trauma Res Dept, Lakewood, CO USA; [Lacut, Karine] Univ Bretagne Occidentale, EA3878, Brest, France; [Graham, Catriona] Western Gen Hosp, Wellcome Trust Clin Res Facil, Edinburgh, Midlothian, Scotland; [Dennis, Martin] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Wells, Philip S.] Univ Ottawa, Dept Med, Div Hematol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Universite de Bretagne Occidentale; University of Edinburgh; University of Edinburgh; University of Ottawa	Yogendrakumar, V (corresponding author), Univ Ottawa, Div Neurol, Dept Med, Ottawa, ON, Canada.	vyogendrakumar@toh.ca	Yogendrakumar, Vignan/ABC-4597-2021	Yogendrakumar, Vignan/0000-0001-8814-6853; Dowlatshahi, Dar/0000-0003-1379-3612; , Faizan/0000-0001-7570-0755; Lacut, Karine/0000-0002-4849-0454				Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; BOEER A, 1991, J NEUROL NEUROSUR PS, V54, P466, DOI 10.1136/jnnp.54.5.466; Brady MA, 2015, OBSTET GYNECOL, V125, P19, DOI 10.1097/AOG.0000000000000554; Brown S, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-110; Cameron C, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0133-0; Cherian LJ, 2018, NEUROSURGERY, V82, P85, DOI 10.1093/neuros/nyx146; Dennis M, 2011, J THROMB HAEMOST, V9, P2193, DOI 10.1111/j.1538-7836.2011.04486.x; Dennis M, 2010, ANN INTERN MED, V153, P553, DOI 10.7326/0003-4819-153-9-201011020-00280; Dennis M, 2009, LANCET, V373, P1958, DOI 10.1016/S0140-6736(09)60941-7; Dennis M, 2013, LANCET, V382, P516, DOI 10.1016/S0140-6736(13)61050-8; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; DICKMANN U, 1988, KLIN WOCHENSCHR, V66, P1182, DOI 10.1007/BF01727666; Faust AC, 2017, NEUROLOGIST, V22, P166, DOI 10.1097/NRL.0000000000000141; Field TS, 2012, CLIN APPL THROMB-HEM, V18, P5, DOI 10.1177/1076029611412362; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Khan MT, 2017, CUREUS, V9, DOI 10.7759/cureus.1982; Kiphuth IC, 2009, CEREBROVASC DIS, V27, P146, DOI 10.1159/000177923; Lacut K, 2005, NEUROLOGY, V65, P865, DOI 10.1212/01.wnl.0000176073.80532.a2; Macatangay Chona, 2008, J Trauma Nurs, V15, P12, DOI 10.1097/01.JTN.0000315783.20213.3b; Orken DN, 2009, NEUROLOGIST, V15, P329, DOI 10.1097/NRL.0b013e3181a93bac; Paciaroni M, 2011, J THROMB HAEMOST, V9, P893, DOI 10.1111/j.1538-7836.2011.04241.x; Pavon JM, 2016, J ARTHROPLASTY, V31, P524, DOI 10.1016/j.arth.2015.09.043; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Rudd A, 2017, TLS-TIMES LIT SUPPL, P6; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Vignon P, 2013, INTENS CARE MED, V39, P872, DOI 10.1007/s00134-013-2814-2; Wu TC, 2011, STROKE, V42, P705, DOI 10.1161/STROKEAHA.110.600593; Yogendrakumar V, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-024405; Zhang DD, 2018, WORLDV EVID-BASED NU, V15, P189, DOI 10.1111/wvn.12288	32	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234957	10.1371/journal.pone.0234957	http://dx.doi.org/10.1371/journal.pone.0234957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579570	gold, Green Published			2022-12-27	WOS:000545646600012
J	Hatsuda, Y; Ishizaka, T; Koizumi, N; Yasui, Y; Saito, T; Maki, S; Omotani, S; Mukai, J; Tachi, T; Teramachi, H; Myotoku, M				Hatsuda, Yasutoshi; Ishizaka, Toshihiko; Koizumi, Naonori; Yasui, Yukako; Saito, Takako; Maki, Syou; Omotani, Sachiko; Mukai, Junji; Tachi, Tomoya; Teramachi, Hitomi; Myotoku, Michiaki			Influence of analysis conditions for antimicrobial susceptibility test data on susceptibility rates	PLOS ONE			English	Article							ANTIBIOGRAM	Background To support effective antibiotic selection in empirical treatments, infection control interventions, and antimicrobial resistance containment strategies, many medical institutions collect antimicrobial susceptibility test data conducted at their facilities to prepare cumulative antibiograms. Aim To evaluate how the setpoints of duplicate isolate removal period and data collection period affect the calculated susceptibility rates in antibiograms. Methods The Sakai City Medical Center is a regional core hospital for tertiary emergency medical care with 480 beds for general clinical care. In this study, all thePseudomonas aeruginosa,Escherichia coli, andKlebsiella pneumoniaeisolates collected at the Sakai City Medical Center Clinical Laboratory between July 2013 and December 2018 were subjected to antimicrobial susceptibility tests and the resulting data was analyzed. Findings The longer the duplicate isolate removal period, the fewer the isolates are available for every bacterial species. Differences in the length of the duplicate isolate removal period affectedP.aeruginosasusceptibility rates to beta-lactam antibiotics by up to 10.8%. The setpoint of the data collection period affected the antimicrobial susceptibility rates by up to 7.3%. We found that a significant change in susceptibility could be missed depending on the setting of the data collection period, in preparing antibiogram of beta-lactam antibiotics forP.aeruginosa. Conclusions When referring to antibiograms, medical professionals involved in infectious disease treatment should be aware that the parameter values, such as the duplicate isolate removal period and the data collection period, affectP.aeruginosasusceptibility rates especially to beta-lactam antibiotics. And antibiogram should be updated within the shortest time period that is practically possible, taking into account restrictions such as numbers of specimen.	[Hatsuda, Yasutoshi; Maki, Syou; Omotani, Sachiko; Mukai, Junji; Myotoku, Michiaki] Osaka Ohtani Univ, Fac Pharm, Tondabayashi, Osaka, Japan; [Ishizaka, Toshihiko; Koizumi, Naonori; Yasui, Yukako; Saito, Takako; Omotani, Sachiko] Sakai City Med Ctr, Sakai, Osaka, Japan; [Tachi, Tomoya; Teramachi, Hitomi] Gifu Pharmaceut Univ, Gifu, Gifu, Japan	Gifu Pharmaceutical University	Hatsuda, Y (corresponding author), Osaka Ohtani Univ, Fac Pharm, Tondabayashi, Osaka, Japan.	hatuday@osaka-ohtani.ac.jp	Tachi, Tomoya/AAM-8441-2020	Tachi, Tomoya/0000-0002-5380-0218				CLSI, 2014, M39A4 CLSI, VFourth; CLSI, 2016, M100S CLSI, V26th; Hindler JF, 2007, CLIN INFECT DIS, V44, P867, DOI 10.1086/511864; Ishimaki, 2019, INT J BIOMEDICAL SOF, V24, P39; Joshi S, 2010, INDIAN J MED MICROBI, V28, P277, DOI 10.4103/0255-0857.71802; Kohlmann R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147965; Lax S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6500; Moehring RW, 2015, J CLIN MICROBIOL, V53, P2977, DOI 10.1128/JCM.01077-15; Mulvey MR, 2009, CAN MED ASSOC J, V180, P408, DOI 10.1503/cmaj.080239; Simpao AF, 2018, APPL CLIN INFORM, V9, DOI 10.1055/s-0037-1615787; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1	11	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235059	10.1371/journal.pone.0235059	http://dx.doi.org/10.1371/journal.pone.0235059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574199	Green Published, gold			2022-12-27	WOS:000544972400034
J	Deng, GY; Yue, XF; Miao, L; Lu, FY				Deng, Guangyao; Yue, Xiaofang; Miao, Lu; Lu, Fengying			Identification of key sectors of water resource utilization in China from the perspective of water footprint	PLOS ONE			English	Article							DECOMPOSITION ANALYSIS; ECONOMIC-GROWTH; OUTPUT; TRADE; CONSUMPTION; EFFICIENCY; EMISSIONS; ENERGY; CARBON; RIVER	We identified the key sectors of water resource use in China from the perspective of the water footprint to improve the use of water resources. The empirical results showed that there were six key sectors (including Crop Cultivation; Forestry; Livestock and Livestock Products; Fishery, Technical Services for Agriculture, Forestry, Livestock and Fishing; Other Food Products, and Scrap and Waste) for water consumption in China in 2015.We analyzed the use of green water, blue water, and grey water. These six sectors accounted for 66.15% of the total impact and 90.76% of the direct impact. Seven key sectors (the six sectors above plus Steel Processing)for the consumption of blue water in China can explain 59.70% of the total impact and 86.94% of the direct effect in 2015. Eight key sectors (Crop cultivation, Other food products, Scrap and Waste, Railway Freight Transport, Highway Freight and Passengers Transport, Water Freight and Passengers Transport, Pipeline Transport, and Health Services) responsible for the consumption of grey water in China in 2015 can explain 81.28% of the total impact and 95.73% of the direct impact. Therefore, the Chinese government should focus on the departments that manage water resources in these sectors when designing water-saving policies and improving water-use efficiency, such as promoting water-saving irrigation technology (including sprinkler irrigation and drip irrigation) in the agricultural sector.	[Deng, Guangyao; Lu, Fengying] Lanzhou Univ Finance & Econ, Sch Stat, Lanzhou, Peoples R China; [Yue, Xiaofang; Miao, Lu] Shenzhen Univ, China Ctr Special Econ Zone Res, Shenzhen, Peoples R China	Lanzhou University of Finance & Economics; Shenzhen University	Yue, XF (corresponding author), Shenzhen Univ, China Ctr Special Econ Zone Res, Shenzhen, Peoples R China.	harborangel@163.com	Miao, Lu/GNH-1924-2022	Miao, Lu/0000-0002-6468-4195	Natural Science Foundation of China [71704070]; Ministry of Education for the Humanities and Social Sciences Research Young Fund on the West and Borderland Project [17XJC790002]; Guangdong Provincial Natural Science Foundation of China [2017A030313443]; Program of Lanzhou University of Finance and Economics [Lzufe2018B-06]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education for the Humanities and Social Sciences Research Young Fund on the West and Borderland Project; Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Program of Lanzhou University of Finance and Economics	This work was supported by the Natural Science Foundation of China under Grant [number 71704070]; Ministry of Education for the Humanities and Social Sciences Research Young Fund on the West and Borderland Project [number 17XJC790002]; Guangdong Provincial Natural Science Foundation of China under Grant [number 2017A030313443];and Program of Lanzhou University of Finance and Economics under Grant [number Lzufe2018B-06].	Alcantara V, 2003, ENERG POLICY, V31, P1673, DOI 10.1016/S0301-4215(02)00233-1; Alcantara V., 2006, WORKING PAPERS; Allan J., 1993, PRIORITIES WATER RES; [Anonymous], 2016, REV CAMBIOS PERMANEN, V7, P113; Antonelli M, 2012, WATER RESOUR MANAG, V26, P4133, DOI 10.1007/s11269-012-0135-9; Chen WM, 2017, ECOL INDIC, V74, P321, DOI 10.1016/j.ecolind.2016.11.037; Deng GY, 2018, ECOL INDIC, V93, P1302, DOI 10.1016/j.ecolind.2018.06.019; Deng GY, 2016, J CLEAN PROD, V112, P4674, DOI 10.1016/j.jclepro.2015.07.129; Deng GY, 2015, WATER RESOUR MANAG, V29, P2947, DOI 10.1007/s11269-015-0980-4; Hirschman A., 1958, STRATEGY EC DEV; Hoekstra A.Y., 2011, WATER FOOTPRINT ASSE, DOI DOI 10.1080/0969160X.2011.593864; Hoekstra AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032688; Hou SY, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10082822; Huang HP, 2018, WATER-SUI, V10, DOI 10.3390/w10111664; Huang Y, 2017, WATER POLICY, V19, P197, DOI 10.2166/wp.2016.002; Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938; Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x; Long HY, 2019, SCI TOTAL ENVIRON, V690, P1321, DOI 10.1016/j.scitotenv.2019.06.311; Long XL, 2018, ENVIRON SCI POLLUT R, V25, P13093, DOI 10.1007/s11356-018-1549-6; Long XL, 2015, RENEW SUST ENERG REV, V52, P680, DOI 10.1016/j.rser.2015.07.176; Long XL, 2015, ENERG POLICY, V81, P61, DOI 10.1016/j.enpol.2015.02.012; Long XL, 2013, J CLEAN PROD, V39, P161, DOI 10.1016/j.jclepro.2012.08.005; Lu SB, 2020, ENVIRON GEOCHEM HLTH, V42, P863, DOI 10.1007/s10653-019-00315-5; Luo YS, 2017, J CLEAN PROD, V159, P220, DOI 10.1016/j.jclepro.2017.05.076; Metulini R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153982; Okadera T, 2014, ECON SYST RES, V26, P444, DOI 10.1080/09535314.2014.934324; Rasmusen P, 1956, STUDIES INTERSECTORA; Salman M, 2019, SCI TOTAL ENVIRON, V686, P1019, DOI 10.1016/j.scitotenv.2019.06.019; Schyns JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099705; Steen-Olsen K, 2012, ENVIRON SCI TECHNOL, V46, P10883, DOI 10.1021/es301949t; Wahba SM, 2018, J CLEAN PROD, V198, P1526, DOI 10.1016/j.jclepro.2018.06.266; Wang HX, 2018, WATER-SUI, V10, DOI [10.3390/w10040494, 10.3390/w1004]; Wang XM, 2016, ECOL INDIC, V69, P26, DOI 10.1016/j.ecolind.2016.03.029; Wang ZY, 2013, J CLEAN PROD, V42, P172, DOI 10.1016/j.jclepro.2012.11.007; Winter JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093084; Xu M, 2018, J CLEAN PROD, V176, P1283, DOI 10.1016/j.jclepro.2017.11.203; Zhang C, 2014, ECOL ECON, V100, P159, DOI 10.1016/j.ecolecon.2014.02.006; Zhang Y, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0315-9; ZHANG YY, 2019, WATER-SUI, V11, DOI DOI 10.3390/W11010034; Zhao DD, 2017, J CLEAN PROD, V167, P919, DOI 10.1016/j.jclepro.2017.07.012; Zhao X, 2009, ECOL MODEL, V220, P245, DOI 10.1016/j.ecolmodel.2008.09.016; Zhi Y, 2014, HYDROL EARTH SYST SC, V18, P1549, DOI 10.5194/hess-18-1549-2014	42	2	2	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234307	10.1371/journal.pone.0234307	http://dx.doi.org/10.1371/journal.pone.0234307			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569328	Green Published, gold			2022-12-27	WOS:000543547900052
J	Grundel, R; Dulin, GS; Pavlovic, NB				Grundel, Ralph; Dulin, Gary S.; Pavlovic, Noel B.			Changes in conservation value from grasslands to savannas to forests: How a temperate canopy cover gradient affects butterfly community composition	PLOS ONE			English	Article							HABITAT STRUCTURE; OAK SAVANNAS; MANAGEMENT; DIVERSITY; BIODIVERSITY; RESTORATION; ABANDONMENT; RESOURCES; WOODLANDS; ABUNDANCE	Temperate savannas and grasslands are globally threatened. In the Midwest United States of America (USA), for example, oak savannas persist today at a small percentage of recent historic coverage. Therefore, restoration of habitats of low and intermediate canopy cover is a landscape conservation priority that often emphasizes returning tree density to a savanna-like target value. Understanding how animal species react to such changes in vegetation structure is important for assessing the value of these restoration plans. We examined how butterfly community attributes in northwest Indiana USA, including community composition, richness, and abundance responded to a grassland-to-forest gradient of canopy cover. Butterfly community composition under intermediate canopy cover differed significantly from community composition in the most open or closed-canopy habitats. Composition of the plant community in flower was a significant predictor of three assessed attributes of the butterfly community-composition, richness, and abundance. Phenology, expressed as day-of-the-year, was also a strong predictor of these butterfly community attributes. Few butterfly species were habitat specialists as adults although canopy cover was a more important predictor of adult community composition than of richness or abundance of butterflies. Therefore, adult butterfly community differences along the canopy cover gradient were less about butterfly communities filled with habitat specialists for different canopy-defined habitats and more about gradual changes in community composition along this gradient. Overall, butterfly community richness was predicted to peak at about 34% canopy cover, butterfly abundance at about 53% canopy cover, community conservation value at about 59% canopy cover, and a combination of desirable conservation attributes-high diversity, high abundance, and high conservation value-was predicted to reach a peak of co-occurrence at about 67% canopy cover suggesting that habitats of intermediate canopy cover might be particularly effective for butterfly conservation in this region.	[Grundel, Ralph; Pavlovic, Noel B.] US Geol Survey, Great Lakes Sci Ctr, Chesterton, IN 46304 USA; [Dulin, Gary S.] Valparaiso Univ, Dept Biol, Valparaiso, IN 46383 USA	United States Department of the Interior; United States Geological Survey; Valparaiso University	Grundel, R (corresponding author), US Geol Survey, Great Lakes Sci Ctr, Chesterton, IN 46304 USA.	rgrundel@usgs.gov		Grundel, Ralph/0000-0002-2949-7087	U.S. Geological Survey's Grassland's Research Initiative	U.S. Geological Survey's Grassland's Research Initiative	This project was supporting by funding from the U.S. Geological Survey's Grassland's Research Initiative to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MD, 2019, ANN FOREST SCI, V76, DOI 10.1007/s13595-018-0790-y; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson RC, 1999, SAVANNAS BARRENS ROC; Anderson Roger C., 1998, Transactions of the Wisconsin Academy of Sciences Arts and Letters, V86, P1; [Anonymous], 2015, PC ORD MULTIVARIATE; [Anonymous], 1989, YALE J CRIT, V3, P103; AUCLAIR AN, 1976, ECOLOGY, V57, P431, DOI 10.2307/1936429; Benes J, 2006, FOREST ECOL MANAG, V237, P353, DOI 10.1016/j.foreco.2006.09.058; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blowes SA, 2019, SCIENCE, V366, P339, DOI 10.1126/science.aaw1620; Broome A, 2011, BIODIVERS CONSERV, V20, P729, DOI 10.1007/s10531-010-9974-y; Brudvig LA, 2017, J APPL ECOL, V54, P1013, DOI 10.1111/1365-2664.12940; Buckland S.T., 2001, pi; Buisson E, 2018, BIOL REV; Capmourteres V, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1476; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Colwell RK, 2013, ESTIMATES STAT ESTIM; De Marco P, 2008, BIOL LETTERS, V4, P577, DOI 10.1098/rsbl.2008.0210; De'ath G, 1999, PLANT ECOL, V144, P191, DOI 10.1023/A:1009763730207; Dey DC, 2017, J FOREST, V115, P202, DOI 10.5849/jof.15-152; Diniz JAF, 2008, GLOBAL ECOL BIOGEOGR, V17, P479, DOI 10.1111/j.1466-8238.2008.00395.x; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elzinga C.L., 1998, 17301 BUR LAND MAN; ESRI, 2016, ARCGIS DESKT VERS 10; Fahey Robert T., 2015, OAK ECOSYSTEMS RECOV; Fartmann T, 2013, BIOL CONSERV, V159, P396, DOI 10.1016/j.biocon.2012.11.024; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grundel R, 1998, OECOLOGIA, V114, P243, DOI 10.1007/s004420050442; Grundel R, 1998, BIOL CONSERV, V85, P47, DOI 10.1016/S0006-3207(97)00165-1; Grundel R, 2008, J APPL ECOL, V45, P315, DOI 10.1111/j.1365-2664.2007.01422.x; Grundel R, 2007, CONDOR, V109, P734, DOI 10.1650/0010-5422(2007)109[734:ROBSDT]2.0.CO;2; Grundel R, 2007, AUK, V124, P969, DOI 10.1642/0004-8038(2007)124[969:DUAVOM]2.0.CO;2; Grundel R, 2007, BIOL CONSERV, V135, P135, DOI 10.1016/j.biocon.2006.10.003; Grundel R, 2015, BIODIVERS CONSERV, V24, P1089, DOI 10.1007/s10531-014-0844-x; Grundel R, 2010, ECOL APPL, V20, P1678, DOI 10.1890/08-1792.1; Hijmans RJ., 2017, DISMO SPECIES DISTRI, V9, P1; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Kleckova I, 2014, J THERM BIOL, V41, P50, DOI 10.1016/j.jtherbio.2014.02.002; Ladwig LM, 2018, ECOL EVOL, V8, P8458, DOI 10.1002/ece3.4251; Lawler JJ, 2015, CONSERV BIOL, V29, P618, DOI 10.1111/cobi.12505; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; McCleery R, 2018, BIOL CONSERV, V226, P54, DOI 10.1016/j.biocon.2018.07.020; Miller LD, 1981, J LEPID SOC; MK Leach, 1995, MIDWEST OAK SAVANNA; Mullerova J, 2015, FOREST ECOL MANAG, V343, P88, DOI 10.1016/j.foreco.2015.02.003; Mullerova J, 2014, FOREST ECOL MANAG, V331, P104, DOI 10.1016/j.foreco.2014.07.032; NatureServe, 2017, NATURESERVE EXPL ONL; Nielsen TF, 2019, ECOL LETT, V22, P1650, DOI 10.1111/ele.13361; NUZZO V A, 1986, Natural Areas Journal, V6, P6; Ogle D.H., 2019, FSA FISHERIES STOCK; Ohwaki A, 2017, EUR J ENTOMOL, V114, P533, DOI 10.14411/eje.2017.068; Patterson TA, 2020, CONSERV SCI PRACT, V2, DOI 10.1111/csp2.147; R Core Team, 2018, R LANG ENV STAT COMP; Ramilo P, 2017, ENVIRON ENTOMOL, V46, P1235, DOI 10.1093/ee/nvx140; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Sebek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060456; Simpson GL, 2014, COCORRESP COCORRESPO; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Stuhldreher G, 2018, ECOL INDIC, V94, P83, DOI 10.1016/j.ecolind.2018.06.043; Systat Software Inc, 2008, SIGMAPLOT V 11 2; ter Braak CJF, 2004, ECOLOGY, V85, P834, DOI 10.1890/03-0021; Thomas M, 2009, J HOMEL SECUR EMERG, V6; Touboul JD, 2018, P NATL ACAD SCI USA, V115, pE1336, DOI 10.1073/pnas.1712356115; Transeau EN, 1935, ECOLOGY, V16, P423, DOI 10.2307/1930078; Tulowiecki SJ, 2020, ANN AM ASSOC GEOGR, V110, P184, DOI 10.1080/24694452.2019.1629871; Ubach A, 2020, INSECT CONSERV DIVER, V13, P151, DOI 10.1111/icad.12397; Verdasca MJ, 2012, BIOL CONSERV, V146, P14, DOI 10.1016/j.biocon.2011.10.031; Walsh C., 2011, PCURVE PRINCIPAL CUR; Weerakoon B. M. B., 2015, Journal of Tropical Forestry and Environment, V5, P41; WIKLUND C, 1977, OIKOS, V28, P56, DOI 10.2307/3543323; Wilcox CA, 2005, AM MIDL NAT, V154, P11, DOI 10.1674/0003-0031(2005)154[0011:ROBOQV]2.0.CO;2	76	2	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234139	10.1371/journal.pone.0234139	http://dx.doi.org/10.1371/journal.pone.0234139			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559760	Green Published, gold			2022-12-27	WOS:000543261600044
J	Korth, B; Kretzschmar, J; Bartz, M; Kuchenbuch, A; Harnisch, F				Korth, Benjamin; Kretzschmar, Joerg; Bartz, Manuel; Kuchenbuch, Anne; Harnisch, Falk			Determining incremental coulombic efficiency and physiological parameters of early stage Geobacter spp. enrichment biofilms	PLOS ONE			English	Article							MICROBIAL FUEL-CELLS; ANODIC ELECTRON-TRANSFER; ACETATE OXIDATION; SULFATE REDUCERS; SP-NOV; SULFURREDUCENS; TRANSPORT; REDUCTION; PERFORMANCE; GROWTH	Geobacterspp. enrichment biofilms were cultivated in batch using one-chamber and two-chamber bioelectrochemical reactors. Time-resolved substrate quantification was performed to derive physiological parameters as well as incremental coulombic efficiency (i.e., coulombic efficiency during one batch cycle, here every 6h) during early stage biofilm development. The results of one-chamber reactors revealed an intermediate acetate increase putatively due to the presence of acetogens. Total coulombic efficiencies of two-chamber reactors were considerable lower (19.6 +/- 8.3% and 49.3 +/- 13.2% for 1(st)and 2(nd)batch cycle, respectively) compared to usually reported values of matureGeobacterspp. enrichment biofilms presumably reflecting energetic requirements for biomass production (i.e., cells and extracellular polymeric substances) during early stages of biofilm development. The incremental coulombic efficiency exhibits considerable changes during batch cycles indicating shifts between phases of maximizing metabolic rates and maximizing biomass yield. Analysis based on Michaelis-Menten kinetics yielded maximum substrate uptake rates (v(max,Ac),v(max,I)) and half-saturation concentration coefficients (K-M,K-Ac,K-M,K-I) based on acetate uptake or current production, respectively. The latter is usually reported in literature but neglects energy demands for biofilm growth and maintenance as well as acetate and electron storage. From 1(st)to 2(nd)batch cycle,v(max,Ac)andK(M,Ac), decreased from 0.0042-0.0051 mmol Ac(-)h(-1)cm(-2)to 0.0031-0.0037 mmol Ac(-)h(-1)cm(-2)and 1.02-2.61 mM Ac(-)to 0.28-0.42 mM Ac-, respectively. Furthermore, differences betweenK(M,Ac)/K(M,I)andv(max,Ac)/v(max,I)were observed providing insights into the physiology ofGeobacterspp. enrichment biofilms. Notably,K(M,I)considerably scattered whilev(max,Ac)/v(max,I)andK(M,Ac)remained rather stable indicating that acetate transport within biofilm only marginally affects reaction rates. The observed data variation mandates the requirement of a more detailed analysis with an improved experimental system, e.g., using flow conditions and a comparison withGeobacterspp. pure cultures.	[Korth, Benjamin; Bartz, Manuel; Kuchenbuch, Anne; Harnisch, Falk] UFZ Helmholtz Ctr Environm Res, Dept Environm Microbiol, Leipzig, Germany; [Kretzschmar, Joerg] DBFZ Deutsch Biomasseforschungszentrum Gemeinnutz, Biochem Convers Dept, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Harnisch, F (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Environm Microbiol, Leipzig, Germany.	falk.harnisch@ufz.de	Harnisch, Falk/J-5888-2012; Korth, Benjamin/E-1291-2015; Kretzschmar, Jörg JK/M-5672-2016	Harnisch, Falk/0000-0002-0014-4640; Korth, Benjamin/0000-0002-5105-2439; Kretzschmar, Jörg JK/0000-0001-5970-6399; Kuchenbuch, Anne/0000-0002-6287-1974	Helmholtz Association within the Research Program Renewable Energies; German ministry of economy affairs and energy within the research program "Biomass Energy Use" [03KB115]	Helmholtz Association within the Research Program Renewable Energies; German ministry of economy affairs and energy within the research program "Biomass Energy Use"	This work was supported by the Helmholtz Association within the Research Program Renewable Energies. JK gratefully acknowledges funding by the German ministry of economy affairs and energy within the research program "Biomass Energy Use" (Project "OptiMand", Project ID 03KB115). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, J CLIN GASTROENTE S1, V48, pS96; [Anonymous], 2019, FRONTIERS PLANT SCI; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Baudler A, 2014, FRONT ENERGY RES, DOI 10.3389/fenrg.2014.00030; Birkett J, 1999, MICROBIOLOGY CHEM EN; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Call DF, 2009, APPL ENVIRON MICROB, V75, P7579, DOI 10.1128/AEM.01760-09; Cao XX, 2009, ENVIRON SCI TECHNOL, V43, P7148, DOI 10.1021/es901950j; Chadwick GL, 2019, P NATL ACAD SCI USA, V116, P20716, DOI 10.1073/pnas.1912498116; Commault AS, 2015, BIOELECTROCHEMISTRY, V106, P150, DOI 10.1016/j.bioelechem.2015.04.011; Cusick RD, 2011, APPL MICROBIOL BIOT, V89, P2053, DOI 10.1007/s00253-011-3130-9; Elferink SJWHO, 1998, APPL ENVIRON MICROB, V64, P2301; Esteve-Nunez A, 2005, ENVIRON MICROBIOL, V7, P641, DOI 10.1111/j.1462-2920.2005.00731.x; Esteve-Nunez A, 2008, ENVIRON MICROBIOL, V10, P497, DOI 10.1111/j.1462-2920.2007.01470.x; Fernandes TM, 2018, BIOCHEM J, V475, P2861, DOI 10.1042/BCJ20180457; Fricke K, 2008, ENERG ENVIRON SCI, V1, P144, DOI 10.1039/b802363h; Geelhoed JS, 2011, ENVIRON SCI TECHNOL, V45, P815, DOI 10.1021/es102842p; Gimkiewicz C, 2013, JOVE-J VIS EXP, DOI 10.3791/50800; Harnisch F, 2012, CHEMSUSCHEM, V5, P1027, DOI 10.1002/cssc.201100817; Illanes Andrs, 2008, P155, DOI 10.1007/978-1-4020-8361-7_4; Jung S, 2007, APPL MICROBIOL BIOT, V77, P393, DOI 10.1007/s00253-007-1162-y; Kim JR, 2005, APPL MICROBIOL BIOT, V68, P23, DOI 10.1007/s00253-004-1845-6; Kimura Z, 2013, ISME J, V7, P1472, DOI 10.1038/ismej.2013.40; Klupfel L, 2014, NAT GEOSCI, V7, P195, DOI 10.1038/NGEO2084; Koch C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01890; Koch C, 2016, CHEMELECTROCHEM, V3, P1282, DOI 10.1002/celc.201600079; Koch C, 2014, CHEMELECTROCHEM, V1, P1923, DOI 10.1002/celc.201402216; Korth B, 2016, ENERG ENVIRON SCI, V9, P2539, DOI 10.1039/c6ee01428c; Korth B, 2015, BIOELECTROCHEMISTRY, V106, P194, DOI 10.1016/j.bioelechem.2015.03.010; Kretzschmar J, 2016, CHEM ENG TECHNOL, V39, P637, DOI 10.1002/ceat.201500406; Kubannek F, 2018, BIOELECTROCHEMISTRY, V121, P160, DOI 10.1016/j.bioelechem.2018.01.014; Kumar A, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0024; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee HS, 2010, ENVIRON SCI TECHNOL, V44, P948, DOI 10.1021/es9025358; Lee HS, 2009, ENVIRON SCI TECHNOL, V43, P7971, DOI 10.1021/es900204j; Lee HS, 2009, ENVIRON SCI TECHNOL, V43, P7571, DOI 10.1021/es9015519; LEFFELAAR PA, 1988, SOIL SCI, V146, P335, DOI 10.1097/00010694-198811000-00006; Levar CE, 2017, ISME J, V11, P741, DOI 10.1038/ismej.2016.146; Logan BE, 2019, NAT REV MICROBIOL, V17, P307, DOI 10.1038/s41579-019-0173-x; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; Lovley DR, 2017, ANNU REV MICROBIOL, V71, P643, DOI 10.1146/annurev-micro-030117-020420; LOVLEY DR, 1987, NATURE, V330, P252, DOI 10.1038/330252a0; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Ly HK, 2013, CHEMSUSCHEM, V6, P487, DOI 10.1002/cssc.201200626; Malvankar NS, 2012, ENERG ENVIRON SCI, V5, P5790, DOI 10.1039/c2ee03388g; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; Molenaar SD, 2018, CHEMSUSCHEM, V11, P2171, DOI 10.1002/cssc.201800589; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Nevin KP, 2008, ENVIRON MICROBIOL, V10, P2505, DOI 10.1111/j.1462-2920.2008.01675.x; Ortiz-Medina JF, 2019, FRONT ENERGY RES, V7, DOI 10.3389/fenrg.2019.00103; Paitier A, 2017, BIOSENS BIOELECTRON, V92, P357, DOI 10.1016/j.bios.2016.10.096; Parameswaran P, 2011, BIORESOURCE TECHNOL, V102, P263, DOI 10.1016/j.biortech.2010.03.133; Pfeffer C, 2012, NATURE, V491, P218, DOI 10.1038/nature11586; Popat SC, 2016, BIORESOURCE TECHNOL, V215, P265, DOI 10.1016/j.biortech.2016.04.136; Qian XL, 2011, BBA-BIOENERGETICS, V1807, P404, DOI 10.1016/j.bbabio.2011.01.003; Rabaey K, 2005, ENVIRON SCI TECHNOL, V39, P3401, DOI 10.1021/es048563o; Santos TC, 2015, DALTON T, V44, P9335, DOI 10.1039/c5dt00556f; Scholten JCM, 2002, FEMS MICROBIOL ECOL, V42, P375, DOI 10.1111/j.1574-6941.2002.tb01027.x; SCHONHEIT P, 1982, ARCH MICROBIOL, V132, P285, DOI 10.1007/BF00407967; Schroder U, 2007, PHYS CHEM CHEM PHYS, V9, P2619, DOI 10.1039/b703627m; Schroder U, 2015, ENERG ENVIRON SCI, V8, P513, DOI 10.1039/c4ee03359k; Snider RM, 2012, P NATL ACAD SCI USA, V109, P15467, DOI 10.1073/pnas.1209829109; Spaans SK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00742; Speers AM, 2012, APPL ENVIRON MICROB, V78, P437, DOI 10.1128/AEM.06782-11; Sun D, 2014, INT J SYST EVOL MICR, V64, P3485, DOI 10.1099/ijs.0.061598-0; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; von Stockar U, 2010, J NON-EQUIL THERMODY, V35, P415, DOI 10.1515/JNETDY.2010.024; Yi HN, 2009, BIOSENS BIOELECTRON, V24, P3498, DOI 10.1016/j.bios.2009.05.004; Yoho RA, 2014, CHEMSUSCHEM, V7, P3413, DOI 10.1002/cssc.201402589; Zacharoff L, 2016, BIOELECTROCHEMISTRY, V107, P7, DOI 10.1016/j.bioelechem.2015.08.003; Zarabadi MP, 2019, CHEMELECTROCHEM, V6, P2715, DOI 10.1002/celc.201900732; Zhu XP, 2013, BIOELECTROCHEMISTRY, V90, P30, DOI 10.1016/j.bioelechem.2012.10.004	73	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234077	10.1371/journal.pone.0234077	http://dx.doi.org/10.1371/journal.pone.0234077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559199	Green Published, gold			2022-12-27	WOS:000543261600011
J	Pei, JY; Wang, XP; Xing, ZH; Chen, PF; Su, W; Deng, SM; Hu, XQ				Pei, Junyu; Wang, Xiaopu; Xing, Zhenhua; Chen, Pengfei; Su, Wen; Deng, Simin; Hu, Xinqun			Association between admission systolic blood pressure and major adverse cardiovascular events in patients with acute myocardial infarction	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; GLOBAL REGISTRY; MANAGEMENT; MORTALITY; RISK	Background Several studies have previously demonstrated that higher systolic blood pressure level means lower risk of adverse cardiovascular outcomes. However, there is a lack of further investigation into the nonlinear relationship between admission systolic blood pressure (SBP) and adverse outcomes of acute myocardial infarction (AMI) patients. Objectives The aim of this study was to investigate the specific relationship between admission SBP and incidence of major adverse cardiovascular events (MACE) in 30 days for AMI patients. Methods and results Using data from the ACS-QUIK trial, we analyzed 21,364 patients from Kerala, India. In univariate linear-regression model, the OR was 0.90 per 10mmHg, the confidence interval (CI) was 95% (0.87-0.92) andP< 0.0001. The generalized additive model (GAM) showed a nearly U-shaped curve between admission SBP and MACE. Using a two-piecewise linear regression model, we calculated an inflection point of 159 mmHg. We found that the higher admission SBP is associated with lower incidence of MACE of AMI patients. In addition, subgroups with different LVEF have distinct effects on blood pressure-related outcomes. Lower SBP has a greater risk when LVEF < 40%. Conclusion The present study revealed the U-shaped relationship between admission SBP and the risk of adverse cardiovascular outcome. The admission SBP could be a marker to provide clinical assessment and treatment.	[Pei, Junyu; Wang, Xiaopu; Xing, Zhenhua; Chen, Pengfei; Su, Wen; Deng, Simin; Hu, Xinqun] Cent South Univ, Xiangya Hosp 2, Dept Cardiovasc Med, Changsha, Hunan, Peoples R China	Central South University	Hu, XQ (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Cardiovasc Med, Changsha, Hunan, Peoples R China.	huxinqun@csu.edu.cn						Abrahamsson P, 2009, EUR HEART J, V30, P338, DOI 10.1093/eurheartj/ehn503; Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2713, DOI 10.1016/j.jacc.2014.10.011; [Anonymous], 2008, INDIAN HEART J, V60, pB4; Bhatnagar P, 2015, HEART, V101, P1182, DOI 10.1136/heartjnl-2015-307516; Bohm M, 2018, EUR HEART J, V39, P3105, DOI 10.1093/eurheartj/ehy287; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Catena C, 2012, J ATHEROSCLER THROMB, V19, P471; Chronicle of Higher Education, 2011, CHRON HIGHER EDUC, V20, P20; Elbarouni B, 2009, AM HEART J, V158, P392, DOI 10.1016/j.ahj.2009.06.010; Fox KAA, 2002, EUR HEART J, V23, P1177, DOI 10.1053/euhj.2001.3081; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Goodman SG, 2009, AM HEART J, V158, P193, DOI 10.1016/j.ahj.2009.06.003; Huffman MD, 2018, JAMA-J AM MED ASSOC, V319, P567, DOI 10.1001/jama.2017.21906; Huffman MD, 2017, AM HEART J, V185, P154, DOI 10.1016/j.ahj.2016.10.026; JULIUS S, 1993, HYPERTENSION, V21, P886, DOI 10.1161/01.HYP.21.6.886; KATZ LN, 1958, CIRC RES, V6, P656, DOI 10.1161/01.RES.6.5.656; Konstantinou K, 2019, J CLIN HYPERTENS, V21, P1135, DOI 10.1111/jch.13622; Lee D, 2013, AM HEART J, V166, P716, DOI 10.1016/j.ahj.2013.06.025; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Park JS, 2015, AM J HYPERTENS, V28, P797, DOI 10.1093/ajh/hpu230; Roth D, 2015, INT J CLIN PRACT, V69, P812, DOI 10.1111/ijcp.12588; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Santulli G, 2011, AM J CARDIOL, V107, P1125, DOI 10.1016/j.amjcard.2010.12.006; Shlomai G, 2015, J AM SOC HYPERTENS, V9, P97, DOI 10.1016/j.jash.2014.11.005; Tan YC, 2016, EUR HEART J-ACUTE CA, V5, P51, DOI 10.1177/2048872615610886; Vedanthan R, 2014, CIRC RES, V114, P1959, DOI 10.1161/CIRCRESAHA.114.302782	27	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234935	10.1371/journal.pone.0234935	http://dx.doi.org/10.1371/journal.pone.0234935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559257	gold, Green Published			2022-12-27	WOS:000543261600048
J	Brownstone, S; Connor, A; Stein, D				Brownstone, Steven; Connor, Alison; Stein, Daniel			Improving measles vaccine uptake rates in Nigeria: An RCT evaluating the impact of incentive sizes and reminder calls on vaccine uptake	PLOS ONE			English	Article							PRIMARY-HEALTH-CARE; IMMUNIZATION COVERAGE; COMPLETION	Objective To assess the impact of increasing incentive size and reminder calls on the measles vaccine uptake rate. Design Randomized controlled trial, randomized at individual level, stratified by clinic. Setting Nigeria Participants 1088 caregivers with children aged nine months or older; had received at least one previous conditional cash transfer (CCT) at a program clinic, had received their Penta-3 immunization but had not yet received their measles immunization, and the caregiver had provided a phone number. Intervention Nine clinics were randomized to two models; caregivers in Model 1 received a default of 2000 Nigerian Naira (NGN) for completing the measles vaccine, and those in Model 2 received by 3000 NGN. Caregivers from the respective clinics were then randomized to one of the four arms: 1) control (baseline amount of 2000 NGN or 3000 NGN), 2) baseline amount plus a reminder call, 3) baseline amount plus 1000 NGN and a reminder call, and 4) baseline amount plus 3000 NGN and a reminder call. Main outcome measure Receipt of measles vaccine as reported on a child health card. Results Overall, there was no clear trend that increasing the incentive amount resulted in an increase in vaccine uptake rates. In Model 1 households, an additional 1000 NGN and 3000 NGN resulted in a 6.4 percentage point (95% CI: -2.3-15, p-value = 0.15) and 11.8 percentage point (95% CI: 3.9-19.6, p-value = 0.003) increase in the probability of completing the measles vaccines, respectively. This increase, however, was only significant for the 3000 NGN increase. On the other hand, in Model 2 households, increasing the incentive by 1000 NGN and 3000 NGN increased the probability by 3.3 (95% CI: -3.8-10.4, p-value = 0.36) and 3.3 (95% CI: -3.7-10.4, p-value = 0.35) percentage points. These increases were not statistically significant. Adding reminder calls to CCTs increased the probability of completing the measles vaccine; caregivers who received reminder calls plus CCTs were 5.1 percentage points more likely to get their children vaccinated (95% CI: 0.50-9.8, p-value = 0.03) compared to those who received CCTs and did not receive a reminder call. These results were largely driven by caregivers who went to clinics in Model 1. Conclusion A combination of increasing incentive amounts and reminder calls modestly improves measles immunization rates. However, this program also shows that there is substantial regional heterogeneity in response to both incentives and calls. While one possible conclusion is that a larger incentive and phone reminders are more likely to work in higher income and higher baseline coverage settings, the study is not designed to evaluate this claim. Rather, policymakers could consider experimenting with a similar low-cost calling study as part of the design of other cash transfer programs to identify whether adding reminder phone calls could increase the impact of the program.	[Brownstone, Steven; Connor, Alison; Stein, Daniel] IDinsight, San Francisco, CA 94105 USA		Stein, D (corresponding author), IDinsight, San Francisco, CA 94105 USA.	daniel.stein@idinsight.org			GiveWell	GiveWell	SB, AC, and DS work was funded from a grants from GiveWell to IDinsight (https://www.givewell.org/charities/IDinsight/may-2017-grant), during the conduct of the study; The funders approved the publication of the manuscript, but played no other role.	Adedokun ST, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4137-7; [Anonymous], 2010, BMJ-BRIT MED J, V340, pb5463; Ataguba JE, 2016, HEALTH POLICY PLANN, V31, P1212, DOI 10.1093/heapol/czw053; Babalola S, 2011, J PAEDIATR CHILD H, V47, P276, DOI 10.1111/j.1440-1754.2010.01956.x; Bangure D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1470-6; Brown VB, 2016, J COMMUN HEALTH, V41, P265, DOI 10.1007/s10900-015-0092-3; Chandir S, 2010, VACCINE, V28, P3473, DOI 10.1016/j.vaccine.2010.02.061; Eboreime E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144876; Filmer D, 2009, ARE THERE DIMINISHIN, DOI [10.1596/1813-9450-4999, DOI 10.1596/1813-9450-4999]; Gibson DG, 2017, LANCET GLOB HEALTH, V5, pE428, DOI [10.1016/S2214-109X(17)30072-4, 10.1016/s2214-109x(17)30072-4]; LOEVINSOHN BP, 1986, LANCET, V1, P1314; Moher D., 2010, BMC MED, V8, P18, DOI [DOI 10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18]; Morris SS, MONETARY INCENTIVES, peweb, DOI [10.1016/S0140-6736(04)17515-6, DOI 10.1016/S0140-6736(04)17515-6]; National Population Commission (NPC) [Nigeria] & ICF, 2019, NIG DEM HLTH SURV 20; NICS, 2017, NAT IMM COV SURV BRI; Schlumberger M, 2015, Bull Soc Pathol Exot, V108, P349, DOI 10.1007/s13149-015-0455-4; StataCorp, 2015, STAT SOFTW REL 14; WHO, 2018, MEASL	18	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0233149	10.1371/journal.pone.0233149	http://dx.doi.org/10.1371/journal.pone.0233149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555681	Green Published, gold			2022-12-27	WOS:000543273200005
J	Butolo, NP; Azevedo, P; de Alencar, LD; Domingues, CEC; Miotelo, L; Malaspina, O; Nocelli, RCF				Butolo, Nicole Pavan; Azevedo, Patricia; de Alencar, Luciano Delmondes; Domingues, Caio E. C.; Miotelo, Lucas; Malaspina, Osmar; Ferreira Nocelli, Roberta Cornelio			A high quality method for hemolymph collection from honeybee larvae	PLOS ONE			English	Article							APIS-MELLIFERA HYMENOPTERA; MALPIGHIAN TUBULES; FAT-BODY; BEE; THIAMETHOXAM; PROTEIN; SURVIVAL; SYSTEM; EYE	The drastic decline of bees is associated with several factors, including the immune system suppression due to the increased exposure to pesticides. A widely used method to evaluate these effects on these insects' immune systems is the counting of circulating hemocytes in the hemolymph. However, the extraction of hemolymph from larvae is quite difficult, and the collected material is frequently contaminated with other tissues and gastrointestinal fluids, which complicates counting. Therefore, the present work established a high quality and easily reproducible method of extracting hemolymph from honeybee larvae(Apis mellifera), the extraction with ophthalmic scissors. Extraction methods with the following tools also were tested: 30G needle, fine-tipped forceps, hypodermic syringe, and capillaries tubes. The hemolymph was obtained via an incision on the larvae's right side for all methods, except for the extraction with ophthalmic scissors, in which the hemolymph was extracted from the head region. To assess the purity of the collected material, turbidity analyses of the samples using a turbidimeter were proposed, tested, and evaluated. The results showed that the use of ophthalmic scissors provided the clearest samples and was free from contamination. A reference range between 22,432.35 and 24,504.87 NTU (nephelometric turbidity units) was established, in which the collected samples may be considered of high quality and free from contamination.	[Butolo, Nicole Pavan; Domingues, Caio E. C.; Miotelo, Lucas; Malaspina, Osmar; Ferreira Nocelli, Roberta Cornelio] Univ Estadual Paulista Julio de Mesquita Filho UN, Ctr Estudos Insetos Sociais CEIS, Inst Biociencias, Programa Pos Grad Biol Celular & Mol, Rio Claro, SP, Brazil; [Azevedo, Patricia; de Alencar, Luciano Delmondes] Univ Estadual Campinas UNICAMP SP, Inst Biol, Grp Genet & Genom Conservacao, Programa Pos Grad Genet & Biol Mol, Campinas, SP, Brazil; [Ferreira Nocelli, Roberta Cornelio] Univ Fed Sao Carlos UFSCar SP, Ctr Ciencias Agr, Dept Ciencias Nat Matemat & Educ, Araras, SP, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas	Butolo, NP (corresponding author), Univ Estadual Paulista Julio de Mesquita Filho UN, Ctr Estudos Insetos Sociais CEIS, Inst Biociencias, Programa Pos Grad Biol Celular & Mol, Rio Claro, SP, Brazil.; Azevedo, P (corresponding author), Univ Estadual Campinas UNICAMP SP, Inst Biol, Grp Genet & Genom Conservacao, Programa Pos Grad Genet & Biol Mol, Campinas, SP, Brazil.	nicole.butolo@gmail.com; azevedo.p89@gmail.com	Malaspina, Osmar/AAL-9167-2021; Miotelo, Lucas/ABB-1559-2020; Nocelli, elvis0307%/AAD-7652-2022; Domingues, Caio Eduardo C/V-4142-2017; Alencar, Luciano Delmondes de/M-5334-2018	Malaspina, Osmar/0000-0002-1650-257X; Miotelo, Lucas/0000-0003-3211-5534; Domingues, Caio Eduardo C/0000-0001-8575-2735; Azevedo, Patricia/0000-0003-4866-9478; Alencar, Luciano Delmondes de/0000-0002-4190-575X	Coordination of Superior Level Staff Improvement - CAPES [001, 88887.318480/2019-00, 88887.464706/2019-00]; Sao Paulo Research Foundation - FAPESP [2016/15743-7]; Sao Paulo Research Foundation -FAPESP [17/21097-3]; Braziian National Council for Scientific and Technological Development - CNPQ [400540/2018-5]	Coordination of Superior Level Staff Improvement - CAPES; Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo Research Foundation -FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Braziian National Council for Scientific and Technological Development - CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	BUTOLO N. P., AZEVEDO P., ALENCAR L. D. received scholarship from Coordination of Superior Level Staff Improvement - CAPES (grant numbers: 001; 88887.318480/2019-00 and 88887.464706/2019-00) (url:http://www.capes.gov.br) and DOMINGUES C. E. C. received scholarship from Sao Paulo Research Foundation - FAPESP (grant number: 2016/15743-7). This work was supported by Sao Paulo Research Foundation -FAPESP (grant number: 17/21097-3) (url:https://bv.fapesp.br/pt/auxilios/101901/interacoes-abelha-agricultura-perspectivas-para-a-utilizacao-sustentavel/) and by Braziian National Council for Scientific and Technological Development - CNPQ (grant number: 400540/2018-5)(url:http://www.cnpq.br/web/guest/chamadas-publicas?p_p_id=resultadosportlet_WAR_resultadoscnpqportlet_ INSTANCE_0ZaM&filtro=encerradas&detalha= chamadaDetalhada&exibe=exibe&idResultado=47-1073-5328&id=47-1073-5328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljedani Dalal M., 2018, Journal of Entomology, V15, P114, DOI 10.3923/je.2018.114.124; Balsamo PJ, 2020, J APICULT RES, V59, P350, DOI 10.1080/00218839.2019.1686575; Bania J, 1999, EUR J BIOCHEM, V262, P680, DOI 10.1046/j.1432-1327.1999.00406.x; Battefeld M, 2017, U.S. Patent, Patent No. [9,851,297, 9851297]; Beasley CM, 2019, J BIOPHARM STAT, V29, P516, DOI 10.1080/10543406.2019.1579223; Beye M, 2002, INSECT MOL BIOL, V11, P527, DOI 10.1046/j.1365-2583.2002.00361.x; BINDOKAS V, 1984, BIOELECTROMAGNETICS, V5, P305, DOI 10.1002/bem.2250050303; Borsuk G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170487; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04734-1; Brandt A, 2016, J INSECT PHYSIOL, V86, P40, DOI 10.1016/j.jinsphys.2016.01.001; Brasil. Ministerio do Meio Ambiente, 2020, BOL AN PROD IMP EXP; Burritt NL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167752; Catae AF, 2014, MICROSC RES TECHNIQ, V77, P274, DOI 10.1002/jemt.22339; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Cruz-Landim C., 2009, ABELHAS MORFOLOGIA F; Domingues CEC, 2017, CHEMOSPHERE, V186, P994, DOI 10.1016/j.chemosphere.2017.07.133; Dorigo AS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213109; Erban T, 2016, APIDOLOGIE, V47, P805, DOI 10.1007/s13592-016-0437-7; Fine JD, 2017, SCI REP-UK, V7, DOI 10.1038/srep40499; Furtado WCA, 2013, MICROSC MICROANAL, V19, P1502, DOI 10.1017/S1431927613013445; FYG W. von, 1942, SCHWEIZ BIENEN ZEITUNG, V65, P120; Garido MP, 2013, J APICULT RES, V52, P67; GILLIAM M, 1970, EXPERIENTIA, V26, P908; GILLIAM M, 1967, J INVERTEBR PATHOL, V9, P387, DOI 10.1016/0022-2011(67)90074-2; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gregorc A, 2018, INSECTS, V9, DOI 10.3390/insects9020055; Gregorc A, 2016, CHEMOSPHERE, V147, P328, DOI 10.1016/j.chemosphere.2015.12.030; Higes M, 2020, VET PATHOL, V57, P132, DOI 10.1177/0300985819864302; Hung KLJ, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2140; Iqbal J, 2019, SAUDI J BIOL SCI, V26, P563, DOI 10.1016/j.sjbs.2018.08.002; Koleoglu G, 2018, PARASITOL RES, V117, P1175, DOI 10.1007/s00436-018-5796-8; Kruger NJ, 2009, SPRINGER PROTOC HAND, P17, DOI 10.1007/978-1-59745-198-7_4; Kucharski R, 1998, GENE, V211, P343, DOI 10.1016/S0378-1119(98)00114-0; Larsen A, 2019, REV MEX CIENC PECU, V10, P705, DOI 10.22319/rmcp.v10i3.4785; Liao LH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15066-5; Locke B, 2016, APIDOLOGIE, V47, P467, DOI 10.1007/s13592-015-0412-8; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Ma LT, 2016, J ASIA-PAC ENTOMOL, V19, P769, DOI 10.1016/j.aspen.2016.07.005; Macedo TC., 2017, MANUAL AVALIACAO RIS, P105; Martins GF, 2011, TISSUE CELL, V43, P83, DOI 10.1016/j.tice.2010.12.003; Mondet F, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4668-z; Nazzi F, 2016, ANNU REV ENTOMOL, V61, P417, DOI 10.1146/annurev-ento-010715-023731; Oliveira RA, 2014, ENVIRON TOXICOL, V29, P1122, DOI 10.1002/tox.21842; Paes-de-Oliveira Vagner Tadeu, 2006, Brazilian Journal of Morphological Sciences, V23, P385; PALLI SR, 1987, INSECT BIOCHEM, V17, P711, DOI 10.1016/0020-1790(87)90041-2; Perveen N, 2017, SAUDI J BIOL SCI, V24, P1016, DOI 10.1016/j.sjbs.2016.12.011; Poiani SB, 2012, MICRON, V43, P475, DOI 10.1016/j.micron.2011.11.006; Potts S. G., 2016, SUMMARY POLICYMAKERS, P36; Ramsey SD, 2019, P NATL ACAD SCI USA, V116, P1792, DOI 10.1073/pnas.1818371116; Randolt K, 2008, ARCH INSECT BIOCHEM, V69, P155, DOI 10.1002/arch.20269; Richardson RT, 2018, APIDOLOGIE, V49, P397, DOI 10.1007/s13592-018-0566-2; Roat TC, 2013, ARCH ENVIRON CON TOX, V64, P456, DOI 10.1007/s00244-012-9849-1; Roat TC, 2010, MICRON, V41, P382, DOI 10.1016/j.micron.2010.01.003; Rossi CD, 2013, MICROSC RES TECHNIQ, V76, P552, DOI 10.1002/jemt.22199; Sadar MJ, 1998, TECHNICAL INFORM SER, V11; Silva-Zacarin E.C.M., 2012, CURRENT MICROSCOPY C, P696; Snodgrass R.E., 1956, ANATOMY HONEYBEE; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tavares DA, 2017, ENVIRON POLLUT, V229, P386, DOI 10.1016/j.envpol.2017.05.092; Trajano M. C., 2019, DIAGNOSTICO CRIACAO, P56; TRIPATHI RK, 1968, CAN J ZOOLOG, V46, P1013, DOI 10.1139/z68-141; Walton A, 2016, BEHAV ECOL SOCIOBIOL, V70, P999, DOI 10.1007/s00265-016-2084-4; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Xuereb B, 2009, AQUAT TOXICOL, V93, P225, DOI 10.1016/j.aquatox.2009.05.006	67	2	2	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234637	10.1371/journal.pone.0234637	http://dx.doi.org/10.1371/journal.pone.0234637			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555675	Green Published, gold			2022-12-27	WOS:000543273200012
J	Tun, MMN; Muthugala, R; Nabeshima, T; Soe, AM; Dumre, SP; Rajamanthri, L; Jayawardana, D; Attanayake, S; Inoue, S; Morita, K				Tun, Mya Myat Ngwe; Muthugala, Rohitha; Nabeshima, Takeshi; Soe, Aung Min; Dumre, Shyam Prakash; Rajamanthri, Lakmali; Jayawardana, Dulani; Attanayake, Shanthi; Inoue, Shingo; Morita, Kouichi			Complete genome analysis and characterization of neurotropic dengue virus 2 cosmopolitan genotype isolated from the cerebrospinal fluid of encephalitis patients	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEUROLOGICAL MANIFESTATIONS; JAPANESE ENCEPHALITIS; INFECTION; INVOLVEMENT; PERFORMANCE; DIAGNOSIS; ALIGNMENT; CHILDREN; MYANMAR	Dengue virus (DENV) infection remains a major public health concern in many parts of the world, including Southeast Asia and the Americas. Sri Lanka experienced its largest dengue outbreak in 2017. Neurological symptoms associated with DENV infection have increasingly been reported in both children and adults. Here, we characterize DENV type 2 (DENV-2) strains, which were isolated from cerebrospinal fluid (CSF) and/or serum of patients with dengue encephalitis. Acute serum and CSF samples from each patient were subjected to dengue-specific non-structural protein 1 (NS1) antigen test, IgM and IgG enzyme-linked immunosorbent assay (ELISA), virus isolation, conventional and real-time polymerase chain reaction (PCR), and next-generation sequencing (NGS). Among the 5 dengue encephalitis patients examined, 4 recovered and 1 died. DENV-2 strains were isolated from serum and/or CSF samples of 3 patients. The highest viral genome levels were detected in the CSF and serum of the patient who succumbed to the illness. A phylogenetic tree revealed that the DENV-2 isolates belonged to a new clade of cosmopolitan genotype and were genetically close to strains identified in China, South Korea, Singapore, Malaysia, Thailand, and the Philippines. According to the NGS analysis, greater frequencies of nonsynonymous and synonymous mutations per gene were identified in the nonstructural genes. The full genomes of serum- and CSF-derived DENV-2 from the same patient shared 99.7% similarity, indicating that the virus spread across the blood-brain barrier. This is the first report to describe neurotropic DENV-2 using whole-genome analysis and to provide the clinical, immunological, and virological characteristics of dengue encephalitis patients during a severe dengue outbreak in Sri Lanka in 2017.	[Tun, Mya Myat Ngwe; Nabeshima, Takeshi; Soe, Aung Min; Inoue, Shingo; Morita, Kouichi] Nagasaki Univ, Inst Trop Med, Dept Virol, Nagasaki, Japan; [Muthugala, Rohitha; Rajamanthri, Lakmali; Jayawardana, Dulani; Attanayake, Shanthi] Teaching Hosp Kandy, Dept Virol, Kandy, Sri Lanka; [Dumre, Shyam Prakash] Nagasaki Univ, Inst Trop Med, Dept Immunogenet, Nagasaki, Japan	Nagasaki University; Nagasaki University	Tun, MMN; Morita, K (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Virol, Nagasaki, Japan.	myamyat@tm.nagasaki-u.ac.jp; moritak@nagasaki-u.ac.jp		Dumre, Shyam Prakash/0000-0002-4072-0745	Japan Initiative for Global Research Network on Infectious Diseases (JGRID) of the Japan Science and Technology Agency (JST) [JP19fm0108001]; Research Program on Emerging and Re-emerging Infectious Diseases of the Agency for Research and Development (AMED) [19fk0108035h1203]	Japan Initiative for Global Research Network on Infectious Diseases (JGRID) of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Research Program on Emerging and Re-emerging Infectious Diseases of the Agency for Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by grants from the Japan Initiative for Global Research Network on Infectious Diseases (JGRID) of the Japan Science and Technology Agency (JST) (Grant number JP19fm0108001), and Research Program on Emerging and Re-emerging Infectious Diseases of the Agency for Research and Development (AMED, 19fk0108035h1203).	Ali SKA, 2017, INFECT DIS HLTH, V23, P114; American Institute of Ultrasound in Medicine, 2009, J Ultrasound Med, V28, P114; Araujo FMC, 2011, J VIROL METHODS, V177, P128, DOI 10.1016/j.jviromet.2011.07.003; Araujo F, 2012, EMERG INFECT DIS, V18, P677, DOI [10.3201/eid1804.111522, 10.3201/eid1804.111552]; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BUNDO K, 1985, J VIROL METHODS, V11, P15, DOI 10.1016/0166-0934(85)90120-X; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Oliveira DB, 2016, REV SOC BRAS MED TRO, V49, P125, DOI 10.1590/0037-8682-0208-2015; Dhenni R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006198; Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040; Gomez-Barrena E, 2015, BONE, V70, P93, DOI 10.1016/j.bone.2014.07.033; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hapuarachchi HC, 2013, J CLIN VIROL, V57, P91, DOI 10.1016/j.jcv.2012.12.021; Inoue S, 2010, VECTOR-BORNE ZOONOT, V10, P143, DOI 10.1089/vbz.2008.0153; Ito M, 2004, J CLIN MICROBIOL, V42, P5935, DOI 10.1128/JCM.42.12.5935-5937.2004; Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9; Jiang XY, 2010, CRIT CARE, V14, pR66; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kumar R, 2008, J NEUROL SCI, V269, P41, DOI 10.1016/j.jns.2007.12.018; Kyaw AK, 2017, EPIDEMIOL INFECT, V145, P1886, DOI 10.1017/S0950268817000735; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Li GH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00449; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Massad E, 2011, LANCET, V377, P1630, DOI 10.1016/S0140-6736(11)60470-4; Misra UK, 2015, J CLIN VIROL, V72, P146, DOI 10.1016/j.jcv.2015.08.021; MORITA K, 1991, J CLIN MICROBIOL, V29, P2107, DOI 10.1128/JCM.29.10.2107-2110.1991; Tun MMN, 2016, INFECT GENET EVOL, V43, P31, DOI 10.1016/j.meegid.2016.04.025; Tun MMN, 2013, J MED VIROL, V85, P1258, DOI 10.1002/jmv.23577; Saini L, 2017, NEUROL INDIA, V65, P636, DOI [10.4103/neuroindia.NI_1367_15, 10.4103/neuroindia.ni_1367_15]; Scherer FM, 2001, HEALTH AFFAIR, V20, P216, DOI 10.1377/hlthaff.20.5.216; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068; Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; Srey VH, 2002, AM J TROP MED HYG, V66, P200, DOI 10.4269/ajtmh.2002.66.200; Thisyakorn Usa, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P504; Tun MMN, 2014, EMERG INFECT DIS, V20, P1378, DOI 10.3201/eid2008.131431; Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 1997, DENG GUID DIAGN TREA; 2010, LASER PHOTON REV, V4, pE854; 2011, PHILOS PUBLIC AFFAIR, V39, P3	49	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234508	10.1371/journal.pone.0234508	http://dx.doi.org/10.1371/journal.pone.0234508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555732	Green Published, gold			2022-12-27	WOS:000543273200003
J	Rivera-Izquierdo, M; Valero-Ubierna, MD; R-delAmo, JL; Fernandez-Garcia, MA; Martinez-Diz, S; Tahery-Mahmoud, A; Rodriguez-Camacho, M; Gamiz-Molina, AB; Barba-Gyengo, N; Gamez-Baeza, P; Cabrero-Rodriguez, C; Guirado-Ruiz, PA; Martin-Romero, DT; Lainez-Ramos-Bossini, AJ; Sanchez-Perez, MR; Mancera-Romero, J; Garcia-Martin, M; Martin-delosReyes, LM; Martinez-Ruiz, V; Lardelli-Claret, P; Jimenez-Mejias, E				Rivera-Izquierdo, Mario; del Carmen Valero-Ubierna, Maria; R-delAmo, Juan Luis; Fernandez-Garcia, Miguel Angel; Martinez-Diz, Silvia; Tahery-Mahmoud, Arezu; Rodriguez-Camacho, Marta; Gamiz-Molina, Ana Belen; Barba-Gyengo, Nicolas; Gamez-Baeza, Pablo; Cabrero-Rodriguez, Celia; Guirado-Ruiz, Pedro Antonio; Martin-Romero, Divina Tatiana; Lainez-Ramos-Bossini, Antonio Jesus; Sanchez-Perez, Maria Rosa; Mancera-Romero, Jose; Garcia-Martin, Miguel; Martin-delosReyes, Luis Miguel; Martinez-Ruiz, Virginia; Lardelli-Claret, Pablo; Jimenez-Mejias, Eladio			Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: A retrospective observational study	PLOS ONE			English	Article							CORONAVIRUS DISEASE 2019	Background To identify and quantify associations between baseline characteristics on hospital admission and mortality in patients with COVID-19 at a tertiary hospital in Spain. Methods and findings This retrospective case series included 238 patients hospitalized for COVID-19 at Hospital Universitario Clinico San Cecilio (Granada, Spain) who were discharged or who died. Electronic medical records were reviewed to obtain information on sex, age, personal antecedents, clinical features, findings on physical examination, and laboratory results for each patient. Associations between mortality and baseline characteristics were estimated as hazard ratios (HR) calculated with Cox regression models. Series mortality was 25.6%. Among patients with dependence for basic activities of daily living, 78.7% died, and among patients residing in retirement homes, 80.8% died. The variables most clearly associated with a greater hazard of death were age (3% HR increase per 1-year increase in age; 95%CI 1-6), diabetes mellitus (HR 2.42, 95%CI 1.43-4.09), SatO(2)/FiO(2)ratio (43% HR reduction per 1-point increase; 95%CI 23-57), SOFA score (19% HR increase per 1-point increase, 95%CI 5-34) and CURB-65 score (76% HR increase per 1-point increase, 95%CI 23-143). Conclusions The patients residing in retirement homes showed great vulnerability. The main baseline factors that were independently associated with mortality in patients hospitalized for COVID-19 were older age, diabetes mellitus, low SatO(2)/FiO(2)ratio, and high SOFA and CURB-65 scores.	[Rivera-Izquierdo, Mario; del Carmen Valero-Ubierna, Maria; Fernandez-Garcia, Miguel Angel; Martinez-Diz, Silvia; Martin-Romero, Divina Tatiana; Mancera-Romero, Jose] Hosp Univ Clin San Cecilio, Prevent Med & Publ Hlth Serv, Granada, Spain; [Rivera-Izquierdo, Mario; Martin-delosReyes, Luis Miguel; Martinez-Ruiz, Virginia; Lardelli-Claret, Pablo; Jimenez-Mejias, Eladio] Univ Granada, Dept Prevent Med & Publ Hlth, Granada, Spain; [Rivera-Izquierdo, Mario; Martinez-Ruiz, Virginia; Lardelli-Claret, Pablo; Jimenez-Mejias, Eladio] IBS Granada, Inst Biosanitario Granada, Granada, Spain; [R-delAmo, Juan Luis; Rodriguez-Camacho, Marta; Guirado-Ruiz, Pedro Antonio] Hosp Univ Clin San Cecilio, Neurol Serv, Granada, Spain; [Tahery-Mahmoud, Arezu] Hosp Univ Clin San Cecilio, Psychiat Serv, Granada, Spain; [Gamiz-Molina, Ana Belen; Barba-Gyengo, Nicolas; Gamez-Baeza, Pablo; Cabrero-Rodriguez, Celia] Hosp Univ Clin San Cecilio, Pulmonol Serv, Granada, Spain; [Lainez-Ramos-Bossini, Antonio Jesus; Martin-delosReyes, Luis Miguel] Univ Granada, Doctorate Program, Clin Med & Publ Heath, Granada, Spain; [Sanchez-Perez, Maria Rosa; Mancera-Romero, Jose; Jimenez-Mejias, Eladio] Univ Granada, SEMERGEN UGR Chair Teaching & Res Family Med, Granada, Spain; [Garcia-Martin, Miguel; Martin-delosReyes, Luis Miguel; Martinez-Ruiz, Virginia; Lardelli-Claret, Pablo; Jimenez-Mejias, Eladio] CIBERESP, CIBER Epidemiol & Salud Publ Espana, Madrid, Spain	University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Martin-delosReyes, LM (corresponding author), Univ Granada, Dept Prevent Med & Publ Hlth, Granada, Spain.; Martin-delosReyes, LM (corresponding author), Univ Granada, Doctorate Program, Clin Med & Publ Heath, Granada, Spain.; Martin-delosReyes, LM (corresponding author), CIBERESP, CIBER Epidemiol & Salud Publ Espana, Madrid, Spain.	luismiguelmr@ugr.es	Rivera-Izquierdo, Mario/AAJ-8726-2021; Martínez-Ruiz, Virginia/Y-1794-2018; Ramos-Bossini, Antonio Jesús Láinez/AAN-2848-2021	Rivera-Izquierdo, Mario/0000-0001-6159-6037; Martínez-Ruiz, Virginia/0000-0001-6512-8935; Martin-delosReyes, Luis Miguel/0000-0002-2163-354X	SEMERGEN-UGR Chair of Teaching and Research in Family Medicine (Catedra de Docencia e Investigacion en Medicina de Familia SEMERGEN-UGR), University of Granada, Spain	SEMERGEN-UGR Chair of Teaching and Research in Family Medicine (Catedra de Docencia e Investigacion en Medicina de Familia SEMERGEN-UGR), University of Granada, Spain	This work was supported by the SEMERGEN-UGR Chair of Teaching and Research in Family Medicine (Catedra de Docencia e Investigacion en Medicina de Familia SEMERGEN-UGR), University of Granada, Spain to MRI. The funder played no role in the study design, data collection or analysis, and decision to publish.	Abbatecola AM, 2020, J NUTR HEALTH AGING, V24, P453, DOI 10.1007/s12603-020-1357-9; [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; [Anonymous], 2020, EL INDEPENDIENTE; [Anonymous], 2020, J KOREAN MED SCI, V35, pe112; Cattaruzza Maria Sofia, 2020, Acta Biomed, V91, P106, DOI 10.23750/abm.v91i2.9698; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Centro Nacional de Epidemiologia, 2020, 14 CTR NAC EP; Chan JCK, 2007, RESPIROLOGY, V12, P531, DOI 10.1111/j.1440-1843.2007.01102.x; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Goh KJ, 2020, ANN ACAD MED SINGAP, V49, P108; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang L L, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P466, DOI 10.3760/cma.j.cn112338-20200209-00080; Ki M, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020007; Lai CC, 2020, J MICROBIOL IMMUNOL, V53, P404, DOI 10.1016/j.jmii.2020.02.012; Lovato A, 2020, ENT-EAR NOSE THROAT, V99, P569, DOI 10.1177/0145561320920762; Ministerio de Sanidad, 2020, INF CIENT TECN ENF C; Ministerio de Sanidad. Gobierno de Espana, 2020, ACT N 86 ENF COR COV; Ministerio de Sanidad. Gobierno de Espana, 2020, SIT COVID 19 ESP INC; Ministerio de Sanidad. Gobierno de Espana, 2020, ACT N 85 ENF COR COV; Morra ME, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1977; Ng Ming-Yen, 2020, Radiol Cardiothorac Imaging, V2, pe200034, DOI 10.1148/ryct.2020200034; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Red Nacional de Vigilancia Epidemiologica, 2020, AN IMP CRIS COVID 19; Riccardo F, 2020, MEDRXIV, DOI [10.1101/2020.04.08.20056861, DOI 10.1101/2020.04.08.20056861V1]; Singh AK, 2020, DIABETES METAB SYND, V14, P283, DOI 10.1016/j.dsx.2020.03.016; Speth MM, 2020, OTOLARYNG HEAD NECK, V163, P114, DOI 10.1177/0194599820929185; StataCorp, 2017, STAT STAT SOFTW REL; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WKLY; Vardavas CI, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/119324; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang L, 2020, J INFECTION, V80, P639, DOI 10.1016/j.jinf.2020.03.019; WHO, 2019, REP WHO CHIN JOINT M; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang J., 2020, INT J INFECT DIS, V94, P91, DOI [10.1016/j.ijid.2020.03.017, DOI 10.1016/J.IJID.2020.03.017]; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhang LT, 2020, J THROMB HAEMOST, V18, P1324, DOI 10.1111/jth.14859; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou Y., 2020, ABERRANT PATHOGENIC, DOI [10.1101/2020.02.12.945576, DOI 10.1101/2020.02.12.945576, 10.1101/2020.02.12.945576.]	44	51	52	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235107	10.1371/journal.pone.0235107	http://dx.doi.org/10.1371/journal.pone.0235107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584868	Green Published, gold			2022-12-27	WOS:000545747200027
J	Pereira, GC; Lee, LR; Rawlings, N; Ouwendijk, J; Parker, JE; Andrienko, TN; Henley, JM; Halestrap, AP				Pereira, Goncalo C.; Lee, Laura; Rawlings, Nadiia; Ouwendijk, Joke; Parker, Joanne E.; Andrienko, Tatyana N.; Henley, Jeremy M.; Halestrap, Andrew P.			Hexokinase II dissociation alone cannot account for changes in heart mitochondrial function, morphology and sensitivity to permeability transition pore opening following ischemia	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; CONTACT SITES; REPERFUSION; INHIBITION; MEMBRANE; BINDING; LIVER; CARDIOPROTECTION; CYCLOSPORINE; MECHANISM	We previously demonstrated that hexokinase II (HK2) dissociation from mitochondria during cardiac ischemia correlates with cytochrome c (cyt-c) loss, oxidative stress and subsequent reperfusion injury. However, whether HK2 release is the primary signal mediating this ischemia-induced mitochondrial dysfunction was not established. To investigate this, we studied the effects of dissociating HK2 from isolated heart mitochondria. Mitochondria isolated from Langendorff-perfused rat hearts before and after 30 min global ischemia +/- ischemic preconditioning (IPC) were subject toin vitrodissociation of HK2 by incubation with glucose-6-phosphate at pH 6.3. Prior HK2 dissociation from pre- or end-ischemic heart mitochondria had no effect on their cyt-c release, respiration (+/- ADP) or mitochondrial permeability transition pore (mPTP) opening. Inner mitochondrial membrane morphology was assessed indirectly by monitoring changes in light scattering (LS) and confirmed by transmission electron microscopy. Although no major ultrastructure differences were detected between pre- and end-ischemia mitochondria, the amplitude of changes in LS was reduced in the latter. This was prevented by IPC but not mimickedin vitroby HK2 dissociation. We also observed more Drp1, a mitochondrial fission protein, in end-ischemia mitochondria. IPC failed to prevent this increase but did decrease mitochondrial-associated dynamin 2.In vitroHK2 dissociation alone cannot replicate ischemia-induced effects on mitochondrial function implying thatin vivodissociation of HK2 modulates end-ischemia mitochondrial function indirectly perhaps involving interaction with mitochondrial fission proteins. The resulting changes in mitochondrial morphology and cristae structure would destabilize outer / inner membrane interactions, increase cyt-c release and enhance mPTP sensitivity to [Ca2+].	[Pereira, Goncalo C.; Ouwendijk, Joke; Parker, Joanne E.; Andrienko, Tatyana N.; Halestrap, Andrew P.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Pereira, Goncalo C.; Ouwendijk, Joke; Parker, Joanne E.; Andrienko, Tatyana N.; Halestrap, Andrew P.] Univ Bristol, Bristol Heart Inst, Bristol, Avon, England; [Lee, Laura; Rawlings, Nadiia; Henley, Jeremy M.] Univ Bristol, Ctr Synapt Plast, Sch Biochem, Bristol, Avon, England; [Ouwendijk, Joke] Univ Bristol, Wolfson Bioimaging Facil, Bristol, Avon, England; [Pereira, Goncalo C.] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England	University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Cambridge	Pereira, GC (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.; Pereira, GC (corresponding author), Univ Bristol, Bristol Heart Inst, Bristol, Avon, England.; Pereira, GC (corresponding author), Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.	g.pereira@mrc-mbu.cam.ac.uk	Pereira, Gonçalo C./C-7954-2009	Pereira, Gonçalo C./0000-0001-9638-0615; Lee, Laura/0000-0002-7974-6803; Henley, Jeremy/0000-0003-3589-8335	British Heart Foundation [RG/08/001/24717, PG/12/40/29634, PG/14/60/3014]; BBSRC [BB/R00787X/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Programme and Project Grants from the British Heart Foundation (RG/08/001/24717 to APH, PG/12/40/29634 to APH, and PG/14/60/3014 to JMH). There was no additional external funding received for this study. The funding agency and the University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrienko T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167300; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; Baev AY, 2018, ANAL BIOCHEM, V552, P38, DOI 10.1016/j.ab.2017.07.006; Baines CP, 2018, CELL CALCIUM, V73, P121, DOI 10.1016/j.ceca.2018.05.003; BAKKER A, 1995, HISTOL HISTOPATHOL, V10, P405; BRYANT R, 1995, CONF PROC LECT NOT G, V4, P1; Chen Z, 2009, BBA-BIOENERGETICS, V1787, P553, DOI 10.1016/j.bbabio.2009.03.003; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; Chinopoulos C, 2018, NEUROCHEM INT, V117, P49, DOI 10.1016/j.neuint.2017.06.010; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Clarke SJ, 2008, CIRC RES, V102, P1082, DOI 10.1161/CIRCRESAHA.107.167072; CROMPTON M, 1988, BIOCHEM J, V255, P357; Das M, 2003, J PHYSIOL-LONDON, V547, P893, DOI 10.1113/jphysiol.2002.035006; Disatnik MH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000461; Doran E, 2000, BIOCHEM J, V348, P343, DOI 10.1042/0264-6021:3480343; Gao DC, 2016, CELL PHYSIOL BIOCHEM, V39, P2121, DOI 10.1159/000447908; Gurel E, 2009, J APPL PHYSIOL, V106, P1909, DOI 10.1152/japplphysiol.90537.2008; HAID E, 1975, CLIN CHEM, V21, P884; Halestrap AP, 2015, BRIT J PHARMACOL, V172, P2085, DOI 10.1111/bph.12899; Halestrap AP, 2015, J MOL CELL CARDIOL, V78, P129, DOI 10.1016/j.yjmcc.2014.08.018; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; HALESTRAP AP, 1991, BIOCHEM J, V278, P715, DOI 10.1042/bj2780715; Hall AE, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.91; Izzo V, 2016, TRENDS CELL BIOL, V26, P655, DOI 10.1016/j.tcb.2016.04.006; Javadov SA, 2003, J PHYSIOL-LONDON, V549, P513, DOI 10.1113/jphysiol.2003.034231; Juhaszova M, 2008, ANN NY ACAD SCI, V1123, P197, DOI 10.1196/annals.1420.023; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Karch J, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw4597; Khaliulin I, 2010, CARDIOVASC RES, V88, P324, DOI 10.1093/cvr/cvq190; Kluesner MG, 2018, CRISPR J, V1, P239, DOI 10.1089/crispr.2018.0014; KOTTKE M, 1988, BIOCHIM BIOPHYS ACTA, V935, P87, DOI 10.1016/0005-2728(88)90111-9; Kraus F, 2017, J CELL SCI, V130, P2953, DOI 10.1242/jcs.199562; Leung AWC, 2008, J BIOL CHEM, V283, P26312, DOI 10.1074/jbc.M805235200; Liang QR, 2002, CARDIOVASC RES, V53, P423, DOI 10.1016/S0008-6363(01)00495-3; Lim KHH, 2002, J PHYSIOL-LONDON, V545, P961, DOI 10.1113/jphysiol.2002.031484; McCommis KS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000355; Nederlof R, 2016, J PHYSIOL BIOCHEM, V73, P323, DOI 10.1007/s13105-017-0555-3; Ong SB, 2017, CARDIOVASC DRUG THER, V31, P87, DOI 10.1007/s10557-016-6710-1; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Osellame LD, 2016, J CELL SCI, V129, P2170, DOI 10.1242/jcs.185165; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V303, pH243, DOI 10.1152/ajpheart.00185.2012; Pasdois P, 2013, CIRC RES, V112, pE3, DOI 10.1161/CIRCRESAHA.112.274233; Pasdois P, 2011, BIOCHEM J, V436, P493, DOI 10.1042/BJ20101957; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Pell VR, 2018, J MOL CELL CARDIOL, V123, P88, DOI 10.1016/j.yjmcc.2018.08.010; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; Porceddu M, 2012, TOXICOL SCI, V129, P332, DOI 10.1093/toxsci/kfs197; RUTTER GA, 1988, BIOCHEM J, V252, P181, DOI 10.1042/bj2520181; SCHERER B, 1974, BIOCHEMISTRY-US, V13, P161, DOI 10.1021/bi00698a025; Sharp WW, 2014, FASEB J, V28, P316, DOI 10.1096/fj.12-226225; Shulga N, 2009, CELL CYCLE, V8, P3355, DOI 10.4161/cc.8.20.9853; Smeele KM, 2010, PFLUG ARCH EUR J PHY, V459, P705, DOI 10.1007/s00424-010-0787-3; Smeele KMA, 2011, CIRC RES, V108, P1165, DOI 10.1161/CIRCRESAHA.111.244962; Smith G, 2017, DEV NEUROBIOL, V77, P1260, DOI 10.1002/dneu.22519; STONER CD, 1973, J CELL BIOL, V56, P51, DOI 10.1083/jcb.56.1.51; Tan VP, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1965-7; Vyssokikh M, 2004, BBA-MOL CELL RES, V1644, P27, DOI 10.1016/j.bbamcr.2003.10.007; Xiao AQ, 2017, BIOCHEM BIOPH RES CO, V483, P765, DOI 10.1016/j.bbrc.2016.12.068; Xu SC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13189; Yingzhong Chen, 2016, Springerplus, V5, P1117, DOI 10.1186/s40064-016-2751-y; Yu R, 2019, J BIOL CHEM, V294, P17262, DOI 10.1074/jbc.RA119.008202; Zar JH., 1999, BIOSTAT ANAL, V663rd	64	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234653	10.1371/journal.pone.0234653	http://dx.doi.org/10.1371/journal.pone.0234653			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579577	Green Published, gold			2022-12-27	WOS:000545646600047
J	Klein, PW; Cohen, SM; Jacobson, EU; Li, ZH; Clark, G; Fanning, M; Sterling, R; Young, SR; Sansom, S; Hauck, H				Klein, Pamela W.; Cohen, Stacy M.; Uzun Jacobson, Evin; Li, Zihao; Clark, Glenn; Fanning, Miranda; Sterling, Rene; Young, Steven R.; Sansom, Stephanie; Hauck, Heather			A mathematical model to estimate the state-specific impact of the Health Resources and Services Administration's Ryan White HIV/AIDS Program	PLOS ONE			English	Article							UNITED-STATES; CARE; TRANSMISSION; THERAPY	Background Access to and engagement in high-quality HIV medical care and treatment is essential for ending the HIV epidemic. The Health Resources and Services Administration's (HRSA) Ryan White HIV/AIDS Program (RWHAP) plays a critical role in ensuring that people living with diagnosed HIV (PLWH) are linked to and consistently engaged in high quality care and receive HIV medication in a timely manner. State variation in HIV prevalence, the proportion of PLWH served by the RWHAP, and local health care environments could influence the state-specific impact of the RWHAP. This analysis sought to measure the state-specific impact of the RWHAP on the HIV service delivery system and health outcomes for PLWH, and presents template language to communicate this impact for state planning and stakeholder engagement. Methods and findings The HRSA's HIV/AIDS Bureau (HAB) and the Centers for Disease Control and Prevention's Division of HIV/AIDS Prevention (CDC DHAP) have developed a mathematical model to estimate the state-specific impact of the RWHAP. This model was parameterized using RWHAP data, HIV surveillance data, an existing CDC model of HIV transmission and disease progression, and parameters from the literature. In this study, the model was used to analyze the hypothetical scenario of an absence of the RWHAP and to calculate the projected impact of this scenario on RWHAP clients, RWHAP-funded providers, mortality, new HIV cases, and costs compared with the current state inclusive of the RWHAP. To demonstrate the results of the model, we selected two states, representing high HIV prevalence and low HIV prevalence areas. These states serve to demonstrate the functionality of the model and how state-specific results can be translated into a state-specific impact statement using template language. Conclusions In the example states presented, the RWHAP provides HIV care, treatment, and support services to a large proportion of PLWH in each state. The absence of the RWHAP in these states could result in substantially more deaths and HIV cases than currently observed, resulting in considerable lifetime HIV care and treatment costs associated with additional HIV cases. State-specific impact statements may be valuable in the development of state-level HIV prevention and care plans or for communications with planning bodies, state health department leadership, and other stakeholders. State-specific impact statements will be available to RWHAP Part B recipients upon request from HRSA's HIV/AIDS Bureau.	[Klein, Pamela W.; Cohen, Stacy M.; Clark, Glenn; Fanning, Miranda; Sterling, Rene; Young, Steven R.; Hauck, Heather] Hlth Resources & Serv Adm, HIV AIDS Bur, Rockville, MD 20851 USA; [Uzun Jacobson, Evin; Li, Zihao; Sansom, Stephanie] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA	United States Health Resources & Service Administration (HRSA); Centers for Disease Control & Prevention - USA	Klein, PW (corresponding author), Hlth Resources & Serv Adm, HIV AIDS Bur, Rockville, MD 20851 USA.	pklein@hrsa.gov		Klein, Pamela/0000-0003-4613-3725; Cohen, Stacy/0000-0002-0475-1122				Bradley H, 2019, AIDS BEHAV, V23, P557, DOI 10.1007/s10461-019-02442-7; Centers for Disease Control and Prevention, 2018, HIV SURV REP 2017; Centers for Disease Control and Prevention, NCHHSTP ATL UPD; Centers for Disease Control and Prevention Health Resources and Services Administration, 2015, INT HIV PREV CAR PLA; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Davies C, 2019, J ACQUIRED IMMUNE DE; Eisinger RW, 2019, JAMA-J AM MED ASSOC, V321, P451, DOI 10.1001/jama.2018.21167; Fanning M, 2018, CONDITIONAL PROBABIL; Farnham PG, 2013, JAIDS-J ACQ IMM DEF, V64, P183, DOI 10.1097/QAI.0b013e3182973966; Gopalappa C, 2017, MED DECIS MAKING, V37, P224, DOI 10.1177/0272989X16668509; Health Resources and Services Administration Ryan White HIV/AIDS Program, 2018, RYAN WHIT HIV AIDS P; Khurana N, 2018, JAIDS-J ACQ IMM DEF, V78, P399, DOI 10.1097/QAI.0000000000001707; Li ZH, 2019, MMWR-MORBID MORTAL W, V68, P267; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V73, P39, DOI 10.1097/QAI.0000000000001014; National Academy for State Health Policy, 2018, ROOLK STAT STRAT IMP; Weiser J, 2015, JAMA INTERN MED, V175, P1650, DOI 10.1001/jamainternmed.2015.4095	17	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234652	10.1371/journal.pone.0234652	http://dx.doi.org/10.1371/journal.pone.0234652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569330	Green Published, gold			2022-12-27	WOS:000543547900038
J	Mwakawanga, DL; Mselle, LT				Mwakawanga, Dorkasi Lushindiho; Mselle, Lilian Teddy			Early or delayed umbilical cord clamping? Experiences and perceptions of nurse-midwives and obstetricians at a regional referral hospital in Tanzania	PLOS ONE			English	Article							PRETERM INFANTS; VENTILATION; ATTITUDES; BIRTH	Background Umbilical cord clamping is a crucial step during the third stage of labour that separates the newborn from the placenta. Despite the available evidence that delayed umbilical cord clamping is more beneficial to infants, as well as the existence of 2014 WHO recommendation that the umbilical cord should be clamped between 1 and 3 minutes, its implementation is still low in many countries including Tanzania. Objective This study describes the experiences and perceptions of nurse-midwives`and obstetricians`about the timing of umbilical cord clamping at a regional referral hospital in Tanzania. Methods A descriptive qualitative study design that adopted a purposeful sampling strategy to recruit 19 participants was used. Nine semi-structured interviews with six nurse-midwives`and three obstetricians`, as well as one focus group discussion with ten nurse-midwives`were conducted. Thematic analysis guided the analysis of data. Results Three main themes generated from the data, each having 2 to 5 subthemes. 1. Experiences about the timing of umbilical cord clamping. 2. Perceptions about the umbilical cord clamping. 3. Factors influencing the practice of delayed umbilical cord clamping to improve newborn health outcomes. Conclusion Although the nurse-midwives`and obstetricians`commonly practiced clamping the umbilical cord immediately after delivery, they understood that delayed cord clamping has a potential benefit of oxygenation to the newborn in the event of the need for resuscitation. To move forward with the good practice in maternal and newborn care, proper pre-service and providers training on matters underlying childbirth is essential to address the gap of knowledge. Delayed cord clamping should be practiced widely to improve the health outcomes of the newborn.	[Mwakawanga, Dorkasi Lushindiho] Muhimbili Univ Hlth & Allied Sci, Sch Nursing, Dept Community Hlth Nursing, Dar Es Salaam, Tanzania; [Mselle, Lilian Teddy] Muhimbili Univ Hlth & Allied Sci, Sch Nursing, Dept Clin Nursing, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences	Mwakawanga, DL (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Nursing, Dept Community Hlth Nursing, Dar Es Salaam, Tanzania.	dorkasmwakawanga@gmail.com		Lushindiho Mwakawanga, Dorkasi/0000-0003-0975-4493				Andersson O, 2015, JAMA PEDIATR, V169, P631, DOI 10.1001/jamapediatrics.2015.0358; Andersson O, 2013, ACTA OBSTET GYN SCAN, V92, P567, DOI 10.1111/j.1600-0412.2012.01530.x; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2000, BENTON COUNTY PIONEE, V45, P4; Ashish KC, 2017, JAMA PEDIATR, V171, P264, DOI 10.1001/jamapediatrics.2016.3971; Bayer K, 2016, ADV NEONAT CARE, V16, P68, DOI 10.1097/ANC.0000000000000247; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Bhatt S, 2013, J PHYSIOL-LONDON, V591, P2113, DOI 10.1113/jphysiol.2012.250084; Boere I, 2015, NEONATOLOGY, V107, P50, DOI 10.1159/000365836; Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Chiruvolu A, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.016; Clarke V, 2013, PSYCHOLOGIST, V26, P120; Creswell J.W., 2018, QUAL INQ, V4th; Ersdal HL, 2016, BJOG-INT J OBSTET GY, V123, P1370, DOI 10.1111/1471-0528.13778; FAAIR Scientific Advisory Panel, 2002, CLIN INFECT DIS S3, V34, pS76; Fogarty M, 2018, AM J OBSTET GYNECOL, V218, P1, DOI 10.1016/j.ajog.2017.10.231; Heale Roberta, 2013, Evid Based Nurs, V16, P98, DOI 10.1136/eb-2013-101494; Hege A, 2017, PEDIATRICS, V134, P265; Hutton EK, 2013, BIRTH-ISS PERINAT C, V40, P39, DOI 10.1111/birt.12027; Ibrahim NO, 2017, ANN SAUDI MED, V37, P216, DOI 10.5144/0256-4947.2017.216; Jelin AC, 2014, J MATERN-FETAL NEO M, V27, P1457, DOI 10.3109/14767058.2013.864275; Katheria AC, 2017, J PERINATOL, V37, P105, DOI 10.1038/jp.2016.151; Katheria AC, 2017, J PEDIATR-US, V187, P313, DOI 10.1016/j.jpeds.2017.04.033; Leshchyns'ka I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6427537; Lundberg Camilla, 2013, Tidsskr Nor Laegeforen, V133, P2369, DOI 10.4045/tidsskr.12.0707; McAdams Ryan M, 2015, Matern Health Neonatol Perinatol, V1, P10, DOI 10.1186/s40748-015-0011-8; McDonald S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004741.pub2; McDonald Susan J, 2014, Evid Based Child Health, V9, P303, DOI 10.1002/ebch.1971; Ministry of Health, 2016, TANZ DEM HLTH SURV M; Mohammad K, 2021, J MATERN-FETAL NEO M, V34, P231, DOI 10.1080/14767058.2019.1602603; Nancarrow L, 2015, J PERINAT MED; O'Sullivan T, 2014, J SWINE HEALTH PROD, V22, P63; Polglase GR, 2018, ARCH DIS CHILD-FETAL, V103, pF530, DOI 10.1136/archdischild-2017-313657; Polit D.F., 2008, NURSING RES PRINCIPL, V8th edn; Radlowski EC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00585; Ranjit T, 2015, INDIAN J PEDIATR, V82, P29, DOI 10.1007/s12098-013-1329-8; Rheenen P Van, 2011, BMJ-BRIT MED J, V7127, P1; Ryan F, 2009, INT J THER REHABIL, V16, P309, DOI 10.12968/ijtr.2009.16.6.42433; Schneider Z WD, 2013, NURSING MIDWIFERY RE; Shimoda K, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-017-0447-6; Stranak Z, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00039; Temeke Regional Referral Hospital, 2017, ANN MAT REP SUMM BOO; Temple B., 2004, QUALITATIVE RES, V4, P161, DOI [10.1177/1468794104044430, DOI 10.1177/1468794104044430]; Weeks A D, 2015, BMJ Innov, V1, P53; World Health Organization,, 2012, GUID BAS NEWB RES; World Health Organization, 2014, GUID DEL UMB CORD CL; 2016, CANC DISCOV, V6, pe1140; 2016, CIRE ANTILLES GUYANE, V4, P1	49	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234854	10.1371/journal.pone.0234854	http://dx.doi.org/10.1371/journal.pone.0234854			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569338	Green Published, gold			2022-12-27	WOS:000543547900029
J	Villanova, F; Barreiros, M; Leal, E				Villanova, Fabiola; Barreiros, Marta; Leal, Elcio			Is the tryptophan codon of genevifthe Achilles' heel of HIV-1?	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIF; APOBEC3G	To evaluate the impact of hypermutation on the HIV-1 dissemination at the population level we studied 7072 sequences HIV-1 genevifretrieved from the public databank. From this dataset 854 sequences were selected because they had associated values of CD4+ T lymphocytes counts and viral loads and they were used to assess the correlation between clinical parameters and hypermutation. We found that the frequency of stop codons at sites 5, 11 and 79 ranged from 2.8x10(-4)to 4.2x10(-4). On the other hand, at codons 21, 38, 70, 89 and 174 the frequency of stop codons ranged from 1.4x10(-3)to 2.5x10(-3). We also found a correlation between clinical parameters and hypermutation where patients harboring proviruses with one or more stop codons at the tryptophan sites of the genevifhad higher CD4+ T lymphocytes counts and lower viral loads compared to the population. Our findings indicate that A3 activity potentially restrains HIV-1 replication because individuals with hypermutated proviruses tend to have lower numbers of RNA copies. However, owing to the low frequency of hypermutated sequences observed in the databank (44 out of 7072), it is unlikely that A3 has a significant impact to curb HIV-1 dissemination at the population level.	[Villanova, Fabiola; Barreiros, Marta; Leal, Elcio] Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil; [Barreiros, Marta] Univ Fed Maranhao, Dept Elect Engn, Sao Luis, Maranhao, Brazil	Universidade Federal do Para; Universidade Federal do Maranhao	Leal, E (corresponding author), Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil.	elcioleal@gmail.com	Leal, Elcio/M-5275-2019; VILLANOVA, FABIOLA E/E-7437-2013; Leal, Elcio/J-6236-2016	Leal, Elcio/0000-0003-3463-0492; Leal, Elcio/0000-0003-3463-0492	Coordenacao de Aperfeicoamento de Pessoal de Nivel; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq [302677/2019-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	M.B was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel; EL is supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq (#302677/2019-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005921; [Anonymous], 2014, ALZHEIMERS DEMENT J, V10, pe47; Ara A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004024; Arias JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00275; Armitage AE, 2008, J VIROL, V82, P8743, DOI 10.1128/JVI.00584-08; Binning JM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006830; Bizinoto MC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-173; Chen J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005471; Colson P, 2014, CLIN MICROBIOL INFEC, V20, P1280, DOI 10.1111/1469-0691.12807; Cuevas JM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002251; Ebrahimi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087679; Eyzaguirre LM, 2013, VIROLOGY, V443, P306, DOI 10.1016/j.virol.2013.05.019; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Kobayashi T, 2014, J VIROL, V88, P5881, DOI 10.1128/JVI.00062-14; Land AM, 2008, J VIROL, V82, P8172, DOI 10.1128/JVI.01115-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039776; Moris A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00534; Mussil B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-77; Ronsard L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15438; Russell RA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-16; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Sato K, 2010, J VIROL, V84, P9546, DOI 10.1128/JVI.00823-10; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Venkatesan S, 2018, ANN ONCOL, V29, P563, DOI 10.1093/annonc/mdy003; Villanova F, 2017, AIDS RES HUM RETROV, V33, P952, DOI [10.1089/aid.2016.0230, 10.1089/AID.2016.0230]; Wolfe LS, 2010, J VIROL, V84, P7135, DOI 10.1128/JVI.00031-10; Yamashita T, 2008, MICROBES INFECT, V10, P1142, DOI 10.1016/j.micinf.2008.06.003; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0225563	10.1371/journal.pone.0225563	http://dx.doi.org/10.1371/journal.pone.0225563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32570272	Green Submitted, gold, Green Published			2022-12-27	WOS:000543547900043
J	Fofana, F; Bazeley, P; Regnault, A				Fofana, Fatoumata; Bazeley, Pat; Regnault, Antoine			Applying a mixed methods design to test saturation for qualitative data in health outcomes research	PLOS ONE			English	Article							SAMPLE-SIZE; PATIENT	Saturation, a core concept in qualitative research, suggests when data collection might end. It is reached when no new relevant information emerges with additional interviews. The aim of this research was to explore whether a mixed methods design could contribute to the demonstration of saturation. Firstly, saturation was conceptualized mathematically using set theory. Secondly, a conversion mixed design was conducted: a set of codes derived from qualitative interviews were quantitized and analyzed using partial least squares (PLS) regression to document whether saturation was reached. A qualitative study conducted by other researchers prior to this work (i.e. none of the present authors was involved in this study) was used to test saturation using PLS regression. This illustrative qualitative study aimed to investigate the impact ofClostridium difficileinfection (CDI) on nurses' work in the hospital and the results were published elsewhere (Guillemin et al. 2015). Semi-structured interviews were conducted with 12 nurses. Saturation was characterized by the cumulative percentage of variability accounted for by PLS factors. After 12 interviews, this percentage was 51% which suggests that saturation was achieved at least on main themes. Two main themes identifying similarities in the experience of nurses caring for patients with CDI were identified:Organization/Coordination of the working dayandTime-consuming work. Although dependent on the coding of qualitative data, PLS regression of quantitized data from qualitative interviews generated useful information for the determination of saturation.	[Fofana, Fatoumata] ICON Plc, Patient Ctr Outcomes, Lyon, France; [Fofana, Fatoumata] Univ Tours, Univ Nantes, SPHERE MethodS Patients Ctr Outcomes & Hlth Res, UMR 1246,INSERM, Nantes, France; [Bazeley, Pat] Western Sydney Univ, Sydney, NSW, Australia; [Regnault, Antoine] Modus Outcomes, Lyon, France	ICON plc; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite de Tours; Western Sydney University	Fofana, F (corresponding author), ICON Plc, Patient Ctr Outcomes, Lyon, France.; Fofana, F (corresponding author), Univ Tours, Univ Nantes, SPHERE MethodS Patients Ctr Outcomes & Hlth Res, UMR 1246,INSERM, Nantes, France.	ffofana.cisse@outlook.com		Bazeley, Pat/0000-0002-4047-5962; Fofana, Fatoumata/0000-0003-3051-0098	French National Association of Research and Technology ('Association Nationale de la Recherche et de la Technologie' [ANRT]) [2012/0326]	French National Association of Research and Technology ('Association Nationale de la Recherche et de la Technologie' [ANRT])	This work was conducted as part of FF's PhD program. The PhD was supported by the 'Conventions Industrielles de Formation par la REcherche' (CIFRE) program (no 2012/0326) from the French National Association of Research and Technology ('Association Nationale de la Recherche et de la Technologie' [ANRT]). Modus Outcomes provided funding for the payment of publication fees. The funder of the illustrative qualitative study did not play any role in the study design, quantitative data analysis, decision to publish, or preparation of the present manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Abdi H, 2011, PARTIAL LEAST SQUARE; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; Arbuckle R, 2019, VALUE HEALTH, V22, P340, DOI 10.1016/j.jval.2018.09.2845; Bazeley P., 2018, INTEGRATING ANAL MIX; Bharmal M, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0835-1; Brod M, 2009, QUAL LIFE RES, V18, P1263, DOI 10.1007/s11136-009-9540-9; Coon CD, 2016, THER INNOV REGUL SCI, V50, P22, DOI 10.1177/2168479015622667; Creswell J. W., 2007, DESIGNING CONDUCTING; Curry L., 2015, MIXED METHODS HLTH S; Eriksson L., 2001, MULTI MEGAVARIATE DA; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Guevel MR, 2012, SANTE PUBLIQUE, V24, P23, DOI 10.3917/spub.121.0023; Guillemin I, 2015, INT J NURS PRACT, V21, P38, DOI 10.1111/ijn.12166; Hennink MM, 2019, QUAL HEALTH RES, V29, P1483, DOI 10.1177/1049732318821692; Kerr C, 2010, EXPERT REV PHARM OUT, V10, P269, DOI 10.1586/ERP.10.30; Lowe A, 2018, FIELD METHOD, V30, P191, DOI 10.1177/1525822X17749386; Martens H., 2001, MULTIVARIATE ANAL QU; Mason M., 2010, FORUM QUAL SOC RES, V11; Morse JM, 1998, QUAL HEALTH RES, V8, P147, DOI 10.1177/104973239800800201; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; Onwuegbuzie AJ, 2007, QUAL QUANT, V41, P105, DOI 10.1007/s11135-005-1098-1; Parker S, 2019, MOL GENET METAB, V126, pS115, DOI 10.1016/j.ymgme.2018.12.292; Regnault A, 2018, J PATIENT-REP OUTCOM, V2, DOI 10.1186/s41687-018-0043-8; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Sandelowski M, 2009, J MIX METHOD RES, V3, P208, DOI 10.1177/1558689809334210; Sartorius-Umetrics Suite, 2020, SART UM SUIT; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Sivesind KH, 1999, QUAL QUANT, V33, P361, DOI 10.1023/A:1004691318311; Tashakkori A, 2007, J MIX METHOD RES, DOI [10.1177/1558689807302453, DOI 10.1177/1558689807302453]; Teddlie C., 2009, FDN MIXED METHODS RE; Tenenhaus M, 2005, FOOD QUAL PREFER, V16, P315, DOI 10.1016/j.foodqual.2004.05.013; Tenenhaus M, 1998, REGRESSION PLS THERO; Tran VT, 2016, J CLIN EPIDEMIOL, V80, P88, DOI 10.1016/j.jclinepi.2016.07.014; Turner-Bowker DM, 2018, VALUE HEALTH, V21, P839, DOI 10.1016/j.jval.2017.11.014; US Food and Drug Administration, PAT FOC DRUG DEV COL; van Rijnsoever FJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181689; Tran VT, 2017, J CLIN EPIDEMIOL, V82, P71, DOI 10.1016/j.jclinepi.2016.10.001; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052	40	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234898	10.1371/journal.pone.0234898	http://dx.doi.org/10.1371/journal.pone.0234898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559246	Green Published, gold			2022-12-27	WOS:000543261600042
J	Fullar, A; Karaszi, K; Hollosi, P; Lendvai, G; Olah, L; Reszegi, A; Papp, Z; Sobel, G; Dudas, J; Kovalszky, I				Fullar, Alexandra; Karaszi, Katalin; Hollosi, Peter; Lendvai, Gabor; Olah, Laszlone; Reszegi, Andrea; Papp, Zoltan; Sobel, Gabor; Dudas, Jozsef; Kovalszky, Ilona			Two ways of epigenetic silencing of TFPI2 in cervical cancer	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR-2; TUMOR MICROENVIRONMENT; BIG ROLE; EXPRESSION; FIBROBLASTS; MICRORNAS; PREECLAMPSIA; ACTIVATION; GROWTH; GENES	Objective Comparison of human mRNA microarray results from tumor-associated and normal cervical fibroblasts revealed significantTFPI2downregulation in tumor-associated fibroblasts isolated from cervical cancer, indicating thatTFPI2downregulation may play an important role in the pathogenesis of the disease. In the present work, we investigated the mechanism ofTFPI2downregulation in tumor-associated fibroblasts and tumor cells. Methods In vitromodels of monocultures and co-cultures were established with tumor cells and fibroblasts to explore the changes of TFPI-2 expression and epigenetic modifications of theTFPI2gene. Results TheTFPI2gene was hypermethylated only in tumor cells. Reduction of TFPI-2 protein levels in tumor-associated fibroblasts, although the gene was not methylated, suggested alternative regulatory mechanisms of gene expression, such as inhibition by microRNAs. The expression pattern ofmiR-23a, a gene thought to inhibitTFPI2translation, showed changes strongly correlated to detected TFPI-2 protein alterations. Transfections withmiR-23amimics resulted in a decrease of TFPI-2 protein expression whereasmiR-23ainhibitors increased the TFPI-2 amount. Due to downregulation ofmiR-23aexpression by HPV in cancer cells,TFPI2was silenced by promoter methylation. In contrary,miR-23awas active in HPV-free fibroblasts and inactivatedTFPI2. Conclusion These results indicate dual epigenetic inhibition ofTFPI2on the transcription level by promoter methylation in cancer cells and on the translation level bymiR-23ain tumor-associated fibroblasts. As a consequence, inactivation of theTFPI2gene plays a strategic role in the progression of cervical cancer.	[Fullar, Alexandra; Karaszi, Katalin; Hollosi, Peter; Olah, Laszlone; Reszegi, Andrea; Kovalszky, Ilona] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, Budapest, Hungary; [Hollosi, Peter] Hungarian Acad Sci, Tumor Progress Res Grp, Budapest, Hungary; [Lendvai, Gabor] Semmelweis Univ, Dept Pathol 2, Budapest, Hungary; [Papp, Zoltan] Matern Obstet & Gynecol Private Clin, Budapest, Hungary; [Papp, Zoltan; Sobel, Gabor] Semmelweis Univ, Dept Obstet & Gynecol, Budapest, Hungary; [Dudas, Jozsef] Med Univ Innsbruck, Dept Otorhinolaryngol, Innsbruck, Austria	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Medical University of Innsbruck	Kovalszky, I (corresponding author), Semmelweis Univ, Dept Pathol & Expt Canc Res 1, Budapest, Hungary.	kovalszky.ilona@med.semmelweis-univ.hu	Dudás, József/AAY-9352-2020; Lendvai, Gabor/GZL-5723-2022; Kovalszky, Ilona/ABH-2832-2020	Dudás, József/0000-0002-9877-3399; Kovalszky, Ilona/0000-0002-0179-3378; Reszegi, Andrea/0000-0001-6902-7883; Olah, Laszlone/0000-0002-1388-2204; Fullar, Alexandra/0000-0003-4368-1523	Hungarian Scientific Research Fund [67925, 100904, 119283]; "Development of the Scientific Workshops of Medical, Health Science and Pharmacist Education" predoctoral fellowship [EFOP-3.6.3-VEKOP-16-201700009, HRDOP-3.6.3-CCHOP-16]; Austrian Science Fund [FWF P 22287-B13]; European Union Horizon 2020 Marie Sklodowska-Curie Actions (MSCA) Research and Innovation Staff Exchange Evaluations (RISE) project [645756 GLYCANC]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); "Development of the Scientific Workshops of Medical, Health Science and Pharmacist Education" predoctoral fellowship; Austrian Science Fund(Austrian Science Fund (FWF)); European Union Horizon 2020 Marie Sklodowska-Curie Actions (MSCA) Research and Innovation Staff Exchange Evaluations (RISE) project	This work was supported in part by the Hungarian Scientific Research Fund, grants 67925, 100904 and 119283 (to IK) -https://nkfih.gov.hu, by the EFOP-3.6.3-VEKOP-16-201700009 (HRDOP-3.6.3-CCHOP-16: Human Resources Development Operational Programme, Competitive Central Hungary Operational Programme)"Development of the Scientific Workshops of Medical, Health Science and Pharmacist Education" predoctoral fellowship (to KK) -https://ec.europa.eu/, by the Austrian Science Fund, grant FWF P 22287-B13 (to JD) -https://ec.europa.eu/and European Union Horizon 2020 Marie Sklodowska-Curie Actions (MSCA) Research and Innovation Staff Exchange Evaluations (RISE) project 645756 GLYCANC -Matrix glycans as multifunctional pathogenesis factors and therapeutic targets in cancer. (to IK) -https://ec.europa.eu/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Maternity Obstetrics and Gynecology Private Clinic) provided support in the form of author's salaries for author (ZP), but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific role of this author is articulated in the `author contributions' section.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baghy K, 2011, LAB INVEST, V91, P439, DOI 10.1038/labinvest.2010.172; BOHN H, 1977, ARCH GYNAKOL, V223, P179, DOI 10.1007/BF00667387; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Chou J, 2012, CANCER DISCOV, V2, P1078, DOI 10.1158/2159-8290.CD-12-0465; Dey P, 2011, INDIAN J CANCER, V48, P507, DOI 10.4103/0019-509X.92246; Dong YL, 2015, INT J CLIN EXP PATHO, V8, P1844; Fule T, 2006, GYNECOL ONCOL, V100, P570, DOI 10.1016/j.ygyno.2005.09.019; Fullar A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1272-3; Fullar A, 2012, EXP CELL RES, V318, P1517, DOI 10.1016/j.yexcr.2012.03.023; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gocze K, 2015, ANTICANCER RES, V35, P523; Hazelbag S, 2001, GYNECOL ONCOL, V83, P235, DOI 10.1006/gyno.2001.6378; Honegger A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004712; Huang FY, 2015, ONCOTARGET, V6, P34941, DOI 10.18632/oncotarget.5472; Huisman C, 2016, MOL THER, V24, P536, DOI 10.1038/mt.2015.226; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karaszi K, 2019, PLACENTA, V76, P30, DOI 10.1016/j.placenta.2019.01.011; Kempaiah P, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-20; KISIEL W, 1994, BLOOD, V84, P4384, DOI 10.1182/blood.V84.12.4384.bloodjournal84124384; Kunita A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27128-3; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Ma S, 2011, CANCER RES, V71, P583, DOI 10.1158/0008-5472.CAN-10-2587; Mitra AK, 2012, CANCER DISCOV, V2, P1100, DOI 10.1158/2159-8290.CD-12-0206; Ogawa M, 2007, PLACENTA, V28, P224, DOI 10.1016/j.placenta.2006.01.023; Poyyakkara A, 2018, J CELL BIOCHEM, V119, P4907, DOI 10.1002/jcb.26718; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Rao CN, 1996, ARCH BIOCHEM BIOPHYS, V335, P82, DOI 10.1006/abbi.1996.0484; Rathore MG, 2012, INT J BIOCHEM CELL B, V44, P1448, DOI 10.1016/j.biocel.2012.05.011; Rollin J, 2007, LUNG CANCER, V56, P273, DOI 10.1016/j.lungcan.2006.11.021; Soon P, 2013, ENDOCR-RELAT CANCER, V20, pR257, DOI 10.1530/ERC-13-0119; Toth M, 2003, BIOCHEM BIOPH RES CO, V308, P386, DOI 10.1016/S0006-291X(03)01405-0; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang GL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14148-8; Wang N, 2019, CANCERS, V11, DOI 10.3390/cancers11010007; Wojtukiewicz MZ, 2003, THROMB HAEMOSTASIS, V90, P140; Yang N, 2010, CELL ONCOL, V32, P131, DOI 10.3233/CLO-2009-0510; Zhang Q, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-1; Zheng HX, 2014, CARCINOGENESIS, V35, P173, DOI 10.1093/carcin/bgt274	43	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234873	10.1371/journal.pone.0234873	http://dx.doi.org/10.1371/journal.pone.0234873			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559232	Green Published, gold			2022-12-27	WOS:000543261600015
J	Teng, CF; Tsai, HW; Li, TC; Wang, T; Wang, J; Shyu, WC; Wu, HC; Su, IJ; Jeng, LB				Teng, Chiao-Fang; Tsai, Hung-Wen; Li, Tsai-Chung; Wang, Ting; Wang, John; Shyu, Woei-Cherng; Wu, Han-Chieh; Su, Ih-Jen; Jeng, Long-Bin			Detection of hepatitis B virus pre-S mutants in plasma by a next-generation sequencing-based platform determines their patterns in liver tissues	PLOS ONE			English	Article							GROUND GLASS HEPATOCYTES; HEPATOCELLULAR-CARCINOMA; MANAGEMENT; INFECTION; DELETION	Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related death worldwide. Patients with hepatitis B virus (HBV) pre-S mutants in liver tissues or blood have been regarded as a high-risk population for HCC development and recurrence. Detection of pre-S mutants in clinical specimens is thus important for early diagnosis and prognosis of HCC to improve patient survival. Recently, we have developed a next-generation sequencing (NGS)-based platform that can quantitatively detect pre-S mutants in patient plasma with superior sensitivity and accuracy. In this study, we compared the pre-S genotyping results from plasma by the NGS-based analysis with those from liver tissues by the immunohistochemistry (IHC)-based analysis in 30 HBV-related HCC patients. We demonstrated that the detection rate of pre-S mutants was significantly higher by NGS- than by IHC-based analysis. There was a moderate to good agreement between both analyses in detection of pre-S mutants. Compared with the IHC, the NGS-based detection of pre-S mutants in patient plasma could determine the patterns of pre-S mutants in liver tissues more efficiently in a noninvasive manner. Our data suggest that the NGS-based platform may represent a promising approach for detection of pre-S mutants as biomarkers of HBV-related HCC in clinical practice.	[Teng, Chiao-Fang; Shyu, Woei-Cherng] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Teng, Chiao-Fang; Wang, Ting; Jeng, Long-Bin] China Med Univ Hosp, Organ Transplantat Ctr, Taichung, Taiwan; [Teng, Chiao-Fang] China Med Univ, Res Ctr Canc Biol, Taichung, Taiwan; [Tsai, Hung-Wen] Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan, Taiwan; [Li, Tsai-Chung] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Med & Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan; [Wang, John] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Shyu, Woei-Cherng] Asia Univ, Dept Occupat Therapy, Taichung, Taiwan; [Shyu, Woei-Cherng] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Shyu, Woei-Cherng] China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan; [Wu, Han-Chieh] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan; [Su, Ih-Jen] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Health Research Institutes - Taiwan; Southern Taiwan University of Science & Technology	Jeng, LB (corresponding author), China Med Univ Hosp, Organ Transplantat Ctr, Taichung, Taiwan.; Su, IJ (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	chiaofangteng@gmail.com; suihjen0704@mail.stust.edu.tw; longbin.cmuh@gmail.com	Teng, Chiao-Fang/L-6679-2013; Wu, Han-Chieh/K-6928-2013	Wu, Han-Chieh/0000-0003-2638-7883; Teng, Chiao-Fang/0000-0002-5218-0571	China Medical University, Taichung, Taiwan [CMU107-N-09]	China Medical University, Taichung, Taiwan(China Medical University)	This work was supported by the China Medical University, Taichung, Taiwan (Grant Number CMU107-N-09) (to CFT). The funder had no role in study design, data collection and analysis, decision to publish, or preparation the manuscript.	BEASLEY RP, 1984, SEMIN LIVER DIS, V4, P113, DOI 10.1055/s-2008-1040651; Bosetti C, 2014, BEST PRACT RES CL GA, V28, P753, DOI 10.1016/j.bpg.2014.08.007; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Cheng KC, 2016, BIOMEDICINE-TAIWAN, V6, DOI 10.7603/s40681-016-0016-2; Fan YF, 2001, HEPATOLOGY, V33, P277, DOI 10.1053/jhep.2001.21163; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Kubo S, 2015, WORLD J GASTROENTERO, V21, P8249, DOI 10.3748/wjg.v21.i27.8249; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee Hannah M, 2019, Curr Treat Options Gastroenterol, V17, P271, DOI 10.1007/s11938-019-00236-3; Llovet JM, 2000, BEST PRACT RES CL GA, V14, P991, DOI 10.1053/bega.2000.0143; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Marin-Hargreaves G, 2003, CRIT REV ONCOL HEMAT, V47, P13, DOI 10.1016/S1040-8428(02)00213-5; Pollicino T, 2014, J HEPATOL, V61, P408, DOI 10.1016/j.jhep.2014.04.041; Poon RTP, 1999, ANN SURG, V229, P216, DOI 10.1097/00000658-199902000-00009; Sinn DH, 2013, DIGEST DIS SCI, V58, P751, DOI 10.1007/s10620-012-2408-9; Su IJ, 2008, J GASTROEN HEPATOL, V23, P1169, DOI 10.1111/j.1440-1746.2008.05348.x; Teng CF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33051-4; Teng CF, 2017, CELL TRANSPLANT, V26, P429, DOI 10.3727/096368916X694382; Teng YC, 2017, J PATHOL, V241, P463, DOI 10.1002/path.4850; Thampanitchawong P, 1999, WORLD J GASTROENTERO, V5, P301; Tsai HW, 2016, ONCOTARGET, V7, P27724, DOI 10.18632/oncotarget.8388; Tsai HW, 2011, CANCER-AM CANCER SOC, V117, P2951, DOI 10.1002/cncr.25837; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wall WJ, 2000, LIVER TRANSPLANT, V6, pS16, DOI 10.1053/jlts.2000.19010; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; Yen CJ, 2018, HEPATOLOGY, V68, P815, DOI 10.1002/hep.29790; Zamor PJ, 2017, J GASTROINTEST ONCOL, V8, P229, DOI 10.21037/jgo.2017.03.14	29	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234773	10.1371/journal.pone.0234773	http://dx.doi.org/10.1371/journal.pone.0234773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559248	gold, Green Published			2022-12-27	WOS:000543261600052
J	Lanza, E; Masetti, C; Messana, G; Muglia, R; Pugliese, N; Ceriani, R; de Nalda, AL; Rimassa, L; Torzilli, G; Poretti, D; D'Antuono, F; Politi, LS; Pedicini, V; Aghemo, A				Lanza, Ezio; Masetti, Chiara; Messana, Gaia; Muglia, Riccardo; Pugliese, Nicola; Ceriani, Roberto; de Nalda, Ana Lleo; Rimassa, Lorenza; Torzilli, Guido; Poretti, Dario; D'Antuono, Felice; Politi, Letterio Salvatore; Pedicini, Vittorio; Aghemo, Alessio		Humanitas HCC Multidisciplinary Gr	Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma	PLOS ONE			English	Article								Sarcopenia has been associated with lower overall survival in patients with cirrhosis and hepatocellular carcinoma (HCC) undergoing surgical resection, TACE, TARE, or transplantation. This monocentric study evaluated the prognostic significance of sarcopenia in patients affected by HCC who received bland transarterial embolization (TAE) therapy, by analyzing its impact on survival and treatment-related complications. All consecutive patients who underwent the 1st TAE between March 1st 2011 and July 1st 2019 in our Institution were retrospectively studied. To evaluate sarcopenia, the skeletal muscle index (SMI) was calculated by normalizing the cross-sectional muscle area at the level of L3 on an abdominal CT scan prior to embolization (cm2) by patient height (m2). SMI cut-off values for sarcopenia were considered <= 39 cm2/m2 for women and <= 55 cm2/m2 for men. Data about age, gender, body mass index (BMI), underlying liver disease, liver function, MELD score, Child-Pugh score, multifocal disease, performance status, previous interventions, length of stay (LOS), complications after the procedure, readmission rate within 30 days, survival time from TAE and total number and type of TAE received following the first procedure were collected. From 2011 to 2019, 142 consecutive patients underwent 305 TAEs. Observation time ranged from 1.4 to 100.5 months (median 20.1 SD = 22). Sarcopenia at baseline was present in 121 (85%) patients. Overall 87 (61.2%) patients died during follow-up with survival rates at 1-, 2-, 3-, 4-, and 5-year of 71%, 41%, 22%, 16% and 11% respectively. After multivariate analysis sarcopenia (HR = 2.22, p = 0.046), previous ablation/resection (HR = 0.51, p = 0.005) and multifocal disease (HR = 1.84, p = 0.02) were associated with reduced survival. Sarcopenia did not influence the safety of TAE in terms of LOS (2 days vs 1.5 days, p = 0.2), early complications rate (8% vs 5%, p = 0.5) and readmission rate within 30 days (7% vs 5%, p = 0.74). Sarcopenia, estimated by the L3SMI method, is an emerging prognostic factor in patients with HCC undergoing bland TAE therapy as it is associated with increased mortality, without impairing the safety of the locoregional treatment. Measures to ameliorate the SMI, such as nutritional support and physical exercise, should be evaluated in clinical trials for HCC patients receiving liver embolization to determine their impact on overall survival.	[Lanza, Ezio; Muglia, Riccardo; Poretti, Dario; D'Antuono, Felice; Pedicini, Vittorio] Humanitas Res Hosp IRCCS, Dept Radiol, Div Intervent Radiol, Rozzano, Italy; [Masetti, Chiara; Muglia, Riccardo; Pugliese, Nicola; Ceriani, Roberto; de Nalda, Ana Lleo; Aghemo, Alessio] Humanitas Res Hosp IRCCS, Dept Gastroenterol, Div Internal Med & Hepatol, Rozzano, Italy; [Messana, Gaia; Muglia, Riccardo; Pugliese, Nicola; de Nalda, Ana Lleo; Rimassa, Lorenza; Politi, Letterio Salvatore; Aghemo, Alessio] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Rimassa, Lorenza; Politi, Letterio Salvatore] Humanitas Clin & Res Ctr IRCCS, Humanitas Canc Ctr, Med Oncol & Hematol Unit, Milan, Italy; [Torzilli, Guido; Politi, Letterio Salvatore] Humanitas Clin & Res Ctr IRCCS, Dept Surg, Div Hepatobiliary & Gen Surg, Rozzano, Italy; [Politi, Letterio Salvatore] Humanitas Clin & Res Ctr IRCCS, Dept Radiol, Rozzano, Italy	IRCCS Humanitas Research Hospital; IRCCS Humanitas Research Hospital; Humanitas University	Lanza, E (corresponding author), Humanitas Res Hosp IRCCS, Dept Radiol, Div Intervent Radiol, Rozzano, Italy.	eziolanza@gmail.com; guido.torzilli@humanitas.it	Rimassa, Lorenza/N-4884-2016; Aghemo, Alessio/ABE-5976-2021; Lanza, Ezio/AAO-8516-2020; D'Antuono, Felice/AAV-2822-2020; pugliese, nicola/ABC-7622-2020; Politi, Letterio Salvatore/AAB-1092-2021; LLEO, Ana/AAA-5759-2019	Rimassa, Lorenza/0000-0001-9957-3615; Aghemo, Alessio/0000-0003-0941-3226; Lanza, Ezio/0000-0003-1889-8798; D'Antuono, Felice/0000-0002-9973-0593; pugliese, nicola/0000-0001-6466-1412; Politi, Letterio Salvatore/0000-0002-6190-6688; Messana, Gaia/0000-0002-3212-5305; pedicini, vittorio/0000-0001-7830-6307; LLEO, Ana/0000-0002-0561-7902; Ceriani, Roberto/0000-0003-4838-7366; Masetti, Chiara/0000-0002-1689-4876				Chang KV, 2018, LIVER CANCER, V7, P90, DOI 10.1159/000484950; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dimitroulis D, 2017, WORLD J GASTROENTERO, V23, P5282, DOI 10.3748/wjg.v23.i29.5282; Dolan E, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9110642; Donadon M, 2019, UPDATES SURG, V71, P57, DOI 10.1007/s13304-019-00626-3; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Foerster F, 2018, EUR J INTERN MED, V55, P57, DOI 10.1016/j.ejim.2018.05.024; Forner A, 2019, JHEP REP, V1, P17, DOI 10.1016/j.jhepr.2019.02.003; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; Ikeda M, 2018, JPN J CLIN ONCOL, V48, P103, DOI 10.1093/jjco/hyx180; Kaido T, 2019, HEPATOBIL SURG NUTR, V8, P59, DOI 10.21037/hbsn.2018.11.05; Katsanos K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184597; Koya S, 2019, J GASTROEN HEPATOL, V34, P580, DOI 10.1111/jgh.14538; Lanza E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227711; Lanza E, 2017, NUCL MED COMMUN, V38, P826, DOI 10.1097/MNM.0000000000000719; Lanza E, 2017, LIVER CANCER, V6, P27, DOI 10.1159/000449347; Liguori I, 2018, CLIN INTERV AGING, V13, P913, DOI 10.2147/CIA.S149232; Loosen SH, 2019, CANCERS, V11, DOI 10.3390/cancers11101503; Martinez-Arnau FM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102504; Menyhart O, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.181006; Nishikawa H, 2017, ONCOL LETT, V14, P1637, DOI 10.3892/ol.2017.6287; Phu S, 2015, J CLIN DENSITOM, V18, P488, DOI 10.1016/j.jocd.2015.04.011; Portal D, 2019, CANCER MANAG RES, V11, P2579, DOI 10.2147/CMAR.S195869; Tamandl D, 2016, EUR RADIOL, V26, P1359, DOI 10.1007/s00330-015-3963-1	24	18	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0232371	10.1371/journal.pone.0232371	http://dx.doi.org/10.1371/journal.pone.0232371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555707	gold, Green Published			2022-12-27	WOS:000542759600010
J	Ma, H; Lundy, JD; Cottle, EL; O'Malley, KJ; Trichel, AM; Klimstra, WB; Hartman, AL; Reed, DS; Teichert, T				Ma, Henry; Lundy, Jeneveve D.; Cottle, Emily L.; O'Malley, Katherine J.; Trichel, Anita M.; Klimstra, William B.; Hartman, Amy L.; Reed, Douglas S.; Teichert, Tobias			Applications of minimally invasive multimodal telemetry for continuous monitoring of brain function and intracranial pressure in macaques with acute viral encephalitis	PLOS ONE			English	Article							EASTERN EQUINE ENCEPHALITIS; CYNOMOLGUS MACAQUES; WAVE ACTIVITY; VIRUS; DELTA; ENCEPHALOMYELITIS; INFECTION; ALPHA; BETA; ELECTROENCEPHALOGRAM	Alphaviruses such as Venezuelan equine encephalitis virus (VEEV) and Eastern equine encephalitis virus (EEEV) are arboviruses that can cause severe zoonotic disease in humans. Both VEEV and EEEV are highly infectious when aerosolized and can be used as biological weapons. Vaccines and therapeutics are urgently needed, but efficacy determination requires animal models. The cynomolgus macaque (Macaca fascicularis) provides a relevant model of human disease, but questions remain whether vaccines or therapeutics can mitigate CNS infection or disease in this model. The documentation of alphavirus encephalitis in animals relies on traditional physiological biomarkers and behavioral/neurological observations by veterinary staff; quantitative measurements such as electroencephalography (EEG) and intracranial pressure (ICP) can recapitulate underlying encephalitic processes. We detail a telemetry implantation method suitable for continuous monitoring of both EEG and ICP in awake macaques, as well as methods for collection and analysis of such data. We sought to evaluate whether changes in EEG/ICP suggestive of CNS penetration by virus would be seen after aerosol exposure of naive macaques to VEEV IC INH9813 or EEEV V105 strains compared to mock-infection in a cohort of twelve adult cynomolgus macaques. Data collection ran continuously from at least four days preceding aerosol exposure and up to 50 days thereafter. EEG signals were processed into frequency spectrum bands (delta: [0.4 - 4Hz); theta: [4 - 8Hz); alpha: [8-12Hz); beta: [12-30] Hz) and assessed for viral encephalitis-associated changes against robust background circadian variation while ICP data was assessed for signal fidelity, circadian variability, and for meaningful differences during encephalitis. Results indicated differences in delta, alpha, and beta band magnitude in infected macaques, disrupted circadian rhythm, and proportional increases in ICP in response to alphavirus infection. This novel enhancement of the cynomolgus macaque model offers utility for timely determination of onset, severity, and resolution of encephalitic disease and for the evaluation of vaccine and therapeutic candidates.	[Ma, Henry; Lundy, Jeneveve D.; Cottle, Emily L.; O'Malley, Katherine J.; Trichel, Anita M.; Klimstra, William B.; Hartman, Amy L.; Reed, Douglas S.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Reed, Douglas S.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA; [Teichert, Tobias] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA; [Teichert, Tobias] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reed, DS (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.; Reed, DS (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA.; Teichert, T (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA.; Teichert, T (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	dsreed@pitt.edu; teichert@pitt.edu	Teichert, Tobias/F-6295-2014	Reed, Douglas/0000-0003-0076-9023; Hartman, Amy/0000-0002-0857-2973; Teichert, Tobias/0000-0001-6500-9573; /0000-0003-4506-7842	Defense Threat Reduction Agency (DTRA) [W911QY-15-1-0019]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This research was funded by Defense Threat Reduction Agency (DTRA, https://www.dtra.mil/), grant number W911QY-15-1-0019 and The APC was funded by the same.	Aills L, 2008, SURG OBES RELAT DI S, V4, pS73; ALBECK MJ, 1991, J NEUROSURG, V74, P597, DOI 10.3171/jns.1991.74.4.0597; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2014, GUID IND PROD DEV AN; [Anonymous], 2012, PLACENTA S, V33, pS15; [Anonymous], 2015, J CROHNS COLITIS S1, V9, pS15; [Anonymous], 2012, REGEN MED S3, V7, pS14; Arechiga-Ceballos N, 2015, REV SCI TECH OIE, V34, P491, DOI 10.20506/rst.34.2.2374; Authier S., 2009, Journal of Pharmacological and Toxicological Methods, V60, P88, DOI 10.1016/j.vascn.2008.12.003; Badar Z, 2014, PEDIATR INFECT DIS J, V6, P66; Baron S, 1996, MED MICROBIOLOGY; Benoit O, 2000, CLIN NEUROPHYSIOL, V111, P2103, DOI 10.1016/S1388-2457(00)00470-3; Bohannon JK, 2016, INHAL TOXICOL, V28, P670, DOI 10.1080/08958378.2016.1247199; Bowling JD, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00747-19; Brandenberger G, 2001, CLIN NEUROPHYSIOL, V112, P992, DOI 10.1016/S1388-2457(01)00507-7; Burns DL, 2012, CURR OPIN VIROL, V2, P353, DOI 10.1016/j.coviro.2012.01.004; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; CHAPMAN PH, 1990, NEUROSURGERY, V26, P181, DOI 10.1227/00006123-199002000-00001; Darko DF, 1995, P NATL ACAD SCI USA, V92, P12080, DOI 10.1073/pnas.92.26.12080; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deresiewicz RL, 1997, NEW ENGL J MED, V336, P1867, DOI 10.1056/NEJM199706263362604; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; FEINBERG I, 1985, ELECTROEN CLIN NEURO, V61, P134, DOI 10.1016/0013-4694(85)91051-X; Ferri R, 2001, CLIN NEUROPHYSIOL, V112, P2046, DOI 10.1016/S1388-2457(01)00656-3; Garlick J, 2016, EMERG INFECT DIS, V22, P2216, DOI 10.3201/eid2212.160844; Gronvalli GK, 2007, NAT BIOTECHNOL, V25, P1084, DOI 10.1038/nbt1007-1084; Gwin JT, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00258; Homan R. W., 1988, American Journal of EEG Technology, V28, P269; Hurst EW, 1936, J PATHOL BACTERIOL, V42, P270; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Kim Choong-Yong, 2006, Journal of Toxicological Sciences, V31, P529, DOI 10.2131/jts.31.529; KOPROWSKI H, 1947, NEW ENGL J MED, V236, P647, DOI 10.1056/NEJM194705012361801; KRAUSE G, 1983, EUR J APPL PHYSIOL O, V51, P61, DOI 10.1007/BF00952538; Lackemeyer MG, 2014, VIRUSES-BASEL, V6, P137, DOI 10.3390/v6010137; Lawley JS, 2017, J PHYSIOL-LONDON, V595, P2115, DOI 10.1113/JP273557; Lennette EH, 1943, J AMER MED ASSOC, V123, P1088, DOI 10.1001/jama.1943.02840520004002; LIVESAY HR, 1949, J INFECT DIS, V84, P306, DOI 10.1093/infdis/84.3.306; Lury Kenneth M, 2004, Emerg Radiol, V11, P46; Ma H, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040240; Majde JA, 2005, J ALLERGY CLIN IMMUN, V116, P1188, DOI 10.1016/j.jaci.2005.08.005; MASUDA H, 1989, ANN THORAC SURG, V47, P890, DOI 10.1016/0003-4975(89)90030-1; Molaee-Ardekani B, 2007, P ANN INT IEEE EMBS, P1294, DOI 10.1109/IEMBS.2007.4352534; Moran GJ, 2002, EMERG MED CLIN N AM, V20, P311, DOI 10.1016/S0733-8627(01)00003-7; National Research Council, GUIDE CARE USE LAB A; OPP MR, 1992, P SOC EXP BIOL MED, V201, P16; OTOMO E, 1966, J NEUROL NEUROSUR PS, V29, P383, DOI 10.1136/jnnp.29.5.383; Pratt WD, 1998, VACCINE, V16, P1056, DOI 10.1016/S0264-410X(97)00192-8; Rachalski A, 2014, J SLEEP RES, V23, P619, DOI 10.1111/jsr.12189; Reed DS, 2007, J INFECT DIS, V196, P441, DOI 10.1086/519391; Reed DS, 2014, PATHOG DIS, V71, P225, DOI 10.1111/2049-632X.12157; Reed DS, 2005, J INFECT DIS, V192, P1173, DOI 10.1086/444397; Reed DS, 2004, J INFECT DIS, V189, P1013, DOI 10.1086/382281; Rottenberg M, 2002, VIRAL IMMUNOL, V15, P247, DOI 10.1089/08828240260066206; Roy CJ, 2013, VACCINE, V31, P1464, DOI 10.1016/j.vaccine.2013.01.014; Silverman MA, 2013, EMERG INFECT DIS, V19, P194, DOI 10.3201/eid1902.120039; Solomon T, 2004, ARTHROPOD BORNE VIRA; Taha AR, 2020, HIGHLY INFECT DIS CR, P147; UCHIDA S, 1994, BRAIN RES, V659, P243, DOI 10.1016/0006-8993(94)90886-9; Vacca Jr VM, 2016, NURSING CRITICAL CAR, V11, P14; WEBSTER HDF, 1956, NEW ENGL J MED, V255, P267, DOI 10.1056/NEJM195608092550604; Wendell LC, 2013, NEUROCRIT CARE, V19, P111, DOI 10.1007/s12028-013-9822-5; Wyckoff RWG, 1939, J IMMUNOL, V37, P329; Yilmaz G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00504; Yoshida H, 2004, BRAIN RES, V1009, P129, DOI 10.1016/j.brainres.2004.02.055; Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023	65	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0232381	10.1371/journal.pone.0232381	http://dx.doi.org/10.1371/journal.pone.0232381			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584818	Green Published, Green Submitted, gold			2022-12-27	WOS:000545747200020
J	O'Halloran, P; Kingsley, M; Nicholson, M; Staley, K; Randle, E; Wright, A; Bauman, A				O'Halloran, Paul; Kingsley, Michael; Nicholson, Matthew; Staley, Kiera; Randle, Erica; Wright, Annemarie; Bauman, Adrian			Responsiveness of the single item measure to detect change in physical activity	PLOS ONE			English	Article							SELF-REPORT; RELIABILITY; VALIDITY; ACCELEROMETER; QUESTIONNAIRE	Objective The objective of this study was to evaluate the responsiveness of the single item measure (SIM) to detect change in PA when compared to hip-worn accelerometry. A secondary aim was to provide further data on validity of the measure at a single time point. Methods Validity of the SIM to determine the number of days of >= 30 minutes of accelerometer-derived moderate-to-vigorous physical activity (MVPA) was assessed in 120 participants (78% female, 19% male, 3% other; age: 46 +/- 11 years). Analysis of change was based on change in the number of days that participants completed >= 30 minutes of MVPA determined by the SIM and accelerometry over two 7-day periods in 90 participants (age: 47 +/- 11 years). Accelerometer data were analysed as total minutes of MVPA per day (MVPA-total) and as sustained bouts of 10 minutes or more of MVPA (MVPA-bouts). Validity of the SIM to detect change in MVPA, using accelerometer data as the reference measurement, was examined through Spearman's correlation and agreement in classification of change between SIM and accelerometry. Responsiveness to change was assessed by standardised response means and Cohen's d. Results Standardised response means for PA change were moderate for the SIM (0.77), MVPA-total (0.57) and MVPA-bouts (0.79). The correlation for change in number of days >= 30 minutes MVPA between the SIM and accelerometry were small to moderate (MVPA-total: r = 0.36 and MVP-bouts: r = 0.40). The SIM displayed moderate accuracy (60%-63%), using accelerometer data as the reference measurement, in detecting increases in days >= 30 minutes of MVPA. Conclusion The SIM is a potentially useful assessment tool for evaluating change in MVPA, particularly when device-based measures or longer self-report measures are not feasible.	[O'Halloran, Paul] La Trobe Univ, Sch Psychol & Publ Hlth, Bundoora, Vic, Australia; [O'Halloran, Paul; Kingsley, Michael; Nicholson, Matthew; Staley, Kiera; Randle, Erica] La Trobe Univ, Ctr Sport & Social Impact, Bundoora, Vic, Australia; [Kingsley, Michael] La Trobe Univ, Holsworth Res Initiat, Bendigo, Australia; [Kingsley, Michael] Univ Auckland, Dept Exercise Sci, Auckland, New Zealand; [Wright, Annemarie] Victorian Hlth Promot Fdn VicHlth, Carlton, Vic, Australia; [Wright, Annemarie] Univ Melbourne Honorary, Parkville, Vic, Australia; [Bauman, Adrian] Sydney Univ Australia, Sch Publ Hlth, Sydney, NSW, Australia	La Trobe University; La Trobe University; La Trobe University; University of Auckland; University of Melbourne	O'Halloran, P (corresponding author), La Trobe Univ, Sch Psychol & Publ Hlth, Bundoora, Vic, Australia.; O'Halloran, P (corresponding author), La Trobe Univ, Ctr Sport & Social Impact, Bundoora, Vic, Australia.	p.ohalloran@latrobe.edu.au	Staley, Kiera/GZL-3343-2022	Kingsley, Michael/0000-0002-1953-4067; Wright, Annemarie/0000-0003-3353-3658; O'Halloran, Paul/0000-0001-6495-2359; Staley, Kiera/0000-0002-2664-0300	Victorian Health Promotion Foundation (VicHealth)	Victorian Health Promotion Foundation (VicHealth)	This research was supported by the Victorian Health Promotion Foundation (VicHealth), www.vichealth.vic.gov.au. One of the co-authors, AW, is a staff member of the funding body, and as such the funder had a role in the preparation of the manuscript. However, the funder had no role in the design of the study or the analysis of data.	[Anonymous], 2012, PACIFIC AM STUDIES, V12, P20; Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID; Brannan MGT, 2019, PROG CARDIOVASC DIS, V62, P135, DOI 10.1016/j.pcad.2019.02.001; Cardon G, 2007, PEDIATR EXERC SCI, V19, P205, DOI 10.1123/pes.19.2.205; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Cleland CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1255; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Corder K, 2010, AM J EPIDEMIOL, V171, P1065, DOI 10.1093/aje/kwq068; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Department of Health and Social Care, 2013, GEN PRACT PHYS ACT Q; Dowd KP, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-017-0636-2; Grimby G, 2015, SCAND J MED SCI SPOR, V25, P119, DOI 10.1111/sms.12611; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Horne D, 2013, CAN J CARDIOL, V29, P1649, DOI 10.1016/j.cjca.2013.09.015; Kingsley MIC, 2019, J SCI MED SPORT, V22, P677, DOI 10.1016/j.jsams.2018.12.003; Lee WYH, 2015, J PHYS ACT HEALTH, V12, P1082, DOI 10.1123/jpah.2013-0265; Limb ES, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-018-0762-5; Milton K, 2011, BRIT J SPORT MED, V45, P203, DOI 10.1136/bjsm.2009.068395; Milton K, 2017, SELECTION PROJECT LE; Milton K, 2013, BRIT J SPORT MED, V47, P44, DOI 10.1136/bjsports-2011-090899; Molina L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168148; Murphy JJ, 2017, MEAS PHYS EDUC EXERC, V21, P134, DOI 10.1080/1091367X.2017.1297711; Nicaise V, 2014, J PHYS ACT HEALTH, V11, P846, DOI 10.1123/jpah.2011-0412; Pedisic Z, 2015, BRIT J SPORT MED, V49, P219, DOI 10.1136/bjsports-2013-093407; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Portegijs E, 2017, SCAND J MED SCI SPOR, V27, P1423, DOI 10.1111/sms.12782; Reeves MM, 2010, J PHYS ACT HEALTH, V7, P194, DOI 10.1123/jpah.7.2.194; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Scott JJ, 2015, J PAEDIATR CHILD H, V51, P787, DOI 10.1111/jpc.12836; Silsbury Z, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008430; Slootmaker SM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-17; Steene-Johannessen J, 2016, MED SCI SPORT EXER, V48, P235, DOI 10.1249/MSS.0000000000000760; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Swartz AM, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093520; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Vandelanotte C, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6717-1; Wanner Miriam, 2017, BMJ Open Sport Exerc Med, V3, pe000206, DOI 10.1136/bmjsem-2016-000206; Wanner M, 2014, BRIT J SPORT MED, V48, P1570, DOI 10.1136/bjsports-2012-092122; WHO, 2005, WHO STEPS SURV MAN W; Zwolinsky S, 2015, PUBLIC HEALTH, V129, P1630, DOI 10.1016/j.puhe.2015.07.015	42	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234420	10.1371/journal.pone.0234420	http://dx.doi.org/10.1371/journal.pone.0234420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584830	Green Published, gold			2022-12-27	WOS:000545747200060
J	Manzoni, A; Mooi-Reci, I				Manzoni, Anna; Mooi-Reci, Irma			The cumulative disadvantage of unemployment: Longitudinal evidence across gender and age at first unemployment in Germany	PLOS ONE			English	Article							LABOR-MARKET; FUTURE UNEMPLOYMENT; UNITED-STATES; NETHERLANDS; INEQUALITY; DYNAMICS; DURATION; BENEFITS; EARNINGS; IMPACT	Unemployment is an important predictor of one's future employment success. Yet, much about the endurance of unemployment effects on workers' careers remains poorly understood. Our study complements this knowledge gap by examining the rate of recovery in the quality of careers following an unemployment spell among a representative sample of previously unemployed workers with different socio-demographic characteristics in Germany. We apply a new dynamic measure that quantifies the quality of binary sequences, distinguishing between "good" (i.e., employment) from "bad" labor force status activities (i.e., unemployment and inactivity). We use longitudinal data from the German Socio-Economic Panel (GSOEP) before the Great Financial Recession over the period 1984-2005 and deploy a series of hybrid models that control for unobserved heterogeneity. We find a non-linear recovery process after unemployment across gender and age groups. That is, after a period of recovery, career quality worsens. Least impacted are men experiencing unemployment when aged between 25-34 years, while men 55-66 have rather stable, though stronger, penalties. Furthermore, we find that recovery processes are contingent uponwhenrespondents experience unemployment.	[Manzoni, Anna] North Carolina State Univ, Dept Sociol & Anthropol, Raleigh, NC 27695 USA; [Mooi-Reci, Irma] Univ Melbourne, Fac Arts, Sch Social & Polit Sci, Parkville, Vic, Australia	University of North Carolina; North Carolina State University; University of Melbourne	Manzoni, A (corresponding author), North Carolina State Univ, Dept Sociol & Anthropol, Raleigh, NC 27695 USA.	anna.manzoni@gmail.com	; Mooi-Reci, Irma/E-9144-2014	Manzoni, Anna/0000-0003-3264-177X; Mooi-Reci, Irma/0000-0002-3802-3676				Allison P, 2009, FIXED EFFECTS MODEL; [Anonymous], 2018, SEQUENCE ANAL RELATE; [Anonymous], 2017, AM J TRANSPLANT, V17, P1, DOI DOI 10.1093/jisesa/iew097; Arulampalam W, 2000, OXFORD ECON PAP, V52, P24, DOI 10.1093/oep/52.1.24; Becker G.S., 1964, HUMAN CAPITAL THEORE; Berger Joseph, 1977, STATUS CHARACTERISTI; Blau G, 2013, J WORKPLACE BEHAV HE, V28, P212, DOI 10.1080/15555240.2013.808081; Blau G, 2013, CAREER DEV INT, V18, P257, DOI 10.1108/CDI-10-2012-0095; Blossfeld H.-P., 2006, ROUTLEDGE ADV SOCIOL; CORCORAN M, 1985, J HUM RESOUR, V20, P165, DOI 10.2307/146006; Correll SJ, 2007, AM J SOCIOL, V112, P1297, DOI 10.1086/511799; Curry M, 2019, SOC SCI RES, V81, P61, DOI 10.1016/j.ssresearch.2019.03.004; Danziger S, 2010, FUTURE CHILD, V20, P133; den Haan WJ, 2005, J EUR ECON ASSOC, V3, P1360, DOI 10.1162/154247605775012897; DIPRETE TA, 1981, AM J SOCIOL, V87, P286, DOI 10.1086/227459; DiPrete TA, 2000, AM SOCIOL REV, V65, P343, DOI 10.2307/2657461; DiPrete TA, 2006, ANNU REV SOCIOL, V32, P271, DOI 10.1146/annurev.soc.32.061604.123127; Edin PA, 2008, IND LABOR RELAT REV, V61, P163, DOI 10.1177/001979390806100202; ELIASON SR, 1995, AM SOCIOL REV, V60, P247, DOI 10.2307/2096386; Ellwood D., 1982, YOUTH LABOR MARKET P, P349; Elzinga CH, 2003, SOCIOL METHOD RES, V32, P3, DOI 10.1177/0049124103253373; Eriksson S, 2014, AM ECON REV, V104, P1014, DOI 10.1257/aer.104.3.1014; Ermisch J, 2004, J R STAT SOC A STAT, V167, P69, DOI 10.1111/j.1467-985X.2004.00292.x; Frick JR, 2006, DESIGN CONTENTS DATA; Gangl M, 2006, AM SOCIOL REV, V71, P986, DOI 10.1177/000312240607100606; Gregg P, 2004, WRK P SER, V04/097; Gregg Paul, 2001, ECON J, V111, P623; Gregory M, 2001, ECON J, V111, pF607, DOI 10.1111/1468-0297.00665; HECKMAN JJ, 1980, ECONOMICA, V47, P247, DOI 10.2307/2553150; Hochmuth B, 2019, IAB DISC P, V3, P1; JACOBSON LS, 1993, AM ECON REV, V83, P685; Kroft K, 2013, Q J ECON, V128, P1123, DOI 10.1093/qje/qjt015; LOCKWOOD B, 1991, REV ECON STUD, V58, P733, DOI 10.2307/2297830; Luijkx R, 2009, EUR SOCIOL REV, V25, P647, DOI 10.1093/esr/jcp002; Manzoni Anna, 2011, SCHMOLLERS JB J APPL, V131, P339; Mooi-Reci I, 2015, SOC SCI RES, V52, P642, DOI 10.1016/j.ssresearch.2014.10.005; Mooi-Reci I, 2012, SOC FORCES, V91, P583, DOI 10.1093/sf/sos111; Mooi-Reci I, 2012, EUR SOCIOL REV, V28, P594, DOI 10.1093/esr/jcr028; Neumark D, 2002, REV ECON STAT, V84, P462, DOI 10.1162/003465302320259475; OECD, 2016, EC SURV GERM; Omori Y, 1997, ECON INQ, V35, P394, DOI 10.1111/j.1465-7295.1997.tb01918.x; Pedulla DS, 2018, SOC FORCES, V96, P1477, DOI 10.1093/sf/soy002; PIORE MJ, 1975, LABOR MARKET SEGMENT; PISSARIDES CA, 1992, Q J ECON, V107, P1371, DOI 10.2307/2118392; Schmieder JF, 2016, AM ECON REV, V106, P739, DOI 10.1257/aer.20141566; Schmieder JF, 2012, AM ECON REV, V102, P514, DOI 10.1257/aer.102.3.514; Schmillen A, 2017, INT LABOUR REV, V156, P465, DOI 10.1111/ilr.12079; Schunck R, 2017, STATA J, V17, P89, DOI 10.1177/1536867X1701700106; SPENCE M, 1973, Q J ECON, V87, P355, DOI 10.2307/1882010; Stevens AH, 1997, J LABOR ECON, V15, P165, DOI 10.1086/209851; Stewart MB, 2007, J APPL ECONOMET, V22, P511, DOI 10.1002/jae.922; Torgovitsky A, 2019, NONPARATMETRIC INFER, V11, P1	52	2	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234786	10.1371/journal.pone.0234786	http://dx.doi.org/10.1371/journal.pone.0234786			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579610	Green Published, gold			2022-12-27	WOS:000545646600058
J	Wasylewski, MT; Strzebonska, K; Koperny, M; Polak, M; Kimmelman, J; Waligora, M				Wasylewski, Mateusz T.; Strzebonska, Karolina; Koperny, Magdalena; Polak, Maciej; Kimmelman, Jonathan; Waligora, Marcin			Clinical development success rates and social value of pediatric Phase 1 trials in oncology	PLOS ONE			English	Article								Objectives Drug development trials must fulfill social value requirement but no estimates of value provided by pediatric Phase 1 trials in oncology exist. These trials involve a particularly vulnerable population. Our objective was to assess of surrogates of social value of Phase 1 trials performed in pediatric oncology: rates of approval of tested interventions, transition to further phases of testing and citation in subsequent primary research reports. Methods We performed an analysis on a subset of eligible trials included in a previous meta-analysis. That study systematically searched EMBASE and PubMed for small sample size, non-randomized, dose escalation pediatric cancer Phase 1 studies of any malignancy, assessing chemotherapy and/or targeted therapy and looked at risk and benefit. The current analysis assessed all studies in that review published between January 1st 2004 and December 31st 2013 for predictors of social value. This time range allowed for at least five years of subsequent development activity. Sources of data included FDA and EMA medicine databases (for approval), ClinicalTrials.gov and EU Clinical Trials Register (for transition) and Google Scholar (for citation). Results One hundred thirty-nine trials enrolling 3814 patients met the eligibility criteria. Seven trials (5%) led to drugs being registered for pediatric use in therapy of cancer. Fifty-two (37%) transitioned to later phases of pediatric oncology trials according to ClinicalTrials.gov and/or EU Register. Over 90% of trials were cited by at least one subsequent primary research report or systematic review. Most of the citations were preclinical studies. Conclusions Our analysis shows that treatments tested in pediatric Phase 1 trials in oncology have low rates of regulatory approval. However, a large proportion of Phase 1 trials inform further testing and development of tested interventions.	[Wasylewski, Mateusz T.; Strzebonska, Karolina; Koperny, Magdalena; Polak, Maciej; Waligora, Marcin] Jagiellonian Univ, Dept Philosophy & Bioeth, Res Eth Med Study Grp, Med Coll,REMEDY, Krakow, Poland; [Polak, Maciej] Jagiellonian Univ, Dept Epidemiol & Populat Studies, Coll Med, Krakow, Poland; [Kimmelman, Jonathan] McGill Univ, Biomed Eth Unit, Studies Translat Eth & Med STREAM, Montreal, PQ, Canada	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; McGill University	Waligora, M (corresponding author), Jagiellonian Univ, Dept Philosophy & Bioeth, Res Eth Med Study Grp, Med Coll,REMEDY, Krakow, Poland.	m.waligora@uj.edu.pl	Koperny, Magdalena/AFV-2977-2022; Waligora, Marcin/H-5023-2012	Koperny, Magdalena/0000-0002-3352-0972; Waligora, Marcin/0000-0002-1553-1416; Wasylewski, Mateusz/0000-0001-9523-8254; Strzebonska, Karolina/0000-0003-2652-2635	National Science Center, Poland [UMO-2015/18/E/HS1/00354]	National Science Center, Poland(National Science Centre, Poland)	This study was funded by the National Science Center, Poland, UMO-2015/18/E/HS1/00354 (www.ncn.gov.pl).Authors who received the funding: MTW, KS, MK, MP, MW(PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, BMJ-BRIT MED J, V350, ph1033; Camacho LH, 2005, CANCER, V104, P1497, DOI 10.1002/cncr.21337; CIOMS, 2016, COUNC INT ORG MED SC; Cohen JW, 2020, ONCOLOGIST, V25, P532, DOI 10.1634/theoncologist.2019-0615; Eisenhauer EA, 2015, PHASE 1 CANC CLIN TR; European Medicines Agency, 2018, PAED INV PLANS; European Medicines Agency, EUR MED AG SEARCH ME; Franshaw L, 2019, ONCOLOGIST; Gore L, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.74.4144; Habets MGJL, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-66; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Hutchinson N, 2020, J CLIN ONCOL, V38, P669, DOI 10.1200/JCO.19.02456; Kimmelman J., 2009, GENE TRANSFER ETHICS; Kimmelman J, 2019, JAMA PEDIATR, V173, P8, DOI 10.1001/jamapediatrics.2018.3629; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Neel DV, 2019, EUR J CANCER, V112, P49, DOI 10.1016/j.ejca.2019.02.011; Piasecki J, 2018, SCI ENG ETHICS, V24, P809, DOI 10.1007/s11948-017-0010-4; Sisk Bryan Anthony, 2019, Ethics Hum Res, V41, P2, DOI 10.1002/eahr.500033; Thomas DW, 2016, BIO IND ANAL; Waligora M, 2018, CHILDREN PHASE 1 TRI; Waligora M, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002505; Wendler D, 2017, BIOETHICS, V31, P77, DOI 10.1111/bioe.12325; Wong CH, 2019, BIOSTATISTICS, V20, P273, DOI 10.1093/biostatistics/kxx069; Zachary Brennan, 2018, PEDIAT STUDY PLANS F	24	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234911	10.1371/journal.pone.0234911	http://dx.doi.org/10.1371/journal.pone.0234911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579564	Green Published, gold			2022-12-27	WOS:000545646600014
J	Allado, E; Wittoek, R; Ferrero, S; Albuisson, E; Chary-Valckenaere, I; Roux, C; Loeuille, D				Allado, Edem; Wittoek, Ruth; Ferrero, Stephanie; Albuisson, Eliane; Chary-Valckenaere, Isabelle; Roux, Christian; Loeuille, Damien			Assessment of structural lesions, synovitis and bone marrow lesions in erosive hand osteoarthritis on MRI (0.3T) compared to the radiographic anatomical Verbruggen-Veys score	PLOS ONE			English	Article							RADIOLOGICAL ASSESSMENT; RELIABILITY; ARTHRITIS; FEATURES; RECOMMENDATIONS; ASSOCIATIONS; SENSITIVITY; PROGRESSION; MANAGEMENT	Objective To evaluate prevalence of structural lesions, synovitis and bone marrow lesions (BMLs) on MRI performed with a 0.3T imaging system in patients with erosive hand osteoarthritis (EHOA) and to compare them to the anatomic radiographic Verbruggen-Veys score (VV). Design For this Cross-sectional study, fifty-five EHOA patients were studied with 0.3T contrast-enhanced MRI and radiography (RX) of their dominant hand. Structural lesions were scored according to the OMERACT Hand Osteoarthritis MRI Scoring System as follows: osteophytes and erosions were graded from 0 to 3. On joint destruction lesion synovitis and BMLs were graded from 0 to 1. And on MRI, we evaluated the presence of several structural features: N: normal, O: osteophytic lesions, E: erosive lesions, E/O: osteophytic and erosive lesions and D: joint destruction. RX was scored according to the VV system. Relations between MRI features and VV stages were analysed. Results MRI identified more structural lesions than RX (77.3% versus 74.8%) and particularly more erosive lesions (E or E/O) than VV Phase E (33.5% versus 20.2%). E/O and D were mostly found on MRI. Synovitis and BMLs were significantly associated with E/O and D with the following odds ratios (ORs): 8.4 (95% CI 1.8-13.6); OR: 13.7 (95% CI 2.9-21.0); OR: 15.7 (95% CI 3.2-23.5); OR: 38.5 (95% CI 9.5-57.0), respectively. Conclusion MRI 0.3T appears completely relevant for EHOA lesion analysis. First, MRI shows more erosive lesions than RX in EHOA; second, it allows for the analysis of synovitis and BMLs to be associated with more specific structural MRI features (E/O and D).	[Allado, Edem; Chary-Valckenaere, Isabelle; Loeuille, Damien] Univ Hosp Nancy, Dept Rheumatol, Nancy, France; [Allado, Edem] Univ Hosp Nancy, Dept Pulm Funct Testing & Exercise Physiol, Nancy, France; [Allado, Edem] Univ Lorraine, Dev Adaptat & Disadvantage, Cardioresp Regulat & Motor Control EA DevAH 3450, Nancy, France; [Wittoek, Ruth] Univ Ghent, Dept Rheumatol, Fac Med & Hlth Sci, Lab Mol Immunol & Inflammat, Ghent, Belgium; [Ferrero, Stephanie; Roux, Christian] Univ Cote dAzur, Dept Rheumatol, Nice Hosp, Lab LAMHESS,IBV CNRS IMR INSERM UNS,EA6312, Nice, France; [Albuisson, Eliane] Univ Hosp Nancy, PARC, Pole S2R, Nancy, France; [Albuisson, Eliane] Univ Lorraine, InSciDens, Nancy, France; [Albuisson, Eliane] CNRS, Inst Elie Cartan Lorraine, UMR, Nancy, France	CHU de Nancy; Universite de Lorraine; CHU de Nancy; Universite de Lorraine; Universite de Lorraine; Ghent University; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU de Nancy; Universite de Lorraine; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Allado, E (corresponding author), Univ Hosp Nancy, Dept Rheumatol, Nancy, France.; Allado, E (corresponding author), Univ Hosp Nancy, Dept Pulm Funct Testing & Exercise Physiol, Nancy, France.; Allado, E (corresponding author), Univ Lorraine, Dev Adaptat & Disadvantage, Cardioresp Regulat & Motor Control EA DevAH 3450, Nancy, France.	e.allado@chru-nancy.fr		ALLADO, Edem/0000-0002-1760-6979	"Clinical Research Hospital Program" from the French Ministry of Health	"Clinical Research Hospital Program" from the French Ministry of Health	This work was supported by a grant from the "Clinical Research Hospital Program" from the French Ministry of Health obtained by Pr ch roux.	Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; [Anonymous], 2017, PLASMONICS, V12, P1; Bijsterbosch J, 2011, ANN RHEUM DIS, V70, P1465, DOI 10.1136/ard.2010.143479; Conaghan PG, 2008, BRIT MED J, V336, P502, DOI 10.1136/bmj.39490.608009.AD; Grainger AJ, 2007, SKELETAL RADIOL, V36, P737, DOI 10.1007/s00256-007-0287-5; Haugen IK, 2016, OSTEOARTHR CARTILAGE, V24, P647, DOI 10.1016/j.joca.2015.11.014; Haugen IK, 2013, OSTEOARTHR CARTILAGE, V21, P1191, DOI 10.1016/j.joca.2013.04.004; Haugen IK, 2016, ANN RHEUM DIS, V75, P117, DOI 10.1136/annrheumdis-2014-205949; Haugen IK, 2014, J RHEUMATOL, V41, P386, DOI 10.3899/jrheum.131086; Haugen IK, 2012, ANN RHEUM DIS, V71, P345, DOI 10.1136/annrheumdis-2011-200028; Haugen IK, 2011, ANN RHEUM DIS, V70, P1033, DOI 10.1136/ard.2010.144527; Haugen IK, 2017, RHEUMATOLOGY, V56, P371, DOI 10.1093/rheumatology/kew419; Hunter DJ, 2015, OSTEOARTHR CARTILAGE, V23, P732, DOI 10.1016/j.joca.2015.03.003; KALLMAN DA, 1989, ARTHRITIS RHEUM, V32, P1584, DOI 10.1002/anr.1780321213; KALLMAN DA, 1990, ARTHRITIS RHEUM-US, V33, P1323, DOI 10.1002/art.1780330904; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kloppenburg M, 2019, ANN RHEUM DIS, V78, P16, DOI 10.1136/annrheumdis-2018-213826; Kortekaas MC, 2015, J RHEUMATOL, V42, P1224, DOI 10.3899/jrheum.140338; Kortekaas MC, 2013, ANN RHEUM DIS, V72, P930, DOI 10.1136/annrheumdis-2012-201458; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Maheu E, 2007, ANN RHEUM DIS, V66, P464, DOI 10.1136/ard.2006.060277; Mathiessen A, 2016, ANN RHEUM DIS, V75, P825, DOI 10.1136/annrheumdis-2015-207241; Mathiessen A, 2013, ANN RHEUM DIS, V72, P51, DOI 10.1136/annrheumdis-2011-201195; Michou L., 2011, REV RHUM, V78, P134, DOI [10.1016/j.rhum.2010.08.002, DOI 10.1016/J.RHUM.2010.08.002]; Persson MSM, 2018, RHEUMATOLOGY, V57, P1830, DOI 10.1093/rheumatology/key131; Poole JL, 2011, ARTHRIT CARE RES, V63, pS189, DOI 10.1002/acr.20631; Punzi L, 2004, BEST PRACT RES CL RH, V18, P739, DOI 10.1016/j.berh.2004.05.010; Punzi L, 2010, BEST PRACT RES CL RH, V24, P301, DOI 10.1016/j.berh.2009.12.007; Ramonda R, 2016, CLIN RHEUMATOL, V35, P2079, DOI 10.1007/s10067-016-3303-0; Slatkowsky-Christensen B, 2007, ARTHRIT RHEUM-ARTHR, V57, P1404, DOI 10.1002/art.23079; Tan AL, 2006, ARTHRITIS RHEUM-US, V54, P1328, DOI 10.1002/art.21736; Verbruggen G, 1996, ARTHRITIS RHEUM, V39, P308, DOI 10.1002/art.1780390221; Vlychou M, 2013, CLIN RHEUMATOL, V32, P755, DOI 10.1007/s10067-013-2166-x; Zhang W, 2007, ANN RHEUM DIS, V66, P377, DOI 10.1136/ard.2006.062091	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234972	10.1371/journal.pone.0234972	http://dx.doi.org/10.1371/journal.pone.0234972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574222	Green Published, gold			2022-12-27	WOS:000544972400046
J	Gulamhussene, G; Joeres, F; Rak, M; Pech, M; Hansen, C				Gulamhussene, Gino; Joeres, Fabian; Rak, Marko; Pech, Maciej; Hansen, Christian			4D MRI: Robust sorting of free breathing MRI slices for use in interventional settings	PLOS ONE			English	Article							RESPIRATORY MOTION; IMAGE; 4D-MRI; RECONSTRUCTION; ACQUISITIONS	Purpose We aim to develop a robust 4D MRI method for large FOVs enabling the extraction of irregular respiratory motion that is readily usable with all MRI machines and thus applicable to support a wide range of interventional settings. Method We propose a 4D MRI reconstruction method to capture an arbitrary number of breathing states. It uses template updates in navigator slices and search regions for fast and robust vessel cross-section tracking. It captures FOVs of 255 mm x 320 mm x 228 mm at a spatial resolution of 1.82 mm x 1.82 mm x 4mm and temporal resolution of 200ms. A total of 37 4D MRIs of 13 healthy subjects were reconstructed to validate the method. A quantitative evaluation of the reconstruction rate and speed of both the new and baseline method was performed. Additionally, a study with ten radiologists was conducted to assess the subjective reconstruction quality of both methods. Results Our results indicate improved mean reconstruction rates compared to the baseline method (79.4% vs. 45.5%) and improved mean reconstruction times (24s vs. 73s) per subject. Interventional radiologists perceive the reconstruction quality of our method as higher compared to the baseline (262.5 points vs. 217.5 points, p = 0.02). Conclusions Template updates are an effective and efficient way to increase 4D MRI reconstruction rates and to achieve better reconstruction quality. Search regions reduce reconstruction time. These improvements increase the applicability of 4D MRI as a base for seamless support of interventional image guidance in percutaneous interventions.	[Gulamhussene, Gino; Joeres, Fabian; Rak, Marko; Hansen, Christian] Otto von Guericke Univ, Fac Comp Sci, Magdeburg, Germany; [Pech, Maciej] Univ Hosp Magdeburg, Clin Radiol & Nucl Med, Magdeburg, Germany	Otto von Guericke University; University Hospital Magdeburg	Hansen, C (corresponding author), Otto von Guericke Univ, Fac Comp Sci, Magdeburg, Germany.	hansen@isg.cs.uni-magdeburg.de		Gulamhussene, Gino/0000-0003-0026-0032; Hansen, Christian/0000-0002-5734-7529; Joeres, Fabian/0000-0001-8105-9263	Investitionsbank Sachsen-Anhalt [1704/00038]	Investitionsbank Sachsen-Anhalt	This study was supported by funding from the Investitionsbank Sachsen-Anhalt (https://www.ib-sachsen-anhalt.de/) to GG with the grant number 1704/00038. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Barth M, 2016, MAGN RESON MED, V75, P63, DOI 10.1002/mrm.25897; Bled E, 2011, CONTRAST MEDIA MOL I, V6, P275, DOI 10.1002/cmmi.429; Bradski G., 2000, DOBBS J SOFTWARE TOO; Cai J, 2011, MED PHYS, V38, P6384, DOI 10.1118/1.3658737; Celicanin Z, 2015, MAGN RESON MED, V73, P669, DOI 10.1002/mrm.25134; Colvill E, 2016, RADIOTHER ONCOL, V119, P159, DOI 10.1016/j.radonc.2016.03.006; Deng ZX, 2016, MAGN RESON MED, V75, P1574, DOI 10.1002/mrm.25753; Giger A, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aaca1d; Gulamhussene G, 2D MRI LIVER SLICES, DOI [10.24352/UB.OVGU-2019-093, DOI 10.24352/UB.0VGU-2019-093]; Han F, 2018, RADIOTHER ONCOL, V127, P467, DOI 10.1016/j.radonc.2018.04.029; Han F, 2017, MED PHYS, V44, P1359, DOI 10.1002/mp.12139; Kim YC, 2014, MAGN RESON MED, V71, P1501, DOI 10.1002/mrm.24808; Lee D, 2019, J MED IMAG RADIAT ON, V63, P360, DOI 10.1111/1754-9485.12877; Merchavy S, 2016, OTOLARYNG HEAD NECK, V154, P446, DOI 10.1177/0194599815618199; Mickevicius NJ, 2017, PHYS MED BIOL, V62, P2910, DOI 10.1088/1361-6560/aa54f2; Pang J, 2016, INT J RADIAT ONCOL, V96, pS62, DOI 10.1016/j.ijrobp.2016.06.160; Preiswerk F, 2017, MAGN RESON MED, V78, P897, DOI 10.1002/mrm.26467; Rank CM, 2017, MAGN RESON MED, V77, P1170, DOI 10.1002/mrm.26206; Romaguera LV, 2019, INT J COMPUTER ASSIS, P1; Stemkens B, 2015, INT J RADIAT ONCOL, V91, P571, DOI 10.1016/j.ijrobp.2014.10.050; Tong Y, 2017, MED IMAGE ANAL, V35, P345, DOI 10.1016/j.media.2016.08.001; von Siebenthal M, 2007, PHYS MED BIOL, V52, P1547, DOI 10.1088/0031-9155/52/6/001; von Siebenthal M, 2005, LECT NOTES COMPUT SC, V3750, P336, DOI 10.1007/11566489_42	23	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235175	10.1371/journal.pone.0235175	http://dx.doi.org/10.1371/journal.pone.0235175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569335	Green Published, gold, Green Submitted			2022-12-27	WOS:000543547900024
J	Hou, JH; Yang, XC; Chen, CM				Hou, Jianhua; Yang, Xiucai; Chen, Chaomei			Measuring researchers' potential scholarly impact with structural variations: Four types of researchers in information science (1979-2018)	PLOS ONE			English	Article							AUTHOR COCITATION; SCIENTIFIC COLLABORATION; CITATION ANALYSIS; SELF-CITATIONS; CO-AUTHORSHIP; ALTMETRICS; PRODUCTIVITY; INDICATORS; WEB; VISIBILITY	We propose a method to measure the potential scholarly impact of researchers based on network structural variations they introduced to the underlying author co-citation network of their field. We applied the method to the information science field based on 91,978 papers published between 1979 and 2018 from the Web of Science. We divided the entire period into eight consecutive intervals and measured structural variation change rates (Delta M) of individual authors in corresponding author co-citation networks. Four types of researchers are identified in terms of temporal dynamics of their potential scholarly impact-1) Increasing, 2) Decreasing, 3) Sustained, and 4) Transient. The study contributes to the understanding of how researchers' scholarly impact might evolve in a broad context of the corresponding research community. Specifically, this study illustrated a crucial role played by structural variation metrics in measuring and explaining the potential scholarly impact of a researcher. This method based on the structural variation analysis offers a theoretical framework and a practical platform to analyze the potential scholarly impact of researchers and their specific contributions.	[Hou, Jianhua] Sun Yat Sen Univ, Sch Informat Management, Guangzhou, Guangdong, Peoples R China; [Yang, Xiucai] Dalian Univ, Coll Econ & Management, Dalian Econ Technol Dev Zone, Dalian, Peoples R China; [Chen, Chaomei] Drexel Univ, Coll Comp & Informat, Philadelphia, PA 19104 USA; [Chen, Chaomei] Yonsei Univ, Dept Informat Sci, Seoul, South Korea	Sun Yat Sen University; Dalian University; Drexel University; Yonsei University	Hou, JH (corresponding author), Sun Yat Sen Univ, Sch Informat Management, Guangzhou, Guangdong, Peoples R China.	houjh5@mail.sysu.edu.cn	Chen, Chaomei/A-1252-2007	Chen, Chaomei/0000-0001-8584-1041	SciSIP Program of the National Science Foundation [1633286]; National Social Science Foundation of China [17BGL031]	SciSIP Program of the National Science Foundation; National Social Science Foundation of China	This study was funded by the SciSIP Program of the National Science Foundation (1633286) to Chaomei Chen and National Social Science Foundation of China (17BGL031) to Dr. Jianhua Hou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajiferuke I, 2010, SCIENTOMETRICS, V83, P623, DOI 10.1007/s11192-009-0127-6; [Anonymous], 1989, IRAN US CL TRIB REP, V15, P189; Ronda-Pupo GA, 2016, J ASSOC INF SCI TECH, V67, P2565, DOI 10.1002/asi.23575; Barnes C, 2015, AUST ACAD RES LIBR, V46, P121, DOI 10.1080/00048623.2014.1003174; BEAVER DD, 1979, SCIENTOMETRICS, V1, P133, DOI 10.1007/BF02016966; Bollen J, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006022, 10.1371/journal.pone.0004803]; Bornmann L, 2008, J DOC, V64, P45, DOI 10.1108/00220410810844150; Bornmann L, 2019, J INFORMETR, V13, P325, DOI 10.1016/j.joi.2019.01.008; Bornmann L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197133; Bornmann L, 2014, J INFORMETR, V8, P895, DOI 10.1016/j.joi.2014.09.005; Bornmann L, 2013, J INFORMETR, V7, P286, DOI 10.1016/j.joi.2012.12.003; Brandao LC, 2019, EUR J OPER RES, V276, P357, DOI 10.1016/j.ejor.2018.12.033; Chen C., 2017, REPRESENTING SCI KNO, P139, DOI 10.1007/978-3-319-62543-0; Chen CM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223994; Chen Chaomei, 2018, Journal of Information Management, V6, P6, DOI 10.1633/JISTaP.2018.6.2.1; Chen CM, 2018, J INFORMETR, V12, P158, DOI 10.1016/j.joi.2017.12.004; Chen CM, 2017, J DATA INFO SCI, V2, P1, DOI 10.1515/jdis-2017-0006; Chen CM, 2012, J AM SOC INF SCI TEC, V63, P431, DOI 10.1002/asi.21694; Chen CM, 2010, J AM SOC INF SCI TEC, V61, P1386, DOI 10.1002/asi.21309; Chen CM, 2009, J INFORMETR, V3, P191, DOI 10.1016/j.joi.2009.03.004; Chen CM, 2006, J AM SOC INF SCI TEC, V57, P359, DOI 10.1002/asi.20317; Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100; Contandriopoulos D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161281; Copiello S, 2019, LEARN PUBL, V32, P249, DOI 10.1002/leap.1235; Corley EA, 2010, PUBLIC ADMIN, V88, P627, DOI 10.1111/j.1467-9299.2010.01830.x; Costas R, 2015, J ASSOC INF SCI TECH, V66, P2003, DOI 10.1002/asi.23309; Cronin B, 1998, J AM SOC INFORM SCI, V49, P1319, DOI 10.1002/(SICI)1097-4571(1998)49:14<1319::AID-ASI9>3.0.CO;2-W; CRONIN B, 1994, J AM SOC INFORM SCI, V45, P61, DOI 10.1002/(SICI)1097-4571(199403)45:2<61::AID-ASI1>3.0.CO;2-F; Della Sala S, 2009, CORTEX, V45, P911, DOI 10.1016/j.cortex.2009.04.002; Desrochers N, 2018, SOC SCI INFORM, V57, P223, DOI 10.1177/0539018417752089; Ding WW, 2010, MANAGE SCI, V56, P1439, DOI 10.1287/mnsc.1100.1195; Duque RB, 2005, SOC STUD SCI, V35, P755, DOI 10.1177/0306312705053048; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Erdt M, 2016, SCIENTOMETRICS, V109, P1117, DOI 10.1007/s11192-016-2077-0; Fowler JH, 2007, SCIENTOMETRICS, V72, P427, DOI 10.1007/s11192-007-1777-2; Franceschet M, 2010, J INFORMETR, V4, P540, DOI 10.1016/j.joi.2010.06.003; Galvez RH, 2017, SCIENTOMETRICS, V111, P1801, DOI 10.1007/s11192-017-2330-1; Garfield E, 1999, CAN MED ASSOC J, V161, P979; GARFIELD E, 1963, AM DOC, V14, P195, DOI 10.1002/asi.5090140304; Garfield E., 1962, ESSAYS INFORM SCI, V1, P84; Gauffriau M, 2008, SCIENTOMETRICS, V77, P147, DOI 10.1007/s11192-007-1934-2; Glanzel W, 2004, SCIENTOMETRICS, V59, P63, DOI 10.1023/B:SCIE.0000013299.38210.74; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hou H.J., 2019, CURRENT SCI, V116, P422; Hsu JW, 2011, SCIENTOMETRICS, V86, P317, DOI 10.1007/s11192-010-0265-x; Ibekwe-SanJuan F., 2009, PROC AM SOC INF SCI, V46, P1, DOI [10.1002/meet.2009.1450460227, DOI 10.1002/MEET.2009.1450460227]; Jin BH, 2007, CHINESE SCI BULL, V52, P855, DOI 10.1007/s11434-007-0145-9; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Ke WM, 2013, SCIENTOMETRICS, V94, P981, DOI 10.1007/s11192-012-0787-5; Klavans R., 2009, P INT C SCIENT INF R; Klavans R, 2011, J AM SOC INF SCI TEC, V62, P1, DOI 10.1002/asi.21444; Lee S, 2005, SOC STUD SCI, V35, P673, DOI 10.1177/0306312705052359; Leydesdorff L, 2011, J AM SOC INF SCI TEC, V62, P2133, DOI 10.1002/asi.21609; Li XM, 2012, SCIENTOMETRICS, V91, P461, DOI 10.1007/s11192-011-0580-x; Liu XM, 2005, INFORM PROCESS MANAG, V41, P1462, DOI 10.1016/j.ipm.2005.03.012; Ortega JL, 2019, ASLIB J INFORM MANAG, V71, P124, DOI 10.1108/AJIM-06-2018-0153; MACROBERTS MH, 1989, J AM SOC INFORM SCI, V40, P342, DOI 10.1002/(SICI)1097-4571(198909)40:5<342::AID-ASI7>3.0.CO;2-U; Moed H. F., 2017, APPLIE DEVALUATIVE I; Moed HF, 2015, J ASSOC INF SCI TECH, V66, P1988, DOI 10.1002/asi.23314; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016131; Nuzzolese AG, 2019, SCIENTOMETRICS, V118, P539, DOI 10.1007/s11192-018-2988-z; Phelan TJ, 1999, SCIENTOMETRICS, V45, P117, DOI 10.1007/BF02458472; Ravenscroft J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173152; Rodriguez MA, 2008, J INFORMETR, V2, P195, DOI 10.1016/j.joi.2008.04.002; Rousseau R, 2012, J AM SOC INF SCI TEC, V63, P416, DOI 10.1002/asi.21684; Shibata N, 2007, J AM SOC INF SCI TEC, V58, P872, DOI 10.1002/asi.20529; SMITH LC, 1981, LIBR TRENDS, V30, P83; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; Thelwall M, 2015, PROF INFORM, V24, P587, DOI 10.3145/epi.2015.sep.08; Thelwall M, 2015, PROF INFORM, V24, P607, DOI 10.3145/epi.2015.sep.09; Timilsina M, 2016, PROCEEDINGS OF THE 2016 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING ASONAM 2016, P1388, DOI 10.1109/ASONAM.2016.7752425; Uddin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057546; WHITE HD, 1981, J AM SOC INFORM SCI, V32, P163, DOI 10.1002/asi.4630320302; White HD, 1998, J AM SOC INFORM SCI, V49, P327, DOI 10.1002/(SICI)1097-4571(19980401)49:4<327::AID-ASI4>3.0.CO;2-W; White MD, 1997, LIBR QUART, V67, P122, DOI 10.1086/629929; Yan EJ, 2010, SCIENTOMETRICS, V83, P115, DOI 10.1007/s11192-009-0027-9; Yan EJ, 2009, J AM SOC INF SCI TEC, V60, P2107, DOI 10.1002/asi.21128; Yang SL, 2016, J INFORMETR, V10, P132, DOI 10.1016/j.joi.2015.12.003; Yang SL, 2015, J INFORMETR, V9, P208, DOI 10.1016/j.joi.2015.01.001; Ynalvez MA, 2011, RES POLICY, V40, P204, DOI 10.1016/j.respol.2010.10.004; Zhang X, 2019, SCIENTOMETRICS, V119, P1311, DOI 10.1007/s11192-019-03088-x; Zhao DZ, 2008, J AM SOC INF SCI TEC, V59, P2070, DOI 10.1002/asi.20910; Zhao DZ, 2008, J INFORMETR, V2, P229, DOI 10.1016/j.joi.2008.05.004; Zhao DZ, 2008, J AM SOC INF SCI TEC, V59, P916, DOI 10.1002/asi.20799; Zhao DZ, 2014, J ASSOC INF SCI TECH, V65, P995, DOI 10.1002/asi.23027	87	8	9	7	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234347	10.1371/journal.pone.0234347	http://dx.doi.org/10.1371/journal.pone.0234347			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569295	Green Published, gold			2022-12-27	WOS:000543547900048
J	Park, S; Moon, S; Pai, H; Kim, B				Park, Seonghun; Moon, Shinje; Pai, Hyunjoo; Kim, Bongyoung			Appropriate duration of peripherally inserted central catheter maintenance to prevent central line-associated bloodstream infection	PLOS ONE			English	Article							CENTRAL VENOUS CATHETERS; GUIDELINES; RISK	Background/aim Prolonged maintenance of central venous catheters, including peripherally inserted central catheters (PICCs), is a major risk factor for central line-associated bloodstream infection (CLABSI). This study was conducted to evaluate the appropriate duration of PICC maintenance to prevent CLABSI. Methods A single-center retrospective study was conducted at an 824-bed tertiary hospital in Korea between January 2010 and December 2017. All hospitalized patients who underwent ultrasound-guided PICC insertion were enrolled. CLABSI was diagnosed according to the definitions of the National Health Safety Network. CLABSI caused by PICC was defined as PICC-associated bloodstream infection (PABSI). To identifying statistical correlations between catheter days and PABSI, the odds ratio for PABSI on the basis of the continuous value of catheter days was analyzed using restricted cubic spline splits with five knots. The optimal cut-off value for catheter days was identified by maximizing the area under the receiver operating characteristic (ROC) curve (AUC). Results A total of 1,053 patients underwent ultrasound-guided PICC insertion during the study period. Among them, 36 were confirmed as having a PABSI (3.5%, 36/1014; 1.14 per 1000 catheter days). In the restricted cubic spline regression, catheter days showed a dose-dependent relationship with the risk of PABSI. The AUC of the ROC curve for developing a PABSI according to the duration of catheter maintenance was 0.715 (95% CI, 0.639-0.790); the calculated optimal cut-off value was 25 days. Conclusion The incidence of PABSI was 1.14 per 1000 catheter days and the optimal cut-off value of catheter days to avoid a PABSI was 25 days.	[Park, Seonghun] Hanyang Univ, Coll Med, Sch Med, Seoul, South Korea; [Moon, Shinje] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea; [Pai, Hyunjoo; Kim, Bongyoung] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Hanyang University; Hallym University; Hanyang University	Kim, B (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	sobakas@hanyang.ac.kr	Kim, Bongyoung/H-3409-2018	Kim, Bongyoung/0000-0002-5029-6597				Chopra V, 2015, ANN INTERN MED, V163, pS1, DOI 10.7326/M15-0744; Chopra V, 2014, AM J MED, V127, P319, DOI 10.1016/j.amjmed.2014.01.001; Chopra V, 2013, INFECT CONT HOSP EP, V34, P908, DOI 10.1086/671737; Chopra V, 2013, J HOSP MED, V8, P309, DOI 10.1002/jhm.2031; COBB DK, 1992, NEW ENGL J MED, V327, P1062, DOI 10.1056/NEJM199210083271505; EYER S, 1990, CRIT CARE MED, V18, P1073, DOI 10.1097/00003246-199010000-00005; Fallouh N, 2015, AM J MED, V128, P722, DOI 10.1016/j.amjmed.2015.01.027; Frykholm P, 2014, ACTA ANAESTH SCAND, V58, P508, DOI 10.1111/aas.12295; Gahlot Rupam, 2014, Int J Crit Illn Inj Sci, V4, P162, DOI 10.4103/2229-5151.134184; GIL RT, 1989, ARCH INTERN MED, V149, P1139, DOI 10.1001/archinte.149.5.1139; Johansson E, 2013, ACTA ONCOL, V52, P886, DOI 10.3109/0284186X.2013.773072; LOUGHRAN SC, 1995, JPEN-PARENTER ENTER, V19, P133, DOI 10.1177/0148607195019002133; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; Safdar N, 2005, CHEST, V128, P489, DOI 10.1378/chest.128.2.489; Seo HK, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e280	17	6	8	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234966	10.1371/journal.pone.0234966	http://dx.doi.org/10.1371/journal.pone.0234966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569313	Green Published, gold			2022-12-27	WOS:000543547900022
J	Rivera, JN; Kierski, TM; Kasoji, SK; Abrantes, AS; Dayton, PA; Chang, SX				Rivera, Judith N.; Kierski, Thomas M.; Kasoji, Sandeep K.; Abrantes, Anthony S.; Dayton, Paul A.; Chang, Sha X.			Conventional dose rate spatially-fractionated radiation therapy (SFRT) treatment response and its association with dosimetric parameters-A preclinical study in a Fischer 344 rat model	PLOS ONE			English	Article							SYNCHROTRON MICROBEAM; RADIOTHERAPY; FEASIBILITY; IRRADIATION	Purpose To identify key dosimetric parameters that have close associations with tumor treatment response and body weight change in SFRT treatments with a large range of spatial-fractionation scale at dose rates of several Gy/min. Methods Six study arms using uniform tumor radiation, half-tumor radiation, 2mm beam array radiation, 0.3mm minibeam radiation, and an untreated arm were used. All treatments were delivered on a 320kV x-ray irradiator. Forty-two female Fischer 344 rats with fibrosarcoma tumor allografts were used. Dosimetric parameters studied are peak dose and width, valley dose and width, peak-to-valley-dose-ratio (PVDR), volumetric average dose, percentage volume directly irradiated, and tumor- and normal-tissue EUD. Animal survival, tumor volume change, and body weight change (indicative of treatment toxicity) are tested for association with the dosimetric parameters using linear regression and Cox Proportional Hazards models. Results The dosimetric parameters most closely associated with tumor response are tumor EUD (R-2= 0.7923, F-stat = 15.26*; z-test = -4.07***), valley (minimum) dose (R-2= 0.7636, F-stat = 12.92*; z-test = -4.338***), and percentage tumor directly irradiated (R-2= 0.7153, F-stat = 10.05*; z-test = -3.837***) per the linear regression and Cox Proportional Hazards models, respectively. Tumor response is linearly proportional to valley (minimum) doses and tumor EUD. Average dose (R-2= 0.2745, F-stat = 1.514 (no sig.); z-test = -2.811**) and peak dose (R-2= 0.04472, F-stat = 0.6874 (not sig.); z-test = -0.786 (not sig.)) show the weakest associations to tumor response. Only the uniform radiation arm did not gain body weight post-radiation, indicative of treatment toxicity; however, body weight change in general shows weak association with all dosimetric parameters except for valley (minimum) dose (R-2= 0.3814, F-stat = 13.56**), valley width (R-2= 0.2853, F-stat = 8.783**), and peak width (R-2= 0.2759, F-stat = 8.382**). Conclusions For a single-fraction SFRT at conventional dose rates, valley, not peak, dose is closely associated with tumor treatment response and thus should be used for treatment prescription. Tumor EUD, valley (minimum) dose, and percentage tumor directly irradiated are the top three dosimetric parameters that exhibited close associations with tumor response.	[Rivera, Judith N.; Kierski, Thomas M.; Kasoji, Sandeep K.; Dayton, Paul A.; Chang, Sha X.] Joint Program Univ North Carolina Chapel Hill & N, Dept Biomed Engn, Chapel Hill, NC 27515 USA; [Abrantes, Anthony S.] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27515 USA; [Chang, Sha X.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chang, SX (corresponding author), Joint Program Univ North Carolina Chapel Hill & N, Dept Biomed Engn, Chapel Hill, NC 27515 USA.; Chang, SX (corresponding author), Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27515 USA.	sha_chang@med.unc.edu						Allison M, 2010, NY TIMES BK REV, P5; [Anonymous], 2014, EARLY HUM DEV S1, V90, pS35; [Anonymous], [No title captured]; [Anonymous], 2015, AM J PHARM BENEFITS, V7, pe141; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Bazyar S, 2017, PHYS MED BIOL, V62, P8924, DOI 10.1088/1361-6560/aa926b; Billena C, 2019, INT J RADIAT ONCOL, V104, P177, DOI 10.1016/j.ijrobp.2019.01.073; Bouchet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081874; Brauer-Krisch E, 2010, MUTAT RES-REV MUTAT, V704, P160, DOI 10.1016/j.mrrev.2009.12.003; Bravin A, 2015, PHYS MEDICA, V31, P561, DOI 10.1016/j.ejmp.2015.06.002; Chang SX, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-5051; Dilmanian FA, 2015, INT J RADIAT ONCOL, V92, P469, DOI 10.1016/j.ijrobp.2015.01.018; Eling L, 2019, RADIOTHER ONCOL, V139, P56, DOI 10.1016/j.radonc.2019.06.030; Faustino-Rocha A, 2013, LAB ANIMAL, V42, P217, DOI 10.1038/laban.254; Favaudon V, 2015, CANCER RADIOTHER, V19, P526, DOI 10.1016/j.canrad.2015.04.006; Fontanella AN, 2015, RAD RES, P183; Gessner RC, 2013, INT JURNAL BIOMEDICA, V2013, DOI [10.1155/2013/154860, DOI 10.1155/2013/154860]; Ha JK, 2006, MED PHYS, V33, P76, DOI 10.1118/1.2140116; Hickman DL, 2010, J AM ASSOC LAB ANIM, V49, P155; Ibahim MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100547; Kasoji SK, 2018, THERANOSTICS, V8, P156, DOI 10.7150/thno.19703; Kutner M., 2005, APPL LINEAR STAT MOD; Laissue JA, 2012, Z MED PHYS, V22, P90, DOI 10.1016/j.zemedi.2011.07.002; Martinez-Rovira I, 2017, MED PHYS, V44, P4223, DOI 10.1002/mp.12383; Mavroidis P, 2001, PHYS MED BIOL, V46, P2607, DOI 10.1088/0031-9155/46/10/307; Montay-Gruel P, 2018, RADIOTHER ONCOL, V129, P582, DOI 10.1016/j.radonc.2018.08.016; Narayanasamy G, 2017, ACTA ONCOL, V56, P1043, DOI 10.1080/0284186X.2017.1299219; Neuner G, 2012, INT J RADIAT ONCOL, V82, P1642, DOI 10.1016/j.ijrobp.2011.01.065; Niemierko A, 1997, MED PHYS, V24, P103, DOI 10.1118/1.598063; Piccolo R, 2017, CATHETER CARDIOVASC, V90, pE73, DOI 10.1002/ccd.26921; Prezado Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17543-3; Prezado Y, 2015, RADIAT RES, V184, P314, DOI 10.1667/RR14018.1; Prezado Y, 2012, J SYNCHROTRON RADIAT, V19, P60, DOI 10.1107/S0909049511047042; Priyadarshika RCU, 2011, BRIT J RADIOL, V84, P833, DOI 10.1259/bjr/58503354; Schroeder T, 2005, CANCER RES, V65, P5163, DOI 10.1158/0008-5472.CAN-04-3900; Serduc R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009028; Serduc R, 2009, PHYS MED BIOL, V54, P6711, DOI 10.1088/0031-9155/54/21/017; Society C-SbNCITR, 2018, WORKSH UND HIGH DOS; Terahara A, 1999, INT J RADIAT ONCOL, V45, P351, DOI 10.1016/S0360-3016(99)00146-7; Wu QW, 2002, INT J RADIAT ONCOL, V52, P224, DOI 10.1016/S0360-3016(01)02585-8; Yang YQ, 2019, RADIOTHER ONCOL, V133, P93, DOI 10.1016/j.radonc.2019.01.006; Zhang X, 2013, MED INNOVATION CHINA, V9, P5	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0229053	10.1371/journal.pone.0229053	http://dx.doi.org/10.1371/journal.pone.0229053			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569277	Green Published, Green Submitted, gold			2022-12-27	WOS:000543547900033
J	Chandrashekar, DS; Golonka, RM; San Yeoh, B; Gonzalez, DJ; Heikenwalder, M; Gerwirtz, AT; Varambally, S; Vijay-Kumar, M				Chandrashekar, Darshan Shimoga; Golonka, Rachel M.; San Yeoh, Beng; Gonzalez, David J.; Heikenwaelder, Mathias; Gerwirtz, Andrew T.; Varambally, Sooryanarayana; Vijay-Kumar, Matam			Fermentable fiber-induced hepatocellular carcinoma in mice recapitulates gene signatures found in human liver cancer	PLOS ONE			English	Article							MAJOR URINARY PROTEIN; GUT-MICROBIOTA; MOUSE MODELS; IDENTIFICATION; POLYMORPHISMS; PROGRESSION; GUIDE	Hepatocellular carcinoma (HCC), the most malignant form of primary liver cancer, is the fourth most prevalent cause of cancer mortality globally. It was recently discovered that the dietary fermentable fiber, inulin, can reprogram the murine liver to favor HCC development in a gut microbiota-dependent manner. Determining the molecular pathways that are either over expressed or repressed during inulin-induced HCC would provide a platform of potential therapeutic targets. In the present study, we have combined analysis of the novel inulin-induced HCC murine model and human HCC samples to identify differentially expressed genes (DEGs) in hepatocarcinogenesis. Hepatic transcriptome profiling revealed that there were 674 DEGs in HCC mice compared to mice safeguarded from HCC. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis uncovered enrichment in ECM-receptor interaction, steroid hormone biosynthesis, PPAR signaling pathway, focal adhesion and protein digestion and absorption during inulin-induced HCC. Tandem mass tag based quantitative, multiplexed proteomic analysis delineated 57 differentially expressed proteins, where the over-expressed proteins were associated with cell adhesion molecules, valine, leucine and isoleucine degradation and ECM-receptor interaction. After obtaining the human orthologs of the mouse genes, we did a comparison analysis to level 3 RNA-seq data found in the Cancer Genome Atlas (TCGA) database, corresponding to human HCC (n = 361) and healthy liver (n = 50) samples. Out of the 549 up-regulated and 68 down-regulated human orthologs identified, 142 genes (137 significantly over-expressed and 5 significantly under-expressed) were associated with human HCC. Using univariate survival analysis, we found 27 over-expressed genes involved in cell-cell adhesion and cell division that were associated with poor HCC patient survival. Overall, the genetic and proteomics signatures highlight potential underlying mechanisms in inulin-induced HCC and support that this murine HCC model is human relevant.	[Chandrashekar, Darshan Shimoga; Varambally, Sooryanarayana] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Golonka, Rachel M.; San Yeoh, Beng; Vijay-Kumar, Matam] Univ Toledo, Dept Physiol & Pharmacol, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Gonzalez, David J.] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Gonzalez, David J.] Univ Calif San Diego, Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Heikenwaelder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, Heidelberg, Germany; [Gerwirtz, Andrew T.] Georgia State Univ, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30303 USA; [Varambally, Sooryanarayana] Univ Alabama Birmingham, Comprehens Canc Ctr, Birmingham, AL 35294 USA; [Vijay-Kumar, Matam] Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA	University of Alabama System; University of Alabama Birmingham; University System of Ohio; University of Toledo; University of California System; University of California San Diego; University of California System; University of California San Diego; Helmholtz Association; German Cancer Research Center (DKFZ); University System of Georgia; Georgia State University; University of Alabama System; University of Alabama Birmingham; University System of Ohio; University of Toledo	Varambally, S (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.; Vijay-Kumar, M (corresponding author), Univ Toledo, Dept Physiol & Pharmacol, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.; Varambally, S (corresponding author), Univ Alabama Birmingham, Comprehens Canc Ctr, Birmingham, AL 35294 USA.; Vijay-Kumar, M (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	svarambally@uabmc.edu; MatamVijay.Kumar@UToledo.edu			R01 grant from the National Institutes of Health (NIH) [CA219144]	R01 grant from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MVK is supported by R01 grant from the National Institutes of Health (NIH) [grant number CA219144]. Funders website: https://www.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhdar H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167543; [Anonymous], 2017, LANCET HIV, V2017, pPE475; Bakiri L, 2013, MOL ONCOL, V7, P206, DOI 10.1016/j.molonc.2013.01.005; Chen C, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0919-8; Chen X, 2015, CANCER SCI, V106, P972, DOI 10.1111/cas.12700; Cusato J, 2018, CANCER CHEMOTH PHARM, V81, P615, DOI 10.1007/s00280-018-3520-0; Davis-Turak J, 2017, EXPERT REV MOL DIAGN, V17, P225, DOI 10.1080/14737159.2017.1282822; Debes JD, 2019, ANN HEPATOL, V18, P786, DOI 10.1016/j.aohep.2019.07.009; Dennis G, 2003, GENOME BIOL, V4; Dow M, 2018, P NATL ACAD SCI USA, V115, pE9879, DOI 10.1073/pnas.1811029115; DRAGANI TA, 1989, MOL CARCINOGEN, V2, P355, DOI 10.1002/mc.2940020610; Elchuri S, 2007, PROTEOMICS, V7, P2121, DOI 10.1002/pmic.200601011; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fan CY, 1996, J BIOL CHEM, V271, P24698, DOI 10.1074/jbc.271.40.24698; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Golonka RM, 2020, AM J PHYSIOL-GASTR L, V318, pG955, DOI 10.1152/ajpgi.00349.2019; Hackl H, 2016, NAT REV GENET, V17, P441, DOI 10.1038/nrg.2016.67; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Hsu HT, 2014, J HEPATOCELL CARCINO, V1, P127, DOI 10.2147/JHC.S48512; Jin X, 2019, J CELL PHYSIOL, V234, P16592, DOI 10.1002/jcp.28331; Kew MC, 2013, J GASTROINTEST LIVER, V22, P305; Kraus WE, 2015, J CARDIOVASC TRANSL, V8, P449, DOI 10.1007/s12265-015-9648-y; Leung WKC, 2011, ONCOGENE, V30, P4464, DOI 10.1038/onc.2011.161; Li L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080637, 10.1371/journal.pone.0075104]; Li MJ, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0208-8; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Liu G, 2019, FASEB J, V33, P10089, DOI 10.1096/fj.201802619RR; Liu XJ, 2020, J CANCER, V11, P83, DOI 10.7150/jca.36495; Ma HP, 2019, CANCERS, V11, DOI 10.3390/cancers11060786; Marshall A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059459; Nath A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14752; Navarro VJ, 2017, HEPATOLOGY, V65, P363, DOI 10.1002/hep.28813; Newell P, 2008, J HEPATOL, V48, P858, DOI 10.1016/j.jhep.2008.01.008; Okada H, 2005, INT J ONCOL, V26, P369; Olsen LR, 2014, CANCER IMMUNOL IMMUN, V63, P1235, DOI 10.1007/s00262-014-1627-7; Rosenthal N, 2007, NAT CELL BIOL, V9, P993, DOI 10.1038/ncb437; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Schroder PC, 2011, FUNCT INTEGR GENOMIC, V11, P419, DOI 10.1007/s10142-011-0230-7; Singh V, 2018, CELL, V175, P679, DOI 10.1016/j.cell.2018.09.004; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Torres CM, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1644; Tung YT, 2017, INT J MED SCI, V14, P257, DOI 10.7150/ijms.17792; U.S. Food and Drug Administration,, 2018, DECL CERT IS SYNTH N; Uehara Takeki, 2014, Curr Protoc Pharmacol, V66, DOI 10.1002/0471141755.ph1430s66; Vandamme TF, 2014, J PHARM BIOALLIED SC, V6, P2, DOI 10.4103/0975-7406.124301; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300; Wan MLY, 2018, HEPATOBIL SURG NUTR, V7, P11, DOI 10.21037/hbsn.2017.12.07; Wang B, 2017, INT J MED SCI, V14, P880, DOI 10.7150/ijms.19620; Wang ZN, 2016, METHODS MOL BIOL, V1418, P111, DOI 10.1007/978-1-4939-3578-9_6; Xiong Y, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20182384; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Yau YK, 2013, J GASTROEN HEPATOL, V28, P1076, DOI 10.1111/jgh.12193; Yi QY, 2020, GENE, V725, DOI 10.1016/j.gene.2019.144159; Zavadil JA, 2019, MOL CARCINOGEN, V58, P309, DOI 10.1002/mc.22929; Zhou YJ, 2010, VITAM HORM, V83, P151, DOI 10.1016/S0083-6729(10)83006-7; Zhu Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0894-1; Zhu YT, 2014, NAT METHODS, V11, P599, DOI 10.1038/nmeth.2956	60	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234726	10.1371/journal.pone.0234726	http://dx.doi.org/10.1371/journal.pone.0234726			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559205	Green Published, gold			2022-12-27	WOS:000543261600025
J	Clem, CS; Sparbanie, TM; Luro, AB; Harmon-Threatt, AN				Clem, C. Scott; Sparbanie, Taylor M.; Luro, Alec B.; Harmon-Threatt, Alexandra N.			Can anthophilous hover flies (Diptera: Syrphidae) discriminate neonicotinoid insecticides in sucrose solution?	PLOS ONE			English	Article							ENVIRONMENTAL RISKS; ERISTALIS-TENAX; EXPOSURE; INSECTS; POLLEN; COLORS; PLANTS; CROPS; BEES	Understanding how neonicotinoid insecticides affect non-target arthropods, especially pollinators, is an area of high priority and popular debate. Few studies have considered how pollinators interact and detect neonicotinoids, and almost none have examined for these effects in anthophilous Diptera such as hover flies (Syrphidae). We investigated behavioral responses of two species of hover flies,Eristalis arbustorumL. (Eristalinae) andToxomerus marginatusSay (Syrphinae), when given a choice between artificial flowers with uncontaminated sucrose solution and neonicotinoid-contaminated (clothianidin) sucrose solution at field-realistic levels 2.5 ppb (average) and 150 ppb (high). We examined for 1) evidence that wild-caught flies could detect the insecticide gustatorily by analyzing amount of time spent feeding on floral treatments, and 2) whether flies could discriminate floral treatments visually by comparing visitation rates, spectral reflectance differences, and hover fly photoreceptor sensitivities. We did not find evidence that either species fed more or less on either of the treatment solutions. Furthermore,T.marginatusdid not appear to visit one of the flower choices over the other.Eristalis arbustorum, however, visited uncontaminated flowers more often than contaminated flowers. Spectral differences between the flower treatments overlap withEristalisphotoreceptor sensitivities, opening the possibility thatE.arbustorumcould discriminate sucrose-clothianidin solution visually. The relevance of our findings in field settings are uncertain but they do highlight the importance of visual cues in lab-based choice experiments involving insecticides. We strongly encourage further research in this area and the consideration of both behavioral responses and sensory mechanisms when determining insecticidal impacts on beneficial arthropods.	[Clem, C. Scott; Harmon-Threatt, Alexandra N.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Sparbanie, Taylor M.] Ohio Univ, Environm & Plant Biol Dept, Athens, OH 45701 USA; [Luro, Alec B.] Univ Illinois, Dept Evolut Ecol & Behav, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University System of Ohio; Ohio University; University of Illinois System; University of Illinois Urbana-Champaign	Clem, CS (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	carlc2@illinois.edu	Clem, Scott/AFH-2758-2022	Clem, Scott/0000-0001-9104-193X; Sparbanie, Taylor/0000-0002-1261-4689	USDA NIFA EWD [2019-67011-29504]; USDA [2018-67013-27537]; U.S. Department of Education Graduates Assistance in Areas of Need Fellowship through the University of Illinois School of Integrative Biology	USDA NIFA EWD; USDA(United States Department of Agriculture (USDA)); U.S. Department of Education Graduates Assistance in Areas of Need Fellowship through the University of Illinois School of Integrative Biology	Funding to CSC provided by USDA NIFA EWD grant 2019-67011-29504. Funding to AHT and TS by USDA grant 2018-67013-27537. Funding to CSC and ABL also provided by the U.S. Department of Education Graduates Assistance in Areas of Need Fellowship through the University of Illinois School of Integrative Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovic BF, 2010, CHEMOSPHERE, V81, P114, DOI 10.1016/j.chemosphere.2010.07.016; An LN, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.184788; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2013, TEXTS STAT SCI SERIE; [Anonymous], INSECTS ARACHNIDS 18; Arce AN, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0655; Arnold SEJ, 2009, ARTHROPOD-PLANT INTE, V3, P27, DOI 10.1007/s11829-009-9056-9; Basley K, 2018, PEERJ, V6, DOI 10.7717/peerj.4258; BISHOP LG, 1974, J COMP PHYSIOL, V91, P267, DOI 10.1007/BF00698058; Botias C, 2016, SCI TOTAL ENVIRON, V566, P269, DOI 10.1016/j.scitotenv.2016.05.065; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Bugg R.L, 2008, AGR NATURAL RESOURCE, V8285, P1; Calvo-Agudo M, 2019, P NATL ACAD SCI USA, V116, P16817, DOI 10.1073/pnas.1904298116; Cloyd RA, 2011, PEST MANAG SCI, V67, P3, DOI 10.1002/ps.2015; Easton AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054819; Federoff NE, 2005, EFED REGISTRATION CH; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Guedes RNC, 2017, CURR OPIN INSECT SCI, V21, P47, DOI 10.1016/j.cois.2017.04.010; Hannah L, 2019, CURR ZOOL, V65, P483, DOI 10.1093/cz/zoz008; Hennemeyer M, 2008, SENSORS-BASEL, V8, P10, DOI 10.3390/s8010010; Hladik ML, 2018, ENVIRON SCI TECHNOL, V52, P3329, DOI 10.1021/acs.est.7b06388; Hladik ML, 2014, ENVIRON POLLUT, V193, P189, DOI 10.1016/j.envpol.2014.06.033; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Kruschke JK, 2018, ADV METH PRACT PSYCH, V1, P270, DOI 10.1177/2515245918771304; Larson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066375; Linnaeus C., 1753, SPECIES PLANTARUM, P968, DOI [10.5962/bhl.title.669, DOI 10.5962/BHL.TITLE.669]; Linnaeus C., 1758, SYSTEMA NATURAE REGN, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; LUNAU K, 1994, J COMP PHYSIOL A, V174, P575, DOI 10.1007/BF00217378; Lunau K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194167; Lunau K, 2014, J COMP PHYSIOL A, V200, P497, DOI 10.1007/s00359-014-0895-1; Lundin O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136928; Makowski D, 2019, INDICES EFFECT EXIST, DOI [10.31234/osf.io/2zexr, DOI 10.31234/OSF.IO/2ZEXR]; Mengual X, 2015, CLADISTICS, V31, P491, DOI 10.1111/cla.12105; Muller C, 2018, BASIC APPL ECOL, V30, P1, DOI 10.1016/j.baae.2018.05.001; Mulligan RA, 2015, PEST MANAG SCI, V71, P1419, DOI 10.1002/ps.3946; Orford KA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2934; Ottenheim MM, 1995, NETH J ZOOL, V45, P305; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Primante C, 2010, J CHEM ECOL, V36, P1207, DOI 10.1007/s10886-010-9871-6; Rader R, 2016, P NATL ACAD SCI USA, V113, P146, DOI 10.1073/pnas.1517092112; Ramsden M, 2017, AGR FOREST ENTOMOL, V19, P139, DOI 10.1111/afe.12191; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Say T., 1823, J ACAD NATURAL SCI P, V3, P9; Shrestha M, 2019, PLANT BIOLOGY, V21, P745, DOI 10.1111/plb.12968; Shrestha M, 2016, PLANT BIOLOGY, V18, P842, DOI 10.1111/plb.12456; Skevington J.H., 2019, FIELD GUIDE FLOWER F; Ssymank Axel, 2008, Biodiversity (Ottawa), V9, P86; Stan Development Team, 2019, RSTAN R INT STAN R P; Wacht S, 1996, ENTOMOL EXP APPL, V80, P50, DOI 10.1007/BF00194723; Wacht S, 2000, J COMP PHYSIOL A, V186, P193, DOI 10.1007/s003590050019	53	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234820	10.1371/journal.pone.0234820	http://dx.doi.org/10.1371/journal.pone.0234820			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559247	Green Published, gold			2022-12-27	WOS:000543261600056
J	Gnepp, J; Klayman, J; Williamson, IO; Barlas, S				Gnepp, Jackie; Klayman, Joshua; Williamson, Ian O.; Barlas, Sema			The future of feedback: Motivating performance improvement through future-focused feedback	PLOS ONE			English	Article							SELF-REGULATION; DEVELOPMENTAL FEEDBACK; PREFACTUAL THOUGHTS; MENTAL SIMULATIONS; APPRAISAL; ATTRIBUTION; MANAGEMENT; HINDSIGHT; BEHAVIOR; CONSEQUENCES	Managerial feedback discussions often fail to produce the desired performance improvements. Three studies shed light on why performance feedback fails and how it can be made more effective. In Study 1, managers described recent performance feedback experiences in their work settings. In Studies 2 and 3, pairs of managers role-played a performance review meeting. In all studies, recipients of mixed and negative feedback doubted the accuracy of the feedback and the providers' qualifications to give it. Disagreement regarding past performance was greater following the feedback discussion than before, due to feedback recipients' increased self-protective and self-enhancing attributions. Managers were motivated to improve to the extent they perceived the feedback conversation to be focused on future actions rather than on past performance. Our findings have implications for the theory and practice of performance management.	[Gnepp, Jackie] Humanly Possible Inc, Oak Pk, IL 60302 USA; [Klayman, Joshua] Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA; [Williamson, Ian O.] Victoria Univ Wellington, Wellington Sch Business & Govt, Wellington, New Zealand; [Barlas, Sema] Univ Chicago, Sci Analyt, Chicago, IL 60637 USA	University of Chicago; Victoria University Wellington; University of Chicago	Gnepp, J (corresponding author), Humanly Possible Inc, Oak Pk, IL 60302 USA.	Jackie@HumanlyPossible.com			Melbourne Business School	Melbourne Business School	This research received funding from the Melbourne Business School while the first three authors were either visiting (JG, JK) or permanent (IOW) faculty there. While working on this research, the first two authors (JG, JK) also worked as owners and employees of management consulting firm Humanly Possible. Humanly Possible provided support in the form of salaries and profit-sharing compensation for authors JG and JK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Anseel F., 2019, FEEDBACK WORK, P29, DOI [DOI 10.1007/978-3-030-30915-2, 10.1007/978-3-030-30915-2]; Audia PG, 2007, ORGAN BEHAV HUM DEC, V102, P255, DOI 10.1016/j.obhdp.2006.01.007; Bandura A., 1997, SELF EFFICACY EXERCI; BANNISTER BD, 1986, J APPL PSYCHOL, V71, P203, DOI 10.1037/0021-9010.71.2.203; Baumeister RF, 2016, REV GEN PSYCHOL, V20, P3, DOI 10.1037/gpr0000060; Breiman L., 1984, CLASSIFICATION REGRE; Buehler R, 2003, ORGAN BEHAV HUM DEC, V92, P80, DOI 10.1016/S0749-5978(03)00089-X; Campbell W. K., 1999, REV GEN PSYCHOL, V3, P23, DOI DOI 10.1037/1089-2680.3.1.23; Canning EA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4734; Cappelli P, 2016, HARVARD BUS REV, V94, P58; CARSON KP, 1991, GROUP ORGAN STUD, V16, P143, DOI 10.1177/105960119101600203; Cianci AM, 2010, J APPL PSYCHOL, V95, P618, DOI 10.1037/a0019130; Cohen GL, 1999, PERS SOC PSYCHOL B, V25, P1302, DOI 10.1177/0146167299258011; Davis AS, 1990, DEV BUSINESS SIMULAT, V17, P226; DeNisi A.S., 2006, MANAGE ORGAN REV, V2, P253, DOI DOI 10.1111/J.1740-8784.2006.00042.X; DeNisi AS, 2017, J APPL PSYCHOL, V102, P421, DOI 10.1037/apl0000085; DePaulo BM, 1996, J PERS SOC PSYCHOL, V71, P703, DOI 10.1037/0022-3514.71.4.703; Donovan JJ, 2018, J APPL SOC PSYCHOL, V48, P661, DOI 10.1111/jasp.12556; DUNNING D, 1989, J PERS SOC PSYCHOL, V57, P1082, DOI 10.1037/0022-3514.57.6.1082; Dweck CS, 2018, PSYCHOLOGY OF THINKING ABOUT THE FUTURE, P362; EISENSTADT D, 1994, J PERS SOC PSYCHOL, V67, P611, DOI 10.1037/0022-3514.67.4.611; Eisenstadt D, 2006, SELF IDENTITY, V5, P35, DOI 10.1080/15298860500348079; Epstude K, 2016, REV GEN PSYCHOL, V20, P48, DOI 10.1037/gpr0000064; Ferrante D, 2013, J EXP PSYCHOL GEN, V142, P23, DOI 10.1037/a0027947; FISCHHOFF B, 1975, J EXP PSYCHOL HUMAN, V1, P288, DOI 10.1037/0096-1523.1.3.288; GILBERT DT, 1995, PSYCHOL BULL, V117, P21, DOI 10.1037/0033-2909.117.1.21; GIOIA DA, 1986, ORGAN BEHAV HUM DEC, V37, P197, DOI 10.1016/0749-5978(86)90052-X; Goerke M, 2004, J APPL PSYCHOL, V89, P279, DOI 10.1037/0021-9010.89.2.279; Goldsmith M., 2007, WHAT GOT YOU HERE WO; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; GREEN SG, 1979, ORGAN BEHAV HUM PERF, V23, P429, DOI 10.1016/0030-5073(79)90008-4; Hart W, 2009, PSYCHOL BULL, V135, P555, DOI 10.1037/a0015701; Hattie J, 2007, REV EDUC RES, V77, P81, DOI 10.3102/003465430298487; HAWKINS SA, 1990, PSYCHOL BULL, V107, P311, DOI 10.1037/0033-2909.107.3.311; ILGEN DR, 1981, ORGAN BEHAV HUM PERF, V28, P311, DOI 10.1016/0030-5073(81)90002-7; ILGEN DR, 1980, ORGAN BEHAV HUM PERF, V25, P441, DOI 10.1016/0030-5073(80)90039-2; Ilgen DR, 2000, APPL PSYCHOL-INT REV, V49, P550, DOI 10.1111/1464-0597.00031; ILGEN DR, 1979, J APPL PSYCHOL, V64, P349, DOI 10.1037/0021-9010.64.4.349; Ilies R, 2005, J APPL PSYCHOL, V90, P453, DOI 10.1037/0021-9010.90.3.453; Itzchakov G, 2018, PERS SOC PSYCHOL B, V44, P762, DOI 10.1177/0146167217747874; Jones E. E., 1972, ATTRIBUTION PERCEIV; JONES EE, 1967, J EXP SOC PSYCHOL, V3, P1, DOI 10.1016/0022-1031(67)90034-0; Jordan AH, 2012, ACAD MANAGE REV, V37, P211, DOI 10.5465/amr.2010.0108; Kalaian HA, 1996, PSYCHOL METHODS, V1, P227, DOI 10.1037/1082-989X.1.3.227; Kenney DA, 2018, MEDIATION; Kluger AN, 1996, PSYCHOL BULL, V119, P254, DOI 10.1037/0033-2909.119.2.254; Kluger AN, 2010, HUM RESOUR MANAGE R, V20, P235, DOI 10.1016/j.hrmr.2009.08.002; Korn CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148581; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; LARRICK RP, 1993, PSYCHOL BULL, V113, P440, DOI 10.1037/0033-2909.113.3.440; LARSON JR, 1989, ACAD MANAGE REV, V14, P408, DOI 10.2307/258176; Levy PE, 2004, J MANAGE, V30, P881, DOI 10.1016/j.jm.2004.06.005; Li N, 2011, J APPL PSYCHOL, V96, P1317, DOI 10.1037/a0024029; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; Locke EA, 2006, CURR DIR PSYCHOL SCI, V15, P265, DOI 10.1111/j.1467-8721.2006.00449.x; MacGeorge E.L., 2016, COMMUNICATION YB, V40, P213, DOI [DOI 10.1080/23808985.2015.11735261, 10.1080/23808985.2015.11735261]; MADDEN TJ, 1992, PERS SOC PSYCHOL B, V18, P3, DOI 10.1177/0146167292181001; Maddux JE, 2018, PSYCHOLOGY OF THINKING ABOUT THE FUTURE, P174; MCFARLAND C, 1982, J PERS SOC PSYCHOL, V43, P937, DOI 10.1037/0022-3514.43.5.937; MILLER DT, 1975, PSYCHOL BULL, V82, P213, DOI 10.1037/h0076486; Nash RA, 2018, J EXP PSYCHOL LEARN, V44, P1864, DOI 10.1037/xlm0000549; Nowack K., 2017, PRACTICE RES, V69, P153; Nussbaum AD, 2008, PERS SOC PSYCHOL B, V34, P599, DOI 10.1177/0146167207312960; Oettingen G, 2001, J PERS SOC PSYCHOL, V80, P736, DOI 10.1037//0022-3514.80.5.736; Overall NC, 2017, CURR OPIN PSYCHOL, V13, P1, DOI 10.1016/j.copsyc.2016.03.002; PEARCE JL, 1986, J APPL PSYCHOL, V71, P211, DOI 10.1037/0021-9010.71.2.211; Pham LB, 1999, PERS SOC PSYCHOL B, V25, P250, DOI 10.1177/0146167299025002010; Porath CL, 2006, J APPL PSYCHOL, V91, P185, DOI 10.1037/0021-9010.91.1.185; Pritchard D, 2004, NEW IDEAS PSYCHOL, V22, P1, DOI 10.1016/j.newideapsych.2004.03.001; Pronin E, 2008, SCIENCE, V320, P1177, DOI 10.1126/science.1154199; Pulakos ED, 2011, IND ORGAN PSYCHOL-US, V4, P146, DOI 10.1111/j.1754-9434.2011.01315.x; Reis HT, 2018, J EXP SOC PSYCHOL, V79, P21, DOI 10.1016/j.jesp.2018.05.006; Roese NJ, 2012, PERSPECT PSYCHOL SCI, V7, P411, DOI 10.1177/1745691612454303; Ross L., 1977, ADV EXP SOC PSYCHOL, V10, P173, DOI DOI 10.1016/S0065-2601(08)60357-3; St-Pierre NR, 2001, J DAIRY SCI, V84, P741, DOI 10.3168/jds.S0022-0302(01)74530-4; STEPHAN WG, 1989, BASIC APPL SOC PSYCH, V10, P27, DOI 10.1207/s15324834basp1001_4; Thompson SC, 1999, CURR DIR PSYCHOL SCI, V8, P187, DOI 10.1111/1467-8721.00044; Thompson SC, 1998, PSYCHOL BULL, V123, P143, DOI 10.1037/0033-2909.123.2.143; Vancouver JB, 2004, J APPL PSYCHOL, V89, P1092, DOI 10.1037/0021-9010.89.6.1092; WEINER B, 1985, PSYCHOL REV, V92, P548, DOI 10.1037/0033-295X.92.4.548; Winer BJ, 1971, STATISTICAL PRINCIPL, P399; Zhou J, 2003, J APPL PSYCHOL, V88, P413, DOI 10.1037/0021-9010.88.3.413; ZUCKERMAN M, 1979, J PERS, V47, P245, DOI 10.1111/j.1467-6494.1979.tb00202.x	83	8	8	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234444	10.1371/journal.pone.0234444	http://dx.doi.org/10.1371/journal.pone.0234444			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559254	gold, Green Submitted, Green Published			2022-12-27	WOS:000543261600033
J	Ordonez, A; Eikvil, L; Salberg, AB; Harbitz, A; Murray, SM; Kampffmeyer, MC				Ordonez, Alba; Eikvil, Line; Salberg, Arnt-Borre; Harbitz, Alf; Murray, Sean Meling; Kampffmeyer, Michael C.			Explaining decisions of deep neural networks used for fish age prediction	PLOS ONE			English	Article							GREENLAND HALIBUT; OTOLITHS	Age-reading of fish otoliths (ear stones) is important for the sustainable management of fish resources. However, the procedure is challenging and requires experienced readers to carefully examine annual growth zones. In a recent study, convolutional neural networks (CNNs) have been demonstrated to perform reasonably well on automatically predicting fish age from otolith images. In the present study, we carefully investigate the prediction rule learned by such neural networks to provide insight into the features that identify certain fish age ranges. For this purpose, a recent technique for visualizing and analyzing the predictions of the neural networks was applied to different versions of the otolith images. The results indicate that supplementary knowledge about the internal structure improves the results for the youngest age groups, compared to using only the contour shape attribute of the otolith. However, the contour shape and size attributes are, in general, sufficient for older age groups. In addition, within specific age ranges we find that the network tends to focus on particular areas of the otoliths and that the most discriminating factors seem to be related to the central part and the outer edge of the otolith. Explaining age predictions from otolith images as done in this study will hopefully help build confidence in the potential of deep learning algorithms for automatic age prediction, as well as improve the quality of the age estimation.	[Ordonez, Alba; Eikvil, Line; Salberg, Arnt-Borre; Murray, Sean Meling] Norwegian Comp Ctr, Dept Stat Anal Machine Learning & Image Anal, Oslo, Norway; [Harbitz, Alf] Inst Marine Res, Dept Deep Water Species & Cartilaginous Fish, Tromso, Norway; [Kampffmeyer, Michael C.] Univ Tromso, Dept Phys & Technol, Tromso, Norway	Institute of Marine Research - Norway; UiT The Arctic University of Tromso	Ordonez, A (corresponding author), Norwegian Comp Ctr, Dept Stat Anal Machine Learning & Image Anal, Oslo, Norway.	albao@nr.no		Kampffmeyer, Michael/0000-0002-7699-0405; Ordonez, Alba/0000-0002-8720-0288	Research Council of Norway [270966]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway, grant 270966. There was no additional external funding received for this study. The founders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber M, 2018, ARXIV180804260V1; Albert OT, 2016, MAR FRESHWATER RES, V67, P937, DOI 10.1071/MF15089; Albert O. T., 2009, J NW ATLANTIC FISHER, V40, P81, DOI DOI 10.2960/J.V40.M659; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/cjfas-58-1-30; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; CAMPANA SE, 1995, T AM FISH SOC, V124, P131, DOI 10.1577/1548-8659(1995)124<0131:GASMFD>2.3.CO;2; Chinchor N, 1992, P 4 MESS UND C; Chollet F, 2018, KERAS 2 1 3; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Frie AK, 2011, ICES J MAR SCI, V68, P1942, DOI 10.1093/icesjms/fsr116; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; Harbitz A, 2005, ICES J MAR SCI, V72, P2090; Jolliffe IT., 2002, PRINCIPAL COMPONENT, DOI DOI 10.1007/B98835; Lapuschkin S, 2019, ARXIV190210178; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Madhun A.S., 2020, RAPPORT HAVFORSKNING; Moen E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204713; Montavon G., 2019, EXPLAINABLE INTERPRE, P193, DOI DOI 10.1007/978-3-030-28954-6_10; Montavon G, 2017, ARXIV170607979; Montavon G, 2015, ARXIV151202479; Morison AK, 2005, MAR FRESHWATER RES, V56, P773, DOI 10.1071/MF04217; Noh H, 2015, IEEE I CONF COMP VIS, P1520, DOI 10.1109/ICCV.2015.178; Ribeiro MT, 2016, ARXIV160204938V3; Samek W, 2017, IEEE T NEUR NET LEAR, V28, P2660, DOI 10.1109/TNNLS.2016.2599820; Simonyan K., 2013, 13126034 ARXIV, DOI DOI 10.1038/S41591-018-0335-9; Springenberg JT, 2014, ARXIV; Stransky C, 2008, FISH RES, V90, P26, DOI 10.1016/j.fishres.2007.09.009; SZEGEDY C, 2016, PROC CVPR IEEE, P2818, DOI DOI 10.1109/CVPR.2016.308; Treble Margaret A., 2008, Northwest Atlantic Fisheries Organization Scientific Council Studies, V41, P1, DOI 10.2960/S.v41.m1; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Von Luxburg UV, 2007, ARXIV07110189; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53	34	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0235013	10.1371/journal.pone.0235013	http://dx.doi.org/10.1371/journal.pone.0235013			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559222	gold, Green Published			2022-12-27	WOS:000543261600038
J	Sano, M; Ichihara, G; Katsumata, Y; Hiraide, T; Hirai, A; Momoi, M; Tamura, T; Ohata, S; Kobayashi, E				Sano, Motoaki; Ichihara, Genki; Katsumata, Yoshinori; Hiraide, Takahiro; Hirai, Akeo; Momoi, Mizuki; Tamura, Tomoyoshi; Ohata, Shigeo; Kobayashi, Eiji			Pharmacokinetics of a single inhalation of hydrogen gas in pigs	PLOS ONE			English	Article							MOLECULAR-HYDROGEN; RAT MODEL; CONSUMPTION; ANTIOXIDANT; INFARCTION; SAFETY; BODY	The benefits of inhaling hydrogen gas (H-2) have been widely reported but its pharmacokinetics have not yet been sufficiently analyzed. We developed a new experimental system in pigs to closely evaluate the process by which H(2)is absorbed in the lungs, enters the bloodstream, and is distributed, metabolized, and excreted. We inserted and secured catheters into the carotid artery (CA), portal vein (PV), and supra-hepatic inferior vena cava (IVC) to allow repeated blood sampling and performed bilateral thoracotomy to collapse the lungs. Then, using a hydrogen-absorbing alloy canister, we filled the lungs to the maximum inspiratory level with 100% H-2. The pig was maintained for 30 seconds without resuming breathing, as if they were holding their breath. We collected blood from the three intravascular catheters after 0, 3, 10, 30, and 60 minutes and measured H(2)concentration by gas chromatography. H(2)concentration in the CA peaked immediately after breath holding; 3 min later, it dropped to 1/40 of the peak value. Peak H(2)concentrations in the PV and IVC were 40% and 14% of that in the CA, respectively. However, H(2)concentration decay in the PV and IVC (half-life: 310 s and 350 s, respectively) was slower than in the CA (half-life: 92 s). At 10 min, H(2)concentration was significantly higher in venous blood than in arterial blood. At 60 min, H(2)was detected in the portal blood at a concentration of 6.9-53 nL/mL higher than at steady state, and in the SVC 14-29 nL/mL higher than at steady state. In contrast, H(2)concentration in the CA decreased to steady state levels. This is the first report showing that inhaled H(2)is transported to the whole body by advection diffusion and metabolized dynamically.	[Sano, Motoaki; Ichihara, Genki; Katsumata, Yoshinori; Hiraide, Takahiro; Hirai, Akeo; Momoi, Mizuki; Kobayashi, Eiji] Keio Univ, Dept Cardiol, Sch Med, Shinjuku Ku, Tokyo, Japan; [Sano, Motoaki; Ichihara, Genki; Katsumata, Yoshinori; Tamura, Tomoyoshi; Kobayashi, Eiji] Keio Univ, Ctr Mol Hydrogen Med, Minato Ku, Tokyo, Japan; [Tamura, Tomoyoshi] Keio Univ, Dept Emergency & Crit Care Med, Shinjuku Ku, Tokyo, Japan; [Kobayashi, Eiji] Keio Univ, Dept Organ Fabricat, Sch Med, Shinjuku Ku, Tokyo, Japan; [Ohata, Shigeo] Juntendo Univ, Dept Neurol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan	Keio University; Keio University; Keio University; Keio University; Juntendo University	Sano, M (corresponding author), Keio Univ, Dept Cardiol, Sch Med, Shinjuku Ku, Tokyo, Japan.; Sano, M (corresponding author), Keio Univ, Ctr Mol Hydrogen Med, Minato Ku, Tokyo, Japan.	msano@a8.keio.jp	Katsumata, Yoshinori/AAC-4159-2021; Sano, Motoaki/L-3405-2013	Katsumata, Yoshinori/0000-0001-5576-5789; Sano, Motoaki/0000-0003-1771-8310	SESA Corporation	SESA Corporation	This work was supported by grants from SESA Corporation (E.K.) Sou Hashimoto (Doctors Man Co., Ltd.) provided us with the H2 filling device. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinese Non-government Medical Institutions Association, 2020, REC US HYDR OX AT CL; Hayashida K, 2014, CIRCULATION, V130, P2173, DOI 10.1161/CIRCULATIONAHA.114.011848; Hayashida K, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003459; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Katsumata Y, 2017, CIRC J, V81, P940, DOI 10.1253/circj.CJ-17-0105; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kobayashi E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222863; Matsuoka T, 2017, J TRAUMA ACUTE CARE, V83, P469, DOI 10.1097/TA.0000000000001620; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta S, 2015, METHOD ENZYMOL, V555, P289, DOI 10.1016/bs.mie.2014.11.038; Ono H, 2017, J STROKE CEREBROVASC, V26, P2587, DOI 10.1016/j.jstrokecerebrovasdis.2017.06.012; Pedersen SF, 2020, J CLIN INVEST, V130, P2202, DOI 10.1172/JCI137647; Sano M, 2018, ACUTE MED SURG, V5, P113, DOI 10.1002/ams2.320; Shimouchi A, 2013, ADV EXP MED BIOL, V789, P315, DOI 10.1007/978-1-4614-7411-1_42; Shimouchi A, 2012, ADV EXP MED BIOL, V737, P245, DOI 10.1007/978-1-4614-1566-4_36; Suzuki Y, 2009, FEBS LETT, V583, P2157, DOI 10.1016/j.febslet.2009.05.052; Tamaki I, 2018, LIVER TRANSPLANT, V24, P1589, DOI 10.1002/lt.25326; Tamura T, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2246-3; Tamura T, 2016, CIRC J, V80, P1870, DOI 10.1253/circj.CJ-16-0127; Tamura1 T., 2020, SHOCK; Yamamoto R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38180-4	21	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234626	10.1371/journal.pone.0234626	http://dx.doi.org/10.1371/journal.pone.0234626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559239	gold, Green Published			2022-12-27	WOS:000543261600059
J	Goemans, N; Wong, B; Van den Hauwe, M; Signorovitch, J; Sajeev, G; Cox, D; Landry, J; Jenkins, M; Dieye, I; Yao, ZW; Hossain, I; Ward, SJ				Goemans, Nathalie; Wong, Brenda; Van den Hauwe, Marleen; Signorovitch, James; Sajeev, Gautam; Cox, David; Landry, John; Jenkins, Madeline; Dieye, Ibrahima; Yao, Zhiwen; Hossain, Intekhab; Ward, Susan J.		Collaborative Trajectory Anal Proj	Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaboration	PLOS ONE			English	Article							DRISAPERSEN; ATALUREN; DISEASE; DESIGN; TRIAL	The timed 4-stair climb (4SC) assessment has been used to measure function in Duchenne muscular dystrophy (DMD) practice and research. We sought to identify prognostic factors for changes in 4SC, assess their consistency across data sources, and the extent to which prognostic scores could be useful in DMD clinical trial design and analysis. Data from patients with DMD in the placebo arm of a phase 3 trial (Tadalafil DMD trial) and two real-world sources (Universitaire Ziekenhuizen, Leuven, Belgium [Leuven] and Cincinnati Children's Hospital Medical Center [CCHMC]) were analyzed. One-year changes in 4SC completion time and velocity (stairs/second) were analyzed. Prognostic models included age, height, weight, steroid use, and multiple timed function tests and were developed using multivariable regression, separately in each data source. Simulations were used to quantify impacts on trial sample size requirements. Data on 1-year changes in 4SC were available from the Tadalafil DMD trial (n = 92) Leuven (n = 67), and CCHMC (n = 212). Models incorporating multiple timed function tests, height, and weight significantly improved prognostic accuracy for 1-year change in 4SC (R-2: 29%-36% for 4SC velocity, and 29%-34% for 4SC time) compared to models including only age, baseline 4SC and steroid duration (R-2:8%-17% for 4SC velocity and 2%-13% for 4SC time). Measures of walking and rising ability contributed important prognostic information for changes in 4SC. In a randomized trial with equal allocation to treatment and placebo, adjustment for such a prognostic score would enable detection (at 80% power) of a treatment effect of 0.25 stairs/second with 100-120 patients, compared to 170-190 patients without prognostic score adjustment. Combining measures of ambulatory function doubled prognostic accuracy for 1-year changes in 4SC completion time and velocity. Randomized clinical trials incorporating a validated prognostic score could reduce sample size requirements by approximately 40%. Knowledge of important prognostic factors can also inform adjusted comparisons to external controls.	[Goemans, Nathalie; Van den Hauwe, Marleen] Univ Hosp Leuven, Dept Child Neurol, Leuven, Belgium; [Wong, Brenda] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA; [Signorovitch, James; Sajeev, Gautam; Dieye, Ibrahima; Yao, Zhiwen; Hossain, Intekhab] Anal Grp Inc, Boston, MA USA; [Signorovitch, James; Ward, Susan J.] Collaborat Trajectory Anal Project, Cambridge, MA USA; [Cox, David] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Landry, John] Eli Lilly & Co, Toronto, ON, Canada; [Jenkins, Madeline] Anal Grp Inc, London, England	KU Leuven; University Hospital Leuven; University of Massachusetts System; University of Massachusetts Worcester; Analysis Group Inc.; Eli Lilly; Eli Lilly; Analysis Group Inc.	Goemans, N (corresponding author), Univ Hosp Leuven, Dept Child Neurol, Leuven, Belgium.	nathalie.goemans@uzleuven.be		goemans, nathalie/0000-0002-5157-7155	Astellas Pharma (Mitobridge); Catabasis; FibroGen Inc.; Italfarmaco SpA; Pfizer Inc.; PTC Therapeutics; Roche; Sarepta Therapeutics; Shire plc; Solid Biosciences; Wave Life Sciences; Parent Project Muscular Dystrophy; Charley's Fund; CureDuchenne; Fonds Spierzieke Kinderen; Collaborative Trajectory Analysis Project (cTAP)	Astellas Pharma (Mitobridge)(Astellas Pharmaceuticals); Catabasis; FibroGen Inc.; Italfarmaco SpA; Pfizer Inc.(Pfizer); PTC Therapeutics; Roche(Roche Holding); Sarepta Therapeutics; Shire plc; Solid Biosciences; Wave Life Sciences; Parent Project Muscular Dystrophy; Charley's Fund; CureDuchenne; Fonds Spierzieke Kinderen; Collaborative Trajectory Analysis Project (cTAP)	This study was conducted within the collaborative Trajectory Analysis Project (cTAP), a pre-competitive coalition of academic clinicians, drug developers, and patient foundations formed in 2015 to overcome the challenges of high variation in clinical trials in Duchenne muscular dystrophy. cTAP has received sponsorship from Astellas Pharma (Mitobridge), Catabasis, FibroGen Inc., Italfarmaco SpA, Pfizer Inc., PTC Therapeutics, Roche, Sarepta Therapeutics, Shire plc, Solid Biosciences, Wave Life Sciences, Parent Project Muscular Dystrophy, Charley's Fund, and CureDuchenne, a founding patient advocacy partner and provider of initial seed funding to cTAP. Physical function testing at Universitaire Ziekenhuizen Leuven was funded by Fonds Spierzieke Kinderen. cTAP was involved in study design, analysis, manuscript preparation, and the decision to publish. James Signorovitch, Gautam Sajeev, Madeline Jenkins, Ibrahima Dieye, Zhiwen Yao, and Intekhab Hossain are employees of Analysis Group Inc., which received funding from the study sponsors via the Collaborative Trajectory Analysis Project (cTAP). David Cox and John Landry are shareholders and paid employees of Eli Lilly and Company. Susan J. Ward has received funding from the study sponsors via the Collaborative Trajectory Analysis Project (cTAP). The specific roles of these authors are articulated in the `author contributions' section."	[Anonymous], 2015, AM J PHARM BENEFIST, V7, pe141; Bushby Kate, 2011, Clin Investig (Lond), V1, P1217; Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Emery AE, 2015, OXFORD MONOGRAPHS G, V67; FDA, 2019, ENR STRAT CLIN TRIAL; FDA, 2016, FDA GRANTS ACC APPR; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Goemans N, 2017, INT ANN C WORLD MUSC; Goemans N, 2018, NEUROMUSCULAR DISORD, V28, P4, DOI 10.1016/j.nmd.2017.10.004; Goemans N, 2017, NEUROMUSCULAR DISORD, V27, P203, DOI 10.1016/j.nmd.2016.11.013; Goemans N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164684; Irazabal MV, 2016, KIDNEY INT REP, V1, P213, DOI 10.1016/j.ekir.2016.08.001; Mah JK, 2016, NEUROPSYCH DIS TREAT, V12, P1795, DOI 10.2147/NDT.S93873; Mayhew A, 2013, DEV MED CHILD NEUROL, V55, P1038, DOI 10.1111/dmcn.12213; Mayhew A, 2011, DEV MED CHILD NEUROL, V53, P535, DOI 10.1111/j.1469-8749.2011.03939.x; Mazzone ES, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151445; McDonald CM, 2018, LANCET, V391, P451, DOI 10.1016/S0140-6736(17)32160-8; McDonald CM, 2017, LANCET, V390, P1489, DOI 10.1016/S0140-6736(17)31611-2; McDonald CM, 2013, MUSCLE NERVE, V48, P32, DOI 10.1002/mus.23807; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Mercuri E, 2016, NEUROMUSCULAR DISORD, V26, P576, DOI 10.1016/j.nmd.2016.05.016; Moat SJ, 2013, EUR J HUM GENET, V21, P1049, DOI 10.1038/ejhg.2012.301; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; PTC Therapeutics, 2014, PTC THER REC COND AP; Ricotti V, 2016, J NEUROL NEUROSUR PS, V87, P149, DOI 10.1136/jnnp-2014-309405; Skalsky AJ, 2009, MUSCLE NERVE, V39, P647, DOI 10.1002/mus.21212; Victor RG, 2017, NEUROLOGY, V89, P1811, DOI 10.1212/WNL.0000000000004570; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4	29	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0232870	10.1371/journal.pone.0232870	http://dx.doi.org/10.1371/journal.pone.0232870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555695	Green Published, gold			2022-12-27	WOS:000543273200065
J	Brain, D; Mitchell, J; O'Beirne, J				Brain, David; Mitchell, Jonathan; O'Beirne, James			Cost-effectiveness analysis of an outreach model of Hepatitis C Virus (HCV) assessment to facilitate HCV treatment in primary care	PLOS ONE			English	Article							ANTIVIRAL TREATMENT; SYRINGE PROGRAMS; INFECTION; AUSTRALIA; PEOPLE; NEEDLE	The effects of hepatitis C virus (HCV), such as morbidity and mortality associated with cirrhosis and liver cancer, is a major public health issue in Australia. Highly effective treatment has recently been made available to all Australians living with HCV. A decision-analytic model was developed to evaluate the cost-effectiveness of the hepatology partnership, compared to usual care. A Markov model was chosen, as it is state-based and able to include recursive events, which accurately reflects the natural history of the chronic and repetitive nature of HCV. Cost-effectiveness of the new model of care is indicated by the incremental cost-effectiveness ratio (ICER), where the mean change to costs associated with the new model of care is divided by the mean change in quality adjusted life-years (QALYs). Ten thousand iterations of the model were run, with the majority (73%) of ICERs representing cost-savings. In comparison to usual care, the intervention improves health outcomes (22.38 QALYs gained) and reduces costs by $42,122 per patient. When compared to usual care, a partnership approach to management of HCV is cost-effective and good value for money, even when key model parameters are changed in scenario analyses. Reduction in costs is driven by improved efficiency of the new model of care, where more patients are treated in a timely manner, away from the expensive tertiary setting. From an economic perspective, a reduction in hospital-based care is a positive outcome and represents a good investment for decision-makers who wish to maximise health gain per dollar spent.	[Brain, David] Australian Ctr Hlth Serv Innovat, Melbourne, Vic, Australia; [Brain, David] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia; [Mitchell, Jonathan; O'Beirne, James] Sunshine Coast Univ Hosp, Britinya, Australia; [Mitchell, Jonathan; O'Beirne, James] Univ Sunshine Coast, Sunshine Coast Hlth Inst, Britinya, Australia	Queensland University of Technology (QUT); University of the Sunshine Coast	Brain, D (corresponding author), Australian Ctr Hlth Serv Innovat, Melbourne, Vic, Australia.; Brain, D (corresponding author), Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia.	david.brain@qut.edu.au	O'Beirne, James/I-8251-2019	O'Beirne, James/0000-0003-3400-2816; Brain, David/0000-0002-6612-348X				[Anonymous], 2008, PAIN PHYS S, V11, pS5; Belperio PS, 2019, J HEPATOL, V70, P15, DOI 10.1016/j.jhep.2018.09.018; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Briggs A, 2006, DECISION MODELLING H; Clemens S, 2014, QUAL LIFE RES, V23, P2375, DOI 10.1007/s11136-014-0676-x; Cunningham EB, 2018, INT J DRUG POLICY, V62, P14, DOI 10.1016/j.drugpo.2018.08.013; D'Ambrosio R, 2019, J HEPATOL, V70, P379, DOI 10.1016/j.jhep.2018.11.011; Dore GJ, 2018, INFECT DIS CLIN N AM, V32, P269, DOI 10.1016/j.idc.2018.02.006; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Edney LC, 2018, PHARMACOECONOMICS, V36, P239, DOI 10.1007/s40273-017-0585-2; Grebely J, 2016, CLIN INFECT DIS, V63, P1479, DOI 10.1093/cid/ciw579; Hainsworth SW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198336; Hajarizadeh B, 2018, J VIRAL HEPATITIS, V25, P640, DOI 10.1111/jvh.12852; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hellard ME, 2012, MED J AUSTRALIA, V196, P638, DOI 10.5694/mja11.10981; Husereau D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1049; Iversen J, 2013, AM J PUBLIC HEALTH, V103, P1436, DOI 10.2105/AJPH.2012.301206; Kwon JA, 2019, J VIRAL HEPATITIS, V26, P83, DOI 10.1111/jvh.13013; Kwon JA, 2012, AIDS, V26, P2201, DOI 10.1097/QAD.0b013e3283578b5d; Martin NK, 2016, J HEPATOL, V65, P17, DOI 10.1016/j.jhep.2016.02.007; Midgard H, 2016, J HEPATOL, V64, P1020, DOI 10.1016/j.jhep.2016.01.001; Page K, 2013, J HOSP INFECT, V84, P200, DOI 10.1016/j.jhin.2013.03.006; Pharmaceutical Benefits Advisory Committee, 2013, GUID PREP SUBM PHARM; Scott N, 2015, J GASTROEN HEPATOL, V31, P872; Scott N, 2017, GUT, V66, P1507, DOI 10.1136/gutjnl-2016-311504; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; The Kirby Institute, 2019, MON HEP C TREATM UPT; Tsuchiya A, 2001, EC EVALUATION HLTH C, P22; Visconti AJ, 2012, J GASTROEN HEPATOL, V28, P707; Waziry R, 2016, J HEPATOL, V65, P1086, DOI 10.1016/j.jhep.2016.08.010; York Health Economics Consortium, 2016, PERSPECTIVE	31	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234577	10.1371/journal.pone.0234577	http://dx.doi.org/10.1371/journal.pone.0234577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555696	Green Published, gold			2022-12-27	WOS:000542759600035
J	Dadi, AF; Miller, ER; Woodman, RJ; Azale, T; Mwanri, L				Dadi, Abel Fekadu; Miller, Emma R.; Woodman, Richard J.; Azale, Telake; Mwanri, Lillian			Effect of antenatal depression on adverse birth outcomes in Gondar town, Ethiopia: A community-based cohort study	PLOS ONE			English	Article							POISSON REGRESSION APPROACH; COMMON MENTAL-DISORDERS; RISK-FACTORS; PRENATAL DEPRESSION; MATERNAL DEPRESSION; PRETERM BIRTH; POSTNATAL-DEPRESSION; PERINATAL-MORTALITY; PREGNANCY; WEIGHT	Background The impact of antenatal depression on pregnancy outcomes has been well investigated in developed countries, but few studies have been conducted in low-income countries. As depression is significantly affected by socio-economic and cultural factors, it would be difficult to generalize evidence from high-income countries to low-income countries. We conducted a community-based cohort study to estimate the incidence of adverse birth outcomes and the direct and indirect pathways via which depression and other psychosocial risk factors may impact such birth outcomes within Gondar town, Ethiopia. Methods The study followed 916 pregnant women who were screened for antenatal depression using the Edinburgh Postnatal Depression Scale (EPDS). We also assessed the incidence of preterm births, Low Birth Weight (LBW) and stillbirths. Modified Poisson regression was used to estimate the relative risk of predictors on adverse birth outcomes and a Generalized Structural Equation Model (GSEM) was used to estimate the direct and indirect effect of antenatal depression and other psychological risk factors on adverse birth outcomes. Results The cumulative incidence of stillbirth, LBW and preterm was 1.90%, 5.25%, and 16.42%, respectively. The risk of preterm birth was 1.61, 1.46, 1.49, and 1.77 times higher among participants who identified as Muslim, reported being fearful of delivery, were government employee's, and who had no antenatal care services, respectively. Partner support moderated the association between depression, preterm birth, and LBW. Depression had no direct effect on birth outcomes but indirectly affected preterm birth via partner support. Religion had both direct and indirect effects on preterm birth, while occupation and fear of delivery had direct effects. The risk of LBW was 9.44 and 2.19 times higher among preterm births and those who had exposure to tobacco, respectively. Stress coping was indirectly associated, and preterm birth and tobacco exposure were directly associated with LBW. The risk of stillbirth was 3.22 times higher in women with antenatal depression and 73% lower in women with higher coping abilities. Conclusions There was a high incidence of all adverse birth outcomes in Gondar Town. Depression and psychosocial risk factors had important indirect negative effects on risk, while partner support provided a positive indirect effect on the incidence of adverse birth outcomes. Interventions that focus on increasing partner engagement and participation in antenatal support may help reduce adverse birth outcomes by enhancing maternal resilience.	[Dadi, Abel Fekadu] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Dadi, Abel Fekadu; Miller, Emma R.; Mwanri, Lillian] Flinders Univ S Australia, Coll Med & Publ Hlth, Bedford Pk, SA, Australia; [Woodman, Richard J.] Flinders Univ S Australia, Coll Med & Publ Hlth, Ctr Epidemiol & Biostat, Bedford Pk, SA, Australia; [Azale, Telake] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Hlth Promot & Behav Sci, Gondar, Ethiopia	University of Gondar; Flinders University South Australia; Flinders University South Australia; University of Gondar	Dadi, AF (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.; Dadi, AF (corresponding author), Flinders Univ S Australia, Coll Med & Publ Hlth, Bedford Pk, SA, Australia.	Fekten@yahoo.com	Dadi, Abel Fekadu/AAU-3433-2020; Miller, Emma R/G-9615-2018; Miller, Emma/GXW-3128-2022; Mwanri, Lillian/AGG-3711-2022	Dadi, Abel Fekadu/0000-0001-9967-7713; Miller, Emma R/0000-0002-6373-5720; Mwanri, Lillian/0000-0002-5792-7785; Woodman, Richard/0000-0002-4094-1222				Accortt EE, 2015, MATERN CHILD HLTH J, V19, P1306, DOI 10.1007/s10995-014-1637-2; Adam Z, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2315-6; Adane AA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-90; Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; [Anonymous], 2013, PANCREATOLOGY, V13, pe1; [Anonymous], 2017, FUEL CELLS B, V2017, P7, DOI [10.1016/S1464-2859(17)30385-1, DOI 10.1016/S1464-2859(17)30385-1]; [Anonymous], 2016, ADDIT POLYM, V2016, P5; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2016, LANCET, V387, pe9; BARKER DJP, 1986, LANCET, V1, P1077; Behrman RE, 2007, PRETERM BIRTH CAUSES; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P29, DOI 10.4314/ejhs.v24i0.4S; Berhie Kidanemariam Alem, 2016, Matern Health Neonatol Perinatol, V2, P10, DOI 10.1186/s40748-016-0038-5; Biratu A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0092-x; Bitew T, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1462-4; Bitew T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1383-8; Bitew T, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1099-1; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Bobo FT, 2018, BMC RES NOTES, V11, P1; Bonari L, 2004, CAN J PSYCHIAT, V49, P726, DOI 10.1177/070674370404901103; Buis ML, 2010, STATA J, V10, P11, DOI 10.1177/1536867X1001000104; Central Statistical Agency Addis Ababa Ethiopia, 2016, ETH DEM HLTH SURV KE; Chatillon O, 2010, ENCEPHALE, V36, P443, DOI 10.1016/j.encep.2010.02.004; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Corraini P, 2017, CLIN EPIDEMIOL, V9, P331, DOI 10.2147/CLEP.S129728; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; CSA, 2007, POP HOUS CENS REP ET; de Bernabe JV, 2004, EUR J OBSTET GYN R B, V116, P3, DOI 10.1016/j.ejogrb.2004.03.007; Dean AG, 2010, EPI INFO OPENEPI EPI; Delnord M, 2015, CURR OPIN OBSTET GYN, V27, P133, DOI 10.1097/GCO.0000000000000156; Deressa AT, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1957-0; Diabelkova J, 2018, CENT EUR J PUBL HEAL, V26, pS25, DOI 10.21101/cejph.a5273; Diego MA, 2009, EARLY HUM DEV, V85, P65, DOI 10.1016/j.earlhumdev.2008.07.002; Dunkel Schetter C, 2012, PREGNANCY BIRTH OUTC; Dunkel-Schetter C., 2011, HDB STRESS SCI BIOL, P321; East CE, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000198.pub3; Engmann C, 2012, J PERINATOL, V32, P585, DOI 10.1038/jp.2011.154; Ethiopia FMoHE, 2015, HLTH SECT TRANSF PLA; Federal ministry of health, 2015, ETH PROF PRET LOW BI; Feingold A, 2019, ADDICT BEHAV, V94, P26, DOI 10.1016/j.addbeh.2018.12.018; GAIL MH, 1984, BIOMETRIKA, V71, P431; Gebremedhin M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0658-1; Gelaye B, 2016, LANCET PSYCHIAT, V3, P973, DOI 10.1016/S2215-0366(16)30284-X; Gilles M, 2018, PSYCHONEUROENDOCRINO, V94, P152, DOI 10.1016/j.psyneuen.2018.04.022; Goedhart G, 2010, PSYCHOSOM MED, V72, P769, DOI 10.1097/PSY.0b013e3181ee4a62; Gondar town health office, 2016, ZON HLTH OFF HLTH SE; Grace J. B., 2005, B ECOL SOC AM, V15, P283, DOI [10.1890/0012-9623(2005)86[283:ITRFMR]2.0.CO;2, DOI 10.1890/0012-9623(2005)86[283:ITRFMR]2.0.CO;2]; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Hanlon C, 2008, J AFFECT DISORDERS, V108, P251, DOI 10.1016/j.jad.2007.10.023; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Hawsawi AM, 2015, RESP CARE, V60, P135, DOI 10.4187/respcare.02798; Heazell AEP, 2016, LANCET, V387, P604, DOI 10.1016/S0140-6736(15)00836-3; Herrero T, 2020, J MATERN-FETAL NEO M, V33, P212, DOI 10.1080/14767058.2018.1488162; Kassahun EA, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4387-9; Kharrazi M, 2004, EPIDEMIOLOGY, V15, P660, DOI 10.1097/01.ede.0000142137.39619.60; Kinney MV, 2015, SEMIN PERINATOL, V39, P326, DOI 10.1053/j.semperi.2015.06.004; Kupek Emil, 2006, BMC Med Res Methodol, V6, P13, DOI 10.1186/1471-2288-6-13; Kuruvilla S, 2016, B WORLD HEALTH ORGAN, V94, P398, DOI 10.2471/BLT.16.170431; Lakew D, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1573-4; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lewis AJ, 2016, J DEV ORIG HLTH DIS, V7, P416, DOI 10.1017/S2040174416000076; Lindtjorn B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197708; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lucas A, 1991, CIBA F SYMP; Luiza JW, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0466-7; Mamica ., 2018, EC ENV STUD, V18, P265, DOI [10.25167/ees.2018.45.15, DOI 10.25167/EES.2018.45.15]; McDonnell BP, 2019, EUR J OBSTET GYN R B, V232, P1, DOI 10.1016/j.ejogrb.2018.11.005; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Megabiaw BM, 2012, PAN AFR MED J, V4, P11; Mekonen DG, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-018-4037-7; Meltzer H., 2003, EUROHIS DEV COMMON I; Milgrom J, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16081426; Mochache K, 2018, ANN GEN PSYCHIATR, V17, DOI 10.1186/s12991-018-0202-6; Moore KA, 2017, LANCET GLOB HEALTH, V5, pE1101, DOI 10.1016/S2214-109X(17)30340-6; MUTHEN B, 1984, PSYCHOMETRIKA, V49, P115, DOI 10.1007/BF02294210; Nasreen HE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-515; National forum on early childhood program evaluation, 82009 NAT EARL CHILD; Nazzari S, 2019, PSYCHONEUROENDOCRINO, V101, P253, DOI 10.1016/j.psyneuen.2018.11.018; Neggers Y, 2006, ACTA OBSTET GYN SCAN, V85, P277, DOI 10.1080/00016340600566121; Negrato CA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-49; NEUHAUS JM, 1993, BIOMETRIKA, V80, P807, DOI 10.2307/2336872; NHMRC, 2007, NAT STAT ETH COND HU; Nylen KJ, 2013, J BEHAV MED, V36, P427, DOI 10.1007/s10865-012-9436-y; Omidvar S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191723; Orta OR, 2018, ARCH WOMEN MENT HLTH, V21, P43, DOI 10.1007/s00737-017-0777-y; Osborne S, 2018, PSYCHONEUROENDOCRINO, V98, P211, DOI 10.1016/j.psyneuen.2018.06.017; Reinebrant HE, 2018, BJOG-INT J OBSTET GY, V125, P212, DOI 10.1111/1471-0528.14971; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Araujo DMR, 2010, CAD SAUDE PUBLICA, V26, P219, DOI 10.1590/S0102-311X2010000200002; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Seth S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0915-y; Sion MY, 2016, J MATERN-FETAL NEO M, V29, P863, DOI 10.3109/14767058.2015.1023708; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Smith J.A., 2009, INTERPRETATIVE PHENO; Staneva A, 2015, WOMEN BIRTH, V28, P179, DOI 10.1016/j.wombi.2015.02.003; Stewart RC, 2007, MATERN CHILD NUTR, V3, P94, DOI 10.1111/j.1740-8709.2007.00088.x; Szegda K, 2014, J MATERN-FETAL NEO M, V27, P960, DOI 10.3109/14767058.2013.845157; Talie A, 2019, J PREGNANCY, V2019, DOI 10.1155/2019/3587239; Tang SF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061232; Teklay Girmay, 2018, BMC Res Notes, V11, P571, DOI 10.1186/s13104-018-3693-y; Tsegaye B, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0631-3; Tshotetsi L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213058; University of Washington, 2008, OP DAT KIT ODK; Ververs Mija-Tesse, 2013, PLoS Curr, V5, DOI 10.1371/currents.dis.54a8b618c1bc031ea140e3f2934599c8; Vidaeff AC, 2006, AM J PERINAT, V23, P75, DOI 10.1055/s-2006-931803; Weng SC, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3254-z; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2004, UN CHILDR FUND LOW B; WHO, 2016, PRET BIRTH FACT SHEE; WHO, 2001, WHO PUBLICATION; Woldeyohannes D., 2019, CLIN MOTHER CHILD HL, V16, P2; Woreta Town Administration Agriculture Office, 2016, WORETA TOWN ADM ANIM; World Health Organization, 2014, GLOBAL NUTR TARGETS; Yali AM, 1999, J PSYCHOSOM OBST GYN, V20, P39, DOI 10.3109/01674829909075575; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Yismaw Ayenew Engida, 2018, BMC Res Notes, V11, P867, DOI 10.1186/s13104-018-3970-9; Zerfu TA, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0060-y; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	120	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234728	10.1371/journal.pone.0234728	http://dx.doi.org/10.1371/journal.pone.0234728			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555631	gold, Green Published			2022-12-27	WOS:000542759600029
J	Huang, X; Luo, MJ; Jin, HD				Huang, Xing; Luo, Mengjie; Jin, Huidong			Application of improved ELM algorithm in the prediction of earthquake casualties	PLOS ONE			English	Article								Background Earthquake casualties prediction is a basic work of the emergency response. Traditional forecasting methods have strict requirements on sample data and lots of parameters are required to be set manually, which can result in poor results with low prediction accuracy and slow learning speed. Method In this paper, the Extreme Leaning Machine (ELM) is introduced into the earthquake disaster casualty predictions with the purpose of improving the prediction accuracy. However, traditional ELM model still has the problems of poor network structure stability and low prediction accuracy. So an Adaptive Chaos Particle Swarm Optimization (ACPSO) is proposed to the optimize traditional ELM's network parameters to enhance network stability and prediction accuracy, and the improved ELM model is applied to earthquake disaster casualty prediction. Results The experimental results show that the earthquake disaster casualty prediction model based on ACPSO-ELM algorithm has better stability and prediction accuracy. Conclusion ACPSO-ELM algorithm has better practicality and generalization in earthquake disaster casualty prediction.	[Huang, Xing; Luo, Mengjie] Southwest Univ Sci & Technol, Sch Econ & Management, Mianyang, Sichuan, Peoples R China; [Jin, Huidong] CSIRO Data61, Canberra, ACT, Australia	Southwest University of Science & Technology - China; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Luo, MJ (corresponding author), Southwest Univ Sci & Technol, Sch Econ & Management, Mianyang, Sichuan, Peoples R China.	lmj1714981490@qq.com	jin, Huidong/B-3187-2009	jin, Huidong/0000-0002-3925-0256	key projects of Sichuan circular economy research center, China, "Research on the countermeasures to improve the technological innovation efficiency of Mianyang enterprises under the effect of environmental regulation" [XHJJ-1809]; Sichuan information management and service center, China, "Disaster risk assessment and demand identification of coastal cities based on multi-source data mining" [SCXX2019ZD02]	key projects of Sichuan circular economy research center, China, "Research on the countermeasures to improve the technological innovation efficiency of Mianyang enterprises under the effect of environmental regulation"; Sichuan information management and service center, China, "Disaster risk assessment and demand identification of coastal cities based on multi-source data mining"	The work was supported by the key projects of Sichuan circular economy research center, China, "Research on the countermeasures to improve the technological innovation efficiency of Mianyang enterprises under the effect of environmental regulation"(Grand No. XHJJ-1809) and Sichuan information management and service center, China, "Disaster risk assessment and demand identification of coastal cities based on multi-source data mining"(Grand No. SCXX2019ZD02).	Bible King James, 2013, DEUTERONOMY, V23, P20; Cao Wen-bin, 2013, Advances in Information Sciences and Service Sciences, V5, P38; Coburn A.W., 1989, P INT WORKSH EARTHQ, P107; Gao H, 2010, J CATASTROPHOLOGY, V25, P275; Huang X, 2018, NAT HAZARDS, V94, P999, DOI 10.1007/s11069-018-3452-3; Huang X, 2015, NAT HAZARDS, V77, P717, DOI 10.1007/s11069-015-1620-2; [刘彩霞 Liu Caixia], 2017, [铁道科学与工程学报, Journal of Rail Way Science and Engineering], V14, P2013; Ma H, 2015, 2015 IEEE 9TH INTERNATIONAL CONFERENCE ON ANTI-COUNTERFEITING, SECURITY, AND IDENTIFICATION (ASID), P155, DOI 10.1109/ICASID.2015.7405682; Ma Yuhong, 2000, EARTHQ ENG ENG VIB, V24, P140; Muhammet G, 2016, NAT HAZARDS, V84, P2163, DOI [10.1007/s11069-016-2541-4, DOI 10.1007/S11069-016-2541-4, DOI 10.1007/s11069-016-2541-4]; Murakami HO., 1992, 10 WORLD C EARTHQ EN; Okada S, 1992, 10 WORLD C EARTHQ EN, V10, P6037; [任宁宁 Ren Ningning], 2015, [地震工程与工程振动, Journal of Earthquake Engineering and Engineering Vibration], V35, P226; Samardjieva E, 1992, J NAT DISASTER SCI, V14, P17; Huang X, 2020, NAT HAZARDS, V102, P873, DOI 10.1007/s11069-020-03937-6; [张洁 ZHANG Jie], 2011, [中国安全科学学报, China Safety Science Journal], V21, P59	16	1	2	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235236	10.1371/journal.pone.0235236	http://dx.doi.org/10.1371/journal.pone.0235236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584903	Green Published, gold			2022-12-27	WOS:000545747200055
J	Ionova, Y; Wilson, L				Ionova, Yelena; Wilson, Leslie			Biologic excipients: Importance of clinical awareness of inactive ingredients	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; POLYSORBATE-80; ANAPHYLAXIS; IMMUNOGLOBULIN; ALLERGY	Due to the complexity and fragility of biological drug products, several challenges exist in their formulation development. Excipients are added to increase product stability, maintain tonicity, and facilitate drug delivery. The potential implications of these additive substances merit clinical consideration. We assessed the safety risk of excipients on the basis of their type and variability through an assessment framework, which quantifies excipient complexity in 230 biological formulations, and identifies excipient-related adverse events through published case reports. A biologic on average contained 4.45 excipients, half of that found in oral medications. The frequency distribution was heavily skewed towards the most commonly occurring excipients: water (40.4%), sodium chloride (38.3%), polysorbate 80 (28.7%), sucrose (24.4%), and mannitol (20.9%), with 44.4% of formulations not listing the concentration of the most commonly occurring inactive ingredients. A literature search revealed only 17 case reports of excipient-related adverse events, suggesting the need for more clarity for clinicians on the safety of chemical additives. These cases included injection site reactions, anaphylaxis, hyperglycemia, and acute renal failure. With the expansion of the biopharmaceutical market, it is important to consider the safety data of biologic excipients, so that therapy can be tailored appropriately for a specific patient.	[Ionova, Yelena] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Wilson, Leslie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Wilson, Leslie] Univ Calif San Francisco, Dept Pharm, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ionova, Y (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	yelena.ionova@ucsf.edu		, Yelena/0000-0002-9635-350X	U.S. Pharmacopeia	U.S. Pharmacopeia	This work was funded by a grant from U.S. Pharmacopeia, who participated in the design and conduct of the study, analysis and interpretation of the data, and review of the final manuscript, although the decision to submit the manuscript for publication was the authors' alone.	[Anonymous], 2014, PREV CHRONIC DIS, V11, pE62; [Anonymous], 2019, US PHARM 42 NAT FORM; Caballero ML, 2016, J INVEST ALLERG CLIN, V26, P398, DOI 10.18176/jiaci.0089; Chakraborty S, 2016, J NEURO-ONCOL, V128, P405, DOI 10.1007/s11060-016-2099-8; Chi EY., PHARM EXCIPIENTS PRO, DOI [10.1002/9781118992432.ch4, DOI 10.1002/9781118992432.CH4]; Pastor AIE, 2018, J INVEST ALLERG CLIN, V28, P419, DOI 10.18176/jiaci.0298; Findlay SR, 1984, J ALLERGY CLIN IMM 1, V73, P83; GIN H, 1987, DIABETES CARE, V10, P789, DOI 10.2337/diacare.10.6.789; Ha E, 2002, J PHARM SCI-US, V91, P2252, DOI 10.1002/jps.10216; Haskin JA, 1999, ANN PHARMACOTHER, V33, P800, DOI 10.1345/aph.18305; Hegde VL, 2004, CLIN EXP ALLERGY, V34, P1602, DOI 10.1111/j.1365-2222.2004.02079.x; Mahjoubi N, 2017, IRAN J PHARM RES, V16, P103; Morikawa Miki, 2016, Arerugi, V65, P200, DOI 10.15036/arerugi.65.200; Muelas MW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54288-7; Perez-Perez L, 2011, BRIT J DERMATOL, V164, P1119, DOI 10.1111/j.1365-2133.2011.10220.x; Perino E, 2018, ANN ALLERG ASTHMA IM, V120, P664, DOI 10.1016/j.anai.2018.02.018; Price KS, 2007, ALLERGY ASTHMA PROC, V28, P313, DOI 10.2500/aap.2007.28.3003; Reker D, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau6753; Roncati L, 2013, FORENSIC SCI INT, V228, pE28, DOI 10.1016/j.forsciint.2013.02.036; Singh SK, 2018, J PHARM SCI-US, V107, P2735, DOI 10.1016/j.xphs.2018.07.016; Singh SK, 2011, J PHARM SCI-US, V100, P354, DOI 10.1002/jps.22276; Singh SR, 2012, AAPS PHARMSCITECH, V13, P422, DOI 10.1208/s12249-012-9759-6; Stone CA, 2017, J ALLERGY CLIN IMMUN, V139, P1710, DOI 10.1016/j.jaci.2016.10.037; Subtirelu MM, 2005, PEDIATR TRANSPLANT, V9, P801, DOI 10.1111/j.1399-3046.2005.00379.x; U.S. Food and Drug Administration, 2019, BEST PRACT DRUG BIOL, DOI [10.18553/jmcp.2019.19041, DOI 10.18553/JMCP.2019.19041]; U.S. Food and Drug Administration, 2018, COMMUNICATION    JUL; US Food and Drug Administration, 2018, BIOS ACT PLAN BAL IN; Usach I, 2019, ADV THER, V36, P2986, DOI 10.1007/s12325-019-01101-6; Usmani SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181748; Wajanaponsan Non, 2004, Hawaii Med J, V63, P266; Weber C, 2015, TOXICOL REP, V2, P194, DOI 10.1016/j.toxrep.2014.11.019; Yalcin AD, 2014, CLIN LAB, V60, P1561, DOI 10.7754/Clin.Lab.2013.130302	32	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235076	10.1371/journal.pone.0235076	http://dx.doi.org/10.1371/journal.pone.0235076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584876	Green Published, gold			2022-12-27	WOS:000545747200053
J	Kim, KM; Lee, MW; Lim, HB; Koo, HM; Shin, YI; Kim, JY				Kim, Kyeung-Min; Lee, Min-Woo; Lim, Hyung-Bin; Koo, Hyung-Moon; Shin, Yong-Il; Kim, Jung-Yeul			Repeatability of measuring the vessel density in patients with retinal vein occlusion: An optical coherence tomography angiography study	PLOS ONE			English	Article							FOVEAL AVASCULAR ZONE; INNER PLEXIFORM LAYER; REPRODUCIBILITY; PREVALENCE; THICKNESS	Purpose To determine the repeatability of superficial vessel density measurements using Spectral domain Ocular coherence tomography angiography(SD-OCTA) in patients diagnosed with retinal vein occlusion(RVO). Design Prospective observational study. Subjects Patients who visited our retinal clinic from August 2017 to August 2018, diagnosed with RVO were recruited for the study. Methods Two consecutive 3x3 mm pattern scans were performed using the Cirrus HD-OCT 5000 along with AngioPlex software (Carl Zeiss Meditec) in each eye by single skilled examiner. All scans were analyzed using en face OCTA images to measure vessel density (VD) automatically. For further analysis of the effect of central macular thickness(CMT), eyes were divided into two groups according to CMT of 400 mu m (Group 1: CMT > 400 mu m, Group 2: CMT < 400 mu m). To identify factors affecting the repeatability of VD measurements, linear regression analyses were conducted for the coefficient of variation (CV) of VD by investigating demographics and ocular variables. Main outcome measures The intraclass correlation coefficient (ICC), coefficient of variation (CV) of VD measurements. Results A total of 57 eyes from 57 patients were examined: 35 eyes with BRVO and 22 eyes with CRVO. In all 57 eyes with RVO, the ICC and CV of the full VD(VD of 3mm diameter circle) were 0.800 and 10.61%, respectively. Univariate analyses showed that the mean CMT (B, 0.001; p<0.001) and mean ganglion cell-Inner plexiform layer (GC-IPL) thickness (B, -0.002; p = 0.020) were significant factors that affected the repeatability. Multivariate analyses of these two factors showed that only mean CMT was a significant factor. The ICC and CV of the full VD in group 1 (CMT > 400 mu m) were 0.348 and 22.55% respectively. In group 2 (CMT < 400 mu m), the ICC and CV of the full VD were 0.910 and 7.76%, respectively. Conclusions The repeatability of VD measurement in eyes with RVO was reasonably comparable to previous studies. Repeatability of VD measurement was significantly affected by central macular thickness.	[Kim, Kyeung-Min; Lee, Min-Woo; Lim, Hyung-Bin; Koo, Hyung-Moon; Shin, Yong-Il; Kim, Jung-Yeul] Chungnam Natl Univ, Dept Ophthalmol, Coll Med, Daejeon, South Korea; [Lee, Min-Woo] Konyang Univ, Dept Ophthalmol, Coll Med, Daejeon, South Korea	Chungnam National University; Konyang University; Konyang University Hospital	Kim, JY (corresponding author), Chungnam Natl Univ, Dept Ophthalmol, Coll Med, Daejeon, South Korea.	kimjy@cnu.ac.kr		Kim, Jung yeul/0000-0003-3679-1310				Al-Sheikh M, 2016, BRIT J OPHTHALMOL; Cardoso JN, 2016, AM J OPHTHALMOL, V163, P93, DOI 10.1016/j.ajo.2015.11.025; Carpineto P, 2015, BRIT J OPHTHALMOL; Chen FK, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.1.6; Chung CY, 2018, INT OPHTHALMOL, V38, P1119, DOI 10.1007/s10792-017-0570-y; Corvi F, 2018, AM J OPHTHALMOL, V186, P25, DOI 10.1016/j.ajo.2017.11.011; Guo JX, 2017, OPHTHALMOLOGICA, V237, P21, DOI 10.1159/000453112; HAYREH SS, 1994, AM J OPHTHALMOL, V117, P429, DOI 10.1016/S0002-9394(14)70001-7; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; Lee HJ, 2015, AM J OPHTHALMOL, V160, P283, DOI 10.1016/j.ajo.2015.05.015; Lee M-W, 2018, BRIT J OPHTHALMOL; Mitchell P, 1996, ARCH OPHTHALMOL-CHIC, V114, P1243, DOI 10.1001/archopht.1996.01100140443012; Nicolai M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101636; PARODI MB, 1995, INT OPHTHALMOL, V19, P25, DOI 10.1007/BF00156415; Pechauer AD, 2015, INVEST OPHTH VIS SCI, V56, P3287, DOI 10.1167/iovs.15-16655; Rispoli M, 2015, RETINA-J RET VIT DIS, V35, P2332, DOI 10.1097/IAE.0000000000000845; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Shin IH, 2018, RETINA-J RET VIT DIS, V38, P253, DOI 10.1097/IAE.0000000000001535; SNMMI Newsline, 2016, J NUCL MED, V57, p19N, DOI DOI 10.1167/iovs.15-18904; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616; Suzuki N, 2016, AM J OPHTHALMOL, V161, P126, DOI 10.1016/j.ajo.2015.09.038; Wang Q, 2018, GRAEF ARCH CLIN EXP, V256, P1615, DOI 10.1007/s00417-018-4038-1; Wong TY, 2010, NEW ENGL J MED, V363, P2135, DOI 10.1056/NEJMcp1003934	23	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234933	10.1371/journal.pone.0234933	http://dx.doi.org/10.1371/journal.pone.0234933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584907	Green Published, gold			2022-12-27	WOS:000545747200030
J	Kim, SB; Lee, WY; Lee, JH; Lee, SJ; Lee, MK; Kim, SH; Uh, Y; Jung, SH; Shin, B				Kim, Sae Byol; Lee, Won-Yeon; Lee, Ji-Ho; Lee, Seok Jeong; Lee, Myoung Kyu; Kim, Sang-Ha; Uh, Young; Jung, Soon-Hee; Shin, Beomsu			A variety of bacterial aetiologies in the lower respiratory tract at patients with endobronchial tuberculosis	PLOS ONE			English	Article							EPITHELIAL-CELLS; LUNG MICROBIOME; PULMONARY; DISEASE; BRONCHIECTASIS; COLONIZATION; PATHOGENESIS; PROGRESSION; MORTALITY; FIBROSIS	Recently, our understanding of the elusive bacterial communities in the lower respiratory tract and their role in chronic lung disease has increased significantly. However, little is known about the respiratory microorganisms in patients with endobronchial tuberculosis (EBTB), which is a chronic inflammatory disease characterized by destruction of the tracheobronchial tree due toMycobacterium tuberculosis(MTB) infection. We retrospectively reviewed data for histopathologically and microbiologically confirmed EBTB patients diagnosed at a tertiary referral hospital in South Korea between January 2013 and January 2019. Bacterial cultures were performed on bronchial washing from these patients at the time of EBTB diagnosis. A total of 216 patients with EBTB were included in the study. The median age was 73 years and 142 (65.7%) patients were female. Bacteria were detected in 42 (19.4%) patients. Additionally, bacterial co-infection was present in 6 (2.8%) patients. Apart from MTB, the most common microorganisms identified wereStaphylococcus aureus(n = 14, 33.3%) followed byKlebsiellaspecies (n = 12, 28.6%; 10Klebsiella pneumoniae, 2Klebsiella oxytoca),Streptococcusspecies (n = 5, 11.9%),Enterobacterspecies (n = 4, 9.5%), andPseudomonas aeruginosa(n = 3, 7.1%). A variety of microorganisms were isolated from the bronchial washing indicating that changes in microorganism composition occur in the airways of patients with EBTB. Further studies are needed to investigate the clinical significance of this finding.	[Kim, Sae Byol; Lee, Won-Yeon; Lee, Ji-Ho; Lee, Seok Jeong; Lee, Myoung Kyu; Kim, Sang-Ha; Shin, Beomsu] Yonsei Univ, Dept Internal Med, Wonju Coll Med, Wonju, South Korea; [Uh, Young] Yonsei Univ, Dept Lab Med, Wonju Coll Med, Wonju, South Korea; [Jung, Soon-Hee] Yonsei Univ, Dept Pathol, Wonju Coll Med, Wonju, South Korea	Yonsei University; Yonsei University; Yonsei University	Shin, B (corresponding author), Yonsei Univ, Dept Internal Med, Wonju Coll Med, Wonju, South Korea.	bsshin83@gmail.com	Lee, Seok Jeong/ABF-7548-2020; Lee, Seok Jeong/ABG-4864-2020	Lee, Seok Jeong/0000-0001-6648-5985; Shin, Beomsu/0000-0002-8449-0195				Aksamit TR, 2017, CHEST, V151, P982, DOI 10.1016/j.chest.2016.10.055; [Anonymous], 2008, J GASTROINTEST SURG, V12, P57; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Cabello H, 1997, EUR RESPIR J, V10, P1137, DOI 10.1183/09031936.97.10051137; Chalmers JD, 2013, MOL IMMUNOL, V55, P27, DOI 10.1016/j.molimm.2012.09.011; Chung HS, 2000, CHEST, V117, P385, DOI 10.1378/chest.117.2.385; Cui ZL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-276; Dickson RP, 2016, ANNU REV PHYSIOL, V78, P481, DOI 10.1146/annurev-physiol-021115-105238; Dickson RP, 2015, ANN AM THORAC SOC, V12, P821, DOI 10.1513/AnnalsATS.201501-029OC; Dickson RP, 2014, LANCET, V384, P691, DOI 10.1016/S0140-6736(14)61136-3; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Esteban J, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02651; Han MK, 2014, LANCET RESP MED, V2, P548, DOI 10.1016/S2213-2600(14)70069-4; Hiemstra PS, 2015, EUR RESPIR J, V45, P1150, DOI 10.1183/09031936.00141514; Hugle T, 2011, J INFLAMM RES, V4, P21, DOI 10.2147/JIR.S10602; Ishikawa S, 2019, J INFECT CHEMOTHER, V25, P45, DOI 10.1016/j.jiac.2018.10.005; Jung SS, 2015, RESPIROLOGY, V20, P488, DOI 10.1111/resp.12474; LEE JH, 1992, CHEST, V102, P990, DOI 10.1378/chest.102.4.990; Lee N, 2014, TUBERC RESPIR DIS, V77, P251, DOI 10.4046/trd.2014.77.6.251; Loebinger MR, 2009, EUR RESPIR J, V34, P843, DOI 10.1183/09031936.00003709; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Meyer KC, 2012, AM J RESP CRIT CARE, V185, P1004, DOI 10.1164/rccm.201202-0320ST; Molyneaux PL, 2013, EUR RESPIR REV, V22, P376, DOI 10.1183/09059180.00000713; Molyneaux PL, 2014, AM J RESP CRIT CARE, V190, P906, DOI 10.1164/rccm.201403-0541OC; Ozkaya S, 2012, MULTIDISCIP RESP MED, V7, DOI 10.1186/2049-6958-7-34; Paharik AE, 2016, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 5 EDITION, P529, DOI 10.1128/microbiolspec.VMBF-0022-2015; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; Salsgiver EL, 2016, CHEST, V149, P390, DOI 10.1378/chest.15-0676; Shim Y S, 1996, Respirology, V1, P95, DOI 10.1111/j.1440-1843.1996.tb00017.x; Shimazaki T, 2018, INT J TUBERC LUNG D, V22, P65, DOI 10.5588/ijtld.17.0389; Shirai M, 2001, Respirology, V6, P311, DOI 10.1046/j.1440-1843.2001.00349.x; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Wang JX, 2019, INT J CHRONIC OBSTR, V14, P1923, DOI 10.2147/COPD.S217971; Zalacain R, 1999, EUR RESPIR J, V13, P343, DOI 10.1034/j.1399-3003.1999.13b21.x	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234558	10.1371/journal.pone.0234558	http://dx.doi.org/10.1371/journal.pone.0234558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584852	Green Published, gold			2022-12-27	WOS:000545747200002
J	Moghavvemi, S; Jaafar, NI; Sulaiman, A; Tajudeen, FP				Moghavvemi, Sedigheh; Jaafar, Noor Ismawati; Sulaiman, Ainin; Parveen Tajudeen, Farzana			Feelings of guilt and pride: Consumer intention to buy LED lights	PLOS ONE			English	Article							PRO-ENVIRONMENTAL BEHAVIOR; SELF-REGULATORY FUNCTION; PLANNED BEHAVIOR; ANTICIPATED PRIDE; ECOLOGICAL BEHAVIOR; PERSONAL NORMS; EMOTIONS; DETERMINANTS; ANTECEDENTS; DECISIONS	The adoption of energy-efficient lighting systems such as light-emitting diode (LED) lights is an effective strategy to address global warming and climate change. The adoption of LED light usage is largely shaped by consumer behavior. Understanding the factors that influence consumers' awareness of the advantages of using LED lights and consumers' eventual buying behavior is critical to industry players and policy-makers. The objective of this study is to investigate the significant factors that affect consumer intention to use LED lights among Malaysian households. A survey questionnaire of 1,075 potential consumers was employed and the partial least squares technique was applied in data analysis. The results show that consumer awareness creates responsibility and influences consumers' personal norms and attitudes, and their ultimate intention to buy LED lights. Feelings of guilt about contributing to air pollution and an awareness of the advantages of using LED lights both activate individual personal norms and attitudes, and influence the intention to buy LED lights. Awareness of the advantages of using LED lights, and of the negative consequences of not using them, prompts consumers to have feelings of guilt. The findings point to the importance of creating awareness among consumers.	[Moghavvemi, Sedigheh; Jaafar, Noor Ismawati; Sulaiman, Ainin; Parveen Tajudeen, Farzana] Univ Malaya, Fac Business & Accountancy, Kuala Lumpur, Malaysia	Universiti Malaya	Moghavvemi, S (corresponding author), Univ Malaya, Fac Business & Accountancy, Kuala Lumpur, Malaysia.	sedigheh@um.edu.my	Tajudeen, Farzana Parveen/B-5640-2017; Moghavvemi, Sedigheh/AAU-1969-2020; Jaafar, Noor Ismawati/B-7963-2010	Tajudeen, Farzana Parveen/0000-0001-9903-7898; Moghavvemi, Sedigheh/0000-0002-0628-6906; Jaafar, Noor Ismawati/0000-0002-8604-6004	Long-Term Research Grant Scheme by the Malaysia Ministry of Education (MOE); University of Malaya, Malaysia [LR001B-2016A]	Long-Term Research Grant Scheme by the Malaysia Ministry of Education (MOE); University of Malaya, Malaysia(Universiti Malaya)	This research was funded by the Long-Term Research Grant Scheme by the Malaysia Ministry of Education (MOE) and under University of Malaya, Malaysia grant number LR001B-2016A.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1980, UNDERSTANDING ATTITU; [Anonymous], 2011, CLIN CHEM, V57, P788, DOI 10.1373/clinchem.2011.164400; [Anonymous], 2005, CRIT CARE, V9, pR32; [Anonymous], 1993, SELF CONSCIOUS EMOTI; Averdung A., 2011, J BUSINESS MANAGEMEN, V2, P98, DOI [10.3390/su9122351, DOI 10.3390/SU9122351]; Bagozzi R, 2003, J BEHAV DECIS MAKING, V16, P273, DOI 10.1002/bdm.446; Bamberg S, 2007, J ENVIRON PSYCHOL, V27, P190, DOI 10.1016/j.jenvp.2007.04.001; Bamberg S, 2007, J ENVIRON PSYCHOL, V27, P14, DOI 10.1016/j.jenvp.2006.12.002; Bank World, 2018, UND POV EN OV; Batson CD, 2002, J PERS SOC PSYCHOL, V83, P330, DOI 10.1037//0022-3514.83.2.330; BAUMEISTER RF, 1995, BASIC APPL SOC PSYCH, V17, P173, DOI 10.1207/s15324834basp1701&2_10; Bissing-Olson MJ, 2016, J ENVIRON PSYCHOL, V45, P145, DOI 10.1016/j.jenvp.2016.01.001; Byun J, 2013, IEEE T CONSUM ELECTR, V59, P70, DOI 10.1109/TCE.2013.6490243; Chai L.T., 2010, MANAGEMENT SCI ENG, V4, P27, DOI DOI 10.3968/J.MSE.1913035X20100402.002; Chin WW, 2003, INFORM SYST RES, V14, P189, DOI 10.1287/isre.14.2.189.16018; Cialdini RB, 1991, PSYCHOL INQ, V2, P124, DOI DOI 10.1207/S15327965PLI0202_; Cowan K.R., 2011, TECHN MAN EN SMART W, P1; De Bellefroid H, 2017, IIIEE SED REPORTS; de Groot J, 2007, J APPL SOC PSYCHOL, V37, P1817, DOI 10.1111/j.1559-1816.2007.00239.x; De Groot JIM, 2009, J SOC PSYCHOL, V149, P425, DOI 10.3200/SOCP.149.4.425-449; Eagly A. H., 1993, PSYCHOL ATTITUDES; Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128; Han H, 2017, J TRAVEL TOUR MARK, V34, P1155, DOI 10.1080/10548408.2017.1304317; Harland P, 1999, J APPL SOC PSYCHOL, V29, P2505, DOI 10.1111/j.1559-1816.1999.tb00123.x; Harland P, 2007, BASIC APPL SOC PSYCH, V29, P323, DOI 10.1080/01973530701665058; Harth NS, 2013, J ENVIRON PSYCHOL, V34, P18, DOI 10.1016/j.jenvp.2012.12.005; Heath Y, 2002, J APPL SOC PSYCHOL, V32, P2154, DOI 10.1111/j.1559-1816.2002.tb02068.x; Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8; IEA, 2012, EN TECHN PERSP 2012; JONES WH, 1993, J PERS ASSESS, V61, P246, DOI 10.1207/s15327752jpa6102_6; Kamaruzzaman SN, 2014, 2 INT C RES SCI ENG, P165; Klockner CA, 2013, GLOBAL ENVIRON CHANG, V23, P1028, DOI 10.1016/j.gloenvcha.2013.05.014; Klockner CA, 2010, J ENVIRON PSYCHOL, V30, P574, DOI 10.1016/j.jenvp.2010.03.001; Mellers BA, 2001, CURR DIR PSYCHOL SCI, V10, P210, DOI 10.1111/1467-8721.00151; Motherway B, 2017, ENERGY EFFICIENCY 20; Nardelli A, 2017, RENEW SUST ENERG REV, V75, P368, DOI 10.1016/j.rser.2016.11.002; Onwezen MC, 2014, J ENVIRON PSYCHOL, V40, P239, DOI 10.1016/j.jenvp.2014.07.003; Onwezen MC, 2014, EUR J SOC PSYCHOL, V44, P53, DOI 10.1002/ejsp.1991; Onwezen MC, 2013, J ECON PSYCHOL, V39, P141, DOI 10.1016/j.joep.2013.07.005; Pandharipande A, 2011, ENERG BUILDINGS, V43, P944, DOI 10.1016/j.enbuild.2010.12.018; Paul J, 2016, J RETAIL CONSUM SERV, V29, P123, DOI 10.1016/j.jretconser.2015.11.006; Rees JH, 2014, EUR J SOC PSYCHOL, V44, P466, DOI 10.1002/ejsp.2032; Richardson C, 2007, LED APPL DRIV TECHN; Schwartz S. H., 1977, NORMATIVE INFLUENCES, P221; Schwartz S.H., 1981, ALTRUISM HELP BEHAV, P189; Singh N, 2013, SOC RESPONSIB J, V9, P4, DOI 10.1108/17471111311307787; Staub E., 2013, POSITIVE SOCIAL BEHA; Steg L, 2010, BRIT J SOC PSYCHOL, V49, P725, DOI 10.1348/014466609X477745; Su H.-J., 2011, ASIA PAC MANAG REV, V16, P255; Taguchi T, 2008, IEEJ T ELECTR ELECTR, V3, P21, DOI 10.1002/tee.20228; Tan CS, 2013, IOP C SER EARTH ENV, V16, DOI 10.1088/1755-1315/16/1/012126; Tangney J.D., 2003, SHAME GUILT; Tracy JL, 2007, J PERS SOC PSYCHOL, V92, P506, DOI 10.1037/0022-3514.92.3.506; Tracy JL, 2004, PSYCHOL INQ, V15, P103, DOI 10.1207/s15327965pli1502_01; van der Werff E, 2013, GLOBAL ENVIRON CHANG, V23, P1258, DOI 10.1016/j.gloenvcha.2013.07.018; Vining J., 1987, J ENVIRON PSYCHOL, V7, P13, DOI [10.1016/S0272-4944(87)80042-7, DOI 10.1016/S0272-4944(87)80042-7]; VINING JA, 1992, ENVIRON BEHAV, V24, P3, DOI 10.1177/0013916592241001; Williams LA, 2009, PSYCHOL SCI, V20, P284, DOI 10.1111/j.1467-9280.2009.02292.x; Zhang XJ, 2018, RESOUR CONSERV RECY, V134, P121, DOI 10.1016/j.resconrec.2018.03.003; Zhang YX, 2013, ENERG POLICY, V62, P1120, DOI 10.1016/j.enpol.2013.07.036	61	8	8	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234602	10.1371/journal.pone.0234602	http://dx.doi.org/10.1371/journal.pone.0234602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584847	Green Published, gold			2022-12-27	WOS:000545747200016
J	Parreira, P; Sousa, LB; Marques, IA; Costa, P; Cortez, S; Carneiro, F; Cruz, A; Salgueiro-Oliveira, A				Parreira, Pedro; Sousa, Liliana B.; Marques, Ines A.; Costa, Paulo; Cortez, Sara; Carneiro, Filipa; Cruz, Armenio; Salgueiro-Oliveira, Anabela			Development of an innovative double-chamber syringe for intravenous therapeutics and flushing: Nurses' involvement through a human-centred approach	PLOS ONE			English	Article							HEALTH TECHNOLOGY-ASSESSMENT; MEDICAL DEVICE DEVELOPMENT; ACCESS DEVICES; CHALLENGES; GUIDELINES; INFECTIONS; CATHETERS; DESIGN	Background In nursing practice, flushing the catheters pre and post-drug administration is considered an important clinical procedure to prevent complications, and requires the use of several syringes to comply with international standards of care. We envisioned an innovative double-chamber syringe that enables the filling and administration of both solutions. Following current international recommendations, the development of new medical devices should integrate Health Technology Assessment. The Human-centred design is usually used for that assessment purposes, as a method that actively include end-users in the devices development process. Method Application of the Human-Centred Design through the involvement of nurses in the initial stages of the device development in order to accomplish the initial stages of Technology Readiness Level. A multi-method approach was used, including literature/guidelines review, focus groups with end-users and expert panels. Results The involvement of nurses enabled the definition of user requirements and contexts of use, as well as the evaluation of design solutions and prototypes in order to accomplish with usability and ergonomic features of the medical device. Conclusions Significant contributions were made regarding the final design solution of this innovative double-chamber syringe.	[Parreira, Pedro; Sousa, Liliana B.; Costa, Paulo; Cruz, Armenio; Salgueiro-Oliveira, Anabela] Nursing Sch Coimbra ESEnfC, Hlth Sci Res Unit Nursing UICISA E, Coimbra, Portugal; [Marques, Ines A.] Univ Coimbra, Coimbra Inst Clin & Biomed Res iCBR, Area CIMAGO, CNC,IBILI,Fac Med, Coimbra, Portugal; [Cortez, Sara] Muroplas Plast Engn Ind, Muro, Portugal; [Carneiro, Filipa] PIEP Innovat Polymer Engn, Guimaraes, Portugal	Nursing School of Coimbra; Universidade de Coimbra	Parreira, P (corresponding author), Nursing Sch Coimbra ESEnfC, Hlth Sci Res Unit Nursing UICISA E, Coimbra, Portugal.	parreira@esenfc.pt	Marques, Inês Alexandra Figueira/AAE-4286-2021; Marques, Inês A./AAE-4281-2021; Parreira, Pedro/AAD-9966-2019; Santos-Costa, Paulo/S-1406-2018; Cruz, Armenio/U-8490-2017	Marques, Inês A./0000-0001-5690-3020; Parreira, Pedro/0000-0002-3880-6590; Carneiro, Ana Filipa Goncalves da Costa/0000-0002-4439-4166; Santos-Costa, Paulo/0000-0003-0761-6548; Cruz, Armenio/0000-0003-3254-3176; Cortez, Sara/0000-0002-2794-084X; B. Sousa, Liliana/0000-0002-8914-6975	Portugal's National Innovation Agency [POCI-01-0247-FEDER-017604]; Portuguese National Funding Agency for Science, Research and Technology (FCT) [SFRH/BD/136487/2018, SFRH/BD/136973/2018]	Portugal's National Innovation Agency; Portuguese National Funding Agency for Science, Research and Technology (FCT)	The Duo Syringe project is funded by Portugal's National Innovation Agency, specifically on behalf of the Research & Technological Development Incentive System (SI I&DT Co-Promotion; Project reference: POCI-01-0247-FEDER-017604). The authors PC (SFRH/BD/136487/2018) and IAM (SFRH/BD/136973/2018) also thank the Portuguese National Funding Agency for Science, Research and Technology (FCT) for the financial support granted through the 2018 PhD scholarship program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hak Charifi Kamel, 2014, Texto contexto - enferm., V23, P633, DOI 10.1590/0104-07072014000900013; Ngo A, 2005, J INFUS MURS, V28, P173, DOI 10.1097/00129804-200505000-00005; [Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S001; [Anonymous], 1999, 13407 ISO; [Anonymous], 2012, 14971 ISO; Bardin L, 2007, ANAL CONTENU; Bishop L, 2007, INT J LAB HEMATOL, V29, P261, DOI 10.1111/j.1751-553X.2007.00931.x; Borsci S, 2018, EXPERT REV MED DEVIC, V15, P15, DOI 10.1080/17434440.2018.1418661; Borsci S, 2014, EXPERT REV MED DEVIC, V11, P513, DOI 10.1586/17434440.2014.940312; Borsci S, 2013, ACM T COMPUT-HUM INT, V20, DOI 10.1145/2506210; Braga LM, 2018, REV LAT-AM ENFERM, V26, DOI 10.1590/1518-8345.2377.3002; Capdevila JA, 2016, CIR CARDIOVASC, V23, P192, DOI 10.1016/j.circv.2016.06.001; Chopra V, 2015, ANN INTERN MED, V163, pS1, DOI 10.7326/M15-0744; Ciani O, 2017, HEALTH ECON, V26, P13, DOI 10.1002/hec.3479; Ciurana J, 2014, INT J COMPUT INTEG M, V27, P901, DOI 10.1080/0951192X.2014.934292; Clinical Excellence Commission, 2017, DEV US HDB INTR RES; EUnetHTA Joint action European Network for Health Technology, 2015, EUNETHTA JOINT ACT E; Fuchs S, 2017, HEALTH POLICY, V121, P215, DOI 10.1016/j.healthpol.2016.08.010; Goossens GA, 2015, NURS RES PRACT, V2015, DOI 10.1155/2015/985686; Guiffant G, 2012, J VASC ACCESS, V13, P75, DOI 10.5301/JVA.2011.8487; Harte Richard, 2017, JMIR Hum Factors, V4, pe8, DOI 10.2196/humanfactors.5443; Hwang TJ, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3323; India State Level Disease Burden Initiative Road Injury Collaborators, 2020, LANCET PUBLIC HLTH, V5, pe86; International organization for standardization, 2011, 14155 ISO; International Organization for Standardization, 2015, 623661 ISO IEC; Keogh S, 2015, INT J NURS STUD, V52, P1678, DOI 10.1016/j.ijnurstu.2015.07.001; Keogh S, 2014, J INFUS MURS, V37, P96, DOI 10.1097/NAN.0000000000000024; Kramer DB, 2017, JAMA-J AM MED ASSOC, V318, P332, DOI 10.1001/jama.2017.8976; Loveday HP, 2014, J HOSP INFECT, V86, pS1, DOI 10.1016/S0195-6701(13)60012-2; Maresova P, 2015, THER CLIN RISK MANAG, V11, P1505, DOI 10.2147/TCRM.S88574; Martin JL, 2008, APPL ERGON, V39, P271, DOI 10.1016/j.apergo.2007.10.002; Martin JL, 2006, PHYSIOL MEAS, V27, pR49, DOI 10.1088/0967-3334/27/8/R01; Martin JL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-74; Neugebauer EAM, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2168-0; OECD/OCDE, OECD GUIDELINE TESTI, DOI [10.1787/9789264091016-en, DOI 10.1787/9789264091016-EN]; Parreira P, 2020, TRIALS, V21, DOI 10.1186/s13063-019-3887-1; Polisena J, 2018, INT J TECHNOL ASSESS, V34, P276, DOI 10.1017/S0266462318000314; Privitera MB, 2017, APPL ERGON, V59, P251, DOI 10.1016/j.apergo.2016.08.034; Quinn P, 2017, COMPUT LAW SECUR REV, V33, P361, DOI 10.1016/j.clsr.2017.03.019; Danski MTR, 2015, ACTA PAUL ENFERM, V28, P517, DOI 10.1590/1982-0194201500087; Rojas-Sanchez LZ, 2015, REV ENFERM REF, P61, DOI [10.12707/RIII13141, DOI 10.12707/RIII13141, 10,12707/RIII13141]; Royal College of Nursing,, 2016, STAND INF THER; Royon L, 2012, CHEM ENG RES DES, V90, P803, DOI 10.1016/j.cherd.2011.10.004; Salgueiro-Oliveira A, 2012, AUST J ADV NURS, V30, P32; Santos ICT, 2013, EXPERT REV MED DEVIC, V10, P411, DOI [10.1586/erd.12.89, 10.1586/ERD.12.89]; Schnell-Inderst P, 2015, Z EVIDENZ FORTBILD Q, V109, P309, DOI 10.1016/j.zefq.2015.06.011; Sedrakyan A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2372; Strisland F, 2017, STUD HEALTH TECHNOL, V237, P49, DOI 10.3233/978-1-61499-761-0-49; Tarricone R, 2017, HEALTH ECON, V26, P70, DOI 10.1002/hec.3471; Tarricone R, 2017, HEALTH ECON, V26, P5, DOI 10.1002/hec.3469; Tarricone R, 2016, EUR RESPIR REV, V25, P259, DOI 10.1183/16000617.0016-2016; Vigier J., 2005, ITBM RBM, V26, P147, DOI DOI 10.1016/J.RBMRET.2005.03.001; Vincent CJ, 2014, APPL ERGON, V45, P413, DOI 10.1016/j.apergo.2013.05.009; Werk T, 2016, J PHARM SCI-US, V105, P4, DOI 10.1016/j.xphs.2015.11.025	54	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235087	10.1371/journal.pone.0235087	http://dx.doi.org/10.1371/journal.pone.0235087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584864	Green Published, gold			2022-12-27	WOS:000545747200006
J	Fernandez, JM; Dobrick, JB; Jadavji, A; Adam, RD				Fernandez, Jennifer M.; Dobrick, Jenna B.; Jadavji, Afraaz; Adam, Rodney D.			Staphylococcus aureusbacteremia at a referral medical center in Kenya: A retrospective review of cases from 2010 to 2018	PLOS ONE			English	Review							AUREUS BACTEREMIA; NASAL CARRIAGE; CARE; PATHOPHYSIOLOGY; EPIDEMIOLOGY; INFECTIONS; MANAGEMENT; CHILDREN; AFRICA	Background Many studies have shown thatStaphylococcus aureusis a leading cause of both community onset and hospital onset bloodstream infections. However, relatively little is known about the occurrence and outcome ofS. aureusbacteremia in sub-Saharan Africa. A previous report indicated thatS. aureusaccounts for 16% of community onset and 6% of hospital onset bloodstream infections at Aga Khan University Hospital Nairobi (AKUHN). Data about the etiology ofS. aureusbacteremia in sub-Saharan Africa will help optimize recognition and treatment. This study was performed in order to understand the etiologies and risk factors forS.aureusbacteremia in a sub-Saharan location. Materials and methods A review of the electronic record of laboratory results from September 2010 through December 2018 identified 201 patients seen at AKUHN withS. aureusbacteremia. The source and/or focus of infection was identified and in-hospital mortality was determined. Cases with bacteremia after three days of hospitalization were considered hospital acquired. Community onset cases were divided into community acquired and health care associated. Results Most cases (71%; 143/201) were community onset, but only 41% (83/201) of these cases were community acquired. The most commonly identified foci of infection for community acquired bacteremia were musculoskeletal (25%; 21/83) and skin and soft tissue (24%; 20/83). The majority of health care associated (70%; 40/57) and hospital acquired cases (74%; 43/58) were associated with invasive vascular devices, with peripheral IVs being the most common for hospital acquired and dialysis catheters being the most common for health care associated infections. In-hospital mortality rates were 23% (19/83) for community acquired, 19% (11/57) for health care associated and 33% (19/58) for hospital acquired infections. Conclusion Invasive vascular devices were associated with a substantial portion of cases ofS.aureusbacteremia and provide an important target for infection control efforts.	[Fernandez, Jennifer M.; Dobrick, Jenna B.] Univ Arizona, Coll Med, Tucson, AZ USA; [Jadavji, Afraaz] Univ Waterloo, Waterloo, ON, Canada; [Adam, Rodney D.] Aga Khan Univ, Nairobi, Kenya	University of Arizona; University of Waterloo; Aga Khan University	Adam, RD (corresponding author), Aga Khan Univ, Nairobi, Kenya.	Rodney.adam@aku.edu		Adam, Rodney/0000-0002-6665-4280; Fernandez, Jennifer/0000-0001-9213-6551				Adam RD, 2019, INT J INFECT DIS, V85, P182, DOI 10.1016/j.ijid.2019.06.001; Aiken AM, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-22; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Cardoso T, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-40; Chansky PB, 2017, BRIT J DERMATOL, V176, P853, DOI 10.1111/bjd.15433; Fortuin-de Smidt MC, 2015, INT J INFECT DIS, V30, P41, DOI 10.1016/j.ijid.2014.10.011; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Groome MJ, 2012, PAEDIATR INT CHILD H, V32, P140, DOI 10.1179/1465328111Y.0000000044; Health KMo, 2017, GOV STEPS FIGHT KIDN; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; Kabinga SK, 2019, KIDNEY INT REP, V4, P1638, DOI 10.1016/j.ekir.2019.08.011; Kibet E, 2014, AM J CLIN PATHOL, V141, P188, DOI 10.1309/AJCPV8A9MRWHGXEF; Laupland Kevin B, 2015, BMC Res Notes, V8, P123, DOI 10.1186/s13104-015-1051-x; Maina D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147659; Naber CK, 2009, CLIN INFECT DIS, V48, pS231, DOI 10.1086/598189; Omuse G, 2012, J HOSP INFECT, V80, P71, DOI 10.1016/j.jhin.2011.09.009; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Salvador VBD, 2017, TEX HEART I J, V44, P10, DOI 10.14503/THIJ-15-5359; Steinberg JP, 1996, CLIN INFECT DIS, V23, P255, DOI 10.1093/clinids/23.2.255; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Trinh TT, 2011, INFECT CONT HOSP EP, V32, P579, DOI 10.1086/660099; UNAIDS, HIV KEN 2020; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Wangai FK, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4245-3; Wenzler E, 2017, CLIN INFECT DIS, V65, P194, DOI 10.1093/cid/cix315; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234914	10.1371/journal.pone.0234914	http://dx.doi.org/10.1371/journal.pone.0234914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574220	Green Published, gold			2022-12-27	WOS:000544972400013
J	Domensino, AF; van Haastregt, JCM; Winkens, I; van Bennekom, CAM; van Heugten, CM				Domensino, Anne-Fleur; van Haastregt, Jolanda C. M.; Winkens, Ieke; van Bennekom, Coen A. M.; van Heugten, Caroline M.			Feasibility of a minimal dataset for adults with acquired brain injury in Dutch healthcare practice	PLOS ONE			English	Article							FATIGUE SEVERITY SCALE; QUALITY-OF-LIFE; SCREENING INSTRUMENTS; HOSPITAL ANXIETY; UTRECHT SCALE; REHABILITATION; DEPRESSION; VALIDITY; COMPREHENSION; INTERVENTION	Objective Data collection in the field of acquired brain injury (ABI) lacks uniformity due to the broad spectrum of available measurement instruments, leading to incomparability of data and the need for patients to 'repeat their story'. To pursue uniform data collection, an ABI-specific minimal dataset (MDS-ABI) is currently under development. The current study aimed to assess the feasibility (performance according to protocol, user opinion, potential implementation barriers, and suggested improvements) of the MDS-ABI in clinical settings. Methods A mixed-methods approach was used in a range of healthcare sectors for persons with ABI. Clinicians of several relevant disciplines within these sectors were asked to administer the MDS-ABI to five patients. Subsequently, feasibility according to clinicians was assessed by means of a paper questionnaire about every administration and an online questionnaire about the feasibility in general. Feasibility according to patients was assessed with a paper questionnaire and think aloud interviews. Results Thirteen clinicians and 50 patients were included. In general, the MDS-ABI performed according to protocol. Both clinicians and patients were overall satisfied with the content of the MDS-ABI. The Cumulative Illness Rating Scale was regarded incomprehensible, leading to missing data. Further, clinicians indicated that the MDS-ABI would not be suitable for all ABI-patients, as some are incapable of self-report due to potential cognitive problems, communicative problems, fatigue, perceptual problems, or impaired awareness of deficits. Conclusion The MDS-ABI is a promising tool for obtaining core information on ABI-patients. The MDS-ABI will be adjusted according to the suggestions. For patients who are incapable of self-report, a proxy-reported version of the self-reported part was developed.	[Domensino, Anne-Fleur; van Heugten, Caroline M.] Maastricht Univ, Sch Mental Hlth & Neurosci, Fac Hlth Med & Life Sci, Med Ctr, Maastricht, Netherlands; [Domensino, Anne-Fleur; Winkens, Ieke; van Heugten, Caroline M.] Limburg Brain Injury Ctr, Maastricht, Netherlands; [van Haastregt, Jolanda C. M.] Maastricht Univ, Med Ctr, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst, Maastricht, Netherlands; [Winkens, Ieke; van Heugten, Caroline M.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [van Bennekom, Coen A. M.] Heliomare Rehabil Ctr, Dept Res & Dev, Wijk Aan Zee, Netherlands; [van Bennekom, Coen A. M.] Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Coronel Inst Occupat Hlth,AMC, Amsterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Domensino, AF (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Fac Hlth Med & Life Sci, Med Ctr, Maastricht, Netherlands.; Domensino, AF (corresponding author), Limburg Brain Injury Ctr, Maastricht, Netherlands.	fleur.domensino@maastrichtuniversity.nl		Domensino, Anne-Fleur/0000-0003-3908-1816; van Bennekom, coen/0000-0002-9754-261X	Organisation of Health Research and Development (ZonMw - The Netherlands) [845004001]; Brain Foundation of The Netherlands	Organisation of Health Research and Development (ZonMw - The Netherlands); Brain Foundation of The Netherlands	Financial support for this work was received from the 'Gewoon Bijzonder' Programme on behalf of the Organisation of Health Research and Development (ZonMw - The Netherlands; www.zonmw.nl) (Grant reference 845004001), cofinanced by the Brain Foundation of The Netherlands to CMvH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aben I, 2002, PSYCHOSOMATICS, V43, P386, DOI 10.1176/appi.psy.43.5.386; Al-Jabr H, 2018, RES SOCIAL ADM PHARM; Amsterdam G, 2016, RESULTATEN AMSTERDAM; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Aujla N, 2018, J HEALTH PSYCHOL, DOI 10.1177/1359105318781942; Barkham M, 2005, AGING MENT HEALTH, V9, P235, DOI 10.1080/13607860500090052; Barlow S, 2007, EFSA J, V5, DOI 10.2903/j.efsa.2007.438; Bryman A., 2006, QUAL RES, V6, P97, DOI [10.1177/1468794106058877, DOI 10.1177/1468794106058877]; Centraal Bureau voor Statistiek, 2019, FEM MAJ ON 3 HIGH LE; Corporations IBM, 2016, IBM SPSS STAT MACBOO; Creswell JW, 2003, HDB MIXED METHODS SO, P240; Cumming TB, 2014, J PSYCHOSOM RES, V77, P374, DOI 10.1016/j.jpsychores.2014.08.009; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Domensino AF, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01286-3; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Gerafi J, 2017, EUR J NEUROL, V24, P1407, DOI 10.1111/ene.13406; Grimm P., 2010, WILEY INT ENCY MARKE, DOI DOI 10.1080/14787210.2016.1227702; Holdsworth LK, 2012, PHYS THER, V92, P378, DOI 10.2522/ptj.20110001; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Jones FW, 2007, J INTELL DISABIL RES, V51, P545, DOI 10.1111/j.1365-2788.2006.00926.x; Jones TM, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0039-x; Juniper E, 2009, EUR RESP SOC; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lazar RM, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0797-z; LEDORZE G, 1995, APHASIOLOGY, V9, P239; Lerdal A, 2011, INT J NURS STUD, V48, P1258, DOI 10.1016/j.ijnurstu.2011.02.019; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Lutomski JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081673; Mahoney FI, 1965, MARYLAND STATE MED J; Markovic G, 2017, BRAIN INJURY, V31, P9, DOI 10.1080/02699052.2016.1206213; Monahan PO, 2019, J GEN INTERN MED; Moores KL, 2012, INT J QUAL HEALTH C, V24, P517, DOI 10.1093/intqhc/mzs051; Naess H, 2012, VASC HEALTH RISK MAN, V8, P407, DOI 10.2147/VHRM.S32780; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; NCCN Clinical Practice, 2018, ACUTE MYELOID LEUKEM, VV2, pMS28; Nelson EC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7818; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Post MWM, 2012, DISABIL REHABIL, V34, P478, DOI 10.3109/09638288.2011.608148; Prinsen CAC, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1555-2; Rasquin SMC, 2009, NEUROPSYCHOL REHABIL, V19, P208, DOI 10.1080/09602010802091159; Robertson K, 2015, BRAIN INJURY, V29, P848, DOI 10.3109/02699052.2015.1005135; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Saunders RP, 2005, HEALTH PROMOT PRACT, V6, P134, DOI 10.1177/1524839904273387; Sharma B, 2017, DISABIL REHABIL, V39, P1380, DOI 10.1080/09638288.2016.1195453; Stewart JC, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-21; Stiekema A, 2019, FINDING NEW BALANCE; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; Thoma-Lurken T, 2018, APPL NURS RES, V42, P35, DOI 10.1016/j.apnr.2018.04.008; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601; van den Haak M, 2003, BEHAV INFORM TECHNOL, V22, P339, DOI 10.1080/0044929031000; van der Mark L, 2015, GERON, V17, P29; van der Zee CH, 2010, J REHABIL MED, V42, P752, DOI 10.2340/16501977-0589; van Heugten C, 2020, NEUROPSYCHOL REHABIL, V30, P1598, DOI 10.1080/09602011.2019.1589533; Van Heugten CM, 2015, CLIN REHABIL, V29, P694, DOI 10.1177/0269215514553012; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	59	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235085	10.1371/journal.pone.0235085	http://dx.doi.org/10.1371/journal.pone.0235085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569269	gold, Green Published			2022-12-27	WOS:000543547900001
J	Zaeh, SE; Hayes, MM; Eakin, MN; Rand, CS; Turnbull, AE				Zaeh, Sandra E.; Hayes, Margaret M.; Eakin, Michelle N.; Rand, Cynthia S.; Turnbull, Alison E.			Housestaff perceptions on training and discussing the Maryland Orders for Life Sustaining Treatment Form (MOLST)	PLOS ONE			English	Article							RESUSCITATE ORDERS; PHYSICIAN ORDERS; MEDICAL ORDERS; CODE STATUS; RESIDENTS; COMMUNICATION; PROGRAM; SKILLS	Background On-line tutorials are being increasingly used in medical education, including in teaching housestaff skills regarding end of life care. Recently an on-line tutorial incorporating interactive clinical vignettes and communication skills was used to prepare housestaff at Johns Hopkins Hospital to use the Maryland Orders for Life Sustaining Treatment (MOLST) form, which documents patient preferences regarding end of life care. 40% of housestaff who viewed the module felt less than comfortable discussing choices on the MOLST with patients. We sought to understand factors beyond knowledge that contributed to housestaff discomfort in MOLST discussions despite successfully completing an on-line tutorial. Methods We conducted semi-structured telephone interviews with 18 housestaff who completed the on-line MOLST training module. Housestaff participants demonstrated good knowledge of legal and regulatory issues related to the MOLST compared to their peers, but reported feeling less than comfortable discussing the MOLST with patients. Transcripts of interviews were coded using thematic analysis to describe barriers to using the MOLST and suggestions for improving housestaff education about end of life care discussions. Results Qualitative analysis showed three major factors contributing to lack of housestaff comfort completing the MOLST form: [1] physician barriers to completion of the MOLST, [2] perceived patient barriers to completion of the MOLST, and [3] design characteristics of the MOLST form. Housestaff recommended a number of adaptations for improvement, including in-person training to improve their skills conducting conversations regarding end of life preferences with patients. Conclusions Some housestaff who scored highly on knowledge tests after completing a formal on-line curriculum on the MOLST form reported barriers to using a mandated form despite receiving training. On-line modules may be insufficient for teaching communication skills to housestaff. Additional training opportunities including in-person training mechanisms should be incorporated into housestaff communication skills training related to end of life care.	[Zaeh, Sandra E.; Eakin, Michelle N.; Rand, Cynthia S.; Turnbull, Alison E.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21218 USA; [Hayes, Margaret M.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Hayes, Margaret M.] Harvard Med Sch, Shapiro Inst Educ & Res, Boston, MA 02115 USA; [Hayes, Margaret M.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Turnbull, Alison E.] Johns Hopkins Univ, Outcomes Crit Illness & Surg OACIS Grp, Baltimore, MD USA; [Turnbull, Alison E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zaeh, SE (corresponding author), Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21218 USA.	szaeh1@jhmi.edu		Hayes, Margaret M/0000-0002-5848-6088; Zaeh, Sandra/0000-0002-5091-1975	Johns Hopkins Department of Medical Affairs; National Heart, Blood, and Lung Institute [T32HL007534-36]	Johns Hopkins Department of Medical Affairs; National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Turnbull was supported by the Johns Hopkins Department of Medical Affairs. Dr. Zaeh was supported by the National Heart, Blood, and Lung Institute under Grant T32HL007534-36. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Buss Mary Kathleen, 2005, J Palliat Med, V8, P363, DOI 10.1089/jpm.2005.8.363; Calam B, 2000, CAN MED ASSOC J, V163, P1255; Dimeff LA, 2009, BEHAV RES THER, V47, P921, DOI 10.1016/j.brat.2009.07.011; Farrelly CA, COMMUNICATION; Fromme EK, 2012, JAMA-J AM MED ASSOC, V307, P34, DOI 10.1001/jama.2011.1956; Gorman TE, 2005, ACAD MED, V80, P622, DOI 10.1097/00001888-200507000-00004; Hickman SE, 2015, J AM GERIATR SOC, V63, P341, DOI 10.1111/jgs.13248; Hickman SE, 2011, J AM GERIATR SOC, V59, P2091, DOI 10.1111/j.1532-5415.2011.03656.x; Hope AA, 2015, ANN AM THORAC SOC, V12, P505, DOI 10.1513/AnnalsATS.201501-040OC; KOLB 8DAVID A., 2015, EXPERIENTIAL LEARNIN; Mann Karen V, 2002, J Contin Educ Health Prof, V22, P69, DOI 10.1002/chp.1340220202; Mirarchi FL, 2015, J PATIENT SAF, V11, P1, DOI 10.1097/PTS.0000000000000165; Moore KA, 2016, JAMA-J AM MED ASSOC, V315, P259, DOI 10.1001/jama.2015.17362; National POLST Paradigm, POLST PAR FUND; Office of Health Care Quality, MAR MOLST MED ORD LI; Schwartz Charles E, 2003, J Palliat Med, V6, P37, DOI 10.1089/10966210360510109; Siddiqui MF, 2011, AM J HOSP PALLIAT ME, V28, P94, DOI 10.1177/1049909110374599; Stevens L, 2002, CRIT CARE MED, V30, P290, DOI 10.1097/00003246-200202000-00004; Sulmasy DP, 1996, J GEN INTERN MED, V11, P657, DOI 10.1007/BF02600156; Szmuilowicz E, 2012, J PALLIAT MED, V15, P768, DOI 10.1089/jpm.2011.0446; Tarzian AJ, 2017, J PALLIAT MED, V20, P939, DOI 10.1089/jpm.2016.0440; Turnbull AE, 2016, ANN AM THORAC SOC, V13, P926, DOI 10.1513/AnnalsATS.201511-738OC; van den Eertwegh V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125958; Williams DM, 2011, AM J HOSP PALLIAT ME, V28, P328, DOI 10.1177/1049909110391646; Wittenberg-Lyles E, 2014, J PALLIAT MED, V17, P400, DOI 10.1089/jpm.2013.0270; Zante B, 2019, J INTENSIVE CARE MED, V34, P301, DOI 10.1177/0885066617716057	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234973	10.1371/journal.pone.0234973	http://dx.doi.org/10.1371/journal.pone.0234973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559244	gold, Green Published			2022-12-27	WOS:000543261600046
J	Wubishet, BL; Harris, ML; Forder, PM; Byles, JE				Wubishet, Befikadu L.; Harris, Melissa L.; Forder, Peta M.; Byles, Julie E.			Age and cohort rise in diabetes prevalence among older Australian women: Case ascertainment using survey and healthcare administrative data	PLOS ONE			English	Article							LIFE-STYLE; EPIDEMIOLOGY; TRENDS; ADULTS; LIMITATIONS; ADJUSTMENT	Background Due to the absence and or costliness of biological measures such as glycated haemoglobin, diabetes case ascertainment and prevalence studies are usually conducted using surveys or routine health service use databases. However, the use of each of these sources is associated with its limitations potentially impacting the quality of the case ascertainment and prevalence estimation. This study aimed at ascertaining diabetes cases and estimating prevalence among mid- and older-age women through simultaneous use of a longitudinal survey and multiple healthcare administrative data sources. Methods Data were available for 12,432 and 13,714 women born in 1921-26 and 1946-51 from the Australian Longitudinal Study on Women's Health (ALSWH). Diabetes was ascertained using the ALSWH survey, health service use, and cause of death data. Parsimonious multiple logistic regression analyses tested associations between sociodemographic and health variables and the presence of diabetes. Results In both cohorts, two or more of the sources captured more than 80% of the women with diabetes. The point prevalence of diabetes increased from 8.4% when the mean age of the women were aged 73, to 22.0% of surviving women at age 90 in the 1921-26 cohort; and from 2.6% at age 48 to 15.8% at age 68 in the 1946-51 cohort. In the 1921-26 cohort, women who were obese (OR: 3.56; 95 CI: 3.04-4.17) and women who were sedentary (OR: 1.18; 95 CI: 1.09-1.40) were more likely to have diabetes compared to those who had a normal weight and engaged in a moderate level of physical activity. In the 1946-51 cohort, the odds of diabetes increased three times (OR: 2.99; 95 CI: 2.54-3.52) for overweight women and nine times (OR: 8.78; 95 CI: 7.46-10.33) for obese women compared to those who had normal weight. Conclusions The simultaneous use of multiple data sources improved the validity of diabetes case ascertainment. Application of this methodology in future studies may have important benefits including estimation of disease burden, health service needs, and resource allocation with improved precision. Diabetes prevalence increased with age, was much higher in the 1946-51 cohort than in 1921-26 at similar ages, and was significantly associated with physical inactivity and obesity. Interventions to promote physical activity and a healthy weight are needed to prevent the rising prevalence of diabetes across successive generations.	[Wubishet, Befikadu L.; Harris, Melissa L.; Forder, Peta M.; Byles, Julie E.] Univ Newcastle, Hunter Med Res Inst, Res Ctr Generat Hlth & Ageing, Newcastle, NSW, Australia; [Wubishet, Befikadu L.] Mekelle Univ, Sch Pharm, Mekelle, Tigray, Ethiopia	Hunter Medical Research Institute; University of Newcastle; Mekelle University	Wubishet, BL (corresponding author), Univ Newcastle, Hunter Med Res Inst, Res Ctr Generat Hlth & Ageing, Newcastle, NSW, Australia.; Wubishet, BL (corresponding author), Mekelle Univ, Sch Pharm, Mekelle, Tigray, Ethiopia.	BefikaduLegesse.Wubishet@uon.edu.au	Wubishet, Befikadu/AAI-6038-2020	Wubishet, Befikadu/0000-0001-9896-8893	Australian Government Department of Health [G1700929]; University of Newcastle; Australian Research Council Centre of Excellence in Population Ageing Research [CE170100005]; Population Health Research Network	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); University of Newcastle; Australian Research Council Centre of Excellence in Population Ageing Research(Australian Research Council); Population Health Research Network	The research on which this paper is based was conducted as part of the Australian Longitudinal Study on Women's Health (ALSWH) by the University of Queensland and the University of Newcastle. ALSWH is funded by the Australian Government Department of Health (https://www.health.gov.au/) (G1700929). BLW is a recipient of a University of Newcastle PhD scholarship and a topup scholarship from the Australian Research Council Centre of Excellence in Population Ageing Research (https://www.neura.edu.au/project/arc-centre-of-excellence-in-population-ageing-research/) (project number CE170100005).; The authors also acknowledge 1) Centre for Health Record Linkage (CHeReL), NSW Ministry of Health and ACT Health for the NSW and ACT Admitted Patients Data Collections; 2) Queensland Health, including the Statistical Services Branch, for the QLD Hospital Admitted Patient Data Collection; 3) Department of Health Western Australia, including the Data Linkage Branch, and the WA Hospital Morbidity Data Collection; 4) SA NT Datalink and SA Health for the SA Public Hospital Separations Data Collection. This project is supported by the Population Health Research Network which is a capability of the Australian Government National Collaborative Research Infrastructure Strategy and Education Investment Fund Super Science Initiative.	Akushevich I, 2018, J DIABETES COMPLICAT, V32, P362, DOI 10.1016/j.jdiacomp.2017.12.014; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Amed S, 2010, DIABETES CARE, V33, P786, DOI 10.2337/dc09-1013; Andersson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104033; Anwar H, 2011, DIABETIC MED, V28, P1514, DOI 10.1111/j.1464-5491.2011.03432.x; Australian Institute of Health and Welfare, 2017, NAT DEATH IND NDI AI; Australian Institute of Health Welfare, AUSTR HLTH 2016; Bannier K, 2015, J DIABETES COMPLICAT, V29, P1130, DOI 10.1016/j.jdiacomp.2015.08.010; Bloomgarden Z, 2013, J DIABETES, V5, P369, DOI 10.1111/1753-0407.12086; Brown W, 2007, PHYS ACTIVITY HLTH M; Bullard KM, 2018, MMWR-MORBID MORTAL W, V67, P359, DOI 10.15585/mmwr.mm6712a2; Byles J, 2015, CHRONIC CONDITIONS P; Centre for Health Record Linkage, ICD 10 AM ACHI ACS; Cheng SW, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011602; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; DeFronzo RA, 2011, DIABETES CARE, V34, pS202, DOI 10.2337/dc11-s221; Deshpande AD, 2008, PHYS THER, V88, P1254, DOI 10.2522/ptj.20080020; Dobson AJ, 2015, INT J EPIDEMIOL, V44, DOI 10.1093/ije/dyv110; Duckett S., 2015, AUSTR HLTH CARE SYST, V5th ed.; Fang M, 2018, AM J PREV MED, V55, P497, DOI 10.1016/j.amepre.2018.05.018; Fishman EI, 2014, DIABETES CARE, pDC_131982; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Harvey J. N., 2002, Journal of Epidemiology and Community Health, V56, P18, DOI 10.1136/jech.56.1.18; Haut ER, 2012, JAMA-J AM MED ASSOC, V307, P2589, DOI 10.1001/jama.2012.6626; Huang XB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170250; International Diabetes Federation, 2019, ADV GUID IDF DIAB AT; Iwasa T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160632; Joshy G, 2009, J EPIDEMIOL COMMUN H, V63, P386, DOI 10.1136/jech.2008.078873; Kleefstra N, 2016, J DIABETES, V8, P863, DOI 10.1111/1753-0407.12370; Knott RJ, 2015, AUST ECON REV, V48, P122, DOI 10.1111/1467-8462.12103; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Leikauf J, 2009, J AM GERIATR SOC, V57, P1219, DOI 10.1111/j.1532-5415.2009.02313.x; Lin S, 2016, J DIABETES, V8, P533, DOI 10.1111/1753-0407.12326; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; Mendis S, 2011, PRIORITIZED RES AGEN; Meza R, 2015, PREV MED, V81, P445, DOI 10.1016/j.ypmed.2015.10.015; Mishra G, 2016, FUTURE HLTH SERVICE; Morgan CL, 2000, DIABETIC MED, V17, P141, DOI 10.1046/j.1464-5491.2000.00221.x; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Papoz L, 1996, INT J EPIDEMIOL, V25, P474, DOI 10.1093/ije/25.3.474; Ramke J, 2012, J DIABETES, V4, P392, DOI 10.1111/j.1753-0407.2012.00217.x; Taylor AW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125233; Taylor R, 2016, J DIABETES, V8, P766, DOI 10.1111/1753-0407.12447; Van Netten JJ, 2017, AUSTR DIABETES RELAT; Waller M, 2017, EMERG THEMES EPIDEMI, V14, P1, DOI 10.1186/s12982-017-0057-3; Webbie K, 2006, BULLETIN, V47; WHO, 2016, GLOB REP PSOR; World Health Organization, 2019, CLASS DIAB MELL; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	50	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234812	10.1371/journal.pone.0234812	http://dx.doi.org/10.1371/journal.pone.0234812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555738	Green Published, gold			2022-12-27	WOS:000543273200055
J	Cao, ZH; Li, TZ; Liang, LC; Wang, HB; Wei, FL; Meng, S; Cai, MT; Zhang, YL; Xu, H; Zhang, JY; Jin, RH				Cao, Zhenhuan; Li, Tongzeng; Liang, Lianchun; Wang, Haibo; Wei, Feili; Meng, Sha; Cai, Miaotian; Zhang, Yulong; Xu, Hui; Zhang, Jiaying; Jin, Ronghua			Clinical characteristics of Coronavirus Disease 2019 patients in Beijing, China	PLOS ONE			English	Article							WUHAN	The outbreak of Coronavirus Disease (COVID-19) in Wuhan have affected more than 250 countries and regions worldwide. However, most of the clinical studies have been focused on Wuhan, and little is known about the disease outside of Wuhan in China. In this retrospective cohort study, we report the early clinical features of 80 patients with COVID-19 admitted to the hospital in Beijing. The results show that 27 (33.8%) patients had severe illness. Six (7.5%) patients were admitted to the ICU, and 3 (3.8%) patients died. Forty-eight percent (39/80) of the patients had a history of living/traveling in Wuhan. Patients with severe- illness were significantly older (average age, 71 years old vs 44 years old) and had a high incidence of expectoration (59.3% vs 34.0%), shortness of breath (92.6% vs 9.4%), anorexia (51.9% vs 18.9%) and confusion(18.5% vs 0%) compared with nonsevere patients. The systolic blood pressure (median, 130 mmHg vs 120 mmHg) was higher and the oxygen saturation (median, 98.3% vs 92.0%) was significantly lower in severe patients than nonsevere patients. In addition, myoglobin (median, 56.0 ng/mL vs 35.0 ng/mL), troponin I (median, 0.02 pg/mL vs 0.01 pg/mL), C-reactive protein (median, 69.7 mg/L vs 12.9 mg/L) and neutrophils (median, 3.3x10(9)/L vs 2.2x10(9)/L) were significantly increased, while lymphocytes (median, 0.8x10(9)/L vs 1.2x10(9)/L), albumin (mean, 32.8 g/L vs 36.8 g/L) and the creatinine clearance rate (median, 91.2 vs 108.2 ml/min/1.73m(2)) were significantly decreased among severe patients. Our study revealed that older patients with high levels of C-reactive protein, myoglobin, troponin I, and neutrophil and high systolic blood pressure as well as low levels of lymphocytes, and albumin and a low creatinine clearance rate and oxygen saturation were more likely to have severe disease.	[Cao, Zhenhuan; Li, Tongzeng; Liang, Lianchun; Cai, Miaotian; Zhang, Yulong; Xu, Hui; Zhang, Jiaying; Jin, Ronghua] Capital Med Univ, Beijing Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Wang, Haibo] Peking Univ, Clin Res Inst, Beijing, Peoples R China; [Wei, Feili] Beijing Inst Hepatol, Beijing, Peoples R China; [Meng, Sha] Capital Med Univ, Beijing Youan Hosp, Dept Sci & Technol, Beijing, Peoples R China	Capital Medical University; Peking University; Capital Medical University	Jin, RH (corresponding author), Capital Med Univ, Beijing Youan Hosp, Dept Infect Dis, Beijing, Peoples R China.	93353503@qq.com		Cao, Zhenhuan/0000-0003-4204-1049				Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Chang D, 2020, JAMA-J AM MED ASSOC, V323, P1092, DOI 10.1001/jama.2020.1623; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; McCloskey B, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000254; National Health Commission of the People' Republic of China, 2020, DIAGN TREATM PNEUM I; Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757; Ryan Michael, 2020, COMMUNICATION   0213; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	12	29	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234764	10.1371/journal.pone.0234764	http://dx.doi.org/10.1371/journal.pone.0234764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555674	gold, Green Published			2022-12-27	WOS:000542759600020
J	Imeah, B; Penz, E; Rana, M; Trask, C				Imeah, Biaka; Penz, Erika; Rana, Masud; Trask, Catherine		Needle-Less Injector Study Team	Economic analysis of new workplace technology including productivity and injury: The case of needle-less injection in swine	PLOS ONE			English	Article							MILKING SYSTEM; WORK; UNCERTAINTY; COSTS	Increasing intensification in swine production has led to new and specialized technologies, but the occupational health and safety impacts are rarely quantified in the business plans for adoption. Needle-less injection has potential to increase productivity and eliminate needle stick injury in workers, but it is not clear whether these benefits offset high capital investment and potential increases in musculoskeletal loads. This economic evaluation employed probabilistic scenario analysis using injury, cost, and production data gathered from interviews with swine producers in Manitoba and Saskatchewan. After adoption of needle-less injection, rates of needle-stick injury went down with no measureable effect on upper limb musculoskeletal disorders, resulting in lower health and safety costs for needle-less injectors. Needle-less injection duration was 40% faster once workers acclimatized, but large start-up costs mean economic benefits are realized only after the first year. The incremental benefit cost ratio promoted adoption of needle-less injectors over conventional needles for the base case of a 1200 sow barn; the conventional method is beneficial for barns with 600 sows or less. Findings indicate that well-designed technologies have the potential to achieve the dual ergonomics goals of enhancing human wellbeing and system performance. We anticipate that the economic and decision models developed in this study can be applied to other new technologies in agriculture and animal production.	[Imeah, Biaka; Trask, Catherine] Univ Saskatchewan, Coll Med, Canadian Ctr Hlth & Safety Agr, Saskatoon, SK, Canada; [Penz, Erika] Univ Saskatchewan, Coll Med, Saskatoon, SK, Canada; [Rana, Masud] Univ Saskatchewan, Collaborat Program Biostat, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Trask, C (corresponding author), Univ Saskatchewan, Coll Med, Canadian Ctr Hlth & Safety Agr, Saskatoon, SK, Canada.	catherine.trask@usask.ca	Penz, Erika/AAZ-9541-2020	Penz, Erika/0000-0003-2610-8450; Trask, Catherine/0000-0003-0799-1735	Canada Research Chairs program [228136]; Workers Compensation Board of Manitoba	Canada Research Chairs program(Canada Research Chairs); Workers Compensation Board of Manitoba	CT & EP: Workers Compensation Board of Manitoba https://www.wcb.mb.ca/research-andworkplace-innovation-program-0 CT: Canada Research Chairs program [#228136] http://www.chairs-chaires.gc.ca/chairholders-titulaires/profileeng.aspx?profileId=3030 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2020, FAO STAT ONL DAT; Bath B, 2019, PHYSIOTHER CAN, V71, P24, DOI 10.3138/ptc.2017-65; Blaha T.G., 2001, PREHARVEST FOOD SAFE; Daniels C., 2009, PREVALENCE CARCASS D; Douphrate DI, 2009, J AGROMEDICINE, V14, P406, DOI 10.1080/10599240903260444; Drugs C.A.f., 2006, GUIDELINES EC EVALUA; Escorpizo R, 2008, INT J IND ERGONOM, V38, P291, DOI 10.1016/j.ergon.2007.10.018; EVANS JS, 1994, REGUL TOXICOL PHARM, V20, P15, DOI 10.1016/S0273-2300(05)80003-0; FAO, 2012, STAT YB 2012; FAO F.a.A.O., 2007, SUST AGR RUR DEV SAR; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Government of Saskatchewan, 2017, SASK VAR GUID 2017 S; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Hafer A. L., 1996, Swine Health and Production, V4, P128; Houser T., 2003, FEASIBILITY TRANSDER; Jakob M, 2011, J AGROMEDICINE, V16, P280, DOI 10.1080/1059924X.2011.605713; Janssen B, 2017, J AGROMEDICINE, V22, P47, DOI [10.1080/1059924X.2016.1249444, 10.1080/1059924x.2016.1249444]; Khushrushahi N., INVESTOR GUIDANCE OC; Lash TL, 2014, INT J EPIDEMIOL, V43, P1969, DOI 10.1093/ije/dyu149; Lash TL, 2011, APPL QUANTITATIVE BI; Leigh JP, 2001, PUBLIC HEALTH REP, V116, P235, DOI 10.1093/phr/116.3.235; Leigh JP, 1997, ARCH INTERN MED, V157, P1557, DOI 10.1001/archinte.157.14.1557; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Mousel MR, 2008, J ANIM SCI, V86, P1468, DOI 10.2527/jas.2007-0839; Nonnenmann MW, 2010, J OCCUP ENVIRON HYG, V7, P483, DOI 10.1080/15459624.2010.487036; Peters JC, 2008, J ANIM SCI, V86, P2261, DOI 10.2527/jas.2007-0577; Rey M, 2015, CAN VET J, V56, P405; Saia M, 2010, BIOMED INT, V1, P41; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Stal M, 2003, ANN AGR ENV MED, V10, P67; StatisticsCanada, 2015, CHANG FAC CAN HOG IN; Temple D, 2017, PORCINE HEALTH MANAG, V3, DOI 10.1186/s40813-017-0056-3; Vansickle J., 2001, BROKEN NEEDLES ONE I; Wohl M., 1984, TRANSPORTATION INVES; Wu JY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1018; Zeng XK, 2018, CAN VET J, V59, P871; Zhang Y., 2008, PLOS ONE, V3, pe3933; 2013, ANCIENT NEAR E MONOG, V5, P14	39	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0233599	10.1371/journal.pone.0233599	http://dx.doi.org/10.1371/journal.pone.0233599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555636	Green Published, gold			2022-12-27	WOS:000542759600022
J	Rumbou, A; Candresse, T; Marais, A; Svanella-Dumas, L; Landgraf, M; von Bargen, S; Buttner, C				Rumbou, Artemis; Candresse, Thierry; Marais, Armelle; Svanella-Dumas, Laurence; Landgraf, Maria; von Bargen, Susanne; Buettner, Carmen			Unravelling the virome in birch: RNA-Seq reveals a complex of known and novel viruses	PLOS ONE			English	Article							LEAF-ROLL-VIRUS; POPULATION; VIROIDS	To unravel the virome in birch trees of German and Finnish origin exhibiting symptoms of birch leaf-roll disease (BRLD), high-throughput sequencing (HTS) was employed. In total five viruses, among which three were so far unknown, were detected by RNAseq. One to five virus variants were identified in the transcriptome of individual trees. The novel viruses were genetically-fully or partially-characterized, belonging to the generaCarlavirus,IdaeovirusandCapillovirusand are tentatively namedbirch carlavirus,birch idaeovirus, andbirch capillovirus, respectively. The recently discovered birch leafroll-associated virus was systematically detected by HTS in symptomatic seedlings but not in symptomless ones. The new carlavirus was detected only in one of the three symptomatic seedlings. The novel putativeCapilloviruswas detected in all seedlings-irrespective of their BLRD status-while theIdaeoviruswas identified in a plant without leaf symptoms at the time of sampling. Further efforts are needed to complete Koch's postulates and to clarify the possible association of the detected viruses with the BLR disease. Our study elucidates the viral population in single birch seedlings and provides a comprehensive overview for the diversities of the viral communities they harbor, to date.	[Rumbou, Artemis; Landgraf, Maria; von Bargen, Susanne; Buettner, Carmen] Humboldt Univ, Albrecht Daniel Thaer Inst, Fac Life Sci, Berlin, Germany; [Candresse, Thierry; Marais, Armelle; Svanella-Dumas, Laurence] Univ Bordeaux, Biol Fruit & Pathol, INRA, UMR 1332, Bordeaux, France	Humboldt University of Berlin; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Rumbou, A (corresponding author), Humboldt Univ, Albrecht Daniel Thaer Inst, Fac Life Sci, Berlin, Germany.	artemis.rumbou@agrar.hu-berlin.de	Rumbou, Artemis/AAD-5694-2019; von Bargen, Susanne/AAJ-9794-2021	Rumbou, Artemis/0000-0002-7237-7355; von Bargen, Susanne/0000-0001-8321-1572; Candresse, Thierry/0000-0001-9757-1835; Marais, Armelle/0000-0003-2482-1543	DFG (Deutsche Forschunsgemeinschaft) [BU890/14-1, BU890/23-1]	DFG (Deutsche Forschunsgemeinschaft)(German Research Foundation (DFG))	DFG (Deutsche Forschunsgemeinschaft), projects BU890/14-1 ("Modes of transmission of Cherry leaf roll virus: genetic basis of seed transmissibility and investigation of possible arthropod vectors") and BU890/23-1 ("Modes of vector transmission of Cherry leaf roll virus (CLRV) - molecular basis and potential arthropod vector species").	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; [Anonymous], 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/glan290; Beuve M, 2018, ARCH VIROL, V163, P2937, DOI 10.1007/s00705-018-3949-9; Buttner C, 2013, INFECTIOUS FOREST DISEASES, P50, DOI 10.1079/9781780640402.0050; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Hacquard S, 2016, NEW PHYTOL, V209, P454, DOI 10.1111/nph.13760; Hily JM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01782; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; International Committee on Taxonomy of Viruses (ICTV), 2016, VIR TAX 2016 REL, P924; Jalkanen R, 2007, SILVA FENN, V41, P755, DOI 10.14214/sf.927; James D, 2017, ARCH VIROL, V162, P1705, DOI 10.1007/s00705-017-3257-9; Jo Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20256-w; Landgraf M., 2017, VIRUSERKRANKUNGEN UR, P327; Landgraf M, 2016, JB BAUMPFLEGE, P276; Langer J, 2016, FOREST PATHOL, V46, P595, DOI 10.1111/efp.12276; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Maree HJ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01082; Massart S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00045; Massart S, 2014, VIRUS RES, V188, P90, DOI 10.1016/j.virusres.2014.03.029; McKenna OE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071433; Opoku EB, 2018, J HORTICULTURE BIOL, V5, P2, DOI [10.4172/2376-0354.1000233, DOI 10.4172/2376-0354.1000233]; Roossinck MJ, 2015, PHYTOPATHOLOGY, V105, P716, DOI 10.1094/PHYTO-12-14-0356-RVW; Rosenberg E., 2013, HOLOGENOME CONCEPT H; Rumbou A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193888; Rumbou A, 2016, SCAND J FOREST RES, V31, P546, DOI 10.1080/02827581.2016.1165283; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thekke-Veetil T, 2017, EUR J PLANT PATHOL, V149, P751, DOI 10.1007/s10658-017-1211-z; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Vayssier-Taussat M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00029; von Bargen S, 2009, SILVA FENN, V43, P727, DOI 10.14214/sf.169; Wu QF, 2015, ANNU REV PHYTOPATHOL, V53, P425, DOI 10.1146/annurev-phyto-080614-120030; Youssef F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-488	32	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2020	15	6							e0221834	10.1371/journal.pone.0221834	http://dx.doi.org/10.1371/journal.pone.0221834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0YE	32589631	Green Published, Green Submitted, gold			2022-12-27	WOS:000545759800001
J	Sorengard, M; Lindh, AS; Ahrens, L				Sorengard, M.; Lindh, A-S.; Ahrens, L.			Thermal desorption as a high removal remediation technique for soils contaminated with per- and polyfluoroalkyl substances (PFASs)	PLOS ONE			English	Article							FILM-FORMING FOAM; PERFLUORINATED ALKYL SUBSTANCES; PERFLUOROALKYL SUBSTANCES; PERFLUOROOCTANESULFONATE PFOS; TREATMENT TECHNOLOGIES; IMPACTED GROUNDWATER; SUBSURFACE TRANSPORT; CARBOXYLIC-ACIDS; WATER; SEDIMENT	Soils contaminated with per- and polyfluoroalkyl substances (PFASs) are an important source for impacting drinking water delivery systems and surface water bodies world-wide, posing an urgent risk to human health and environmental quality. However, few treatment techniques have been tested for PFAS-contaminated soil hotspots. This study investigated the possibility of thermal desorption as a possible technique to remediate soils contaminated with multiple PFASs. Two fortified soils ( n-ary sumation (9)PFAS approximate to 4 mg kg(-1)) and one field-contaminated soil ( n-ary sumation (9)PFAS approximate to 0.025 mg kg(-1)) were subjected to a 75-min thermal treatment at temperatures ranging from 150 to 550 degrees C. Soil concentrations of PFASs showed a significant decrease at 350 degrees C, with the n-ary sumation (9)PFAS concentration decreasing by, on average, 43% and 79% in the fortified and field contaminated soils, respectively. At 450 degrees C, >99% of PFASs were removed from the fortified soils, while at 550 degrees C the fraction removed ranged between 71 and 99% for the field contaminated soil. In the field contaminated soil, PFAS classes with functional groups of sulfonates (PFSAs) and sulfonamides (FOSAs) showed higher removal than the perfluoroalkyl carboxylates (PFCAs). Thus thermal desorption has the potential to remove a wide variety of PFASs from soil, although more studies are needed to investigate the cost-effectiveness, creation of transformation products, and air-phase vacuum filtration techniques.	[Sorengard, M.; Lindh, A-S.; Ahrens, L.] Swedish Univ Agr Sci SLU, Dept Aquat Sci & Assessment, Uppsala, Sweden	Swedish University of Agricultural Sciences	Sorengard, M (corresponding author), Swedish Univ Agr Sci SLU, Dept Aquat Sci & Assessment, Uppsala, Sweden.	mattias.sorengard@slu.se	Ahrens, Lutz/S-6266-2019	Ahrens, Lutz/0000-0002-5430-6764; Sorengard, Mattias/0000-0002-4625-2495	 [2015-03561]		M.S. VINNOVA 2015-03561 https://www.vinnova.se/en/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens L, 2015, CHEMOSPHERE, V129, P33, DOI 10.1016/j.chemosphere.2014.03.136; Ahrens L, 2010, CHEMOSPHERE, V79, P266, DOI 10.1016/j.chemosphere.2010.01.045; Anderson RH, 2016, CHEMOSPHERE, V150, P678, DOI 10.1016/j.chemosphere.2016.01.014; Ashley-Martin J, 2017, AM J EPIDEMIOL, V185, P185, DOI 10.1093/aje/kww213; Baduel C, 2015, J HAZARD MATER, V296, P46, DOI 10.1016/j.jhazmat.2015.03.007; Barzen-Hanson KA, 2017, ENVIRON SCI TECHNOL, V51, P2047, DOI 10.1021/acs.est.6b05843; Borg D, 2013, ENVIRON INT, V59, P112, DOI 10.1016/j.envint.2013.05.009; Brendel S, 2018, ENVIRON SCI EUR, V30, DOI 10.1186/s12302-018-0134-4; Buck Robert C., 2011, Integrated Environmental Assessment and Management, V7, P513, DOI 10.1002/ieam.258; Chu SG, 2015, CHEMOSPHERE, V138, P60, DOI 10.1016/j.chemosphere.2015.05.043; Crownover E, 2019, REMEDIATION, V29, P77, DOI 10.1002/rem.21623; Das P, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1714-y; Du ZW, 2014, J HAZARD MATER, V274, P443, DOI 10.1016/j.jhazmat.2014.04.038; Filipovic M, 2015, CHEMOSPHERE, V129, P39, DOI 10.1016/j.chemosphere.2014.09.005; Franke V, 2019, ENVIRON SCI-WAT RES, V5, P1887, DOI [10.1039/C9EW00339H, 10.1039/c9ew00339h]; Gellrich V, 2013, J ENVIRON SCI HEAL A, V48, P129, DOI 10.1080/10934529.2013.719431; Gitipour S, 2015, ECOL J, V41, P643; Gobelius L, 2018, ENVIRON SCI TECHNOL, V52, P4340, DOI 10.1021/acs.est.7b05718; Gobelius L, 2017, ENVIRON SCI TECHNOL, V51, P12602, DOI 10.1021/acs.est.7b02926; Guelfo JL, 2013, ENVIRON SCI TECHNOL, V47, P4164, DOI 10.1021/es3048043; Guemiza K, 2017, J HAZARD MATER, V333, P194, DOI 10.1016/j.jhazmat.2017.03.021; Hale SE, 2017, CHEMOSPHERE, V171, P9, DOI 10.1016/j.chemosphere.2016.12.057; HEPA, 2018, PFAS NAT ENV MAN PLA; Higgins CP, 2006, ENVIRON SCI TECHNOL, V40, P7251, DOI 10.1021/es061000n; Houtz EF, 2013, ENVIRON SCI TECHNOL, V47, P8187, DOI 10.1021/es4018877; Kirchmann H, 2005, ACTA AGR SCAND B-S P, V55, P98, DOI 10.1080/09064710510008711; Krafft MP, 2015, CHEMOSPHERE, V129, P4, DOI 10.1016/j.chemosphere.2014.08.039; Kuppusamy S, 2017, CHEMOSPHERE, V168, P944, DOI 10.1016/j.chemosphere.2016.10.115; Kupryianchyk D, 2016, CHEMOSPHERE, V142, P35, DOI 10.1016/j.chemosphere.2015.04.085; Li YS, 2018, SCI TOTAL ENVIRON, V628-629, P110, DOI 10.1016/j.scitotenv.2018.01.167; Li Y, 2018, OCCUP ENVIRON MED, V75, P46, DOI 10.1136/oemed-2017-104651; Lim MW, 2016, MAR POLLUT BULL, V109, P14, DOI 10.1016/j.marpolbul.2016.04.023; Liu J, 2015, ENVIRON SCI POLLUT R, V22, P19538, DOI 10.1007/s11356-015-5136-9; Liu YM, 2015, ENVIRON SCI TECHNOL, V49, P13528, DOI 10.1021/acs.est.5b03147; Loganathan BG, 2007, WATER RES, V41, P4611, DOI 10.1016/j.watres.2007.06.045; Mahinroosta R, 2020, J ENVIRON MANAGE, V255, DOI 10.1016/j.jenvman.2019.109896; Mascolo G, 2013, INT J ENVIRON AN CH, V93, P1030, DOI 10.1080/03067319.2012.708745; McCleaf P, 2017, WATER RES, V120, P77, DOI 10.1016/j.watres.2017.04.057; McGregor R, 2018, REMEDIATION, V28, P33, DOI 10.1002/rem.21558; Mejia-Avendano S, 2017, ANAL CHEM, V89, P2539, DOI 10.1021/acs.analchem.6b04746; Murakami M, 2009, ENVIRON SCI TECHNOL, V43, P3480, DOI 10.1021/es803556w; Nguyen MA, 2017, ENVIRON POLLUT, V220, P1438, DOI 10.1016/j.envpol.2016.10.089; Pereira HC, 2018, CHEMOSPHERE, V207, P183, DOI 10.1016/j.chemosphere.2018.05.012; Qi ZF, 2014, ENVIRON SCI POLLUT R, V21, P4697, DOI 10.1007/s11356-013-2392-4; Rahman A., 2014, HYDR WAT RES S 2014, P962; Rayne S, 2009, J ENVIRON SCI HEAL A, V44, P1388, DOI 10.1080/10934520903217278; Rayne S, 2009, J ENVIRON SCI HEAL A, V44, P317, DOI 10.1080/10934520802659620; Ross I, 2018, REMEDIATION, V28, P101, DOI 10.1002/rem.21553; Sorengard M, 2019, CHEMOSPHERE, V232, P224, DOI 10.1016/j.chemosphere.2019.05.088; Sorengard M, 2019, J HAZARD MATER, V367, P639, DOI 10.1016/j.jhazmat.2019.01.005; Vidonish JE, 2016, ENGINEERING-PRC, V2, P426, DOI 10.1016/J.ENG.2016.04.005; Wang F, 2015, ENVIRON SCI TECHNOL, V49, P5672, DOI 10.1021/es506234b; Wang F, 2013, ENVIRON SCI TECHNOL, V47, P2621, DOI 10.1021/es305352p; Wang ZY, 2017, ENVIRON SCI TECHNOL, V51, P2508, DOI 10.1021/acs.est.6b04806; Wang ZY, 2011, ENVIRON CHEM, V8, P389, DOI 10.1071/EN10143; Watanabe N, 2016, J MATER CYCLES WASTE, V18, P625, DOI 10.1007/s10163-016-0532-x; Weber AK, 2017, ENVIRON SCI TECHNOL, V51, P4269, DOI 10.1021/acs.est.6b05573; Yamada T, 2005, CHEMOSPHERE, V61, P974, DOI 10.1016/j.chemosphere.2005.03.025; Yao Y., 2015, P 38 AMOP TECHN SEM, P265; Zhao ZH, 2017, ENVIRON SCI POLLUT R, V24, P11800, DOI 10.1007/s11356-017-8734-x; Zhi Y, 2018, CHEM ENG J, V346, P682, DOI 10.1016/j.cej.2018.04.042	62	25	28	19	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234476	10.1371/journal.pone.0234476	http://dx.doi.org/10.1371/journal.pone.0234476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584848	Green Published, gold			2022-12-27	WOS:000545747200068
J	Pitchforth, J; Nelson, EC; van den Helder, M; Oosting, W				Pitchforth, Jegar; Nelson, Elizabeth C.; van den Helder, Marc; Oosting, Wouter			The work environment pilot: An experiment to determine the optimal office design for a technology company (vol 15, e0232943, 2020)	PLOS ONE			English	Correction																		Pitchforth J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232943	1	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235428	10.1371/journal.pone.0235428	http://dx.doi.org/10.1371/journal.pone.0235428			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579591	gold, Green Published			2022-12-27	WOS:000545646600041
J	Yoon, HE; Kim, DW; Kim, D; Kim, Y; Shin, SJ; Shin, YR				Yoon, Hye Eun; Kim, Da Won; Kim, Dongryul; Kim, Yaeni; Shin, Seok Joon; Shin, Yu Ri			A pilot trial to evaluate the clinical usefulness of contrast-enhanced ultrasound in predicting renal outcomes in patients with acute kidney injury	PLOS ONE			English	Article							RESISTIVE INDEX; PERFUSION; OXYGENATION; BIOMARKERS; DIAGNOSIS; DISEASE; URINARY; CORTEX	Objectives Contrast-enhanced ultrasound (CEUS) enables the assessment of real-time renal microcirculation. This study investigated CEUS-driven parameters as hemodynamic predictors for renal outcomes in patients with acute kidney injury (AKI). Methods Forty-eight patients who were diagnosed with AKI were prospectively enrolled and underwent CEUS at the occurrence of AKI. Parameters measured were the wash-in slope (WIS), time to peak intensity, peak intensity (PI), area under the time-intensity curve (AUC), mean transit time (MTT), time for full width at half maximum, and rise time (RT). The predictive performance of the CEUS-driven parameters for Kidney Disease Improving Global Outcomes (KDIGO) AKI stage, initiation of renal replacement therapy (RRT), AKI recovery, and chronic kidney disease (CKD) progression was assessed. Receiver operating characteristic (ROC) analysis was performed to evaluate the diagnostic performance of CEUS. Results Cortical RT (Odds ratio [OR] = 1.21) predicted the KDIGO stage 3 AKI. Cortical MTT (OR = 1.07) and RT (OR = 1.20) predicted the initiation of RRT. Cortical WIS (OR = 76.23) and medullary PI (OR = 1.25) predicted AKI recovery. Medullary PI (OR = 0.78) and AUC (OR = 1.00) predicted CKD progression. The areas under the ROC curves showed reasonable performance for predicting the initiation of RRT and AKI recovery. The sensitivity and specificity of the quantitative CEUS parameters were 60-83% and 62-77%, respectively, with an area under the curve of 0.69-0.75. Conclusion CEUS may be a supplemental tool in diagnosing the severity of AKI and predicting renal prognosis in patients with AKI.	[Yoon, Hye Eun; Kim, Da Won; Kim, Dongryul; Shin, Seok Joon] Catholic Univ Korea, Incheon St Marys Hosp, Dept Internal Med, Coll Med, Incheon, South Korea; [Kim, Yaeni] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Shin, Yu Ri] Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Shin, YR (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Coll Med, Seoul, South Korea.	crystal57@daum.net			Catholic Medical Center Research Foundation	Catholic Medical Center Research Foundation	Dr. Yu Ri Shin is supported by the Catholic Medical Center Research Foundation made in the program year of 2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, Kidney Int Suppl (2011), V3, P19; [Anonymous], 2002, CURR PROB CARDIOLOGY, V27, P454, DOI 10.1067/mcd.2002.129364; Averkiou M, 2010, ULTRASOUND MED BIOL, V36, P68, DOI 10.1016/j.ultrasmedbio.2009.07.005; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Calzavacca P, 2015, CRIT CARE MED, V43, pE431, DOI 10.1097/CCM.0000000000001198; Cao W, 2017, ANTIOXID REDOX SIGN, V27, P1397, DOI 10.1089/ars.2017.7006; Cheng XY, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0622-6; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Dong Y, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140350; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Hall ME, 2016, CARDIORENAL MED, V6, P261, DOI 10.1159/000445302; Harrois A, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2067-0; Harvey CJ, 2013, ULTRASCHALL MED, V34, P319, DOI 10.1055/s-0033-1350138; HELLBERG POA, 1990, KIDNEY INT, V38, P432, DOI 10.1038/ki.1990.223; HELLBERG POA, 1991, KIDNEY INT, V40, P625, DOI 10.1038/ki.1991.254; HELLBERG POA, 1990, KIDNEY INT, V37, P1240, DOI 10.1038/ki.1990.107; Jang JY, 2013, CLIN MOL HEPATOL, V19, P1, DOI 10.3350/cmh.2013.19.1.1; Kalantarinia K, 2009, CURR DRUG TARGETS, V10, P1184, DOI 10.2174/138945009789753246; Kim JH, 2017, KIDNEY RES CLIN PRAC, V36, P58, DOI 10.23876/j.krcp.2017.36.1.58; Lankadeva YR, 2019, KIDNEY INT, V95, P1338, DOI 10.1016/j.kint.2019.01.032; Lankadeva YR, 2018, CRIT CARE MED, V46, pE41, DOI 10.1097/CCM.0000000000002797; Lebkowska U, 2009, TRANSPL P, V41, P3024, DOI 10.1016/j.transproceed.2009.08.023; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lima A, 2018, CRIT CARE MED, V46, P1284, DOI 10.1097/CCM.0000000000003209; MANDAL AK, 1991, LAB INVEST, V65, P566; Mannucci T, 2019, J SMALL ANIM PRACT, V60, P471, DOI 10.1111/jsap.13001; MASON J, 1984, KIDNEY INT, V26, P283, DOI 10.1038/ki.1984.171; Obermuller N, 2014, INT UROL NEPHROL, V46, P1, DOI 10.1007/s11255-013-0448-5; PLATT JF, 1990, AM J ROENTGENOL, V154, P1223, DOI 10.2214/ajr.154.6.2110732; Post EH, 2017, KIDNEY INT, V91, P45, DOI 10.1016/j.kint.2016.07.032; Ray SC, 2019, SEMIN NEPHROL, V39, P520, DOI 10.1016/j.semnephrol.2019.10.002; Schneider AG, 2013, CRIT CARE, V17, DOI 10.1186/cc12817; Schneider AG, 2012, NEPHROL DIAL TRANSPL, V27, P674, DOI 10.1093/ndt/gfr345; Tsuruoka K, 2010, INT HEART J, V51, P176, DOI 10.1536/ihj.51.176; Vanmassenhove J, 2013, NEPHROL DIAL TRANSPL, V28, P254, DOI 10.1093/ndt/gfs380; Wang L, 2015, J NEPHROL, V28, P669, DOI 10.1007/s40620-015-0183-3	37	11	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235130	10.1371/journal.pone.0235130	http://dx.doi.org/10.1371/journal.pone.0235130			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579595	Green Published, gold			2022-12-27	WOS:000545646600033
J	Goodliffe, J; Rubakovic, A; Chang, WE; Pathak, D; Luebke, J				Goodliffe, Joseph; Rubakovic, Anastasia; Chang, Wayne; Pathak, Dhruba; Luebke, Jennifer			Structural and functional features of medium spiny neurons in the BACHD Delta N17 mouse model of Huntington's Disease	PLOS ONE			English	Article							HUMAN MUTANT HUNTINGTIN; BASAL GANGLIA; PROJECTION NEURONS; DIFFERENTIAL LOSS; PREFERENTIAL LOSS; N-17 DOMAIN; AGGREGATION; PROTEIN; DOPAMINE; NUCLEAR	In the BACHD mouse model of Huntington's disease (HD), deletion of the N17 domain of the Huntingtin gene (BACHD Delta N17, Q97) has been reported to lead to nuclear accumulation of mHTT and exacerbation of motor deficits, neuroinflammation and striatal atrophy (Gu et al., 2015). Here we characterized the effect of N17 deletion on dorsolateral striatal medium spiny neurons (MSNs) in BACHD Delta N17 (Q97) and BACWT Delta N17 (Q31) mice by comparing them to MSNs in wildtype (WT) mice. Mice were characterized on a series of motor tasks and subsequently whole cell patch clamp recordings with simultaneous biocytin filling of MSNs in in vitro striatal slices from these mice were used to comprehensively assess their physiological and morphological features. Key findings include that: Q97 mice exhibit impaired gait and righting reflexes but normal tail suspension reflexes and normal coats while Q31 mice do not differ from WT; intrinsic membrane and action potential properties are altered -but differentially so- in MSNs from Q97 and from Q31 mice; excitatory and inhibitory synaptic currents exhibit higher amplitudes in Q31 but not Q97 MSNs, while excitatory synaptic currents occur at lower frequency in Q97 than in WT and Q31 MSNs; there is a reduced total dendritic length in Q31 -but not Q97- MSNs compared to WT, while spine density and number did not differ in MSNs in the three groups. The findings that Q31 MSNs differed from Q97 and WT neurons with regard to some physiological features and structurally suggest a novel role of the N17 domain in the function of WT Htt. The motor phenotype seen in Q97 mice was less robust than that reported in an earlier study (Gu et al., 2015), and the alterations to MSN physiological properties were largely consistent with changes reported previously in a number of other mouse models of HD. Together this study indicates that N17 plays a role in the modulation of the properties of MSNs in both mHtt and WT-Htt mice, but does not markedly exacerbate HD-like pathogenesis in the BACHD model.	[Goodliffe, Joseph; Rubakovic, Anastasia; Chang, Wayne; Pathak, Dhruba; Luebke, Jennifer] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA	Boston University	Goodliffe, J (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	jwg@bu.edu		Pathak, Dhruba/0000-0002-4005-2900	CHDI Foundation; CHDI	CHDI Foundation; CHDI	The CHDI Foundation funded this work. The funders had no role in the study design, data collecion, and analysis, decision to publish, or preparation of the manuscript.; We thank CHDI for financial support of this project and Drs. Maya Medalla and Christina Weaver for helpful comments.	Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; ALBIN RL, 1992, ANN NEUROL, V31, P425, DOI 10.1002/ana.410310412; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Aldaz T, 2019, J NEUROL, V266, P1340, DOI 10.1007/s00415-019-09263-7; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andre VM, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00046; Ariano MA, 2005, J NEUROSCI RES, V80, P634, DOI 10.1002/jnr.20492; Ariano MA, 2005, J NEUROPHYSIOL, V93, P2565, DOI 10.1152/jn.00791.2004; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Aylward EH, 2011, J NEUROL NEUROSUR PS, V82, P405, DOI 10.1136/jnnp.2010.208264; Barry J, 2018, J NEUROSCI, V38, P4678, DOI 10.1523/JNEUROSCI.0434-18.2018; Blum D, 2015, HUM MOL GENET, V24, P76, DOI 10.1093/hmg/ddu421; Cepeda C, 2003, J NEUROSCI, V23, P961; Cepeda C, 2013, J NEUROSCI, V33, P7393, DOI 10.1523/JNEUROSCI.2137-12.2013; Cepeda C, 2010, ASN NEURO, V2, DOI 10.1042/AN20090058; Chan EYW, 2002, HUM MOL GENET, V11, P1939, DOI 10.1093/hmg/11.17.1939; Deng YP, 2004, J CHEM NEUROANAT, V27, P143, DOI 10.1016/j.jchemneu.2004.02.005; DiProspero NA, 2004, J NEUROCYTOL, V33, P517, DOI 10.1007/s11068-004-0514-8; Fernandez-Nogales M, 2016, BRAIN PATHOL, V26, P772, DOI 10.1111/bpa.12430; Futter M, 2009, J MED GENET, V46, P438, DOI 10.1136/jmg.2009.066399; Glass M, 2000, NEUROSCIENCE, V97, P505, DOI 10.1016/S0306-4522(00)00008-7; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Goodliffe JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200626; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gu XF, 2015, NEURON, V85, P726, DOI 10.1016/j.neuron.2015.01.008; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Guo ZH, 2012, MOVEMENT DISORD, V27, P1379, DOI 10.1002/mds.25159; Haddad MS, 1997, PSYCHIAT CLIN N AM, V20, P791, DOI 10.1016/S0193-953X(05)70345-2; Hatzipetros T, 2015, JOVE-J VIS EXP, DOI 10.3791/53257; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hodges JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101770; Indersmitten T, 2015, J NEUROPHYSIOL, V113, P2953, DOI 10.1152/jn.01056.2014; Karam A, 2015, NEUROBIOL DIS, V80, P15, DOI 10.1016/j.nbd.2015.05.008; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; KEMP JM, 1971, PHILOS T R SOC B, V262, P429, DOI 10.1098/rstb.1971.0105; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Langfelder P, 2016, NAT NEUROSCI, V19, P623, DOI 10.1038/nn.4256; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Luesse HG, 2001, BEHAV BRAIN RES, V126, P185, DOI 10.1016/S0166-4328(01)00261-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; McColgan P, 2018, EUR J NEUROL, V25, P24, DOI 10.1111/ene.13413; Medalla M, 2017, J NEUROSCI, V37, P4717, DOI 10.1523/JNEUROSCI.3757-16.2017; Medalla M, 2015, J NEUROSCI, V35, P112, DOI 10.1523/JNEUROSCI.3426-14.2015; Mishra R, 2012, J MOL BIOL, V424, P1, DOI 10.1016/j.jmb.2012.09.011; Niccolini F, 2018, J NEUROL NEUROSUR PS, V89, P185, DOI 10.1136/jnnp-2017-316633; Ochaba J, 2016, NEURON, V90, P507, DOI 10.1016/j.neuron.2016.03.016; Paulsen JS, 2010, BRAIN RES BULL, V82, P201, DOI 10.1016/j.brainresbull.2010.04.003; Phan J, 2009, HUM MOL GENET, V18, P1006, DOI 10.1093/hmg/ddn428; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Richfield EK, 1995, ANN NEUROL, V38, P852, DOI 10.1002/ana.410380605; RICHFIELD EK, 1995, ANN NEUROL, V37, P335, DOI 10.1002/ana.410370309; Rocher AB, 2016, NEUROBIOL DIS, V86, P131, DOI 10.1016/j.nbd.2015.10.016; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Rosas HD, 2006, MOVEMENT DISORD, V21, P1317, DOI 10.1002/mds.20979; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sebastianutto I, 2017, NEUROBIOL DIS, V105, P117, DOI 10.1016/j.nbd.2017.05.011; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Smith GS, 1998, NEUROPSYCHOPHARMACOL, V18, P18; Southwell AL, 2016, HUM MOL GENET, V25, P3654, DOI 10.1093/hmg/ddw212; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Tousley A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212337; Tousley A, 2019, J HUNTINGTONS DIS, V8, P53, DOI 10.3233/JHD-180311; Tyler WA, 2015, J NEUROSCI, V35, P6142, DOI 10.1523/JNEUROSCI.0335-15.2015; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; Veldman MB, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0063-2; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wilson H, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00011; Younes L, 2014, HUM BRAIN MAPP, V35, P792, DOI 10.1002/hbm.22214; Yushchenko T, 2018, BIOPHYS J, V114, P1847, DOI 10.1016/j.bpj.2018.02.037; Zheng ZQ, 2013, J BIOL CHEM, V288, P6063, DOI 10.1074/jbc.M112.413575	78	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234394	10.1371/journal.pone.0234394	http://dx.doi.org/10.1371/journal.pone.0234394			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574176	Green Published, gold			2022-12-27	WOS:000544972400017
J	Geervliet, M; Lute, LCP; Jansen, CA; Rutten, VPMG; Savelkoul, HFJ; Tijhaar, E				Geervliet, Mirelle; Lute, Laura C. P.; Jansen, Christine A.; Rutten, Victor P. M. G.; Savelkoul, Huub F. J.; Tijhaar, Edwin			Differential immunomodulation of porcine bone marrow derived dendritic cells byE.coliNissle 1917 and beta-glucans	PLOS ONE			English	Article							ESCHERICHIA-COLI NISSLE; HUMAN ROTAVIRUS; CRYOPRESERVATION; MONOCYTES; IMMATURE; RECOGNITION; MATURATION; DECTIN-1; INNATE	In early life and around weaning, pigs are at risk of developing infectious diseases which compromise animal welfare and have major economic consequences for the pig industry. A promising strategy to enhance resistance against infectious diseases is immunomodulation by feed additives. To assess the immune stimulating potential of feed additivesin vitro, bone marrow-derived dendritic cells were used. These cells play a central role in the innate and adaptive immune system and are the first cells encountered by antigens that pass the epithelial barrier. Two different feed additives were tested on dendritic cells cultured from fresh and cryopreserved bone marrow cells; a widely used commercial feed additive based on yeast-derived beta-glucans and the gram-negative probiotic strainE.coliNissle 1917.E.coliNissle 1917, but not beta-glucans, induced a dose-dependent upregulation of the cell maturation marker CD80/86, whereas both feed additives induced a dose-dependent production of pro- and anti-inflammatory cytokines, including TNF alpha, IL-1 beta, IL-6 and IL-10. Furthermore,E.coliNissle 1917 consistently induced higher levels of cytokine production than beta-glucans. These immunomodulatory responses could be assessed by fresh as well as cryopreservedin vitrocultured porcine bone marrow-derived dendritic cells. Taken together, these results demonstrate that both beta-glucans andE.coliNissle 1917 are able to enhance dendritic cell maturation, but in a differential manner. A more mature dendritic cell phenotype could contribute to a more efficient response to infections. Moreover, both fresh and cryopreserved bone marrow-derived dendritic cells can be used asin vitropre-screening tools which enable an evidence based prediction of the potential immune stimulating effects of different feed additives.	[Geervliet, Mirelle; Lute, Laura C. P.; Savelkoul, Huub F. J.; Tijhaar, Edwin] Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands; [Jansen, Christine A.; Rutten, Victor P. M. G.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Rutten, Victor P. M. G.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Pretoria, South Africa	Wageningen University & Research; Utrecht University; University of Pretoria	Tijhaar, E (corresponding author), Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands.	edwin.tijhaar@wur.nl	Rutten, Victor PMG/AAB-6833-2022	Rutten, Victor PMG/0000-0002-6171-1805; Geervliet, Mirelle/0000-0001-8011-4144	Dutch Research Council (NWO); Vereniging Diervoeders Nederland (VDN); NWO Top Sector Project [868.15.033]	Dutch Research Council (NWO)(Netherlands Organization for Scientific Research (NWO)); Vereniging Diervoeders Nederland (VDN); NWO Top Sector Project	This research was funded by The Dutch Research Council (NWO) and Vereniging Diervoeders Nederland (VDN). The award was received by H.F.J. (Huub) Savelkoul (grant number: 868.15.033, NWO Top Sector Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL: https://www.nwo.nl/en.	Adam E, 2010, EUR J IMMUNOL, V40, P1995, DOI 10.1002/eji.200939913; [Anonymous], 2008, Sentinel Event Alert, P1; Batbayar S, 2012, BIOMOL THER, V20, P433, DOI 10.4062/biomolther.2012.20.5.433; BLECHA F, 1994, VET IMMUNOL IMMUNOP, V43, P269, DOI 10.1016/0165-2427(94)90147-3; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Bullido R, 1997, DEV COMP IMMUNOL, V21, P311, DOI 10.1016/S0145-305X(97)00008-6; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Dudek AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00438; Duncker SC, 2006, VET IMMUNOL IMMUNOP, V111, P239, DOI 10.1016/j.vetimm.2006.01.017; Facci MR, 2010, IMMUNOLOGY, V129, P396, DOI 10.1111/j.1365-2567.2009.03192.x; Geervliet M, 2020, DIFFERENTIAL IMMUNOM, DOI [10.4121/uuid:f27e43c4-ab38-41a2-be4d-c0753855b508, DOI 10.4121/UUID:F27E43C4-AB38-41A2-BE4D-C0753855B508]; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Hayden H, 2009, J IMMUNOTHER, V32, P638, DOI 10.1097/CJI.0b013e3181a5bc13; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; John J, 2003, J IMMUNOL METHODS, V272, P35, DOI 10.1016/S0022-1759(02)00430-1; Kandasamy S, 2016, J IMMUNOL, V196, P1780, DOI 10.4049/jimmunol.1501705; Li CF, 2009, CHINESE J CANCER RES, V21, P122, DOI 10.1007/s11670-009-0122-8; Matsuura M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00109; Meijerink M, 2011, J IMMUNOL METHODS, V373, P136, DOI 10.1016/j.jim.2011.08.010; Pardali E, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0232-5; Shin DI, 1999, IMMUNOL INVEST, V28, P165, DOI 10.3109/08820139909061145; Silveira GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071291; Sonck E, 2011, CLIN VACCINE IMMUNOL, V18, P1441, DOI 10.1128/CVI.00080-11; Sonck E, 2009, VET IMMUNOL IMMUNOP, V130, P131, DOI 10.1016/j.vetimm.2009.01.010; Stagg AJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02883; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Stier H, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-38; Summerfield A, 1997, J LEUKOCYTE BIOL, V62, P176, DOI 10.1002/jlb.62.2.176; Summerfield A, 2009, DEV COMP IMMUNOL, V33, P299, DOI 10.1016/j.dci.2008.05.005; Summerfield A, 2015, ANNU REV ANIM BIOSCI, V3, P533, DOI 10.1146/annurev-animal-022114-111009; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Tsukida K, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0160-1; VanderWaal K, 2018, P NATL ACAD SCI USA, V115, P11495, DOI 10.1073/pnas.1806068115; Vetvicka Vaclav, 2014, Open Biochem J, V8, P89, DOI 10.2174/1874091X01408010089; Vlasova AN, 2016, EUR J IMMUNOL, V46, P2426, DOI 10.1002/eji.201646498; Volman JJ, 2008, PHYSIOL BEHAV, V94, P276, DOI 10.1016/j.physbeh.2007.11.045; Vreman S, 2018, DEV COMP IMMUNOL, V84, P361, DOI 10.1016/j.dci.2018.03.012; Wassenaar TM, 2016, EUR J MICROBIOL IMMU, V6, P147, DOI 10.1556/1886.2016.00029; Zhang Y., 2005, EXPT MATH PEDAGOGY T, P1	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0233773	10.1371/journal.pone.0233773	http://dx.doi.org/10.1371/journal.pone.0233773			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559198	gold, Green Published			2022-12-27	WOS:000543261600062
J	Roodbeen, R; Vreke, A; Boland, G; Rademakers, J; van den Muijsenbergh, M; Noordman, J; van Dulmen, S				Roodbeen, Ruud; Vreke, Astrid; Boland, Gudule; Rademakers, Jany; van den Muijsenbergh, Maria; Noordman, Janneke; van Dulmen, Sandra			Communication and shared decision-making with patients with limited health literacy; helpful strategies, barriers and suggestions for improvement reported by hospital-based palliative care providers	PLOS ONE			English	Article							CANCER; INFORMATION; KNOWLEDGE; FAMILIES; RECALL; PEOPLE; IMPACT	Background Communication and shared decision-making (SDM) are essential to patient-centered care. Hospital-based palliative care with patients with limited health literacy (LHL) poses particular demands on communication. In this context, patients' emotions and vulnerable condition impact their skills to obtain, understand, process and apply information about health and healthcare even more. If healthcare providers (HCPs) meet these demands, it could enhance communication. In this study, HCPs were interviewed and asked for their strategies, barriers and suggestions for improvement regarding communication and SDM with LHL patients in hospital-based palliative care. Methods A qualitative interview study was conducted in 2018 in four Dutch hospitals with 17 HCPs-11 physicians and 6 nurses. Transcripts were analyzed using thematic analysis. Results In general HCPs recognized limited literacy as a concept, however, they did not recognize limitedhealthliteracy. Regarding SDM some HCPs were strong advocates, others did not believe in SDM as a concept and perceived it as unfeasible. Furthermore, five themes, acting as either strategies, barriers or suggestions for improvement emerged from the interviews: 1) time management; 2) HCPs' communication skills; 3) information tailoring; 4) characteristics of patients and significant others; 5) the content of the medical information. Conclusions According to HCPs, more time to communicate with their patients could resolve the most prominent barriers emerged from this study. Further research should investigate the organizational possibilities for this and the actual effectiveness of additional time on effective communication and SDM. Additionally, more awareness for the concept of LHL is needed as a precondition for recognizing LHL. Furthermore, future research should be directed towards opportunities for tailoring communication, and the extent to which limited knowledge and complex information affect communication and SDM. This study provides first insights into perspectives of HCPs, indicating directions for research on communication, SDM and LHL in hospital-based palliative care.	[Roodbeen, Ruud; Vreke, Astrid; Rademakers, Jany; Noordman, Janneke; van Dulmen, Sandra] Nivel Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Roodbeen, Ruud] Tilburg Univ, Dept Tranzo Sci Ctr Care & Wellbeing, Tilburg, Netherlands; [Boland, Gudule; van den Muijsenbergh, Maria] Dutch Ctr Expertise Hlth Dispar, Pharos, Utrecht, Netherlands; [Rademakers, Jany] Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Dept Family Med, Maastricht, Netherlands; [van den Muijsenbergh, Maria; van Dulmen, Sandra] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Primary & Community Care, Med Ctr, Nijmegen, Netherlands; [van Dulmen, Sandra] Univ South Eastern Norway, Fac Hlth & Social Sci, Drammen, Norway	Netherlands Institute for Health Services Research; Tilburg University; Maastricht University; Radboud University Nijmegen; University College of Southeast Norway	Roodbeen, R (corresponding author), Nivel Netherlands Inst Hlth Serv Res, Utrecht, Netherlands.; Roodbeen, R (corresponding author), Tilburg Univ, Dept Tranzo Sci Ctr Care & Wellbeing, Tilburg, Netherlands.	r.roodbeen@nivel.nl	van Dulmen, A.M./L-4287-2015	van Dulmen, A.M./0000-0002-1651-7544; /0000-0003-1109-7963; Roodbeen, Ruud/0000-0001-7315-4367	ZonMw (the Netherlands Organisation for Health and Research Development) [844001403]	ZonMw (the Netherlands Organisation for Health and Research Development)	This work was supported by awards from ZonMw (the Netherlands Organisation for Health and Research Development) project number 844001403 to authors RR, GB, JR, MvdM, JN, and SvD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No commercial companies funded the study or authors.	[Anonymous], 2019, PALL ZORG, V2019; [Anonymous], 2009, RESPIROLOGY S2, V14, pS44; [Anonymous], 2018, IEEE T SYSTEMS MAN C, P1, DOI DOI 10.2861/86313; Banerjee SC, 2016, NURSE EDUC PRACT, V16, P193, DOI 10.1016/j.nepr.2015.07.007; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Belanger E, 2011, PALLIATIVE MED, V25, P242, DOI 10.1177/0269216310389348; Berkman Nancy D, 2011, Evid Rep Technol Assess (Full Rep), P1; Boeije H., 2005, ANAL KWALITATIEF OND; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Buisman M., 2013, PIAAC KERNVAARDIGHED; Chou WS, 2015, TXB PALLIATIVE CARE, P90; Connor SR, 2014, GLOBAL ATLAS PALLIAT; Crombie I.K., 2005, CLOSING HLTH INEQUAL; Edwards M, 2015, HEALTH EXPECT, V18, P1180, DOI 10.1111/hex.12093; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Gabrijel S, 2008, J CLIN ONCOL, V26, P297, DOI 10.1200/JCO.2007.13.0609; Hamstra DA, 2015, MED DECIS MAKING, V35, P27, DOI 10.1177/0272989X14551639; Harper D., 2002, VISUAL STUD, V17, P13, DOI [10.1080/14725860220137345, DOI 10.1080/14725860220137345]; Heijmans M, 2018, HLTH LITERACY NEDERL; Jansen J, 2007, CANCER NURS, V30, P251, DOI 10.1097/01.NCC.0000281735.25609.af; Jansen J, 2010, PATIENT EDUC COUNS, V79, P218, DOI 10.1016/j.pec.2009.10.010; Kooijman M, 2018, GEZAMENLIJKE BESLUIT; Lopez-Perez B, 2017, J HEALTH PSYCHOL, V22, P788, DOI 10.1177/1359105315615931; Morris Nancy S, 2006, BMC Fam Pract, V7, P21, DOI 10.1186/1471-2296-7-21; Murugesu L, 2018, BETER OMGAAN MET BEP; Negarandeh R, 2013, PRIM CARE DIABETES, V7, P111, DOI 10.1016/j.pcd.2012.11.001; Noordman J, 2019, BMC PALLIAT CARE, V18, DOI 10.1186/s12904-019-0421-x; Noordman J, 2017, PATIENT EDUC COUNS, V100, P2262, DOI 10.1016/j.pec.2017.06.009; Oosterveld M, 2019, SAMEN BESLISSEN SPRE; Pharos, 2019, KENN EENV VOORL, V2019; Rademakers J., 2014, KENNISSYNTHESE GEZON; Rajah R, 2018, PERSPECT PUBLIC HEAL, V138, P122, DOI 10.1177/1757913917733775; Sadeghi S, 2013, CHRON RESP DIS, V10, P65, DOI 10.1177/1479972312471548; Schell JO, 2012, SEMIN DIALYSIS, V25, P611, DOI 10.1111/sdi.12017; Sep MSC, 2014, PATIENT EDUC COUNS, V95, P45, DOI 10.1016/j.pec.2013.12.022; Seymour Jane, 2010, BMC Palliat Care, V9, P4, DOI 10.1186/1472-684X-9-4; Shaw A, 2009, PATIENT EDUC COUNS, V75, P114, DOI 10.1016/j.pec.2008.09.026; Sorensen K., 2013, HLTH LITERACY NEGLEC; Spence A, 2009, PALLIATIVE MED, V23, P126, DOI 10.1177/0269216308098804; Stiggelbout AM, 2015, PATIENT EDUC COUNS, V98, P1172, DOI 10.1016/j.pec.2015.06.022; Stuurgroep Passende zorg in de laatste levensfase, 2015, NIET ALL WAT KAN HOE; Twickler Th B Marcel, 2009, Ned Tijdschr Geneeskd, V153, pA250; Vermeir P, 2015, INT J CLIN PRACT, V69, P1257, DOI 10.1111/ijcp.12686; Virdun C, 2015, PALLIATIVE MED, V29, P774, DOI 10.1177/0269216315583032; Wang C, 1997, HEALTH EDUC BEHAV, V24, P369, DOI 10.1177/109019819702400309; World Health Organization, WHO DEF PALL CAR	46	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234926	10.1371/journal.pone.0234926	http://dx.doi.org/10.1371/journal.pone.0234926			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559237	Green Published, gold			2022-12-27	WOS:000543261600040
J	Bleser, WK; Salmon, DA; Miranda, PY				Bleser, William K.; Salmon, Daniel A.; Miranda, Patricia Y.			A hidden vulnerable population: Young children up-to-date on vaccine series recommendations except influenza vaccines	PLOS ONE			English	Article							CHRONIC MEDICAL CONDITIONS; AGED 19-35 MONTHS; PARENTAL PERSPECTIVES; UNITED-STATES; CONFIRMED INFLUENZA; US CHILDREN; IMMUNIZATION; COVERAGE; COMMUNITY; ATTITUDES	Very young children (under 2 years old) have high risk for influenza-related complications. Children 6 months or older in the US are recommended to receive influenza vaccination annually, yet uptake is substantially lower than other routinely-recommended vaccines. Existing nationally-representative studies on very young child influenza vaccine uptake has several limitations: few examine provider-verified influenza vaccination (relying on parental report), few contain parental vaccine attitudes variables (known to be crucial to vaccine uptake), and none to our knowledge consider intersectionality of social disadvantage nor how influenza vaccine determinants differ from those of other recommended vaccines. This nationally-representative study examines provider-verified data on 7,246 children aged 6-23 months from the most recent (2011) National Immunization Survey to include the restricted Parental Concerns module, focusing on children up-to-date on a series of vaccines (the 4:3:1:3:3:1:4 series) but not influenza vaccines ("hidden vulnerability to influenza"). About 71% of children were up-to-date on the series yet only 33% on influenza vaccine recommendations by their second birthday; 44% had hidden vulnerability to influenza. Independent of parental history of vaccine refusal and a myriad of health services use factors, no parental history of delaying vaccination was associated with 7.5% (2.6-12.5) higher probability of hidden vulnerability to influenza despite being associated with 15.5% (10.8-20.2) lower probability of being up-to-date on neither the series nor influenza vaccines. Thus, parental compliance with broad child vaccine recommendations and lack of vaccine hesitancy may not indicate choice to vaccinate children against influenza. Examination of intersectionality suggests that maternal college education may not confer improved vaccination among non-Hispanic Black and Hispanic children despite that it does for non-Hispanic White children. Policymakers and researchers from public health, sociology, and other sectors need to collaborate to further examine how vaccine hesitancy and intersectional social disadvantage interact to affect influenza vaccine uptake in young US children.	[Bleser, William K.] Duke Univ, Robert J Margolis MD Ctr Hlth Policy, Washington, DC 20004 USA; [Salmon, Daniel A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Bleser, William K.; Miranda, Patricia Y.] Penn State Univ, Dept Hlth Policy & Adm, University Pk, PA 16802 USA	Duke University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bleser, WK (corresponding author), Duke Univ, Robert J Margolis MD Ctr Hlth Policy, Washington, DC 20004 USA.; Bleser, WK (corresponding author), Penn State Univ, Dept Hlth Policy & Adm, University Pk, PA 16802 USA.	william.bleser@duke.edu		Bleser, William/0000-0002-4640-8680	NIH [2R24HD041025-11]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR000127, KL2 TR000126]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	There was no external funding received for this study. We acknowledge indirect support provided by Pennsylvania State University's Department of Health Policy and Administration, Demography program, and Population Research Institute. The Population Research Institute is supported by an infrastructure grant from NIH (2R24HD041025-11). This publication was also supported, in part, by Grant UL1 TR000127 and KL2 TR000126 from the National Center for Advancing Translational Sciences (NCATS). The funders provided support in the form of salaries or infrastructure for authors WKB and PYM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Aldrich J.H., 1984, SAGE U PAPER SERIES; Allison MA, 2010, PEDIATR INFECT DIS J, V29, P751, DOI 10.1097/INF.0b013e3181d8562c; Allison P., 2014, LISTWISE DELETION IT; Andersen RM., 2007, CHANGING US HLTH CAR; Angrist JD, 2001, J BUS ECON STAT, V19, P2, DOI 10.1198/07350010152472571; [Anonymous], 2015, EPIDEMIOLOGY PREVENT; [Anonymous], 2006, PLAST RECONSTR SURG, V117, p45S; [Anonymous], 1999, LANCET, V354, P1277; [Anonymous], 2012, DRUG DISCOV TODAY TE; Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Bleser WK, 2019, AM J PREV MED, V56, P251, DOI 10.1016/j.amepre.2018.09.013; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; Centers for Disease Control, 2019, 2010 11 2018 19 INFL; Centers for Disease Control and Prevention, 2014, VACC CHILDR PROGR VF; Centers for Disease Control and Prevention, 2014, KEY FACTS SEAS FLU V; Centers for Disease Control and Prevention, 2013, INF VACC SAF; Centers for Disease Control and Prevention, 2014, WHAT AR BEN FLU VACC; Centers for Disease Control and Prevention, 2013, CHILDR FLU FLU VACC; Centers for Disease Control and Prevention, 2015, PEOPL HIGH RIS DEV F; Centers for Disease Control and Prevention NORC at the University of Chicago, 2012, NAT IMM SURV US GUID; Chatterjee Archana, 2010, Expert Rev Vaccines, V9, P497, DOI 10.1586/erv.10.36; Collins P.H., 2000, BLACK FEMINIST THOUG; Daley MF, 2006, PEDIATRICS, V117, pE268, DOI 10.1542/peds.2005-1752; Daley MF, 2005, ARCH PEDIAT ADOL MED, V159, P986, DOI 10.1001/archpedi.159.10.986; DeVoe JE, 2003, AM J PUBLIC HEALTH, V93, P786, DOI 10.2105/AJPH.93.5.786; Dill B.T., 2009, EMERGING INTERSECTIO; Elam-Evans LD, 2014, MMWR-MORBID MORTAL W, V63, P741; Ferdinands JM, 2014, J INFECT DIS, V210, P674, DOI 10.1093/infdis/jiu185; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Flood EM, 2010, CLIN THER, V32, P1448, DOI 10.1016/j.clinthera.2010.06.020; Fraaij PLA, 2011, VACCINE, V29, P7524, DOI 10.1016/j.vaccine.2011.08.010; Gnanasekaran SK, 2006, PUBLIC HEALTH REP, V121, P181, DOI 10.1177/003335490612100213; Gnanasekaran SK, 2006, AMBUL PEDIATR, V6, P1, DOI 10.1016/j.ambp.2005.08.004; Gusten R, 2006, ZOOTAXA, P1; Heckman JJ, 1997, RAND J ECON, V28, pS142, DOI 10.2307/3087459; Hemingway CO, 2004, PEDIATRICS, V114, P948, DOI 10.1542/peds.2003-0509-F; Hill Collins P., 1991, BLACK FEMINIST THOUG; Hill HA, 2018, MMWR-MORBID MORTAL W, V67, P1123, DOI 10.15585/mmwr.mm6740a4; Jordan R, 2006, VACCINE, V24, P1047, DOI 10.1016/j.vaccine.2005.09.017; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lin CJ, 2006, J URBAN HEALTH, V83, P874, DOI 10.1007/s11524-006-9084-z; Lin CJ, 2006, J NATL MED ASSOC, V98, P148; Malosh R, 2014, VACCINE, V32, P1841, DOI 10.1016/j.vaccine.2014.01.075; Meng Y., 2013, THESIS; Mirza A, 2008, SOUTH MED J, V101, P1101, DOI 10.1097/SMJ.0b013e318182ee8d; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; NORC at the University of Chicago, 2011, NIS CHILD HARD COP Q; Nowalk MP, 2007, J NATL MED ASSOC, V99, P636; Nowalk MP, 2005, AM J PREV MED, V29, P210, DOI 10.1016/j.amepre.2005.05.010; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Poehling KA, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e99; Poland GA, 2001, VACCINE, V19, P2440, DOI 10.1016/S0264-410X(00)00469-2; Principi N, 2003, PEDIATR INFECT DIS J, V22, pS207, DOI 10.1097/01.inf.0000092188.48726.e4; Rudolph L, 2013, HLTH ALL POLICIES GU; Salleras L, 2006, VACCINE, V24, P6638, DOI 10.1016/j.vaccine.2006.05.034; Salmon DA, 2015, AM J PREV MED, V49, pS391, DOI 10.1016/j.amepre.2015.06.009; Santibanez TA, 2006, PEDIATRICS, V118, P1167, DOI 10.1542/peds.2006-0831; Santibanez TA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3280; Schwartz JL, 2011, PRIMARY CARE, V38, P717, DOI 10.1016/j.pop.2011.07.009; StataCorp, 2013, STATA STAT SOFTW REL; SZILAGYI PG, 1992, PEDIATRICS, V90, P871; Teo SSS, 2005, ARCH DIS CHILD, V90, P532, DOI 10.1136/adc.2004.051896; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; U.S. Department of Health and Human Services, 2012, AFF CAR ACT IMM; Uwemedimo OT, 2012, J COMMUN HEALTH, V37, P663, DOI 10.1007/s10900-011-9497-9; Vesikari T, 2006, PEDIATRICS, V118, P2298, DOI 10.1542/peds.2006-0725; Warner DF, 2011, SOC SCI MED, V72, P1236, DOI 10.1016/j.socscimed.2011.02.034; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025; Zhao Z, 2013, VACCINE, V31, P2324, DOI 10.1016/j.vaccine.2013.03.018; Zhao Z, 2010, AM J PREV MED, V38, P127, DOI 10.1016/j.amepre.2009.10.035	73	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234466	10.1371/journal.pone.0234466	http://dx.doi.org/10.1371/journal.pone.0234466			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555653	Green Published, gold			2022-12-27	WOS:000543273200082
J	Keller, M; Roth, WT; Petrowski, K				Keller, Marius; Roth, Walton T.; Petrowski, Katja			Supplementing sleep actigraphy with button pressing while awake	PLOS ONE			English	Article							WRIST ACTIGRAPHY; ONSET; AGREEMENT; ACCURACY; WAKE	Objective/background Wrist-worn sleep actigraphs are limited for evaluating sleep, especially in sleepers who lie awake in bed without moving for extended periods. Sleep logs depend on the accuracy of perceiving and remembering times of being awake. Here we evaluated pressing an event-marker button while lying awake under two conditions: self-initiated pressing every 5 to 10 minutes or pressing when signaled every 5 minutes by a vibration pulse from a wristband. We evaluated the two conditions for acceptability and their concordance with actigraphically scored sleep. Participants and methods Twenty-nine adults wore actigraphs on six nights. On nights 1 and 4, they pressed the marker to a vibration signal, and on nights 2 and 5, they self-initiated presses without any signal. On nights 3 and 6, they were told not to press the marker. Every morning they filled out a sleep log about how they had slept. Results The vibration band was unacceptable to 42% of the participants, who judged it too disturbing to their sleep. Self-initiated pressing was acceptable to all, although it reduced log reported sleep depth compared to a no pressing condition. Estimations of sleep onset latency were considerably longer by button pressing than by actigraphy. Agreement of epoch-by-epoch sleep scoring by actigraphy and by button pressing was poor (kappa = 0.23) for self-initiated pressing and moderate (kappa = 0.46) for pressing in response to a vibration. Conclusions Self-initiated button pressing to indicate being awake while lying in bed is acceptable to many, interferes little with sleep, and adds substantially to the information given by actigraphy.	[Keller, Marius; Petrowski, Katja] Johannes Gutenberg Univ Mainz, Med Psychol & Med Sociol, Univ Med Ctr, Mainz, Germany; [Keller, Marius] Elblandklinikum Meissen, Dept Neurol, Meissen, Germany; [Roth, Walton T.] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA USA; [Roth, Walton T.] VA Palo Alto Hlth Care Syst, War Related Illness & Injury Ctr, Palo Alto, CA USA; [Petrowski, Katja] Tech Univ Dresden, Med Sch, Dept Psychotherapy & Psychosomat Med, Dresden, Germany	Johannes Gutenberg University of Mainz; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Technische Universitat Dresden	Keller, M (corresponding author), Johannes Gutenberg Univ Mainz, Med Psychol & Med Sociol, Univ Med Ctr, Mainz, Germany.; Keller, M (corresponding author), Elblandklinikum Meissen, Dept Neurol, Meissen, Germany.	keller.marius@outlook.com		Keller, Marius/0000-0002-3532-6348				Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; [Anonymous], ULUSLARARASI ILISKIL; Beattie Z, 2017, PHYSIOL MEAS, V38, P1968, DOI 10.1088/1361-6579/aa9047; Blackwell T, 2011, J CLIN SLEEP MED, V7, P357, DOI 10.5664/JCSM.1190; Blake H, 1939, J NEUROPHYSIOL, V2, P48, DOI 10.1152/jn.1939.2.1.48; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boyne K, 2013, SLEEP BREATH, V17, P411, DOI 10.1007/s11325-012-0709-z; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Casagrande M, 1997, SLEEP, V20, P301, DOI 10.1093/sleep/20.4.301; Cellini N, 2013, CHRONOBIOL INT, V30, P691, DOI 10.3109/07420528.2013.782312; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Danker-Hopfe H, 2009, J SLEEP RES, V18, P74, DOI 10.1111/j.1365-2869.2008.00700.x; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; European Food Safety Authority (EFSA), 2015, EFSA J, V13, pe4138, DOI 10.2903/j.efsa.2015.4138; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Gruwez A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210569; HAURI PJ, 1992, SLEEP, V15, P293, DOI 10.1093/sleep/15.4.293; Hauri PJ, 1999, SLEEP, V22, P1110, DOI 10.1093/sleep/22.8.1110; Jean-Louis G, 2001, J NEUROSCI METH, V105, P185, DOI 10.1016/S0165-0270(00)00364-2; Johnson NL, 2007, SLEEP, V30, P899, DOI 10.1093/sleep/30.7.899; Kleitman N, 1965, SLEEP WAKEFULNESS RE, P108; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee J, 2015, STUD HEALTH TECHNOL, V210, P458, DOI 10.3233/978-1-61499-512-8-458; Levendowski DJ, 2017, J CLIN SLEEP MED, V13, P791, DOI 10.5664/jcsm.6618; Miller KE, 2019, J CLIN SLEEP MED, V15, P1675, DOI 10.5664/jcsm.8038; Ogilvie RD, 2001, SLEEP MED REV, V5, P247, DOI 10.1053/smrv.2001.0145; OGILVIE RD, 1989, SLEEP, V12, P458, DOI 10.1093/sleep/12.5.458; OGILVIE RD, 1984, PSYCHOPHYSIOLOGY, V21, P510, DOI 10.1111/j.1469-8986.1984.tb00234.x; Paquet J, 2007, SLEEP, V30, P1362, DOI 10.1093/sleep/30.10.1362; Thurman SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191883	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234060	10.1371/journal.pone.0234060	http://dx.doi.org/10.1371/journal.pone.0234060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555652	gold, Green Published			2022-12-27	WOS:000543273200069
J	Milali, MP; Kiware, SS; Govella, NJ; Okumu, F; Bansal, N; Bozdag, S; Charlwood, JD; Maia, MF; Ogoma, SB; Dowell, FE; Corliss, GF; Sikulu-Lord, MT; Povinelli, RJ				Milali, Masabho P.; Kiware, Samson S.; Govella, Nicodem J.; Okumu, Fredros; Bansal, Naveen; Bozdag, Serdar; Charlwood, Jacques D.; Maia, Marta F.; Ogoma, Sheila B.; Dowell, Floyd E.; Corliss, George F.; Sikulu-Lord, Maggy T.; Povinelli, Richard J.			An autoencoder and artificial neural network-based method to estimate parity status of wild mosquitoes from near-infrared spectra	PLOS ONE			English	Article							MALARIA TRANSMISSION; SENSITIVITY; AGE	After mating, female mosquitoes need animal blood to develop their eggs. In the process of acquiring blood, they may acquire pathogens, which may cause different diseases in humans such as malaria, zika, dengue, and chikungunya. Therefore, knowing the parity status of mosquitoes is useful in control and evaluation of infectious diseases transmitted by mosquitoes, where parous mosquitoes are assumed to be potentially infectious. Ovary dissections, which are currently used to determine the parity status of mosquitoes, are very tedious and limited to few experts. An alternative to ovary dissections is near-infrared spectroscopy (NIRS), which can estimate the age in days and the infectious state of laboratory and semi-field reared mosquitoes with accuracies between 80 and 99%. No study has tested the accuracy of NIRS for estimating the parity status of wild mosquitoes. In this study, we train an artificial neural network (ANN) models on NIR spectra to estimate the parity status of wild mosquitoes. We use four different datasets:An.arabiensiscollected from Minepa, Tanzania (Minepa-ARA);An.gambiae s.scollected from Muleba, Tanzania (Muleba-GA);An.gambiae s.scollected from Burkina Faso (Burkina-GA); andAn.gambiae s.sfrom Muleba and Burkina Faso combined (Muleba-Burkina-GA). We train ANN models on datasets with spectra preprocessed according to previous protocols. We then use autoencoders to reduce the spectra feature dimensions from 1851 to 10 and re-train the ANN models. Before the autoencoder was applied, ANN models estimated parity status of mosquitoes in Minepa-ARA, Muleba-GA, Burkina-GA and Muleba-Burkina-GA with out-of-sample accuracies of 81.9 +/- 2.8 (N = 274), 68.7 +/- 4.8 (N = 43), 80.3 +/- 2.0 (N = 48), and 75.7 +/- 2.5 (N = 91), respectively. With the autoencoder, ANN models tested on out-of-sample data achieved 97.1 +/- 2.2% (N = 274), 89.8 +/- 1.7% (N = 43), 93.3 +/- 1.2% (N = 48), and 92.7 +/- 1.8% (N = 91) accuracies for Minepa-ARA, Muleba-GA, Burkina-GA, and Muleba-Burkina-GA, respectively. These results show that a combination of an autoencoder and an ANN trained on NIR spectra to estimate the parity status of wild mosquitoes yields models that can be used as an alternative tool to estimate parity status of wild mosquitoes, especially since NIRS is a high-throughput, reagent-free, and simple-to-use technique compared to ovary dissections.	[Milali, Masabho P.; Kiware, Samson S.; Bansal, Naveen; Corliss, George F.; Povinelli, Richard J.] Marquette Univ, Dept Math & Stat Sci, Milwaukee, WI 53233 USA; [Milali, Masabho P.; Kiware, Samson S.; Govella, Nicodem J.; Okumu, Fredros] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania; [Bozdag, Serdar] Marquette Univ, Dept Comp Sci, Milwaukee, WI 53233 USA; [Charlwood, Jacques D.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Maia, Marta F.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Maia, Marta F.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Maia, Marta F.] Univ Basel, Basel, Switzerland; [Ogoma, Sheila B.] Clinton Hlth Access Initiat, Nairobi, Kenya; [Dowell, Floyd E.] ARS, Ctr Grain & Anim Hlth Res, USDA, Manhattan, KS USA; [Corliss, George F.; Povinelli, Richard J.] Marquette Univ, Dept Elect & Comp Engn, Milwaukee, WI 53233 USA; [Sikulu-Lord, Maggy T.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia	Marquette University; Ifakara Health Institute; Marquette University; Liverpool School of Tropical Medicine; Kenya Medical Research Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; United States Department of Agriculture (USDA); Marquette University; University of Queensland	Milali, MP (corresponding author), Marquette Univ, Dept Math & Stat Sci, Milwaukee, WI 53233 USA.; Milali, MP (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania.	pmasabho@ihi.or.tz		Povinelli, Richard/0000-0001-8439-0146; Bozdag, Serdar/0000-0002-4813-4310; Ferreira Maia, Marta/0000-0003-3302-5610	Grand Challenges Canada Stars for Global Health - government of Canada [043901]; DFID/MRC/Wellcome Trust through the Joint Health Trials Scheme [MR/L004437/1]; National Institute of Allergy and Infectious Diseases [R01-AI094349-01A1]; Marquette University Graduate School	Grand Challenges Canada Stars for Global Health - government of Canada; DFID/MRC/Wellcome Trust through the Joint Health Trials Scheme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Marquette University Graduate School	Data collection was funded by: Grand Challenges Canada Stars for Global Health funded by the government of Canada grant 043901 awarded to MTSL; DFID/MRC/Wellcome Trust through the Joint Health Trials Scheme awarded to JDC (Award Number MR/L004437/1); National Institute of Allergy and Infectious Diseases grant R01-AI094349-01A1; and Marquette University Graduate School, for studentship awarded to MPM.	Abdi H., 2003, ENCY RES METHODS SOC, V6, P792; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; [Anonymous], 1992, REPRESENTATIONS, V37, P1; [Anonymous], 2017, DRUG SAF UPDATE, DOI DOI 10.1186/s13104-016-2345-3; Baldi P., 2012, P ICML WORKSH UNS TR, P37; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Bourlard H, 2000, AUTOASSOCIATION MULT; Chicco D., 2014, P 5 ACM C BIOINF COM, P533; Coleman S, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1971-0; De Lathauwer L, 2000, SIAM J MATRIX ANAL A, V21, P1253, DOI 10.1137/S0895479896305696; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Detinova T. S., 1945, MEDITSINSKA PARAZITOLOG[IMAGE] I PARAZITARNYE BOLEZNI [MED PARASITOL AND PARASITIC DIS], V14, P45; Dietterich TG, 1997, AI MAG, V18, P97; Domingos P, 2012, COMMUN ACM, V55, P78, DOI 10.1145/2347736.2347755; Dowell FE, 2011, AM J TROP MED HYG, V85, P1093, DOI 10.4269/ajtmh.2011.11-0438; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; GOLUB GH, 1970, NUMER MATH, V14, P403, DOI 10.1007/BF02163027; Kingma D, 2013, AUTOENCODING VARIATI; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; LeClair C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1972-z; Liou CY, 2008, NEUROCOMPUTING, V71, P3150, DOI 10.1016/j.neucom.2008.04.030; Liou CY, 2014, NEUROCOMPUTING, V139, P84, DOI 10.1016/j.neucom.2013.09.055; Liu Y, 2018, PROCEDIA COMPUT SCI, V139, P529, DOI 10.1016/j.procs.2018.10.237; MAGESA SM, 1991, ACTA TROP, V49, P97, DOI 10.1016/0001-706X(91)90057-Q; Maia MF, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2719-9; Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192; Mayagaya VS, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0661-4; Milali MP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209451; Milali MP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198245; Milali MP, 2018, ARABIENSIS USING NEA, P490326; Mouazen AM, 2010, GEODERMA, V158, P23, DOI 10.1016/j.geoderma.2010.03.001; Ntamatungiro AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-298; PASKEWITZ SM, 1990, MED VET ENTOMOL, V4, P367, DOI 10.1111/j.1365-2915.1990.tb00453.x; Polovodova V. P., 1941, Medical Parasitology and Parasitic Diseases Moscow, V10, P387; Powers D., 2011, J MACH LEARN TECHNOL, V2, P37; ROBERT V, 1991, B WORLD HEALTH ORGAN, V69, P735; Shlens J., 2014, ARXIV; Sikulu M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-49; Sikulu MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090657; Sikulu-Lord MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005040; Sikulu-Lord MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004759; Smith CJ, 2012, PHLEBOLOGY, V27, P250, DOI 10.1258/phleb.2012.012J05; Stone P, 2000, EUR C MACH LEARN; Storkey A, 2009, NEURAL INF PROCESS S, P3; Xu QS, 2004, J CHEMOMETR, V18, P112, DOI 10.1002/cem.858	47	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234557	10.1371/journal.pone.0234557	http://dx.doi.org/10.1371/journal.pone.0234557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555660	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000543273200004
J	Cunanan, J; Deacon, E; Cunanan, K; Yang, ZF; Ask, A; Morikawa, L; Todorova, E; Bridgewater, D				Cunanan, Joanna; Deacon, Erin; Cunanan, Kristina; Yang, Zifan; Ask, Antje; Morikawa, Lily; Todorova, Ekaterina; Bridgewater, Darren			Quercetin treatment reduces the severity of renal dysplasia in a beta-catenin dependent manner	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; KIDNEY DEVELOPMENT; E-CADHERIN; HYPERTENSION; PATHWAY; CELLS; INVASIVENESS; DYSFUNCTION; INHIBITOR; VIMENTIN	Renal dysplasia, the major cause of childhood renal failure, is characterized by defective branching morphogenesis and nephrogenesis. Beta-catenin, a transcription factor and cell adhesion molecule, is markedly increased in the nucleus of kidney cells in human renal dysplasia and contributes to its pathogenesis by altering target genes that are essential for kidney development. Quercetin, a naturally occurring flavonoid, reduces nuclear beta-catenin levels and reduces beta-catenin transcriptional activity. In this study, we utilized wild type and dysplastic mouse kidney organ explants to determine if quercetin reduces beta-catenin activity during kidney development and whether it improves the severity of renal dysplasia. In wild type kidney explants, quercetin treatment resulted in abnormal branching morphogenesis and nephrogenesis in a dose dependent manner. In wild type embryonic kidneys, quercetin reduced nuclear beta-catenin expression and decreased expression of beta-catenin target genesPax2,Six2, andGdnf, which are essential for kidney development. OurRD(B)mouse model of renal dysplasia recapitulates the overexpression of beta-catenin and histopathological changes observed in human renal dysplasia.RD(B)kidneys treated with quercetin resulted in improvements in the overall histopathology, tissue organization, ureteric branching morphogenesis, and nephrogenesis. Quercetin treatment also resulted in reduced nuclear beta-catenin and reducedPax2expression. These improvements were associated with the proper organization of vimentin, NCAM, and E-cadherin, and a 45% increase in the number of developing and maturing nephrons. Further, our results show that in human renal dysplasia, beta-catenin, vimentin, and e-cadherin also have abnormal expression patterns. Taken together, these data demonstrate that quercetin treatment reduces nuclear beta-catenin and this is associated with improved epithelial organization of developing nephrons, resulting in increased developing nephrons and a partial rescue of renal dysplasia.	[Cunanan, Joanna; Deacon, Erin; Cunanan, Kristina; Yang, Zifan; Ask, Antje; Morikawa, Lily; Todorova, Ekaterina; Bridgewater, Darren] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University	Bridgewater, D (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	bridgew@mcmaster.ca		Cunanan, Joanna/0000-0001-9587-4533	Canadian Institutes of Health Research; Kidney Foundation of Canada; National Science and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	DB-Canadian Institutes of Health Research; DB-Kidney Foundation of Canada; DB-National Science and Engineering Research Council.	[Anonymous], 2012, J OPT COMMUN NETW, V4, pB94; Aygul A, 2019, PHYTOMEDICINE, V57, P65, DOI 10.1016/j.phymed.2018.12.014; Balakrishnan S, 2016, CELL PROLIFERAT, V49, P678, DOI 10.1111/cpr.12296; Barker N, 2012, CELL REP, V2, P540, DOI 10.1016/j.celrep.2012.08.018; Bhat FA, 2014, J NUTR BIOCHEM, V25, P1132, DOI 10.1016/j.jnutbio.2014.06.008; Boivin FJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00081; Boivin FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120347; Boyle SC, 2011, DEVELOPMENT, V138, P4245, DOI 10.1242/dev.070433; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Bridgewater D, 2011, J AM SOC NEPHROL, V22, P718, DOI 10.1681/ASN.2010050562; Cain JE, 2010, PEDIATR RES, V68, P91, DOI 10.1203/00006450-201011001-00175; Cao CN, 2015, PANCREAS, V44, P1334, DOI 10.1097/MPA.0000000000000400; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; Chaw SY, 2012, ORAL ONCOL, V48, P997, DOI 10.1016/j.oraloncology.2012.05.011; Chen DQ, 2019, THER ADV CHRONIC DIS, V10, DOI 10.1177/2040622319869116; Chen DQ, 2018, TRENDS PHARMACOL SCI, V39, P937, DOI 10.1016/j.tips.2018.09.002; Chen DQ, 2017, REDOX BIOL, V12, P505, DOI 10.1016/j.redox.2017.03.017; Chen H, 2018, PHYTOMEDICINE, V42, P207, DOI 10.1016/j.phymed.2018.03.034; Chen RY, 2015, ARCH PATHOL LAB MED, V139, P547, DOI 10.5858/arpa.2013-0660-RS; Chong E, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/760580; Ding A, 2019, J DEV ORIG HLTH DIS, V10, P154, DOI 10.1017/S2040174418000673; Dressler GR, 1999, INT J DEV BIOL, V43, P463; Drukker A, 2002, ISRAEL MED ASSOC J, V4, P191; Fanos V, 2019, AM J PERINAT, V36, pS33, DOI 10.1055/s-0039-1691798; Feng JH, 2018, BIOCHEM BIOPH RES CO, V498, P132, DOI 10.1016/j.bbrc.2018.02.044; Feng YL, 2020, MED RES REV, V40, P54, DOI 10.1002/med.21596; Fosang AJ, 2015, J BIOL CHEM, V290, P29692, DOI 10.1074/jbc.E115.000002; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hermankova E, 2019, FREE RADICAL BIO MED, V143, P240, DOI 10.1016/j.freeradbiomed.2019.08.001; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; Hu MC, 2003, DEVELOPMENT, V130, P2753, DOI 10.1242/dev.00478; Hu Y, 2019, FREE RADICAL BIO MED, V145, P146, DOI 10.1016/j.freeradbiomed.2019.09.024; Kakkar N, 2006, FETAL PEDIATR PATHOL, V25, P73, DOI 10.1080/15513810600788764; Kee JY, 2016, PHYTOMEDICINE, V23, P1680, DOI 10.1016/j.phymed.2016.09.011; Lewinska A, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101337; Lin YS, 2011, CANCER SCI, V102, P1829, DOI 10.1111/j.1349-7006.2011.02035.x; Liu D, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.108990; Luo WR, 2012, INT J CANCER, V131, P1863, DOI 10.1002/ijc.27467; Mah SP, 2000, DEV BIOL, V223, P38, DOI 10.1006/dbio.2000.9738; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; MCGRAW M, 1984, INT J PED NEPHROL, V5, P67; McMahon AP, 2016, CURR TOP DEV BIOL, V117, P31, DOI 10.1016/bs.ctdb.2015.10.010; Metsuyanim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006709; Miller JR, 1997, DEV BIOL, V192, P310, DOI 10.1006/dbio.1997.8739; Moritz KM, 2002, HYPERTENSION, V39, P1071, DOI 10.1161/01.HYP.0000019131.77075.54; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Orsulic S, 1999, J CELL SCI, V112, P1237; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Postoev VA, 2016, BIRTH DEFECTS RES A, V106, P185, DOI 10.1002/bdra.23475; Ren JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep23968; Rezabakhsh A, 2019, PHYTOMEDICINE, V56, P183, DOI 10.1016/j.phymed.2018.11.008; Roper JC, 2018, ELIFE, V7, DOI 10.7554/eLife.33381; Sanna-Cherchi S, 2007, PEDIATR NEPHROL, V22, P1675, DOI 10.1007/s00467-007-0479-1; Sarin S, 2014, AM J PATHOL, V184, P1395, DOI 10.1016/j.ajpath.2014.01.018; Srinivasan A, 2016, MOL CARCINOGEN, V55, P743, DOI 10.1002/mc.22318; Tafrihi M, 2017, NUTR CANCER, V69, P702, DOI 10.1080/01635581.2017.1320415; Vivante A, 2016, NAT REV NEPHROL, V12, P133, DOI 10.1038/nrneph.2015.205; Vrolijk MF, 2020, BRIT J PHARMACOL, V177, P1841, DOI 10.1111/bph.14955; Wang M, 2018, BRIT J PHARMACOL, V175, P2689, DOI 10.1111/bph.14333; Wang M, 2018, J AGR FOOD CHEM, V66, P1828, DOI 10.1021/acs.jafc.8b00099; Wang YP, 2018, PROG MOL BIOL TRANSL, V153, P181, DOI 10.1016/bs.pmbts.2017.11.019; Woods LL, 1999, AM J PHYSIOL-REG I, V276, pR974, DOI 10.1152/ajpregu.1999.276.4.R974; Yang Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24618-2; You WJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55654-1	65	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234375	10.1371/journal.pone.0234375	http://dx.doi.org/10.1371/journal.pone.0234375			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555682	Green Published, gold			2022-12-27	WOS:000542759600046
J	Higashihara, A; Nakagawa, K; Inami, T; Fukano, M; Iizuka, S; Maemichi, T; Hashizume, S; Narita, T; Hirose, N				Higashihara, Ayako; Nakagawa, Kento; Inami, Takayuki; Fukano, Mako; Iizuka, Satoshi; Maemichi, Toshihiro; Hashizume, Satoru; Narita, Takaya; Hirose, Norikazu			Regional differences in hamstring muscle damage after a marathon	PLOS ONE			English	Article							RECOVERY; INJURY; FATIGUE; SPEED; JUICE	Previous studies suggest that marathon running induces lower extremity muscle damage. This study aimed to examine inter- and intramuscular differences in hamstring muscle damage after a marathon using transverse relaxation time (T-2)-weighted magnetic resonance images (MRI). 20 healthy collegiate marathon runners (15 males) were recruited for this study. T-2-MRI was performed before (PRE) and at 1 (D1), 3 (D3), and 8 days (D8) after marathon, and the T(2)values of each hamstring muscle at the distal, middle, and proximal sites were calculated. Results indicated that no significant intermuscular differences in T(2)changes were observed and that, regardless of muscle, the T(2)values of the distal and middle sites increased significantly at D1 and D3 and recovered at D8, although those values of the proximal site remained constant. T(2)significantly increased at distal and middle sites of the biceps femoris long head on D1 (p= 0.030 andp= 0.004, respectively) and D3 (p= 0.007 andp= 0.041, respectively), distal biceps femoris short head on D1 (p= 0.036), distal semitendinosus on D1 (p= 0.047) and D3 (p= 0.010), middle semitendinosus on D1 (p= 0.005), and distal and middle sites of the semimembranosus on D1 (p= 0.008 andp= 0.040, respectively) and D3 (p= 0.002 andp= 0.018, respectively). These results suggest that the distal and middle sites of the hamstring muscles are more susceptible to damage induced by running a full marathon. Conditioning that focuses on the distal and middle sites of the hamstring muscles may be more useful in improving recovery strategies after prolonged running.	[Higashihara, Ayako; Inami, Takayuki] Keio Univ, Inst Phys Educ, Kanagawa, Japan; [Nakagawa, Kento; Iizuka, Satoshi; Maemichi, Toshihiro; Hirose, Norikazu] Waseda Univ, Fac Sport Sci, Saitama, Japan; [Fukano, Mako] Shibaura Inst Technol, Tokyo, Japan; [Hashizume, Satoru] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Narita, Takaya] Toin Univ Yokohama, Dept Sport Technol, Kanagawa, Japan	Keio University; Waseda University; Shibaura Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST); Toin University of Yokohama	Higashihara, A (corresponding author), Keio Univ, Inst Phys Educ, Kanagawa, Japan.	higashihara@keio.jp	Maemichi, Toshihiro/AAX-4597-2021; Hirose, Norikazu/ABF-4753-2020	Maemichi, Toshihiro/0000-0001-8683-2059; Nakagawa, Kento/0000-0002-6203-6602; Iizuka, Satoshi/0000-0002-0480-3754	Mizuno Sports Promotion Foundation	Mizuno Sports Promotion Foundation	This work was supported by the Mizuno Sports Promotion Foundation.	Akima H, 2002, J APPL PHYSIOL, V92, P679, DOI 10.1152/japplphysiol.00267.2001; [Anonymous], 2017, LANCET HIV, V2017, pPE475; Askling CM, 2007, AM J SPORT MED, V35, P1716, DOI 10.1177/0363546507303563; BROOKS SV, 1995, J PHYSIOL-LONDON, V488, P459, DOI 10.1113/jphysiol.1995.sp020980; Clifford T, 2017, APPL PHYSIOL NUTR ME, V42, P263, DOI 10.1139/apnm-2016-0525; Coutts AJ, 2010, J SCI MED SPORT, V13, P543, DOI 10.1016/j.jsams.2009.09.004; Crema MD, 2016, J SCI MED SPORT, V19, P317, DOI 10.1016/j.jsams.2015.04.005; Dankel SJ, 2021, J STRENGTH COND RES, V35, P1773, DOI 10.1519/JSC.0000000000002946; Duhig S, 2016, BRIT J SPORT MED, V50, P1536, DOI 10.1136/bjsports-2015-095679; Fyfe JJ, 2013, J ELECTROMYOGR KINES, V23, P523, DOI 10.1016/j.jelekin.2012.12.006; Higashihara A, 2016, EUR J SPORT SCI, V16, P36, DOI 10.1080/17461391.2014.973913; Hill JA, 2014, J STRENGTH COND RES, V28, P2228, DOI 10.1519/JSC.0000000000000469; Howatson G, 2010, SCAND J MED SCI SPOR, V20, P843, DOI 10.1111/j.1600-0838.2009.01005.x; Inami T, 2019, J STRENGTH COND RES, V33, P3431, DOI 10.1519/JSC.0000000000002495; Larsen RG, 2007, SCAND J MED SCI SPOR, V17, P76, DOI 10.1111/j.1600-0838.2005.00525.x; LIEBER RL, 1993, J APPL PHYSIOL, V74, P520, DOI 10.1152/jappl.1993.74.2.520; Maeo S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06129-8; McHugh MP, 2003, SCAND J MED SCI SPOR, V13, P88, DOI 10.1034/j.1600-0838.2003.02477.x; MORGAN DL, 1990, BIOPHYS J, V57, P209, DOI 10.1016/S0006-3495(90)82524-8; Nakagawa K, 2018, SCAND J MED SCI SPOR, V28, P621, DOI 10.1111/sms.12911; Ochi E, 2016, EUR J APPL PHYSIOL, V116, P2145, DOI 10.1007/s00421-016-3462-3; Orchard JW, 2013, AM J SPORT MED, V41, P734, DOI 10.1177/0363546513476270; Petersen K, 2007, EUR J APPL PHYSIOL, V101, P385, DOI 10.1007/s00421-007-0504-x; Ruddy JD, 2018, BRIT J SPORT MED, V52, P919, DOI 10.1136/bjsports-2016-096777; Schache AG, 2013, EUR J APPL PHYSIOL, V113, P2813, DOI 10.1007/s00421-013-2713-9; Schache AG, 2012, MED SCI SPORT EXER, V44, P647, DOI 10.1249/MSS.0b013e318236a3d2; Schache AG, 2011, MED SCI SPORT EXER, V43, P1260, DOI 10.1249/MSS.0b013e3182084929; Silder A, 2010, J BIOMECH, V43, P2254, DOI 10.1016/j.jbiomech.2010.02.038; Thelen DG, 2005, MED SCI SPORT EXER, V37, P1931, DOI 10.1249/01.mss.0000176674.42929.de	29	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234401	10.1371/journal.pone.0234401	http://dx.doi.org/10.1371/journal.pone.0234401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584826	Green Published, gold			2022-12-27	WOS:000545747200074
J	Okuma, H; Sudah, M; Kettunen, T; Niukkanen, A; Sutela, A; Masarwah, A; Kosma, VM; Auvinen, P; Mannermaa, A; Vanninen, R				Okuma, Hidemi; Sudah, Mazen; Kettunen, Tiia; Niukkanen, Anton; Sutela, Anna; Masarwah, Amro; Kosma, Veli-Matti; Auvinen, Paivi; Mannermaa, Arto; Vanninen, Ritva			Peritumor to tumor apparent diffusion coefficient ratio is associated with biologically more aggressive breast cancer features and correlates with the prognostication tools	PLOS ONE			English	Article							LYMPHOVASCULAR INVASION; INDEX; PREDICT; STROMA; EDEMA; WOMEN; KI-67	Purpose The apparent diffusion coefficient (ADC) is increasingly used to characterize breast cancer. The peritumor/tumor ADC ratio is suggested to be a reliable and generally applicable index. However, its overall prognostication value remains unclear. We aimed to evaluate the associations between the peritumor/tumor ADC ratio and histopathological biomarkers and published prognostic tools in patients with invasive breast cancer. Materials and methods This prospective study included 88 lesions (five bilateral) in 83 patients with primary invasive breast cancer who underwent preoperative 3.0-T magnetic resonance imaging. The lowest intratumoral mean ADC value on the slice with the largest tumor cross-sectional area was designated the tumor ADC, and the highest mean ADC value on the peritumoral breast parenchymal tissue adjacent to the tumor border was designated the peritumor ADC. The peritumor/tumor ADC ratio was then calculated. The tumor and peritumor ADC values and peritumor/tumor ADC ratios were compared with histopathological parameters using an unpairedttest, and their correlations with published prognostic tools were evaluated with Pearson's correlation coefficient. Results The peritumor/tumor ADC ratio was significantly associated with tumor size (p<0.001), histological grade (p = 0.005), Ki-67 index (p = 0.006), axillary-lymph-node metastasis (p = 0.001), and lymphovascular invasion (p = 0.006), but was not associated with estrogen receptor status (p = 0.931), progesterone receptor status (p = 0.160), or human epidermal growth factor receptor 2 status (p = 0.259). The peritumor/tumor ADC ratio showed moderate positive correlations with the Nottingham Prognostic Index (r= 0.498, p<0.001) and mortality predicted using PREDICT (r= 0.436, p<0.001). Conclusion The peritumor/tumor ADC ratio was correlated with histopathological biomarkers in patients with invasive breast cancer, showed significant correlations with published prognostic indexes, and may provide an easily applicable imaging index for the preoperative prognostic evaluation of breast cancer.	[Okuma, Hidemi; Sudah, Mazen; Niukkanen, Anton; Sutela, Anna; Masarwah, Amro; Vanninen, Ritva] Univ Eastern Finland, Inst Clin Med, Sch Med, Clin Radiol, Kuopio, Finland; [Okuma, Hidemi; Sudah, Mazen; Niukkanen, Anton; Sutela, Anna; Masarwah, Amro; Vanninen, Ritva] Kuopio Univ Hosp, Dept Clin Radiol, Diagnost Imaging Ctr, Kuopio, Finland; [Kettunen, Tiia; Auvinen, Paivi] Univ Eastern Finland, Inst Clin Med, Sch Med, Oncol, Kuopio, Finland; [Kettunen, Tiia; Auvinen, Paivi] Kuopio Univ Hosp, Dept Oncol, Canc Ctr, Kuopio, Finland; [Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Inst Clin Med, Sch Med Pathol & Forens Med, Kuopio, Finland; [Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Translat Canc Res Area, Kuopio, Finland; [Kosma, Veli-Matti; Mannermaa, Arto] Kuopio Univ Hosp, Biobank Eastern Finland, Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Okuma, H (corresponding author), Univ Eastern Finland, Inst Clin Med, Sch Med, Clin Radiol, Kuopio, Finland.; Okuma, H (corresponding author), Kuopio Univ Hosp, Dept Clin Radiol, Diagnost Imaging Ctr, Kuopio, Finland.	Hidemi.Okuma@kuh.fi	Okuma, Hidemi/M-2660-2018	Okuma, Hidemi/0000-0001-5325-2699	Cancer Society of Finland; RV VTR [5063542]; RV Mauri and Sirkka Wiljasalo Foundation	Cancer Society of Finland; RV VTR; RV Mauri and Sirkka Wiljasalo Foundation	Cancer Society of Finland; RV VTR (5063542); RV Mauri and Sirkka Wiljasalo Foundation; HO The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arponen O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18035-0; Arponent O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138702; Artacho-Cordon A, 2012, CANCER BIOL THER, V13, P14, DOI 10.4161/cbt.13.1.18869; Aydin H, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170705; BALSLEV I, 1994, BREAST CANCER RES TR, V32, P281, DOI 10.1007/BF00666005; Baltzer P, 2020, EUR RADIOL, V30, P1436, DOI 10.1007/s00330-019-06510-3; Baltzer PAT, 2010, BREAST J, V16, P233, DOI 10.1111/j.1524-4741.2010.00915.x; Blamey RW, 2007, EUR J CANCER, V43, P1548, DOI 10.1016/j.ejca.2007.01.016; Cheon H, 2018, RADIOLOGY, V287, P68, DOI 10.1148/radiol.2017171157; Cheon H, 2017, J MAGN RESON IMAGING, V46, P1037, DOI 10.1002/jmri.25710; Cvetkovi D, 2020, BIOL SERBICA, V41; de Glas NA, 2016, BRIT J CANCER, V114, P395, DOI 10.1038/bjc.2015.466; Engelhardt EG, 2017, EUR J CANCER, V78, P37, DOI 10.1016/j.ejca.2017.03.015; Fan M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03122-z; Franchi M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020213; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Horvat JV, 2019, J MAGNETIC RESONANCE; Iima M, 2020, J MAGN RESON IMAGING, V52, P70, DOI 10.1002/jmri.26908; Kettunen T, 2019, EUROPEAN RADIOLOGY; Lakhani SR, 2012, WHO CLASSIFICATION T, DOI [10.1016/j.breast.2011.12.011, DOI 10.1016/J.BREAST.2011.12.011]; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee AHS, 2006, EUR J CANCER, V42, P357, DOI 10.1016/j.ejca.2005.10.021; Meng L, 2016, J CANCER RES THER, V12, P36, DOI 10.4103/0973-1482.150418; Phung MT, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5442-6; Mori N, 2016, EUR RADIOL, V26, P331, DOI 10.1007/s00330-015-3847-4; Mori N, 2015, RADIOLOGY, V274, P66, DOI 10.1148/radiol.14140283; Nishimura R, 2010, EXP THER MED, V1, P747, DOI 10.3892/etm.2010.133; Panzironi G, 2020, BREAST CANCER RES TR, V181, P53, DOI 10.1007/s10549-020-05592-8; Park HS, 2018, ACTA RADIOL, V59, P1168, DOI 10.1177/0284185117753728; Polyak K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003244; Roknsharifi S, 2019, ACAD RADIOL, V26, P923, DOI 10.1016/j.acra.2018.09.003; Roozdar A, 2018, ARCH IRAN MED, V21, P185; Sardanelli F, 2010, EUR J CANCER, V46, P1296, DOI 10.1016/j.ejca.2010.02.015; Schmeel FC, 2019, EUR RADIOL, V29, P2243, DOI 10.1007/s00330-018-5866-4; Senkus E, 2015, ANN ONCOL, V26, pV8, DOI 10.1093/annonc/mdv298; Shin HJ, 2016, EUR J RADIOL, V85, P1004, DOI 10.1016/j.ejrad.2016.02.017; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; van Overstraeten AD, 2017, COLORECTAL DIS, V19, DOI 10.1111/codi.13539; Wishart GC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2464; Wu X, 2017, J NATL CANC I, V109; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	43	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235278	10.1371/journal.pone.0235278	http://dx.doi.org/10.1371/journal.pone.0235278			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584887	Green Published, gold			2022-12-27	WOS:000545747200098
J	Decker, HC; Hubner, G; Nwabuo, A; Johnson, L; Texada, M; Marquez, R; Orellana, J; Henderson, T; Dicker, R; Plevin, RE; Juillard, C				Decker, Hannah C.; Hubner, Gwendolyn; Nwabuo, Adaobi; Johnson, Leslie; Texada, Michael; Marquez, Ruben; Orellana, Julia; Henderson, Terrell; Dicker, Rochelle; Plevin, Rebecca E.; Juillard, Catherine			"You don't want anyone who hasn't been through anything telling you what to do,because how do they know?": Qualitative analysis of case managers in a hospital-based violence intervention program	PLOS ONE			English	Article							REINJURY; INJURY	Statement of purpose Intentional violent injury is a leading cause of disability and death among young adults in the United States. Hospital-based violence intervention programs (HVIPs), which strive to prevent re-injury through intensive case management, have emerged as a successful and cost-effective strategy to address this issue. Despite the importance of strong therapeutic relationships between clients and their case managers, specific case manager behaviors and attributes that drive the formation of these relationships have not been elucidated. Methods A qualitative analysis with a modified grounded theory approach was conducted to gain insight into what clients perceive to be crucial to the formation of a strong client-case manager relationship. Twenty-four semi-structured interviews were conducted with prior clients of our hospital's HVIP. The interviews were analyzed using constant comparison method for recurrent themes. Results Several key themes emerged from the interviews. Clients emphasized that their case managers must: 1) understand and relate to their sociocultural contexts, 2) navigate the initial in-hospital meeting to successfully create connection, 3) exhibit true compassion and care, 4) serve as role models, 5) act as portals of opportunity, and 6) engender mutual respect and pride. Conclusions This study identifies key behaviors of case managers that facilitate the formation of strong therapeutic relationships at the different stages of client recovery. This study's findings emphasize the importance of case managers being culturally aligned with and embedded in their clients' communities. This work can provide a roadmap for case managers to form optimally effective relationships with clients.	[Decker, Hannah C.; Hubner, Gwendolyn; Nwabuo, Adaobi; Texada, Michael; Marquez, Ruben; Orellana, Julia; Henderson, Terrell; Plevin, Rebecca E.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Johnson, Leslie] Emory Univ, Sch Med, Rollins Sch Publ Hlth, Atlanta, GA USA; [Dicker, Rochelle; Juillard, Catherine] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA	University of California System; University of California San Francisco; Emory University; Rollins School Public Health; University of California System; University of California Los Angeles	Decker, HC (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.	hannah.decker@ucsf.edu	Johnson, Leslie/AAI-5472-2020	Johnson, Leslie/0000-0003-4574-847X; Nwabuo, Adaobi/0000-0002-9263-5470				ATLAS, QUAL DAT AN RES SOFT; Bell TM, 2018, J TRAUMA ACUTE CARE, V84, P175, DOI 10.1097/TA.0000000000001671; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, WEB BAS INJ STAT QUE; Cooper C, 2000, ARCH SURG-CHICAGO, V135, P837, DOI 10.1001/archsurg.135.7.837; Cooper C, 2006, J TRAUMA, V61, P534, DOI 10.1097/01.ta.0000236576.81860.8c; Cunningham RM, 2015, JAMA PEDIATR, V169, P63, DOI 10.1001/jamapediatrics.2014.1900; Curtis Florence, 2013, MMWR-MORBID MORTAL W; Cutcliffe JR, 2005, J ADV NURS, V51, P421, DOI 10.1111/j.1365-2648.2005.03514.x; Florence C, 2015, MMWR-MORBID MORTAL W, V64, P1074, DOI 10.15585/mmwr.mm6438a4; Glaser B., 1973, DISCOVERY GROUNDED T; Glaser B., 2001, GROUNDED THEORY PERS; Griffin RL, 2014, J FORENSIC SCI, V59, P986, DOI 10.1111/1556-4029.12416; Hennink M., 2020, QUALITATIVE RES METH; Holbrook TL, 2005, J TRAUMA, V59, P1126, DOI 10.1097/01.ta.0000196433.61423.f2; Horvat L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009405.pub2; Hosking JE, 2011, ANN SURG, V253, P233, DOI 10.1097/SLA.0b013e3182075553; Juillard C, 2016, J TRAUMA ACUTE CARE, V81, P1156, DOI 10.1097/TA.0000000000001261; Juillard C, 2015, J TRAUMA ACUTE CARE, V78, P252, DOI 10.1097/TA.0000000000000527; Kramer EJ, 2017, J SURG RES, V217, P177, DOI 10.1016/j.jss.2017.05.023; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; Martin-Mollard M, KEY COMPONENTS HOSP; McCoy AM, 2013, J TRAUMA ACUTE CARE, V75, P116, DOI 10.1097/TA.0b013e31829231b7; Murphy SL, 2017, DEATHS FINAL DATA 20, V66; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Shibru D, 2007, J AM COLL SURGEONS, V205, P684, DOI 10.1016/j.jamcollsurg.2007.05.029; Smith R, 2013, AM J SURG, V206, P223, DOI 10.1016/j.amjsurg.2012.11.025; Smith R, 2013, J TRAUMA ACUTE CARE, V74, P976, DOI 10.1097/TA.0b013e31828586c9; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042	28	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234608	10.1371/journal.pone.0234608	http://dx.doi.org/10.1371/journal.pone.0234608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579607	Green Published, gold			2022-12-27	WOS:000545646600038
J	Lozano-Hernandez, CM; Lopez-Rodriguez, JA; Leiva-Fernandez, F; Calderon-Larranaga, A; Barrio-Cortes, J; Gimeno-Feliu, LA; Poblador-Plou, B; del Cura-Gonzalez, I				Lozano-Hernandez, Cristina M.; Lopez-Rodriguez, Juan A.; Leiva-Fernandez, Francisca; Calderon-Larranaga, Amaia; Barrio-Cortes, Jaime; Gimeno-Feliu, Luis A.; Poblador-Plou, Beatriz; del Cura-Gonzalez, Isabel		MULTIPAP Grp	Social support, social context and nonadherence to treatment in young senior patients with multimorbidity and polypharmacy followed-up in primary care. MULTIPAP Study	PLOS ONE			English	Article							ADHERENCE; QUESTIONNAIRE; MEDICATION; VALIDATION; NONCOMPLIANCE; VALIDITY; ADULTS; SCALE	Objective To estimate the prevalence of nonadherence to treatment and its relationship with social support and social context in patients with multimorbidity and polypharmacy followed-up in primary care. Methods This was an observational, descriptive, cross-sectional, multicenter study with an analytical approach. A total of 593 patients between 65-74 years of age with multimorbidity (>= 3 diseases) and polypharmacy (>= 5 drugs) during the last three months and agreed to participate in the MULTIPAP Study. The main variable was adherence (Morisky-Green). The predictors were social support (structural support and functional support (DUFSS)); sociodemographic variables; indicators of urban objective vulnerability; health-related quality of life (EQ-5D-5L-VAS & QALY); and clinical variables. Descriptive, bivariate and multivariate analyses with logistic regression models and robust estimators were performed. Results Four out of ten patients were nonadherent, 47% had not completed primary education, 28.7% had an income <= 1050 euro/month, 35% reported four or more IUVs, and the average perceived health-related quality of life (HRQOL) EQ-5D-5L-VAS was 65.5. The items that measure functional support, with significantly different means between nonadherent and adherent patients were receiving love and affection (-0.23; 95%CI: -0.40;-0.06), help when ill (-0.25; 95%CI: -0.42;-0.08), useful advice (-0.20; 95%CI: -0.37;-0.02), social invitations (-0.22; 95%CI:-0.44;-0.01), and recognition (-0.29; 95%CI:-0.50;-0.08). Factors associated with nonadherence were belonging to the medium vs. low tertile of functional support (0.62; 95%CI: 0.42;0.94), reporting less than four IUVs (0.69; 95%CI: 0.46;1.02) and higher HRQOL perception (0.98; 95%CI: 0.98;0.99). Conclusions Among patients 65-74 years of age with multimorbidity and polypharmacy, lower functional support was related to nonadherence to treatment. The nonadherence decreased in those patients with higher functional support, lower urban vulnerability and higher perceived health status according to the visual analog scale of health-related quality of life.	[Lozano-Hernandez, Cristina M.; Lopez-Rodriguez, Juan A.; Barrio-Cortes, Jaime; del Cura-Gonzalez, Isabel] Primary Hlth Care Management, Res Unit, Madrid, Spain; [Lozano-Hernandez, Cristina M.] Rey Juan Carlos Univ, Interuniv Doctoral Program Epidemiol & Publ Hlth, Madrid, Spain; [Lozano-Hernandez, Cristina M.; Lopez-Rodriguez, Juan A.; Leiva-Fernandez, Francisca; Calderon-Larranaga, Amaia; Gimeno-Feliu, Luis A.; Poblador-Plou, Beatriz; del Cura-Gonzalez, Isabel] Res Network Hlth Serv Chron Dis REDISSEC ISCIII, Madrid, Spain; [Lozano-Hernandez, Cristina M.; Lopez-Rodriguez, Juan A.; Barrio-Cortes, Jaime] Biosanitary Res & Innovat Fdn Primary Care FIIBAP, Madrid, Spain; [Lopez-Rodriguez, Juan A.; del Cura-Gonzalez, Isabel] Rey Juan Carlos Univ, Dept Med Specialties & Publ Hlth, Fac Hlth Sci, Madrid, Spain; [Lopez-Rodriguez, Juan A.] Gen Ricardos Primary Hlth Care Ctr, Madrid, Spain; [Leiva-Fernandez, Francisca] Multiprofess Teaching Unit Family & Community Car, Malaga, Spain; [Leiva-Fernandez, Francisca] Andalusian Hlth Serv, Biomed Res Inst Malaga IBIMA, Malaga, Spain; [Calderon-Larranaga, Amaia] Joint Act Chron Dis JA CHRODIS European Commiss, Brussels, Belgium; [Calderon-Larranaga, Amaia] Karolinska Inst, Aging Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Calderon-Larranaga, Amaia] Stockholm Univ, Stockholm, Sweden; [Calderon-Larranaga, Amaia; Gimeno-Feliu, Luis A.; Poblador-Plou, Beatriz] IIS Arago, Aragonese Inst Hlth Sci IACS, EpiChron Res Grp Chron Dis, Zaragoza, Spain; [Gimeno-Feliu, Luis A.] Aragon Hlth Serv, San Pablo Primary Hlth Care Ctr, Zaragoza, Spain; [Gimeno-Feliu, Luis A.] Univ Zaragoza, Dept Med Psychiat & Dermatol, Zaragoza, Spain; [Poblador-Plou, Beatriz] Miguel Servet Univ Hosp, Zaragoza, Spain	Universidad Rey Juan Carlos; Universidad Rey Juan Carlos; Universidad de Malaga; Karolinska Institutet; Stockholm University; University of Zaragoza; Miguel Servet University Hospital	Lozano-Hernandez, CM (corresponding author), Primary Hlth Care Management, Res Unit, Madrid, Spain.; Lozano-Hernandez, CM (corresponding author), Rey Juan Carlos Univ, Interuniv Doctoral Program Epidemiol & Publ Hlth, Madrid, Spain.; Lozano-Hernandez, CM (corresponding author), Res Network Hlth Serv Chron Dis REDISSEC ISCIII, Madrid, Spain.; Lozano-Hernandez, CM (corresponding author), Biosanitary Res & Innovat Fdn Primary Care FIIBAP, Madrid, Spain.	cristinamaria.lozano@salud.madrid.org	Calderón-Larrañaga, Amaia/ABC-6828-2021; Gimeno-Feliu, Luis Andrés/E-5390-2016; Gimeno-Miguel, Antonio/AAC-9611-2019; Lopez-Rodriguez, Juan A/F-2322-2010; Poblador-Plou, Beatriz/ABC-7915-2020; Prados-Torres, Alexandra/P-5818-2017; POLENTINOS-CASTRO, ELENA/B-7373-2019; del Cura-Gonzalez, Isabel/G-9040-2018; Lozano Hernandez, Cristina Maria/G-9362-2018	Calderón-Larrañaga, Amaia/0000-0001-9064-9222; Gimeno-Feliu, Luis Andrés/0000-0003-2928-6623; Gimeno-Miguel, Antonio/0000-0002-5440-1710; Lopez-Rodriguez, Juan A/0000-0002-4985-2314; Poblador-Plou, Beatriz/0000-0002-5119-5093; Prados-Torres, Alexandra/0000-0002-5704-6056; POLENTINOS-CASTRO, ELENA/0000-0001-9460-2966; Leiva-Fernandez, Francisca/0000-0001-6919-4817; del Cura-Gonzalez, Isabel/0000-0002-3931-5304; Rogero Blanco, Maria Eloisa/0000-0002-8732-6120; Azcoaga-Lorenzo, Amaya/0000-0003-3307-878X; Hernandez Santiago, Virginia/0000-0002-8544-1483; Lozano Hernandez, Cristina Maria/0000-0002-6981-303X; Barrio Cortes, Jaime/0000-0002-2582-0203	Fondo de Investigaciones Sanitarias ISCIII [PI15/00276, PI15/00572, PI15/00996, RD16/0001/0006, RD16/0001/0005, RD16/0001/0004]; European Regional Development Fund	Fondo de Investigaciones Sanitarias ISCIII(Instituto de Salud Carlos III); European Regional Development Fund(European Commission)	This study was funded by the Fondo de Investigaciones Sanitarias ISCIII (Grant Numbers PI15/00276, PI15/00572, PI15/00996), REDISSEC (Project Numbers RD16/0001/0006, RD16/0001/0005 and RD16/0001/0004), and the European Regional Development Fund ("A way to build Europe"). Funders had no role in study design or in the decision to submit the report for publication.	ALFONSO PIÑA LOPEZ JULIO, 2007, Cienc. enferm., V13, P53, DOI 10.4067/S0717-95532007000200007; AlGhurair SA, 2012, J CLIN HYPERTENS, V14, P877, DOI 10.1111/j.1751-7176.2012.00699.x; Alvarado Beatriz Eugenia, 2005, Cad. Saúde Pública, V21, P724, DOI 10.1590/S0102-311X2005000300006; Alves KB, 2018, EINSTEIN-SAO PAULO, V16, DOI [10.1590/S1679-45082018AO4036, 10.1590/s1679-45082018ao4036]; Ambrosio L, 2016, PARKINSONISM RELAT D, V25, P52, DOI 10.1016/j.parkreldis.2016.02.012; Ayala A, 2012, GAC SANIT, V26, P317, DOI 10.1016/j.gaceta.2011.08.009; Azpiazu Garrido M, 2003, ATEN PRIM, V30, P285, DOI [10.1157/13045701, DOI 10.1157/13045701]; Bellon Saameno J A, 1996, Aten Primaria, V18, P153; Blasco Patino F., 2005, INFORMACI N TERAP UT, V29, P152; Luz TCB, 2011, CAD SAUDE PUBLICA, V27, P269, DOI 10.1590/S0102-311X2011000200008; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; Conde P, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081617; COONS SJ, 1994, CLIN THER, V16, P110; Cottrell E, 2015, CHRONIC ILLN, V11, P279, DOI 10.1177/1742395315574764; Cuellar-Flores I, 2012, REV IBEROAM DIAGN EV, V1, P89; Curtis Sarah E, 2017, Am J Manag Care, V23, pe208; de la Revilla Ahumada L, 1991, Aten Primaria, V8, P688; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Domingo-Salvany A, 2013, GAC SANIT, V27, P263, DOI 10.1016/j.gaceta.2012.12.009; DONOVAN JL, 1992, SOC SCI MED, V34, P507, DOI 10.1016/0277-9536(92)90206-6; Epino HM, 2012, AIDS CARE, V24, P1576, DOI 10.1080/09540121.2012.661840; Feehan M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014435; Fomento Ministerio . Gobierno de Espana . Instituto Juan de Herrera DUYOT, 2010, ANALISIS URBANISTICO; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gottlieb BH, 2010, J PSYCHOSOM RES, V69, P511, DOI 10.1016/j.jpsychores.2009.10.001; HAYNES RB, 1980, GERIATRICS, V35, P91; Johnson VR, 2010, PATIENT EDUC COUNS, V79, P14, DOI 10.1016/j.pec.2009.07.002; Magrin ME, 2015, ANN BEHAV MED, V49, P307, DOI 10.1007/s12160-014-9663-2; Malmen M, 2019, SCIENCEDIRECT METHOD, P2, DOI [10.1016/j.jval.2018.08.006, DOI 10.1016/J.JVAL.2018.08.006]; Mansur N, 2012, AM J GERIATR PHARMAC, V10, P223, DOI 10.1016/j.amjopharm.2012.06.002; Martos-Mendez M.J., 2015, J BEHAV HLTH SOC ISS, V7, P19, DOI [10.5460/jbhsi.v7.2.52889, DOI 10.5460/JBHSI.V7.2.52889]; Mas-Exposito L, 2013, SOC PSYCH PSYCH EPID, V48, P1675, DOI 10.1007/s00127-012-0633-3; Mclane CG, 1995, FACTORS ASS MED NONC; Mondesir FL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198578; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Munoz-Cobos F, 2016, AN PSICOL-SPAIN, V32, P18, DOI 10.6018/analesps.32.1.186211; Naderi SH, 2012, AM J MED, V125, P882, DOI 10.1016/j.amjmed.2011.12.013; Oppe M, 2014, VALUE HEALTH, V17, P445, DOI 10.1016/j.jval.2014.04.002; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Prados-Torres A, 2017, ATEN PRIM, V49, P300, DOI 10.1016/j.aprim.2016.11.013; Prados-Torres A, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0584-x; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Salive ME, 2013, EPIDEMIOL REV, V35, P75, DOI 10.1093/epirev/mxs009; Saracino R, 2015, PALLIAT SUPPORT CARE, V13, P1153, DOI 10.1017/S1478951514000996; Takahashi PY, 2016, HHS PUBLIC ACCESS, DOI [10.1136/jech-2015-205925.A, DOI 10.1136/JECH-2015-205925.A]; The Academy of Medical Sciences Working Group, 2018, MULT PRIOR GLOB HLTH, P1; THOITS PA, 1982, J HEALTH SOC BEHAV, V23, P145, DOI 10.2307/2136511; Thomson GE, 2006, EXAMINING HLTH DISPA, DOI [10.17226/11602, DOI 10.17226/1160221850786]; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Van der Wees PJ, 2014, MILBANK Q, V92, P754, DOI 10.1111/1468-0009.12091; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149	53	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235148	10.1371/journal.pone.0235148	http://dx.doi.org/10.1371/journal.pone.0235148			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579616	Green Published, gold			2022-12-27	WOS:000545646600046
J	Sedov, L; Krasnochub, A; Polishchuk, V				Sedov, Leonid; Krasnochub, Alexander; Polishchuk, Valentin			Modeling quarantine during epidemics and mass-testing using drones	PLOS ONE			English	Article							BLOOD	We extend the classical SIR epidemic spread model by introducing the "quarantined" compartment. We solve (numerically) the differential equations that govern the extended model and quantify how quarantining "flattens the curve" for the proportion of infected population over time. Furthermore, we explore the potential of using drones to deliver tests, enabling mass-testing for the infection; we give a method to estimate the drone fleet needed to deliver the tests in a metropolitan area. Application of our models to COVID-19 spread in Sweden shows how the proposed methods could substantially decrease the peak number of infected people, almost without increasing the duration of the epidemic.	[Sedov, Leonid; Polishchuk, Valentin] Linkoping Univ, Commun & Transport Syst, ITN, Norrkoping, Sweden; [Krasnochub, Alexander] Joint Inst High Temp, Moscow, Russia	Linkoping University; Russian Academy of Sciences; Joint Institute for High Temperatures of the Russian Academy of Sciences	Sedov, L (corresponding author), Linkoping Univ, Commun & Transport Syst, ITN, Norrkoping, Sweden.	leonid.sedov@liu.se						ALLAN A, 2020, OPENSTREETMAP CARTO; Amukele T, 2017, TRANSFUSION, V57, P582, DOI 10.1111/trf.13900; Amukele TK, 2017, AM J CLIN PATHOL, V148, P427, DOI [10.1093/AJCP/AQX090, 10.1093/ajcp/aqx090]; Amukele TK, 2016, J CLIN MICROBIOL, V54, P2622, DOI 10.1128/JCM.01204-16; Amukele TK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134020; Ancel E, 2019, 2019 IEEE AIAA 38TH, P1, DOI [10.1109/DASC43569.2019.9081659, DOI 10.1109/DASC43569.2019.9081659]; Andersson H, 2012, PROCEEDINGS OF THE 3, V151; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Barasona JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115608; Barr L.C., 2017, 17 AIAA AV TECHN INT, P3272; Belcastro C.M., 2017, 17 AIAA AVIATION TEC, P3269; Britton T, 2019, LECT NOTES MATH, V2255, P5, DOI 10.1007/978-3-030-30900-8_1; Britton T, 2010, MATH BIOSCI, V225, P24, DOI 10.1016/j.mbs.2010.01.006; Carrasco-Escobar G, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007105; *EUR CDCP, DATA ON THE GEOGRAPH; FERGUSON N, 2020, REPORT 9 IMPACT OF N; Gardner JM, 2020, PREPRINT, DOI [10.1101/2020.04.11.20062133, DOI 10.1101/2020.04.11.20062133, 10.1101/20 20.04.11.20062133.]; Geoghegan JL, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060300; Grasas A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-12; Hardy A, 2017, OPENSTREETMAP TILE S, V10, P1; Hardy A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1973-3; Harko T, 2014, APPL MATH COMPUT, V236, P184, DOI 10.1016/j.amc.2014.03.030; Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4; Katariya M, 2018, ANAL BIOCHEM, V545, P1, DOI 10.1016/j.ab.2018.01.004; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; NISHIURA H, 2020, ESTIMATION OF THE AS; Nishiura H, 2020, SIR GEOGEBRA APPLET; *OPENSTREETMAP, 2020, OPENSTREETMAP DATA; Optimization G., 2020, GUROBI OPTIMIZER REF; Perron L., OR TOOLS; Primatesta S, 2020, J INTELL ROBOT SYST, V97, P489, DOI 10.1007/s10846-019-01015-z; Sanche S, 2020, TRANSACTIONS OF THE, V2020; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Sawant SS, 2019, WORK HYPERSP IMAG; Scalea JR, 2018, IEEE J TRANSL ENG HE, V6, DOI 10.1109/JTEHM.2018.2875704; SJODIN H, COVID 19 HLTH CARE D; *STAT SWED, B13 TOTALBEFOLKNING; Statistics Sweden, 2012, STOCHASTIC EPIDEMIC; Toda, 2020, CEPR PRESS ISSUE COV; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151; Washington A, 2017, PROG AEROSP SCI, V95, P24, DOI 10.1016/j.paerosci.2017.10.001; World Health Organzation (WHO), 2020, LAB TESTING CORONAVI; Zeng Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082768; Zeng Q, 2019, TRANSPORTMETRICA A, V15, P1867, DOI 10.1080/23249935.2019.1652867; Zeng Q, 2020, J TRANSP SAF SECUR, V12, P566, DOI 10.1080/19439962.2018.1516259	47	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235307	10.1371/journal.pone.0235307	http://dx.doi.org/10.1371/journal.pone.0235307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579590	Green Published, gold			2022-12-27	WOS:000545646600042
J	Su, HA; Hsu, YC; Siao, FY; Yen, HH				Su, Hsuan-An; Hsu, Yu-Chun; Siao, Fu-Yuan; Yen, Hsu-Heng			Diagnosis and management of jejunoileal diverticular haemorrhage: An update on the experience in a single centre	PLOS ONE			English	Article							DOUBLE-BALLOON ENTEROSCOPY; CLINICAL-SIGNIFICANCE; DISEASE; DECADE	Introduction Jejunoileal diverticular haemorrhage is a rare disease that is difficult to diagnose and treat. Despite advances in endoscopic technology, recommendations on diagnosis and management for jejunoileal diverticular haemorrhage have remained unchanged and these new options have not been compared against traditional surgical management. Materials and methods We retrospectively reviewed the diagnosis, management, and outcome for jejunoileal diverticular haemorrhage cases at our institution over the past 20 years. Data were organized and analysed by chi-square test, studentt-test and Kaplan-Meier survival analysis. Results The most utilised diagnostic procedure was computed tomography, followed by enteroscopy, angiography, small bowel flow-through and surgery. Primary treatments included, in a decreasing order, medical therapy, surgery, endoscopy and radiology. Surgical treatment was not associated with rebleeding, but it did result in longer hospital stays and larger blood transfusions than non-surgical treatments. The bleeding-related mortality rate was very low. Notably, there was also little change in the diagnosis and treatment between decades. Conclusion We presented our experience with the diagnosis and management of jejunoileal diverticular haemorrhage, as well as long-term follow-up after treatments that have not been reported previously. Surgical treatment continues to dominate management for jejunoileal diverticular haemorrhage, but we support increasing the role of endoscopy for select patient groups.	[Su, Hsuan-An] Kaohsiung Chang Gung Mem Hosp, Dept Med Educ, Kaohsiung, Taiwan; [Hsu, Yu-Chun; Yen, Hsu-Heng] Changhua Christian Hosp, Endoscopy Ctr, Changhua, Taiwan; [Siao, Fu-Yuan] Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan; [Yen, Hsu-Heng] Chien Kuo Technol Univ, Gen Educ Ctr, Changhua, Taiwan; [Yen, Hsu-Heng] Chung Shan Med Univ, Coll Med, Taichung, Taiwan; [Yen, Hsu-Heng] Taiwan Assoc Study Small Intestinal Dis TASSID, Taipei, Taiwan	Chang Gung Memorial Hospital; Changhua Christian Hospital; Chienkuo Technology University; Chung Shan Medical University	Yen, HH (corresponding author), Changhua Christian Hosp, Endoscopy Ctr, Changhua, Taiwan.; Yen, HH (corresponding author), Chien Kuo Technol Univ, Gen Educ Ctr, Changhua, Taiwan.; Yen, HH (corresponding author), Chung Shan Med Univ, Coll Med, Taichung, Taiwan.; Yen, HH (corresponding author), Taiwan Assoc Study Small Intestinal Dis TASSID, Taipei, Taiwan.	blaneyen@gmail.com		Su, Hsuan-An/0000-0002-6710-9911; Yen, Hsu-Heng/0000-0002-3494-2245	Changhua Christian Hospital [106CCHIRP-030, 108-CCHIRP-018, 105-CCH-IRP-071]	Changhua Christian Hospital	The authors received funding from Changhua Christian Hospital (http://www2.cch.org.tw/cch_english/) for this work: numbers 106CCHIRP-030 and 108-CCHIRP-018 for Dr HsuHeng Yen, and number 105-CCH-IRP-071 for Dr Fu-Yuan Siao. The funder played NO role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardelt M, 2017, AM SURGEON, V83, pE455; Bosanquet DC, 2010, BRIT J HOSP MED, V71, P552, DOI 10.12968/hmed.2010.71.10.78937; Chauhan SS, 2015, GASTROINTEST ENDOSC, V82, P975, DOI 10.1016/j.gie.2015.06.012; Chen TH, 2010, WORLD J GASTROENTERO, V16, P5616, DOI 10.3748/wjg.v16.i44.5616; Chen YY, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/564536; de Bree E, 1998, AM J GASTROENTEROL, V93, P2523, DOI 10.1016/S0002-9270(98)00486-9; Eun SH, 2009, ENDOSCOPY, V41, pE29, DOI 10.1055/s-2007-967053; Forcione DG, 2009, NEW ENGL J MED, V360, P1239, DOI 10.1056/NEJMcpc0810836; Heise CP, 2008, J GASTROINTEST SURG, V12, P1309, DOI 10.1007/s11605-008-0492-0; Horesh N, 2016, J LAPAROENDOSC ADV S, V26, P596, DOI 10.1089/lap.2016.0066; Iwamuro M, 2011, WORLD J GASTRO ENDOS, V3, P154, DOI 10.4253/wjge.v3.i7.154; Jeyarajah R., 2016, SLEISENGER FORDTRANS, P397; LONGO WE, 1992, DIS COLON RECTUM, V35, P381, DOI 10.1007/BF02048119; Su W.W., 2005, DOUBLE BALLOON ENTER, V22, P310; TAYLOR MT, 1969, AM J SURG, V118, P117, DOI 10.1016/0002-9610(69)90106-8; Xin L, 2011, GASTROINTEST ENDOSC, V74, P563, DOI 10.1016/j.gie.2011.03.1239; Yang CW, 2009, J LAPAROENDOSC ADV S, V19, P637, DOI 10.1089/lap.2009.0157; Yaqub S, 2011, WORLD J EMERG SURG, V6, DOI 10.1186/1749-7922-6-17; Yen HH, 2007, GUT, V56, P167, DOI 10.1136/gut.2006.093757; Yen HH, 2006, GASTROINTEST ENDOSC, V63, P328, DOI 10.1016/j.gie.2005.06.063; Yen HH, 2012, J DIGEST DIS, V13, P316, DOI 10.1111/j.1751-2980.2012.00591.x; Yen HH, 2010, DIGEST DIS SCI, V55, P3473, DOI 10.1007/s10620-010-1211-8	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234417	10.1371/journal.pone.0234417	http://dx.doi.org/10.1371/journal.pone.0234417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574171	Green Published, gold			2022-12-27	WOS:000544972400043
J	Metfies, K; Hessel, J; Klenk, R; Petersen, W; Wiltshire, KH; Kraberg, A				Metfies, Katja; Hessel, Johanna; Klenk, Robin; Petersen, Wilhelm; Wiltshire, Karen Helen; Kraberg, Alexandra			Uncovering the intricacies of microbial community dynamics at Helgoland Roads at the end of a spring bloom using automated sampling and 18S meta-barcoding	PLOS ONE			English	Article							NORTH-SEA; CLIMATE-CHANGE; PHYTOPLANKTON; DIVERSITY; PRESERVATION; VARIABILITY; PHENOLOGY; PATTERNS; FERRYBOX; DIATOMS	In May 2016, the remote-controlledAutomatedFiltration System forMarine Microbes (AUTOFIM) was implemented in parallel to the Long Term Ecological Research (LTER) observatory Helgoland Roads in the German Bight. We collected samples for characterization of dynamics within the eukaryotic microbial communities at the end of a phytoplankton bloom via 18S meta-barcoding. Understanding consequences of environmental change for key marine ecosystem processes, such as phytoplankton bloom dynamics requires information on biodiversity and species occurrences with adequate temporal and taxonomic resolution via time series observations. Sampling automation and molecular high throughput methods can serve these needs by improving the resolution of current conventional marine time series observations. A technical evaluation based on an investigation of eukaryotic microbes using the partial 18S rRNA gene suggests that automated filtration with the AUTOFIM device and preservation of the plankton samples leads to highly similar 18S community profiles, compared to manual filtration and snap freezing. The molecular data were correlated with conventional microscopic counts. Overall, we observed substantial change in the eukaryotic microbial community structure during the observation period. A simultaneous decline of diatom and ciliate sequences succeeded a peak ofMiracula helgolandica, suggesting a potential impact of these oomycete parasites on diatom bloom dynamics and phenology in the North Sea. As oomycetes are not routinely counted at Helgoland Roads LTER, our findings illustrate the benefits of combining automated filtration with metabarcodingto augment classical time series observations, particularly for taxa currently neglected due to methodological constraints.	[Metfies, Katja; Hessel, Johanna] Helmholtz Ctr Polar & Marine, Alfred Wegener Inst, Helmholtz Young Investigators Grp PLANKTOSENS, Bremerhaven, Germany; [Metfies, Katja] Univ Oldenburg HIFMB, Helmholtz Inst Funct Marine Biodivers, Oldenburg, Germany; [Klenk, Robin; Wiltshire, Karen Helen; Kraberg, Alexandra] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Shelf Sea Syst Ecol, Biol Anstalt Helgoland, Helgoland, Germany; [Petersen, Wilhelm] Helmholtz Zentrum Geesthacht Ctr Mat & Coastal Re, Inst Coastal Res, Geesthacht, Germany; [Wiltshire, Karen Helen] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Biol Anstalt Helgoland Coastal Ecol, List Auf Sylt, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Metfies, K (corresponding author), Helmholtz Ctr Polar & Marine, Alfred Wegener Inst, Helmholtz Young Investigators Grp PLANKTOSENS, Bremerhaven, Germany.; Metfies, K (corresponding author), Univ Oldenburg HIFMB, Helmholtz Inst Funct Marine Biodivers, Oldenburg, Germany.	Katja.Metfies@awi.de		Petersen, Wilhelm/0000-0003-4287-1544	Alfred -Wegener-Institut HelmholtzZentrum fur Polar-und Meeresforschung, Germany; Helmholtz Association [VHNG-500]	Alfred -Wegener-Institut HelmholtzZentrum fur Polar-und Meeresforschung, Germany; Helmholtz Association(Helmholtz Association)	This work was supported by institutional funds of the Alfred -Wegener-Institut HelmholtzZentrum fur Polar-und Meeresforschung, Germany and funds of the Helmholtz Association for financing the Helmholtz-University Young Investigators Group PLANKTOSENS (Grant VHNG-500).	Andersen K. S., 2018, BIORXIV; Anthony TB, 2017, MYCOL PROG, V16, P1041, DOI 10.1007/s11557-017-1345-6; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Breier JA, 2009, DEEP-SEA RES PT I, V56, P1579, DOI 10.1016/j.dsr.2009.04.005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carstensen J, 2015, ESTUAR COAST SHELF S, V162, P98, DOI 10.1016/j.ecss.2015.05.005; Cermeno P, 2014, J PLANKTON RES, V36, P1135, DOI 10.1093/plankt/fbu033; Clay BL, 1999, BOT J LINN SOC, V131, P131, DOI 10.1006/bojl.1999.0259; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Ebenezer V, 2012, MAR BIOTECHNOL, V14, P129, DOI 10.1007/s10126-011-9427-y; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; ELWOOD HJ, 1985, MOL BIOL EVOL, V2, P399; Frenken T, 2016, GLOBAL CHANGE BIOL, V22, P299, DOI 10.1111/gcb.13095; Gescher C, 2008, APPL ENVIRON MICROB, V74, P5305, DOI 10.1128/AEM.01271-08; Gray MA, 2013, FEMS MICROBIOL ECOL, V83, P468, DOI 10.1111/1574-6941.12008; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; Haller M, 2015, OCEAN SCI, V11, P879, DOI 10.5194/os-11-879-2015; Hardge K, 2017, MAR ECOL PROG SER, V571, P43, DOI 10.3354/meps12134; Hoppenrath M, 2004, HELGOLAND MAR RES, V58, P243, DOI 10.1007/s10152-004-0190-6; Hoppenrath M, 2007, EUR J PHYCOL, V42, P271, DOI 10.1080/09670260701352288; Houliez E, 2017, J MARINE SYST, V169, P40, DOI 10.1016/j.jmarsys.2017.01.007; Kilias E, 2014, POLAR BIOL, V37, P1271, DOI 10.1007/s00300-014-1519-5; Kraberg A, 2010, PHOTO GUIDE NO EUROP, P204; Loder MGJ, 2012, HELGOLAND MAR RES, V66, P11, DOI 10.1007/s10152-010-0242-z; McQuillan JS, 2017, CURR OPIN BIOTECH, V45, P43, DOI 10.1016/j.copbio.2016.11.022; Metfies K, 2005, METHOD ENZYMOL, V395, P258, DOI 10.1016/S0076-6879(05)95016-7; Metfies K, 2007, J PLANKTON RES, V29, P1071, DOI 10.1093/plankt/fbm080; Metfies K, 2016, OCEAN SCI, V12, P1237, DOI 10.5194/os-12-1237-2016; Metfies K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148512; Metfies K, 2010, J PHYCOL, V46, P1152, DOI 10.1111/j.1529-8817.2010.00902.x; MILLS DK, 1994, NETH J SEA RES, V33, P65, DOI 10.1016/0077-7579(94)90052-3; Ottesen EA, 2016, CURR OPIN MICROBIOL, V31, P132, DOI 10.1016/j.mib.2016.03.012; Ottesen EA, 2011, ISME J, V5, P1881, DOI 10.1038/ismej.2011.70; Peacock EE, 2014, MAR ECOL PROG SER, V503, P1, DOI 10.3354/meps10784; Petersen W, 2014, J MARINE SYST, V140, P4, DOI 10.1016/j.jmarsys.2014.07.003; Renshaw MA, 2015, MOL ECOL RESOUR, V15, P168, DOI 10.1111/1755-0998.12281; Scharfe M, 2019, ECOL MODEL, V404, P46, DOI 10.1016/j.ecolmodel.2019.01.001; Schnepf E, 1977, HELGOLAND MARINE RES, V54, P237; Scholz B, 2016, FUNGAL ECOL, V19, P59, DOI 10.1016/j.funeco.2015.09.002; Southward AJ, 2005, ADV MAR BIOL, V47, P1; Stern RF, 2015, PROG OCEANOGR, V137, P409, DOI 10.1016/j.pocean.2015.04.015; Thines M, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-015-1099-y; Wiltshire KH, 2010, ESTUAR COAST, V33, P295, DOI 10.1007/s12237-009-9228-y; Wiltshire KH, 2004, HELGOLAND MAR RES, V58, P269, DOI 10.1007/s10152-004-0196-0; Wolf C, 2013, ANTARCTIC SCI, DOI [10.1017/S0954102013000308, DOI 10.1017/S0954102013000308]; Wolf C, 2014, MAR BIOL RES, V10, P771, DOI 10.1080/17451000.2013.852685; Wollschlager J, 2015, J SEA RES, V99, P83, DOI 10.1016/j.seares.2015.02.005; Wollschlager J, 2014, J PLANKTON RES, V36, P695, DOI 10.1093/plankt/fbu003; Wulff T, 2016, DEEP-SEA RES PT I, V115, P253, DOI 10.1016/j.dsr.2016.07.001; Yang JP, 2015, J SEA RES, V101, P19, DOI 10.1016/j.seares.2014.07.010	53	1	1	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0233921	10.1371/journal.pone.0233921	http://dx.doi.org/10.1371/journal.pone.0233921			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569285	gold, Green Published			2022-12-27	WOS:000543547900034
J	Kotepui, M; Kotepui, KU; Milanez, GD; Masangkay, FR				Kotepui, Manas; Kotepui, Kwuntida Uthaisar; Milanez, Giovanni D.; Masangkay, Frederick R.			Severity and mortality of severePlasmodium ovaleinfection: A systematic review and meta-analysis	PLOS ONE			English	Review							RAPID DIAGNOSTIC-TESTS; RESPIRATORY-DISTRESS-SYNDROME; POLYMERASE-CHAIN-REACTION; PLASMODIUM-OVALE; MALARIA; INFECTIONS; PARASITE; PREVALENCE; TRAVELERS; ACCURACY	Plasmodium ovalecan infect humans, causing malaria disease. We aimed to investigate the severity and mortality of severeP.ovaleinfection to increase the awareness of physicians regarding the prognosis of this severe disease and outcome-related deaths in countries in which this disease is endemic. Articles that were published in the PubMed, Scopus, and ISI Web of Science databases prior to January 5, 2020 and reported the prevalence of severeP.ovaleinfection were systematically searched and reviewed. Studies that mainly reported severeP.ovaleinfection according to the 2014 WHO criteria for the treatment of malaria were included. Two reviewers selected, identified, assessed, and extracted data from studies independently. The pooled prevalence of severeP.ovalemono-infections was estimated using the command "metaprop case population, random/fixed", which yielded the pooled estimate, 95% confidence interval (CI) and the I(2)value, indicating the level of heterogeneity. Meta-analyses of the proportions were performed using a random-effects model to explore the different proportions of severity between patients withP.ovaleand those with otherPlasmodiumspecies infections. Among the eight studies that were included and had a total of 1,365 ovale malaria cases, the pooled prevalence of severeP.ovalewas 0.03 (95% CI = 0.03-0.05%, I-2= 54.4%). Jaundice (1.1%), severe anemia (0.88%), and pulmonary impairments (0.59%) were the most common severe complications found in patients infected withP.ovale. The meta-analysis demonstrated that a smaller proportion of patients withP.ovalethan of patients withP.falciparumhad severe infections (P-value = 0.01, OR = 0.36, 95% CI = 0.16-0.81, I-2= 72%). The mortality rate of severeP.ovaleinfections was 0.15% (2/1,365 cases). Although severe complications ofP.ovaleinfections in patients are rare, it is very important to increase the awareness of physicians regarding the prognosis of severeP.ovaleinfections in patients, especially in a high-risk population.	[Kotepui, Manas; Kotepui, Kwuntida Uthaisar] Walailak Univ, Sch Allied Hlth Sci, Med Technol, Nakhon Si Thammarat, Thailand; [Milanez, Giovanni D.; Masangkay, Frederick R.] Far Eastern Univ Manila, Inst Arts & Sci, Dept Med Technol, Manila, Philippines	Walailak University; Far Eastern University	Kotepui, M (corresponding author), Walailak Univ, Sch Allied Hlth Sci, Med Technol, Nakhon Si Thammarat, Thailand.	manas.ko@wu.ac.th	Masangkay, Frederick/GLR-5890-2022; Milanez, Giovanni D/O-9282-2016; Milanez, Giovanni De Jesus/HGA-9959-2022	Milanez, Giovanni D/0000-0002-4467-3173; Milanez, Giovanni De Jesus/0000-0002-4467-3173; Kotepui, Manas/0000-0001-9172-3615; Masangkay, Frederick/0000-0002-3511-8602	new strategic research (P2P) project, Walailak University, Thailand	new strategic research (P2P) project, Walailak University, Thailand	This research was partially supported by the new strategic research (P2P) project, Walailak University, Thailand. The funders had a role in the collection, analysis, and interpretation of the data. There was no additional external funding received for this study.	[Anonymous], 2013, CILIP UPDATE, V12, P8; Bigaillon C, 2005, J CLIN MICROBIOL, V43, P1011, DOI 10.1128/JCM.43.2.1011.2005; Bottieau E, 2006, AM J TROP MED HYG, V75, P133, DOI 10.4269/ajtmh.2006.75.133; Brent AJ, 2008, LANCET INFECT DIS, V8, P208, DOI 10.1016/S1473-3099(08)70044-6; Calderaro A, 2007, J CLIN MICROBIOL, V45, P1624, DOI 10.1128/JCM.02316-06; Chambers D, 2009, J CLIN EPIDEMIOL, V62, P1253, DOI 10.1016/j.jclinepi.2008.12.010; Collins WE, 2005, CLIN MICROBIOL REV, V18, P570, DOI 10.1128/CMR.18.3.570-581.2005; D'Abramo A, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2289-2; de Laval F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-358; Dini S, 2020, BMC MED, V18, DOI 10.1186/s12916-020-1497-0; Evans JT, 2019, LANCET, V393, P647, DOI 10.1016/S0140-6736(18)31665-9; Faye FBK, 2002, J INFECT DIS, V186, P690, DOI 10.1086/342395; Groger M, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1759-2; Hachimi MA, 2013, REV PNEUMOL CLIN, V69, P283, DOI 10.1016/j.pneumo.2013.03.001; Haydoura S, 2011, PARASITOL INT, V60, P114, DOI 10.1016/j.parint.2010.10.005; Higgins JPT, 2019, COCHRANE HDB SYSTEMA; Hwang J, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu034; Imbert P, 2009, TRAVEL MED INFECT DI, V7, P147, DOI 10.1016/j.tmaid.2009.01.002; Jackson D, 2014, CLIN CASE REP, V2, P23, DOI 10.1002/ccr3.58; Langford S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004195; Lau YL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-389; Leder K, 2004, CLIN INFECT DIS, V39, P1104, DOI 10.1086/424510; Lo CKL, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-45; LYSENKO AJ, 1969, B WORLD HEALTH ORGAN, V40, P383; Marx A, 2005, ANN INTERN MED, V142, P836, DOI 10.7326/0003-4819-142-10-200505170-00009; Mason DP, 2002, ACTA TROP, V82, P51, DOI 10.1016/S0001-706X(02)00031-1; May J, 1999, AM J TROP MED HYG, V61, P339, DOI 10.4269/ajtmh.1999.61.339; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Mehlotra RK, 2000, AM J TROP MED HYG, V62, P225, DOI 10.4269/ajtmh.2000.62.225; MILNE LM, 1994, J CLIN PATHOL, V47, P740, DOI 10.1136/jcp.47.8.740; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; Murad MH, 2018, BMJ EVID-BASED MED, V23, P60, DOI 10.1136/bmjebm-2017-110853; Murphy KJ, 2020, TRANSFUSION, V60, P955, DOI 10.1111/trf.15775; Nakamura T, 2014, WORLD J CLIN CASES, V2, P608, DOI 10.12998/wjcc.v2.i11.608; Nissen Trygve, 2014, BMC Res Notes, V7, P264, DOI 10.1186/1756-0500-7-264; Nolder D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002711; Obare P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-113; Ramos JM, 2016, B MALARIOL SALUD AMB, V56, P75; Rojo-Marcos G, 2018, MALARIA J, V17, P11, DOI [10.1186/s12936-017-2153-9, DOI 10.1186/S12936-017-2153-9]; Rojo-Marcos G, 2008, AM J TROP MED HYG, V79, P391, DOI 10.4269/ajtmh.2008.79.391; Rojo-Marcos G, 2014, EMERG INFECT DIS, V20, P409, DOI 10.3201/eid2003.130745; Sampayo-Cordero M, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1202-6; Sharma S, 2020, INFECT GENET EVOL, V78, DOI 10.1016/j.meegid.2019.104122; Smith AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a120; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Stephens J. W., 1922, Annals of Tropical Medicine and Parasitology, V16, P383; Strydom KA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-85; Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240; Tanizaki Ryutaro, 2014, Trop Med Health, V42, P149, DOI 10.2149/tmh.2014-07; Taylor T, 2012, HUNTERS TROPICAL MED; Taylor WRJ, 2002, CLIN CHEST MED, V23, P457, DOI 10.1016/S0272-5231(02)00004-7; Tomar LR, 2015, TROP DOCT, V45, P140, DOI 10.1177/0049475515571989; Wangdahl A, 2019, J INFECT DIS, V220, P1335, DOI 10.1093/infdis/jiz292; WHO, WORLD MAL REP 2018; World Health Organization, 2015, GUID TREATM MAL, Vthird; Yerlikaya S, 2018, J INFECT DIS, V218, P265, DOI 10.1093/infdis/jiy150; Yu T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64593-1	58	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0235014	10.1371/journal.pone.0235014	http://dx.doi.org/10.1371/journal.pone.0235014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559238	gold, Green Published			2022-12-27	WOS:000543261600036
J	Grandhi, R; Karsy, M; Taussky, P; Ricker, CN; Malhotra, A				Grandhi, Ramesh; Karsy, Michael; Taussky, Philipp; Ricker, Christine Nichols; Malhotra, Ajay			Reduced 2-year aneurysm retreatment and costs among patients treated with flow diversion versus non-flow diversion embolization: A Premier Healthcare Database retrospective cohort study	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; ENDOVASCULAR TREATMENT; CEREBRAL ANEURYSMS; PIPELINE; DEVICE; SAFETY; TRIAL; COMPLICATIONS; COILING; TRENDS	Introduction The use of endovascular treatments, including Pipeline embolization devices (PEDs) and coiling approaches (non-PEDs), has played an increasingly important role in the treatment of intracranial aneurysms. Despite multiple studies evaluating PEDs, a real-world evaluation of follow-up outcomes and costs remains to be completed. Methods The Premier Healthcare Database (PHD), 2010-2017, was queried to identify patients with unruptured intracranial aneurysms treated endovascularly. Rates of readmission, retreatment, and cost at the same hospital were compared between patients who underwent PED and non-PED endovascular treatments of their aneurysms. One-to-three (PED-to-non-PED) propensity score (PS) matching was performed to adjust for potential case selection bias into the PED cohort, with covariates including age group, sex, Charlson Comorbidity Index (CCI) group, payor, region, and randomized hospital identifier. Results A total of 679 patients underwent PED placement and 8432 had non-PED treatments. Prior to PS matching, there were significant but minor differences in age (56.7 +/- 12.8 vs. 58.2 +/- 12.6 years, p = 0.004) and sex (male 16.6% vs. 24.4%, p<0.0001) for PED and non-PED, respectively, but no differences in CCI (p = 0.08), length of stay (p = 0.88), or rate of routine discharge (p = 0.21). All-cause readmission/emergency department reevaluation rates in the two cohorts were similar at 30, 90, and 180 days and 1 and 2 years. Our results identified a significantly lower retreatment rate for PEDs at all follow-up time points over a 2-year period (range: 0.9-8.1%) compared with non-PED treatments (range: 1.7-11.6%). These findings remained consistent after PS matching: all-cause readmission/reevaluation rates were significantly lower in patients treated with PED at 90 days, 180 days, 1 year, and 2 years (p<0.001). Although the initial treatment costs were higher for PED at time of treatment (p<0.001), cumulative follow-up emergency department visit and readmission costs (inclusive of patients with no readmission and/or no retreatment) were significantly lower for patients with initial PED relative to non-PED treatment at 2 years (p = 0.021). Conclusions These results suggest that PEDs may potentially reduce downstream retreatment rates and costs. Further work is required to improve identification of patient subgroups that could benefit from PED over non-PED treatments both initially and during follow-up.	[Grandhi, Ramesh; Karsy, Michael; Taussky, Philipp] Univ Utah, Clin Neurosci Ctr, Dept Neurosurg, Salt Lake City, UT 84112 USA; [Ricker, Christine Nichols] Medtron Pain Therapies, Fridley, MN USA; [Malhotra, Ajay] Yale Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT USA	Utah System of Higher Education; University of Utah; Yale University	Grandhi, R (corresponding author), Univ Utah, Clin Neurosci Ctr, Dept Neurosurg, Salt Lake City, UT 84112 USA.	neuropub@hsc.utah.edu	Malhotra, Ajay/ABC-2951-2020	Grandhi, Ramesh/0000-0001-9000-6083; Malhotra, Ajay/0000-0001-9223-6640	Medtronic, Inc.	Medtronic, Inc.(Medtronic)	Medtronic, Inc. provided support in the form of salary for author CR, purchase of database access, and funding of open access but did not have any additional role in funding the study design, data collection and analysis, decision to publish, or preparation of the manuscript executed by the other authors. The specific roles of these authors are articulated in the `author contributions.' The roles of author CR are articulated in the contributions section, but arerepeated here: data curation, formal analysis, methodology, writing - original draft, writing -review & editing.	Andaluz N, 2008, J NEUROSURG, V108, P1163, DOI 10.3171/JNS/2008/108/6/1163; Arrese I, 2013, NEUROSURGERY, V73, P193, DOI 10.1227/01.neu.0000430297.17961.f1; Becske T, 2017, J NEUROSURG, V127, P81, DOI 10.3171/2015.6.JNS15311; Becske T, 2013, RADIOLOGY, V267, P858, DOI 10.1148/radiol.13120099; Brinjikji W, 2013, STROKE, V44, P442, DOI 10.1161/STROKEAHA.112.678151; Campi A, 2007, STROKE, V38, P1538, DOI 10.1161/STROKEAHA.106.466987; Chalouhi N, 2013, STROKE, V44, P3613, DOI 10.1161/STROKEAHA.113.002390; Chen ML, 2018, STROKE, V49, P2029, DOI 10.1161/STROKEAHA.118.021985; Colby GP, 2012, NEUROSURGERY, V71, P944, DOI 10.1227/NEU.0b013e3182690b8b; Currie S, 2011, POSTGRAD MED J, V87, P41, DOI 10.1136/pgmj.2010.105387; Gonda DD, 2014, J NEUROSURG, V120, P1349, DOI 10.3171/2014.3.JNS131159; Le EJ, 2017, J NEUROINTERV SURG, V9, P188, DOI 10.1136/neurintsurg-2016-012261; Li MH, 2013, ANN INTERN MED, V159, P514, DOI 10.7326/0003-4819-159-8-201310150-00004; Lin LM, 2013, SURG NEUROL INT, V4, P114, DOI [10. 4103/2152-7806. 117711, DOI 10.4103/2152-7806.117711]; Lopes DK, 2018, NEUROSURGERY, V83, P488, DOI 10.1093/neuros/nyx467; Malhotra A, 2020, J NEUROSURG, V132, P42, DOI 10.3171/2018.8.JNS181080; McDonald RJ, 2015, INTERV NEURORADIOL, V21, P6, DOI 10.1177/1591019915576289; McDougall CG, 2012, J NEUROSURG, V116, P135, DOI 10.3171/2011.8.JNS101767; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Naggara ON, 2010, RADIOLOGY, V256, P887, DOI 10.1148/radiol.10091982; Nelson PK, 2011, AM J NEURORADIOL, V32, P34, DOI 10.3174/ajnr.A2421; Orru E, 2013, EUR J RADIOL, V82, P1653, DOI 10.1016/j.ejrad.2012.12.011; Petr O, 2016, AM J NEURORADIOL, V37, P1106, DOI 10.3174/ajnr.A4699; Phillips TJ, 2012, AM J NEURORADIOL, V33, P1225, DOI 10.3174/ajnr.A3166; Pierot L, 2010, RADIOLOGY, V256, P916, DOI 10.1148/radiol.10092209; Pierot L, 2009, RADIOLOGY, V251, P846, DOI 10.1148/radiol.2513081056; Premier, 2018, PREM HEALTHC DAT WHI; Rajah G, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2017.3.FOCUS16427; Twitchell S, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.1.FOCUS17775; Yu SCH, 2012, RADIOLOGY, V265, P893, DOI 10.1148/radiol.12120422; Zhao JJ, 2018, ANGIOLOGY, V69, P17, DOI 10.1177/0003319717700503	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234478	10.1371/journal.pone.0234478	http://dx.doi.org/10.1371/journal.pone.0234478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555657	gold, Green Published			2022-12-27	WOS:000543273200008
J	Ibabe, A; Rayon, F; Martinez, JL; Garcia-Vazquez, E				Ibabe, Aitor; Rayon, Fernando; Martinez, Jose Luis; Garcia-Vazquez, Eva			Environmental DNA from plastic and textile marine litter detects exotic and nuisance species nearby ports	PLOS ONE			English	Article							MICROPLASTIC DEBRIS; SARGASSUM-MUTICUM; DEEP-SEA; INVASION; DISPERSAL; DIVERSITY; VECTOR; LIFE; BIODIVERSITY; COMMUNITIES	Marine debris is currently a significant source of environmental and economic problems. Floating litter can be employed by marine organisms as a surface to attach to and use as spreading vector. Human activities are promoting the expansion of potentially harmful species into novel ecosystems, endangering autochthonous communities. In this project, more than 1,000 litter items were collected and classified from five beaches eastwards the port of Gijon, in Asturias, Spain. Next generation sequencing was employed to study biofouling communities attached to items of different materials. A dominance of DNA from Florideophyceae, Dinophyceae and Arthropoda was found, and four non-indigenous species (NIS) were identified. Results showed a clear preference of Florideophyceae and Bryozoa to attach on textile surfaces versus plastic ones. Considering that these taxa contain several highly invasive species described to date, these data emphasize the potential of textile marine debris as a vector for dispersal of NIS. Moreover, the closest beaches to the port contained a more similar biota profile than the farther ones, confirming that both plastic and textile marine litter can be vectors for species dispersal from ports.	[Ibabe, Aitor; Rayon, Fernando; Martinez, Jose Luis; Garcia-Vazquez, Eva] Univ Oviedo, Dept Funct Biol, C Julian Claveria S-N, Oviedo, Spain	University of Oviedo	Ibabe, A (corresponding author), Univ Oviedo, Dept Funct Biol, C Julian Claveria S-N, Oviedo, Spain.	ibabeaitor@gmail.com	Rayón Viña, Fernando/AAE-4989-2022; Martínez Fernández, Jose Luis/AAW-5618-2021	Rayón Viña, Fernando/0000-0002-1622-2180; Martínez Fernández, Jose Luis/0000-0001-7716-2428	Spanish Ministry of Economy and Competitiveness [CGL-2016-79209-R]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was funded by the Spanish Ministry of Economy and Competitiveness, Grant CGL-2016-79209-R.	Alexandrov B., 2004, GLOBALLAST MON SER, V7; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; [Anonymous], 2006, Health News, V12, P14; [Anonymous], 2002, J AM PHARM ASS, V42, pS60; Barboza LGA, 2018, MAR POLLUT BULL, V133, P336, DOI 10.1016/j.marpolbul.2018.05.047; Appeltans W, 2012, WORLD REGISTER MARIN; Ardura A, 2015, J MOLLUS STUD, V81, P495, DOI 10.1093/mollus/eyv022; Autoridad Portuaria de Gijon, 2017, PUERT GIJ AUT PORT G; Ayuntamiento de Gijon, 2016, SEND VERD CONC GIJ; Barnes DKA, 2002, NATURE, V416, P808, DOI 10.1038/416808a; Bax N, 2001, CONSERV BIOL, V15, P1234, DOI 10.1046/j.1523-1739.2001.99487.x; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; BOTAS J A, 1989, Scientia Marina, V53, P755; Boudouresque CF, 2002, MAR POLLUT BULL, V44, P32, DOI 10.1016/S0025-326X(01)00150-3; Bouillon Jean, 2006, Memoires du Museum National d'Histoire Naturelle, V194, P1; Bravo M, 2011, MAR ECOL PROG SER, V439, P1, DOI 10.3354/meps09344; Breitenbach M, 2002, CHEM IMMUNOL, V81, P48; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Bugoni L, 2001, MAR POLLUT BULL, V42, P1330, DOI 10.1016/S0025-326X(01)00147-3; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlton JT, 2017, SCIENCE, V357, P1402, DOI 10.1126/science.aao1498; Carlton JT, 1996, BIOL CONSERV, V78, P97, DOI 10.1016/0006-3207(96)00020-1; CARR A, 1987, MAR POLLUT BULL, V18, P352, DOI 10.1016/S0025-326X(87)80025-5; Carson HS, 2013, MAR POLLUT BULL, V75, P126, DOI 10.1016/j.marpolbul.2013.07.054; Corinaldesi C, 2008, MOL ECOL, V17, P3939, DOI 10.1111/j.1365-294X.2008.03880.x; Cornelius P.F.S., 1981, Porcupine Newsletter, V2, P47; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Deiner K, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms12544; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dyrynda PEJ, 2000, J NAT HIST, V34, P1993, DOI 10.1080/00222930050144828; FERNANDEZ C, 1990, BOT MAR, V33, P423, DOI 10.1515/botm.1990.33.5.423; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; FOWLER CW, 1987, MAR POLLUT BULL, V18, P326, DOI 10.1016/S0025-326X(87)80020-6; Garate-Lizarraga I, 2009, MAR POLLUT BULL, V58, P145, DOI 10.1016/j.marpolbul.2008.09.016; Garcia-Vazquez E, 2018, MAR POLLUT BULL, V131, P314, DOI 10.1016/j.marpolbul.2018.04.037; Goldstein MC, 2012, BIOL LETTERS, V8, P817, DOI 10.1098/rsbl.2012.0298; Gong J, 2013, PROTIST, V164, P369, DOI 10.1016/j.protis.2012.11.006; Graham A., 1988, MOLLUSCS PROSOBRANCH, V2; Grassle J.F., 1991, BIOL INT, V23, P1; GREVE W, 1994, ICES J MAR SCI, V51, P355, DOI 10.1006/jmsc.1994.1037; GRIIS, 2016, GLOB REG INTR INV SP; Guiry MD, 2014, SEAWEED SITE INFORM; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvey CT, 2009, DIVERS DISTRIB, V15, P429, DOI 10.1111/j.1472-4642.2008.00550.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hering D., 2018, WATER RES; Howard D. H., 2002, PATHOGENIC FUNGI HUM; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Jang YC, 2014, MAR POLLUT BULL, V81, P49, DOI 10.1016/j.marpolbul.2014.02.021; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kershaw P. J., 2017, SOURCES FATE EFFECTS; Kiessling T, 2015, MARINE ANTHROPOGENIC LITTER, P141, DOI 10.1007/978-3-319-16510-3_6; Kogame K, 2017, S AFR J BOT, V108, P337, DOI 10.1016/j.sajb.2016.08.013; Kudryavtsev A, 2013, PROTIST, V164, P13, DOI 10.1016/j.protis.2012.07.003; Laroche O, 2017, PEERJ, V5, DOI 10.7717/peerj.3347; Le Gall L, 2010, J PHYCOL, V46, P374, DOI 10.1111/j.1529-8817.2010.00807.x; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Lindsay DS, 1997, CLIN MICROBIOL REV, V10, P19, DOI 10.1128/CMR.10.1.19; MACKENZIE D.I., 2006, OCCUPANCY ESTIMATION; Maso M, 2003, SCI MAR, V67, P107, DOI 10.3989/scimar.2003.67n1107; Mattlin R.H., 1986, NZ ENV, V51, P3; Miralles L, 2016, MAR POLLUT BULL, V112, P183, DOI 10.1016/j.marpolbul.2016.08.022; Miralles L, 2018, J NAT CONSERV, V42, P12, DOI 10.1016/j.jnc.2018.01.005; Moestrup O, 2009, IOC UNESCO TAXONOMIC; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; MOSER ML, 1992, COLON WATERBIRD, V15, P83, DOI 10.2307/1521357; Mouat J., 2010, EC IMPACTS MARINE LI; Nyberg CD, 2005, BIOL INVASIONS, V7, P265, DOI 10.1007/s10530-004-0738-z; Oshikata C, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-16; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pochon X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187636; Pochon X, 2015, BIOFOULING, V31, P241, DOI 10.1080/08927014.2015.1028923; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rech S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191859; Rech S, 2016, MAR POLLUT BULL, V113, P40, DOI 10.1016/j.marpolbul.2016.08.032; Reisser J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100289; Rey A, 2018, J SEA RES, V133, P134, DOI 10.1016/j.seares.2017.06.001; Robba L, 2006, AM J BOT, V93, P1101, DOI 10.3732/ajb.93.8.1101; ROUSE G.W., 2001, POLYCHAETES; Ryland J.S., 1977, Synopses of the British Fauna New Series, P1; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sanchez I, 2005, J PHYCOL, V41, P942, DOI 10.1111/j.1529-8817.2005.00122.x; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Sliwa Cathryn, 2009, V204, P425; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Somervuo P, 2017, METHODS ECOL EVOL, V8, P398, DOI 10.1111/2041-210X.12721; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; Van der Land J., 2008, UNESCO IOC REGISTER; Verlaque M, 2001, OCEANOL ACTA, V24, P29, DOI 10.1016/S0399-1784(00)01127-0; VERLAQUE M, 1994, OCEANOL ACTA, V17, P1; Walton WC, 2002, J EXP MAR BIOL ECOL, V272, P171, DOI 10.1016/S0022-0981(02)00127-2; Watts PC, 1998, PHILOS T R SOC B, V353, P453, DOI 10.1098/rstb.1998.0222; Weigand H., 2019, DNA BARCODE REFERENC, V576553; Williams SL, 2007, ANNU REV ECOL EVOL S, V38, P327, DOI 10.1146/annurev.ecolsys.38.091206.095543; Winston Judith E., 1997, P81; Wonham MJ, 2001, MAR ECOL PROG SER, V215, P1, DOI 10.3354/meps215001; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	99	15	15	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0228811	10.1371/journal.pone.0228811	http://dx.doi.org/10.1371/journal.pone.0228811			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555686	Green Published, gold			2022-12-27	WOS:000543273200020
J	Krenzlin, H; Bettag, C; Rohde, V; Ringel, F; Keric, N				Krenzlin, Harald; Bettag, Christoph; Rohde, Veit; Ringel, Florian; Keric, Naureen			Involuntary ambulatory triage during the COVID-19 pandemic - A neurosurgical perspective	PLOS ONE			English	Article								Background The coronavirus disease 2019 (COVID-19) pandemic poses an unprecedented challenge to health-care systems around the world. As approximately one-third of the world ' s population is living under "lockdown" conditions, medical resources are being reallocated and hospital admissions are limited to emergencies. We examined the decision-making impact of these actions and their effects on access to hospital treatment in patients with neurosurgical conditions. Methods This retrospective cohort study analyzes hospital admissions of two major neurosurgical services in Germany during the nationwide lockdown period (March 16(th)to April 16(th), 2020). Spinal or cranial conditions requiring immediate hospital admission and treatment constituted emergencies. Results A total of 243 in-patients were treated between March 16(th)and April 16(th)2020 (122 patients at the University Medical Center Mainz, 121 patients at the University Medical Center Gottingen). Of these, 38.0 +/- 16% qualified as emergency admission. Another 1,688 admissions were reviewed during the same periods in 2018 and 2019, providing a frame of reference. Overall, emergency admissions declined by 44.7 +/- 0.7% during lockdown. Admissions for cranial emergencies fell by 48.1 +/- 4.44%, spinal emergencies by 30.9 +/- 14.6%. Conclusion Above findings indicate that in addition to postponing elective procedures, emergency admissions were dramatically curtailed during the COVID-19 lockdown. As this surely is unexpected and unintended, reasons are undoubtedly complex. As consequences in morbidity and mortality are still unpredictable, efforts should be made to accommodate all patients in need of hospital access going forward.	[Krenzlin, Harald; Ringel, Florian; Keric, Naureen] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurosurg, Mainz, Rhineland Palat, Germany; [Bettag, Christoph; Rohde, Veit] Georg August Univ, Univ Med Hosp, Dept Neurosurg, Gottingen, Lower Saxony, Germany	Johannes Gutenberg University of Mainz; University of Gottingen	Krenzlin, H (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurosurg, Mainz, Rhineland Palat, Germany.	harald.krenzlin@unimedizin-mainz.de	Ringel, Florian/E-4933-2014; Krenzlin, Harald/AAS-7602-2020					Baracchini C, 2020, NEUROL SCI, V41, P1003, DOI 10.1007/s10072-020-04375-9; Cascella M, 2020, FEATURES EVALUATION, V1st, DOI DOI 10.1016/j.autrev.2016.07.022; Caso V, 2020, NEUROL SCI, V41, P999, DOI 10.1007/s10072-020-04389-3; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Group C-S, 2020, CHAR COVID 19 PAT DY; Hu YJ, 2020, J NEURO-ONCOL, V148, P199, DOI 10.1007/s11060-020-03489-6; Khosravani Houman, 2020, Stroke, V51, P1891, DOI 10.1161/STROKEAHA.120.029838; Kim SYH, 2020, NEUROLOGY, V94, P1007, DOI 10.1212/WNL.0000000000009520; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; Mohile NA, 2020, NEURO-ONCOLOGY, V22, P912, DOI 10.1093/neuonc/noaa090; Ramakrishna R, 2020, J NEURO-ONCOL, V147, P525, DOI 10.1007/s11060-020-03488-7	11	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234956	10.1371/journal.pone.0234956	http://dx.doi.org/10.1371/journal.pone.0234956			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555723	Green Published, gold			2022-12-27	WOS:000543273200011
J	Mena-Chamorro, P; Ferrer-Urbina, R; Sepulveda-Paez, G; Cortes-Mercado, F; Gutierrez-Mamani, C; Lagos-Maldonado, K; Pena-Daldo, M				Mena-Chamorro, Patricio; Ferrer-Urbina, Rodrigo; Sepulveda-Paez, Geraldy; Cortes-Mercado, Francisca; Gutierrez-Mamani, Carolina; Lagos-Maldonado, Kyara; Pena-Daldo, Maria			Development and evidence of validity of the HIV risk perception scale for young adults in a Hispanic-American context (vol 15, e0231558, 2020)	PLOS ONE			English	Correction													Mena-Chamorro, Patricio/AAM-7917-2021; Ferrer, Rodrigo/E-8230-2018	Mena-Chamorro, Patricio/0000-0001-7397-2845; Ferrer, Rodrigo/0000-0001-5407-3158				Mena-Chamorro P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231558	1	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0235212	10.1371/journal.pone.0235212	http://dx.doi.org/10.1371/journal.pone.0235212			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555737	gold, Green Published			2022-12-27	WOS:000543273200041
J	Okoli, GN; Lam, OLT; Racovitan, F; Reddy, VK; Righolt, CH; Neilson, C; Chit, A; Thommes, E; Abou-Setta, AM; Mahmud, SM				Okoli, George N.; Lam, Otto L. T.; Racovitan, Florentin; Reddy, Viraj K.; Righolt, Christiaan H.; Neilson, Christine; Chit, Ayman; Thommes, Edward; Abou-Setta, Ahmed M.; Mahmud, Salaheddin M.			Seasonal influenza vaccination in older people: A systematic review and meta-analysis of the determining factors	PLOS ONE			English	Review							HEALTH-CARE; HONG-KONG; PATIENT CHARACTERISTICS; IMMUNIZATION PRACTICES; SOCIOECONOMIC-STATUS; PREVENTIVE SERVICES; ADVISORY-COMMITTEE; ETHNIC DISPARITIES; UNITED-STATES; ADULTS	Background/Objectives Despite influenza vaccination programs in various jurisdictions, seasonal influenza vaccine (SIV) uptake remains suboptimal among older people (>= 65years old), an important subpopulation for influenza vaccination. We sought to summarize determinants of SIV uptake (any vaccine receipt) and vaccination adherence (receipt of vaccine in two or more seasons in sequence) among older people. Methods We searched for population-based studies conducted in community-dwelling older people (irrespective of their health status) from 2000-2019. Two reviewers independently selected publications for inclusion. One reviewer extracted data from the included studies; a second checked the extracted data for errors. Disagreements were resolved by discussion and consensus, or a third reviewer. We were interested in the determinants of SIV uptake and vaccination adherence. Where appropriate, we pooled adjusted results using the inverse variance, random-effects method and reported the odds ratios (OR) and their 95% confidence intervals (CI). Results Out of 11,570 citations screened, we included 34 cross-sectional studies. The following were associated with increased SIV uptake: being older (OR 1.52, 95%CI 1.38-1.67 [21 studies]), white (1.30, 1.14-1.49 [10 studies]), married (1.23, 1.17-1.28 [9 studies]), non-smoker (1.28, 1.11-1.47 [7 studies]), of a higher social class (1.20, 1.06-1.36 [2 studies]), having a higher education (1.12, 1.04-1.21 [14 studies]), having a higher household income (1.11, 1.05-1.18 [8 studies]), having a chronic illness (1.53, 1.44-1.63 [16 studies]), having poor self-assessed health (1.23, 1.02-1.40 [9 studies]), having a family doctor (2.94, 1.79-4.76 [2 studies]), and having health insurance (1.58, 1.13-2.21 [6 studies]). The influence of these factors varied across geographical regions. Being older (1.26, 1.11-1.44 [2 studies]) was also associated with increased vaccination adherence. Conclusions Several factors may determine SIV uptake and vaccination adherence among older people. More studies are needed to provide a stronger evidence base for planning more effective influenza vaccination programs.	[Okoli, George N.; Lam, Otto L. T.; Racovitan, Florentin; Reddy, Viraj K.; Abou-Setta, Ahmed M.; Mahmud, Salaheddin M.] Univ Manitoba, George & Fay Yee Ctr Healthcare Innovat, Winnipeg, MB, Canada; [Okoli, George N.; Mahmud, Salaheddin M.] Univ Manitoba, Coll Pharm, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Okoli, George N.; Righolt, Christiaan H.; Mahmud, Salaheddin M.] Univ Manitoba, Vaccine & Drug Evaluat Ctr, Winnipeg, MB, Canada; [Righolt, Christiaan H.; Abou-Setta, Ahmed M.; Mahmud, Salaheddin M.] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Community Hlth Sci, Winnipeg, MB, Canada; [Neilson, Christine] Univ Manitoba, Neil John Maclean Hlth Sci Lib, Winnipeg, MB, Canada; [Chit, Ayman; Thommes, Edward] Sanofi Pasteur, Swiftwater, PA USA; [Chit, Ayman] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Thommes, Edward] Univ Guelph, Dept Math & Stat, Guelph, ON, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; Sanofi-Aventis; University of Toronto; University of Guelph	Okoli, GN (corresponding author), Univ Manitoba, George & Fay Yee Ctr Healthcare Innovat, Winnipeg, MB, Canada.; Okoli, GN (corresponding author), Univ Manitoba, Coll Pharm, Rady Fac Hlth Sci, Winnipeg, MB, Canada.; Okoli, GN (corresponding author), Univ Manitoba, Vaccine & Drug Evaluat Ctr, Winnipeg, MB, Canada.	George.Okoli@umanitoba.ca	Neilson, Christine/K-8429-2013	Neilson, Christine/0000-0002-0525-737X	Sanofi Pasteur USA	Sanofi Pasteur USA	AC and ET are employees of Sanofi Pasteur. SMM has received unrestricted research grants from GlaxoSmithKline, Merck, Sanofi Pasteur, Pfizer and Roche-Assurex for unrelated studies, and fees as an advisory board member for Sanofi Pasteur. This study was also partially funded through a research grant from Sanofi Pasteur USA for a related, and already published, study. The specific roles of these authors are articulated in the 'author contributions' section.	Abramson ZH, 2008, PREV MED, V47, P550, DOI 10.1016/j.ypmed.2008.08.001; Agenor M, 2020, ETHNIC HEALTH, V25, P393, DOI 10.1080/13557858.2018.1427703; Aguilar I, 2012, EUROSURVEILLANCE, V17, P36; [Anonymous], 2013, AJR EDITORIAL UPDATE, V3, P8; Appel A, 2006, MED CARE, V44, P1054, DOI 10.1097/01.mlr.0000228017.83672.c3; Ashton CM, 2003, J GEN INTERN MED, V18, P146, DOI 10.1046/j.1525-1497.2003.20532.x; Beckett MK, 2015, J GERONTOL A-BIOL, V70, P1242, DOI 10.1093/gerona/glv037; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Black CL, 2017, MMWR-MORBID MORTAL W, V66, P728, DOI 10.15585/mmwr.mm6627a4; Burns VE, 2005, VACCINE, V23, P3604, DOI 10.1016/j.vaccine.2004.12.031; Byars-Winston A, 2015, J VOCAT BEHAV, V87, P54, DOI 10.1016/j.jvb.2014.12.003; Caille-Brillet AL, 2014, VACCINE, V32, P2007, DOI 10.1016/j.vaccine.2013.12.045; Canada Revenue Agency, 2016, TYP REG CHAR DES; Chan Denise P C, 2015, Prev Med Rep, V2, P803, DOI 10.1016/j.pmedr.2015.09.002; Chang YC, 2013, VACCINE, V31, P410, DOI 10.1016/j.vaccine.2012.10.086; Chen JY, 2005, AM J PREV MED, V29, P388, DOI 10.1016/j.amepre.2005.08.006; Chiatti C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-207; Chokshi DA, 2018, JAMA-J AM MED ASSOC, V319, P1312, DOI 10.1001/jama.2018.2521; Connelly R., 2016, METHODOLOGICAL INNOV, V9, P1, DOI [10.1177/2059799116642885, DOI 10.1177/2059799116638003, 10.1177/2059799116638001]; Crawford VLS, 2011, AGE AGEING, V40, P35, DOI 10.1093/ageing/afq152; Daniels NA, 2006, J NATL MED ASSOC, V98, P1089; Dios-Guerra C, 2017, VACCINE, V35, P7095, DOI 10.1016/j.vaccine.2017.10.086; Djamba YK, 2011, INT J POPULATION RES, V2011, P305873; Dyda A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1820-8; Dyda A, 2015, VACCINE, V33, P3299, DOI 10.1016/j.vaccine.2015.05.046; Egede LE, 2006, J GEN INTERN MED, V21, P667, DOI 10.1111/j.1525-1497.2006.0512.x; Egede LE, 2003, AM J PUBLIC HEALTH, V93, P324, DOI 10.2105/AJPH.93.2.324; Expert Panel on Gastrointestinal Imaging, 2019, J AM COLL RADIOL, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; Fabiani M, 2019, VACCINE, V37, P5314, DOI 10.1016/j.vaccine.2019.07.054; Fletcher Jason M, 2009, J Hum Cap, V3, P144; Fox JB, 2014, MMWR-MORBID MORTAL W, V63, P666; Gazibara T, 2019, J HEALTH POPUL NUTR, V38, DOI 10.1186/s41043-018-0159-8; Grohskopf LA, 2017, MMWR RECOMM REP, V66, P3, DOI 10.15585/mmwr.rr6602a1; Henning-Smith C, 2017, MED CARE, V55, P823, DOI 10.1097/MLR.0000000000000761; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hilderman T, 2011, MANITOBA IMMUNIZATIO, P1; Hinman AR, 2004, CLIN INFECT DIS, V38, P1445, DOI 10.1086/420748; Ho HJ, 2019, AM J PUBLIC HEALTH, V109, P1776, DOI 10.2105/AJPH.2019.305328; Hochschild JL, 2014, OXFORD HDB RACIAL ET; Jain A, 2017, VACCINE, V35, P2315, DOI 10.1016/j.vaccine.2017.03.013; Jimenez-Garcia R, 2008, VACCINE, V26, P4218, DOI 10.1016/j.vaccine.2008.05.053; Jin L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25561-y; Kamimura Akiko, 2017, J Prev Med Public Health, V50, P268, DOI 10.3961/jpmph.17.061; Khan SR, 2018, DISABIL HEALTH J, V11, P339, DOI 10.1016/j.dhjo.2017.11.004; Kwon DS, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012618; La EM, 2018, HUM VACC IMMUNOTHER, V14, P430, DOI 10.1080/21645515.2017.1403697; Landi F, 2005, VACCINE, V23, P3896, DOI 10.1016/j.vaccine.2005.03.008; Lau JTF, 2008, J INFECTION, V56, P460, DOI 10.1016/j.jinf.2008.03.008; Lau JTF, 2006, VACCINE, V24, P5526, DOI 10.1016/j.vaccine.2006.04.014; de Andres A, 2007, EUR J PUBLIC HEALTH, V17, P272, DOI 10.1093/eurpub/ckl242; Lu PJ, 2019, AM J PREV MED, V57, P458, DOI 10.1016/j.amepre.2019.04.007; Lu PJ, 2015, HUM VACC IMMUNOTHER, V11, P2849, DOI 10.1080/21645515.2015.1075108; Maestri V, 2017, EDUC ECON, V25, P290, DOI 10.1080/09645292.2016.1238879; Mahmud SM, 2012, EMERG INFECT DIS, V18, P801, DOI 10.3201/eid1805.111596; Martinez-Baz I, 2012, PREV MED, V55, P246, DOI 10.1016/j.ypmed.2012.06.020; McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021; Mereckiene J, 2010, EUROSURVEILLANCE, V15, P11; Mo PKH, 2015, HEALTH EDUC RES, V30, P706, DOI 10.1093/her/cyv038; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Mytton OT, 2013, OCCUP MED-OXFORD, V63, P189, DOI 10.1093/occmed/kqt002; Nagata JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-388; [National Advisory Committee on Immunization Canada MoPWaGS], 2017, ADV COMM STAT CAN IM; National Institutes of Health, QUAL ASS TOOL OBS CO; Okoli GN, 2019, GERONTOL GERIATR MED, V5, DOI 10.1177/2333721419870345; Ortiz JR, 2016, VACCINE, V34, P5400, DOI 10.1016/j.vaccine.2016.07.045; Parmar MC, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0979-9; Pena-Rey I, 2004, PUBLIC HEALTH, V118, P582, DOI 10.1016/j.puhe.2004.04.010; Praphasiri P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188422; Public Health Agency of Canada, 2017, VACC COV GOALS VACC; Public Health Agency of Canada, 2017, INFL VACC UPT RES 20; Roy M, 2018, HEALTH REP, V29, P12; Ryu SY, 2011, INT J ENV RES PUB HE, V8, P4197, DOI 10.3390/ijerph8114197; Sander W., 1992, ECON EDUC REV, V11, P119, DOI DOI 10.1016/0272-7757(92)90003-L; Seo J, 2018, VACCINE, V36, P3666, DOI 10.1016/j.vaccine.2018.05.024; SINGLETON J, 1977, COMP EDUC REV, V21, P329, DOI 10.1086/445946; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Takayama M, 2012, PREV MED, V54, P358, DOI 10.1016/j.ypmed.2012.03.008; Thompson AE, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0440-0; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Tumin D, 2018, HEALTH EQUITY, V2, P37, DOI 10.1089/heq.2017.0058; Williams M, 2013, INT J SOC RES METHOD, V16, P285, DOI 10.1080/13645579.2012.682794; WINGARD DL, 1984, ANNU REV PUBL HEALTH, V5, P433, DOI 10.1146/annurev.pu.05.050184.002245; World Health Organization, 2003, PREV CONTR INFL PAND; Yeung MPS, 2016, J PUBLIC HEALTH-UK, V38, P746, DOI 10.1093/pubmed/fdv194; Yoshimitsu Koji, 2017, BMC Res Notes, V10, P512, DOI 10.1186/s13104-017-2836-x; Zajacova A, 2018, ANNU REV PUBL HEALTH, V39, P273, DOI 10.1146/annurev-publhealth-031816-044628; Zurcher K, 2019, SWISS MED WKLY, V149, DOI 10.4414/smw.2019.14705; Zwysen W, 2018, J ETHN MIGR STUD, V44, P154, DOI 10.1080/1369183X.2017.1338559	91	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234702	10.1371/journal.pone.0234702	http://dx.doi.org/10.1371/journal.pone.0234702			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555628	Green Published, gold			2022-12-27	WOS:000543273200078
J	Zhou, YK; Fan, JF; Wang, XY				Zhou, Yuke; Fan, Junfu; Wang, Xiaoying			Assessment of varying changes of vegetation and the response to climatic factors using GIMMS NDVI3g on the Tibetan Plateau	PLOS ONE			English	Article							QINGHAI-TIBET; MANN-KENDALL; TREND ANALYSIS; TIME-SERIES; PRECIPITATION; DYNAMICS; CHINA; TEMPERATURE; HOMOGENEITY; PHENOLOGY	Under the context of global climate change, vegetation on the Tibetan Plateau (TP) has experienced significant changes during the past three decades. In this study, the spatiotemporal changes of growing season vegetation index (GSVI) on the TP were analyzed using various methods from pixel level to ecoregion level. In addition, a relative importance approach was employed to investigate the regulating effect of temperature and precipitation on vegetation. During the period of 1982-2012, vegetation on the TP was generally experiencing a greening trend, but with pronounced fluctuations. The interannual variation of the long-term GSVI was most significant in the Qaidam Basin and southern forest. At ecoregion scale, vegetation in the arid and frigid arid zones showed a browning tendency, with other ecoregions presenting greener trends. Over a large proportion of the TP, there exist change points in the GSVI time series, which were mainly concentered around the year 1996 and 2000. The Hurst exponent identified that a majority (88%) of the vegetation on the plateau would maintain a persistent trend in the future, which would mainly consist of undetermined development and greening trends. TP vegetation during the 1990s experienced more greening than in the 1980s or 2000s according to the interdecadal analysis. The long-term change in growing season vegetation was most positively correlated with the temperature during the same period, followed by the temperature in the preseason and postseason periods. There were more negative relationships of vegetation change with precipitation than with temperature. The relative contribution of the temperature to the vegetation changes exhibited an opposite spatial pattern to that of precipitation. Overall, the findings in this work provide an essential archive of decade-scale vegetation dynamics that may be helpful for projecting the future ecosystem dynamics on the Tibetan Plateau, such as the consistent greening.	[Zhou, Yuke] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Zhou, Yuke] Southern Marine Sci & Engn Guangdong Lab Guangzho, Guangzhou, Peoples R China; [Fan, Junfu] Shandong Univ Technol, Sch Civil & Architectural Engn, Zibo, Peoples R China; [Wang, Xiaoying] CMA, Inst Atmospher Environm, Shenyang, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Hong Kong Branch of the Southern Marine Science & Engineering Guangdong Laboratory (Guangzhou); Shandong University of Technology; China Meteorological Administration	Fan, JF (corresponding author), Shandong Univ Technol, Sch Civil & Architectural Engn, Zibo, Peoples R China.	fanjf@sdut.edu.cn	FAN, Junfu/L-8975-2014	FAN, Junfu/0000-0001-8987-7930	National Key R&D Program of China [2018YFB0505301, 2016YFC0500103, 2017YFB0503500]; Key Special Project for Introduced Talents Team of Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou) [GML2019ZD0301]	National Key R&D Program of China; Key Special Project for Introduced Talents Team of Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou)	This study was supported by National Key R&D Program of China (Grant No.2018YFB0505301, 2016YFC0500103, 2017YFB0503500). The publish charge is partly provided by the Key Special Project for Introduced Talents Team of Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), No. GML2019ZD0301.	ALEXANDERSSON H, 1986, J CLIMATOL, V6, P661, DOI 10.1002/joc.3370060607; [Anonymous], 2005, KRITIKA, V6, P789; [Anonymous], 2006, PROGR HUMAN GEOGRAPH, V30, P1; [Anonymous], 2013, LANCET GLOB HLTH; [Anonymous], 2012, INNOVATION, V3, P52, DOI DOI 10.1016/J.ENVDEV.2012.04.002; [Anonymous], 2005, KENDALL RANK CORRELA; [Anonymous], 2011, GEORGE WASHINGTON J, V2, P2; Anyamba A, 2014, REMOTE SENS-BASEL, V6, P3101, DOI 10.3390/rs6043101; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Brown MH, 1998, SOFTWARE VISUALIZATION, P155; BUISHAND TA, 1982, J HYDROL, V58, P11, DOI 10.1016/0022-1694(82)90066-X; Chen C, 2019, NAT SUSTAIN, V2, P122, DOI 10.1038/s41893-019-0220-7; Chen XQ, 2015, GLOBAL CHANGE BIOL, V21, P3635, DOI 10.1111/gcb.12954; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Cong N, 2017, INT J BIOMETEOROL, V61, P1433, DOI 10.1007/s00484-017-1321-5; Ding MJ, 2007, J GEOGR SCI, V17, P259, DOI 10.1007/s11442-007-0259-7; Du MY, 2004, GLOBAL PLANET CHANGE, V41, P241, DOI 10.1016/j.gloplacha.2004.01.010; Eastman JR, 2009, INT J REMOTE SENS, V30, P2721, DOI 10.1080/01431160902755338; Eklundh L, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016772; Feldman B., 2005, RELATIVE IMPORTANCE, DOI [10.2139/ssrn.2255827, DOI 10.2139/SSRN.2255827]; Forkel M, 2013, REMOTE SENS-BASEL, V5, P2113, DOI 10.3390/rs5052113; Gerten D, 2004, J HYDROL, V286, P249, DOI 10.1016/j.jhydrol.2003.09.029; Gocic M, 2013, GLOBAL PLANET CHANGE, V100, P172, DOI 10.1016/j.gloplacha.2012.10.014; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Hamed KH, 1998, J HYDROL, V204, P182, DOI 10.1016/S0022-1694(97)00125-X; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Huang C, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12071163; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Jin HJ, 2008, COLD REG SCI TECHNOL, V53, P317, DOI 10.1016/j.coldregions.2007.07.005; JINGSHENG W, 2013, J RESOURCES ECOLOGY, V4, P43, DOI DOI 10.5814/J.ISSN.1674-764X.2013.01.006; Kaufmann RK, 2000, IEEE T GEOSCI REMOTE, V38, P2584, DOI 10.1109/36.885205; Lamsal Pramod, 2017, Global and Planetary Change, V159, P77, DOI 10.1016/j.gloplacha.2017.09.010; Liu YS, 2013, PLANT SOIL, V366, P491, DOI 10.1007/s11104-012-1442-x; Meybeck M, 2001, MT RES DEV, V21, P34, DOI 10.1659/0276-4741(2001)021[0034:ANTFMA]2.0.CO;2; Morton K, 2011, SURVIVAL, V53, P121, DOI 10.1080/00396338.2011.555606; Neeti N, 2011, T GIS, V15, P599, DOI 10.1111/j.1467-9671.2011.01280.x; Ni J, 2000, MT RES DEV, V20, P80, DOI 10.1659/0276-4741(2000)020[0080:ASOBOT]2.0.CO;2; NORTH GR, 1984, J ATMOS SCI, V41, P879, DOI 10.1175/1520-0469(1984)041<0879:EOFANM>2.0.CO;2; Peng J, 2012, ECOL INDIC, V14, P28, DOI 10.1016/j.ecolind.2011.08.011; PENUELAS J, 1993, REMOTE SENS ENVIRON, V46, P110, DOI 10.1016/0034-4257(93)90088-F; Pettitt A. N., 1979, Applied Statistics, V28, P126, DOI 10.2307/2346729; Piao SL, 2006, CLIMATIC CHANGE, V74, P253, DOI 10.1007/s10584-005-6339-8; Piao SL, 2012, GLOBAL PLANET CHANGE, V98-99, P73, DOI 10.1016/j.gloplacha.2012.08.009; Pinzon JE, 2014, REMOTE SENS-BASEL, V6, P6929, DOI 10.3390/rs6086929; Qian B., 2004, P 2 IASTED INT C FIN, P203; Sayemuzzaman M, 2014, ATMOS RES, V137, P183, DOI 10.1016/j.atmosres.2013.10.012; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Shen MG, 2015, P NATL ACAD SCI USA, V112, P9299, DOI 10.1073/pnas.1504418112; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Suguitan Jr AL, 2011, PLOS ONE, V6; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P2970, DOI 10.1016/j.rse.2010.08.003; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P106, DOI 10.1016/j.rse.2009.08.014; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang JB, 2014, REMOTE SENS-BASEL, V6, P2108, DOI 10.3390/rs6032108; Wang XF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10235-8; Weron R, 2002, PHYSICA A, V312, P285, DOI 10.1016/S0378-4371(02)00961-5; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Woodward FI, 1997, GLOBAL ECOL BIOGEOGR, V6, P413, DOI 10.2307/2997350; Wu DH, 2015, GLOBAL CHANGE BIOL, V21, P3520, DOI 10.1111/gcb.12945; Wu JJ, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-01700-9, 10.1038/s41598-017-15530-2]; [吴绍洪 Wu Shaohong], 2003, [地理学报, Acta Geographica Sinica], V58, P686; Xu C, 2012, ENVIRON MONIT ASSESS, V184, P1275, DOI 10.1007/s10661-011-2039-1; Xu WX, 2007, CHINESE GEOGR SCI, V17, P151, DOI 10.1007/s11769-007-0151-5; Xu XJ, 2019, J ENVIRON MANAGE, V246, P605, DOI 10.1016/j.jenvman.2019.06.023; Xu XK, 2008, CHINESE SCI BULL, V53, P915, DOI 10.1007/s11434-008-0115-x; Xue X, 2009, GEOMORPHOLOGY, V108, P182, DOI 10.1016/j.geomorph.2009.01.004; Yang K, 2014, GLOBAL PLANET CHANGE, V112, P79, DOI 10.1016/j.gloplacha.2013.12.001; Yang K, 2011, CLIMATIC CHANGE, V109, P517, DOI 10.1007/s10584-011-0099-4; Yang Q-Y, 2002, ADV NATURAL SCI, V12, P287; Yeh ET, 2009, GEOFORUM, V40, P884, DOI 10.1016/j.geoforum.2009.06.004; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Yue S, 2002, J HYDROL, V259, P254, DOI 10.1016/S0022-1694(01)00594-7; Zheng D., 1999, STUDY ECOGEOGRAPHIC; Zhong L, 2010, CLIMATIC CHANGE, V103, P519, DOI 10.1007/s10584-009-9787-8; Zhu ZC, 2013, REMOTE SENS-BASEL, V5, P927, DOI 10.3390/rs5020927; Zhuang Q, 2010, GLOBAL ECOL BIOGEOGR, V19, P649, DOI 10.1111/j.1466-8238.2010.00559.x; Zuo ZY, 2011, CLIM DYNAM, V36, P1207, DOI 10.1007/s00382-010-0863-6	78	10	10	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234848	10.1371/journal.pone.0234848	http://dx.doi.org/10.1371/journal.pone.0234848			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555722	gold, Green Published			2022-12-27	WOS:000542759600023
J	Ogbe, E; Harmon, S; Van den Bergh, R; Degomme, O				Ogbe, Emilomo; Harmon, Stacy; Van den Bergh, Rafael; Degomme, Olivier			A systematic review of intimate partner violence interventions focused on improving social support and/mental health outcomes of survivors	PLOS ONE			English	Article							ADVOCACY INTERVENTION; WOMEN SURVIVORS; MENTAL-HEALTH; ABUSED WOMEN; SERVICES; PROGRAM; PROJECT; SAFETY; TRIAL	Background Intimate partner violence (IPV) is a key public health issue, with a myriad of physical, sexual and emotional consequences for the survivors of violence. Social support has been found to be an important factor in mitigating and moderating the consequences of IPV and improving health outcomes. This study's objective was to identify and assess network oriented and support mediated IPV interventions, focused on improving mental health outcomes among IPV survivors. Methods A systematic scoping review of the literature was done adhering to PRISMA guidelines. The search covered a period of 1980 to 2017 with no language restrictions across the following databases, Medline, Embase, Web of Science, PROQUEST, and Cochrane. Studies were included if they were primary studies of IPV interventions targeted at survivors focused on improving access to social support, mental health outcomes and access to resources for survivors. Results 337 articles were subjected to full text screening, of which 27 articles met screening criteria. The review included both quantitative and qualitative articles. As the focus of the review was on social support, we identified interventions that were i) focused on individual IPV survivors and improving their access to resources and coping strategies, and ii) interventions focused on both individual IPV survivors as well as their communities and networks. We categorized social support interventions identified by the review asSurvivor focused,advocate/case management interventions (15 studies), survivor focused, advocate/case management interventions with a psychotherapy component (3 studies),community-focused,social support interventions (6 studies),community-focused,social support interventions with a psychotherapy component (3 studies). Most of the studies, resulted in improvements in social support and/or mental health outcomes of survivors, with little evidence of their effect on IPV reduction or increase in healthcare utilization. Conclusion There is good evidence of the effect of IPV interventions focused on improving access to social support through the use of advocates with strong linkages with community based structures and networks, on better mental health outcomes of survivors, there is a need for more robust/ high quality research to assess in what contexts and for whom, these interventions work better compared to other forms of IPV interventions.	[Ogbe, Emilomo; Degomme, Olivier] Univ Ghent, Int Ctr Reprod Hlth, Ghent, Belgium; [Harmon, Stacy] Georgia State Univ Alumna, Atlanta, GA USA; [Van den Bergh, Rafael] Med Sans Frontieres, Operat Ctr Brussels, Brussels, Belgium	Ghent University; Doctors Without Borders	Ogbe, E (corresponding author), Univ Ghent, Int Ctr Reprod Hlth, Ghent, Belgium.	emilomo.ogbe@ugent.be		Van den Bergh, Rafael/0000-0001-6277-8713; Ogbe, Emilomo/0000-0003-2707-3405	University of Gent BOF startkrediet [BOF.STA.2016.0031.01]	University of Gent BOF startkrediet	E.O- University of Gent BOF startkrediet (BOF.STA.2016.0031.01) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; Babineau J, 2014, J CAN HEALTH LIBRARI, V35, P68, DOI 10.5596/c14-016; Bourcier E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191211; Breiding M.J., 2015, INTIMATE PARTNER VIO; Bybee DI, 2002, AM J COMMUN PSYCHOL, V30, P103, DOI 10.1023/A:1014376202459; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; Coker AL, 2012, VIOLENCE AGAINST WOM, V18, P118, DOI 10.1177/1077801212437908; Constantino Rose, 2005, Issues Ment Health Nurs, V26, P575, DOI 10.1080/01612840590959416; Constantino RE, 2015, ISSUES MENT HEALTH N, V36, P430, DOI 10.3109/01612840.2014.991049; Cripe SM, 2010, J INTERPERS VIOLENCE, V25, P2054, DOI 10.1177/0886260509354517; Dam AEH, 2016, MATURITAS, V85, P117, DOI 10.1016/j.maturitas.2015.12.008; De Prince AP, 2012, J CONSULT CLIN PSYCH, V80, P211, DOI 10.1037/a0027224; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Frohmann L, 2005, VIOLENCE AGAINST WOM, V11, P1396, DOI 10.1177/1077801205280271; Gilbert L, 2015, CRIM BEHAV MENT HEAL, V25, P314, DOI 10.1002/cbm.1979; Goodman LA, 2016, VIOLENCE AGAINST WOM, V22, P64, DOI 10.1177/1077801215599080; Goodman LA, 2011, PSYCHOL VIOLENCE, V1, P79, DOI 10.1037/a0022977; Hamberger LK, 2015, J FAM VIOLENCE, V30, P699, DOI 10.1007/s10896-015-9732-8; Hansen NB, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.24797; Howarth E, 2016, VIOLENCE AGAINST WOM, V22, P41, DOI 10.1177/1077801215597789; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Kelly UA, 2014, ISSUES MENT HEALTH N, V35, P906, DOI 10.3109/01612840.2014.931496; Krasnoff M, 2002, ANN EMERG MED, V40, P485, DOI 10.1067/mem.2002.128872; Kulkarni S, 2019, J FAM VIOLENCE, V34, P55, DOI 10.1007/s10896-018-0001-5; Kyegombe N, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25082; McFarlane J, 1997, J Community Health Nurs, V14, P237, DOI 10.1207/s15327655jchn1404_3; McFarlane JM, 2006, NURS RES, V55, P52, DOI 10.1097/00006199-200601000-00007; McGann J, 2005, NEW LITERARY HIST, V36, P71, DOI 10.1353/nlh.2005.0024; McLeroy KR., 2003, COMMUNITY BASED INTE; McWhirter PT, 2011, J INTERPERS VIOLENCE, V26, P2457, DOI 10.1177/0886260510383026; Miller LE, 2014, AM J ORTHOPSYCHIAT, V84, P321, DOI 10.1037/h0099840; Nicolaidis C, 2013, PROG COMM HLTH PARTN, V7, P395, DOI 10.1353/cpr.2013.0051; Programme CAS, 2018, CASP QUAL RES CHECKL; Prosman GJ, 2014, FAM PRACT, V31, P71, DOI 10.1093/fampra/cmt058; Ragavan MI, 2019, PSYCHOL VIOLENCE, V9, P139, DOI 10.1037/vio0000183; Ramsay J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub2; Schuler SR, 2011, VIOLENCE AGAINST WOM, V17, P1421, DOI 10.1177/1077801211433990; Sharps PW, 2016, J WOMENS HEALTH, V25, P1129, DOI 10.1089/jwh.2015.5547; SHUMAKER SA, 1984, J SOC ISSUES, V40, P11, DOI 10.1111/j.1540-4560.1984.tb01105.x; Stevens J, 2015, VIOLENCE AGAINST WOM, V21, P1528, DOI 10.1177/1077801215596849; SULLIVAN CM, 1992, AM J COMMUN PSYCHOL, V20, P309, DOI 10.1007/BF00937912; Sullivan CM, 1999, J CONSULT CLIN PSYCH, V67, P43, DOI 10.1037/0022-006X.67.1.43; Sullivan CM, 2018, AM J ORTHOPSYCHIAT, V88, P563, DOI 10.1037/ort0000286; Sylaska KM, 2014, TRAUMA VIOLENCE ABUS, V15, P3, DOI 10.1177/1524838013496335; Taft AJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-178; Thomas H, 2003, QUAL ASS TOOL QUANT; Tiwari A, 2010, JAMA-J AM MED ASSOC, V304, P536, DOI 10.1001/jama.2010.1052; Trabold N, 2018, J TRAUMA VIOLENCE AB; Wuest J, 2015, RES NURS HEALTH, V38, P82, DOI 10.1002/nur.21636; Zlotnick C, 2011, ARCH WOMEN MENT HLTH, V14, P55, DOI 10.1007/s00737-010-0195-x	50	36	37	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235177	10.1371/journal.pone.0235177	http://dx.doi.org/10.1371/journal.pone.0235177			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584910	Green Published, gold			2022-12-27	WOS:000545747200077
J	Schmidt, SB; Gruter, L; Boltzmann, M; Rollnik, JD				Schmidt, Simone B.; Grueter, Ludwig; Boltzmann, Melanie; Rollnik, Jens D.			Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff	PLOS ONE			English	Article								The SARS-CoV-2 pandemic threatens health care providers and society. For planning of treatment capacities, it is of major importance to obtain reliable information on infection and fatality rates of the novel coronavirus. A German community study, the so-called Heinsberg study, found a 5-fold higher infection rate (and thus a remarkably lower fatality rate) than the officially reported cases suggest. We were interested to examine the SARS-CoV-2-IgG antibody status among clinic staff of a large neurological center in Northern Germany. Blood samples and questionnaires (demographic data, medical history) were collected pseudonymously. In total, 406 out of 525 (77.3%) of our employees participated in the study. The infection rate among the staff was as high as 2.7%. Including drop-outs (missing questionnaire but test result available), the infection rate was even higher (2.9%). Only 36% of the positively tested employees did suffer from flu-like symptoms in 2020. None of the nurses-having closest and longest contact to patients-were found to be positive. Despite the fact that the infection rate among clinic staff may not be directly compared to the situation in the surrounding county (due to different testing procedures), one might hypothesize that the infection rate could be more than 30-fold higher than the number of officially reported cases for the county of Hameln-Pyrmont. The high rate of IgG-positive, asymptomatic healthcare workers might help to overcome fears in daily work.	[Schmidt, Simone B.; Boltzmann, Melanie; Rollnik, Jens D.] Hannover Med Sch, Associated Inst, Inst Neurorehabil Res, BDH Clin Hessisch Oldendorf, Hessisch Oldendorf, Germany; [Grueter, Ludwig] Nordlab, Hameln, Germany	Hannover Medical School	Schmidt, SB (corresponding author), Hannover Med Sch, Associated Inst, Inst Neurorehabil Res, BDH Clin Hessisch Oldendorf, Hessisch Oldendorf, Germany.	si.schmidt@bdh-klinik-hessisch-oldendorf.de						Bao L, 2020, REINFECTION COULD NO, DOI [10.1101/2020.03.13.990226v1, DOI 10.1101/2020.03.13.990226V1]; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Guo L, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa310, DOI 10.1093/CID/CIAA31032198501]; MAHASE E, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M1036; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Streeck H, 2020, INFECT FATALITY RATE; TYRRELL DAJ, 1965, BMJ-BRIT MED J, V1, P1467, DOI 10.1136/bmj.1.5448.1467; World Health Organization, 104 WHO; World Health Organization, SUMM PROB SARS CAS O; Zhou GY, 2020, INT J BIOL SCI, V16, P1718, DOI 10.7150/ijbs.45123	10	40	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235417	10.1371/journal.pone.0235417	http://dx.doi.org/10.1371/journal.pone.0235417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584894	gold, Green Published			2022-12-27	WOS:000545747200018
J	Zhang, YK; Zhang, YY; Sholle, E; Abedian, S; Sharko, M; Turchioe, MR; Wu, YY; Ancker, JS				Zhang, Yongkang; Zhang, Yiye; Sholle, Evan; Abedian, Sajjad; Sharko, Marianne; Turchioe, Meghan Reading; Wu, Yiyuan; Ancker, Jessica S.			Assessing the impact of social determinants of health on predictive models for potentially avoidable 30-day readmission or death	PLOS ONE			English	Article							HOSPITAL READMISSIONS; SOCIOECONOMIC-STATUS; RISK; DISABILITY; SCORE; VALIDATION; ETHNICITY; MORTALITY; OBESITY; RACE	Objectives Early hospital readmissions or deaths are key healthcare quality measures in pay-for-performance programs. Predictive models could identify patients at higher risk of readmission or death and target interventions. However, existing models usually do not incorporate social determinants of health (SDH) information, although this information is of great importance to address health disparities related to social risk factors. The objective of this study is to examine the impact of social determinants of health on predictive models for potentially avoidable 30-day readmission. Methods We extracted electronic health record data for 19,941 hospital admissions between January 2015 and November 2017 at an academic medical center in New York City. We applied the Simplified HOSPITAL score model to predict potentially avoidable 30-day readmission or death and examined if incorporating individual- and community-level SDH could improve the prediction using cross-validation. We calculated the C-statistic for discrimination, Brier score for accuracy, and Hosmer-Lemeshow test for calibration for each model using logistic regression. Analysis was conducted for all patients and three subgroups that may be disproportionately affected by social risk factors, namely Medicaid patients, patients who are 65 or older, and obese patients. Results The Simplified HOSPITAL score model achieved similar performance in our sample compared to previous studies. Adding SDH did not improve the prediction among all patients. However, adding individual- and community-level SDH at the US census tract level significantly improved the prediction for all three subgroups. Specifically, C-statistics improved from 0.70 to 0.73 for Medicaid patients, from 0.66 to 0.68 for patients 65 or older, and from 0.70 to 0.73 for obese patients. Conclusions Patients from certain subgroups may be more likely to be affected by social risk factors. Incorporating SDH into predictive models may be helpful to identify these patients and reduce health disparities associated with vulnerable social conditions.	[Zhang, Yongkang; Zhang, Yiye; Sharko, Marianne; Turchioe, Meghan Reading; Wu, Yiyuan; Ancker, Jessica S.] Weill Cornell Med Coll, Dept Populat Hlth Sci, New York, NY 10065 USA; [Sholle, Evan; Abedian, Sajjad] Weill Cornell Med, Informat Technol & Serv Dept, New York, NY USA	Cornell University; Cornell University	Zhang, YK (corresponding author), Weill Cornell Med Coll, Dept Populat Hlth Sci, New York, NY 10065 USA.	yoz2009@med.cornell.edu	Sharko, Marianne/AAU-6812-2021; Zhang, Yongkang/AAV-6930-2020	Zhang, Yongkang/0000-0001-6312-9686; Abedian, Sajjad/0000-0002-0411-5185; Reading Turchioe, Meghan/0000-0002-6264-6320	Weill Cornell Medicine Dean's Diversity and Healthcare Disparities Award; Weill Cornell Clinical and Translational Science Center (CTSC) [UL1 TR000457]; Center for Transportation, Environment, and Community Health New Research Initiatives Fund; Patient-Centered Outcomes Research Institute Health Systems Demonstration Project [HSD-1604-35187]; National Institute on Aging [K99AG064030]; U.S. Department of Transportation's University Transportation Centers Program	Weill Cornell Medicine Dean's Diversity and Healthcare Disparities Award; Weill Cornell Clinical and Translational Science Center (CTSC); Center for Transportation, Environment, and Community Health New Research Initiatives Fund; Patient-Centered Outcomes Research Institute Health Systems Demonstration Project; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); U.S. Department of Transportation's University Transportation Centers Program	This study received support from the following sources: 1. Weill Cornell Medicine Dean's Diversity and Healthcare Disparities Award (Co-PIs: Ancker and Yiye Zhang): https://cpb-us-e1.wpmucdn.com/blogs.cornell.edu/dist/5/7827/files/2017/12/2019-Deans-Diversity-and-HealthcareDisparity-Research-Awards-RFP-12v3kjn.pdf 2. Weill Cornell Clinical and Translational Science Center (CTSC) (UL1 TR000457, PI: Julianne Imperato-McGinley) https://ctscweb.weill.cornell.edu/3.Center for Transportation, Environment, and Community Health New Research Initiatives Fund (PI: Yiye Zhang): https://ctech.cee.cornell.edu/4.The Patient-Centered Outcomes Research Institute Health Systems Demonstration Project (HSD-1604-35187, PI: Kaushal, Yongkang Zhang was supported by this grant). https://www.pcori.org/research-results/2016/identifying-andpredicting-patients-preventable-high-utilization 5. National Institute on Aging (Grant no. K99AG064030, PI: Yongkang Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this report reflect the views of the authors, who are responsible for the facts and the accuracy of the information presented herein. This document is disseminated in the interest of information exchange. The report is funded, partially or entirely, by a grant from the U.S. Department of Transportation's University Transportation Centers Program. However, the U.S. Government assumes no liability for the contents or use thereof.	[Anonymous], 2018, VOX             0919; [Anonymous], 2016, CHILD NEUROPSYCHOL, V13, P1; Aubert CE, 2017, BMJ QUAL SAF, V26, P799, DOI 10.1136/bmjqs-2016-006239; Basu J, 2018, INQUIRY-J HEALTH CAR, V55, DOI 10.1177/0046958018774180; Brennan N, 2014, HEALTH AFFAIR, V33, P1195, DOI 10.1377/hlthaff.2014.0130; Burke RE, 2017, MED CARE, V55, P285, DOI 10.1097/MLR.0000000000000665; Bynum J, 2018, JAMA INTERN MED, V178, P1507, DOI 10.1001/jamainternmed.2018.4142; Cantor MN, 2018, HEALTH AFFAIR, V37, P585, DOI 10.1377/hlthaff.2017.1252; Cantor MN, 2018, J AM MED INFORM ASSN, V25, P419, DOI 10.1093/jamia/ocx117; Centers for Disease Control and Prevention, 2018, ATL CDCS SOC VULN IN; Centers for Medicare and Medicaid Services, 2019, BALT COMM BAS CAR TR; Centers for Medicare and Medicaid Services, 2019, BALT HOSP READM RED; Centers for Medicare and Medicaid Services, 2017, BALT 30 DAY ALL CAUS; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; City of New York, 2017, NEW YORK NEW YORK CI; Cockerham WC, 2017, AM J PREV MED, V52, pS5, DOI 10.1016/j.amepre.2016.09.010; Daniel H, 2018, ANN INTERN MED, V168, P577, DOI 10.7326/M17-2441; Daniel-Robinson L., 2019, INNOVATION OPPORTUNI; Donze J, 2013, JAMA INTERN MED, V173, P632, DOI 10.1001/jamainternmed.2013.3023; Donze JD, 2016, JAMA INTERN MED, V176, P496, DOI 10.1001/jamainternmed.2015.8462; Eapen ZJ, 2013, JACC-HEART FAIL, V1, P245, DOI 10.1016/j.jchf.2013.01.008; Feigenbaum P, 2012, MED CARE, V50, P599, DOI 10.1097/MLR.0b013e318249ce72; Fothergill A, 1999, DISASTERS, V23, P156, DOI 10.1111/1467-7717.00111; Froehlich-Grobe K, 2011, AM J PREV MED, V41, P541, DOI 10.1016/j.amepre.2011.07.015; Glance LG, 2016, ANN SURG, V263, P698, DOI 10.1097/SLA.0000000000001363; Hair R. L., 2010, MULTIVARIATE DATA AN, V7th; Herrin J, 2015, HEALTH SERV RES, V50, P20, DOI 10.1111/1475-6773.12177; Hu JH, 2018, AM J MED QUAL, V33, P493, DOI 10.1177/1062860617753063; Jencks SF, 2019, ANN INTERN MED, V171, P91, DOI 10.7326/M16-2671; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Karliner LS, 2012, MED CARE, V50, P283, DOI 10.1097/MLR.0b013e318249c949; Kasthurirathne SN, 2018, J AM MED INFORM ASSN, V25, P47, DOI 10.1093/jamia/ocx130; Kaushal R, 2014, J AM MED INFORM ASSN, V21, P587, DOI 10.1136/amiajnl-2014-002764; Kind AJH, 2014, ANN INTERN MED, V161, P765, DOI 10.7326/M13-2946; Kripalani S, 2014, ANNU REV MED, V65, P471, DOI 10.1146/annurev-med-022613-090415; Krumholz HM, 2014, ANN INTERN MED, V161, P833, DOI 10.7326/M14-2308; Kwok CS, 2018, AM J CARDIOL, V121, P810, DOI 10.1016/j.amjcard.2017.12.032; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; Leppin AL, 2014, JAMA INTERN MED, V174, P1095, DOI 10.1001/jamainternmed.2014.1608; Lu MLR, 2016, INT J CARDIOL, V222, P313, DOI 10.1016/j.ijcard.2016.07.185; Maddox KEJ, 2019, HEALTH SERV RES, V54, P327, DOI 10.1111/1475-6773.13133; Manatt PP, 2019, MED ROLE ADDRESSING; McClellan M.B., 2014, ADOPTING ACCOUNTABLE; Meddings J, 2017, J GEN INTERN MED, V32, P71, DOI 10.1007/s11606-016-3869-x; Nagasako EM, 2014, HEALTH AFFAIR, V33, P786, DOI 10.1377/hlthaff.2013.1148; *NAT AC SCI ENG ME, 2017, ACC SOC RISK FACT ME; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Nguyen TN, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071244; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Roberts ET, 2018, JAMA INTERN MED, V178, P1498, DOI 10.1001/jamainternmed.2018.4481; Sholle ET, 2018, AMIA ANN S P, V2017, P1581; Sholle ET, 2019, J AM MED INFORM ASSN, V26, P722, DOI 10.1093/jamia/ocz040; Silow-Carroll S., 2011, REDUCING HOSP READMI; United States Census Bureau, 2019, SUITL GLOSS; United States Census Bureau, 2020, SUITL AM COMM SURV; United States Department of Agriculture USEPA, 2019, WASH FOOD ACC RES AT; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; Vincent HK, 2010, OBES REV, V11, P568, DOI 10.1111/j.1467-789X.2009.00703.x; Zhou HQ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011060	59	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235064	10.1371/journal.pone.0235064	http://dx.doi.org/10.1371/journal.pone.0235064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584879	gold, Green Published			2022-12-27	WOS:000545747200036
J	Akalu, TY; Gebremichael, B; Desta, KW; Aynalem, YA; Shiferaw, WS; Alamneh, YM				Akalu, Tadesse Yirga; Gebremichael, Bereket; Desta, Kalkidan Wondwossen; Aynalem, Yared Asmare; Shiferaw, Wondimeneh Shibabaw; Alamneh, Yoseph Merkeb			Predictors of neonatal sepsis in public referral hospitals, Northwest Ethiopia: A case control study	PLOS ONE			English	Article							RISK-FACTORS	Background Despite remarkable progress in the reduction of death in under-five children, neonatal mortality has shown little or no concomitant reduction globally. It is also one of the most common causes of neonatal death in Ethiopia. Little is known on predictors of neonatal sepsis. Risk based screening and commencement of treatment appreciably reduces neonatal death and illness. Therefore, the main aim of this study was to identify predictors of neonatal sepsis in public referral hospitals of Northwest Ethiopia. Methods Institutional based unmatched case-control study was conducted among a total of 231 neonates in Debre Markos and Felege Hiwot referral hospitals from March 2018- April 2018. Neonates who fulfill the preseted criteria for sepsis were considered as cases and neonates diagnosed with other medical reasons except sepsis were controls. For each case, two consecutive controls were selected by simple random sampling method. Data were collected using structured pretested questionnaire through a face to face interview with index mothers and by reviewing neonatal record using checklist. The collected data were entered into Epi data version 3.1 and exported to STATA/ SE software version 14. Binary and multivariable logistic regression analyses were employed. Statistical significance was declared at PResult Multivariable logistic regression analysis showed that, duration of rupture of membrane >= 18hours was significantly associated with sepsis (AOR = 10.4, 95%CI = 2.3-46.5). The other independent predictors of neonatal sepsis were number of maternal antenatal care service <= 3 (AOR = 4.4, 95%CI = 1.7-11.5), meconium stained amniotic fluid (AOR = 3.9, 95%CI = 1.5-9.8), urinary tract infection during pregnancy (AOR = 10.8, 95% CI = 3.4-33.9), intranatal fever (AOR = 3.2, 95% CI = 1.1-9.5), first minute APGAR score <7 (AOR = 3.2, 95% CI = 1.3-7.7), resuscitation at birth (AOR = 5.4, 95% CI = 1.9-15.5), nasogastric tube insertion (AOR = 3.7, 95% CI = 1.4-10.2). Conclusion Neonatal invasive procedures, ANC follow up during pregnancy, different conditions during birth like meconium stained amniotic fluid, low APGAR score and resuscitation at birth were the independent predictors of neonatal sepsis.	[Akalu, Tadesse Yirga] Debre Markos Univ, Coll Hlth Sci, Debre Markos, Ethiopia; [Gebremichael, Bereket; Desta, Kalkidan Wondwossen] Addis Ababa Univ, Coll Hlth Sci, Addis Ababa, Ethiopia; [Aynalem, Yared Asmare; Shiferaw, Wondimeneh Shibabaw] Debre Berihan Univ, Coll Hlth Sci, Debre Berihan, Ethiopia; [Alamneh, Yoseph Merkeb] Debre Markos Univ, Scool Med, Debre Markos, Ethiopia	Addis Ababa University	Akalu, TY (corresponding author), Debre Markos Univ, Coll Hlth Sci, Debre Markos, Ethiopia.	tadesseyirga680@gmail.com	shiferaw, wondimeneh/ABB-2928-2020; Alamneh, Yoseph Merkeb/AAQ-6706-2020	shiferaw, wondimeneh/0000-0003-4348-591X; Alamneh, Yoseph M./0000-0001-7612-4809; Desta, Kalkidan Wondwossen/0000-0002-3508-1272; Yirga, Tadesse/0000-0002-5475-6183	Addis Ababa University	Addis Ababa University	First of all, our special thanks & deepest gratitude goes to Addis Ababa University for financial support to undertake this research work. We would also like to extend our heartfelt thanks for the study participants, data collectors and supervisor who participated in the study. We are also thankful for administrators of Hospitals, and head nurses of NICU in the respective Hospitals.	Alam MM, 2014, J INFECT DEV COUNTR, V8, P67, DOI 10.3855/jidc.3136; [Anonymous], 2016, J LARGE SCALE RES FA, V2, pA49; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2014, CANC DISCOV, V4, pOF1; [Anonymous], 2017, DRUG SAF UPDATE, DOI DOI 10.1186/s13104-016-2345-3; [Anonymous], 2015, AM J CLIN EXP MED, DOI [10.11648/j.ajcem.20150303.11, DOI 10.11648/j.ajcem.20150303.11]; [Anonymous], 2017, COMMUN MATH STAT, V5, P1, DOI DOI 10.1007/S40304-017-0103-Z; [Anonymous], 2010, INT J COMPUT SCI COM, V1, P23; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Central SA Ababa A Ethiopia, 2011, ETHIOPIA DEMOGRAPHIC, P1; Chan GJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0813-3; CSA Ethiopia and ICF, 2016, ETH DEM HLTH SURV 20; Drassinower D, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.12.031; Edmond K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000213; Eidelman Arthur I, 2002, J Perinatol, V22, P467, DOI 10.1038/sj.jp.7210774; Gebremedhin D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154798; Geyesus T, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0892-y; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P1, DOI 10.1002/pip.2452; Hall NF, 2002, BRIT MED J, V325, P1, DOI 10.1136/bmj.325.7354.1; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Jabiri A., 2016, TANZAN J HLTH RES, V18, P1; John Bua, 2015, BMC Res Notes, V8, P339, DOI 10.1186/s13104-015-1308-4; KA S, 2006, HDB PEDIAT; Kung YH, 2016, J MICROBIOL IMMUNOL, V49, P430, DOI 10.1016/j.jmii.2013.10.001; Leal YA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-48; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Opiyo N, 2011, ARCH DIS CHILD, V96, P1052, DOI 10.1136/adc.2010.186049; Salem Shimrit Yaniv, 2006, Archives of Gynecology and Obstetrics, V274, P198, DOI 10.1007/s00404-006-0135-1; Schrag SJ, 2012, PEDIATR INFECT DIS J, V31, P821, DOI 10.1097/INF.0b013e31825c4b5a; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Shah G S, 2006, Kathmandu Univ Med J (KUMJ), V4, P187; Stefanovic IM, 2011, BIOCHEM MEDICA, V21, P276; UNICEF, 2014, COMMITTING CHILD SUR, P1; Wilson W, 2006, MATERNAL CHILD NURSI; Wu S, 2016, IEEE T KNOWL DATA EN, V28, P2000, DOI 10.1109/TKDE.2016.2562621; 2014, REG ANESTH PAIN MED, V9; 2015, SEWAGE DISPOSAL CLOV, V15	39	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234472	10.1371/journal.pone.0234472	http://dx.doi.org/10.1371/journal.pone.0234472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579580	gold, Green Published			2022-12-27	WOS:000545646600015
J	Carvalho, C; Varela, SAM; Marques, TA; Knight, A; Vicente, L				Carvalho, Constanca; Varela, Susana A. M.; Marques, Tiago A.; Knight, Andrew; Vicente, Luis			Are in vitro and in silico approaches used appropriately for animal-based major depressive disorder research?	PLOS ONE			English	Article								The current paradigm for biomedical research and drug testing postulates thatin vitroandin silicodata inform animal studies that will subsequently inform human studies. Recent evidence points out that animal studies have made a poor contribution to current knowledge of Major Depressive Disorder, whereas the contribution ofin vitroandin silicostudies to animal studies- within this research area- is yet to be properly quantified. This quantification is important since biomedical research and drug discovery and development includes two steps of knowledge transferability and we need to evaluate the effectiveness of both in order to properly implement 3R principles (Replacement, Reduction and Refinement). Here, we used the citation tracking facility within Web of Science to locate citations of original research papers onin vitroandin silicorelated to MDD published identified in PubMed by relevant search terms. 67 publications describing target papers were located. Bothin vitroandin silicopapers are more cited by human medical papers than by animal papers. The results suggest that, at least concerning MDD research, the current two steps of knowledge transferability are not being followed, indicating a poor compliance with the 3R principles.	[Carvalho, Constanca; Vicente, Luis] Univ Lisbon, Ctr Filosofia Ciencias, Fac Ciencias, Lisbon, Portugal; [Varela, Susana A. M.] Univ Lisbon, cE3c Ctr Ecol Evolut & Environm Changes, Fac Ciencias, Lisbon, Portugal; [Marques, Tiago A.] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Scotland; [Marques, Tiago A.] Univ Lisbon, Dept Biol Anim, Ctr Estat & Aplicacoes, Fac Ciencias, Lisbon, Portugal; [Knight, Andrew] Univ Winchester, Ctr Anim Welf, Winchester, Hants, England; [Varela, Susana A. M.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Universidade de Lisboa; Universidade de Lisboa; University of St Andrews; Universidade de Lisboa; University of Winchester; Instituto Gulbenkian de Ciencia	Carvalho, C (corresponding author), Univ Lisbon, Ctr Filosofia Ciencias, Fac Ciencias, Lisbon, Portugal.	constanca.carvalho@sapo.pt	Marques, Tiago A/A-5530-2010; Marques, Tiago A./M-3253-2019; Vicente, Luis/A-7443-2013; VICENTE, LIERN/B-6112-2008; Varela, Susana A. M./M-9564-2014; Knight, Andrew/AAA-3707-2020	Marques, Tiago A/0000-0002-2581-1972; Marques, Tiago A./0000-0002-2581-1972; Vicente, Luis/0000-0002-3383-5480; VICENTE, LIERN/0000-0001-5883-9640; Varela, Susana A. M./0000-0002-9947-4024; Knight, Andrew/0000-0002-9753-6199; Carvalho, Constanca/0000-0002-6902-4241	Animalfree Research-Switzerland; Centro de Estatistica e Aplicacoes (CEAUL) through Fundacao para a Ciencia e a Tecnologia, Portugal (FCT) [UID/MAT/00006/2019]; Portuguese national funds within the Centro de Filosofia das Ciencia da Universidade de Lisboa (CFCUL) research center strategic project - Fundacao para a Ciencia e a Tecnologia (FCT) [UIDB/00678/2020]	Animalfree Research-Switzerland; Centro de Estatistica e Aplicacoes (CEAUL) through Fundacao para a Ciencia e a Tecnologia, Portugal (FCT); Portuguese national funds within the Centro de Filosofia das Ciencia da Universidade de Lisboa (CFCUL) research center strategic project - Fundacao para a Ciencia e a Tecnologia (FCT)	This study was supported by Animalfree Research-Switzerland in the form of funds awarded to CC. Centro de Estatistica e Aplicacoes (CEAUL) provided partial support to TAM, through project funding from Fundacao para a Ciencia e a Tecnologia, Portugal (FCT) (UID/MAT/00006/2019). The publication fee was financed by Portuguese national funds awarded to LV within the Centro de Filosofia das Ciencia da Universidade de Lisboa (CFCUL) research center strategic project, funded by Fundacao para a Ciencia e a Tecnologia (FCT) (UIDB/00678/2020). These funders played no role in study conception, design, data collection and analysis, manuscript authorship or the decision to submit for publication.	[Anonymous], 2014, CANC DISCOV, V4, pOF1; Carvalho C., 2019, ANIMAL EXPT WORKING, P376, DOI [10.1163/9789004391192_017, DOI 10.1163/9789004391192_017]; Carvalho C, 2019, ATLA-ALTERN LAB ANIM, V47, P128, DOI 10.1177/0261192919885578; Chirita AL, 2015, ROM J MORPHOL EMBRYO, V56, P651; Choudhuri S, 2018, TOXICOL SCI, V161, P5, DOI 10.1093/toxsci/kfx186; Garfield E., 1979, CITATION INDEXING IT, V8; Herrmann K., 2019, ANIMAL EXPT WORKING; Leenaars M, 2012, LAB ANIM-UK, V46, P24, DOI 10.1258/la.2011.011087; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Russell WMS., 1959, MED J AUSTRALIA; Taylor K, 2019, ANIMAL EXPT WORKING, P583, DOI 10.1163/9789004391192_002; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yin JY, 2020, NUCLEIC ACIDS RES, V48, pD1042, DOI 10.1093/nar/gkz779	13	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0233954	10.1371/journal.pone.0233954	http://dx.doi.org/10.1371/journal.pone.0233954			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579547	Green Published, gold			2022-12-27	WOS:000545646600026
J	Silva, ASG; Raso, TF; Costa, EA; Gomez, SYM; Martins, NRD				Silva, Aila Solimar Goncalves; Raso, Tania Freitas; Costa, Erica Azevedo; Gomez, Sandra Yuliet Marin; Martins, Nelson Rodrigo da Silva			Parrot bornavirus in naturally infected Brazilian captive parrots: Challenges in viral spread control	PLOS ONE			English	Article							PROVENTRICULAR DILATATION DISEASE; COCKATIELS NYMPHICUS-HOLLANDICUS; AVIAN BORNAVIRUS; PSITTACINE BIRDS; ABV; PATHOGENESIS; GENOTYPE	Psittaciform orthobornaviruses are currently considered to be a major threat to the psittacine bird population worldwide. Parrot bornavirus (PaBV) was identified recently in Brazil and, since then, few studies have been conducted to understand the epidemiology of PaBV in captive psittacine birds. In the present study, natural infections by PaBV in South American parrots were investigated in two breeding facilities: commercial (A) and conservationist (B). Thirty-eight psittacine of 21 different species were presented for postmortem examination. Tissue samples were collected and investigated for the presence of PaBV-RNA using RT-PCR. In addition, clinical information about these birds was used when available. PaBV infection was detected in 73.7% of all birds investigated, indicating a wide dissemination of this virus in both facilities. From birds investigated in aviary A, 66.7% showed clinical signs, 100% had typical lesions of proventricular dilatation disease (PDD), 100% had mild to severe proventricular dilatation and 88.9% were PaBV-positive. In birds from aviary B, 27.6% showed clinical signs, 65.5% had typical lesions of PDD, 62% had mild to severe proventricular dilatation and 69% were PaBV-positive. Neurological disease was observed more frequently than gastrointestinal disease. Sequencing analysis of the matrix gene fragment revealed the occurrence of genotype 4 (PaBV-4) in both places. About 15.8% of birds in this study are threatened species. We discussed the difficulties and challenges for controlling viral spread in these aviaries and implications for South American psittacine conservation. These results emphasize the urgent need to develop a national regulatory and health standard for breeding psittacine birds in the country.	[Silva, Aila Solimar Goncalves; Gomez, Sandra Yuliet Marin; Martins, Nelson Rodrigo da Silva] Univ Fed Minas Gerais, Vet Coll, Lab Avian Dis, Belo Horizonte, MG, Brazil; [Raso, Tania Freitas] Univ Sao Paulo, Sch Vet Med & Anim Sci, Avian Ecopathol Lab, Sao Paulo, Brazil; [Costa, Erica Azevedo] Univ Fed Minas Gerais, Vet Coll, Anim Virol Res Lab, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade Federal de Minas Gerais	Martins, NRD (corresponding author), Univ Fed Minas Gerais, Vet Coll, Lab Avian Dis, Belo Horizonte, MG, Brazil.	nelrosmart@gmail.com	; Freitas Raso, Tania/I-2571-2012	Costa, Erica/0000-0002-5396-3818; Freitas Raso, Tania/0000-0002-1572-5026; Silva, Aila/0000-0002-3195-9586	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Support was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AssociacAo Brasileira de Industria de Produtos para Animais de EstimacAo (ABINPET), DAD MERC; de Araujo JL, 2017, PESQUI VET BRASIL, V37, P1331, DOI [10.1590/s0100-736x2017001100022, 10.1590/S0100-736X2017001100022]; De Kloet SR, 2009, AVIAN DIS, V53, P568, DOI 10.1637/8828-040209-Reg.1; Deb A, 2008, EUROPEAN ASS ZOO WIL, P239; Donatti RV, 2014, AVIAN DIS, V58, P187, DOI 10.1637/10588-061013-Case.1; Gancz AY, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-100; Gray P, 2010, EMERG INFECT DIS, V16, P473, DOI 10.3201/eid1603.091257; Gregory Christopher R., 1994, Journal of the Association of Avian Veterinarians, V8, P69; Heffels-Redmann U, 2011, AVIAN PATHOL, V40, P419, DOI 10.1080/03079457.2011.589825; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kistler AL, 2010, J VIROL, V84, P2176, DOI 10.1128/JVI.02191-09; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Last RD, 2012, J S AFR VET ASSOC, V83, DOI 10.4102/jsava.v83i1.938; Lierz M, 2009, AVIAN PATHOL, V38, P491, DOI 10.1080/03079450903349238; Maes P, 2019, ARCH VIROL, V164, P1233, DOI 10.1007/s00705-018-04126-4; Mirhosseini N, 2011, J AVIAN MED SURG, V25, P199, DOI 10.1647/2010-030.1; Payne S, 2011, AVIAN PATHOL, V40, P15, DOI 10.1080/03079457.2010.536978; Payne Susan L, 2012, Anim Health Res Rev, V13, P145, DOI 10.1017/S1466252312000205; Philadelpho NA, 2014, VET MICROBIOL, V174, P584, DOI 10.1016/j.vetmic.2014.10.020; Piepenbring AK, 2012, EMERG INFECT DIS, V18, P234, DOI 10.3201/eid1802.111525; Raghav R, 2010, J VET DIAGN INVEST, V22, P495, DOI 10.1177/104063871002200402; Rinder M, 2009, J VIROL, V83, P5401, DOI 10.1128/JVI.00133-09; Rubbenstroth D, 2012, VET MICROBIOL, V161, P36, DOI 10.1016/j.vetmic.2012.07.004; Rubbenstroth D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160936; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tizard I, 2016, ANIM HEALTH RES REV, V17, P110, DOI 10.1017/S1466252316000189; Weissenbock H, 2009, EMERG INFECT DIS, V15, P1453, DOI 10.3201/eid1509.090353	31	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0232342	10.1371/journal.pone.0232342	http://dx.doi.org/10.1371/journal.pone.0232342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579594	gold, Green Published			2022-12-27	WOS:000545646600035
J	Sumasgutner, P; Jenkins, A; Amar, A; Altwegg, R				Sumasgutner, Petra; Jenkins, Andrew; Amar, Arjun; Altwegg, Res			Nest boxes buffer the effects of climate on breeding performance in an African urban raptor	PLOS ONE			English	Article							SPARROWHAWKS ACCIPITER-MELANOLEUCUS; KESTREL FALCO-TINNUNCULUS; HOME-RANGE SIZE; PEREGRINE FALCONS; SEASONAL PATTERNS; CAPE PENINSULA; LANNER FALCONS; HABITAT USE; SPACE USE; SUCCESS	As the world's human population increases, transformation of natural landscapes into urban habitats continues to increase. In Africa, rates of human population growth and urbanisation are among the highest in the world, but the impacts of these processes on the continent's biodiversity remain largely unexplored. Furthermore, the effects of ongoing anthropogenic climate change are likely to be severe and to interact with urbanisation. Some organisms appear resilient to urbanisation, and even proliferate in human-modified environments. One such species is the peregrine falconFalco peregrinusin Cape Town, South Africa. Using a long-term data set (1989-2014), we investigate the relationship between breeding attempts, timing of breeding and breeding performance under varying weather conditions. Exploring these issues along an urbanisation gradient, we focus on the role of artificially provided nest boxes, and their capacity to buffer against extreme weather events. Pairs in more urbanised areas, and particularly those in nest boxes, were more likely to breed and to commence breeding earlier. Additionally, pairs using nest boxes were more likely to breed in years with higher rainfall. Warm and dry weather conditions generally advanced the timing of breeding, although this relationship with weather was not seen for urban pairs using nest boxes. Furthermore, weather did not impact breeding performance directly (breeding success and fledged brood size), but timing of breeding did, with earlier breeders producing more fledglings. Our study shows that falcons breeding in specially provided nest boxes were less sensitive to local weather dynamics than pairs using more natural nest sites. This has important implications as it suggests that the managed provision of such nesting sites can help this key urban species to cope with extreme weather events, which are predicted to increase with climate change.	[Sumasgutner, Petra; Jenkins, Andrew; Amar, Arjun] Univ Cape Town, FitzPatrick Inst African Ornithol FIAO, DST NRF Ctr Excellence, Cape Town, South Africa; [Sumasgutner, Petra; Jenkins, Andrew; Altwegg, Res] Univ Cape Town, Dept Stat Sci, Stat Ecol Evolut & Conservat SEEC, Cape Town, South Africa; [Sumasgutner, Petra] Univ Vienna, Konrad Lorenz Res Ctr KLF, Core Facil Behav & Cognit, Grunau Almtal, Austria	National Research Foundation - South Africa; University of Cape Town; University of Cape Town; University of Vienna	Sumasgutner, P (corresponding author), Univ Cape Town, FitzPatrick Inst African Ornithol FIAO, DST NRF Ctr Excellence, Cape Town, South Africa.; Sumasgutner, P (corresponding author), Univ Cape Town, Dept Stat Sci, Stat Ecol Evolut & Conservat SEEC, Cape Town, South Africa.; Sumasgutner, P (corresponding author), Univ Vienna, Konrad Lorenz Res Ctr KLF, Core Facil Behav & Cognit, Grunau Almtal, Austria.	petra.sumasgutner@univie.ac.at		Sumasgutner, Petra/0000-0001-7042-3461	AVISENSE Consulting; South Africa (NRF)/Sweden (STINT) science and technology research collaboration [STINT 160909188048]; Raptor Research Foundation; Steve Phelps of Peregrine Properties and BirdLife South Africa; DST-NRF Centre of Excellence; Claude Leon Foundation; Leslie Brown Memorial Grant of the Raptor Research Foundation; National Research Foundation of South Africa [85802, 119125]	AVISENSE Consulting; South Africa (NRF)/Sweden (STINT) science and technology research collaboration; Raptor Research Foundation; Steve Phelps of Peregrine Properties and BirdLife South Africa; DST-NRF Centre of Excellence(Department of Science & Technology (India)); Claude Leon Foundation; Leslie Brown Memorial Grant of the Raptor Research Foundation; National Research Foundation of South Africa(National Research Foundation - South Africa)	The peregrine project was funded by AVISENSE Consulting (https://www.avisense.co.za/).Open access funding was provided by a South Africa (NRF)/Sweden (STINT) science and technology research collaboration (Grant no. STINT 160909188048). AJ: Leslie Brown Memorial Grant of the Raptor Research Foundation (https://www.raptorresearchfoundation.org/), Steve Phelps of Peregrine Properties and BirdLife South Africa. PS: DST-NRF Centre of Excellence, the Claude Leon Foundation (https://www.leonfoundation.co.za/) and the Leslie Brown Memorial Grant of the Raptor Research Foundation. RA: National Research Foundation of South Africa (https://www.nrf.ac.za/grant numbers 85802 and 119125). The funders provided support in the form of salaries for the author AJ, and a post-doc bursary for PS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Altwegg R, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P299; Altwegg R, 2014, IBIS, V156, P107, DOI 10.1111/ibi.12125; Amar A, 2012, BIOL CONSERV, V145, P86, DOI 10.1016/j.biocon.2011.10.014; Anctil A, 2014, OECOLOGIA, V174, P1033, DOI 10.1007/s00442-013-2800-y; [Anonymous], 1982, Prog Clin Biol Res, V108, P1; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Atkins A, 2017, J WILDLIFE MANAGE, V81, P610, DOI 10.1002/jwmg.21227; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bivand R., 2017, R PACKAGE VERSION 1; Bivand R.S., 2013, APPL SPATIAL DATA AN, DOI 10.1007/978-1-4614-7618-4; Boggie MA, 2014, LANDSCAPE URBAN PLAN, V124, P34, DOI 10.1016/j.landurbplan.2014.01.001; BORTOLOTTI GR, 1994, J RAPTOR RES, V28, P127; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Bradley M, 1997, AUK, V114, P786, DOI 10.2307/4089303; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Charter M, 2007, J RAPTOR RES, V41, P143, DOI 10.3356/0892-1016(2007)41[143:TEODNT]2.0.CO;2; Charter M, 2007, J RAPTOR RES, V41, P139, DOI 10.3356/0892-1016(2007)41[139:BSOTEK]2.0.CO;2; Cunningham SJ, 2016, DIVERS DISTRIB, V22, P17, DOI 10.1111/ddi.12381; Cunningham SJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080036, 10.1371/journal.pone.0082492]; DEA, 2011, S AFR 2 NAT COMM UN; Diamond SE, 2014, ECOLOGY, V95, P2613, DOI 10.1890/13-1848.1; Dixon Andrew, 2008, Falco (Carmarthen), V32, P8; DRENT RH, 1980, ARDEA, V68, P225; Drewitt Edward J. A., 2008, British Birds, V101, P58; Dunn Peter O., 2010, P113; Dykstra C.R., 2018, URBAN RAPTORS ECOLOG, P110, DOI [10.5822/978-1-61091-841-1_8, DOI 10.5822/978-1-61091-841-1_8]; Dykstra CR, 2001, WILSON BULL, V113, P308, DOI 10.1676/0043-5643(2001)113[0308:HRAHUO]2.0.CO;2; Engelbrecht FA, 2009, INT J CLIMATOL, V29, P1013, DOI 10.1002/joc.1742; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Ferrer M, 2015, IBIS, V157, P849, DOI 10.1111/ibi.12289; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Fox J., 2019, R COMPANION APPL REG; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Gahbauer MA, 2015, J WILDLIFE MANAGE, V79, P10, DOI 10.1002/jwmg.803; Gruebler MU, 2010, J AVIAN BIOL, V41, P282, DOI 10.1111/j.1600-048X.2009.04865.x; Guneralp B, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014025; Harriman VB, 2017, ECOL EVOL, V7, P2122, DOI 10.1002/ece3.2815; Hastie TJ, 2019, R PACKAGE VERSION 1; Hendry AP, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0028; Heuck C, 2017, IBIS, V159, P297, DOI 10.1111/ibi.12444; Hijmans R. J., 2016, R PACKAGE VERSION, V2, P5; Huchler K, FRONTIERS ECOLOGY EV; Imhoff ML, 2010, REMOTE SENS ENVIRON, V114, P504, DOI 10.1016/j.rse.2009.10.008; Jenkins AR, 1999, J RAPTOR RES, V33, P190; Jenkins AR, 2000, ARDEA, V88, P17; Jenkins AR, 2005, OSTRICH, V76, P175, DOI 10.2989/00306520509485490; Jenkins AR, 1998, J RAPTOR RES, V32, P90; Jenkins AR, 2000, OSTRICH, V71, P385, DOI 10.1080/00306525.2000.9639837; Jokimaki J, 2018, LANDSCAPE URBAN PLAN, V178, P73, DOI 10.1016/j.landurbplan.2018.05.020; Kettel EF, 2019, URBAN ECOSYST, V22, P117, DOI 10.1007/s11252-018-0799-x; Kettel EF, 2018, J ORNITHOL, V159, P1, DOI 10.1007/s10336-017-1497-9; Kreiderits A, 2016, BIRD STUDY, V63, P369, DOI 10.1080/00063657.2016.1213791; Kruger AC, 2013, INT J CLIMATOL, V33, P661, DOI 10.1002/joc.3455; Lamarre V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26131-y; Lambrechts M, 2012, J ORNITHOL, V153, P23, DOI 10.1007/s10336-011-0720-3; Mainwaring MC, 2015, J NAT CONSERV, V25, P17, DOI 10.1016/j.jnc.2015.02.007; Martin RO, 2014, OIKOS, V123, P1457, DOI 10.1111/oik.01058; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; McPherson S, SURVIVING URBAN JUNG; McPherson SC, 2019, J RAPTOR RES, V53, P180, DOI 10.3356/JRR-17-83; MEARNS R, 1988, J ANIM ECOL, V57, P903, DOI 10.2307/5100; Mueller R, 2020, CONDOR, DOI [10.1093/condor/duaa009, DOI 10.1093/CONDOR/DUAA009]; Murgatroyd M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09044-w; Murgatroyd M, 2016, CONDOR, V118, P238, DOI 10.1650/CONDOR-15-142.1; Newton I, 1979, POPULATION ECOLOGY R, P321; OLSEN PD, 1989, EMU, V89, P1, DOI 10.1071/MU9890001; Pagel JE, 2018, URBAN RAPTORS ECOLOG, P180, DOI [10.5822/978-1-61091-841-1_13, DOI 10.5822/978-1-61091-841-1_13]; Pebesma E. J., 2005, R NEWS, V5, P9; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; Pinheiro J., 2020, PACKAGE NLME LINEAR, DOI DOI 10.1016/S0006-3207(01)00201-4; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; R Development Core Team, 2009, R LANG ENV STAT COMP; Ratcliffe D.A., 1993, PEREGRINE FALCON; Renner SS, 2018, ANNU REV ECOL EVOL S, V49, P165, DOI 10.1146/annurev-ecolsys-110617-062535; Revi A, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P535; Reynolds JS, 2019, J ORNITHOL, DOI [10.1007/s10336-019-01638-x, DOI 10.1007/S10336-019-01638-X]; Riegert J, 2010, POPUL ECOL, V52, P73, DOI 10.1007/s10144-009-0168-y; Ritchie EG, 2012, TRENDS ECOL EVOL, V27, P265, DOI 10.1016/j.tree.2012.01.001; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Robinson BG, 2017, J AVIAN BIOL, V48, P748, DOI 10.1111/jav.01130; Rose S, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00047; Rutz C, 2008, J ANIM ECOL, V77, P1008, DOI 10.1111/j.1365-2656.2008.01420.x; Rutz C, 2006, ARDEA, V94, P185; Salo P, 2008, J ANIM ECOL, V77, P1092, DOI 10.1111/j.1365-2656.2008.01430.x; Sarkar D, 2008, USE R, P1; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Stofberg M, INFLUENCE HEAT STRES; Streutker DR, 2003, REMOTE SENS ENVIRON, V85, P282, DOI 10.1016/S0034-4257(03)00007-5; Sumasgutner P, 2014, THESIS; Sumasgutner P, 2016, BIRD STUDY, V63, P430, DOI 10.1080/00063657.2016.1214814; Sumasgutner P, 2016, J ANIM ECOL, V85, P1043, DOI 10.1111/1365-2656.12518; Sumasgutner P, 2014, LANDSCAPE URBAN PLAN, V127, P94, DOI 10.1016/j.landurbplan.2014.03.009; Sumasgutner P, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-48; Suri J, 2017, IBIS, V159, P38, DOI 10.1111/ibi.12422; Treinys R, 2017, IBIS, V159, P343, DOI 10.1111/ibi.12454; United Nations Department of Economic and Social Affairs Population Division, 2019, WORLD URB PROSP 2018; United-Nations-Secretariat, 2015, WORLD URB PROSP 2014; Venables W.N., 2002, MODERN APPL STAT S, VFourth; Venu P, 2018, ASSESSMENT PEREGRINE; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zohner CM, 2019, NAT ECOL EVOL, V3, P1618, DOI 10.1038/s41559-019-1043-7	108	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234503	10.1371/journal.pone.0234503	http://dx.doi.org/10.1371/journal.pone.0234503			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579609	Green Published, gold			2022-12-27	WOS:000545646600057
J	Valdes, A; Castro-Puyana, M; Garcia-Pastor, C; Lucio-Cazana, FJ; Marina, ML				Valdes, Alberto; Castro-Puyana, Maria; Garcia-Pastor, Coral; Lucio-Cazana, Francisco J.; Marina, Maria Luisa			Time-series proteomic study of the response of HK-2 cells to hyperglycemic, hypoxic diabetic-like milieu	PLOS ONE			English	Article							PROXIMAL TUBULAR CELLS; HIGH GLUCOSE; MITOCHONDRIAL DYSFUNCTION; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; APOPTOSIS; KIDNEY; PROTEIN; ACTIVATION; EXPRESSION	During diabetes, renal proximal tubular cells (PTC) are exposed to a combination of high glucose and hypoxic conditions, which plays a relevant role in the development of diabetic kidney disease (DKD). In this work, a time-series proteomic study was performed to analyse the effect of a diabetic-like microenvironment induced changes on HK-2 cells, a human cell line derived from normal proximal tubular epithelial cells. Cells simultaneously exposed to high glucose (25 mM) and hypoxia (1% O-2) were compared to cells in control conditions for up to 48 h. Diabetic conditions increased the percentage of death cells after 24 and 48 h, but no differences in the protein/cell ratio were found. The relative protein quantification using dimethyl-labeling and UHPLC-MS/MS analysis allowed the identification of 317, 296 and 259 proteins at 5, 24 and 48 h, respectively. The combination of statistical and time expression profile analyses indicated an increased expression of proteins involved in glycolysis, and a decrease of cytoskeletal-related proteins. The exposure of HK-2 cells to high glucose and hypoxia reproduces some of the effects of diabetes on PTC and, with the limitations inherent toin vitrostudies, propose new mechanisms and targets to be considered in the management of DKD.	[Valdes, Alberto; Castro-Puyana, Maria; Marina, Maria Luisa] Univ Alcala, Dept Quim Analit Quim Fis & Ingn Quim, Madrid, Spain; [Castro-Puyana, Maria; Marina, Maria Luisa] Univ Alcala, Inst Invest Quim Andres M del Rio, IQAR, Madrid, Spain; [Garcia-Pastor, Coral; Lucio-Cazana, Francisco J.] Univ Alcala, Dept Biol Sistemas, Madrid, Spain	Universidad de Alcala; Universidad de Alcala; Universidad de Alcala	Marina, ML (corresponding author), Univ Alcala, Dept Quim Analit Quim Fis & Ingn Quim, Madrid, Spain.; Marina, ML (corresponding author), Univ Alcala, Inst Invest Quim Andres M del Rio, IQAR, Madrid, Spain.	mluisa.marina@uah.es	Valdés, Alberto/C-3454-2019; Castro-Puyana, Maria/A-3359-2014; Marina Alegre, Maria Luisa/F-3485-2016	Valdés, Alberto/0000-0002-7901-5816; Lucio-Cazana, Francisco-Javier/0000-0001-9249-8501; Castro-Puyana, Maria/0000-0003-1412-4103; Marina Alegre, Maria Luisa/0000-0002-5583-1624	Spanish Ministry of Economy and Competitiveness [CTQ2016-76368-P, SAF201453218-R, FJCI-2016-30741, RYC2013-12688]; Comunidad of Madrid (Spain); FSE European program [S2018/BAA-4393 -AVANSECAL-II-CM, B2017/BMD3686]; FEDER European program [S2018/BAA-4393 -AVANSECAL-II-CM, B2017/BMD3686]; University of Alcala	Spanish Ministry of Economy and Competitiveness(Spanish Government); Comunidad of Madrid (Spain)(Comunidad de Madrid); FSE European program; FEDER European program(European Commission); University of Alcala	This work was supported by the Spanish Ministry of Economy and Competitiveness (CTQ2016-76368-P to MLM and MC, SAF201453218-R to FJL, FJCI-2016-30741 to AV, and RYC2013-12688 to MC), by the Comunidad of Madrid (Spain) and the FSE and FEDER European programs (S2018/BAA-4393 -AVANSECAL-II-CM to MLM and B2017/BMD3686 to FJL), and by the University of Alcala '. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Altelaar AFM, 2013, NAT REV GENET, V14, P35, DOI 10.1038/nrg3356; [Anonymous], 2010, CURR PROTOC PROTEIN; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Belletti B, 2011, EXPERT OPIN THER TAR, V15, P1249, DOI 10.1517/14728222.2011.620951; Bera A, 2017, AM J PHYSIOL-CELL PH, V313, pC430, DOI 10.1152/ajpcell.00081.2017; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Brezniceanu ML, 2008, DIABETES, V57, P451, DOI 10.2337/db07-0013; Chebotareva N, 2017, CELL STRESS CHAPERON, V22, P319, DOI 10.1007/s12192-017-0790-0; Chevrollier A, 2011, BBA-BIOENERGETICS, V1807, P562, DOI 10.1016/j.bbabio.2010.10.008; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Czajka A, 2016, REDOX BIOL, V10, P100, DOI 10.1016/j.redox.2016.09.007; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; DICKMAN KG, 1989, AM J PHYSIOL, V257, pC333, DOI 10.1152/ajpcell.1989.257.2.C333; ELHAMRI M, 1993, RENAL PHYSIOL BIOCH, V16, P311; Fan Y, 2019, DIABETES, V68, P2301, DOI 10.2337/db19-0204; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Gallicchio MA, 2013, BBA-MOL CELL RES, V1833, P2922, DOI 10.1016/j.bbamcr.2013.05.024; Garcia-Pastor C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52310-6; Gilbert RE, 2017, DIABETES, V66, P791, DOI 10.2337/db16-0796; Gu HF, 2013, DIABETES CARE, V36, P415, DOI 10.2337/dc12-1125; Guan SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep14561; GUDER WG, 1986, KIDNEY INT, V29, P41, DOI 10.1038/ki.1986.6; Guo CC, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01433; Higgins GC, 2014, BRIT J PHARMACOL, V171, P1917, DOI 10.1111/bph.12503; Huang YF, 2016, EUR REV MED PHARMACO, V20, P4055; Iori E, 2008, BBA-MOL BASIS DIS, V1782, P627, DOI 10.1016/j.bbadis.2008.08.012; Isoe T, 2010, KIDNEY INT, V78, P48, DOI 10.1038/ki.2010.99; Kumar D, 2004, NEPHRON EXP NEPHROL, V96, pE77, DOI 10.1159/000076749; Kumar D, 2004, MOL CELL BIOCHEM, V259, P67, DOI 10.1023/B:MCBI.0000021346.03260.7e; Kumar N, 2018, HYPERTENSION, V71, P1133, DOI 10.1161/HYPERTENSIONAHA.118.10952; Kuwagata S, 2016, KIDNEY INT, V90, P1211, DOI 10.1016/j.kint.2016.06.036; Lenco J, 2018, ANAL CHEM, V90, P5381, DOI 10.1021/acs.analchem.8b00525; Li L, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-02170-5; Li M, 2010, AM J NEPHROL, V32, P522, DOI 10.1159/000321491; Liu T, 2019, FASEB J, V33, P1565, DOI 10.1096/fj.201701355RR; Lopez-Sanz L, 2018, LAB INVEST, V98, P1276, DOI 10.1038/s41374-018-0043-6; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Magri CJ, 2009, EUR J INTERN MED, V20, P551, DOI 10.1016/j.ejim.2008.12.012; MANDEL LJ, 1985, ANNU REV PHYSIOL, V47, P85; Mimura I, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13203; Munusamy S, 2009, FREE RADICAL BIO MED, V46, P1149, DOI 10.1016/j.freeradbiomed.2009.01.022; MUNYON WH, 1959, EXP CELL RES, V17, P490, DOI 10.1016/0014-4827(59)90069-2; Nordquist L, 2015, J AM SOC NEPHROL, V26, P328, DOI 10.1681/ASN.2013090990; Ohtomo S, 2008, NEPHROL DIAL TRANSPL, V23, P1166, DOI 10.1093/ndt/gfm715; Parrish AR, 2016, PHARMACOL THERAPEUT, V166, P1, DOI 10.1016/j.pharmthera.2016.06.006; Pavlacky J, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00057; Persson P, 2017, CURR OPIN NEPHROL HY, V26, P345, DOI 10.1097/MNH.0000000000000341; Qi W, 2017, NAT MED, V23, P753, DOI 10.1038/nm.4328; Rosenberger C, 2008, KIDNEY INT, V73, P34, DOI 10.1038/sj.ki.5002567; Sabatier P, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800118; Sanchez-Romero N, 2016, EUR J PHARMACOL, V790, P36, DOI 10.1016/j.ejphar.2016.07.010; SANDERS MC, 1992, P NATL ACAD SCI USA, V89, P4678, DOI 10.1073/pnas.89.10.4678; Sasaki M, 2017, DIABETES, V66, P2339, DOI 10.2337/db16-1602; Slyne J, 2015, NEPHROL DIAL TRANSPL, V30, P60, DOI 10.1093/ndt/gfv264; So EJ, 2008, PROTEOM CLIN APPL, V2, P1118, DOI 10.1002/prca.200780151; SUGDEN MC, 1989, BIOCHEM J, V263, P313, DOI 10.1042/bj2630313; Sun YM, 2013, BIOCHEM BIOPH RES CO, V433, P359, DOI 10.1016/j.bbrc.2013.02.120; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Takiyama Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/837421; Tanaka T, 2003, BIOCHEM BIOPH RES CO, V309, P222, DOI 10.1016/S0006-291X(03)01557-2; Tang SCW, 2010, AM J NEPHROL, V32, P145, DOI 10.1159/000316056; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; THAYSEN JH, 1961, NATURE, V190, P919, DOI 10.1038/190919a0; Thelen S, 2015, AM J PHYSIOL-RENAL, V309, pF501, DOI 10.1152/ajprenal.00220.2014; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vallon V, 2011, COMPR PHYSIOL, V1, P1175, DOI 10.1002/cphy.c100049; Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang J, 2019, EXP THER MED, V17, P4409, DOI 10.3892/etm.2019.7495; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Yamagishi N, 2011, BIOCHEM BIOPH RES CO, V409, P90, DOI 10.1016/j.bbrc.2011.04.114; Yang ZZ, 2003, AM J PHYSIOL-RENAL, V284, pF1207, DOI 10.1152/ajprenal.00017.2002; Yuan J, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0708-1; Zager RA, 2003, AM J PHYSIOL-RENAL, V285, pF1092, DOI 10.1152/ajprenal.00187.2003; Zahedi K, 2006, AM J PHYSIOL-RENAL, V290, pF1559, DOI 10.1152/ajprenal.00424.2005; Zhang GS, 2018, SEMIN NEPHROL, V38, P111, DOI 10.1016/j.semnephrol.2018.01.002; Zhang XL, 2019, AM J TRANSL RES, V11, P669; Zhu J, 2015, AM J THER, V22, P141, DOI 10.1097/MJT.0b013e3182785ecc	81	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235118	10.1371/journal.pone.0235118	http://dx.doi.org/10.1371/journal.pone.0235118			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579601	Green Published, gold			2022-12-27	WOS:000545646600055
J	Wacker, M; Kiesswetter, V; Slottosch, I; Awad, G; Paunel-Gorgulu, A; Varghese, S; Klopfleisch, M; Kupitz, D; Klemm, D; Nietzsche, S; Petzold-Welcke, K; Kramer, F; Wippermann, J; Veluswamy, P; Scherner, M				Wacker, Max; Kiesswetter, Viktoria; Slottosch, Ingo; Awad, George; Paunel-Goerguelue, Adnana; Varghese, Sam; Klopfleisch, Maurice; Kupitz, Dennis; Klemm, Dieter; Nietzsche, Sandor; Petzold-Welcke, Katrin; Kramer, Friederike; Wippermann, Jens; Veluswamy, Priya; Scherner, Maximilian			In vitro hemo- and cytocompatibility of bacterial nanocelluose small diameter vascular grafts: Impact of fabrication and surface characteristics.	PLOS ONE			English	Article							COMPLEMENT ACTIVATION; PLATELET ACTIVATION; PROTEIN ADSORPTION; CELLULOSE; BIOMATERIAL; ROUGHNESS; TITANIUM; POLYMER; DACRON	Objective There is an increasing need for small diameter vascular grafts with superior host hemo- and cytocompatibilities, such as low activation of platelets and leukocytes. Therefore, we aimed to investigate whether the preparation of bacterial nanocellulose grafts with different inner surfaces has an impact on in vitro host cytocompatibility. Methods We have synthesized five different grafts in a bioreactor, namely open interface surface (OIS), inverted (INV), partially air dried (PAD), surface formed in air contact (SAC) and standard (STD) that were characterized by a different surface roughness. The grafts (length 55 mm, inner diameter 5 mm) were attached to heparinized polyvinyl chloride tubes, loaded with human blood and rotated at 37 degrees C for 4 hours. Then, blood was analyzed for frequencies of cellular fractions, oxidative products, soluble complement and thrombin factors. The results were compared to clinically approved grafts made of polyethylene terephthalate and expanded polytetrafluoroethylene. Additionally, blood platelets were labelled with(111)Indium-oxine to visualize the distribution of adherent platelets in the loop by scintigraphy. Results SAC nanocellulose grafts with the lowest surface roughness exhibited superior performance with 65% leukocyte and >90% thrombocyte loss. Of note, SAC nanocellulose grafts showed lowest radioactivity with scintigraphy analyses, indicating reduced platelet adhesion. Although the levels of reactive oxygen species and cell free DNA did not differ significantly, the levels of thrombin-antithrombin complexes were lowest in SAC grafts. However, all nanocellulose grafts exhibited enhanced complement activation. Conclusion The systematic variation of the inner surfaces of BNC vascular grafts significantly improves biocompatibility. Especially, SAC grafts exhibited the lowest loss of platelets as well as leukocytes and additionally significantly diminished activation of the coagulation system. Further animal studies are needed to study in vivo biocompatibilities.	[Wacker, Max; Kiesswetter, Viktoria; Slottosch, Ingo; Awad, George; Varghese, Sam; Wippermann, Jens; Veluswamy, Priya; Scherner, Maximilian] Univ Hosp Magdeburg, Dept Cardiothorac Surg, Magdeburg, Germany; [Paunel-Goerguelue, Adnana] Univ Cologne, Heart Ctr, Dept Cardiothorac Surg, Cologne, Germany; [Klopfleisch, Maurice; Kupitz, Dennis] Univ Hosp Magdeburg, Dept Nucl Med, Magdeburg, Germany; [Klemm, Dieter; Petzold-Welcke, Katrin; Kramer, Friederike] KKF Gesell UG Haftungsbeschrankt, Jena, Germany; [Nietzsche, Sandor] Univ Hosp Jena, Ctr Electron Microscopy, Jena, Germany	University Hospital Magdeburg; University of Cologne; University Hospital Magdeburg; Friedrich Schiller University of Jena	Wacker, M (corresponding author), Univ Hosp Magdeburg, Dept Cardiothorac Surg, Magdeburg, Germany.	max.wacker@med.ovgu.de	Scherner, Maximilian/ABG-5500-2020; Wacker, Max/GNH-6289-2022	Wacker, Max/0000-0003-0664-2613	Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany [KF212/2016]; BBraun-foundation [BBST-D-17-00019R1]; Koln Fortune program	Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany; BBraun-foundation; Koln Fortune program	This study was funded by the Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany (grant number KF212/2016, donated to corresponding author M.W.). The URL of the funder website is: https://medfak.unikoeln.de/19728.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Furthermore, this study was funded by the BBraun-foundation (grant number BBST-D-17-00019R1, donated to corresponding author M.W.). The URL of the funder website is: https://www.bbraunstiftung.de/de.html. The creation of our grafts is based on a scientific collaboration with Professor Klemm, a former University Professor of Chemistry of the University of Jena. Within this collaboration, Professor Klemm and his team developed a technique to create tubular nanocellulose grafts on the basis of our surgical expertise and input. After retirering from his University career, Professor started the KKF company in order to offer counselling for the use of polymer technology. Therefore, the affiliation in our manuscript is named as KKF company. However, the basis of our work is a scientific collaboration. Concerning the financial aspects, the whole funding of our project is based on research funds of the Koln Fortune program and was raised by our scientific working group (M. Wacker), as stated above. Based on this, we were able to finance the creation and the modifications of our grafts (personnel and material costs). In this context, we like to state, that the KKF company did not fund any of the described work, nor did they influence our scientific research, and KKF Jena did not have any influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nevertheless, in order to be transparent, we decided to mention the occupational affiliation of all our authors. The specific roles of these authors are articulated in the `author contributions' section. The authors declare that no competing interests exist. The BNC grafts used in this study were obtained from KKF without any restrictions regarding use and publishing of scientific results yielded with the grafts described in this study. Publishing of scientific evidence linked to the BNC grafts does not interfere with any patent held by KKF Jena.	Ermakov AV, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/649747; Esposito CJ, 2003, THROMB HAEMOSTASIS, V90, P1128, DOI 10.1160/TH03-04-0226; Falkenback D, 2000, EUR J VASC ENDOVASC, V19, P468, DOI 10.1053/ejvs.1999.1075; Fink H, 2011, J BIOMED MATER RES A, V97A, P52, DOI 10.1002/jbm.a.33031; Frank RD, 2001, KIDNEY INT, V60, P1972, DOI 10.1046/j.1523-1755.2001.00009.x; Golightly M., 2019, DIHYDRORHODAMINE DHR, VII; Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228; Gould TJ, 2015, ARTERIOSCL THROM VAS, V35, P2544, DOI 10.1161/ATVBAHA.115.306035; HECKER JF, 1985, J BIOMED MATER RES, V19, P381, DOI 10.1002/jbm.820190404; HEHRLEIN FW, 1984, J CARDIOVASC SURG, V25, P549; International Organisation for Standardisation, 2017, 109934 DIN ISO; JOHNSON RJ, 1990, PROG CLIN BIOL RES, P507; Kammerer PW, 2012, CLIN ORAL IMPLAN RES, V23, P504, DOI 10.1111/j.1600-0501.2011.02153.x; Klemm D, 2000, METHOD DEVICE PRODUC; Klemm D., 2013, Patent No. [UG DE102012201272B4, 102012201272]; Klemm D, 2018, MATER TODAY, V21, P720, DOI 10.1016/j.mattod.2018.02.001; Leitao AF, 2013, COLLOID SURFACE B, V111, P493, DOI 10.1016/j.colsurfb.2013.06.031; Lin QH, 2015, INT J BIOL MACROMOL, V73, P264, DOI 10.1016/j.ijbiomac.2014.11.011; Loscalzo J, 2003, BIOCHEM SOC T, V31, P1059; Miao S, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1367-x; Milleret V, 2012, ACTA BIOMATER, V8, P4349, DOI 10.1016/j.actbio.2012.07.032; Ogawa R, 2003, SCI TECHNOL ADV MAT, V4, P523, DOI 10.1016/j.stam.2003.10.030; Oshima T, 2011, CARBOHYD POLYM, V83, P953, DOI 10.1016/j.carbpol.2010.09.005; Osorio M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46918-x; Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6; Pashneh-Tala S, 2015, TISSUE ENG PART B-RE, DOI [10.1089/ten.teb.2015.0100, DOI 10.1089/TEN.TEB.2015.010026447530]; Qiao JL, 2018, REDOX BIOL, V14, P126, DOI 10.1016/j.redox.2017.08.021; Rodrigues M, 1999, EUR J NUCL MED, V26, P1614, DOI 10.1007/s002590050503; Rychlik IJ, 2014, J VASC SURG, V60, P506, DOI 10.1016/j.jvs.2014.05.049; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Scherner M, 2014, J SURG RES, V189, P340, DOI 10.1016/j.jss.2014.02.011; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Solakoglu O, 2019, CLIN ORAL INVEST, V23, P4243, DOI 10.1007/s00784-019-02867-3; Swystun LL, 2016, BLOOD, V128, P753, DOI 10.1182/blood-2016-05-718114; The Abu Dhabi Declaration, 2010, J NATL COMPR CANC S3, V8, pS1; Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059; Wang XW, 2007, WORLD J SURG, V31, P682, DOI 10.1007/s00268-006-0731-z; Weber C, 2018, J VASC SURG, V68, p177S, DOI 10.1016/j.jvs.2017.09.038; Weber M, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00099; Wei Q, 2014, ANGEW CHEM INT EDIT, V53, P8004, DOI 10.1002/anie.201400546; Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; Yi M, 2003, P NATL ACAD SCI USA, V100, P11435, DOI 10.1073/pnas.1635112100	43	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235168	10.1371/journal.pone.0235168	http://dx.doi.org/10.1371/journal.pone.0235168			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579611	Green Published, gold			2022-12-27	WOS:000545646600017
J	Lori, JR; Perosky, JE; Rominski, S; Munro-Kramer, ML; Cooper, F; Kofa, A; Nyanplu, A; James, KH; Cole, GG; Coley, K; Liu, HY; Moyer, CA				Lori, Jody R.; Perosky, Joseph E.; Rominski, Sarah; Munro-Kramer, Michelle L.; Cooper, Faith; Kofa, Alphonso; Nyanplu, Aloysius; James, Katherine H.; Cole, G. Gorma; Coley, Katrina; Liu, Haiyin; Moyer, Cheryl A.			Maternity waiting homes in Liberia: Results of a countrywide multi-sector scale-up	PLOS ONE			English	Article								Objective Descriptions of maternity waiting homes (MWHs) as an intervention to increase facility delivery for women living in remote geographic areas dates back to the 1950s, yet there is limited information on the scale-up and sustainability of MWHs. The objective of this study was to describe the evolutionary scale-up of MWHs as a component of health system strengthening efforts and document the successes, challenges, and barriers to sustainability in Liberia. Methods Data were collected from a national sample of 119 MWHs in Liberia established between 2010-2018. The study used a mixed method design that included focus group discussions, individual interviews, logbook reviews, and geographic information systems. Qualitative data were grouped into themes using Glaser's constant comparative method. Quantitative data were analyzed using negative binomial regression to measure the differences in the counts of monthly stays at facilities with different funding sources and presence of advisory committee. Additionally, each MWH was geo-located for purposes of geo-visualization. Results In the years since the original construction of five MWHs, an additional 114 MWHs were constructed in 14 of the 15 counties in Liberia. Monthly stays at facilities funded by community were 2 center dot 5 times those funded by NGOs (IRR, 2 center dot 46, 95% CI 1 center dot 33-4 center dot 54). Attributes of sustainability included strong local leadership/active community engagement and community ownership and governance. Conclusion Success factors for scale-up and sustainability included strong government support through development of public policy, local and county leadership, early and sustained engagement with communities, and self-governance. A multi-pronged approach with strong community engagement is key to the scale-up and sustainability of MWHs as an intervention to increase facility delivery for women living the farthest from a healthcare facility.	[Lori, Jody R.; Munro-Kramer, Michelle L.; Coley, Katrina; Liu, Haiyin] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Perosky, Joseph E.] Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA; [Rominski, Sarah] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Cooper, Faith] Int Rescue Comm, Monrovia, Liberia; [Kofa, Alphonso; Nyanplu, Aloysius; Cole, G. Gorma] Bong Cty Hlth Team, Suakoko Dist, Liberia; [James, Katherine H.; Moyer, Cheryl A.] Univ Michigan, Sch Med, Dept Learning Hlth Sci, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Michigan State University; Michigan State University College of Human Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lori, JR (corresponding author), Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA.	jrlori@umich.edu		Perosky, Joseph/0000-0002-1992-8111; Lori, Jody/0000-0003-0564-5783	Bill & Melinda Gates Foundation [OPP1170983]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	JRL Grant #OPP1170983 The Bill & Melinda Gates Foundation https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database/Grants/2017/06/OPP1170983.The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell OMR, 2016, LANCET, V388, P2193, DOI 10.1016/S0140-6736(16)31528-8; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Eckermann E, 2008, J OBSTET GYNAECOL RE, V34, P767, DOI 10.1111/j.1447-0756.2008.00924.x; EJ-C T, 2017, ASIAN ED DEV STUDIES, V6, P110, DOI [10.1108/AEDS-01-2017-0013, DOI 10.1108/AEDS-01-2017-0013]; Fraser B, 2008, LANCET, V371, P1233, DOI 10.1016/S0140-6736(08)60541-3; Prado AG, 2012, INT J HEALTH PLAN M, V27, P150, DOI 10.1002/hpm.1107; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Glaser BG, 1992, EMERGENCE VS FORCING; Gorry C, 2011, MEDICC REV, V13, P12, DOI 10.37757/MR2011V13.N3.4; James KH, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4224-1; Kyokan M, 2016, MIDWIFERY, V39, P49, DOI 10.1016/j.midw.2016.04.013; Liberia Institute of Statistics and Geo-Information Services, 2013, LIB DEM HLTH SURV 20; Lori JR, 2013, INT J GYNECOL OBSTET, V123, P114, DOI 10.1016/j.ijgo.2013.05.024; Ministry of Health and Social Welfare, 2013, ANN REPORT; Ministry of Health and Social Welfare Republic of Liberia, 2013, STAND HLTH INFR; Ministry of Health and Social Welfare Republic of Liberia., 2014, LIB COMM HLTH ROAD M; MINKLER DH, 1972, AM J OBSTET GYNECOL, V113, P474, DOI 10.1016/S0002-9378(15)32497-2; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; Penn-Kekana L, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1444-z; POOVAN P, 1990, World Health Forum, V11, P440; Sandelowski M, 2003, QUAL HEALTH RES, V13, P781, DOI 10.1177/1049732303013006003; USAID, 2015, USAID LIB REB BAS HL; van Lonkhuijzen Luc, 2003, Afr J Reprod Health, V7, P32, DOI 10.2307/3583343; van Lonkhuijzen L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006759.pub3; Vermeiden T, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1670-z; WHO, 1996, MAT WAIT HOM REV EXP; WHO UNICEF UNFPA World Bank Group and the United Nations Population Division, 2015, TRENDS MAT MORT 2015, P1990; Wild K, 2012, B WORLD HEALTH ORGAN, V90, P97, DOI 10.2471/BLT.11.088955; Wilson JB, 1997, INT J GYNECOL OBSTET, V59, pS165, DOI 10.1016/S0020-7292(97)00162-8; World Bank Group, 2017, GLOB FIN FAC GFF 201; World Health Organization (WHO), 2020, GLOB HLTH OBS GHO DA; World Health Organization (WHO), 2008, SKILL BIRTH ATT	32	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234785	10.1371/journal.pone.0234785	http://dx.doi.org/10.1371/journal.pone.0234785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574182	Green Published, gold			2022-12-27	WOS:000544972400056
J	Margraf, J; Zhang, XC; Lavallee, KL; Schneider, S				Margraf, Juergen; Zhang, Xiao Chi; Lavallee, Kristen L.; Schneider, Silvia			Longitudinal prediction of positive and negative mental health in Germany, Russia, and China	PLOS ONE			English	Article							ANXIETY STRESS SCALES; DISORDER PREVALENCE EVIDENCE; DIMENSIONAL LIABILITY MODEL; SOCIAL PHOBIA; MEASUREMENT INVARIANCE; DEPRESSION; COMMUNITY; VALIDITY; RHYTHMS; ILLNESS	The present study examines a broad range of longitudinal predictors of dimensional positive mental health (PMH) and negative mental health (NMH), using data from the BOOM study. Participants were drawn from university student samples in Germany (1,608), Russia (677) and China (12,057). A structural equation model was conducted with four groups of predictors and PMH/NMH as criteria (outcomes). Five of the six salutogenic predictors were predictive of both positive mental health (positively) and negative mental health, as measured by depression (negatively). Pathogenic predictors anxiety and depression were related to future depression, but not to positive mental health. Stress at baseline was related to both future positive mental health (negatively) and future depression (positively). Being male in this study was associated with increased future depression. Results hold across Germany, Russia, and China. Results support the conceptualization of positive and negative mental health as related, but independent dimensions across three cultures.	[Margraf, Juergen; Zhang, Xiao Chi; Lavallee, Kristen L.; Schneider, Silvia] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Bochum, Germany	Ruhr University Bochum	Margraf, J (corresponding author), Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Bochum, Germany.	juergen.margraf@rub.de	Margraf, Jürgen/A-6873-2008; Schneider, Silvia/C-5229-2015	Margraf, Jürgen/0000-0001-5207-7016; Schneider, Silvia/0000-0003-0698-8411	Alexander von Humboldt-Foundation	Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation)	This study was supported by Alexander von Humboldt Professorship awarded to Jurgen Margraf by the Alexander von Humboldt-Foundation.	[Anonymous], 1999, B UE, P7; [Anonymous], 2007, THORAX S2, V62, pii1; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Batterham PJ, 2012, SOC PSYCH PSYCH EPID, V47, P79, DOI 10.1007/s00127-010-0313-0; Bayram N, 2008, SOC PSYCH PSYCH EPID, V43, P667, DOI 10.1007/s00127-008-0345-x; Becker ES, 2003, J NERV MENT DIS, V191, P688, DOI 10.1097/01.nmd.0000092198.20420.fc; Becker ES, 2001, INT J OBESITY, V25, pS5, DOI 10.1038/sj.ijo.0801688; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bieda A, 2017, PSYCHOL ASSESSMENT, V29, P408, DOI 10.1037/pas0000353; Boyce W, 2006, SOC INDIC RES, V78, P473, DOI 10.1007/s11205-005-1607-6; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Browne MW., 1993, SOCIOL METHOD RES, V154, P136; Chang-Quan H, 2010, INT J PSYCHIAT MED, V40, P109, DOI 10.2190/PM.40.1.i; Chen FF, 2008, STRUCTURAL EQUATION, V14, P464; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Eaton NR, 2012, J ABNORM PSYCHOL, V121, P282, DOI 10.1037/a0024780; Ehlers A, 1989, FRESH PERSPECTIVES A; EHLERS CL, 1988, ARCH GEN PSYCHIAT, V45, P948; Francine Risk, 2014, PREVALENCE RISK FACT, V2, p[58, 3, 58], DOI 10.13189/ujph.2014.020204; Fydrich T, 1987, Z KLIN PSYCHOL, V16, P434; Fydrich T., 2009, Z MED PSYCHOL, V18, P43, DOI DOI 10.1026//0012-1924.45.4.212; Grandin LD, 2006, CLIN PSYCHOL REV, V26, P679, DOI 10.1016/j.cpr.2006.07.001; Group TE, EQ 5D 3L US GUIDE201; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hoertel N, 2015, J PSYCHIATR RES, V64, P107, DOI 10.1016/j.jpsychires.2015.03.017; Hofmann Stefan G., 2007, Cognitive Behaviour Therapy, V36, P193, DOI 10.1080/16506070701421313; HOUSE JS, 1988, ANNU REV SOCIOL, V14, P293, DOI 10.1146/annurev.so.14.080188.001453; Iacovides A, 2008, CURR OPIN PSYCHIATR, V21, P417, DOI 10.1097/YCO.0b013e328303ba42; Jacobi F, 2014, INT J METH PSYCH RES, V23, P304, DOI 10.1002/mpr.1439; Keyes CLM, 2002, J PERS SOC PSYCHOL, V82, P1007, DOI 10.1037//0022-3514.82.6.1007; Keyes CLM, 2005, J CONSULT CLIN PSYCH, V73, P539, DOI 10.1037/0022-006X.73.3.539; Kline P, 2000, HDB PSYCHOL TESTING, P744; Larsson CL, 2002, J ADOLESCENT HEALTH, V31, P190, DOI 10.1016/S1054-139X(02)00344-0; Linden M, 2020, WORLD PSYCHIATRY, V19, P55, DOI 10.1002/wps.20718; Lindorff M, 2000, INT J PSYCHOL, V35, P326; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Luhmann M, 2011, J RES PERS, V45, P186, DOI 10.1016/j.jrp.2011.01.004; Lukat J, 2017, CLIN PSYCHOL PSYCHOT, V24, P322, DOI 10.1002/cpp.2026; Lukat Justina, 2016, BMC Psychol, V4, P8, DOI 10.1186/s40359-016-0111-x; MacCallum RC, 2001, MULTIVAR BEHAV RES, V36, P611, DOI 10.1207/S15327906MBR3604_06; Maercker A, 2004, BRIT J PSYCHIAT, V184, P482, DOI 10.1192/bjp.184.6.482; Maercker A, 2015, INT J CLIN HLTH PSYC, V15, P8, DOI 10.1016/j.ijchp.2014.06.001; Margraf J, 2005, VERHALTENSTHERAPIE, V15, P136, DOI 10.1159/000087950; Margraf J., 2007, PSYCHIATRY, V6, P136, DOI [10.1016/j.mppsy.2007.01.007, DOI 10.1016/J.MPPSY.2007.01.007]; Margraf J, 1989, PANIC DISORDER RES T; Margraf J., 2017, BOCHUM OPTIMIS UNPUB; Margraf J, 1998, GESUNDHEITS ODER KRA; Margraf J, 2009, LEHRBUCH VERHALTENST, V1, P3; Margraf J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150312; Marmot MG., 2006, SOCIAL DETERMINANTS; Maske UE, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0463-4; Mauz E, 2008, PSYCHIAT PRAX, V35, P343, DOI 10.1055/s-2008-1067557; Mitchell AJ, 2012, MEDICINE, V40, P662, DOI [10.1016/j.mpmed.2012.10.002, DOI 10.1016/J.MPMED.2012.10.002]; Ng F, 2007, ACTA NEUROPSYCHIATR, V19, P304, DOI 10.1111/j.1601-5215.2007.00217.x; Nover T., 2012, THESIS; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pickett KE, 2006, J EPIDEMIOL COMMUN H, V60, P646, DOI 10.1136/jech.2006.046631; Prisciandaro JJ, 2009, PSYCHOL MED, V39, P1087, DOI 10.1017/S0033291708004522; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Rudaz M, 2010, DEPRESS ANXIETY, V27, P404, DOI 10.1002/da.20645; Scholten S, ARE STRUCTURAL UNPUB; Schumacher J, 2005, Z KLIN PSYCH PSYCHIA, V53, P16; Seligman M.E., 2012, FLOURISH VISIONARY N; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Stone AA, 2010, P NATL ACAD SCI USA, V107, P9985, DOI 10.1073/pnas.1003744107; Sylvia LG, 2009, BEHAV THER, V40, P131, DOI 10.1016/j.beth.2008.04.003; Thase ME, 2002, HANDBOOK OF DEPRESSION, P192; Trumpf J, 2010, SOC PSYCH PSYCH EPID, V45, P1161, DOI 10.1007/s00127-009-0159-5; Trumpf J, 2010, SOC PSYCH PSYCH EPID, V45, P853, DOI 10.1007/s00127-009-0133-2; Trumpf J, 2010, J ANXIETY DISORD, V24, P87, DOI 10.1016/j.janxdis.2009.09.002; Trumpf J, 2009, J ANXIETY DISORD, V23, P958, DOI 10.1016/j.janxdis.2009.06.005; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Ullmann H., 2000, ECS T, V138, P79; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Vriends N., 2011, GERMAN J PSYCHIAT, V14, P80; Vriends N, 2007, J ANXIETY DISORD, V21, P320, DOI 10.1016/j.janxdis.2006.06.005; Vriends N, 2007, J ANXIETY DISORD, V21, P59, DOI 10.1016/j.janxdis.2006.05.002; Wagnild G M, 1993, J Nurs Meas, V1, P165; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wittchen HU, 2011, CONCEPTUAL EVOLUTION OF DSM-5, P119; Wood AM, 2020, WORLD PSYCHIATRY, V19, P53, DOI 10.1002/wps.20717; Wood AM, 2010, CLIN PSYCHOL REV, V30, P819, DOI 10.1016/j.cpr.2010.06.003; World Health Organisation, 2021, MENT HLTH ACT PLAN 2; World Health Organization, 2004, PROM MENT HLTH; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; World Health Organization (WHO), MENT HLTH STAT WELL; Zhang XC, 2017, COMPUT HUM BEHAV, V71, P172, DOI 10.1016/j.chb.2017.02.006	90	5	5	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234997	10.1371/journal.pone.0234997	http://dx.doi.org/10.1371/journal.pone.0234997			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME9KK	32574202	gold, Green Published			2022-12-27	WOS:000544972400006
J	Almomani, BA; Al-Sawalha, NA; Al-Keilani, MS; Aman, HA				Almomani, Basima A.; Al-Sawalha, Nour A.; Al-Keilani, Maha S.; Aman, Hatem A.			The difference in knowledge and concerns between healthcare professionals and patients about genetic-related issues: A questionnaire-based study	PLOS ONE			English	Article							CHRONIC DISEASE; GENOME-PROJECT; PERCEPTIONS; INFORMATION; PHYSICIANS; ATTITUDES; EDUCATION; PROVIDERS; LITERACY; BARRIERS	Effective adoption of genetics in clinical practice requires the support of and interaction between the different partners of healthcare system; healthcare professionals (HCPs) and patients. The study aimed to assess and compare the knowledge, factors affecting the knowledge, and concerns of HCPs and patients regarding genetic-related issues such as lack of knowledge about genetics and genetic conditions, awareness of the importance of genetics in clinical practice and genetic services and resources deficits. A cross sectional study was conducted in different areas of Jordan using a convenient sampling approach. An English questionnaire was self-administered to HCPs. Face-to-face interviews were conducted with patients in Arabic by trained researcher. A total of 1000 HCPs and 1448 patients were recruited. There was a significant difference (p<0.001) in the knowledge between HCPs and patients. Among HCPs, physicians (OR = 2.278, 95%CI = 1.410-3.680, p = 0.001) and pharmacists (OR = 2.163, 95%CI = 1.362-3.436, p = 0.001) were more knowledgeable than nurses. In addition, females were more knowledgeable than males (OR = 1.717, 95%CI = 1.203-2.451, p = 0.003). Among patients, participants who had a bachelor degree (OR = 1.579, 95%CI = 1.231-2.025, p<0.001) were more knowledgeable compared to those who only had school education. HCPs appeared to have more concerns than patients (p<0.001) regarding all genetic-related issues. These findings suggested a positive association between education and genetic knowledge as well as concerns; as HCPs were more knowledgeable and concerned than patients. Appropriate integration and expansion of basic genetic knowledge courses and clinical genetic training in the curriculum should be adopted to prepare HCPs to enhance the integration of genetic information in clinical settings.	[Almomani, Basima A.; Al-Sawalha, Nour A.; Al-Keilani, Maha S.] Jordan Univ Sci & Technol, Dept Clin Pharm, Fac Pharm, Irbid, Jordan; [Aman, Hatem A.] Jordan Univ Sci & Technol, Dept Appl Biol Sci, Irbid, Jordan	Jordan University of Science & Technology; Jordan University of Science & Technology	Almomani, BA (corresponding author), Jordan Univ Sci & Technol, Dept Clin Pharm, Fac Pharm, Irbid, Jordan.	baalmomani1@just.edu.jo		Almomani, Basima/0000-0002-2229-5837; Al-Sawalha, Nour/0000-0002-7401-8065	Jordan University of Science and Technology, Irbid, Jordan [156/2017]	Jordan University of Science and Technology, Irbid, Jordan	BAA received a grant (reference number 156/2017) from Deanship of Research at Jordan University of Science and Technology, Irbid, Jordan. http://www.just.edu.jo/Pages/Default.aspx.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahram M, 2014, INT J NEUROSCI, V124, P812, DOI 10.3109/00207454.2014.886204; Al-Ali M, 2018, J HUM GENET, V63, P533, DOI 10.1038/s10038-017-0402-y; Al-Sawalha NA, 2018, J OBSTET GYNAECOL, V38, P217, DOI 10.1080/01443615.2017.1345876; Alnaif MS, 2009, J FAM COMMUNITY MED, V16, P27; AlSafar HS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50876-9; [Anonymous], 2015, BIOLAW J, V2, P7; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2007, PHARMACOEPIDEM DR S, V16, P493; Campion M, 2019, GENET MED, V21, P2422, DOI 10.1038/s41436-019-0548-4; Chapman R, 2019, J COMMUN GENET, V10, P73, DOI 10.1007/s12687-018-0363-7; Clarke MA, 2016, HEALTH INFORM J, V22, P992, DOI 10.1177/1460458215602939; Cutilli CC, 2010, ORTHOP NURS, V29, P214, DOI 10.1097/NOR.0b013e3181db5471; Delikurt T, 2015, EUR J HUM GENET, V23, P739, DOI 10.1038/ejhg.2014.180; Etchegary H, 2010, PUBLIC HEALTH GENOMI, V13, P80, DOI 10.1159/000220034; Eum H, 2018, EUR J HUM GENET, V26, P1432, DOI 10.1038/s41431-018-0191-6; Falahee M, 2018, J RISK RES, V21, P129, DOI 10.1080/13669877.2016.1153503; Gharaibeh H, 2010, INT NURS REV, V57, P435, DOI 10.1111/j.1466-7657.2010.00814.x; Haga SB, 2012, CLIN GENET, V82, P388, DOI 10.1111/j.1399-0004.2012.01908.x; Haga SB, 2019, MOL DIAGN THER, V23, P459, DOI 10.1007/s40291-019-00407-z; Haga SB, 2019, J PERS MED, V9, DOI 10.3390/jpm9020029; Hajjej A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192269; Hauser D, 2018, HEALTH AFFAIR, V37, P793, DOI 10.1377/hlthaff.2017.1548; Horowitz CR, 2017, J HEALTH CARE POOR U, V28, P248, DOI 10.1353/hpu.2017.0020; Kaphingst KA, 2016, J HEALTH COMMUN, V21, P58, DOI 10.1080/10810730.2016.1144661; Klitzman R, 2013, J GENET COUNS, V22, P90, DOI 10.1007/s10897-012-9504-z; Lopes LC, 2017, NURS HEALTH SCI, V19, P66, DOI 10.1111/nhs.12304; McGill BC, 2019, CLIN GENET, V95, P10, DOI 10.1111/cge.13253; Mulhern M, 2018, J GENET COUNS, V27, P675, DOI 10.1007/s10897-017-0161-0; Olwi D, 2016, PUBLIC HEALTH GENOM, V19, P260, DOI 10.1159/000446511; Pet DB, 2019, GENET MED, V21, P311, DOI 10.1038/s41436-018-0047-z; Prince AER, 2019, EUR J HUM GENET, V27, P340, DOI 10.1038/s41431-018-0293-1; Puryear L, 2018, J COMMUN GENET, V9, P283, DOI 10.1007/s12687-017-0349-x; Scott EM, 2016, NAT GENET, V48, P1071, DOI 10.1038/ng.3592; Wilson BJ, 2015, RISK MANAG HEALTHC P, V8, P9, DOI 10.2147/RMHP.S58728	34	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0235001	10.1371/journal.pone.0235001	http://dx.doi.org/10.1371/journal.pone.0235001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559245	Green Published, gold			2022-12-27	WOS:000543261600010
J	Diez-Hermano, S; Mejias, A; Sanchez, D; Gutierrez, G; Ganfornina, MD				Diez-Hermano, Sergio; Mejias, Andres; Sanchez, Diego; Gutierrez, Gabriel; Ganfornina, Maria D.			Control of the neuroprotective Lipocalin Apolipoprotein D expression by alternative promoter regions and differentially expressed mRNA 5' UTR variants	PLOS ONE			English	Article							GENE-EXPRESSION; IDENTIFICATION; PREDICTION; MODULATION; PROTECTION; REDUCTION; EVOLUTION; ELEMENTS; BIOLOGY	The Lipocalin Apolipoprotein D (ApoD) is one of the few genes consistently overexpressed in the aging brain, and in most neurodegenerative and psychiatric diseases. Its functions include metabolism regulation, myelin management, neuroprotection, and longevity regulation. Knowledge of endogenous regulatory mechanisms controlling brain disease-triggered ApoD expression is relevant if we want to boost pharmacologically its neuroprotecting potential. In addition to classical transcriptional control, Lipocalins have a remarkable variability in mRNA 5'UTR-dependent translation efficiency. Using bioinformatic analyses, we uncover strong selective pressures preserving ApoD 5'UTR properties, indicating unexpected functional conservation. PCR amplifications demonstrate the production of five 5'UTR variants (A-E) in mouse ApoD, with diverse expression levels across tissues and developmental stages. Importantly, Variant E is specifically expressed in the oxidative stress-challenged brain. Predictive analyses of 5'UTR secondary structures and enrichment in elements restraining translation, point to Variant E as a tight regulator of ApoD expression. We find two genomic regions conserved in human and mouse ApoD: a canonical (alpha) promoter region and a previously unknown region upstream of Variant E that could function as an alternative mouse promoter (beta). Luciferase assays demonstrate that both alpha and beta promoter regions can drive expression in cultured mouse astrocytes, and that Promoter beta activity responds proportionally to incremental doses of the oxidative stress generator Paraquat. We postulate that Promoter beta works in association with Variant E 5'UTR as a regulatory tandem that organizes ApoD gene expression in the nervous system in response to oxidative stress, the most common factor in aging and neurodegeneration.	[Diez-Hermano, Sergio; Sanchez, Diego; Ganfornina, Maria D.] Univ Valladolid, Inst Biol & Genet Mol, Dept Bioquim & Biol Mol & Fisiol, CSIC, Valladolid, Spain; [Diez-Hermano, Sergio] Univ Complutense, Dept Matemat Aplicada, Madrid, Spain; [Mejias, Andres; Gutierrez, Gabriel] Univ Seville, Dept Genet, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Complutense University of Madrid; University of Sevilla	Ganfornina, MD (corresponding author), Univ Valladolid, Inst Biol & Genet Mol, Dept Bioquim & Biol Mol & Fisiol, CSIC, Valladolid, Spain.	opabinia@ibgm.uva.es	Diez-Hermano, Sergio/ABC-4198-2021; Ganfornina, Maria D/N-5743-2014; Gutierrez Pozo, Gabriel/S-7646-2017	Diez-Hermano, Sergio/0000-0003-3830-7297; Ganfornina, Maria D/0000-0002-8567-4826; Gutierrez Pozo, Gabriel/0000-0002-1354-2883	Ministerio de Ciencia e Innovacion [BFU2015-68149-R]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	M.D.G. adn D.S. BFU2015-68149-R Ministerio de Ciencia e Innovacion http://www.ciencia.gob.es/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom Bo, 2006, P1; [Anonymous], 2006, TENZONE REV ASOCIACI, V7, P114; [Anonymous], 2006, CIRCULATION, V114, pe257; Bajo-Graneras R, 2011, GLIA, V59, P1551, DOI 10.1002/glia.21200; Bajo-Graneras R, 2011, J NEUROCHEM, V117, P949, DOI 10.1111/j.1471-4159.2011.07266.x; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Bellaousov S, 2013, NUCLEIC ACIDS RES, V41, pW471, DOI 10.1093/nar/gkt290; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bhatia S, 2019, J MOL NEUROSCI, V67, P125, DOI 10.1007/s12031-018-1217-9; Bhatia S, 2012, BIOCHEM J, V442, P713, DOI 10.1042/BJ20111166; Byun Y, 2006, NUCLEIC ACIDS RES, V34, pW416, DOI 10.1093/nar/gkl210; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Castrignano T, 2008, BIOINFORMATICS, V24, P1300, DOI 10.1093/bioinformatics/btn113; Dassati S, 2014, NEUROBIOL AGING, V35, P1632, DOI 10.1016/j.neurobiolaging.2014.01.148; Davuluri RV, 2000, GENOME RES, V10, P1807, DOI 10.1101/gr.GR-1460R; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Do Carmo S, 2002, J BIOL CHEM, V277, P5514, DOI 10.1074/jbc.M105057200; Do Carmo S, 2007, BBA-MOL CELL RES, V1773, P954, DOI 10.1016/j.bbamcr.2007.03.007; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ganfornina M.D., 2006, LIPOCALINS, P17; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Ganfornina MD, 2010, GLIA, V58, P1320, DOI 10.1002/glia.21010; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Garcia-Mateo N, 2018, GLIA, V66, P670, DOI 10.1002/glia.23274; Garcia-Mateo N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00374; Giegerich R, 2004, NUCLEIC ACIDS RES, V32, P4843, DOI 10.1093/nar/gkh779; He X, 2009, NEUROSCI LETT, V455, P183, DOI 10.1016/j.neulet.2009.03.038; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Hochsmann M, 2004, IEEE ACM T COMPUT BI, V1, P53, DOI 10.1109/TCBB.2004.11; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Kim WS, 2009, J NEUROCHEM, V109, P1053, DOI 10.1111/j.1471-4159.2009.06031.x; Klingenhoff A, 1999, BIOINFORMATICS, V15, P180, DOI 10.1093/bioinformatics/15.3.180; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; LAMBERT J, 1993, BIOCHIM BIOPHYS ACTA, V1172, P190, DOI 10.1016/0167-4781(93)90292-L; Leppek K, 2018, NAT REV MOL CELL BIO, V19, P158, DOI 10.1038/nrm.2017.103; Levros LC, 2010, BBA-MOL CELL RES, V1803, P1062, DOI 10.1016/j.bbamcr.2010.04.011; Liu HL, 2012, GENE, V507, P106, DOI 10.1016/j.gene.2012.07.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui M, 2007, FEBS LETT, V581, P4184, DOI 10.1016/j.febslet.2007.07.057; Mejias A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213206; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Pascua-Maestro R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006603; Pulido-Salgado M, 2015, PROG NEUROBIOL, V132, P1, DOI 10.1016/j.pneurobio.2015.06.003; Rabani M, 2008, P NATL ACAD SCI USA, V105, P14885, DOI 10.1073/pnas.0803169105; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Reindl M, 2001, J NEUROIMMUNOL, V119, P327, DOI 10.1016/S0165-5728(01)00378-2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanchez D, 2003, MOL BIOL EVOL, V20, P775, DOI 10.1093/molbev/msg079; Sanchez D., 2006, MOL BIOL INTELLIGENC, P5; Sanchez D, 2015, EXP GERONTOL, V67, P19, DOI 10.1016/j.exger.2015.04.003; Solovyev VV, 2010, METHODS MOL BIOL, V674, P57, DOI 10.1007/978-1-60761-854-6_5; Suresh S, 1998, J NEUROCHEM, V70, P242; Thomas EA, 2001, P NATL ACAD SCI USA, V98, P4066, DOI 10.1073/pnas.071056198; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; Wang XK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-12; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zuker M, 2000, CURR OPIN STRUC BIOL, V10, P303, DOI 10.1016/S0959-440X(00)00088-9	64	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234857	10.1371/journal.pone.0234857	http://dx.doi.org/10.1371/journal.pone.0234857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559215	Green Published, Green Accepted, gold			2022-12-27	WOS:000543261600050
J	Genet, C; Andualem, T; Melese, A; Mulu, W; Mekonnen, F; Abera, B				Genet, Chalachew; Andualem, Tesfaye; Melese, Addisu; Mulu, Wondemagegn; Mekonnen, Feleke; Abera, Bayeh			Quality of care for tuberculosis patients in public health facilities of Debre Tabor town, Northwest Ethiopia	PLOS ONE			English	Article								Background Even though there are different tuberculosis (TB) prevention and control measures implemented globally including Ethiopia, TB is still major public health problem. This is partly due to compromised quality of care delivered for tuberculosis patients in health facilities (HFs) during diagnosis, treatment and follows-up. Thus this study is intended to determine the quality of care delivered for TB patients in all public HFs of Debre Tabor town, Northwest Ethiopia. Methods Cross sectional study was conducted from January to May 2018. Data were collected with face-to-face interview and TB registration book review using structured questionnaire and checklist respectively. Collected data was entered and processed using SPSS and P value <0.05 was considered statistically significant. The quality of care for each HF was graded as very good, good, moderate, poor and very poor if HFs achieve [90-100%], [80-90%), [70-80%), [60-70%) and <60% of performance indicators respectively using Donabedian structure, process and outcome model of health care quality. Results All HFs have sputum collection area, enough microscopic slide, at least one functional microscope and sufficient anti TB drug supply. But HFs lack backup laboratory stains. Overall structural aspects of quality of care in all HFs were very poor achieving 42.5-52.9% structural performance indicators out of 100%. Similarly the overall process aspects of quality of care was poor in all public HFs which achieved 60-68.9% of the scores out of 100%. In the study; 68.9%, 54.5% and 80.6% of Medical Laboratory, pharmacy and other healthcare workers (HWs) provided correct response respectively on TB causative agent, risk factor, transmission, treatment, prevention, case management and case finding strategies. HWs who knew at least two TB case finding strategies in DTH was significantly higher than those HWs working in Health Centers (P = 0.004). On the other hand, except Ginbot 20 HC, HFs was graded as good by scoring 86.6-89.3% of performance indicators on the outcome aspects of quality of care. In all HFs studied, all TB patients' unit TB registration number, sex, age, TB category, treatment initiation date and intensive phase treatment start year were properly registered. Moreover 110 (78%) and 147 (69%) contact person address in DTH and HCs was properly registered on TB unit register book respectively with no statistical difference in hospital and HCs (P = 0.063). There was proper TB patients' address registration in hospital than HCs studied (P< 0.001). Conclusions The outcome aspects of quality of care for TB patients in all HFs were promising. But structural & process aspects of quality of care was compromised which necessitate different corrective actions to be taken by different stakeholders to enhance quality of care for TB patients in public HFs studied. Moreover based on the study findings, continuous supply of drugs, laboratory equipment and reagents, availing current guideline/s in HFs, providing up-to-date training for HWs on TB and proper documentation are important to improve quality of care provided for TB patients.	[Genet, Chalachew; Melese, Addisu; Mulu, Wondemagegn; Mekonnen, Feleke; Abera, Bayeh] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Bahir Dar, Ethiopia; [Andualem, Tesfaye] Debre Tabor Univ, Coll Hlth Sci, Dept Med Lab Sci, Debre Tabor, Ethiopia	Bahir Dar University	Genet, C (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Bahir Dar, Ethiopia.	chaliegenet@gmail.com	Abera, Bayeh/AAU-8754-2020; Melese, Addisu/S-3175-2017	Melese, Addisu/0000-0002-2362-5500; Andualem, Tesafye/0000-0001-5984-4281; Genet, Chalachew/0000-0001-8631-5094				Blobel B, 2015, HEALTHCARE, V3, P6; Bulage L, 2014, TUBERCULOSIS RES TRE, DOI [10.1155/2014/685982, DOI 10.1155/2014/685982]; Desalegn D, 2016, J MICROBIOL INFECT D, V6, P156; Ethiopian MOH, 2016, NAT COMPR TUB LEPR T; FMOH, 2012, GUID CLIN PROGR MAN, V5; Gebrekidan Gezahegn, 2014, Tuberc Res Treat, V2014, P720432, DOI 10.1155/2014/720432; Geremew T, 2011, ETHIOP J HEALTH SCI, V21, P39; Megene S. L., 2018, Journal of Public Health and Epidemiology, V10, P332; Mesfin MM, 2009, HEALTH POLICY PLANN, V24, P457, DOI 10.1093/heapol/czp030; Tobin-West CI, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.60.8497; WHO, 2017, GLOB TUB REP; WHO, DOTS STRAT WHO; World health organization, 2016, 2016 WORLD HLTH STAT	13	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234988	10.1371/journal.pone.0234988	http://dx.doi.org/10.1371/journal.pone.0234988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559256	gold, Green Published			2022-12-27	WOS:000543261600058
J	Gonzalez-Feliciano, JA; Akamine, P; Capo-Velez, CM; Delgado-Velez, M; Dussupt, V; Krebs, SJ; Wojna, V; Polonis, VR; Baerga-Ortiz, A; Lasalde-Dominicci, JA				Gonzalez-Feliciano, Jose A.; Akamine, Pearl; Capo-Velez, Coral M.; Delgado-Velez, Manuel; Dussupt, Vincent; Krebs, Shelly J.; Wojna, Valerie; Polonis, Victoria R.; Baerga-Ortiz, Abel; Lasalde-Dominicci, Jos A.			A recombinant gp145 Env glycoprotein from HIV-1 expressed in two different cell lines: Effects on glycosylation and antigenicity	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; ENVELOPE GLYCOPROTEIN; RATIONAL DESIGN; VACCINE; GP120; PROTEINS; TRIMERS; PROTECTION; INFECTION; SUBTYPE	The envelope glycoprotein (Env) of the human immunodeficiency virus (HIV), has been the primary target for the development of a protective vaccine against infection. The extensiveN-linked glycosylation on Env is an important consideration as it may affect efficacy, stability, and expression yields. The expression host has been shown to influence the extent and type of glycosylation that decorates the protein target. Here, we report the glycosylation profile of the candidate subtype C immunogen CO6980v0c22 gp145, which is currently in Phase I clinical trials, produced in two different host cells: CHO-K1 and Expi293F. The amino acid sequence for both glycoproteins was confirmed to be identical by peptide mass fingerprinting. However, the isoelectric point of the proteins differed; 4.5-5.5 and 6.0-7.0 for gp145 produced in CHO-K1 and Expi293F, respectively. These differences in pI were eliminated by enzymatic treatment with sialidase, indicating a large difference in the incorporation of sialic acid between hosts. This dramatic difference in the number of sialylated glycans between hosts was confirmed by analysis of PNGase F-released glycans using MALDI-ToF MS. These differences in glycosylation, however, did not greatly translate into differences in antibody recognition. Biosensor assays showed that gp145 produced in CHO-K1 had similar affinity toward the broadly neutralizing antibodies, 2G12 and PG16, as the gp145 produced in Expi293F. Additionally, both immunogens showed the same reactivity against plasma of HIV-infected patients. Taken together, these results support the notion that there are sizeable differences in the glycosylation of Env depending on the expression host. How these differences translate to vaccine efficacy remains unknown.	[Gonzalez-Feliciano, Jose A.; Akamine, Pearl; Capo-Velez, Coral M.; Delgado-Velez, Manuel; Baerga-Ortiz, Abel; Lasalde-Dominicci, Jos A.] Univ Puerto Rico, Mol Sci Res Ctr Inc, San Juan, PR 00936 USA; [Dussupt, Vincent; Krebs, Shelly J.; Polonis, Victoria R.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Dussupt, Vincent; Krebs, Shelly J.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Wojna, Valerie] Univ Puerto Rico, Internal Med Dept, Div Neurol, Med Sci Campus, San Juan, PR 00936 USA; [Wojna, Valerie] Univ Puerto Rico, NeuroHIV Res Program, Med Sci Campus, San Juan, PR 00936 USA; [Baerga-Ortiz, Abel] Univ Puerto Rico, Dept Biochem, Med Sci Campus, San Juan, PR 00936 USA; [Lasalde-Dominicci, Jos A.] Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA	University of Puerto Rico; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras	Baerga-Ortiz, A; Lasalde-Dominicci, JA (corresponding author), Univ Puerto Rico, Mol Sci Res Ctr Inc, San Juan, PR 00936 USA.; Baerga-Ortiz, A (corresponding author), Univ Puerto Rico, Dept Biochem, Med Sci Campus, San Juan, PR 00936 USA.; Lasalde-Dominicci, JA (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA.	abel.baerga@upr.edu; jose.lasalde@upr.edu	; Krebs, Shelly/D-8015-2016	Wojna, Valerie/0000-0002-4014-9921; Delgado-Velez, Manuel/0000-0002-2146-1071; Capo-Velez, Coral/0000-0002-2384-8376; Baerga-Ortiz, Abel/0000-0001-9487-1015; Krebs, Shelly/0000-0003-1136-1760	National Institutes of Health (NIH) [R01AI122935]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DoD) [W81XWH-07-2-0067]; US Civilian Research and Development Foundation (CRDF) [OISE9531011-NIH]; NIH [U54NS43011, S11NS046278, U54MD007587]; Puerto Rico Science, Technology Research Trust	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DoD)(United States Department of Defense); US Civilian Research and Development Foundation (CRDF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Puerto Rico Science, Technology Research Trust	This work was supported by the National Institutes of Health (NIH) grant R01AI122935 to JAL-D and AB-O. This work was also supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DoD). JAL-D wants to acknowledge the US Civilian Research and Development Foundation (CRDF) for providing the necessary funds (funding agreement OISE9531011-NIH) to establish the Clinical Bioreagent Center (CBC). Additional support from NIH grants U54NS43011, S11NS046278, and U54MD007587 to VW enabled the patient sample repository. The authors also acknowledge the Puerto Rico Science, Technology & Research Trust, for financing the acquisition of key instruments.	Aldon Y, 2018, CELL REP, V24, P3324, DOI 10.1016/j.celrep.2018.08.051; BERMAN PW, 1990, NATURE, V345, P622, DOI 10.1038/345622a0; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; CLELAND JL, 1994, AIDS RES HUM RETROV, V10, pS21; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; Crooks ET, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007024; de Taeye SW, 2016, TRENDS IMMUNOL, V37, P221, DOI 10.1016/j.it.2016.01.007; Doores KJ, 2015, FEBS J, V282, P4679, DOI 10.1111/febs.13530; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Etemad-Moghadam B, 1999, J VIROL, V73, P8873, DOI 10.1128/JVI.73.10.8873-8879.1999; Go EP, 2015, J VIROL, V89, P8245, DOI 10.1128/JVI.00628-15; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Joseph S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00149; Khayat R, 2013, J VIROL, V87, P9865, DOI 10.1128/JVI.01222-13; Kiptoo M, 2011, CHANGING TRENDS HIV, DOI [10.5772/19591, DOI 10.5772/19591]; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Lu ML, 2019, NATURE, V568, P415, DOI 10.1038/s41586-019-1101-y; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; O'Rourke SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197656; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pitisuttithum P, 2004, JAIDS-J ACQ IMM DEF, V37, P1160, DOI 10.1097/01.qai.0000136091.72955.4b; Pritchard LK, 2015, J VIROL, V89, P8932, DOI 10.1128/JVI.01190-15; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ringe RP, 2015, J VIROL, V89, P12189, DOI 10.1128/JVI.01768-15; Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Seabright GE, 2019, J MOL BIOL, V431, P2223, DOI 10.1016/j.jmb.2019.04.016; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Stadtmueller BM, 2018, IMMUNITY, V49, P235, DOI 10.1016/j.immuni.2018.06.017; Struwe WB, 2018, CELL REP, V24, P1958, DOI 10.1016/j.celrep.2018.07.080; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Verrier F, 2000, J VIROL, V74, P10025, DOI 10.1128/JVI.74.21.10025-10033.2000; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wang XD, 2017, MABS-AUSTIN, V9, P319, DOI 10.1080/19420862.2016.1261774; Werner RG, 2007, ACTA PAEDIATR, V96, P17, DOI 10.1111/j.1651-2227.2007.00199.x; Wibmer CK, 2015, CURR OPIN HIV AIDS, V10, P135, DOI 10.1097/COH.0000000000000153; Wieczorek L, 2015, J VIROL, V89, P7478, DOI 10.1128/JVI.00412-15; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043903	51	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0231679	10.1371/journal.pone.0231679	http://dx.doi.org/10.1371/journal.pone.0231679			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559193	Green Published, Green Submitted, gold			2022-12-27	WOS:000543261600060
J	Ong, CJ; Orfanoudaki, A; Zhang, R; Caprasse, FPM; Hutch, M; Ma, L; Fard, D; Balogun, O; Miller, MI; Minnig, M; Saglam, H; Prescott, B; Greer, DM; Smirnakis, S; Bertsimas, D				Ong, Charlene Jennifer; Orfanoudaki, Agni; Zhang, Rebecca; Caprasse, Francois Pierre M.; Hutch, Meghan; Ma, Liang; Fard, Darian; Balogun, Oluwafemi; Miller, Matthew, I; Minnig, Margaret; Saglam, Hanife; Prescott, Brenton; Greer, David M.; Smirnakis, Stelios; Bertsimas, Dimitris			Machine learning and natural language processing methods to identify ischemic stroke, acuity and location from radiology reports	PLOS ONE			English	Article							ANNOTATION	Accurate, automated extraction of clinical stroke information from unstructured text has several important applications. ICD-9/10 codes can misclassify ischemic stroke events and do not distinguish acuity or location. Expeditious, accurate data extraction could provide considerable improvement in identifying stroke in large datasets, triaging critical clinical reports, and quality improvement efforts. In this study, we developed and report a comprehensive framework studying the performance of simple and complex stroke-specific Natural Language Processing (NLP) and Machine Learning (ML) methods to determine presence, location, and acuity of ischemic stroke from radiographic text. We collected 60,564 Computed Tomography and Magnetic Resonance Imaging Radiology reports from 17,864 patients from two large academic medical centers. We used standard techniques to featurize unstructured text and developed neurovascular specific word GloVe embeddings. We trained various binary classification algorithms to identify stroke presence, location, and acuity using 75% of 1,359 expert-labeled reports. We validated our methods internally on the remaining 25% of reports and externally on 500 radiology reports from an entirely separate academic institution. In our internal population, GloVe word embeddings paired with deep learning (Recurrent Neural Networks) had the best discrimination of all methods for our three tasks (AUCs of 0.96, 0.98, 0.93 respectively). Simpler NLP approaches (Bag of Words) performed best with interpretable algorithms (Logistic Regression) for identifying ischemic stroke (AUC of 0.95), MCA location (AUC 0.96), and acuity (AUC of 0.90). Similarly, GloVe and Recurrent Neural Networks (AUC 0.92, 0.89, 0.93) generalized better in our external test set than BOW and Logistic Regression for stroke presence, location and acuity, respectively (AUC 0.89, 0.86, 0.80). Our study demonstrates a comprehensive assessment of NLP techniques for unstructured radiographic text. Our findings are suggestive that NLP/ML methods can be used to discriminate stroke features from large data cohorts for both clinical and research-related investigations.	[Ong, Charlene Jennifer; Hutch, Meghan; Ma, Liang; Fard, Darian; Balogun, Oluwafemi; Miller, Matthew, I; Minnig, Margaret; Greer, David M.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Ong, Charlene Jennifer; Hutch, Meghan; Balogun, Oluwafemi; Prescott, Brenton; Greer, David M.] Boston Med Ctr, Boston, MA 02118 USA; [Ong, Charlene Jennifer; Saglam, Hanife; Smirnakis, Stelios] Harvard Med Sch, Boston, MA 02115 USA; [Ong, Charlene Jennifer; Orfanoudaki, Agni; Zhang, Rebecca; Caprasse, Francois Pierre M.; Bertsimas, Dimitris] MIT, Operat Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bertsimas, Dimitris] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Boston University; Boston Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ong, CJ (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.; Ong, CJ (corresponding author), Boston Med Ctr, Boston, MA 02118 USA.; Ong, CJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Ong, CJ (corresponding author), MIT, Operat Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cjong@bu.edu	Sağlam, Hacı/GLN-8241-2022	Sağlam, Hacı/0000-0002-6598-8262; Saglam, Hanife/0000-0003-3256-1227; Balogun, Oluwafemi/0000-0002-6578-1851				Banerjee I, 2018, J BIOMED INFORM, V77, P11, DOI 10.1016/j.jbi.2017.11.012; Bertsimas D., 2019, MACHINE LEARNING MOD; Bertsimas D, 2017, MACH LEARN, V106, P1039, DOI 10.1007/s10994-017-5633-9; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1984, CLASSIFICATION REGRE; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; D Damayanti D., 2018, BULLWHIP EFFECT SUPP, V1, P1, DOI DOI 10.1080/09593330.2018.1526217; Devlin J., 2019, NAACL, P4171; Dietterich T, 1996, 1 OR STAT U, V1, P1; Fox GN, 2003, J FAM PRACTICE, V52, P706; Garg R, 2019, J STROKE CEREBROVASC, V28, P2045, DOI 10.1016/j.jstrokecerebrovasdis.2019.02.004; Goldberg Y., 2017, SYNTHESIS LECT HUMAN, V10, P1, DOI DOI 10.2200/S00762ED1V01Y201703HLT037; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hastie T., 2009, SPRINGER SERIES STAT, DOI 10.1007/978-0-387-84858-7; Haykin S., 1994, NEURAL NETWORKS COMP, V1st; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jones SA, 2014, STROKE, V45, P3219, DOI 10.1161/STROKEAHA.114.006316; Joulin Armand, 2016, ARXIV160701759; Kim C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212778; Lai SW, 2015, AAAI CONF ARTIF INTE, P2267; Lancet Global Health, 2019, LANCET GLOBAL HLTH, V7, pe1; Liang ZH, 2019, COMPUT METH PROG BIO, V174, P17, DOI 10.1016/j.cmpb.2018.05.008; Manning C, 1999, FDN STAT NATURAL LAN; Mendelow AD, 2015, STROKE PATHOPHYSIOLO; Mikolov T., 2013, PREPRINT; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pennington Jeffrey, 2014, PROC 2014 C EMPIRICA, P1532, DOI [DOI 10.3115/V1/D14-1162, 10.3115/v1/D14-1162]; Pons E, 2016, RADIOLOGY, V279, P329, DOI 10.1148/radiol.16142770; Rao GZ, 2018, NEUROCOMPUTING, V308, P49, DOI 10.1016/j.neucom.2018.04.045; Rumeng L, 2017, AMIA ANN S P; Sanderson M, 2010, NAT LANG ENG, V16, P100, DOI 10.1017/S1351324909005129; Shi Tianze, 2014, ARXIV14115595; Taggart M, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3451; Wu S, 2020, J AM MED INFORM ASSN, V27, P457, DOI 10.1093/jamia/ocz200; Yin W., 2017, ARXIV170201923; Yousem DM, 2010, NEURORADIOLOGY REQUI; Zech J, 2018, RADIOLOGY, V287, P570, DOI 10.1148/radiol.2018171093	38	27	27	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234908	10.1371/journal.pone.0234908	http://dx.doi.org/10.1371/journal.pone.0234908			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559211	Green Published, gold			2022-12-27	WOS:000543261600002
J	Schmidt, K; Forkmann, K; Elsenbruch, S; Bingel, U				Schmidt, Katharina; Forkmann, Katarina; Elsenbruch, Sigrid; Bingel, Ulrike			Enhanced pain-related conditioning for face compared to hand pain	PLOS ONE			English	Article							FEAR-AVOIDANCE MODEL; NEURAL CIRCUITRY; EXTINCTION; REINSTATEMENT; RETURN; ACQUISITION; RESPONSES; VALENCE; FIBROMYALGIA; PATHWAY	Pain is evolutionarily hardwired to signal potential danger and threat. It has been proposed that altered pain-related associative learning processes, i.e., emotional or fear conditioning, might contribute to the development and maintenance of chronic pain. Pain in or near the face plays a special role in pain perception and processing, especially with regard to increased pain-related fear and unpleasantness. However, differences in pain-related learning mechanisms between the face and other body parts have not yet been investigated. Here, we examined body-site specific differences in associative emotional conditioning using electrical stimuli applied to the face and the hand. Acquisition, extinction, and reinstatement of cue-pain associations were assessed in a 2-day emotional conditioning paradigm using a within-subject design. Data of 34 healthy subjects revealed higher fear of face pain as compared to hand pain. During acquisition, face pain (as compared to hand pain) led to a steeper increase in pain-related negative emotions in response to conditioned stimuli (CS) as assessed using valence ratings. While no significant differences between both conditions were observed during the extinction phase, a reinstatement effect for face but not for hand pain was revealed on the descriptive level and contingency awareness was higher for face pain compared to hand pain. Our results indicate a stronger propensity to acquire cue-pain-associations for face compared to hand pain, which might also be reinstated more easily. These differences in learning and resultant pain-related emotions might play an important role in the chronification and high prevalence of chronic facial pain and stress the evolutionary significance of pain in the head and face.	[Schmidt, Katharina; Forkmann, Katarina; Bingel, Ulrike] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany; [Elsenbruch, Sigrid] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany; [Elsenbruch, Sigrid] Ruhr Univ Bochum, Dept Med Psychol & Med Sociol, Bochum, Germany	University of Duisburg Essen; University of Duisburg Essen; Ruhr University Bochum	Schmidt, K (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany.	Katharina.schmidt@uk-essen.de		Schmidt, Katharina/0000-0001-9397-5285; Elsenbruch, Sigrid/0000-0002-6528-2665	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [316803389 - SFB 1280]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - project number 316803389 - SFB 1280. Grant given to KF and UB.	Bates D, 2014, ARXIV14065823; Benson S., 2019, PAIN; Biggs EE, 2017, J PAIN, V18, P1505, DOI 10.1016/j.jpain.2017.08.002; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Bufacchi RJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12466-5; Burch R, 2018, HEADACHE, V58, P496, DOI 10.1111/head.13281; Claassen J, 2017, CEREBELLUM, V16, P508, DOI 10.1007/s12311-016-0832-7; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; De Peuter S, 2011, EUR J PAIN, V15, P889, DOI 10.1016/j.ejpain.2011.03.002; Dirikx T, 2004, LEARN MEMORY, V11, P549, DOI 10.1101/lm.78004; Domjan M, 2005, ANNU REV PSYCHOL, V56, P179, DOI 10.1146/annurev.psych.55.090902.141409; Dour HJ, 2016, J BEHAV THER EXP PSY, V50, P277, DOI 10.1016/j.jbtep.2015.09.010; Drexler SM, 2014, BEHAV NEUROSCI, V128, P474, DOI 10.1037/a0036688; Duits P, 2015, DEPRESS ANXIETY, V32, P239, DOI 10.1002/da.22353; Flor H, 2012, CURR OPIN PSYCHIATR, V25, P109, DOI 10.1097/YCO.0b013e3283503510; Fullana MA, 2016, MOL PSYCHIATR, V21, P500, DOI 10.1038/mp.2015.88; Gawronski B, 2014, COGNITION EMOTION, V28, P577, DOI 10.1080/02699931.2013.843506; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; Giustino TF, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00043; Glogan E, 2019, J PAIN, V20, P325, DOI 10.1016/j.jpain.2018.09.010; Gramsch C, 2014, NEUROBIOL LEARN MEM, V116, P36, DOI 10.1016/j.nlm.2014.08.003; Haaker J, 2014, LEARN MEMORY, V21, P424, DOI 10.1101/lm.036053.114; Harvie DS, 2017, J PAIN, V18, P889, DOI 10.1016/j.jpain.2017.02.430; Harvie DS, 2016, PSYCHOPHYSIOLOGY, V53, P921, DOI 10.1111/psyp.12631; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Hofmann W, 2010, PSYCHOL BULL, V136, P390, DOI 10.1037/a0018916; Hosoba T, 2001, BEHAV RES THER, V39, P465, DOI 10.1016/S0005-7967(00)00025-5; Icenhour A, 2015, NEUROGASTROENT MOTIL, V27, P114, DOI 10.1111/nmo.12489; Icenhour A, 2015, HUM BRAIN MAPP, V36, P3179, DOI 10.1002/hbm.22837; Kattoor J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051149; Klinger R, 2010, PAIN, V150, P66, DOI 10.1016/j.pain.2010.03.036; Koenen LR, 2018, PSYCHOSOMATIC MED; Labrenz F, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00318; Lautenbacher S, 2009, CLIN J PAIN, V25, P92, DOI 10.1097/AJP.0b013e3181850dce; Laux L, 1992, STATE TRAIT ANGSTINV; Lonsdorf TB, 2017, NEUROSCI BIOBEHAV R, V77, P247, DOI 10.1016/j.neubiorev.2017.02.026; Lovibond PF, 2002, J EXP PSYCHOL-ANIM B, V28, P3, DOI 10.1037//0097-7403.28.1.3; MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P; Mertens G, 2020, NEUROSCI BIOBEHAV R, V108, P254, DOI 10.1016/j.neubiorev.2019.11.012; Meulders A, 2017, J PAIN, V18, P79, DOI 10.1016/j.jpain.2016.10.004; Meulders A, 2015, J EXP PSYCHOPATHOL, V6, P206, DOI 10.5127/jep.043614; Meulders A, 2015, PAIN, V156, P108, DOI 10.1016/j.pain.0000000000000016; Nees F, 2018, NEUROSCIENCE, V387, P72, DOI 10.1016/j.neuroscience.2017.08.051; Nishiyama R, 2020, LEARN MOTIV, V69, DOI 10.1016/j.lmot.2019.101600; Pace-Schott EF, 2015, PSYCHOL BULL, V141, P835, DOI 10.1037/bul0000014; Porreca F, 2017, PAIN, V158, pS43, DOI 10.1097/j.pain.0000000000000798; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; Sambo CF, 2012, J NEUROSCI, V32, P12921, DOI 10.1523/JNEUROSCI.0607-12.2012; Sambo CF, 2012, J NEUROPHYSIOL, V107, P880, DOI 10.1152/jn.00731.2011; Schiller D, 2008, LEARN MEMORY, V15, P394, DOI 10.1101/lm.909208; Schmidt K, 2016, NEUROIMAGE; Schmidt K, 2019, J PAIN OFFICIAL J AM; Schmidt K, 2018, J PAIN, V19, P135, DOI 10.1016/j.jpain.2017.09.005; Schmidt K, 2015, J PAIN, V16, P781, DOI 10.1016/j.jpain.2015.05.003; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Sussman TJ, 2016, BIOL PSYCHOL, V121, P160, DOI 10.1016/j.biopsycho.2016.08.006; Traxler J, 2019, PEERJ, V7, DOI 10.7717/peerj.6486; Turk DC, 2010, CURR PAIN HEADACHE R, V14, P88, DOI 10.1007/s11916-010-0094-x; van den Akker K, 2015, J BEHAV THER EXP PSY, V48, P50, DOI 10.1016/j.jbtep.2015.02.001; van ME, 2017, PEDIAT PHYS THER S3, V29, pS73; Vervliet B, 2013, ANNU REV CLIN PSYCHO, V9, P215, DOI 10.1146/annurev-clinpsy-050212-185542; Vlaeyen JWS, 2016, PAIN, V157, P1588, DOI 10.1097/j.pain.0000000000000574; Vlaeyen JWS, 2015, PAIN, V156, pS86, DOI 10.1097/j.pain.0000000000000107; Volders S, 2015, CLIN J PAIN, V31, P933, DOI 10.1097/AJP.0000000000000187; Walter B, 2002, SCHMERZ, V16, P83; Wicking M, 2016, NEUROBIOL LEARN MEM, V136, P116, DOI 10.1016/j.nlm.2016.09.016; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; Wise T, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007341; Zaman J, 2015, NEUROSCI BIOBEHAV R, V51, P118, DOI 10.1016/j.neubiorev.2015.01.009	72	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234160	10.1371/journal.pone.0234160	http://dx.doi.org/10.1371/journal.pone.0234160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559202	Green Published, gold			2022-12-27	WOS:000543261600016
J	Xu, P; Zhu, YM; Liang, XS; Gong, CM; Xu, YF; Huang, CH; Liu, XL; Zhou, JC				Xu, Ping; Zhu, Yumei; Liang, Xiongshun; Gong, Chunmei; Xu, Yuanfei; Huang, Changhua; Liu, Xiao-Li; Zhou, Ji-Chang			Genetic polymorphisms of superoxide dismutase 1 are associated with the serum lipid profiles of Han Chinese adults in a sexually dimorphic manner	PLOS ONE			English	Article							SEX-SPECIFIC ASSOCIATION; SOD1 GENE; DIABETIC-NEPHROPATHY; ALLELIC VARIATIONS; METABOLISM; RISK; DYSLIPIDEMIA; ACCUMULATION; PREVALENCE; LIVER	Inspired by the mechanistic correlations between superoxide dismutase 1 (SOD1) and lipid metabolism, the associations ofSOD1single nucleotide polymorphisms (SNPs) with circulating lipid levels were explored. In 2621 Chinese Han adults, randomly recruited from a health examination center without organic diseases, cancers, and pregnancy, three tag SNPs, rs4998557, rs1041740, and rs17880487 selected by Haploview software were genotyped with a probe-based real-time quantitative PCR method. In both genders, most parameters of the dyslipidemia adults were inferior (P< 0.001) to those of the non-dyslipidemia adults, and genotype frequencies of rs4998557 and rs17880487 were significantly different (P< 0.05) between the normal and abnormal subgroups of total cholesterol (TC) or high-density lipoprotein cholesterol (HDLC). Adjusted for confounding factors, logistic regression analyses revealed that in males rs4998557A, rs1041740T, and rs17880487T reduced the risk of high TC and/or LDLC (P< 0.05), and rs4998557A and rs17880487T increased the risk of low HDLC (P< 0.05); but in females, none of the SNPs had associations with any of the lipid parameters (P> 0.05). Conclusively, characterized by a sexual dimorphism, theSOD1polymorphisms were associated with the lipid disorders in the adult males but not females of the Chinese Han population.	[Xu, Ping; Zhou, Ji-Chang] Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Shenzhen, Guangdong, Peoples R China; [Zhu, Yumei; Liang, Xiongshun; Gong, Chunmei; Xu, Yuanfei; Liu, Xiao-Li; Zhou, Ji-Chang] Shenzhen Ctr Chron Dis Control, Shenzhen, Guangdong, Peoples R China; [Huang, Changhua] Shenzhen Qilinshan Sanat, Shenzhen, Guangdong, Peoples R China; [Zhou, Ji-Chang] Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Guangdong, Peoples R China; [Zhou, Ji-Chang] Guangdong Prov Engn Lab Nutr Translat, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Zhou, JC (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Shenzhen, Guangdong, Peoples R China.; Zhou, JC (corresponding author), Shenzhen Ctr Chron Dis Control, Shenzhen, Guangdong, Peoples R China.; Zhou, JC (corresponding author), Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Guangdong, Peoples R China.; Zhou, JC (corresponding author), Guangdong Prov Engn Lab Nutr Translat, Guangzhou, Guangdong, Peoples R China.	zhoujch8@mail.sysu.edu.cn	Liu, Xiaoli/HGE-7614-2022	Zhou, Ji-Chang/0000-0003-4177-614X	National Natural Science Foundation of China [81973038]; Healthcare Research Projects of Shenzhen, China [SZGW2017010, SZGW2017015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Healthcare Research Projects of Shenzhen, China	The study was partly supported by the National Natural Science Foundation of China (grant number 81973038 to JCZ) and Healthcare Research Projects of Shenzhen, China (grant number SZGW2017010 to JCZ and SZGW2017015 to CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Website of the National Natural Science Foundation of China: http://www.nsfc.gov.cn/.Website of the Shenzhen Municipal Health Commission: http://wjw.sz.gov.cn/.These were all the sources of funding supporting this study, and there was no additional external funding received for it.	[Anonymous], 2013, THYROID S1, V23, pA13; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2016, J GERIATR CARDIOL; Aung LHH, 2014, INT J MED SCI, V11, P471, DOI 10.7150/ijms.8489; Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019; Bartosz G, 2005, HANDB ENVIRON CHEM, V2, P109; Battistini S, 2010, J NEUROL SCI, V293, P112, DOI 10.1016/j.jns.2010.03.009; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Paes AMD, 2019, ADV EXP MED BIOL, V1127, P97, DOI 10.1007/978-3-030-11488-6_7; Eskandari-Nasab Ebrahim, 2014, Acta Med Iran, V52, P591; Fetherolf MM, 2017, METALLOMICS, V9, P1047, DOI 10.1039/c6mt00298f; Flekac M, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-30; Ghattas MH, 2012, DNA CELL BIOL, V31, P1598, DOI 10.1089/dna.2012.1739; Guo T, 2016, INT J CLIN EXP PATHO, V9, P12942; Guo T, 2015, INT J CLIN EXP PATHO, V8, P665; Hernandez-Guerrero C, 2016, ARCH MED RES, V47, P331, DOI 10.1016/j.arcmed.2016.08.007; [胡盛寿 Hu Shengshou], 2019, [中国循环杂志, Chinese Circulation Journal], V34, P209; Huang YX, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0028-7; Icli A, 2016, ANGIOLOGY, V67, P146, DOI 10.1177/0003319715579781; Kitoh R, 2016, ACTA OTO-LARYNGOL, V136, P465, DOI 10.3109/00016489.2015.1116047; Kolovou V, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-62; Kurahashi T, 2015, BIOCHEM BIOPH RES CO, V467, P866, DOI 10.1016/j.bbrc.2015.10.052; Li S, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0240-3; Lim HJ, 2015, PLATELETS, V26, P758, DOI 10.3109/09537104.2014.995613; Mittendorfer B, 2005, J NUTR, V135, P681, DOI 10.1093/jn/135.4.681; Mohammedi K, 2011, MOL GENET METAB, V104, P654, DOI 10.1016/j.ymgme.2011.08.033; Mondola P, 2002, BIOCHEM BIOPH RES CO, V295, P603, DOI 10.1016/S0006-291X(02)00720-9; Mondola P, 2000, FEBS LETT, V467, P57, DOI 10.1016/S0014-5793(00)01123-6; Mondola P, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00594; Neves AL, 2012, MOL GENET METAB, V106, P359, DOI 10.1016/j.ymgme.2012.04.023; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Otaki Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164732; Palmisano BT, 2018, MOL METAB, V15, P45, DOI 10.1016/j.molmet.2018.05.008; Pan L, 2016, ATHEROSCLEROSIS, V248, P2, DOI 10.1016/j.atherosclerosis.2016.02.006; Panduru NM, 2010, ROM J MORPHOL EMBRYO, V51, P37; Ramasamy I, 2016, CLIN CHIM ACTA, V454, P143, DOI 10.1016/j.cca.2015.10.033; Reusch JEB, 2018, ENDOCRINOLOGY, V159, P9, DOI 10.1210/en.2017-03019; Schwab S, 2017, EUR J GASTROEN HEPAT, V29, P800, DOI 10.1097/MEG.0000000000000878; Seo E, 2019, AGING CELL, V18, DOI 10.1111/acel.12895; Shastry BS, 2007, J HUM GENET, V52, P871, DOI 10.1007/s10038-007-0200-z; Spisak K, 2014, NEUROL NEUROCHIR POL, V48, P342, DOI 10.1016/j.pjnns.2014.09.002; Traglia M, 2017, GENETICS, V205, P979, DOI 10.1534/genetics.116.193623; Tsang CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4446; Uchiyama S, 2006, J BIOL CHEM, V281, P31713, DOI 10.1074/jbc.M603422200; Wang L, 2012, FREE RADICAL BIO MED, V53, P1689, DOI 10.1016/j.freeradbiomed.2012.08.570; Wang XW, 2011, J CLIN ENDOCR METAB, V96, P885, DOI 10.1210/jc.2010-2061; Wang Y, 2018, J CELL BIOL, V217, P1915, DOI 10.1083/jcb.201708007; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yi JF, 2010, WORLD J GASTROENTERO, V16, P4738, DOI 10.3748/wjg.v16.i37.4738; Zhang M, 2018, INT J CARDIOL, V260, P196, DOI 10.1016/j.ijcard.2017.12.069; Zhang Y.L., 2011, GOLD, V32, P9, DOI [10.3969/j.issn.1001-1277.2011.09.003, DOI 10.3969/J.ISSN.1001-1277.2011.09.003]; Zhou JC, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0332-0	53	1	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							SICI 10.1371/journal.pone.0234716.r003	10.1371/journal.pone.0234716	http://dx.doi.org/10.1371/journal.pone.0234716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559230	Green Published, gold			2022-12-27	WOS:000543261600008
J	Chowdhury, R; Taneja, S; Dhabhai, N; Mazumder, S; Upadhyay, RP; Sharma, S; Tupaki-Sreepurna, A; Dewan, R; Mittal, P; Chellani, H; Bahl, R; Bhan, MK; Bhandari, N				Chowdhury, Ranadip; Taneja, Sunita; Dhabhai, Neeta; Mazumder, Sarmila; Upadhyay, Ravi Prakash; Sharma, Sitanshi; Tupaki-Sreepurna, Ananya; Dewan, Rupali; Mittal, Pratima; Chellani, Harish; Bahl, Rajiv; Bhan, Maharaj Kishan; Bhandari, Nita			Burden of preconception morbidity in women of reproductive age from an urban setting in North India	PLOS ONE			English	Article							PREGNANCY; OBESITY; HEALTH; VALIDATION; ORIGINS; ANEMIA	Background There is a growing interest in the life course approach for the prevention, early detection and subsequent management of morbidity in women of reproductive age to ensure optimal health and nutrition when they enter pregnancy. Reliable estimates of such morbidities are lacking. We report the prevalence of health or nutrition-related morbidities, specifically, anemia, undernutrition, overweight and obesity, sexually transmitted infections (STIs) or reproductive tract infections (RTIs), diabetes or prediabetes, hypothyroidism, hypertension, and depressive symptoms, during the preconception period among women aged 18 to 30 years. Methods A cross-sectional study was conducted among 2000 nonpregnant married women aged 18 to 30 years with no or one child who wished to have more children in two low- to middle-income urban neighborhoods in Delhi, India, in the context of a randomized controlled trial. STIs and RTIs were measured by symptoms and signs, blood pressure by a digital device, height by stadiometer and weight by a digital weighing scale. A blood specimen was taken to screen for anemia, diabetes, thyroid disorders and syphilis. Maternal depressive symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9). Multivariable logistic regression analysis was performed to identify sociodemographic factors associated with individual morbidity. Results Overall, 58.7% of women were anemic; 16.5%, undernourished; 26%, overweight or obese; 13.2%, hypothyroid; and 10.5% with both symptoms and signs of STIs/RTIs. There was an increased risk of RTI/STI symptoms and signs in undernourished women and an increased risk of diabetes or prediabetes in overweight or obese women. An increased risk of undernutrition was also observed in women from lower categories of wealth quintiles. A decreased risk of moderate to severe anemia was seen in overweight women and those who completed at least secondary education. Conclusions Our findings show a high burden of undernutrition, anemia, RTIs, hypothyroidism and prediabetes among women in the study. This information will aid policymakers in planning special programs for women of reproductive age.	[Chowdhury, Ranadip; Taneja, Sunita; Dhabhai, Neeta; Mazumder, Sarmila; Upadhyay, Ravi Prakash; Sharma, Sitanshi; Tupaki-Sreepurna, Ananya; Bhandari, Nita] Ctr Hlth Res & Dev, Soc Appl Studies, New Delhi, India; [Dewan, Rupali; Mittal, Pratima; Chellani, Harish] Vardhman Mahavir Med Coll, New Delhi, India; [Dewan, Rupali; Mittal, Pratima; Chellani, Harish] Safdarjang Hosp, New Delhi, India; [Bahl, Rajiv] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland; [Bhan, Maharaj Kishan] Govt India, Dept Biotechnol, Biotechnol Ind Res Assistance Council BIRAC, Knowledge Integrat & Translat Platform KnIT, New Delhi, India	Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital; World Health Organization; Biotechnology Industry Research Assistance Council (BIRAC); Department of Biotechnology (DBT) India	Bhandari, N (corresponding author), Ctr Hlth Res & Dev, Soc Appl Studies, New Delhi, India.	nita.bhandari@sas.org.in	Tupaki-Sreepurna, Ananya/GMW-9192-2022	Tupaki-Sreepurna, Ananya/0000-0001-6665-1488	Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology, Government of India under the Grand Challenges India-All Children Thriving initiative [BIRAC/GCI/0085/03/14-ACT]; Bill & Melinda Gates Foundation, USA [OPP1191052]; Department of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva (WHO Collaborating Centre) [IND-158]; Centre for Intervention Science in Maternal and Child Health (RCN), Centre for International Health, University of Bergen (Norway) [223269]	Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology, Government of India under the Grand Challenges India-All Children Thriving initiative; Bill & Melinda Gates Foundation, USA(Bill & Melinda Gates Foundation); Department of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva (WHO Collaborating Centre); Centre for Intervention Science in Maternal and Child Health (RCN), Centre for International Health, University of Bergen (Norway)	N Initials of the authors who received each award: NB Grant numbers awarded to each author: BIRAC/GCI/0085/03/14-ACT) and Grant ID OPP1191052 The full name of each funder: Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology, Government of India under the Grand Challenges India-All Children Thriving initiative and the Bill & Melinda Gates Foundation, USA. URL of each funder website: https://birac.nic.in/; https://www.gatesfoundation.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Society for Applied Studies acknowledges the core support provided by the Department of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva (WHO Collaborating Centre IND-158) and the Centre for Intervention Science in Maternal and Child Health (RCN Project No. 223269), Centre for International Health, University of Bergen (Norway). We are thankful to Dr. Nikhil Tandon (Professor and Head, Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi), Dr. Anju Virmani (Senior Consultant Endocrinologist) and Dr. Navin Dang (Senior Consultant Microbiologist) for their technical advice on diagnostic criteria and management of thyroid disorders. We are also thankful to Dr. Deepak More for supervising the quality assurance for the different assays. All authors approved the final version of the manuscript.	American Diabetes AssociationStandards of Medical Care in Diabetes, 2018, CLIN DIABETES, V36, P14, DOI DOI 10.2337/cd17-0119; [Anonymous], 2016, IND FACT SHEET NAT F; [Anonymous], 2017, BMJ-BRIT MED J, V358, pj3545, DOI 10.1136/bmj.j3545; Centers for Disease Control USA, LAB PROC MAN; De-Regil Luz Maria, 2015, Cochrane Database Syst Rev, pCD007950, DOI 10.1002/14651858.CD007950.pub3; Dean SV, 2014, REPROD HEALTH, V11, DOI [10.1186/1742-4755-11-S3-S1, 10.1186/1742-4755-11-S3-S3]; Dzakpasu S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0452-0; Fernandez T., 2001, LAB HEMATOLOGY, V7, P217; Fleming TP, 2018, LANCET, V391, P1842, DOI [10.1016/S0140-6736(18)30312-X, 10.1016/s0140-6736(18)30312-x]; Fleming TP, 2015, REPROD FERT DEVELOP, V27, P684, DOI 10.1071/RD14455; Government of India, 2015, HOUS HOUS CENS DAT 2; Government of India: Ministry of Health and Family Welfare, 2016, NAT MENT HLTH SURV I; Government of India: Ministry of Health and Family Welfare, 2018, INT NAT IR PLUS IN 1; Hambidge KM, 2019, AM J CLIN NUTR, V109, P457, DOI 10.1093/ajcn/nqy228; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Khan MN, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0181-0; Kochhar PH, 2007, J POSTGRAD MED, V53, P102, DOI 10.4103/0022-3859.32209; Kordas K, 2013, J NUTR, V143, P175, DOI 10.3945/jn.112.167767; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S3-S5; Maraka S, 2016, THYROID, V26, P580, DOI 10.1089/thy.2015.0418; McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428; Meng LH, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-015-0177-z; Ministry of Health and Family Welfare Government of India, 2014, NAT GUID PREV MAN CO; Msemo OA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208413; Nicholas LM, 2016, INT J OBESITY, V40, P229, DOI 10.1038/ijo.2015.178; Nicholas LM, 2013, FASEB J, V27, P3786, DOI 10.1096/fj.13-227918; Pfizer Inc, PAT HLTH QUEST PHQ 9; Poonam Muttreja, 2018, Indian Journal of Medical Research, V148, P1; Ray K, 2009, INT J INFECT DIS, V13, pE352, DOI 10.1016/j.ijid.2008.11.021; Reisin E, 2014, J AM SOC NEPHROL, V25, P2419, DOI 10.1681/ASN.2014040371; Ronnenberg AG, 2004, J NUTR, V134, P2586, DOI 10.1093/jn/134.10.2586; Ruebel ML, 2017, J CLIN ENDOCR METAB, V102, P2029, DOI 10.1210/jc.2016-3524; Sahay Rakesh Kumar, 2012, Indian J Endocrinol Metab, V16, P364, DOI 10.4103/2230-8210.95667; Satia J, 2018, INDIAN J COMMUN MED, V43, P1, DOI 10.4103/ijcm.IJCM_331_18; Seca Germany, SEC 213; Short MW, 2013, AM FAM PHYSICIAN, V87, P98; Siemens Healthcare Private Limited, ADVIA CENT XP IMM SY; Stephenson J, 2018, LANCET, V391, P1830, DOI [10.1016/S0140-6736(18)30311-8, 10.1016/s0140-6736(18)30311-8]; Tosoh Europe NV, HPLC AN; Tripathy JP, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0207-3; University of California San Franciso, ADVIA CENT SYST FERR; Unnikrishnan Ambika Gopalakrishnan, 2013, Indian J Endocrinol Metab, V17, P647, DOI 10.4103/2230-8210.113755; WHO, 2011, SER FERR CONC ASS IR; Witt WP, 2012, MATERN CHILD HLTH J, V16, P1525, DOI 10.1007/s10995-011-0916-4; World Health Organization, 2011, VITAMIN MINERAL NUTR; Wyman A, 2008, ENDOCRINOLOGY, V149, P466, DOI 10.1210/en.2007-1273	46	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234768	10.1371/journal.pone.0234768	http://dx.doi.org/10.1371/journal.pone.0234768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555694	gold, Green Published			2022-12-27	WOS:000543273200033
J	Anwar, O; Gunawardene, MA; Dickow, J; Scherschel, K; Jungen, C; Munkler, P; Eickholt, C; Willems, S; Gessler, N; Meyer, C				Anwar, Omar; Gunawardene, Melanie A.; Dickow, Jannis; Scherschel, Katharina; Jungen, Christiane; Muenkler, Paula; Eickholt, Christian; Willems, Stephan; Gessler, Nele; Meyer, Christian			Contemporary analysis of phrenic nerve injuries following cryoballoon-based pulmonary vein isolation: A single-centre experience with the systematic use of compound motor action potential monitoring	PLOS ONE			English	Article							2ND-GENERATION CRYOBALLOON; ATRIAL-FIBRILLATION; ABLATION; EFFICACY; 1ST; RECORDINGS; SAFETY; PALSY	Background Phrenic nerve injury (PNI) remains one of the most frequent complications during cryoballoon-based pulmonary vein isolation (CB-PVI). Since its introduction in 2013, the use of compound motor action potential (CMAP) for the prevention of PNI during CB-PVI is increasing; however, systematic outcome data are sparse. Methods The CMAP technique was applied in conjunction with abdominal palpation during pacing manoeuvres (10 mV, 2 ms) from the superior vena cava for 388 consecutive patients undergoing CB-PVI between January 2015 and May 2017 at our tertiary arrhythmia centre. Cryoablation was immediately terminated when CMAP amplitude was reduced by 30%. Results Reductions in CMAP amplitude were observed in 16 (4%) of 388 patients during isolation of the right veins. Of these, 11 (69%) patients did not manifest a reduction in diaphragmatic excursions. The drop in CMAP amplitude was observed in 10 (63%) patients during ablation of the right superior pulmonary veins (PVs) and in 7 (44%) patients during ablation of the right inferior PVs. Postprocedural persistent PNI was observed in three of four patients for a duration of 6 months, with one of these patients remaining symptomatic at the 24-month follow-up. One of the four patients was lost to long-term follow-up. Conclusions All PNIs occurred during right-sided CB-PVI and were preceded by a reduction in CMAP amplitude. Thus, the standardized use of CMAP surveillance during CB-PVI is easily applicable, reliable and compared with other studies, results in a lower number of PNIs.	[Anwar, Omar; Gunawardene, Melanie A.; Eickholt, Christian; Willems, Stephan; Gessler, Nele] Semmelweis Univ, Fac Med, Asklepios Clin St Georg, Dept Cardiol, Campus Hamburg, Hamburg, Germany; [Dickow, Jannis; Scherschel, Katharina; Jungen, Christiane; Muenkler, Paula; Meyer, Christian] Univ Hosp Hamburg Eppendorf, Dept Cardiac Electrophysiol, Heart & Vasc Ctr, Hamburg, Germany; [Scherschel, Katharina; Jungen, Christiane; Muenkler, Paula; Eickholt, Christian; Willems, Stephan; Gessler, Nele; Meyer, Christian] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Luebeck, Berlin, Germany; [Scherschel, Katharina; Meyer, Christian] EVK Dusseldorf, Div Cardiol Cardiac Neuro & Electrophysiol Res Co, Dusseldorf, Germany; [Meyer, Christian] Heinrich Heine Univ Dusseldorf, Cardiac Neuro & Electrophysiol Res Consortium cNE, Inst Neural & Sensory Physiol, Fac Med, Dusseldorf, Germany	Asklepios Klinik St. Georg; Semmelweis University; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; Heinrich Heine University Dusseldorf	Meyer, C (corresponding author), Univ Hosp Hamburg Eppendorf, Dept Cardiac Electrophysiol, Heart & Vasc Ctr, Hamburg, Germany.; Meyer, C (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Luebeck, Berlin, Germany.; Meyer, C (corresponding author), EVK Dusseldorf, Div Cardiol Cardiac Neuro & Electrophysiol Res Co, Dusseldorf, Germany.; Meyer, C (corresponding author), Heinrich Heine Univ Dusseldorf, Cardiac Neuro & Electrophysiol Res Consortium cNE, Inst Neural & Sensory Physiol, Fac Med, Dusseldorf, Germany.	c.mey@web.de	Eickholt, Christian/G-1466-2013	Eickholt, Christian/0000-0002-5458-9688; Jungen, Christiane/0000-0003-4062-3299; Meyer, Christian/0000-0003-0217-3960				[Anonymous], 2015, J OPER OCEANOGR, V8, ps80, DOI 10.1080/1755876X.2015.1022329; [Anonymous], 2009, REPORT SCOTTISH CIVL, V2, P43; Boveda S, 2018, JACC-CLIN ELECTROPHY, V4, P1440, DOI 10.1016/j.jacep.2018.07.007; Casado-Arroyo R, 2013, HEART RHYTHM, V10, P1318, DOI 10.1016/j.hrthm.2013.07.005; Chierchia GB, 2014, EUROPACE, V16, P639, DOI 10.1093/europace/eut417; Ciconte G, 2015, HEART RHYTHM, V12, P673, DOI 10.1016/j.hrthm.2014.12.026; DAVIS JN, 1967, J NEUROL NEUROSUR PS, V30, P420, DOI 10.1136/jnnp.30.5.420; Di Giovanni G, 2014, J CARDIOVASC ELECTR, V25, P834, DOI 10.1111/jce.12409; Franceschi F, 2011, HEART RHYTHM, V8, P1068, DOI 10.1016/j.hrthm.2011.01.047; Furnkranz A, 2015, EUROPACE, V17, P574, DOI 10.1093/europace/euu320; Furnkranz A, 2014, J CARDIOVASC ELECTR, V25, P840, DOI 10.1111/jce.12417; Ghosh J, 2013, HEART RHYTHM, V10, P646, DOI 10.1016/j.hrthm.2013.01.011; Gunawardene MA, 2018, EUROPACE, V20, P43, DOI 10.1093/europace/euw307; Han KY, 2015, PM&R, V7, P214, DOI 10.1016/j.pmrj.2014.11.005; Kokatnur Laxmi, 2018, DISEASES, V6, P16; Kuck KH, 2016, NEW ENGL J MED, V374, P2235, DOI 10.1056/NEJMoa1602014; Lakhani M, 2014, HEART RHYTHM, V11, P369, DOI 10.1016/j.hrthm.2013.11.015; Martins RP, 2014, HEART RHYTHM, V11, P386, DOI 10.1016/j.hrthm.2014.01.002; Meissner A, 2016, INT J MED SCI, V13, P403, DOI 10.7150/ijms.14383; Metzner A, 2014, CIRC-ARRHYTHMIA ELEC, V7, P288, DOI 10.1161/CIRCEP.114.001473; Miyazaki S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008249; Molenaar MMD, 2019, PACE, V42, P508, DOI 10.1111/pace.13626; Mondesert B, 2014, CIRC-ARRHYTHMIA ELEC, V7, P605, DOI 10.1161/CIRCEP.113.001238; Mugnai Giacomo, 2015, EP EUROPACE, V18, P702; Okishige K, 2018, J INTERV CARD ELECTR, V53, P233, DOI 10.1007/s10840-018-0379-2; Prochnau D, 2018, IJC HEART VASC, V21, P50, DOI 10.1016/j.ijcha.2018.09.009; Saitoh Yukio, 2015, EP EUROPACE, V18, P1179; Sharma PS, 2016, J CARDIOVASC ELECTR, V27, P1384, DOI 10.1111/jce.13082; Straube F, 2014, CIRC-ARRHYTHMIA ELEC, V7, P293, DOI 10.1161/CIRCEP.113.000899; Stroker E, 2016, HEART RHYTHM, V13, P342, DOI 10.1016/j.hrthm.2015.10.017; Su W, 2015, HEART RHYTHM, V12, P1658, DOI 10.1016/j.hrthm.2015.03.021; Zhang Xiaoming, 2015, INT J U AND E SERV S, V8, P303, DOI DOI 10.14257/IJUNESST.2015.8.9.31	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235132	10.1371/journal.pone.0235132	http://dx.doi.org/10.1371/journal.pone.0235132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584880	Green Published, gold			2022-12-27	WOS:000545747200021
J	Azam, MW; Kumar, A; Khan, AU				Azam, Mohd W.; Kumar, Amit; Khan, Asad U.			ACD: Antimicrobial chemotherapeutics database	PLOS ONE			English	Article								Antimicrobial resistance is becoming a growing health problem, which has become a challenge for the physicians to control infection and also an economic burden on the healthcare. This increase in resistance to the present antimicrobial agents led the researchers to find some alternative and more efficient drugs which can fight with the resistant microorganisms more effectively. Hence,in silicoapproach is used to design some novel drugs against various targets of microorganisms. For effective virtual screening of the drugs, there is a need to know about the chemical structure and properties of the antimicrobial agents. Therefore, we have prepared a comprehensive database as a platform for the researcher to search for possible lead molecules. Antimicrobial chemotherapeutics database (ACD) is comprised of similar to 4100 synthetic antimicrobial compounds as well as similar to 1030 active antimicrobial peptides. The Antimicrobial peptides are mainly from biological sources but some of them are synthetic in nature. Only those compounds, which are found to be active against either bacteria (both Gram-positive and negative) or fungus, are selected for this database.The ACD database is freely available at URL:, and it is compatible with desktops, smartphones, and tablets.	[Azam, Mohd W.; Kumar, Amit; Khan, Asad U.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Khan, AU (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India.	asad.k@rediffmail.com	Khan, Asad U/K-8157-2013	Khan, Asad U/0000-0001-9191-9423; Azam, Mohammad/0000-0002-4274-2796				[Anonymous], 2016, NUCLEIC ACIDS RES, V44, pD7; Bienfait B, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-24; Chen JH, 2007, BIOINFORMATICS, V23, P2348, DOI 10.1093/bioinformatics/btm341; Hammami R, 2009, NUCLEIC ACIDS RES, V37, pD963, DOI 10.1093/nar/gkn655; Khan AU, 2012, SCAND J INFECT DIS, V44, P531, DOI 10.3109/00365548.2012.669046; Khan SN, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00174; Matar GM, 2020, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00458; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; The Gene Ontology Consortium, 2019, NUCLEIC ACIDS RES, V47, pD330; Waghu FH, 2015, NUCL ACIDS RES, pgkv1051v1; Wang YL, 2017, NUCLEIC ACIDS RES, V45, pD955, DOI 10.1093/nar/gkw1118; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037	12	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235193	10.1371/journal.pone.0235193	http://dx.doi.org/10.1371/journal.pone.0235193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584882	gold, Green Published			2022-12-27	WOS:000545747200045
J	Chansaenroj, J; Chuchaona, W; Lestari, FB; Pasittungkul, S; Klinfueng, S; Wanlapakorn, N; Vongpunsawad, S; Chirathaworn, C; Poovorawan, Y				Chansaenroj, Jira; Chuchaona, Watchaporn; Lestari, Fajar Budi; Pasittungkul, Siripat; Klinfueng, Sirapa; Wanlapakorn, Nasamon; Vongpunsawad, Sompong; Chirathaworn, Chintana; Poovorawan, Yong			High prevalence of DS-1-like rotavirus infection in Thai adults between 2016 and 2019	PLOS ONE			English	Article							NATIONAL IMMUNIZATION PROGRAM; POLYMERASE-CHAIN-REACTION; GROUP-A ROTAVIRUS; ACUTE GASTROENTERITIS; EQUINE-LIKE; REASSORTANT ROTAVIRUS; VACCINE EFFECTIVENESS; G3 ROTAVIRUS; CHILDREN; STRAINS	Rotavirus infection is the most common cause of viral diarrhea in infants and young children but uncommon and usually asymptomatic in adults. In the winter of 2017-2018, a large-scale outbreak of rotavirus in both children and adults was reported in Thailand. The current study focused on the prevalence, genotyping, and molecular characterization of rotavirus infections in Thai adults from July 2016 to December 2019. In 2,598 stool samples collected from adult residents of Bangkok (aged #x2265; 15 years) with acute gastroenteritis, rotavirus was detected via real-time RT-PCR analysis of theVP6gene.G,PandIgenotypes were determined by direct sequencing ofVP7,VP4, andVP6genes, respectively. Our results showed 8.7% (226/2,598) of stool samples were positive for rotavirus. The incidence of rotavirus was high during the winter season of 2017-2018 (17.7%) compared to another studied periods (4.5% between July 2016- October 2017 and 2.8% between March 2018- December 2019). Nucleotide sequencing ofVP7andVP4revealedG3P[8]as the predominant strain (33.2%,75/226), followed byG9P[8](17.3%,39/226), andG2P[4](15.0%,34/226). Uncommon G and P combinations were additionally detected at low frequencies.VP6sequencing was conducted to discriminateIgenotype between the Wa and DS-1 genogroup. The unusual DS-1-likeG3P[8]strain was most prevalent amomg rotavirus strains detected in this study (29.6%, 67/226), and the correspondingVP7sequences showed high nucleotide identity with unusual DS-1-like globally circulating strains. Our study demonstrates that rotavirus outbreaks in adults are attributable not only to high prevalence of RV infection but also the unusual DS-like genogroup. The collective findings reinforce the importance of investigating rotavirus diagnosis in adults suffering from acute gastroenteritis and taking appropriate preventive measures.	[Chansaenroj, Jira; Chuchaona, Watchaporn; Lestari, Fajar Budi; Pasittungkul, Siripat; Klinfueng, Sirapa; Wanlapakorn, Nasamon; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand; [Chirathaworn, Chintana] Chulalongkorn Univ, Dept Microbiol, Fac Med, Bangkok, Thailand; [Lestari, Fajar Budi] Univ Gadjah Mada, Anim Hlth Study Program, Dept Bioresources Technol & Vet, Vocat Coll, Bangkok, Thailand; [Wanlapakorn, Nasamon] Chulalongkorn Univ, Fac Med, Div Acad Affairs, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand.	Yong.P@chula.ac.th	Lestari, Fajar Budi/GLS-9734-2022; ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Lestari, Fajar Budi/0000-0002-9684-5344; vongpunsawad, sompong/0000-0001-7520-8728; Poovorawan, Yong/0000-0002-2337-6807	National Science and Technology Development Agency [P-15-50004]; Center of Excellence in Clinical Virology, Chulalongkorn University Jira Chansaenroj [GCE 59-009-30-005]; Rachadapisek Sompote Fund	National Science and Technology Development Agency; Center of Excellence in Clinical Virology, Chulalongkorn University Jira Chansaenroj; Rachadapisek Sompote Fund	Yong Poovorawan; P-15-50004, The Research Chair Grant from the National Science and Technology Development Agency Yong Poovorawan; GCE 59-009-30-005, The Center of Excellence in Clinical Virology, Chulalongkorn University Jira Chansaenroj; Rachadapisek Sompote Fund for Postdoctoral Fellowship, Chulalongkorn University The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2004, LANCET INFECT DIS, V4, P91, DOI 10.1016/S1473-3099(04)00928-4; Anderson EJ, 2013, CLIN INFECT DIS, V56, P755, DOI 10.1093/cid/cis1010; Anderson EJ, 2012, J INFECTION, V64, P89, DOI 10.1016/j.jinf.2011.09.003; Arana A, 2016, INFECT GENET EVOL, V44, P137, DOI 10.1016/j.meegid.2016.06.048; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Bahl R, 2005, J INFECT DIS, V192, pS114, DOI 10.1086/431497; Braeckman T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4752; Chan-It W, 2018, J MED VIROL, V90, P477, DOI 10.1002/jmv.24985; Chansaenroj J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182078; Chieochansin T, 2008, JPN J INFECT DIS, V61, P479; Chieochansin T, 2016, INFECT GENET EVOL, V37, P129, DOI 10.1016/j.meegid.2015.11.011; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; Cowley D, 2016, J GEN VIROL, V97, P403, DOI 10.1099/jgv.0.000352; Crawford SE, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.83; Doro R, 2016, ACTA MICROBIOL IMM H, V63, P243, DOI 10.1556/030.63.2016.2.8; ECHEVERRIA P, 1983, J CLIN MICROBIOL, V18, P663, DOI 10.1128/JCM.18.3.663-667.1983; Fukuda S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231099; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; GRIMWOOD K, 1983, BRIT MED J, V287, P575, DOI 10.1136/bmj.287.6392.575; Jere KC, 2019, EMERG INFECT DIS, V25, P1734, DOI 10.3201/eid2509.190258; Kang G, 2004, J MED VIROL, V73, P118, DOI 10.1002/jmv.20053; Katz EM, 2019, VIROLOGY, V534, P114, DOI 10.1016/j.virol.2019.06.007; Kikuchi W, 2018, ARCH VIROL, V163, P791, DOI 10.1007/s00705-017-3668-7; KIM HW, 1977, JAMA-J AM MED ASSOC, V238, P404, DOI 10.1001/jama.238.5.404; Kirkwood CD, 2011, PEDIATR INFECT DIS J, V30, pS48, DOI 10.1097/INF.0b013e3181fefd90; Kittigul L, 2014, SE ASIAN J TROP MED, V45, P816; Lestari FB, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00649-8; Luchs A, 2019, J GEN VIROL, V100, P7, DOI 10.1099/jgv.0.001171; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Muangchana C, 2012, VACCINE, V30, P2839, DOI 10.1016/j.vaccine.2012.02.047; Nakagomi T, 2020, EMERG INFECT DIS, V26, P184, DOI 10.3201/eid2601.191377; Nakagomi T, 2017, ARCH VIROL, V162, P739, DOI 10.1007/s00705-016-3155-6; Ono M, 2020, PEDIATR INT, V62, P569, DOI 10.1111/ped.14150; Perkins C, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.01341-17; Phumpholsup T, 2015, ARCH VIROL, V160, P2603, DOI 10.1007/s00705-015-2545-5; Pongsuwannna Y, 2010, J MED VIROL, V82, P157, DOI 10.1002/jmv.21596; Roczo-Farkas S, 2018, J INFECT DIS, V218, P546, DOI 10.1093/infdis/jiy197; Guerra SFS, 2016, J GEN VIROL, V97, P3131, DOI 10.1099/jgv.0.000626; Satter SM, 2017, PEDIATR INFECT DIS J, V36, P168, DOI 10.1097/INF.0000000000001381; Sriwanna P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-193; Tacharoenmuang R, 2020, J MED VIROL, V92, P174, DOI 10.1002/jmv.25591; Theamboonlers A, 2014, INFECT GENET EVOL, V21, P295, DOI 10.1016/j.meegid.2013.11.020; Tsugawa T, 2014, J VIROL, V88, P5543, DOI 10.1128/JVI.00041-14; Utsumi T, 2018, INFECT GENET EVOL, V61, P224, DOI 10.1016/j.meegid.2018.03.027; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; WENMAN WM, 1979, NEW ENGL J MED, V301, P303, DOI 10.1056/NEJM197908093010604; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	51	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235280	10.1371/journal.pone.0235280	http://dx.doi.org/10.1371/journal.pone.0235280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584905	Green Published, gold			2022-12-27	WOS:000545747200063
J	Cuesta, LM; Liron, JP; Farias, MVN; Dolcini, GL; Ceriani, MC				Cuesta, Lucia Martinez; Liron, Juan Pedro; Nieto Farias, Maria Victoria; Dolcini, Guillermina Laura; Ceriani, Maria Carolina			Effect of bovine leukemia virus (BLV) infection on bovine mammary epithelial cells RNA-seq transcriptome profile	PLOS ONE			English	Article							IMMUNE-RESPONSE; EXPRESSION	Bovine leukemia virus (BLV) is a delta-retrovirus responsible for Enzootic Bovine Leukosis (EBL), a lymphoproliferative disease that affects cattle. The virus causes immune system deregulation, favoring the development of secondary infections. In that context, mastitis incidence is believed to be increased in BLV infected cattle. The aim of this study was to analyze the transcriptome profile of a BLV infected mammary epithelial cell line (MAC-T). Our results show that BLV infected MAC-T cells have an altered expression of IFN I signal pathway and genes involved in defense response to virus, as well as a collagen catabolic process and some protooncogenes and tumor suppressor genes. Our results provide evidence to better understand the effect of BLV on bovine mammary epithelial cell's immune response.	[Cuesta, Lucia Martinez; Nieto Farias, Maria Victoria; Dolcini, Guillermina Laura; Ceriani, Maria Carolina] Consejo Nacl Invest Cient & Tecn CONICET, Ctr Invest Vet Tandil CIVETAN, SAMP Dept, Virol, Tandil, Buenos Aires, Argentina; [Liron, Juan Pedro] Consejo Nacl Invest Cient & Tecn CONICET, Ctr Invest Vet Tandil CIVETAN, FISFARVET Dept, Pharmacol, Tandil, Buenos Aires, Argentina		Ceriani, MC (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Ctr Invest Vet Tandil CIVETAN, SAMP Dept, Virol, Tandil, Buenos Aires, Argentina.	cceriani@vet.unicen.edu.ar	Dolcini, Guillermina Laura/AAC-2546-2022		AGENCIA NACIONAL DE PROMOCION CIENTIFICA Y TECNOLOGICA [GLD. PICT 2016-4409, MCC.PICT 2017-0378]	AGENCIA NACIONAL DE PROMOCION CIENTIFICA Y TECNOLOGICA(ANPCyT)	GLD. PICT 2016-4409 AGENCIA NACIONAL DE PROMOCION CIENTIFICA Y TECNOLOGICA. www.agencia.mincyt.gob.ar.MCC.PICT 2017-0378 AGENCIA NACIONAL DE PROMOCION CIENTIFICA Y TECNOLOGICA. www.agencia.mincyt.gob.ar.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Arainga M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-121; Artesi M, 2015, NEURO-ONCOLOGY, V17, P392, DOI 10.1093/neuonc/nou215; Bartlett PC, 2014, JAVMA-J AM VET MED A, V244, P914, DOI 10.2460/javma.244.8.914; Bohnekamp J, 2011, J BIOL CHEM, V286, P41912, DOI 10.1074/jbc.C111.265934; Brym P, 2017, MOL BIOL REP, V44, P109, DOI 10.1007/s11033-016-4088-6; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Cui KS, 2020, ONCOGENE, V39, P786, DOI 10.1038/s41388-019-1026-9; DiMartino JF, 2006, LEUKEMIA, V20, P426, DOI 10.1038/sj.leu.2404102; Dubail J, 2010, CELL MOL LIFE SCI, V67, P4213, DOI 10.1007/s00018-010-0431-6; Florins A, 2007, FRONT BIOSCI-LANDMRK, V12, P1520, DOI 10.2741/2165; Guo L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00247; Howell C, 2018, CLIN EXP ALLERGY, V48, P1214, DOI 10.1111/cea.13215; HUYNH HT, 1991, EXP CELL RES, V197, P191, DOI 10.1016/0014-4827(91)90422-Q; Katsounas A, 2011, INT REV IMMUNOL, V30, P366, DOI 10.3109/08830185.2011.593105; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kumar M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26350; Lam WY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-344; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lin TY, 2016, ONCOTARGET, V7, P10228, DOI 10.18632/oncotarget.7169; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Cuesta LM, 2019, VIRUS RES, V271, DOI 10.1016/j.virusres.2019.197678; Cuesta LM, 2018, VIRUS RES, V256, P11, DOI 10.1016/j.virusres.2018.07.013; Cuesta LM, 2018, J MAMMARY GLAND BIOL, V23, P101, DOI 10.1007/s10911-018-9397-z; Nick JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162490; Nookala AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078855; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Parker D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003951; Penzo M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010055; Said N, 2013, J CLIN INVEST, V123, P4089, DOI 10.1172/JCI71241; Sandev Nikolay, 2004, Veterinarski Arhiv, V74, P411; Sayar N, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0138-5; Warnes G.R., Various R Programming Tools for Plotting Data 2020; Watanabe A, 2019, J VET MED SCI, V81, P1431, DOI 10.1292/jvms.19-0285; Wu XL, 2019, KAOHSIUNG J MED SCI, V35, P209, DOI 10.1002/kjm2.12037; Zhang M, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0176-z; Zhao Y, 2019, PHOSPHORUS CHEMISTRY: THE ROLE OF PHOSPHORUS IN PREBIOTIC CHEMISTRY, P1	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234939	10.1371/journal.pone.0234939	http://dx.doi.org/10.1371/journal.pone.0234939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579585	Green Published, gold			2022-12-27	WOS:000545646600052
J	Singh, S; Toor, JS; Sharma, A; Arora, SK				Singh, Sukhvinder; Toor, Jaideep S.; Sharma, Aman; Arora, Sunil K.			Signature genes associated with immunological non-responsiveness to anti-retroviral therapy in HIV-1 subtype-c infection	PLOS ONE			English	Article							COUNT RECOVERY; EXPRESSION; COMBINATION; RESTORATION; MECHANISMS; RESPONSES; CELLS; RISK; AIDS	Objective HIV-infected individuals undergoing therapy may show an immunological-discordant response to therapy, with poor CD4(+)T cells recovery, despite viral suppression below the detection limit. The present study was carried out to delineate the underlying molecular mechanisms of immunological non-responsiveness to HIV therapy. Design We conducted microarray-based whole gene expression profiles of 30 subjects infected with HIV-1 subtype C, in peripheral blood to discern the signature genes associated with immunological non-responsiveness. After a thorough analysis and comparison of gene-expression profiles, microarray data was validated via qRT-PCR approach. Results Overall, we found 10 genes significantly up-regulated and 60 genes down-regulated (>= 2-fold change) in immunological non-responders as compared to responders. Based on these results and pathway analysis of the protein-protein interaction, 20 genes were shortlisted for validation in human infected cases. We found statistically significant differences in expression levels of twelve genesIL-1 alpha,IL-1 beta,IL-7R,TNF-alpha,FoxP3,PDCD5,COX7B,SOCS1,SOCS3,RPL9,RPL23,and LRRN3respectively among immunological non-responders compared to therapy responders, confirming their an intimate relationship with immunological responsiveness to therapy. Conclusions Altogether, microarray and qRT-PCR validation results indicated that the aberrant expression of key genes involved in the regulation of T cell homeostasis, immune activation, inflammatory cytokine production, apoptosis, and immune-regulatory processes are possibly associated with immunological non-responsiveness in HIV-1 C infected individuals on ART.	[Singh, Sukhvinder; Toor, Jaideep S.; Arora, Sunil K.] Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh, India; [Sharma, Aman] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Arora, SK (corresponding author), Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh, India.	arora.sunilkumar@pgimer.edu.in		Arora, Sunil K/0000-0002-8294-5360	Department of Biotechnology (DBT), Ministry of Science and Technology, Govt. of India [BT/PR4564/MED/29/348/2012]	Department of Biotechnology (DBT), Ministry of Science and Technology, Govt. of India(Department of Biotechnology (DBT) India)	The study was supported by a research grant (No. BT/PR4564/MED/29/348/2012) from the Department of Biotechnology (DBT), Ministry of Science and Technology, Govt. of India, which now stands expired. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Albano F, 2014, ONCOTARGET, V5, P649, DOI 10.18632/oncotarget.1619; Autran B, 1999, IMMUNOL LETT, V66, P207, DOI 10.1016/S0165-2478(98)00159-X; Bandera A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00214; Benveniste O, 2005, J INFECT DIS, V191, P1670, DOI 10.1086/429670; Boulware DR, 2010, JAIDS-J ACQ IMM DEF, V55, P428, DOI 10.1097/QAI.0b013e3181ef4963; de Kivit S, 2015, CLIN IMMUNOL, V156, P28, DOI 10.1016/j.clim.2014.10.009; Donatin E, 2012, MED MALADIES INFECT, V42, P453, DOI 10.1016/j.medmal.2012.07.017; Dragsted UB, 2004, J INFECT DIS, V190, P148, DOI 10.1086/420786; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Engsig FN, 2014, CLIN INFECT DIS, V58, P1312, DOI 10.1093/cid/ciu038; Estes JD, 2015, J INFECT DIS, V211, P744, DOI 10.1093/infdis/jiu519; Gaardbo JC, 2014, JAIDS-J ACQ IMM DEF, V66, P349, DOI 10.1097/QAI.0000000000000173; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Girard A, 2016, J ACQUIR IMMUNE DEFI; Guihot A, 2011, TRENDS IMMUNOL, V32, P131, DOI 10.1016/j.it.2010.12.002; Haas DW, 2006, J INFECT DIS, V194, P1098, DOI 10.1086/507313; Hartling HJ, 2014, AIDS, V28, P1739, DOI 10.1097/QAD.0000000000000354; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luque MC, 2014, MOL IMMUNOL, V62, P63, DOI 10.1016/j.molimm.2014.05.016; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Piketty C, 1998, AIDS, V12, P745, DOI 10.1097/00002030-199807000-00011; Schechter M, 2006, J ANTIMICROB CHEMOTH, V58, P506, DOI 10.1093/jac/dkl263; Singh S, 2016, CYTOKINE, V77, P135, DOI 10.1016/j.cyto.2015.11.009; Singh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098020; Tincati C, 2016, AIDS; Toor JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106815; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052; Zoufaly A, 2011, J INFECT DIS, V203, P364, DOI 10.1093/jinfdis/jiq055	29	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234270	10.1371/journal.pone.0234270	http://dx.doi.org/10.1371/journal.pone.0234270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579550	gold, Green Published			2022-12-27	WOS:000545646600002
J	Alhassan, RK; Karley, QOB; Ackah, EF; Adodoaji, I				Alhassan, Robert Kaba; Karley, Quarshie-Odoo Benedicta; Ackah, Ennin Francis; Adodoaji, Irene			Implementation of the policy protocol for management of surgical and non-surgical wounds in selected public health facilities in Ghana: An analytic case study	PLOS ONE			English	Article							CARE	Background It is estimated that millions of patients are affected by healthcare associated infections (HAIs) each year. In Ghana, high prevalence of HAIs in relation to non-surgical (also called contaminated wounds) and surgical wounds (also called sterile wounds) is largely attributed to poor adherence to policy protocols for wound management by frontline clinical staff especially nurses. Objective Investigate the extent to which nursing staff adhere to the policy protocol for management of non-surgical and surgical wounds in selected public health facilities in Ghana. Methodology This is an analytic case study among nursing staff (n = 140) in three government facilities in the Volta region of Ghana. Subjective and objective performance scores of staff on adherence proxies were compared using the Wilcoxon Signed-rank test, and univariate ordered logistic regression analysis used to predict staff likelihood of adherence to policy protocols on non-surgical and surgical wound management. Findings Overall, staff self-rated themselves higher on subjective performance proxies relative to their objective scores (p<0.05). Staff with more years of work experience did not translate into a higher likelihood of adhering to standard protocol on wound management (Coef. = -0.49, CI = -0.93-0.05, p = 0.036). Being a senior nursing officer relative to lower nursing ranks increased staff likelihood of complying particularly with standard policy protocol for management of non-surgical wounds (Coef. 5.27, CI = 0.59 9.95, p = 0.027). Conclusion There is the need for accelerated in-service training for staff on standard protocols for wound management coupled with supportive supervisions. Staff adherence to standard quality care protocols should be a pre-requisite for licensing of health facilities by regulatory bodies like Health Facilities Regulatory Agency and National Health Insurance Authority.	[Alhassan, Robert Kaba] Univ Hlth & Allied Sci, Inst Hlth Res, Ho, Ghana; [Karley, Quarshie-Odoo Benedicta; Ackah, Ennin Francis; Adodoaji, Irene] Univ Hlth & Allied Sci, Sch Nursing & Midwifery, Dept Nursing, Ho, Ghana		Alhassan, RK (corresponding author), Univ Hlth & Allied Sci, Inst Hlth Res, Ho, Ghana.	arkabason@gmail.com		Alhassan, Robert Kaba/0000-0003-4227-4854				Abdullah F, 2011, J SURG RES, V171, P461, DOI 10.1016/j.jss.2010.04.016; Ackumey MM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001187; Addison NO, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005331; Adugbire BA, 2018, BMC NURS, V17, DOI 10.1186/s12912-018-0299-6; Alhassan RK, 2019, TROP MED HEALTH, V47, DOI 10.1186/s41182-019-0163-8; Alhassan RK, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3931-6; Allegranzi B, 2013, LANCET INFECT DIS, V13, P843, DOI 10.1016/S1473-3099(13)70163-4; Ameyaw J. A. O., 2014, THESIS; [Anonymous], 2009, CARDIOVASCULAR THERA, V8, pS4; [Anonymous], 2019, OPTICS EXPRESS, V27, pA581; Apanga S., 2014, INT J RES HLTH SCI, V2, P207; Avoka Asamani James, 2014, Br J Nurs, V23, P48; BaMohammed A., 2018, IOSR J NURSING HLTH, V7, P01; Carroll E, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.5.FOCUS19250; Clegg-Lamptey J N A, 2007, East Afr Med J, V84, P561; Deal Jr J. B., 2019, J HAND SURG; Dinh A, 2019, MED MALADIES INFECT, V49, P9, DOI 10.1016/j.medmal.2018.05.004; Dobson MW, 2011, COLORECTAL DIS, V13, P811, DOI 10.1111/j.1463-1318.2010.02302.x; Faraway J., 2004, LINEAR MODELS R; Ghana Health Service (GHS), 2019, FACTAND FIG; Gonzaga de Faria GB, 2016, REV ENFERM UFPE, V10, P4532, DOI DOI 10.5205/1981-8963-V10I12A11520P4532-4538-2016; Grouzard V., 2018, MED SANS FRONTIERES; Judson R. T., 2019, TXB SURG, P45; Kpeli GS, 2019, CHAM, V29, P227, DOI DOI 10.1007/978-3-030-11114-4_13; Krejcie R.V., 1960, EDUC PSYCHOL MEAS, V30, P607; Labi AK, 2019, J HOSP INFECT, V101, P60, DOI 10.1016/j.jhin.2018.04.019; McCluskey P, 2012, WOUNDS UK, V8, P37; Nursing and Midwifery Council (NMC) of Ghana, 2015, REV CURR REG GEN NUR; Ranjeva SL, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000347; Stewart BT, 2015, INT J SURG, V21, P168, DOI 10.1016/j.ijsu.2015.08.002; Tindall B, 2014, BAILLIERES NURSES DI; Velding K, 2014, AM J TROP MED HYG, V91, P313, DOI 10.4269/ajtmh.13-0255; Welsh L, 2018, INT WOUND J, V15, P53, DOI 10.1111/iwj.12822; World Health Organization, 2018, GLOB GUID PREV SURG; 2019, J WOUND CARE, V28, pS	35	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234874	10.1371/journal.pone.0234874	http://dx.doi.org/10.1371/journal.pone.0234874			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574200	Green Published, gold			2022-12-27	WOS:000544972400008
J	Giao, DM; Wang, Y; Rojas, R; Takaba, K; Badathala, A; Spaulding, KA; Soon, G; Zhang, Y; Wang, VY; Haraldsson, H; Liu, J; Saloner, D; Guccione, JM; Ge, L; Wallace, AW; Ratcliffe, MB				Giao, Duc M.; Wang, Yan; Rojas, Renan; Takaba, Kiyoaki; Badathala, Anusha; Spaulding, Kimberly A.; Soon, Gilbert; Zhang, Yue; Wang, Vicky Y.; Haraldsson, Henrik; Liu, Jing; Saloner, David; Guccione, Julius M.; Ge, Liang; Wallace, Arthur W.; Ratcliffe, Mark B.			Left ventricular geometry during unloading and the end-systolic pressure volume relationship: Measurement with a modified real-time MRI-based method in normal sheep	PLOS ONE			English	Article							HEART-FAILURE; WALL STRESS; CONTRACTILITY; FERUMOXYTOL; DYSFUNCTION; MYOCARDIUM; STIFFNESS; RISK	The left ventricular (LV) end-systolic (ES) pressure volume relationship (ESPVR) is the cornerstone of systolic LV function analysis. We describe a 2D real-time (RT) MRI-based method (RTPVR) with separate software tools for 1) semi-automatic level set-based shape prior method (LSSPM) of the LV, 2) generation of synchronized pressure area loops and 3) calculation of the ESPVR. We used the RTPVR method to measure ventricular geometry, ES pressure area relationship (ESPAR) and ESPVR during vena cava occlusion (VCO) in normal sheep. 14 adult sheep were anesthetized and underwent measurement of LV systolic function. Ten of the 14 sheep underwent RTMRI and eight of the 14 underwent measurement with conductance catheter; 4 had both RTMRI and conductance measurements. 2D cross sectional RTMRI were performed at apex, mid-ventricle and base levels during separate VCOs. The Dice similarity coefficient was used to compare LSSPM and manual image segmentation and thus determine LSSPM accuracy. LV cross-sectional area, major and minor axis length, axis ratio, major axis orientation angle and ESPAR were measured at each LV level. ESPVR was calculated with a trapezoidal rule. The Dice similarity coefficient between LSSPM and manual segmentation by two readers was 87.31 +/- 2.51% and 88.13 +/- 3.43%. All cross sections became more elliptical during VCO. The major axis orientation shifted during VCO but remained in the septo-lateral direction. LV chamber obliteration at the apical level occurred during VCO in 7 of 10 sheep that underwent RTMRI. ESPAR was non-linear at all levels. Finally, ESPVR was non-linear because of apical collapse. ESPVR measured by conductance catheter (E-ES,E-Index= 2.23 +/- 0.66 mmHg/ml/m(2)) and RT (E-ES,E-Index= 2.31 +/- 0.31 mmHg/ml/m(2)) was not significantly different. LSSPM segmentation of 2D RT MRI images is accurate and allows calculation of LV geometry, ESPAR and ESPVR during VCO. In the future, RTPVR will facilitate determination of regional systolic material parameters underlying ESPVR.	[Giao, Duc M.; Rojas, Renan; Takaba, Kiyoaki; Badathala, Anusha; Spaulding, Kimberly A.; Soon, Gilbert; Zhang, Yue; Wang, Vicky Y.; Saloner, David; Guccione, Julius M.; Ge, Liang; Wallace, Arthur W.; Ratcliffe, Mark B.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Giao, Duc M.; Rojas, Renan; Takaba, Kiyoaki; Badathala, Anusha; Spaulding, Kimberly A.; Soon, Gilbert; Zhang, Yue; Wang, Vicky Y.; Guccione, Julius M.; Ge, Liang; Wallace, Arthur W.; Ratcliffe, Mark B.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Giao, Duc M.; Rojas, Renan; Takaba, Kiyoaki; Badathala, Anusha; Spaulding, Kimberly A.; Soon, Gilbert; Zhang, Yue; Wang, Vicky Y.; Guccione, Julius M.; Ge, Liang; Ratcliffe, Mark B.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Wang, Yan; Haraldsson, Henrik; Liu, Jing; Saloner, David] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Wallace, Arthur W.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ratcliffe, MB (corresponding author), Vet Affairs Med Ctr, San Francisco, CA 94121 USA.; Ratcliffe, MB (corresponding author), Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA.; Ratcliffe, MB (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.	Mark.Ratcliffe@va.gov	Wang, Vicky Y./O-9043-2018	Wang, Vicky Y./0000-0003-0895-3132; Zhang, Yue/0000-0003-3835-9409; Saloner, David/0000-0002-6989-8547; Giao, Duc/0000-0002-4053-7692	National Heart, Lung and Blood Institute [R01-HL084431]	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Heart, Lung and Blood Institute Grant R01-HL084431 (M. Ratcliffe).	[Anonymous], 2005, AM J PHYSIOL-HEART C, V289, pH1898; BAAN J, 1984, CIRCULATION, V70, P812, DOI 10.1161/01.CIR.70.5.812; Bai WJ, 2018, J CARDIOVASC MAGN R, V20, DOI 10.1186/s12968-018-0471-x; Bashir MR, 2015, J MAGN RESON IMAGING, V41, P884, DOI 10.1002/jmri.24691; Bernard O, 2018, IEEE T MED IMAGING, V37, P2514, DOI 10.1109/TMI.2018.2837502; Biederman Robert W W, 2015, J Biomed Sci Eng, V8, P213; Contijoch FJ, 2016, ANN THORAC SURG, V102, P796, DOI 10.1016/j.athoracsur.2016.02.055; Dahle GO, 2016, AM J PHYSIOL-HEART C, V310, pH1330, DOI 10.1152/ajpheart.00947.2015; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Farman GP, 2011, AM J PHYSIOL-HEART C, V300, pH2155, DOI 10.1152/ajpheart.01221.2010; Ferziger H, 1981, NUMERICAL METHODS EN; GLOWER DD, 1985, CIRCULATION, V71, P994, DOI 10.1161/01.CIR.71.5.994; GORDON AM, 1980, CIRC RES, V47, P610, DOI 10.1161/01.RES.47.4.610; GUCCIONE JM, 1991, J BIOMECH ENG-T ASME, V113, P42, DOI 10.1115/1.2894084; GUCCIONE JM, 1993, J BIOMECH ENG-T ASME, V115, P72, DOI 10.1115/1.2895473; Hope MD, 2015, AM J ROENTGENOL, V205, pW366, DOI 10.2214/AJR.15.14534; Kane GC, 2011, JAMA-J AM MED ASSOC, V306, P856, DOI 10.1001/jama.2011.1201; KASS DA, 1989, CIRCULATION, V79, P167, DOI 10.1161/01.CIR.79.1.167; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Knutsen AK, 2012, ANN THORAC SURG, V93, P1121, DOI 10.1016/j.athoracsur.2011.12.067; Kono A, 1984, CIRCULATION, V65, P988; KRAMER CM, 1993, CIRCULATION, V88, P1279, DOI 10.1161/01.CIR.88.3.1279; Lam CSP, 2011, CIRCULATION, V124, P24, DOI 10.1161/CIRCULATIONAHA.110.979203; LEUNG JM, 1994, ANESTHESIOLOGY, V81, P1102, DOI 10.1097/00000542-199411000-00003; Maniar HS, 2014, J THORAC CARDIOV SUR, V148, P1694, DOI 10.1016/j.jtcvs.2014.05.088; NAKANO K, 1990, CIRCULATION, V82, P1352, DOI 10.1161/01.CIR.82.4.1352; OLSEN CO, 1983, CIRC RES, V52, P85, DOI 10.1161/01.RES.52.1.85; OLSEN CO, 1981, CIRC RES, V49, P843, DOI 10.1161/01.RES.49.4.843; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Pak PH, 1996, CIRCULATION, V94, P52, DOI 10.1161/01.CIR.94.1.52; RANKIN JS, 1977, CIRC RES, V41, P37, DOI 10.1161/01.RES.41.1.37; RATCLIFFE MB, 1995, IEEE T BIO-MED ENG, V42, P587, DOI 10.1109/10.387198; SAGAWA K, 1981, CIRCULATION, V63, P1223, DOI 10.1161/01.CIR.63.6.1223; Shimkunas R, 2013, ANN THORAC SURG, V95, P1619, DOI 10.1016/j.athoracsur.2013.02.005; SPRATT JA, 1987, CIRCULATION, V75, P1295, DOI 10.1161/01.CIR.75.6.1295; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; Sun K, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3148464; Tulner SAF, 2006, J THORAC CARDIOV SUR, V132, P610, DOI 10.1016/j.jtcvs.2005.12.016; Turk G, 1999, P 26 ANN C COMP GRAP; TYSON GS, 1984, CIRC RES, V54, P173, DOI 10.1161/01.RES.54.2.173; VANDERVELDE ET, 1991, CIRCULATION, V83, P315, DOI 10.1161/01.CIR.83.1.315; Wang WJ, 2019, IEEE ACCESS, V7, P47918, DOI 10.1109/ACCESS.2019.2907564; Wang Y, 2016, MED PHYS, V43, P1777, DOI 10.1118/1.4943375; Wang YH, 2018, INT J OCCUP ENV MED, V9, P10, DOI 10.15171/ijoem.2018.1143; Wissmann L, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0063-3; Witschey WRT, 2014, ANN THORAC SURG, V97, P1597, DOI 10.1016/j.athoracsur.2014.01.010; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Zhang P, 2005, J THORAC CARDIOV SUR, V130, P1032, DOI 10.1016/j.jtcvs.2005.05.039; Zhang S, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-39; Zhang ZY, 2020, INFORM SCIENCES, V506, P1, DOI 10.1016/j.ins.2019.08.003; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	51	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234896	10.1371/journal.pone.0234896	http://dx.doi.org/10.1371/journal.pone.0234896			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569290	Green Published, gold			2022-12-27	WOS:000543547900032
J	Gluszek, S; Ciesla, E; Gluszek-Osuch, M; Koziel, D; Kiebzak, W; Wypchlo, L; Suliga, E				Gluszek, Stanislaw; Ciesla, Elzbieta; Gluszek-Osuch, Martyna; Koziel, Dorota; Kiebzak, Wojciech; Wypchlo, Lukasz; Suliga, Edyta			Anthropometric indices and cut-off points in the diagnosis of metabolic disorders	PLOS ONE			English	Article							CARDIOMETABOLIC RISK-FACTORS; BODY-MASS INDEX; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; OBESITY; DYSLIPIDEMIA; BMI; ADIPOSITY; VALUES	Objective Identifying metabolic disorders at the earliest phase of their development allows for an early intervention and the prevention of serious consequences of diseases. However, it is difficult to determine which of the anthropometric indices of obesity is the best tool for diagnosing metabolic disorders. The aims of this study were to evaluate the usefulness of selected anthropometric indices and to determine optimal cut-off points for the identification of single metabolic disorders that are components of metabolic syndrome (MetS). Design Cross-sectional study. Participants We analyzed the data of 12,328 participants aged 55.7 +/- 5.4 years. All participants were of European descent. Primary outcome measure Four MetS components were included: high glucose concentration, high blood triglyceride concentration, low high-density lipoprotein cholesterol concentration, and elevated blood pressure. The following obesity indices were considered: waist circumference (WC), body mass index (BMI), waist-to-height ratio (WHtR), body fat percentage (%BF), Clinica Universidad de Navarra-body adiposity estimator (CUN-BAE), body roundness index (BRI), and a body shape index (ABSI). Results The following indices had the highest discriminatory power for the identification of at least one MetS component: CUN-BAE, BMI, and WC in men (AUC = 0.734, 0.728, and 0.728, respectively) and WHtR, CUN-BAE, and WC in women (AUC = 0.715, 0.714, and 0.712, respectively) (p<0.001 for all). The other indices were similarly useful, except for the ABSI. Conclusions For the BMI, the optimal cut-off point for the identification of metabolic abnormalities was 27.2 kg/m(2)for both sexes. For the WC, the optimal cut-off point was of 94 cm for men and 87 cm for women. Prospective studies are needed to identify those indices in which changes in value predict the occurrence of metabolic disorders best.	[Gluszek, Stanislaw; Wypchlo, Lukasz] Jan Kochanowski Univ Humanities & Sci, Inst Med Sci, Med Coll, Kielce, Poland; [Ciesla, Elzbieta; Gluszek-Osuch, Martyna; Koziel, Dorota; Kiebzak, Wojciech; Suliga, Edyta] Jan Kochanowski Univ Humanities & Sci, Inst Hlth Sci, Med Coll, Kielce, Poland	Jan Kochanowski University; Jan Kochanowski University	Suliga, E (corresponding author), Jan Kochanowski Univ Humanities & Sci, Inst Hlth Sci, Med Coll, Kielce, Poland.	edyta.suliga@ujk.edu.pl		Koziel, Dorota/0000-0001-8114-1814; Gluszek, Stanislaw/0000-0001-7752-0459; Gluszek-Osuch, Martyna/0000-0001-5287-0962	 [024/RID/2018/19]		The project was supported under the program of the Minister of Science and Higher Education under the name "Regional Initiative of Excellence" in 2019-2022, project number: 024/RID/2018/19, financing amount: 11.999.000,00PLN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2013, AM J CLIN NUTR, V98, P637, DOI 10.3945/ajcn.112.047506; Al-Rubean K, 2017, ANN SAUDI MED, V37, P21, DOI 10.5144/0256-4947.2017.21; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2014, TRIALS, V15, P243; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010159; Au WS, 2003, DIABETES, V52, P1073, DOI 10.2337/diabetes.52.5.1073; Bays HE, 2013, J CLIN LIPIDOL, V7, P304, DOI 10.1016/j.jacl.2013.04.001; Bhaskaran K, 2018, LANCET DIABETES ENDO, V6, P944, DOI [10.1016/s2213-8587(18)30288-2, 10.1016/S2213-8587(18)30288-2]; Biskup M, 2019, MED STUD, V35, P32, DOI 10.5114/ms.2019.84049; Anchuelo AC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216877; Davila-Batista V, 2019, EUR J NUTR, V58, P1853, DOI 10.1007/s00394-018-1743-9; Di Daniele N, 2017, ONCOTARGET, V8, P8947, DOI 10.18632/oncotarget.13553; Dlamini Z, 2019, DIABETES METAB SYNDR, V12, P1597, DOI 10.2147/DMSO.S188680; Fenwick PH, 2019, CRIT REV FOOD SCI, V59, P2028, DOI 10.1080/10408398.2018.1437022; Gomez-Ambrosi J, 2012, DIABETES CARE, V35, P383, DOI 10.2337/dc11-1334; Gomez-Marcos MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209992; Gomez-Peralta F, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0323-8; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; Heymsfield SB, 2016, OBES REV, V17, P262, DOI 10.1111/obr.12358; Hosseini-Esfahani F, 2018, INT J ENDOCRINOL MET, V16, DOI 10.5812/ijem.84772; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Khader YS, 2010, DIABETES METAB SYNDR, V3, P395, DOI [10.2147/DMSOTT.S15154, 10.2147/DMSO.S15154]; Kilpelainen TO, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08008-w; Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Mongraw-Chaffin M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139559; Myers J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071652; Ofer K, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014712; Rashid S, 2007, OBESITY, V15, P2875, DOI 10.1038/oby.2007.342; Rost S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5350-8; Salazar MR, 2014, J AM COLL NUTR, V33, P32, DOI 10.1080/07315724.2014.869982; Song X, 2015, NUTR METAB CARDIOVAS, V25, P295, DOI 10.1016/j.numecd.2014.09.004; Stefanescu A, 2019, J INT MED RES, V48, P1; Suliga E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112764; Suliga E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112598; Suliga E, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121366; Suliga E, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0045-9; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HLTH, V8, pe545; Thomas DM, 2013, OBESITY, V21, P2264, DOI 10.1002/oby.20408; TIAN S, 2016, MEDICINE, V95, P34; Vinknes KJ, 2017, CLIN EPIDEMIOL, V9, P555, DOI 10.2147/CLEP.S145130; Wang F, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0754-z; World Cancer Research Fund/American Institute for Cancer Research, 2018, DIET NUT PHYS ACT CA; World Health Organization, 2016, OB OV FACT SHEET; Wu X, 2019, CLIN EXP HYPERTENS, V41, P373, DOI 10.1080/10641963.2018.1489546; Yung JHM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030706; Zaid M, 2017, J PHYSIOL ANTHROPOL, V36, DOI 10.1186/s40101-017-0134-x; Zhang J, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/1067603	50	15	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235121	10.1371/journal.pone.0235121	http://dx.doi.org/10.1371/journal.pone.0235121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569336	Green Published			2022-12-27	WOS:000543547900008
J	Kim, T; Choi, SD; Xiong, SP				Kim, Taekyoung; Choi, Sang D.; Xiong, Shuping			Epidemiology of fall and its socioeconomic risk factors in community-dwelling Korean elderly	PLOS ONE			English	Article							OLDER-ADULTS; PEOPLE; PREVALENCE; FEAR; QUALITY; PATIENT; TIME; GAIT; LIFE; MEN	Although falls in older people are a major public health problem globally, to date there are scarce reports on socioeconomic risk factors for falls. The aim of the present study was to investigate the epidemiology of fall, its associated socioeconomic risk factors and relative importance among community-dwelling Korean elderly. Secondary analysis of national survey data with 31,684 community-dwelling Korean elderly was performed. Eleven socioeconomic factors (age, gender, household type, marital status, education level, current occupation, past occupation, income, wealth, number of children, and relationship satisfaction) were selected for analysing their associations with the epidemiology of fall through complex sample analysis and logistic regressions. Results showed that 15.9%similar to 25.1% of community-dwelling Korean elderly experienced fall yearly. The groups with significantly higher fall risks were identified as older aged, being female, not married or widowed, less educated, unemployed, and having lower relationship satisfaction. Gender (adjusted odds ratio-AOR = 1.548) and relationship satisfaction (AOR = 1.276) were the utmost important fall risk factors, indicating being older female with lower relationship satisfaction were the foremost socioeconomic characteristics for risk of falling. These findings could contribute to better understanding of the socioeconomic fall risk profiles among Korean elderly and effective strategies for fall prevention.	[Kim, Taekyoung; Xiong, Shuping] Korea Adv Inst Sci & Technol, Dept Ind & Syst Engn, Daejoen, South Korea; [Choi, Sang D.] Univ Wisconsin, Dept Occupat & Environm Safety & Hlth, Whitewater, WI 53190 USA	Korea Advanced Institute of Science & Technology (KAIST); University of Wisconsin System	Xiong, SP (corresponding author), Korea Adv Inst Sci & Technol, Dept Ind & Syst Engn, Daejoen, South Korea.	shupingx@kaist.ac.kr	Xiong, Shuping/G-3073-2016	Xiong, Shuping/0000-0003-1549-515X	Basic Science Research Program through the National Research Foundation of Korea [2017R1C1B2006811]; High Risk High Return Project of KAIST [N10180020]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); High Risk High Return Project of KAIST	This work was funded by Basic Science Research Program through the National Research Foundation of Korea (Grant No. 2017R1C1B2006811) and High Risk High Return Project of KAIST (Grant No. N10180020) to Dr. Shuping Xiong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Baker EH, 2014, WILEY BLACKWELL ENCY; Bongue B, 2011, J CLIN EPIDEMIOL, V64, P1152, DOI 10.1016/j.jclinepi.2010.12.014; Bueno-Cavanillas A, 2000, EUR J EPIDEMIOL, V16, P849, DOI 10.1023/A:1007636531965; Burns ER, 2016, J SAFETY RES, V58, P99, DOI 10.1016/j.jsr.2016.05.001; Chang HH, 2011, J SOCIO-ECON, V40, P815, DOI 10.1016/j.socec.2011.08.008; Chang VC, 2015, AM J EPIDEMIOL, V181, P521, DOI 10.1093/aje/kwu268; Choi KW, 2010, J KOREAN ACAD NURS, V40, P589, DOI 10.4040/jkan.2010.40.4.589; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Delbaere K, 2010, J AM GERIATR SOC, V58, P1679, DOI 10.1111/j.1532-5415.2010.03017.x; Dhargave P, 2016, J CLIN GERONTOL GERI, V7, P99, DOI 10.1016/j.jcgg.2016.03.004; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gill T, 2005, GERONTOLOGY, V51, P340, DOI 10.1159/000086372; Huisman M, 2003, SOC SCI MED, V57, P861, DOI 10.1016/S0277-9536(02)00454-9; Hung CH, 2017, ARCH GERONTOL GERIAT, V70, P214, DOI 10.1016/j.archger.2017.02.001; Hyun-Joo Choi，, 2016, [The Korean Society of Sports Science, 한국체육과학회지], V25, P329; Jo Jaegoog, 2018, [Health Policy and Mangemnet, 보건행정학회지], V28, P217; Johansson J, 2016, J AM MED DIR ASSOC, V17, P535, DOI 10.1016/j.jamda.2016.02.009; Kim H, 2020, PHYS STATUS SOLIDI-R, V14, DOI 10.1002/pssr.201900435; Korea Institute for Health and Social Affairs, 2017, 2017 STAT AG; Kumar A, 2014, AGE AGEING, V43, P76, DOI 10.1093/ageing/aft154; Lew FL, 2014, ERGONOMICS, V57, P1927, DOI 10.1080/00140139.2014.937771; Matthews RJ, 2005, SOC SCI MED, V61, P1567, DOI 10.1016/j.socscimed.2005.02.007; Mokhtarian PL, 2008, TRANSPORT RES B-METH, V42, P204, DOI 10.1016/j.trb.2007.07.006; Moncada LV, 2011, AM FAM PHYSICIAN, V84, P1267; Mu QY, 2017, ADDIT MANUF, V18, P74, DOI 10.1016/j.addma.2017.08.011; Noh JW, 2017, ARCH GERONTOL GERIAT, V73, P279, DOI 10.1016/j.archger.2017.08.008; Oh E, 2017, AGING MENT HEALTH, V21, P369, DOI 10.1080/13607863.2015.1099034; Parsons VL, 2006, VITAL HLTH STAT SE 2, V2, P1; Pluijm SMF, 2006, OSTEOPOROSIS INT, V17, P417, DOI 10.1007/s00198-005-0002-0; Pourhoseingholi Mohamad Amin, 2012, Gastroenterol Hepatol Bed Bench, V5, P79; Qiu H, 2017, INT J IND ERGONOM, V58, P25, DOI 10.1016/j.ergon.2017.01.004; Qiu H, 2015, INT J IND ERGONOM, V47, P37, DOI 10.1016/j.ergon.2015.02.004; Ryu E, 2017, ANN EPIDEMIOL, V27, P415, DOI 10.1016/j.annepidem.2017.05.019; Sangiovanni A, 2007, PHILOS PUBLIC AFF, V35, P3, DOI 10.1111/j.1088-4963.2007.00097.x; Saylor J, 2012, NURS RES, V61, P231, DOI 10.1097/NNR.0b013e3182533403; Schoufour JD, 2018, MATURITAS, V107, P71, DOI 10.1016/j.maturitas.2017.10.010; Segev-Jacubovski O, 2011, EXPERT REV NEUROTHER, V11, P1057, DOI [10.1586/ern.11.69, 10.1586/ERN.11.69]; Skinner C, 2017, STAT SCI, V32, P165, DOI 10.1214/17-STS614; Sohng Kyeong-Yae, 2004, Taehan Kanho Hakhoe Chi, V34, P1483; Sotoudeh GR, 2018, ARCH GERONTOL GERIAT, V79, P123, DOI 10.1016/j.archger.2018.08.001; Sperandei S, 2014, BIOCHEM MEDICA, V24, P12, DOI 10.11613/BM.2014.003; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Todd C., 2007, REV SOCIODEMOGRAPHIC; Turrell G, 2003, PUBLIC HEALTH NUTR, V6, P191, DOI 10.1079/PHN2002416; Vafaei A, 2016, SSM-POPUL HLTH, V2, P468, DOI 10.1016/j.ssmph.2016.06.003; van de Coevering P, 2015, TRANSPORT REV, V35, P512, DOI 10.1080/01441647.2015.1025455; WHO, 2007, WHO GLOB REP FALLP; Zhou YC, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0136-4	52	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234787	10.1371/journal.pone.0234787	http://dx.doi.org/10.1371/journal.pone.0234787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559206	gold, Green Published			2022-12-27	WOS:000543261600057
J	Liu, ZY; Wang, XL; Ou, SQ; Hou, DX; He, JH				Liu, Zhu-Ying; Wang, Xiao-Long; Ou, Shu-Qi; Hou, De-Xing; He, Jian-Hua			Sanguinarine modulate gut microbiome and intestinal morphology to enhance growth performance in broilers	PLOS ONE			English	Article							DIETARY SUPPLEMENTATION; PROTEIN-SYNTHESIS; ALKALOIDS; IDENTIFICATION; CHELERYTHRINE; EXPRESSION; BACTERIA; INDEXES; OBESITY; SAFETY	Sanguinarine is a bioactive compound as a quaternary benzophenanthridine alkaloid from plant of theMacleaya cordata,Papaveraceaefamily. The present study was conducted to investigate the effects of dietary sanguinarine supplementation on growth performance, serum biochemistry parameters, intestinal mucosal morphology and gut microbiome in yellow feathered broilers. Two hundred and seventy 1-d-old female broilers were randomly assigned to 3 treatments. Basal diet (NG); Basal diet containing bacitracin methylene disalicylate (50mg/Kg diet) (ANT); Basal diet containing sanguinarine (0.7 mg/ kg of feed) (SAG). The statistical results showed that dietary sanguinarine supplementation enhanced growth performance and decreased glucose, uric acid as well as urea nitrogen levels of broilers at 28d of age (P<0.05). The 16S rRNA gene sequence analysis revealed that sanguinarine significantly decreased the species from the phyla Bacteroidetes, and increased the species from phyla Firmicutes. Moreover, dietary sanguinarine supplementation improved mucosal morphology to achieve higher ratio of intestinal villus height to crypt depth (P < 0.05), and decreased the concentrations of TNF-alpha and IL-4 in jejunum mucosal. This study demonstrated that sanguinarine supplementation in the diet of yellow feathered broilers improved intestinal morphology and microbiota community structure to promote growth performance on 1-28d.	[Liu, Zhu-Ying; Wang, Xiao-Long; Ou, Shu-Qi; He, Jian-Hua] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Hunan, Peoples R China; [Liu, Zhu-Ying; Hou, De-Xing] Kagoshima Univ, United Grad Sch Agr Sci, Fac Agr, Kagoshima, Japan	Hunan Agricultural University; Kagoshima University	He, JH (corresponding author), Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Hunan, Peoples R China.	jianhuahy@hunau.net	JIANHUA, HE/G-3340-2014; Hou, De-Xing/C-9296-2011	JIANHUA, HE/0000-0002-9289-4405; liu, zhuying/0000-0002-4267-3700	National Nature Science Foundation of China [31972600, 31872991]; National Top Disciplines Development Project for Innovation Teams [kxk201801004]; Hunan Provincial Innovation Foundation for Postgraduate [CX2017B347]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Top Disciplines Development Project for Innovation Teams; Hunan Provincial Innovation Foundation for Postgraduate	This study was supported by the National Nature Science Foundation of China (No.31972600, 31872991), National Top Disciplines Development Project for Innovation Teams (kxk201801004), and Hunan Provincial Innovation Foundation for Postgraduate (CX2017B347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Hernandez JA, 2016, J ANIM SCI, V94, P267, DOI 10.2527/jas.2015-9376; [Anonymous], 2018, J CANCER RES THER, V14, pS622; [Anonymous], 2018, IEEE T SYSTEMS MAN C, P1, DOI DOI 10.2861/86313; [Anonymous], 2017, EPLASTY, V17, pic25; Bavarsadi M, 2017, J ANIM PHYSIOL AN N, V101, P936, DOI 10.1111/jpn.12528; BECCI PJ, 1987, J TOXICOL ENV HEALTH, V20, P199, DOI 10.1080/15287398709530972; Boroojeni FG, 2018, ARCH ANIM NUTR, V72, P178, DOI [10.1080/1745039X.2018.1459342, 10.1080/1745039x.2018.1459342]; Brisbin Jennifer T., 2008, Animal Health Research Reviews, V9, P101, DOI 10.1017/S146625230800145X; Chaturvedi MM, 1997, J BIOL CHEM, V272, P30129, DOI 10.1074/jbc.272.48.30129; Chen JS, 2018, J ANIM PHYSIOL AN N, V102, P1666, DOI 10.1111/jpn.12976; Choi JH, 2018, POULTRY SCI, V97, P970, DOI 10.3382/ps/pex360; CHRISTENSON JG, 1970, ARCH BIOCHEM BIOPHYS, V141, P356, DOI 10.1016/0003-9861(70)90144-X; Clavijo V, 2018, POULTRY SCI, V97, P1006, DOI 10.3382/ps/pex359; Ding ZH, 2002, BIOCHEM PHARMACOL, V63, P1415, DOI 10.1016/S0006-2952(02)00902-4; Drsata J, 1996, J ENZYM INHIB, V10, P231, DOI 10.3109/14756369609036530; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Hallock S, 2007, TOXICOL PATHOL, V35, P300, DOI 10.1080/01926230701194211; Hosek J, 2017, ACTA VET BRNO, V86, P223, DOI 10.2754/avb201786030223; Huang P, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0590-5; Jankowski J, 2009, ARCH GEFLUGELKD, V73, P95; Juskiewicz J, 2011, J ANIM PHYSIOL AN N, V95, P171, DOI 10.1111/j.1439-0396.2010.01037.x; Kang P, 2010, ASIAN AUSTRAL J ANIM, V23, P750, DOI 10.5713/ajas.2010.90526; Karimi M., 2014, Biosciences, Biotechnology Research Asia, V11, P855, DOI 10.13005/bbra/1348; Kosina P, 2004, FOOD CHEM TOXICOL, V42, P85, DOI 10.1016/j.fct.2003.08.007; Kosina P, 2010, FITOTERAPIA, V81, P1006, DOI 10.1016/j.fitote.2010.06.020; Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116; Lee KC, 2017, J MICROBIOL, V55, P939, DOI 10.1007/s12275-017-7202-0; Lee KW, 2015, J POULT SCI, V52, P15, DOI 10.2141/jpsa.0140073; Li B, 2018, J ZHEJIANG UNIV-SC B, V19, P776, DOI [10.1631/jzus.B1700435, 10.1631/jzus.b1700435]; Lin L, 2018, PHYTOTHER RES, V32, P19, DOI 10.1002/ptr.5952; Liu G, 2016, J ANIM SCI, V94, P75, DOI 10.2527/jas.2015-9719; Liu G, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1069585; Matulka R.A., 2018, OPEN J ANIM SCI, V8, P294, DOI [10.4236/ojas.2018.83022, DOI 10.4236/OJAS.2018.83022]; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; Michels A, 2018, ASIAN AUSTRAL J ANIM, V31, P1474, DOI 10.5713/ajas.17.0868; Niu XF, 2012, EUR J PHARMACOL, V689, P262, DOI 10.1016/j.ejphar.2012.05.039; Och A, 2019, TOXINS, V11, DOI 10.3390/toxins11090485; Park H, 2010, BIOCHEM BIOPH RES CO, V399, P446, DOI 10.1016/j.bbrc.2010.07.114; Pickler L, 2013, J APPL POULTRY RES, V22, P430, DOI 10.3382/japr.2012-00649; Puyalto M., 2014, INT J POULT SCI, V13, P390; Qing ZX, 2015, J PHARMACEUT BIOMED, V103, P26, DOI 10.1016/j.jpba.2014.11.002; Qing ZX, 2014, RAPID COMMUN MASS SP, V28, P1033, DOI 10.1002/rcm.6874; Rawling MD, 2009, AQUACULTURE, V294, P118, DOI 10.1016/j.aquaculture.2009.05.005; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Singh N, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00021; Tschirner K., 2013, VITAMINE ZUSATZSTOFF, V9, P275; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vieira SL, 2008, J APPL POULTRY RES, V17, P128, DOI 10.3382/japr.2007-00054; Vieira SL, 2008, BRAZ J POULT SCI, V10, P67, DOI 10.1590/S1516-635X2008000100010; Weerasinghe P, 2001, EXP MOL PATHOL, V71, P89, DOI 10.1006/exmp.2001.2355; Whelan RA, 2019, POULTRY SCI, V98, P3450, DOI 10.3382/ps/pey500; Wu Y, 2020, J VET PHARMACOL THER, V43, P208, DOI 10.1111/jvp.12835; Xue GD, 2017, POULTRY SCI, V96, P3581, DOI 10.3382/ps/pex164; Yakhkeshi S, 2011, LUNION MEDICALE CANA, V113, P826; Yao J, 2020, FREE RADIC BIOL MED; Yeoman Carl J., 2012, Animal Health Research Reviews, V13, P89, DOI 10.1017/S1466252312000138; Yu QF, 2016, MITOCHONDRIAL DNA A, V27, P216, DOI 10.3109/19401736.2014.880895; Zdarilova A, 2008, FOOD CHEM TOXICOL, V46, P3721, DOI 10.1016/j.fct.2008.09.054; Zhang L, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0061-4; Zhao L., 2017, OPEN J ANIM SCI, V7, P93, DOI [10.4236/ojas.2017.72008, DOI 10.4236/OJAS.2017.72008]; Zitterl-Eglseer K., 2007, EFSA SUPP PUBL, V4, P1, DOI [10.2903/sp.efsa.2007.ZN-001, DOI 10.2903/SP.EFSA.2007.ZN-001]	62	19	20	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234920	10.1371/journal.pone.0234920	http://dx.doi.org/10.1371/journal.pone.0234920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559224	gold, Green Published			2022-12-27	WOS:000543261600019
J	Li, QH; Laflamme, DP; Bauer, JE				Li, Qinghong; Laflamme, Dorothy P.; Bauer, John E.			Serum untargeted metabolomic changes in response to diet intervention in dogs with preclinical myxomatous mitral valve disease	PLOS ONE			English	Article							MEDIUM-CHAIN TRIGLYCERIDES; FATTY-ACID-COMPOSITION; FAILING HEART; OXIDATION DISORDERS; MECHANISMS; PLASMA; RAT; IDENTIFICATION; BIOMARKERS; CARNITINE	Myocardial energy deprivation plays a causal role in the development of heart failure. A cardiac protection blend (CPB) of nutrients including medium chain triglycerides, fish oil and other key nutrients was developed to slow the progression of canine myxomatous mitral valve disease (MMVD). A six-month dietary intervention demonstrated efficacy of CPB in slowing MMVD progression. Untargeted metabolomic analysis of serum from these dogs identified 102 differential metabolites (adjusted P < 0.05). The ratios of omega-6 to omega-3 fatty acid (FA) changed from 2.41 and 1.46 in control and CPB groups at baseline to 4.30 and 0.46 at 6 months respectively. A 2.7-fold increase of alpha-aminobutyrate, a myocardial modulator of glutathione homeostasis, was found in CPB dogs compared to 1.3-fold increase in control dogs. Arginine and citrulline, precursors of nitric oxide biosynthesis, were both increased 2-fold; caprate, a medium chain FA, was increased 3-fold; and deoxycarnitine, precursor of carnitine biosynthesis, was increased 2.5-fold in CPB dogs. Margarate and methylpalmitate decreased in response to CPB, a potential benefit in MMVD dogs as positive correlations were found between changes in both these FAs and left atrial diameter (r = 0.69, r = 0.87 respectively, adjusted P < 0.05). Sphingomyelins with very long chain saturated FAs associated with decreased risk of heart failure in humans were increased in MMVD dogs fed the CPB diet. Our data supports the hypothesis that CPB improves FA utilization and energetics, reduces oxidative stress and inflammation in MMVD dogs. More studies are needed to understand the roles of specific metabolites in MMVD.	[Li, Qinghong] Nestle Purina Res, St Louis, MO 63102 USA; [Laflamme, Dorothy P.] Sci Commun Consultant, Floyd, VA USA; [Bauer, John E.] Texas A&M Univ, Longmont, CO USA	Nestle SA	Li, QH (corresponding author), Nestle Purina Res, St Louis, MO 63102 USA.	qinghong.li@rd.nestle.com		Li, Qinghong/0000-0002-2584-6024	Nestle Purina PetCare Company - Nestle Purina PetCare Company	Nestle Purina PetCare Company - Nestle Purina PetCare Company	This study was funded by the Nestle Purina PetCare Company. All authors are employee or consultants of the company. The funder provided support in the form of salaries for author QL and consulting fees for DPL and JEB, and financially supported the research, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors would like to thank Kristen Lower and Cynthia Steeby for laboratory assistance and Dr. Melanie Barnes for veterinary service. The study was funded by the Nestle Purina PetCare Company.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; [Anonymous], 2015, NUCLEIC ACIDS RES, V43, pD204; [Anonymous], 2005, DID GOD COMMAND EXTE, V57, P78; Aubert G, 2016, CIRCULATION, V133, P698, DOI 10.1161/CIRCULATIONAHA.115.017355; BACH A, 1976, HORM METAB RES, V8, P375, DOI 10.1055/s-0028-1093617; BACH A, 1977, J NUTR, V107, P1863, DOI 10.1093/jn/107.10.1863; BACH AC, 1982, AM J CLIN NUTR, V36, P950, DOI 10.1093/ajcn/36.5.950; Bedi KC, 2016, CIRCULATION, V133, P706, DOI 10.1161/CIRCULATIONAHA.115.017545; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchanan JW., 1999, TXB CANINE FELINE CA, V2nd, P458; Davoodbasha M, 2018, MICROB PATHOGENESIS, V115, P233, DOI 10.1016/j.micpath.2017.12.049; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115; Durbin B P, 2002, Bioinformatics, V18 Suppl 1, pS105; El-Agamy DS, 2017, CANCER CHEMOTH PHARM, V79, P399, DOI 10.1007/s00280-016-3233-1; Messias MCF, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0685-9; Ford L, 2020, J APPL LAB MED, V5, P342, DOI 10.1093/jalm/jfz026; Freeman LM, 2010, J SMALL ANIM PRACT, V51, P462, DOI 10.1111/j.1748-5827.2010.00968.x; Freeman LM, 2005, J VET INTERN MED, V19, P537, DOI 10.1892/0891-6640(2005)19[537:ASABOO]2.0.CO;2; Greenhouse DG, 2016, GENE, V586, P56, DOI 10.1016/j.gene.2016.04.004; GROSS RW, 1985, BIOCHEMISTRY-US, V24, P1662, DOI 10.1021/bi00328a014; Gupte AA, 2014, CIRC-CARDIOVASC GENE, V7, P266, DOI 10.1161/CIRCGENETICS.113.000404; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Irino Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep36749; Jacobs S, 2014, EUR J CLIN NUTR, V68, P517, DOI 10.1038/ejcn.2014.18; Jenkins B, 2015, MOLECULES, V20, P2425, DOI 10.3390/molecules20022425; Jiang LM, 2019, METABOLOMICS, V15, DOI 10.1007/s11306-019-1518-1; KAUNITZ H, 1986, J ENVIRON PATHOL TOX, V6, P115; Khaw KT, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001255; KUNZ F, 1971, ATHEROSCLEROSIS, V13, P413, DOI 10.1016/0021-9150(71)90083-9; Labarthe F, 2008, CARDIOVASC DRUG THER, V22, P97, DOI 10.1007/s10557-008-6084-0; Lai L, 2014, CIRC-HEART FAIL, V7, P1022, DOI 10.1161/CIRCHEARTFAILURE.114.001469; Lanfear DE, 2017, JACC-HEART FAIL, V5, P823, DOI 10.1016/j.jchf.2017.07.009; Lemaitre RN, 2019, CIRC-HEART FAIL, V12, DOI 10.1161/CIRCHEARTFAILURE.118.005708; Lemaitre RN, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010019; Li QH, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2169-1; Li QH, 2015, OMICS, V19, P461, DOI 10.1089/omi.2015.0057; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Lu CC, 2015, VET J, V204, P23, DOI 10.1016/j.tvjl.2015.02.021; Markby G, 2017, VET SCI, V4, P3; McGarrah RW, 2018, CIRC RES, V122, P1238, DOI 10.1161/CIRCRESAHA.117.311002; Morita M, 2014, BIOCHEM BIOPH RES CO, V454, P53, DOI 10.1016/j.bbrc.2014.10.029; National Institute of Infectious Diseases, 2005, IASR, V26, P33; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Oyama MA, 2006, AM J VET RES, V67, P1307, DOI 10.2460/ajvr.67.8.1307; Oyama MA, 2020, CARDIOVASC PATHOL, V46, DOI 10.1016/j.carpath.2019.107196; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Pedersen HD, 2000, CARDIOVASC RES, V47, P234, DOI 10.1016/S0008-6363(00)00113-9; Peterson LR, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007931; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; Saeed NM, 2012, TOXICOL APPL PHARM, V264, P84, DOI 10.1016/j.taap.2012.07.020; Saifudeen I, 2017, J CARD FAIL, V23, P240, DOI 10.1016/j.cardfail.2016.08.001; SARTORELLI L, 1982, ITAL J BIOCHEM, V31, P261; Shah AA, 2012, J THORAC CARDIOV SUR, V143, P873, DOI 10.1016/j.jtcvs.2011.09.070; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; SILIPRANDI N, 1987, BASIC RES CARDIOL, V82, P53; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Strijdom H, 2009, CARDIOVASC J AFR, V20, P303; Team RC., 2013, R LANG ENV STAT COMP; Temelli Oztun, 2017, Gulf J Oncolog, V1, P26; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Verkade PE, 1934, BIOCHEM J, V28, P31, DOI 10.1042/bj0280031; Wanders RJA, 2011, FEBS J, V278, P182, DOI 10.1111/j.1742-4658.2010.07947.x; Wink DA, 2001, ANTIOXID REDOX SIGN, V3, P203, DOI 10.1089/152308601300185179; XP Z., 2006, FOOD DRUG, V8, P17	67	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234404	10.1371/journal.pone.0234404	http://dx.doi.org/10.1371/journal.pone.0234404			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555688	gold, Green Published			2022-12-27	WOS:000543273200025
J	Ling, TB; He, YY				Ling, Tianbai; He, Yongyi			The remanufacturing evaluation for feasibility and comprehensive benefit of retired grinding machine	PLOS ONE			English	Article							TOOL; PRODUCTS; PARADIGM; STRATEGY; DESIGN; END	Grinding is the last and most important process of parts processing, the purpose is to achieve high precision and surface roughness. Therefore, grinding machine has the characteristics of high added value, high technology content and great remanufacturing value. However, the evaluation of machine tool remanufacturing is based on imprecise and fuzzy information at present. The aim of this study is to present the remanufacturing evaluation for feasibility and comprehensive benefit of retired grinder. Firstly, according to the unique structure of grinder, the feasibility evaluation model of grinder remanufacturing is established, including technical feasibility criterion, economic feasibility criterion and resource environment feasibility criterion. Secondly, the comprehensive benefit evaluation model of remanufacturing grinder is established, in which the weight of each evaluation criterion is determined by Analytic Hierarchy Process (AHP). Finally, combined with the remanufacturing case of the cylindrical grinder, the evaluation method is verified and analyzed. The results show that the remanufacturing of the waste grinding machine through the feasibility evaluation can obtain better comprehensive benefits, and the remanufacturer can get considerable benefits and reduce the potential risks in the remanufacturing process.	[Ling, Tianbai; He, Yongyi] Shanghai Univ, Sch Mechatron Engn & Automat, Shanghai, Peoples R China	Shanghai University	Ling, TB (corresponding author), Shanghai Univ, Sch Mechatron Engn & Automat, Shanghai, Peoples R China.	lingskywhite@shu.edu.cn			Shanghai Science and Technology Development Foundation (CN) [Z16030384]	Shanghai Science and Technology Development Foundation (CN)	Ling Tianbai (LTB) Z16030384 Shanghai Science and Technology Development Foundation (CN) http://www.stefg.org/mobile/about/inventory. aspx?key=&hangye=&fenhui= 72634837642510336 no sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GASTROENTEROLOGY S1, V10, P1; Aronson RB, 2003, MANUF ENG, V131, P75; Ayag Z, 2006, J INTELL MANUF, V17, P179, DOI 10.1007/s10845-005-6635-1; Bernard S, 2011, J ENVIRON ECON MANAG, V62, P337, DOI 10.1016/j.jeem.2011.05.005; Charter Martin, 2008, International Journal of Product Development, V6, P375, DOI 10.1504/IJPD.2008.020406; Du YB, 2014, J CLEAN PROD, V66, P272, DOI 10.1016/j.jclepro.2013.10.033; Ferguson M, 2009, PROD OPER MANAG, V18, P300, DOI [10.3401/poms.1080.01033, 10.1111/j.1937-5956.2009.01033.x]; Guide VDR, 2000, J OPER MANAG, V18, P467, DOI 10.1016/S0272-6963(00)00034-6; Ijomah WL, 2007, INT J PROD RES, V45, P4513, DOI 10.1080/00207540701450138; Jiang ZG, 2019, J CLEAN PROD, V210, P419, DOI 10.1016/j.jclepro.2018.10.316; Jiang ZG, 2013, DISCRETE DYN NAT SOC, V2013, DOI 10.1155/2013/120256; Korhonen P, 2006, EUR J OPER RES, V175, P1285, DOI 10.1016/j.ejor.2005.04.046; Li CB, 2009, INT J PROD RES, V47, P3657, DOI 10.1080/00207540701837029; Liu WW, 2014, APPL SURF SCI, V292, P142, DOI 10.1016/j.apsusc.2013.11.102; McAfee PC, 2010, J SPINAL DISORD TECH, V23, P1, DOI 10.1097/BSD.0b013e31819e2ab8; Ohiwa H, 1990, CIRP ANN-MANUF TECHN, V13, P44; Peng JX, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00066; PengjiaWang, 2014, PROC CIRP, V15, P443, DOI 10.1016/j.procir.2014.06.085; Pigosso DCA, 2010, J CLEAN PROD, V18, P21, DOI 10.1016/j.jclepro.2009.09.005; Pokharel S, 2012, INT J PROD ECON, V138, P170, DOI 10.1016/j.ijpe.2012.03.019; Rashid A, 2013, J CLEAN PROD, V57, P166, DOI 10.1016/j.jclepro.2013.06.012; Saaty TL, 2008, INT J SERVICES SCI, V1, P83, DOI [DOI 10.1504/IJSSCI.2008.017590, 10.1504/IJSSCI.2008.017590]; Shapira A, 2009, J CONSTR ENG M, V135, P307, DOI 10.1061/(ASCE)0733-9364(2009)135:4(307); Subramoniam R, 2009, J CLEAN PROD, V17, P1163, DOI 10.1016/j.jclepro.2009.03.004; Ullah SMS, 2016, INT J PR ENG MAN-GT, V3, P19, DOI 10.1007/s40684-016-0003-9; Xiong W, 2017, CHINA IND INFORM TEC, VZ1, P44; Xu Binshi, 2012, Journal of Mechanical Engineering, V48, P96, DOI 10.3901/JME.2012.15.096; Yang SS, 2016, ADV MANUF, V4, P189, DOI 10.1007/s40436-016-0149-2; Zhou F, 2014, CASE BASED REASONING; Zwolinski P, 2006, J CLEAN PROD, V14, P1333, DOI 10.1016/j.jclepro.2005.11.028; 2013, ATLAS RISK STATE NUE, V1, P8	31	5	5	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234603	10.1371/journal.pone.0234603	http://dx.doi.org/10.1371/journal.pone.0234603			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555621	gold, Green Published			2022-12-27	WOS:000543273200032
J	Mizuki, I; Ito, H; Yamasaki, M; Fukumoto, S; Okamoto, Y; Katsuki, M; Fukushima, K; Sakai, M; Sakaguchi, S; Fujiki, D; Nakagawa, H; Ishihara, MI; Takayanagi, A				Mizuki, Inoue; Ito, Hiroki; Yamasaki, Michimasa; Fukumoto, Shigeru; Okamoto, Yuuki; Katsuki, Masaya; Fukushima, Keitaro; Sakai, Masaru; Sakaguchi, Shota; Fujiki, Daisuke; Nakagawa, Hikaru; Ishihara, Masae Iwamoto; Takayanagi, Atsushi			Seasonal and annual fluctuations of deer populations estimated by a Bayesian state-space model	PLOS ONE			English	Article							SIKA-DEER; CARRYING-CAPACITY; EASTERN HOKKAIDO; RED DEER; DYNAMICS; MIGRATION; IMPACTS; HABITAT; WEATHER; FOREST	Deer overabundance is a contributing factor in the degradation of plant communities and ecosystems worldwide. The management and conservation of the deer-affected ecosystems requires us to urgently grasp deer population trends and to identify the factors that affect them. In this study, we developed a Bayesian state-space model to estimate the population dynamics of sika deer (Cervus nippon) in a cool-temperate forest in Japan, where wolves (Canis lupus hodophilax) are extinct. The model was based on field data collected from block count surveys, road count surveys by vehicles, mortality surveys during the winter, and nuisance control for 12 years (2007-2018). We clarified the seasonal and annual fluctuation of the deer population. We found a peak of deer abundance (2010) over 12 years. In 2011 the estimated deer abundance decreased drastically and has remained at a low level then. The deer abundance gradually increased from April to December during 2013-2018. The seasonal fluctuation we detected could reflect the seasonal migration pattern of deer and the population recruitment through fawn births in early summer. In our model, snowfall accumulation, which can be a lethal factor for deer, may have slightly affected their mortality during the winter. Although we could not detect a direct effect of snow on population dynamics, snowfall decrease due to global warming may decelerate the winter migration of deer; subsequently, deer staying on-site may intensively forage evergreen perennial plants during the winter season. The nuisance control affected population dynamics. Even in wildlife protection areas and national parks where hunting is regulated, nuisance control could be effective in buffering the effect of deer browsing on forest ecosystems.	[Mizuki, Inoue; Okamoto, Yuuki; Katsuki, Masaya] Nihon Univ, Coll Humanities & Sci, Dept Biosci, Tokyo, Japan; [Ito, Hiroki] Forestry & Forest Prod Res Inst, Hokkaido Res Ctr, Sapporo, Hokkaido, Japan; [Yamasaki, Michimasa; Takayanagi, Atsushi] Kyoto Univ, Grad Sch Agr, Lab Forest Biol, Kyoto, Japan; [Fukumoto, Shigeru] Gen Off Hirano Cho, Osaka, Japan; [Fukushima, Keitaro] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Sakai, Masaru] Natl Inst Environm Studies, Fukushima Branch, Tsukuba, Ibaraki, Japan; [Sakaguchi, Shota] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan; [Fujiki, Daisuke] Univ Hyogo, Inst Nat & Environm Sci, Sanda, Hyogo, Japan; [Nakagawa, Hikaru] Kyoto Univ, Ctr Southeast Asian Studies, Kyoto, Japan; [Ishihara, Masae Iwamoto] Kyoto Univ, Field Sci Educ & Res Ctr, Kyoto, Japan	Nihon University; Forestry & Forest Products Research Institute - Japan; Kyoto University; Kyoto University; National Institute for Environmental Studies - Japan; Kyoto University; University of Hyogo; Kyoto University; Kyoto University	Mizuki, I (corresponding author), Nihon Univ, Coll Humanities & Sci, Dept Biosci, Tokyo, Japan.	mizuki@chs.nihon-u.ac.jp	Fukushima, Keitaro/J-9598-2017; Yamasaki, Michimasa/I-1757-2019; Nakagawa, Hikaru/HGC-7805-2022; Sakai, Masaru/R-3927-2018	Fukushima, Keitaro/0000-0001-5968-5938; Nakagawa, Hikaru/0000-0001-8908-2011; Ito, Hiroki/0000-0003-2243-1007; MIZUKI, INOUE/0000-0001-7390-3655; Sakai, Masaru/0000-0001-5361-0978; Yamasaki, Michimasa/0000-0002-0724-9234	28th PRO NATURA FUND from Pro Natura Foundation Japan	28th PRO NATURA FUND from Pro Natura Foundation Japan	Financial support was provided by the 28th PRO NATURA FUND from Pro Natura Foundation Japan (http://www.pronaturajapan.com/foundation/pronaturafund/30pnfbosyu).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi N, 1999, FOREST ECOL MANAG, V113, P75, DOI 10.1016/S0378-1127(98)00415-0; [Anonymous], 2013, TEXTS STAT SCI SERIE; Bonardi A, 2017, INTEGR ZOOL, V12, P61, DOI 10.1111/1749-4877.12237; Calder C, 2003, ECOLOGY, V84, P1395, DOI 10.1890/0012-9658(2003)084[1395:IMSOSI]2.0.CO;2; Ciach M, 2018, INT J BIOMETEOROL, V62, P2173, DOI 10.1007/s00484-018-1619-y; Clark JS, 2004, ECOLOGY, V85, P3140, DOI 10.1890/03-0520; Commandeur J. J. F., 2007, INTRO STATE SPACE TI; Coulson T, 2004, ECOLOGY, V85, P411, DOI 10.1890/03-0009; Filazzola A, 2014, FOREST ECOL MANAG, V313, P10, DOI 10.1016/j.foreco.2013.10.040; Fujiki D, 2018, J FOREST RES-JPN, V23, P260, DOI 10.1080/13416979.2018.1488653; Fujiki D, 2010, J FOREST RES-JPN, V15, P140, DOI 10.1007/s10310-009-0172-2; Fukuda A., 2008, Forest Research, Kyoto, P5; Fuller RJ, 2001, FORESTRY, V74, P193, DOI 10.1093/forestry/74.3.193; Gabry J, 2019, J R STAT SOC A STAT, V182, P389, DOI 10.1111/rssa.12378; GILL RMA, 1992, FORESTRY, V65, P145, DOI 10.1093/forestry/65.2.145; Goda R., 2008, Forest Research, Kyoto, P89; Hagen R, 2018, EUR J WILDLIFE RES, V64, DOI 10.1007/s10344-018-1204-z; HOBBS NT, 1985, J WILDLIFE MANAGE, V49, P814, DOI 10.2307/3801716; Igota H, 2004, ECOL RES, V19, P169, DOI 10.1111/j.1440-1703.2003.00621.x; Iijima H, 2016, J MAMMAL, V97, P734, DOI 10.1093/jmammal/gyw001; Iijima H, 2013, J WILDLIFE MANAGE, V77, P1038, DOI 10.1002/jwmg.556; KAJI K, 1988, ACTA THERIOL, V33, P187, DOI 10.4098/AT.arch.88-15; KATO M, 1990, Contributions from the Biological Laboratory Kyoto University, V27, P309; Kato Makoto, 2004, Contributions from the Biological Laboratory Kyoto University, V29, P437; Kawase H, 2015, J METEOROL SOC JPN, V93, P571, DOI 10.2151/jmsj.2015-034; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Loison A, 1998, OECOLOGIA, V116, P489, DOI 10.1007/s004420050614; Marshal JP, 2016, EUR J WILDLIFE RES, V62, P549, DOI 10.1007/s10344-016-1027-8; Mizuki I, 2013, J FOREST RES-JPN, V18, P491, DOI 10.1007/s10310-012-0379-5; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Pellerin M, 2017, WILDLIFE BIOL, DOI 10.2981/wlb.00274; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Royle J. A., 2008, HIERARCHICAL MODELIN; Sakaguchi S., 2012, Forest Research, Kyoto, P71; Stan Development Team, 2019, RSTAN VERS 2 18 2 SO; TAKATSUKI S, 1994, ECOL RES, V9, P215, DOI 10.1007/BF02347497; Takatsuki S, 2009, BIOL CONSERV, V142, P1922, DOI 10.1016/j.biocon.2009.02.011; Takeshita K, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2398; Takeshita K, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-017-1128-z; Takii A, 2012, MAMM STUDY, V37, P331, DOI 10.3106/041.037.0407; Tanaka Y., 2008, Forest Research, Kyoto, P13; Trenkel VM, 2000, J AM STAT ASSOC, V95, P363, DOI 10.2307/2669373; Ueno M, 2018, WILDLIFE RES, V45, P143, DOI 10.1071/WR17103; Uno H, 2006, ECOL RES, V21, P624, DOI 10.1007/s11284-006-0158-x; Valente AM, 2016, EUR J WILDLIFE RES, V62, P577, DOI 10.1007/s10344-016-1030-0	45	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0225872	10.1371/journal.pone.0225872	http://dx.doi.org/10.1371/journal.pone.0225872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555639	gold, Green Published, Green Submitted			2022-12-27	WOS:000543273200002
J	Brown, H				Brown, Heather			Understanding the role of policy on inequalities in the intergenerational correlation in health and wages: Evidence from the UK from 1991-2017	PLOS ONE			English	Article							EDUCATIONAL-ATTAINMENT; CHILDHOOD HEALTH; PERSISTENCE; EARNINGS; MOBILITY; IMPACT	Social mobility is high on the policy agenda and is an important component of reducing inequalities. Estimating the relationship across generations of multiple dimensions of mobility such as health and wages can be used to understand the current state of mobility. However, there has been little research on how policy impacts on the relationship of multiple outcomes across generations and how that may be contributing to health inequalities and long-term mobility. In this paper, we use the UK as a case study to evaluate the impact of three distinct policy periods: 1991-1998 (Increasing neo-liberalism); 1998-2009 (English Health Inequalities Strategy); 2010-2017 (Austerity) on the relationship across generations in health (self-assessed health (SAH) and mental health measured by General Health Questionnaire 12 (GHQ-12)) and hourly wages. We employ fixed effects models on data from the British Household Panel Survey (1991-2008) and its successor the Understanding Society Survey (2009-2017). To investigate the role of policy on inequalities, sub-group analysis is performed by parental socioeconomic status measured by parental educational attainment, parental occupation, and if a single parent household. Results show that for the population on average, a changing policy focus has no impact on the strength of the relationship across generations in both health and wages. However, when looking at sub-groups the strength of the relationship in SAH and wages is increasing for parents with basic and higher qualifications and their young adult children. Whereas the influence of parents on their young adult children's SAH, mental health, and wages has remained fairly constant over the period 1991-2017 for parents with manual occupations and professional occupations. There has been a slight weakening in the influence of parents on their young adult children's SAH and wages for single parent families from 2010.	[Brown, Heather] Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Brown, H (corresponding author), Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England.	heather.brown@ncl.ac.uk	Brown, Heather/GYU-1759-2022	Brown, Heather/0000-0002-0067-991X	HB-Understanding Society Policy Fellowship; ESRC [ES/K005146/1] Funding Source: UKRI	HB-Understanding Society Policy Fellowship; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	HB-Understanding Society Policy Fellowship https://www.understandingsociety.ac.uk/2018/02/20/understanding-society-policy-fellowships No-The funders had no role in study design, data collection and analysis, decision to public, or preparation of the manuscript.	Acheson D., 1998, INDEPENDENT INQUIRY; Aizer A, 2014, SCIENCE, V344, P856, DOI 10.1126/science.1251872; Al Baghal T., 2015, UNDERSTANDING SOC UK; Barr B, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3310; Black S., 2010, RECENT DEV INTERGENE; Blanden J, 2013, J ECON SURV, V27, P38, DOI 10.1111/j.1467-6419.2011.00690.x; Breen R, 2005, ANNU REV SOCIOL, V31, P223, DOI 10.1146/annurev.soc.31.041304.122232; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Case A, 2002, AM ECON REV, V92, P1308, DOI 10.1257/000282802762024520; Chetty R, 2014, Q J ECON, V129, P1553, DOI 10.1093/qje/qju022; Currie J, NBER WORKING PAPER; Currie J., 1999, HDB LABOR EC, V3, P3309, DOI DOI 10.1016/S1573-4463(99)30041-9; Department of Health, TACKL HLTH IN 2007 S; GROSSMAN M, 1972, J POLIT ECON, V80, P223, DOI 10.1086/259880; Haas SA, 2008, J HEALTH SOC BEHAV, V49, P178, DOI 10.1177/002214650804900205; Hadiz VR, 2017, INT POLIT SCI REV, V38, P399, DOI 10.1177/0192512117693908; Halliday T, 2018, 11304 IZA; Johnston DW, 2013, J HEALTH ECON, V32, P1077, DOI 10.1016/j.jhealeco.2013.09.001; Jones AM, 2019, EC HUMAN BIOL, V14, P100811; Kim Y, 2015, J ECON AGEING, V6, P44, DOI 10.1016/j.jeoa.2014.08.004; Mackenbach JP, 2011, LANCET, V377, P1986, DOI 10.1016/S0140-6736(10)62055-7; Pachaud D, 2001, J SOC POLICY, V30, P95; Pascual M, 2009, APPL ECON, V41, P451, DOI 10.1080/00036840701367523; Peugny C, 2019, RES POLITICS, V6, DOI 10.1177/2053168018823131; Restuccia D, 2004, AM ECON REV, V94, P1354, DOI 10.1257/0002828043052213; Robinson T, 2019, J EPIDEMIOL COMMUN H, V73, P564, DOI 10.1136/jech-2018-211679; Smith JP, 2009, REV ECON STAT, V91, P478, DOI 10.1162/rest.91.3.478; Solon G, 2002, J ECON PERSPECT, V16, P59, DOI 10.1257/089533002760278712; The Equality Trust, HAS IN CHANG; University of Essex Institute for Social and Economic Research, 2018, UND SOC WA 1 8 2009, V6614, DOI [10.5255/UKDA-SN-6614-12, DOI 10.5255/UKDA-SN-6614-12, 10.5255/UKDA-SN-6614-14, DOI 10.5255/UKDA-SN-6614-14]	30	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234737	10.1371/journal.pone.0234737	http://dx.doi.org/10.1371/journal.pone.0234737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555700	Green Published, gold			2022-12-27	WOS:000542759600040
J	Cornelius, DC; Travis, OK; Tramel, RW; Borges-Rodriguez, M; Baik, CH; Greer, M; Giachelli, CA; Tardo, GA; Williams, JM				Cornelius, Denise C.; Travis, Olivia K.; Tramel, Robert W.; Borges-Rodriguez, Marivee; Baik, Cedar H.; Greer, Mallory; Giachelli, Chelsea A.; Tardo, Geilda A.; Williams, Jan M.			NLRP3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture	PLOS ONE			English	Article							FLUORESCEIN-LABELED SINISTRIN; ACUTE KIDNEY INJURY; ACUTE LUNG INJURY; PROTECTS; MARKER; ROLES	Sepsis is characterized by organ dysfunction due to a dysregulated immune response to infection. Currently, no effective treatment for sepsis exists. Platelets are recognized as mediators of the immune response and may be a potential therapeutic target for the treatment of sepsis. We previously demonstrated that NLRP3 inflammasome activation in sepsis-induced activated platelets was associated with multi-organ injury in the cecal-ligation puncture (CLP) rat model of sepsis. In this study, we tested the hypothesis that inhibition of NLRP3 would inhibit platelet activation and attenuate multi-organ injury in the CLP rat. CLP (n = 10) or Sham (n = 10) surgery were performed in male and female Sprague-Dawley rats. A subset of CLP rats were treated with MCC950 (50mg/kg/d), a specific NLRP3 inhibitor (CLP+MCC950, n = 10). At 72 hrs. post-CLP, blood and organs were harvested for analysis of platelet activation, NLRP3 activation, inflammation and end organ damage. Platelet activation increased from 8 +/- 0.8% in Sham to 16 +/- 1% in CLP, and was reduced to 9 +/- 1% in CLP+M rats (p<0.05). NLRP3 activation was also increased in platelets of CLP vs Sham. NLRP3 expression was unchanged in kidney and lung after CLP, but Caspase 1 expression and IL-1 beta were increased. MCC950 treatment attenuated NLRP3 activation in platelets. Plasma, kidney, and lung levels of NLRP3 inflammasome associated cytokines, IL-1ss and IL-18, were significantly increased in CLP compared to Sham rats. Inhibition of NLRP3 normalized cytokine levels. Glomerular injury, pulmonary edema, and endothelial dysfunction markers were increased in CLP rats vs Sham. MCC950 treatment significantly decreased renal and pulmonary injury and endothelial dysfunction in CLP+M. Our results demonstrate a role for NLRP3 in contributing to platelet activation and multi-organ injury in sepsis.	[Cornelius, Denise C.; Tramel, Robert W.; Baik, Cedar H.; Greer, Mallory; Giachelli, Chelsea A.; Tardo, Geilda A.] Univ Mississippi, Med Ctr, Dept Emergency Med, Jackson, MS 39216 USA; [Cornelius, Denise C.; Travis, Olivia K.; Williams, Jan M.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Cornelius, Denise C.; Travis, Olivia K.; Williams, Jan M.] Univ Mississippi, Med Ctr, Cardiovasc Renal Res Ctr, Jackson, MS 39216 USA; [Borges-Rodriguez, Marivee] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Cornelius, DC (corresponding author), Univ Mississippi, Med Ctr, Dept Emergency Med, Jackson, MS 39216 USA.; Cornelius, DC (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA.; Cornelius, DC (corresponding author), Univ Mississippi, Med Ctr, Cardiovasc Renal Res Ctr, Jackson, MS 39216 USA.	dcornelius@umc.edu		Tramel, Robert/0000-0002-5489-1086; Travis, Olivia/0000-0001-7392-9054; Williams, Jan/0000-0002-7078-9567; Cornelius, Denise/0000-0002-6730-6499	NHLBI/NIH [HL103456]; NIGMS/NIH [P20GM104357]; NIDDK/NIH [DK109133]; IDeA COBRE award from the NIGMS/NIH [GM103328]	NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); IDeA COBRE award from the NIGMS/NIH	DCC is supported by funds from the NHLBI/NIH HL103456 and NIGMS/NIH P20GM104357. JMW is supported by funds from the NIDDK/NIH DK109133. A portion of this research was conducted in the Imaging Core of the Center for Psychiatric Neuroscience, funded through an IDeA COBRE award from the NIGMS/NIH (GM103328).	Abderrazak A, 2015, REDOX BIOL, V4, P296, DOI 10.1016/j.redox.2015.01.008; Bagshaw SM, 2009, INTENS CARE MED, V35, P871, DOI 10.1007/s00134-008-1367-2; Brown GT, 2013, J IMMUNOL, V191, P5196, DOI 10.4049/jimmunol.1300354; Cornelius DC, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14073; de Stoppelaar SF, 2014, THROMB HAEMOSTASIS, V112, P666, DOI 10.1160/TH14-02-0126; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Gong ZZ, 2015, MOL NUTR FOOD RES, V59, P2132, DOI 10.1002/mnfr.201500316; Greco E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102200; Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Jiao JH, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00037; Kalbitz M, 2016, FASEB J, V30, P3997, DOI 10.1096/fj.201600728R; Layios N, 2017, INTENS CARE MED EXP, V5, DOI 10.1186/s40635-017-0145-2; Long HB, 2016, AM J EMERG MED, V34, P772, DOI 10.1016/j.ajem.2015.12.075; Luo YP, 2014, INT IMMUNOPHARMACOL, V20, P24, DOI 10.1016/j.intimp.2014.02.017; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Miyashita T, 2016, IN VIVO, V30, P341; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Pill J, 2005, EUR J MED CHEM, V40, P1056, DOI 10.1016/j.ejmech.2005.03.020; Pill J, 2006, N-S ARCH PHARMACOL, V373, P204, DOI 10.1007/s00210-006-0067-0; Poston JT, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k4891; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; Schock-Kusch D, 2009, NEPHROL DIAL TRANSPL, V24, P2997, DOI 10.1093/ndt/gfp225; Shao BZ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00262; Steinhagen F, PHARM THER, V2020, P107476; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Umbro I, 2016, J INFECTION, V72, P131, DOI 10.1016/j.jinf.2015.11.008; Vincent JL, 2011, CRIT CARE MED, V39, P1050, DOI 10.1097/CCM.0b013e31820eda29; Wang P, 2015, INT J MOL SCI, V16, P20595, DOI 10.3390/ijms160920595; Wang RQ, 2017, LAB INVEST, V97, P922, DOI 10.1038/labinvest.2017.30; Xu KY, 2018, BIOCHEM BIOPH RES CO, V503, P3031, DOI 10.1016/j.bbrc.2018.08.089; Zhang C, 2012, HYPERTENSION, V60, P154, DOI 10.1161/HYPERTENSIONAHA.111.189688; Zhang XY, 2018, DIGEST DIS SCI, V63, P81, DOI 10.1007/s10620-017-4801-x; Zhong YJ, 2020, MOL IMMUNOL, V122, P80, DOI 10.1016/j.molimm.2020.03.020	37	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234039	10.1371/journal.pone.0234039	http://dx.doi.org/10.1371/journal.pone.0234039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555710	Green Published, gold			2022-12-27	WOS:000542759600007
J	Fabianska, I; Pesch, L; Koebke, E; Gerlach, N; Bucher, M				Fabianska, Izabela; Pesch, Lina; Koebke, Eva; Gerlach, Nina; Bucher, Marcel			Neighboring plants divergently modulate effects of loss-of-function in maize mycorrhizal phosphate uptake on host physiology and root fungal microbiota	PLOS ONE			English	Article							TRANSPORTER; GENE; DIVERSITY; PATHWAY; GROWTH; SOIL; COLONIZATION; ABUNDANCE; RESPONSES; NITROGEN	Maize, a main crop worldwide, establishes a mutualistic symbiosis with arbuscular mycorrhizal (AM) fungi providing nutrients to the roots from soil volumes which are normally not in reach of the non-colonized root. The mycorrhizal phosphate uptake pathway (MPU) spans from extraradical hyphae to root cortex cells housing fungal arbuscules and promotes the supply of phosphate to the mycorrhizal host in exchange for photosynthetic carbon. This symbiotic association with the mycobiont has been shown to affect plant host nutritional status and growth performance. However, whether and how the MPU affects the root microbial community associated with mycorrhizal hosts in association with neighboring plants, remains to be demonstrated. Here the maize germinal Mu transposon insertion mutantpht1;6, defective in mycorrhiza-specific Pi transporterPHT1;6gene, and wild type B73 (wt) plants were grown in mono- and mixed culture and examined under greenhouse and field conditions. Disruption of the MPU inpht1;6resulted in strongly diminished growth performance, in reduced P allocation to photosynthetic source leaves, and in imbalances in leaf elemental composition beyond P. At the microbial community level a loss of MPU activity had a minor effect on the root-associated fungal microbiome which was almost fully restricted to AM fungi of the Glomeromycotina. Moreover, while wt grew better in presence ofpht1;6,pht1;6accumulated little biomass irrespective of whether it was grown in mono- or mixed culture and despite of an enhanced fungal colonization of its roots in co-culture with wt. This suggested that a functional MPU is prerequisite to maintain maize growth and that neighboring plants competed for AM fungal Pi in low P soil. Thus future strategies towards improving yield in maize populations on soils with low inputs of P fertilizer could be realized by enhancing MPU at the individual plant level while leaving the root-associated fungal community largely unaffected.	[Fabianska, Izabela; Pesch, Lina; Koebke, Eva; Gerlach, Nina; Bucher, Marcel] Univ Cologne, Inst Plant Sci, Cologne Bioctr, Cologne, Germany; [Bucher, Marcel] Univ Cologne, Cluster Excellence Plant Sci, Cologne, Germany	University of Cologne; University of Cologne	Bucher, M (corresponding author), Univ Cologne, Inst Plant Sci, Cologne Bioctr, Cologne, Germany.; Bucher, M (corresponding author), Univ Cologne, Cluster Excellence Plant Sci, Cologne, Germany.	m.bucher@uni-koeln.de	Bucher, Marcel/D-4596-2013	Bucher, Marcel/0000-0003-1680-9413; Fabianska, Izabela/0000-0002-8440-682X; Pesch, Lina/0000-0002-1828-7447	University of Cologne; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Initiative [EXC-1028]	University of Cologne; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Initiative(German Research Foundation (DFG))	This project has been funded by University of Cologne and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany ' s Excellence Initiative (EXC-1028). There was no additional external funding received for this study	[Anonymous], 2018, DTSCH ARZTEBL, V115, pA; [Anonymous], 2007, NPSA, V22, P1; [Anonymous], 2017, DTSCH ZRZTEBLATT JG, V114, pA741; [Anonymous], 2016, LANCET ONCOL, V17, pe198; [Anonymous], 2017, EUR J TRANSL MYOL, V27, p7X; [Anonymous], 2018, DTSCH ARZTEBL, V115, pA; Banhara A, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.00667, 10.3389/fpfs.2015.00667]; Berg G, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00148, 10.3389/fmicb.2014.00491]; Bucher M, 2007, NEW PHYTOL, V173, P11, DOI 10.1111/j.1469-8137.2006.01935.x; Carmichael SK, 2015, ENV MICROBIOL REP, V7, P592, DOI 10.1111/1758-2229.12291; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Delaux PM, 2015, P NATL ACAD SCI USA, V112, P13390, DOI 10.1073/pnas.1515426112; Engelmoer DJP, 2015, NEW PHYTOL, V205, P1485, DOI 10.1111/nph.13086; Fabianska I, 2019, CURR OPIN MICROBIOL, V49, P90, DOI 10.1016/j.mib.2019.10.004; Fabianska Izabela, 2019, New Phytol, V221, P2123, DOI 10.1111/nph.15538; Fuentes-Arderiu X, 2013, BIOCHEM MEDICA, V23, P141, DOI 10.11613/BM.2013.017; Gerlach N, 2015, PLANT CELL ENVIRON, V38, P1591, DOI 10.1111/pce.12508; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; Giovannetti M, 2004, NEW PHYTOL, V164, P175, DOI 10.1111/j.1469-8137.2004.01145.x; Gomes EA, 2018, PHYTOBIOMES J, V2, P129, DOI 10.1094/PBIOMES-03-18-0012-R; Groten K, 2015, PLANT CELL ENVIRON, V38, P2398, DOI 10.1111/pce.12561; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Hassani MA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0445-0; Hiruma K, 2016, CELL, V165, P464, DOI 10.1016/j.cell.2016.02.028; Hohnjec N, 2003, MOL PLANT MICROBE IN, V16, P903, DOI 10.1094/MPMI.2003.16.10.903; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Javot H, 2011, PLANT J, V68, P954, DOI 10.1111/j.1365-313X.2011.04746.x; Jiang YN, 2017, SCIENCE, V356, P1172, DOI 10.1126/science.aam9970; Karandashov V, 2004, P NATL ACAD SCI USA, V101, P6285, DOI 10.1073/pnas.0306074101; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kobae Y, 2010, PLANT CELL PHYSIOL, V51, P341, DOI 10.1093/pcp/pcq013; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lota F, 2013, PLANT J, V74, P280, DOI 10.1111/tpj.12120; Loth-Pereda V, 2011, PLANT PHYSIOL, V156, P2141, DOI 10.1104/pp.111.180646; Luginbuehl LH, 2017, SCIENCE, V356, P1175, DOI 10.1126/science.aan0081; Lynn Margulis, 1991, SYMBIOGENESIS SYMBIO, P1; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Nagy R, 2006, PLANT BIOLOGY, V8, P186, DOI 10.1055/s-2005-873052; Nagy R, 2009, NEW PHYTOL, V181, P950, DOI 10.1111/j.1469-8137.2008.02721.x; Okubo A, 2009, ECOL RES, V24, P1399, DOI 10.1007/s11284-009-0602-9; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Pimprikar P, 2018, PLANT CELL PHYSIOL, V59, P678, DOI 10.1093/pcp/pcy024; Rausch C, 2004, PLANT J, V39, P13, DOI 10.1111/j.1365-313X.2004.02106.x; Rausch C, 2001, NATURE, V414, P462, DOI 10.1038/35106601; Saravanakumar K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01680-w; Sawers RJH, 2017, NEW PHYTOL, V214, P632, DOI 10.1111/nph.14403; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Schluter U, 2012, PLANT PHYSIOL, V160, P1384, DOI 10.1104/pp.112.204420; Simon JC, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0619-4; Smith SE, 2004, NEW PHYTOL, V162, P511, DOI 10.1111/j.1469-8137.2004.01039.x; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; Spatafora JW, 2016, MYCOLOGIA, V108, P1028, DOI 10.3852/16-042; The Gene Ontology Consortium, 2019, NUCL ACIDS RES, V47, pD330; Thiergart T, 2019, MBIO, V10, DOI 10.1128/mBio.01833-19; Tkacz A, 2015, ISME J, V9, P2349, DOI 10.1038/ismej.2015.41; Toju H, 2018, NAT PLANTS, V4, P247, DOI 10.1038/s41477-018-0139-4; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Wagner MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12151; Walder F, 2012, PLANT PHYSIOL, V159, P789, DOI 10.1104/pp.112.195727; Walters WA, 2018, P NATL ACAD SCI USA, V115, P7368, DOI 10.1073/pnas.1800918115; Willmann M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00533; Xue L, 2019, NEW PHYTOL, V224, P409, DOI 10.1111/nph.15958; Yu P, 2018, NEW PHYTOL, V217, P1240, DOI 10.1111/nph.14893; [No title captured]	66	3	3	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0232633	10.1371/journal.pone.0232633	http://dx.doi.org/10.1371/journal.pone.0232633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555651	Green Published, gold			2022-12-27	WOS:000542759600038
J	Newton, A; Predina, J; Mison, M; Runge, J; Bradley, C; Stefanovski, D; Singhal, S; Holt, D				Newton, Andrew; Predina, Jarrod; Mison, Michael; Runge, Jeffrey; Bradley, Charles; Stefanovski, Darko; Singhal, Sunil; Holt, David			Intraoperative near-infrared imaging can identify canine mammary tumors, a spontaneously occurring, large animal model of human breast cancer	PLOS ONE			English	Article							CARCINOMA-IN-SITU; EUROPEAN ORGANIZATION; CONSERVING THERAPY; MARGIN ASSESSMENT; LUNG-CANCER; FLUORESCENCE; SURGERY; LUMPECTOMY; CONSERVATION; BIOPSY	Introduction Current methods of intraoperative margin assessment in breast conserving surgery are impractical, unreliable, or time consuming. We hypothesized that intraoperative near-infrared (NIR) imaging with an FDA-approved NIR optical contrast agent could identify canine mammary tumors, a spontaneous large animal model of human breast cancer, during surgery. Methods Dogs with mammary tumors underwent a standard of care lumpectomy or mastectomy with wide surgical margins 20 hours after indocyanine green administration (3 mg/kg IV). During surgery, NIR imaging was performed on tumors and wound marginsin situand tumors and lymph nodesex vivo. Following resection, the wound bed was examined for residual fluorescence. Fluorescence intensity was determined by signal-to-background ratio (SBR). All tumors, areas of residual fluorescence, and lymph nodes underwent histopathologic analysis. Results There were 41 mammary tumors in 16 female dogs. Twenty tumors were malignant and 21 were benign. Twenty-eight tumors were fluorescent (mean SBR 1.5 +/- 0.2). Sensitivity of fluorescence for all malignant tumors was 80% (16/20) and 93.3% (14/15) for malignant tumors > 2 cm. Specificity for malignancy was low (< 2cm = 55%; > 2cm = 30%). Tumors > 2 cm were more likely to be fluorescent (OR 6.05, 95% CI 1.50-24.44, P = 0.011) but not more likely to be malignant (OR 3.09, 95% CI 0.86-11.14, P = 0.085) than tumors <= 2 cm. Four out of seven inguinal lymph nodes excised in the mastectomy specimen fluoresced. All four drained malignant tumors; however only 2/4 contained metastatic disease. Conclusion Systemic ICG accumulates reliably in malignant canine mammary tumors > 2 cm. Although no tumor margins fluoresced, a wider margin of normal tissue is removed in canine mastectomy, making direct comparisons with breast conserving surgery difficult. Targeted NIR imaging agents are likely required to improve detection of smaller tumors and improve the specificity of NIR imaging for residual disease and metastatic lymph node detection.	[Newton, Andrew; Predina, Jarrod; Singhal, Sunil] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mison, Michael; Runge, Jeffrey; Holt, David] Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA; [Bradley, Charles] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Stefanovski, Darko] Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Holt, D (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA.	dholt@vet.upenn.edu			Mari Lowe Center for Comparative Oncology, University of Pennsylvania School of Veterinary Medicine	Mari Lowe Center for Comparative Oncology, University of Pennsylvania School of Veterinary Medicine	This study was funded by the Mari Lowe Center for Comparative Oncology, University of Pennsylvania School of Veterinary Medicine.	Abadie J, 2018, BREAST CANCER RES TR, V167, P459, DOI 10.1007/s10549-017-4542-8; ABE O, 1995, NEW ENGL J MED, V333, P1444; Baliski CR, 2017, ANN SURG ONCOL, V24, P632, DOI 10.1245/s10434-016-5678-1; Bijker N, 2001, J CLIN ONCOL, V19, P2263, DOI 10.1200/JCO.2001.19.8.2263; Boogerd LSF, 2016, ONCOTARGET, V7, P17442, DOI 10.18632/oncotarget.7856; Bos R, 2011, JNCI-J NATL CANCER I, V93, P309; Camp MS, 2013, AM J SURG, V206, P526, DOI 10.1016/j.amjsurg.2013.01.046; Chi CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083927; de Boer E, 2015, BRIT J SURG, V102, pE56, DOI 10.1002/bjs.9713; Esbona K, 2012, ANN SURG ONCOL, V19, P3236, DOI 10.1245/s10434-012-2492-2; Fidel J, 2015, CANCER RES, V75, P4283, DOI 10.1158/0008-5472.CAN-15-0471; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Goyal A, 2006, BREAST CANCER RES TR, V99, P203, DOI 10.1007/s10549-006-9192-1; Graham JC, 1999, J VET INTERN MED, V13, P416, DOI 10.1892/0891-6640(1999)013&lt;0416:TPSOAI&gt;2.3.CO;2; Gray RJ, 2001, ANN SURG ONCOL, V8, P711; Gurfinkel M, 2000, PHOTOCHEM PHOTOBIOL, V72, P94, DOI 10.1562/0031-8655(2000)072<0094:POIAHC>2.0.CO;2; Heneweer C, 2011, J NUCL MED, V52, P625, DOI 10.2967/jnumed.110.083998; Holt D, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.7.076002; Holt D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103342; Jeevan R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4505; Keating J, 2016, J SURG ONCOL, V113, P508, DOI 10.1002/jso.24167; Keating JJ, 2017, CANCER-AM CANCER SOC, V123, P1051, DOI 10.1002/cncr.30419; KleinJan GH, 2016, EUR J NUCL MED MOL I, V43, P1857, DOI 10.1007/s00259-016-3372-y; Kosaka N, 2011, INT J CANCER, V129, P1671, DOI 10.1002/ijc.26113; Krekel NMA, 2013, LANCET ONCOL, V14, P48, DOI 10.1016/S1470-2045(12)70527-2; Langhans L, 2017, JAMA SURG, V152, P378, DOI 10.1001/jamasurg.2016.4751; Liu DL, 2014, CANCER RES, V74, P5045, DOI 10.1158/0008-5472.CAN-14-0392; Madajewski B, 2012, CLIN CANCER RES, V18, P5741, DOI 10.1158/1078-0432.CCR-12-1188; Maeda H, 2011, ADV DRUG DELIVER REV, V63, P129, DOI 10.1016/j.addr.2010.05.001; MATSUMURA Y, 1986, CANCER RES, V46, P6387; McCahill LE, 2012, JAMA-J AM MED ASSOC, V307, P467, DOI 10.1001/jama.2012.43; Moore MM, 2001, ANN SURG, V233, P761, DOI 10.1097/00000658-200106000-00005; Valejo FAM, 2013, REV BRAS GINECOL OBS, V35, P221, DOI 10.1590/S0100-72032013000500006; Nguyen F, 2018, BREAST CANCER RES TR, V167, P635, DOI 10.1007/s10549-017-4548-2; Olsen MA, 2015, ANN SURG ONCOL, V22, P2003, DOI 10.1245/s10434-014-4200-x; Queiroga FL, 2011, IN VIVO, V25, P455; Reynolds JS, 1999, PHOTOCHEM PHOTOBIOL, V70, P87, DOI 10.1111/j.1751-1097.1999.tb01953.x; Samorani D, 2015, EJSO-EUR J SURG ONC, V41, P64, DOI 10.1016/j.ejso.2014.10.047; Schnabel F, 2014, ANN SURG ONCOL, V21, P1589, DOI 10.1245/s10434-014-3602-0; Schulman AM, 2017, ANN SURG ONCOL, V24, P52, DOI 10.1245/s10434-016-5516-5; Siegel R. L., 2017, CA CANC J CLIN; Sleeckx N, 2014, J COMP PATHOL, V150, P175, DOI 10.1016/j.jcpa.2013.09.005; Sorenmo KU, 2011, VET PATHOL, V48, P85, DOI 10.1177/0300985810389480; Stang A, 2013, EUR J EPIDEMIOL, V28, P689, DOI 10.1007/s10654-013-9816-9; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; Verbeek FPR, 2014, BREAST CANCER RES TR, V143, P333, DOI 10.1007/s10549-013-2802-9; Weng EY, 2000, CANCER, V88, P1643, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1643::AID-CNCR19>3.0.CO;2-O; Wilke LG, 2014, JAMA SURG, V149, P1296, DOI 10.1001/jamasurg.2014.926	49	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234791	10.1371/journal.pone.0234791	http://dx.doi.org/10.1371/journal.pone.0234791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555698	gold, Green Published			2022-12-27	WOS:000542759600009
J	Burnside, R; Ullsperger, M				Burnside, Rebecca; Ullsperger, Markus			Social comparison impacts stimulus evaluation in a competitive social learning task	PLOS ONE			English	Article							DECISION-MAKING; FEEDBACK; BRAIN; PERFORMANCE; POTENTIALS; ATTENTION; FAILURE; OTHERS; REWARD	When we perform an action, the outcome that follows it can change the value we place on that behaviour, making it more or less likely to be repeated in the future. However, the values that we learn are not objective: we interpret the outcomes that we receive for ourselves relative to those that share our environment, i.e. we engage in social comparison. The temporal dynamics of physiological responses to stimulus valuation in social learning tasks are poorly understood, particularly in human participants. Therefore, we recorded stimulus-locked event-related potentials with 64-channel EEG to examine stimulus valuation, following the design of a study previously used in macaques. Pairs of participants performed a social learning task in which they received outcomes sequentially for a presented stimulus (partner first) by pressing a button in response to a cue. There were two conditions: one in which stimulus values varied for the participant but output a constant rate of reward for the partner (self-variable blocks), and another condition in which this payout was reversed (other-variable blocks). We then measured participants' self-reported competitiveness. Approximately 200 ms post-stimulus, an ERP related to stimulus evaluation and attentional processing appeared to encode own stimulus value in self-variable blocks. In other-variable blocks the same pattern of activity was reversed, even though the value of the stimulus for the participant did not depend on the stimulus presented. Outcome-locked analyses further showed that attention dedicated to the partner's outcome was greater in more competitive participants. We conclude that subjective stimulus value can be reflected in early stimulus-locked ERP responses and that competitive participants may be more invested in their own performance relative to the other player, hence their increased interest in the outcome of their partner.	[Burnside, Rebecca; Ullsperger, Markus] Otto von Guericke Univ, Inst Psychol, Dept Neuropsychol, Magdeburg, Germany; [Ullsperger, Markus] Otto von Guericke Univ, Ctr Behav Brain Sci, Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University	Burnside, R (corresponding author), Otto von Guericke Univ, Inst Psychol, Dept Neuropsychol, Magdeburg, Germany.	rebecca.burnside@ovgu.de			German Research Foundation [DFG: UL 196/4-1]	German Research Foundation(German Research Foundation (DFG))	This work was funded by the German Research Foundation (DFG: UL 196/4-1, https://www.dfg.de/) to MU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BA, 2019, ATTEN PERCEPT PSYCHO, V81, P607, DOI 10.3758/s13414-019-01670-2; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; [Anonymous], 2019, Support Care Cancer, P1, DOI 10.1007/s00520-019-04813-1; [Anonymous], 2002, J COMPUT CHEM, V23, P759; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2019, INTEL 64 IA 32 ARCHI, V3; [Anonymous], 2004, J NEUROSCI METH, V134, P9; [Anonymous], 1996, MITTELUNGEN, V9, P3; Bellebaum C, 2014, J COGNITIVE NEUROSCI, V26, P2111, DOI 10.1162/jocn_a_00612; Bland AR, 2011, BRAIN RES, V1417, P55, DOI 10.1016/j.brainres.2011.08.031; Boksem MAS, 2011, PSYCHOPHYSIOLOGY, V48, P973, DOI 10.1111/j.1469-8986.2010.01163.x; Bourisly AK, 2018, TRANSL NEUROSCI, V9, P72, DOI 10.1515/tnsci-2018-0013; Carretie L, 2001, INT J PSYCHOPHYSIOL, V41, P75, DOI 10.1016/S0167-8760(00)00195-1; Chen XP, 2011, MANAGE ORGAN REV, V7, P353, DOI 10.1111/j.1740-8784.2011.00215.x; Delgado MR, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.033.2009; Donohue SE, 2016, J COGNITIVE NEUROSCI, V28, P529, DOI 10.1162/jocn_a_00917; Evans KM, 2007, NEUROPSYCHOLOGIA, V45, P1777, DOI 10.1016/j.neuropsychologia.2006.12.014; Galaro JK, 2019, J NEUROSCI, V39, P1236, DOI 10.1523/JNEUROSCI.1254-18.2018; Garcia-Lazaro HG, 2019, J COGNITIVE NEUROSCI, V31, P469, DOI 10.1162/jocn_a_01356; Jung TP, 1998, ADV NEUR IN, V10, P894; Kistruck GM, 2016, ACAD MANAGE J, V59, P1174, DOI 10.5465/amj.2014.0201; Koban L, 2012, COGN AFFECT BEHAV NE, V12, P460, DOI 10.3758/s13415-012-0091-0; Krigolson OE, 2018, INT J PSYCHOPHYSIOL, V132, P175, DOI 10.1016/j.ijpsycho.2017.11.007; Li J, 2020, INT J PSYCHOPHYSIOL, V150, P83, DOI 10.1016/j.ijpsycho.2020.02.003; Li P, 2010, NEUROIMAGE, V52, P1727, DOI 10.1016/j.neuroimage.2010.04.275; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Luo Y, 2018, HUM BRAIN MAPP, V39, P440, DOI 10.1002/hbm.23854; Luque D, 2015, PSYCHOPHYSIOLOGY, V52, P238, DOI 10.1111/psyp.12302; Marco-Pallares J, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-86; Noritake A, 2018, NAT NEUROSCI, V21, P1452, DOI 10.1038/s41593-018-0229-7; Parvaz MA, 2012, PSYCHIAT RES-NEUROIM, V203, P75, DOI 10.1016/j.pscychresns.2012.01.001; Peterburs J, 2016, PSYCHOPHYSIOLOGY, V53, P209, DOI 10.1111/psyp.12560; Potts GF, 2006, J COGNITIVE NEUROSCI, V18, P1112, DOI 10.1162/jocn.2006.18.7.1112; Prescott MJ, 2010, J NEUROSCI METH, V193, P167, DOI 10.1016/j.jneumeth.2010.09.003; Roux C, 2015, J CONSUM RES, V42, P615, DOI 10.1093/jcr/ucv048; Smith BW, 2009, NEUROIMAGE, V44, P600, DOI 10.1016/j.neuroimage.2008.08.016; Suguitan Jr AL, 2011, PLOS ONE, V6; van der Helden J, 2010, CEREB CORTEX, V20, P1596, DOI 10.1093/cercor/bhp224; Wischnewski M, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13379; Wu Y, 2012, INT J PSYCHOPHYSIOL, V85, P145, DOI 10.1016/j.ijpsycho.2012.06.004; Xie X, 2006, ACTA PSYCHOL SINICA; Yu H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01162; Yu RJ, 2006, NEUROREPORT, V17, P1747, DOI 10.1097/01.wnr.0000239960.98813.50; Yu RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13452; Zhao L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00984	45	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234397	10.1371/journal.pone.0234397	http://dx.doi.org/10.1371/journal.pone.0234397			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584827	Green Published, gold			2022-12-27	WOS:000545747200011
J	Borzee, A; Messenger, KR; Chae, S; Andersen, D; Groffen, J; Kim, YI; An, J; Othman, SN; Ri, K; Nam, TY; Bae, Y; Ren, JL; Li, JT; Chuang, MF; Yi, Y; Shin, Y; Kwon, T; Jang, Y; Min, MS				Borzee, Amael; Messenger, Kevin R.; Chae, Shinhyeok; Andersen, Desiree; Groffen, Jordy; Kim, Ye Inn; An, Junghwa; Othman, Siti N.; Ri, Kyongsin; Nam, Tu Yong; Bae, Yoonhyuk; Ren, Jin-Long; Li, Jia-Tang; Chuang, Ming-Feng; Yi, Yoonjung; Shin, Yucheol; Kwon, Taejoon; Jang, Yikweon; Min, Mi-Sook			Yellow sea mediated segregation between North East Asian Dryophytes species	PLOS ONE			English	Article							TREEFROGS GENUS HYLA; TREE FROGS; GENETIC CONSEQUENCES; MICROHABITAT USE; CLIMATIC OSCILLATIONS; JAPANESE TREEFROG; MITOCHONDRIAL-DNA; CONTINENTAL-SHELF; MARGINAL SEAS; LEVEL CHANGE	While comparatively few amphibian species have been described on the North East Asian mainland in the last decades, several species have been the subject of taxonomical debates in relation to the Yellow sea. Here, we sampledDryophytessp. treefrogs from the Republic of Korea, the Democratic People's Republic of Korea and the People's Republic of China to clarify the status of this clade around the Yellow sea and determine the impact of sea level change on treefrogs' phylogenetic relationships. Based on genetics, call properties, adult morphology, tadpole morphology and niche modelling, we determined the segregated status species ofD.suweonensisandD.immaculatus. We then proceeded to describe a new treefrog species,D.flaviventrissp. nov., from the central lowlands of the Republic of Korea. The new species is geographically segregated fromD.suweonensisby the Chilgap mountain range and known to occur only in the area of Buyeo, Nonsan and Iksan in the Republic of Korea. While the Yellow sea is the principal element to the current isolation of the three clades, the paleorivers of the Yellow sea basin are likely to have been the major factor for the divergences within this clade. We recommend conducting rapid conservation assessments as these species are present on very narrow and declining ranges.	[Borzee, Amael; Messenger, Kevin R.; Shin, Yucheol] Nanjing Forestry Univ, Coll Biol & Environm, Nanjing, Jiangsu, Peoples R China; [Chae, Shinhyeok; Kwon, Taejoon] Ulsan Natl Inst Sci & Technol UNIST, Sch Life Sci, Dept Biomed Engn, Ulsan, South Korea; [Andersen, Desiree; Groffen, Jordy; Kim, Ye Inn; Othman, Siti N.; Bae, Yoonhyuk; Chuang, Ming-Feng; Yi, Yoonjung; Jang, Yikweon] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Andersen, Desiree; Groffen, Jordy; Kim, Ye Inn; Othman, Siti N.; Bae, Yoonhyuk; Chuang, Ming-Feng; Yi, Yoonjung; Jang, Yikweon] Ewha Womans Univ, Div EcoSci, Seoul, South Korea; [Groffen, Jordy] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [An, Junghwa] Natl Inst Biol Resources, Anim Resources Div, Incheon, South Korea; [Ri, Kyongsin] Minist Land & Environm Protect, Dept Int Econ Cooperat, Pyongyang, North Korea; [Nam, Tu Yong] State Acad Sci, Inst Zool, Pyongyang, North Korea; [Ren, Jin-Long; Li, Jia-Tang] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Min, Mi-Sook] Seoul Natl Univ, Res Inst Vet Sci, Coll Vet Med, Seoul, South Korea	Nanjing Forestry University; Ulsan National Institute of Science & Technology (UNIST); Ewha Womans University; Ewha Womans University; Virginia Polytechnic Institute & State University; National Institute of Biological Resources; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Seoul National University (SNU)	Borzee, A (corresponding author), Nanjing Forestry Univ, Coll Biol & Environm, Nanjing, Jiangsu, Peoples R China.; Min, MS (corresponding author), Seoul Natl Univ, Res Inst Vet Sci, Coll Vet Med, Seoul, South Korea.	amaelborzee@gmail.com; minbio@yahoo.co.kr	Kwon, Taejoon/S-3835-2016; OTHMAN, SITI NORHIDAYAH BINTI/AGP-4655-2022; Borzée, Amaël/P-6247-2018; Chuang, Ming-Feng/GWQ-6299-2022	Kwon, Taejoon/0000-0002-9794-6112; OTHMAN, SITI NORHIDAYAH BINTI/0000-0002-3894-7553; Borzée, Amaël/0000-0003-1093-677X; Chuang, Ming-Feng/0000-0002-7328-2577; Andersen, Desiree/0000-0003-0690-8688; Groffen, Jordy/0000-0002-4772-3068	Conservation Research grant from The Biodiversity Foundation; National Research Foundation of Korea [2017R1A2B2003579]; National Institute of Biological Resources (NIBR) - Ministry of Environment (MOE) of the Republic of Korea [NIBR201803101]	Conservation Research grant from The Biodiversity Foundation; National Research Foundation of Korea(National Research Foundation of Korea); National Institute of Biological Resources (NIBR) - Ministry of Environment (MOE) of the Republic of Korea	This work was supported by a Conservation Research grant from The Biodiversity Foundation to AB, a research grant from the National Research Foundation of Korea (2017R1A2B2003579) to YJ, and by a grant from the National Institute of Biological Resources (NIBR), funded by the Ministry of Environment (MOE) of the Republic of Korea (NIBR201803101) to MSM and TK.	Aizawa M, 2012, J PLANT RES, V125, P713, DOI 10.1007/s10265-012-0488-4; Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; Anderson K, 1991, CHROMOSOME EVOLUTION; [Anonymous], 2012, CARDIOVASCULAR THERA, V4, P31; [Anonymous], 2008, SERPIENTE ASCLEPIOS, V24, P25; [Anonymous], 2010, APO NEWS, V14, P1; [Anonymous], 2010, PALAEOHISPANICA, V10, P201; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 1972, NICHE OVERLAP FUNCTI; [Anonymous], FIGTREE V1 3 1 TREE; [Anonymous], 1980, FEEDING ECOLOGY THIR; Avise JC, 2000, PHYLOGEOGRAPHY THE H; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baek HJ, 2011, MOL CELLS, V31, P105, DOI 10.1007/s10059-011-0014-x; Balogova M., 2017, INT J SPELEOL, V46, P1; Bannikov A, 1977, PROSVESHCHENIE MOSCO; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Berman D I, 2016, Dokl Biol Sci, V471, P276, DOI 10.1134/S0012496616060065; Boettger O., 1892, KATALOG BATRACHIER S; Boettger O, 1895, VERHANDLUNGEN DER NA, V10, P187; Boettger O, 1888, AUFZAHLUNG EINIGER N, P189; Borkin LJ, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P329; Borzee A., 2016, HERPETOL REV, V47, P418; Borzee A, 2017, PEERJ; Borzee A, 2018, WHY ARE ANURANS THRE; Borzee A, BIODIVERSITY CONSERV; Borzee AEL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177860; Borzee A, 2019, ACTA HERPETOL, V14, P27, DOI 10.13128/Acta_Herpetol-24102; Borzee A, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00055; Borzee A, 2019, FRONT ENV SCI-SWITZ, V7, DOI 10.3389/fenvs.2019.00039; Borzee A, 2019, SCIENCE, V363, P1161, DOI 10.1126/science.aaw9023; Borzee Amael, 2018, Conservation Evidence, V15, P6; Borzee A, 2018, NAT CONSERV RES, V3, P120, DOI 10.24189/ncr.2018.008; Borzee A, 2018, HERPETOL J, V28, P160; Borzee A, 2018, PEERJ, V6, DOI 10.7717/peerj.5568; Borzee A, 2018, ETHOL ECOL EVOL, V30, P515, DOI 10.1080/03949370.2018.1441192; Borzee A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26222-w; Borzee A, 2018, AMPHIBIA-REPTILIA, V39, P163, DOI 10.1163/15685381-17000036; Borzee A, 2017, PEERJ, V5, DOI 10.7717/peerj.3872; Borzee A, 2016, INTEGR ZOOL, V11, P375, DOI 10.1111/1749-4877.12200; Borzee A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32569; Borzee A, 2015, ANIM CELLS SYST, V19, P216, DOI 10.1080/19768354.2015.1028442; Borzee A, 2013, ANIM CELLS SYST, V17, P348, DOI 10.1080/19768354.2013.842931; Bouckaert R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006650; Boulenger G, 1887, ANN MAG NAT HIST SER, V14, P67; Boulenger G. A., 1890, Annals of Natural History, V(6), P137; Brett CE, 2007, PALAIOS, V22, P228, DOI 10.2110/palo.2005.p05-028r; Broecker WS, 1997, SCIENCE, V278, P1582, DOI 10.1126/science.278.5343.1582; Camoin GF, 2001, PALAEOGEOGR PALAEOCL, V175, P325, DOI 10.1016/S0031-0182(01)00378-9; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chun S., 2012, KOREAN J HERPETOL, V4, P31, DOI DOI 10.1080/23802359.2017.1292475; Chung CH, 2007, GEOSCI J, V11, P147, DOI 10.1007/BF02913928; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Duellman WE, 2001, HYLID FROGS MIDDLE A; Duellman WF, 1977, LISTE REZENTEN AMPHI; Duellman WE, 2016, ZOOTAXA, V4104, P1, DOI 10.11646/zootaxa.4104.1.1; Dufresnes C, 2014, HEREDITY, V113, P9, DOI 10.1038/hdy.2014.26; Dufresnes C, 2016, PHYLOGEOGRAPHY REVEA; Dufresnes C, 2019, BIOL J LINN SOC, V128, P130, DOI 10.1093/biolinnean/blz076; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Feder M. E., 1992, ENV PHYSL AMPHIBIANS; Fei Liang, 2012, P1; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Fleming K, 1998, EARTH PLANET SC LETT, V163, P327, DOI 10.1016/S0012-821X(98)00198-8; Frost D.R., 2017, AMPHIBIAN SPECIES WO; GERHARDT HC, 1994, COPEIA, P51; Gorham SW, 1974, CHECKLIST WORLD AMPH; Gosner K. L., 1960, Herpetologica, V16, P183; Groffen J, 2018, ANIM CELLS SYST, V22, P205, DOI 10.1080/19768354.2018.1475301; Gunther A, 1958, CATALOGUE BATRACHIA; Han WX, 2012, QUATERNARY RES, V78, P174, DOI 10.1016/j.yqres.2012.05.001; He LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15645; Heo K, 2019, RUSS J HERPETOL, V26, P87, DOI 10.30906/1026-2296-2019-26-2-87-90; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans R.J., 2017, RASTER GEOGRAPHIC DA; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill J, 2009, GENUS TREE FROG HYLA; Hogarth LJ, 2012, MAR GEOL, V303, P99, DOI 10.1016/j.margeo.2012.02.005; Hua X, 2009, HERPETOLOGICA, V65, P246, DOI 10.1655/08-058R1.1; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016063; Jiang D, 2019, NATL SCI REV; Johnson JR, 2008, HERPETOLOGICA, V64, P259, DOI 10.1655/07-064.1; Kim E, 2017, ASIAN HERPETOL RES, V8, P235, DOI 10.16373/j.cnki.ahr.170069; Kim H.-T., 2019, ARROW GUIDE AMPHIBIA; Kim MY, 2015, TESTING EXPLOITATIVE; Kitamura A, 2000, GEOLOGY, V28, P723, DOI 10.1130/0091-7613(2000)28<723:MRTEPR>2.0.CO;2; Kohler J, 2017, ZOOTAXA, V4251, P1, DOI 10.11646/zootaxa.4251.1.1; Kong WS, 2000, GLOBAL ECOL BIOGEOGR, V9, P391, DOI 10.1046/j.1365-2699.2000.00203.x; KOSTIN ANATOLY A., 1935, ANNOT ZOOL JAP, V15, P28; Kumar S, 2017, MOL BIOL EVOL, V34, P1812, DOI 10.1093/molbev/msx116; KURAMOTO M, 1980, COPEIA, P100; LAMB T, 1986, P NATL ACAD SCI USA, V83, P2526, DOI 10.1073/pnas.83.8.2526; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; Li CX, 2001, MAR GEOL, V173, P97, DOI 10.1016/S0025-3227(00)00169-9; Li GX, 2014, EARTH-SCI REV, V139, P390, DOI 10.1016/j.earscirev.2014.09.007; Li JT, 2015, MOL PHYLOGENET EVOL, V87, P80, DOI 10.1016/j.ympev.2015.02.018; Li YL, 2018, MOL ECOL RESOUR, V18, P176, DOI 10.1111/1755-0998.12719; Lima AP, 1993, EFFECTS PREY SIZE FO; Linnaeus C, 1758, SYSTEMA NATURAE REGN, V1, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; Lister A, 2004, PHILOS T R SOC B, V359, P195; Liu C. C., 1961, CHINESE TAILLESS BAT; Lobo FJ, 2014, MAR GEOL, V352, P215, DOI 10.1016/j.margeo.2013.10.009; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; LOMOLINO MV, 1990, OIKOS, V57, P297, DOI 10.2307/3565957; Macarthur R, 1967, LIMITING SIMILARITYC; Fernandez-Palacios JM, 2016, NATURE, V532, P42, DOI 10.1038/nature17880; MERTENS ROBERT, 1967, SENCKENBERG BIOL, V48, P1; Min MS, 2016, ZOOTAXA, V4169, P475, DOI 10.11646/zootaxa.4169.3.4; Mix AC, 2001, QUATERNARY SCI REV, V20, P627, DOI 10.1016/S0277-3791(00)00145-1; Moen DS, 2009, EVOLUTION, V63, P195, DOI 10.1111/j.1558-5646.2008.00538.x; Ni G, 2014, MOL ECOL, V23, P534, DOI 10.1111/mec.12620; Nikolskii AM, 1918, FAUNA RUSSIA ADJACEN; Osterberg EC, 2006, MAR GEOL, V229, P159, DOI 10.1016/j.margeo.2006.03.005; Paris JR, 2017, METHODS ECOL EVOL, V8, P1360, DOI 10.1111/2041-210X.12775; Park D, 2009, J ECOL FIELD BIOL, V29, P425; Park J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31002-7; Park S, 2013, BEHAV ECOL SOCIOBIOL, V67, P1345, DOI 10.1007/s00265-013-1563-0; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Phillips SJ., 2017, MAXENT SOFTWARE MODE; Pope C. H., 1940, Peking Natural History Bulletin, V15, P13; Poyarkov NA, 2012, ZOOTAXA, P1; Pritchard JK., 2010, DOCUMENTATION STRUCT; Rabineau M, 2006, EARTH PLANET SC LETT, V252, P119, DOI 10.1016/j.epsl.2006.09.033; Reis AT, 2013, GEOMORPHOLOGY, V203, P25, DOI 10.1016/j.geomorph.2013.04.037; Rex MA, 1997, NATURE, V385, P577, DOI 10.1038/385577a0; RIEHL CJ, 1995, BIOCHEM SYST ECOL, V23, P245, DOI 10.1016/0305-1978(94)00091-T; Roh G, 2014, ECOL INFORM, V24, P78, DOI 10.1016/j.ecoinf.2014.07.009; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Ruban DA, 2007, PALAEOGEOGR PALAEOCL, V251, P422, DOI 10.1016/j.palaeo.2007.04.008; Rudh A, 2007, MOL ECOL, V16, P4284, DOI 10.1111/j.1365-294X.2007.03479.x; Ryu E, 2008, QUATERN INT, V176, P36, DOI 10.1016/j.quaint.2007.05.015; SCHLEFER EK, 1986, J HERPETOL, V20, P210, DOI 10.2307/1563946; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Shen KN, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-83; Shi LY, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00486; Shu GC, 2017, PEERJ, V5, DOI 10.7717/peerj.3805; Smith SA, 2005, EVOLUTION, V59, P2433; Song J.-Y., 2009, KOREAN J HERPETOLOGY, V1, P15; Song Wonkyong, 2015, [Journal of the Korea Society of Environmental Restoration Technology, 한국환경복원기술학회지], V18, P71, DOI 10.13087/kosert.2015.18.1.71; Stejneger LH, 1907, HERPETOLOGY JAPAN AD; Stock M, 2012, MOL PHYLOGENET EVOL, V65, P1, DOI 10.1016/j.ympev.2012.05.014; Stock M, 2008, MOL PHYLOGENET EVOL, V49, P1019, DOI 10.1016/j.ympev.2008.08.029; STOREY KB, 1992, ANNU REV PHYSIOL, V54, P619, DOI 10.1146/annurev.physiol.54.1.619; STUMPEL A H P, 1990, Amphibia-Reptilia, V11, P304, DOI 10.1163/156853890X00230; Sugimoto K, 2008, COMP BIOCHEM PHYS A, V151, P628, DOI 10.1016/j.cbpa.2008.07.027; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Terentev PV, 1949, KEY AMPHIBIANS REPTI; Toft CA, 1985, RESOURCE PARTITIONIN; Tytar V, 2018, Vestnik Zoologii, V52, P341, DOI 10.2478/vzoo-2018-0036; Verardi A, 2009, ANN ZOOLOGICI FENNIC; Wang J, 2017, SCI REP-UK, V7, DOI 10.1038/srep41418; Wang PX, 1999, MAR GEOL, V156, P5, DOI 10.1016/S0025-3227(98)00172-8; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wassmann R, 2009, ADV AGRON, V102, P91, DOI 10.1016/S0065-2113(09)01003-7; Webb RG, 1962, SOME REPTILES AMPHIB; Xiao JL, 1999, PALAEOGEOGR PALAEOCL, V154, P179, DOI 10.1016/S0031-0182(99)00110-8; Xiao JL, 1999, QUATERNARY SCI REV, V18, P147, DOI 10.1016/S0277-3791(97)00097-8; Yang S. Y., 1962, Korean Journal of Zoology, V5, P35; Yang W D, 2001, MAR GEOL QUAT GEOL, V21, P1; Yang Z.G., 2001, MAR GEOL QUAT GEOL, V21, P1, DOI DOI 10.16562/J.CNKI.0256-1492.2001.03.001; Yoo DG, 2016, MAR PETROL GEOL, V73, P212, DOI 10.1016/j.marpetgeo.2016.03.005; Zhang H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-21; Zhang JY, 2019, INT J BIOL MACROMOL, V132, P461, DOI 10.1016/j.ijbiomac.2019.03.220; 李广雪, 2005, [中国科学. D辑, 地球科学, Science in China], V35, P284	170	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234299	10.1371/journal.pone.0234299	http://dx.doi.org/10.1371/journal.pone.0234299			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579561	Green Published, gold			2022-12-27	WOS:000545646600049
J	Ueki, Y; Lilholt, H; Madsen, B				Ueki, Yosuke; Lilholt, Hans; Madsen, Bo			Experimental evaluation of stiffness predictions of multiaxial flax fibre composites by classical laminate theory	PLOS ONE			English	Article							BEHAVIOR	Despite the good mechanical properties of natural fibre composites, their use in load-bearing components is still limited, which may be due to lack of knowledge and confidence in calculating the performance of the composites by mechanical models. The present study is providing an experimental evaluation of stiffness predictions of multiaxial flax fibre composite by classical laminate theory (CLT). The experimental base is (i) multiaxial flax fibre composites fabricated with two types of biaxial non-crimp fabrics, having a nominal yarn orientation of +/- 45 degrees, and (ii) uniaxial flax fibre composites fabricated with the same flax yarn as used in the fabrics. The fabricated composites are characterised by volumetric composition, yarn orientation and tensile properties. A fast and easy operational Fast Fibre Orientation (FFO) method is developed to determine the actual yarn orientation in fabrics and composites. It is demonstrated that the FFO method is a robust method, giving repeatable results for yarn orientations, and it can be used both on fabrics and composites. CLT predictions of stiffness of the multiaxial flax fibre composites are shown to be in good agreement with the measured stiffnesses of the composites in three testing directions (0 degrees, 45 degrees, and 90 degrees). The use of the actual yarn orientations measured by the FFO method, instead of the nominal yarn orientations of +/- 45 degrees, is shown to result in improved CLT predictions of stiffness with a mean deviation between predictions and measurements on 0.2 GPa. Altogether, it is demonstrated that stiffness of multiaxial flax fibre composites can be accurately predicted by CLT, without any fitting constants, based on independently determined stiffness parameters of the related uniaxial flax fibre composite, and based on measured yarn orientations in the flax fibre fabric.	[Ueki, Yosuke] Hitachi Ltd, Reliabil Sci Res Dept, Ctr Technol Innovat Mech Engn, Res & Dev Grp, Hitachinaka, Ibaraki, Japan; [Lilholt, Hans; Madsen, Bo] Tech Univ Denmark, Sect Composite Mat, Sect Composite Mech & Struct, Dept Wind Energy, Lyngby, Denmark	Hitachi Limited; Technical University of Denmark	Ueki, Y (corresponding author), Hitachi Ltd, Reliabil Sci Res Dept, Ctr Technol Innovat Mech Engn, Res & Dev Grp, Hitachinaka, Ibaraki, Japan.	yosuke.ueki.aq@hitachi.com		Madsen, Bo/0000-0002-5221-3732				Aslan M, 2013, J MATER SCI, V48, P3812, DOI 10.1007/s10853-013-7182-3; Baley C, 2012, FLAX HEMP FIBRES NAT; Baley C, 2006, MATER LETT, V60, P2984, DOI 10.1016/j.matlet.2006.02.028; Barbero E.J., 2018, INTRO COMPOSITE MAT, V3; Campilho RDSG, 2017, WOODH PUB S COMPOS S, P275, DOI 10.1016/B978-0-08-100793-8.00010-7; Cichocki FR, 2002, COMPOS SCI TECHNOL, V62, P669, DOI 10.1016/S0266-3538(02)00011-8; Corona A, 2016, CIRP ANN-MANUF TECHN, V65, P13, DOI 10.1016/j.cirp.2016.04.032; Halpin J, 1967, EFFECT ENV FACTORS C; Hughes M, 2007, J MATER SCI, V42, P2499, DOI 10.1007/s10853-006-1027-2; Jones R.M., 1999, MECH COMPOS MATER, V2nd, DOI DOI 10.1201/9781498711067; Koh R, 2018, MECH MATER, V124, P26, DOI 10.1016/j.mechmat.2018.05.005; Krenchel H., 1964, FIBRE REINFORCEMENT; Madsen B.LilholtH, 2002, 23 RISO INT S MAT SC; Madsen B, 2007, COMPOS SCI TECHNOL, V67, P1584, DOI 10.1016/j.compscitech.2006.07.009; Madsen B, 2009, COMPOS SCI TECHNOL, V69, P1057, DOI 10.1016/j.compscitech.2009.01.016; Mehmood S, 2012, J REINF PLAST COMP, V31, P1746, DOI 10.1177/0731684412441686; Mussig J, 2010, IND APPL PLANT FIBRE; Ray D, 2017, WOODH PUB S COMPOS S, P1; Shaker K, 2016, J IND TEXT, V46, P549, DOI 10.1177/1528083715591579; Zeeshan M, 2021, J IND TEXT, V51, P768, DOI 10.1177/1528083719891420	20	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234701	10.1371/journal.pone.0234701	http://dx.doi.org/10.1371/journal.pone.0234701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579569	Green Published, gold			2022-12-27	WOS:000545646600056
J	Waliczek, M; Wierzbicka, M; Arkuszewski, M; Kijewska, M; Jaremko, L; Rajagopal, P; Szczepski, K; Sroczynska, A; Jaremko, M; Stefanowicz, P				Waliczek, Mateusz; Wierzbicka, Magdalena; Arkuszewski, Maciej; Kijewska, Monika; Jaremko, Lukasz; Rajagopal, Priyadharshni; Szczepski, Kacper; Sroczynska, Amanda; Jaremko, Mariusz; Stefanowicz, Piotr			Attempting to synthesize lasso peptides using high pressure	PLOS ONE			English	Article							CYCLIC PEPTIDE; FERMENTATION; ANTAGONIST; STRAIN	Lasso peptides are unique in that the tail of the lasso peptide threads through its macrolactam ring. The unusual structure and biological activity of lasso peptides have generated increased interest from the scientific community in recent years. Because of this, many new types of lasso peptides have been discovered. These peptides can be synthesized by microorganisms efficiently, and yet, their chemical assembly is challenging. Herein, we investigated the possibility of high pressure inducing the cyclization of linear precursors of lasso peptides. Unlike other molecules like rotaxanes which mechanically interlock at high pressure, the threaded lasso peptides did not form, even at pressures the high pressure up to 14 000 kbar.	[Waliczek, Mateusz; Wierzbicka, Magdalena; Arkuszewski, Maciej; Kijewska, Monika; Szczepski, Kacper; Sroczynska, Amanda; Stefanowicz, Piotr] Univ Wroclaw, Fac Chem, Wroclaw, Poland; [Jaremko, Lukasz; Rajagopal, Priyadharshni; Szczepski, Kacper; Jaremko, Mariusz] King Abdullah Univ Sci & Technol KAUST, Biol & Environm Sci & Engn Div BESE, Thuwal, Saudi Arabia	University of Wroclaw; King Abdullah University of Science & Technology	Stefanowicz, P (corresponding author), Univ Wroclaw, Fac Chem, Wroclaw, Poland.; Jaremko, M (corresponding author), King Abdullah Univ Sci & Technol KAUST, Biol & Environm Sci & Engn Div BESE, Thuwal, Saudi Arabia.	mariusz.jaremko@kaust.edu.sa; piotr.stefanowicz@chem.uni.wroc.pl	Wierzbicka, Magdalena/AAR-7949-2020; Jaremko, Lukasz/A-3101-2009; Wierzbicka, Magdalena/ABA-4887-2021; Szczepski, Kacper/AAZ-4679-2020; Jaremko, Lukasz/GQB-5017-2022	Wierzbicka, Magdalena/0000-0003-1572-1874; Jaremko, Lukasz/0000-0001-7684-9359; Waliczek, Mateusz/0000-0003-3238-2747; Jaremko, Mariusz/0000-0002-0787-702X; Kijewska, Monika/0000-0001-6227-7169; Szczepski, Kacper/0000-0003-1038-3538	National Science Centre, Poland [UMO-2015/19/B/ST5/00659]; King Abdullah University of Science and Technology (KAUST)	National Science Centre, Poland(National Science Centre, Poland); King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	Piotr Stefanowicz -This work was supported by Grant No.UMO-2015/19/B/ST5/00659 from the National Science Centre, Poland https://www.ncn.gov.pl/The co-authors: Lukasz Jaremko, Mariusz Jaremko, Priyadharshni Rajagopal and Kacper Szczepski are grateful to King Abdullah University of Science and Technology (KAUST) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Prof. Oh for supplying the natural sungsanpin. The authors are also grateful to Andrzej Reszka (Shim-Pol, Poland) for providing the Shimadzu LCMS-IT-TOF and LCMS 8050 instrument. Thanks to the Perlan Technologies (Poland) for providing access to the Agilent Technologies 6470 Triple Quad LC/MS apparatus equipped with the Agilent Technologies 1290 Infinity II system. We would like to thank Benjamin Gabriel Poulson for English editing.	Allen CD, 2016, ACS CHEM BIOL, V11, P3043, DOI 10.1021/acschembio.6b00588; [Anonymous], 2016, CRIT CARE NURSE, V36, pe11; CARPINO LA, 1972, J ORG CHEM, V37, P3404, DOI 10.1021/jo00795a005; Chen M, 2019, CHEM COMMUN, V55, P3323, DOI 10.1039/c8cc10301a; Clavel C, 2015, CHEM SCI, V6, P4828, DOI 10.1039/c5sc01722j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiCaprio AJ, 2019, J AM CHEM SOC, V141, P290, DOI 10.1021/jacs.8b09928; Elashal HE, 2018, ANGEW CHEM INT EDIT, V57, P6150, DOI 10.1002/anie.201801299; Elsard SS, 2015, J ORG CHEM, V80, P10252, DOI 10.1021/acs.joc.5b01878; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Grigera JR, 2010, BIOPHYS J, V98, P1626, DOI 10.1016/j.bpj.2009.12.4298; HARRISON IT, 1967, J AM CHEM SOC, V89, P5723, DOI 10.1021/ja00998a052; Hegemann JD, 2018, CHEM COMMUN, V54, P9007, DOI 10.1039/c8cc04411b; Hegemann JD, 2015, ACCOUNTS CHEM RES, V48, P1909, DOI 10.1021/acs.accounts.5b00156; Hegemann JD, 2013, BIOPOLYMERS, V100, P527, DOI 10.1002/bip.22326; Hegemann JD, 2013, J AM CHEM SOC, V135, P210, DOI 10.1021/ja308173b; Jeanne Dit Fouque K, 2015, ANAL CHEM, V87, P1166, DOI 10.1021/ac503772n; Kimura KI, 1997, J ANTIBIOT, V50, P373, DOI 10.7164/antibiotics.50.373; Knappe TA, 2008, J AM CHEM SOC, V130, P11446, DOI 10.1021/ja802966g; Kneller, 2003, SPARKY 3; Lear S, 2016, ORG BIOMOL CHEM, V14, P4534, DOI 10.1039/c6ob00631k; Martin-Gomez H, 2018, ORG BIOMOL CHEM, V16, P5065, DOI 10.1039/c8ob01304g; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Metelev M, 2015, CHEM BIOL, V22, P241, DOI 10.1016/j.chembiol.2014.11.017; MORISHITA Y, 1994, J ANTIBIOT, V47, P269, DOI 10.7164/antibiotics.47.269; Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R; Paul W. R., 2017, AUST J CHEM, V70, P172; Roche J, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0244; Saito F, 2017, CHEM SCI, V8, P2878, DOI 10.1039/c7sc00021a; SALOMON RA, 1992, J BACTERIOL, V174, P7428, DOI 10.1128/jb.174.22.7428-7435.1992; Sauvage JP, 1998, ACCOUNTS CHEM RES, V31, P611, DOI 10.1021/ar960263r; Sorensen A, 2013, CHEM COMMUN, V49, P5936, DOI 10.1039/c3cc42201a; Stefanowicz P, 2010, BIOSCIENCE REP, V30, P91, DOI 10.1042/BSR20090015; Taichi M, 2013, ORG LETT, V15, P2620, DOI 10.1021/ol400801k; Tokunaga Y, 2006, TETRAHEDRON LETT, V47, P2679, DOI 10.1016/j.tetlet.2006.02.107; TSUNAKAWA M, 1995, J ANTIBIOT, V48, P433, DOI 10.7164/antibiotics.48.433; Um S, 2013, J NAT PROD, V76, P873, DOI 10.1021/np300902g; WEBER W, 1991, J ANTIBIOT, V44, P164, DOI 10.7164/antibiotics.44.164; Wolczanski G, 2019, TETRAHEDRON LETT, V60, P1814, DOI 10.1016/j.tetlet.2019.05.069; Wuethrich K., 1986, NMR PROTEINS NUCL AC; Xue M, 2015, CHEM REV, V115, P7398, DOI 10.1021/cr5005869; Zhang WQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00286-0; Zimmermann M, 2013, CHEM BIOL, V20, P558, DOI 10.1016/j.chembiol.2013.03.013	43	2	2	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234901	10.1371/journal.pone.0234901	http://dx.doi.org/10.1371/journal.pone.0234901			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579565	Green Published, gold			2022-12-27	WOS:000545646600060
J	Dun, H; Ye, L; Zhu, YH; Wong, BW				Dun, Hao; Ye, Li; Zhu, Yuehui; Wong, Brian W.			Combined abdominal heterotopic heart and aorta transplant model in mice	PLOS ONE			English	Article							CARDIAC TRANSPLANTATION; CHRONIC REJECTION; INVESTIGATE	Background Allograft vasculopathy (AV) remains a major obstacle to long-term allograft survival. While the mouse aortic transplantation model has been proven as a useful tool for study of the pathogenesis of AV, simultaneous transplantation of the aorta alongside the transplantation of another organ may reveal more clinically relevant mechanisms that contribute to the pathogenesis of chronic allograft rejection. Therefore, we developed a combined abdominal heart and aorta transplantation model in mice which benefits from reducing animal and drug utilization, while providing an improved model to study the progressive nature of AV. Methods The middle of the infrarenal aorta of the recipient mouse was ligatured between the renal artery and its bifurcation. Proximal and distal aortotomies were performed at this site above and below the ligature, respectively, for the subsequent anastomoses of the donor aorta and heart grafts to the recipient infrarenal aorta in an end-to-side fashion. The distal anastomotic site of the recipient infrarenal aorta was connected with the outlet of the donor aorta. Uniquely, the proximal anastomotic site on the recipient infrarenal aorta was shared to connect with both the inlet of the donor aorta and the inflow tract to the donor heart. The outflow tract from the donor heart was connected to the recipient inferior vena cava (IVC). Results The median times for harvesting the heart graft, aorta graft, recipient preparation and anastomosis were 11.5, 8.0, 9.0 and 40.5 min, respectively, resulting in a total median ischemic time of 70 min. The surgery survival rate was more than 96% (29/30). Both the syngeneicC57Bl/6aorta and heart grafts survived more than 90 days in 29C57Bl/6recipients. Further,Balb/ctoC57Bl/6allografts treated with anti-CD40L and CTLA4.Ig survived more than 90 days with a 100% (3/3) survival rate. (3/3). Conclusions This model is presented as a new tool for researchers to investigate transplant immunology and assess immunosuppressive strategies. It is possible to share a common anastomotic stoma on the recipient abdominal aorta to reconstruct both the aorta graft entrance and heart graft inflow tract. This allows for the study of allogeneic effects on both the aorta and heart from the same animal in a single survival surgery.	[Dun, Hao; Ye, Li; Zhu, Yuehui; Wong, Brian W.] Washington Univ, Sch Med, Dept Surg, Lab Lymphat Metab Epigenet, St Louis, MO 63110 USA	Washington University (WUSTL)	Wong, BW (corresponding author), Washington Univ, Sch Med, Dept Surg, Lab Lymphat Metab Epigenet, St Louis, MO 63110 USA.	brian.wong@wustl.edu	Wong, Brian/B-6168-2009	Wong, Brian/0000-0001-8447-3064	Joel D. Cooper Career Development Award from the International Society of Heart and Lung Transplantation (BWW)	Joel D. Cooper Career Development Award from the International Society of Heart and Lung Transplantation (BWW)	This work was supported by the Joel D. Cooper Career Development Award from the International Society of Heart and Lung Transplantation (BWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 1995, World Health Forum, V16, P110; [Anonymous], 2007, NEPHROL DIAL TRANSPL, V22, P12; [Anonymous], 2017, ISMP MED SAFETY ALER, V22, P1, DOI DOI 10.1016/j.ebiom.2017.07.026; AZUMA H, 1994, CURR OPIN IMMUNOL, V6, P770, DOI 10.1016/0952-7915(94)90083-3; Baldwin WM, 2014, CURR OPIN ORGAN TRAN, V19, P525, DOI 10.1097/MOT.0000000000000113; Chereshnev I, 2003, J SURG RES, V111, P171, DOI 10.1016/S0022-4804(03)00039-8; Chih S, 2016, J AM COLL CARDIOL, V68, P80, DOI 10.1016/j.jacc.2016.04.033; Chong AS, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015495; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; Ensminger SM, 2000, J HEART LUNG TRANSPL, V19, P1039, DOI 10.1016/S1053-2498(00)00195-9; Gilson CR, 2009, J IMMUNOL, V183, P1625, DOI 10.4049/jimmunol.0900339; Lee MS, 2018, CATHETER CARDIO INTE, V92, pE527, DOI 10.1002/ccd.27893; Lund LH, 2017, J HEART LUNG TRANSPL, V36, P1037, DOI 10.1016/j.healun.2017.07.019; Mao MJ, 2009, J HEART LUNG TRANSPL, V28, P1102, DOI 10.1016/j.healun.2009.05.025; Perico N, 1997, DRUGS, V54, P533, DOI 10.2165/00003495-199754040-00003; Qin LF, 2013, JOVE-J VIS EXP, DOI 10.3791/50290; Ryll M, 2019, JOVE-J VIS EXP, DOI 10.3791/59983; Sho M, 2002, J IMMUNOL, V169, P3744, DOI 10.4049/jimmunol.169.7.3744; Soleimani B, 2008, J HEART LUNG TRANSPL, V27, P450, DOI 10.1016/j.healun.2008.01.015; Solini S, 2012, TRANSPL INT, V25, P347, DOI 10.1111/j.1432-2277.2011.01425.x; Su S, 2011, ASIAN J SURG, V34, P86, DOI 10.1016/S1015-9584(11)60025-0; Sun H, 1998, MICROSURG, V18, P368, DOI 10.1002/(SICI)1098-2752(1998)18:6<368::AID-MICR5>3.0.CO;2-F; Tejani A, 2002, AM J TRANSPLANT, V2, P142, DOI 10.1034/j.1600-6143.2002.020205.x; Tepperman E, 2010, CAN J SURG, V53, P57; US FDA, 2016, FED REGISTER, V2, P22; Zheng XX, 1999, J IMMUNOL, V162, P4983	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0230649	10.1371/journal.pone.0230649	http://dx.doi.org/10.1371/journal.pone.0230649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569305	Green Published, gold, Green Submitted			2022-12-27	WOS:000543547900028
J	Jonesco, DS; Karsdal, MA; Henriksen, K				Jonesco, Ditte S.; Karsdal, Morten A.; Henriksen, Kim			The CNS-specific proteoglycan, brevican, and its ADAMTS4-cleaved fragment show differential serological levels in Alzheimer's disease, other types of dementia and non-demented controls: A cross-sectional study	PLOS ONE			English	Article							ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; THROMBOSPONDIN MOTIFS; NATIONAL INSTITUTE; MEMORY; TAU; EXPRESSION; PROTECT; METALLOPROTEINASE; RECOMMENDATIONS	Evidence indicate that the brain-specific protein, brevican, is proteolytically cleaved during neurodegeneration, hence positioning fragments of brevican as potential blood biomarkers of neurodegenerative diseases, such as dementia. We aimed to develop two assays capable of detecting the brevican N-terminal (N-Brev) and the ADAMTS4-generated fragment (Brev-A), cleaved at Ser(401), in serum and to perform a preliminary assessment of their diagnostic potential in dementias. Monoclonal antibodies against N-Brev and Brev-A were used to develop two ELISAs detecting each epitope. A comparison of brevican fragments in serum from individuals with AD (n = 28), other dementia (OD) (n = 41), and non-dementia-related memory complaints (NDCs) (n = 48) was conducted. Anti-N-Brev and anti-Brev-A antibodies selectively recognized their targets and dilution and spike recoveries were within limits of +/- 20%. Intra- and inter-assay CVs were below limits of 10% and 15%, respectively. For the N-Brev biomarker, serum from patients with OD showed significantly lower levels than those with AD (p= 0.05) and NDCs (p< 0.01). The opposite pattern was evident for Brev-A: serum levels in patients with OD were significantly higher than for AD (p= 0.04) and NDCs (p= 0.01). For both N-Brev and Brev-A, levels did not differ between AD and NDCs. The ratio of N-Brev/Brev-A resulted in increased significant differences between OD and AD (p< 0.01) and between OD and NDCs (p< 0.0001). The ratio discriminated between NDCs and OD (AUC: 0.75, 95% CI: 0.65-0.85,p< 0.0001) and between OD and AD (AUC: 0.72, 95% CI: 0.59-0.85,p< 0.01). In conclusion, we developed the first assays detecting the N-terminal of brevican as well as an ADAMTS4-cleaved fragment of brevican in blood. Differential levels of N-Brev and Brev-A between AD and OD allow for these biomarkers to possibly distinguish between different forms of dementias.	[Jonesco, Ditte S.; Karsdal, Morten A.; Henriksen, Kim] Nord Biosci, Biomarkers & Res, Herlev, Denmark	Nordic Bioscience	Jonesco, DS (corresponding author), Nord Biosci, Biomarkers & Res, Herlev, Denmark.	kh@nordicbio.com		Karsdal, Morten/0000-0001-5026-8740; Jonesco, Ditte/0000-0002-3211-9335	Danish research foundation "Den Danske Forskningsfond"	Danish research foundation "Den Danske Forskningsfond"	The Danish research foundation "Den Danske Forskningsfond" supported this study by funding DSJ PhD project. DSJ, KH and MAK are employed by Nordic Bioscience and thus received support in the form of a salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ajmo JM, 2010, J NEUROCHEM, V71, P233; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; [Anonymous], 1998, Neurobiol Aging, V19, P109; [Anonymous], 2017, PLASMONICS, V12, P1; [Anonymous], 2012, REGEN MED S3, V7, pS14; Barascuk N, 2010, CLIN BIOCHEM, V43, P899, DOI 10.1016/j.clinbiochem.2010.03.012; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Blennow K, 2018, J INTERN MED, V284, P643, DOI 10.1111/joim.12816; Brakebusch C, 2002, MOL CELL BIOL, V22, P7417, DOI 10.1128/MCB.22.21.7417-7427.2002; Combet C., 2000, COMPUT CORNER, P147; de Souza LC, 2011, J NEUROL NEUROSUR PS, V82, P240, DOI 10.1136/jnnp.2010.207183; Martin-de-Saavedra MD, 2011, NEUROCHEM INT, V58, P676, DOI 10.1016/j.neuint.2011.02.006; GEFTER ML, 1977, SOMAT CELL GENET, V3, P231, DOI 10.1007/BF01551818; Gogolla N, 2016, SCI AAAS, V325, P1258; Gottschall PE, 2015, MATRIX BIOL, V44-46, P70, DOI 10.1016/j.matbio.2015.01.014; Gundelfinger ED, 2010, EUR J NEUROSCI, V31, P2156, DOI 10.1111/j.1460-9568.2010.07253.x; Hampel H, 2018, NAT REV NEUROL, V14, P639, DOI 10.1038/s41582-018-0079-7; Happel M. F., 2016, COMPOSITION FUNCTION, P143, DOI DOI 10.5772/62452; Hellwig K, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0161-y; Henriksen K, 2015, J ALZHEIMERS DIS, V43, P1331, DOI 10.3233/JAD-140984; Henriksen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064990; Howell MD, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0233-z; Inekci D, 2015, CURR ALZHEIMER RES, V12, P829, DOI 10.2174/1567205012666150710111211; Inekci D, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00090; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Karsdal MA, 2010, CLIN BIOCHEM, V43, P793, DOI 10.1016/j.clinbiochem.2010.03.015; Kvartsberg H, 2015, ALZHEIMERS DEMENT, V11, P1180, DOI 10.1016/j.jalz.2014.10.009; Lendvai D, 2013, ACTA NEUROPATHOL, V125, P215, DOI 10.1007/s00401-012-1042-0; Lewczuk P, 2015, J ALZHEIMERS DIS, V43, P183, DOI 10.3233/JAD-140771; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; Mayer J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-52; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Minta K, 2019, CLIN CHEM LAB MED, P1, DOI [10.1515/cclm-2019-0625, DOI 10.1515/CCLM-2019-0625]; Minta K, 2019, J ALZHEIMERS DIS, V69, P1213, DOI 10.3233/JAD-190187; Miyata S, 2007, BRAIN RES, V1150, P200, DOI 10.1016/j.brainres.2007.02.066; Molinuevo JL, 2018, ACTA NEUROPATHOL, V136, P821, DOI 10.1007/s00401-018-1932-x; Morawski M, 2004, EXP NEUROL, V188, P309, DOI 10.1016/j.expneurol.2004.04.017; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Ogawa T, 2001, J COMP NEUROL, V432, P285, DOI 10.1002/cne.1103; OKAMOTO M, 1994, NEUROSCI LETT, V172, P51, DOI 10.1016/0304-3940(94)90660-2; PORTELIUS E, 2015, BRAIN 11, V138, DOI DOI 10.1093/BRAIN/AWV267; Portelius E, 2018, ACTA NEUROPATHOL, V136, P363, DOI 10.1007/s00401-018-1851-x; Preische O, 2019, NAT MED, V25, P277, DOI 10.1038/s41591-018-0304-3; Romberg C, 2013, J NEUROSCI, V33, P7057, DOI 10.1523/JNEUROSCI.6267-11.2013; Saroja SR, 2014, J NEUROCHEM, V130, P797, DOI 10.1111/jnc.12783; Satoh K, 2000, NEUROSCI LETT, V289, P177, DOI 10.1016/S0304-3940(00)01285-4; Schoonenboom NSM, 2012, NEUROLOGY, V78, P47, DOI 10.1212/WNL.0b013e31823ed0f0; Seidenbecher CI, 2002, J NEUROCHEM, V83, P738, DOI 10.1046/j.1471-4159.2002.01183.x; Sheikh-Bahaei N, 2017, J ALZHEIMERS DIS REP, V1, P71, DOI 10.3233/ADR-170013; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P1, DOI DOI 10.1016/J.JALZ.2011.03.005; Thon N, 2000, EUR J NEUROSCI, V12, P2547, DOI 10.1046/j.1460-9568.2000.00109.x; Vegh MJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0076-z; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Wellington H, 2016, NEUROLOGY, V86, P829, DOI 10.1212/WNL.0000000000002423; Yang S, 2015, EXP NEUROL, V265, P48, DOI 10.1016/j.expneurol.2014.11.013; Yuan W, 2002, NEUROSCIENCE, V114, P1091, DOI 10.1016/S0306-4522(02)00347-0; Zhang H, 1998, J NEUROSCI, V18, P2370	59	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234632	10.1371/journal.pone.0234632	http://dx.doi.org/10.1371/journal.pone.0234632			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559242	gold, Green Published			2022-12-27	WOS:000543261600004
J	Odafe, S; Onotu, D; Fagbamigbe, JO; Ene, U; Rivadeneira, E; Carpenter, D; Omoigberale, AI; Adamu, Y; Lawal, I; James, E; Boyd, AT; Dirlokov, E; Swaminathan, M				Odafe, Solomon; Onotu, Dennis; Fagbamigbe, Johnson Omodele; Ene, Uzoma; Rivadeneira, Emilia; Carpenter, Deborah; Omoigberale, Austin, I; Adamu, Yakubu; Lawal, Ismail; James, Ezekiel; Boyd, Andrew T.; Dirlokov, Emilio; Swaminathan, Mahesh			Increasing pediatric HIV testing positivity rates through focused testing in high-yield points of service in health facilities-Nigeria, 2016-2017	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; SCREENING TOOL; PREVALENCE	Background In 2017, UNAIDS estimated that 140,000 children aged 0-14 years are living with HIV in Nigeria, but only 35% have been diagnosed and are receiving antiretroviral therapy. Children are tested primarily in outpatient clinics, which show low HIV-positive rates. To demonstrate efficient facility-based HIV testing among children aged 0-14 years, we evaluated pediatric HIV-positivity rates in points of service in select health facilities in Nigeria. Methods We conducted a retrospective analysis of HIV testing and case identification among children aged 0-14 years at all points of service at nine purposively sampled hospitals (November 2016-March 2017). Points of service included family index testing, pediatric outpatient department (POPD), tuberculosis (TB) clinics, immunization clinics, and pediatric inpatient ward. Eligibility for testing at POPD was done using a screening tool while all children with unknown status were eligible for HIV test at other points of service. The main outcome was HIV positivity rates stratified by the testing point of service and by age group. Predictors of an HIV-positive result were assessed using logistic regression. All analyses were done using Stata 15 statistical software. Results Of 2,180 children seen at all facility points of service with unknown HIV status, 1,822 (83.6%) were tested for HIV, of whom 43 (2.4%) tested HIV positive. The numbers of children tested by age group were <1 years = 230 (12.6%); 1-4 years = 752 (41.3%); 5-9 years = 520 (28.5%); and 10-14 years = 320 (17.6%). The number of children tested by point of service were POPD = 906 (49.7%); family index testing = 693 (38.0%); pediatric inpatient ward = 192 (10.5%); immunization clinic = 16 (0.9%); and TB clinic = 15 (0.8%). HIV positivity rates by point of service were TB clinic = 6.7% (95% Confidence Interval (CI): 0.9-35.2%); pediatric inpatient ward = 4.7% (95%CI: 2.5-8.8%); family index testing = 3.5% (95%CI: 2.3-5.1%); POPD = 1.0% (95%CI: 0.5-1.9%); and immunization clinic = 0%. The percentage contribution to total HIV positive children found by point of services was: family index testing = 55.8% (95%CI: 40.9-69.8%); POPD = 20.9% (95%CI: 11.3-35.6%); inpatient ward = 20.9 (95%CI: 11.3-35.6%) and TB Clinic = 2.3% (95%CI: 0.3-14.8%). Compared with the POPD, the adjusted odds ratio (95% CI) for finding an HIV positive child by point of service were TB clinic = 7.2 (95% CI: 0.9-60.9); pediatric inpatient ward = 4.9 (95% CI: 1.9-12.8); and family index testing = 3.7 (95% CI: 1.5-8.8). HIV-positivity rates did not significantly differ by age group. Conclusion In Nigeria, to improve facility-based HIV positivity rates among children aged 0-14 years, an increased focus on HIV testing among children seeking care in pediatric inpatient wards, through family index testing, and perhaps TB clinics is appropriate.	[Odafe, Solomon; Onotu, Dennis; Fagbamigbe, Johnson Omodele; Ene, Uzoma; Swaminathan, Mahesh] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Abuja, Nigeria; [Rivadeneira, Emilia; Carpenter, Deborah; Boyd, Andrew T.; Dirlokov, Emilio] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Atlanta, GA USA; [Omoigberale, Austin, I] Univ Benin, Dept Pediat, Teaching Hosp, Benin, Nigeria; [Adamu, Yakubu; Lawal, Ismail] Walter Reed Army Inst Res, Mil HIV Res Program, Abuja, Nigeria; [James, Ezekiel] US Agcy Int Dev, HIV AIDS Care & Treatment, Washington, DC 20523 USA	Centers for Disease Control & Prevention - USA; University of Benin; United States Agency for International Development (USAID)	Odafe, S (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Abuja, Nigeria.	wsp7@cdc.gov		Dirlikov, Emilio/0000-0003-4631-2643; Odafe, Solomon/0000-0002-2452-0532	President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC) [GH002097, GH002098, GH002099, GH002100]	President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC) under the terms of GH002097, GH002098, GH002099 and GH002100.	[Anonymous], 2012, J AM COLL CARDIOL, V60, pe44; [Anonymous], 2013, AIDS, V27, pS159; Auld AF, 2017, MMWR-MORBID MORTAL W, V66, P558, DOI 10.15585/mmwr.mm6621a3; Bandason T, 2016, AIDS, V30, P779, DOI 10.1097/QAD.0000000000000959; Chamla D, 2015, PAEDIATR INT CHILD H, V35, P298, DOI 10.1080/20469047.2015.1109233; Dalhatu I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170912; Division HA, 2016, NAT ACC PLAN PAED HI; Federal Ministry of Health, 2016, NAT ACC PLAN PAED HI; Gautier SV, 2013, VESTNIK TRANSPLANTOL, VXV, P8; Govindasamy D, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20182; Health CfG, 2015, STRAT ID LINK HIV IN, P4; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; Luyirika E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069548; Moucheraud C, 2018, JAIDS-J ACQ IMM DEF, V79, P352, DOI 10.1097/QAI.0000000000001804; Odafe S, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17424; Oluwagbemiga Adeyemi Ezekiel, 2007, SAHARA J, V4, P668; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Sau Mealiny Sokun, 2016, J Int Assoc Provid AIDS Care, V15, P345, DOI 10.1177/2325957415599208; Shamu S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210826; Thorne C, 2016, LANCET HIV, V3, pE5, DOI 10.1016/S2352-3018(15)00243-X; Tilahun G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3193-8; UNAIDS, 2019, HIV AIDS EST; UNAIDS, 2019, COUNTR HIV FACTSH; UNAIDS, 2019, COUNTR FACTSH; UNAIDS, 2014, 90 90 90 AMB TREATM; UNICEF, 2019, PAED CAR TREATM; UNICEF, 2020, KEY DEM IND CHILD SU; van Lettow M, 2018, B WORLD HEALTH ORGAN, V96, P256, DOI 10.2471/BLT.17.203265; Vrazo AC, 2018, GLOB HEALTH-SCI PRAC, V6, P249, DOI 10.9745/GHSP-D-17-00097; World Health Organization, 2015, HIV TEST SERV 5CS CO, P91; Yumo HA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214251; Yumo HA, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1276-7; 2016, AM J HLTH SYST PH S2, V73, pE83	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234717	10.1371/journal.pone.0234717	http://dx.doi.org/10.1371/journal.pone.0234717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559210	gold, Green Published			2022-12-27	WOS:000543261600017
J	Tedoldi, A; Ludwig, P; Fulgenzi, G; Takeshima, H; Pedarzani, P; Stocker, M				Tedoldi, Angelo; Ludwig, Petra; Fulgenzi, Gianluca; Takeshima, Hiroshi; Pedarzani, Paola; Stocker, Martin			Calcium-induced calcium release and type 3 ryanodine receptors modulate the slow afterhyperpolarising current, sI(AHP), and its potentiation in hippocampal pyramidal neurons	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CURRENT; MUTANT MICE LACKING; DEPENDENT PROTEIN-KINASE; CA2+ RELEASE; SARCOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; SENSITIVE STORES; CHANNELS; ACTIVATION; MECHANISMS	The slow afterhyperpolarising current, sI(AHP), is a Ca2+-dependent current that plays an important role in the late phase of spike frequency adaptation. sI(AHP)is activated by voltage-gated Ca(2+)channels, while the contribution of calcium from ryanodine-sensitive intracellular stores, released by calcium-induced calcium release (CICR), is controversial in hippocampal pyramidal neurons. Three types of ryanodine receptors (RyR1-3) are expressed in the hippocampus, with RyR3 showing a predominant expression in CA1 neurons. We investigated the specific role of CICR, and particularly of its RyR3-mediated component, in the regulation of the sI(AHP)amplitude and time course, and the activity-dependent potentiation of the sI(AHP)in rat and mouse CA1 pyramidal neurons. Here we report that enhancement of CICR by caffeine led to an increase in sI(AHP)amplitude, while inhibition of CICR by ryanodine caused a small, but significant reduction of sI(AHP). Inhibition of ryanodine-sensitive Ca(2+)stores by ryanodine or depletion by the SERCA pump inhibitor cyclopiazonic acid caused a substantial attenuation in the sI(AHP)activity-dependent potentiation in both rat and mouse CA1 pyramidal neurons. Neurons from mice lacking RyR3 receptors exhibited a sI(AHP)with features undistinguishable from wild-type neurons, which was similarly reduced by ryanodine. However, the lack of RyR3 receptors led to a faster and reduced activity-dependent potentiation of sI(AHP). We conclude that ryanodine receptor-mediated CICR contributes both to the amplitude of the sI(AHP)at steady state and its activity-dependent potentiation in rat and mouse hippocampal pyramidal neurons. In particular, we show that RyR3 receptors play an essential and specific role in shaping the activity-dependent potentiation of the sI(AHP). The modulation of activity-dependent potentiation of sI(AHP)by RyR3-mediated CICR contributes to plasticity of intrinsic neuronal excitability and is likely to play a critical role in higher cognitive functions, such as learning and memory.	[Tedoldi, Angelo; Ludwig, Petra; Fulgenzi, Gianluca; Pedarzani, Paola; Stocker, Martin] UCL, Res Dept Neurosci Physiol & Pharmacol, London, England; [Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto, Japan; [Tedoldi, Angelo] Univ Auckland, Dept Physiol, Auckland, New Zealand; [Fulgenzi, Gianluca] NCI, Neural Dev Sect, Mouse Canc Genet Program, Ctr Canc Res,NIH, Frederick, MD 21701 USA	University of London; University College London; Kyoto University; University of Auckland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pedarzani, P; Stocker, M (corresponding author), UCL, Res Dept Neurosci Physiol & Pharmacol, London, England.	m.stocker@ucl.ac.uk; p.pedarzani@ucl.ac.uk	Stocker, Martin/C-1844-2008; Tedoldi, Angelo/I-5704-2017	Tedoldi, Angelo/0000-0001-5601-0353; Pedarzani, Paola/0000-0002-2665-7911	Medical Research Council - MRC-CASE PhD Studentship; UK Medical Research Council [CEG G0100066]; Wellcome Trust [061198/Z/00A]; JSPS Core-to-core program (Japan Society for the Promotion of Science); MRC [G0100066] Funding Source: UKRI	Medical Research Council - MRC-CASE PhD Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); JSPS Core-to-core program (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council - MRC-CASE PhD Studentship to A. T. -https://mrc.ukri.org/Career Establishment Grant from the UK Medical Research Council to P. P. (CEG G0100066) https://mrc.ukri.org/Wellcome Trust Senior Research fellowship to M. S. (061198/Z/00A) - https://wellcome.ac.uk/JSPS Core-to-core program (Japan Society for the Promotion of Science) to H. T. -https://www.jsps.go.jp/english/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita T, 2000, J GEN PHYSIOL, V116, P697, DOI 10.1085/jgp.116.5.697; ALGER BE, 1980, SCIENCE, V210, P1122, DOI 10.1126/science.7444438; Balschun D, 1999, EMBO J, V18, P5264, DOI 10.1093/emboj/18.19.5264; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Borde M, 1999, PFLUG ARCH EUR J PHY, V437, P261, DOI 10.1007/s004240050778; BORDE M, 1995, J NEUROPHYSIOL, V74, P1714, DOI 10.1152/jn.1995.74.4.1714; Borde M, 2000, HIPPOCAMPUS, V10, P198; BOTELHO LHP, 1988, J BIOL CHEM, V263, P5301; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; BUTCHER RW, 1962, J BIOL CHEM, V237, P1244; Chen SRW, 1997, J BIOL CHEM, V272, P24234, DOI 10.1074/jbc.272.39.24234; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; Chen-Engerer HJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11207-8; Cordoba-Rodriguez R, 1999, P NATL ACAD SCI USA, V96, P7650, DOI 10.1073/pnas.96.14.7650; Davies PJ, 1996, J PHYSIOL-LONDON, V495, P353, DOI 10.1113/jphysiol.1996.sp021599; FURUICHI T, 1994, J NEUROSCI, V14, P4794; Galeotti N, 2008, J NEUROCHEM, V106, P2385, DOI 10.1111/j.1471-4159.2008.05581.x; Galeotti N, 2008, LEARN MEMORY, V15, P315, DOI 10.1101/lm.929008; Gamelli AE, 2011, HIPPOCAMPUS, V21, P133, DOI 10.1002/hipo.20728; Gant JC, 2006, J NEUROSCI, V26, P3482, DOI 10.1523/JNEUROSCI.4171-05.2006; Gant JC, 2011, J NEUROSCI, V31, P1693, DOI 10.1523/JNEUROSCI.4805-10.2011; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Hillsley K, 2000, J NEUROPHYSIOL, V84, P2777, DOI 10.1152/jn.2000.84.6.2777; HOTSON JR, 1980, J NEUROPHYSIOL, V43, P409, DOI 10.1152/jn.1980.43.2.409; Huddleston AT, 2008, J NEUROPHYSIOL, V99, P1565, DOI 10.1152/jn.00659.2007; Jahromi BS, 1999, NEUROSCIENCE, V88, P719, DOI 10.1016/S0306-4522(98)00203-6; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; JOBLING P, 1993, J AUTONOM NERV SYST, V42, P251, DOI 10.1016/0165-1838(93)90370-A; Kaczorowski CC, 2011, EUR J NEUROSCI, V34, P1756, DOI 10.1111/j.1460-9568.2011.07899.x; Kong HH, 2007, BIOPHYS J, V92, P2757, DOI 10.1529/biophysj.106.100545; Kouzu Y, 2000, MOL BRAIN RES, V76, P142, DOI 10.1016/S0169-328X(99)00344-7; Kumar A, 2004, J NEUROPHYSIOL, V91, P2437, DOI 10.1152/jn.01148.2003; LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268, DOI 10.1152/jn.1986.55.6.1268; Lima PA, 2007, BRAIN RES, V1150, P74, DOI 10.1016/j.brainres.2007.02.067; Liu J, 2014, CHANNELS, V8, DOI 10.4161/chan.27471; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Matsuo N, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.003.2009; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; Meissner G, 2017, J GEN PHYSIOL, V149, P1065, DOI 10.1085/jgp.201711878; More JY, 2018, ANTIOXID REDOX SIGN, V29, P1125, DOI 10.1089/ars.2017.7277; Mori F, 2000, NEUROSCI LETT, V285, P57, DOI 10.1016/S0304-3940(00)01046-6; MOYER JR, 1992, J NEUROPHYSIOL, V68, P2100, DOI 10.1152/jn.1992.68.6.2100; Murayama T, 1997, J BIOL CHEM, V272, P24030, DOI 10.1074/jbc.272.38.24030; Naylor J., 2009, OPEN DRUG DISCOV J, V1, P36, DOI [10.2174/1877381800901010036, DOI 10.2174/1877381800901010036]; Pedarzani P, 1998, J NEUROPHYSIOL, V79, P3252, DOI 10.1152/jn.1998.79.6.3252; PEDARZANI P, 1993, NEURON, V11, P1023, DOI 10.1016/0896-6273(93)90216-E; Pineda JC, 1999, NEUROREPORT, V10, P1951, DOI 10.1097/00001756-199906230-00029; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Qin ZH, 2012, J NEUROSCI, V32, P4271, DOI 10.1523/JNEUROSCI.6271-11.2012; Rankovic V, 2010, EUR J NEUROSCI, V31, P439, DOI 10.1111/j.1460-9568.2010.07081.x; RASCOL O, 1991, FUNDAM CLIN PHARM, V5, P299, DOI 10.1111/j.1472-8206.1991.tb00725.x; Rothman JS, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00014; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; Saar D, 2003, EUR J NEUROSCI, V17, P2727, DOI 10.1046/j.1460-9568.2003.02699.x; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sah P, 1996, J NEUROSCI, V16, P4537; SAH P, 1991, NEURON, V7, P257, DOI 10.1016/0896-6273(91)90264-Z; Sahu G, 2019, CELL REP, V28, P2427, DOI 10.1016/j.celrep.2019.07.075; Sandler VM, 1999, J NEUROSCI, V19, P4325; SAWYNOK J, 1993, PHARMACOL REV, V45, P43; Shah M, 2000, J NEUROPHYSIOL, V83, P2554, DOI 10.1152/jn.2000.83.5.2554; Shimuta M, 2001, MOL CELL NEUROSCI, V17, P921, DOI 10.1006/mcne.2001.0981; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Takeshima H, 1996, J BIOL CHEM, V271, P19649, DOI 10.1074/jbc.271.33.19649; Tanabe M, 1998, J NEUROPHYSIOL, V80, P2268, DOI 10.1152/jn.1998.80.5.2268; Thomas NL, 2012, WILEY INTERDISCIP RE, V1, P383, DOI DOI 10.1002/WMTS.34; Tinker A, 1996, BIOPHYS J, V70, P2110, DOI 10.1016/S0006-3495(96)79777-1; Torres GE, 1996, MOL PHARMACOL, V50, P1316; van de Vrede Y, 2007, PFLUG ARCH EUR J PHY, V455, P297, DOI 10.1007/s00424-007-0277-4; Vogalis F, 2001, J NEUROPHYSIOL, V85, P1941, DOI 10.1152/jn.2001.85.5.1941; Wan K, 1999, BIOCHEM BIOPH RES CO, V266, P588, DOI 10.1006/bbrc.1999.1871; Wang Z., 2010, 2010 2 INT C MECH EL, V2; YOSHIZAKI K, 1995, J PHYSIOL-LONDON, V486, P177, DOI 10.1113/jphysiol.1995.sp020801; Zhang L, 1995, J NEUROPHYSIOL, V74, P2225, DOI 10.1152/jn.1995.74.6.2225; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	79	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0230465	10.1371/journal.pone.0230465	http://dx.doi.org/10.1371/journal.pone.0230465			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559219	Green Published, gold, Green Submitted			2022-12-27	WOS:000543261600055
J	Wong, MYW; Saad, S; Wong, MG; Stangenberg, S; Jarolimek, W; Schilter, H; Zaky, A; Gill, A; Pollock, C				Wong, May Y. W.; Saad, Sonia; Wong, Muh Geot; Stangenberg, Stefanie; Jarolimek, Wolfgang; Schilter, Heidi; Zaky, Amgad; Gill, Anthony; Pollock, Carol			Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy	PLOS ONE			English	Article							VASCULAR ADHESION PROTEIN-1; CELL-SURFACE; RENAL FIBROSIS; KNOCKOUT MICE; INFLAMMATION; DEFICIENCY; MORTALITY; INJURY	Semicarbazide-sensitive amine oxidase (SSAO) is an enzyme with a unique dual function in controlling inflammation as well as reactive oxygen species (ROS) generation. We have demonstrated benefit of SSAO inhibition in acute kidney fibrosis. However the function of SSAO in chronic kidney disease (CKD) and diabetic kidney disease (DKD) is yet to be determined. We aimed to assess the effectiveness of a SSAO inhibitor (SSAOi; PXS-4728A) as an antifibrotic agent using a diabetic model of CKD. Diabetic mice were treated with SSAOi for 24 weeks and outcomes compared with untreated diabetic mice and telmisartan treated animals as a standard of care comparator. Extracellular matrix markers, fibronectin and oxidative stress, were downregulated in diabetic mice treated with SSAOi compared with untreated diabetic mice. Expression of the pan-leukocyte marker CD45 was also supressed by SSAOi. SSAO inhibition in diabetic mice resulted in a significant reduction in glomerulosclerosis and associated albuminuria compared to untreated diabetic mice. However, the effect of SSAO inhibition was less obvious in the tubulointerstitial compartment than in the glomeruli. Therefore, SSAO may be a potential target for diabetic glomerulosclerosis.	[Wong, May Y. W.; Zaky, Amgad] Royal North Shore Hosp, Dept Gastroenterol, Sydney, NSW, Australia; [Wong, May Y. W.; Saad, Sonia; Wong, Muh Geot; Stangenberg, Stefanie; Pollock, Carol] Univ Sydney, Royal North Shore Hosp, Kolling Inst Med Res, Sydney, NSW, Australia; [Jarolimek, Wolfgang; Schilter, Heidi] Pharmaxis Ltd, Sydney, NSW, Australia; [Gill, Anthony] Royal North Shore Hosp, Dept Anat Pathol, Sydney, NSW, Australia; [Gill, Anthony] Univ Sydney, Sydney, NSW, Australia	Royal North Shore Hospital; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Pharmaxis; Royal North Shore Hospital; University of Sydney	Pollock, C (corresponding author), Univ Sydney, Royal North Shore Hosp, Kolling Inst Med Res, Sydney, NSW, Australia.	carol.pollock@sydney.edu.au	Gill, Anthony/D-4215-2015; Zaky, Amgad/D-8367-2015	Gill, Anthony/0000-0002-9447-1967; Zaky, Amgad/0000-0001-7738-5330; Wong, May/0000-0003-2856-7327; Saad, Sonia/0000-0001-8067-8046	Pharmaxis	Pharmaxis	Pharmaxis (http://www.pharmaxis.com.au) supported the study in addition to a successful peer reviewed application to the Australian Research Council. WJ provided critical scientific review in the preparation of the manuscript but the content of the manuscript was at all times decided by the academic investigators. They approved the study design but were not directly involved. They were not directly involved with data collection or analysis. HS provided support with the SSAO activity assay. Both WJ and HS reviewed the manuscript prior to publication but were not involved in the decision to publish nor were they involved in the preparation of the manuscript.	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Alexakis C, 2006, NEPHRON EXP NEPHROL, V102, pE71, DOI 10.1159/000089684; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Berl Tomas, 2009, J Renin Angiotensin Aldosterone Syst, V10, P1, DOI 10.1177/1470320309102747; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Carpene C, 2005, J PHYSIOL BIOCHEM, V61, P405, DOI 10.1007/BF03167058; de Zeeuw D, 2018, LANCET DIABETES ENDO, V6, P925, DOI 10.1016/S2213-8587(18)30289-4; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Enrique-Tarancon G, 1998, J BIOL CHEM, V273, P8025, DOI 10.1074/jbc.273.14.8025; Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Komala MG, 2016, NEPHROLOGY, V21, P423, DOI 10.1111/nep.12618; Kosugi T, 2010, AM J PATHOL, V176, P619, DOI 10.2353/ajpath.2010.090578; Lin MS, 2008, CLIN BIOCHEM, V41, P1362, DOI 10.1016/j.clinbiochem.2008.06.019; Lv WS, 2018, EUR J PHARMACOL, V820, P65, DOI 10.1016/j.ejphar.2017.12.016; Maric C, 2004, J AM SOC NEPHROL, V15, P1546, DOI 10.1097/01.ASN.0000128219.65330.EA; MCEWEN CM, 1963, J LAB CLIN MED, V62, P766; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Meshkani R, 2016, CLIN CHIM ACTA, V462, P77, DOI 10.1016/j.cca.2016.08.015; Morin N, 2001, J PHARMACOL EXP THER, V297; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Pershadsingh HA, 2004, DIABETES CARE, V27, P1015, DOI 10.2337/diacare.27.4.1015; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Shinohara M, 2018, NEPHROL DIAL TRANSPL, V33, pi173; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Sterzel RB, 2000, KIDNEY INT, V58, P1588, DOI 10.1046/j.1523-1755.2000.00320.x; Stolen CM, 2005, IMMUNITY, V22, P105, DOI 10.1016/j.immuni.2004.12.006; Stolen CM, 2004, FASEB J, V18, P702, DOI 10.1096/fj.03-0562fje; Suksomboon N, 2012, J CLIN PHARM THER, V37, P319, DOI 10.1111/j.1365-2710.2011.01295.x; Tanaka S, 2017, KIDNEY INT, V92, P154, DOI 10.1016/j.kint.2017.01.014; Wang EY, 2006, J MED CHEM, V49, P2166, DOI 10.1021/jm050538l; Wong M, 2014, AM J PHYSIOL-RENAL, V307, pF908, DOI 10.1152/ajprenal.00698.2013; Yong R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073428; Yu CD, 2002, AM J PATHOL, V161, P2003, DOI 10.1016/S0002-9440(10)64478-1; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170; Yung S, 2006, NEPHROL DIAL TRANSPL, V21, P1504, DOI 10.1093/ndt/gfl017; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7; Zorzano A, 2003, BBA-PROTEINS PROTEOM, V1647, P3, DOI 10.1016/S1570-9639(03)00039-6	40	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234617	10.1371/journal.pone.0234617	http://dx.doi.org/10.1371/journal.pone.0234617			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555665	Green Published, gold			2022-12-27	WOS:000543273200054
J	Perez-Fuentes, MD; Jurado, MDM; Martinez, AM; Linares, JJG				Perez-Fuentes, Maria del Carmen; Molero Jurado, Maria del Mar; Martos Martinez, Africa; Gazquez Linares, Jose Jesus			Threat of COVID-19 and emotional state during quarantine: Positive and negative affect as mediators in a cross-sectional study of the Spanish population	PLOS ONE			English	Article							INFORMATION; BURNOUT; WORRY	Aims The objective of this study was therefore to analyze the effect of exceptionally stressful situations, such as the current health risk, on the cognitive and emotive state of the individual, that is, perceived threat and emotional state on affect and mood. Method This was a cross-sectional study with snowball sampling. The sample came to 1014 Spanish adults (67.2% women and 32.8% men). The Perception of Threat from COVID-19 questionnaire, the Affective Balance Scale and the Mood Evaluation Scale were used. Results The results showed that the perception of threat from COVID-19 was related positively to negative affect and emotional signs, that is, sadness-depression, anxiety and anger-hostility. There was a direct positive effect of perceived threat from COVID-19 on sadness-depression, anxiety and anger-hostility moods, while anxiety and anger-hostility had a direct positive effect on perception of threat from the virus. Thus, there was a circular relationship, in which perceived threat influenced the presence of negative mood, and negative mood, in turn, linked to emotions of irritation and agitation from a present situation, promoted the feeling of threat. Conclusions A negative affective balance increases both one's perception of threat from COVID-19 and negative mood. Thus, knowing the emotional and cognitive effects on the population would enable measures to be put into service to facilitate their effective coping.	[Perez-Fuentes, Maria del Carmen; Molero Jurado, Maria del Mar; Martos Martinez, Africa; Gazquez Linares, Jose Jesus] Univ Almeria, Fac Psychol, Dept Psychol, Almeria, Spain; [Perez-Fuentes, Maria del Carmen] Univ Politecn & Artist Paraguay, Fac Psychol, Dept Psychol, Asuncion, Paraguay; [Gazquez Linares, Jose Jesus] Univ Autonoma Chile, Dept Psychol, Providencia, Chile	Universidad de Almeria; Universidad Autonoma de Chile	Perez-Fuentes, MD; Jurado, MDM (corresponding author), Univ Almeria, Fac Psychol, Dept Psychol, Almeria, Spain.; Perez-Fuentes, MD (corresponding author), Univ Politecn & Artist Paraguay, Fac Psychol, Dept Psychol, Asuncion, Paraguay.	mpf421@ual.es; mmj130@ual.es	Molero Jurado, María del Mar/X-7805-2018; del Carmen Pérez-Fuentes, María/C-3018-2011; Linares, José Jesús Gázquez/M-9230-2019; GAZQUEZ, JOSE JESUS/AAZ-7371-2021	Molero Jurado, María del Mar/0000-0001-9187-1474; del Carmen Pérez-Fuentes, María/0000-0001-5950-5175; Linares, José Jesús Gázquez/0000-0002-6969-1781; Martos Martinez, Africa/0000-0002-6794-3906				[Anonymous], 2015, BAYESFACTOR 0 9 12 2; Bauer EA, 2020, J AFFECT DISORDERS, V266, P456, DOI 10.1016/j.jad.2020.01.092; Biesanz JC, 2010, MULTIVAR BEHAV RES, V45, P661, DOI 10.1080/00273171.2010.498292; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8, 10.1016/S0140-6736(20)30460-8.]; Castellano E, 2019, PSICOTHEMA, V31, P73, DOI 10.7334/psicothema2018.228; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Chang BP, 2019, GEN HOSP PSYCHIAT, V60, P83, DOI 10.1016/j.genhosppsych.2019.07.014; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Carvalho PMD, 2020, PSYCHIAT RES, V286, DOI 10.1016/j.psychres.2020.112902; Perez-Fuentes MD, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041196; Perez-Fuentes MD, 2019, EUR J PSYCHOL APPL L, V11, P33, DOI 10.5093/ejpalc2018a13; Godoy J. F, 2008, CLIN SALUD, V19, P175; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; JASP, 2019, TEAM JASP VERS 0 11; Jin Y, 2019, PUBLIC RELAT REV, V45, P167, DOI 10.1016/j.pubrev.2018.12.003; Kan T, 2018, PUBLIC HEALTH, V156, P67, DOI 10.1016/j.puhe.2017.12.007; Khot Wasim Yunus, 2020, J Assoc Physicians India, V68, P67; Lombardi A, 2020, J HOSP INFECT; Macatee RJ, 2017, BEHAV RES THER, V90, P96, DOI 10.1016/j.brat.2016.12.013; McDonald RP, 1999, TEST THEORY UNIFIED; Ministry of Health, 2020, PREV CONTR INF MAN P; Jurado MDM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061116; Jurado MDM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00424; Park SC, 2020, PSYCHIAT INVEST, V17, P85, DOI 10.30773/pi.2020.0058; Sanz J., 2001, ANALISIS MODIFICACIO, V27, P71; Sapolsky RM, 2019, ANIM BEHAV, P163; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Valero-Moreno S, 2020, REV LAT-AM ENFERM, V28, DOI 10.1590/1518-8345.3144.3242; Ventura-Leon JL., 2017, REV LATINOAM CIENC S, V15, P625; Vicente de Vera MI, 2019, EUR J INVESTIG HLTH, V9, P159; Vizoso-Gomez C, 2018, EUR J EDUC PSYCHOL, V11, P47, DOI 10.30552/ejep.v11i1.185; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; WARR P, 1983, J PERS SOC PSYCHOL, V44, P644, DOI 10.1037/0022-3514.44.3.644	34	79	82	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235305	10.1371/journal.pone.0235305	http://dx.doi.org/10.1371/journal.pone.0235305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584897	Green Published, gold			2022-12-27	WOS:000545747200083
J	Pitz, KJ; Guo, JC; Johnson, SB; Campbell, TL; Zhang, HB; Vrijenhoek, RC; Chavez, FP; Geller, J				Pitz, Kathleen J.; Guo, Jinchen; Johnson, Shannon B.; Campbell, Tracy L.; Zhang, Haibin; Vrijenhoek, Robert C.; Chavez, Francisco P.; Geller, Jonathan			Zooplankton biogeographic boundaries in the California Current System as determined from metabarcoding	PLOS ONE			English	Article							EL-NINO; NORTHERN CALIFORNIA; VARIABILITY; COASTAL; PATTERNS; OREGON; BIODIVERSITY	Within the southern California Current ecosystem there are two well-documented breaks in marine community structure at Point Conception and Punta Eugenia. We explored the presence of similar breaks in a diverse zooplankton community through metabarcoding of mixed net tow tissue samples collected during an expedition from Monterey to Baja California in February of 2012. We recovered a high diversity of species as well as patterns of species presence that align with their previously documented ranges in this region. We found a clear break at Punta Eugenia in overall zooplankton community structure, while Point Conception was weakly linked to changes in community structure. We analyzed this dataset through two parallel bioinformatic pipelines to examine the robustness of these results. Our overall conclusions were consistent across both pipelines, however there were differences in species detection. This study illustrates the utility of metabarcoding analysis on mixed tissue samples for recovering known patterns of diversity, as well as allowing elucidation of broad patterns of community differentiation across many groups of organisms.	[Pitz, Kathleen J.; Johnson, Shannon B.; Zhang, Haibin; Vrijenhoek, Robert C.; Chavez, Francisco P.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Guo, Jinchen; Campbell, Tracy L.; Geller, Jonathan] Moss Landing Marine Labs, Pob 450, Moss Landing, CA 95039 USA; [Zhang, Haibin] Chinese Acad Sci, Inst Deep Sea Sci & Engn, Sanya, Peoples R China	Monterey Bay Aquarium Research Institute; Moss Landing Marine Laboratories; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS	Pitz, KJ (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	kpitz@mbari.org		Pitz, Kathleen/0000-0002-4931-8592; Guo, Jinchen/0000-0001-5828-0859	David and Lucile Packard Foundation at MBARI; NSF [OISE1243541]; NASA under the National Ocean Partnership Program [NNX14AP62A, NOPP RFP NOAA-NOS-IOOS-2014-2003803]; NASA under the National Ocean Partnership Program (U.S. Integrated Ocean Observing System (IOOS) Program Office) [NNX14AP62A]; NASA under the National Ocean Partnership Program (NOAA Ocean Exploration program) [NNX14AP62A]; SIO Pelagic Invertebrates Collection; David and Lucile Packard Foundation; NASA; NOPP; NOAA; BOEM; IOOS	David and Lucile Packard Foundation at MBARI; NSF(National Science Foundation (NSF)); NASA under the National Ocean Partnership Program; NASA under the National Ocean Partnership Program (U.S. Integrated Ocean Observing System (IOOS) Program Office); NASA under the National Ocean Partnership Program (NOAA Ocean Exploration program); SIO Pelagic Invertebrates Collection; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NASA(National Aeronautics & Space Administration (NASA)); NOPP; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); BOEM; IOOS	This research was supported by the David and Lucile Packard Foundation at MBARI (KJP, SBJ, HZ, RCV, FPC), NSF grant #OISE1243541 (JG, TLC, JG), as well as NASA grant NNX14AP62A "National Marine Sanctuaries as Sentinel Sites for a Demonstration Marine Biodiversity Observation Network (MBON)" funded under the National Ocean Partnership Program (NOPP RFP NOAA-NOS-IOOS-2014-2003803 in partnership between NOAA, BOEM, and NASA, including the U.S. Integrated Ocean Observing System (IOOS) Program Office and the NOAA Ocean Exploration program) (KJP, FPC). CALCOFI data and plankton sample analysis supported by NSF grants to M.D. Ohman, Scripps Institution of Oceanography and by the SIO Pelagic Invertebrates Collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. David and Lucile Packard Foundation (https://www.packard.org/); NSF (https://www.nsf.gov/); NASA (https://www.nasa.gov/); NOPP (https://www.nopp.org/); NOAA (https://www.noaa.gov/); BOEM (https://www.boem.gov/); IOOS (https://ioos.noaa.gov/); SIO Pelagic Invertebrates Collection (https://scripps.ucsd.edu/collections/pi).	Allen LG, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P1; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; [Anonymous], 2016, THE TOTAL AUDIENCE R; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Batchelder HP, 2013, OCEANOGRAPHY, V26, P34, DOI 10.5670/oceanog.2013.74; Beaugrand G, 2003, FISH OCEANOGR, V12, P270, DOI 10.1046/j.1365-2419.2003.00248.x; Bernardi G, 2003, EVOLUTION, V57, P1599; Bjorkstedt EP, 2012, CAL COOP OCEAN FISH, V53, P41; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bograd SJ, 2003, DEEP-SEA RES PT II, V50, P2355, DOI 10.1016/S0967-0645(03)00131-0; BRINTON E, 1967, LIMNOL OCEANOGR, V12, P451, DOI 10.4319/lo.1967.12.3.0451; Brinton E, 2003, DEEP-SEA RES PT II, V50, P2449, DOI 10.1016/S0967-0645(03)00126-7; Brinton E., 1981, California Cooperative Oceanic Fisheries Investigations Reports, V22, P135; Brinton E., 1962, DISTRIBUTION PACIFIC; BRODEUR RD, 1986, J CRUSTACEAN BIOL, V6, P686, DOI 10.2307/1548382; Bucklin A, 2016, J PLANKTON RES, V38, P393, DOI 10.1093/plankt/fbw023; Burton RS, 1998, EVOLUTION, V52, P734, DOI 10.1111/j.1558-5646.1998.tb03698.x; Clarke KR, 2015, PRIM PLYMOUTH PLYMOU, V20; Doyle R.F., 1985, BIOGEOGRAPHICAL STUD; Durazo R, 2015, J GEOPHYS RES-OCEANS, V120, P1173, DOI 10.1002/2014JC010405; Edgar R. C., 2016, PREPRINT, DOI [10.1101/081257, DOI 10.1101/081257]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gagne TO, PLOS ONE, V15, P1; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Hajibabaei M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220953; Harvey JBJ, 2018, MAR ECOL PROG SER, V604, P99, DOI 10.3354/meps12742; Hewitt R., 1981, CAL COOP OCEAN FISH, V22, P9698; Hooff RC, 2006, LIMNOL OCEANOGR, V51, P2607, DOI 10.4319/lo.2006.51.6.2607; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Johansson ML, 2015, MOL ECOL, V24, P4866, DOI 10.1111/mec.13371; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Keister JE, 2011, GLOBAL CHANGE BIOL, V17, P2498, DOI 10.1111/j.1365-2486.2010.02383.x; Keister JE, 2005, MAR ECOL PROG SER, V295, P43, DOI 10.3354/meps295043; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Lavin MF, 2003, NONLINEAR PROCESSES IN GEOPHYSICAL FLUID DYNAMICS, P173; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Lilly LE, 2018, DEEP-SEA RES PT I, V140, P36, DOI 10.1016/j.dsr.2018.07.015; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; O'Donnell JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148698; Ohman M.D., 2017, US CLIVAR VARIATIONS, V15, P8; Oksanen J., 2019, R PACKAGE VERSION, P5; Oliphant TE, 2006, A GUIDE TO NUMPY, V1; Pares-Escobar F, 2018, PROG OCEANOGR, V160, P53, DOI 10.1016/j.pocean.2017.11.009; Peterson DL, 2013, J BIOGEOGR, V40, P1664, DOI 10.1111/jbi.12107; Peterson WT, 2003, DEEP-SEA RES PT II, V50, P2499, DOI 10.1016/S0967-0645(03)00130-9; Peterson WT, 2002, PROG OCEANOGR, V53, P389, DOI 10.1016/S0079-6611(02)00038-1; R Core Team, 2018, R LANG ENV STAT COMP; Riginos C, 2005, EVOLUTION, V59, P2678; RODEN GI, 1971, J GEOPHYS RES, V76, P3462, DOI 10.1029/JC076i015p03462; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Skovgaard A, 2006, MAR ECOL PROG SER, V327, P37, DOI 10.3354/meps327037; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Whitaker D, 2014, CLUSTSIG SIGNIFICANT; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	59	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235159	10.1371/journal.pone.0235159	http://dx.doi.org/10.1371/journal.pone.0235159			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584911	gold, Green Published			2022-12-27	WOS:000545747200096
J	Wei, JB; Yang, JF; Jiang, WB; Pang, YZ				Wei, Jiebing; Yang, Junfeng; Jiang, Wenbo; Pang, Yongzhen			Stacking triple genes increased proanthocyanidins level inArabidopsis thaliana	PLOS ONE			English	Article							LEUCOANTHOCYANIDIN REDUCTASE; CONDENSED TANNINS; BIOSYNTHESIS; EXPRESSION; TEA; PATHWAYS; ENZYMES; PLANTS; FLUX	Anthocyanins and proanthocyanidins are two important plant secondary metabolites, and they contribute to plant survival and human health. In particular, proanthocyanidins could also prevent ruminants from the damage of pasture bloat. However, the improvement of proanthocyanidins content remain unsatisfied. In this study, we attempted to improve proanthocyanidins level by gene stacking inArabidopsis thalianaas prove-of-concept. Two proanthocyanidin pathway genes from tea plant,CsF3'5'HandCsANR2, were co-expressed in the wild type andPAP1over-expressionArabidopsis. Over-expression ofCsF3'5'Hslightly affected anthocyanins level in leaves and proanthocyanidins in mature seed when expressed alone in thepap1-Dline. Over-expression ofCsANR2led to an obvious decrease in anthocyanins in leaves of both wild type andpap1-Dlines, but increase in proanthocyanidin level in mature seeds. Over-expression ofCsANR2inpap1-Dlines lead to production of DMACA-reactive soluble proanthocyanidins in leaves, but not in wild type orpap1-D lines. Anthocyanins level was decreased in the leaves ofCsF3'5'H,CsANR2andpap1-Dco-expression lines, but proanthocyanidins were increased remarkably in both leaves and mature seeds in the co-expression line. It is concluded that co-expression ofCsANR2andPAP1inArabidopsisproduce soluble proanthocyanidins in leaves, and co-expression ofCsF3'5'H,CsANR2andPAP1lead to a significant increase in proanthocyanidins in mature seeds. The transcript levels of endogenousCHS,DFR,ANSandANRgenes inArabidopsiswere up-regulated in the triple genes co-expression line. Based on these studies, it is possible to develop new plant germplasm with improved proanthocyanidins by co-expressing of multiple genes.	[Wei, Jiebing; Yang, Junfeng] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Wei, Jiebing; Yang, Junfeng] Chinese Acad Sci, Inst Bot, Beijing Bot Garden, Beijing, Peoples R China; [Wei, Jiebing; Yang, Junfeng; Jiang, Wenbo; Pang, Yongzhen] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Wei, Jiebing; Yang, Junfeng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, WB; Pang, YZ (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China.	jiangwenbo@caas.cn; pangyongzhen@caas.cn	Jiang, Wenbo/AGX-5151-2022	Pang, Yongzhen/0000-0002-2336-7476	National Natural Science Foundation of China [31870281]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (31670305) to YP, and the National Natural Science Foundation of China (31870281) to WJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 2003, PLANT J, V35, P624, DOI 10.1046/j.1365-313X.2003.01834.x; [Anonymous], 2006, ILM, V45, P895; Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; CHAPPLE C, 1994, RECENT ADV PHYTOCHEM, V28, P251; Chen Q, 2012, SCI HORTIC-AMSTERDAM, V141, P61, DOI 10.1016/j.scienta.2012.04.025; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; de Colmenares NG, 1998, J SCI FOOD AGR, V77, P368, DOI [10.1002/(SICI)1097-0010(199807)77:3&lt;368::AID-JSFA52&gt;3.0.CO;2-V, 10.1002/(SICI)1097-0010(199807)77:3<368::AID-JSFA52>3.3.CO;2-M]; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; Dixon RA, 2003, PLANT PHYSIOL, V131, P878, DOI 10.1104/pp.102.017319; Dixon RA, 2013, CURR OPIN BIOTECH, V24, P329, DOI 10.1016/j.copbio.2012.07.004; Lee Y, 2005, J PLANT BIOL, V48, P356, DOI 10.1007/BF03030577; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li PH, 2016, PLANT BIOTECHNOL J, V14, P1604, DOI 10.1111/pbi.12524; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pang YZ, 2013, PLANT PHYSIOL, V161, P1103, DOI 10.1104/pp.112.212050; Peel GJ, 2009, PLANT J, V59, P136, DOI 10.1111/j.1365-313X.2009.03885.x; Prasad R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043064; Punyasiri PAN, 2004, ARCH BIOCHEM BIOPHYS, V431, P22, DOI 10.1016/j.abb.2004.08.003; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Schaefer HM, 2004, TRENDS ECOL EVOL, V19, P577, DOI 10.1016/j.tree.2004.08.003; Sharma SB, 2005, PLANT J, V44, P62, DOI 10.1111/j.1365-313X.2005.02510.x; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Verdier J, 2012, P NATL ACAD SCI USA, V109, P1766, DOI 10.1073/pnas.1120916109; Wang YS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0347-7	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234799	10.1371/journal.pone.0234799	http://dx.doi.org/10.1371/journal.pone.0234799			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584850	Green Published, gold			2022-12-27	WOS:000545747200001
J	Neumann, B; Bender, JK; Maier, BF; Wittig, A; Fuchs, S; Brockmann, D; Semmler, T; Einsele, H; Kraus, S; Wieler, LH; Vogel, U; Werner, G				Neumann, Bernd; Bender, Jennifer K.; Maier, Benjamin F.; Wittig, Alice; Fuchs, Stephan; Brockmann, Dirk; Semmler, Torsten; Einsele, Hermann; Kraus, Sabrina; Wieler, Lothar H.; Vogel, Ulrich; Werner, Guido			Comprehensive integrated NGS-based surveillance and contact-network modeling unravels transmission dynamics of vancomycin-resistant enterococci in a high-risk population within a tertiary care hospital	PLOS ONE			English	Article							SEQUENCE TYPING SCHEME; INFECTION; ALIGNMENT; CANCER; IDENTIFICATION; PREVENTION; EMERGENCE; DISCOVERY; SURVIVAL; BACTERIA	Vancomycin-resistantE.faecium(VRE) are an important cause of nosocomial infections, which are rapidly transmitted in hospitals. To identify possible transmission routes, we applied combined genomics and contact-network modeling to retrospectively evaluate routine VRE screening data generated by the infection control program of a hemato-oncology unit. Over 1 year, a total of 111 VRE isolates from 111 patients were collected by anal swabs in a tertiary care hospital in Southern Germany. All isolated VRE were whole-genome sequenced, followed by different in-depth bioinformatics analyses including genotyping and determination of phylogenetic relations, aiming to evaluate a standardized workflow. Patient movement data were used to overlay sequencing data to infer transmission events and strain dynamics over time. A predominant clone harboringvanBand exhibiting genotype ST117/CT469 (n = 67) was identified. Our comprehensive combined analyses suggested intra-hospital spread, especially of clone ST117/CT469, despite of extensive screening, single room placement, and contact isolation. A new interactive tool to visualize these complex data was designed. Furthermore, a patient-contact network-modeling approach was developed, which indicates both the periodic import of the clone into the hospital and its spread within the hospital due to patient movements. The analyzed spread of VRE was most likely due to placement of patients in the same room prior to positivity of screening. We successfully demonstrated the added value for this combined strategy to extract well-founded knowledge from interdisciplinary data sources. The combination of patient-contact modeling and high-resolution typing unraveled the transmission dynamics within the hospital department and, additionally, a constant VRE influx over time.	[Neumann, Bernd; Bender, Jennifer K.; Fuchs, Stephan; Werner, Guido] Robert Koch Inst, Div Nosocomial Pathogens & Antibiot Resistance, Wernigerode, Germany; [Maier, Benjamin F.; Wittig, Alice; Brockmann, Dirk] Robert Koch Inst, Computat Epidemiol, Berlin, Germany; [Maier, Benjamin F.] Humboldt Univ, Dept Phys, Berlin, Germany; [Wittig, Alice; Brockmann, Dirk] Humboldt Univ, Inst Theoret Biol, Berlin, Germany; [Semmler, Torsten] Robert Koch Inst, Microbial Genom, Berlin, Germany; [Einsele, Hermann; Kraus, Sabrina] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Wieler, Lothar H.] Robert Koch Inst, Berlin, Germany; [Vogel, Ulrich] Julius Maximilians Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany	Robert Koch Institute; Robert Koch Institute; Humboldt University of Berlin; Humboldt University of Berlin; Robert Koch Institute; University of Wurzburg; Robert Koch Institute; University of Wurzburg	Neumann, B (corresponding author), Robert Koch Inst, Div Nosocomial Pathogens & Antibiot Resistance, Wernigerode, Germany.	neumannb@rki.de	Neumann, Bernd/GQB-4151-2022; Semmler, Torsten/Q-7716-2018	Neumann, Bernd/0000-0002-3580-2105; Semmler, Torsten/0000-0002-2225-7267; Kraus, Sabrina/0000-0001-8954-4220; Maier, Benjamin/0000-0001-7414-8823	German Federal Ministry of Education and Research, IRMRESS project [03ZZ0805C]; Add-on Fellow for Interdisciplinary Life Science by the Joachim Herz Stiftung	German Federal Ministry of Education and Research, IRMRESS project; Add-on Fellow for Interdisciplinary Life Science by the Joachim Herz Stiftung	BN was supported by the German Federal Ministry of Education and Research as part of the IRMRESS project, being part of the InfectControl2020 initiative (BMBF grant no. 03ZZ0805C). https://www.infectcontrol.de/de/english.html BFM was financially supported as an Add-on Fellow for Interdisciplinary Life Science by the Joachim Herz Stiftung. https://www.joachimherz-stiftung.de/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizakos M, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw246; [Anonymous], 2014, LANCET ONCOL, V15, pe475; [Anonymous], 2017, JLSRF, V3, pA104; Arias CA, 2008, EXPERT REV ANTI-INFE, V6, P637, DOI 10.1586/14787210.6.5.637; Becker L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00322; Bender JK, 2016, SCI REP-UK, V6, DOI 10.1038/srep21847; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Ciccolini M, 2013, INT J MED MICROBIOL, V303, P380, DOI 10.1016/j.ijmm.2013.02.003; Cirrincione S, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00071; Cohen B, 2018, INFECT CONT HOSP EP, V39, P541, DOI 10.1017/ice.2018.22; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; de Been M, 2015, J CLIN MICROBIOL, V53, P3788, DOI 10.1128/JCM.01946-15; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gastmeier P, 2014, J ANTIMICROB CHEMOTH, V69, P1660, DOI 10.1093/jac/dku035; Halbedel S, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00119-18, 10.1128/jcm.00119-18]; Hammerum AM, 2012, CLIN MICROBIOL INFEC, V18, P619, DOI 10.1111/j.1469-0691.2012.03829.x; Hammerum AM, 2017, J ANTIMICROB CHEMOTH, V72, P2184, DOI 10.1093/jac/dkx138; Hegstad K, 2010, CLIN MICROBIOL INFEC, V16, P541, DOI 10.1111/j.1469-0691.2010.03226.x; Henri C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02351; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Hughes A, 2019, INFECT DIS HEALTH, V24, P82, DOI 10.1016/j.idh.2018.12.002; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Klare I BJ, 2018, J ENV OCCUPATIONAL H, V23, P401; Klare IBJ, 2017, EPID B, V46, P519, DOI [10.17886/EpiBull-2017-063.2017, DOI 10.17886/EPIBULL-2017-063.2017]; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kommission fur Krankenhaushygiene und Infektionspravention beim Robert Koch-Institut, 2018, BUNDESGESUNDHEITSBLA, V61, P1310; Leavis HL, 2006, CURR OPIN MICROBIOL, V9, P454, DOI 10.1016/j.mib.2006.07.001; Lebreton F, 2018, J ANTIMICROB CHEMOTH, V73, P1479, DOI 10.1093/jac/dky039; Lebreton F, 2013, MBIO, V4, DOI 10.1128/mBio.00534-13; Lebreton F, 2011, ANTIMICROB AGENTS CH, V55, P4606, DOI 10.1128/AAC.00714-11; Lee RS, 2018, J ANTIMICROB CHEMOTH, V73, P3268, DOI 10.1093/jac/dky331; Leong KWC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24614-6; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liese J, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.01978-18, 10.1128/aac.01978-18]; Mellmann A, 2016, J CLIN MICROBIOL, V54, P2874, DOI 10.1128/JCM.00790-16; Neely AN, 2000, J CLIN MICROBIOL, V38, P724, DOI 10.1128/JCM.38.2.724-726.2000; Neumann B, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/JCM.01686-18, 10.1128/jcm.01686-18]; Paganelli FL, 2012, TRENDS MICROBIOL, V20, P40, DOI 10.1016/j.tim.2011.11.001; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/ERI.13.12, 10.1586/eri.13.12]; Pinholt M, 2017, J ANTIMICROB CHEMOTH, V72, P40, DOI 10.1093/jac/dkw360; Pinholt M, 2015, J ANTIMICROB CHEMOTH, V70, P2474, DOI 10.1093/jac/dkv142; Raven KE, 2017, CLIN INFECT DIS, V64, P886, DOI 10.1093/cid/ciw872; Raven KE, 2016, GENOME RES, V26, P1388, DOI 10.1101/gr.204024.116; Remschmidt C, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0353-x; Reuter S, 2013, JAMA INTERN MED, V173, P1397, DOI 10.1001/jamainternmed.2013.7734; Rolston KVI, 2007, BONE MARROW TRANSPL, V39, P567, DOI 10.1038/sj.bmt.1705639; Salipante SJ, 2015, J CLIN MICROBIOL, V53, P1072, DOI 10.1128/JCM.03385-14; Simon S, 2018, FOOD MICROBIOL, V71, P46, DOI 10.1016/j.fm.2017.08.017; Sims GE, 2009, P NATL ACAD SCI USA, V106, P2677, DOI 10.1073/pnas.0813249106; Snyder GM, 2008, INFECT CONT HOSP EP, V29, P583, DOI 10.1086/588701; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tacconelli E, 2004, CLIN INFECT DIS, V39, P964, DOI 10.1086/423961; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/S1473-3099(17)30753-3, 10.1016/s1473-3099(17)30753-3]; Van Tyne D, 2017, MBIO, V8, DOI 10.1128/mBio.00066-17; Vanhems P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073970; Vehreschild MJGT, 2019, INFECTION, V47, P7, DOI 10.1007/s15010-018-1202-9; Voirin N, 2015, INFECT CONT HOSP EP, V36, P254, DOI 10.1017/ice.2014.53; von Mentzer A, 2014, NAT GENET, V46, P1321, DOI 10.1038/ng.3145; Warnke P, 2016, SCI REP-UK, V6, DOI 10.1038/srep30427; Weber DJ, 2013, CURR OPIN INFECT DIS, V26, P338, DOI 10.1097/QCO.0b013e3283630f04; Wendt C, 1998, J CLIN MICROBIOL, V36, P3734, DOI 10.1128/JCM.36.12.3734-3736.1998; Wu YL, 2019, J HOSP INFECT, V101, P231, DOI 10.1016/j.jhin.2018.10.014; Zaas AK, 2002, CLIN INFECT DIS, V35, P1139, DOI 10.1086/342904; 2014, REG ANESTH PAIN MED, V9	66	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235160	10.1371/journal.pone.0235160	http://dx.doi.org/10.1371/journal.pone.0235160			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579600	Green Published, gold			2022-12-27	WOS:000545646600005
J	Yang, HN; Xu, XJ; Liang, HL; Wang, XF				Yang, Hao-Nan; Xu, Xin-Jian; Liang, Haili; Wang, Xiaofan			A comparative study of online communities and popularity of BBS in four Chinese universities	PLOS ONE			English	Article							SOCIAL NETWORK FORMATION	Online forums in Chinese universities play an important role in understanding collective behavior of college students. Of particular interest are community and popularity. We address these two issues by examining data from Bulletin Board Systems (BBSs) of four Chinese universities. To characterize users' behavior, we introduce a hypothesis test to infer individual preferred boards, which yields a polarization of users. We also perform a multilevel algorithm to detect communities of each BBS network. We measure the similarity between the board-preferred polarization and the algorithmically identified community structure by quantitative and visual tools. The resulting discrepancy indicates that board labels are inadequate to represent underlying communities. To reveal online popularity, we employ latent Dirichlet allocation to mine topics from threads to compare popularity in different universities. Based on which, we implement the Cox-Stuart test to explore the change in popularity over time and reproduce significantly ascending and descending topics around a decade. Finally, we devise a two-step model based on users' preference and interests to reproduce the observed connectivity patterns.	[Yang, Hao-Nan; Xu, Xin-Jian] Shanghai Univ, Dept Math, Shanghai, Peoples R China; [Liang, Haili; Wang, Xiaofan] Shanghai Univ, Sch Mechatron Engn & Automat, Shanghai, Peoples R China	Shanghai University; Shanghai University	Xu, XJ (corresponding author), Shanghai Univ, Dept Math, Shanghai, Peoples R China.	xinjxu@shu.edu.cn	Xu, Xin-Jian/G-7653-2011	Xu, Xin-Jian/0000-0001-6088-976X; Yang, Hao-Nan/0000-0001-8692-8317	Science and Technology Commission of Shanghai Municipality [17ZR1445000]; Natural Science Foundation of China [61703255]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	XJX was supported by the Science and Technology Commission of Shanghai Municipality under Grant No. 17ZR1445100. HL was supported by the Natural Science Foundation of China under Grant No. 61703261 and the Science and Technology Commission of Shanghai Municipality under Grant No. 17ZR1445000. XW was supported by the Natural Science Foundation of China under Grant No. 61703255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests: The authors have declared	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; [Anonymous], 2003, J MARKETING, V67, pIII; Asur S., 2011, P 5 SNAKDD WORKSH 20, DOI [10.2139/ssrn.1888779, DOI 10.2139/SSRN.1888779]; Barua A, 2014, EMPIR SOFTW ENG, V19, P619, DOI 10.1007/s10664-012-9231-y; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; COX DR, 1955, BIOMETRIKA, V42, P80, DOI 10.1093/biomet/42.1-2.80; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066123; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Guillaume JL, 2006, PHYSICA A, V371, P795, DOI 10.1016/j.physa.2006.04.047; J Di, 2018, ARXIV180803733; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Manning, 2008, P C EMP METH NAT LAN, P363, DOI [DOI 10.3115/1613715.1613763, DOI 10.3115/1613715]; Mayer A, 2008, J PUBLIC ECON, V92, P329, DOI 10.1016/j.jpubeco.2007.09.001; Nguyen X. V., 2009, P 26 ANN INT C MACHI, P1073, DOI [10.1145/1553374.1553511, DOI 10.1145/1553374.1553511]; Panzarasa P, 2006, J ASSOC INF SCI TECH, V60, P911; Panzarasa P, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062821; Phan TQ, 2015, P NATL ACAD SCI USA, V112, P6595, DOI 10.1073/pnas.1404770112; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Red V, 2011, SIAM REV, V53, P526, DOI 10.1137/080734315; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Sung YS, 2018, INFORM SYST FRONT, V20, P1041, DOI 10.1007/s10796-016-9696-0; Yao LM, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P937; Zhou Q, 2009, 2009 INTERNATIONAL CONFERENCE ON NEW TRENDS IN INFORMATION AND SERVICE SCIENCE (NISS 2009), VOLS 1 AND 2, P586, DOI 10.1109/NISS.2009.67	30	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234469	10.1371/journal.pone.0234469	http://dx.doi.org/10.1371/journal.pone.0234469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579588	Green Published, gold			2022-12-27	WOS:000545646600054
J	Taborelli, M; Sozzi, M; Del Zotto, S; Toffolutti, F; Montico, M; Zanier, L; Serraino, D				Taborelli, Martina; Sozzi, Michele; Del Zotto, Stefania; Toffolutti, Federica; Montico, Marcella; Zanier, Loris; Serraino, Diego			Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; COLORECTAL-CANCER; FOLLOW-UP; ULCERATIVE-COLITIS; EPIDEMIOLOGY; PREVALENCE; MANAGEMENT; METAANALYSIS; NEOPLASIA; TRACT	The cancer risk of patients with inflammatory bowel diseases (IBD) has not been well documented in southern Europe. This study aimed to evaluate the overall pattern of cancer risk among patients with IBD in Friuli Venezia Giulia, northeastern Italy. A population-based cohort study was performed through a record linkage between local healthcare databases and the cancer registry (1995-2013). We identified 3664 IBD patients aged 18-84 years, including 2358 with ulcerative colitis (UC) and 1306 with Crohn's disease (CD). Sex- and age-standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) were used to compare the cancer incidence of IBD patients with the general population. The cumulative cancer risk among IBD patients reached about 10% after 10 years of follow-up. A total of 246 cancers occurred among UC patients (SIR = 1.05, 95% CI: 0.92-1.19), and 141 among CD patients (SIR = 1.20, 95% CI: 1.01-1.41). As compared with the general population, no increased risk of colorectal cancers was observed for either UC or CD patients, whereas the risk of anal cancer was significantly elevated among UC patients (SIR = 6.03, 95% CI: 1.24-17.60). Increased risks were seen for specific extra-intestinal cancers, including corpus uteri (SIR = 2.67, 95% CI: 1.07-5.50) and kidney (SIR = 2.06, 95% CI: 1.03-3.69) among UC patients; thyroid (SIR = 5.58, 95% CI: 2.41-11.00) and skin non-melanoma (SIR = 1.86, 95% CI: 1.32-2.55) among CD patients. This population-based study showed that both UC and CD patients had a colorectal cancer risk similar to that of the general population. However, they were at a higher risk of developing certain extra-intestinal cancer types. Although detection biases cannot be excluded, the study findings pointed to a role of long-standing exposures to immunosuppressive therapies, underlying disease status, as well as the interactions with lifestyle factors. Our findings lent additional support to the need for monitoring the cancer burden in this at-risk population.	[Taborelli, Martina; Toffolutti, Federica; Serraino, Diego] Ctr Riferimento Oncol Aviano CRO IRCCS, Canc Epidemiol Unit, Aviano, Italy; [Sozzi, Michele; Serraino, Diego] Ctr Riferimento Oncol Aviano CRO IRCCS, Friuli Venezia Giulia Canc Registry, Aviano, Italy; [Del Zotto, Stefania; Zanier, Loris] Agenzia Reg Coordinamento Salute, SC Data Warehouse Flussi Informat & Epidemiol, Udine, Italy; [Montico, Marcella] Ctr Riferimento Oncol Aviano CRO IRCCS, Sci Directorate, Aviano, Italy		Taborelli, M (corresponding author), Ctr Riferimento Oncol Aviano CRO IRCCS, Canc Epidemiol Unit, Aviano, Italy.	mtaborelli@cro.it	Serraino, Diego/J-3915-2018; Toffolutti, Federica/AAA-8868-2019; Taborelli, Martina/J-3595-2018; Montico, Marcella/B-5290-2013	Serraino, Diego/0000-0003-0565-8920; Toffolutti, Federica/0000-0002-2907-0745; Taborelli, Martina/0000-0002-6731-7569; Montico, Marcella/0000-0003-0377-8232; Del Zotto, Stefania/0000-0001-5738-4584	Italian Ministry of Health (Ricerca Corrente)	Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health (Ricerca Corrente).	Algaba A, 2015, J CROHNS COLITIS, V9, P326, DOI 10.1093/ecco-jcc/jjv032; Annese V, 2015, J CROHNS COLITIS, V9, P945, DOI 10.1093/ecco-jcc/jjv141; Bernheim O, 2013, GUT, V62, P1523, DOI 10.1136/gutjnl-2013-305300; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Cao LH, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1485-4; Chang MN, 2018, CLIN COLORECTAL CANC, V17, pE29, DOI 10.1016/j.clcc.2017.06.009; Di Domenicantonio R, 2014, DIGEST LIVER DIS, V46, P777, DOI 10.1016/j.dld.2014.04.014; Dulai PS, 2016, CANCER PREV RES, V9, P887, DOI 10.1158/1940-6207.CAPR-16-0124; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Egan L, 2014, J CROHNS COLITIS, V8, P19, DOI 10.1016/j.crohns.2013.04.009; Friedman MY, 2018, CLIN EPIDEMIOL, V10, P671, DOI 10.2147/CLEP.S151339; Fung BM, 2019, WORLD J GASTROENTERO, V25, P659, DOI 10.3748/wjg.v25.i6.659; Gini A, 2016, CANCER EPIDEMIOL, V41, P80, DOI 10.1016/j.canep.2016.01.011; Gnavi R, 2008, EPIDEMIOL PREV, V32, P15; Hazenberg HMJL, 2018, INFLAMM BOWEL DIS, V24, P510, DOI 10.1093/ibd/izx062; Herrinton LJ, 2007, INFLAMM BOWEL DIS, V13, P451, DOI 10.1002/ibd.20021; Hovde O, 2017, J CROHNS COLITIS, V11, P571, DOI 10.1093/ecco-jcc/jjw193; Jess T, 2013, AM J GASTROENTEROL, V108, P1869, DOI 10.1038/ajg.2013.249; Jess T, 2012, GUT, V61, P1279, DOI 10.1136/gutjnl-2011-301095; Jess T, 2012, GASTROENTEROLOGY, V143, P375, DOI 10.1053/j.gastro.2012.04.016; Jung YS, 2017, J CROHNS COLITIS, V11, P954, DOI 10.1093/ecco-jcc/jjx040; Kappelman MD, 2014, CLIN GASTROENTEROL H, V12, P265, DOI 10.1016/j.cgh.2013.03.034; Katsanos KH, 2011, J CROHNS COLITIS, V5, P430, DOI 10.1016/j.crohns.2011.04.013; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Long MD, 2011, INFLAMM BOWEL DIS, V17, P1423, DOI 10.1002/ibd.21484; Long MD, 2012, GASTROENTEROLOGY, V143, P390, DOI 10.1053/j.gastro.2012.05.004; Loo SY, 2019, J CROHNS COLITIS, V13, P1302, DOI 10.1093/ecco-jcc/jjz058; Lutgens MWMD, 2013, INFLAMM BOWEL DIS, V19, P789, DOI 10.1097/MIB.0b013e31828029c0; Olen O, 2020, LANCET, V395, P123, DOI 10.1016/S0140-6736(19)32545-0; Pasternak B, 2013, AM J EPIDEMIOL, V177, P1296, DOI 10.1093/aje/kws375; Pedersen N, 2010, AM J GASTROENTEROL, V105, P1480, DOI 10.1038/ajg.2009.760; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Scharl S, 2019, AM J GASTROENTEROL, V114, P116, DOI 10.1038/s41395-018-0360-9; Sebastian S, 2014, J CROHNS COLITIS, V8, P5, DOI 10.1016/j.crohns.2013.04.008; Shizuma T, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5187061; Siegel CA, 2009, CLIN GASTROENTEROL H, V7, P874, DOI 10.1016/j.cgh.2009.01.004; So J, 2017, INFLAMM BOWEL DIS, V23, P2061, DOI 10.1097/MIB.0000000000001240; Soderlund S, 2010, GASTROENTEROLOGY, V138, P1697, DOI 10.1053/j.gastro.2010.02.007; Taborelli M, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1283-4; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Valent F, 2018, NEUROL SCI, V39, P699, DOI 10.1007/s10072-018-3273-x; Valpiani D, 2018, DIGEST LIVER DIS, V50, P32, DOI 10.1016/j.dld.2017.09.120; van den Heuvel TRA, 2016, INT J CANCER, V139, P1270, DOI 10.1002/ijc.30183; von Roon AC, 2007, DIS COLON RECTUM, V50, P839, DOI 10.1007/s10350-006-0848-z; Wadhwa V, 2016, INFLAMM BOWEL DIS, V22, P2902, DOI 10.1097/MIB.0000000000000963; Wilson JC, 2016, J GASTROENTEROL, V51, P1050, DOI 10.1007/s00535-016-1199-8; Wisniewski A, 2017, J CROHNS COLITIS, V11, P1011, DOI 10.1093/ecco-jcc/jjx035; Yadav S, 2015, MAYO CLIN PROC, V90, P738, DOI 10.1016/j.mayocp.2015.03.024	48	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235142	10.1371/journal.pone.0235142	http://dx.doi.org/10.1371/journal.pone.0235142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574216	Green Published, gold			2022-12-27	WOS:000544972400044
J	Murtagh, CF; Brownlee, TE; Rienzi, E; Roquero, S; Moreno, S; Huertas, G; Lugioratto, G; Baumert, P; Turner, DC; Lee, D; Dickinson, P; Lyon, KA; Sheikhsaraf, B; Biyik, B; O'Boyle, A; Morgans, R; Massey, A; Drust, B; Erskine, RM				Murtagh, Conall F.; Brownlee, Thomas E.; Rienzi, Edgardo; Roquero, Sebastian; Moreno, Sacha; Huertas, Gustavo; Lugioratto, Giovani; Baumert, Philipp; Turner, Daniel C.; Lee, Dongsun; Dickinson, Peter; Lyon, K. Amber; Sheikhsaraf, Bahare; Biyik, Betul; O'Boyle, Andrew; Morgans, Ryland; Massey, Andrew; Drust, Barry; Erskine, Robert M.			The genetic profile of elite youth soccer players and its association with power and speed depends on maturity status	PLOS ONE			English	Article							AMP-DEAMINASE DEFICIENCY; VITAMIN-D; ACTN3 GENOTYPE; TALENT IDENTIFICATION; POLYMORPHISM; PERFORMANCE; ALPHA-ACTININ-3; FOOTBALL; ENDURANCE; STRENGTH	We investigated the association of multiple single nucleotide polymorphisms (SNPs) with athlete status and power/speed performance in elite male youth soccer players (ESP) and control participants (CON) at different stages of maturity. ESP (n = 535; aged 8-23 years) and CON (n = 151; aged 9-26 years) were genotyped for 10 SNPs and grouped according to years from predicted peak-height-velocity (PHV), i.e. pre- or post-PHV, to determine maturity status. Participants performed bilateral vertical countermovement jumps, bilateral horizontal-forward countermovement jumps, 20m sprints and modified 505-agility tests. Compared to CON, pre-PHV ESP demonstrated a higherACTN3(rs1815739) XX ('endurance') genotype frequency distribution, while post-PHV ESP revealed a higher frequency distribution of thePPARA(rs4253778) C-allele,AGT(rs699) GG genotype andNOS3(rs2070744) T-allele ('power' genotypes/alleles).BDNF(rs6265) CC,COL5A1(rs12722) CC andNOS3TT homozygotes sprinted quicker than A-allele carriers, CT heterozygotes and CC homozygotes, respectively.COL2A1(rs2070739) CC andAMPD1(rs17602729) GG homozygotes sprinted faster than their respective minor allele carrier counterparts in CON and pre-PHV ESP, respectively.BDNFCC homozygotes jumped further than T-allele carriers, while ESPCOL5A1CC homozygotes jumped higher than TT homozygotes. To conclude, we have shown for the first time that pre- and post-PHV ESP have distinct genetic profiles, with pre-PHV ESP more suited for endurance, and post-PHV ESP for power and speed (the latter phenotypes being crucial attributes for post-PHV ESP). We have also demonstrated that power, acceleration and sprint performance were associated with five SNPs, both individually and in combination, possibly by influencing muscle size and neuromuscular activation.	[Murtagh, Conall F.; Brownlee, Thomas E.; Baumert, Philipp; Turner, Daniel C.; Lee, Dongsun; Dickinson, Peter; Lyon, K. Amber; Sheikhsaraf, Bahare; Biyik, Betul; O'Boyle, Andrew; Drust, Barry; Erskine, Robert M.] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England; [Rienzi, Edgardo; Roquero, Sebastian; Moreno, Sacha; Huertas, Gustavo] Estadio Campeon Siglo, Club Atlet Penarol, Montevideo, Uruguay; [Lugioratto, Giovani] Defensor Sporting Club, Montevideo, Uruguay; [O'Boyle, Andrew] Premier League, London, England; [Morgans, Ryland] Cardiff Metropolitan Univ, Sch Sport & Hlth, Cardiff, Wales; [Massey, Andrew] Liverpool Football Club, Liverpool, Merseyside, England; [Erskine, Robert M.] UCL, Inst Sport Exercise & Hlth ISEH, London, England	Liverpool John Moores University; Cardiff Metropolitan University; University of London; University College London	Erskine, RM (corresponding author), Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England.; Erskine, RM (corresponding author), UCL, Inst Sport Exercise & Hlth ISEH, London, England.	R.M.Erskine@ljmu.ac.uk	Baumert, Philipp/AAF-4749-2019; Baumert, Philipp/AAZ-7436-2020; Drust, Barry/AAM-9776-2020; Brownlee, Thomas/ABD-6493-2021	Baumert, Philipp/0000-0002-5463-1954; Baumert, Philipp/0000-0002-5463-1954; Drust, Barry/0000-0003-2092-6962; Brownlee, Thomas/0000-0002-3355-1867; massey, andrew/0000-0002-8253-932X; Erskine, Robert/0000-0002-5705-0207; Turner, Daniel/0000-0002-7786-4152				Ahmetov II, 2011, EXP PHYSIOL, V96, P1302, DOI 10.1113/expphysiol.2011.060293; [Anonymous], 2019, THESIS; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIRK DE, 1990, J CELL SCI, V95, P649; Brazilian Society of Cardiology Brazilian Society of Hypertension Brazilian Society of Nephrology, 2010, J BRAS NEFROL, V95, P1, DOI DOI 10.1590/S0066-782X2010001700001; Brown T, 2019, SCAND J OCCUP THER, V26, P475, DOI 10.1080/11038128.2018.1473489; Casamichana D, 2012, J STRENGTH COND RES, V26, P837, DOI 10.1519/JSC.0b013e31822a61cf; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cieszczyk P, 2012, J SPORT SCI, V30, P31, DOI 10.1080/02640414.2011.623710; Coelho DB, 2016, J SPORT MED PHYS FIT, V56, P241; Colin EM, 2000, CLIN ENDOCRINOL, V52, P211, DOI 10.1046/j.1365-2265.2000.00909.x; De Moor MHM, 2007, TWIN RES HUM GENET, V10, P812, DOI 10.1375/twin.10.6.812; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Egorova ES, 2014, J SPORT SCI, V32, P1286, DOI 10.1080/02640414.2014.898853; Erskine RM, 2014, SCAND J MED SCI SPOR, V24, P642, DOI 10.1111/sms.12055; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Foster BP, 2014, EUR J APPL PHYSIOL, V114, P1393, DOI 10.1007/s00421-014-2868-z; Gilliver SF, 2009, EXP PHYSIOL, V94, P1070, DOI 10.1113/expphysiol.2009.048314; Gineviciene V, 2014, EUR J SPORT SCI, V14, pS289, DOI 10.1080/17461391.2012.691117; Gomez-Gallego F, 2009, APPL PHYSIOL NUTR ME, V34, P1108, DOI 10.1139/H09-108; Gomez-Gallego F, 2009, EUR J APPL PHYSIOL, V107, P565, DOI 10.1007/s00421-009-1166-7; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Gordon SE, 2001, AM J PHYSIOL-ENDOC M, V280, pE150, DOI 10.1152/ajpendo.2001.280.1.E150; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Kubo K, 1999, J APPL PHYSIOL, V87, P2090, DOI 10.1152/jappl.1999.87.6.2090; Kubo K, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-343; Kumagai K, 2000, J APPL PHYSIOL, V88, P811, DOI 10.1152/jappl.2000.88.3.811; Kuntz LA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189668; Maciejewska-Skrendo A, 2019, J HUM KINET, V68, P17, DOI 10.2478/hukin-2019-0053; Maxwell S.E., 2018, DESIGNING EXPT ANAL, V3rd; Micheli ML, 2011, J STRENGTH COND RES, V25, P2084, DOI 10.1519/JSC.0b013e31820238aa; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Morin JB, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00404; MORISAKI T, 1992, P NATL ACAD SCI USA, V89, P6457, DOI 10.1073/pnas.89.14.6457; Morse CI, 2007, EUR J APPL PHYSIOL, V100, P267, DOI 10.1007/s00421-007-0429-4; Murtagh CF, 2019, RES Q EXERCISE SPORT, V90, P234, DOI 10.1080/02701367.2019.1576838; Murtagh CF, 2018, EUR J APPL PHYSIOL, V118, P1737, DOI 10.1007/s00421-018-3905-0; Murtagh CF, 2018, INT J SPORT PHYSIOL, V13, P604, DOI 10.1123/ijspp.2017-0589; Murtagh CF, 2018, J STRENGTH COND RES, V32, P297, DOI 10.1519/JSC.0000000000002367; Murtagh CF, 2017, J SCI MED SPORT, V20, P1018, DOI 10.1016/j.jsams.2017.03.016; Nakayama M, 2000, AM J CARDIOL, V86, P628, DOI 10.1016/S0002-9149(00)01041-9; NORMAN B, 1995, MUSCLE NERVE, V18, P239, DOI 10.1002/mus.880180216; North KN, 1996, NEUROMUSCULAR DISORD, V6, P229, DOI 10.1016/0960-8966(96)00361-6; Owens DJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE1019, DOI 10.1152/ajpendo.00375.2015; Pimenta EM, 2013, J STRENGTH COND RES, V27, P3286, DOI 10.1519/JSC.0b013e3182915e66; Reeves ND, 2004, EUR J APPL PHYSIOL, V91, P116, DOI 10.1007/s00421-003-0961-9; Ruiz JR, 2010, J APPL PHYSIOL, V108, P561, DOI 10.1152/japplphysiol.01242.2009; Sarmento H, 2018, SPORTS MED, V48, P907, DOI 10.1007/s40279-017-0851-7; Sethi AA, 2003, ARTERIOSCL THROM VAS, V23, P1269, DOI 10.1161/01.ATV.0000079007.40884.5C; Seto JT, 2013, J CLIN INVEST, V123, P4255, DOI 10.1172/JCI67691; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Stafilidis S, 2007, J SPORT SCI, V25, P1035, DOI 10.1080/02640410600951589; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Venturelli M, 2008, INT J SPORT PHYSIOL, V3, P558, DOI 10.1123/ijspp.3.4.558; Whitfield GK, 2001, MOL CELL ENDOCRINOL, V177, P145; Williams AG, 2008, J PHYSIOL-LONDON, V586, P113, DOI 10.1113/jphysiol.2007.141887; Williams AM, 2000, J SPORT SCI, V18, P657, DOI 10.1080/02640410050120041; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Zarebska A, 2013, J STRENGTH COND RES, V27, P2898, DOI 10.1519/JSC.0b013e31828155b5; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	64	12	12	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234458	10.1371/journal.pone.0234458	http://dx.doi.org/10.1371/journal.pone.0234458			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569264	Green Published, gold, Green Accepted			2022-12-27	WOS:000543547900030
J	Roulaux, PEM; van Herwijnen, IR; Beerda, B				Roulaux, Pascalle E. M.; van Herwijnen, Ineke R.; Beerda, Bonne			Self-reports of Dutch dog owners on received professional advice, their opinions on castration and behavioural reasons for castrating male dogs	PLOS ONE			English	Article							COGNITIVE-DISSONANCE; INFORMATION-SEEKING; RELINQUISHMENT; NONRESPONSE; AGGRESSION; ENGAGEMENT; BREED	Male dogs are often castrated based on the thought that it facilitates well-behavedness. However, the causal evidence for this from prospective studies lacks and the existing associative studies present mixed results depending on the studied behaviours. We aimed to gain insight into possible factors driving an owner's decision to castrate their male dog, through a quantitative survey based on a convenience sample. We determined the advice owners received from three types of dog professionals (veterinarian practitioners, behavioural trainers, behavioural therapists) and the owners' assessments of castration's behavioural effects. Data on 491 Dutch owners of castrated and intact male dogs were analysed with Chi-square tests. Results indicate that owners of both castrated and intact dogs received castration advice most often from veterinarian practitioners, with pro-castration at higher frequencies for owners of castrated dogs (Chi-square, P<0.001). Overall, most owners disagreed with or were neutral about statements on castration positively affecting male dog behaviour at a population level. Nevertheless, 58% (N= 145) of the owners of castrated dogs (N= 249) reported that correcting unwanted behaviour was a reason to castrate their own male dog. Unwanted behaviour involved aggression in 50% (N= 70) of the owner-dog dyads. Castrated dog's aggression changes were reported on most as 'no change'. The second most common answer indicated an aggression decrease in dogs castrated to correct unwanted behaviour and an increase in dogs castrated for other reasons (Chi-square, P<0.001). The increase in aggression in a subset of castrated dogs is concerning, as aggression can pose risks to the dog's welfare. We acknowledge the limitations of our study which identifies associations rather than provides causal evidence. Still, we recommend professionals' awareness of possible negative behavioural changes following castration, like increased aggression. Future research on behavioural consequences of castrating dogs needs to build a more solid knowledge base for balanced advice regarding castration.	[Roulaux, Pascalle E. M.; van Herwijnen, Ineke R.; Beerda, Bonne] Wageningen Univ & Res, Dept Anim Sci, Behav Ecol Grp, Wageningen, Netherlands	Wageningen University & Research	Roulaux, PEM (corresponding author), Wageningen Univ & Res, Dept Anim Sci, Behav Ecol Grp, Wageningen, Netherlands.	pascalleroulaux@hotmail.com	van+Herwijnen, Ineke/AAN-9135-2021	Roulaux, Pascalle/0000-0003-0860-4450				Adkins-Regan E, 2005, HORMONES ANIMAL SOCI; Aikey JL, 2002, HORM BEHAV, V42, P448, DOI 10.1006/hbeh.2002.1838; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; Bamberger M, 2006, JAVMA-J AM VET MED A, V229, P1591, DOI 10.2460/javma.229.10.1591; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; Case DO, 2005, J MED LIBR ASSOC, V93, P353; Choi JC, 2017, ACTA ANAESTH SCAND, V61, P668, DOI 10.1111/aas.12908; Chung T, 2011, J VET BEHAV, V11, P26; Coe JB, 2014, J APPL ANIM WELF SCI, V17, P253, DOI 10.1080/10888705.2014.899910; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; D'Onise K, 2017, INJURY PREV, V23, P212, DOI 10.1136/injuryprev-2016-042141; Diesel G, 2010, VET REC, V166, P455, DOI 10.1136/vr.b4798; Dunning David, 2004, Psychol Sci Public Interest, V5, P69, DOI 10.1111/j.1529-1006.2004.00018.x; Farhoody P, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00018; Fatjo J, 2006, ANIM WELFARE, V15, P179; FREY D, 1982, J PERS SOC PSYCHOL, V43, P1175, DOI 10.1037/0022-3514.43.6.1175; Galac S, 1997, ANIM WELFARE, V6, P9; Gates MC, 2018, NEW ZEAL VET J, V66, P210, DOI 10.1080/00480169.2018.1464977; Guy NC, 2001, APPL ANIM BEHAV SCI, V74, P15, DOI 10.1016/S0168-1591(01)00153-8; Harmon-Jones E, 2015, CURR DIR PSYCHOL SCI, V24, P184, DOI 10.1177/0963721414566449; Heath C, 2001, J PERS SOC PSYCHOL, V81, P1028, DOI 10.1037//0022-3514.81.6.1028; Herron ME, 2009, APPL ANIM BEHAV SCI, V117, P47, DOI 10.1016/j.applanim.2008.12.011; Howell TJ, 2016, J VET BEHAV, V12, P4, DOI 10.1016/j.jveb.2015.12.005; Jackson LA, 2001, SEX ROLES, V44, P363, DOI 10.1023/A:1010937901821; Jacobs JA, 2018, PREV VET MED, V161, P143, DOI 10.1016/j.prevetmed.2017.02.005; Kaufmann C.A., 2017, VET MED OPEN J, V2, P22, DOI [10.17140/VMOJ-2-113, DOI 10.17140/VMOJ-2-113]; Krasimira U., 2011, MACED VET REV, V34, P47; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Kwan JY, 2013, J APPL ANIM WELF SCI, V16, P168, DOI 10.1080/10888705.2013.768923; Lambert K, 2015, PREV VET MED, V118, P148, DOI 10.1016/j.prevetmed.2014.11.002; Maarschalkerweerd RJ, 1997, VET REC, V140, P617, DOI 10.1136/vr.140.24.617; Martikainen P, 2007, SCAND J PUBLIC HEALT, V35, P212, DOI 10.1080/14034940600996563; Mondelli Francesca, 2004, Journal of Applied Animal Welfare Science, V7, P253, DOI 10.1207/s15327604jaws0704_3; Neilson JC, 1997, J AM VET MED ASSOC, V211, P180; Norman C, 2020, VET REC, V186, DOI 10.1136/vr.105380; Packer RMA, 2017, ANIM WELFARE, V26, P191, DOI 10.7120/09627286.26.2.191; Packer RMA, 2012, ANIM WELFARE, V21, P81, DOI 10.7120/096272812X13345905673809; Pavel S. R., 2012, J AVIATION TECHNOLOG, V2, P125, DOI DOI 10.5703/1288284314864; Podberscek AL, 1997, APPL ANIM BEHAV SCI, V52, P215, DOI 10.1016/S0168-1591(96)01124-0; Porter SR, 2005, RES HIGH EDUC, V46, P127, DOI 10.1007/s11162-004-1597-2; Puurunen J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60546-w; Reisner IR, 2005, JAVMA-J AM VET MED A, V227, P1594, DOI 10.2460/javma.2005.227.1594; Rohlf VI, 2010, ANTHROZOOS, V23, P143, DOI 10.2752/175303710X12682332909972; Salman M D, 1998, J Appl Anim Welf Sci, V1, P207, DOI 10.1207/s15327604jaws0103_2; Smith G, 2008, ED501717, P1; Sullivan PJ, 2019, INT J SPORT EXERC PS, V17, P591, DOI 10.1080/1612197X.2018.1444079; Urfer SR, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9121086; van Herwijnen IR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204592; Volsche S., 2016, Human-Animal Interaction Bulletin, V4, P1	50	4	4	7	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234917	10.1371/journal.pone.0234917	http://dx.doi.org/10.1371/journal.pone.0234917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569273	Green Published, gold			2022-12-27	WOS:000543547900016
J	Gitsels, LA; Cortina-Borja, M; Rahi, JS				Gitsels, Lisanne Andra; Cortina-Borja, Mario; Rahi, Jugnoo Sangeeta			Is amblyopia associated with school readiness and cognitive performance during early schooling? Findings from the Millennium Cohort Study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; VISUAL IMPAIRMENT; VISION; CHILDREN; PREVALENCE; HEALTH; LIFE; EYE	Background Amblyopia is a neurodevelopmental condition causing reduced vision, for which programmes of whole population child vision screening exist throughout the world. There is an ongoing debate about the value of screening due to the lack of evidence about meaningful functional impacts of amblyopia. Our objective was to determine whether amblyopia is associated with school readiness and early cognitive performance. Methods and findings Data from the prospective Millennium Cohort Study of children born in the United Kingdom in 2000-01 and followed-up to age 7 years (n= 13,967). Using parental self-report on eye conditions and treatment coded by clinical reviewers, participants were grouped into no eye conditions, strabismus alone, refractive amblyopia, or strabismic/mixed (refractive plus strabismic) amblyopia. The outcomes were poor school readiness using Bracken School Readiness Assessment <25th percentile (age 3); and cognitive tests and their age-related trajectories using British Ability Scale II Naming Vocabulary (ages 3/5) and Pattern Construction (ages 5/7). Multivariable analyses showed that compared to children without any eye conditions, only those with strabismic/mixed amblyopia had an increased risk of poor school readiness (OR = 2.04, 95%CI 1.09-3.82). Small differences in mean scores for NV and PC of children with amblyopia (all types) compared to those without any eye condition were not clinically significant (>10 points) irrespective of whether treatment had already started. The age-related cognitive trajectories of children with amblyopia did not differ from those without any eye conditions for either NV (p= 0.62) or PC (p= 0.51). These associations are at population rather than individual level, so it might be that some individuals with amblyopia did experience significant adverse outcomes that are not captured by summary statistics. Conclusions Amblyopia is not significantly associated with adverse cognitive performance and trajectories in early schooling and there is no evidence that this is due to a mediating effect of treatment. Although amblyopia combined with strabismus is associated with poor school readiness, this is not translated into poor cognitive performance. These novel findings may explain the lack of association reported between amblyopia and educational outcomes in adult life and suggest that the impact of amblyopia on education is not of itself a justification for whole population child vision screening aimed at detecting this disorder.	[Gitsels, Lisanne Andra; Cortina-Borja, Mario; Rahi, Jugnoo Sangeeta] UCL, Populat Policy & Practice Res & Teaching Dept, Great Ormond St Inst Child Hlth, London, England; [Gitsels, Lisanne Andra; Rahi, Jugnoo Sangeeta] UCL, Great Ormond St Inst Child Hlth, Ulverscroft Vis Res Grp, London, England; [Rahi, Jugnoo Sangeeta] Great Ormond St Hosp Children NHS Fdn Trust, London, England; [Rahi, Jugnoo Sangeeta] UCL, Inst Ophthalmol, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Rahi, JS (corresponding author), UCL, Populat Policy & Practice Res & Teaching Dept, Great Ormond St Inst Child Hlth, London, England.; Rahi, JS (corresponding author), UCL, Great Ormond St Inst Child Hlth, Ulverscroft Vis Res Grp, London, England.; Rahi, JS (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, London, England.; Rahi, JS (corresponding author), UCL, Inst Ophthalmol, London, England.	j.rahi@ucl.ac.uk		Rahi, Jugnoo/0000-0002-5718-9209; /0000-0001-9066-3702	National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Ulverscroft Vision Research Group	National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Ulverscroft Vision Research Group	JSR is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. All research at Great Ormond Street Hospital NHS Foundation Trust and UCL Great Ormond Street Institute of Child Health is made possible by the NIHR Great Ormond Street Hospital Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. LAG is supported by the Ulverscroft Vision Research Group.	Abreu L, 2016, CHILDRENS EARLY YEAR; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; Bracken B. A., 2002, SCH READINESS ASSESS; Chia EM, 2006, OPHTHAL EPIDEMIOL, V13, P371, DOI 10.1080/09286580600864794; Chua B, 2004, BRIT J OPHTHALMOL, V88, P1119, DOI 10.1136/bjo.2004.041863; Cox's Bazar Bangladesh, 2019, GEND PROF NO 2 ROH R, V11, P1; Cumberland PM, 2010, OPHTHALMOLOGY, V117, P2184, DOI 10.1016/j.ophtha.2010.03.004; Editorial, 2016, NAT CLIM CHANGE, V6, P1, DOI [10.1038/nclimate2911, DOI 10.1038/s41598-016-0001-8]; Eicher S, 2019, J CHINESE HIST, V3, P1, DOI 10.1017/jch.2017.39; Elflein HM, 2019, J PEDIAT OPHTH STRAB, V56, P397, DOI 10.3928/01913913-20190925-01; Elliott C.D., 1997, BRIT ABILITY SCALES; Hansen K., 2014, MILLENNIUM COHORT ST; Hrisos S, 2006, BRIT J OPHTHALMOL, V90, P836, DOI 10.1136/bjo.2006.090910; Kelly KR, 2015, J AAPOS, V19, P515, DOI 10.1016/j.jaapos.2015.09.002; Londra M, 2006, MILLENNIUM COHORT ST; Majeed M, 2008, BRIT J OPHTHALMOL, V92, P965, DOI 10.1136/bjo.2007.134841; Pathai S, 2010, ARCH PEDIAT ADOL MED, V164, P250, DOI 10.1001/archpediatrics.2009.297; Public Health England, 2019, CHILD VIS SCREEN SER; R Core Team, 2019, R VERS 3 5 3 LANG EN; Rahi JS, 2006, BRIT MED J, V332, P820, DOI 10.1136/bmj.38751.597963.AE; Rahi JS, 2003, LANCET, V362, P1359, DOI 10.1016/S0140-6736(03)14631-4; Rahi JS, 2002, LANCET, V360, P621, DOI 10.1016/S0140-6736(02)09775-1; Rahi JS., 2019, CHILDHOOD VISION SCR; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Sloot F, 2015, J MED SCREEN, V22, P55, DOI 10.1177/0969141315572403; Solebo AL, 2015, LANCET, V385, P2308, DOI 10.1016/S0140-6736(14)60522-5; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Stifter E, 2005, BRIT J OPHTHALMOL, V89, P1324, DOI 10.1136/bjo.2005.066688; Webber AL, 2018, CLIN EXP OPTOM, V101, P443, DOI 10.1111/cxo.12663; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Williams C, 2008, BRIT J OPHTHALMOL, V92, P959, DOI 10.1136/bjo.2007.134700; Wilson GA, 2013, CLIN EXP OPHTHALMOL, V41, P127, DOI 10.1111/j.1442-9071.2012.02842.x	32	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234414	10.1371/journal.pone.0234414	http://dx.doi.org/10.1371/journal.pone.0234414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559208	Green Published, gold			2022-12-27	WOS:000543261600041
J	Jenkins, SP; Calvert, MJ; Draper, H				Jenkins, Simon Paul; Calvert, Melanie J.; Draper, Heather			Potential research participants' use of information during the consent process: A qualitative pilot study of patients enrolled in a clinical trial	PLOS ONE			English	Article							INFORMED-CONSENT; DOCUMENTS; PART	There is increasing evidence that clinical trial participants are uninformed about the trials in which they participate, raising ethical concerns regarding informed consent. The aim of this pilot study was to explore clinical trial participants' use of consent discussions and information sheets when considering participating in clinical trials research. A qualitative, interview-based pilot study was designed in order to elicit, through dialogue, details of the reasons for participants' use of, and preferences regarding, different modes of information provision. Semi-structured interviews were undertaken with two different groups of patients who were participants in the Reinforcement of Closure of Stoma Site trial. The first group comprised newly-consented trial participants, who had been recruited up to 72 hours before our interview; the second group comprised patients attending a follow-up clinic 12 months after joining the trial. Thirteen participants were recruited in total: three newly-consented patients, and ten follow-up patients. The study found that participants' use of consent discussions to gain information about clinical trials was varied, and that they only minimally used information sheets after providing initial consent for the trial. Participants demonstrated varying degrees of knowledge about the trial, with some having forgotten that they were still involved in the trial. Participants reported a high level of trust in medical staff as a reason for not seeking more information about the trial. Some participants reported dissatisfaction with the timing of information provision. Some were amenable to novel ways of receiving trial information, such as web-based methods. The pilot study demonstrated the feasibility of a larger study into the provision of information to prospective clinical trial participants. The results suggest that considering alternative ways of providing information and the appropriateness of existing information provision may be acceptable to and useful for potential trial participants.	[Jenkins, Simon Paul; Draper, Heather] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry, W Midlands, England; [Calvert, Melanie J.] Univ Birmingham, Ctr Patient Reported Outcomes Res, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Calvert, Melanie J.] Univ Birmingham, Natl Inst Hlth Res, Birmingham Biomed Res Ctr, Birmingham, W Midlands, England; [Calvert, Melanie J.] Univ Birmingham, Natl Inst Hlth Res, Appl Res Ctr West Midlands, Birmingham, W Midlands, England; [Calvert, Melanie J.] Univ Birmingham, Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Calvert, Melanie J.] Birmingham Hlth Partners Ctr Regulatory Sci & Inn, Birmingham, W Midlands, England	University of Warwick; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Jenkins, SP (corresponding author), Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry, W Midlands, England.	s.jenkins.4@warwick.ac.uk	Jenkins, Simon Paul/B-8522-2019; Calvert, Melanie/F-7055-2011	Jenkins, Simon Paul/0000-0001-8298-0847; Calvert, Melanie/0000-0002-1856-837X; Draper, Heather/0000-0002-0020-4252	Medical Research Council (MRC) Midlands Hub for Trials Methodology Research [G0800808]; NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham; NIHR Surgical Reconstruction and Microbiology Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham; MRC [G0800808] Funding Source: UKRI	Medical Research Council (MRC) Midlands Hub for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham; NIHR Surgical Reconstruction and Microbiology Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (MRC) Midlands Hub for Trials Methodology Research (Grant ID G0800808). All three authors were named on this award. Funder URL: https://www.birmingham.ac.uk/research/applied-health/research/mrc-hub-for-trialsmethodology/index.aspx MC is funded by the NIHR Birmingham Biomedical Research Centre and the NIHR Surgical Reconstruction and Microbiology Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali V, 2003, HASTINGS LAW J, V54, P1575; [Anonymous], 1996, BRIT MED J, V313, P1448; [Anonymous], 2004, MED HUMAN USE CLIN T; Antoniou EE, 2011, J MED ETHICS, V37, P557, DOI 10.1136/jme.2010.041871; Armstrong N, 2012, SOCIOL HEALTH ILL, V34, P1230, DOI 10.1111/j.1467-9566.2012.01469.x; Beauchamp T, 2013, PRINCIPLES BIOMEDICA; Brehaut JC, 2012, J CLIN EPIDEMIOL, V65, P708, DOI 10.1016/j.jclinepi.2012.01.004; Bryman A, 2012, SOCIAL RES METHODS, Vfourth, DOI [10.1016/j.ymeth.2012.10.003, DOI 10.1016/J.YMETH.2012.10.003]; CHALMERS I, 2007, INT J PHARM MED, V21, P395; Chase S.E., 2018, HDB QUALITATIVE RES, V5th ed., P936; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Cox K, 2002, PATIENT EDUC COUNS, V46, P31, DOI 10.1016/S0738-3991(01)00147-1; Davis TC, 1998, JNCI-J NATL CANCER I, V90, P668, DOI 10.1093/jnci/90.9.668; Dixon-Woods M, 2007, SOC SCI MED, V65, P2212, DOI 10.1016/j.socscimed.2007.08.010; Doyal L, 1997, BMJ-BRIT MED J, V314, P1107, DOI 10.1136/bmj.314.7087.1107; Ennis L, 2016, BRIT J PSYCHIAT, V208, P189, DOI 10.1192/bjp.bp.114.156687; Faden R., 1986, HIST THEORY INFORM C; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; Harris J, 2005, J MED ETHICS, V31, P242, DOI 10.1136/jme.2005.011973; Jefford M, 2008, LANCET ONCOL, V9, P485, DOI 10.1016/S1470-2045(08)70128-1; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Kartch F., 2017, SAGE ENCY COMMUNICAT; Kiguba R, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-21; Kirkby HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076435; LIDZ CW, 1988, ARCH INTERN MED, V148, P1385, DOI 10.1001/archinte.148.6.1385; Luna F, 2009, COMPANION BIOETHICS, P457; Medical Research Council, 1998, GUID GOOD CLIN PRACT; O'Neill O, 2003, J MED ETHICS, V29, P4, DOI 10.1136/jme.29.1.4; Onwuegbuzie AJ, 2007, QUAL QUANT, V41, P105, DOI 10.1007/s11135-005-1098-1; Silverman D., 2013, DOING QUALITATIVE RE; Taylor M.C., 2005, QUALITATIVE RES HLTH, P39; World Medical Association, 2013, DECL HELS ETH PRINC; 2020, LANCET, V395, P417	33	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234388	10.1371/journal.pone.0234388	http://dx.doi.org/10.1371/journal.pone.0234388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555664	Green Published, gold			2022-12-27	WOS:000543273200080
J	Ribeiro, HMN; Civiero, M; Kebreab, E				Ribeiro-Filho, Henrique M. N.; Civiero, Mauricio; Kebreab, Ermias			Potential to reduce greenhouse gas emissions through different dairy cattle systems in subtropical regions	PLOS ONE			English	Article							SPECIAL TOPICS-MITIGATION; NITROUS-OXIDE EMISSIONS; ENTERIC METHANE EMISSIONS; LIFE-CYCLE ASSESSMENT; TOTAL MIXED RATION; CARBON FOOTPRINT; MILK-PRODUCTION; ENVIRONMENTAL IMPACTS; CLIMATE-CHANGE; FARM SYSTEMS	Carbon (C) footprint of dairy production, expressed in kg C dioxide (CO2) equivalents (CO(2)e) (kg energy-corrected milk (ECM))(-1), encompasses emissions from feed production, diet management and total product output. The proportion of pasture on diets may affect all these factors, mainly in subtropical climate zones, where cows may access tropical and temperate pastures during warm and cold seasons, respectively. The aim of the study was to assess the C footprint of a dairy system with annual tropical and temperate pastures in a subtropical region. The system boundary included all processes up to the animal farm gate. Feed requirement during the entire life of each cow was based on data recorded from Holstein x Jersey cow herds producing an average of 7,000 kg ECM lactation(-1). The milk production response as consequence of feed strategies (scenarios) was based on results from two experiments (warm and cold seasons) using lactating cows from the same herd. Three scenarios were evaluated: total mixed ration (TMR)ad libitumintake, 75, and 50% ofad libitumTMR intake with access to grazing either a tropical or temperate pasture during lactation periods. Considering IPCC and international literature values to estimate emissions from urine/dung, feed production and electricity, the C footprint was similar between scenarios, averaging 1.06 kg CO(2)e (kg ECM)(-1). Considering factors from studies conducted in subtropical conditions and actual inputs for on-farm feed production, the C footprint decreased 0.04 kg CO(2)e (kg ECM)(-1)in scenarios including pastures compared toad libitumTMR. Regardless of factors considered, emissions from feed production decreased as the proportion of pasture went up. In conclusion, decreasing TMR intake and including pastures in dairy cow diets in subtropical conditions have the potential to maintain or reduce the C footprint to a small extent.	[Ribeiro-Filho, Henrique M. N.; Kebreab, Ermias] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Ribeiro-Filho, Henrique M. N.; Civiero, Mauricio] Univ Estado Santa Catarina, Programa Posgrad Ciencia Anim, Lages, SC, Brazil	University of California System; University of California Davis; Universidade do Estado de Santa Catarina	Ribeiro, HMN (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.; Ribeiro, HMN (corresponding author), Univ Estado Santa Catarina, Programa Posgrad Ciencia Anim, Lages, SC, Brazil.	henrique.ribeiro@udesc.br	Ribeiro-Filho, Henrique/D-1178-2014	Ribeiro-Filho, Henrique/0000-0002-4455-6866	Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior - Brazil (CAPES) [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq) [403754/2016-0]; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) [TR 584 2019]	Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior - Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC)(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	HRF Grant number (Finance code) 001, Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior - Brazil (CAPES) https://www.capes.gov.br; Grant number 403754/2016-0, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq) http://www.cnpq.br; Grant number TR 584 2019, Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) http://www.fapesc.sc.gov.br.The funders had no role in study design, ata collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JGR, 2020, ANIMAL, V14, P1184, DOI 10.1017/S1751731119003057; [Anonymous], 2006, 14044 ISO, V2006, P46; [Anonymous], 2016, ENV PERF LARG RUM SU; Baek CY, 2014, J CLEAN PROD, V70, P50, DOI 10.1016/j.jclepro.2014.02.010; Bargo F, 2002, J DAIRY SCI, V85, P2948, DOI 10.3168/jds.S0022-0302(02)74381-6; Barros MV, 2018, ENERGIES, V11, DOI 10.3390/en11061412; Scaravelli Luciene Fernanda Barros, 2007, Cienc. Rural, V37, P841, DOI 10.1590/S0103-84782007000300037; Boddey RM, 2010, GLOBAL CHANGE BIOL, V16, P784, DOI 10.1111/j.1365-2486.2009.02020.x; Camargo GGT, 2013, BIOSCIENCE, V63, P263, DOI 10.1525/bio.2013.63.4.6; Chobtang J, 2017, J IND ECOL, V21, P1139, DOI 10.1111/jiec.12484; Civiero M, 2019, 7 GREENH GAS AN AGR, P141; Clark CEF, 2018, J DAIRY SCI, V101, P5454, DOI 10.3168/jds.2017-13388; Dall-Orsoletta AC, 2019, ANIM FEED SCI TECH, V253, P65, DOI 10.1016/j.anifeedsci.2019.05.009; Dall-Orsoletta AC, 2016, J DAIRY SCI, V99, P4374, DOI 10.3168/jds.2015-10396; de Leis CM, 2015, INT J LIFE CYCLE ASS, V20, P46, DOI 10.1007/s11367-014-0813-3; Delagarde R, 2011, GRASS FORAGE SCI, V66, P45, DOI 10.1111/j.1365-2494.2010.00770.x; Dickhoefer U, 2018, LIVEST SCI, V216, P109, DOI 10.1016/j.livsci.2018.08.004; Duchini PG, 2016, CROP PASTURE SCI, V67, P574, DOI 10.1071/CP15170; Eggleston H.S., 2006, IPCC GUIDLINES NATL; Eugene M, 2019, J ENVIRON MANAGE, V231, P982, DOI 10.1016/j.jenvman.2018.10.086; FAOSTAT, 2017, US; Fernandes HC, 2008, CIENC AGROTEC, V32, P1582, DOI 10.1590/S1413-70542008000500034; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Garg MR, 2016, ANIM PROD SCI, V56, P423, DOI 10.1071/AN15464; Gollnow S, 2014, INT DAIRY J, V37, P31, DOI 10.1016/j.idairyj.2014.02.005; Herrero M, 2016, NAT CLIM CHANGE, V6, P452, DOI [10.1038/nclimate2925, 10.1038/NCLIMATE2925]; Herzog A, 2018, AGR ECOSYST ENVIRON, V267, P174, DOI 10.1016/j.agee.2018.07.029; Hristov AN, 2013, J ANIM SCI, V91, P5045, DOI 10.2527/jas.2013-6583; Hristov AN, 2013, J ANIM SCI, V91, P5095, DOI 10.2527/jas.2013-6585; INRA, 2007, AL BOV OV CAPR BES A; IPCC, 2019, FOOD SECUR; IPCC, 2014, AR5 SYNTH REP CLIM C; Jayasundara S, 2019, J CLEAN PROD, V229, P1018, DOI 10.1016/j.jclepro.2019.04.013; da Silva MSJ, 2015, REV BRAS ZOOTECN, V44, P303, DOI 10.1590/S1806-92902015000900001; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Ledgard SF, 2019, AGR WATER MANAGE, V213, P155, DOI 10.1016/j.agwat.2018.10.009; Lizarralde C., 2014, SUSTAIN AGR RES, V3, P1, DOI [10.5539/sar.v3n2p1, DOI 10.5539/SAR.V3N2P1, DOI 10.5539/sar.v3n2p1]; Lorenz H, 2019, J CLEAN PROD, V211, P161, DOI 10.1016/j.jclepro.2018.11.113; Ludington D, 2003, NEW YORK STATE ENERG; Ma BL, 2012, NUTR CYCL AGROECOSYS, V94, P15, DOI 10.1007/s10705-012-9522-0; McConkey B. G., 2014, CANADIAN AGR GREENHO; Mendoza A, 2016, J DAIRY SCI, V99, P1938, DOI 10.3168/jds.2015-10257; Montes F, 2013, J ANIM SCI, V91, P5070, DOI 10.2527/jas.2013-6584; Mostert PF, 2018, AGR SYST, V167, P206, DOI 10.1016/j.agsy.2018.09.006; Mostert PF, 2018, J CLEAN PROD, V171, P773, DOI 10.1016/j.jclepro.2017.10.019; Naranjo A, 2020, J DAIRY SCI, V103, P3760, DOI 10.3168/jds.2019-16576; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Niu M, 2016, ANIM PROD SCI, V56, P312, DOI 10.1071/AN15498; Niu M, 2018, GLOBAL CHANGE BIOL, V24, P3368, DOI 10.1111/gcb.14094; Noizere P, 2018, INRA FEEDING SYSTEM, DOI [10.3920/978-90-8686-872-8, DOI 10.3920/978-90-8686-872-8]; O'Brien D, 2016, ANIM PROD SCI, V56, P495, DOI 10.1071/AN15490; O'Brien D, 2014, J DAIRY SCI, V97, P1835, DOI 10.3168/jds.2013-7174; O'Brien D, 2014, INT J LIFE CYCLE ASS, V19, P1469, DOI 10.1007/s11367-014-0755-9; O'Brien D, 2012, AGR SYST, V107, P33, DOI 10.1016/j.agsy.2011.11.004; Pirlo G, 2019, J CLEAN PROD, V211, P962, DOI 10.1016/j.jclepro.2018.11.070; Ramalho B, 2020, EUR J SOIL SCI, V71, P1106, DOI 10.1111/ejss.12933; Raucci GS, 2015, J CLEAN PROD, V96, P418, DOI 10.1016/j.jclepro.2014.02.064; Reed KF, 2015, J DAIRY SCI, V98, P3025, DOI 10.3168/jds.2014-8397; Rivera-Ferre MG, 2016, WIRES CLIM CHANGE, V7, P869, DOI 10.1002/wcc.421; Rotz CA, 2010, J DAIRY SCI, V93, P1266, DOI 10.3168/jds.2009-2162; Salou T, 2017, J CLEAN PROD, V140, P445, DOI 10.1016/j.jclepro.2016.05.019; Sbrissia AF, 2018, CROP SCI, V58, P945, DOI 10.2135/cropsci2017.07.0447; Schwab CG, 2017, J DAIRY SCI, V100, P10094, DOI 10.3168/jds.2017-13320; Simon PL, 2018, AGR ECOSYST ENVIRON, V267, P74, DOI 10.1016/j.agee.2018.08.013; Sordi A, 2014, AGR ECOSYST ENVIRON, V190, P94, DOI 10.1016/j.agee.2013.09.004; SOU, 2006, STATENS OFFENTLIGA U, V2006, P1, DOI DOI 10.1109/EC0C.2006.4801430; Thoma G, 2013, INT DAIRY J, V31, pS41, DOI 10.1016/j.idairyj.2012.08.012; van Zanten HHE, 2016, INT J LIFE CYCLE ASS, V21, P747, DOI 10.1007/s11367-015-0944-1; Vibart RE, 2008, J DAIRY RES, V75, P471, DOI 10.1017/S0022029908003361; Vogeler I, 2016, SCI TOTAL ENVIRON, V565, P564, DOI 10.1016/j.scitotenv.2016.05.006; Waghorn GC, 2019, ANIM PROD SCI, V59, P1261, DOI [10.1071/AN18018, 10.1071/an18018]; Wales WJ, 2013, ANIM PROD SCI, V53, P1167, DOI 10.1071/AN13207; Wang MQ, 2007, GREET 1 8A SPREADSHE; Wang XQ, 2018, SCI TOTAL ENVIRON, V625, P486, DOI 10.1016/j.scitotenv.2017.12.259; Wilkinson JM, 2020, GRASS FORAGE SCI, V75, P1, DOI 10.1111/gfs.12458; Williams SRO, 2014, INT J LIFE CYCLE ASS, V19, P69, DOI 10.1007/s11367-013-0619-8	76	6	6	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234687	10.1371/journal.pone.0234687	http://dx.doi.org/10.1371/journal.pone.0234687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555654	gold, Green Published			2022-12-27	WOS:000543273200027
J	Kogure, A; Naito, Y; Yamamoto, Y; Yashiro, M; Kiyono, T; Yanagihara, K; Hirakawa, K; Ochiya, T				Kogure, Akiko; Naito, Yutaka; Yamamoto, Yusuke; Yashiro, Masakazu; Kiyono, Tohru; Yanagihara, Kazuyoshi; Hirakawa, Kosei; Ochiya, Takahiro			Cancer cells with high-metastatic potential promote a glycolytic shift in activated fibroblasts	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; AEROBIC GLYCOLYSIS; METABOLISM; GROWTH; MYOFIBROBLASTS; BIOLOGY; STROMA	Cancer-associated fibroblasts (CAFs) are activated fibroblasts and are the major stromal component in various types of malignancies. CAFs often undergo metabolic reprogramming to create an appropriate microenvironment for cancer progression. However, it remains unclear whether the metastatic properties of cancer cells affect aerobic glycolysis in stromal cells. Here, we show that gastric cancer (GC) cells with high metastatic potential strongly promote the metabolic switch from oxidative phosphorylation to aerobic glycolysis in fibroblasts. Transcriptome analysis showed that the expression of glycolysis-related genes, such as LDHA and ENO2, significantly changed in fibroblasts when they were cocultured with cancer cells with high metastatic potential compared to fibroblasts incubated with cancer cells with low metastatic potential. Glucose uptake, lactate production and oxygen consumption in fibroblasts were changed by coculture with GC cells with high metastatic potential. Thus, metabolic reprogramming in CAFs may reflect the metastatic properties of GC cells.	[Kogure, Akiko; Ochiya, Takahiro] Tokyo Med Univ, Inst Med Sci, Dept Mol & Cellular Med, Tokyo, Japan; [Naito, Yutaka] Francis Crick Inst, Tumor Cell Biol Lab, London, England; [Yamamoto, Yusuke] Natl Canc Ctr, Div Cellular Signaling, Tokyo, Japan; [Yashiro, Masakazu; Hirakawa, Kosei] Osaka City Univ, Mol Oncol & Therapeut, Grad Sch Med, Osaka, Japan; [Kiyono, Tohru] Natl Canc Ctr, Div Carcinogenesis & Canc Prevent, Tokyo, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Biomarker Discovery, Tokyo, Japan	Tokyo Medical University; Francis Crick Institute; National Cancer Center - Japan; Osaka Metropolitan University; National Cancer Center - Japan; National Cancer Center - Japan	Ochiya, T (corresponding author), Tokyo Med Univ, Inst Med Sci, Dept Mol & Cellular Med, Tokyo, Japan.	tochiya@tokyo-med.ac.jp	Asada, Akiko/ABF-7324-2020		JSPS KAKENHI [15K21646, 17H04991, 17K19625]; Japan Agency for Medical Research and Developmentfrom, AMED [16ae0101011h0003]; JSPS [15J10473];  [16cm0106402h0001]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Developmentfrom, AMED; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported by JSPS KAKENHI Grant Number 15K21646, 17H04991 and 17K19625, and JSPS Fellows 15J10473 and in part by a Grant-in-Aid for the Project for Cancer Research And Therapeutic Evolution (P-CREATE, Grant Number 16cm0106402h0001) and the Project focused on developing key technology for discovering and manufacturing drugs for nextgeneration treatment and diagnosis (Grant Number 16ae0101011h0003) from the Japan Agency for Medical Research and Developmentfrom, AMED.	Belli C, 2018, CANCER TREAT REV, V65, P22, DOI 10.1016/j.ctrv.2018.02.004; Chen F, 2019, NAT CELL BIOL, V21, P498, DOI 10.1038/s41556-019-0299-0; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fiaschi T, 2012, CANCER RES, V72, P5130, DOI 10.1158/0008-5472.CAN-12-1949; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Givel AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03348-z; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Naito Y, 2019, ONCOGENE, V38, P5566, DOI 10.1038/s41388-019-0832-4; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Ramamonjisoa N, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00003; Raz Y, 2018, J EXP MED, V215, P3075, DOI 10.1084/jem.20180818; Roswall P, 2018, NAT MED, V24, P463, DOI 10.1038/nm.4494; Sounni NE, 2013, CLIN CHEM, V59, P85, DOI 10.1373/clinchem.2012.185363; Vaughan RA, 2013, INT J CANCER, V133, P2504, DOI 10.1002/ijc.28264; Vaughan RA, 2013, PROSTATE, V73, P1538, DOI 10.1002/pros.22703; Yan W, 2018, NAT CELL BIOL, V20, P597, DOI 10.1038/s41556-018-0083-6; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; Zhang DX, 2015, CELL REP, V10, P1335, DOI 10.1016/j.celrep.2015.02.006; Zhao HY, 2016, ELIFE, V5, DOI 10.7554/eLife.10250	24	6	6	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234613	10.1371/journal.pone.0234613	http://dx.doi.org/10.1371/journal.pone.0234613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555715	Green Published, gold			2022-12-27	WOS:000542759600033
J	Alva, ML				Alva, Maria L.			Co-occurrence of diabetes and depression in the US	PLOS ONE			English	Article								Evidence exists that depression interacts with physical illness to amplify the impact of chronic conditions like diabetes. The co-occurrence of these two conditions leads to worse health outcomes and higher healthcare costs. This study seeks to understand what demographic and socio-economic indicators can be used to predict co-occurrence at both the state and the individual level. Diabetes and depression are modeled as a bivariate normal distribution using data from the Behavioral Risk Factor Surveillance System 2016-2017 cohorts. The tetrachoric (latent) correlation between diabetes and depression is 17.2% and statistically significant, however the likelihood of any person being diagnosed with both conditions is small-as high as 4.3% (Arizona) and as low as 2.3% (Utah). We find that demographic characteristics (sex, age, and race) operate in opposite directions in predicting diabetes and depression diagnosis. Behavioral indicators (BMI >= 30, smoking, and exercise); and life outcomes, (schooling attainment, marital and veteran status) work in the same direction to produce co-occurrence and as such are more powerful predictors of co-occurrence than demographic characteristics. It is important to have a rapid and efficient instrument to diagnoses co-occurrence. Simple questions about lifestyle choices, educational attainment and family life could help bridge the gap between primary care and psychological services with beneficial spillovers for patient-doctor communication.	[Alva, Maria L.] Georgetown Univ, Mass Data Inst, Washington, DC 20057 USA	Georgetown University	Alva, ML (corresponding author), Georgetown Univ, Mass Data Inst, Washington, DC 20057 USA.	mla72@georgetown.edu		Alva, Maria/0000-0003-0989-2730				Anderson R, 2001, DIABETES CARE, V24, P6; [Anonymous], 2017, JLSRF, V3, pA104; Anonymous, 2005, RESUSCITATION SUPPL, V67, pS3; [Anonymous], 2016, INT J ORAL MAXILLO S, V31, ps198; [Anonymous], 1997, DIABETES CARE; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Centers for Disease Control and Prevention, 2017, EST DIAB ITS BURD US; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Dorgan J.F., 2010, BREAST CANC RES, V12, pR98; Frasure-Smith N, 1993, JAMA, V270; Jaffe D.J, FUNDS TREATING INDIV; KENT A, 1995, HUM RIGHTS QUART, V17, P1, DOI 10.1353/hrq.1995.0008; Kessler R.C., 2003, J OCCUP ENV MED, V45; Mulvaney-Day N, 2018, J GEN INTERN MED, V33, P335, DOI 10.1007/s11606-017-4181-0; National Center for Health Statistics, PREVALENCE DEPRESSIO; STATA, STATA REL 15; The American Dental Association, STAT DIAB; The Lancet HIV, 2016, LANCET HIV, V3, pe191; The US Preventive Services Task Force (USPSTF), 2016, JAMA, V315	19	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234718	10.1371/journal.pone.0234718	http://dx.doi.org/10.1371/journal.pone.0234718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584823	Green Published, gold			2022-12-27	WOS:000545747200015
J	Angrimani, DSR; Francischini, MCP; Brito, MM; Vannucchi, CI				Angrimani, Daniel S. R.; Francischini, Maria Claudia P.; Brito, Maira M.; Vannucchi, Camila I.			Prostatic hyperplasia: Vascularization, hemodynamic and hormonal analysis of dogs treated with finasteride or orchiectomy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BLOOD-FLOW; 5-ALPHA-REDUCTASE INHIBITOR; RELATIVE QUANTIFICATION; VENTRAL PROSTATE; GLAND; EXPRESSION; VEGF; TESTOSTERONE; MODEL	As a consequence of a hormonal imbalance, Prostatic Hyperplasia (PH) is characterized by increased prostate volume, along with higher local angiogenesis and vascularization. Orchiectomy is the common treatment for dogs, however it is not an option for breeding animals. Thus, finasteride arises as the drug of choice for stud dogs. Therefore, the aim of this study was to evaluate the effects of orchiectomy or finasteride therapies on hormonal and vascular dynamics of PH dogs. Fifteen dogs, aged 6-13 years were assigned to: Untreated Group (dogs diagnosed with PH-n = 5), Finasteride treated group (PH dogs treated with finasteride-n = 5) and Orchiectomy treated group (PH dogs submitted to orchiectomy-n = 5). Evaluations were performed in a monthly interval (first day of treatment; after 30 and 60 days). Doppler ultrasonography was performed to measure prostatic volume, vascularization and hemodynamic profile of prostatic artery. Dihydrotestosterone, estrogen and testosterone concentrations were measured. At day 60, prostatic biopsy was performed for histological, immunohistochemical and qPCR analysis forVEGF-Aexpression. At day 60, vascularization score was higher in untreated compared to treated groups (finasteride and orchiectomy). Furthermore,VEGF-Aexpression was lower in the Orchiectomy Treated Group, but VEGF-A was immunohistochemically lower in both treated groups (finasteride and orchiectomy) compared to the Untreated Group. The efficiency of finasteride treatment in reducing clinical signs, prostate volume and vascularization appears to be similar to orchiectomy. In conclusion, both PH medical and surgical therapy lead to reduction in prostate dimension andVEGF-Aexpression and, consequently, lower local vascularization. However, orchiectomy promotes marked hormonal changes, which ultimately lead to prostate atrophy.	[Angrimani, Daniel S. R.; Francischini, Maria Claudia P.; Brito, Maira M.; Vannucchi, Camila I.] Univ Sao Paulo, Fac Vet Med, Dept Anim Reprod, Sao Paulo, Brazil	Universidade de Sao Paulo	Vannucchi, CI (corresponding author), Univ Sao Paulo, Fac Vet Med, Dept Anim Reprod, Sao Paulo, Brazil.	cacavann@usp.br		Brito, Maira/0000-0002-0351-3069	Sao Paulo Research Foundation [FAPESP 2015/05419-5 DSRA, FAPESP 2013/25966-5]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	CIV granted by Sao Paulo Research Foundation (http://www.fapesp.br/en/) - FAPESP 2015/05419-5 DSRA granted by Sao Paulo Research Foundation (http://www.fapesp.br/en/) - FAPESP 2013/25966-5 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dissi AN, 2010, CAN VET J, V51, P1109; Amory JK, 2007, J CLIN ENDOCR METAB, V92, P1659, DOI 10.1210/jc.2006-2203; Angrimani DSR, 2018, THERIOGENOLOGY, V114, P103, DOI 10.1016/j.theriogenology.2018.03.031; Angrimani DSR, 2016, 8 INT S PAR CAN FEL, P7; Atalan G, 1999, J SMALL ANIM PRACT, V40, P119, DOI 10.1111/j.1748-5827.1999.tb03052.x; BAMBERGTHALEN B, 1993, J AM ANIM HOSP ASSOC, V29, P221; BARSANTI JA, 1986, VET CLIN N AM-SMALL, V16, P587, DOI 10.1016/S0195-5616(86)50063-2; Bauman TM, 2014, PROSTATE, V74, P923, DOI 10.1002/pros.22810; BERRY SJ, 1986, PROSTATE, V9, P363, DOI 10.1002/pros.2990090406; BRENDLER CB, 1983, J CLIN INVEST, V71, P1114, DOI 10.1172/JCI110861; Buttyan R, 2000, Curr Opin Urol, V10, P415, DOI 10.1097/00042307-200009000-00009; Carson C, 2003, UROLOGY, V61, P2, DOI 10.1016/S0090-4295(03)00045-1; Chen HL, 2004, ENDOCRINOLOGY, V145, P4441, DOI 10.1210/en.2004-0639; Cheng L, 2004, ANTICANCER RES, V24, P2135; Chevalier S, 2002, MOL CELL ENDOCRINOL, V189, P169, DOI 10.1016/S0303-7207(01)00728-6; COCHRAN RC, 1981, INVEST UROL, V19, P142; COHEN SM, 1995, PROSTATE, V26, P55, DOI 10.1002/pros.2990260202; de Matos LL, 2010, BIOMARK INSIGHTS, V5, P9; Eisermann K, 2017, CANCERS, V9, DOI 10.3390/cancers9040032; Ghafar Mohamed A, 2002, Curr Urol Rep, V3, P292, DOI 10.1007/s11934-002-0051-2; Giantin M, 2012, J COMP PATHOL, V147, P419, DOI 10.1016/j.jcpa.2012.01.011; Gilmore KM, 2015, EXP GERONTOL, V71, P14, DOI 10.1016/j.exger.2015.08.008; Gobello C, 2006, THERIOGENOLOGY, V66, P1560, DOI 10.1016/j.theriogenology.2006.02.005; Gunzel-Apel AR, 2001, REPROD DOMEST ANIM, V36, P236, DOI 10.1046/j.1439-0531.2001.00288.x; HAGER DA, 1985, VET RADIOLOGY, V26, P82, DOI 10.1111/j.1740-8261.1985.tb01388.x; Haggstrom S, 2002, SCAND J UROL NEPHROL, V36, P182; Holak P, 2010, POL J VET SCI, V13, P765, DOI 10.2478/v10181-010-0024-1; IguerOuada M, 1997, J REPROD FERTIL, P139; Johnston SD, 2000, ANIM REPROD SCI, V60, P405, DOI 10.1016/S0378-4320(00)00101-9; JUNIEWICZ PE, 1993, ENDOCRINOLOGY, V133, P904, DOI 10.1210/en.133.2.904; Kamolpatana K, 1998, AM J VET RES, V59, P762; Kaplan SA, 2001, UROLOGY, V58, P65, DOI 10.1016/S0090-4295(01)01347-4; Kawakami E, 2001, J VET MED SCI, V63, P407, DOI 10.1292/jvms.63.407; LAROQUE PA, 1995, PROSTATE, V27, P121, DOI 10.1002/pros.2990270302; LAROQUE PA, 1994, PROSTATE, V24, P93, DOI 10.1002/pros.2990240207; Lekas E, 1997, UROL RES, V25, P309, DOI 10.1007/BF01294656; Veiga GAL, 2017, BIOL REPROD, V96, P58, DOI 10.1095/biolreprod.116.140780; Opoku-Acheampong AB, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00360; Palmieri C, 2019, J COMP PATHOL, V171, P30, DOI 10.1016/j.jcpa.2019.07.005; Pareek G, 2003, J UROLOGY, V169, P20, DOI 10.1016/S0022-5347(05)64025-6; Parsons JK, 2012, EUR UROL, V62, P234, DOI 10.1016/j.eururo.2012.03.007; Pasikowska J, 2015, REPROD DOMEST ANIM, V50, P776, DOI 10.1111/rda.12587; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polisca A, 2016, THERIOGENOLOGY, V85, P835, DOI 10.1016/j.theriogenology.2015.10.030; Polisca A, 2013, REPROD DOMEST ANIM, V48, P673, DOI 10.1111/rda.12143; Qiu CW, 2008, VET RES COMMUN, V32, P463, DOI 10.1007/s11259-008-9049-7; RIFKIN MD, 1993, RADIOLOGY, V186, P509, DOI 10.1148/radiology.186.2.7678467; Santos A, 2016, VET COMP ONCOL, V14, pE83, DOI 10.1111/vco.12107; Shabsigh A, 1998, PROSTATE, V36, P201, DOI 10.1002/(SICI)1097-0045(19980801)36:3<201::AID-PROS9>3.0.CO;2-J; Shidaifat F, 2007, ENDOCR J, V54, P521, DOI 10.1507/endocrj.K07-009; Smith J, 2008, THERIOGENOLOGY, V70, P375, DOI 10.1016/j.theriogenology.2008.04.039; Stachon A, 2009, GROWTH FACTORS, V27, P71, DOI 10.1080/08977190802709619; Stefanov M, 2004, MICROSC RES TECHNIQ, V63, P188, DOI 10.1002/jemt.20028; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; Teske E, 2002, MOL CELL ENDOCRINOL, V197, P251, DOI 10.1016/S0303-7207(02)00261-7; Walsh K, 2002, PROSTATE CANCER P D, V5, P119, DOI 10.1038/sj.pcan.4500575; White RAS, 2000, CLIN TECH SMALL AN P, V15, P46, DOI 10.1053/svms.2000.7304; Wolf K, 2012, REPROD DOMEST ANIM, V47, P243, DOI 10.1111/rda.12083; Zelli R, 2013, REPROD DOMEST ANIM, V48, P768, DOI 10.1111/rda.12159	59	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234714	10.1371/journal.pone.0234714	http://dx.doi.org/10.1371/journal.pone.0234714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584842	Green Published, gold			2022-12-27	WOS:000545747200003
J	Bertoni, L; Jacquet-Guibon, S; Branly, T; Legendre, F; Desance, M; Mespoulhes, C; Melin, M; Hartmann, DJ; Schmutz, A; Denoix, JM; Galera, P; Demoor, M; Audigie, F				Bertoni, Lelia; Jacquet-Guibon, Sandrine; Branly, Thomas; Legendre, Florence; Desance, Melanie; Mespoulhes, Celine; Melin, Martine; Hartmann, Daniel-Jean; Schmutz, Amandine; Denoix, Jean-Marie; Galera, Philippe; Demoor, Magali; Audigie, Fabrice			An experimentally induced osteoarthritis model in horses performed on both metacarpophalangeal and metatarsophalangeal joints: Technical, clinical, imaging, biochemical, macroscopic and microscopic characterization	PLOS ONE			English	Article							POSTTRAUMATIC OSTEOARTHRITIS; SYNOVIAL-FLUID; COMPUTED-TOMOGRAPHY; SUBCHONDRAL BONE; EQUINE; EXERCISE; HISTOPATHOLOGY; PREVALENCE; BIOMARKERS; FRACTURES	Osteoarthritis is a common cause of pain and economic loss in both humans and horses. The horse is recognized as a suitable model for human osteoarthritis, because the thickness, structure, and mechanical properties of equine articular cartilage are highly comparable to those of humans. Although a number of equine experimental osteoarthritis models have been described in the literature, these cases generally involve the induction of osteoarthritis in just one joint of each animal. This approach necessitates the involvement of large numbers of horses to obtain reliable data and thus limits the use of this animal model, for both economic and ethical reasons. This study adapts an established equine model of post-traumatic osteoarthritis to induce osteoarthritis-associated lesions in all 4 fetlock joints of the same horse in order to reduce the number of animals involved and avoid individual variability, thus obtaining a more reliable method to evaluate treatment efficacy in future studies. The objectives are to assess the feasibility of the procedure, evaluate variability of the lesions according to interindividual and operated-limb position and describe the spontaneous evolution of osteoarthritis-associated pathological changes over a twelve-week period. The procedure was well tolerated by all 8 experimental horses and successfully induced mild osteoarthritis-associated changes in the four fetlock joints of each horse. Observations were carried out using clinical, radiographic, ultrasonographic, and magnetic resonance imaging methods as well as biochemical analyses of synovial fluid and postmortem microscopic and macroscopic evaluations of the joints. No significant differences were found in the progression of osteoarthritis-associated changes between horses or between the different limbs, with the exception of higher synovial effusion in hind fetlocks compared to front fetlocks and higher radiographic scores for left fetlocks compared to the right. This model thus appears to be a reliable means to evaluate the efficacy of new treatments in horses, and may be of interest for translational studies in human medicine.	[Bertoni, Lelia; Jacquet-Guibon, Sandrine; Denoix, Jean-Marie; Audigie, Fabrice] Ecole Natl Vet Alfort, INRA, BPLC, CIRALE,USC 957, Maisons Alfort, France; [Branly, Thomas; Legendre, Florence; Desance, Melanie; Galera, Philippe; Demoor, Magali] NORMANDIE UNIV, UNICAEN, BIOTARGEN, Caen, France; [Mespoulhes, Celine] UPEC, Ecole Natl Vet Alfort, Equine Clin, Maisons Alfort, France; [Melin, Martine; Hartmann, Daniel-Jean] NOVOTEC, ZAC Chene, Europarc, Bron, France; [Schmutz, Amandine] Ecole Natl Vet Alfort, CWD VetLab, USC 957, BPLC,INRA, Maisons Alfort, France	Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Universite de Caen Normandie; Ecole Nationale Veterinaire d'Alfort (ENVA); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE	Bertoni, L (corresponding author), Ecole Natl Vet Alfort, INRA, BPLC, CIRALE,USC 957, Maisons Alfort, France.	lelia.bertoni@vet-alfort.fr		Bertoni, Lelia/0000-0001-6367-3040; legendre, florence/0000-0002-9951-1585	ERDF (European Regional Development Funds) [2897/33535, 917RB148, HIPPOCART 917CB174]; Normandy County Council program [2013-AGRI-236/13P07492, 917CB166]; GIS CENTAUREequine research (EQUISTEM-G program) [014CJ061]; Normandy County Council through the ANR TecSan PROMOCART program [917RB020, 917RB072]; French Ministry of Research and Technology; CENTAURE European project; European Union; Normandy County Council; Fonds Eperon [N80-2014, 917CB194]; French National Research Agency (ANR)	ERDF (European Regional Development Funds)(European Commission); Normandy County Council program; GIS CENTAUREequine research (EQUISTEM-G program); Normandy County Council through the ANR TecSan PROMOCART program(French National Research Agency (ANR)); French Ministry of Research and Technology; CENTAURE European project; European Union(European Commission); Normandy County Council; Fonds Eperon; French National Research Agency (ANR)(French National Research Agency (ANR))	This research was funded by ERDF (European Regional Development Funds) grants to SJ, FA, PG and M. Demoor (HIPPOCART 1 no. 2897/33535, 917RB148; HIPPOCART 917CB174), by a Normandy County Council program to SJ, FA, PG and M. Demoor (HIPPOCART No 2013-AGRI-236/13P07492, 917CB166), by Fonds Eperon to SJ, FA, PG and M. Demoor (EQUISTEM, N80-2014, 917CB194), by the GIS CENTAUREequine research (EQUISTEM-G program to PG, 014CJ061), by the French National Research Agency (ANR) and by Normandy County Council through the ANR TecSan PROMOCART program to PG (917RB020 and 917RB072 respectively), by the French Ministry of Research and Technology to PG, by CENTAURE European project co-founded by Normandy County Council, European Union in the framework of the ERDFESF operational programe 2014-2020. M. Desance was the recipient of a PhD fellowship from the Normandy County Council. TB was supported by a PhD scholarship from the French Ministry of Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. They provided support in the form of salaries (technicians, PhD students), operating costs and materials.	American Association of Equine Practitioners (AAEP), 1991, GUIDE VET SERVICE JU; Bertone AL, 2001, VET SURG, V30, P528, DOI 10.1053/jvet.2001.28430; Bertoni L, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/9431894; Blum A, 2009, J RADIOL, V90, P1789, DOI 10.1016/S0221-0363(09)73586-3; Boyce MK, 2013, OSTEOARTHR CARTILAGE, V21, P746, DOI 10.1016/j.joca.2013.02.653; Broeckx SY, 2019, AM J VET RES, V80, P246, DOI 10.2460/ajvr.80.3.246; Chateau H, 2002, VET RES, V33, P371, DOI 10.1051/vetres:2002023; Christgau S, 2001, BONE, V29, P209, DOI 10.1016/S8756-3282(01)00504-X; Cruz AM, 2008, VET CLIN N AM-EQUINE, V24, P101, DOI 10.1016/j.cveq.2007.12.001; Denoix J. M., 2004, Equine sports medicine and surgery: basic and clinical sciences of the equine athlete, P161, DOI 10.1016/B978-0-7020-2671-3.50014-3; Denoix JM, 1996, EQUINE VET J, V28, P54, DOI 10.1111/j.2042-3306.1996.tb01590.x; Denoix JM, 1998, EQUINE DIAGNOSTIC ULTRASONOGRAPHY, P475; FOLAND JW, 1994, VET SURG, V23, P369, DOI 10.1111/j.1532-950X.1994.tb00497.x; Frisbie DD, 2008, OSTEOARTHR CARTILAGE, V16, P1196, DOI 10.1016/j.joca.2008.03.008; Gregory MH, 2012, ARTHRITIS, DOI 10.1155/2012/764621; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kawcak CE, 2008, OSTEOARTHR CARTILAGE, V16, P1519, DOI 10.1016/j.joca.2008.04.015; Kawcak CE, 2000, AM J VET RES, V61, P1252, DOI 10.2460/ajvr.2000.61.1252; KAWCAK CE, 1994, EQUINE VET J, V26, P392, DOI 10.1111/j.2042-3306.1994.tb04409.x; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Maninchedda U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115089; Marijnissen ACA, 2002, OSTEOARTHR CARTILAGE, V10, P145, DOI 10.1053/joca.2001.0491; Matyas JR, 2004, ARTHRITIS RHEUM-US, V50, P543, DOI 10.1002/art.20027; McIlwraith CW, 2012, BONE JOINT RES, V1, P297, DOI 10.1302/2046-3758.111.2000132; McIlwraith CW, 2010, OSTEOARTHR CARTILAGE, V18, pS93, DOI 10.1016/j.joca.2010.05.031; MCILWRAITH CW, 1982, J AM VET MED ASSOC, V180, P239; Nelson BB, 2018, EQUINE VET J, V50, P564, DOI 10.1111/evj.12808; Neundorf RH, 2010, AM J VET RES, V71, P1284, DOI 10.2460/ajvr.71.11.1284; NISHIJIMA T, 1981, Journal of the Japanese Orthopaedic Association, V55, P601; Oke S. L., 2010, Proceedings of the 56th Annual Convention of the American Association of Equine Practitioners, Baltimore, Maryland, USA, 4-8 December 2010, P12; Olive J, 2010, VET RADIOL ULTRASOUN, V51, P267, DOI 10.1111/j.1740-8261.2009.01653.x; Powell SE, 2012, EQUINE VET J, V44, P169, DOI 10.1111/j.2042-3306.2011.00389.x; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; RICHARDSON DW, 1993, AM J VET RES, V54, P449; Rickey EJ, 2012, AM J VET RES, V73, P1540, DOI 10.2460/ajvr.73.10.1540; Smith AD, 2014, OSTEOARTHR CARTILAGE, V22, pS285, DOI 10.1016/j.joca.2014.02.528; Smith AD, 2016, VET RADIOL ULTRASOUN, V57, P502, DOI 10.1111/vru.12369; Steel CM, 2008, VET CLIN N AM-EQUINE, V24, P437, DOI 10.1016/j.cveq.2008.05.004; Trumble TN, 2008, OSTEOARTHR CARTILAGE, V16, P779, DOI 10.1016/j.joca.2007.11.008; United States Department of Agriculture UAVSNHM, 2001, NAT EC COST EQ LAM C; YOVICH JV, 1986, J AM VET MED ASSOC, V188, P273	41	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235251	10.1371/journal.pone.0235251	http://dx.doi.org/10.1371/journal.pone.0235251			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584901	Green Published, gold			2022-12-27	WOS:000545747200022
J	Kawanishi, H; Ohashi, K; Ogawa, H; Otaka, N; Takikawa, T; Fang, LX; Ozaki, Y; Takefuji, M; Murohara, T; Ouchi, N				Kawanishi, Hiroshi; Ohashi, Koji; Ogawa, Hayato; Otaka, Naoya; Takikawa, Tomonobu; Fang, Lixin; Ozaki, Yuta; Takefuji, Mikito; Murohara, Toyoaki; Ouchi, Noriyuki			A novel selective PPAR alpha modulator, pemafibrate promotes ischemia-induced revascularization through the eNOS-dependent mechanisms	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; ADIPONECTIN STIMULATES ANGIOGENESIS; FOLLISTATIN-LIKE 1; FGF21; MUSCLE; TISSUE; PHOSPHORYLATION; INFLAMMATION; DEFICIENCY	Objective Cardiovascular disease is a leading cause of death worldwide. Obesity-related metabolic disorders including dyslipidemia cause impaired collateralization under ischemic conditions, thereby resulting in exacerbated cardiovascular dysfunction. Pemafibrate is a novel selective PPAR alpha modulator, which has been reported to improve atherogenic dyslipidemia, in particular, hypertriglyceridemia and low HDL-cholesterol. Here, we investigated whether pemafibrate modulates the revascularization process in a mouse model of hindlimb ischemia. Methods and results Male wild-type (WT) mice were randomly assigned to two groups, normal diet or pemafibrate admixture diet from the ages of 6 weeks. After 4 weeks, mice were subjected to unilateral hindlimb surgery to remove the left femoral artery and vein. Pemafibrate treatment enhanced blood flow recovery and capillary formation in ischemic limbs of mice, which was accompanied by enhanced phosphorylation of endothelial nitric oxide synthase (eNOS). Treatment of cultured endothelial cells with pemafibrate resulted in increased network formation and migratory activity, which were blocked by pretreatment with the NOS inhibitorN(G)-nitro-L-arginine methyl ester (L-NAME). Pemafibrate treatment also increased plasma levels of the PPAR alpha-regulated gene, fibroblast growth factor (FGF) 21 in WT mice. Systemic administration of adenoviral vectors expressing FGF21 (Ad-FGF21) to WT mice enhanced blood flow recovery, capillary density and eNOS phosphorylation in ischemic limbs. Treatment of cultured endothelial cells with FGF21 protein led to increases in endothelial cell network formation and migration, which were canceled by pretreatment with L-NAME. Furthermore, administration of pemafibrate or Ad-FGF21 had no effects on blood flow in ischemic limbs in eNOS-deficient mice. Conclusion These data suggest that pemafibrate can promote revascularization in response to ischemia, at least in part, through direct and FGF21-mediated modulation of endothelial cell function. Thus, pemafibrate could be a potentially beneficial drug for ischemic vascular disease.	[Kawanishi, Hiroshi; Ogawa, Hayato; Otaka, Naoya; Takikawa, Tomonobu; Fang, Lixin; Ozaki, Yuta; Takefuji, Mikito; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Med & Cardiol, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Ohashi, K; Ouchi, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Mol Med & Cardiol, Nagoya, Aichi, Japan.	ohashik@med.nagoya-u.ac.jp; nouchi@med.nagoya-u.ac.jp	Takefuji, Mikito/GXG-5982-2022	Ohashi, Koji/0000-0002-9666-026X	Takeda Science Foundation [2620H00571, 2617H04175, 2616K09512]; Suzuken Memorial Foundation [2600007594, 2600007051];  [2600007887]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; 	This work was supported by Grant-in-Aid for Scientific Research (2620H00571 to N.O., 2617H04175 to N.O., 2616K09512 to K.O.); grants from Takeda Science Foundation (2600007594 and 2600007051 to N.O); and a grant from the Suzuken Memorial Foundation (2600007887 to N.O.).	[Anonymous], 2010, AM J PHYSIOL-HEART C, V299, pH1633; Araki M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072148; Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; CATAPANO AL, 2016, ATHEROSCLEROSIS, V253, P281, DOI [DOI 10.1016/J.ATHER0SCLER0SIS.2016.08.018, 10.1093/eurheartj/ehw272]; Davidson MH, 2007, AM J CARDIOL, V99, p3C, DOI 10.1016/j.amjcard.2006.11.016; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Fruchart JC, 1999, CURR OPIN LIPIDOL, V10, P245, DOI 10.1097/00041433-199906000-00007; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hennuyer N, 2016, ATHEROSCLEROSIS, V249, P200, DOI 10.1016/j.atherosclerosis.2016.03.003; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Jimenez V, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708791; Joki Y, 2015, BIOCHEM BIOPH RES CO, V459, P124, DOI 10.1016/j.bbrc.2015.02.081; Katayama A, 2009, J CARDIOVASC PHARM, V54, P399, DOI 10.1097/FJC.0b013e3181bad05d; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Lewis JE, 2019, TRENDS ENDOCRIN MET, V30, P491, DOI 10.1016/j.tem.2019.05.007; Lin ZF, 2015, CIRCULATION, V131, P1861, DOI 10.1161/CIRCULATIONAHA.115.015308; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Luo ZY, 2000, J CLIN INVEST, V106, P493, DOI 10.1172/JCI9419; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Matsuba I, 2018, J DIABETES INVEST, V9, P1323, DOI 10.1111/jdi.12845; Miyake H, 2011, CIRC RES, V108, P1170, DOI 10.1161/CIRCRESAHA.110.236174; Murakami H, 2006, BIOCHEM BIOPH RES CO, V341, P973, DOI 10.1016/j.bbrc.2006.01.052; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Ohashi K, 2010, J BIOL CHEM, V285, P22291, DOI 10.1074/jbc.M110.123794; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Okayasu T, 2008, LIFE SCI, V82, P884, DOI 10.1016/j.lfs.2008.02.002; Okopien B, 2017, EXPERT REV CARDIOVAS, V15, P913, DOI 10.1080/14779072.2017.1408410; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Turhan H, 2005, CORONARY ARTERY DIS, V16, P281, DOI 10.1097/00019501-200508000-00004; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Yamashita S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225537; Yilmaz MB, 2003, INT J OBESITY, V27, P1541, DOI 10.1038/sj.ijo.0802474; Yokote K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030706	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235362	10.1371/journal.pone.0235362	http://dx.doi.org/10.1371/journal.pone.0235362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584895	gold, Green Published			2022-12-27	WOS:000545747200007
J	Li, Z; Xu, ZK; Liu, Q; Chen, XL; Li, LR				Li, Zhen; Xu, Zhike; Liu, Qiang; Chen, Xiaoli; Li, Linrui			Comparisons of retinal vessel density and glaucomatous parameters in optical coherence tomography angiography	PLOS ONE			English	Article							VISUAL-FIELD; BLOOD-FLOW; LAYER	Purpose To compare the retinal vessel density and glaucomatous parameters in primary angle closure glaucoma (PACG), to evaluate the diagnostic and monitoring abilities of the peripapillary and macular vessel density in the progression of glaucoma. Methods This was a observational, prospective and cross-sectional study. According to Glaucoma Staging System, 218 eyes (116 participants) were divided into 5 groups: no glaucoma, early glaucoma, moderate glaucoma, advance glaucoma, severe glaucoma. All participants underwent a comprehensive ocular examination, which included corrected distance visual acuity measurement, slit-lamp biomicroscopy, intra ocular pressure (IOP), gonioscopy, fundus examination, stereoscopic optic disc photography, Humphrey visual field test(VF), peripapillary and macular optical coherence tomography angiography(OCTA) scan. SPSS software was used to calculate and compare retinal vessel density (peripapillary vessel density, PVD and macular vessel density, MVD) and glaucomatous parameters (mean deviation (MD),pattern standard deviation(PSD), retinal nerve fiber layer (RNFL), ganglion cell-inner plexiform layer(GCIPL),rim area, average cup/disc(C/D) ratio). Results The GCIPL thickness, RNFL thickness, PVD and MVD are significantly reduced in PACG. There were significant differences in all measurements among the groups (P<0.01).Reduced peripapillary and macular vessel density in glaucoma were detected and a statistically significant correlation with glaucoma stages (P<0.01). In addition, the results of retinal vessel density, reduced RNFL thickness and GCIPL thickness were also statistically related to the stage of glaucoma. As expected, the rim area was significantly smaller with higher C/D area ratios in glaucomatous eyes corresponding to the severity of disease. Conclusions The changes of PVD and MVD had strongly positive correlation with GCIPL thickness and RNFL thickness, had negative correlation with the severity of glaucoma, which meant the more severe the glaucoma was, the lower PVD and MVD were. Compared to traditional glaucoma staging system judged by VF, the changes of PVD and MVD obtained by OCTA might be a new method to grade the stage of glaucoma. These findings theorize that the changes of PVD and MVD may be better facilitated for the observation and monitoring of glaucoma progression.	[Li, Zhen; Xu, Zhike; Liu, Qiang; Chen, Xiaoli; Li, Linrui] Peoples Hosp Leshan, Dept Ophthalmol, Leshan, Sichuan, Peoples R China		Li, Z (corresponding author), Peoples Hosp Leshan, Dept Ophthalmol, Leshan, Sichuan, Peoples R China.	lizhen81131@163.com			science and technology foundation of Sichuan provincial health and family planning commission [190065]	science and technology foundation of Sichuan provincial health and family planning commission	This study was supported by the science and technology foundation of Sichuan provincial health and family planning commission (NO: 190065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TORRENTIAL RAIN DISA, DOI DOI 10.3969/J.ISSN.1004-9045.2013.01.002; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Garway-Heath DF, 2013, OPHTHALMOLOGY, V120, P68, DOI 10.1016/j.ophtha.2012.07.028; Hwang JC, 2012, INVEST OPHTH VIS SCI, V53, P3020, DOI 10.1167/iovs.11-8552; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Lee JW, 2017, BRIT J OPHTHALMOL, V101, P1052, DOI 10.1136/bjophthalmol-2016-309208; Leung CKS, 2005, OPHTHALMOLOGY, V112, P391, DOI 10.1016/j.ophtha.2004.10.020; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Manalastas PIC, 2018, J GLAUCOMA, V27, P227, DOI 10.1097/IJG.0000000000000862; Mills RP, 2006, AM J OPHTHALMOL, V141, P24, DOI 10.1016/j.ajo.2005.07.044; Pollet-Villard F, 2014, INVEST OPHTH VIS SCI, V55, P2953, DOI 10.1167/iovs.13-13482; Rao HL, 2017, AM J OPHTHALMOL, V177, P106, DOI 10.1016/j.ajo.2017.02.020; Richter GM, 2018, J GLAUCOMA, V27, P281, DOI 10.1097/IJG.0000000000000888; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Wang XL, 2015, GRAEF ARCH CLIN EXP, V253, P1557, DOI 10.1007/s00417-015-3095-y; Wu JH, 2019, CURR EYE RES, V44, P533, DOI 10.1080/02713683.2018.1563195; Yarmohammadi A, 2016, OPHTHALMOLOGY, V171, P75; Yarmohammadi A, 2016, INVEST OPHTH VIS SCI, V57, pOCT451, DOI 10.1167/iovs.15-18944	20	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234816	10.1371/journal.pone.0234816	http://dx.doi.org/10.1371/journal.pone.0234816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584833	gold, Green Published			2022-12-27	WOS:000545747200046
J	Lussier, EC; Yeh, SJ; Chih, WL; Lin, SM; Chou, YC; Huang, SP; Chen, MR; Chang, TY				Lussier, Eric C.; Yeh, Shu-Jen; Chih, Wan-Ling; Lin, Shan-Miao; Chou, Yu-Ching; Huang, Szu-Ping; Chen, Ming-Ren; Chang, Tung-Yao			Reference ranges and Z-scores for fetal cardiac measurements from two-dimensional echocardiography in Asian population	PLOS ONE			English	Article							CROSS-SECTIONAL ECHOCARDIOGRAPHY; PULMONARY-ATRESIA; DIMENSIONS; PREDICTORS; NOMOGRAMS; RATIO	Currently available fetal echocardiographic reference values are derived mainly from North American and European population studies, and there is a lack of reference z-score for fetal echocardiographic measurement in Asian populations. The aim of this study was to establish normal ranges of echocardiographic measurements and z-scores in healthy Asian fetuses. A total of 575 healthy pregnant Taiwanese with an estimated gestational age from 14 to 38 weeks were enrolled voluntarily for this observational study. Standard two-dimensional echocardiography was performed to obtain measurements of the cardiac chambers and great arteries of the developing fetuses. In contrast to past studies, our sample was more evenly distributed for estimated gestational age (p<0.001). We present percentile graphs for 13 fetal echocardiographic measurements from the knowledge of estimated gestational age, biparietal distance, head circumference, abdominal circumference, and femur length. Most cardiac structures and developmental markers had linear models as the best-fitting, except for transverse aortic isthmus by estimated gestational age and transverse ductus arteriosus by femur length. Our findings indicate that estimated gestational age was generally the best model for fetal heart development, while head circumferences could be used as an optimal developmental marker to predict left atrium, right atrium, right ventricle, pulmonary annulus, and ductus arteriosus. Lastly, we developed nomograms for each of the 13 fetal heart measurements by each developmental markers. This is the first study providing echocardiographic reference ranges and nomograms for Asian fetuses. Computing z-scores from nomograms helps in standardizing comparisons and adds additional prognostic information to the diagnosis of congenital heart disease.	[Lussier, Eric C.; Chih, Wan-Ling; Chou, Yu-Ching; Huang, Szu-Ping; Chang, Tung-Yao] Taiji Clin, Taipei, Taiwan; [Yeh, Shu-Jen; Chih, Wan-Ling; Lin, Shan-Miao; Chen, Ming-Ren] MacKay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Yeh, Shu-Jen; Lin, Shan-Miao; Chen, Ming-Ren; Chang, Tung-Yao] Mackay Med Coll, Taipei, Taiwan; [Chen, Ming-Ren] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management	Chen, MR (corresponding author), MacKay Mem Hosp, Dept Pediat, Taipei, Taiwan.; Chen, MR (corresponding author), Mackay Med Coll, Taipei, Taiwan.; Chen, MR (corresponding author), Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan.	mingren44@gmail.com		Lussier, Eric/0000-0001-8137-9953				[Anonymous], 2009, CONGENITAL DIS OFTHE; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Cantinotti M, 2018, J AM SOC ECHOCARDIOG, V31, P1368, DOI 10.1016/j.echo.2018.09.018; Cantinotti M, 2017, TRENDS CARDIOVAS MED, V27, P336, DOI 10.1016/j.tcm.2017.01.006; COMSTOCK CH, 1991, AM J OBSTET GYNECOL, V165, P1038, DOI 10.1016/0002-9378(91)90466-5; DeVore GR, 2005, ULTRASOUND OBST GYN, V26, P596, DOI 10.1002/uog.2605; DeVore GR, 2017, J ULTRAS MED, V36, P459, DOI 10.7863/ultra.16.03025; Firpo C, 2001, AM J CARDIOL, V87, P594, DOI 10.1016/S0002-9149(00)01437-5; Gabbay-Benziv R, 2015, J ULTRAS MED, V34, P2049, DOI 10.7863/ultra.14.10022; Gu XY, 2017, J PERINAT MED, V45, P171, DOI 10.1515/jpm-2015-0385; Krishnan A, 2016, J AM SOC ECHOCARDIOG, V29, P1197, DOI 10.1016/j.echo.2016.08.019; Lee W, 2010, ULTRASOUND OBST GYN, V35, P28, DOI 10.1002/uog.7483; Li XY, 2015, PRENATAL DIAG, V35, P117, DOI 10.1002/pd.4498; Matsui H, 2008, CIRCULATION, V118, P1793, DOI 10.1161/CIRCULATIONAHA.108.787598; McElhinney DB, 2008, AM HEART ASS; McElhinney DB, 2009, CIRCULATION, V120, P1482, DOI 10.1161/CIRCULATIONAHA.109.848994; Pasquini L, 2007, ULTRASOUND OBST GYN, V29, P628, DOI 10.1002/uog.4021; Quartermain MD, 2013, ULTRASOUND OBST GYN, V41, P47, DOI 10.1002/uog.11196; Quartermain MD, 2009, J AM SOC ECHOCARDIOG, V22, P1296, DOI 10.1016/j.echo.2009.08.008; Riggs T, 2011, ULTRASOUND OBST GYN, V38, P332, DOI 10.1002/uog.8989; Rychik J, 2004, J AM SOC ECHOCARDIOG, V17, P803, DOI 10.1016/j.echo.2004.04.011; Salvin JW, 2006, PEDIATRICS, V118, pE415, DOI 10.1542/peds.2006-0428; Schneider C, 2005, ULTRASOUND OBST GYN, V26, P599, DOI 10.1002/uog.2597; Shapiro I, 1998, ULTRASOUND OBST GYN, V12, P404, DOI 10.1046/j.1469-0705.1998.12060404.x; SHARLAND GK, 1992, ULTRASOUND OBST GYN, V2, P175, DOI 10.1046/j.1469-0705.1992.02030175.x; Steed RD, 1998, AM J CARDIOL, V81, P1059, DOI 10.1016/S0002-9149(98)00028-9; TAN J, 1992, AM J CARDIOL, V70, P1459, DOI 10.1016/0002-9149(92)90300-N; Tworetzky W, 2009, PEDIATRICS, V124, pE510, DOI 10.1542/peds.2008-2014; Valenzuela-Alcaraz B, 2013, CIRCULATION, V128, P1442, DOI 10.1161/CIRCULATIONAHA.113.002428; Vigneswaran TV, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.118.007575; Wong SF, 2007, ULTRASOUND OBST GYN, V30, P275, DOI 10.1002/uog.4105	31	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0233179	10.1371/journal.pone.0233179	http://dx.doi.org/10.1371/journal.pone.0233179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584813	Green Published, gold			2022-12-27	WOS:000545747200057
J	Hamy, AS; Darrigues, L; Laas, E; De Croze, D; Topciu, L; Lam, GT; Evrevin, C; Rozette, S; Laot, L; Lerebours, F; Pierga, JY; Osdoit, M; Faron, M; Feron, JG; Lae, M; Reyal, F				Hamy, Anne-Sophie; Darrigues, Lauren; Laas, Enora; De Croze, Diane; Topciu, Lucian; Lam, Giang-Thanh; Evrevin, Clemence; Rozette, Sonia; Laot, Lucie; Lerebours, Florence; Pierga, Jean-Yves; Osdoit, Marie; Faron, Matthieu; Feron, Jean-Guillaume; Lae, Marick; Reyal, Fabien			Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy	PLOS ONE			English	Article							TRIAL CALGB 150007/150012; PATHOLOGICAL RESPONSE; ENDOCRINE THERAPY; SURVIVAL; EXPRESSION; RISK	Introduction The Residual Cancer Burden (RCB) quantifies residual disease after neoadjuvant chemotherapy (NAC). Its predictive value has not been validated on large cohorts with long-term follow up. The objective of this work is to independently evaluate the prognostic value of the RCB index depending on BC subtypes (Luminal,HER2-positive and triple negative (TNBCs)). Methods We retrospectively evaluated the RCB index on surgical specimens from a cohort of T1-T3NxM0 BC patients treated with NAC between 2002 and 2012. We analyzed the association between RCB index and relapse-free survival (RFS), overall survival (OS) among the global population, after stratification by BC subtypes. Results 717 patients were included (luminal BC (n = 222, 31%), TNBC (n = 319, 44.5%),HER2-positive (n = 176, 24.5%)). After a median follow-up of 99.9 months, RCB index was significantly associated with RFS. The RCB-0 patients displayed similar prognosis when compared to the RCB-I group, while patients from the RCB-II and RCB-III classes were at increased risk of relapse (RCB-IIversusRCB-0: HR = 3.25 CI [2.1-5.1]pversusRCB-0: HR = 5.6 CI [3.5-8.9]p<0.001). The prognostic impact of RCB index was significant for TNBC andHER2-positive cancers; but not for luminal cancers (P-interaction= 0.07). The prognosis of RCB-III patients was poor (8-years RFS: 52.7%, 95% CI [44.8-62.0]) particularly in the TNBC subgroup, where the median RFS was 12.7 months. Conclusion RCB index is a reliable prognostic score. RCB accurately identifies patients at a high risk of recurrence (RCB-III) with TNBC orHER2-positive BC who must be offered second-line adjuvant therapies.	[Hamy, Anne-Sophie] Inst Curie, INSERM, U932 Immun & Canc, Residual Tumor & Response Treatment Lab,RT2Lab, Paris, France; [Hamy, Anne-Sophie; Evrevin, Clemence; Rozette, Sonia; Lerebours, Florence; Pierga, Jean-Yves; Reyal, Fabien] Inst Curie, Dept Med Oncol, St Cloud, France; [Darrigues, Lauren; Laas, Enora; Lam, Giang-Thanh; Laot, Lucie; Pierga, Jean-Yves; Osdoit, Marie; Feron, Jean-Guillaume; Reyal, Fabien] Univ Paris, Inst Curie, Fac Med Descartes, Dept Surg, Paris, France; [De Croze, Diane] Inst Curie, Dept Tumor Biol, St Cloud, France; [Topciu, Lucian; Lae, Marick] Inst Curie, Dept Tumor Biol, Paris, France; [Lam, Giang-Thanh] Geneva Univ Hosp, Dept Gynecol & Obstet, Geneva, Switzerland; [Faron, Matthieu] INSERM, Dept Biostat & Epidemiol, CESP Oncostat Team 1018, Gustave Roussy Canc Campus, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Reyal, F (corresponding author), Inst Curie, Dept Med Oncol, St Cloud, France.; Reyal, F (corresponding author), Univ Paris, Inst Curie, Fac Med Descartes, Dept Surg, Paris, France.	fabien.reyal@curie.fr		Osdoit, Marie/0000-0003-1123-3400	Roche France; Site de Recherche Integree en Cancerologie/Institut National du Cancer [INCa-DGOS-4654]; ITMO-INSERM-AVIESAN translational cancer research grant	Roche France(Roche Holding); Site de Recherche Integree en Cancerologie/Institut National du Cancer; ITMO-INSERM-AVIESAN translational cancer research grant	We thank Roche France for financial support for the construction of the Institut Curie neoadjuvant database (NEOREP). Funding was also obtained from the Site de Recherche Integree en Cancerologie/Institut National du Cancer (Grant No. INCa-DGOS-4654). A-S Hamy-Petit was supported by an ITMO-INSERM-AVIESAN translational cancer research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossuyt V, 2015, ANN ONCOL, V26, P1280, DOI 10.1093/annonc/mdv161; Campbell JI, 2017, BREAST CANCER RES TR, V165, P181, DOI 10.1007/s10549-017-4303-8; Cockburn A, 2014, HUM PATHOL, V45, P249, DOI 10.1016/j.humpath.2013.09.002; Corben AD, 2013, ARCH PATHOL LAB MED, V137, P1074, DOI 10.5858/arpa.2012-0290-OA; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Cureton EL, 2014, ANN SURG ONCOL, V21, P2889, DOI 10.1245/s10434-014-3721-7; Emens LA, 2018, CLIN CANCER RES, V24, P511, DOI 10.1158/1078-0432.CCR-16-3001; Hamy AS, 2017, ANN ONCOL, V28, P2233, DOI 10.1093/annonc/mdx309; Hamy A.-S., 2019, CLIN CANC RES CLIN, V3017; Hamy AS, 2018, BREAST CANCER RES TR, V169, P295, DOI 10.1007/s10549-017-4610-0; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hatzis C., 2013, CANCER RES, V73, pP6; Hylton NM, 2016, RADIOLOGY, V279, P44, DOI 10.1148/radiol.2015150013; Jeruss JS, 2008, CANCER RES, V68, P6477, DOI 10.1158/0008-5472.CAN-07-6520; Lee SM, 2014, CLIN NUCL MED, V39, P882, DOI 10.1097/RLU.0000000000000531; Loi S, 2016, CLIN CANCER RES, V22, P1499, DOI 10.1158/1078-0432.CCR-15-1125; Martin M., 2017, ONCOLOGIST; Masuda N, 2017, NEW ENGL J MED, V376, P2147, DOI 10.1056/NEJMoa1612645; McArthur HL, 2016, CLIN CANCER RES, V22, P5729, DOI 10.1158/1078-0432.CCR-16-0190; Mittendorf EA, 2016, JAMA ONCOL, V2, P929, DOI 10.1001/jamaoncol.2015.6478; Nanda R, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.506; Peintinger F, 2015, MODERN PATHOL, V28, P913, DOI 10.1038/modpathol.2015.53; R Foundation for Statistical Computing, 2009, R DEV COR TEAM; Romero A, 2013, ANN ONCOL, V24, P655, DOI 10.1093/annonc/mds493; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sheri A, 2015, ANN ONCOL, V26, P75, DOI 10.1093/annonc/mdu508; Symmans WF, 2007, J CLIN ONCOL, V25, P4414, DOI 10.1200/JCO.2007.10.6823; Symmans WF, 2017, J CLIN ONCOL, V35, P1049, DOI 10.1200/JCO.2015.63.1010; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; van Buuren S, 2011, J STAT SOFTW, V45, P1; von Minckwitz G, 2019, NEW ENGL J MED, V380, P617, DOI 10.1056/NEJMoa1814017; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Vonderheide RH, 2010, CLIN CANCER RES, V16, P3485, DOI 10.1158/1078-0432.CCR-10-0505; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yau C., 2019, SABCS ABSTRACT	35	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234191	10.1371/journal.pone.0234191	http://dx.doi.org/10.1371/journal.pone.0234191			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579551	Green Published, gold, Green Submitted			2022-12-27	WOS:000545646600003
J	Ostman, E; Samigullin, A; Heyman-Linden, L; Andersson, K; Bjorck, I; Oste, R; Humpert, PM				Ostman, Elin; Samigullin, Azat; Heyman-Linden, Lovisa; Andersson, Kristina; Bjorck, Inger; Oste, Rickard; Humpert, Per M.			A novel nutritional supplement containing amino acids and chromium decreases postprandial glucose response in a randomized, double-blind, placebo-controlled study	PLOS ONE			English	Article							MIXED-NUTRIENT DRINK; PLASMA-GLUCOSE; GLYCEMIC LOAD; BLOOD-GLUCOSE; WHEY-PROTEIN; CARDIOVASCULAR-DISEASE; INSULIN CONCENTRATION; DIABETES-MELLITUS; OXIDATIVE STRESS; DIETARY FIBER	High postprandial blood glucose levels are associated with increased mortality, cardiovascular events and development of diabetes in the general population. Interventions targeting postprandial glucose have been shown to prevent both cardiovascular events and diabetes. This study evaluates the efficacy and safety of a novel nutritional supplement targeting postprandial glucose excursions in non-diabetic adults. Sixty overweight healthy male and female participants were recruited at two centers and randomized in a double-blind, placebo-controlled, crossover design. The supplement, a water-based drink containing 2.6g of amino acids (L-Leucine, L-Threonine, L-Lysine Monohydrochloride, L-Isoleucine, L-Valine) and 250 mcg of chromium picolinate, was consumed with a standardized carbohydrate-rich meal. The primary endpoint was the incremental area under the curve (iAUC) for venous blood glucose from 0 to 120 minutes. Secondary endpoints included glucose iAUC(0-180 minutes)and the maximum glucose concentration (C-max), for both venous and capillary blood glucose. In the intention-to-treat-analysis (n = 60) the supplement resulted in a decreased venous blood glucose iAUC(0-120min)compared to placebo, mean (SE) of 68.7 (6.6) versus 52.2 (6.8) respectively, a difference of -16.5 mmol/L center dot min (95% CI -3.1 to -30.0,p= 0.017). The C(max)for venous blood glucose for the supplement and placebo were 6.45 (0.12) versus 6.10 (<0.12), respectively, a difference of -0.35 mmol/L (95% CI -0.17 to -0.53,p<0.001). In the per protocol-analysis (n = 48), the supplement resulted in a decreased C(max)compared to placebo from 6.42 (0.14) to 6.12 (0.14), a difference of -0.29 mmol/L (95% CI -0.12 to -0.47,p= 0.002). No significant differences in capillary blood glucose were found, as measured by regular bed-side glucometers. The nutritional supplement drink containing amino acids and chromium improves the postprandial glucose homeostasis in overweight adults without diabetes. Future studies should clarify, whether regular consumption of the supplement improves markers of disease or could play a role in a diet aiming at preventing the development of diabetes.	[Ostman, Elin; Bjorck, Inger; Oste, Rickard] Lund Univ, Food Hlth Sci Ctr, Lund, Sweden; [Samigullin, Azat; Humpert, Per M.] StarScience GmbH, Heidelberg, Germany; [Heyman-Linden, Lovisa; Andersson, Kristina; Oste, Rickard] Aventure AB, Lund, Sweden; [Andersson, Kristina] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Humpert, Per M.] Stoffwechselzentrum Rhein Pfalz, Mannheim, Germany; [Humpert, Per M.] Heidelberg Univ, Dept Internal Med, Heidelberg, Germany; [Ostman, Elin] Good Idea Inc, Larkspur, CA 94939 USA	Lund University; Lund University; Ruprecht Karls University Heidelberg	Ostman, E (corresponding author), Lund Univ, Food Hlth Sci Ctr, Lund, Sweden.; Ostman, E (corresponding author), Good Idea Inc, Larkspur, CA 94939 USA.	elin.ostman@goodideadrinks.com	Ostman, Elin/G-3975-2012	Ostman, Elin/0000-0003-0831-6176				Akhavan T, 2010, AM J CLIN NUTR, V91, P966, DOI 10.3945/ajcn.2009.28406; Anderson RA, 1997, J AM COLL NUTR, V16, P404, DOI 10.1080/07315724.1997.10718705; Anderson RA, 1998, J AM COLL NUTR, V17, P548, DOI 10.1080/07315724.1998.10718802; [Anonymous], 2015, LANCET NEUROL, V14, P1, DOI 10.1016/S1474-4422(14)70312-6; [Anonymous], 2018, VOX             0919; Augustin LSA, 2015, NUTR METAB CARDIOVAS, V25, P795, DOI 10.1016/j.numecd.2015.05.005; Balk EM, 2007, DIABETES CARE, V30, P2154, DOI 10.2337/dc06-0996; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Baruffol C, 2014, NEUROGASTROENT MOTIL, V26, P999, DOI 10.1111/nmo.12354; Bergman M, 2016, DIABETIC MED, V33, P1060, DOI 10.1111/dme.13116; Bergman M, 2016, DIABETES RES CLIN PR, V120, P221, DOI 10.1016/j.diabres.2016.08.013; BERGSTROM RW, 1990, J CLIN ENDOCR METAB, V71, P1447, DOI 10.1210/jcem-71-6-1447; Bhupathiraju SN, 2014, AM J CLIN NUTR, V100, P218, DOI 10.3945/ajcn.113.079533; Brouns F, 2005, NUTR RES REV, V18, P145, DOI 10.1079/NRR2005100; Brun AC, 2012, CLIN NUTR, V31, P108, DOI 10.1016/j.clnu.2011.07.009; Cefalu WT, 1999, J TRACE ELEM EXP MED, V12, P71, DOI 10.1002/(SICI)1520-670X(1999)12:2&lt;71::AID-JTRA4&gt;3.0.CO;2-8; Cefalu WT, 2004, DIABETES CARE, V27, P2741, DOI 10.2337/diacare.27.11.2741; Ceriello A, 2002, CIRCULATION, V106, P1211, DOI 10.1161/01.CIR.0000027569.76671.A8; Chartrand D, 2017, CAN J DIABETES, V41, P329, DOI 10.1016/j.jcjd.2016.10.009; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Cust AE, 2009, EUR J CLIN NUTR, V63, pS37, DOI 10.1038/ejcn.2009.74; DIAMOND MP, 1989, FERTIL STERIL, V52, P204; Einarson TR, 2011, CURR MED RES OPIN, V27, P2155, DOI 10.1185/03007995.2011.626760; FASCHING P, 1994, METABOLISM, V43, P385, DOI 10.1016/0026-0495(94)90109-0; Federation ID, 2017, IDF DIABETES ATLAS; Frauchiger MT, 2004, J AM COLL NUTR, V23, P351, DOI 10.1080/07315724.2004.10719378; Freckmann Guido, 2012, J Diabetes Sci Technol, V6, P1060; Gannon MC, 2002, AM J CLIN NUTR, V76, P1016, DOI 10.1093/ajcn/76.5.1016; GANNON MC, 1986, DIABETOLOGIA, V29, P784, DOI 10.1007/BF00873217; Gross LS, 2004, AM J CLIN NUTR, V79, P774; Hanefeld M, 1999, ATHEROSCLEROSIS, V144, P229, DOI 10.1016/S0021-9150(99)00059-3; Hayashi T, 2013, DIABETES CARE, V36, P1229, DOI 10.2337/dc12-0246; Hill Jones N, 1997, JMPER CABLE, P9; Holman RR, 2017, LANCET DIABETES ENDO, V5, P877, DOI 10.1016/S2213-8587(17)30309-1; Humpert PM, 2010, DIABETOLOGIA, V53, P403, DOI 10.1007/s00125-009-1652-9; Hutchison AT, 2015, AM J CLIN NUTR, V102, P1323, DOI 10.3945/ajcn.115.114538; Hutchison AT, 2015, AM J CLIN NUTR, V102, P1574, DOI 10.3945/ajcn.115.117556; Kalogeropoulo D, 2008, METABOLISM, V57, P1747, DOI 10.1016/j.metabol.2008.09.001; Kalogeropoulou D, 2009, AM J CLIN NUTR, V90, P314, DOI 10.3945/ajcn.2008.27381; Kodama S, 2012, J ATHEROSCLER THROMB, V19, P385, DOI 10.5551/jat.10975; LEFLOCH JP, 1990, DIABETES CARE, V13, P172, DOI 10.2337/diacare.13.2.172; Matsumoto K, 1997, DIABETES CARE, V20, P1562, DOI 10.2337/diacare.20.10.1562; Nilsson M, 2004, AM J CLIN NUTR, V80, P1246, DOI 10.1093/ajcn/80.5.1246; Ning F, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-76; Node K, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-23; Ostman E, 2017, FUNCT FOODS HEALTH D, V7, P88; Ostman EM, 2001, AM J CLIN NUTR, V74, P96; Petersen BL, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-47; Power O, 2009, AMINO ACIDS, V37, P333, DOI 10.1007/s00726-008-0156-0; Rice MJ, 2016, CRIT CARE MED, V44, pE97, DOI 10.1097/CCM.0000000000001389; Robitaille A, 2006, J CARDIOTHOR VASC AN, V20, P331, DOI 10.1053/j.jvca.2005.11.018; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; San Mauro-Martin I, 2016, NUTR HOSP, V33, P685, DOI 10.20960/nh.279; Schulze MB, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2396; Shahim B, 2017, DIABETES CARE, V40, P1233, DOI 10.2337/dc17-0245; Sluijs I, 2013, J NUTR, V143, P93, DOI 10.3945/jn.112.165605; Standardization I-IOf, 2010, 266422010 ISO IOF; Stanstrup J, 2014, J PROTEOME RES, V13, P2396, DOI 10.1021/pr401214w; Thomas D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006296.pub2; Ullrich SS, 2017, J NUTR, V147, P1275, DOI 10.3945/jn.117.252213; Ullrich SS, 2016, AM J CLIN NUTR, V104, P1274, DOI 10.3945/ajcn.116.140640; Wildova E, 2017, PHYSIOL RES, V66, P993, DOI 10.33549/physiolres.933477; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; Yeh S-T, NESUG, V15, P1	67	0	0	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234237	10.1371/journal.pone.0234237	http://dx.doi.org/10.1371/journal.pone.0234237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579549	Green Published, gold			2022-12-27	WOS:000545646600009
J	Padilla-Rodriguez, JC; Olivera, MJ; Guevara-Garcia, BD				Padilla-Rodriguez, Julio Cesar; Olivera, Mario J.; Guevara-Garcia, Bryan David			Parasite density in severe malaria in Colombia	PLOS ONE			English	Article							PLASMODIUM-VIVAX MALARIA; FALCIPARUM-MALARIA; RISK-FACTORS	Background Colombia has officially adopted the parasite density levels of severe malaria established by the WHO (>50,000 parasites/mu l). These values have been inferred from areas of high transmission in Africa and are not consistent with the dynamics of low and unstable transmission in Colombia. The objective of this study was therefore to determine the parasite density values observed in patients with severe malaria and their distribution in the different ecoepidemiological regions of Colombia. Methods A retrospective and descriptive study of confirmed cases of severe malaria was conducted in endemic areas of malaria in Colombia over the period 2014-2017. Data were collected from secondary sources of the Subnational Programs of Malaria Prevention and Control. Person, place, and time variables were selected. The official definition of severe malaria was adopted, and compliance with these criteria was determined. Univariate and bivariate analyses were conducted with absolute and relative frequency measures, and the relevant statistical tests were applied. Results The overall parasite density values in Colombia showed a geometric mean of 5,919 parasites/mu l (95% CI: 5,608-6,248). By parasite species, the values were 6,151 (95% CI: 5,631-6,718) forPlasmodium falciparumand 5,815 (95% CI: 5,428-6,230) forPlasmodium vivax. The highest parasite density values were recorded in the Amazon ecoepidemiological region (8,177; 95% CI: 6,015-11,116), and the lowest values were recorded in the Andean region (5,026; 95% CI: 2,409-10,480). Conclusions In endemic areas of low and unstable malaria transmission in the Colombian territory, the parasite density levels observed in populations with severe malaria are lower than the officially established values. The parasite density criterion is not really a relevant criterion for the definition of severe cases in Colombia and it certainly not be used to make a clinical decision about the severity of the disease.	[Padilla-Rodriguez, Julio Cesar; Guevara-Garcia, Bryan David] Minist Salud & Protecc Social, Bogota, DC, Colombia; [Olivera, Mario J.] Inst Nacl Salud, Grp Parasitol, Bogota, DC, Colombia	Instituto Nacional de Salud (Colombia)	Olivera, MJ (corresponding author), Inst Nacl Salud, Grp Parasitol, Bogota, DC, Colombia.	molivera@ins.gov.co	; Olivera, Mario/T-5486-2018	Padilla-Rodriguez, Julio/0000-0001-7608-9863; Olivera, Mario/0000-0002-6885-6353	National Institute of Health of Colombia	National Institute of Health of Colombia	This study was supported by the National Institute of Health of Colombia.	Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; [Anonymous], REV BRAS EPIDEMIOL; Anstey NM, 2012, ADV PARASIT, V80, P151, DOI 10.1016/B978-0-12-397900-1.00003-7; Arevalo-Herrera M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0678-3; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Castaneda A, 1989, THESIS U ANTIOQUIA; Chaparro-Narvaez PE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1323-5; Grillet ME, 2019, LANCET INFECT DIS, V19, pE149, DOI 10.1016/S1473-3099(18)30757-6; Instituto Nacional de Salud, 2017, INF EV MAL 2017; Instituto Nacional de Salud, 2016, INF FIN EV MAL; Instituto Nacional de Salud, 2017, PROT VIG SAL PUBL; Instituto Nacional de Salud, 2000, INF EV MAL 2000; Instituto Nacional de Salud, 2018, INF EV MAL 2018; Kotepui M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121057; Malaria S, 2014, TROP MED INT HEALTH, V19, P7, DOI [10.1111/tmi.12313, 10.1111/tmi.12313_2]; Medina-Morales DA, 2016, J INFECT PUBLIC HEAL, V9, P172, DOI 10.1016/j.jiph.2015.09.001; Ministerio de Salud, 1997, GUIA INT MAN ENF TRA; Ministerio de Salud y Proteccio&PRIME;n Social, 2010, GUIA AT CLIN INT PAC; Murillo-Palacios Olga L., 2018, Rev. salud pública, V20, P73, DOI [10.15446/rsap.V20n1.50077, 10.15446/rsap.v20n1.50077]; Najera JA., 1998, MALARIA EPIDEMICS DE; Olivera MJ, 2020, AM J TROP MED HYG, V102, P1056, DOI 10.4269/ajtmh.19-0954; Organizacion Panamericana de la Salud, 1988, ORG PAN SAL PUBL CIE, V512; PAHO, 2019, MAN ESTR SEG RIESG; Pan American Health Organization, 2016, REP SIT MAL AM 2000; Pan American Health Organization, 2016, PLAN ACC EL MAL 2016; Pan American Health Organization, 2019, DAT EST; Phillips A, 2009, CLIN INFECT DIS, V48, P871, DOI 10.1086/597258; Roper MH, 2000, AM J TROP MED HYG, V62, P247, DOI 10.4269/ajtmh.2000.62.247; Tobon-Castano A, 2012, BIOMEDICA, V32, P79, DOI 10.1590/S0120-41572012000500010; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2005, MAL CONTR COMPL EM; Wilairatana Polrat, 2013, Asian Pac J Trop Biomed, V3, P586, DOI 10.1016/S2221-1691(13)60119-7; World Health Organization, 2018, WORLD MAL REP 2018; World Health Organization, 2018, PAL DAT CIFR; World Health Organization, 2012, TRAT PAL GRAV; World Health Organization, 2015, GUID TREATM MAL, Vthird	36	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235119	10.1371/journal.pone.0235119	http://dx.doi.org/10.1371/journal.pone.0235119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574179	Green Published, gold			2022-12-27	WOS:000544972400051
J	Ben Kayale, L; Ling, J; Henderson, E; Carter, N				Ben Kayale, Lilahom; Ling, Jonathan; Henderson, Emily; Carter, Noel			The influence of cultural attitudes to nut exposure on reported nut allergy: A pilot cross sectional study	PLOS ONE			English	Article							PEANUT ALLERGY; FOOD ALLERGY; CHILDREN; PREVALENCE; RISK; EPIDEMIOLOGY; PATHOGENESIS; CONSUMPTION; PREVENTION; DIAGNOSIS	Food allergies in children have become a common management and diagnostic concern and have a significant influence on general health-related quality of life. We investigated the prevalence of reported nut allergy between populations with different cultural attitudes to nuts during pregnancy and infancy. We conducted a survey to investigate the relationship between cultural differences in the consumption of nuts during pregnancy, breastfeeding and exposure to nuts in early childhood against the reported prevalence of nut allergy between three populations: Libyan, UK Libyan and a general UK population. The survey was administered to a representative sample of UK and Libyan parents with children aged between 3 and 16 years who were asked to report prevalence of nut allergy and to describe the factors that might affect this such as cultural behaviours and diet. A total of 1,123 parents responded. Nut allergy was defined as an allergic reaction that required medical treatment. The reported rates of nut allergy showed a significant difference in nut allergy between the Libyan populations and the general UK population with an increased odds ratio of nut allergy of similar to 10 when comparing the Native Libyan population to the UK population. The UK Libyan population reported the same low rate of allergic reactions as the Libyan population which were both significantly lower than the UK population (p < .0001). The Libyan populations showed significant differences from the UK population in exposure to nuts during pregnancy, breastfeeding and early infancy. The development of peanut and almond allergy through tolerance induction could be prevented by frequent and early ingestion of a moderate quantity of nuts during infancy and by maternal ingestion during pregnancy or lactation.	[Ben Kayale, Lilahom; Ling, Jonathan; Carter, Noel] Univ Sunderland, Fac Hlth Sci & Wellbeing, Sunderland, Tyne & Wear, England; [Henderson, Emily] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England	University of Sunderland; Newcastle University - UK	Carter, N (corresponding author), Univ Sunderland, Fac Hlth Sci & Wellbeing, Sunderland, Tyne & Wear, England.	noel.carter@sunderland.ac.uk	Ling, Jonathan/AAY-4098-2020	Ling, Jonathan/0000-0003-2932-4474; Carter, Noel/0000-0002-6888-3829	Fuse, the Centre for Translational Research in Public Health	Fuse, the Centre for Translational Research in Public Health	The work was all conducted as part of a self funded MPhil research project by the lead author, as such the student had a primary role in the study design, data collection, data analysis, decision to publish and preparation of the manuscript. JL received funding for this study from Fuse, the Centre for Translational Research in Public Health (www.fuse.ac.uk).The views expressed in this paper do not necessarily represent those of the funders or UKCRC and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou K, 2014, LANCET, V383, P1297, DOI 10.1016/S0140-6736(13)62301-6; Bowling A., 2014, RES METHODS HLTH INV, Vfourth; Boye Joyce Irene, 2012, Clin Transl Allergy, V2, P25, DOI 10.1186/2045-7022-2-25; Chatzi L, 2007, THORAX, V62, P677, DOI 10.1136/thx.2006.069419; Cummings AJ, 2010, PEDIAT ALLERG IMM-UK, V21, P586, DOI 10.1111/j.1399-3038.2009.00975.x; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Enrique E, 2005, J ALLERGY CLIN IMMUN, V116, P1073, DOI 10.1016/j.jaci.2005.08.027; Food standards Agency, 1998, COT REP PEAN ALL; Hofmann AM, 2009, J ALLERGY CLIN IMMUN, V124, P286, DOI 10.1016/j.jaci.2009.03.045; Hourihane JO, 2007, J ALLERGY CLIN IMMUN, V119, P1197, DOI 10.1016/j.jaci.2006.12.670; Katz Y, 2010, J ALLERGY CLIN IMMUN, V126, P77, DOI 10.1016/j.jaci.2010.04.020; Koplin JJ, 2010, J ALLERGY CLIN IMMUN, V126, P807, DOI 10.1016/j.jaci.2010.07.028; Kull I, 2006, ALLERGY, V61, P1009, DOI 10.1111/j.1398-9995.2006.01115.x; Lack G, 2012, J ALLERGY CLIN IMMUN, V129, P1187, DOI 10.1016/j.jaci.2012.02.036; Longo G, 2008, J ALLERGY CLIN IMMUN, V121, P343, DOI 10.1016/j.jaci.2007.10.029; Lopez-Exposito I, 2009, J ALLERGY CLIN IMMUN, V124, P1039, DOI 10.1016/j.jaci.2009.08.024; McWilliam V, 2019, J ALLERGY CLIN IMMUN, V143, P644, DOI 10.1016/j.jaci.2018.07.038; Panjari M, 2016, CLIN EXP ALLERGY, V46, P602, DOI 10.1111/cea.12699; Poole JA, 2006, PEDIATRICS, V117, P2175, DOI 10.1542/peds.2005-1803; R Development Core Team, 2009, R LANG ENV STAT COMP; RStudio, 2021, RSTUDIO INT DEV ENV; Sahyoun N. R., 2016, Mediterranean diet: dietary guidelines and impact on health and disease, P43; Schoonjans F, MEDCALC STAT SOFTWAR; Sicherer SH, 2007, J ALLERGY CLIN IMMUN, V120, P491, DOI 10.1016/j.jaci.2007.07.015; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V126, P1191, DOI 10.1016/j.jaci.2010.08.036; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Togias A, 2017, ANN ALLERG ASTHMA IM, V118, P166, DOI 10.1016/j.anai.2016.10.004	29	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234846	10.1371/journal.pone.0234846	http://dx.doi.org/10.1371/journal.pone.0234846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559218	Green Published, gold, Green Accepted			2022-12-27	WOS:000543261600029
J	Lin, DM; Chen, XJ				Lin, Dongming; Chen, Xinjun			Top predator reveals the stability of prey community in the western subarctic Pacific	PLOS ONE			English	Article							NEON FLYING SQUID; FATTY-ACID-COMPOSITION; 2 OMMASTREPHID SQUIDS; NORTH PACIFIC; FEEDING-HABITS; STOMACH CONTENTS; STABLE-ISOTOPES; LIFE-HISTORIES; MOROTEUTHIS-INGENS; TROPHIC POSITION	The stability of the ecosystems depends on the dynamics of the prey community, but changes in the composition and abundance of prey species are poorly understood, especially in open ocean ecosystems. We used neon flying squidOmmastrephes bartramii, an active top predator, as a biological sampler to investigate the dynamics of the prey community in the southwestern part of the Western Subarctic Gyre in the northwestern Pacific Ocean. Squid were collected monthly from July to November 2016. There were no significant differences among months in stable isotopes (delta C-13 and delta N-15) in the digestive gland, a fast turnover organ reflecting recent dietary information. Similar findings were obtained from analyses of isotopic niche width and fatty acid profiles. The potential influence of the environment (monthly mean sea surface temperature, SST, and chlorophyll-a, Chl-a) on the prey community was examined with SST and Chl-aboth varying significantly among sampling months. We found little evidence for significant effects of SST and Chl-aon the isotopic values, nor on the fatty acid profiles except for 20:4n6 and 24:1n9. These lines of evidence indicate that the prey community in the southwestern part of the gyre remains stable, with little evidence for systematic changes at the community level. This study provides a novel understanding of the dynamics of the prey community and highlights the use of top predators to study the trophic dynamics of an oceanic system where a long-term scientific survey is unavailable.	[Lin, Dongming; Chen, Xinjun] Shanghai Ocean Univ, Coll Marine Sci, Shanghai, Peoples R China; [Lin, Dongming; Chen, Xinjun] Minist Educ, Key Lab Sustainable Exploitat Ocean Fishery Resou, Shanghai, Peoples R China; [Lin, Dongming; Chen, Xinjun] Natl Distant Water Fisheries Engn Res Ctr, Shanghai, Peoples R China; [Lin, Dongming; Chen, Xinjun] Minist Agr & Rural Affairs, Key Lab Ocean Fisheries Explorat, Shanghai, Peoples R China; [Chen, Xinjun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China	Shanghai Ocean University; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology	Chen, XJ (corresponding author), Shanghai Ocean Univ, Coll Marine Sci, Shanghai, Peoples R China.; Chen, XJ (corresponding author), Minist Educ, Key Lab Sustainable Exploitat Ocean Fishery Resou, Shanghai, Peoples R China.; Chen, XJ (corresponding author), Natl Distant Water Fisheries Engn Res Ctr, Shanghai, Peoples R China.; Chen, XJ (corresponding author), Minist Agr & Rural Affairs, Key Lab Ocean Fisheries Explorat, Shanghai, Peoples R China.; Chen, XJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.	xjchen@shou.edu.cn		Lin, Dongming/0000-0002-6826-0306	National Key Research and Development Project [2019YFD0901404]; National Natural Science Foundation of China [41876144, 41876141]; Natural Science Foundation of Shanghai [16ZR1415400]; Shanghai Science and Technology Innovation Program [19DZ1207502]	National Key Research and Development Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Science and Technology Innovation Program	This work was supported by National Key Research and Development Project (2019YFD0901404), National Natural Science Foundation of China (41876144, 41876141), Natural Science Foundation of Shanghai (16ZR1415400) and Shanghai Science and Technology Innovation Program (19DZ1207502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J, 2017, STAT REFERENCE ONLIN, P1, DOI [10.1002/9781118445112.stat07841, DOI 10.1002/9781118445112.STAT07841]; Arkhipkin AI, 2013, DEEP-SEA RES PT II, V95, P7, DOI 10.1016/j.dsr2.2012.07.003; BALLANTYNE JS, 1981, MAR BIOL LETT, V2, P75; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bell G, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1463; Boyle P, 2005, CEPHALOPODS: ECOLOGY AND FISHERIES, P1, DOI 10.1002/9780470995310; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chen XJ, 2008, FISH RES, V92, P221, DOI 10.1016/j.fishres.2008.01.011; Cherel Y, 2005, P ROY SOC B-BIOL SCI, V272, P1601, DOI 10.1098/rspb.2005.3115; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P979, DOI 10.1098/rstb.1996.0088; Cline TJ, 2019, NAT ECOL EVOL, V3, P935, DOI 10.1038/s41559-019-0901-7; Coll M, 2013, DEEP-SEA RES PT II, V95, P21, DOI 10.1016/j.dsr2.2012.08.020; de la Chesnais T, 2019, REV FISH BIOL FISHER, V29, P313, DOI 10.1007/s11160-019-09554-2; Dee LE, 2019, TRENDS ECOL EVOL, V34, P746, DOI 10.1016/j.tree.2019.03.010; Espinoza P, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3119-8; Fang Z, 2016, FISH RES, V177, P153, DOI 10.1016/j.fishres.2016.01.011; Fluckiger M, 2008, MAR BIOL, V154, P363, DOI 10.1007/s00227-008-0932-0; Fujinami Y, 2018, PAC SCI, V72, P21, DOI 10.2984/72.1.2; GAQSIQ, 2008, DET TOT FAT SAT FAT; Goetsch C, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00430; Gong Y, 2018, MAR ECOL PROG SER, V607, P99, DOI 10.3354/meps12768; Gould P, 1997, CAN J ZOOL, V75, P549, DOI 10.1139/z97-068; Graeve M, 2002, MAR ECOL PROG SER, V231, P67, DOI 10.3354/meps231067; Griffith GP, 2018, GLOBAL CHANGE BIOL, V24, pE90, DOI 10.1111/gcb.13891; Guerreiro M, 2015, MAR ECOL PROG SER, V530, P119, DOI 10.3354/meps11266; Harrison PJ, 2004, J OCEANOGR, V60, P93, DOI 10.1023/B:JOCE.0000038321.57391.2a; Harrison PJ, 1999, PROG OCEANOGR, V43, P205, DOI 10.1016/S0079-6611(99)00015-4; ICES, 2010, WORKSH SEX MAT STAG; Imai K, 2002, DEEP-SEA RES PT II, V49, P5395, DOI 10.1016/S0967-0645(02)00198-4; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jereb P., 2010, MYOPSID OEGOPSID SQU, V2, P605; Kato Y, 2016, FISH RES, V173, P169, DOI 10.1016/j.fishres.2015.09.016; Kefi S, 2019, ECOL LETT, V22, P1349, DOI 10.1111/ele.13340; Kuhnen VV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181188; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; LIPINSKI MR, 1988, S AFR J MARINE SCI, V6, P43, DOI 10.2989/025776188784480573; Lourenco S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00467; Mackas DL, 1999, PROG OCEANOGR, V43, P335, DOI 10.1016/S0079-6611(99)00012-9; Magurran Anne E, 2018, Proc Natl Acad Sci U S A, V115, P1843, DOI 10.1073/pnas.1712594115; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Meyer L, 2019, FUNCT ECOL, V33, P1243, DOI 10.1111/1365-2435.13328; MOMMSEN TP, 1981, EUR J BIOCHEM, V120, P345, DOI 10.1111/j.1432-1033.1981.tb05710.x; Murase H, 2012, FISHERIES SCI, V78, P761, DOI 10.1007/s12562-012-0508-2; Navarro J, 2013, DEEP-SEA RES PT II, V95, P93, DOI 10.1016/j.dsr2.2013.01.031; Ohshimo S, 2019, PROG OCEANOGR, V175, P124, DOI 10.1016/j.pocean.2019.04.003; Ohshimo S, 2018, MAR FRESHWATER RES, V69, P585, DOI 10.1071/MF17058; Oksanen J., 2016, VEGAN COMMUNITY ECOL; Okuda T, 2017, DEEP-SEA RES PT II, V140, P45, DOI 10.1016/j.dsr2.2016.11.013; Parrish CC, 2000, HANDB ENVIRON CHEM, V5, P193; Parry M, 2008, MAR BIOL, V153, P249, DOI 10.1007/s00227-007-0800-3; Parry M, 2006, MAR ECOL PROG SER, V318, P229, DOI 10.3354/meps318229; Parry MP, 2003, TROPHIC ECOLOGY 2 OM; Pecl GT, 2004, OECOLOGIA, V139, P515, DOI 10.1007/s00442-004-1537-z; Pethybridge HR, 2013, DEEP-SEA RES PT II, V95, P119, DOI 10.1016/j.dsr2.2012.07.025; Phillips KL, 2003, POLAR BIOL, V26, P474, DOI 10.1007/s00300-003-0509-9; Phillips KL, 2001, MAR ECOL PROG SER, V215, P179, DOI 10.3354/meps215179; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Qiu B., 2001, ENCY OCEAN SCI, P1413, DOI DOI 10.1006/RWOS.2001.0350; R Development Core Team, 2009, R LANG ENV STAT COMP; Rodhouse PG, 1996, PHILOS T ROY SOC B, V351, P1003, DOI 10.1098/rstb.1996.0090; Roo J, 2017, AQUAC RES, V48, P633, DOI 10.1111/are.12910; Rosas-Luis R, 2017, REG STUD MAR SCI, V11, P17, DOI 10.1016/j.rsma.2017.02.003; Sanchez-Hernandez J, 2018, FISH FISH, V19, P1003, DOI 10.1111/faf.12308; Sogawa S, 2017, J CRUSTACEAN BIOL, V37, P29, DOI 10.1093/jcbiol/ruw014; Stowasser G, 2006, J EXP MAR BIOL ECOL, V333, P97, DOI 10.1016/j.jembe.2005.12.008; Sunday JM, 2015, ECOL LETT, V18, P944, DOI 10.1111/ele.12474; Tsuda A, 2004, FISH OCEANOGR, V13, P10, DOI 10.1111/j.1365-2419.2004.00315.x; Watanabe H, 2004, MAR ECOL PROG SER, V266, P173, DOI 10.3354/meps266173; Watanabe H, 2008, J MAR BIOL ASSOC UK, V88, P381, DOI 10.1017/S0025315408000635; Yamaguchi A, 2017, PROG OCEANOGR, V150, P13, DOI 10.1016/j.pocean.2015.04.011; Yeakel JD, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00001; Yuan XJ, 1996, J GEOPHYS RES-OCEANS, V101, P16491, DOI 10.1029/96JC01249; ZAR J.H., 2009, BIOSTAT ANAL, V5th; Zhao QH, 2019, ECOL LETT, V22, P1152, DOI 10.1111/ele.13282; Zuur A.F., 2009, MIXED EFFECTS MODELS, P574; Zuur AF, 2007, STAT BIOL HEALTH, P1	80	0	0	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234905	10.1371/journal.pone.0234905	http://dx.doi.org/10.1371/journal.pone.0234905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559216	Green Published, gold			2022-12-27	WOS:000543261600001
J	Baudry, AS; Christophe, V; Constant, E; Piessen, G; Anota, A				Baudry, Anne-Sophie; Christophe, Veronique; Constant, Emilie; Piessen, Guillaume; Anota, Amelie		FREGAT Working Grp	The Profile of Emotional Competence (PEC): A French short version for cancer patients	PLOS ONE			English	Article							ITEM RESPONSE THEORY; SAMPLE-SIZE; INTELLIGENCE; QLQ-C30; ANXIETY; HEALTH; POWER; LIFE	Background Intrapersonal and interpersonal Emotional Competence (EC) predicts better health and disease adjustment. This study aimed to validate a short version of the Profile of Emotional Competence (PEC) scale for cancer patients. Methods Five hundred and thirty-five patients with cancer completed a self-reported questionnaire assessing their intra- and interpersonal EC (PEC), their anxiety and depression symptoms (HADS), and their health-related quality of life (QLQ-C30). Confirmatory factor analyses and Item Response Theory models with the Partial Credit Model were performed to validate and reduce the scale. Findings The Short-PEC (13 items), composed of 2 sub-scores of intra- (6 items) and interpersonal (7 items) EC, showed an improved factorial structure (Root Mean Square Error of Approximation (RMSEA) = 0.075 (90% confidence interval 0.066-0.085), comparative fit index = 0.915) with good psychometric properties. Discussion Future studies should use the Short-PEC to explain and predict the adjustment of cancer patients. The short-PEC could be also used in clinical routine to assess the level of EC of patients and to adapt psychosocial intervention.	[Baudry, Anne-Sophie] Ctr Hosp Valenciennes, Pole Cancerol & Specialites Med, Valenciennes, France; [Baudry, Anne-Sophie; Christophe, Veronique; Constant, Emilie] Univ Lille, CNRS, CHU Lille, UMR 9193,SCALab,Sci Cognit & Sci Affect, Lille, France; [Christophe, Veronique; Anota, Amelie] French Natl Platform Qual Life & Canc, Lille, France; [Christophe, Veronique] Ctr Leon Berard, Human & Social Sci Dept, Lyon, France; [Piessen, Guillaume] Univ Lille, Claude Huriez Univ Hosp, Dept Digest & Oncol Surg, Lille, France; [Anota, Amelie] Univ Hosp Besancon, UMR 1098, NSERM, Methodol & Qual Life Oncol Unit, Besancon, France	CH de Valenciennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; CHU Lille; Universite de Lille; UNICANCER; Centre Leon Berard; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon	Baudry, AS (corresponding author), Ctr Hosp Valenciennes, Pole Cancerol & Specialites Med, Valenciennes, France.; Baudry, AS; Christophe, V (corresponding author), Univ Lille, CNRS, CHU Lille, UMR 9193,SCALab,Sci Cognit & Sci Affect, Lille, France.; Christophe, V (corresponding author), French Natl Platform Qual Life & Canc, Lille, France.; Christophe, V (corresponding author), Ctr Leon Berard, Human & Social Sci Dept, Lyon, France.	anne-sophie.baudry@univ-lille.fr; veronique.christophe@univ-lille.fr		Christophe, Veronique/0000-0002-0000-0663	SIRIC ONCOLille [INCa-DGOS Inserm 6041]; Region Hauts-de-France; French National Cancer Institute (INCa); CHU de Lille	SIRIC ONCOLille; Region Hauts-de-France(Region Hauts-de-France); French National Cancer Institute (INCa)(Institut National du Cancer (INCA) France); CHU de Lille	This work was supported by the SIRIC ONCOLille (Grant INCa-DGOS Inserm 6041) to VC and the "Region Hauts-de-France." FREGAT was funded with support from the French National Cancer Institute (INCa) and the CHU de Lille is the sponsor of the FREGAT study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Austin EJ, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00974; Baudry AS, 2018, SUPPORT CARE CANCER, V26, P223, DOI 10.1007/s00520-017-3838-x; Baudry AS, 2019, PSYCHO-ONCOLOGY, V28, P799, DOI 10.1002/pon.5023; Baudry AS, 2018, SCAND J PSYCHOL, V59, P206, DOI 10.1111/sjop.12424; Brasseur S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062635; Coccaro EF, 2016, PRIM CARE DIABETES, V10, P334, DOI 10.1016/j.pcd.2016.05.006; Edelen MO, 2007, QUAL LIFE RES, V16, P5, DOI 10.1007/s11136-007-9198-0; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; Liu M, 2012, CORROS SCI, V54, P139, DOI 10.1016/j.corsci.2011.09.004; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Malouff JM, 2014, AM J FAM THER, V42, P53, DOI 10.1080/01926187.2012.748549; Mariette C, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-3991-8; Martins A, 2010, PERS INDIV DIFFER, V49, P554, DOI 10.1016/j.paid.2010.05.029; Mikolajczak M, 2015, EMOTION, V15, P653, DOI 10.1037/emo0000034; Naz R., 2016, PAFMJ, V66, P903; O'Boyle EH, 2011, J ORGAN BEHAV, V32, P788, DOI 10.1002/job.714; Teques AP, 2016, PSYCHO-ONCOLOGY, V25, P324, DOI 10.1002/pon.3921; Petersen MA, 2006, J CLIN EPIDEMIOL, V59, P36, DOI 10.1016/j.jclinepi.2005.04.010; RAZAVI D, 1989, REV PSYCHOL APPL, V39, P295; Sanchez-Alvarez N, 2016, J POSIT PSYCHOL, V11, P276, DOI 10.1080/17439760.2015.1058968; Schinckus L, 2018, PERS INDIV DIFFER, V131, P124, DOI 10.1016/j.paid.2018.03.028; Schmidt JE, 2004, HEALTH PSYCHOL, V23, P259, DOI 10.1037/0278-6133.23.3.259; Smith SG, 2012, SUPPORT CARE CANCER, V20, P2933, DOI 10.1007/s00520-012-1423-x; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Wolf EJ, 2013, EDUC PSYCHOL MEAS, V73, P913, DOI 10.1177/0013164413495237; Zeidner M, 2012, APPL PSYCHOL-HLTH WE, V4, P1, DOI 10.1111/j.1758-0854.2011.01062.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0232706	10.1371/journal.pone.0232706	http://dx.doi.org/10.1371/journal.pone.0232706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555672	Green Published, gold			2022-12-27	WOS:000543273200045
J	Kitagawa, K; So, R; Nomura, N; Mizuno, Y; Misawa, F; Kodama, M; Uchida, H; Mimura, M; Takeuchi, H				Kitagawa, Kohei; So, Ryuhei; Nomura, Nobuyuki; Mizuno, Yuya; Misawa, Fuminari; Kodama, Masafumi; Uchida, Hiroyuki; Mimura, Masaru; Takeuchi, Hiroyoshi			Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J)	PLOS ONE			English	Article							TREATMENT-RESISTANT SCHIZOPHRENIA; RATING-SCALE; MANAGEMENT; EFFICACY; BLIND; RISPERIDONE; OLANZAPINE	The purpose of this study was to develop the Glasgow Antipsychotic Side effects Scale for Clozapine Japanese version (GASS-C-J) and examine its reliability to assess clozapine-related side effects. We developed the GASS-C-J using forward and backward translation. Semantic equivalence of the GASS-C-J to the GASS-C was confirmed by the original author. We then administered the GASS-C-J twice to 109 patients on clozapine treatment at two psychiatric hospitals in Japan. We assessed the internal consistency and test-retest reliability of the GASS-C-J using Cronbach's alpha and weighted kappa coefficient, respectively. We also examined if discrepancies in each GASS-C-J item score between the first and second rating were correlated with items of the Brief Evaluation of Psychosis Symptom Domains (BE-PSD). The Cronbach's alpha coefficient of the GASS-C-J at the first and second rating was 0.78 (95% CI: 0.72 to 0.84) and 0.82 (95% CI: 0.76 to 0.88), respectively. The weighted kappa coefficient of individual and total GASS-C-J item scores ranged from 0.45 to 0.88. Some symptom domains were correlated with discrepancies in specific items of the GASS-C-J: psychotic symptoms and nausea/vomiting (r(s)= 0.27), thirst (r(s)= 0.31), and appetite/weight gain (r(s)= 0.27); disorganized thinking and urinary incontinence (r(s)= 0.26); depression/anxiety and myoclonus (r(s)= 0.25), hypersalivation (r(s)= -0.27), and blurred vision (r(s)= -0.22). These findings demonstrate that the GASS-C-J can be used in clinical and research settings as a reliable scale to assess clozapine-related side effects.	[Kitagawa, Kohei; So, Ryuhei; Kodama, Masafumi] Okayama Psychiat Med Ctr, Dept Neuropsychiat, Okayama, Japan; [Nomura, Nobuyuki; Misawa, Fuminari; Takeuchi, Hiroyoshi] Yamanashi Prefectural Kita Hosp, Dept Neuropsychiat, Kofu, Yamanashi, Japan; [Nomura, Nobuyuki; Mizuno, Yuya; Uchida, Hiroyuki; Mimura, Masaru; Takeuchi, Hiroyoshi] Keio Univ, Dept Neuropsychiat, Sch Med, Tokyo, Japan; [Mizuno, Yuya] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England	Keio University; University of London; King's College London	Takeuchi, H (corresponding author), Yamanashi Prefectural Kita Hosp, Dept Neuropsychiat, Kofu, Yamanashi, Japan.; Takeuchi, H (corresponding author), Keio Univ, Dept Neuropsychiat, Sch Med, Tokyo, Japan.	hirotak@dk9.so-net.ne.jp	Nomura, Nobuyuki/AAX-2283-2021; Uchida, Hiroyuki/I-4867-2015	Nomura, Nobuyuki/0000-0001-6516-4573; Uchida, Hiroyuki/0000-0002-0628-7036; Takeuchi, Hiroyoshi/0000-0002-8844-4786	Kobayashi Magobe Memorial Medical Foundation; Inokashira Hospital	Kobayashi Magobe Memorial Medical Foundation; Inokashira Hospital	This research was supported by a grant from Kobayashi Magobe Memorial Medical Foundation to RS and Inokashira Hospital to NN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azorin JM, 2001, AM J PSYCHIAT, V158, P1305, DOI 10.1176/appi.ajp.158.8.1305; Bachmann CJ, 2017, ACTA PSYCHIAT SCAND, V136, P37, DOI 10.1111/acps.12742; Chakos M, 2001, AM J PSYCHIAT, V158, P518, DOI 10.1176/appi.ajp.158.4.518; GROHMANN R, 1989, PSYCHOPHARMACOLOGY, V99, pS101, DOI 10.1007/BF00442571; Hynes C, 2015, SCHIZOPHR RES, V168, P505, DOI 10.1016/j.schres.2015.07.052; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Legge SE, 2016, SCHIZOPHR RES, V174, P113, DOI 10.1016/j.schres.2016.05.002; LEPPIG M, 1989, PSYCHOPHARMACOLOGY, V99, pS77, DOI 10.1007/BF00442565; Lewis SW, 2006, SCHIZOPHRENIA BULL, V32, P715, DOI 10.1093/schbul/sbj067; Lin CC, 2013, J CLIN PSYCHOPHARM, V33, P211, DOI 10.1097/JCP.0b013e31828700c7; MARINKOVIC D, 1994, PROG NEURO-PSYCHOPH, V18, P537, DOI 10.1016/0278-5846(94)90010-8; McEvoy JP, 2006, AM J PSYCHIAT, V163, P600, DOI 10.1176/appi.ajp.163.4.600; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mustafa FA, 2013, J CLIN PSYCHOPHARM, V33, P63, DOI 10.1097/JCP.0b013e31827a813b; NABER D, 1989, PSYCHOPHARMACOLOGY, V99, pS73, DOI 10.1007/BF00442564; NABER D, 1992, BRIT J PSYCHIAT, V160, P54, DOI 10.1192/S0007125000296931; Souza JS, 2013, CNS SPECTRUMS, V18, P82, DOI 10.1017/S1092852912000806; Still DJ, 1996, PSYCHIATR SERV, V47, P1382; Takeuchi H, 2016, PSYCHIAT RES, V244, P415, DOI 10.1016/j.psychres.2016.07.055; Takeuchi H, 2016, J PSYCHIATR RES, V80, P87, DOI 10.1016/j.jpsychires.2016.06.005; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Waddell L, 2008, J PSYCHOPHARMACOL, V22, P238, DOI 10.1177/0269881107087976; Warnez S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-102; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; Young CR, 1998, SCHIZOPHRENIA BULL, V24, P381, DOI 10.1093/oxfordjournals.schbul.a033333	26	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234864	10.1371/journal.pone.0234864	http://dx.doi.org/10.1371/journal.pone.0234864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555706	Green Published, gold			2022-12-27	WOS:000543273200075
J	Mackay, AI; Bailleul, F; Carroll, EL; Andrews-Goff, V; Baker, CS; Bannister, J; Boren, L; Carlyon, K; Donnelly, DM; Double, M; Goldsworthy, SD; Harcourt, R; Holman, D; Lowther, A; Parra, GJ; Childerhouse, SJ				Mackay, Alice I.; Bailleul, Frederic; Carroll, Emma L.; Andrews-Goff, Virginia; Baker, C. Scott; Bannister, John; Boren, Laura; Carlyon, Kris; Donnelly, David M.; Double, Michael; Goldsworthy, Simon D.; Harcourt, Robert; Holman, Dirk; Lowther, Andrew; Parra, Guido J.; Childerhouse, Simon J.			Satellite derived offshore migratory movements of southern right whales (Eubalaena australis) from Australian and New Zealand wintering grounds (vol 15, e0231577, 2020)	PLOS ONE			English	Correction													Carroll, Emma/U-9133-2019	Carroll, Emma/0000-0003-3193-7288; Andrews-Goff, Virginia/0000-0002-4609-7317; Lowther, Andrew/0000-0003-4294-3157; Goldsworthy, Simon/0000-0003-4988-9085				Mackay AI, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231577	1	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0235186	10.1371/journal.pone.0235186	http://dx.doi.org/10.1371/journal.pone.0235186			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555689	gold, Green Published			2022-12-27	WOS:000543273200061
J	Tolu, LB; Ararso, R; Abdulkadir, A; Feyissa, GT; Worku, Y				Tolu, Lemi Belay; Ararso, Roba; Abdulkadir, Abdulfetah; Feyissa, Garumma Tolu; Worku, Yoseph			Perinatal outcome of growth restricted fetuses with abnormal umbilical artery Doppler waveforms compared to growth restricted fetuses with normal umbilical artery Doppler waveforms at a tertiary referral hospital in urban Ethiopia	PLOS ONE			English	Article							VELOCIMETRY	Background Intrauterine growth restriction is defined as a fetal weight below the 10th percentile for a given gestational age and can be identified using umbilical artery Doppler velocimetry which is a non-invasive technique. The objective of this study was to determine the perinatal outcome of growth-restricted fetuses with abnormal umbilical artery Doppler study compared to those with normal umbilical artery Doppler waveforms at a tertiary referral hospital in Ethiopia. Methods A prospective cohort study was conducted among pregnant mothers with fetal growth restriction admitted for labour and delivery from September 2018-February 2019. The data were entered and analyzed using SPSS version 23. After conducting descriptive analysis, exploring the entire data, and checking for, statistical associations between abnormal umbilical artery Doppler and outcome variables, multiple logistic regression was conducted to control for confounders. Results A total of 170 pregnant mothers complicated with growth-restricted fetuses were included in the study, among which 133 were with normal umbilical artery Doppler studies and 37 were with abnormal umbilical artery Doppler studies. Four (3%) of normal and 9(24.3%) of abnormal umbilical artery Doppler studies ended in perinatal death-value = 0.001. Twenty (15%) of normal and 24(64.9%) of abnormal umbilical artery Doppler study neonates required neonatal intensive care admission-value = 0.002. Growth restricted fetuses complicated with abnormal Doppler were two times more likely to require neonatal intensive care unit admissions compared to growth-restricted fetuses with normal umbilical artery Doppler flow, P-value 0.002, (OR = 2.059,95%CI 1.449-2.926). Growth restricted fetuses complicated with abnormal Doppler were four times more likely to end in early neonatal death compared to growth-restricted fetuses with normal umbilical artery Doppler flow, P-value 0.001, (OR = 4.136, 95%CI 3.423-4.998). However, the study is unmatched and there is a possibility of gestational age confounding the result and should be seen with the context of preterm morbidity and mortality. Conclusion The abnormal umbilical artery Doppler waveform is associated with cesarean section delivery, neonatal intensive care unit admission, respiratory distress syndrome, neonatal sepsis, neonatal hyperbilirubinemia, and early neonatal death compared to normal umbilical artery Doppler flow.	[Tolu, Lemi Belay; Ararso, Roba; Abdulkadir, Abdulfetah; Worku, Yoseph] St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia; [Feyissa, Garumma Tolu] Jimma Univ, Dept Hlth Behav & Soc, Jimma, Ethiopia	Jimma University	Tolu, LB (corresponding author), St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia.	lemi.belay@gmail.com	Feyissa, Garumma/AAP-9097-2020; Worku, Yoseph/AAX-3398-2021	Feyissa, Garumma/0000-0001-6179-0024; Worku, Yoseph/0000-0002-6885-0437; Tolu, Lemi Belay/0000-0001-6703-828X				Alfirevic Z, 2017, COCHRANE DATABASE SY; Ali Azmat, 2014, J Ayub Med Coll Abbottabad, V26, P344; Ananth CV, 2007, OBSTET GYNECOL, V110, P128, DOI 10.1097/01.AOG.0000266983.77458.71; [Anonymous], 2016, ETH DEM HLTH SURV 20; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Arora D, 2005, J OBSTETGYNAECOL IND, V55, P138; Berkley E, 2012, AM J OBSTET GYNECOL, V206, P300, DOI 10.1016/j.ajog.2012.01.022; Cappell MS, 2017, OBSTET NORMAL PROBLE, P824; Chauhan SP, 2014, AM J PERINAT, V31, P187, DOI 10.1055/s-0033-1343771; Doctor BA, 2001, AM J OBSTET GYNECOL, V185, P652, DOI 10.1067/mob.2001.116749; Figueras F, 2008, BJOG-INT J OBSTET GY, V115, P590, DOI 10.1111/j.1471-0528.2008.01670.x; GILES WB, 1985, BRIT J OBSTET GYNAEC, V92, P31, DOI 10.1111/j.1471-0528.1985.tb01045.x; Khawar N, 2013, ANN KING EDWARD MED, V19, P216; Kolobo HA, 2019, J CLIN NEONATOL, V8, P232, DOI 10.4103/jcn.JCN_23_19; Lancet Global Health, 2019, LANCET GLOB HEALTH, V7, pe1; Malhotra Neena, 2006, Indian J Med Sci, V60, P311; Oros D, 2011, ULTRASOUND OBST GYN, V37, P191, DOI 10.1002/uog.7738; Rana MJ, 2005, BIOMEDICA, V21, P4; Rekha BR, 2017, INT J REPROD CONTRAC, V6, P955, DOI DOI 10.18203/2320-1770.IJRCOG20170563; Seyam YS, 2002, INT J GYNECOL OBSTET, V77, P131, DOI 10.1016/S0020-7292(02)00027-9; Soregaroli M, 2002, J Matern Fetal Neonatal Med, V11, P199	21	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234810	10.1371/journal.pone.0234810	http://dx.doi.org/10.1371/journal.pone.0234810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555633	gold, Green Published			2022-12-27	WOS:000543273200049
J	Krishnagopal, S; von Coelln, R; Shulman, LM; Girvan, M				Krishnagopal, Sanjukta; von Coelln, Rainer; Shulman, Lisa M.; Girvan, Michelle			Identifying and predicting Parkinson's disease subtypes through trajectory clustering via bipartite networks	PLOS ONE			English	Article							CLINICAL SUBTYPES; HETEROGENEITY; MOTOR; IDENTIFICATION; PROGRESSION; MEDICINE; COHORT	Chronic medical conditions show substantial heterogeneity in their clinical features and progression. We develop the novel data-driven, network-based Trajectory Profile Clustering (TPC) algorithm for 1) identification of disease subtypes and 2) early prediction of subtype/disease progression patterns. TPC is an easily generalizable method that identifies subtypes by clustering patients with similar disease trajectory profiles, based not only on Parkinson's Disease (PD) variable severity, but also on their complex patterns of evolution. TPC is derived from bipartite networks that connect patients to disease variables. Applying our TPC algorithm to a PD clinical dataset, we identify 3 distinct subtypes/patient clusters, each with a characteristic progression profile. We show that TPC predicts the patient's disease subtype 4 years in advance with 72% accuracy for a longitudinal test cohort. Furthermore, we demonstrate that other types of data such as genetic data can be integrated seamlessly in the TPC algorithm. In summary, using PD as an example, we present an effective method for subtype identification in multidimensional longitudinal datasets, and early prediction of subtypes in individual patients.	[Krishnagopal, Sanjukta; Girvan, Michelle] Univ Maryland, College Pk, MD 20742 USA; [von Coelln, Rainer; Shulman, Lisa M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Girvan, Michelle] Santa Fe Inst, Santa Fe, NM 87501 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore; The Santa Fe Institute	Krishnagopal, S (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	sanju33@gmail.com		Girvan, Michelle/0000-0001-7519-2842	UMB-UMD Research and Innovation Seed Grant Program; NSF [DGE-1632976]	UMB-UMD Research and Innovation Seed Grant Program; NSF(National Science Foundation (NSF))	This work was supported in part by the UMB-UMD Research and Innovation Seed Grant Program. S.K. and M.G. also received support for their contributions through NSF award DGE-1632976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Braun P, 2008, P NATL ACAD SCI USA, V105, P9849, DOI 10.1073/pnas.0805644105; Castaldi PJ, 2014, THORAX, V69, P415, DOI 10.1136/thoraxjnl-2013-203601; Chan SY, 2012, CIRC RES, V111, P359, DOI 10.1161/CIRCRESAHA.111.258541; Cooper CA, 2017, ANN CLIN TRANSL NEUR, V4, P15, DOI 10.1002/acn3.371; Davis AA, 2016, NEUROBIOL AGING, V37, DOI 10.1016/j.neurobiolaging.2015.09.014; Fereshtehnejad SM, 2017, BRAIN, V140, P1959, DOI 10.1093/brain/awx118; Fereshtehnejad SM, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0738-x; Fereshtehnejad SM, 2015, JAMA NEUROL, V72, P863, DOI 10.1001/jamaneurol.2015.0703; Foltynie T, 2002, J NEUROL, V249, P138, DOI 10.1007/PL00007856; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Ivanov PC, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/10/100201; Iwaki H, 2019, MOVEMENT DISORD, V34, P1839, DOI 10.1002/mds.27845; Iwaki H, 2019, NEUROL-GENET, V5, DOI 10.1212/NXG.0000000000000348; Javed MA, 2018, J NETW COMPUT APPL, V108, P87, DOI 10.1016/j.jnca.2018.02.011; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Latourelle JC, 2017, LANCET NEUROL, V16, P908, DOI 10.1016/S1474-4422(17)30328-9; Lawton M, 2018, J NEUROL NEUROSUR PS, V89, P1279, DOI 10.1136/jnnp-2018-318337; Lees AJ, 2009, LANCET, V374, P684; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Marras C, 2013, J NEUROL NEUROSUR PS, V84, P409, DOI 10.1136/jnnp-2012-303455; Nalls MA, 2019, LANCET NEUROL, V18, P1091, DOI 10.1016/S1474-4422(19)30320-5; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Rajput AH, 2017, NEUROLOGY, V89, P138, DOI 10.1212/WNL.0000000000004078; Santiago JA, 2014, TRENDS MOL MED, V20, P694, DOI 10.1016/j.molmed.2014.10.002; Thenganatt MA, 2014, JAMA NEUROL, V71, P499, DOI 10.1001/jamaneurol.2013.6233; Vinayagam A, 2016, P NATL ACAD SCI USA, V113, P4976, DOI 10.1073/pnas.1603992113; von Coelln R, 2016, CURR OPIN NEUROL, V29, P727, DOI 10.1097/WCO.0000000000000384	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0233296	10.1371/journal.pone.0233296	http://dx.doi.org/10.1371/journal.pone.0233296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555729	Green Published, gold, Green Submitted			2022-12-27	WOS:000542759600059
J	Xiong, ZQ; Yu, QZ; Sun, T; Chen, W; Wu, YH; Yin, J				Xiong, ZhengQiang; Yu, Qiuze; Sun, Tao; Chen, Wen; Wu, Yuhao; Yin, Jie			Super-resolution reconstruction of real infrared images acquired with unmanned aerial vehicle	PLOS ONE			English	Article							HIGH-RESOLUTION IMAGE; DISCRETE; SEQUENCE; FRAMES	Super-resolution (SR) technology provides a far promising computational imaging approach in obtaining a high-resolution (HR) image (or image sequences) from observed multiple low-resolution (LR) images by incorporating complementary information. In this paper, a three-stage SR method is proposed to generate a HR image from infrared (IR) LR Images acquired with Unmanned Aerial Vehicle (UAV). The proposed method integrates a high-level image capturing process and a low-level SR process. In this integrated process, we incorporate UAV path optimization, sub-pixel image registration, and sparseness constraint into a computational imaging framework of a region of interest (ROI). To refine ROI complementary feathers, we design an optimal flight control scheme to acquire adequate image sequences from multi-angles. In particular, a phase correlation approach achieving reliable sub-pixel image feature matching is adapted, on the basis of which an effective sparseness regularization model is built to enhance the fine structures of the IR image. Unlike most traditional multiple-frame SR algorithms that mainly focus on signal processing and achieve good performances when using standard test datasets, the performed experiments with real-life IR sequences indicate the three-stage SR method can also deal with practical LR IR image sequences collected by UAVs. The experimental results demonstrate that the proposed method is capable of generating HR images with good performance in terms of edge preservation and detail enhancement.	[Xiong, ZhengQiang; Yu, Qiuze; Sun, Tao; Wu, Yuhao; Yin, Jie] Wuhan Univ, Elect Informat Sch, Wuhan, Peoples R China; [Chen, Wen] Shanghai Inst Spaceflight Control Technol, Shanghai Key Lab Aerosp Intelligent Control Techn, Shanghai, Peoples R China	Wuhan University	Sun, T (corresponding author), Wuhan Univ, Elect Informat Sch, Wuhan, Peoples R China.	suntao@whu.edu.cn		Sun, Tao/0000-0001-6006-2762	Science and Technology on Near-Surface Detection Laboratory Foundation of China [614241409041317]; National Key R&D Program of China [2018YFB10046]; Innovation Fund of Shanghai Academy of Spaceflight Technology [SAST2017-080]	Science and Technology on Near-Surface Detection Laboratory Foundation of China; National Key R&D Program of China; Innovation Fund of Shanghai Academy of Spaceflight Technology	This work was supported in part by the Science and Technology on Near-Surface Detection Laboratory Foundation of China (614241409041317) to TS, the National Key R&D Program of China (2018YFB10046) to ZQX, and the Innovation Fund of Shanghai Academy of Spaceflight Technology (SAST2017-080) to WC.	[Anonymous], 2007, PLOS ONE, V2, pe779; Aziz SA, 2009, T ASABE, V52, P1057, DOI 10.13031/2013.27775; Bose NK, 2001, INT S CIRC SYST; Chainais P, 2011, J MATH IMAGING VIS, V39, P28, DOI 10.1007/s10851-010-0222-6; Chan TF, 2007, APPL COMPUT HARMON A, V23, P3, DOI 10.1016/j.acha.2006.09.005; Chappalli MB, 2005, IEEE SIGNAL PROC LET, V12, P772, DOI 10.1109/LSP.2005.856875; CLARK JJ, 1985, IEEE T ACOUST SPEECH, V33, P1151, DOI 10.1109/TASSP.1985.1164714; De Lathauwer L, 2000, SIAM J MATRIX ANAL A, V21, P1253, DOI 10.1137/S0895479896305696; Demirel H, 2011, IEEE T IMAGE PROCESS, V20, P1458, DOI 10.1109/TIP.2010.2087767; Dong C, 2016, IEEE T PATTERN ANAL, V38, P295, DOI 10.1109/TPAMI.2015.2439281; Evgeniou T, 2000, ADV COMPUT MATH, V13, P1, DOI 10.1023/A:1018946025316; Hardie RC, 1998, OPT ENG, V37, P247, DOI 10.1117/1.601623; Hennings-Yeomans P. H., 2008, COMPUTER VISION PATT; Hong M, 1997, INT C IM PROC; Hu Y, 2011, IEEE T IMAGE PROCESS, V20, P433, DOI 10.1109/TIP.2010.2063437; Kang MG, 1998, OPT ENG, V37, P2953, DOI 10.1117/1.601883; Kim SP, 1993, IEEE T IMAGE PROCESS, V2, P534, DOI 10.1109/83.242363; KIM SP, 1990, IEEE T ACOUST SPEECH, V38, P1013, DOI 10.1109/29.56062; KIM SP, 1990, IEE PROC-F, V137, P197, DOI 10.1049/ip-f-2.1990.0030; Lin ZC, 2004, IEEE T PATTERN ANAL, V26, P83, DOI 10.1109/TPAMI.2004.1261081; Luo H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194690; Obuchi T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188012; Schultz RR, 1996, IEEE T IMAGE PROCESS, V5, P996, DOI 10.1109/83.503915; Shen HF, 2007, IEEE T IMAGE PROCESS, V16, P479, DOI 10.1109/TIP.2006.888334; Shi XY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212735; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Solomon O, 2018, OPT EXPRESS, V26, P18238, DOI 10.1364/OE.26.018238; Sroubek F, 2007, IEEE T IMAGE PROCESS, V16, P2322, DOI 10.1109/TIP.2007.903256; Sun T, 2013, OPT LETT, V38, P3471, DOI [10.1364/OL.38.083471, 10.1364/OL.38.003471]; Tian J, 2010, J VIS COMMUN IMAGE R, V21, P232, DOI 10.1016/j.jvcir.2010.01.001; Tsai R.Y., 1984, ADV COMPUTER VISION, V1, P317; Wang X, 2018, 2018 IEEE CVF C COMP; Zhao S, 2003, P IEEE INT C IMAGE P, V2, P983	35	2	2	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234775	10.1371/journal.pone.0234775	http://dx.doi.org/10.1371/journal.pone.0234775			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555724	Green Published, gold			2022-12-27	WOS:000542759600036
J	Du, XY; Wang, YB; Liu, MX; Liu, XQ; Jiang, ZW; Zhao, LL; Tang, Y; Sun, YX; Zhang, XY; Liu, DL; Song, LQ				Du, Xiaoyun; Wang, Yanbo; Liu, Minxiao; Liu, Xueqing; Jiang, Zhongwu; Zhao, Lingling; Tang, Yan; Sun, Yanxia; Zhang, Xueyong; Liu, Daliang; Song, Laiqing			The assessment of epigenetic diversity, differentiation, and structure in the 'Fuji' mutation line implicates roles of epigenetic modification in the occurrence of different mutant groups as well as spontaneous mutants	PLOS ONE			English	Article							DNA METHYLATION PATTERNS; AMPLIFICATION; MSAP; PIGMENTATION; ANTHOCYANIN; PROGRAM; GENOME; MDMYB1; PLANTS; SPORT	The 'Fuji' line includes many varieties with a similar genetic background and consistent inducement factors with epigenetic occurrence, thus it may be considered an ideal candidate for epigenetic research. In this study, 91 bud mutations of 'Fuji' apple were used as the test materials. Using the genetic variation within 'Fuji' as the control, the characteristics of epigenetic variation at different levels in both varieties and mutant groups were examined. The results showed that: (1) the global genomic DNA methylation level of the 91 bud mutants of 'Fuji' ranged from 29.120%-45.084%, with an average of 35.910%. Internal cytosine methylation was the main DNA methylation pattern. Regarding the variation of methylation patterns of 'Fuji' mutants, the vast majority of loci maintained the original methylation pattern existed in 'Fuji'. CHG methylation variation was the main type of variation; (2) the variation in methylation patterns between the mutant groups was greater than that of methylation levels. Among these patterns, the variation in CHG methylation patterns (including CHG hypermethylation and CHG demethylation) was expected to be dominant. The observed variation in methylation levels was more important in the Color mutant group; however, the variation in methylation patterns was more obvious in both the early maturation and Spur mutant groups. Moreover, the range of variation in the Early-maturation group was much wider than that in the Spur mutant group; (3) epigenetic diversity and genetic diversity were both low between the mutant groups. In the 'Fuji' mutant groups, there was few correlation between genetic and epigenetic variation, and epigenetic differentiation resulted in more loci with moderate or greater differentiation; (4) the purifying selection seemed to play a major role in the differentiation of different groups of 'Fuji' mutants (65.618%), but epigenetic diversity selection still occurred at nearly 35% of loci. Sixteen epigenetic outlier loci were detected.	[Du, Xiaoyun; Wang, Yanbo; Liu, Minxiao; Liu, Xueqing; Jiang, Zhongwu; Zhao, Lingling; Tang, Yan; Sun, Yanxia; Zhang, Xueyong; Liu, Daliang; Song, Laiqing] Yantai Acad Agr Sci, Yantai, Shandong, Peoples R China; [Jiang, Zhongwu; Zhao, Lingling] Yantai Univ, Yantai, Shandong, Peoples R China	Yantai University	Song, LQ (corresponding author), Yantai Acad Agr Sci, Yantai, Shandong, Peoples R China.	sdslq@126.com	Wang, Yin/HCI-9352-2022; wangwangwang, yuanyaun/HHN-6432-2022; Wang, Yu/GZL-9655-2022; wang, yanbo/GSN-0409-2022; Wang, Yuan/HHC-1520-2022; wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022		"Double-Hundred Talent Plan" on 100 Foreign Experts [WST2018013]; 100 Foreign Expert Teams Introduction in Shandong Province [WST2018013]; Key Research and Development project of Shandong Province [2018GHZ005]; Shandong Provincial Agricultural Variety Improvement Project [2019LZGC007]; Taishan scholar seed industry talent team construction project in Shandong Province	"Double-Hundred Talent Plan" on 100 Foreign Experts; 100 Foreign Expert Teams Introduction in Shandong Province; Key Research and Development project of Shandong Province; Shandong Provincial Agricultural Variety Improvement Project; Taishan scholar seed industry talent team construction project in Shandong Province	This research was supported by "Double-Hundred Talent Plan" on 100 Foreign Experts and 100 Foreign Expert Teams Introduction in Shandong Province (WST2018013), Key Research and Development project of Shandong Province (2018GHZ005), Shandong Provincial Agricultural Variety Improvement Project (2019LZGC007), and Taishan scholar seed industry talent team construction project in Shandong Province.	Bai SL, 2016, PLANTA, V244, P573, DOI 10.1007/s00425-016-2524-4; Balao F, 2018, PLANT BIOLOGY, V20, P38, DOI 10.1111/plb.12594; Baranek M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165749; Bartels A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072144; Chen C., 2020, TBTOOLS TOOLKIT BIOL, V289660, P289660, DOI DOI 10.1101/289660; Cheng JF, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1587-x; Cho HJ, 2020, SCI HORTIC-AMSTERDAM, V261, DOI 10.1016/j.scienta.2019.108944; Chwialkowska K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02056; Daccord N, 2017, NAT GENET, V49, P1099, DOI 10.1038/ng.3886; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eccleston A, 2007, NATURE, V447, P395, DOI 10.1038/447395a; El-Sharkawy I, 2015, J EXP BOT, V66, P7359, DOI 10.1093/jxb/erv433; Finnegan EJ, 2000, CURR OPIN GENET DEV, V10, P217, DOI 10.1016/S0959-437X(00)00061-7; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foster TM, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0062-x; Guarino F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215096; Guarino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131480; Huang H, 2019, P NATL ACAD SCI USA, V116, P1430, DOI 10.1073/pnas.1815441116; IBM Corp, REL 2013 IBM SPSS ST; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jeffreys H., 1939, OXFORD CLASSIC TEXTS; Jiang SH, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5499-2; Jiang SH, 2020, PLANT BIOTECHNOL J, V18, P1736, DOI 10.1111/pbi.13337; Jing Shixi works collection Editorial Board, 2009, JING SHIXI WORKS COL, P24; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Kapoor A, 2005, FEBS LETT, V579, P5889, DOI 10.1016/j.febslet.2005.08.039; Lamo K., 2017, INT J CURR MICROBIOL, V6, P3620, DOI [10.20546/ijcmas.2017.612.418, DOI 10.20546/IJCMAS.2017.612.418]; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li LG, 2008, ENHANCEMENT IDENTIFI; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Mozgova I., 2019, EPIGENETICS PLANTS A, P1, DOI [10.1007/978-3-030-14760-0_1, DOI 10.1007/978-3-030-14760-0_1]; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Niederhuth CE, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1059-0; Noyer JL, 2005, GENETICA, V124, P61, DOI 10.1007/s10709-004-7319-z; Okie W.R., 1998, HDB PEACH NECTARINE; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez-Figueroa A, 2013, MOL ECOL RESOUR, V13, P522, DOI 10.1111/1755-0998.12064; Pritchard J, 2003, DOCUMENTATION STRUCT; Qian MJ, 2014, PHYTOCHEMISTRY, V107, P16, DOI 10.1016/j.phytochem.2014.08.001; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; ROHLF F, 2000, NTSYS NUMERICAL TAXO; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saez-Laguna E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103145; Sahu PP, 2013, PLANT CELL REP, V32, P1151, DOI 10.1007/s00299-013-1462-x; Schellenbaum P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-78; Schulz B, 2013, MOL ECOL RESOUR, V13, P642, DOI 10.1111/1755-0998.12100; Shamel AD, 1936, J HERED, V27, P487, DOI 10.1093/oxfordjournals.jhered.a104171; Sheriff O, 2018, COGENT FOOD AGR, V4, DOI 10.1080/23311932.2018.1459062; Shu HR, 1999, APPLE; Song L.Q., 2016, CHINA FRUIT VEGETABL, V36, P54; Telias A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-93; Vogt G, 2017, ENVIRON EPIGENETICS, V3, DOI 10.1093/eep/dvx002; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang ZG, 2013, PLANT PHYSIOL, V162, P885, DOI 10.1104/pp.113.214700; Whalley K, 2007, NAT REV NEUROSCI, V8, P323, DOI 10.1038/nrn2133; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu JD, 2018, PLANT BIOTECHNOL J, V16, P672, DOI 10.1111/pbi.12820; Xu JD, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00607; Xu YT, 2012, EUPHYTICA, V185, P157, DOI 10.1007/s10681-011-0494-y; Zhang CF, 2013, INVESTIGATION FUJI A; Zhang HM, 2018, NAT REV MOL CELL BIO, V19, P489, DOI 10.1038/s41580-018-0016-z; Zhang LY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09518-x; Zhou BB, 2014, MODIFICATION DNA MET; 2016, CIRE ANTILLES GUYANE, V4, P1	64	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235073	10.1371/journal.pone.0235073	http://dx.doi.org/10.1371/journal.pone.0235073			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584862	Green Published, gold			2022-12-27	WOS:000545747200043
J	Gudmundsson, L; Vohryzek, J; Fornari, E; Clarke, S; Hagmann, P; Crottaz-Herbette, S				Gudmundsson, Louis; Vohryzek, Jakub; Fornari, Eleonora; Clarke, Stephanie; Hagmann, Patric; Crottaz-Herbette, Sonia			A brief exposure to rightward prismatic adaptation changes resting-state network characteristics of the ventral attentional system	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; SPATIAL NEGLECT; STROKE PATIENTS; BRAIN; CORTEX; ORGANIZATION; LESIONS; DORSAL; OPTIMIZATION; REGISTRATION	A brief session of rightward prismatic adaptation (R-PA) has been shown to alleviate neglect symptoms in patients with right hemispheric damage, very likely by switching hemispheric dominance of the ventral attentional network (VAN) from the right to the left and by changing task-related activity within the dorsal attentional network (DAN). We have investigated this very rapid change in functional organisation with a network approach by comparing resting-state connectivity before and after a brief exposure i) to R-PA (14 normal subjects; experimental condition) or ii) to plain glasses (12 normal subjects; control condition). A whole brain analysis (comprising 129 regions of interest) highlighted R-PA-induced changes within a bilateral, fronto-temporal network, which consisted of 13 nodes and 11 edges; all edges involved one of 4 frontal nodes, which were part of VAN. The analysis of network characteristics within VAN and DAN revealed a R-PA-induced decrease in connectivity strength between nodes and a decrease in local efficiency within VAN but not within DAN. These results indicate that the resting-state connectivity configuration of VAN is modulated by R-PA, possibly by decreasing its modularity.	[Gudmundsson, Louis; Vohryzek, Jakub; Hagmann, Patric] CHU Vaudois, Dept Radiol, Lausanne, Switzerland; [Gudmundsson, Louis; Vohryzek, Jakub; Fornari, Eleonora; Clarke, Stephanie; Hagmann, Patric; Crottaz-Herbette, Sonia] Univ Lausanne, Lausanne, Switzerland; [Gudmundsson, Louis; Clarke, Stephanie; Crottaz-Herbette, Sonia] CHU Vaudois, Neuropsychol & Neurorehabil Serv, Lausanne, Switzerland; [Vohryzek, Jakub] Univ Oxford, Dept Psychiat, Hedonia Res Grp, Oxford, England; [Fornari, Eleonora] CHU Vaudois, CIBM Ctr Imagerie Biomed, Dept Radiol, Lausanne, Switzerland; [Hagmann, Patric] Ecole Polytech Fed Lausanne, Signal Proc Lab 5 LTS5, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Oxford; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Crottaz-Herbette, S (corresponding author), Univ Lausanne, Lausanne, Switzerland.; Crottaz-Herbette, S (corresponding author), CHU Vaudois, Neuropsychol & Neurorehabil Serv, Lausanne, Switzerland.	sonia.crottaz-herbette@chuv.ch	Crottaz-Herbette, Sonia/AAG-8546-2021; Vohryzek, Jakub/GQB-3939-2022	Crottaz-Herbette, Sonia/0000-0003-3944-3952; 	Swiss National Science Foundation [FNS 320030-159708, FNS PMPDP3_129028]; Gianni Biaggi de Blasys Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gianni Biaggi de Blasys Foundation	This work was supported by the Swiss National Science Foundation (http://www.snf.ch) grants to S.C. (FNS 320030-159708) and S.C-H. (Marie-Heim-Vogtlin fellowship FNS PMPDP3_129028), and by the Gianni Biaggi de Blasys Foundation to S.C-H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani M, 2003, NEUROIMAGE, V20, pS66, DOI 10.1016/j.neuroimage.2003.09.007; Anticevic A, 2010, NEUROIMAGE, V49, P2638, DOI 10.1016/j.neuroimage.2009.11.008; Arcaro MJ, 2009, J NEUROSCI, V29, P10638, DOI 10.1523/JNEUROSCI.2807-09.2009; Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; Association Clarke S., 1994, P BIOL SCI, V257, P87, DOI [10.1098/rspb.1994.0098, DOI 10.1098/RSPB.1994.0098]; Bednarz HM, 2017, BRAIN LANG, V169, P39, DOI 10.1016/j.bandl.2017.01.002; Berberovic N, 2003, NEUROPSYCHOLOGIA, V41, P493, DOI 10.1016/S0028-3932(02)00090-8; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; BURKHALTER A, 1989, P NATL ACAD SCI USA, V86, P1071, DOI 10.1073/pnas.86.3.1071; Calford MB, 2002, NEUROSCIENCE, V111, P709, DOI 10.1016/S0306-4522(02)00022-2; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Clarke S, 2016, NEUROPSYCHOLOGIA, V92, P31, DOI 10.1016/j.neuropsychologia.2016.06.022; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crottaz-Herbette S, 2017, NEUROPSYCHOLOGIA, V104, P54, DOI 10.1016/j.neuropsychologia.2017.08.005; Crottaz-Herbette S, 2014, J NEUROSCI, V34, P11803, DOI 10.1523/JNEUROSCI.3184-13.2014; Daducci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048121; Danckert J, 2008, EUR J NEUROSCI, V28, P1696, DOI 10.1111/j.1460-9568.2008.06460.x; de Haan B, 2015, CEREB CORTEX, V25, P2321, DOI 10.1093/cercor/bhu046; de Reus MA, 2013, NEUROIMAGE, V70, P402, DOI 10.1016/j.neuroimage.2012.12.066; DiVirgilio G, 1997, HUM BRAIN MAPP, V5, P347, DOI 10.1002/(SICI)1097-0193(1997)5:5<347::AID-HBM3>3.0.CO;2-3; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fornito A, 2011, BIOL PSYCHIAT, V70, P64, DOI 10.1016/j.biopsych.2011.02.019; Fortis P, 2010, NEUROPSYCHOLOGY, V24, P681, DOI 10.1037/a0019476; Frassinetti F, 2002, BRAIN, V125, P608, DOI 10.1093/brain/awf056; Freeze J, 2018, PROCEEDINGS OF THE 51ST ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES (HICSS), P913; Gallen CL, 2019, TRENDS COGN SCI, V23, P293, DOI 10.1016/j.tics.2019.01.014; Gallen CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169015; Galuske RAW, 2000, SCIENCE, V289, P1946, DOI 10.1126/science.289.5486.1946; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hakamata Y, 2018, J AFFECT DISORDERS, V238, P472, DOI 10.1016/j.jad.2018.06.018; Hatada Y, 2006, EXP BRAIN RES, V169, P417, DOI 10.1007/s00221-005-0159-y; Indovina I, 2004, MAGN RESON IMAGING, V22, P1477, DOI 10.1016/j.mri.2004.10.016; Innocenti GM, 2017, BRAIN STRUCT FUNCT, V222, P1169, DOI 10.1007/s00429-016-1266-1; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Keane S, 2006, ARCH PHYS MED REHAB, V87, P1668, DOI 10.1016/j.apmr.2006.08.322; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Maravita A, 2003, NEUROLOGY, V60, P1829, DOI 10.1212/WNL.60.11.1829; McIntosh RD, 2002, CORTEX, V38, P309, DOI 10.1016/S0010-9452(08)70662-2; Mizuno K, 2011, NEUROREHAB NEURAL RE, V25, P711, DOI 10.1177/1545968311407516; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Panico F, 2020, CORTEX, V123, P57, DOI 10.1016/j.cortex.2019.10.003; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, J NEUROSCI, V4, P1863; Rode G, 2001, NEUROPSYCHOLOGIA, V39, P1250, DOI 10.1016/S0028-3932(01)00064-1; Rode G, 1998, BEHAV NEUROL, V11, P251; Rode G, 2006, NEUROPSYCHOLOGIA, V44, P2487, DOI 10.1016/j.neuropsychologia.2006.04.002; Rode G, 2006, RESTOR NEUROL NEUROS, V24, P347; Rode Gilles, 2003, Prog Brain Res, V142, P273; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Rushworth MFS, 2001, J COGNITIVE NEUROSCI, V13, P698, DOI 10.1162/089892901750363244; Sacco CB, 2009, ACTA NEUROBIOL EXP, V69, P469; Saevarsson S, 2009, NEUROPSYCHOLOGIA, V47, P717, DOI 10.1016/j.neuropsychologia.2008.11.026; Saj A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079938; Serino A, 2007, NEUROPSYCHOL REHABIL, V17, P657, DOI 10.1080/09602010601052006; Shiraishi H, 2008, NEUROREHABILITATION, V23, P137; Shiraishi H, 2010, NEUROREHABILITATION, V27, P165, DOI 10.3233/NRE-2010-0593; Siegel JS, 2018, CORTEX, V101, P44, DOI 10.1016/j.cortex.2017.12.019; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Sporns O, 2012, DISCOVERING HUMAN CO; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Sporns O, 2016, ANNU REV PSYCHOL, V67, P613, DOI 10.1146/annurev-psych-122414-033634; Striemer CL, 2010, TRENDS COGN SCI, V14, P308, DOI 10.1016/j.tics.2010.04.001; Tardif E, 2001, EUR J NEUROSCI, V13, P1045, DOI 10.1046/j.0953-816x.2001.01456.x; Tardif E, 2007, CEREB CORTEX, V17, P2949, DOI 10.1093/cercor/bhm021; Tilikete C, 2001, CURR BIOL, V11, P524, DOI 10.1016/S0960-9822(01)00151-8; Tissieres I, 2018, BRAIN STRUCT FUNCT, V223, P1459, DOI 10.1007/s00429-017-1572-2; Tissieres I, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/8721240; Tsujimoto K, 2019, DATA BRIEF, V22, P583, DOI 10.1016/j.dib.2018.12.053; Tsujimoto K, 2019, CORTEX, V119, P594, DOI 10.1016/j.cortex.2018.10.018; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; Vangkilde S, 2010, NEUROPSYCHOLOGIA, V48, P1994, DOI 10.1016/j.neuropsychologia.2010.03.020; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Vossel S, 2012, J NEUROSCI, V32, P10637, DOI 10.1523/JNEUROSCI.0414-12.2012; WEINER MJ, 1983, NEUROLOGY, V33, P766, DOI 10.1212/WNL.33.6.766; Wilf M, 2019, NEUROIMAGE, V200, P210, DOI 10.1016/j.neuroimage.2019.06.050; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	82	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234382	10.1371/journal.pone.0234382	http://dx.doi.org/10.1371/journal.pone.0234382			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584824	Green Published, gold			2022-12-27	WOS:000545747200054
J	Roquelaure, Y; Garlantezec, R; Rousseau, V; Descatha, A; Evanoff, B; Mattioli, S; Goldberg, M; Zins, M; Bodin, J				Roquelaure, Yves; Garlantezec, Ronan; Rousseau, Vincent; Descatha, Alexis; Evanoff, Bradley; Mattioli, Stefano; Goldberg, Marcel; Zins, Marie; Bodin, Julie			Carpal tunnel syndrome and exposure to work-related biomechanical stressors and chemicals: Findings from the Constances cohort	PLOS ONE			English	Article							RISK-FACTORS; NEUROTOXICITY; SURVEILLANCE; ASSOCIATIONS; ENTRAPMENT; PREVALENCE	Objective To investigate the effects of co-exposure to biomechanical wrist stressors and chemicals on the risk of CTS in a large cohort of French workers. Methods Prospective study using the data collected at baseline and at the first 12 month-follow-up for the 18,018 participants included in the population-based Constances cohort between 2012 and 2015. CTS at follow-up and exposure to biomechanical wrist stressors and chemicals at baseline were assessed using a self-administered questionnaire. Associations between CTS and co-exposure to biomechanical wrist stressors and chemicals were studied using multivariate logistic regression models, adjusted for personal/medical factors. Results 184 men (2.1%, 95%CI 1.8-2.4) and 331 women (3.6%, 3.2-3.9) free from chronic hand symptoms at baseline declared suffering from unilateral/bilateral CTS at follow-up. A potentiating effect of co-exposure to biomechanical wrist stressors and chemicals on the risk of CTS was found for both genders, with higher OR in the co-exposure group (OR = 3.38 [2.29-5.01] in men and OR = 4.12 [2.73-6.21] in women) than in the biomechanical exposure group (OR = 2.14 [1.51-3.03] in men and OR = 2.19 [1.72-2.78] in women) compared to no exposure group. Conclusions The study showed an association between CTS and co-exposure to biomechanical wrist stressors and chemicals, after adjustment for the main personal and medical factors. This finding should be confirmed using more objective case definition of CTS and assessment of the chemical exposure before drawing conclusions on the possible synergistic effects of mechanical stressors and chemical on the median nerve.	[Roquelaure, Yves; Rousseau, Vincent; Descatha, Alexis; Bodin, Julie] Univ Angers, Univ Rennes, Irset Inst Rech Sante Prime, CHU Angers, Angers, France; [Garlantezec, Ronan; Descatha, Alexis] Univ Rennes, INSERM, CHU Rennes, Rennes, France; [Rousseau, Vincent; Descatha, Alexis; Goldberg, Marcel; Zins, Marie] INSERM UMS 011, Populat Based Epidemiol Cohorts Unit, Paris, France; [Rousseau, Vincent; Descatha, Alexis; Goldberg, Marcel; Zins, Marie] Paris Descartes Univ, Paris, France; [Evanoff, Bradley] Washington Univ, Div Gen Med Sci, Sch Med, St Louis, MO USA; [Mattioli, Stefano] Univ Bologna, Dept Med & Surg Sci, Occupat Med, Bologna, Italy	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Washington University (WUSTL); University of Bologna	Bodin, J (corresponding author), Univ Angers, Univ Rennes, Irset Inst Rech Sante Prime, CHU Angers, Angers, France.	julie.bodin@univ-angers.fr	BODIN, Julie/J-8673-2015; Zins, Marie/AAX-6551-2021; ronan, Garlantezec/ABF-7638-2020; ROQUELAURE, Yves/J-8208-2015; Goldberg, Marcel/I-7834-2012	BODIN, Julie/0000-0002-8994-4870; Mattioli, Stefano/0000-0002-9639-7430; ROQUELAURE, Yves/0000-0001-6918-0909; Goldberg, Marcel/0000-0002-6161-5880	Caisse Nationale d'Assurance Maladie (CNAM); French Ministry of Health; Ministry of Research; Institut national de la sante et de la recherche medicale; French National Research Agency [ANR-11-INBS-0002]; MSD; AstraZeneca; Lundbeck; French National Research Program for Environmental and Occupational Health of Anses [EST-2014/1/077]	Caisse Nationale d'Assurance Maladie (CNAM); French Ministry of Health; Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Institut national de la sante et de la recherche medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); French National Research Agency(French National Research Agency (ANR)); MSD; AstraZeneca(AstraZeneca); Lundbeck(Lundbeck Corporation); French National Research Program for Environmental and Occupational Health of Anses	The CONSTANCES Cohort Study is supported by the Caisse Nationale d'Assurance Maladie (CNAM), the French Ministry of Health, the Ministry of Research, the Institut national de la sante et de la recherche medicale. CONSTANCES benefits from a grant from the French National Research Agency [grant number ANR-11-INBS-0002] and is also partly funded by MSD, AstraZeneca and Lundbeck. This work was also supported by the French National Research Program for Environmental and Occupational Health of Anses (EST-2014/1/077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	[Anonymous], 2010, MOV DISORD S1, V25, pS104; Barcenilla A, 2012, RHEUMATOLOGY, V51, P250, DOI 10.1093/rheumatology/ker108; Bertin M, 2020, J OCCUP HEALTH, V62, DOI 10.1002/1348-9585.12090; Bland JDP, 2005, MUSCLE NERVE, V32, P527, DOI 10.1002/mus.20408; Bland JDP, 2003, J NEUROL NEUROSUR PS, V74, P1674, DOI 10.1136/jnnp.74.12.1674; BLEECKER ML, 1986, J OCCUP ENVIRON MED, V28, P991, DOI 10.1097/00043764-198610000-00018; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Calvert GM, 1998, AM J PUBLIC HEALTH, V88, P1774, DOI 10.2105/AJPH.88.12.1774; da Costa BR, 2010, AM J IND MED, V53, P285, DOI 10.1002/ajim.20750; Dale AM, 2013, SCAND J WORK ENV HEA, V39, P495, DOI 10.5271/sjweh.3351; de Cabo EE, 2003, EUR J EPIDEMIOL, V18, P983, DOI 10.1023/A:1025899506009; Goldberg M, 2017, OCCUP ENVIRON MED, V74, P66, DOI 10.1136/oemed-2016-103678; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Harris-Adamson C, 2016, OCCUP ENVIRON MED, V73, P727, DOI 10.1136/oemed-2016-103634; Harris-Adamson C, 2013, OCCUP ENVIRON MED, V70, P529, DOI 10.1136/oemed-2013-101365; Horinouchi S, 2014, J DIABETES INVEST, V5, P709, DOI 10.1111/jdi.12211; Koch P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-37; Kozak A, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0685-0; Li H, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0202-y; Li K, 2015, CLIN NEUROPHYSIOL, V126, P194, DOI 10.1016/j.clinph.2014.05.004; LoPachin RM, 2015, NEUROSCI LETT, V596, P78, DOI 10.1016/j.neulet.2014.08.054; Mansfield Michael, 2018, Hand (N Y), V13, P501, DOI 10.1177/1558944717736398; Mattioli S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-343; Mattioli S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-374; Mondelli M, 2002, NEUROLOGY, V58, P289, DOI 10.1212/WNL.58.2.289; Mondelli M, 2016, ARCH PHYS MED REHAB, V97, P1456, DOI 10.1016/j.apmr.2016.03.028; Nguyen THY, 2018, SAF HEALTH WORK-KR, V9, P239, DOI 10.1016/j.shaw.2018.04.002; Nora DB, 2007, BRAZ J MED BIOL RES, V40, P81, DOI 10.1590/S0100-879X2007000100011; Nordstrom DL, 1997, OCCUP ENVIRON MED, V54, P734, DOI 10.1136/oem.54.10.734; Ophir A, 2014, NEUROTOXICOLOGY, V45, P338, DOI 10.1016/j.neuro.2014.08.004; Palmer KT, 2011, BEST PRACT RES CL RH, V25, P15, DOI 10.1016/j.berh.2011.01.014; Park SK, 2012, ARCH ENVIRON OCCUP H, V67, P78, DOI 10.1080/19338244.2011.573022; Petit A, 2015, APPL ERGON, V47, P1, DOI 10.1016/j.apergo.2014.08.007; Pourmemari MH, 2014, MUSCLE NERVE, V49, P345, DOI 10.1002/mus.23922; Richardson JR, 2019, ACTA NEUROPATHOL, V138, P343, DOI 10.1007/s00401-019-02033-9; Roquelaure Y, 2017, SCAND J WORK ENV HEA, V43, P75, DOI 10.5271/sjweh.3594; Roquelaure Y, 2016, SAF HEALTH WORK-KR, V7, P171, DOI 10.1016/j.shaw.2016.02.001; Rota E, 2016, WORLD J DIABETES, V7, P342, DOI 10.4239/wjd.v7.i17.342; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Schmid AB, 2011, MANUAL THER, V16, P557, DOI 10.1016/j.math.2011.05.005; Shiri R, 2016, SCAND J RHEUMATOL, V45, P339, DOI 10.3109/03009742.2015.1114141; Shiri R, 2015, OBES REV, V16, P1094, DOI 10.1111/obr.12324; Siegrist J, 2019, INT ARCH OCC ENV HEA, V92, P467, DOI 10.1007/s00420-018-1374-8; Silverstein B, 2009, SCAND J WORK ENV HEA, V35, P113, DOI 10.5271/sjweh.1309; SIMONSEN L, 1994, SCAND J WORK ENV HEA, V20, P1; Sluiter JK, 2001, SCAND J WORK ENV HEA, V27, P1; Spencer P, 2000, EXPT CLIN NEUROTOXIC; van Rijn RM, 2009, SCAND J WORK ENV HEA, V35, P19, DOI 10.5271/sjweh.1306; van Valen E, 2009, NEUROTOXICOLOGY, V30, P1172, DOI 10.1016/j.neuro.2009.06.002; Vela MM, 2003, ARCH PREV RIESGOS LA, V6, P17; Viikari-Juntura E, 1999, SCAND J WORK ENV HEA, V25, P163, DOI 10.5271/sjweh.423; Violante FS, 2016, SCAND J WORK ENV HEA, V42, P280, DOI 10.5271/sjweh.3566; Weng CH, 2017, KIDNEY BLOOD PRESS R, V42, P827, DOI 10.1159/000484422; You D, 2014, SAF HEALTH WORK-KR, V5, P27, DOI 10.1016/j.shaw.2014.01.003	54	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235051	10.1371/journal.pone.0235051	http://dx.doi.org/10.1371/journal.pone.0235051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584856	Green Published, gold			2022-12-27	WOS:000545747200072
J	Shida, H; Okabayashi, S; Yoshioka, M; Takase, N; Nishiura, M; Okazawa, Y; Kiyohara, K; Konda, M; Nishioka, N; Kawamura, T; Iwami, T				Shida, Haruka; Okabayashi, Satoe; Yoshioka, Masami; Takase, Naoko; Nishiura, Masahiro; Okazawa, Yui; Kiyohara, Kosuke; Konda, Manako; Nishioka, Norihiro; Kawamura, Takashi; Iwami, Taku			Effectiveness of a digital device providing real-time visualized tooth brushing instructions: A randomized controlled trial	PLOS ONE			English	Article							PERIODONTAL-DISEASE; PLAQUE REMOVAL; APP; RISK	Introduction The aim of this trial was to investigate whether a digital device that provides real-time visualized brushing instructions would contribute to the removal of dental plaque over usual brushing instructions. Methods We conducted a single-center, parallel-group, stratified permuted block randomized control trial with 1:1 allocation ratio. Eligibility criteria included people aged >= 18 years, and exclude people who met the following criteria: severely crowded teeth; using interdental cleaning implement; having external injury in the oral cavity, or stomatitis; having less than 20 teeth; using orthodontic apparatus; visited to a dental clinic; having the possibility of consulting a dental clinic; having a dental license; not owning a smartphone or tablet device; smoker; taken antibiotics; pregnant; an allergy to the staining fluid; and employee of Sunstar Inc. All participants received tooth brushing instructions using video materials and were randomly assigned to one of two groups for four weeks: (1) an intervention group who used the digital device, providing real-time visualized instructions by connection with a mobile application; and (2) a control group that used a digital device which only collected their brushing logs. The primary outcome was the change in 6-point method plaque control record (PCR) score of all teeth between baseline and week 4. Thet-test was used to compare the two groups in accordance with intention-to-treat principles. Results Among 118 enrolled individuals, 112 participants were eligible for our analyses. The mean of PCR score at week 4 was 45.05% in the intervention group and 49.65% in the control group, and the change of PCR score from baseline was -20.46% in the intervention group and -15.77% in the control group (p= 0.088, 95% confidence interval -0.70-10.07). Conclusions A digital device providing real-time visualized brushing instructions may be effective for the removal of dental plaque.	[Shida, Haruka; Konda, Manako; Nishioka, Norihiro] Kyoto Univ, Sch Publ Hlth, Dept Prevent Serv, Kyoto, Japan; [Okabayashi, Satoe; Kawamura, Takashi; Iwami, Taku] Kyoto Univ Hlth Serv, Kyoto, Japan; [Yoshioka, Masami] Tokushima Bunri Univ, Fac Hlth & Welf, Dept Oral Hlth Sci, Tokushima, Japan; [Takase, Naoko; Nishiura, Masahiro; Okazawa, Yui] Sunstar Inc, R&D Dept, Osaka, Japan; [Kiyohara, Kosuke] Otsuma Womens Univ, Dept Food Sci, Tokyo, Japan	Kyoto University; Kyoto University; Tokushima Bunri University	Okabayashi, S (corresponding author), Kyoto Univ Hlth Serv, Kyoto, Japan.	okabayashi.satoe.8c@kyoto-u.ac.jp	IWAMI, Taku/HCH-0599-2022; Kiyohara, Kosuke/ABD-5652-2020; Nishioka, Norihiro/GRY-3140-2022	IWAMI, Taku/0000-0002-4150-7065; Kiyohara, Kosuke/0000-0003-0644-6129; Nishioka, Norihiro/0000-0001-5218-9819; Okabayashi, Satoe/0000-0001-9919-6768				Alkilzy M, 2019, CARIES RES, V53, P628, DOI 10.1159/000499868; BASS C C, 1954, J La State Med Soc, V106, P57; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Chang WJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225453; Claydon NC, 2008, PERIODONTOL 2000, V48, P10, DOI 10.1111/j.1600-0757.2008.00273.x; Creeth Jonathan E, 2009, J Dent Hyg, V83, P111; Deleuse M, 2020, EUR J ORTHODONT, V42, P605, DOI 10.1093/ejo/cjz105; Erbe C, 2019, AM J ORTHOD DENTOFAC, V155, P462, DOI 10.1016/j.ajodo.2018.12.013; Ganss C, 2009, CLIN ORAL INVEST, V13, P203, DOI 10.1007/s00784-008-0230-8; Graetz C, 2013, J PERIODONTOL, V84, P186, DOI 10.1902/jop.2012.110675; Grau AJ, 2004, STROKE, V35, P496, DOI 10.1161/01.STR.0000110789.20526.9D; Jacobson D, 2019, PEDIATR DENT, V41, P299; Japanese Society of Periodontology, 2016, JSP EV REP PER DIS S; Khader YS, 2004, J PERIODONTOL, V75, P1046, DOI 10.1902/jop.2004.75.8.1046; Kim KS, 2009, COMPUT METH PROG BIO, V96, P125, DOI 10.1016/j.cmpb.2009.04.006; Lin CY, 2014, J FORMOS MED ASSOC, V113, P742, DOI 10.1016/j.jfma.2014.02.009; Matsunaga M, 1989, Nihon Shishubyo Gakkai Kaishi, V31, P717; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Pace CC, 2010, DYSPHAGIA, V25, P307, DOI 10.1007/s00455-010-9298-9; Poyato-Ferrera M, 2003, Int J Dent Hyg, V1, P110, DOI 10.1034/j.1601-5037.2003.00018.x; R Core Team, 2018, R LANG ENV STAT COMP; Ramezaninia J, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5040050; Renton-Harper P, 1999, J CLIN PERIODONTOL, V26, P752, DOI 10.1034/j.1600-051X.1999.t01-8-261101.x; Scheerman JFM, 2020, INT J DENT HYG, V18, P73, DOI 10.1111/idh.12415; Schlueter N, 2010, CLIN ORAL INVEST, V14, P99, DOI 10.1007/s00784-009-0269-1; The Japanese Society of Periodontology, 2016, JSP CLIN PRACT GUID; The Ministry of Health Labour and Welfare, SURV DENT DIS; Zotti F, 2016, ANGLE ORTHOD, V86, P101, DOI 10.2319/010915-19.1	28	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235194	10.1371/journal.pone.0235194	http://dx.doi.org/10.1371/journal.pone.0235194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584893	Green Published, gold			2022-12-27	WOS:000545747200044
J	Viar, K; Njoku, D; McVoy, JS; Oh, U				Viar, Kenneth; Njoku, Daniel; Secor McVoy, Julie; Oh, Unsong			Sarm1knockout protects against early but not late axonal degeneration in experimental allergic encephalomyelitis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; WALLERIAN DEGENERATION; MOUSE MODEL; SARM1; INJURY; ACTIVATION; PATHOLOGY; NECROSIS; DELETION	Programmed axonal degeneration, also known as Wallerian degeneration, occurs in immune-mediated central nervous system (CNS) inflammatory disorders such as multiple sclerosis and the animal model experimental allergic encephalomyelitis (EAE). Sterile alpha and TIR domain containing protein 1 (SARM1) functions to promote programmed axonal degeneration. To test the hypothesis that loss of SARM1 will reduce axonal degeneration in immune-mediated CNS inflammatory disorders, the course and pathology of EAE was compared inSarm1knockout mice and wild type littermates. The clinical course of EAE was similar inSarm1knockout and wild type. Analysis of EAE in mice expressing neuronal yellow fluorescent protein (YFP) showed significantly less axonal degeneration inSarm1knockout mice compared to wild type littermates at 14 days post-induction of EAE. At 21 days post-induction, however, difference in axonal degeneration was not significant. At 42 days post-induction,Sarm1knockout mice were indistinguishable from wild type with respect to markers of axonal injury, and were similar with respect to axonal density in the lumbar cords. There was no significant change in peripheral immune activation or CNS inflammatory cell infiltration associated with EAE inSarm1knockout mice. In conclusion,Sarm1deletion delayed axonal degeneration early in the course of CNS inflammation, but did not confer long-term protection from axonal degeneration in an animal model of immune-mediated CNS inflammation.	[Viar, Kenneth; Njoku, Daniel; Secor McVoy, Julie; Oh, Unsong] Virginia Commonwealth Univ, Sch Med, Dept Neurol, Richmond, VA 23298 USA	Virginia Commonwealth University	Oh, U (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Neurol, Richmond, VA 23298 USA.	uoh@vcu.edu		Oh, Unsong/0000-0002-1762-5299	Virginia Commonwealth University Excellence Fund	Virginia Commonwealth University Excellence Fund	This study was supported by Virginia Commonwealth University Excellence Fund (internal funding to U.O.). There was no additional external funding received for this study.	Arun T, 2013, BRAIN, V136, P106, DOI 10.1093/brain/aws325; Bannerman PG, 2007, J NEUROL SCI, V260, P23, DOI 10.1016/j.jns.2007.03.020; Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109; Carlsson E, 2016, BBA-MOL CELL RES, V1863, P244, DOI 10.1016/j.bbamcr.2015.11.021; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Cheng YL, 2019, DIABETES, V68, P2120, DOI 10.2337/db18-1233; Clark K, 2017, ASN NEURO, V9, DOI 10.1177/1759091417745426; Clark KC, 2016, GLIA, V64, P1190, DOI 10.1002/glia.22991; Dziedzic T, 2010, BRAIN PATHOL, V20, P976, DOI 10.1111/j.1750-3639.2010.00401.x; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Geisler S, 2016, BRAIN, V139, P3092, DOI 10.1093/brain/aww251; Gerdts J, 2016, NEURON, V89, P449, DOI 10.1016/j.neuron.2015.12.023; Gilley J, 2017, CELL REP, V21, P10, DOI 10.1016/j.celrep.2017.09.027; Gilley J, 2015, CELL REP, V10, P1974, DOI 10.1016/j.celrep.2015.02.060; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Hou YJ, 2013, J IMMUNOL, V191, P875, DOI 10.4049/jimmunol.1300374; Kaneko S, 2006, J NEUROSCI, V26, P9794, DOI 10.1523/JNEUROSCI.2116-06.2006; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Peng J, 2010, EUR J IMMUNOL, V40, P1738, DOI 10.1002/eji.200940034; Peters OM, 2018, HUM MOL GENET, V27, P3761, DOI 10.1093/hmg/ddy260; Schattling B, 2012, NAT MED, V18, P1805, DOI 10.1038/nm.3015; Singh S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0831-8; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09; Tallantyre EC, 2010, MULT SCLER J, V16, P406, DOI 10.1177/1352458510364992; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Uccellini MB, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.062; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; White MA, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0800-9; Ziogas NK, 2018, J NEUROSCI, V38, P4031, DOI 10.1523/JNEUROSCI.2343-17.2018	38	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235110	10.1371/journal.pone.0235110	http://dx.doi.org/10.1371/journal.pone.0235110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584865	Green Published, gold			2022-12-27	WOS:000545747200052
J	O'Driscoll, R; Turicchi, J; Duarte, C; Michalowska, J; Larsen, SC; Palmeira, AL; Heitmann, BL; Horgan, GW; Stubbs, RJ				O'Driscoll, R.; Turicchi, J.; Duarte, C.; Michalowska, J.; Larsen, S. C.; Palmeira, A. L.; Heitmann, B. L.; Horgan, G. W.; Stubbs, R. J.			A novel scaling methodology to reduce the biases associated with missing data from commercial activity monitors	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; HEART-RATE; ACCELEROMETERS; IMPUTATION	Background Commercial physical activity monitors have wide utility in the assessment of physical activity in research and clinical settings, however, the removal of devices results in missing data and has the potential to bias study conclusions. This study aimed to evaluate methods to address missingness in data collected from commercial activity monitors. Methods This study utilised 1526 days of near complete data from 109 adults participating in a European weight loss maintenance study (NoHoW). We conducted simulation experiments to test a novel scaling methodology (NoHoW method) and alternative imputation strategies (overall/individual mean imputation, overall/individual multiple imputation, Kalman imputation and random forest imputation). Methods were compared for hourly, daily and 14-day physical activity estimates for steps, total daily energy expenditure (TDEE) and time in physical activity categories. In a second simulation study, individual multiple imputation, Kalman imputation and the NoHoW method were tested at different positions and quantities of missingness. Equivalence testing and root mean squared error (RMSE) were used to evaluate the ability of each of the strategies relative to the true data. Results The NoHoW method, Kalman imputation and multiple imputation methods remained statistically equivalent (p<0.05) for all physical activity metrics at the 14-day level. In the second simulation study, RMSE tended to increase with increased missingness. Multiple imputation showed the smallest RMSE for Steps and TDEE at lower levels of missingness (<19%) and the Kalman and NoHoW methods were generally superior for imputing time in physical activity categories. Conclusion Individual centred imputation approaches (NoHoW method, Kalman imputation and individual Multiple imputation) offer an effective means to reduce the biases associated with missing data from activity monitors and maximise data retention.	[O'Driscoll, R.; Turicchi, J.; Duarte, C.; Stubbs, R. J.] Univ Leeds, Sch Psychol, Appetite Control & Energy Balance Grp, Leeds, W Yorkshire, England; [Michalowska, J.] Poznan Univ Med Sci, Med Fac, Dept Treatment Obes Metab Disorders & Clin Dietet, Poznan, Poland; [Larsen, S. C.; Heitmann, B. L.] Bispebjerg & Frederiksberg Hosp, Parker Inst, Res Unit Dietary Studies, Copenhagen, Capital Region, Denmark; [Palmeira, A. L.] Univ Lisbon, Fac Motricidade Humana, Lisbon, Portugal; [Palmeira, A. L.] Univ Lusofona, Lisbon, Portugal; [Heitmann, B. L.] Univ Copenhagen, Sect Gen Med, Dept Publ Hlth, Copenhagen, Denmark; [Heitmann, B. L.] Univ Sydney, Boden Inst, Charles Perkins Ctr, Sydney, NSW, Australia; [Horgan, G. W.] Biomath & Stat Scotland, Aberdeen, Scotland	University of Leeds; Poznan University of Medical Sciences; University of Copenhagen; Bispebjerg Hospital; Universidade de Lisboa; Lusofona University; University of Copenhagen; University of Sydney; James Hutton Institute	O'Driscoll, R (corresponding author), Univ Leeds, Sch Psychol, Appetite Control & Energy Balance Grp, Leeds, W Yorkshire, England.	psrod@leeds.ac.uk	Stubbs, R James/AAH-4739-2021; Larsen, Sofus Christian/AAO-5894-2020	Stubbs, R James/0000-0002-0843-9064; Larsen, Sofus Christian/0000-0002-0838-9378; O'Driscoll, Ruairi/0000-0003-3995-0073; Heitmann, Berit Lilienthal/0000-0002-6809-4504; Duarte, Cristiana/0000-0002-6566-273X	European Union [643309]	European Union(European Commission)	The NoHoW study has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 643309. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, J CHIROPR MED, V15, P155, DOI DOI 10.1016/J.JCM.2016.02.012; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Beaulieu K, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0473-3; Benedetto S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192691; Berkemeyer K, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-015-0316-z; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen CH, 2009, J PHYS ACT HEALTH, V6, P354, DOI 10.1123/jpah.6.3.354; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Diaz Keith M, 2016, BMC Res Notes, V9, P213, DOI 10.1186/s13104-016-2020-8; Doherty A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169649; Feehan LM, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/10527; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Herrmann SD, 2013, J PHYS ACT HEAL; Hills Andrew P, 2014, Front Nutr, V1, P5, DOI 10.3389/fnut.2014.00005; Kapteyn A, 2018, J EPIDEMIOL COMMUN H, V72, P471, DOI 10.1136/jech-2017-209703; Katapally TR, 2014, J SPORT SCI MED, V13, P379; Kerns JC, 2017, OBESITY, V25, P1838, DOI 10.1002/oby.21986; Krauchi K, 2001, NEUROPSYCHOPHARMACOL, V25, pS92, DOI 10.1016/S0893-133X(01)00315-3; Lee JA, 2018, STAT METHODS MED RES, V27, P490, DOI 10.1177/0962280216633248; Lee PH, 2013, AM J CLIN NUTR, V97, P965, DOI 10.3945/ajcn.112.052738; Liu BM, 2016, STAT MED, V35, P5170, DOI 10.1002/sim.7049; Loprinzi PD, 2013, J PHYS ACT HEALTH, V10, P79, DOI 10.1123/jpah.10.1.79; Meng YW, 2020, IEEE J BIOMED HEALTH, V24, P878, DOI 10.1109/JBHI.2019.2922178; O'Driscoll R, 2020, HEALTH TECHNOL-GER, V10, P637, DOI 10.1007/s12553-019-00392-7; O'Driscoll R, 2020, J SPORT SCI, V38, P1496, DOI 10.1080/02640414.2020.1746088; O'Driscoll R, 2020, BRIT J SPORT MED, V54, P332, DOI 10.1136/bjsports-2018-099643; Plasqui G, 2013, OBES REV, V14, P451, DOI 10.1111/obr.12021; Rennie KL, 2001, MED SCI SPORT EXER, V33, P939, DOI 10.1097/00005768-200106000-00013; Ridgers ND, 2011, EUR J SPORT SCI, V11, P205, DOI 10.1080/17461391.2010.501116; Schoeller DA, 1997, AM J CLIN NUTR, V66, P551, DOI 10.1093/ajcn/66.3.551; Schrack JA, 2018, J GERONTOL A-BIOL, V73, P668, DOI 10.1093/gerona/gly029; Scott SE, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029425; Shiroma EJ, 2019, MED SCI SPORT EXER, V51, P35, DOI 10.1249/MSS.0000000000001762; Shook RP, 2018, J NUTR, V148, P490, DOI 10.1093/jn/nxx029; Silva AM, 2015, EUR J CLIN NUTR, V69, P20, DOI 10.1038/ejcn.2014.51; Sirard JR, 2000, MED SCI SPORT EXER, V32, P695, DOI 10.1097/00005768-200003000-00022; Staudenmayer J, 2012, MED SCI SPORT EXER, V44, pS61, DOI 10.1249/MSS.0b013e3182399e0f; Stephens S, 2018, RHEUM DIS CLIN N AM, V44, P317, DOI 10.1016/j.rdc.2018.01.012; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Swartz AM, 2000, MED SCI SPORT EXER, V32, pS450, DOI 10.1097/00005768-200009001-00003; Swift DL, 2018, PROG CARDIOVASC DIS, V61, P206, DOI 10.1016/j.pcad.2018.07.014; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Thraen-Borowski KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182554; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110332; Wadden TA, 2011, OBESITY, V19, P1987, DOI 10.1038/oby.2011.230; Whybrow S, 2013, BRIT J NUTR, V109, P173, DOI 10.1017/S0007114512000645; Xu SY, 2018, STAT METHODS MED RES, V27, P1168, DOI 10.1177/0962280216657119; 2017, HUMBOLDT FORUM, V1, P4	49	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235144	10.1371/journal.pone.0235144	http://dx.doi.org/10.1371/journal.pone.0235144			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579613	Green Accepted, gold, Green Published			2022-12-27	WOS:000545646600043
J	Zhao, XN; Zhang, HJ; Li, D; Zhou, JN; Chen, YY; Sun, YH; Adeola, AC; Fu, XQ; Shao, Y; Zhang, ML				Zhao, Xiao-Nan; Zhang, Han-Ju; Li, Duo; Zhou, Jie-Nan; Chen, Yao-Yao; Sun, Yan-Hong; Adeola, Adeniyi C.; Fu, Xiao-Qing; Shao, Yong; Zhang, Mei-Ling			Whole-genome sequencing reveals origin and evolution of influenza A(H1N1)pdm09 viruses in Lincang, China, from 2014 to 2018	PLOS ONE			English	Article							VACCINE EFFECTIVENESS; RECEPTOR-BINDING; ANTIGENIC CHANGE; H1N1; SUBSTITUTIONS; GENE	The continuous variation of the seasonal influenza viruses, particularly A(H1N1)pdm09, persistently threatens human life and health around the world. In local areas of southwest china, the large time-scale genomic research on A(H1N1)pdm09 is still insufficient. Here, we sequenced 45 whole-genome sequences of influenza A(H1N1)pdm09 viruses in Lincang, China, from 2014 to 2018, by next-generation sequencing technology to characterize molecular mechanisms of their origin and evolution. Our phylogenetic analyses suggest that the A(H1N1)pdm09 strains circulating in Lincang belong to clade 6B and the subclade 6B.1A predominates in 2018. Further, the strains in 2018 possess elevated evolutionary rate as compared to strains in other years. Several newly emerged mutations for HA (hemagglutinin) in 2018 are revealed (i.e., S183P and R221K). Intriguingly, the substitution R221K falls into the RBS (receptor binding site) of HA protein, which could affect antigenic properties of influenza A(H1N1)pdm09 viruses, and another substitution S183P near to RBS with a high covering frequency (11/14 strains) in 2018 is exactly located at the epitope B. Notably, the NA (neuraminidase) protein harbors a new mutation I23T, potentially involved in N-glycosylation. Based on the background with a higher evolutionary rate in 2018 strains, we deeply evaluate the potential vaccine efficacy against Lincang strains and discover a substantive decline of the vaccine efficacy in 2018. Our analyses reaffirm that the real-time molecular surveillance and timely updated vaccine strains for prevention and control of influenza A(H1N1)pdm09 are crucial in the future.	[Zhao, Xiao-Nan; Li, Duo; Zhou, Jie-Nan; Chen, Yao-Yao; Sun, Yan-Hong; Fu, Xiao-Qing; Zhang, Mei-Ling] Yunnan Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Kunming, Yunnan, Peoples R China; [Zhang, Han-Ju] Lincang Ctr Dis Control & Prevent, Lincang, Yunnan, Peoples R China; [Adeola, Adeniyi C.; Shao, Yong] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology	Zhang, ML (corresponding author), Yunnan Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Kunming, Yunnan, Peoples R China.; Shao, Y (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	Yong_Shao_dws@126.com; meilingz2011@163.com	Adeola, Adeniyi Charles/GQH-3891-2022; Shao, Yong/AHC-2325-2022	Adeola, Adeniyi Charles/0000-0001-5171-7878; Shao, Yong/0000-0003-1704-8425; , meiling/0000-0001-9849-4237				Al Khatib HA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3930-6; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P117; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; Barrero PR, 2011, J VIROL, V85, P1058, DOI 10.1128/JVI.00936-10; Butler J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004065; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; CCfDCaP, REC SEAS INFL EP CHI; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046688, 10.1371/journal.pone.0039927]; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Vries RP, 2013, J VIROL, V87, P13868, DOI 10.1128/JVI.01955-13; Deem MW, 2009, PROTEIN ENG DES SEL, V22, P543, DOI 10.1093/protein/gzp027; Falchi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024471; Fofana I, 2013, IEEE ELECTR INSUL M, V29, P13, DOI 10.1109/MEI.2013.6585853; Friedman N, 2017, ONCOTARGET, V8, P32856, DOI 10.18632/oncotarget.16459; Fu XF, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4181-2; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Guldemir D, 2019, J MED VIROL, V91, P2074, DOI 10.1002/jmv.25565; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; Horm SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110713; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Khan A, 2019, J INFECT PUBLIC HEAL, V12, P557, DOI 10.1016/j.jiph.2019.01.067; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Koel BF, 2015, J VIROL, V89, P3763, DOI 10.1128/JVI.02962-14; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Liu SS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08282-6; Mir MA, 2012, J MED VIROL, V84, P386, DOI 10.1002/jmv.23205; Monamele CG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210119; Opanda S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228029; Pan K, 2011, PROTEIN ENG DES SEL, V24, P291, DOI 10.1093/protein/gzq105; Puig-Barbera J, 2017, VACCINE, V35, P7331, DOI 10.1016/j.vaccine.2017.10.100; Sun YP, 2014, J VIROL, V88, P4600, DOI 10.1128/JVI.03158-13; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064439; Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139958; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Wichmann O, 2010, EUROSURVEILLANCE, V15, P2; Zhou JF, 2011, BIOINFORMATICS, V27, P1255, DOI 10.1093/bioinformatics/btr140; Zolotarova O, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040194	39	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234869	10.1371/journal.pone.0234869	http://dx.doi.org/10.1371/journal.pone.0234869			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579578	Green Published, gold			2022-12-27	WOS:000545646600059
J	Abshire, MA; Nolan, MT; Dy, SM; Gallo, JJ				Abshire, Martha A.; Nolan, Marie T.; Dy, Sydney M.; Gallo, Joseph J.			What matters when doctors die: A qualitative study of family perspectives	PLOS ONE			English	Article							OF-LIFE CARE; DECISION-MAKING; PALLIATIVE CARE; DIGNITY THERAPY; HEALTH LITERACY; END; PATIENT; DEATH; INTERVENTION; CAREGIVERS	Background The challenges of supporting the end-of-life preferences of patients and their families have often been attributed to poor understanding of the patient's condition. Understanding how physicians, as patients, communicate their end-of-life care preferences to their families may inform shared decision making at end of life. Objectives The purpose of this study was to understand what matters to families of physicians when decision making with and for a physician who is approaching the end of life. Design Cross-sectional qualitative design. Participants We conducted interviews with family members of deceased physicians. Approach We analyzed the data using the constant comparison method to identify themes. Key results Family members (N = 26) rarely were unclear about the treatment preferences of physicians who died. Three overarching themes emerged about what matters most to physicians' families: (1) honoring preferences for the context of end-of-life care; (2) supporting the patient's control and dignity in care; and, (3) developing a shared understanding of preferences. Families struggled to make decisions and provide the care needed by the physicians at the end of life, often encountering significant challenges from the healthcare system. Conclusions Even when disease and prognosis are well understood as in this group of physicians, families still experienced difficulties in end-of-life decision making. These findings highlight the need to specifically address preferences for caregiver, care setting and symptom management in shared end-of-life decision making conversations with patients and families.	[Abshire, Martha A.; Nolan, Marie T.; Gallo, Joseph J.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA; [Dy, Sydney M.] Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Gallo, Joseph J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Abshire, MA (corresponding author), Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA.	mabshir1@jhu.edu		Abshire, Martha/0000-0003-1824-1542	National Institute of Nursing Research [R01 NR014068]	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	JJG and MTN were co-PIs on R01 NR014068 funded by the National Institute of Nursing Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Bernacki RE, 2014, JAMA INTERN MED, V174, P1994, DOI 10.1001/jamainternmed.2014.5271; Blecker S, 2016, JAMA-J AM MED ASSOC, V315, P301, DOI 10.1001/jama.2015.16976; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Brazil K, 2005, PALLIATIVE MED, V19, P492, DOI 10.1191/0269216305pm1050oa; Chochinov HM, 2002, JAMA-J AM MED ASSOC, V287, P2253, DOI 10.1001/jama.287.17.2253; Chochinov HM, 2005, J CLIN ONCOL, V23, P5520, DOI 10.1200/JCO.2005.08.391; Fromme EK, 2004, J FAM PRACTICE, V53, P299; Gallo JJ, 2003, J AM GERIATR SOC, V51, P961, DOI 10.1046/j.1365-2389.2003.51309.x; Gallo JJ, 2019, J PAIN SYMPTOM MANAG, V57, P556, DOI 10.1016/j.jpainsymman.2018.12.328; GRAY C, 1980, CAN MED ASSOC J, V122, P206; Guo QH, 2014, PALLIATIVE MED, V28, P931, DOI 10.1177/0269216314528399; Jeon BM, 2018, NURS HEALTH SCI, V20, P472, DOI 10.1111/nhs.12537; Kamal AH, 2016, J PAIN SYMPTOM MANAG, V51, P497, DOI 10.1016/j.jpainsymman.2015.12.313; Kehl Karen A, 2006, Am J Hosp Palliat Care, V23, P277, DOI 10.1177/1049909106290380; Kim Y, 2017, PSYCHO-ONCOLOGY, V26, P484, DOI 10.1002/pon.4042; Klag M J, 1993, Ann Epidemiol, V3, P442; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; Krikorian A, 2020, J PAIN SYMPTOM MANAG, V59, P152, DOI 10.1016/j.jpainsymman.2019.07.033; Kwak J, 2005, GERONTOLOGIST, V45, P634, DOI 10.1093/geront/45.5.634; Martinez M, 2017, PALLIATIVE MED, V31, P492, DOI 10.1177/0269216316665562; Meier EA, 2016, AM J GERIAT PSYCHIAT, V24, P261, DOI 10.1016/j.jagp.2016.01.135; Melhado L, 2011, AM J HOSP PALLIAT ME, V28, P495, DOI 10.1177/1049909110398005; Morrow SL, 2005, J COUNS PSYCHOL, V52, P250, DOI 10.1037/0022-0167.52.2.250; Nilsson J, 2017, ASIA-PAC J CLIN ONCO, V13, P356, DOI 10.1111/ajco.12678; Odejide OO, 2016, J CLIN ONCOL, V34, P3126, DOI 10.1200/JCO.2016.67.8177; Pellegrino ED, 2008, HUMAN DIGNITY BIOETH; Puchalski CM, 2019, ESMO OPEN, V4, DOI 10.1136/esmoopen-2018-000465; Stjernsward J, 2003, PALLIATIVE MED GLOBA; Stjernsward J, 2007, J PAIN SYMPTOM MANAG, V33, P486, DOI 10.1016/j.jpainsymman.2007.02.016; Teno JM, 2015, J PALLIAT MED, V18, P662, DOI 10.1089/jpm.2015.0039; Vig EK, 2006, J AM GERIATR SOC, V54, P1688, DOI 10.1111/j.1532-5415.2006.00911.x; Virdun C, 2017, PALLIATIVE MED, V31, P587, DOI 10.1177/0269216316673547; Virdun C, 2015, PALLIATIVE MED, V29, P774, DOI 10.1177/0269216315583032; Volandes AE, 2008, J PALLIAT MED, V11, P754, DOI 10.1089/jpm.2007.0224; Wunsch H, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7650; [No title captured]	37	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235138	10.1371/journal.pone.0235138	http://dx.doi.org/10.1371/journal.pone.0235138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME9KK	32574209	gold, Green Published			2022-12-27	WOS:000544972400027
J	Kotepui, M; Kotepui, KU; Milanez, GD; Masangkay, FR				Kotepui, Manas; Kotepui, Kwuntida Uthaisar; Milanez, Giovanni D.; Masangkay, Frederick R.			Reduction in total leukocytes in malaria patients compared to febrile controls: A systematic review and meta-analysis	PLOS ONE			English	Review							PLASMODIUM-VIVAX MALARIA; BLOOD-CELL COUNTS; HEMATOLOGICAL PARAMETERS; FALCIPARUM-MALARIA; NITRIC-OXIDE; CYTOKINES; CHILDREN; PARASITE; CD4(+); ANEMIA	Background Leukocyte alterations are a common hematological alteration among malaria patients. Objectives This systematic review and meta-analysis aimed to provide data and evidence comparing alterations in total leukocyte counts in malaria patients compared to febrile/healthy subjects at baseline before treatment. A systematic review was conducted by following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement for reporting systematic reviews and meta-analyses. Data sources Web of Science (ISI), Scopus, and Medline. Study eligibility criteria, participants, and interventions All published articles reporting a total leukocyte count of patients infected with malaria, non-malaria (febrile or healthy group) at baseline before treatment before August 27, 2019, were retrieved, and data were extracted by two main reviewers independently. Study appraisal and synthesis methods We used a forest plot, heterogeneity test (Cochran's Q), and the degree of heterogeneity (I-2) to test whether the included studies were heterogeneous. The quality of the included studies was determined by a quality assessment guide based on the quality assessment tool developed by the Newcastle-Ottawa Scale (NOS). Cochran's Q (Chi-square) and Moran's I(2)were used to evaluate heterogeneity. Meta-regression using STATA software was conducted to find the source of heterogeneity. A funnel plot with Egger's test was used to examine the significance of publication bias among the included studies. The mean differences were estimated using a random-effects model. Results Out of the 2,261 articles screened, 29 articles were included in this systematic review and meta-analysis. The heterogeneity test indicated that there was heterogeneity among the included studies with no publication bias. The meta-analysis demonstrated that the total leukocyte count was significantly lower in patients with malaria (n = 4,619) than in those without malaria (n = 10,056) (Z = 4.0, P-value < 0.00001, mean difference = -1.38, 95% CI = -2.06-(-0.71)). Leukocyte differential alterations, low lymphocyte counts (P-value <0.0001, mean difference = -1.03, 95% CI = -1.53-(-0.53)) and a high NL ratio were found in the malaria group (n = 1,579) compared to the non-malaria group (n = 4,991) (P-value <0.0001, mean difference = 0.6, 95% CI = 0.32-0.88). The subgroup analysis indicated that there was a significantly lower total leukocyte count in the malaria group (n = 3,545) than in the febrile group (n = 8,947) (Z = 1.33, P-value < 0.0001, mean difference = -1.76, 95% CI = -2.56-(-0.96)), but no significant difference was found between the malaria group (n = 1,232) and the healthy group (n = 1,679) (P-value > 0.05). Limitations As the specific diagnoses in the febrile groups were not reported in the included studies so that the results of the present study need to be carefully interpreted. Conclusions and implications of key findings This systematic review demonstrated that the total leukocyte count was affected by malarial infection at baseline despite the heterogeneity of the included studies. Future work must aim to understand the treatment-related total leukocyte reduction during follow-up or post-treatment outcomes in malaria-endemic settings.	[Kotepui, Manas; Kotepui, Kwuntida Uthaisar] Walailak Univ, Sch Allied Hlth Sci, Med Technol, Thasala, Nakhon Si Thamm, Thailand; [Milanez, Giovanni D.; Masangkay, Frederick R.] Far Eastern Univ, Inst Arts & Sci, Dept Med Technol, Manila, Philippines	Walailak University; Far Eastern University	Kotepui, M (corresponding author), Walailak Univ, Sch Allied Hlth Sci, Med Technol, Thasala, Nakhon Si Thamm, Thailand.	manas.ko@wu.ac.th	Milanez, Giovanni D/O-9282-2016; Masangkay, Frederick/GLR-5890-2022; Milanez, Giovanni De Jesus/HGA-9959-2022	Milanez, Giovanni D/0000-0002-4467-3173; Milanez, Giovanni De Jesus/0000-0002-4467-3173; Kotepui, Manas/0000-0001-9172-3615; Masangkay, Frederick/0000-0002-3511-8602	new strategic research (P2P) project, Walailak University, Thailand	new strategic research (P2P) project, Walailak University, Thailand	This research was partially supported by the new strategic research (P2P) project, Walailak University, Thailand. The funders had a role in the collection, analysis, and interpretation of the data. There was no additional external funding received for this study.	[Anonymous], 2008, OIL GAS J, V106, P39; [Anonymous], 2016, FORTUNE, V15, pF29; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Ansart S, 2010, J TRAVEL MED, V17, P124, DOI 10.1111/j.1708-8305.2009.00382.x; Anstey NM, 1999, AM J TROP MED HYG, V61, P249, DOI 10.4269/ajtmh.1999.61.249; Anwar A, 2016, PAK J MED HLTH SCI, V10, P294; Awoke N, 2019, INFECT DRUG RESIST, V12, P521, DOI 10.2147/IDR.S184489; Buprenorphine + naloxone: new combination, 2007, PRESCRIRE INT, V16, P232; Church LWP, 1997, J INFECT DIS, V175, P915, DOI 10.1086/513990; Leoratti FMD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001710; &DLANGBRAC;Dermite des Tephras&drangbrac, 2013, ANN DERMATOL VENEREO, V12, pS443; Erhart LM, 2004, AM J TROP MED HYG, V70, P8, DOI 10.4269/ajtmh.2004.70.8; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Goncalves RM, 2010, INFECT IMMUN, V78, P4763, DOI 10.1128/IAI.00578-10; Gonzalez B, 2009, INVEST CLIN, V50, P187; Grobusch MP, 2005, CURR TOP MICROBIOL, V295, P83; Hanscheid T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-109; Hisaeda H, 2005, INT J BIOCHEM CELL B, V37, P700, DOI 10.1016/j.biocel.2004.10.009; Hojo-Souza NS, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-5; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Igbeneghu C, 2011, MED PRIN PRACT, V20, P459, DOI 10.1159/000327673; Kayode O. T., 2011, Journal of Biological Sciences, V11, P367, DOI 10.3923/jbs.2011.367.373; Kini RG, 2016, J CLIN DIAGN RES, V10, pEC44, DOI 10.7860/JCDR/2016/16425.7887; Koltas IS, 2007, SAUDI MED J, V28, P535; Kotepui M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-218; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; Maghendji-Nzondo S, 2016, PARASITE, V23, DOI 10.1051/parasite/2016032; Manas Kotepui CR, J HLTH RES, V31, P281; McKenzie FE, 2005, J INFECT DIS, V192, P323, DOI 10.1086/431152; MEANS RT, 1992, J CELL PHYSIOL, V150, P59, DOI 10.1002/jcp.1041500109; Miller AR, 1996, J INTERF CYTOK RES, V16, P1055, DOI 10.1089/jir.1996.16.1055; Modiano D, 2001, T ROY SOC TROP MED H, V95, P175, DOI 10.1016/S0035-9203(01)90152-X; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Nabil Hasona, 2016, Asian Pacific Journal of Tropical Disease, V6, P695; Okafor U E, 2016, SAMJ, S. Afr. med. j., V106, P413, DOI [10.7196/SAMJ.2016.v106i4.9758, 10.7196/samj.2016.v106i4.9758]; Ourives S. S., 2015, Research Journal of Parasitology, V10, P1, DOI 10.3923/jp.2015.1.14; Philipose Cheryl Sarah, 2016, Trop Parasitol, V6, P147; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Rodrigues-da-Silva RN, 2014, MEM I OSWALDO CRUZ, V109, P154, DOI 10.1590/0074-0276140275; Rzepczyk CM, 1996, SCAND J IMMUNOL, V43, P219, DOI 10.1046/j.1365-3083.1996.d01-24.x; Salih MM, 2018, J INFECT DEV COUNTR, V12, P273, DOI 10.3855/jidc.9906; SCHOFIELD L, 1993, ANN TROP MED PARASIT, V87, P617, DOI 10.1080/00034983.1993.11812820; SIMMS HH, 1991, J IMMUNOL, V147, P265; Squire D S, 2016, J Parasit Dis, V40, P303, DOI 10.1007/s12639-014-0501-z; Tangpukdee N, 2008, PARASITOL INT, V57, P490, DOI 10.1016/j.parint.2008.06.005; Taylor Walter R J, 2008, Malar J, V7, P259, DOI 10.1186/1475-2875-7-259; van Wolfswinkel ME, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2108-1; van Wolfswinkel ME, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-101; Warrell DA, 1993, CLIN FEATURES MALARI; Wells G., NEWCASTLE OTTAWA SCA; WHO, 2010, GUID TREATM MALARIA2; Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072; Worku S, 1997, CLIN EXP IMMUNOL, V108, P34, DOI 10.1046/j.1365-2249.1997.d01-981.x; World Health Organization, WORLD MAL REP 2019; Zahorec R, 2001, Bratisl Lek Listy, V102, P5; 2018, EUR UROL SUPPL, V17	56	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0233913	10.1371/journal.pone.0233913	http://dx.doi.org/10.1371/journal.pone.0233913			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574170	Green Published, gold			2022-12-27	WOS:000544972400029
J	Sevillano, V; Holt, K; Aznarte, JL				Sevillano, Victor; Holt, Katherine; Aznarte, Jose L.			Precise automatic classification of 46 different pollen types with convolutional neural networks	PLOS ONE			English	Article							PALYNOLOGY; SYSTEM; DISCRIMINATION; IDENTIFICATION	In palynology, the visual classification of pollen grains from different species is a hard task which is usually tackled by human operators using microscopes. Many industries, including medical and pharmaceutical, rely on the accuracy of this manual classification process, which is reported to be around 67%. In this paper, we propose a new method to automatically classify pollen grains using deep learning techniques that improve the correct classification rates in images not previously seen by the models. Our proposal manages to properly classify up to 98% of the examples from a dataset with 46 different classes of pollen grains, produced by the Classifynder classification system. This is an unprecedented result which surpasses all previous attempts both in accuracy and number and difficulty of taxa under consideration, which include types previously considered as indistinguishable.	[Sevillano, Victor; Aznarte, Jose L.] Univ Nacl Educ Distancia, Dept Artificial Intelligence, Madrid, Spain; [Holt, Katherine] Massey Univ, Inst Nat Resources, Palmerston North, New Zealand	Universidad Nacional de Educacion a Distancia (UNED); Massey University	Aznarte, JL (corresponding author), Univ Nacl Educ Distancia, Dept Artificial Intelligence, Madrid, Spain.	jlaznarte@dia.uned.es	Aznarte, Jose L./B-3372-2015	Aznarte, Jose L./0000-0002-1636-244X				[Anonymous], 2014, PEERJ, V2, pe447; [Anonymous], 2004, DVM NEWSMAGAZINE VET, V35, p16S; Bogota-A RG, 2011, QUATERNARY SCI REV, V30, P3321, DOI 10.1016/j.quascirev.2011.08.003; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; Daood Amar, 2016, Advances in Visual Computing. 12th International Symposium, ISVC 2016. Proceedings: LNCS 10072, P321, DOI 10.1007/978-3-319-50835-1_30; Daood A., 2018, 31 INT FLAIRS C; Daood A, 2016, INT C PATT RECOG, P3091, DOI 10.1109/ICPR.2016.7900109; Dell'Anna R, 2009, ANAL BIOANAL CHEM, V394, P1443, DOI 10.1007/s00216-009-2794-9; Dhawale VR, 2013, 2013 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P79, DOI 10.1109/ICACCI.2013.6637150; ERDTMAN G., 1960, SVENSK BOT TIDSKR, V54, P561; Flantua SGA, 2016, CLIM PAST, V12, P483, DOI 10.5194/cp-12-483-2016; Flenley J. R., 1968, PROBLEMS PICTURE INT, P141; Goncalves AB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157044; Holt K, 2011, REV PALAEOBOT PALYNO, V167, P175, DOI 10.1016/j.revpalbo.2011.08.006; Holt KA, 2014, NEW PHYTOL, V203, P735, DOI 10.1111/nph.12848; Ivleva NP, 2005, ANAL BIOANAL CHEM, V381, P261, DOI 10.1007/s00216-004-2942-1; Kaya Y, 2013, REV PALAEOBOT PALYNO, V189, P50, DOI 10.1016/j.revpalbo.2012.11.004; Khanzhina N, 2018, ESANN; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lagerstrom R, 2015, ADV EXP MED BIOL, V823, P207, DOI 10.1007/978-3-319-10984-8_12; Lagerstrom R, 2013, AIP CONF PROC, V1559, P250, DOI 10.1063/1.4825017; Li P, 2004, J QUATERNARY SCI, V19, P755, DOI 10.1002/jqs.874; Menad Hanane, 2019, JOURNEE ETUDE RECHER; Mildenhall DC, 2006, FORENSIC SCI INT, V163, P163, DOI 10.1016/j.forsciint.2006.07.012; Mitsumoto K, 2009, J BIOSCI BIOENG, V107, P90, DOI 10.1016/j.jbiosc.2008.10.001; Moar N.T., 1994, POLLEN GRAINS NZ DIC; Odgaard BV, 1999, J BIOGEOGR, V26, P7, DOI 10.1046/j.1365-2699.1999.00280.x; Sevillano V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201807; Stillman EC, 1996, QUATERNARY SCI REV, V15, P1, DOI 10.1016/0277-3791(95)00076-3; Ticay-Rivas JR, 2011, IFIP ADV INF COMM TE, V364, P342; Treloar WJ, 2004, J QUATERNARY SCI, V19, P745, DOI 10.1002/jqs.871; Marcos JV, 2015, MICRON, V68, P36, DOI 10.1016/j.micron.2014.09.002; 2017, COLORECTAL DIS, V19, pE152	33	31	33	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0229751	10.1371/journal.pone.0229751	http://dx.doi.org/10.1371/journal.pone.0229751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574174	Green Submitted, Green Published, gold			2022-12-27	WOS:000544972400004
J	Tarrahimofrad, H; Meimandipour, A; Arjmand, S; Nassiri, MB; Jahangirian, E; Tavana, H; Zamani, J; Rahimnahal, S; Aminzadeh, S				Tarrahimofrad, Hossein; Meimandipour, Amir; Arjmand, Sareh; Beigi Nassiri, Mohammadtaghi; Jahangirian, Ehsan; Tavana, Hossein; Zamani, Javad; Rahimnahal, Somayyeh; Aminzadeh, Saeed			Structural and biochemical characterization of a novel thermophilic Coh01147 protease	PLOS ONE			English	Article							ALKALINE PROTEASE; BACILLUS-STEAROTHERMOPHILUS; THERMODYNAMIC PROPERTIES; CYSTEINE PROTEASE; STEP PURIFICATION; ESCHERICHIA-COLI; STABLE PROTEASE; SERINE-PROTEASE; FLUORESCENCE; STABILITY	Proteases play an essential role in living organisms and represent one of the largest groups of industrial enzymes. The aim of this work was recombinant production and characterization of a newly identified thermostable protease 1147 from thermophilum indigenous Cohnella sp. A01. Phylogenetic tree analysis showed that protease 1147 is closely related to the cysteine proteases from DJ-1/ThiJ/PfpI superfamily, with the conserved catalytic tetrad. Structural prediction using MODELLER 9v7 indicated that protease 1147 has an overall alpha/beta sandwich tertiary structure. The gene of protease 1147 was cloned and expressed in Escherichia coli (E. coli) BL21. The recombinant protease 1147 appeared as a homogenous band of 18 kDa in SDS-PAGE, which was verified by western blot and zymography. The recombinant protein was purified with a yield of approximately 88% in a single step using Ni-NTA affinity chromatography. Furthermore, a rapid one-step thermal shock procedure was successfully implemented to purify the protein with a yield of 73%. Using casein as the substrate, K-m, and k(cat), k(ca)t/K(m)values of 13.72 mM, 3.143 x 10(-3)(s(-1)), and 0.381 (M-1S-1) were obtained, respectively. The maximum protease activity was detected at pH = 7 and 60 degrees C with the inactivation rate constant (kin) of 2.10 x 10-3 (m(-1)), and half-life (t(1/2)) of 330.07 min. Protease 1147 exhibited excellent stability to organic solvent, metal ions, and 1% SDS. The protease activity was significantly enhanced by Tween 20 and Tween 80 and suppressed by cysteine protease specific inhibitors. Docking results and molecular dynamics (MD) simulation revealed that Tween 20 interacted with protease 1147 via hydrogen bonds and made the structure more stable. CD and fluorescence spectra indicated structural changes taking place at 100 degrees C, very basic and acidic pH, and in the presence of Tween 20. These properties make this newly characterized protease a potential candidate for various biotechnological applications.	[Tarrahimofrad, Hossein; Meimandipour, Amir; Jahangirian, Ehsan; Zamani, Javad; Rahimnahal, Somayyeh; Aminzadeh, Saeed] Natl Inst Genet Engn & Biotechnol NIGEB, Inst Ind & Environm Biotechnol, Bioproc Engn Grp, Tehran, Iran; [Tarrahimofrad, Hossein; Beigi Nassiri, Mohammadtaghi; Rahimnahal, Somayyeh] Agr Sci & Nat Resources Univ Khouzestan, Dept Anim Sci & Food Technol, Ahvaz, Iran; [Arjmand, Sareh] Shahid Beheshti Univ, Prot Res Ctr, GC, Tehran, Iran; [Tavana, Hossein] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA	Shahid Beheshti University; University System of Ohio; University of Akron	Aminzadeh, S (corresponding author), Natl Inst Genet Engn & Biotechnol NIGEB, Inst Ind & Environm Biotechnol, Bioproc Engn Grp, Tehran, Iran.	aminzade@nigeb.ac.ir	Jahangirian, Ehsan/AAV-5954-2021	Jahangirian, Ehsan/0000-0002-9982-7846	National Institute of Genetic Engineering and Biotechnology (NIGEB) [971215-I-712]	National Institute of Genetic Engineering and Biotechnology (NIGEB)	Yes Saeed Aminzadeh, National Institute of Genetic Engineering and Biotechnology (NIGEB) grant number 971215-I-712; The authors would like to thank the National Institute of Genetic Engineering and Biotechnology (NIGEB) for providing the research facility by grant number 971215-I-712.	Abdel-Naby MA, 2017, INT J BIOL MACROMOL, V96, P265, DOI 10.1016/j.ijbiomac.2016.11.094; Ahmed SA, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01674; Aliabadi N, 2016, BRAZ J MICROBIOL, V47, P931, DOI 10.1016/j.bjm.2016.07.009; Amid M, 2014, BIOMED RES INT, P2014; [Anonymous], 2008, AM J TRANSPLANT, V8, P57; [Anonymous], 2017, CRIT CARE NURSE, V37, pe19; Benmrad MO, 2016, INT J BIOL MACROMOL, V91, P961, DOI 10.1016/j.ijbiomac.2016.06.025; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Lopez-Rodriguez JC, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101256; Chittoor JT, 2016, IRAN J BIOTECHNOL, V14, P23, DOI 10.15171/ijb.1269; Correcirc DH, 2009, J BIOCH, V3, P164, DOI DOI 10.1038/NPR0T.2006.204; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; Dhanavade MJ, 2013, COMPUT BIOL MED, V43, P2063, DOI 10.1016/j.compbiomed.2013.09.021; Doddapaneni KK, 2009, MICROBIOL RES, V164, P383, DOI 10.1016/j.micres.2007.04.005; Aguilar JGD, 2018, FOOD RES INT, V103, P253, DOI 10.1016/j.foodres.2017.10.044; Foukis A, 2012, BIORESOURCE TECHNOL, V123, P214, DOI 10.1016/j.biortech.2012.06.090; Fu ZB, 2003, PROTEIN EXPRES PURIF, V28, P63, DOI 10.1016/S1046-5928(02)00637-X; GARCIACARRENO FL, 1993, ANAL BIOCHEM, V214, P65, DOI 10.1006/abio.1993.1457; Garidel P, 2009, BIOPHYS CHEM, V143, P70, DOI 10.1016/j.bpc.2009.04.004; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gohel SD, 2015, INT J BIOL MACROMOL, V72, P421, DOI 10.1016/j.ijbiomac.2014.08.008; Gohel SD, 2013, INT J BIOL MACROMOL, V56, P20, DOI 10.1016/j.ijbiomac.2013.01.028; Golaki BP, 2015, PROTEIN J, V34, P267, DOI 10.1007/s10930-015-9622-1; Guleria S, 2016, J BASIC MICROB, V56, P138, DOI 10.1002/jobm.201500341; Gulmez C, 2018, INT J BIOL MACROMOL, V108, P436, DOI 10.1016/j.ijbiomac.2017.11.133; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; Hamza TA., 2017, INT J CHEM BIOMOL SC, V3, P1; Hernandez-Martinez R, 2011, PROCESS BIOCHEM, V46, P2001, DOI 10.1016/j.procbio.2011.07.013; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Jalkute CB, 2017, BIOCATAL AGR BIOTECH, V10, P91, DOI 10.1016/j.bcab.2017.02.012; Jamir K, 2018, INT J BIOL MACROMOL, V106, P277, DOI 10.1016/j.ijbiomac.2017.08.019; Joshi S, 2013, BIORESOURCE TECHNOL, V131, P76, DOI 10.1016/j.biortech.2012.12.124; Kandasamy S, 2018, BIOCATAL AGR BIOTECH, V13, P95, DOI 10.1016/j.bcab.2017.11.016; Kerwin BA, 2008, J PHARM SCI-US, V97, P2924, DOI 10.1002/jps.21190; Kikani BA, 2020, STARCH-STARKE, V72, DOI 10.1002/star.201900105; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Koma D, 2007, EXTREMOPHILES, V11, P769, DOI 10.1007/s00792-007-0103-0; Kumar D, 2008, MICROBIAL PROTEASES; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li Q, 2013, FEBS LETT, V587, P1155, DOI 10.1016/j.febslet.2012.12.019; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Ma XJ, 2016, PROTEIN EXPRES PURIF, V128, P52, DOI 10.1016/j.pep.2016.08.008; Madsen JK, 2019, COLLOID INTERFAC, V3, DOI 10.3390/colloids3010042; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Margrethe Oxenboll K, 2011, USE PROTEASE POULTRY; Monsellier E, 2005, PROTEIN ENG DES SEL, V18, P445, DOI 10.1093/protein/gzi046; Nigam PS, 2013, BIOMOLECULES, V3, DOI 10.3390/biom3030597; OKA M, 1989, BIOTECHNOL APPL BIOC, V11, P307; Papamichael E. M., 2019, ADV ENZYME TECHNOLOG, P71, DOI [10.1016/B978-0-444-64114-4.00003-0, DOI 10.1016/B978-0-444-64114-4.00003-0]; Qadeer A, 2014, BIOCHEMISTRY-MOSCOW+, V79, P785, DOI 10.1134/S0006297914080069; Randolph Theodore W, 2002, Pharm Biotechnol, V13, P159; Reed CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089452; Ruiz-Pena M, 2010, COLLOID SURFACE B, V75, P282, DOI 10.1016/j.colsurfb.2009.08.046; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shaikh I. K., 2018, Journal of Genetic Engineering and Biotechnology, V16, P273, DOI 10.1016/j.jgeb.2018.07.003; Sharma AK, 2020, INT J BIOL MACROMOL, V153, P680, DOI 10.1016/j.ijbiomac.2020.03.006; Sharma Kanupriya Miglani, 2017, Journal of Genetic Engineering and Biotechnology, V15, P115, DOI 10.1016/j.jgeb.2017.02.001; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Tcherkasskaya O, 2000, J BIOL CHEM, V275, P36285, DOI 10.1074/jbc.M003008200; Toymentseva AA, 2016, RUSS J BIOORG CHEM+, V42, P53, DOI 10.1134/S1068162015060175; Tripathi P, 2011, FOOD CHEM, V125, P1005, DOI 10.1016/j.foodchem.2010.09.108; Udatha DBRKG, 2015, J STRUCT BIOL, V190, P314, DOI 10.1016/j.jsb.2015.04.009; Wehaidy HR, 2018, INT J BIOL MACROMOL, V111, P296, DOI 10.1016/j.ijbiomac.2017.12.125; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Zhan DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103902	67	6	7	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234958	10.1371/journal.pone.0234958	http://dx.doi.org/10.1371/journal.pone.0234958			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574185	Green Published, gold			2022-12-27	WOS:000544972400012
J	Yen, FS; Hsu, CC; Li, HL; Wei, JCC; Hwu, CM				Yen, Fu-Shun; Hsu, Chih-Cheng; Li, Hsin-Lun; Wei, James Cheng-Chung; Hwu, Chii-Min			Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout	PLOS ONE			English	Article							SERUM URIC-ACID; CORONARY-HEART-DISEASE; ALLOPURINOL USE; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; HYPERURICEMIA; FAILURE; HEALTH; LIPIDS; IMPACT	Objectives Although studies have demonstrated the association of hyperuricemia with cardiovascular (CV) diseases, few have explored the effect of urate-lowering therapy (ULT) on the incidence of CV diseases. Therefore, we compared the risks of hospitalized coronary artery disease (CAD), stroke, heart failure (HF), and all-cause mortality between ULT users and nonusers among patients with gout. Methods We performed this retrospective cohort study using Taiwan's population-based National Health Insurance Research Database. In total, 5218 patients with gout were included from 2000 to 2012. We compared the incidence rates (IRs) of hospitalized CAD, stroke, HF, and all-cause mortality between ULT users and matched nonusers. Results The IRs of hospitalized stroke were 0.6 and 1.0 per 100 person-years for ULT users and nonusers, respectively, after adjusting for age, sex, residence, comorbidities, and medications. ULT users showed lower adjusted hazard ratios (aHR) for hospitalized stroke (aHR: 0.52,p< 0.001) and all-cause mortality (aHR: 0.6,p= 0.02) than nonusers. Subgroup analyses revealed that uricosuric agents and xanthine oxidase inhibitors were significantly associated with lower risks of hospitalized stroke and all-cause mortality, respectively. The effect of uricosuric agents on the decrease in hospitalized stroke risk indicated a dose-response relationship. Conclusions Our study showed lower risks of hospitalized stroke and all-cause mortality in ULT users than in nonusers among patients with gout. Therefore, patients with gout may receive ULT to mitigate the risks of hospitalized stroke and mortality.	[Yen, Fu-Shun] Dr Yens Clin, Taoyuan, Taiwan; [Hsu, Chih-Cheng] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Miaoli County, Taiwan; [Hsu, Chih-Cheng] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Hsu, Chih-Cheng] Min Sheng Gen Hosp, Dept Family Med, Taoyuan, Taiwan; [Li, Hsin-Lun] China Med Univ, Management Off Hlth Data, Taichung, Taiwan; [Li, Hsin-Lun] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Dept Med, Taichung, Taiwan; [Wei, James Cheng-Chung] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Hwu, Chii-Min] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan; [Hwu, Chii-Min] Taipei Vet Gen Hosp, Sect Endocrinol & Metab, Dept Med, Taipei, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Wei, JCC (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Wei, JCC (corresponding author), Chung Shan Med Univ Hosp, Dept Med, Taichung, Taiwan.; Wei, JCC (corresponding author), China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan.; Hwu, CM (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan.; Hwu, CM (corresponding author), Taipei Vet Gen Hosp, Sect Endocrinol & Metab, Dept Med, Taipei, Taiwan.	wei3228@gmail.com; chhwu@vghtpe.gov.tw	Hwu, Chii-Min/AAZ-7384-2021	Li, Hsin-Lun/0000-0003-1497-1599	Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW108-TDU-B-212-133004]; China Medical University Hospital, Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 107-2321-B-039 -004-]; Tseng-Lien Lin Foundation (Taichung, Taiwan); Katsuzo and Kiyo Aoshima Memorial Funds (Japan)	Taiwan Ministry of Health and Welfare Clinical Trial Center; China Medical University Hospital, Academia Sinica Stroke Biosignature Project; MOST Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation (Taichung, Taiwan); Katsuzo and Kiyo Aoshima Memorial Funds (Japan)	This work was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW108-TDU-B-212-133004), China Medical University Hospital, Academia Sinica Stroke Biosignature Project (BM10701010021), MOST Clinical Trial Consortium for Stroke (MOST 107-2321-B-039 -004-), Tseng-Lien Lin Foundation (Taichung, Taiwan), and Katsuzo and Kiyo Aoshima Memorial Funds (Japan), The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; de Abajo FJ, 2015, HEART, V101, P679, DOI 10.1136/heartjnl-2014-306670; Doehner W, 2005, HEART, V91, P707, DOI 10.1136/hrt.2004.057190; Doehner W, 2007, INT J CARDIOL, V115, P156, DOI 10.1016/j.ijcard.2006.05.003; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; GERTLER MM, 1951, ANN INTERN MED, V34, P1421, DOI 10.7326/0003-4819-34-6-1421; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Grimaldi-Bensouda L, 2015, ANN RHEUM DIS, V74, P836, DOI 10.1136/annrheumdis-2012-202972; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; Huang H, 2014, EUR J HEART FAIL, V16, P15, DOI 10.1093/eurjhf/hft132; Jin M, 2012, FRONT BIOSCI-LANDMRK, V17, P656, DOI 10.2741/3950; Khan F, 2008, CARDIOVASC THER, V26, P247, DOI 10.1111/j.1755-5922.2008.00057.x; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Kojima S, 2019, EUR HEART J, V40, P1778, DOI 10.1093/eurheartj/ehz119; Krca M, 2016, J RECEPT SIG TRANSD, V12, P1; Krishnan E, 2010, RHEUMATOLOGY, V49, P1229, DOI 10.1093/rheumatology/keq037; Luk AJ, 2009, RHEUMATOLOGY, V48, P804, DOI 10.1093/rheumatology/kep069; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Muir SW, 2008, STROKE, V39, P3303, DOI 10.1161/STROKEAHA.108.519793; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; SIMONS LA, 1991, AUST NZ J MED, V21, P701, DOI 10.1111/j.1445-5994.1991.tb01373.x; Singh JA, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0513-6; Struthers AD, 2002, HEART, V87, P229, DOI 10.1136/heart.87.3.229; VIGNA GB, 1992, CIRCULATION, V85, P2205, DOI 10.1161/01.CIR.85.6.2205; Wei L, 2011, BRIT J CLIN PHARMACO, V71, P600, DOI 10.1111/j.1365-2125.2010.03887.x; Weisman A, 2019, DIABETES OBES METAB, V21, P1322, DOI 10.1111/dom.13656; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024; Wheeler JG, 2005, PLOS MED, V2, P236, DOI 10.1371/journal.pmed.0020076; Zhao G, 2013, ATHEROSCLEROSIS, V231, P61, DOI 10.1016/j.atherosclerosis.2013.08.023	34	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234909	10.1371/journal.pone.0234909	http://dx.doi.org/10.1371/journal.pone.0234909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574194	gold, Green Published			2022-12-27	WOS:000544972400005
J	Kumari, S; Mohan, A; Saberwal, G				Kumari, Sangeeta; Mohan, Abhilash; Saberwal, Gayatri			Hidden duplicates: 10s or 100s of Indian trials, registered with ClinicalTrials.gov, have not been registered in India, as required by law	PLOS ONE			English	Article							CLINICAL-TRIALS	Background This study's primary goal was based on the fact that since 15 June 2009 it has been mandatory to register regulatory trials running in India with Clinical Trials Registry-India (CTRI). Were all such trials, registered with ClinicalTrials.gov (CTG) after 2009, that included India as a location, also registered with CTRI? We first had to determine how to correctly identify a trial that was registered in both the registries, but that lacked the relevant secondary ID. Therefore the secondary goal of this study was to identify the best method to do this. Methods We used a control set of 1013 trials that cross-referenced a record in the other registry. We used two algorithms to-in a blinded fashion-identify CTRI matches for the 1013 CTG records. 80% of the predictions were correct. Using the same methodology, we identified matches for the CTG trials without known CTRI matches. We then used a logistic regression model to predict which of these matches were correct. Results (i) 3664 CTG records listed India as a location, but did not list any CTRI ID, and were not identified by any CTRI records either. (ii) The best single field to find a CTRI match for a CTG trial was the title field. (iii) Between 50 and 300 of 581 relevant CTG trials were not registered with CTRI. Conclusions This is the first study to use hidden duplicates to determine that the law on trial registration has been broken (in India). Similar studies need to be done for trials run in other countries.	[Kumari, Sangeeta; Mohan, Abhilash; Saberwal, Gayatri] Inst Bioinformat & Appl Biotechnol, Biotech Pk, Bengaluru, Karnataka, India		Saberwal, G (corresponding author), Inst Bioinformat & Appl Biotechnol, Biotech Pk, Bengaluru, Karnataka, India.	gayatri@ibab.ac.in		Saberwal, Gayatri/0000-0003-2410-1431				[Anonymous], 2013, CHEM BUSINESS, V27, P83; [Anonymous], 2010, TRANSF CLIN RES US C, DOI [10.17226/12900, DOI 10.17226/1290021210556]; [Anonymous], 2008, WAIS; Askie Hunter, 2017, CLIN TRIALS LANDSCAP; Chaturvedi Mansi, 2017, Perspect Clin Res, V8, P172, DOI 10.4103/2229-3485.215970; Clinical Research Information Service (CRIS), 2010, OSONGSAENGMYEONG2 IR; Feizabadi Mansoureh, 2017, J Evid Based Med, V10, P91, DOI 10.1111/jebm.12248; Fleminger J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193088; Grobler L, 2008, LANCET, V372, P1201, DOI 10.1016/S0140-6736(08)61498-1; Hillemann J., 2014, INT BUSINESS RES, V9, P27; Martinho AM, 2017, REGEN MED, V12, P419, DOI [10.2217/rme-2017-0002, 10.2217/rme-2017-0015]; Miller Jennifer E, 2017, BMC Res Notes, V10, P350, DOI 10.1186/s13104-017-2687-5; Pandolfini C, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2910-2; Scaffidi J, 2017, BJOG-INT J OBSTET GY, V124, P132, DOI 10.1111/1471-0528.14151; Subherwal S, 2014, CIRCULATION, V130, P1812, DOI 10.1161/CIRCULATIONAHA.114.011021; van Valkenhoef G, 2016, SYST REV, V5, DOI 10.1186/s13643-016-0283-8; World Health Organization, WHAT REG REG CAN DO; World Health Organization, 2018, INT STAND CLIN TRIAL; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; Zarin DA, 2016, NEW ENGL J MED, V375, P1998, DOI 10.1056/NEJMsr1611785	20	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234925	10.1371/journal.pone.0234925	http://dx.doi.org/10.1371/journal.pone.0234925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559240	Green Published, gold			2022-12-27	WOS:000543261600026
J	Cowan, AE; Higgins, KA; Fisher, JO; Tripicchio, GL; Mattes, RD; Zou, PS; Bailey, RL				Cowan, Alexandra E.; Higgins, Kelly A.; Fisher, Jennifer O.; Tripicchio, Gina L.; Mattes, Richard D.; Zou, Peishan; Bailey, Regan L.			Examination of different definitions of snacking frequency and associations with weight status among US adults	PLOS ONE			English	Article							ENERGY-INTAKE; FOOD-INTAKE; UNITED-STATES; DIET QUALITY; NATIONAL-HEALTH; EATING PATTERNS; NUTRITION; CHILDREN; OBESITY; TRENDS	Snacks, while widely consumed in the United States (U.S.), do not have a standard definition, complicating research to understand associations, if any, with weight status. Therefore, the purpose of this study was to examine the association between snacking frequency and weight status using various snacking definitions that exist in the scientific literature among U.S. adults (NHANES 2013-2016; >= 20y n = 9,711). Four event-based snacking definitions were operationalized including participant-defined snacks, eating events outside of meals, and operationally defined snacks based on absolute thresholds of energy consumed (>50 kcal). Weight status was examined using body mass index (BMI), waist circumference, and sagittal abdominal diameter risk. Logistic regression models examined snacking frequency and associations with weight status. Outcomes varied by the definition of a snack employed, but the majority of findings were null. Mean energy from snacks was significantly higher among women with obesity compared to women with normal weight when a snack was defined as any event outside of a typical mealtime (i.e. other than breakfast, lunch, dinner, super, brunch), regardless of whether or not it contributed >= 50 kcal. Further investigation into ingestive behaviors that may influence the relationship between snacking frequency and weight status is needed.	[Cowan, Alexandra E.; Higgins, Kelly A.; Mattes, Richard D.; Zou, Peishan; Bailey, Regan L.] Purdue Univ, Coll Hlth & Human Sci, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Higgins, Kelly A.] Exponent Inc, Ctr Chem Regulat & Food Safety, Washington, DC 20036 USA; [Fisher, Jennifer O.; Tripicchio, Gina L.] Temple Univ, Coll Publ Hlth, Ctr Obes Res & Educ, Philadelphia, PA 19122 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Exponent; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Higgins, KA (corresponding author), Purdue Univ, Coll Hlth & Human Sci, Dept Nutr Sci, W Lafayette, IN 47907 USA.; Higgins, KA (corresponding author), Exponent Inc, Ctr Chem Regulat & Food Safety, Washington, DC 20036 USA.	khiggins@exponent.com		Tripicchio, Gina/0000-0003-2820-5756; Higgins, Kelly/0000-0002-0663-8975				Ahluwalia N, 2016, ADV NUTR, V7, P121, DOI 10.3945/an.115.009258; Almoosawi S, 2016, P NUTR SOC, V75, P487, DOI 10.1017/S0029665116000306; [Anonymous], 2019, KOREAN NATL HLTH NUT; [Anonymous], 2018, BREAKF PERC SEL NUTR; [Anonymous], 2000, WHO TECHN REP SER; Appleton KM, 2011, APPETITE, V56, P602, DOI 10.1016/j.appet.2011.01.032; Bailey RL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010102; Bailey RL, 2017, J NUTR EDUC BEHAV, V49, P639, DOI 10.1016/j.jneb.2016.11.008; Belcher BR, 2010, MED SCI SPORT EXER, V42, P2211, DOI 10.1249/MSS.0b013e3181e1fba9; Bellisle F, 2014, PHYSIOL BEHAV, V134, P38, DOI 10.1016/j.physbeh.2014.03.010; BIRCH LL, 1986, APPETITE, V7, P323, DOI 10.1016/S0195-6663(86)80001-0; Blanton CA, 2006, J NUTR, V136, P2594, DOI 10.1093/jn/136.10.2594; Cecil JE, 2005, AM J CLIN NUTR, V82, P302, DOI 10.1093/ajcn/82.2.302; Center for Disease Control and Prevention, 2016, NAT HLTH NUTR EX SUR; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Cowan AE, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081114; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Duffey KJ, 2014, J NUTR, V144, P1843, DOI 10.3945/jn.114.198192; Garriguet Didier, 2007, Health Rep, V18, P17; Goodwin S, 2002, CLIN NURSE SPEC, V16, P164, DOI [10.1097/00002800-200205000-00016, DOI 10.1097/00002800-200205000-00016]; Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016; Han TS, 1995, BMJ-BRIT MED J, V311; Hess JM, 2018, PHYSIOL BEHAV, V193, P284, DOI 10.1016/j.physbeh.2018.04.019; Hess JM, 2016, ADV NUTR, V7, P466, DOI 10.3945/an.115.009571; Hill RJ, 2001, BRIT J NUTR, V85, P415, DOI 10.1079/BJN2000281; Hunter CD, 2019, INT J INCLUSIVE EDUC, V23, P950, DOI 10.1080/13603116.2019.1602363; *I MED, 2006, DIET REF INT ESS GUI; Johnson GH, 2010, CRIT REV FOOD SCI, V50, P848, DOI 10.1080/10408390903572479; Kachurak A, 2018, OBESITY, V26, P1034, DOI 10.1002/oby.22172; Kahn HS, 2018, DIABETES RES CLIN PR, V136, P7, DOI 10.1016/j.diabres.2017.11.019; Kahn HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108707; Kant AK, 2007, PUBLIC HEALTH NUTR, V10, P158, DOI 10.1017/S1368980007246749; Kant AK, 2015, J ACAD NUTR DIET, V115, P50, DOI 10.1016/j.jand.2014.06.354; Kant AK, 2012, AM J CLIN NUTR, V96, P1369, DOI 10.3945/ajcn.112.044974; Leech RM, 2015, AM J CLIN NUTR, V102, P1229, DOI 10.3945/ajcn.115.114660; Luke A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-387; Ma YS, 2003, AM J EPIDEMIOL, V158, P85, DOI 10.1093/aje/kwg117; Macdiarmid J, 2009, EUR J CLIN NUTR, V63, P1297, DOI 10.1038/ejcn.2009.87; MacLean RR, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5248-5; Masters MA, 2014, J ACAD NUTR DIET, V114, P1533, DOI 10.1016/j.jand.2014.04.023; Mattes R, 2013, CHAPTER 27 SNACKING, P501; Mattes RD, 2001, PHYSIOL BEHAV, V74, P551, DOI 10.1016/S0031-9384(01)00597-2; Mattes RD, 2018, PHYSIOL BEHAV, V193, P279, DOI 10.1016/j.physbeh.2018.02.010; Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585; Murakami K, 2016, BRIT J NUTR, V116, P1633, DOI 10.1017/S0007114516003731; Murakami K, 2016, J ACAD NUTR DIET, V116, P1101, DOI 10.1016/j.jand.2015.12.012; Murakami K, 2015, J NUTR, V145, P2715, DOI 10.3945/jn.115.219808; Murakami K, 2015, BRIT J NUTR, V114, P1294, DOI 10.1017/S0007114515002706; Musialik K, 2017, EUR REV MED PHARMACO, V21, P4379; Ng SW, 2011, EUR J CLIN NUTR, V65, P1328, DOI 10.1038/ejcn.2011.135; OGDEN CL, 2015, NCHS DATA BRIEF, V219, P1, DOI DOI 10.1017/S1368980017000088; Ovaskainen ML, 2010, APPETITE, V54, P623, DOI 10.1016/j.appet.2010.03.012; Piernas C, 2010, J NUTR, V140, P325, DOI 10.3945/jn.109.112763; Poppitt SD, 1998, INT J OBESITY, V22, P303, DOI 10.1038/sj.ijo.0800584; Ritchie LD, 2012, AM J CLIN NUTR, V95, P290, DOI 10.3945/ajcn.111.016881; Skrypnik D, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020469; Skrypnik D, 2019, POL ARCH INTERN MED, V129, P267, DOI 10.20452/pamw.4426; Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634; Tooze JA, 2004, AM J CLIN NUTR, V79, P795; Tripicchio GL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071486; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; U.S. Department of Agriculture Agricultural Research Service, 2018, SNACKS PERC SEL NUTR; U.S. Department of Agriculture ARS Beltsville Human Nutrition Research Center Food Surveys Research Group, 2011, SNACK PATT US AD NHA; US Department of Agriculture, 2018, FOOD NUTRIENT DATABA; VanderWeele TJ, 2019, EUR J EPIDEMIOL, V34, pCP3, DOI 10.1007/s10654-019-00494-6; Veldheer S, 2015, INT J OBESITY, V39, P1727, DOI 10.1038/ijo.2015.127; Wang ZH, 2012, ASIA PAC J CLIN NUTR, V21, P253; Wardle J, 2004, ANN BEHAV MED, V27, P107, DOI 10.1207/s15324796abm2702_5; Woteki CE., 1993, CLIN NUTR INSIGHT, DOI [10.17226/1365, DOI 10.17226/1365]; Zandstra EH, 2000, EUR J CLIN NUTR, V54, P239, DOI 10.1038/sj.ejcn.1600927; Zipf George, 2013, Vital Health Stat 1, P1	71	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234355	10.1371/journal.pone.0234355	http://dx.doi.org/10.1371/journal.pone.0234355			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555712	Green Published, gold			2022-12-27	WOS:000542759600011
J	Jo, S; Jeong, T; Lee, JB; Jin, Y; Yoon, J; Park, B				Jo, Sion; Jeong, Taeoh; Lee, Jae Baek; Jin, Youngho; Yoon, Jaechol; Park, Boyoung			The prognostic value of platelet-to-lymphocyte ratio on in-hospital mortality in admitted adult traffic accident patients	PLOS ONE			English	Article							MULTIPLE-ORGAN FAILURE; INJURY SEVERITY SCORE; POSTTRAUMATIC COMPLICATIONS; NEUTROPHIL-LYMPHOCYTE; DIAGNOSTIC-ACCURACY; TRAUMA; ASSOCIATION; POPULATIONS; PREDICTION; LACTATE	Background The predictive value of platelet-to-lymphocyte ratio (PLR) in acute illness is well known, but further evaluation is needed in traffic accident patients. Methods This retrospective observational study enrolled consecutive adult patients involved in traffic accidents who were admitted to the study hospital's emergency department during 1 year. The initial platelet and lymphocyte counts after arrival at the emergency department were the variables of interest. The primary outcome was in-hospital mortality. Data on baseline characteristics, comorbidities, and physiological and laboratory variables were collected. Multivariate Cox proportional hazard modelings were used to identify the variables independently associated with the outcome. Results A total of 1,522 traffic accident patient were screened, and 488 patients were enrolled. In all, 43 (8.8%) patients died in the hospital. The median PLR was 115.3 (interquartile range 71.3;181.8). The in-hospital mortality rate of the 1(st)tertile of PLR (21.5%) was significantly higher than the rates of the 2(nd)(2.5%) and 3(rd)(2.5%) tertiles. The area under the receiver operating characteristic curve of PLR for in-hospital survival was 0.82 (95% confidential interval [CI], 0.74-0.89), which was greater than that of lymphocyte count (0.72; 95% CI 0.63-0.81) and platelet count (0.67; 95% CI 0.57-0.76). The Kaplan-Meier curves showed a significant difference in survival between the tertiles (p<0.001). The Cox regression model showed that the 2(nd)tertile of PLR was independently associated with lower in-hospital mortality (adjusted hazard ratio 0.30; 95% CI, 0.09-0.98), compared to the 1(st)tertile. Conclusion PLR was significantly associated with an increased risk of in-hospital mortality in admitted adult traffic accident patients.	[Jo, Sion; Jeong, Taeoh; Lee, Jae Baek; Jin, Youngho; Yoon, Jaechol] Chonbuk Natl Univ, Coll Med, Dept Emergency Med, Jeonju Si, South Korea; [Jo, Sion; Jeong, Taeoh; Lee, Jae Baek; Jin, Youngho; Yoon, Jaechol] Chonbuk Natl Univ, Res Inst Clin Med, Jeonju Si, South Korea; [Jo, Sion; Jeong, Taeoh; Lee, Jae Baek; Jin, Youngho; Yoon, Jaechol] Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju Si, South Korea; [Jo, Sion] Vet Hlth Serv Med Ctr, Dept Emergency Med, Seoul, South Korea; [Park, Boyoung] Hanyang Univ, Coll Med, Dept Med, Seoul, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University Hospital; Veterans Health Service Medical Center; Hanyang University	Jeong, T (corresponding author), Chonbuk Natl Univ, Coll Med, Dept Emergency Med, Jeonju Si, South Korea.; Jeong, T (corresponding author), Chonbuk Natl Univ, Res Inst Clin Med, Jeonju Si, South Korea.; Jeong, T (corresponding author), Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju Si, South Korea.	emmd@jbnu.ac.kr			Fund of Biomedical Research Institute, Chonbuk National University Hospital	Fund of Biomedical Research Institute, Chonbuk National University Hospital	Taeoh Jeong received the fund. This paper was supported by Fund of Biomedical Research Institute, Chonbuk National University Hospital. http://www.cuh.co.kr/cuh/bri1/Funders do not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2016, MEDICINE, V95, pe3187; [Anonymous], 2018, MED BALTIMORE, V97, pe9654; [Anonymous], 2016, THE TOTAL AUDIENCE R; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BALAKRISHNAN K, 1995, IMMUNOL INVEST, V24, P233, DOI 10.3109/08820139509062775; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Cetin EHO, 2016, ANGIOLOGY, V67, P336, DOI 10.1177/0003319715591751; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; Cho SK, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0748-4; Curtis K, 2012, AUSTRALAS EMERG NURS, V15, P45, DOI 10.1016/j.aenj.2011.12.001; Dewar DC, 2013, J TRAUMA ACUTE CARE, V74, P774, DOI 10.1097/TA.0b013e31827a6e69; Djordjevic Dragan, 2018, Mediators Inflamm, V2018, P3758068, DOI 10.1155/2018/3758068; Emektar E, 2017, EURASIAN J EMERG MED, V16, P165, DOI 10.5152/eajem.2017.51523; FAIST E, 1986, ARCH SURG-CHICAGO, V121, P1000; Gale SC, 2016, J SURG RES, V205, P446, DOI 10.1016/j.jss.2016.06.103; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Jo S, 2014, EUR J EMERG MED, V21, P199, DOI 10.1097/MEJ.0b013e32836192d6; Kehoe A, 2015, EMERG MED J, V32, P911, DOI 10.1136/emermed-2015-205265; Kornblith LZ, 2014, J TRAUMA ACUTE CARE, V76, P255, DOI 10.1097/TA.0000000000000108; Kumar P, 2017, J THORAC DIS, V9, P1509, DOI 10.21037/jtd.2017.05.77; Menges T, 1999, CRIT CARE MED, V27, P733, DOI 10.1097/00003246-199904000-00026; Moore FA, 1999, CRIT CARE MED, V27, P674, DOI 10.1097/00003246-199904000-00004; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nording HM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00098; Nydam TL, 2011, J TRAUMA, V70, P401, DOI 10.1097/TA.0b013e31820b5c85; Orak M, 2018, NIGER J CLIN PRACT, V21, P667, DOI 10.4103/njcp.njcp_44_17; Pourafkari L, 2018, BIOMARK MED, V12, P63, DOI 10.2217/bmm-2017-0193; Shimoyama Y, 2017, JA CLIN REP, V3, DOI 10.1186/s40981-017-0118-1; Simel DL, 2008, J GEN INTERN MED, V23, P768, DOI 10.1007/s11606-008-0583-3; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; Wang Q, 2018, INT ANGIOL, V37, P4, DOI 10.23736/S0392-9590.17.03848-2; Wang YH, 2018, THROMB RES, V166, P28, DOI 10.1016/j.thromres.2018.04.007; Yao CY, 2017, INT J CHRONIC OBSTR, V12, P2285, DOI 10.2147/COPD.S141760	36	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0233838	10.1371/journal.pone.0233838	http://dx.doi.org/10.1371/journal.pone.0233838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555645	gold, Green Published			2022-12-27	WOS:000542759600032
J	Kebede, Y; Abebe, L; Alemayehu, G; Sudhakar, M; Birhanu, Z				Kebede, Yohannes; Abebe, Lakew; Alemayehu, Guda; Sudhakar, Morankar; Birhanu, Zewdie			School-based social and behavior change communication (SBCC) advances community exposure to malaria messages, acceptance, and preventive practices in Ethiopia: A pre-posttest study	PLOS ONE			English	Article							SCHOOLCHILDREN; EDUCATION; HEALTH	Background Ethiopia has shown incredible success in malaria morbidity, mortality, and control. Community empowerment is a milestone to meet the ambitious plans of eliminating malaria by 2030. Objectives This study aimed to evaluate school-based malaria social behavior change communication (SBCC) in terms of community message exposure, acceptance, knowledge, and practices. Methods A community-based pre-posttest study was conducted in five districts of the Jimma Zone, Ethiopia. 762 and 759 households were sampled for baseline and end-line, respectively. The intervention engaged students from primary schools on participatory peer education within small groups, followed by exposing parents with malaria messages aimed to influencing ideation and preventive practices. The data were analyzed using Statistical Package for Social Sciences (SPSS) version 20.0. Proportion/mean differences were computed to compare both surveys on exposure, knowledge, perceptions, and practices at p <0.05. Finally, a regression analysis was conducted between key changes and school-based exposure. Results The study revealed a sharp increase in exposure to malaria messages with effect size (ES) of 65.7%, p <0.001. School specific exposure has grown to 57.8% (ES = 44.5%). Comprehensive knowledge about malaria increased to 39.1% (ES = 14.8%). Identifying mosquito bites as a cause of malaria was increased by ES = 20.8%. A slight reduction in risk perception (ES = 3.3%) and attitude (ES = 3.8%) and a higher rise in self-efficacy (ES = 8.5%) were observed. Community message acceptance in favor of malaria danger control was significantly improved by 10% i.e. an increase in rational decision making to uptake preventive practices. Consistently, insecticide-treated nets (ITNs) usage was improved to 63.0% (ES = 25.8%). Giving priority to use ITNs for under five years old children and pregnant women grew by 16.3% and 24.8%, respectively. Significant improvements were observed in treatment-seeking for fever (ES = 16.3%) and early treatment-seeking (ES = 15.5%). Not painting or plastering walls 6 months within spraying changed by ES = 61%. No significant change was observed in drug adherence. The school-based content intensity of exposure had effects on comprehensive knowledge, message acceptance, and ITN utilization. Conclusions Engaging school-aged children effectively advances community exposure, perception, and behaviors. We recommend the inclusion of school-based SBCC in the national malaria control programs.	[Kebede, Yohannes; Abebe, Lakew; Sudhakar, Morankar; Birhanu, Zewdie] Jimma Univ, Dept Hlth Behav & Soc, Jimma, Ethiopia; [Alemayehu, Guda] US Agcy Int Dev, Malaria Initiat, Addis Ababa, Ethiopia	Jimma University; United States Agency for International Development (USAID)	Kebede, Y (corresponding author), Jimma Univ, Dept Hlth Behav & Soc, Jimma, Ethiopia.	yohanneskbd@gmail.com	Lemu, Yohannes Kebede/AAB-8494-2020	Lemu, Yohannes Kebede/0000-0003-3142-5266	American People through United States Agency for International Development (USAID)-Ethiopia [AID-663-A-00010]	American People through United States Agency for International Development (USAID)-Ethiopia(United States Agency for International Development (USAID))	This study was made possible by the generous support of the American People through United States Agency for International Development (USAID)-Ethiopia. Project's grant number: AID-663-A-00010. Professor Morankar Sudhakar was the principal investigator who secured the award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Add Logos, 2014, SCH HLTH PROGR MAL A; [Anonymous], 2017, AM J TRANSPLANT, V17, P572, DOI [10.1111/ajt.14179, DOI 10.1111/AJT.14179]; [Anonymous], 2013, CAHIERS VOLTAIRE, V12, P203; [Anonymous], 2006, ITSAS MEMORIA REV ES, V5, P50; [Anonymous], 2010, NATURE MAT, V9, pS5; [Anonymous], 2000, FRAM MON PROGR EV OU; [Anonymous], 2018, VOX             0919; Asingizwe D, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2904-x; Astatkie A, 2010, ETHIOP J HEALTH DEV, V24, P15; Barnett Victoria J., 2012, DIETRICH BONHOEFFER, V11, P313; Bauch JA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-75; Birhanu Z, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2677-2; Breakthrough ACTION Guyana, 2017, USING HUMAN CTR DESI; Buschke H, 2017, ARCH CLIN NEUROPSYCH, V32, P29, DOI 10.1093/arclin/acw083; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; Clarke SE, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000182; Cox SN, 2018, INT Q COMMUNITY HEAL, V38, P147, DOI 10.1177/0272684X17749573; Evaluation Task Force of Roll Back Malaria's Monitoring and Evaluation Reference Group, 2019, FRAM EV NAT MAL PROG; Federal democratic republic of Ethiopia Ministry of Health, 2015, HLTH SECT TRANSF PLA; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, HLTH SECT STRAT PLAN; Federal Democratic Republic of Ethiopia Ministry of Health, 2016, ETH NAT MAL IND SURV; Federal Ministry of Health (FMOH), 2010, NAT STRAT PLAN MAL P; Federal Ministry of Health (FMOH) PATH Malaria Control and Elimination Partnership in Africa (MACEPA)., 2015, ETH ACC MAL EL STAK; Federal Ministry of Health of Ethiopia, 2005, FED MIN HLTH HLTH SE; Festinger L., 1957, THEORY COGNITIVE DIS, V2; FMOH, 2014, NAT STRAT PLAN MAL P; FMOH, 2010, NAT STRAT PLAN MAL P; Gardella F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-124; Goodman C, 2007, AM SOC TROPICAL MED; Kilian A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-259; Masaninga F, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2314-5; Mohammed A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7336-6; Nankabirwa J, 2014, TROP MED INT HEALTH, V19, P1294, DOI 10.1111/tmi.12374; Nonaka D, 2008, PARASITOL INT, V57, P76, DOI 10.1016/j.parint.2007.09.005; Okabayashi H, 2006, PARASITOL INT, V55, P121, DOI 10.1016/j.parint.2005.11.056; Olga A, 2016, GLOBALIZATION AND ITS SOCIO-ECONOMIC CONSEQUENCES, 16TH INTERNATIONAL SCIENTIFIC CONFERENCE PROCEEDINGS, PTS I-V, P50; Onyango-Ouma W, 2005, SOC SCI MED, V61, P1711, DOI 10.1016/j.socscimed.2005.03.041; Owusu-Addo E., 2014, J BIOL AGR HEALTHCAR, V4, P2014; Partnership for Child Development London School of Hygiene and Tropical Medicine Kenya Medical Research Institute-Wellcome Trust Research Programme The World Bank, 2009, MAL CONTR SCH TOOLK; PATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2017, ETH MAL POL LANDSC; President's Malaria Initiative Ghana Health Services Ghana Education services John Hopkins Center for Communication programs, 2016, PROM MAL PREV PRIM S; RBM Partnership to End Malaria, 2017, 2017 MAL SOC BEH CHA; Reda WN, 2015, AFR EDUC RE, V12, P696, DOI 10.1080/18146627.2015.1112162; Roll Back Malaria MEASURE Evaluation USAID UNICEF World Health Organization MACEPA CDC, 2009, GUID COR POP BAS IND; Roll Back Malaria MEASURE Evaluation World Health Organization UNICEF, 2004, GUID COR POP COV IND; Roll Back Malaria Partnership to End Malaria, 2018, STRAT FRAM MAL SOC B; Romay-Barja M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168668; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Seyoum D, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111312; The Federal Democratic Republic Of Ethiopia (FDRE), 2012, NAT SCH HLTH NUTR ST; The Health Communication Capacity Collaborative (HC3), 2017, MAL SSBCC EV LIT REV; U.S. Global Malaria Coordinator U.S. President's Malaria Initiative Ethiopia, 2019, MAL OP PLAN; USAID, 2015, USID CENR AS FUT GRO; Vilay P, 2019, TROP MED HEALTH, V47, DOI 10.1186/s41182-019-0138-9; WHO, 2018, HOUS SURV IND MAL CO; WHO, 2017, CONTRACT NO WHONMHPN; WHO, GLOB TECHN STRAT MAL; WHO, 2017, GLOB MAL PROGR FRAM; WITTE K, 1994, COMMUN MONOGR, V61, P113, DOI 10.1080/03637759409376328; World Health Organization (WHO), 2016, RAIN MOD MAL EL MAL; 2006, PLOS MED, V5	61	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235189	10.1371/journal.pone.0235189	http://dx.doi.org/10.1371/journal.pone.0235189			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584891	Green Published, gold			2022-12-27	WOS:000545747200042
J	Tumwine, G; Palmieri, J; Larsson, M; Gummesson, C; Okong, P; Ostergren, PO; Agardh, A				Tumwine, Gilbert; Palmieri, Jack; Larsson, Markus; Gummesson, Christina; Okong, Pius; Ostergren, Per-Olof; Agardh, Anette			'One-size doesn't fit all': Understanding healthcare practitioners' perceptions, attitudes and behaviours towards sexual and reproductive health and rights in low resource settings: An exploratory qualitative study	PLOS ONE			English	Article							BARRIERS; UGANDA; GAY	Although progress has been made to improve access to sexual and reproductive health services globally in the past two decades, in many low-income countries, improvements have been slow. Discrimination against vulnerable groups and failure to address health inequities openly and comprehensively play a role in this stagnation. Healthcare practitioners are important actors who, often alone, decide who accesses services and how. This study explores how health care practitioners perceive sexual and reproductive health and rights (SRHR) and how background factors influence them during service delivery. Participants were a purposefully selected sample of health practitioners from five low income countries attending a training in at Lund University, Sweden. Semi-structured interviews and qualitative content analysis were used. Three themes emerged. The first theme, "one-size doesn't fit all' in SRHR" reflects health practitioners' perception of SRHR. Although they perceived rights as fundamental to sexual and reproductive health, exercising of these rights was perceived to be context-specific. The second theme, "aligning a pathway to service delivery", illustrates a reflective balancing act between their personal values and societal norms in service delivery, while the third theme, "health practitioners acting as gatekeepers", describes how this balancing act oscillates between enabling and blocking behaviours. The findings suggest that, even though health care practitioners perceive SRHR as fundamental rights, their preparedness to ensure that these rights were upheld in service delivery is influenced by personal values and society norms. This could lead to actions that enable or block service delivery	[Tumwine, Gilbert; Palmieri, Jack; Larsson, Markus; Ostergren, Per-Olof; Agardh, Anette] Lund Univ, Social Med & Global Hlth, Dept Clin Sci, Malmo, Sweden; [Tumwine, Gilbert] St Francis Hosp Nsambya, Kampala, Uganda; [Gummesson, Christina] Lund Univ, Ctr Teaching & Learning, Fac Med, Lund, Sweden; [Okong, Pius] Hlth Serv Commiss, Kampala, Uganda	Lund University; Lund University	Tumwine, G (corresponding author), Lund Univ, Social Med & Global Hlth, Dept Clin Sci, Malmo, Sweden.; Tumwine, G (corresponding author), St Francis Hosp Nsambya, Kampala, Uganda.	gilbert.tumwine@med.lu.se						Abdessamad HM, 2013, J WOMENS HEALTH, V22, P85, DOI 10.1089/jwh.2012.3718; Alan Guttmacher Institute, 1999, SHAR RESP WOM SOC AB; [Anonymous], 2007, QUALITATIVE METHODOL; Bernstein S., 2006, PUBLIC CHOICES PRIVA; Bruno L, 2016, THESIS; Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Gakidou E, 2007, PLOS MED, V4, P381, DOI 10.1371/journal.pmed.0040031; Garrido MV, 2011, SCAND J PRIM HEALTH, V29, P28, DOI 10.3109/02813432.2010.537015; George AS, 2018, HUM RESOUR HEALTH, V16, DOI 10.1186/s12960-018-0302-z; Gilson L, 2014, HEALTH POLICY PLANN, V29, P51, DOI 10.1093/heapol/czu098; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Harper Simpson IDA, 2007, PATTERNS SOCIALIZATI; Hartmann M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167542; ICT Services and System Development and Division of Epidemiology and Global Health, 2013, OPENCODE 4 0; Jewkes RK, 2005, BJOG-INT J OBSTET GY, V112, P1236, DOI 10.1111/j.1471-0528.2005.00697.x; Kiapi-Iwa L, 2004, AIDS CARE, V16, P339, DOI 10.1080/09540120410001665349; Kindig DA, 2007, MILBANK Q, V85, P139, DOI 10.1111/j.1468-0009.2007.00479.x; Larsson M, 2016, INT J SEX HEALTH, V28, P163, DOI 10.1080/19317611.2016.1158763; Mareeuw FV, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2271-7; Mercelis F, 2016, J DEV STUD, V52, P1446, DOI 10.1080/00220388.2016.1166209; Obedin-Maliver J, 2011, JAMA-J AM MED ASSOC, V306, P971, DOI 10.1001/jama.2011.1255; Sanders D, 2006, PLOS MED, V3, P719, DOI 10.1371/journal.pmed.0030186; Semugoma P, 2012, SAHARA J-J SOC ASP H, V9, P173, DOI 10.1080/17290376.2012.744177; Sequeira GM, 2012, OCHSNER J, V12, P379; SHELTON JD, 1992, LANCET, V340, P1334, DOI 10.1016/0140-6736(92)92505-A; Sida, 2016, ITP300 SID; SIMMONS R, 1994, STUD FAMILY PLANN, V25, P1, DOI 10.2307/2137985; Starrs AM, 2018, LANCET, V391, P2642, DOI 10.1016/S0140-6736(18)30293-9; Stephenson R., 2004, BARRIERS FAMILY PLAN; The World Medical Association (WMA), 2017, WMA DECL HELS ETH PR; Tuoane M, 2004, INT FAM PLAN PERSPEC, V30, P77, DOI 10.1363/3007704; van der Elst EM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18748; Wilson JQ, 2001, BUREAUCRACY WHAT GOV; World Health Organization, 2010, SOCIAL DETERMINANTS; World Health Organization, 2015, OPERATIONAL FRAMEWOR; World Health Organization, 2016, WORK HLTH GROWTH INV	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234658	10.1371/journal.pone.0234658	http://dx.doi.org/10.1371/journal.pone.0234658			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584840	gold, Green Published			2022-12-27	WOS:000545747200029
J	Hitch, D; Leech, K; Neale, S; Malcolm, A				Hitch, Danielle; Leech, Kathleen; Neale, Sharon; Malcolm, Avetta			Evaluating the implementation of an early supported discharge (ESD) program for stroke survivors: A mixed methods longitudinal case study	PLOS ONE			English	Article							REHABILITATION; HOME	Background Early supported discharge (ESD) models of care for stroke survivors coordinate inpatient and community services, with the aim of reducing length of stay. While there is an established evidence base around the clinical outcomes of ESD), less is known about the implementation of this approach into existing stroke care service. The aim of this case study was to describe staff perceptions of the implementation of an ESD model of care for stroke survivors at a large metropolitan public hospital in Australia. Methods This case study utilised a mixed methods design, which was designed in explicit alignment with the Consolidated Framework for Implementation Research (CFIR). Participants included staff that referred patients for ESD, and staff involved in the planning, implementation or delivery of ESD. Survey data was collected at three time points (ESD commencement, 3 months and 6 months), and focus groups were undertaken at the conclusion of the study. All quantitative data was analysed descriptive, while qualitative data was evaluated using thematic analysis. Results Results from both sources of data identified changes in staff perceptions of ESD implementation over time. While very few changes were statistically significant, they were diverse patterns of change across the CFIR constructs over time. The characteristics of individuals and ESD characteristics attracted consistently positive perceptions, while patient needs and resources was the most prevalent theme within the data. While perceptions of factors related to the inner setting were mixed, there was a steady improvement in perceptions about the process across the later stages of implementation. Conclusions The sophistication of knowledge translation and implementation in modern complex healthcare environments is highlighted by the multiple interactions between the CFIR domains and constructs. While the implementation process described was generally positive and effective, using the CFIR as a framework confirmed that it also entailed some challenges and unanticipated outcomes.	[Hitch, Danielle; Leech, Kathleen; Neale, Sharon; Malcolm, Avetta] Western Hlth, Allied Hlth, Sunshine, Vic, Australia; [Hitch, Danielle] Deakin Univ, Occupat Therapy, Geelong, Vic, Australia	Deakin University	Hitch, D (corresponding author), Western Hlth, Allied Hlth, Sunshine, Vic, Australia.; Hitch, D (corresponding author), Deakin Univ, Occupat Therapy, Geelong, Vic, Australia.	Danielle.Hitch@wh.org.au		Hitch, Danielle/0000-0003-2798-2246				Mas MA, 2015, INT J STROKE, V10, P7, DOI 10.1111/j.1747-4949.2012.00950.x; [Anonymous], 2013, AIDS, V27, pS159; [Anonymous], 2017, LANCET HIV, V2, pe115; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Barwick M. A., 2019, TRANSL BEHAV MED, pibz005, DOI [10.1093/tbm/ibz005/5304470, DOI 10.1093/TBM/IBZ005/5304470]; Brainard J, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0492-5; Braithwaite J, 2014, INT J QUAL HEALTH C, V26, P321, DOI 10.1093/intqhc/mzu047; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Chouliara N, 2014, CLIN REHABIL, V28, P370, DOI 10.1177/0269215513502212; Churruca K, 2019, J EVALUATION CLIN PR; Collden C, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3488-9; Cresswell J, 2014, RES DESIGN QUALITATA; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; DeCuir-Gunby JT, 2011, FIELD METHOD, V23, P136, DOI 10.1177/1525822X10388468; Dedoose, 2018, DED VERS 8 0 35 WEB; Drug Therapeutics Bulletin, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4147; Fisher R, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0908-0; Fisher RJ, 2011, STROKE, V42, P1392, DOI 10.1161/STROKEAHA.110.606285; Hayes CW, 2015, BMJ QUAL SAF, V24, P100, DOI 10.1136/bmjqs-2014-003673; Kirk MA, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0437-z; Kramer BJ, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0632-6; Kraut JC, 2014, DISABIL REHABIL, V36, P2178, DOI 10.3109/09638288.2014.893373; Kraut J, 2016, INT J THER REHABIL, V23, P464, DOI 10.12968/ijtr.2016.23.10.464; Langhorne P, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000443.pub4; May CR, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0506-3; Merriam S. B., 2009, QUALITATIVE RES GUID; Miller KK, 2019, ARCH PHYS MED REHAB, V100, P1162, DOI 10.1016/j.apmr.2018.10.017; Nanninga CS, 2015, PHYS THER, V95, P558, DOI 10.2522/ptj.20130495; Neale S, 2018, VICTORIAN STROKE CLI; Powell BJ, 2014, RES SOCIAL WORK PRAC, V24, P192, DOI 10.1177/1049731513505778; Salminen A., 2006, AUST OCCUP THER J, V53, P3, DOI [10.1111/j.1440-1630.2006.00540.x, DOI 10.1111/J.1440-1630.2006.00540.X]; Seal A, 2015, RES SOCIAL LIFE, P443; Stokes T, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-025094; Stroke Foundation, 2013, REH STROK SERV FRAM; Stroke Foundation, 2017, CLIN GUID STROK MAN; Turner K, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0799-5; Varsi C, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.5091; Wutzke Sonia, 2016, BMC Res Notes, V9, P327, DOI 10.1186/s13104-016-2133-0	39	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235055	10.1371/journal.pone.0235055	http://dx.doi.org/10.1371/journal.pone.0235055			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579574	gold, Green Published			2022-12-27	WOS:000545646600031
J	Kasetti, RB; Patel, PD; Maddineni, P; Zode, GS				Kasetti, Ramesh B.; Patel, Pinkal D.; Maddineni, Prabhavathi; Zode, Gulab S.			Ex-vivocultured human corneoscleral segment model to study the effects of glaucoma factors on trabecular meshwork	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INDUCED OCULAR HYPERTENSION; AQUEOUS-HUMOR; INTRAOCULAR-PRESSURE; EXTRACELLULAR-MATRIX; ORGAN-CULTURE; TISSUE TRANSGLUTAMINASE; GENE-TRANSFER; MOUSE MODEL; ER STRESS	Glaucoma is the second leading cause of irreversible blindness worldwide. Primary open angle glaucoma (POAG), the most common form of glaucoma, is often associated with elevation of intraocular pressure (IOP) due to the dysfunction of trabecular meshwork (TM) tissues. Currently, anex vivohuman anterior segment perfusion cultured system is widely used to study the effects of glaucoma factors and disease modifying drugs on physiological parameters like aqueous humor (AH) dynamics and IOP homeostasis. This system requires the use of freshly enucleated intact human eyes, which are sparsely available at very high cost. In this study, we explored the feasibility of using human donor corneoscleral segments for modeling morphological and biochemical changes associated with POAG. Among the number of corneas donated each year, many are deemed ineligible for transplantation due to stringent acceptance criteria. These ineligible corneoscleral segments were obtained from the Lions Eye Bank, Tampa, Florida. Each human donor anterior corneoscleral segment was dissected into four equal quadrants and cultured for 7 days by treating with the glaucoma factors dexamethasone (Dex) or recombinant transforming growth factor (TGF) beta 2 or transduced with lentiviral expression vectors containing wild type (WT) and mutant myocilin. Hematoxylin and Eosin (H&E) staining analysis revealed that the TM structural integrity is maintained after 7 days in culture. Increased TUNEL positive TM cells were observed in corneoscleral quadrants treated with glaucoma factors compared to their respective controls. However, these TUNEL positive cells were mainly confined to the scleral region adjacent to the TM. Treatment of corneoscleral quadrants with Dex or TGF beta 2 resulted in glaucomatous changes at the TM, which included increased extracellular matrix (ECM) proteins and induction of endoplasmic reticulum (ER) stress. Western blot analysis of the conditioned medium showed an increase in ECM (fibronectin and collagen IV) levels in Dex- or TGF beta 2-treated samples compared to control. Lentiviral transduction of quadrants resulted in expression of WT and mutant myocilin in TM tissues. Western blot analysis of conditioned medium revealed decreased secretion of mutant myocilin compared to WT myocilin. Moreover, increased ECM deposition and ER stress induction was observed in the TM of mutant myocilin transduced quadrants. Our findings suggest that theex-vivocultured human corneoscleral segment model is cost-effective and can be used as a pre-screening tool to study the effects of glaucoma factors and anti-glaucoma therapeutics on the TM.	[Kasetti, Ramesh B.; Patel, Pinkal D.; Maddineni, Prabhavathi; Zode, Gulab S.] Univ North Texas, Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Kasetti, Ramesh B.; Patel, Pinkal D.; Maddineni, Prabhavathi; Zode, Gulab S.] Univ North Texas, Hlth Sci Ctr Ft Worth, North Texas Eye Res Inst, Ft Worth, TX USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Zode, GS (corresponding author), Univ North Texas, Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA.	gulab.zode@unthsc.edu	Patel, Pinkal D./GQP-2308-2022	Patel, Pinkal D./0000-0002-7704-4381; KASETTI, RAMESH/0000-0001-7874-3988; Maddineni, Prabhavathi/0000-0002-6928-254X; ZODE, GULAB/0000-0002-7823-2595	National Institutes of Health [EY028616, EY026177]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by the National Institutes of Health; EY028616 (GSZ) and EY026177 (GSZ).	ACOTT TS, 1988, INVEST OPHTH VIS SCI, V29, P90; ALVARADO J, 1981, INVEST OPHTH VIS SCI, V21, P714; ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; [Anonymous], 2001, Prescrire Int, V10, P117; ARMALY MF, 1965, FED PROC, V24, P1274; Beckel JM, 2014, GLIA, V62, P1486, DOI 10.1002/glia.22695; Borras T, 1998, INVEST OPHTH VIS SCI, V39, P1503; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; Clark AF, 2009, EXP EYE RES, V88, P752, DOI 10.1016/j.exer.2008.10.004; Clark AF, 2005, CELL MOTIL CYTOSKEL, V60, P83, DOI 10.1002/cm.20049; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; CLARK AF, 1995, INVEST OPHTH VIS SCI, V36, P478; Clark D, 1995, ASPEN INST CONF REP, V10, P1, DOI 10.1016/B978-012397720-5/50002-5; Filla MS, 2011, INVEST OPHTH VIS SCI, V52, P2952, DOI 10.1167/iovs.10-6618; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Gonzalez JM, 2012, INVEST OPHTH VIS SCI, V53, P3395, DOI 10.1167/iovs.11-8570; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; Inatani M, 2001, GRAEF ARCH CLIN EXP, V239, P109, DOI 10.1007/s004170000241; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Joffy S, 2005, AM J KIDNEY DIS, V46, P1, DOI 10.1053/j.ajkd.2005.04.011; Johnson D, 1997, ARCH OPHTHALMOL-CHIC, V115, P375, DOI 10.1001/archopht.1997.01100150377011; JOHNSON DH, 1987, INVEST OPHTH VIS SCI, V28, P945; JOHNSON DH, 1990, INVEST OPHTH VIS SCI, V31, P2568; Jones R, 2006, CURR OPIN OPHTHALMOL, V17, P163; Kahook MY, 2019, AM J OPHTHALMOL, V200, P130, DOI 10.1016/j.ajo.2019.01.003; Kasetti RB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14938-0; Kasetti RB, 2016, Invest Ophthalmol Vis Sci, V57, P6058, DOI 10.1167/iovs.16-19610, Patent No. 20140038221; Kuchtey J, 2014, INVEST OPHTH VIS SCI, V55, P5291, DOI 10.1167/iovs.14-14578; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Liaboe C VJ, 2015, CORNEAL TRANSPLANTAT; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Ochiai Y, 2002, JPN J OPHTHALMOL, V46, P249, DOI 10.1016/S0021-5155(01)00523-8; Ozcan Altan Atakan, 2004, International Ophthalmology, V25, P19, DOI 10.1023/B:INTE.0000018524.48581.79; Pang IH, 2000, J GLAUCOMA, V9, P468; Patel GC, 2017, AM J PATHOL, V187, P713, DOI 10.1016/j.ajpath.2016.12.003; Picht G, 2001, GRAEF ARCH CLIN EXP, V239, P199, DOI 10.1007/s004170000252; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Raghunathan VK, 2015, INVEST OPHTH VIS SCI, V56, P4447, DOI 10.1167/iovs.15-16739; Rao PV, 2017, EXP EYE RES, V158, P23, DOI 10.1016/j.exer.2016.08.023; Razeghinejad MR, 2012, OPHTHALMIC RES, V47, P66, DOI 10.1159/000328630; ROHEN JW, 1983, OPHTHALMOLOGY, V90, P758; ROHEN JW, 1973, KLIN MONATSBL AUGENH, V163, P401; ROSENTHAL J, 1980, J AM OPTOM ASSOC, V51, P1017; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Sethi A, 2011, INVEST OPHTH VIS SCI, V52, P5251, DOI 10.1167/iovs.11-7587; Shepard AR, 2010, INVEST OPHTH VIS SCI, V51, P2067, DOI 10.1167/iovs.09-4567; SHIRATO S, 1989, INVEST OPHTH VIS SCI, V30, P2499; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Swaminathan SS, 2014, J CATARACT REFR SURG, V40, P1263, DOI 10.1016/j.jcrs.2014.06.020; Tanna AP, 2018, OPHTHALMOLOGY, V125, P1741, DOI 10.1016/j.ophtha.2018.04.040; Tawara A, 2008, GRAEF ARCH CLIN EXP, V246, P1021, DOI 10.1007/s00417-008-0800-0; Torrejon KY, 2016, SCI REP-UK, V6, DOI 10.1038/srep38319; Tovar-Vidales T, 2013, INVEST OPHTH VIS SCI, V54, P4741, DOI 10.1167/iovs.13-12203; Tovar-Vidales T, 2011, EXP EYE RES, V93, P442, DOI 10.1016/j.exer.2011.06.011; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Vranka JA, 2017, EXP EYE RES, V158, P67, DOI 10.1016/j.exer.2016.06.009; Welge-Lussen U, 2000, INVEST OPHTH VIS SCI, V41, P2229; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; YUN AJ, 1989, INVEST OPHTH VIS SCI, V30, P2012; Zhou LL, 1998, INT J MOL MED, V1, P339; Zode GS, 2012, INVEST OPHTH VIS SCI, V53, P1557, DOI 10.1167/iovs.11-8837; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	64	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0232111	10.1371/journal.pone.0232111	http://dx.doi.org/10.1371/journal.pone.0232111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579557	Green Published, gold			2022-12-27	WOS:000545646600050
J	Lange, KV; Hopman, EWM; Zemla, JC; Austerweil, JL				Lange, Kendra V.; Hopman, Elise W. M.; Zemla, Jeffrey C.; Austerweil, Joseph L.			Evidence against a relation between bilingualism and creativity	PLOS ONE			English	Article							INTELLIGENCE; ADVANTAGES; FLUENCY	Are bilinguals more creative than monolinguals? Some prior research suggests bilinguals are more creative because the knowledge representations for their second language are similarly structured to those of highly creative people. However, there is contrasting research showing that the knowledge representations of bilinguals' second language are actually structured like those of less creative people. Finally, there is growing skepticism about there being differences between bilinguals and monolinguals on non-language tasks (e.g., the bilingual advantage for executive control). We tested whether bilinguals tested in their second language are more or less creative than both monolinguals and bilinguals tested in their first language. Participants also took a repeated semantic fluency test that we used to estimate individual semantic networks for each participant. We analyzed our results with Bayesian statistics and found support for the null hypothesis that bilingualism offers no advantage for creativity. Further, using best practices for estimating semantic networks, we found support for the hypothesis that there is no association between an individual's semantic network and their creativity. This is in contrast with published research, and suggests that some of those findings may have been the result of idiosyncrasies, outdated methods for estimating semantic networks, or statistical noise. Our results call into question reported relations between bilingualism and creativity, as well as semantic network structure as an explanatory mechanism for individual differences in creativity.	[Lange, Kendra V.; Hopman, Elise W. M.; Zemla, Jeffrey C.; Austerweil, Joseph L.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Lange, Kendra V.] Penn State Univ, Dept Psychol, State Coll, PA USA	University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Austerweil, JL (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	austerweil@wisc.edu		Austerweil, Joseph/0000-0002-1316-4691	UW-Madison L&S Senior Honors Thesis Research Grant; Office of the CVGRE at UW-Madison; WARF; American Family Insurance	UW-Madison L&S Senior Honors Thesis Research Grant; Office of the CVGRE at UW-Madison; WARF; American Family Insurance	KVL was supported by the UW-Madison L&S Senior Honors Thesis Research Grant. JLA was supported by the Office of the CVGRE at UW-Madison with funding provided from the WARF. During the revision process, JLA received a research grant with American Family Insurance and started consulting for the Eureka Program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparations and revision of the manuscript.	Abbott JT, 2015, PSYCHOL REV, V122, P558, DOI 10.1037/a0038693; Abraham A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00325; ANDERSON JR, 1978, PSYCHOL REV, V85, P249, DOI 10.1037/0033-295X.85.4.249; [Anonymous], 2016, NAT PHOTONICS, V10, P1, DOI 10.1038/nphoton.2015.265; ARTHUR W, 1994, EDUC PSYCHOL MEAS, V54, P394, DOI 10.1177/0013164494054002013; Baronchelli A, 2016, TRENDS COGN SCI, V17, P348; Bassett DS, 2017, NAT NEUROSCI, V20, P353, DOI 10.1038/nn.4502; Beckage NM, 2019, COMPLEXITY, V2019, DOI 10.1155/2019/7690869; Benedek M, 2017, THINK REASONING, V23, P158, DOI 10.1080/13546783.2016.1278034; Benedek M, 2014, INTELLIGENCE, V46, P73, DOI 10.1016/j.intell.2014.05.007; Bernard M., 2019, COGSCI, P138; Bialystok E, 2007, NEUROPSYCHOLOGIA, V45, P459, DOI 10.1016/j.neuropsychologia.2006.10.009; Bilson S, 2015, COGNITION, V140, P122, DOI 10.1016/j.cognition.2015.03.013; Birdsong D., 2012, BILINGUAL LANGUAGE P; Borodkin K, 2016, COGNITION, V156, P60, DOI 10.1016/j.cognition.2016.07.014; Chiesi F, 2012, LEARN INDIVID DIFFER, V22, P390, DOI 10.1016/j.lindif.2011.12.007; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; DARCY NT, 1953, J GENET PSYCHOL, V82, P21; Dick AS, 2019, NAT HUM BEHAV, V3, P692, DOI 10.1038/s41562-019-0609-3; FrenckMestre C, 1997, J MEM LANG, V37, P481, DOI 10.1006/jmla.1997.2526; Guilford J. P., 1978, ALTERNATIVE USES MAN; GUILFORD JP, 1959, AM PSYCHOL, V14, P469, DOI 10.1037/h0046827; Hommel B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00273; Jeffreys H., 1939, OXFORD CLASSIC TEXTS; Kaushanskaya M, 2019, LANGUAGE EXPERIENCE, P1; Kenett YN, 2019, TRENDS COGN SCI, V23, P271, DOI 10.1016/j.tics.2019.01.007; Kenett YN, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00407; Kenett YN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023912; Kenett Yoed N., 2016, P 38 ANN M COGN SCI, V8, P313; Kharkhurin A. V., 2012, MULTILINGUALISM CREA, V88; Kharkhurin AV, 2009, J CREATIVE BEHAV, V43, P59, DOI 10.1002/j.2162-6057.2009.tb01306.x; Kharkhurin AV, 2008, CREATIVITY RES J, V20, P404, DOI 10.1080/10400410802391835; Kim KH, 2005, J ADV ACAD, V16, P57; Landis RS, 2014, J BUS PSYCHOL, V29, P163, DOI 10.1007/s10869-014-9347-8; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leikin M, 2014, CREATIVITY RES J, V26, P411, DOI 10.1080/10400419.2014.961779; MACARTHUR RS, 1963, BRIT J EDUC PSYCHOL, V33, P107, DOI 10.1111/j.2044-8279.1963.tb00571.x; Macnamara J., 1966, BILINGUALISM PRIMARY; Marion V, 2007, J SPEECH LANG HEAR R, V50, P940, DOI 10.1044/1092-4388(2007/067); MEDNICK SA, 1962, PSYCHOL REV, V69, P220, DOI 10.1037/h0048850; MENDELSOHN GA, 1976, J PERS, V44, P341, DOI 10.1111/j.1467-6494.1976.tb00127.x; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Nichols ES, 2020, PSYCHOL SCI, V31, P548, DOI 10.1177/0956797620903113; Nusbaum EC, 2011, INTELLIGENCE, V39, P36, DOI 10.1016/j.intell.2010.11.002; Paap KR, 2015, CORTEX, V69, P265, DOI 10.1016/j.cortex.2015.04.014; PEAL E, 1962, PSYCHOL MONOGR, V76, P1, DOI 10.1037/h0093840; Raven J., 1985, MANUAL RAVENS PROGR; RICCIARDELLI LA, 1992, J CREATIVE BEHAV, V26, P242, DOI 10.1002/j.2162-6057.1992.tb01183.x; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; ROSS J, 2017, DEVELOPMENTAL SCI, V20, P4, DOI DOI 10.1111/DESC.12405; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Rumbaut RG, 2014, BILING EDUC BILING, V99, P182; Sandoval TC, 2010, BILING-LANG COGN, V13, P231, DOI 10.1017/S1366728909990514; Stephens M.A., 1997, BILINGUALISM CREATIV; Storms G, 2003, NEUROPSYCHOLOGY, V17, P289, DOI 10.1037/0894-4105.17.2.289; Team R.C, R LANG ENV STAT COMP; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; Verheyen S, 2016, CORTEX, V75, P255, DOI 10.1016/j.cortex.2015.05.012; Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1323-7, 10.3758/s13423-017-1343-3]; Wulff DU, 2019, TRENDS COGN SCI, V23, P686, DOI 10.1016/j.tics.2019.05.003; Zemla JC, 2020, BEHAV RES METHODS, V52, P1681, DOI 10.3758/s13428-019-01343-w; Zemla JC, 2019, COMPLEXITY, DOI 10.1155/2019/4203158; Zemla Jeffrey C, 2018, Comput Brain Behav, V1, P36, DOI 10.1007/s42113-018-0003-7; Zemla Jeffrey C, 2017, Cogsci, V2017, P3646	64	4	4	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234928	10.1371/journal.pone.0234928	http://dx.doi.org/10.1371/journal.pone.0234928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579582	Green Published, gold			2022-12-27	WOS:000545646600036
J	Park, KA; Eum, SY; Oh, H; Cho, MH; Chang, HS; Lee, YS; Kim, S; Park, CS				Park, Kyung Ah; Eum, So Yeon; Oh, Hyeonjung; Cho, Myung Hae; Chang, Hang-Seok; Lee, Yong Sang; Kim, Sanghee; Park, Cheong Soo			Factors affecting online health community participation behavior in patients with thyroid cancer	PLOS ONE			English	Article							HOSPITAL ANXIETY; DISTRESS; SUPPORT; DEPRESSION; SURVIVORS; BREAST; WOMEN	Globally, cancer patients obtain much of their disease information online. Online health communities allow patients to share questions and information about diseases. However, there have been few studies on the factors affecting online health community participation behavior in cancer patients. Online social networking is associated with mental health problems, and patients with thyroid cancer experience high levels of distress, anxiety and depression. The purpose of this study was to investigate factors associated with use of online health communities by patients with thyroid cancer to understand the characteristics of patients participating in such online communities. A questionnaire survey was completed by 114 thyroid cancer patients admitted for surgery at a general hospital in Seoul, Korea. General characteristics, clinical characteristics, attitude toward cancer, distress, and anxiety and depression scores of patients who joined an online health community (user group) and patients who did not (non-user group) were compared. The factors affecting online health community participation were education (p= 0.049), tumor size (p= 0.010), attitude toward cancer (p= 0.022), and anxiety and depression (p= 0.021). The average score of satisfaction with the online health community was 4.25 of 5. The user group had larger tumors, a high awareness of the risk of thyroid cancer, and high levels of anxiety and depression. Patients who actively used the online health community have relatively larger cancer size and had higher levels of mental stress. As such patients are often very anxious and depend heavily on the gathered information, the quality of this information is important. Healthcare professionals need to develop appropriate interventions for patients participating in the online health community.	[Park, Kyung Ah; Chang, Hang-Seok; Lee, Yong Sang; Park, Cheong Soo] Yonsei Univ Hlth Syst, Gangnam Severance Hosp, Thyroid Canc Ctr, Seoul, South Korea; [Park, Kyung Ah; Eum, So Yeon; Oh, Hyeonjung; Cho, Myung Hae] Yonsei Univ Hlth Syst, Gangnam Severance Hosp, Div Nursing, Seoul, South Korea; [Park, Kyung Ah] Yonsei Univ, Grad Sch, Dept Nursing, Seoul, South Korea; [Chang, Hang-Seok; Lee, Yong Sang; Park, Cheong Soo] Yonsei Univ, Dept Surg, Coll Med, Seoul, South Korea; [Chang, Hang-Seok; Lee, Yong Sang; Park, Cheong Soo] Yonsei Univ, Inst Refractory Thyroid Canc, Seoul, South Korea; [Kim, Sanghee] Yonsei Univ, Coll Nursing, Seoul, South Korea; [Kim, Sanghee] Yonsei Univ, Mo Im Kim Nursing Res Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University	Lee, YS (corresponding author), Yonsei Univ Hlth Syst, Gangnam Severance Hosp, Thyroid Canc Ctr, Seoul, South Korea.; Lee, YS (corresponding author), Yonsei Univ, Dept Surg, Coll Med, Seoul, South Korea.; Lee, YS (corresponding author), Yonsei Univ, Inst Refractory Thyroid Canc, Seoul, South Korea.; Kim, S (corresponding author), Yonsei Univ, Coll Nursing, Seoul, South Korea.; Kim, S (corresponding author), Yonsei Univ, Mo Im Kim Nursing Res Inst, Seoul, South Korea.	medilys@yuhs.ac; sangheekim@yuhs.ac		Chang, Hang-Seok/0000-0002-5162-103X; Lee, Yong Sang/0000-0002-8234-8718; Kim, Sanghee/0000-0002-9806-2757				AlGhamdi KM, 2012, INT J MED INFORM, V81, P363, DOI 10.1016/j.ijmedinf.2011.12.004; Algtewi E, 2017, QUAL LIFE RES, V26, P2351, DOI 10.1007/s11136-017-1575-8; An Un-Seok, 2007, [Journal of Product Research, 상품학연구], V25, P99; [Anonymous], 2017 SURV INT US SUM; Beckjord EB, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e20; Bessiere Katie, 2010, J Med Internet Res, V12, pe6, DOI 10.2196/jmir.1149; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Buchmann L, 2015, OTOLARYNG HEAD NECK, V152, P644, DOI 10.1177/0194599814565761; Bujnowska-Fedak MM, 2015, BMC PUBLIC HEALTH, V15, P194, DOI [10.1186/s12889-015-1473-3, DOI 10.1186/S12889-015-1473-3]]; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Dalessandro B, 2015, BIG DATA-US, V3, P90, DOI 10.1089/big.2015.0006; Drabe N, 2016, PSYCHO-ONCOLOGY, V25, P203, DOI 10.1002/pon.3903; Feng JW, 2019, CLIN TRANSL ONCOL, V21, P1482, DOI 10.1007/s12094-019-02076-0; Fogel J, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e9; GRIFFITHS KM, 2009, J MED INTERNET RES, V11, DOI DOI 10.2196/JMIR.1270; Harkin LJ, 2017, J CANCER SURVIV, V11, P658, DOI 10.1007/s11764-017-0616-1; Hoey LM, 2008, PATIENT EDUC COUNS, V70, P315, DOI 10.1016/j.pec.2007.11.016; Hong W, 2018, INT J MED INFORM, V110, P77, DOI 10.1016/j.ijmedinf.2017.11.009; Hong Y, 2012, PATIENT EDUC COUNS, V86, P288, DOI 10.1016/j.pec.2011.06.014; Ito Y, 2018, EJSO-EUR J SURG ONC, V44, P307, DOI 10.1016/j.ejso.2017.03.004; Jacob L, 2017, PSYCHO-ONCOLOGY, V26, P1535, DOI 10.1002/pon.4328; Jeongl S, 2007, HEALTHC INFORM RES, V13, P207, DOI 10.4258/jksmi.2007.13.3.207; Jung KW, 2013, CANCER RES TREAT, V45, P15, DOI 10.4143/crt.2013.45.1.15; Kim Jong-Min, 2011, [Journal of the Korea Institute Of Information and Communication Engineering, 한국정보통신학회논문지], V15, P2426; Kuenzel U, 2018, J CANCER EDUC, V33, P960, DOI 10.1007/s13187-017-1173-z; LeeMinKyu, 2009, [Journal of Communication Science, 언론과학연구], V9, P506; Leenhardt L, 2011, ANN ENDOCRINOL-PARIS, V72, P136, DOI 10.1016/j.ando.2011.03.025; Lobchuk M, 2015, CANCER NURS, V38, pE21, DOI 10.1097/NCC.0000000000000207; Mardani-Hamooleh Marjan, 2017, J Adv Pract Oncol, V8, P680; National Comprehensive Cancer Network (NCCN), 2013, CLIN PRACT GUID ONC; Norum J, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.4.e30; O'Donnell E, 2013, INT J HEALTH CARE Q, V26, P353, DOI 10.1108/09526861311319573; Pantic I, 2014, CYBERPSYCH BEH SOC N, V17, P652, DOI 10.1089/cyber.2014.0070; Papaleontiou M, 2019, THYROID, V29, P1080, DOI 10.1089/thy.2019.0163; Randle RW, 2017, THYROID, V27, P902, DOI 10.1089/thy.2016.0632; Ryu M, 2019, PUBLIC HEALTH NURS, V36, P144, DOI 10.1111/phn.12571; Schmidt H, 2016, AM SURGEON, V82, P397; Seok JH, 2013, YONSEI MED J, V54, P658, DOI 10.3349/ymj.2013.54.3.658; Shaha Maya, 2003, Eur J Oncol Nurs, V7, P191, DOI 10.1016/S1462-3889(03)00026-7; Suh SR, 1998, J KOREAN ACAD ADULT, V10, P268; van Eenbergen MC, 2017, JMIR CANCER, V3, DOI 10.2196/cancer.7312; Winzelberg AJ, 2003, CANCER-AM CANCER SOC, V97, P1164, DOI 10.1002/cncr.11174; Yoo Shijung, 2006, [Journal of Korea Service Management Society, 서비스경영학회지], V7, P153; Yu ES, 2012, PSYCHO-ONCOLOGY, V21, P541, DOI 10.1002/pon.1931; Yu Jung Ok, 2005, Taehan Kanho Hakhoe Chi, V35, P1258; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	3	4	10	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235056	10.1371/journal.pone.0235056	http://dx.doi.org/10.1371/journal.pone.0235056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579575	Green Published, gold			2022-12-27	WOS:000545646600029
J	Anuarbek, S; Abugalieva, S; Pecchioni, N; Laido, G; Maccaferri, M; Tuberosa, R; Turuspekov, Y				Anuarbek, Shynar; Abugalieva, Saule; Pecchioni, Nicola; Laido, Giovanni; Maccaferri, Marco; Tuberosa, Roberto; Turuspekov, Yerlan			Quantitative trait loci for agronomic traits in tetraploid wheat for enhancing grain yield in Kazakhstan environments	PLOS ONE			English	Article							TRITICUM-DURUM DESF.; HIGH-DENSITY; GENETIC-ANALYSIS; ASSOCIATION; POPULATION; SOFTWARE; QTL; DOMESTICATION; DIVERSITY; CLIMATE	Durum wheat (Triticum turgidumL. ssp.durum) is one of the top crops in Kazakhstan, where it is cultivated in different ecological niches, mainly at higher latitudes in the steppe zone of the northern region. Therefore, local breeding programs for durum wheat are primarily focused on selection for high productivity in Northern Kazakhstan based on the introduction of promising foreign germplasm and the adoption of marker-assisted selection. In this study, a world tetraploid wheat collection consisted of 184 primitive and domesticated accessions, which were previously genotyped using 16,425 polymorphic SNP markers, was field-tested in Northern and South-eastern Kazakhstan. The field tests have allowed the identification of 80 durum wheat promising lines in Northern Kazakhstan in comparison with a local standard cultivar. Also, GGE (Genotype and Genotype by Environment) biplot analyses for yield performance revealed that accessions ofT.dicoccum,T.carthlicum, andT.turanicumalso have potential to improve durum wheat yield in the region. The genome-wide association study (GWAS) has allowed the identification of 83 MTAs (marker-trait associations) for heading date, seed maturation time, plant height, spike length, number of fertile spikes, number of kernels per spike, and thousand kernel weight. The comparison of the 83 identified MTAs with those previously reported in GWAS for durum wheat suggests that 38 MTAs are presumably novel, while the co-localization of a large number of MTAs with those previously published confirms the validity of the results of this study. The MTAs reported herewith will provide the opportunity to implement marker-assisted selection in ongoing durum wheat breeding projects targeting higher productivity in the region.	[Anuarbek, Shynar; Abugalieva, Saule; Turuspekov, Yerlan] Inst Plant Biol & Biotechnol, Alma Ata, Kazakhstan; [Anuarbek, Shynar; Turuspekov, Yerlan] al Farabi Kazakh Natl Univ, Alma Ata, Kazakhstan; [Abugalieva, Saule] Kazakh Natl Agr Univ, Alma Ata, Kazakhstan; [Pecchioni, Nicola; Laido, Giovanni] CREA, Res Cereal & Ind Crops, Foggia, Italy; [Maccaferri, Marco; Tuberosa, Roberto] Univ Bologna, Dept Agr & Food Sci, Bologna, Italy	Institute of Plant Biology & Biotechnology in Kazakhstan; Al-Farabi Kazakh National University; Kazakh National Agrarian University; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Bologna	Turuspekov, Y (corresponding author), Inst Plant Biol & Biotechnol, Alma Ata, Kazakhstan.; Turuspekov, Y (corresponding author), al Farabi Kazakh Natl Univ, Alma Ata, Kazakhstan.	yerlant@yahoo.com	Anuarbek, Shynar/AAO-1161-2020; Turuspekov, Yerlan/C-3458-2011; Abugalieva, Saule/M-6690-2015	Turuspekov, Yerlan/0000-0001-8590-1745; Abugalieva, Saule/0000-0002-9748-507X; Anuarbek, Shynar/0000-0002-8673-9820	Ministry of Education and Sciences of the Republic of Kazakhstan [AP05131328]	Ministry of Education and Sciences of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	YT has received the grant for the research purpose. The grant number: AP05131328. Duration of the project: 2018-2020. The funder name: Ministry of Education and Sciences of the Republic of Kazakhstan (https://www.gov.kz/memleket/entities/edu?lang=en).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Fedorenko from "North Kazakhstan Agricultural Experimental Station" for providing phenotypic data.	Acquaah G., 2012, PRINCIPLES PLANT GEN; Almerekova S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221064; [Anonymous], 2018, NAT REV GENET, V19, P1, DOI 10.1038/nrg.2017.141; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; Anuarbek SN, 2019, EURASIAN J ECOLOGY, V59, P39; Bassi FM, 2019, 1 INT EXP WORKSH PRE, P49; BHIVA/ BASHH, 2019, HIV MED S2, V20, ps2; Blanco A, 2012, MOL BREEDING, V30, P79, DOI 10.1007/s11032-011-9600-z; Boden SA, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2014.16, 10.1038/nplants.2014.16]; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chourghal N, 2016, REG ENVIRON CHANGE, V16, P1623, DOI 10.1007/s10113-015-0889-8; Cristina D., 2016, Scientific Bulletin. Series F. Biotechnologies, V20, P27; Ellis MH, 2005, THEOR APPL GENET, V111, P423, DOI 10.1007/s00122-005-2008-6; Genievskaya Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205421; Golabadi M, 2011, EUPHYTICA, V177, P207, DOI 10.1007/s10681-010-0242-8; Graziani M, 2014, CROP PASTURE SCI, V65, P80, DOI 10.1071/CP13349; Iannucci A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02124; Kidane YG, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01230; Laido G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067280; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Maccaferri M, 2016, J EXP BOT, V67, P1161, DOI 10.1093/jxb/erw039; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; Maccaferri M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-873; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Mal'chikov PN, 2018, VAVILOVSKII ZH GENET, V22, P939, DOI 10.18699/VJ18.436; Mangini G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190162; Mengistu DK, 2016, PLANT BIOTECHNOL J, V14, P1800, DOI 10.1111/pbi.12538; Milner SG, 2016, PLANT BIOTECHNOL J, V14, P735, DOI 10.1111/pbi.12424; Morgounov A, 2008, INT S WHEAT YIELD PO, P161; Pauli D, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.11.0037; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Pritchard JK, 2000, GENETICS, V155, P945; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Roncallo PF, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2058-2; Royo C, 2014, GENET RESOUR CROP EV, V61, P1345, DOI 10.1007/s10722-014-0116-3; Sall AT, 2018, AGRICULTURE-BASEL, V8, DOI 10.3390/agriculture8070099; Salvi S, 2015, CURR OPIN BIOTECH, V32, P179, DOI 10.1016/j.copbio.2015.01.001; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Soriano JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178290; Sukumaran S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00081; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Turuspekov Y, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1131-2; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wolde GM, 2019, THEOR APPL GENET, V132, P1661, DOI 10.1007/s00122-019-03305-4; Wurschum T, 2017, PLANT J, V92, P892, DOI 10.1111/tpj.13726; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Zhai HJ, 2018, THEOR APPL GENET, V131, P539, DOI 10.1007/s00122-017-3017-y; 2014, REG ANESTH PAIN MED, V9	55	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234863	10.1371/journal.pone.0234863	http://dx.doi.org/10.1371/journal.pone.0234863			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574201	gold, Green Published			2022-12-27	WOS:000544972400052
J	Engelke, E; Pfarrer, C; Radelof, K; Fehr, M; Mathes, KA				Engelke, Elisabeth; Pfarrer, Christiane; Radelof, Katharina; Fehr, Michael; Mathes, Karina A.			Gross anatomy, histology and blood vessel topography of the alimentary canal of the Inland Bearded Dragon (Pogona vitticeps)	PLOS ONE			English	Article								Imaging techniques have proved to be crucial for diagnosis in reptile species. The topography of the internal organs of bearded dragons has been described in recent studies as meeting the small animal practitioners ' demand for knowledge concerning their anatomy. However, the nomenclature in the respective literature is not uniform, which could lead to misunderstandings concerning the respective and/or affected parts of the alimentary canal. Therefore, the aim of this study was to provide clear information on anatomy and histology of the alimentary canal of bearded dragons including supplying blood vessels. For the dissection of the alimentary canal, 11 Inland Bearded Dragons (Pogona vitticeps) were used (five males, six females), which had been euthanised for clinical reasons other than those concerning the digestive tract or had died spontaneously. The supplying arteries were demonstrated by injecting red latex into the aorta, while the intestinal veins were filled with blue latex via the portal vein. Microscopic examination was carried out on specimens of seven additional bearded dragons using routine histologic procedures. Macroscopically, the sections of the alimentary canal from oral to aboral were distinguished into oesophagus, stomach, small intestine, colic ampulla, colic isthmus, rectum and cloaca. Differentiation of the duodenum, jejunum and ileum was only possible when considering the bile duct, the vasculature and the histology of the organ wall. Arteries supplying the oesophagus and the final straight part of the large intestine originated from the aorta in a segmental manner. Between these, three unpaired arteries arose from the aorta. Their branches supplied stomach and intestine excluding its last part. Based on the findings of the present study, a nomenclature for the different parts of the alimentary canal and the supplying blood vessels of bearded dragons is suggested which is well understandable for veterinary practitioners and is based on zoological knowledge of reptiles.	[Engelke, Elisabeth; Pfarrer, Christiane] Univ Vet Med Hannover, Inst Anat, Hannover, Germany; [Radelof, Katharina; Fehr, Michael; Mathes, Karina A.] Univ Vet Med Hannover, Clin Small Mammals Reptiles & Birds, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Engelke, E (corresponding author), Univ Vet Med Hannover, Inst Anat, Hannover, Germany.	elisabeth.engelke@tiho-hannover.de		Mathes, Karina/0000-0003-2320-4578	Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover, Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation	This publication was supported by Deutsche Forschungsgemeinschaft (https://www.dfg.de) and University of Veterinary Medicine Hannover, Foundation (https://www.tiho-hannover.de) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, JSCOTT, V2, P103; [Anonymous], 1992, ESPACIO TIEMPO FORMA, VV, P283; Banzato T, 2013, ANAT HISTOL EMBRYOL, V42, P453, DOI 10.1111/ahe.12037; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P407; Bucy DS, 2015, JAVMA-J AM VET MED A, V246, P868, DOI 10.2460/javma.246.8.868; Evans H.E..C..J., 1993, HDB AVIAN ANATOMY NO, V23, P301; Evans HE, 1979, MILLERS ANATOMY DOG; Gegenbaur C., 1901, VERGLEICHENDE ANATOM; Grosset C, 2014, VET RADIOL ULTRASOUN, V55, P241, DOI 10.1111/vru.12128; Hertwig O., 1906, HDB VERGLEICHENDEN E; Hochstetter F, 1898, GEGENBAURS MORPHOLOG, V26, P213; International Committee on Veterinary Histological Nomenclature, 2017, NOM HIST VET; Jacobshagen E., 1937, HDB VERGLEICHENDEN A, V3, P563; Johnson Jay D., 2006, Exotic DVM, V8, P38; Liebich H.-G., 1990, FUNKTIONELLE HISTOLO; Lippert H, 2000, LEHRBUCH ANATOMIE; Luppa H., 1977, P225; Mathes KA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221050; Moeller H, 1985, LEHRBUCH ZOOLOGIE, P411; Nomina Anatomica Veterinaria, 2017, NOMINA ANATOMICA VET, V6th; Ottaviani G., 1977, P315; Parsons T.S., 1977, P159; Pernkopf E., 1937, HDB VERGLEICHENDEN A, P349; Radelof K, 2016, GASTROINTESTINALTRAK; Remane A, 1986, SYSTEMATISCHE ZOOLOG; Sinn AD, 2004, THESIS; Sisson S, 1975, ANATOMY DOMESTIC ANI, V1, P104; Smith D, 2001, VET RADIOL ULTRASOUN, V42, P515, DOI 10.1111/j.1740-8261.2001.tb00979.x; Vollmerhaus B., 1992, LEHRBUCH ANATOMIE HA, V5, P176; Wachsmann S, 2010, THESIS; Welsch U, 2010, LEHRBUCH HISTOLOGIE; [No title captured]	32	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234736	10.1371/journal.pone.0234736	http://dx.doi.org/10.1371/journal.pone.0234736			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574166	gold, Green Published			2022-12-27	WOS:000544972400042
J	Luo, G; McHenry, ML; Letterio, JJ				Luo, George; McHenry, Michael L.; Letterio, John J.			Estimating the prevalence and risk of COVID-19 among international travelers and evacuees of Wuhan through modeling and case reports	PLOS ONE			English	Article							CHINA	Coronavirus disease 2019 (COVID-19) started in Wuhan, China and has spread through other provinces and countries through infected travelers. On January 23(rd), 2020, China issued a quarantine and travel ban on Wuhan because travelers from Wuhan were thought to account for the majority of exported COVID-19 cases to other countries. Additionally, countries evacuated their citizens from Wuhan after institution of the travel ban. Together, these two populations account for the vast majority of the "total cases with travel history to China" as designated by the World Health Organization (WHO). The current study aims to assess the prevalence and risk of COVID-19 among international travelers and evacuees of Wuhan. We first used case reports from Japan, Singapore, and Korea to investigate the date of flights of infected travelers. We then used airline traveler data and the number of infected exported cases to correlate the cases with the number of travelers for multiple countries. Our findings suggest that the risk of COVID-19 infection is highest among Wuhan travelers between January 19(th)and 22(nd), 2020, with an approximate infection rate of up to 1.3% among international travelers. We also observed that evacuee infection rates varied heavily between countries and propose that the timing of the evacuation and COVID-19 testing of asymptomatic evacuees played significant roles in the infection rates among evacuees. These findings suggest COVID-19 cases and infectivity are much higher than previous estimates, including numbers from the WHO and the literature, and that some estimates of the infectivity of COVID-19 may need re-assessment.	[Luo, George; Letterio, John J.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [McHenry, Michael L.] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Letterio, John J.] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Letterio, John J.] Univ Hosp, Rainbow Babies & Childrens Hosp, Angie Fowler Adolescent & Young Adult Canc Inst, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Luo, G (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	gxl263@case.edu		Luo, George/0000-0002-0566-2025				Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Chowell G, 2016, PHYS LIFE REV, V18, P66, DOI 10.1016/j.plrev.2016.07.005; Hoehl S, 2020, NEW ENGL J MED, V382, P1278, DOI 10.1056/NEJMc2001899; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Imai N, 2020, 2 IMP COLL LOND; Japan Minister of Health, 2020, PRES SIT NEW COR INF; Japan Ministry of Health, 2020, COR INF 2020; Jung S- M, 2020, J CLIN MED, V9; Korea Ministry of Health, 2020, COR INF 19 DOM OUTBR; Lai Shengjie, 2020, medRxiv, DOI 10.1101/2020.02.04.20020479; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058; Ma J, 2020, 5000000 LEFT WUHAN L; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Ng OT, 2020, NEW ENGL J MED, V382, P1476, DOI 10.1056/NEJMc2003100; Read J. M., 2020, MEDRXIV, DOI 10.1101/2020.01.23.20018549; Rothe C, N ENGL J MED, V3822020, P970; Singapore Ministry of Health, 2020, UPD COVID 19 COR DIS; Thailand Ministry of Public Health, 2020, THAIL REP JAN 24 202; Wang H, 2021, COMPLEX INTELL SYST, V7, P1139, DOI 10.1007/s40747-020-00171-2; Winn P, 2020, CORONAVIRUS FEARS SP; World Health Organization, 2020, COR DIS COVID 19 PAN; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9	25	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234955	10.1371/journal.pone.0234955	http://dx.doi.org/10.1371/journal.pone.0234955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574177	Green Published, gold			2022-12-27	WOS:000544972400014
J	Obeidova, L; Seeman, T; Fencl, F; Blahova, K; Hojny, J; Elisakova, V; Reiterova, J; Stekrova, J				Obeidova, Lena; Seeman, Tomas; Fencl, Filip; Blahova, Kveta; Hojny, Jan; Elisakova, Veronika; Reiterova, Jana; Stekrova, Jitka			Results of targeted next-generation sequencing in children with cystic kidney diseases often change the clinical diagnosis	PLOS ONE			English	Article							MUTATIONS; PROTEIN; NEPHRONOPHTHISIS; CONSEQUENCES; GUIDELINES; MANAGEMENT; SPECTRUM	Cystic kidney diseases are a very heterogeneous group of chronic kidney diseases. The diagnosis is usually based on clinical and ultrasound characteristics and the final diagnosis is often difficult to be made. Next-generation sequencing (NGS) may help the clinicians to find the correct final diagnosis. The aim of our study was to test the diagnostic yield of NGS and its ability to improve the diagnosis precision in a heterogeneous group of children with cystic kidney diseases. Next-generation sequencing of genes responsible for the formation of cystic kidneys was performed in 31 unrelated patients with various clinically diagnosed cystic kidney diseases gathered at the Department of Pediatrics of Motol University Hospital in Prague between 2013 and 2018. The underlying pathogenic variants were detected in 71% of patients (n = 22), no or only one (in case of autosomal recessive inheritance) pathogenic variant was found in 29% of patients (n = 9). The result of NGS correlated with the clinical diagnosis made before the NGS in 55% of patients (n = 17), in the remaining 14 children (45%) the result of NGS revealed another type of cystic kidney disease that was suspected clinically before or did not find causal mutation in suspected genes. The most common unexpected findings were variants in nephronophthisis (NPHP) genes in children with clinically suspected autosomal recessive polycystic kidney disease (ARPKD, n = 4). Overall, 24 pathogenic or probably pathogenic variants were detected in thePKHD1gene, 8 variants in theTMEM67gene, 4 variants in thePKD1gene, 2 variants in theHNF1Bgene and 2 variants inBBS1andNPHP1genes, respectively. NGS is a valuable tool in the diagnostics of various forms of cystic kidney diseases. Its results changed the clinically based diagnoses in 16% (n = 5) of the children.	[Obeidova, Lena; Elisakova, Veronika; Stekrova, Jitka] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Obeidova, Lena; Hojny, Jan; Elisakova, Veronika; Reiterova, Jana; Stekrova, Jitka] Gen Univ Hosp Prague, Prague, Czech Republic; [Seeman, Tomas; Fencl, Filip; Blahova, Kveta] Charles Univ Prague, Fac Med 2, Dept Pediat, Prague, Czech Republic; [Seeman, Tomas; Fencl, Filip; Blahova, Kveta] Motol Univ Hosp, Prague, Czech Republic; [Hojny, Jan] Charles Univ Prague, Fac Med 1, Inst Pathol, Prague, Czech Republic; [Reiterova, Jana] Charles Univ Prague, Dept Nephrol, Fac Med 1, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague; Motol University Hospital; Charles University Prague; Charles University Prague	Obeidova, L (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic.; Obeidova, L (corresponding author), Gen Univ Hosp Prague, Prague, Czech Republic.	lena.obeidova@vfn.cz	Obeidova, Lena/C-8390-2017	Obeidova, Lena/0000-0003-2071-760X	Charles University, First Faculty of Medicine grant [GAUK 1015, PROGRES Q25/LF1, IGA MZCR NT 13090-4]; University Hospital Motol grant [MH CZ -DRO 00064203]	Charles University, First Faculty of Medicine grant; University Hospital Motol grant	This work has been supported by the Charles University, First Faculty of Medicine grant projects GAUK 1015, PROGRES Q25/LF1, IGA MZCR NT 13090-4 and by University Hospital Motol grant MH CZ -DRO 00064203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bergmann C, 2005, KIDNEY INT, V67, P829, DOI 10.1111/j.1523-1755.2005.00148.x; Bergmann C, 2011, J AM SOC NEPHROL, V22, P2047, DOI 10.1681/ASN.2010101080; Bockenhauer D, 2016, PEDIATR NEPHROL, V31, P707, DOI 10.1007/s00467-015-3142-2; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bullich G, 2018, KIDNEY INT, V94, P363, DOI 10.1016/j.kint.2018.02.027; Chaki M, 2011, KIDNEY INT, V80, P1239, DOI 10.1038/ki.2011.284; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046688, 10.1371/journal.pone.0039927]; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Failler M, 2014, AM J HUM GENET, V94, P905, DOI 10.1016/j.ajhg.2014.05.002; Garrison Erik., 2012, HAPLOTYPE BASED VARI, DOI DOI 10.48550/ARXIV.1207.3907; Gimpel C, 2019, NAT REV NEPHROL, V15, P713, DOI 10.1038/s41581-019-0155-2; Gimpel C, 2019, RADIOLOGY, V290, P769, DOI 10.1148/radiol.2018181243; Guay-Woodford LM, 2014, J PEDIATR-US, V165, P611, DOI 10.1016/j.jpeds.2014.06.015; Gunay-Aygun M, 2011, MOL GENET METAB, V104, P677, DOI 10.1016/j.ymgme.2011.09.001; Heidet L, 2010, CLIN J AM SOC NEPHRO, V5, P1079, DOI 10.2215/CJN.06810909; Konig J, 2017, CLIN J AM SOC NEPHRO, V12, P1974, DOI 10.2215/CJN.01280217; Kopanos C, 2019, BIOINFORMATICS, V35, P1978, DOI 10.1093/bioinformatics/bty897; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Loftus H, 2013, PEDIATR NEPHROL, V28, P33, DOI 10.1007/s00467-012-2221-x; Lu H, 2017, NAT GENET, V49, P1025, DOI 10.1038/ng.3871; Lurbe E, 2016, J HYPERTENS, V34, P1887, DOI 10.1097/HJH.0000000000001039; Niederlova V, 2019, HUM MUTAT, V40, P2068, DOI 10.1002/humu.23862; Novarino G, 2011, CELL, V147, P70, DOI 10.1016/j.cell.2011.09.014; Obeidova L, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0261-3; Otto EA, 2009, J MED GENET, V46, P663, DOI 10.1136/jmg.2009.066613; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Tan YC, 2012, J MOL DIAGN, V14, P305, DOI 10.1016/j.jmoldx.2012.02.007	38	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235071	10.1371/journal.pone.0235071	http://dx.doi.org/10.1371/journal.pone.0235071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574212	Green Published, gold			2022-12-27	WOS:000544972400048
J	Page, TM; Diaz-Pulido, G				Page, Tessa M.; Diaz-Pulido, Guillermo			Plasticity of adult coralline algae to prolonged increased temperature and pCO(2) exposure but reduced survival in their first generation	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CLIMATE-CHANGE; CO2 ENRICHMENT; ELEVATED CO2; CARBON-USE; RESPONSES; PHOTOSYNTHESIS; RECRUITMENT; RHODOPHYTA; SETTLEMENT	Crustose coralline algae (CCA) are vital to coral reefs worldwide, providing structural integrity and inducing the settlement of important invertebrate larvae. CCA are known to be impacted by changes in their environment, both during early development and adulthood. However, long-term studies on either life history stage are lacking in the literature, therefore not allowing time to explore the acclimatory or potential adaptive responses of CCA to future global change scenarios. Here, we exposed a widely distributed, slow growing, species of CCA,Sporolithoncf.durum, to elevated temperature andpCO(2)for five months and their first set of offspring (F-1) for eleven weeks. Survival, reproductive output, and metabolic rate were measured in adultS. cf.durum, and survival and growth were measured in the F(1)generation. AdultS. cf.durumexperienced 0% mortality across treatments and reduced their O(2)production after five months exposure to global stressors, indicating a possible expression of plasticity. In contrast, the combined stressors of elevated temperature andpCO(2)resulted in 50% higher mortality and 61% lower growth on germlings. On the other hand, under the independent elevatedpCO(2)treatment, germling growth was higher than all other treatments. These results show the robustness and plasticity ofS. cf.durumadults, indicating the potential for them to acclimate to increased temperature andpCO(2). However, the germlings of this species are highly sensitive to global stressors and this could negatively impact this species in future oceans, and ultimately the structure and stability of coral reefs.	[Page, Tessa M.; Diaz-Pulido, Guillermo] Griffith Univ, Sch Environm & Sci, Brisbane, Qld, Australia; [Page, Tessa M.; Diaz-Pulido, Guillermo] Griffith Univ, Australia Rivers Inst, Brisbane, Qld, Australia	Griffith University; Griffith University	Diaz-Pulido, G (corresponding author), Griffith Univ, Sch Environm & Sci, Brisbane, Qld, Australia.	g.diaz-pulido@griffith.edu.au	Diaz-Pulido, Guillermo/B-3648-2013	Page, Tessa/0000-0002-5575-7049; Diaz-Pulido, Guillermo/0000-0002-0901-3727	Australian Research Council [DP160103071]	Australian Research Council(Australian Research Council)	This project was funded by the Australian Research Council (DP160103071) awarded to G.DP. https://www.arc.gov.au/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey Walter H., 2013, Smithsonian Contributions to the Marine Sciences, P1; ADEY WALTER H., 1965, HYDROBIOLOGIA, V26, P539, DOI 10.1007/BF00045545; Adey WH, 1998, J PHYCOL, V34, P393, DOI 10.1046/j.1529-8817.1998.340393.x; Aguirre J, 2010, PALEOBIOLOGY, V36, P519, DOI 10.1666/09041.1; Anlauf H, 2011, J EXP MAR BIOL ECOL, V397, P13, DOI 10.1016/j.jembe.2010.11.009; [Anonymous], 2010, RAPP COMMUN INT MER; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Armstrong EJ, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3133-x; Bloom AJ, 2012, ECOLOGY, V93, P355, DOI 10.1890/11-0485.1; Bradassi F, 2013, MAR BIOL, V160, P2261, DOI 10.1007/s00227-013-2260-2; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Chamberlain Y.M., 1983, B BRIT MUSEUM NATU B, V11, P291; CHIHARA M, 1974, J PHYCOL, V10, P266, DOI 10.1111/j.1529-8817.1974.tb02712.x; Comeau S, 2019, NAT CLIM CHANGE, V9, P477, DOI 10.1038/s41558-019-0486-9; Comeau S, 2017, ICES J MAR SCI, V74, P1092, DOI 10.1093/icesjms/fsv267; Cornwall CE, 2020, NAT CLIM CHANGE, V10, P143, DOI 10.1038/s41558-019-0681-8; Cornwall CE, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00186; Cornwall CE, 2017, GLOBAL CHANGE BIOL, V23, P4245, DOI 10.1111/gcb.13673; Cornwall CE, 2017, SCI REP-UK, V7, DOI 10.1038/srep46297; Cornwall CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097235; Cornwall CE, 2012, J PHYCOL, V48, P137, DOI 10.1111/j.1529-8817.2011.01085.x; Darrenougue N, 2013, MAR ECOL PROG SER, V474, P105, DOI 10.3354/meps10085; Daume S, 1999, J EXP MAR BIOL ECOL, V234, P125, DOI 10.1016/S0022-0981(98)00143-9; Davies PJ, 2004, PALAIOS, V19, P598, DOI 10.1669/0883-1351(2004)019<0598:HDWABO>2.0.CO;2; Diaz-Pulido G, 2016, CORAL REEFS, V35, P1327, DOI 10.1007/s00338-016-1481-5; Diaz-Pulido G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4310; Diaz-Pulido G, 2012, J PHYCOL, V48, P32, DOI 10.1111/j.1529-8817.2011.01084.x; Dickson A.G., 2007, GUIDE BEST PRACTICES; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Fabricius KE, 2015, SCI REP-UK, V5, DOI 10.1038/srep09537; Gamage D, 2018, PLANT CELL ENVIRON, V41, P1233, DOI 10.1111/pce.13206; Gattuso JP, 2019, SEACARB SEAWATER CAR; Guenther R, 2018, J PHYCOL, V54, P153, DOI 10.1111/jpy.12614; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Harvey A.S., 2005, CORALLINE ALGAE CENT; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; Hofmann LC, 2014, AQUAT BIOL, V22, P261, DOI 10.3354/ab00581; Huisman J, 2009, RECORDS W AUSTR MU S, V77, P50; Johnson MD, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0371; Johnson MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087678; Johnson MD, 2012, J EXP MAR BIOL ECOL, V434, P94, DOI 10.1016/j.jembe.2012.08.005; Kennedy EV, 2017, MAR ECOL PROG SER, V569, P129, DOI 10.3354/meps12076; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Kubler JE, 1999, PLANT CELL ENVIRON, V22, P1303, DOI 10.1046/j.1365-3040.1999.00492.x; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Lewis B, 2016, THESIS; Littler M. M., 1972, OCEANOGR MAR BIOL AN, V10, P311; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Marshall J.F., 1998, Special Publication of the International Association of Sedimentologists, V25, P163; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; McCoy SJ, 2015, J PHYCOL, V51, P6, DOI 10.1111/jpy.12262; Miles H, 2007, MAR POLLUT BULL, V54, P89, DOI 10.1016/j.marpolbul.2006.09.021; Munday Philip L, 2014, F1000Prime Rep, V6, P99, DOI 10.12703/P6-99; Nash MC, 2013, NAT CLIM CHANGE, V3, P268, DOI 10.1038/NCLIMATE1760; Nash MC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221396; Nash MC, 2017, J PHYCOL, V53, P970, DOI 10.1111/jpy.12559; Noisette F, 2013, J EXP MAR BIOL ECOL, V448, P179, DOI 10.1016/j.jembe.2013.07.006; Ordonez A, 2019, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00495; Ordonez A, 2014, BIOL BULL-US, V226, P255, DOI 10.1086/BBLv226n3p255; Padilla-Gamino JL, 2016, EVOL APPL, V9, P1043, DOI 10.1111/eva.12411; Palacios SL, 2007, MAR ECOL PROG SER, V344, P1, DOI 10.3354/meps07084; Pena V, 2020, MOL PHYLOGENET EVOL, V150, DOI 10.1016/j.ympev.2020.106845; Rahman MA, 2014, SCI REP-UK, V4, DOI 10.1038/srep06162; Raven JA, 2017, J EXP BOT, V68, P3701, DOI 10.1093/jxb/erx110; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Rodriguez-Romero A, 2016, EVOL APPL, V9, P1082, DOI 10.1111/eva.12344; Roleda MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140394; Rosler A, 2017, J PHYCOL, V53, P567, DOI 10.1111/jpy.12520; SAGE RF, 1994, PHOTOSYNTH RES, V39, P351, DOI 10.1007/BF00014591; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Talmage SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026941; Tambutte E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8368; TISSUE DT, 1993, PLANT CELL ENVIRON, V16, P859, DOI 10.1111/j.1365-3040.1993.tb00508.x; TOWNSEND RA, 1995, AUST SYST BOT, V8, P85, DOI 10.1071/SB9950085; Underwood A.J, 1997, EXPT ECOLOGY THEIR L; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661; Wood HL, 2010, MAR BIOL, V157, P2001, DOI 10.1007/s00227-010-1469-6; Yoshioka S, 2020, J APPL PHYCOL, V32, P1923, DOI 10.1007/s10811-020-02100-9; Zuljevic A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19642	85	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235125	10.1371/journal.pone.0235125	http://dx.doi.org/10.1371/journal.pone.0235125			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574214	Green Published, gold			2022-12-27	WOS:000544972400018
J	Seale, H; Heywood, AE; Leask, J; Sheel, M; Thomas, S; Durrheim, DN; Bolsewicz, K; Kaur, R				Seale, Holly; Heywood, Anita E.; Leask, Julie; Sheel, Meru; Thomas, Susan; Durrheim, David N.; Bolsewicz, Katarzyna; Kaur, Rajneesh			COVID-19 is rapidly changing: Examining public perceptions and behaviors in response to this evolving pandemic	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; RISK PERCEPTION; HONG-KONG; SWINE FLU; INFLUENZA; OUTBREAK; KNOWLEDGE; EFFICACY; ATTITUDE	Background Since the emergence of SARS-CoV-2, the virus that causes coronavirus disease (COVID-19) in late 2019, communities have been required to rapidly adopt community mitigation strategies rarely used before, or only in limited settings. This study aimed to examine the attitudes and beliefs of Australian adults towards the COVID-19 pandemic, and willingness and capacity to engage with these mitigation measures. In addition, we aimed to explore the psychosocial and demographic factors that are associated with adoption of recommended hygiene-related and avoidance-related behaviors. Methods A national cross-sectional online survey of 1420 Australian adults (18 years and older) was undertaken between the 18 and 24 March 2020. The statistical analysis of the data included univariate and multivariate logistic regression analysis. Findings The survey of 1420 respondents found 50% (710) of respondents felt COVID-19 would 'somewhat' affect their health if infected and 19% perceived their level of risk as high or very high. 84 center dot 9% had performed >= 1 of the three recommended hygiene-related behaviors and 93 center dot 4% performed >= 1 of six avoidance-related behaviors over the last one month. Adopting avoidance behaviors was associated with trust in government/authorities (aOR: 6.0, 95% CI 2.6-11 center dot 0), higher perceived rating of effectiveness of behaviors (aOR: 4 center dot 0, 95% CI: 1 center dot 8-8 center dot 7), higher levels of perceived ability to adopt social distancing strategies (aOR: 5.0, 95% CI: 1 center dot 5-9.3), higher trust in government (aOR: 6.0, 95% CI: 2.6-11.0) and higher level of concern if self-isolated (aOR: 1.8, 95% CI: 1.1-3.0). Interpretation In the last two months, members of the public have been inundated with messages about hygiene and social (physical) distancing. However, our results indicate that a continued focus on supporting community understanding of the rationale for these strategies, as well as instilling community confidence in their ability to adopt or sustain the recommendations is needed.	[Seale, Holly; Heywood, Anita E.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Leask, Julie; Kaur, Rajneesh] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Leask, Julie] Sydney Childrens Hosp Network, Natl Ctr Immunisat Res & Surveillance, Kids Res, Westmead, NSW, Australia; [Sheel, Meru] Australian Natl Univ, ANU Coll Hlth & Med, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Acton, ACT, Australia; [Thomas, Susan; Durrheim, David N.; Bolsewicz, Katarzyna] Univ Newcastle, Sch Med & Publ Hlth, Wallsend, NSW, Australia; [Kaur, Rajneesh] Univ New South Wales, Fac Med, Off Med Educ, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney; Australian National University; University of Newcastle; University of New South Wales Sydney	Seale, H (corresponding author), Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia.	h.seale@unsw.edu.au	Leask, Julie/ABE-2077-2020; Seale, Holly/D-4200-2011	Leask, Julie/0000-0001-5095-1443; Seale, Holly/0000-0002-1877-5395; sheel, meru/0000-0001-5453-070X	Westpac Scholars Trust	Westpac Scholars Trust	No funding was received for this specific study. MS is supported by a fellowship from the Westpac Scholars Trust.	Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, PUBLIC DIVIDED WHETH; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Bandura A, 1994, SOCIAL COGNITIVE THE, P25, DOI DOI 10.1007/978-1-4899-1193-3_3; Bardsley N, 2005, J ECON PSYCHOL, V26, P664, DOI 10.1016/j.joep.2005.02.001; Betsch C., 2020, NATURE HUMAN BEHAV; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Blake KD, 2010, EMERG INFECT DIS, V16, P212, DOI 10.3201/eid1602.090638; Blendon RJ, 2004, CLIN INFECT DIS, V38, P925, DOI 10.1086/382355; Brekke KA, 2003, J PUBLIC ECON, V87, P1967, DOI 10.1016/S0047-2727(01)00222-5; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brewer NT, 2017, PSYCHOL SCI PUBL INT, V18, P149, DOI 10.1177/1529100618760521; Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283; Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; Eastwood K, 2009, B WORLD HEALTH ORGAN, V87, P588, DOI 10.2471/BLT.08.060772; Faasse K, 2020, PUBLIC PERCEPTIONS C, DOI [10.1101/2020.04.25.20079996, DOI 10.1101/2020.04.25.20079996]; Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790; Grow JA, 2008, QUAL HEALTH RES, V18, P1401, DOI 10.1177/1049732308322603; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; HERSHEY JC, 1994, ORGAN BEHAV HUM DEC, V59, P177, DOI 10.1006/obhd.1994.1055; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002; Lau JTF, 2004, EPIDEMIOL INFECT, V132, P727, DOI 10.1017/S0950268804002225; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Leask J., 2020, SYDNEY MORNING HERAL; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; Marshall H, 2009, AM J PUBLIC HEALTH, V99, pS365, DOI 10.2105/AJPH.2008.153056; McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808; Pereira A, 2011, USING EMPATHY IMPROV; Pfattheicher S., 2020, EMOTIONAL PATH ACTIO, DOI 10.31234/osf.io/y2cg5; Rimal RN, 2003, HUM COMMUN RES, V29, P370, DOI 10.1111/j.1468-2958.2003.tb00844.x; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; SCHUNK DH, 2001, SELF REGULATED LEARN, P125; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Seale H, 2009, MED J AUSTRALIA, V191, P267, DOI 10.5694/j.1326-5377.2009.tb02781.x; Sharot T, 2011, CURR BIOL, V21, pR941, DOI 10.1016/j.cub.2011.10.030; Tang CSK, 2003, AM J PUBLIC HEALTH, V93, P1887, DOI 10.2105/AJPH.93.11.1887; Ward H., 2020, PERCEPTIONS BEHAV RE, DOI 10.1101/2020.04.01.20050039	40	119	120	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235112	10.1371/journal.pone.0235112	http://dx.doi.org/10.1371/journal.pone.0235112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME9KK	32574184	Green Published, gold, Green Submitted			2022-12-27	WOS:000544972400059
J	Aguayo, GA; Schritz, A; Ruiz-Castell, M; Villarroel, L; Valdivia, G; Fagherazzi, G; Witte, DR; Lawson, A				Aguayo, Gloria A.; Schritz, Anna; Ruiz-Castell, Maria; Villarroel, Luis; Valdivia, Gonzalo; Fagherazzi, Guy; Witte, Daniel R.; Lawson, Andrew			Identifying hotspots of cardiometabolic outcomes based on a Bayesian approach: The example of Chile	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; PREVALENCE; HEALTH; HYPERTENSION; INEQUALITIES	Background There is a need to identify priority zones for cardiometabolic prevention. Disease mapping in countries with high heterogeneity in the geographic distribution of the population is challenging. Our goal was to map the cardiometabolic health and identify hotspots of disease using data from a national health survey. Methods Using Chile as a case study, we applied a Bayesian hierarchical modelling. We performed a cross-sectional analysis of the 2009-2010 Chilean Health Survey. Outcomes were diabetes (all types), obesity, hypertension, and high LDL cholesterol. To estimate prevalence, we used individual and aggregated data by province. We identified hotspots defined as prevalence in provinces significantly greater than the national prevalence. Models were adjusted for age, sex, their interaction, and sampling weight. We imputed missing data. We applied a joint outcome modelling approach to capture the association between the four outcomes. Results We analysed data from 4,780 participants (mean age (SD) 46 (19) years; 60% women). The national prevalence (percentage (95% credible intervals) for diabetes, obesity, hypertension and high LDL cholesterol were 10.9 (4.5, 19.2), 30.0 (17.7, 45.3), 36.4 (16.4, 57.6), and 13.7 (3.4, 32.2) respectively. Prevalence of diabetes was lower in the far south. Prevalence of obesity and hypertension increased from north to far south. Prevalence of high LDL cholesterol was higher in the north and south. A hotspot for diabetes was located in the centre. Hotspots for obesity were mainly situated in the south and far south, for hypertension in the centre, south and far south and for high LDL cholesterol in the far south. Conclusions The distribution of cardiometabolic risk factors in Chile has a characteristic pattern with a general trend to a north-south gradient. Our approach is reproducible and demonstrates that the Bayesian approach enables the accurate identification of hotspots and mapping of disease, allowing the identification of areas for cardiometabolic prevention.	[Aguayo, Gloria A.; Ruiz-Castell, Maria; Fagherazzi, Guy] Luxembourg Inst Hlth, Populat Hlth Dept, Strassen, Luxembourg; [Schritz, Anna] Luxembourg Inst Hlth, Competence Ctr Methodol & Stat, Strassen, Luxembourg; [Villarroel, Luis; Valdivia, Gonzalo] Pontificia Univ Catolica Chile, Sch Med, Dept Publ Hlth, Santiago, Chile; [Witte, Daniel R.] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Witte, Daniel R.] Danish Diabet Acad, Odense, Denmark; [Lawson, Andrew] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA	Luxembourg Institute of Health; Luxembourg Institute of Health; Pontificia Universidad Catolica de Chile; Aarhus University; Medical University of South Carolina	Aguayo, GA (corresponding author), Luxembourg Inst Hlth, Populat Hlth Dept, Strassen, Luxembourg.	gloria.aguayo@lih.lu	Fagherazzi, Guy/ABB-2555-2020; Fagherazzi, Guy/P-3534-2017; Schritz, Anna/K-8887-2019; Aguayo, Gloria/W-2580-2019; Witte, Daniel/C-1722-2008	Fagherazzi, Guy/0000-0001-5033-5966; Fagherazzi, Guy/0000-0001-5033-5966; Schritz, Anna/0000-0002-8478-8055; Aguayo, Gloria/0000-0002-5625-1664; Ruiz-Castell, Maria/0000-0001-9741-7491; Valdivia, Gonzalo/0000-0001-5368-6745; Witte, Daniel/0000-0002-0769-2922				Albala C, 2002, PUBLIC HEALTH NUTR, V5, P123, DOI 10.1079/PHN2001283; Albers C, COBERTURAS SIG CHILE; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; Ardern CI, 2005, CIRCULATION, V112, P1478, DOI 10.1161/CIRCULATIONAHA.105.548198; Aregay M, 2015, STAT METHODS MED RES; Black HR, 1997, ARCH INTERN MED, V157, P2413; Cabieses B, 2015, INT MIGR, V53, P303, DOI 10.1111/imig.12077; Clark-Nunez X, 2017, COMPENDIO ESTADISTIC; Connolly V, 2000, J EPIDEMIOL COMMUN H, V54, P173, DOI 10.1136/jech.54.3.173; de Groot R, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001017; Di Cesare M, 2015, LANCET GLOB HEALTH, V3, pE229, DOI 10.1016/S2214-109X(15)70001-X; Dintrans PV, 2018, HEALTH POLICY, V122, P184, DOI 10.1016/j.healthpol.2017.11.007; Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550; Ferreccio C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-015-2454-2; Gaglioti AH, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170220; Gavin JR, 1999, DIABETES CARE, V22, pS5; Jaacks LM, 2019, LANCET DIABETEENDO; Kirby RS, 2017, ANN EPIDEMIOL, V27, P1, DOI 10.1016/j.annepidem.2016.12.001; Kuklina Elena V, 2013, NCHS Data Brief, P1; Lawson A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051682; Lawson AB, 2014, STAT PUBLIC POLICY, V1, P99, DOI 10.1080/2330443X.2014.970247; Leng B, 2015, J HYPERTENS, V33, P221, DOI 10.1097/HJH.0000000000000428; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Matute I, 2017, MEDICC REV, V19, P51, DOI 10.37757/MR2017.V19.N2-3.9; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Mindell JS, 2017, AM J EPIDEMIOL, pkwx045; Ministerio de Salud DdPS Departamento de Epidemiologia, 2003, ENC SAL CHIL 2003; Ministerio de Salud DdPS Departamento de Epidemiologia, 2011, ENC NAC SAL CHIL 200; Ministerio de Salud DdPS Departamento de Epidemiologia, 2017, ENCU NAC SAL 2016 20; Misra A, 2018, J DIABETES COMPLICAT, V32, P1068, DOI 10.1016/j.jdiacomp.2018.08.001; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Popkin BM, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0631-4; Pringle DG, 1996, ECON SOC REV, V27, P341; Ramachandran A, 2008, DIABETES CARE, V31, P893, DOI 10.2337/dc07-1207; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Ruiz-Castell M, 2015, AM J PUBLIC HEALTH, V105, pE122, DOI 10.2105/AJPH.2014.302290; Solimano G, 2007, REV MED CHILE, V135, P932; Sturtz S., 2005, R2WINBUGS PACKAGE RU; Subramanian SV, 2003, J EPIDEMIOL COMMUN H, V57, P844, DOI 10.1136/jech.57.11.844; TANNER MA, 1987, J AM STAT ASSOC, V82, P528, DOI 10.2307/2289457; Tennekes M, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.i06; Thornton LE, 2011, J EPIDEMIOL COMMUN H, V65, P873, DOI 10.1136/jech.2009.099614; Timonin S, 2018, INT J EPIDEMIOL, V47, P1594, DOI 10.1093/ije/dyy146; Vandendijck Y, 2016, SPAT STAT-NETH, V18, P455, DOI 10.1016/j.spasta.2016.09.004; Venables WN., 2002, MODERN APPL STAT S; Watjou K, 2017, STAT MED, V36, P3708, DOI 10.1002/sim.7369; WHO. World Health Organization, 1995, TECHNICAL REPORT SER, V854; Yeates K, 2015, CAN J CARDIOL, V31, P1081, DOI 10.1016/j.cjca.2015.06.035; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	51	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235009	10.1371/journal.pone.0235009	http://dx.doi.org/10.1371/journal.pone.0235009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569307	gold, Green Published			2022-12-27	WOS:000543547900003
J	Norden, PR; Sun, ZY; Davis, GE				Norden, Pieter R.; Sun, Zheying; Davis, George E.			Control of endothelial tubulogenesis by Rab and Ral GTPases, and apical targeting of caveolin-1-labeled vacuoles	PLOS ONE			English	Article							CAPILLARY LUMEN FORMATION; IN-VITRO; CELL MORPHOGENESIS; MOLECULAR-BASIS; COLLAGEN; MECHANISMS; REQUIRES; CDC42; VASCULOGENESIS; EXOCYTOSIS	Here, we examine known GTPase regulators of vesicle trafficking events to assess whether they affect endothelial cell (EC) lumen and tube formation. We identify novel roles for the small GTPases Rab3A, Rab3B, Rab8A, Rab11A, Rab27A, RalA, RalB and caveolin-1 in co-regulating membrane trafficking events that control EC lumen and tube formation. siRNA suppression of individual GTPases such as Rab3A, Rab8A, and RalB markedly inhibit tubulogenesis, while greater blockade is observed with combinations of siRNAs such as Rab3A and Rab3B, Rab8A and Rab11A, and RalA and RalB. These combinations of siRNAs also disrupt very early events in lumen formation including the formation of intracellular vacuoles. In contrast, knockdown of the endocytosis regulator, Rab5A, fails to inhibit EC tube formation. Confocal microscopy and real-time videos reveal that caveolin-1 strongly labels intracellular vacuoles and localizes to the EC apical surface as they fuse to form the luminal membrane. In contrast, Cdc42 and Rab11A localize to a perinuclear, subapical region where intracellular vacuoles accumulate and fuse during lumen formation. Our new data demonstrates that EC tubulogenesis is coordinated by a series of small GTPases to control polarized membrane trafficking events to generate, deliver, and fuse caveolin-1-labeled vacuoles to create the apical membrane surface.	[Norden, Pieter R.; Sun, Zheying; Davis, George E.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Davis, GE (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	gedavis@usf.edu		Norden, Pieter/0000-0002-5960-5245	National Institutes of Health [HL126518, HL128584]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (www.nih.gov) grants HL126518 and HL128584 to GED. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2011, ETHNIC DIS, V21, p[S1, S1]; Ariotti N, 2015, J BIOL CHEM, V290, P24875, DOI 10.1074/jbc.M115.644336; Balasubramanian N, 2010, CURR BIOL, V20, P75, DOI 10.1016/j.cub.2009.11.016; Barry DM, 2015, DEVELOPMENT, V142, P3058, DOI 10.1242/dev.125260; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bayless KJ, 2004, J BIOL CHEM, V279, P11686, DOI 10.1074/jbc.M308373200; Bayless KJ, 2002, J CELL SCI, V115, P1123; Bhuin T, 2014, EXP CELL RES, V328, P1, DOI 10.1016/j.yexcr.2014.07.027; Bierings R, 2012, BLOOD, V120, P2757, DOI 10.1182/blood-2012-05-429936; Biesemann A, 2017, J BIOL CHEM, V292, P11631, DOI 10.1074/jbc.M116.773333; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Conte IL, 2016, J CELL SCI, V129, P592, DOI 10.1242/jcs.178285; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis GE, 2003, MICROCIRCULATION, V10, P27, DOI 10.1038/sj.mn.7800175; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; Davis GE, 2015, CELL POLARITY 1: BIOLOGICAL ROLE AND BASIC MECHANISMS, P205, DOI 10.1007/978-3-319-14463-4_9; Davis GE, 2014, DEV CELL, V31, P140, DOI 10.1016/j.devcel.2014.10.011; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Griffoni C, 2000, BIOCHEM BIOPH RES CO, V276, P756, DOI 10.1006/bbrc.2000.3484; Huebner H, 2018, PLACENTA, V62, P58, DOI 10.1016/j.placenta.2017.12.019; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Jiang Y, 2016, J BIOL CHEM, V291, P20729, DOI 10.1074/jbc.M116.752485; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kim DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184461; Kim DJ, 2013, BLOOD, V121, P3521, DOI 10.1182/blood-2012-11-470179; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; Koller GM, 2020, ARTERIOSCL THROM VAS, V40, P365, DOI 10.1161/ATVBAHA.119.313536; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Norden PR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147758; Parker Sara S, 2018, Small GTPases, V9, P116, DOI 10.1080/21541248.2016.1277840; PARTON RG, 2019, TRAFFIC 0909, DOI DOI 10.1111/TRA.12689; Pfeffer SR, 2017, MOL BIOL CELL, V28, P712, DOI 10.1091/mbc.E16-10-0737; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Rondaij MG, 2008, BLOOD, V112, P56, DOI 10.1182/blood-2007-07-099309; Sandvig K, 2018, HISTOCHEM CELL BIOL, V150, P107, DOI 10.1007/s00418-018-1678-5; Shirakawa R, 2015, J BIOCHEM, V157, P285, DOI 10.1093/jb/mvv029; Sigurbjornsdottir S, 2014, NAT REV MOL CELL BIO, V15, P665, DOI 10.1038/nrm3871; Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Yu JXA, 2015, DEVELOPMENT, V142, P2951, DOI 10.1242/dev.123174; Zimnicka AM, 2016, MOL BIOL CELL, V27, P2090, DOI 10.1091/mbc.E15-11-0756; Zografou S, 2012, J CELL SCI, V125, P4780, DOI 10.1242/jcs.104174	52	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235116	10.1371/journal.pone.0235116	http://dx.doi.org/10.1371/journal.pone.0235116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569321	Green Published, gold			2022-12-27	WOS:000543547900047
J	Purtlebaugh, CH; Martin, CW; Allen, MS				Purtlebaugh, Caleb H.; Martin, Charles W.; Allen, Micheal S.			Poleward expansion of common snookCentropomus undecimalisin the northeastern Gulf of Mexico and future research needs	PLOS ONE			English	Article							SNOOK CENTROPOMUS-UNDECIMALIS; SUWANNEE RIVER-BASIN; CLIMATE-CHANGE; AVICENNIA-GERMINANS; MANGROVE EXPANSION; GROWING-SEASON; SALT-MARSHES; LIFE-HISTORY; HABITAT USE; RED DRUM	Globally, rising temperatures have resulted in numerous examples of poleward shifts in species distribution patterns with accompanying changes in community structure and ecosystem processes. In the Gulf of Mexico, higher mean temperatures and less frequent winter freezes have led to the expansion of tropics-associated marine organisms. Our objectives were to quantify changing environmental conditions and the poleward expansion of the common snookCentropomus undecimalisinto the Cedar Keys area of Florida, USA (29 deg N). The snook is an economically and recreationally important sport fish found from southern Brazil to south Florida. Cedar Key and the Lower Suwannee River are north of the snook's historically documented range, likely due to lethal water temperatures during winter. Using data from a long-term monitoring program, we report an increase in catches of snook in this area since 2007. The spatial and temporal expansion of the species began with adult fish in 2007. By 2018, snook of all sizes were found in the region, and we found strong evidence of local reproduction during 2016-2018. The locations of nursery habitat and winter thermal refuges (e.g., freshwater springs) need to be identified and have implications for land-use policy and minimum-flow regulations for rivers. The arrival of the snook in the northern Gulf of Mexico could affect food web ecology and habitat interactions among estuarine predators, and future studies should evaluate snook's food habits and competitive interactions with resident fishes in this expanded range. Our study provides an example of how species range expansions due to changing temperatures should result in new research priorities to evaluate impacts of climate change on coastal systems.	[Purtlebaugh, Caleb H.] Florida Fish & Wildlife Conservat Commiss, Senator George Kirkpatrick Marine Lab, Fish & Wildlife Res Inst, Cedar Key, FL 32625 USA; [Martin, Charles W.; Allen, Micheal S.] Univ Florida, Fisheries & Aquat Sci Program, Inst Food & Agr Sci, Nat Coast Biol Stn, Cedar Key, FL USA	Florida Fish & Wildlife Conservation Commission; State University System of Florida; University of Florida	Purtlebaugh, CH (corresponding author), Florida Fish & Wildlife Conservat Commiss, Senator George Kirkpatrick Marine Lab, Fish & Wildlife Res Inst, Cedar Key, FL 32625 USA.	Caleb.Purtlebaugh@myFWC.com		Martin, Charles/0000-0001-9240-3824	State of Florida saltwater recreational fishing licenses; U.S. Department of the Interior, U.S. Fish and Wildlife Service, Federal Aid for Sportfish Restoration Project	State of Florida saltwater recreational fishing licenses; U.S. Department of the Interior, U.S. Fish and Wildlife Service, Federal Aid for Sportfish Restoration Project	This project was supported by proceeds from State of Florida saltwater recreational fishing licenses, and by funding from the U.S. Department of the Interior, U.S. Fish and Wildlife Service, Federal Aid for Sportfish Restoration Project. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2015, AM FISH S S, V83, P43; Adams Aaron J., 2012, Gulf and Caribbean Research, V24, P13; Aliaume C., 1997, GULF MEX SCI, V2, P77, DOI [10.18785/goms.1502.03, DOI 10.18785/GOMS.1502.03]; Anderson D. R., 2008, MODEL BASED INFERENC; Anderson J, 2020, N AM J FISH MANAGE, V40, P190, DOI 10.1002/nafm.10394; [Anonymous], 2007, HORISONT, V1, P15; [Anonymous], 2014, J ORTHOP RES S1, V32, pS158; Aven A, 2016, W INDIAN MANATEE MOV, DOI [10.7287/peerj.preprints.2072, DOI 10.7287/PEERJ.PREPRINTS.2072]; Avens L, 2012, MAR ECOL PROG SER, V458, P213, DOI 10.3354/meps09720; Barbour AB, 2014, MAR ECOL PROG SER, V507, P263, DOI 10.3354/meps10837; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Beck MW, 2001, AQUAT CONSERV, V11, P235, DOI 10.1002/aqc.449; Berge J, 2005, MAR ECOL PROG SER, V303, P167, DOI 10.3354/meps303167; Bianchi TS, 2013, ESTUAR COAST SHELF S, V119, P7, DOI 10.1016/j.ecss.2012.12.007; Boucek RE, 2017, GLOBAL CHANGE BIOL, V23, P4045, DOI 10.1111/gcb.13761; Brame AB, 2014, MAR ECOL PROG SER, V509, P255, DOI 10.3354/meps10902; Brodeur RD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026614; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; CONOVER DO, 1990, OECOLOGIA, V83, P316, DOI 10.1007/BF00317554; CONOVER DO, 1990, T AM FISH SOC, V119, P416, DOI 10.1577/1548-8659(1990)119<0416:TRBCFG>2.3.CO;2; Crandall CA, 1999, HYDROGEOL J, V7, P454, DOI 10.1007/s100400050218; Fertl D, 2004, J MAMMAL, V85, P816; Fish and Wildlife Research Institute, 2018, FISH IND MON PROGR 2; Florida Fish and Wildlife Conservation Commission, 2019, SPRINGS COAST FISH C; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Foster John M., 2004, Gulf and Caribbean Research, V16, P161; Francis JA, 2017, WIRES CLIM CHANGE, V8, DOI 10.1002/wcc.474; Holbrook SJ, 1997, ECOL APPL, V7, P1299; Hollebone AL, 2007, MAR ECOL PROG SER, V336, P211, DOI 10.3354/meps336211; HOWELLS R G, 1990, Northeast Gulf Science, V11, P155; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Katz BG, 1997, J AM WATER RESOUR AS, V33, P1237, DOI 10.1111/j.1752-1688.1997.tb03549.x; Ley JA, 2013, FISH RES, V144, P60, DOI 10.1016/j.fishres.2012.10.008; Ley JA, 2018, MAR ECOL PROG SER, V606, P151, DOI 10.3354/meps12765; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2592, DOI 10.1111/j.1365-2486.2007.01451.x; Llanso RJ, 1998, ESTUARIES, V21, P294, DOI 10.2307/1352476; Macy A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210144; Malinowski C, 2019, ESTUAR COAST, V42, P842, DOI 10.1007/s12237-018-00512-y; Marshak AR, 2017, J FISH BIOL, V91, P1139, DOI 10.1111/jfb.13406; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; MCMILLAN C, 1986, CONTRIB MAR SCI, V29, P9; Mieszkowska N, 2005, MARINE BIOL ASS OCCA, V20, P43; Muller RG, 2015, 2015004 WILDL RES I; Nehring S, 1998, ICES J MAR SCI, V55, P818, DOI 10.1006/jmsc.1998.0389; Osland MJ, 2019, ESTUAR COAST, V42, P1084, DOI 10.1007/s12237-019-00533-1; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PAULY D, 1980, J CONSEIL, V39, P175; Perera-Garcia MA, 2011, REV BIOL TROP, V59, P669; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Perry CL, 2009, WETLANDS, V29, P396, DOI 10.1672/08-100.1; Peters KM, 1998, B MAR SCI, V62, P509; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Precht WF, 2006, CONSERV BIOL SER, P40; Raabe EA, 2010, THERMAL IMAGING WACC, DOI [10.3133/ofr20101120, DOI 10.3133/OFR20101120]; Saintilan N, 2014, GLOBAL CHANGE BIOL, V20, P147, DOI 10.1111/gcb.12341; Santos RO, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1335; Scheffers BR, 2019, NAT CLIM CHANGE, V9, P581, DOI 10.1038/s41558-019-0526-5; Schulz K, 2019, THESIS; SHAFLAND P L, 1983, Northeast Gulf Science, V6, P175; Solomon S., 2007, CLIMATE CHANGE 2007; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Spivak ED, 2005, P BIOL SOC WASH, V118, P551, DOI 10.2988/0006-324X(2005)118[551:SREOTW]2.0.CO;2; Stevens PW, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1400; Stevens Philip W., 2006, Wetlands Ecology and Management, V14, P435, DOI 10.1007/s11273-006-0006-3; Stevens PW, 2007, B MAR SCI, V80, P93; Stevens PW, 2020, ESTUAR COAST, V43, P438, DOI 10.1007/s12237-019-00674-3; Taylor RG, 1998, J FISH BIOL, V53, P502, DOI 10.1006/jfbi.1998.0721; TUCKER J W JR, 1988, Florida Scientist, V51, P1; Winner BL, 2010, T AM FISH SOC, V139, P62, DOI 10.1577/T08-215.1; Young JM, 2014, MAR ECOL PROG SER, V505, P227, DOI 10.3354/meps10774; Zomlefer WB, 2006, CASTANEA, V71, P239, DOI 10.2179/05-33.1	72	21	21	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234083	10.1371/journal.pone.0234083	http://dx.doi.org/10.1371/journal.pone.0234083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569296	Green Published, gold			2022-12-27	WOS:000543547900015
J	Kumar, SH; Athimoolam, K; Suraj, M; Das, MSDC; Muralidharan, A; Jeyam, D; Ashokan, J; Karthikeyan, P; Krishna, R; Khanna-Gupta, A; Bremadesam, RL				Kumar, Shalini H.; Athimoolam, Kalpana; Suraj, Manikandan; Das, Mary Shoba Das Christu; Muralidharan, Aparna; Jeyam, Divya; Ashokan, Jaicy; Karthikeyan, Priya; Krishna, Ragav; Khanna-Gupta, Arati; Bremadesam Raman, Lakshmi			Comprehensive genetic analysis of 961 unrelated Duchenne Muscular Dystrophy patients: Focus on diagnosis, prevention and therapeutic possibilities	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; PHENOTYPE; DELETIONS; EXPERIENCE; MUTATIONS; STRATEGY; DATABASE; TOOL	Recently DNA sequencing analysis has played a vital role in the unambiguous diagnosis of clinically suspected patients with Duchenne Muscular Dystrophy (DMD). DMD is a monogenic, X-linked, recessive, degenerative pediatric neuromuscular disorder affecting males, invariably leading to fatal cardiopulmonary failure. Early and precise diagnosis of the disease is an essential part of an effective disease management strategy as care guidelines and prevention through counseling need to be initiated at the earliest particularly since therapies are now available for a subset of patients. In this manuscript we report theDMDgene mutational profiles of 961 clinically suspected male DMD patients, 99% of whom were unrelated. We utilized a molecular diagnostic approach which is cost-effective for most patients and follows a systematic process that sequentially involves identification of hotspot deletions using mPCR, large deletions and duplications using MLPA and small insertions/ deletions and point mutations using an NGS muscular dystrophy gene panel. PathogenicDMDgene mutations were identified in 84% of patients. Our data compared well with the frequencies and distribution of deletions and duplications reported in theDMDgene in other published studies. We also describe a number of rare in-frame mutations, which appeared to be enriched in the 5' proximal hotspot region of theDMDgene. Furthermore, we identified a family with a rare non-contiguous deletion mutation in theDMDgene where three males were affected and two females were deemed carriers. A subset of patients with mutations in theDMDgene who are likely to benefit therapeutically from new FDA and EMA approved drugs were found in our cohort. Given that the burden of care for DMD patients invariably falls on the mothers, particularly in rural India, effective genetic counseling followed by carrier screening is crucial for prevention of this disorder. We analyzed the carrier status of consented female relatives of 463 probands to gauge the percentage of patients with familial disease. Our analysis revealed 43.7% of mothers withDMDgene mutations. Our comprehensive efforts, involving complete genetic testing coupled with compassionate genetic counseling provided to DMD patients and their families, are intended to improve the quality of life of DMD patients and to empower carrier females to make informed reproductive choices to impede the propagation of this deadly disease.	[Kumar, Shalini H.; Athimoolam, Kalpana; Suraj, Manikandan; Das, Mary Shoba Das Christu; Muralidharan, Aparna; Jeyam, Divya; Ashokan, Jaicy; Karthikeyan, Priya; Krishna, Ragav; Khanna-Gupta, Arati; Bremadesam Raman, Lakshmi] Royal CareSuper Special Hosp, Mol Diagnost Counseling Care & Res Ctr MDCRC, Coimbatore, Tamil Nadu, India		Bremadesam, RL (corresponding author), Royal CareSuper Special Hosp, Mol Diagnost Counseling Care & Res Ctr MDCRC, Coimbatore, Tamil Nadu, India.	drlakshmi@mdcrcindia.org		/0000-0002-5305-1309; Khanna-Gupta, Arati/0000-0002-0965-1737; BREMADESAM, LAKSHMI/0000-0001-5447-9473				Aartsma-Rus A, 2019, HUM MUTAT, V40, P1630, DOI 10.1002/humu.23850; Abbs Stephen, 2010, Neuromuscul Disord, V20, P422, DOI 10.1016/j.nmd.2010.04.005; Aravind S, 2019, INDIAN J MED RES, V150, P282, DOI 10.4103/ijmr.IJMR_290_18; Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Buzin CH, 2005, HUM MUTAT, V25, P177, DOI 10.1002/humu.20132; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Conklin LS, 2018, PHARMACOL RES, V136, P140, DOI 10.1016/j.phrs.2018.09.007; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Echigoya Y, 2018, J PERS MED, V8, DOI 10.3390/jpm8040041; Fraser HG, 2018, J GENET COUNS, V27, P1349, DOI 10.1007/s10897-018-0266-0; Guiraud S, 2017, CURR OPIN PHARMACOL, V34, P36, DOI 10.1016/j.coph.2017.04.002; Gurvich OL, 2009, HUM MUTAT, V30, P633, DOI 10.1002/humu.20913; Haas M, 2015, NEUROMUSCULAR DISORD, V25, P5, DOI 10.1016/j.nmd.2014.11.011; Hawkins AK, 2011, CLIN GENET, V80, P424, DOI 10.1111/j.1399-0004.2011.01769.x; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoffman EP, 2011, AM J PATHOL, V179, P12, DOI 10.1016/j.ajpath.2011.03.050; Juan-Mateu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135189; Lee T, 2014, J HUM GENET, V59, P46, DOI 10.1038/jhg.2013.119; Lim KRQ, 2017, DRUG DES DEV THER, V11, P533, DOI 10.2147/DDDT.S97635; Malik V, 2010, ANN NEUROL, V67, P771, DOI 10.1002/ana.22024; Manjunath M, 2015, NEUROL INDIA, V63, P58, DOI 10.4103/0028-3886.152635; McDonald CM, 2018, LANCET, V391, P451, DOI 10.1016/S0140-6736(17)32160-8; Miller S.A., 1988, NUCLEIC ACIDS RES, V16, P3, DOI [10.1093/nar/16.3.1215, DOI 10.1093/NAR/16.3.1215]; Moat SJ, 2013, EUR J HUM GENET, V21, P1049, DOI 10.1038/ejhg.2012.301; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Moxley RT, 2010, J CHILD NEUROL, V25, P1116, DOI 10.1177/0883073810371004; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nakamura A, 2017, J HUM GENET, V62, P459, DOI 10.1038/jhg.2016.152; Niks EH, 2017, EXPERT OPIN BIOL TH, V17, P225, DOI 10.1080/14712598.2017.1271872; Prior TW, 2005, J MOL DIAGN, V7, P317, DOI 10.1016/S1525-1578(10)60560-0; Rao MV, 2014, ANN INDIAN ACAD NEUR, V17, P303, DOI 10.4103/0972-2327.138508; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rosenberg AS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7322; Sakthivel Murugan SM, 2013, INDIAN J MED RES, DOI [10.1111/j.1399-0004.1985.tb02281.x, DOI 10.1111/J.1399-0004.1985.TB02281.X]; Sakthivel Murugan SM, 2010, INDIAN J MED RES; Salian S, 2016, GENET COUNSEL, V27, P449; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Taglia A, 2015, ACTA MYOL; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; Vengalil S, 2017, J CLIN NEUROL, V13, P91, DOI 10.3988/jcn.2017.13.1.91; Verhaart IEC, 2019, NEUROMUSCULAR DISORD, V29, P576, DOI 10.1016/j.nmd.2019.06.004; WINNARD AV, 1995, AM J HUM GENET, V56, P158; Zampatti S, 2018, PRENATAL DIAG, V38, P1096, DOI 10.1002/pd.5369	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0232654	10.1371/journal.pone.0232654	http://dx.doi.org/10.1371/journal.pone.0232654			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559196	Green Published, gold			2022-12-27	WOS:000543261600006
J	Basson, AE; Charalambous, S; Hoffmann, CJ; Morris, L				Basson, Adriaan E.; Charalambous, Salome; Hoffmann, Christopher J.; Morris, Lynn			HIV-1 re-suppression on a first-line regimen despite the presence of phenotypic drug resistance	PLOS ONE			English	Article							2ND-LINE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; REVERSE-TRANSCRIPTASE; VIROLOGICAL FAILURE; VIRAL FAILURE; SUBTYPE-C; ADHERENCE; RESUPPRESSION; SWITCH; SUSCEPTIBILITY	We have previously reported on HIV-1 infected patients who fail anti-retroviral therapy but manage to re-suppress without a regimen change despite harbouring major drug resistance mutations. Here we explore phenotypic drug resistance in such patients in order to better understand this phenomenon. Patients (n = 71) failing a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimen, but who subsequently re-suppressed on the same regimen, were assessed for HIV-1 genotypic drug resistance through Sanger sequencing. A subset (n = 23) of these samples, as well as genotypically matched samples from patients who did not re-suppress (n = 19), were further assessed for phenotypic drug resistance in anin vitrosingle cycle assay. Half of the patients (n = 36/71, 51%) harboured genotypic drug resistance, with M184V (n = 18/36, 50%) and K103N (n = 16/36, 44%) being the most prevalent mutations. No significant difference in the median time to re-suppression (31-39 weeks) were observed for either group (p = 0.41). However, re-suppressors with mutant virus rebounded significantly earlier than those with wild-type virus (16 vs. 33 weeks; p = 0.014). Similar phenotypic drug resistance profiles were observed between patients who re-suppressed and patients who failed to re-suppress. While most remained susceptible to stavudine (d4T) and zidovudine (AZT), both groups showed a reduced susceptibility to 3TC and NNRTIs. HIV- 1 infected patients on an NNRTI-based regimen can achieve viral re-suppression on the same regimen despite harbouring viruses with genotypic and phenotypic drug resistance. However, re-suppression was less durable in those with resistance, reinforcing the importance of appropriate regimen choices, ongoing viral load monitoring and adherence counselling.	[Basson, Adriaan E.; Morris, Lynn] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, Gauteng, South Africa; [Basson, Adriaan E.; Morris, Lynn] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, Gauteng, South Africa; [Charalambous, Salome; Hoffmann, Christopher J.] Aurum Inst, Johannesburg, Gauteng, South Africa; [Charalambous, Salome] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, Gauteng, South Africa; [Hoffmann, Christopher J.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; Johns Hopkins University	Basson, AE (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, Gauteng, South Africa.; Basson, AE (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, Gauteng, South Africa.	adriaan.basson@wits.ac.za	; , Lynn/V-3941-2018	Hoffmann, Christopher/0000-0002-9422-0519; , Lynn/0000-0003-3961-7828; Basson, Adriaan/0000-0002-7541-8132; Charalambous, Salome/0000-0001-7143-1009	National Health Laboratory Service (NHLS); Poliomyelitis Research Foundation (PRF)	National Health Laboratory Service (NHLS); Poliomyelitis Research Foundation (PRF)	AEB and LM received research grants from the National Health Laboratory Service (NHLS) and the Poliomyelitis Research Foundation (PRF) to fund this study.	[Anonymous], 2013, ENDOKRYNOL POL, V64, P74; [Anonymous], 2016, LANCET INFECT DIS, V16, P565, DOI [10.1016/S1473-3099(15)00536-8, DOI 10.1016/S1473-3099(15)00536-8]; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Barth RE, 2012, ANTIVIR THER, V17, P377, DOI 10.3851/IMP2010; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Basson AE, 2015, ANTIMICROB AGENTS CH, V59, P960, DOI 10.1128/AAC.04215-14; Ceccherini-Silberstein F, 2018, J ANTIMICROB CHEMOTH, V73, P3460, DOI 10.1093/jac/dky350; Charalambous S, 2007, AIDS CARE, V19, P34, DOI 10.1080/09500340600677872; Chen Y, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/5283706; El-Khatib Z., 2011, Journal of AIDS and Clinical Research, V2, P117; Eron JJ, 2004, JAIDS-J ACQ IMM DEF, V37, P1581, DOI 10.1097/00126334-200412150-00009; Fatti G, 2020, CLIN INFECT DIS, V70, P395, DOI 10.1093/cid/ciz214; Ford N, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25415; Fox MP, 2018, TROP MED INT HEALTH, V23, P1314, DOI 10.1111/tmi.13152; Fox Z, 2008, AIDS, V22, P2279, DOI 10.1097/QAD.0b013e328311d16f; Georgette N, 2016, AIDS BEHAV, V20, P2629, DOI 10.1007/s10461-016-1287-z; Gerber JG, 2003, J CLIN VIROL, V27, P117, DOI 10.1016/S1386-6532(03)00033-7; Gupta RK, 2014, CLIN INFECT DIS, V58, P1023, DOI 10.1093/cid/cit933; Haberer JE, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21371; Hoffmann CJ, 2016, TROP MED INT HEALTH, V21, P219, DOI 10.1111/tmi.12639; Hoffmann CJ, 2014, TROP MED INT HEALTH, V19, P236, DOI 10.1111/tmi.12237; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Huang A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv158; Iacob SA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00831; Jobanputra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116144; Johnston V, 2012, JAIDS-J ACQ IMM DEF, V61, P370, DOI 10.1097/QAI.0b013e318266ee3f; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lucas GM, 2005, J ANTIMICROB CHEMOTH, V55, P413, DOI 10.1093/jac/dki042; McCluskey SM, 2017, JAIDS-J ACQ IMM DEF, V76, P183, DOI 10.1097/QAI.0000000000001479; McCormick AL, 2011, ANTIMICROB AGENTS CH, V55, P1806, DOI 10.1128/AAC.01197-10; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Mukherjee JS, 2016, CURR HIV-AIDS REP, V13, P359, DOI 10.1007/s11904-016-0335-7; Murphy RA, 2017, AIDS RES HUM RETROV, V33, P1181, DOI [10.1089/aid.2017.0134, 10.1089/AID.2017.0134]; Nachega JB, 2016, CURR HIV-AIDS REP, V13, P241, DOI 10.1007/s11904-016-0325-9; NDoH, 2015, NAT CONS GUID PREV M; Orrell C, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/469127; Parry CM, 2009, J VIROL, V83, P9094, DOI 10.1128/JVI.02356-08; Petersen ML, 2014, AIDS, V28, P2097, DOI 10.1097/QAD.0000000000000349; Pretorius E, 2011, THER DRUG MONIT, V33, P265, DOI 10.1097/FTD.0b013e31821b42d1; Rhead R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167852; Rhee SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145772; Rosenbloom DIS, 2012, NAT MED, V18, P1378, DOI 10.1038/nm.2892; Rutstein SE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1611-2; Shet A, 2015, TROP MED INT HEALTH, V20, P1462, DOI 10.1111/tmi.12563; Shubber Z, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002183; Skhosana L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118145; Ssempijja V, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2680-6; Steegen K, 2017, J ANTIMICROB CHEMOTH, V72, P210, DOI 10.1093/jac/dkw358; Sutton SS, 2016, JAAPA-J AM ACAD PHYS, V29, P16, DOI 10.1097/01.JAA.0000502870.89587.b6; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Turner D, 2004, MICROBIOLOGICA, V27, P31; UNAIDS, 2018, UNAIDSJC2929E; Villa G, 2020, ECLINICALMEDICINE, V18, DOI 10.1016/j.eclinm.2019.12.001; von Wyl V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077691; Wainberg MA, 1996, AIDS, V10, pS3, DOI 10.1097/00002030-199612005-00002; Wainberg Mark A., 1997, Leukemia (Basingstoke), V11, P85	56	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234937	10.1371/journal.pone.0234937	http://dx.doi.org/10.1371/journal.pone.0234937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555643	gold, Green Published			2022-12-27	WOS:000543273200071
J	Hollandsworth, HM; Amirfakhri, S; Filemoni, F; Molnar, J; Hoffman, RM; Yazaki, P; Bouvet, M				Hollandsworth, Hannah M.; Amirfakhri, Siamak; Filemoni, Filemoni; Molnar, Justin; Hoffman, Robert M.; Yazaki, Paul; Bouvet, Michael			Near-infrared photoimmunotherapy is effective treatment for colorectal cancer in orthotopic nude-mouse models	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN	Background Photoimmunotherapy (PIT) employs the use of a near-infrared (NIR) laser to activate an antibody conjugated to a NIR-activatable dye to induce cancer cell death. PIT has shown to be effective in a number of studies, however, there are no data on its use in colorectal cancer in an orthotopic model. Methods Humanized anti-CEA antibody (M5A) was conjugated to NIR-activatable IRDye700DX (M5A-700). PIT was validated in vitro with a colon cancer cell-line, using a laser intensity of either 4 J/cm(2), 8 J/cm(2), or 16 J/cm(2). Orthotopic colon cancer mouse models were established by surgical implantation of LS174T tumor fragments onto the cecum. M5A-700 was administered and PIT was performed 24 hours later using a 690 nm laser. Repeat PIT was performed after 7 days in one group. Control mice received laser treatment only. Results In vitro PIT demonstrated tumor cell death in a laser intensity dose-dependent fashion. In orthotopic models, control mice demonstrated persistent tumor growth. Mice that underwent PIT one time had tumor growth arrested for one week, after which re-growth occurred. The group that received repeated PIT exposure had persistent inhibition of tumor growth. Conclusion PIT arrests tumor growth in colon cancer orthotopic nude-mouse models. Repeated PIT arrests colon cancer growth for a longer period of time. PIT may be a useful therapy in the future as an adjunct to surgical resection or as primary therapy to suppress tumor progression.	[Hollandsworth, Hannah M.; Amirfakhri, Siamak; Filemoni, Filemoni; Hoffman, Robert M.; Bouvet, Michael] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hollandsworth, Hannah M.; Amirfakhri, Siamak; Filemoni, Filemoni; Hoffman, Robert M.; Bouvet, Michael] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA; [Hollandsworth, Hannah M.; Amirfakhri, Siamak; Filemoni, Filemoni; Bouvet, Michael] VA San Diego Healthcare Syst, Dept Surg, San Diego, CA 92161 USA; [Molnar, Justin; Yazaki, Paul] Beckman Res Inst City Hope, Dept Mol Imaging & Therapy, Los Angeles, CA USA; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; City of Hope; Beckman Research Institute of City of Hope; Anti Cancer Inc	Bouvet, M (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.; Bouvet, M (corresponding author), Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA.; Bouvet, M (corresponding author), VA San Diego Healthcare Syst, Dept Surg, San Diego, CA 92161 USA.	mbouvet@uscd.edu		Hollandsworth, Hannah/0000-0002-8867-6835	VA [1 I01 BX003856-01A1, 1 I01 BX004494-01]; NIH/NCI [T32CA121938]	VA(US Department of Veterans Affairs); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported by VA Merit Review grant numbers 1 I01 BX003856-01A1 and 1 I01 BX004494-01 (MB), and NIH/NCI grant number T32CA121938 (HH). The funder provided support in the form of salaries for authors [HH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Hoffman is affiliated with the commercial company AntiCancer Inc. This commercial affiliation did not provide salaries for any authors and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Amri R, 2015, JAMA SURG, V150, P890, DOI 10.1001/jamasurg.2015.1525; Boudreau V, 2009, PAC REV, V22, P233, DOI 10.1080/09512740902815359; DeLong JC, 2017, J SURG RES, V218, P139, DOI 10.1016/j.jss.2017.05.069; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hiroshima Y, 2015, ANN SURG ONCOL, V22, pS1469, DOI 10.1245/s10434-015-4553-9; Hoffman RM, 2017, MEMORIAM J RYGAARD 1, P16; Jang Eun Jung, 2011, J Korean Soc Coloproctol, V27, P194, DOI 10.3393/jksc.2011.27.4.194; Kobayashi H, 2020, BIOCONJUGATE CHEM, V31, P28, DOI 10.1021/acs.bioconjchem.9b00546; Kobayashi H, 2019, ACCOUNTS CHEM RES, V52, P2332, DOI 10.1021/acs.accounts.9b00273; Maawy AA, 2015, J SURG RES, V197, P5, DOI 10.1016/j.jss.2015.02.037; Maawy AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121989; Ogata F, 2017, ONCOTARGET, V8, P35069, DOI 10.18632/oncotarget.17047; Ogawa M, 2017, ONCOTARGET, V8, P10425, DOI 10.18632/oncotarget.14425; Sato K, 2015, ONCOTARGET, V6, P19747, DOI 10.18632/oncotarget.3850; Sato K, 2015, MOL CANCER THER, V14, P141, DOI 10.1158/1535-7163.MCT-14-0658; Tiernan JP, 2013, BRIT J CANCER, V108, P662, DOI 10.1038/bjc.2012.605; Yazaki PJ, 2004, PROTEIN ENG DES SEL, V17, P481, DOI 10.1093/protein/gzh056; Zare-Bandamiri Mohammad, 2017, Asian Pac J Cancer Prev, V18, P2465	18	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234643	10.1371/journal.pone.0234643	http://dx.doi.org/10.1371/journal.pone.0234643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555717	Green Published, gold			2022-12-27	WOS:000543273200028
J	Childs, RD; Nakao, H; Isogai, N; Murthy, A; Landis, WJ				Childs, Robin DiFeo; Nakao, Hitomi; Isogai, Noritaka; Murthy, Ananth; Landis, William J.			An analytical study of neocartilage from microtia and otoplasty surgical remnants: A possible application for BMP7 in microtia development and regeneration	PLOS ONE			English	Article							AURICULAR RECONSTRUCTION; STEM-CELL; GENE-EXPRESSION; IN-VITRO; EAR RECONSTRUCTION; CONTROLLED-RELEASE; DONOR SOURCE; CARTILAGE; TISSUE; CHONDROCYTES	To investigate auricular reconstruction by tissue engineering means, this study compared cartilage regenerated from human chondrocytes obtained from either microtia or normal (conchal) tissues discarded from otoplasties. Isolated cells were expanded in vitro, seeded onto nanopolyglycolic acid (nanoPGA) sheets with or without addition of bone morphogenetic protein-7 (BMP7), and implanted in nude mice for 10 weeks. On specimen harvest, cartilage development was assessed by gross morphology, histology, and RT-qPCR and microarray analyses. Neocartilages from normal and microtia surgical tissues were found equivalent in their dimensions, qualitative degree of proteoglycan and elastic fiber staining, and quantitative gene expression levels of types II and III collagen, elastin, and SOX5. Microarray analysis, applied for the first time for normal and microtia neocartilage comparison, yielded no genes that were statistically significantly different in expression between these two sample groups. These results support use of microtia tissue as a cell source for normal auricular reconstruction. Comparison of normal and microtia cells, each seeded on nanoPGA and supplemented with BMP7 in a slow-release hydrogel, showed statistically significant differences in certain genes identified by microarray analysis. Such differences were also noted in several analyses comparing counterpart seeded cells without BMP7. Summary data suggest a possible application for BMP7 in microtia cartilage regeneration and encourage further studies to elucidate whether such genotypic differences translate to phenotypic characteristics of the human microtic ear. The present work advances understanding relevant to the potential clinical use of microtia surgical remnants as a suitable cell source for tissue engineering of the pinna.	[Childs, Robin DiFeo; Landis, William J.] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA; [Childs, Robin DiFeo; Murthy, Ananth] Childrens Hosp Med Ctr, Div Plast & Reconstruct Surg, Akron, OH USA; [Nakao, Hitomi; Isogai, Noritaka] Kindai Univ, Dept Plast & Reconstruct Surg, Med Sch, Osakasayama, Osaka, Japan	University System of Ohio; University of Akron	Landis, WJ (corresponding author), Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.	wlandis@uakron.edu			Children's Hospital Medical Center of Akron, OH	Children's Hospital Medical Center of Akron, OH	Foundation grant from Children's Hospital Medical Center of Akron, OH, (Research grant to A. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasti F, 2009, J MED GENET, V46, P361, DOI 10.1136/jmg.2008.062158; Ali K, 2017, SEMIN PLAST SURG, V31, DOI 10.1055/s-0037-1604261; Bichara DA, 2012, TISSUE ENG PART B-RE, V18, P51, DOI [10.1089/ten.teb.2011.0326, 10.1089/ten.TEB.2011.0326]; bin Ishak MF, 2015, INT J PEDIATR OTORHI, V79, P1634, DOI 10.1016/j.ijporl.2015.06.034; Brent B, 2002, CLIN PLAST SURG, V29, P257, DOI 10.1016/S0094-1298(01)00013-X; Brown KK, 2013, HUM MUTAT, V34, P1347, DOI 10.1002/humu.22367; Cabin JA, 2014, FACIAL PLAST SURG CL, V22, P623, DOI 10.1016/j.fsc.2014.07.004; Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Cohen BP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202356; Cox TC, 2014, EUR J MED GENET, V57, P394, DOI 10.1016/j.ejmg.2014.05.003; Dexheimer V, 2016, SCI REP-UK, V6, DOI 10.1038/srep36655; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Flechtenmacher J, 1996, ARTHRITIS RHEUM-US, V39, P1896, DOI 10.1002/art.1780391117; Groves AK, 2000, DEVELOPMENT, V127, P3489; Haisch A, 2010, ADV OTO-RHINO-LARYNG, V68, P108, DOI 10.1159/000314566; Ishak MF, 2011, INT J PEDIATR OTORHI, V75, P835, DOI 10.1016/j.ijporl.2011.03.021; Jessop ZM, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0273-0; Johnson JS, 2015, J BONE JOINT SURG AM, V97A, P71, DOI 10.2106/JBJS.N.00246; Kamil SH, 2004, LARYNGOSCOPE, V114, P2187, DOI 10.1097/01.mlg.0000149455.68135.de; Kim HY, 2019, LARYNGOSCOPE, V129, P351, DOI 10.1002/lary.27344; Klagsbrun M, 1979, Methods Enzymol, V58, P560; Kobayashi S, 2011, P NATL ACAD SCI USA, V108, P14479, DOI 10.1073/pnas.1109767108; Kolios G, 2013, RESPIRATION, V85, P3, DOI 10.1159/000345615; Krause HM, 2018, TRENDS GENET, V34, P736, DOI 10.1016/j.tig.2018.06.005; Kusuhara H, 2009, WOUND REPAIR REGEN, V17, P136, DOI 10.1111/j.1524-475X.2008.00451.x; Landis WJ, 2017, J TISSUE ENG REGEN M, V11, P2373, DOI 10.1002/term.2137; Lewin S, 2015, FACIAL PLAST SURG, V31, P617, DOI 10.1055/s-0035-1567890; Luquetti DV, 2012, AM J MED GENET A, V158A, P124, DOI 10.1002/ajmg.a.34352; Luquetti DV, 2011, BIRTH DEFECTS RES A, V91, P813, DOI 10.1002/bdra.20836; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708; Melgarejo-Ramirez Y, 2016, CELL TISSUE BANK, V17, P481, DOI 10.1007/s10561-016-9574-5; Miao Y, 2017, ONCOTARGET, V8, P83114, DOI 10.18632/oncotarget.20851; Minoux M, 2013, DEVELOPMENT, V140, P4386, DOI 10.1242/dev.098046; Mussi E, 2019, BIOENGINEERING-BASEL, V6, DOI 10.3390/bioengineering6010014; Nakao H, 2017, PLAST RECONSTR SURG, V139, DOI 10.1097/PRS.0000000000003201; Nayyer L, 2012, PLAST RECONSTR SURG, V129, P1123, DOI 10.1097/PRS.0b013e31824a2c1c; Odabas S, 2013, J TISSUE ENG REGEN M, V7, P831, DOI 10.1002/term.1634; Otto IA, 2018, EUR CELLS MATER, V35, P132, DOI 10.22203/eCM.v035a10; OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x; Park C, 2010, CURR OPIN OTOLARYNGO, V18, P544, DOI 10.1097/MOO.0b013e32833fecb9; Patel KH, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413516782; Qiao RM, 2015, DIS MODEL MECH, V8, P611, DOI 10.1242/dmm.018291; Rafiee A, 2018, BIOTECHNOL GENET ENG, V34, P153, DOI 10.1080/02648725.2018.1471566; Reighard Chelsea L, 2018, J 3D Print Med, V2, P35, DOI 10.2217/3dp-2017-0017; Sabbagh W, 2011, J PLAST RECONSTR AES, V64, P452, DOI 10.1016/j.bjps.2010.07.027; Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, 10.1089/ten.TEB.2012.0138]; Scarfi S, 2016, WORLD J STEM CELLS, V8, P1, DOI 10.4252/wjsc.v8.i1.1; Schiavi J, 2015, NANOMEDICINE-UK, V10, P753, DOI [10.2217/NNM.14.228, 10.2217/nnm.14.228]; Seifert A, 2015, WORLD J STEM CELLS, V7, P583, DOI 10.4252/wjsc.v7.i3.583; Shah CA, 2012, J BIOL CHEM, V287, P18230, DOI 10.1074/jbc.M111.328401; Shasti M, 2014, INT J PEDIATR OTORHI, V78, P416, DOI 10.1016/j.ijporl.2013.11.028; Siegert R, 2009, FACIAL PLAST SURG, V25, P149, DOI 10.1055/s-0029-1239451; Sivayoham E, 2012, CURR OPIN OTOLARYNGO, V20, P287, DOI 10.1097/MOO.0b013e328355b1d9; Sterodimas A, 2009, J PLAST RECONSTR AES, V62, P447, DOI 10.1016/j.bjps.2008.11.046; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wang H, 2016, EUR SPINE J, V25, P2691, DOI 10.1007/s00586-016-4522-4; Wilkes GH, 2014, PLAST RECONSTR SURG, V134, p464E, DOI 10.1097/PRS.0000000000000526; Xue K, 2016, AM J TRANSL RES, V8, P732; Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5; Yanaga H, 2012, TISSUE ENG PT A, V18, P2020, DOI [10.1089/ten.tea.2011.0370, 10.1089/ten.TEA.2011.0370]; Zhang Q, 2009, PLAST RECONSTR SURG, V123, P849, DOI 10.1097/PRS.0b013e318199f057; Zhou GD, 2018, EBIOMEDICINE, V28, P287, DOI 10.1016/j.ebiom.2018.01.011	63	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234650	10.1371/journal.pone.0234650	http://dx.doi.org/10.1371/journal.pone.0234650			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555733	Green Published, gold			2022-12-27	WOS:000542759600048
J	Gutierrez, IGC; Martin, RM; Argent, JS				Garcia-Camacha Gutierrez, Irene; Martin Martin, Raul; Sanz Argent, Josep			Optimal-robust selection of a fuel surrogate for homogeneous charge compression ignition modeling	PLOS ONE			English	Article							AUTO-IGNITION; N-HEPTANE/TOLUENE; HCCI COMBUSTION; GASOLINE FUELS; JET FUEL; DIESEL; OXIDATION; METHODOLOGY; FORMULATION; MECHANISM	Homogeneous Charge Compression Ignition (HCCI) combustion is a potential candidate for dealing with the stringent regulations on vehicle emissions while still providing very good energy efficiency. Despite the promising results obtained in preliminary studies, the lack of autoignition control has delayed its launch in the engine industry. In the development of the HCCI concept, the availability of reliable computer models has proved extremely valuable, due to their flexibility and lower cost compared with experiments using real engines. In order to obtain the best formulation of a fuel surrogate formulated with n-heptane, toluene and cyclohexane that efficiently estimate the autoignition behaviour, regression adjustments are made to the Root-Mean-Square Errors (RMSE) of experimental Starts of Combustion (SOC) from the modeled SOC. The canonical form of the Scheffe polynomials is widely used to fit the data from mixture experiments, however the experimenter might have only partial knowledge. In this paper we present the adaptation of the robust methodology for possibly misspecified blending model and an algorithm to obtain tailor-made optimal designs for mixture experiments, instead of using standard designs which are indiscriminately employed, to make good estimations of the parameters blending model. We maximize the determinant of the mean squared error matrix of the least square estimator over a realistic neighbourhood of the fitted regression mixture model. The maximized determinant is then minimized over the class of possible designs, yielding an optimal design. Thus, the computed desings are robust to the exact form of the true blending model. Standard mixture designs, as the simplex lattice, are around 25% efficient for estimation purposes compared with the designs obtained in this work when deviances from the considered model occur during the experiments. Once an optimal-robust design was selected (based on the level of certainty about model adequacy), we computed the optimal mixture that best reproduces the combustion property to be imitated. Optimal mixtures obtained when the considered model is inadequate agree with the results achieved in empirical studies, which validates the methodology proposed in this work.	[Garcia-Camacha Gutierrez, Irene; Martin Martin, Raul] Univ Castilla La Mancha, Inst Appl Math Sci & Engn IMACI, Toledo, Spain; [Sanz Argent, Josep] Fdn Valenciaport, Valencia, Spain	Universidad de Castilla-La Mancha	Martin, RM (corresponding author), Univ Castilla La Mancha, Inst Appl Math Sci & Engn IMACI, Toledo, Spain.	Raul.MMartin@uclm.es	Gutiérrez, Irene García-Camacha/F-5474-2016; Martín, Raúl Martín/F-2331-2016	Gutiérrez, Irene García-Camacha/0000-0003-3296-056X; Martín, Raúl Martín/0000-0001-9237-9238	Ministerio de Economia, Industria y Competitividad - Agencia Estatal de Investigacion FEDER [MTM2016-80539-C2-1-R]; Junta de Comunidades de Castilla-La Mancha through Fondo Europeo de Desarrollo Regional [SBPLY/17/180501/000380]	Ministerio de Economia, Industria y Competitividad - Agencia Estatal de Investigacion FEDER; Junta de Comunidades de Castilla-La Mancha through Fondo Europeo de Desarrollo Regional(Junta de Comunidades de Castilla-La Mancha)	I. Garcia-Camacha Gutierrez and R. Martin Martin were sponsored by the Ministerio de Economia, Industria y Competitividad - Agencia Estatal de Investigacion FEDER (MTM2016-80539-C2-1-R) and Junta de Comunidades de Castilla-La Mancha through Fondo Europeo de Desarrollo Regional (SBPLY/17/180501/000380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves SM, 2001, SAE TECHNICAL PAPER; Andrae J, 2005, COMBUST FLAME, V140, P267, DOI 10.1016/j.combustflame.2004.11.009; Benajes JV, 2008, EXP TECHNIQUES, V32, P41, DOI 10.1111/j.1747-1567.2007.00296.x; Bounaceur R, 2005, INT J CHEM KINET, V37, P25, DOI 10.1002/kin.20047; Buda F, 2006, ENERG FUEL, V20, P1450, DOI 10.1021/ef060090e; Caton PA, 2003, INT J ENGINE RES, V4, P163, DOI [10.1243/146808703322223306, DOI 10.1243/146808703322223306]; Chen LF, 2015, FUEL, V154, P252, DOI 10.1016/j.fuel.2015.03.081; Curran H.J., 2001, SAE Technical Paper 2001-01-0653; Curran HJ, 1998, COMBUST FLAME, V114, P149, DOI 10.1016/S0010-2180(97)00282-4; Daemi M, 2013, CAN J STAT, V41, P679, DOI 10.1002/cjs.11194; Dagaut P, 2002, PHYS CHEM CHEM PHYS, V4, P1846, DOI 10.1039/b110282f; Fathi M, 2011, APPL ENERG, V88, P4719, DOI 10.1016/j.apenergy.2011.06.017; Granata S, 2003, COMBUST FLAME, V132, P533, DOI 10.1016/S0010-2180(02)00465-0; Hasan MM, 2016, RENEW SUST ENERG REV, V57, P282, DOI 10.1016/j.rser.2015.12.157; Hasegawa R., 2003, SAE TECHNICAL PAPER; Hernandez JJ, 2008, FUEL, V87, P655, DOI 10.1016/j.fuel.2007.05.019; Hernandez JJ, 2010, FUEL, V89, P2561, DOI 10.1016/j.fuel.2009.11.014; Hernandez JJ, 2014, FUEL, V133, P283, DOI 10.1016/j.fuel.2014.05.029; Huang Z, 2018, FUEL, V234, P1259, DOI 10.1016/j.fuel.2018.07.138; Huber J, 2010, TEACH LEARN INDIG IN, P287; Iqbal Sherazi H., 2011, 2011 17th International Conference on Automation and Computing, P315; Jia M, 2006, FUEL, V85, P2593, DOI 10.1016/j.fuel.2006.02.018; Josep SA, 2010, ANALISIS CINETICO QU; Kee RJ, 2004, CHEMKIN RELEASE 4 0; Komninos NP, 2012, RENEW SUST ENERG REV, V16, P1588, DOI 10.1016/j.rser.2011.11.026; Najt PM, 1983, COMPRESSION IGNITED, DOI [10.4271/830264., DOI 10.4271/830264, 10.4271/830264]; Noel L, 2004, SAE TECHNICAL PAPER; Perez PL, 2014, ENERG FUEL, V28, P3377, DOI 10.1021/ef302106m; Perez PL, 2012, ENERG FUEL, V26, P6106, DOI 10.1021/ef300503b; Pitz W, 2001, CHEM KINETIC STUDY T; SCHEFFE H, 1963, J ROY STAT SOC B, V25, P235; SCHEFFE H, 1958, J ROY STAT SOC B, V20, P344; Silke EJ, 2007, J PHYS CHEM A, V111, P3761, DOI 10.1021/jp067592d; Szymkowicz PG, 2018, FUEL, V226, P286, DOI 10.1016/j.fuel.2018.03.157; Szymkowicz PG, 2018, FUEL, V222, P21, DOI 10.1016/j.fuel.2018.01.112; Westbrook CK, 2009, COMBUST FLAME, V156, P181, DOI 10.1016/j.combustflame.2008.07.014; WIENS DP, 1992, J STAT PLAN INFER, V31, P353, DOI 10.1016/0378-3758(92)90142-F; Wiens DP, CANADIAN J STAT, V21, P59; Xu QH, 2017, FUEL, V210, P262, DOI 10.1016/j.fuel.2017.08.055; Yamaoka S., 2005, SAE TECHNICAL PAPER; Yu J, 2016, FUEL, V166, P211, DOI 10.1016/j.fuel.2015.10.085; Yu WB, 2018, FUEL, V231, P361, DOI 10.1016/j.fuel.2018.05.121	43	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234963	10.1371/journal.pone.0234963	http://dx.doi.org/10.1371/journal.pone.0234963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584832	gold, Green Published			2022-12-27	WOS:000545747200017
J	Nega, D; Abebe, A; Abera, A; Gidey, B; Tsadik, AG; Tasew, G				Nega, Desalegn; Abebe, Abnet; Abera, Adugna; Gidey, Bokretsion; Tsadik, G. Abeba; Tasew, Geremew			Comprehensive competency assessment of malaria microscopists and laboratory diagnostic service capacity in districts stratified for malaria elimination in Ethiopia	PLOS ONE			English	Article							EXTERNAL QUALITY ASSESSMENT; HEALTH	Background Federal Ministry of Health (FMoH) Ethiopia achieved significant declines in malaria mortality and incidence and has recently launched malaria elimination in selected low transmission settings. Successful malaria elimination calls for rapid and accurate diagnosis of cases so that the patients can promptly be treated before the occurrence of transmission. Therefore, this study assessed the competency of malaria microscopists using panal slides, and laboratory service availability and readiness in terms of supplies and equipments in malaria elimination targeted districts in Ethiopia. Method A cross-sectional study was conducted from February to June 2018 in all hospitals, health centers and private clinics in 20 malaria elimination targeted districts, selected out of the 6 regional states in Ethiopia. All malaria microscopists available in the study health facilities during the study period were included in the study. Questionnaires were used for interviewing sociodemography of personnel and laboratory supplies. Per World Health Organization (WHO) criteria set for proficiency testing, 10 Giemsa stained malaria slide panels (8 positive low/high density pf/pv/Mixed and 2 negative slides) were administered to each study participant for performance assessment on malaria parasite detection, species identification and parasite count using light microscopy. The slide panels are PCR confirmed and WHO approved ones, which have been stored in the slide banks at the national reference laboratory in Ethiopian Public Health Institute. Result In this assessment, 17(16%) district hospitals, 71(67%) health centers (HCs) and 18(17%) private clinics (PCs) were included. Of the 18 PCs, only 10(55.6%) had license certificate. Of the study facilities, 91.5%(97) use light microscopy, 2.83%(3) use RDTs and 2.9%(3) use both microscopy and RDT to detect malaria. Accessible and appropriate storage of Giemsa was reported by 58.8%(10) hospitals, 81.7%(58) HCs & 72.2%(13) private clinics. Of the 1896 malaria positive & 474 negative slides administered to 237 study participants, 318(16.8%) slides reported falsely negative & 47(9.9%) reported falsely positive. The participants achieved "good"grade [Agreement(A): 84.6%, Kappa(K): 0.6] on parasite detection and "poor"agreement (A: 43.8%; K: 0.11) on every species identification. No or slight agreement seen on differentiation ofP.falciparumfrom other species (A: 28.41%; K:0.29). Above 95%(201) of participants, did not count or used plus system of parasite estimation which is the least accurate and unreccomended method per WHO guideline. Conclusion In the current study, low performance of malaria microscopists particularly in species identification & poor to moderate capacity of laboratories observed. This is really a great obstacle to malaria elimination strategy of the country. Therefore, national malaria control and elimination program in collaboration with partners is supposed to provide comprehensive training for professionals giving laboratory service and to fulfill laboratory supplies to have the gold standard service.	[Nega, Desalegn; Abebe, Abnet; Abera, Adugna; Gidey, Bokretsion; Tsadik, G. Abeba; Tasew, Geremew] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia		Nega, D; Abebe, A (corresponding author), Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.	abnetabas@gmail.com; desalegn24@gmail.com	Reda, Abeba/GNO-9848-2022	Tasew, Geremew/0000-0002-2797-824X; Abebe, Abnet/0000-0002-8539-9131	IFCC FOUNDATION FOR EMERGING NATIONS	IFCC FOUNDATION FOR EMERGING NATIONS	Desalegn Nega; IFCC FOUNDATION FOR EMERGING NATIONS; http://www.ifccfoundation.org/; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe Abnet, 2017, Malariaworld J, V8, P6; Alemu Megbaru, 2017, J Parasitol Res, V2017, P9064917, DOI 10.1155/2017/9064917; [Anonymous], 2009, MAL MICR QUAL ASS MA; [Anonymous], 2011, ANN REV M REP; Ayalew Freshwork, 2014, BMC Res Notes, V7, P839, DOI 10.1186/1756-0500-7-839; Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Bereket Z, 2015, CLIN MED RES, V4, P63; Birx D, 2009, AM J CLIN PATHOL, V131, P849, DOI 10.1309/AJCPGH89QDSWFONS; Deress Teshiwal, 2019, Malar Res Treat, V2019, P7065064, DOI 10.1155/2019/7065064; DOWLING M A C, 1951, Bull World Health Organ, V4, P443; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365; Feachem RGA, 2009, SHRINKING MALARIA MA, P187; FMOH, 2016, ETH NAT MAL EL ROADM; FMoH, 2014, NAT MAL STRAT PLAN 2; Haditsch M, 2004, Travel Med Infect Dis, V2, P149, DOI 10.1016/j.tmaid.2004.03.001; HUMBER JY, 1975, APPL MICROBIOL, V30, P755, DOI 10.1128/AEM.30.5.755-758.1975; Jemere KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203420; Kassahun Mitiku, 2003, Ethiopian Journal of Health Development, V17, P197; Kettelhut MM, 2003, J CLIN PATHOL, V56, P927, DOI 10.1136/jcp.56.12.927; MILNE LM, 1994, J CLIN PATHOL, V47, P740, DOI 10.1136/jcp.47.8.740; Mukadi P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-308; Nathan AJ, 2012, FOREIGN AFF, V91, P459, DOI 10.1017/CBO9781107415324.004; Ngasala B, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2998-1; NIH Public Access Author Manuscript, 2011, J PHYS ACT HLTH, V8, pS257; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; President's Malaria Initiative, 2019, MAL OP PLAN FY 2019; Sim J, 2005, PHYS THER, V85, P257; Tegegne B, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05077-5; Thomson S, 2000, ARCH PATHOL LAB MED, V124, P57; Wilson ML, 2012, CLIN INFECT DIS, V54, P1637, DOI 10.1093/cid/cis228; World Health Organization, 2016, MAL MICR QUAL ASS MA; World Health Organization, 2002, BENCH AIDS DIAGN MAL; 2009, ALC INJ EM DEPT, P1	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235151	10.1371/journal.pone.0235151	http://dx.doi.org/10.1371/journal.pone.0235151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584866	gold, Green Published			2022-12-27	WOS:000545747200092
J	Osei, E; Oppong, S; Der, J				Osei, Eric; Oppong, Samuel; Der, Joyce			Trends of tuberculosis case detection, mortality and co-infection with HIV in Ghana: A retrospective cohort study	PLOS ONE			English	Article							INFECTION; DIAGNOSIS; AFRICA; DEATH; RISK	Background In an era of renewed commitment to accelerate the declines in Tuberculosis (TB) incidence and mortality, there is the need for National Tuberculosis Programmes (NTPs) to monitor trends in key indicators across a geographical location and to provide reliable data for direct measurement of TB incidence and mortality. In this context, we explored the trends of TB case detection, mortality and HIV co-infection, and examined the predictors of TB deaths in Ten districts of the Volta region of Ghana. Methods We conducted a retrospective cohort study of all TB cases registered from 2013 to 2017 in 10 districts of the Volta Region of Ghana. Case detection rate (CDR) was computed as the ratio of the number of new and relapse TB case notified to NTP to the number of estimated incident TB cases in a given year. Case fatality rates were estimated using data from 2012-2016 cohort of TB patients. Simple and multiple logistic regression were used to identify predictors of TB deaths with odds ratios and 95% confidence intervals estimated. Results Overall, there were 3,735 new and relapse TB patients who commenced anti-TB treatment during the period, representing the case detection rate of 40.1% with district variations. The CDR remained stable during the 5 years. Of the total cases, HIV status was documented for 3,144 (84.2%), among whom, 712 (22.6%) were HIV positive. The TB/HIV co-infection was more prevalent among children under 15 years of age (30.1%), males (30.6%), treatment after lost to follow-up patients (33.3%), and smear-negative pulmonary TB patients (29.1%). The prevalence of TB/HIV co-infection did not significantly change over the years. The overall case fatality rate was 13% (n = 486), with considerable variation among HIV-positives and HIV-negative TB patients (21.8% and 11% respectively) (p<0.001) and among districts. TB/HIV co-infection, sputum smear-negative pulmonary TB and district of anti-TB treatment predicted TB mortality. Conclusion TB case detection rate was low and remained stable during the study period, whereas co-infection with HIV and mortality rates were quite high, indicating the need for feasible strategies such as active case finding to improve case detection, and improved case management to reduce mortality.	[Osei, Eric] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Populat & Behav Sci, Ho, Ghana; [Osei, Eric] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea; [Oppong, Samuel; Der, Joyce] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Ho, Ghana	Yonsei University	Osei, E (corresponding author), Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Populat & Behav Sci, Ho, Ghana.; Osei, E (corresponding author), Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea.	eosei@uhas.edu.gh		OSEI, ERIC/0000-0001-6567-1591				Addo KK, 2018, J TUBERC RES, V6, P135; Afoakwa E, 2018, S SUDAN MED J, V11; ALLEN S, 1992, AM REV RESPIR DIS, V146, P1439, DOI 10.1164/ajrccm/146.6.1439; Alobu I, 2014, ASIAN PAC J TROP MED, V7, P977, DOI 10.1016/S1995-7645(14)60172-3; Amenuvegbe Gregory K, 2016, BMC Res Notes, V9, P330, DOI 10.1186/s13104-016-2136-x; Amo-Adjei J, 2013, ARCH PUBLIC HEALTH, V71, DOI 10.1186/2049-3258-71-22; [Anonymous], 2014, KULTURPOETIK, V14, P5; [Anonymous], 2012, GLOB TUB REP 2012; Asgedom Solomon Weldegebreal, 2018, BMC Res Notes, V11, P696, DOI 10.1186/s13104-018-3806-7; Badri M, 2001, AIDS, V15, P1143, DOI 10.1097/00002030-200106150-00009; Basinga P, 2007, MED DECIS MAKING, V27, P53, DOI 10.1177/0272989X06297104; de Almeida CPB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25409-5; Fox GJ, 2018, NEW ENGL J MED, V378, P221, DOI 10.1056/NEJMoa1700209; Gao JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064915; Getahun B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-127; Ghana Statistical Service, 2014, GHANA DEMOGRAPHIC HL; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Heunis JC, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3972-2; Holland DP, 2009, PHARMACOTHERAPY, V29, P503, DOI 10.1592/phco.29.5.503; Horne DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-258; Indian National Tuberculosis Control Programme, 2017, NAT STRAT PLAN TUB E; Karo B, 2016, AIDS, V30, P1089, DOI 10.1097/QAD.0000000000001016; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Lung T, 2019, LANCET GLOB HEALTH, V7, pE376, DOI 10.1016/S2214-109X(18)30520-5; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Mhimbira F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005342; Obasanya J, 2015, TROP MED INT HEALTH, V20, P1396, DOI 10.1111/tmi.12558; Ohene SA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2843-5; Osei E, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2598-z; Osei E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1922-z; Pepper DJ, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0076-5; Russell GK, 2013, INT J TUBERC LUNG D, V17, P1518, DOI 10.5588/ijtld.13.0238; Santos L. C., 2012, OPEN J MED MICROBIOL, V2, P24, DOI DOI 10.4236/ojmm.2012.21004; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; Sterling TR, 2010, CLIN INFECT DIS, V50, pS223, DOI 10.1086/651495; Takarinda Kudakwashe C, 2017, Tuberc Res Treat, V2017, P6232071, DOI 10.1155/2017/6232071; Tarekegne Daniel, 2016, BMC Res Notes, V9, P192, DOI 10.1186/s13104-016-2004-8; Teweldemedhin M, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3604-9; van der Werf MJ, 2016, AIDS, V30, P2845, DOI 10.1097/QAD.0000000000001252; Volta Regional Health Directorate, 2018, 2018 ANN TB RE UNPUB; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2019, GLOB TUB REP; World Health Organization, 2009, GUID CONTR PROPH HIV, DOI [10.1055/s-2001-17501, DOI 10.1055/S-2001-17501]; World Health Organization, GLOB TUB REP 2017; World Health Organization, DEF REP FRAM TUB 201; World Health Organization (WHO), 2013, WHOHTMTB20121; World Health Organization (WHO), A671114 WHO, pA67/11; World Health Organization (WHO), TUB CAS DET RAT; 2015, SEWAGE DISPOSAL CLOV, V15	51	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234878	10.1371/journal.pone.0234878	http://dx.doi.org/10.1371/journal.pone.0234878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579568	gold, Green Published			2022-12-27	WOS:000545646600013
J	Burchiel, SW; Lauer, FT; Factor-Litvak, P; Liu, XH; Islam, T; Eunus, M; Abu Horayara, M; Islam, MT; Rahman, M; Ahmed, A; Cremers, S; Nandakumar, R; Ahsan, H; Olopade, C; Graziano, J; Parvez, F				Burchiel, Scott W.; Lauer, Fredine T.; Factor-Litvak, Pam; Liu, Xinhua; Islam, Tariqul; Eunus, Mahbubul; Abu Horayara, M.; Islam, Md. Tariqul; Rahman, Mizanour; Ahmed, Alauddin; Cremers, Serge; Nandakumar, Renu; Ahsan, Habibul; Olopade, Christopher; Graziano, Joseph; Parvez, Faruque			Arsenic exposure associated T cell proliferation, smoking, and vitamin D in Bangladeshi men and women	PLOS ONE			English	Article							ENVIRONMENTALLY RELEVANT CONCENTRATIONS; CYTOKINE SECRETION; CHILDREN; THYMUS; INHIBITION; DEFICIENCY; ACTIVATION	There are limited data examining the consequences of environmental exposure to arsenic on the immune system in adults, particularly among smokers. Smoking has been shown to exacerbate or contribute to impaired immune function in men chronically exposed to arsenic. In contrast, vitamin D (VitD) is known to have a positive influence on innate and adaptive immune responses. The effect of circulating VitD on arsenic-associated immune dysfunction is not known. Here we examine the relationship of arsenic exposure and T cell proliferation (TCP), a measure of immune responsiveness, and circulating VitD among adult men and women in Bangladesh. Arsenic exposure was assessed using total urinary arsenic as well as urinary arsenic metabolites all adjusted for urinary creatinine. TCP was measuredex vivoin cryopreserved peripheral blood mononuclear cells from 614 adult participants enrolled in the Bangladesh Health Effects of Arsenic Longitudinal Study; serum VitD was also evaluated. The influence of cigarette smoking on arsenic-induced TCP modulation was assessed only in males as there was an inadequate number of female smokers. These studies show that arsenic suppressed TCP in males. The association was significantly strong in male smokers and to a lesser extent in male non-smokers. Interestingly, we found a strong protective effect of high/sufficient serum VitD levels on TCP among non-smoking males. Furthermore, among male smokers with low serum VitD ( square cup 20 ng/ml), we found a strong suppression of TCP by arsenic. On the other hand, high VitD (>20 ng/ml) was found to attenuate effects of arsenic on TCP among male-smokers. Overall, we found a strong protective effect of VitD, when serum levels were >20 ng/ml, on arsenic-induced inhibition of TCP in men, irrespective of smoking status. To our knowledge this is the first large study of immune function in healthy adult males and females with a history of chronic arsenic exposure.	[Burchiel, Scott W.; Lauer, Fredine T.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Factor-Litvak, Pam] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Liu, Xinhua] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Islam, Tariqul; Eunus, Mahbubul; Abu Horayara, M.; Islam, Md. Tariqul; Rahman, Mizanour; Ahmed, Alauddin] Univ Chicago & Columbia Univ Field Res Off, Dhaka, Bangladesh; [Cremers, Serge] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA; [Nandakumar, Renu] Columbia Univ, Irving Inst Clin & Translat Res, Med Ctr, New York, NY USA; [Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Olopade, Christopher] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Graziano, Joseph; Parvez, Faruque] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA	University of New Mexico; Columbia University; Columbia University; Columbia University; Columbia University; University of Chicago; University of Chicago; University of Chicago Medical Center; Columbia University	Burchiel, SW (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA.	sburchiel@salud.unm.edu		Burchiel, Scott/0000-0001-9509-0149	Arsenic Exposure, Impaired Respiratory Function & Immunosuppression [R01ES023888]; Synergistic Immunosuppression by PAHs Arsenite [R01ES019968]; Health Effects & Geochemistry of Arsenic [P42ES010349]; Perkin Elmer NexION 300 Inductively Coupled Mass Spectrometer [S10OD16384]; Center for Environmental Health in Northern Manhattan [P30ES009089]	Arsenic Exposure, Impaired Respiratory Function & Immunosuppression; Synergistic Immunosuppression by PAHs Arsenite; Health Effects & Geochemistry of Arsenic; Perkin Elmer NexION 300 Inductively Coupled Mass Spectrometer; Center for Environmental Health in Northern Manhattan	R01ES023888 (MFP) Arsenic Exposure, Impaired Respiratory Function & Immunosuppression R01ES019968 (SWB) Synergistic Immunosuppression by PAHs & Arsenite P42ES010349 (ANA) Health Effects & Geochemistry of Arsenic S10OD16384 (JG) Perkin Elmer NexION 300 Inductively Coupled Mass Spectrometer P30ES009089 (AB) Center for Environmental Health in Northern Manhattan	[Anonymous], 2017, NATL PROVISIONER, V231, P148; Aranow C, 2011, J INVEST MED, V59, P881, DOI 10.2310/JIM.0b013e31821b8755; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; Attreed Sarah E, 2017, Curr Environ Health Rep, V4, P229, DOI 10.1007/s40572-017-0141-4; Baeke F, 2010, J STEROID BIOCHEM, V121, P221, DOI 10.1016/j.jsbmb.2010.03.037; Biswas R, 2008, HUM EXP TOXICOL, V27, P381, DOI 10.1177/0960327108094607; Bozack AK, 2018, ANNU REV NUTR, V38, P401, DOI 10.1146/annurev-nutr-082117-051757; Brouwer-Brolsma EM, 2016, J STEROID BIOCHEM, V164, P168, DOI 10.1016/j.jsbmb.2015.08.008; Burchiel SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109192; da Silva RC, 2019, GENET MOL BIOL, V42, P351, DOI [10.1590/1678-4685-gmb-2017-0289, 10.1590/1678-4685-GMB-2017-0289]; Dangleben NL, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-73; Dankers W, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01504; Ding W, 2009, J BIOL CHEM, V284, P6809, DOI 10.1074/jbc.M805566200; Ezeh PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093920; Fleet JC, 2020, J STEROID BIOCHEM, V198, DOI 10.1016/j.jsbmb.2019.105557; Fukagawa NK, 2000, AM J CLIN NUTR, V72, P22; Gonzalez SM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222878; Hacihamdioglu DO, 2016, J CLIN RES PEDIATR E, V8, P325, DOI 10.4274/jcrpe.2563; He L, 2019, ISCIENCE, V17, P119, DOI 10.1016/j.isci.2019.06.026; Heinzel S, 2018, CURR OPIN IMMUNOL, V51, P32, DOI 10.1016/j.coi.2018.01.002; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Huhmann BL, 2019, ENVIRON INT, V125, P82, DOI 10.1016/j.envint.2019.01.026; Jeffery LE, 2012, J IMMUNOL, V189, P5155, DOI 10.4049/jimmunol.1200786; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; Lauer F. T., 2017, CURR PROTOC TOXICOL, V74, P18, DOI DOI 10.1002/CPTX.31; Lauer FT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220451; Lauer FT, 2019, CHANGES HUMAN PERIPH; Lee MT, 2018, BLOOD ADV, V2, P969, DOI 10.1182/bloodadvances.2017013979; Lemarie A, 2006, J IMMUNOL, V177, P3019, DOI 10.4049/jimmunol.177.5.3019; Li Q, 2010, TOXICOL APPL PHARM, V245, P344, DOI 10.1016/j.taap.2010.03.020; Lu M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00477; Murdaca G, 2019, AUTOIMMUN REV, V18, DOI 10.1016/j.autrev.2019.102350; Muyayalo KP, 2019, AM J REPROD IMMUNOL, V82, DOI 10.1111/aji.13168; Nadeau KC, 2014, CLIN IMMUNOL, V155, P188, DOI 10.1016/j.clim.2014.09.004; Naujokas MF, 2013, ENVIRON HEALTH PERSP, V121, P295, DOI 10.1289/ehp.1205875; Nygaard UC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179606; O TM, 2018, OTOLARYNGOL CLIN N A, V51, pxvii; Palmeri NO, 2018, ANN NONINVAS ELECTRO, V23, DOI 10.1111/anec.12496; Parvez F, 2019, J IMMUNOTOXICOL, V16, P201, DOI 10.1080/1547691X.2019.1657993; Parvez F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216662; Qin XJ, 2012, TOXICOL SCI, V127, P120, DOI 10.1093/toxsci/kfs099; Rahman A, 2011, ENVIRON HEALTH PERSP, V119, P719, DOI 10.1289/ehp.1002265; Soto-Pena GA, 2006, FASEB J, V20, P779, DOI 10.1096/fj.05-4860fje; Sun X, 2014, TOXICOL APPL PHARM, V274, P313, DOI 10.1016/j.taap.2013.11.010; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Wang F, 2017, ENDOCRINOLOGY, V158, P1951, DOI 10.1210/en.2016-1913; Xu H, 2017, TOXICOL LETT, V279, P60, DOI 10.1016/j.toxlet.2017.07.897; Xu H, 2016, TOXICOL SCI, V154, P153, DOI 10.1093/toxsci/kfw151; Xu H, 2016, TOXICOL LETT, V262, P55, DOI 10.1016/j.toxlet.2016.09.008; Xu H, 2016, TOXICOL LETT, V247, P62, DOI 10.1016/j.toxlet.2016.02.014; Yang LN, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0458-8; Zhou XX, 2015, J BIOL CHEM, V290, P18361, DOI 10.1074/jbc.M115.663906	53	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234965	10.1371/journal.pone.0234965	http://dx.doi.org/10.1371/journal.pone.0234965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574193	Green Published, gold			2022-12-27	WOS:000544972400025
J	Sugiyama, A; Matsuoka, T; Sakamune, K; Akita, T; Makita, R; Kimura, S; Kuroiwa, Y; Nagao, M; Tanaka, J				Sugiyama, Aya; Matsuoka, Toshihiko; Sakamune, Kazuaki; Akita, Tomoyuki; Makita, Ryosuke; Kimura, Shinsuke; Kuroiwa, Yukio; Nagao, Masataka; Tanaka, Junko			The Tokyo subway sarin attack has long-term effects on survivors: A 10-year study started 5 years after the terrorist incident	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; EVENT SCALE; VICTIMS; SYMPTOMS; PREVALENCE; EXPOSURE; IMPACT; JAPAN	Objectives The Tokyo subway sarin attack in 1995 was an unprecedented act of terrorism that killed 13 people and sickened more than 6,000. The long-term somatic and psychological effects on its victims remain unknown. Methods We conducted analyses on the self-rating questionnaire collected annually by the Recovery Support Center (RSC) during the period from 2000 to 2009. The RSC is the only organization that has large-scale follow-up data about sarin attack victims. The prevalence of self-reported symptoms was calculated over 10 years. We also evaluated the prevalence of posttraumatic stress response (PTSR), defined as a score >= 25 on the Japanese-language version of the Impact of Event Scale-Revised. The multivariate Poisson regression model was applied to estimate the risk ratios of age, gender, and year factor on the prevalence of PTSR. Results Subjects were 747 survivors (12% of the total) who responded to the annual questionnaire once or more during the study period. The prevalence of somatic symptoms, especially eye symptoms, was 60-80% and has not decreased. PTSR prevalence was 35.1%, and again there was no change with time. The multivariate Poisson regression model results revealed "old age" and "female" as independent risk factors, but the passage of time did not decrease the risk of PTSR. Conclusions Although symptoms in most victims of the Tokyo subway sarin were transient, this large-scale follow-up data analysis revealed that survivors have been suffering from somatic and psychological long-term effects.	[Sugiyama, Aya; Matsuoka, Toshihiko; Sakamune, Kazuaki; Akita, Tomoyuki; Tanaka, Junko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan; [Makita, Ryosuke; Nagao, Masataka] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Forens Med, Hiroshima, Japan; [Kimura, Shinsuke; Kuroiwa, Yukio] Nonprofit Org NPO Recovery Support Ctr, Tokyo, Japan	Hiroshima University; Hiroshima University	Tanaka, J (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan.	jun-tanaka@hiroshima-u.ac.jp	Tanaka, Junko/G-6166-2019	Tanaka, Junko/0000-0002-5669-4051				[Anonymous], 2016, AIPJ, V27, P88; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Himuro K, 1998, NEUROLOGY, V51, P1195, DOI 10.1212/WNL.51.4.1195; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Iwasa M, 2012, J EYE, V29, P1435; Kadokura M, 2000, JAPANESE J CLIN PSYC, V29, P677; Kato T, 1996, AM J OPHTHALMOL, V121, P209, DOI 10.1016/S0002-9394(14)70587-2; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kawakami N, 2004, PSYCHIAT RES, V121, P293, DOI 10.1016/S0165-1781(03)00239-7; Kawakami N, 2014, J PSYCHIATR RES, V53, P157, DOI 10.1016/j.jpsychires.2014.01.015; Kawana N, 2005, TRAUMATOLOGY, V11, P87, DOI [10.1177/153476560501100204, DOI 10.1177/153476560501100204]; Kinoshita H, 2012, JAPANESE J CLIN PSYC, V41, P1293; Maekawa K, 1996, IGAKU NO AYUMI, V177, P731; Ministry of Health Labour and Welfare Japan, 2011, COMPR SURV LIV COND; MORITA H, 1995, LANCET, V346, P290; Murata K, 1997, J NEUROL, V244, P601, DOI 10.1007/s004150050153; Nakamine S, 2018, J SOC CLIN PSYCHOL, V37, P794; Naoi K, 2009, JPN B SOCIAL PSYCHIA, V18, P52; National Research Institute of Police Science, 1995, KEIJIJIHOU, V54, P22; Ohbu S, 1997, SOUTHERN MED J, V90, P587, DOI 10.1097/00007611-199706000-00002; Ohtani T, 2004, PSYCHIAT CLIN NEUROS, V58, P624, DOI 10.1111/j.1440-1819.2004.01313.x; Okumura T, 2005, ENVIRON TOXICOL PHAR, V19, P447, DOI 10.1016/j.etap.2004.12.005; Okumura T, 1996, ANN EMERG MED, V28, P129, DOI 10.1016/S0196-0644(96)70052-5; Sharp D, 2006, LANCET, V367, P95, DOI 10.1016/S0140-6736(06)67942-7; Shigemura J, 2012, JAMA-J AM MED ASSOC, V308, P667, DOI 10.1001/jama.2012.9699; Shimizu A, 2002, JAPANESE J CLIN PSYC, V31, P549; St. Luke's International Hospital, 1997, JAPAN MED J, V3828, P42; Tochigi M, 2002, NEUROSCI RES, V44, P267, DOI 10.1016/S0168-0102(02)00146-3; Weiss DS, 2004, IMPACT EVENT SCALE R; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; World Health Organization, 2005, Biosecur Bioterror, V3, P268; World Health Organization, FACT SHEETS DEPR; Yokoyama K, 1998, ARCH ENVIRON HEALTH, V53, P249, DOI 10.1080/00039899809605705	33	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234967	10.1371/journal.pone.0234967	http://dx.doi.org/10.1371/journal.pone.0234967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME9KK	32574198	Green Published, gold			2022-12-27	WOS:000544972400030
J	Bouguetoch, A; Grospretre, S; Martin, A				Bouguetoch, Amandine; Grospretre, Sidney; Martin, Alain			Optimal stimulation parameters for spinal and corticospinal excitabilities during contraction, motor imagery and rest: A pilot study	PLOS ONE			English	Article							FACILITATION; REFLEX; REPRESENTATIONS; PERFORMANCE; SIMULATION; MOVEMENTS	Objectives It is commonly accepted that motor imagery (MI), i.e. the mental simulation of a movement, leads to an increased size of cortical motor evoked potentials (MEPs), although the magnitude of this effect differs between studies. Its impact on the spinal level is even more variable in the literature. Such discrepancies may be explained by many different experimental approaches. Therefore, the question of the optimal stimulation parameters to assess both spinal and corticospinal excitabilities remains open. Methods H-reflexes and MEPs of the triceps surae were evoked in 11 healthy subjects during MI, weak voluntary contraction (CON) and rest (REST). In each condition, the full recruitment curve from the response threshold to maximal potential was investigated. Results At stimulation intensities close to the maximal response, MEP amplitude was increased by CON compared to REST on the triceps surae. No effect of the different conditions was found on the H-reflex recruitment curve, except a small variation beyond maximal H-reflex in the soleus muscle. Conclusion Based on our results, we recommend to assess corticospinal excitability between 70% and 100% of maximal MEP intensity instead of the classical use of a percentage of the motor threshold and to elicit H-reflexes on the ascending part of the recruitment curve.	[Bouguetoch, Amandine; Martin, Alain] Univ Bourgogne Franche Comte, Cognit Act & Sensorimotor Plast CAPS, INSERM, Dijon, France; [Grospretre, Sidney] Univ Bourgogne Franche Comte, EA 4660 C3S Culture Sport Hlth Soc, Besancon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Franche-Comte	Bouguetoch, A (corresponding author), Univ Bourgogne Franche Comte, Cognit Act & Sensorimotor Plast CAPS, INSERM, Dijon, France.	amandine.bouguetoch@free.fr		Grospretre, Sidney/0000-0003-1023-5842				Abbruzzese G, 1996, EXP BRAIN RES, V111, P465; ANNETT J, 1995, NEUROPSYCHOLOGIA, V33, P1395, DOI 10.1016/0028-3932(95)00072-B; [Anonymous], 2017, LANCET ONCOL, V18, P1, DOI 10.1016/S1470-2045(16)30642-8; [Anonymous], 1994, BRIT J 18 CENTURY ST, V17, P1, DOI DOI 10.1007/BF02724515; Bonnet M, 1997, COGNITIVE BRAIN RES, V5, P221, DOI 10.1016/S0926-6410(96)00072-9; Crammond DJ, 1997, TRENDS NEUROSCI, V20, P54, DOI 10.1016/S0166-2236(96)30019-2; CRONE C, 1990, EXP BRAIN RES, V81, P35; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Decety J., 1990, PSYCHOL RES, P39, DOI [10.1007/BF00867210, DOI 10.1007/BF00867210]; Ehrsson HH, 2000, EUR J NEUROSCI, V12, P3385, DOI 10.1046/j.1460-9568.2000.00209.x; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Gandevia SC, 1997, J PHYSIOL-LONDON, V505, P259, DOI 10.1111/j.1469-7793.1997.259bc.x; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Grospretre S, 2019, J PHYSIOL-LONDON, V597, P921, DOI 10.1113/JP276694; Grospretre S, 2016, EUR J SPORT SCI, V16, P317, DOI 10.1080/17461391.2015.1024756; Grospretre S, 2012, J NEUROPHYSIOL, V107, P1649, DOI 10.1152/jn.00611.2011; Hale BS, 2003, BEHAV BRAIN RES, V142, P81, DOI 10.1016/S0166-4328(02)00397-2; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Hashimoto R, 1999, DYNAMIC CHANGES CORT, P75; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jeannerod M., 2004, INT J SPORT EXERC PS, V2, P376, DOI [10.1080/1612197X.2004.9671752, DOI 10.1080/1612197X.2004.9671752]; Jeannerod M., 2006, MOTOR COGNITION WHAT, DOI [10.1093/acprof:oso/9780198569657.001.0001, DOI 10.1093/ACPROF:OSO/9780198569657.001.0001]; Kasai T, 1997, BRAIN RES, V744, P147, DOI 10.1016/S0006-8993(96)01101-8; Kiers L, 1997, ELECTROMYOGR MOTOR C, V105, P262, DOI 10.1016/S0921-884X(97)00027-1; Kukke SN, 2014, J CLIN NEUROPHYSIOL, V31, P246, DOI 10.1097/WNP.0000000000000057; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P7113, DOI 10.1073/pnas.1002462107; Oku K, 2011, PERCEPT MOTOR SKILL, V113, P982, DOI 10.2466/05.23.25.PMS.113.6.982-994; Park WH, 2011, NEUROSCI LETT, V494, P255, DOI 10.1016/j.neulet.2011.03.027; Pierrot-Deseilligny E, 2012, CIRCUITRY OF THE HUMAN SPINAL CORD: SPINAL AND CORTICOSPINAL MECHANISMS OF MOVEMENT, P292; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; Porro CA, 1996, J NEUROSCI, V16, P7688; Roth R, 1996, NEUROREPORT, V7, P1280, DOI 10.1097/00001756-199605170-00012; Rupp T, 2012, J NEUROPHYSIOL, V108, P1270, DOI 10.1152/jn.01162.2011; Stephan KM, 1996, NEUROCHEM RES, V21, P1105, DOI 10.1007/BF02532421; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Temesi J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-40; Temesi J, 2013, MED SCI SPORT EXER, V45, P2243, DOI 10.1249/MSS.0b013e31829ce379; Yahagi S, 1996, PERCEPT MOTOR SKILL, V83, P288, DOI 10.2466/pms.1996.83.1.288	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235074	10.1371/journal.pone.0235074	http://dx.doi.org/10.1371/journal.pone.0235074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569326	Green Published, gold			2022-12-27	WOS:000543547900042
J	Grayson, JM; Perez, MD; Blevins, R; Coe, BN; Detty, MR; McIver, ZA				Grayson, Jason M.; Perez, Mildred D.; Blevins, Rebecca; Coe, Benjamin N.; Detty, Michael R.; McIver, Zachariah A.			Photodepletion with 2-Se-Cl prevents lethal graft-versus-host disease while preserving antitumor immunity	PLOS ONE			English	Article							T-CELL EXHAUSTION; BONE-MARROW-TRANSPLANTATION; PERSISTENCE; CD8	Acute graft-versus-host-disease (GVHD), limits the use of hematopoietic cell transplant (HCT) to treat a variety of malignancies. Any new therapeutic approach must satisfy three requirements: 1) Prevent GVHD, 2) Maintain anti-pathogen immunity, and 3) Maintain anti-tumor immunity. In prior studies we have shown that the selective photosensitizer 2-Se-Cl eliminates highly alloreactive lymphocytes from the graft prior to HCT preventing GVHD and that antiviral immune responses were preserved following incubation with 2-Se-Cl. In this report, we investigated whether 2-Se-Cl treatment preserves antitumor immunity, and then used high dimensional flow cytometry to identify the determinants of successful immune reconstitution. Donor C57BL/6 splenocytes were cocultured for 4 days with irradiated BALB/c splenocytes and then exposed to 2-Se-Cl. Photodepletion (PD)-treated splenocytes were then infused into lethally irradiated BALB/c mice inoculated with A20 leukemia/lymphoma cells. Recipient mice that received PD-treated splenocytes survived > 100 days without evidence of GVHD or leukemia. In contrast, mice that did not receive PD-treated cells at time of HCT died of leukemia progression. Multiparameter flow cytometry of cytokines and surface markers on peripheral blood samples 15 days after HCT demonstrated unique patterns of immune reconstitution. We found that before clinical disease onset GVHD was marked by functionally exhausted T cells, while tumor clearance and long-term survival were associated with an expansion of polyfunctional T cells, monocytes, and DCs early after transplantation. Taken together these results demonstrate that 2-Se-Cl photodepletion is a new treatment that can facilitate HCT by preventing GVHD while preserving antiviral and anti-tumor immunity.	[Grayson, Jason M.; Perez, Mildred D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27103 USA; [Blevins, Rebecca; Coe, Benjamin N.; McIver, Zachariah A.] Wake Forest Univ, Bowman Gray Sch Med, Dept Hematol & Oncol, Winston Salem, NC 27109 USA; [Detty, Michael R.] SUNY Buffalo, Dept Chem, Buffalo, NY USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Grayson, JM (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27103 USA.; McIver, ZA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Hematol & Oncol, Winston Salem, NC 27109 USA.	jgrayson@wakehealth.edu; zmciver@wakehealth.edu		Perez, Mildred/0000-0002-8918-6600	Comprehensive Cancer Center of Wake Forest University [NCI CCSG P30CA012197]; Wake Forest Clinical and Translational Science Award [5KL2TR001421-03]	Comprehensive Cancer Center of Wake Forest University; Wake Forest Clinical and Translational Science Award	This work was supported in part by the Comprehensive Cancer Center of Wake Forest University NCI CCSG P30CA012197 grant, and in part by the Wake Forest Clinical and Translational Science Award 5KL2TR001421-03 to Z.A.M.	Bashey ZA, 2018, BONE MARROW TRANSPL, V53, P756, DOI 10.1038/s41409-018-0126-4; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bleakley M, 2015, J CLIN INVEST, V125, P2677, DOI 10.1172/JCI81229; Chen BJ, 2002, BLOOD, V99, P3083, DOI 10.1182/blood.V99.9.3083; Chung DJ, 2016, CANCER IMMUNOL RES, V4, P61, DOI 10.1158/2326-6066.CIR-15-0055; Finak G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-546; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Gatza E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001975; Halpert M, 2018, J IMMUNOL, V200; Hartwell MJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89798; Hill L, 2018, THER ADV HEMATOL, V9, P21, DOI 10.1177/2040620717741860; Hossein MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184254; Kohonen T, 2013, NEURAL NETWORKS, V37, P52, DOI 10.1016/j.neunet.2012.09.018; Kong Y, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.58; Laurent S, 2010, HUM IMMUNOL, V71, P934, DOI 10.1016/j.humimm.2010.07.007; Liu L, 2018, CLIN IMMUNOL, V190, P32, DOI 10.1016/j.clim.2018.02.009; Luznik L, 2008, BIOL BLOOD MARROW TR, V14, P641, DOI 10.1016/j.bbmt.2008.03.005; Martin PJ, 2004, BIOL BLOOD MARROW TR, V10, P552, DOI 10.1016/j.bbmt.2004.04.002; McIver ZA, 2016, J IMMUNOL, V197, P1631, DOI 10.4049/jimmunol.1402445; O'Donnell PV, 2002, BIOL BLOOD MARROW TR, V8, P377, DOI 10.1053/bbmt.2002.v8.pm12171484; Paczesny S, 2018, BLOOD, V131, P2193, DOI 10.1182/blood-2018-02-791509; Pasquini MC, 2008, BEST PRACT RES CL HA, V21, P193, DOI 10.1016/j.beha.2008.02.011; Reddy P, 2008, BIOL BLOOD MARROW TR, V14, P129, DOI 10.1016/j.bbmt.2007.10.021; Sega EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086551; Solomon SR, 2014, BIOL BLOOD MARROW TR, V20, P1828, DOI 10.1016/j.bbmt.2014.07.020; Sugita J., 2018, BONE MARROW TRANSPLA; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Gassen S, 2018, FLOWSOM USING SELF O; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Wahl DR, 2012, IMMUNOL REV, V249, P104, DOI 10.1111/j.1600-065X.2012.01148.x; Wang XB, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-21; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wilson J, 2009, J EXP MED, V206, P1203, DOI 10.1084/jem.20070723041509c; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zarour HM, 2016, CLIN CANCER RES, V22, P1856, DOI 10.1158/1078-0432.CCR-15-1849	36	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234778	10.1371/journal.pone.0234778	http://dx.doi.org/10.1371/journal.pone.0234778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569289	Green Published, gold			2022-12-27	WOS:000543547900031
J	Wietkamp, S; Krock, B; Clarke, D; Voss, D; Salas, R; Kilcoyne, J; Tillmann, U				Wietkamp, Stephan; Krock, Bernd; Clarke, Dave; Voss, Daniela; Salas, Rafael; Kilcoyne, Jane; Tillmann, Urban			Distribution and abundance of azaspiracid-producing dinophyte species and their toxins in North Atlantic and North Sea waters in summer 2018	PLOS ONE			English	Article							DINOFLAGELLATE GENUS AZADINIUM; SP-NOV; QPCR ASSAY; AMPHIDOMATACEAE DINOPHYCEAE; KARLODINIUM-VENEFICUM; MOLECULAR-DETECTION; MEDITERRANEAN SEA; COASTAL WATERS; SHELF WATERS; ALGAL BLOOM	Representatives of the marine dinophyte family Amphidomataceae produce lipophilic phycotoxins called azaspiracids (AZA) which may cause azaspiracid shellfish poisoning (AZP) in humans after consumption of contaminated seafood. Three of the four known toxigenic species are observed frequently in the eastern North Atlantic. In 2018, a research survey was performed to strengthen knowledge on the distribution and abundance of toxigenic Amphidomataceae and their respective toxins in Irish coastal waters and in the North Sea. Species-specific quantification of the three toxigenic species (Azadinium spinosum,Azadinium poporumandAmphidoma languida) was based on recently developed qPCR assays, whose performance was successfully validated and tested with specificity tests and spike experiments. The multi-method approach of on-board live microscopy, qPCR assays and chemical AZA-analysis revealed the presence of Amphidomataceae in the North Atlantic including the three targeted toxigenic species and their respective AZA analogues (AZA-1, -2, -33, -38, -39).Azadinium spinosumwas detected at the majority of Irish stations with a peak density of 8.3 x 10(4)cells L(-1)and AZA (AZA-1, -2, -33) abundances up to 1,274 pg L-1.Amphidoma languidawas also present at most Irish stations but appeared in highest abundance in a bloom at a central North Sea station with a density of 1.2 x 10(5)cells L(-1)and an AZA (AZA-38, -39) abundances of 618 pg L-1.Azadinium poporumwas detected sporadically at the Irish south coast and North Sea and was rather low in abundance during this study. The results confirmed the wide distribution and frequent occurrence of the target species in the North Atlantic area and revealed, for the first time, bloom abundances of toxigenic Amphidomataceae in this area. This emphasizes the importance of future studies and monitoring of amphidomatacean species and their respective AZA analogues in the North Atlantic.	[Wietkamp, Stephan; Krock, Bernd; Tillmann, Urban] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Clarke, Dave; Salas, Rafael; Kilcoyne, Jane] Marine Inst, Galway, Ireland; [Voss, Daniela] Carl vn Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Wilhelmshaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Marine Institute Ireland	Tillmann, U (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany.	urban.tillmann@awi.de	Krock, Bernd/ABB-7541-2020	Wietkamp, Stephan/0000-0001-7516-9861; Salas, Rafael/0000-0003-4688-0579; Clarke, Dave/0000-0002-8122-5193	German Ministry for Education and Research [03F0763A]; PACES II research program of the Alfred-Wegener-Institute as part of the Helmholtz Foundation initiative in Earth and Environment	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); PACES II research program of the Alfred-Wegener-Institute as part of the Helmholtz Foundation initiative in Earth and Environment	This work was supported by funding of the German Ministry for Education and Research (project RIPAZA, 03F0763A) and by the PACES II research program of the Alfred-Wegener-Institute as part of the Helmholtz Foundation initiative in Earth and Environment.	Aasen J, 2006, P 5 INT C MOLL SHELL, P162; Akselman R, 2012, HARMFUL ALGAE, V19, P30, DOI 10.1016/j.hal.2012.05.004; Anderson DM, 2012, HARMFUL ALGAE, V14, P10, DOI 10.1016/j.hal.2011.10.012; [Anonymous], R LANG ENV STAT COMP; Antonella P, 2013, ENVIRON SCI POLLUT R, V20, P6851, DOI 10.1007/s11356-012-1377-z; Araujo AJ de, 2004, J BRAS PNEUMOL, V30, pS1, DOI [10.1590/S1806-37132004000800002, DOI 10.1590/S1806-37132004000800002]; Battocchi C, 2010, MAR POLLUT BULL, V60, P1074, DOI 10.1016/j.marpolbul.2010.01.017; Berdalet E, 2014, DEEP-SEA RES PT II, V101, P4, DOI 10.1016/j.dsr2.2013.09.042; Berdalet E, 2017, OCEANOGRAPHY, V30, P36, DOI 10.5670/oceanog.2017.108; Botana L.M., 2014, SEAFOOD FRESHWATER T; Brown J, 2003, CONT SHELF RES, V23, P533, DOI 10.1016/S0278-4343(03)00008-6; Busch JA, 2016, HARMFUL ALGAE, V55, P191, DOI 10.1016/j.hal.2016.02.012; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; Casabianca S, 2013, ENVIRON SCI TECHNOL, V47, P3788, DOI 10.1021/es305018s; Charnock H, 1994, UNDERSTANDING N SEA; Clarke D, 2018, P 18 C HARMF ALG BLO; Dai XF, 2019, HARMFUL ALGAE, V89, DOI 10.1016/j.hal.2019.101665; Ebenezer V, 2012, MAR BIOTECHNOL, V14, P129, DOI 10.1007/s10126-011-9427-y; Eckford-Soper LK, 2015, HARMFUL ALGAE, V48, P37, DOI 10.1016/j.hal.2015.06.009; Engesmo A, 2018, HARMFUL ALGAE, V75, P105, DOI 10.1016/j.hal.2018.04.007; Forootan Amin, 2017, Biomol Detect Quantif, V12, P1, DOI 10.1016/j.bdq.2017.04.001; Fu MQ, 2019, HARMFUL ALGAE, V84, P1, DOI 10.1016/j.hal.2019.01.011; Galluzzi L, 2010, J APPL PHYCOL, V22, P1, DOI 10.1007/s10811-009-9411-3; Hill AE, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033459; Hinder SL, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-54; Huang HL, 2019, HARMFUL ALGAE, V81, P65, DOI 10.1016/j.hal.2018.12.001; Husson B, 2016, HARMFUL ALGAE, V51, P26, DOI 10.1016/j.hal.2015.10.017; James K., 1998, HARMFUL ALGAE, P468; Jauffrais T, 2013, HARMFUL ALGAE, V27, P138, DOI 10.1016/j.hal.2013.05.009; JOINT I, 1993, MAR ECOL PROG SER, V99, P169, DOI 10.3354/meps099169; Kilcoyne J, 2019, MAR DRUGS, V17, DOI 10.3390/md17090489; Krock B, 2018, PHYS OCEANOGRAPHY HE, DOI [10.1594/PANGAEA.896405, DOI 10.1594/PANGAEA.896405]; Krock B, 2019, HARMFUL ALGAE, V82, P1, DOI 10.1016/j.hal.2018.12.005; Krock B, 2015, MAR DRUGS, V13, P6687, DOI 10.3390/md13116687; Krock B, 2012, TOXICON, V60, P830, DOI 10.1016/j.toxicon.2012.05.007; Krock B, 2009, HARMFUL ALGAE, V8, P254, DOI 10.1016/j.hal.2008.06.003; Luo ZH, 2018, HARMFUL ALGAE, V78, P75, DOI 10.1016/j.hal.2018.08.003; Luo ZH, 2017, HARMFUL ALGAE, V66, P65, DOI 10.1016/j.hal.2017.05.001; Massoud EAS, 2020, AM J OTOLARYNG, V41, DOI 10.1016/j.amjoto.2020.102417; Nielsen LT, 2016, TOXICON, V117, P84, DOI 10.1016/j.toxicon.2016.03.021; PEDERSEN F, 1994, ESTUAR COAST SHELF S, V38, P249, DOI 10.1006/ecss.1994.1017; Percopo I, 2013, J PHYCOL, V49, P950, DOI 10.1111/jpy.12104; Perini F., 2018, MAR POLLUT B; Perini F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017699; PRESTONTHOMAS H, 1990, METROLOGIA, V27, P3, DOI 10.1088/0026-1394/27/1/002; RAINE R, 1990, ESTUAR COAST SHELF S, V30, P579, DOI 10.1016/0272-7714(90)90094-8; Raine R, 1998, CONT SHELF RES, V18, P883, DOI 10.1016/S0278-4343(98)00017-X; Raine R, 2014, DEEP-SEA RES PT II, V101, P21, DOI 10.1016/j.dsr2.2013.06.021; Richardson K, 2000, J PLANKTON RES, V22, P1663, DOI 10.1093/plankt/22.9.1663; Rossi R, 2017, ANAL BIOANAL CHEM, V409, P1121, DOI 10.1007/s00216-016-0037-4; Ruvindy R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03153; Salas R, 2011, HARMFUL ALGAE, V10, P774, DOI 10.1016/j.hal.2011.06.010; Satake Masayuki, 1997, Natural Toxins, V5, P164; Schlitzer R., 2018, OCEAN DATA VIEW; Smith KF, 2016, J APPL PHYCOL, V28, P1125, DOI 10.1007/s10811-015-0667-5; Tillmann U., 2018, HARMFUL ALGAE BLOOMS, P575; Tillmann U., 2014, SEAFOOD FRESHWATER T, P773; Tillmann U, 2020, PHYCOLOGIA, V59, P63, DOI 10.1080/00318884.2019.1670013; Tillmann U, 2019, HARMFUL ALGAE, V84, P244, DOI 10.1016/j.hal.2019.01.008; Tillmann U, 2018, HARMFUL ALGAE, V80, P15, DOI 10.1016/j.hal.2018.08.011; Tillmann U, 2017, REV BIOL MAR OCEANOG, V52, P591, DOI 10.4067/S0718-19572017000300015; Tillmann U, 2017, HARMFUL ALGAE, V62, P113, DOI 10.1016/j.hal.2016.12.001; Tillmann U, 2016, PHYCOL RES, V64, P160, DOI 10.1111/pre.12133; Tillmann Urban, 2015, Marine Biodiversity Records, V8, pe142, DOI 10.1017/S1755267215001128; Tillmann U, 2012, HARMFUL ALGAE, V20, P142, DOI 10.1016/j.hal.2012.10.001; Tillmann U, 2012, PROTIST, V163, P701, DOI 10.1016/j.protis.2011.10.005; Tillmann U, 2011, EUR J PHYCOL, V46, P74, DOI 10.1080/09670262.2011.556753; Tillmann U, 2009, EUR J PHYCOL, V44, P63, DOI 10.1080/09670260802578534; Toebe K, 2013, J PLANKTON RES, V35, P225, DOI 10.1093/plankt/fbs077; Toldra A, 2018, ANAL CHIM ACTA, V1039, P140, DOI 10.1016/j.aca.2018.07.057; Trainer VL, 2020, HARMFUL ALGAE, V91, DOI 10.1016/j.hal.2019.03.009; Twiner M., 2014, SEAFOOD FRESHWATER T, P823; Wells ML, 2018, ECOL STUD-ANAL SYNTH, V232, P77, DOI 10.1007/978-3-319-70069-4_5; Wietkamp S, 2019, HARMFUL ALGAE, V88, DOI 10.1016/j.hal.2019.101637; Wietkamp S, 2019, J PLANKTON RES, V41, P101, DOI 10.1093/plankt/fby052; Zamyadi A, 2019, WATER RES, V152, P96, DOI 10.1016/j.watres.2019.01.002	76	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0235015	10.1371/journal.pone.0235015	http://dx.doi.org/10.1371/journal.pone.0235015			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559229	Green Published, gold			2022-12-27	WOS:000543261600034
J	Sjodin, BMF; Irvine, RL; Russello, MA				Sjodin, Bryson M. F.; Irvine, Robyn L.; Russello, Michael A.			RapidRat: Development, validation and application of a genotyping-by-sequencing panel for rapid biosecurity and invasive species management	PLOS ONE			English	Article							RATS RATTUS-NORVEGICUS; INTRODUCED RATS; NORWAY RATS; NEW-ZEALAND; ERADICATION; ISLANDS; POPULATIONS; SEABIRDS; IMPACTS	Invasive alien species (IAS) are among the main causes of global biodiversity loss. Invasive brown (Rattus norvegicus) and black (R.rattus) rats, in particular, are leading drivers of extinction on islands, especially in the case of seabirds where >50% of all extinctions have been attributed to rat predation. Eradication is the primary form of invasive rat management, yet this strategy has resulted in a similar to 10-38% failure rate on islands globally. Genetic tools can help inform IAS management, but such applications to date have been largely reactive, time-consuming, and costly. Here, we developed a Genotyping-in-Thousands by sequencing (GT-seq) panel for rapid species identification and population assignment of invasive brown and black rats (RapidRat) in Haida Gwaii, an archipelago comprising similar to 150 islands off the central coast of British Columbia, Canada. We constructed an optimized panel of 443 single nucleotide polymorphisms (SNPs) using previously generated double-digest restriction-site associated DNA (ddRAD) genotypic data (27,686 SNPs) from brown (n= 295) and black rats (n= 241) sampled throughout Haida Gwaii. The informativeness of this panel for identifying individuals to species and island of origin was validated relative to the ddRAD results; in all comparisons, admixture coefficients and population assignments estimated using RapidRat were consistent. To demonstrate application, 20 individuals from novel invasions of three islands (Agglomerate, Hotspring, Ramsay) were genotyped using RapidRat, all of which were confidently assigned (>98.5% probability) to Faraday and Murchison Islands as putative source populations. These results indicated that a previous eradication on Hotspring Island was conducted at an inappropriate geographic scale; future management should expand the eradication unit to include neighboring islands to prevent re-invasion. Overall, we demonstrated that RapidRat is an effective tool for managing invasive rat populations in Haida Gwaii and provided a clear framework for GT-seq panel development for informing biodiversity conservation in other systems.	[Sjodin, Bryson M. F.; Russello, Michael A.] Univ British Columbia, Dept Biol, Kelowna, BC, Canada; [Irvine, Robyn L.] Pk Canada, Natl Marine Conservat Area Reserve & Haida Herita, Gwaii Haanas Natl Pk Reserve, Skidegate, BC, Canada	University of British Columbia	Russello, MA (corresponding author), Univ British Columbia, Dept Biol, Kelowna, BC, Canada.	michael.russello@ubc.ca		Russello, Michael/0000-0002-9297-2485	Parks Canada [GC-853]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2014-04736]	Parks Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by Parks Canada (https://www.pc.gc.ca) agreement GC-853 and Natural Sciences and Engineering Research Council of Canada (NSERC; https://www.nserccrsng.gc.ca) Discovery grant RGPIN-2014-04736 to MAR. The funder assisted in sample collection and reviewed drafts of the manuscript.	Amos W, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160110; [Anonymous], 2006, JEWISH CULTURE HIST, V8, P45; Atkinson I.A.E., 1985, International Council for Bird Preservation Technical Publication, P35; BELKHIR K, 2004, GENETIX 4 05 WINDOWS; Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; BERTRAM DF, 1995, CAN FIELD NAT, V109, P6; Bootsma ML, 2020, GT SEQ PANEL WALLEYE; Calder JA, 1968, CANADA DEP AGR RES B; Campbell NR, 2015, MOL ECOL RESOUR, V15, P855, DOI 10.1111/1755-0998.12357; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Clout MN, 2002, Z JAGDWISS, V48, P51, DOI 10.1007/BF02192392; Damin-Pernik M, 2017, DRUG METAB DISPOS, V45, P160, DOI 10.1124/dmd.116.073791; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; De Vos JM, 2015, CONSERV BIOL, V29, P452, DOI 10.1111/cobi.12380; Delomas TA, 2019, MOL ECOL RESOUR, V19, P1545, DOI 10.1111/1755-0998.13073; Doherty TS, 2016, P NATL ACAD SCI USA, V113, P11261, DOI 10.1073/pnas.1602480113; Foster JB, 1965, OCCAS PAP BR COLUMBI, V14, P130; Frichot E, 2015, METHODS ECOL EVOL, V6, P925, DOI 10.1111/2041-210X.12382; Fukami T, 2006, ECOL LETT, V9, P1299, DOI 10.1111/j.1461-0248.2006.00983.x; Galinsky KJ, 2016, AM J HUM GENET, V98, P456, DOI 10.1016/j.ajhg.2015.12.022; GASTON AJ, 2008, P RES GROUP INTR SPE; Gill C, 2014, P VERT PEST C, V26; Golumbia T. E., 1999, P C BIOL MAN SPEC HA, V1, P327; Government of Canada CFIA, 2013 2014 DEP PERF R; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Harfenist A, 2003, SEABIRD COLONIES BAC; Harper GA, 2015, GLOB ECOL CONSERV, V3, P607, DOI 10.1016/j.gecco.2015.02.010; Harris DB, 2007, ECOLOGY, V88, P2330, DOI 10.1890/06-1701.1; Harrison Charles, 1925, ANCIENT WARRIORS N P; Holmes ND, 2015, BIOL CONSERV, V185, P8, DOI 10.1016/j.biocon.2014.12.018; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; Jombart T, 2010, BMC GENET, V11, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jones HP, 2008, CONSERV BIOL, V22, P16, DOI 10.1111/j.1523-1739.2007.00859.x; Jones HP, 2016, P NATL ACAD SCI USA, V113, P4033, DOI 10.1073/pnas.1521179113; Kaiser GW, 1997, ENV CANADA TECHNICAL, V304; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Mackay Jamie W.B., 2007, P294; Meek MH, 2019, MOL ECOL RESOUR, V19, P795, DOI 10.1111/1755-0998.12998; MOODIE G E E, 1973, Canadian Field-Naturalist, V87, P173; Mulder CPH, 2009, BIOL INVASIONS, V11, P1671, DOI 10.1007/s10530-008-9396-x; Otto SP, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.2047; Parker KA, 2019, MOL ECOL, V28, P3171, DOI 10.1111/mec.15136; Parks Canada Agency, 2018, NAT PRIOR REP PARKS, P47; Parks Canada Agency G of C, 2019, WILDL GWAII HAAN NAT; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Piertney SB, 2016, J APPL ECOL, V53, P332, DOI 10.1111/1365-2664.12589; Pimentel D, 2011, BIOLOGICAL INVASIONS: ECONOMIC AND ENVIRONMENTAL COSTS OF ALIEN PLANT, ANIMAL, AND MICROBE SPECIES, 2ND EDITION, P411; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramsey DSL, 2012, FRAMEWORK UNDERTAKIN; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Russell JC, 2008, WILDLIFE RES, V35, P215, DOI 10.1071/WR07032; Russell JC, 2016, NEW ZEAL J ECOL, V40, P197; Russell JC, 2010, BIOL INVASIONS, V12, P1747, DOI 10.1007/s10530-009-9586-1; Russell JC, 2005, NATURE, V437, P1107, DOI 10.1038/4371107a; Schmidt DA, ECOL EVOL; Schmidt DA, 2020, MOL ECOL RESOUR, V20, P114, DOI 10.1111/1755-0998.13090; Shafer ABA, 2018, METHODS ECOL EVOL, P907; Sjodin BMF, 2020, EVOL APPL, V13, P889, DOI 10.1111/eva.12907; Spennemann D.H.R., 1997, Atoll Research Bulletin, V446, P1; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Tabak MA, 2015, NEOBIOTA, V24, P33, DOI 10.3897/neobiota.24.8433; Tabak MA, 2015, CONSERV GENET, V16, P125, DOI 10.1007/s10592-014-0646-4; Taylor RH, 2000, RESTOR ECOL, V8, P151, DOI 10.1046/j.1526-100x.2000.80022.x; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Towns DR, 2009, OIKOS, V118, P420, DOI 10.1111/j.1600-0706.2008.17186.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	71	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234694	10.1371/journal.pone.0234694	http://dx.doi.org/10.1371/journal.pone.0234694			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555734	Green Published, gold			2022-12-27	WOS:000543273200064
J	Vanani, FR; Shabani, L; Sabzalian, MR; Dehghanian, F; Winner, L				Vanani, Fatemeh Raeisi; Shabani, Leila; Sabzalian, Mohammad R.; Dehghanian, Fariba; Winner, Lisa			Comparative physiological and proteomic analysis indicates lower shock response to drought stress conditions in a self-pollinating perennial ryegrass	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; PHOSPHOLIPASE-D; WATER DEFICITS; NITROGEN-METABOLISM; HORMONE METABOLISM; GENE-EXPRESSION; TOLERANCE; DEHYDRATION; PROTEINS; BARLEY	We investigated the physiological and proteomic changes in the leaves of threeLolium perennegenotypes, one Iranian putative self-pollinating genotype named S10 and two commercial genotypes of Vigor and Speedy, subjected to drought stress conditions. The results of this study indeed showed higher RWC (relative water content), SDW (shoot dry weight), proline, ABA (abscisic acid), nitrogen and amino acid contents, and antioxidant enzymes activities of S10 under drought stress in comparison with the two other genotypes. A total of 915 proteins were identified using liquid chromatography-mass spectrometry (LC/MS) analysis, and the number of differentially abundant proteins between normal and stress conditions was 467, 456, and 99 in Vigor, Speedy, and S10, respectively. Proteins involved in carbon and energy metabolism, photosynthesis, TCA cycle, redox, and transport categories were up-regulated in the two commercial genotypes. We also found that some protein inductions, including those involved in amino acid and ABA metabolisms, aquaporin, HSPs, photorespiration, and increases in the abundance of antioxidant enzymes, are essential responses of the two commercial genotypes to drought stress. In contrast, we observed only slight changes in the protein profile of the S10 genotype under drought stress. Higher homozygosity due to self-pollination in the genetic background of the S10 genotype may have led to a lower variation in response to drought stress conditions.	[Vanani, Fatemeh Raeisi; Shabani, Leila] Shahrekord Univ, Fac Sci, Dept Plant Sci, Shahrekord, Iran; [Shabani, Leila] Shahrekord Univ, Res Inst Biotechnol, Shahrekord, Iran; [Sabzalian, Mohammad R.] Isfahan Univ Technol, Coll Agr, Dept Agron & Plant Breeding, Esfahan, Iran; [Dehghanian, Fariba] Univ Isfahan, Fac Biol Sci & Technol, Dept Cell & Mol Biol & Microbiol, Esfahan, Iran; [Winner, Lisa] Univ Freiburg, Ctr Biol Syst Anal ZBSA, Core Facil Prote, Freiburg, Germany	Shahrekord University; Shahrekord University; Isfahan University of Technology; University of Isfahan; University of Freiburg	Shabani, L (corresponding author), Shahrekord Univ, Fac Sci, Dept Plant Sci, Shahrekord, Iran.; Shabani, L (corresponding author), Shahrekord Univ, Res Inst Biotechnol, Shahrekord, Iran.	shabani-l@sku.ac.ir	Dehghanian, Fariba/GLU-7428-2022; Shabani, Leila/ABA-2527-2021; Sabzalian, Mohammad R./E-6279-2013	Shabani, Leila/0000-0001-6194-4708; Dehghanian, Fariba/0000-0003-3357-5903; Sabzalian, Mohammad R./0000-0002-7315-9990	University of Shahrekord, SKU [98GRD30M1032]	University of Shahrekord, SKU	We acknowledge the University of Shahrekord, SKU, for supporting this research (grant number: 98GRD30M1032).	Akinci S, 2011, WATER STRESS, P15; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Aroca R, 2006, ANN BOT-LONDON, V98, P1301, DOI 10.1093/aob/mcl219; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Bargmann BOR, 2009, PLANT CELL PHYSIOL, V50, P78, DOI 10.1093/pcp/pcn173; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bellon MR, 2006, WORLD DEV, V34, P113, DOI 10.1016/j.worlddev.2005.05.012; Ceccarelli S, 2010, J AGR SCI-CAMBRIDGE, V148, P627, DOI 10.1017/S0021859610000651; CHAVES MM, 1991, J EXP BOT, V42, P1, DOI 10.1093/jxb/42.1.1; Cheng LX, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0871-8; Chmielewska K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01108; Choudhary MK, 2009, MOL CELL PROTEOMICS, V8, P1579, DOI 10.1074/mcp.M800601-MCP200; Coleman HD, 2009, P NATL ACAD SCI USA, V106, P13118, DOI 10.1073/pnas.0900188106; CONNOR HE, 1979, NEW ZEAL J BOT, V17, P547, DOI 10.1080/0028825X.1979.10432571; CORNISH MA, 1979, HEREDITY, V43, P95, DOI 10.1038/hdy.1979.63; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deng X, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00425; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; El Maarouf H, 1999, PLANT MOL BIOL, V39, P1257, DOI 10.1023/A:1006165919928; Falloon P, 2010, SCI TOTAL ENVIRON, V408, P5667, DOI 10.1016/j.scitotenv.2009.05.002; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Fulda S, 2011, PLANT BIOLOGY, V13, P632, DOI 10.1111/j.1438-8677.2010.00426.x; Furet PM, 2012, PLANT PHYSIOL BIOCH, V61, P88, DOI 10.1016/j.plaphy.2012.09.011; Garg BK, 2001, BIOL PLANTARUM, V44, P289, DOI 10.1023/A:1010215812791; Ghaffari MR, 2019, ENVIRON EXP BOT, V157, P197, DOI 10.1016/j.envexpbot.2018.10.002; Ghotbi-Ravandi AA, 2014, J AGRON CROP SCI, V200, P403, DOI 10.1111/jac.12062; Grigorova B, 2011, BIOL PLANTARUM, V55, P105, DOI 10.1007/s10535-011-0014-x; Guo BZ, 2006, PLANTA, V223, P512, DOI 10.1007/s00425-005-0112-0; Guo QF, 2008, J PLANT PHYSIOL, V165, P1745, DOI 10.1016/j.jplph.2007.10.002; Hong YY, 2008, MOL PLANT, V1, P262, DOI 10.1093/mp/ssm025; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P385; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Kaldenhoff R, 2008, PLANT CELL ENVIRON, V31, P658, DOI 10.1111/j.1365-3040.2008.01792.x; Kausar R, 2013, AMINO ACIDS, V44, P345, DOI 10.1007/s00726-012-1338-3; Kelen M, 2004, TURK J CHEM, V28, P603; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Kramer P.J., 1983, WATER RELATIONS PLAN; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; LEE JC, 1981, J BIOL CHEM, V256, P7193; Lisiewska Z, 2008, FOOD CHEM, V108, P642, DOI 10.1016/j.foodchem.2007.11.030; Loka D, 2019, FOOD ENERGY SECUR, V8, DOI 10.1002/fes3.152; Man D, 2011, HORTSCIENCE, V46, P1027, DOI 10.21273/HORTSCI.46.7.1027; May MJ, 1993, PLANT PHYSIOL, V103, P157, DOI DOI 10.1104/PP.103.1.157; Miazek A, 2008, BIOL PLANTARUM, V52, P687, DOI 10.1007/s10535-008-0133-1; Mirzaei M, 2012, J PROTEOME RES, V11, P348, DOI 10.1021/pr2008779; Mirzahosseini Z, 2014, EUR J SOIL BIOL, V63, P33, DOI 10.1016/j.ejsobi.2014.05.004; Moon KB, 2018, MOL CELLS, V41, P979, DOI 10.14348/molcells.2018.0312; Nagabhyru P, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-127; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ng LM, 2014, ACTA PHARMACOL SIN, V35, P567, DOI 10.1038/aps.2014.5; Nguema-Ona E, 2013, TRENDS PLANT SCI, V18, P445, DOI 10.1016/j.tplants.2013.03.006; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; NORRIS IB, 1985, GRASS FORAGE SCI, V40, P151, DOI 10.1111/j.1365-2494.1985.tb01732.x; Norton MR, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0362-1; Olmos E, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01092; Pandey V, 2016, PLANTA, V243, P1251, DOI 10.1007/s00425-016-2482-x; Patro L, 2014, J PHOTOCH PHOTOBIO B, V137, P49, DOI 10.1016/j.jphotobiol.2014.03.018; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Raorane ML, 2016, METHODS MOL BIOL, V1385, P139, DOI 10.1007/978-1-4939-3289-4_10; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; SAS, 1999, SAS COMP PROGR; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Shanker AK, 2014, FUNCT INTEGR GENOMIC, V14, P11, DOI 10.1007/s10142-013-0356-x; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Sinclair TR, 2000, AGR ECOSYST ENVIRON, V79, P53, DOI 10.1016/S0167-8809(99)00146-2; Singh NB, 2015, PHYSIOL MOL BIOL PLA, V21, P207, DOI 10.1007/s12298-015-0291-5; Skirycz A, 2010, CURR OPIN BIOTECH, V21, P197, DOI 10.1016/j.copbio.2010.03.002; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Torkian M, 2019, GRASS FORAGE SCI, V74, P559, DOI 10.1111/gfs.12437; TROLL W, 1955, J BIOL CHEM, V215, P655; Turgeon A.J., 2002, TURFGRASS MANAGEMENT; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Volaire F, 2006, ANN BOT-LONDON, V98, P927, DOI 10.1093/aob/mcl195; Wang JB, 2014, PLANTA, V240, P103, DOI 10.1007/s00425-014-2066-6; Wang NB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1657-3; Wang XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101706; Wang YJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112621; Xu CP, 2010, J PLANT PHYSIOL, V167, P1477, DOI 10.1016/j.jplph.2010.05.006; Xu ZZ, 2006, J PLANT GROWTH REGUL, V25, P252, DOI 10.1007/s00344-006-0043-4; Yang YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117475; Ye JX, 2013, PLANT OMICS, V6, P286; Ye TT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01694; Yue C, 2014, PLANT PHYSIOL BIOCH, V83, P65, DOI 10.1016/j.plaphy.2014.07.011; Zang LN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01140; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhang XZ, 2009, CROP SCI, V49, P1893, DOI 10.2135/cropsci2008.09.0521; Zhou SS, 2015, PLANT SCI, V236, P44, DOI 10.1016/j.plantsci.2015.03.017	93	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234317	10.1371/journal.pone.0234317	http://dx.doi.org/10.1371/journal.pone.0234317			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555744	Green Published, gold			2022-12-27	WOS:000543273200009
J	Adamovicz, L; Baker, SJ; Kessler, E; Kelly, M; Johnson, S; Winter, J; Phillips, CA; Allender, MC				Adamovicz, Laura; Baker, Sarah J.; Kessler, Ethan; Kelly, Marta; Johnson, Samantha; Winter, John; Phillips, Christopher A.; Allender, Matthew C.			Erythrocyte sedimentation rate and hemoglobin-binding protein in free-living box turtles (Terrapene spp.)	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; C-REACTIVE PROTEIN; PLASMA ELECTROPHORETIC PROFILES; LINEAR-REGRESSION PROCEDURES; REFERENCE INTERVALS; CAROLINA-CAROLINA; HAPTOGLOBIN CONCENTRATIONS; HEMATOLOGICAL PARAMETERS; INFLAMMATORY MARKERS; BIOCHEMICAL VALUES	The acute phase response is a highly conserved reaction to infection, inflammation, trauma, stress, and neoplasia. Acute phase assays are useful for wildlife health assessment, however, they are infrequently utilized in reptiles. This study evaluated erythrocyte sedimentation rate (ESR) in eastern (Terrapene carolina carolina) and ornate box turtles (Terrapene ornata ornata) and hemoglobin-binding protein (HBP) inT.ornata. Erythrocyte sedimentation rate in 90T.carolinaand 105T.ornatawas negatively associated with packed cell volume and was greater in unhealthy turtles (p < 0.05). FemaleT.ornatahad higher ESR values than males (p < 0.05). Measurement of ESR with a microhematocrit tube proportionally overestimated values from a commercial kit (Winpette), though both methods may retain utility with separate reference intervals. Hemoglobin-binding protein concentration in 184T.ornatawas significantly increased in adults and unhealthy turtles (p < 0.05). Erythrocyte sedimentation rate values were similar between seasons and populations, and HBP values were consistent between years, indicating that these analytes may have more stable baseline values than traditional health metrics in reptiles. This study demonstrates that ESR and HBP are promising diagnostics for health assessment in wild box turtles. Incorporating these tests into wild herptile health assessment protocols may support conservation efforts and improve ecosystem health monitoring.	[Adamovicz, Laura; Baker, Sarah J.; Kessler, Ethan; Kelly, Marta; Johnson, Samantha; Winter, John; Allender, Matthew C.] Univ Illinois, Wildlife Epidemiol Lab, Urbana, IL 61801 USA; [Baker, Sarah J.] Arizona Game & Fish Dept, Phoenix, AZ USA; [Kessler, Ethan; Phillips, Christopher A.] Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey	Adamovicz, L (corresponding author), Univ Illinois, Wildlife Epidemiol Lab, Urbana, IL 61801 USA.	adamovi2@illinois.edu		Winter, John/0000-0002-4262-5450; Adamovicz, Laura/0000-0002-5696-2327	Illinois Department of Natural Resources [T104-R-1]; Friends of Nachusa	Illinois Department of Natural Resources; Friends of Nachusa	Our research was partially funded by the Illinois Department of Natural Resources (State Wildlife Grant T104-R-1; MCA, LA), which supported field work and sampling supplies. Website: https://www.dnr.illinois.gov/conservation/IWAP/Pages/StateWildlifeGrants.aspx We were also partially funded by the Friends of Nachusa, which supported ornate box turtle erythrocyte sedimentation rates and hemoglobin binding protein kits (MCA, LA). Website: https://www.nachusagrasslands.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAIGAR T, 1993, J ZOO WILDLIFE MED, V24, P177; Adamovicz L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195617; Ajadi R. A., 2013, Bulgarian Journal of Veterinary Medicine, V16, P37; Allender MC, 2015, J ZOO WILDLIFE MED, V46, P767, DOI 10.1638/2015-0034.1; Allender MC, 2015, ECOTOXICOLOGY, V24, P1269, DOI 10.1007/s10646-015-1498-5; Anderson NL, 1997, J ZOO WILDLIFE MED, V28, P394; Archer GA, 2017, J ZOO WILDLIFE MED, V48, P1127, DOI 10.1638/2017-0148r.1; BABLOK W, 1988, J CLIN CHEM CLIN BIO, V26, P783; Babu Ram, 2008, Journal of Experimental Zoology India, V11, P63; BANERJEE V, 1981, Journal of the Zoological Society of India, V33, P89; Beechler BR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006122; BERESFORD WA, 1981, B ENVIRON CONTAM TOX, V27, P349, DOI 10.1007/BF01611031; Bernal L, 2011, J WILDLIFE DIS, V47, P829, DOI 10.7589/0090-3558-47.4.829; Bertelsen MF, 2009, J ZOO WILDLIFE MED, V40, P199, DOI 10.1638/2007-0125.1; Boers K, 2017, HERPETOL REV, V48, P300; Bondo KJ, 2019, J WILDLIFE DIS, V55, P544, DOI 10.7589/2018-01-018; CAGLE FRED R., 1939, COPEIA, V1939, P170, DOI 10.2307/1436818; Cai J. J., 2011, HUBEI SPORTS SCI TEC, V20, P74; CALLE PP, 1993, ZOO BIOL, V12, P483, DOI 10.1002/zoo.1430120510; Castellanos R., 1979, Zoologische Garten, V49, P69; Cha CH, 2010, CLIN CHEM LAB MED, V48, P1043, DOI 10.1515/CCLM.2010.162; Christopher MM, 1999, J WILDLIFE DIS, V35, P212, DOI 10.7589/0090-3558-35.2.212; Clayton LA, 2012, J ZOO WILDLIFE MED, V43, P961, DOI 10.1638/2012-0110R.1; Cray C, 2013, J ZOO WILDLIFE MED, V44, P1107, DOI 10.1638/2013-0033R.1; Cray C, 2012, PROG MOL BIOL TRANSL, V105, P113, DOI 10.1016/B978-0-12-394596-9.00005-6; Cray C, 2009, COMPARATIVE MED, V59, P517; Delk KW, 2015, J ZOO WILDLIFE MED, V46, P929, DOI 10.1638/2014-0191.1; Depauw S, 2014, J ZOO WILDLIFE MED, V45, P497, DOI 10.1638/2013-0111R1.1; Dickey M, 2014, J ZOO WILDLIFE MED, V45, P700, DOI 10.1638/2013-0262R1.1; Dodd C.K., 2002, N AM BOX TURTLES NAT; Dolka B, 2014, VET RES COMMUN, V38, P93, DOI 10.1007/s11259-014-9589-y; DUFFY LK, 1993, J WILDLIFE DIS, V29, P353, DOI 10.7589/0090-3558-29.2.353; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; Fair Patricia A., 2006, Aquatic Mammals, V32, P182, DOI 10.1578/AM.32.2.2006.182; Farkas SL, 2009, VET MICROBIOL, V138, P169, DOI 10.1016/j.vetmic.2009.03.016; Feldman SH, 2006, J WILDLIFE DIS, V42, P279, DOI 10.7589/0090-3558-42.2.279; Finnegan D, 2014, REFERENCEINTERVALS R; Flower JE, 2014, J ZOO WILDLIFE MED, V45, P836, DOI 10.1638/2014-0035.1; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Ganheim C, 2007, VET J, V173, P645, DOI 10.1016/j.tvjl.2006.01.011; Glidden CK, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01944; Greunz EM, 2018, J ZOO WILDLIFE MED, V49, P361, DOI 10.1638/2017-0221.1; Heatley JJ, 2010, J EXOT PET MED, V19, P160, DOI 10.1053/j.jepm.2010.06.002; Hernandez-Divers Sonia M., 2002, Journal of Herpetological Medicine and Surgery, V12, P32; HOLCOMB CM, 1979, B ENVIRON CONTAM TOX, V23, P369, DOI 10.1007/BF01769972; Horadagoda NU, 1999, VET REC, V144, P437, DOI 10.1136/vr.144.16.437; Horn PS, 2001, CLIN CHEM, V47, P2137; Hyatt MW, 2016, J ZOO WILDLIFE MED, V47, P984, DOI 10.1638/2016-0048.1; Johnson AJ, 2008, J WILDLIFE DIS, V44, P851, DOI 10.7589/0090-3558-44.4.851; Jou JM, 2011, INT J LAB HEMATOL, V33, P125, DOI 10.1111/j.1751-553X.2011.01302.x; Kane LP, 2017, J WILDLIFE DIS, V53, P285, DOI 10.7589/2016-06-138; Kennedy SN, 2019, J WILDLIFE DIS, V55, P91, DOI 10.7589/2017-10-257; Khan MZ, 1997, VET RES COMMUN, V21, P265, DOI 10.1023/A:1005838809787; Krafft BA, 2006, J WILDLIFE DIS, V42, P442, DOI 10.7589/0090-3558-42.2.442; Kratz A, 2017, INT J LAB HEMATOL, V39, P448, DOI 10.1111/ijlh.12693; Krogh AKH, 2014, J ZOO WILDLIFE MED, V45, P306, DOI 10.1638/2013-0153R.1; Krol L, 2014, J ZOO WILDLIFE MED, V45, P782, DOI 10.1638/2013-0303.1; Kusak J, 2005, J WILDLIFE DIS, V41, P843, DOI 10.7589/0090-3558-41.4.843; Le Boedec K, 2016, VET CLIN PATH, V45, P648, DOI 10.1111/vcp.12390; Lee KA, 2015, J WILDLIFE DIS, V51, P860, DOI 10.7589/2014-04-093; Lehnert B., 2015, BLANDALTMANLEH PLOTS; LEVI A, 1989, AVIAN PATHOL, V18, P321, DOI 10.1080/03079458908418605; Lloyd TC, 2016, ECOHEALTH, V13, P467, DOI 10.1007/s10393-016-1142-8; Mahlangu JN, 2008, J CLIN LAB ANAL, V22, P346, DOI 10.1002/jcla.20267; Mahmood A, 2013, J ANIM PLANT SCI-PAK, V23, P364; Manire CA, 2018, J WILDLIFE DIS, V54, P1, DOI 10.7589/2016-07-152; Mazerolle MJ, 2015, AICCMODAVG MODEL SEL; Mellish JA, 2007, WILDLIFE RES, V34, P43, DOI 10.1071/WR06073; Mishra B, 1988, UTTAR PRADESH J ZOOL, V8, P27; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Muro J, 1998, J ZOO WILDLIFE MED, V29, P40; Nakamura M, 2008, J VET MED SCI, V70, P127, DOI 10.1292/jvms.70.127; Nollens HH, 2019, VET CLIN PATH, V48, P100, DOI 10.1111/vcp.12697; Ohno K, 2006, J VET MED SCI, V68, P1275, DOI 10.1292/jvms.68.1275; Orro T, 2004, COMP IMMUNOL MICROB, V27, P413, DOI 10.1016/j.cimid.2004.01.005; Parkinson L, 2016, J ZOO WILDLIFE MED, V47, P754; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Preet K., 2018, INT J RES MED SCI, V6, P628; Rahman MM, 2010, VET PARASITOL, V168, P293, DOI 10.1016/j.vetpar.2009.12.001; Rose Brittany M. Way, 2011, Journal of Herpetological Medicine and Surgery, V21, P107, DOI 10.5818/1529-9651-21.4.107; Rosenberg JF, 2018, J ZOO WILDLIFE MED, V49, P765, DOI 10.1638/2017-0211.1; Rosenberg JF, 2018, J ZOO WILDLIFE MED, V49, P520, DOI 10.1638/2017-0183.1; Rosenberg JF, 2017, J ZOO WILDLIFE MED, V48, P581, DOI 10.1638/2016-228R1.1; Ryser-Degiorgis MP, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-223; Saadeh C, 1998, SOUTHERN MED J, V91, P220; Schuetzenmeister EMA, 2014, METHOD COMP REGRESSI; Shah Y, 1982, J NATL MED ASSOC, V74, P887; Siemons L, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-368; Sim RR, 2015, VET MICROBIOL, V175, P218, DOI 10.1016/j.vetmic.2014.11.029; SKINNER JG, 1994, VET REC, V134, P33, DOI 10.1136/vr.134.2.33; Smitka P, 2015, ACTA VET BRNO, V84, P25, DOI 10.2754/avb201584010025; SOLTER PF, 1991, AM J VET RES, V52, P1738; Stallknecht DE, 2007, CURR TOP MICROBIOL, V315, P445; Stay NI, 2011, CLIN LAB MED, V31, P87, DOI 10.1016/j.cll.2010.10.006; Sykes John M., 2015, Veterinary Clinics of North America Exotic Animal Practice, V18, P63, DOI 10.1016/j.cvex.2014.09.011; Tamukai K, 2011, VET CLIN PATH, V40, P368, DOI 10.1111/j.1939-165X.2011.00329.x; Tangredi BP, 1997, J ZOO WILDLIFE MED, V28, P97; Team RC., 2013, R LANG ENV STAT COMP; Tecles F, 2007, VET RES COMMUN, V31, P23, DOI 10.1007/s11259-006-3397-y; Thomton JD, 2007, J WILDLIFE DIS, V43, P258, DOI 10.7589/0090-3558-43.2.258; Tsai YL, 2016, AQUAT MAMM, V42, P494, DOI 10.1578/AM.42.4.2016.494; Tvarijonaviciute A, 2017, J WILDLIFE DIS, V53, P718, DOI 10.7589/2016-06-126; van Dijk, 2011, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2011-1.RLTS.T21641A9303747.en, DOI 10.2305/IUCN.UK.2011-1.RLTS.T21641A9303747.EN, 10.2305/IUCN.UK.2011-1.RLTS.T163444A5606651.en]; Varela M de LL, 2009, ENFERMEDADES INFECC, V29, P66; Venn-Watson S, 2008, J WILDLIFE DIS, V44, P318, DOI 10.7589/0090-3558-44.2.318; Venn-Watson Stephanie, 2014, Comparative Clinical Pathology, V23, P1031, DOI 10.1007/s00580-013-1738-0; Venn-Watson S, 2011, J COMP PHYSIOL B, V181, P667, DOI 10.1007/s00360-011-0549-3; VERMA G K, 1981, Annals of Zoology (Agra), V18, P135; Wells RS, 2013, MAR MAMMAL SCI, V29, pE463, DOI 10.1111/mms.12007; Wicher KB, 2006, P NATL ACAD SCI USA, V103, P4168, DOI 10.1073/pnas.0508723103; WOJTASZEK JS, 1991, COMP BIOCHEM PHYS A, V100, P805, DOI 10.1016/0300-9629(91)90296-O; Yonkers SB, 2015, J VET DIAGN INVEST, V27, P408, DOI 10.1177/1040638715589612; ZentenoSavin T, 1997, J WILDLIFE DIS, V33, P64, DOI 10.7589/0090-3558-33.1.64	114	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234805	10.1371/journal.pone.0234805	http://dx.doi.org/10.1371/journal.pone.0234805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555669	Green Published, gold			2022-12-27	WOS:000542759600030
J	Husaini, DC; Kishan, UJV; Wu, CY; Guerra, EN; Bush, CJ; Perez, AW; Coc, I				Husaini, Danladi Chiroma; Kishan, Uppala Jyana Venkata; Wu, Chen-Yi; Guerra, Elsbeth Nerissa; Bush, Cindy J.; Perez, Ayleen Walewska; Coc, Israel			Field-based screening of selected oral antibiotics in Belize	PLOS ONE			English	Article								Introduction The presence of poor quality antibiotics on the market has contributed to the antibiotics resistance and global threat to public health. Antibiotic resistance is now a global concern. One area to address this issue is by evaluating the quality of antibiotics accessible to the public. The purpose of this study was to test and compare (with corresponding pharmacopeia) the quality of common oral antibiotics available in the country of Belize with a view to providing base-line data on the testing of medications imported to the country for public consumption. The study focused only on level 2 field-based screening quality assurance on three Key Access Antibiotics from the World Health Organization (WHO) Model List of Essential Medicines. Methods Five brands of antibiotic tablets/capsules with denoted pharmacopeia imported into the country of Belize were tested for quality at The University of Belize pharmacy laboratory. A sample of 30 tablets/capsules each of the selected antibiotic brand were used for study. Visual inspection and weight variation were done for each sample while Monsanto type tablet hardness tester, Roche(@)Tablet Friability Test Apparatus (single drum), and Ajanta(@)Tablet Disintegration Test Apparatus (double basket) were conducted on selected antibiotics. Results were recorded and compared with corresponding pharmacopoeia references. Results Most of the samples collected passed performed tests. Only a few samples from both BP and USP antibiotics failed in visual inspection and weight variation tests. All antibiotics tested conformed to their corresponding pharmacopeia reference in terms of friability and disintegration time. Conclusion Most of the selected antibiotics passed performed tests when compared with their pharmacopeia. Only a few samples from both BP and USP antibiotics failed the tests conducted. There is need for regular quality assurance tests on all medications imported to Belize especially antibiotics.	[Husaini, Danladi Chiroma; Kishan, Uppala Jyana Venkata] Univ Belize, Fac Hlth Sci, Pharm Program, Belmopan City, Cayo District, Belize; [Wu, Chen-Yi] La Sante Pharm, San Ignacio Town, Cayo District, Belize; [Guerra, Elsbeth Nerissa] Friendly Pharm, Belmopan City, Cayo District, Belize; [Bush, Cindy J.] CJS Pharm, Benque Viejo Del Carmen, Cayo District, Belize; [Perez, Ayleen Walewska] Genesis Med Clin, Orange Walk Town, Orange Walk Dis, Belize; [Coc, Israel] Codds Pharm, Belmopan City, Cayo District, Belize		Husaini, DC (corresponding author), Univ Belize, Fac Hlth Sci, Pharm Program, Belmopan City, Cayo District, Belize.	hchiroma@ub.edu.bz	Husaini, Danladi/AAP-7793-2020	Husaini, Danladi/0000-0003-1655-2873				Addae-Mensah I, 2005, WHO TECH REP SER, V929, P1; [Anonymous], 2013, NATURE, V495, P141, DOI 10.1038/495141a; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2014, J CLIN DIAGN RES, V8; [Anonymous], 2014, DIABETES CARE, V38, pS1; [Anonymous], 2013, CAN J DIABETES S3, V37, pS357; [Anonymous], 2009, KIDNEY INT, V6, pS1; Bartlett JG, 2013, CLIN INFECT DIS, V56, P1445, DOI 10.1093/cid/cit070; British Pharmacopoeia, 2016, FRIAB, pV; British Pharmacopoeia, 2016, DIS, pV; British Pharmacopoeia, 2016, CONS FORM PREP, pV; British Pharmacopoeia, 2016, RES CRUSH TABL, pV; Centers for Disease Control and Prevention, 2018, BIGG THREATS DAT; Dall C, 2018, CIDRAP NEWS     1106; Gross M, ANTIBIOTICS CRISIS; Heyman ML, 2011, J PHARM SCI-US, V100, P1280, DOI 10.1002/jps.22391; IBM Corp. Released, 2017, IBM SPSS STAT WIND V; International Pharmaceutical Federation, 2009, FIP FRAM EST NAT GUI, P16; Kumar DD, 2017, INT J EDUC MATH SCI, V5, P53, DOI 10.18404/ijemst.69590; Michael CA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00145; Microsoft Corporation, 2007, MICR OFF EXC 2007 SO; Nkansah P, 2017, GUIDANCE IMPLEMENTIN; Nwokike J, 2018, B WORLD HEALTH ORGAN, V96, P135, DOI 10.2471/BLT.17.199562; Pharmapporach, 2019, PHARM QUAL CONTR TES; Pisani E, 2015, REV ANTIMICROBIAL RE; ReAct, 2014, PROBL REL QUAL ANT; Sumpradit N, 2017, BMJ-BRIT MED J, V358, P20, DOI 10.1136/bmj.j2423; United States Pharmacopeia, 2011, TABL BREAK FORC; United States Pharmacopeia, 2011, TABL FRIAB; United States Pharmacopeia, 2008, DIS; United States Pharmacopeia, 2011, UN DOS UN; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Ventola C Lee, 2015, P T, V40, P344; WHO (WorldHealthOrganization), 2018, WHO FACT SHEETS; World Health Organization, 1994, BAS TESTS PHARM DOS; World Health Organization, 1996, GUID STAB TEST PHARM; Zaid AN, 2013, SAUDI PHARM J, V21, P71, DOI 10.1016/j.jsps.2011.12.009	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234814	10.1371/journal.pone.0234814	http://dx.doi.org/10.1371/journal.pone.0234814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555711	gold, Green Published			2022-12-27	WOS:000542759600041
J	Playford, RJ; Cattell, M; Marchbank, T				Playford, Raymond J.; Cattell, Meg; Marchbank, Tania			Marked variability in bioactivity between commercially available bovine colostrum for human use; implications for clinical trials	PLOS ONE			English	Article							SECRETORY TRYPSIN-INHIBITOR; HEALTH FOOD SUPPLEMENT; GROWTH-FACTORS; INCREASE; PEPTIDE; MUCOSA; SYSTEM; DAMAGE; MODEL; MILK	Background Colostrum, the milk produced during first few days after birth, is rich in immunoglobulins, antimicrobial peptides & growth factors. Multiple clinical trials using bovine colostrum are ongoing but with no assessment of test product bioactivity. Objectives To examine variability of bioactivity between 20 commercial colostrum products, contribution of TGF beta and EGFR in mediating effects, heat sensitivity of bioactivity and changes in bioactivity of colostrum milkings in the days following calving. Design In vitro bioactivity used AGS, RIE-1 and Caco-2 cell proliferation (Alamar blue) and migration (wounded monolayers) assays. Changes in colostrum bioactivity determined following addition of TGF beta-neutralising antibody, EGFR blocker (Typhostin) and after heating (40-60 degrees C, 60 min). In vivo bioassay assessed ability of colostrum gavage (2ml, 7mg/ml) to reduce gastric damage (NSAID + restraint) in rats. Milkings from 6 cows, days 0-3 post calving were assessed for bioactivity and growth factor concentrations. Result Six-fold differences in pro-proliferative and migratory activity were seen comparing commercial products. Comparison of most- and least-active samples from in vitro studies showed two- to three-fold differences in ability to reduce gastric injury (86% reduction using most-active vs 48% using least-active, p<0.01). Tyrphostin reduced pro-migratory and proliferative activity by 23% and 55%. TGF beta neutralisation reduced migratory activity by 83% but did not affect proliferation Heating colostrum powder to 50 degrees C did not affect immunoactivity of haptoglobin, EGF, TGF beta, IgG, IGF-1 or betacellulin but decreased bioactivity by >40%. Milking studies showed high bioactivity during first and second milkings on day 0 but 77% reduction by day 3. Changes in total protein, haptoglobin, EGF, TGF beta, IgG and IGF-1 paralleled falls in bioactivity. Conclusion Commercial colostrum products possess widely different bioactivity. Variation in heat exposure and/or proportion of day 0 colostrum content may contribute to this. Assessment of colostrum bioactivity has advantages to growth factor quantitation for quality control.	[Playford, Raymond J.; Marchbank, Tania] Queen Mary Univ London, Ctr Immunobiol, Barts & London Sch Med, Blizard Inst, London, England; [Playford, Raymond J.] Univ Plymouth, Peninsula Med Sch, Plymouth, Devon, England; [Playford, Raymond J.; Cattell, Meg] Pantheryx Inc, Dept Res & Dev, Boulder, CO USA	University of London; Queen Mary University London; University of Plymouth	Marchbank, T (corresponding author), Queen Mary Univ London, Ctr Immunobiol, Barts & London Sch Med, Blizard Inst, London, England.	t.marchbank@qmul.ac.uk		Playford, Raymond/0000-0003-1235-8504	Pantheryx Inc.	Pantheryx Inc.	Partially funded by Pantheryx Inc. The funder provided support in the form of salaries for authors (RJP, MC) and provided partial funding for TM in her role as an external consultant. Pantheryx did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	BARRANCO SC, 1983, CANCER RES, V43, P1703; BLAY J, 1984, CELL BIOL INT REP, V8, P551, DOI 10.1016/0309-1651(84)90054-7; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Fiske WH, 2009, EXP CELL RES, V315, P583, DOI 10.1016/j.yexcr.2008.10.043; FitzGerald AJ, 2004, PEPTIDES, V25, P793, DOI 10.1016/j.peptides.2003.12.022; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Gauthier SF, 2006, LAIT, V86, P99, DOI 10.1051/lait:2005048; Jones AW, 2016, BMC SPORTS SCI MED R, V8, DOI 10.1186/s13102-016-0047-8; Khan Z, 2002, ALIMENT PHARM THER, V16, P1917, DOI 10.1046/j.1365-2036.2002.01354.x; Kotsis Y, 2018, EUR J NUTR, V57, P1181, DOI 10.1007/s00394-017-1401-7; LEVI S, 1994, BRIT J RHEUMATOL, V33, P605; M'Rabet L, 2008, J NUTR, V138, p1782S, DOI 10.1093/jn/138.9.1782S; Marchbank T, 1996, AM J PATHOL, V148, P715; Marchbank T, 2007, AM J PATHOL, V171, P1462, DOI 10.2353/ajpath.2007.070192; Marchbank T, 2011, AM J PHYSIOL-GASTR L, V300, pG477, DOI 10.1152/ajpgi.00281.2010; Marchbank T, 2009, AM J PHYSIOL-GASTR L, V296, pG697, DOI 10.1152/ajpgi.90565.2008; McGrath BA, 2016, DAIRY SCI TECHNOL, V96, P133, DOI 10.1007/s13594-015-0258-x; Mihic T, 2016, J EVID-BASED INTEGR, V21, pNP110, DOI 10.1177/2156587216658846; Playford RJ, 2020, J NUTR, V150, P1434, DOI 10.1093/jn/nxaa083; PLAYFORD RJ, 1991, DIGESTION, V49, P198, DOI 10.1159/000200722; Playford RJ, 2001, CLIN SCI, V100, P627, DOI 10.1042/CS20010015; Playford RJ, 2000, AM J CLIN NUTR, V72, P5; Playford RJ, 1999, GUT, V44, P653, DOI 10.1136/gut.44.5.653; Rathe M, 2014, NUTR REV, V72, P237, DOI 10.1111/nure.12089; Sobczuk-Szul G, 2003, TURK J VET ANIM SCI, V37, P43; SVANES K, 1982, GASTROENTEROLOGY, V82, P1409	26	15	16	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234719	10.1371/journal.pone.0234719	http://dx.doi.org/10.1371/journal.pone.0234719			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555629	gold, Green Published			2022-12-27	WOS:000542759600017
J	Gruner, E; Wachendorf, M; Astor, T				Gruener, Esther; Wachendorf, Michael; Astor, Thomas			The potential of UAV-borne spectral and textural information for predicting aboveground biomass and N fixation in legume-grass mixtures	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; SUPPORT VECTOR MACHINE; NITROGEN-FIXATION; RUMEX-OBTUSIFOLIUS; VEGETATION INDEXES; FIXED NITROGEN; AGRICULTURE; QUALITY; FOREST; YIELD	Organic farmers, who rely on legumes as an external nitrogen (N) source, need a fast and easy on-the-go measurement technique to determine harvestable biomass and the amount of fixed N (N-Fix) for numerous farm management decisions. Especially clover- and lucerne-grass mixtures play an important role in the organic crop rotation under temperate European climate conditions. Multispectral sensors mounted on unmanned aerial vehicles (UAVs) are new promising tools for a non-destructive assessment of crop and grassland traits on large and remote areas. One disadvantage of multispectral information and derived vegetations indices is, that both ignore spatial relationships of pixels to each other in the image. This gap can be filled by texture features from a grey level co-occurrence matrix. The aim of this multi-temporal field study was to provide aboveground biomass and N(Fix)estimation models for two legume-grass mixtures through a whole vegetation period based on UAV multispectral information. The prediction models covered different proportions of legumes (0-100% legumes) to represent the variable conditions in practical farming. Furthermore, the study compared prediction models with and without the inclusion of texture features. As multispectral data usually suffers from multicollinearity, two machine learning algorithms, Partial Least Square and Random Forest (RF) regression, were used. The results showed, that biomass prediction accuracy for the whole dataset as well as for crop-specific models were substantially improved by the inclusion of texture features. The best model was generated for the whole dataset by RF with an rRMSE of 10%. For N(Fix)prediction accuracy of the best model was based on RF including texture (rRMSEP = 18%), which was not consistent with crop specific models.	[Gruener, Esther; Wachendorf, Michael; Astor, Thomas] Univ Kassel, Grassland Sci & Renewable Plant Resources, Organ Agr Sci, Witzenhausen, Germany	Universitat Kassel	Gruner, E (corresponding author), Univ Kassel, Grassland Sci & Renewable Plant Resources, Organ Agr Sci, Witzenhausen, Germany.	gnr@uni-kassel.de	Astor, Thomas/G-9944-2018; Wachendorf, Michael/ABG-9819-2020	Astor, Thomas/0000-0003-4608-955X; Wachendorf, Michael/0000-0002-2840-7086; Gruner, Esther/0000-0002-5015-6738				Aasen H, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10071091; Gallardo-Cruz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030506; Ali I, 2017, IEEE J-STARS, V10, P3254, DOI 10.1109/JSTARS.2016.2561618; [Anonymous], 2017, NCCN PRACT GUIDEL, V2017, P1, DOI DOI 10.1155/2017/2683789; Askari MS, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11151835; Assmann JJ, 2019, J UNMANNED VEH SYST, V7, P54, DOI 10.1139/juvs-2018-0018; Barrett B, 2014, REMOTE SENS ENVIRON, V152, P109, DOI 10.1016/j.rse.2014.05.018; Belgiu M, 2016, ISPRS J PHOTOGRAMM, V114, P24, DOI 10.1016/j.isprsjprs.2016.01.011; Bellis LM, 2008, ECOL APPL, V18, P1956, DOI 10.1890/07-0243.1; Bendig J, 2015, INT J APPL EARTH OBS, V39, P79, DOI 10.1016/j.jag.2015.02.012; Berry PM, 2002, SOIL USE MANAGE, V18, P248, DOI 10.1079/SUM2002129; Biewer S, 2009, PRECIS AGRIC, V10, P128, DOI 10.1007/s11119-008-9078-9; BOLLER BC, 1987, PLANT SOIL, V104, P219, DOI 10.1007/BF02372535; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cai SM, 2010, MATH COMPUT MODEL, V51, P1319, DOI 10.1016/j.mcm.2009.10.037; Capolupo A, 2015, ISPRS INT J GEO-INF, V4, P2792, DOI 10.3390/ijgi4042792; Carlsson G, 2003, PLANT SOIL, V253, P353, DOI 10.1023/A:1024847017371; Cho MA, 2007, INT J APPL EARTH OBS, V9, P414, DOI 10.1016/j.jag.2007.02.001; Coburn CA, 2004, INT J REMOTE SENS, V25, P4287, DOI 10.1080/0143116042000192367; Culbert PD, 2009, IEEE J-STARS, V2, P299, DOI 10.1109/JSTARS.2009.2021959; Elgersma A, 2018, GRASS FORAGE SCI, V73, P78, DOI 10.1111/gfs.12287; Eriksen J, 2006, AGR ECOSYST ENVIRON, V116, P165, DOI 10.1016/j.agee.2006.02.004; Fustec J, 2010, AGRON SUSTAIN DEV, V30, P57, DOI 10.1051/agro/2009003; Gebhardt S, 2007, PRECIS AGRIC, V8, P1, DOI 10.1007/s11119-006-9024-7; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Guo X, 2004, J ENVIRON INFORM, V3, P24, DOI 10.3808/jei.200400024; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He Y, 2006, CAN J REMOTE SENS, V32, P98, DOI 10.5589/m06-009; Hogh-Jensen H, 2004, AGR SYST, V82, P181, DOI 10.1016/j.agsy.2003.12.003; HUETE AR, 1985, REMOTE SENS ENVIRON, V17, P37, DOI 10.1016/0034-4257(85)90111-7; JACKSON RD, 1991, PREV VET MED, V11, P185, DOI 10.1016/S0167-5877(05)80004-2; Kaufman YJ, 1992, GEOSC REM SENS S IGR, P1238, DOI DOI 10.1109/IGARSS.1992.578402; Knoblauch C, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17071483; Konstantinides SV, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01647-2019; KOPKE U, 1995, BIOL AGRIC HORTIC, V11, P15; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kupidura P, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11101233; Kusumo BH, 2011, PLANT SOIL, V338, P233, DOI 10.1007/s11104-010-0501-4; Laliberte AS, 2011, REMOTE SENS-BASEL, V3, P2529, DOI 10.3390/rs3112529; Laliberte AS, 2009, IEEE T GEOSCI REMOTE, V47, P761, DOI 10.1109/TGRS.2008.2009355; LEDGARD SF, 1992, PLANT SOIL, V141, P137, DOI 10.1007/BF00011314; Li SY, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11151763; Lu D, 2005, INT J REMOTE SENS, V26, P2509, DOI 10.1080/01431160500142145; Melander B, 2016, AGR ECOSYST ENVIRON, V220, P184, DOI 10.1016/j.agee.2016.01.016; Morin D, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11111275; Nyfeler D, 2011, AGR ECOSYST ENVIRON, V140, P155, DOI 10.1016/j.agee.2010.11.022; Ollinger SV, 2011, NEW PHYTOL, V189, P375, DOI 10.1111/j.1469-8137.2010.03536.x; Psomas A, 2011, INT J REMOTE SENS, V32, P9007, DOI 10.1080/01431161.2010.532172; Rasmussen J, 2016, EUR J AGRON, V74, P75, DOI 10.1016/j.eja.2015.11.026; Rasmussen J, 2012, EUR J AGRON, V36, P66, DOI 10.1016/j.eja.2011.09.003; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; Rouse Jr J.W., 1974, P 3 EARTH RESOURCES, DOI DOI 10.1002/MRM.26868; Schellberg J, 2008, EUR J AGRON, V29, P59, DOI 10.1016/j.eja.2008.05.005; Schroder JJ, 2004, ENVIRON SCI POLICY, V7, P15, DOI 10.1016/j.envsci.2003.10.006; Shah A, 2017, EUR J AGRON, V90, P12, DOI 10.1016/j.eja.2017.07.001; STULPNAGEL R, 1982, Z ACKER PFLANZENBAU, V151, P446; Suter M, 2015, GLOBAL CHANGE BIOL, V21, P2424, DOI 10.1111/gcb.12880; Thilakarathna MS, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8050078; van Eekeren N, 2009, APPL SOIL ECOL, V42, P254, DOI 10.1016/j.apsoil.2009.04.006; van Evert FK, 2009, WEED RES, V49, P164, DOI 10.1111/j.1365-3180.2008.00682.x; von Bueren SK, 2015, BIOGEOSCIENCES, V12, P163, DOI 10.5194/bg-12-163-2015; Wachendorf M, 2018, GRASS FORAGE SCI, V35, P201; Wan SA, 2019, INT J REMOTE SENS, V40, P8076, DOI 10.1080/01431161.2018.1539275; Wang XX, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11161927; Wijaya Arief, 2010, Journal of Forestry Research (Harbin), V21, P1, DOI 10.1007/s11676-010-0001-7; Wood EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063211; Wood EM, 2012, REMOTE SENS ENVIRON, V121, P516, DOI 10.1016/j.rse.2012.01.003; Yang, 2012, ULTRASOUND GLCM TEXT; Yao H, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11121443; Yu X, 2017, INT J REMOTE SENS, V38, P3101, DOI 10.1080/01431161.2016.1230291; Zheng HB, 2019, PRECIS AGRIC, V20, P611, DOI 10.1007/s11119-018-9600-7; Zhou J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03571-6; Zhou ZJ, 2019, COMPUT ELECTRON AGR, V162, P246, DOI 10.1016/j.compag.2019.03.038	73	28	28	7	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234703	10.1371/journal.pone.0234703	http://dx.doi.org/10.1371/journal.pone.0234703			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584839	Green Published, gold			2022-12-27	WOS:000545747200048
J	Ji, J; Wang, C; He, ZL; Hay, KE; Barnes, TS; O'Connor, AM				Ji, Ju; Wang, Chong; He, Zhulin; Hay, Karen E.; Barnes, Tamsin S.; O'Connor, Annette M.			Comparing the estimates of effect obtained from statistical causal inference methods: An example using bovine respiratory disease in feedlot cattle	PLOS ONE			English	Article							VIRAL DIARRHEA VIRUS; PROPENSITY SCORE; EXPOSURE; RISK	The causal effect of an exposure on an outcome of interest in an observational study cannot be estimated directly if the confounding variables are not controlled. Many approaches are available for estimating the causal effect of an exposure. In this manuscript, we demonstrate the advantages associated with using inverse probability weighting (IPW) and doubly robust estimation of the odds ratio in terms of reduced bias. IPW approach can be used to adjust for confounding variables and provide unbiased estimates of the exposure's causal effect. For cluster-structured data, as is common in animal populations, inverse conditional probability weighting (ICPW) approach can provide a robust estimation of the causal effect. Doubly robust estimation can provide a robust method even when the specification of the model form is uncertain. In this paper, the usage of IPW, ICPW, and doubly robust approaches are illustrated with a subset of data with complete covariates from the Australian-based National Bovine Respiratory Disease Initiative as well as simulated data. We evaluate the causal effect of prior bovine viral diarrhea exposure on bovine respiratory disease in feedlot cattle. The results show that the IPW, ICPW and doubly robust approaches would provide a more accurate estimation of the exposure effect than the traditional outcome regression model, and doubly robust approaches are the most preferable overall.	[Ji, Ju; Wang, Chong; He, Zhulin] Iowa State Univ, Dept Stat, Ames, IA 50011 USA; [Hay, Karen E.] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Barnes, Tamsin S.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Hay, Karen E.; Barnes, Tamsin S.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Gatton, Qld, Australia; [O'Connor, Annette M.] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [O'Connor, Annette M.] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA	Iowa State University; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; Iowa State University; Michigan State University	Ji, J (corresponding author), Iowa State Univ, Dept Stat, Ames, IA 50011 USA.	ji_ju@lilly.com	O'Connor, A/AFK-8069-2022; Wang, Chong/AAI-3796-2020; O'Connor, A/E-5591-2010; Hay, Karen/AAY-7863-2021; O'Connor, Annette/GRX-1453-2022	O'Connor, A/0000-0003-0604-7822; Wang, Chong/0000-0003-4489-4344; O'Connor, A/0000-0003-0604-7822; Hay, Karen/0000-0001-8813-5855; O'Connor, Annette/0000-0003-0604-7822; Ji, Ju/0000-0001-7281-1636				[Anonymous], 2016, ZOONOSES PUBLIC HLTH, DOI DOI 10.1111/zph.12315; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Funk MJ, 2011, AM J EPIDEMIOL, V173, P761, DOI 10.1093/aje/kwq439; Greenland S, 1999, STAT SCI, V14, P29; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Greenland Sander, 2009, Epidemiol Perspect Innov, V6, P4, DOI 10.1186/1742-5573-6-4; Hay K, 2015, EPIDEMIOLOGY BOVINE; Hay KE, 2016, PREV VET MED, V127, P121, DOI 10.1016/j.prevetmed.2016.01.024; Hay KE, 2016, PREV VET MED, V126, P159, DOI 10.1016/j.prevetmed.2016.01.025; He Z, 2018, ARXIV180801647; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Hernan MA, 2011, INT J EPIDEMIOL, V40, P780, DOI 10.1093/ije/dyr041; Hernan Miguel A, 2019, CAUSAL INFERENCE WHA; Larson RL, 2015, VET CLIN N AM-FOOD A, V31, P367, DOI 10.1016/j.cvfa.2015.05.007; Martin W, 2014, PREV VET MED, V113, P281, DOI 10.1016/j.prevetmed.2013.09.006; O'Connor A, 2001, CAN J VET RES, V65, P137; Persson E, 2013, STAT MED, V32, P2500, DOI 10.1002/sim.5826; Rose S, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1127; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be	24	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0233960	10.1371/journal.pone.0233960	http://dx.doi.org/10.1371/journal.pone.0233960			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584812	Green Published, gold			2022-12-27	WOS:000545747200039
J	Nagasawa, T; Ohta, M; Uchiyama, H				Nagasawa, Takumi; Ohta, Mitsuaki; Uchiyama, Hidehiko			Effects of the characteristic temperament of cats on the emotions and hemodynamic responses of humans	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; EXECUTIVE FUNCTION; DOG; OWNER; METAANALYSIS; OXYTOCIN; EXERCISE; AROUSAL; SIGNALS; SYSTEMS	Cats positive effects on their owners' physiological and psychological health, including improved mood and activation of the human prefrontal cortex and inferior frontal gyrus in the brain. However, the association between the health benefits provided by cat ownership and the characteristic behaviors and reactions of cats is unclear. We recruited 29 participants to measure human prefrontal cortex activity, using functional near-infrared spectroscopy, during interactions with a cat. After the experiments, participants subjectively responded to a questionnaire regarding success rates for interactions with the cat, and completed the Self-assessment Manikin-a scale used to measure emotion. Interactions comprised eight types in four categories (touch, play, train, and feed). This study showed that interactions with a cat significantly activated the prefrontal cortex, regardless of interaction type. During training, the integral values of oxygenated hemoglobin in the left inferior frontal gyrus were the highest in all the interaction categories; however, success rates were lower than in the touch and feed interactions. Regarding the Self-assessment Manikin scores, all interaction categories showed a positive correlation between success rate and valence score, especially in the train and play interactions than in the touch and feed interactions. These results indicate that interactions with a cat activate the prefrontal cortex in humans, including the inferior frontal gyrus region. Moreover, cats' autonomous behaviors and reactions positively influenced the participants. The characteristic temperament of cats may be a key factor influencing the health benefits of owning cats.	[Nagasawa, Takumi; Ohta, Mitsuaki] Tokyo Univ Agr, Grad Sch Agr Studies, Atsugi, Kanagawa, Japan; [Uchiyama, Hidehiko] Tokyo Univ Agr, Fac Agr, Atsugi, Kanagawa, Japan	Tokyo University of Agriculture; Tokyo University of Agriculture	Uchiyama, H (corresponding author), Tokyo Univ Agr, Fac Agr, Atsugi, Kanagawa, Japan.	h3uchiya@nodai.ac.jp		Uchiyama, Hidehiko/0000-0002-1259-3267; Nagasawa, Takumi/0000-0003-1624-1354				[Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 1992, AAS, V84, P717; [Anonymous], 2012, FRONT PSYCHOL, DOI DOI 10.3389/FPSYG.2012.00234; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2019, PRION S1, V13, P1, DOI [10.1080/19336896.2019.1615197, DOI 10.1080/19336896.2019.1615197]; Becker JL, 2017, ANTHROZOOS, V30, P307, DOI 10.1080/08927936.2017.1311055; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bradshaw JWS, 2016, J VET BEHAV, V11, P113, DOI 10.1016/j.jveb.2015.09.004; Branson S, 2016, ANTHROZOOS, V29, P323, DOI 10.1080/08927936.2016.1152764; Byun KH, 2014, NEUROIMAGE, V98, P336, DOI 10.1016/j.neuroimage.2014.04.067; CROWELL S., 2007, TRANSCENDENTAL HEIDE, P1; Dinis F., 2016, PET BEHAV SCI, V1, P1, DOI DOI 10.21071/PBS.V0I1.3986; Doi T, 2013, AGING CLIN EXP RES, V25, P539, DOI 10.1007/s40520-013-0119-5; Driscoll C, 2011, J HERED, V102, pS87, DOI 10.1093/jhered/esr047; Driscoll CA, 2009, P NATL ACAD SCI USA, V106, P9971, DOI 10.1073/pnas.0901586106; Germone MM, 2019, AUTISM, V23, P1740, DOI 10.1177/1362361319827411; Grant RA, 2019, APPL ANIM BEHAV SCI, V211, P77, DOI 10.1016/j.applanim.2018.12.002; Growth from knowledge, 2016, PET OWN GLOB GFK SUR, P1; Growth from knowledge, 2017, REG ACT MAINT PHYS H; Hart LA, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00039; Hartwright CE, 2016, CORTEX, V85, P133, DOI 10.1016/j.cortex.2016.10.005; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Howell TJ, 2017, BEHAV PROCESS, V141, P305, DOI 10.1016/j.beproc.2017.02.024; Hu YW, 2014, P NATL ACAD SCI USA, V111, P116, DOI 10.1073/pnas.1311439110; Jabbi M, 2008, EMOTION, V8, P775, DOI 10.1037/a0014194; Japan pet food association, 2018, ANN NAT PET OWN SURV; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Keuken MC, 2011, BRAIN RES, V1383, P196, DOI 10.1016/j.brainres.2011.01.073; Kobayashi A, 2017, ANTHROZOOS, V30, P473, DOI 10.1080/08927936.2017.1335115; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Liakakis G, 2011, BEHAV BRAIN RES, V225, P341, DOI 10.1016/j.bbr.2011.06.022; Ling DS, 2016, SOCIAL NEUROSCIENCE, P51; Marinelli L, 2007, APPL ANIM BEHAV SCI, V108, P143, DOI 10.1016/j.applanim.2006.11.018; Miyaji K, 2014, ANTHROZOOS, V27, P165, DOI 10.2752/175303714X13903827487368; Motooka M, 2006, MED J AUSTRALIA, V184, P60, DOI 10.5694/j.1326-5377.2006.tb00116.x; Mubanga M, 2017, SCI REP, V7, P1; Nagasawa M, 2015, SCIENCE, V348, P333, DOI 10.1126/science.1261022; Nagasawa M, 2009, HORM BEHAV, V55, P434, DOI 10.1016/j.yhbeh.2008.12.002; O'Haire ME, 2013, J AUTISM DEV DISORD, V43, P1606, DOI 10.1007/s10803-012-1707-5; Qureshi Adnan I, 2009, J Vasc Interv Neurol, V2, P132; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Stammbach KB, 1999, ANTHROZOOS, V12, P162, DOI 10.2752/089279399787000237; Strickler BL, 2013, J VET BEHAV, V9, P207; Tomaszewska K., 2017, POL ANN MED, V24, P283, DOI [10.1016/j.poamed.2016.11.011, DOI 10.1016/J.POAMED.2016.11.011]; Turner DC, 2003, ANTHROZOOS, V16, P213, DOI 10.2752/089279303786992143; Willson EK, 2017, J VET BEHAV, V21, P64, DOI 10.1016/j.jveb.2017.07.007; Wood LL, 2011, NEW DIR HUM-ANIM BON, P51; Yuan P, 2014, NEUROSCI BIOBEHAV R, V42, P180, DOI 10.1016/j.neubiorev.2014.02.005; Zhang F, 2019, INT J PSYCHOPHYSIOL, V137, P41, DOI 10.1016/j.ijpsycho.2019.01.003	50	5	5	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235188	10.1371/journal.pone.0235188	http://dx.doi.org/10.1371/journal.pone.0235188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584860	gold, Green Published			2022-12-27	WOS:000545747200031
J	Redekar, NR; Glover, NM; Biyashev, RM; Ha, BK; Raboy, V; Maroof, MAS				Redekar, Neelam R.; Glover, Natasha M.; Biyashev, Ruslan M.; Ha, Bo-Keun; Raboy, Victor; Maroof, M. A. Saghai			Genetic interactions regulating seed phytate and oligosaccharides in soybean (Glycine max L.)	PLOS ONE			English	Article							RAFFINOSE FAMILY OLIGOSACCHARIDES; PHYTIC ACID PHENOTYPE; MOLECULAR CHARACTERIZATION; REDUCED PHYTATE; MYOINOSITOL; PHOSPHORUS; BIOSYNTHESIS; MUTATIONS; QUALITY; TRAITS	Two low-phytate soybean (Glycine max(L.) Merr.) mutant lines- V99-5089 (mipsmutation on chromosome 11) and CX-1834 (mrp-landmrp-nmutations on chromosomes 19 and 3, respectively) have proven to be valuable resources for breeding of low-phytate, high-sucrose, and low-raffinosaccharide soybeans, traits that are highly desirable from a nutritional and environmental standpoint. A recombinant inbred population derived from the cross CX1834 x V99-5089 provides an opportunity to study the effect of different combinations of these three mutations on soybean phytate and oligosaccharides levels. Of the 173 recombinant inbred lines tested, 163 lines were homozygous for various combinations of MIPS and two MRP loci alleles. These individuals were grouped into eight genotypic classes based on the combination of SNP alleles at the three mutant loci. The two genotypic classes that were homozygousmrp-l/mrp-nand either homozygous wild-type or mutant at themipslocus (MIPS/mrp-l/mrp-normips/mrp-l/mrp-n) displayed relatively similar similar to 55% reductions in seed phytate, 6.94 mg g(-1)and 6.70 mg g(-1)respectively, as compared with 15.2 mg g(-1)in the wild-type MIPS/MRP-L/MRP-N seed. Therefore, in the presence of the double mutantmrp-l/mrp-n, themipsmutation did not cause a substantially greater decrease in seed phytate level. However, the nutritionally-desirable high-sucrose/low-stachyose/low-raffinose seed phenotype originally observed in soybeans homozygous for themipsallele was reversed in the presence ofmrp-l/mrp-nmutations: homozygousmips/mrp-l/mrp-nseed displayed low-sucrose (7.70%), high-stachyose (4.18%), and the highest observed raffinose (0.94%) contents per gram of dry seed. Perhaps the block in phytic acid transport from its cytoplasmic synthesis site to its storage site, conditioned bymrp-l/mrp-n, alters myo-inositol flux inmipsseeds in a way that restores to wild-type levels themipsconditioned reductions in raffinosaccharides. Overall this study determined the combinatorial effects of three low phytic acid causing mutations on regulation of seed phytate and oligosaccharides in soybean.	[Redekar, Neelam R.; Glover, Natasha M.; Biyashev, Ruslan M.; Maroof, M. A. Saghai] Virginia Tech, Sch Plant & Environm Sci, Blacksburg, VA 24061 USA; [Ha, Bo-Keun] Univ Georgia, Inst Plant Breeding Genet & Genom, Athens, GA 30602 USA; [Raboy, Victor] USDA ARS, Natl Small Grains Germplasm Ctr, Aberdeen, ID USA; [Redekar, Neelam R.] Leidos Biomed Res Inc, Bethesda, MD USA; [Glover, Natasha M.] Swiss Inst Bioinformat, Lausanne, Switzerland; [Glover, Natasha M.] Univ Lausanne, Dept Computat Biol, Lausanne, Switzerland; [Glover, Natasha M.] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Ha, Bo-Keun] Chonnam Natl Univ, Dept Appl Plant Sci, Gwangju, South Korea	Virginia Polytechnic Institute & State University; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Swiss Institute of Bioinformatics; University of Lausanne; University of Lausanne; Chonnam National University	Maroof, MAS (corresponding author), Virginia Tech, Sch Plant & Environm Sci, Blacksburg, VA 24061 USA.	smaroof@vt.edu		Redekar, Neelam/0000-0002-4819-9034; Saghai Maroof, MA/0000-0002-1398-7110	United Soybean Board; Virginia Soybean Board; Agricultural Experiment Station Hatch Program at Virginia Tech; Open Access Subvention Fund at Virginia Tech	United Soybean Board; Virginia Soybean Board; Agricultural Experiment Station Hatch Program at Virginia Tech; Open Access Subvention Fund at Virginia Tech	This project was funded in part by the United Soybean Board and Virginia Soybean Board. Additional funding was provided by the Agricultural Experiment Station Hatch Program and Open Access Subvention Fund - both at Virginia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averitt B, 2017, CROP SCI, V57, P2490, DOI 10.2135/cropsci2016.12.1028; Ayre BG, 2003, PLANT PHYSIOL, V131, P1518, DOI 10.1104/pp.012054; Bilyeu KD, 2016, J AGR FOOD CHEM, V64, P1071, DOI 10.1021/acs.jafc.5b04779; Boehm JD, 2017, CROP SCI, V57, P2555, DOI 10.2135/cropsci2017.02.0107; Bohlke RA, 2005, J ANIM SCI, V83, P2396; Brinch-Pedersen H, 2002, TRENDS PLANT SCI, V7, P118, DOI 10.1016/S1360-1385(01)02222-1; Campion B, 2009, THEOR APPL GENET, V118, P1211, DOI 10.1007/s00122-009-0975-8; Cicek MS, 2006, CROP SCI, V46, P1253, DOI 10.2135/cropsci2005.06-0162; Cichy K. A., 2009, AGRON MONOGR, V51, P177, DOI 10.1234/agron.monogr51.frontmatter; COON CN, 1990, POULTRY SCI, V69, P787, DOI 10.3382/ps.0690787; Ertl DS, 1998, J ENVIRON QUAL, V27, P299, DOI 10.2134/jeq1998.00472425002700020008x; Gao Y, 2008, CROP SCI, V48, P1355, DOI 10.2135/cropsci2007.11.0633; Gao Y, 2007, CROP SCI, V47, P1797, DOI 10.2135/cropsci2007.03.0122; Gillman JD, 2009, PLANT GENOME-US, V2, P179, DOI 10.3835/plantgenome2008.03.0013; GITZELMANN R, 1965, PEDIATRICS, V36, P231; HATA Y, 1991, J CLIN BIOCHEM NUTR, V10, P135; Hitz WD, 2002, PLANT PHYSIOL, V128, P650, DOI [10.1104/pp.010585, 10.1104/pp.128.2.650]; Horbowicz M, 1994, SEED SCI RES, V4, P385, DOI 10.1017/S0960258500002440; Hulke BS, 2004, CROP SCI, V44, P2027, DOI 10.2135/cropsci2004.2027; Jang DA, 2003, POULTRY SCI, V82, P1914, DOI 10.1093/ps/82.12.1914; Jervis J, 2015, J AGR FOOD CHEM, V63, P9879, DOI 10.1021/acs.jafc.5b04002; Karner U, 2004, J EXP BOT, V55, P1981, DOI 10.1093/jxb/erh216; Keller R, 1998, PLANT J, V16, P403, DOI 10.1046/j.1365-313x.1998.00309.x; LEHLE L, 1973, EUR J BIOCHEM, V38, P103, DOI 10.1111/j.1432-1033.1973.tb03039.x; Loewus FA, 2000, PLANT SCI, V150, P1, DOI 10.1016/S0168-9452(99)00150-8; LOEWUS FA, 1983, ANNU REV PLANT PHYS, V34, P137, DOI 10.1146/annurev.pp.34.060183.001033; Maroof MAS, 2009, CROP SCI, V49, P69, DOI 10.2135/cropsci2008.06.0362; Maupin LM, 2011, CROP SCI, V51, P642, DOI 10.2135/cropsci2010.07.0396; Mussatto SI, 2007, CARBOHYD POLYM, V68, P587, DOI 10.1016/j.carbpol.2006.12.011; Nagy R, 2009, J BIOL CHEM, V284, P33614, DOI 10.1074/jbc.M109.030247; Nunes ACS, 2006, PLANTA, V224, P125, DOI 10.1007/s00425-005-0201-0; Oltmans SE, 2005, CROP SCI, V45, P593, DOI 10.2135/cropsci2005.0593; Oltmans SE, 2004, CROP SCI, V44, P433, DOI 10.2135/cropsci2004.0433; Panzeri D, 2011, NEW PHYTOL, V191, P70, DOI 10.1111/j.1469-8137.2011.03666.x; Pennycooke JC, 2003, PLANT PHYSIOL, V133, P901, DOI 10.1104/pp.103.024554; Peterbauer T, 2001, SEED SCI RES, V11, P185; Pilu R, 2003, THEOR APPL GENET, V107, P980, DOI 10.1007/s00122-003-1316-y; Raboy V., 2007, Inositol phosphates: linking agriculture and the environment, P111, DOI 10.1079/9781845931520.0111; Raboy V, 2007, NAT BIOTECHNOL, V25, P874, DOI 10.1038/nbt0807-874; Raboy V, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9020140; Raboy V, 2009, PLANT SCI, V177, P281, DOI 10.1016/j.plantsci.2009.06.012; Redekar N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02029; Redekar NR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2283-9; Saghai Maroof MA, 2008, INVENTORS GOOGLE PAT; Sebastian SA, 2000, SOY ANIMAL NUTR, P56; SHARPLEY AN, 1994, J ENVIRON QUAL, V23, P437, DOI 10.2134/jeq1994.00472425002300030006x; Shi JR, 2007, NAT BIOTECHNOL, V25, P930, DOI 10.1038/nbt1322; Shi JR, 2005, PLANT J, V42, P708, DOI 10.1111/j.1365-313X.2005.02412.x; Skoneczka JA, 2009, CROP SCI, V49, P247, DOI 10.2135/cropsci2008.07.0403; Spencer JD, 2000, J ANIM SCI, V78, P1529; Sprenger N, 2000, PLANT J, V21, P249, DOI 10.1046/j.1365-313x.2000.00671.x; TANNER W, 1968, EUR J BIOCHEM, V4, P233, DOI 10.1111/j.1432-1033.1968.tb00199.x; Wang TL, 2003, PLANT PHYSIOL, V131, P886, DOI 10.1104/pp.102.017665; Wilcox JR, 2000, CROP SCI, V40, P1601, DOI 10.2135/cropsci2000.4061601x; Xu XH, 2009, THEOR APPL GENET, V119, P75, DOI 10.1007/s00122-009-1018-1; Yamka RM, 2006, AM J VET RES, V67, P88, DOI 10.2460/ajvr.67.1.88; YU YG, 1994, PHYTOPATHOLOGY, V84, P60, DOI 10.1094/Phyto-84-60; Yuan FJ, 2007, THEOR APPL GENET, V115, P945, DOI 10.1007/s00122-007-0621-2; Yuan FJ, 2009, J AGR FOOD CHEM, V57, P3632, DOI 10.1021/jf803862a	59	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235120	10.1371/journal.pone.0235120	http://dx.doi.org/10.1371/journal.pone.0235120			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584851	Green Published, gold			2022-12-27	WOS:000545747200008
J	Grant, MC; Geoghegan, L; Arbyn, M; Mohammed, Z; McGuinness, L; Clarke, EL; Wade, RG				Grant, Michael C.; Geoghegan, Luke; Arbyn, Marc; Mohammed, Zakaria; McGuinness, Luke; Clarke, Emily L.; Wade, Ryckie G.			The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries	PLOS ONE			English	Review							CHINA	Background To limit the spread of SARS-CoV-2, an evidence-based understanding of the symptoms is critical to inform guidelines for quarantining and testing. The most common features are purported to be fever and a new persistent cough, although the global prevalence of these symptoms remains unclear. The aim of this systematic review is to determine the prevalence of symptoms associated with COVID-19 worldwide. Methods We searched PubMed, Embase, CINAHL, AMED, medRxiv and bioRxiv on 5(th)April 2020 for studies of adults (>16 years) with laboratory test confirmed COVID-19. No language or publication status restrictions were applied. Data were independently extracted by two review authors into standardised forms. All datapoints were independently checked by three other review authors. A random-effects model for pooling of binomial data was applied to estimate the prevalence of symptoms, subgrouping estimates by country. I(2)was used to assess inter-study heterogeneity. Results Of 851 unique citations, 148 articles were included which comprised 24,410 adults with confirmed COVID-19 from 9 countries. The most prevalent symptoms were fever (78% [95% CI 75%-81%]; 138 studies, 21,701 patients; I(2)94%), a cough (57% [95% CI 54%-60%]; 138 studies, 21,682 patients; I(2)94%) and fatigue (31% [95% CI 27%-35%]; 78 studies, 13,385 patients; I(2)95%). Overall, 19% of hospitalised patients required non-invasive ventilation (44 studies, 6,513 patients), 17% required intensive care (33 studies, 7504 patients), 9% required invasive ventilation (45 studies, 6933 patients) and 2% required extra-corporeal membrane oxygenation (12 studies, 1,486 patients). The mortality rate was 7% (73 studies, 10,402 patients). Conclusions We confirm that fever and cough are the most prevalent symptoms of adults infected by SARS-CoV-2. However, there is a large proportion of infected adults which symptoms-alone do not identify.	[Grant, Michael C.] Univ Sheffield, Sheffield, S Yorkshire, England; [Geoghegan, Luke] Imperial Coll London, Acad Sect Vasc Surg, Dept Surg & Canc, London, England; [Arbyn, Marc] Belgian Canc Ctr, Unit Canc Epidemiol, Sciensano, Belgium; [Mohammed, Zakaria; Wade, Ryckie G.] Univ Leeds, Leeds Inst Med Res, Leeds, W Yorkshire, England; [Mohammed, Zakaria; Wade, Ryckie G.] Leeds Teaching Hosp, Dept Plast & Reconstruct Surg, Leeds, W Yorkshire, England; [McGuinness, Luke] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [McGuinness, Luke] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Clarke, Emily L.] Univ Leeds, Div Pathol & Data Analyt, Leeds, W Yorkshire, England; [Clarke, Emily L.] Leeds Teaching Hosp, Dept Histopathol, Leeds, W Yorkshire, England	University of Sheffield; Imperial College London; Sciensano; University of Leeds; University of Leeds; University of Bristol; University of Bristol; University of Leeds; University of Leeds	Wade, RG (corresponding author), Univ Leeds, Leeds Inst Med Res, Leeds, W Yorkshire, England.; Wade, RG (corresponding author), Leeds Teaching Hosp, Dept Plast & Reconstruct Surg, Leeds, W Yorkshire, England.	ryckiewade@gmail.com	Wade, Ryckie George/H-9277-2016	Wade, Ryckie George/0000-0001-8365-6547; McGuinness, Luke A/0000-0001-8730-9761; Grant, Michael/0000-0001-9504-2147	National Institute for Health Research (NIHR) [DRF-2018-11-ST2-028]; NIHR Doctoral Research Fellowship [DRF-2018-11-ST2-048]; VALCOR project (Sciensano, Brussels, Begium)	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Doctoral Research Fellowship; VALCOR project (Sciensano, Brussels, Begium)	Ryckie G Wade is a Doctoral Research Fellow funded by the National Institute for Health Research (NIHR, DRF-2018-11-ST2-028). Luke McGuinness is supported by an NIHR Doctoral Research Fellowship (DRF-2018-11-ST2-048). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Marc Arbyn was supported by the VALCOR project (Sciensano, Brussels, Begium). The funders had no role in the initiation, conduct or publication of this project.	Ai J-W, OPTIMIZING DIAGNOSTI; [Anonymous], 2020, LANCET, V395, P311, DOI 10.1016/S0140-6736(20)30186-0; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; [Anonymous], 2020, CLIN INFECT DIS; [Anonymous], ASS CARDIOVASCULAR M; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Bian H, MEPLAZUMAB TREATS CO; Cai Q, COVID 19 DESIGNATED; Cao W., CLIN FEATURES LAB IN; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chang D, 2020, AM J RESP CRIT CARE, V201, P1150, DOI 10.1164/rccm.202003-0524LE; Chang D, 2020, JAMA-J AM MED ASSOC, V323, P1092, DOI 10.1001/jama.2020.1623; Chen C, 2020, FAVIPIRAVIR VERSUS A; Chen D, HYPOKALEMIA CLIN IMP; CHEN G, 2020, J CLIN INVEST, DOI [DOI 10.1172/JCI137244, 10.1101/2020.02.16.20023903]; Chen H, 1 CLIN STUDY USING H; Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; Chen J, RETROSPECTIVE ANAL C; Chen L, 2020, CHIN J TUBERC RESP D, V43, DOI DOI 10.3760/CMA.J.ISSN.1001-0939.2020.0005; Chen L, OCULAR MANIFESTATION; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Chen X, RESTORATION LEUKOMON; Chen X, 2020, CLIN CHARACTERISTICS; Chen X, EPIDEMIOLOGICAL CLIN; Chen Z., CAUTION CLIN CHARACT; Cheng Z, 2020, ADV ENG MATER, V22, DOI 10.1002/adem.202000257; Chu JJ, 2020, J MED VIROL, V92, P807, DOI 10.1002/jmv.25793; Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]; COVID-19 National Emergency Response Center Epidemiology and Case Management Team Korea Centers for Disease Control and Prevention, 2020, Osong Public Health Res Perspect, V11, P8, DOI 10.24171/j.phrp.2020.11.1.03; Cui P, CLIN FEATURES SEXUAL; Deng YT, 2020, CAMB CHINA LIBR, P1; dong l., HIGHLY ACCURATE SENS; Duan K, FEASIBILITY CONVALES; Duan LP, 2020, ENERGY TECHNOL-GER, V8, DOI 10.1002/ente.201901401; Easom N, INFLUENZA OTHER RESP; Ebrahimi M, LAB FINDINGS SIGNS S; Fan L, MED TREATMENT 55 PAT; Fan Z, CLIN FEATURES COVID; Fei J, REDUCTION LYMPHOCYTE; Feng C, 2020, SSRN ELECT J, pSSRN, DOI [DOI 10.2139/SSRN.3551355, 10.1101/2020.03.19.20039099, DOI 10.1101/2020.03.19.20039099]; Feng Z, EARLY PREDICTION DIS; Fu H, ASS CLIN LAB CT CHAR; Fu L, INFLUENCE FACTORS DE; Fu S, VIROLOGIC CLIN CHARA; Gao ST, 2020, INT J RHEUM DIS, V23, P499, DOI 10.1111/1756-185X.13795; Gong J, 2019, TOOL EARLY PREDICT S; Gostic K, 2020, ELIFE, V9, DOI 10.7554/eLife.55570; Grant MC, 2020, PREVALENCE DIFFERENT; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P783, DOI 10.1093/oxfordjournals.aje.a117326; Gritti G, USE SILTUXIMAB PATIE; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Han SW, 2020, CANCER MED-US, V9, P6667, DOI 10.1002/cam4.3289; Han Y, LACTATE DEHYDROGENAS; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014; Huang YH, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101606; Huisman J, 2017, SCIENTOMETRICS, V113, P633, DOI 10.1007/s11192-017-2310-5; Jain V, SYSTEMATIC REV METAA; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; Jefferson T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub4; Ji W, ANAL CLIN FEATURES C; Jiang X, 2020, J MED VIROL, V92, P476, DOI 10.1002/jmv.25708; Jin X, 2020, GUT, V69, P1002, DOI 10.1136/gutjnl-2020-320926; Kang Y, 2019, CRITICAL CARE PATIEN; Kluytmans M, SARS COV 2 INFECT 86; Kujawski SA, 2020, MEDRXIV, DOI 10.1101/2020.03.09.20032896; Lake MA, 2020, CLIN MED, V20, P124, DOI 10.7861/clinmed.2019-coron; Lei L, CLIN CHARACTERISTICS; Lei Y, 2019, CLIN FEATURES IMPORT; Leung KS-S, TERRITORY WIDE STUDY; Li, CLIN CHARACTERISTICS; Li J, 2019, EPIDEMIOLOGICAL CLIN; Li J, 2019, SEX DIFFERENCES CLIN; Li K, RADIOGRAPHIC FINDING; Li K, 2020, INVEST RADIOL, V1; Li N, MATERNAL NEONATAL OU; Li Q, SIMPLE LAB PARAMETER; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; Liang Y, 2019, PREVALENCE CLIN FEAT; Liao J, EPIDEMIOLOGICAL CLIN; Lin Y, 2019, ULTRAHIGH RESOLUTION; Liu H., 2020, J INFECTION, V80, P7, DOI [10.1016/j.jinf.2020.03.007, DOI 10.1016/J.JINF.2020.03.007]; Liu J, RETROSPECTIVE CASE S; Liu J, LONGITUDINAL CHARACT; Liu K, 2020, CHIN MED J, V1; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; Liu L, PRELIMINARY STUDY SE; Liu T, 2019, POTENTIAL ROLE IL 6; Liu W, 2020, CHIN MED J, V1; Liu Y, 2019, CLIN CHARACTERISTICS; Liu Y, 2020, INFECT DIS-NOR, V52, P858, DOI 10.1080/23744235.2020.1794027; Liu YSL, 2020, SSRN ELECT J; Livingston Edward, 2020, JAMA, V323, P1122, DOI 10.1001/jama.2020.2633; Lu H, 2020, DESCRIPTIVE STUDY IM, V2020; Lu J, ACP RISK GRADE SIMPL; Luo L, MODES CONTACT RISK T; Luo SH, 2020, CLIN GASTROENTEROL H, V18, P1636, DOI 10.1016/j.cgh.2020.03.043; M C W., 2020, BMJ-BRIT MED J, V368, pm544, DOI 10.1136/bmj.l6968; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mao L, RETROSPECTIVE CASE S; Marchese-Ragona R, SUDDEN HYPOSMIA PREV; McGuinness L, 2020, MEDRXIVR ACCESSING M; McInnes MDF, 2018, JAMA-J AM MED ASSOC, V319, P388, DOI 10.1001/jama.2017.19163; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Miao C, COMP MULTICENTRE STU; MILLER JJ, 1978, AM STAT, V32, P138, DOI 10.2307/2682942; Mo P., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa270, DOI 10.1093/CID/CIAA270]; Nie R, 2019, CLIN FEATURES MATERN; Nie S, METABOLIC DISTURBANC; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370; Pan YY, 2020, EUR RADIOL, V30, P3612, DOI 10.1007/s00330-020-06713-z; Qi D, EPIDEMIOLOGICAL CLIN; Qi S, COMPUTED TOMOGRAPHY; Qifang B., 2020, EPIDEMIOLOGY TRANSMI; Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623; Rossman H, 2020, NAT MED, V26, P634, DOI 10.1038/s41591-020-0857-9; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Song C-Y., COVID 19 EARLY WARNI, DOI 10.1101/2020.03.05.20031906; Song FX, 2020, RADIOLOGY, V295, P210, DOI [10.1148/radiol.2020209021, 10.1148/radiol.2020200274]; Su L, 2020, EMERG MICROBES INFEC, V9, P707, DOI 10.1080/22221751.2020.1744483; Sumner J, 2020, REPRODUCIBILITY REPO; Sun P, CLIN CHARACTERISTICS; SUN X, INFECT EVIDENCE SARS; Sun YXH, 2020, CLIN INFECT DIS, V71, P786, DOI 10.1093/cid/ciaa322; Tabata S, NONSEVERE VS SEVERE; Tahvildari A, CLIN FEATURES DIAGNO, DOI [10.1016/S2468-1253(20)30126-6, DOI 10.1016/S2468-1253(20)30126-6]; Tao Y, HIGH INCIDENCE ASYMP; Tian S, CLIN CHARACTERISTICS; To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149; Tsang T, 2020, COMMUN DIS INTELL, V44; W Y., 2020, J MED VIROL; Wan SX, 2020, J MED VIROL, V92, P797, DOI 10.1002/jmv.25783; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wang W, DEFINITION RISKS CYT; Wang Y, CLIN CHARACTERISTICS; Wang ZW, 2020, BIOSCI TRENDS, V14, P64, DOI 10.5582/bst.2020.01030; Wang ZL, 2020, CLIN INFECT DIS, V71, P769, DOI 10.1093/cid/ciaa272; Woelfel R, 2020, CLIN PRESENTATION VI, DOI 10.1101/2020.03.05.20030502; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; World Health Organization, 2021, RADIOPAEDIA; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu JY, 2020, INFECT DIS THER, V9, P17, DOI 10.1007/s40121-020-00286-6; Wujtewicz MA, 2020, ANAESTH INTENSIVE TH, V52, P34, DOI 10.5114/ait.2020.93756; Xu H, 2019, ACUTE MYOCARDIAL INJ; Xu Y, CLIN FINDINGS CRITIC; Xu Y, CLIN CHARACTERISTICS; Xu YH, 2020, J INFECTION, V80, P394, DOI 10.1016/j.jinf.2020.02.017; Y G., 2020, J INFECT; Y P., 2020, J INFECT DIS; Yang J., 2020, INT J INFECT DIS, V94, P91, DOI [10.1016/j.ijid.2020.03.017, DOI 10.1016/J.IJID.2020.03.017]; Yang SY, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00407-2020; Yang WJ, 2020, J INFECTION, V80, P388, DOI 10.1016/j.jinf.2020.02.016; Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204; Yu N, 2020, LANCET INFECT DIS, V20, P559, DOI 10.1016/S1473-3099(20)30176-6; Zeng L, RISK ASSESSMENT PROG; Zhang, 2020, EFFICACY HYDROXYCHLO, P7, DOI [10.1101/.20040758, 10.1101/2020.03.22.20040758, DOI 10.1101/2020.03.22.20040758]; Zhang G, CLIN FEATURES OUTCOM; Zhang GM, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01338-8; Zhang H-YY, MULTICENTRE STUDY 20; Zhang J, 2021, SURG INFECT, V22, P131, DOI 10.1089/sur.2020.001; Zhang JJ, 2020, ALLERGY, V75, P1809, DOI 10.1111/all.14316; Zhang MQ, 2020, ZHONGHUA JIE HE HE H, V43, P215, DOI 10.3760/cma.j.issn.1001-0939.2020.03.015; Zhang X, 2019, IEEE INFOCOM SER, P82, DOI 10.1109/INFOCOM.2019.8737626; Zhang Y, GASTROINTESTINAL TRA; Zhang Y, ANAESTHETIC MANAGMEN; Zhang Z, 2020, VIROL SIN, V35, P330, DOI 10.1007/s12250-020-00203-8; Zhao KH, 2019, ADV DIFFER EQU-NY, DOI 10.1186/s13662-019-1982-y; Zhao W, 2020, AM J ROENTGENOL, V214, P1072, DOI 10.2214/AJR.20.22976; Zhao X, INCIDENCE CLIN CHARA, DOI 10.1101/2020.03.17.20037572.2020; Zhao Z, CLIN LAB PROFILES 75; Zhou F, CLIN FEATURES OUTCOM; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu WB, 2020, J MED VIROL, V92, P1525, DOI 10.1002/jmv.25763	176	306	316	11	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234765	10.1371/journal.pone.0234765	http://dx.doi.org/10.1371/journal.pone.0234765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574165	Green Published, gold			2022-12-27	WOS:000544972400028
J	Abbasi, SH; Aftab, RA; Chua, SS				Abbasi, Saad Hanif; Aftab, Raja Ahsan; Chua, Siew Siang			Risk factors associated with nosocomial infections among end stage renal disease patients undergoing hemodialysis: A systematic review	PLOS ONE			English	Review							C VIRUS-INFECTION; BLOOD-STREAM INFECTIONS; HEPATITIS-C; GLYCEMIC CONTROL; MOLECULAR EPIDEMIOLOGY; RESISTANT ENTEROCOCCI; MAINTENANCE DIALYSIS; VASCULAR ACCESS; KIDNEY-DISEASE; 3 CONTINENTS	Background Profound healthcare challenges confront societies with an increase in prevalence of end-stage renal disease (ESRD), which is one of the leading causes of morbidity and mortality worldwide. Due to several facility and patient related factors, ESRD is significantly associated with increased morbidity and mortality attributed to infections. Aims and objective The aim of this study was to assess systematically the characteristics of patients and risk factors associated with nosocomial infections among ESRD patients undergoing hemodialysis. Methods A systematic literature search was performed to identify eligible studies published during the period from inception to December 2018 pertaining to risk factors associated with nosocomial infections among hemodialysis patients. The relevant studies were generated through a computerized search on five databases (PubMed, EBSCOhost, Google Scholar, ScienceDirect and Scopus) using the Mesh Words: nosocomial infections, hospital acquired infections, healthcare associated infections, end stage renal disease, end stage renal failure, hemodialysis, and risk factors. The complete protocol has been registered under PROSPERO (CRD42019124099). Results Initially, 1411 articles were retrieved. Out of these, 24 were duplicates and hence were removed. Out of 1387 remaining articles, 1337 were removed based on irrelevant titles and/or abstracts. Subsequently, the full texts of 50 articles were reviewed and 41 studies were excluded at this stage due to lack of relevant information. Finally, nine articles were selected for this review. Longer hospital stay, longer duration on hemodialysis, multiple catheter sites, longer catheterization, age group, lower white blood cell count, history of blood transfusion, and diabetes were identified as the major risk factors for nosocomial infections among hemodialysis patients. Conclusion The results of this review indicate an information gap and potential benefits of additional preventive measures to further reduce the risk of infections in hemodialysis population. Moreover, several patient-related and facility-related risk factors were consistently observed in the studies included in this review, which require optimal control measures.	[Abbasi, Saad Hanif; Aftab, Raja Ahsan; Chua, Siew Siang] Taylors Univ, Fac Hlth & Med Sci, Sch Pharm, Subang Jaya, Malaysia	Taylor's University	Aftab, RA (corresponding author), Taylors Univ, Fac Hlth & Med Sci, Sch Pharm, Subang Jaya, Malaysia.	rajaahsan.aftab@taylors.edu.my	Chua, Siew Siang/AAH-9218-2021; Aftab, Raja Ahsan/J-1261-2014	Abbasi, Saad/0000-0001-7677-1985	Centre for Higher Degrees by Research (CHDR) of Taylor's University	Centre for Higher Degrees by Research (CHDR) of Taylor's University	The Centre for Higher Degrees by Research (CHDR) of Taylor's University provided a fellowship to SHA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alashek WA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-265; [Anonymous], 2014, LANCET INFECT DIS, V14, P1, DOI 10.1016/S1473-3099(13)70368-2; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; [Anonymous], 2007, ECOL B RUSS, V3, P8; [Anonymous], 2006, EUROPEAN DEFENCE AGE, V2, P9; [Anonymous], 2000, REV MUSEU ARQUEOLOGI, V9, P259; [Anonymous], 2017, AM J TRANSPLANT, V17, P1, DOI DOI 10.1093/jisesa/iew097; Ashkani-Esfahani S, 2017, WORLD J GASTROENTERO, V23, P151, DOI 10.3748/wjg.v23.i1.151; Assadian O, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-52; Borzecki Andrzej, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P351; Brunner F P, 1992, Kidney Int Suppl, V38, pS4; Burdick RA, 2003, KIDNEY INT, V63, P2222, DOI 10.1046/j.1523-1755.2003.00017.x; Carrilho FJ, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-13; Caylan R, 2010, TURK J MED SCI, V40, P835, DOI 10.3906/sag-0908-236; CDC, 2019, CDC APPROACH BSI PRE; Comstock J., 1988, INFECT CONT HOSP EP, V9, P534, DOI 10.1086/645772; D'Agata EMC, 2000, AM J KIDNEY DIS, V35, P1083, DOI 10.1016/S0272-6386(00)70044-8; Dalrymple LS, 2015, CLIN J AM SOC NEPHRO, V10, P2170, DOI 10.2215/CJN.03050315; DENTICO P, 1992, CLIN NEPHROL, V38, P49; Fissell RB, 2004, KIDNEY INT, V65, P2335, DOI 10.1111/j.1523-1755.2004.00649.x; Fram Dayana, 2014, BMC Res Notes, V7, P882, DOI 10.1186/1756-0500-7-882; Fysaraki M, 2013, INT J MED SCI, V10, P1632, DOI 10.7150/ijms.6710; Garcia-Garcia G, 2015, CLIN KIDNEY J, V8, P3, DOI 10.1093/ckj/sfu124; Gilad J, 2005, CLIN MICROBIOL INFEC, V11, P547, DOI 10.1111/j.1469-0691.2005.01168.x; Gnass M, 2014, AM J INFECT CONTROL, V42, P182, DOI 10.1016/j.ajic.2013.08.014; Hajarizadeh B, 2005, AM INFER CON, V33, P93; HARDY NM, 1992, CLIN NEPHROL, V38, P44; Herzog R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-154; Hinrichsen H, 2002, GUT, V51, P429, DOI 10.1136/gut.51.3.429; Hua G.H.H.W.H., 2005, INT MED HLTH GUIDANC, V14; Hui-juan L., 2013, CHINESE J NOSOCOMIOL, V11, P33; Ishida JH, 2014, SEMIN DIALYSIS, V27, P26, DOI 10.1111/sdi.12168; KAPLOWITZ LG, 1988, INFECT CONT HOSP EP, V9, P534; Karkar A, 2014, SAUDI J KIDNEY DIS T, V25, P496, DOI 10.4103/1319-2442.132150; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Khan Hassan Ahmed, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P509, DOI 10.1016/j.apjtb.2015.05.001; Knezevic V, 2018, VOJNOSANIT PREGL, V75, P159, DOI 10.2298/VSP160205332K; Lata Chris, 2016, Can J Kidney Health Dis, V3, P24, DOI 10.1186/s40697-016-0115-8; Lim KB, 2005, J ELECTRON IMAGING, V14, DOI 10.1117/1.2137654; Lioussfi Z, 2014, SAUDI J KIDNEY DIS T, V25, P672, DOI 10.4103/1319-2442.132236; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Lok CE, 2011, KIDNEY INT, V79, P587, DOI 10.1038/ki.2010.471; [毛艳卿 Mao Yanqing], 2012, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V22, P2807; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Morioka T, 2001, DIABETES CARE, V24, P909, DOI 10.2337/diacare.24.5.909; Patel K., 2015, NATL J INTEGRATED RE, V6, P19; Pinheiro M.G., 2013, REV BRAS FARM, V94, P72; Purnamasidhi C.A.W., 2017, INDONESIAN J GASTROE, V17, P155; Qasaimeh GR, 2008, SOUTH MED J, V101, P508, DOI 10.1097/SMJ.0b013e31816c0155; Qian XiaoHui, 2010, Chinese Journal of Nosocomiology, V20, P3910; Ricks J, 2012, DIABETES, V61, P708, DOI 10.2337/db11-1015; Robson M., 2018, SUPPLEMENTARY MAT 5, V5; Saab S, 2001, AM J KIDNEY DIS, V37, P308, DOI 10.1053/ajkd.2001.21294; Sahli F, 2017, J INFECT PUBLIC HEAL, V10, P403, DOI 10.1016/j.jiph.2016.06.008; Samani S., 2015, Comparative Clinical Pathology, V24, P275, DOI 10.1007/s00580-014-1890-1; Sanavi S, 2007, SAUDI J KIDNEY DIS T, V18, P43; Saxena AK, 2004, J AM GERIATR SOC, V52, P242, DOI 10.1111/j.1532-5415.2004.52062.x; Schwanke AA, 2018, REV BRAS ENFERM, V71, P1115, DOI 10.1590/0034-7167-2017-0047; Schweiger A, NOSOCOMIAL INFECTION; Schweiger A, 2015, CONTRIB NEPHROL, V184, P205, DOI 10.1159/000366120; Serefhanoglu K, 2012, J FORMOS MED ASSOC, V111, P325, DOI 10.1016/j.jfma.2011.03.004; Shilling AM, 2008, BEST PRACT RES-CLIN, V22, P519, DOI 10.1016/j.bpa.2008.06.005; Shinzato T, 1999, KIDNEY INT, V55, P700, DOI 10.1046/j.1523-1755.1999.00297.x; Shurraw S, 2011, ARCH INTERN MED, V171, P1920, DOI 10.1001/archinternmed.2011.537; Slinin Y, 2006, KIDNEY INT, V70, P1135, DOI 10.1038/sj.ki.5001714; Spada E, 2008, J MED VIROL, V80, P261, DOI 10.1002/jmv.21088; Stevenson KB, 2002, AM J KIDNEY DIS, V39, P549, DOI 10.1053/ajkd.2002.31405; Su YY, 2013, J MED VIROL, V85, P425, DOI 10.1002/jmv.23486; Suleymanlar G., 1997, TURK J GASTROENTEROL, V8, P21; Tang L., 2016, CHINESE J INFECT CON, V15, P930; Tang LY, 2016, ACTA MEDICA MEDITERR, V32, P617; Taylor G, 2004, AM J INFECT CONTROL, V32, P155, DOI 10.1016/j.ajic.2003.05.007; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Thomas B, 2015, J AM SOC NEPHROL, V26, P2621, DOI 10.1681/ASN.2014101017; Tokars JI, 2001, KIDNEY INT, V60, P1511, DOI 10.1046/j.1523-1755.2001.00955.x; Vidales-Braz BM, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0238-z; Vladutiu DS, 2000, J VIRAL HEPATITIS, V7, P313; von Baum H, 1999, CLIN INFECT DIS, V29, P912, DOI 10.1086/520455; Wang PH, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1701-1; Waters D, 2009, TRUSTS TRUSTEES, V15, P12, DOI 10.1093/tandt/ttn116; Wong H., 2016, 24 REPORT MALAYSIAN; Yan-qing M., 2012, CHINESE J NOSOCOMIOL, V13, P42; Yuan- li X., 2009, CHINESE J NOSOCOMIOL, V11, P17; Zuo MH, 2018, INT J INFECT DIS, V68, P115, DOI 10.1016/j.ijid.2018.01.008	84	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234376	10.1371/journal.pone.0234376	http://dx.doi.org/10.1371/journal.pone.0234376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569265	Green Published, gold			2022-12-27	WOS:000543547900041
J	Perez-Rial, S; Barreiro, E; Fernandez-Acenero, MJ; Fernandez-Valle, ME; Gonzalez-Mangado, N; Peces-Barba, G				Perez-Rial, Sandra; Barreiro, Esther; Fernandez-Acenero, Maria Jesus; Fernandez-Valle, Maria Encarnacion; Gonzalez-Mangado, Nicolas; Peces-Barba, German			Early detection of skeletal muscle bioenergetic deficit by magnetic resonance spectroscopy in cigarette smoke-exposed mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MITOCHONDRIAL DYSFUNCTION; FIBER TYPES; IN-VIVO; MODEL; COPD; MANIFESTATIONS; MORTALITY	Skeletal muscle dysfunction is a common complication and an important prognostic factor in patients with chronic obstructive pulmonary disease (COPD). It is associated with intrinsic muscular abnormalities of the lower extremities, but it is not known whether there is an easy way to predict its presence. Using a mouse model of chronic cigarette smoke exposure, we tested the hypothesis that magnetic resonance spectroscopy allows us to detect muscle bioenergetic deficit in early stages of lung disease. We employed this technique to evaluate the synthesis rate of adenosine triphosphate (ATP) and characterize concomitant mitochondrial dynamics patterns in the gastrocnemius muscle of emphysematous mice. The fibers type composition and citrate synthase (CtS) and cytochrome c oxidase subunit IV (COX4) enzymatic activities were evaluated. We found that the rate of ATP synthesis was reduced in the distal skeletal muscle of mice exposed to cigarette smoke. Emphysematous mice showed a significant reduction in body weight gain, in the cross-sectional area of the total fiber and in the COX4 to CtS activity ratio, due to a significant increase in CtS activity of the gastrocnemius muscle. Taken together, these data support the hypothesis that in the early stage of lung disease, we can detect a decrease in ATP synthesis in skeletal muscle, partly caused by high oxidative mitochondrial enzyme activity. These findings may be relevant to predict the presence of skeletal bioenergetic deficit in the early stage of lung disease besides placing the mitochondria as a potential therapeutic target for the treatment of COPD comorbidities.	[Perez-Rial, Sandra; Gonzalez-Mangado, Nicolas; Peces-Barba, German] Fdn Jimenaz Diaz, Biomed Res Inst, Resp Res Unit, Madrid, Spain; [Perez-Rial, Sandra; Barreiro, Esther; Gonzalez-Mangado, Nicolas; Peces-Barba, German] Inst Salud Carlos III, Consorcio Ctr Invest Biomed Red Enfermedades Resp, MP CIBERES, Madrid, Spain; [Barreiro, Esther] Hosp del Mar, Inst Med Res, Resp Med Dept, Muscle Wasting & Cachexia Chron Resp Dis & Lung C, Barcelona Biomed Res Pk, Barcelona, Spain; [Fernandez-Acenero, Maria Jesus] Hosp Clin Univ San Carlos, Dept Pathol, Madrid, Spain; [Fernandez-Valle, Maria Encarnacion] Univ Complutense Madrid, Bioimaging Res Support Ctr, Nucl Magnet Resonance Unit, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Complutense University of Madrid	Perez-Rial, S (corresponding author), Fdn Jimenaz Diaz, Biomed Res Inst, Resp Res Unit, Madrid, Spain.; Perez-Rial, S (corresponding author), Inst Salud Carlos III, Consorcio Ctr Invest Biomed Red Enfermedades Resp, MP CIBERES, Madrid, Spain.	sperezr@fjd.es	; Perez Rial, Sandra/C-6809-2019	Fernandez-Acenero/0000-0002-2439-3553; Perez Rial, Sandra/0000-0002-7349-7682; Fernandez-Valle, Maria Encarnacion/0000-0002-7433-5976	Spanish Society of Pulmonology and Thoracic Surgery Grant (SEPAR 2014); Instituto de Salud Carlos III - Accion Estrategica en Salud [AES 13/01909, 16/01783, 18/00075]; Fundacion Catalana de Pneumologia (FUCAP); Fondazione Internazionale Menarini (Spain); Spanish Society of Pulmonology and Thoracic Surgery Grant (SEPAR 2018)	Spanish Society of Pulmonology and Thoracic Surgery Grant (SEPAR 2014); Instituto de Salud Carlos III - Accion Estrategica en Salud(Instituto de Salud Carlos III); Fundacion Catalana de Pneumologia (FUCAP); Fondazione Internazionale Menarini (Spain); Spanish Society of Pulmonology and Thoracic Surgery Grant (SEPAR 2018)	This study was supported in part by a Spanish Society of Pulmonology and Thoracic Surgery Grant (SPR - SEPAR 2014 and EB SEPAR 2018); Instituto de Salud Carlos III - Accion Estrategica en Salud (GPB -AES 13/01909, GBP - 16/01783, EB - 18/00075); Fundacion Catalana de Pneumologia (EB -FUCAP) 2016 and EB - Unrestricted grant from Fondazione Internazionale Menarini 2018 (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barreiro E, 2018, J THORAC DIS, V10, pS1415, DOI 10.21037/jtd.2018.04.168; Barreiro E, 2012, RESP PHYSIOL NEUROBI, V182, P9, DOI 10.1016/j.resp.2012.02.001; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Boesch C, 2007, J MAGN RESON IMAGING, V25, P321, DOI 10.1002/jmri.20806; Ceco E, 2017, AM J RESP CELL MOL, V57, P28, DOI 10.1165/rcmb.2016-0355TR; Charles AL, 2011, BRIT J SURG, V98, P511, DOI 10.1002/bjs.7384; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Constantinou C, 2011, INT J MOL MED, V27, P15, DOI 10.3892/ijmm.2010.557; Fermoselle C, 2011, ARCH BRONCONEUMOL, V47, P590, DOI 10.1016/j.arbres.2011.07.008; Gea JG, 2001, EUR RESPIR J, V17, P939, DOI 10.1183/09031936.01.17509390; Gea J, 2015, J THORAC DIS, V7, pE418, DOI 10.3978/j.issn.2072-1439.2015.08.04; Gosker HR, 2007, EUR RESPIR J, V30, P73, DOI 10.1183/09031936.00146906; Gosker HR, 2009, AM J RESP CELL MOL, V40, P710, DOI 10.1165/rcmb.2008-0312OC; Gosker HR, 2002, EUR RESPIR J, V19, P617, DOI 10.1183/09031936.02.00762001; Hamaoka T, 2005, RESPIROLOGY, V10, P164, DOI 10.1111/j.1440-1843.2005.00696.x; Harris RS, 2000, AM J RESP CRIT CARE, V161, P432; Hayasaki H, 2001, ACTA HISTOCHEM, V103, P355, DOI 10.1078/0065-1281-00605; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Jucker BM, 2000, P NATL ACAD SCI USA, V97, P6880, DOI 10.1073/pnas.120131997; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; Koopman R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00032; Larsen RG, 2009, J APPL PHYSIOL, V107, P873, DOI 10.1152/japplphysiol.00260.2009; Levine S, 2003, AM J RESP CRIT CARE, V168, P706, DOI 10.1164/rccm.200209-1070OC; Maltais F, 2014, AM J RESP CRIT CARE, V189, P1121, DOI 10.1164/rccrn.201402-0373ST; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Meyer A, 2013, EXP PHYSIOL, V98, P1063, DOI 10.1113/expphysiol.2012.069468; Naimi AI, 2011, CLIN PHYSIOL FUNCT I, V31, P124, DOI 10.1111/j.1475-097X.2010.00988.x; Perez-Rial S, 2014, AM J PHYSIOL-LUNG C, V307, pL718, DOI 10.1152/ajplung.00293.2013; Pouw EM, 2000, EUR RESPIR J, V16, P247, DOI 10.1034/j.1399-3003.2000.16b11.x; Puente-Maestu L, 2009, EUR RESPIR J, V33, P1045, DOI 10.1183/09031936.00112408; Puente-Maestu L, 2009, AM J RESP CELL MOL, V40, P746, DOI 10.1165/rcmb.2008-0289OC; Salazar-Degracia A, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1003-9; Sato Y, 1997, EUR NEUROL, V37, P116, DOI 10.1159/000117421; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; ten Hove M, 2007, HEART FAIL REV, V12, P48, DOI 10.1007/s10741-007-9003-8; Tzika AA, 2013, INT J ONCOL, V43, P886, DOI 10.3892/ijo.2013.1998; van den Borst B, 1985, J APPL PHYSIOL, V114, P1319; VanderVeen BN, 2017, OXID MED CELL LONGEV, V2017, P1, DOI 10.1155/2017/3292087; Venegas JG, 1998, J APPL PHYSIOL, V84, P389, DOI 10.1152/jappl.1998.84.1.389	44	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234606	10.1371/journal.pone.0234606	http://dx.doi.org/10.1371/journal.pone.0234606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569331	Green Published, gold			2022-12-27	WOS:000543547900020
J	Wang, YC; Fang, QL; Dissanayake, STM; Onal, H				Wang, Yicheng; Fang, Qiaoling; Dissanayake, Sahan T. M.; Onal, Hayri			Optimizing conservation planning for multiple cohabiting species	PLOS ONE			English	Article							RESERVE DESIGN MODELS; PROGRAMMING-MODEL; SELECTION; COMPACT; CONNECTIVITY; ALGORITHMS; EXAMPLE; VALUES	Conservation planning often involves multiple species occupying large areas including habitat sites with varying characteristics. For a given amount of financial resources, designing a spatially coherent nature reserve system that provides the best possible protection to targeted species is an important ecological and economic problem. In this paper, we address this problem using optimization methods. Incorporating spatial criteria in an optimization framework considering spatial habitat needs of multiple species poses serious challenges because of modeling and computational complexities. We present a novel linear integer programming model to address this issue considering spatial contiguity and compactness of the reserved area. The model uses the concept of path in graph theory to ensure contiguity and minimizes the sum of distances between selected sites and a central site in individual reserves to promote compactness. We test the computational efficiency of the model using randomly generated data sets. The results show that the model can be solved quite efficiently in most cases. We also present an empirical application of the model to simultaneous protection of two cohabiting species, Gopher Tortoise and Gopher Frogs, in a military installation in Georgia, USA.	[Wang, Yicheng] Qingdao Agr Univ, Coll Resources & Environm, Qingdao, Peoples R China; [Fang, Qiaoling] Ocean Univ China, Coll Management, Qingdao, Peoples R China; [Dissanayake, Sahan T. M.] Portland State Univ, Dept Econ, Portland, OR 97207 USA; [Onal, Hayri] Univ Illinois, Dept Agr & Consumer Econ, Urbana, IL 61801 USA	Qingdao Agricultural University; Ocean University of China; Portland State University; University of Illinois System; University of Illinois Urbana-Champaign	Onal, H (corresponding author), Univ Illinois, Dept Agr & Consumer Econ, Urbana, IL 61801 USA.	h-onal@illinois.edu		Onal, Hayri/0000-0002-0307-1731	National Natural Science Foundation of China [71202096]; Natural Science Foundation of Shandong Province [ZR2019MG011]; Illinois CREES Project [ILLU 05-0361]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Illinois CREES Project	YW and QF received financial support from National Natural Science Foundation of China (71202096) and Natural Science Foundation of Shandong Province (ZR2019MG011), HO received financial support from the Illinois CREES Project (ILLU 05-0361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Bazaraa M. S., 2009, LINEAR PROGRAMMING N; Billionnet A, 2016, ENVIRON MODEL ASSESS, V21, P211, DOI 10.1007/s10666-015-9465-3; Billionnet A, 2013, EUR J OPER RES, V231, P514, DOI 10.1016/j.ejor.2013.03.025; Billionnet A, 2012, APPL MATH MODEL, V36, P2213, DOI 10.1016/j.apm.2011.08.002; Camm JD, 1996, BIOL CONSERV, V78, P353, DOI 10.1016/0006-3207(95)00132-8; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Carwardine J, 2010, CONSERV BIOL, V24, P1529, DOI 10.1111/j.1523-1739.2010.01535.x; Cerdeira JO, 2010, BIOL CONSERV, V143, P408, DOI 10.1016/j.biocon.2009.11.005; Church RL, 1996, BIOL CONSERV, V76, P105, DOI 10.1016/0006-3207(95)00102-6; COCKS KD, 1989, BIOL CONSERV, V49, P113, DOI 10.1016/0006-3207(89)90083-9; Conrad JM, 2012, J ENVIRON ECON MANAG, V63, P1, DOI 10.1016/j.jeem.2011.08.001; Csuti B, 1997, BIOL CONSERV, V80, P83, DOI 10.1016/S0006-3207(96)00068-7; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Dilkina B, 2017, CONSERV BIOL, V31, P192, DOI 10.1111/cobi.12814; Dissanayake STM, 2012, ECOL MODEL, V224, P65, DOI 10.1016/j.ecolmodel.2011.07.016; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellner SP, 2002, CONSERV BIOL, V16, P258, DOI 10.1046/j.1523-1739.2002.00553.x; Gupta A, 2019, CONSERV BIOL, V33, P1023, DOI 10.1111/cobi.13369; Jafari N, 2017, COMPUT OPER RES, V81, P119, DOI 10.1016/j.cor.2016.12.017; Jafari N, 2013, EUR J OPER RES, V231, P202, DOI 10.1016/j.ejor.2013.05.015; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marianov V, 2008, COMPUT OPER RES, V35, P475, DOI 10.1016/j.cor.2006.03.011; Matisziw TC, 2009, LANDSCAPE ECOL, V24, P89, DOI 10.1007/s10980-008-9282-z; McCarthy MA, 2006, AM NAT, V167, P717, DOI 10.1086/503058; Moilanen A., 2009, SPATIAL CONSERVATION; Nicholson E, 2006, ECOL LETT, V9, P1049, DOI 10.1111/j.1461-0248.2006.00956.x; Onal H, 2016, EUR J OPER RES, V251, P957, DOI 10.1016/j.ejor.2015.12.005; Onal H, 2006, OPER RES, V54, P379, DOI 10.1287/opre.1060.0272; St John R, 2018, OPER RES, V66, P1471, DOI 10.1287/opre.2018.1758; UNDERHILL LG, 1994, BIOL CONSERV, V70, P85, DOI 10.1016/0006-3207(94)90302-6; Wang YC, 2016, CONSERV BIOL, V30, P413, DOI 10.1111/cobi.12629; Williams J., 1998, ENVIRON MODEL ASSESS, V3, P77, DOI DOI 10.1023/A:1019006721277; Williams JC, 2005, ENVIRON MODEL ASSESS, V10, P163, DOI 10.1007/s10666-005-9007-5; Williams JC, 2002, GEOGR ANAL, V34, P330, DOI 10.1353/geo.2002.0024; WRIGHT J, 1983, REG SCI URBAN ECON, V13, P31, DOI 10.1016/0166-0462(83)90004-2; Zentelis R, 2015, CONSERV LETT, V8, P299, DOI 10.1111/conl.12155; ZOLTNERS AA, 1983, MANAGE SCI, V29, P1237, DOI 10.1287/mnsc.29.11.1237	39	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234968	10.1371/journal.pone.0234968	http://dx.doi.org/10.1371/journal.pone.0234968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569315	Green Published, gold			2022-12-27	WOS:000543547900019
J	Al-Sawalha, NA; Almahmmod, Y; Awawdeh, MS; Alzoubi, KH; Khabour, OF				Al-Sawalha, Nour A.; Almahmmod, Yehya; Awawdeh, Mofleh S.; Alzoubi, Karem H.; Khabour, Omar F.			Effect of waterpipe tobacco smoke exposure on the development of metabolic syndrome in adult male rats	PLOS ONE			English	Article							INSULIN-RESISTANCE; OXIDATIVE STRESS; ADIPONECTIN; LEPTIN; GHRELIN	The prevalence of metabolic syndrome is increased worldwide. Tobacco smoking increases the risk of developing metabolic syndrome. Waterpipe tobacco smoking has become a global trend of tobacco consumption and is as common as cigarette smoking. In this study, the effect of waterpipe tobacco smoke (WTS) on the development of metabolic syndrome in rats was evaluated. Adult Wistar rats were exposed for 19 weeks to either fresh air (control) or WTS for 1 hour daily/ 5 days per week (WTS). Central obesity, systolic blood pressure, lipid profile, glucose hemostasis and levels of leptin and adiponectin were evaluated. The WTS exposure increased body weight, abdominal circumference, systolic blood pressure and fasting glucose compared to control animals (P<0.05), consistent with inducing metabolic syndrome. The retroperitoneal fat, lipid profile and levels of insulin, leptin and adiponectin were not affected by WTS exposure (P>0.05). In conclusion, exposure to WTS has detrimental health effects leading to the development of metabolic syndrome in experimental animals.	[Al-Sawalha, Nour A.; Almahmmod, Yehya; Alzoubi, Karem H.] Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan; [Awawdeh, Mofleh S.] Jordan Univ Sci & Technol, Fac Vet Med, Dept Vet Pathol & Publ Hlth, Irbid, Jordan; [Khabour, Omar F.] Jordan Univ Sci & Technol, Fac Appl Med Sci, Dept Med Lab Sci, Irbid, Jordan	Jordan University of Science & Technology; Jordan University of Science & Technology; Jordan University of Science & Technology	Al-Sawalha, NA (corresponding author), Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan.	nasawalha@just.edu.jo		Khabour, Omar/0000-0002-3006-3104; Al-Sawalha, Nour/0000-0002-7401-8065	Jordan University of Science and Technology, Irbid, Jordan [118/2017]	Jordan University of Science and Technology, Irbid, Jordan	This study was supported by the deanship of research (grant number 118/2017, NAS, MA, KHA) at Jordan University of Science and Technology, Irbid, Jordan, http://www.just.edu.jo/Deanships/DeanshipofResearch/Pages/Default.aspx.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Akl EA, 2010, INT J EPIDEMIOL, V39, P834, DOI 10.1093/ije/dyq002; Al-Sawalha N, 2018, NICOTINE TOB RES, V20, P508, DOI 10.1093/ntr/ntx142; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; de Artinano AA, 2009, BRIT J NUTR, V102, P1246, DOI 10.1017/S0007114509990729; Ansarimoghaddam A, 2018, DIABETES METAB SYND, V12, P195, DOI 10.1016/j.dsx.2017.11.004; Azar RR, 2016, INHAL TOXICOL, V28, P339, DOI 10.3109/08958378.2016.1171934; Ballantyne CM, 2008, INT J OBESITY, V32, pS21, DOI 10.1038/ijo.2008.31; Baratta Mario, 2002, Med Sci Monit, V8, pRA282; Bhatnagar A, 2019, CIRCULATION, V139, pE917, DOI 10.1161/CIR.0000000000000671; Calo William A, 2014, Int J Prev Med, V5, P849; Chwyeed SH, 2018, MED J BABYLON, V15, P39, DOI [10.4103/MJBL.MJBL_11_18, DOI 10.4103/MJBL.MJBL_11_18]; Cobb C, 2010, AM J HEALTH BEHAV, V34, P275, DOI 10.5993/AJHB.34.3.3; Despres JP, 2006, EUR HEART J SUPPL, V8, pB4, DOI 10.1093/eurheartj/sul002; Faraj M, 2003, J CLIN ENDOCR METAB, V88, P1594, DOI 10.1210/jc.2002-021309; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Golbidi S, 2018, ANTIOXID REDOX SIGN, V28, P741, DOI 10.1089/ars.2017.7257; Jawad M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192191; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Khabour OF, 2012, INHAL TOXICOL, V24, P667, DOI 10.3109/08958378.2012.710918; Knopfholz J, 2014, CHOLESTEROL, DOI 10.1155/2014/261878; Kotani K, 2012, J ATHEROSCLER THROMB, V19, P787, DOI 10.5551/jat.11833; Mahjoub S, 2012, CASP J INTERN MED, V3, P386; Maziak W, 2011, ADDICT BEHAV, V36, P1, DOI 10.1016/j.addbeh.2010.08.030; Meier U, 2004, CLIN CHEM, V50, P1511, DOI 10.1373/clinchem.2004.032482; Moehlecke M, 2016, ARCH ENDOCRIN METAB, V60, P152, DOI 10.1590/2359-3997000000129; Nemmar A, 2017, AM J PHYSIOL-HEART C, V312, pH329, DOI 10.1152/ajpheart.00450.2016; Nolan Paul B, 2017, Prev Med Rep, V7, P211, DOI 10.1016/j.pmedr.2017.07.004; Perkins Kenneth A, 2002, Nicotine Tob Res, V4, P459, DOI 10.1080/1462220021000018434; Pierozan P, 2017, BASIC CLIN PHARMACOL, V121, P113, DOI 10.1111/bcpt.12774; Shafique K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039734; Shi H, 2009, PHYSIOL BEHAV, V97, P199, DOI 10.1016/j.physbeh.2009.02.017; Shihadeh A, 2003, FOOD CHEM TOXICOL, V41, P143, DOI 10.1016/S0278-6915(02)00220-X; Soflaei SS, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0335-4; Speakman JR, 2002, P NUTR SOC, V61, P473, DOI 10.1079/PNS2002194; Toste FP, 2006, BRIT J NUTR, V95, P830, DOI 10.1079/BJN20061726; Ward KD, 2015, NICOTINE TOB RES, V17, P34, DOI 10.1093/ntr/ntu121; Weitzman M, 2005, CIRCULATION, V112, P862, DOI 10.1161/CIRCULATIONAHA.104.520650; Zimmet P, 1999, ANN NY ACAD SCI, V892, P25, DOI 10.1111/j.1749-6632.1999.tb07783.x	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234516	10.1371/journal.pone.0234516	http://dx.doi.org/10.1371/journal.pone.0234516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559253	Green Published, gold			2022-12-27	WOS:000543261600009
J	Veit, T; Munker, D; Leuschner, G; Mummler, C; Sisic, A; Kauke, T; Schneider, C; Irlbeck, M; Michel, S; Eser-Valerie, D; Huber, M; Barton, J; Milger, K; Meiser, B; Behr, J; Kneidinger, N				Veit, Tobias; Munker, Dieter; Leuschner, Gabriela; Muemmler, Carlo; Sisic, Alma; Kauke, Teresa; Schneider, Christian; Irlbeck, Michael; Michel, Sebastian; Eser-Valerie, Daniela; Huber, Maximilian; Barton, Juergen; Milger, Katrin; Meiser, Bruno; Behr, Juergen; Kneidinger, Nikolaus			High prevalence of falsely declaring nicotine abstinence in lung transplant candidates	PLOS ONE			English	Article							SMOKING RESUMPTION; CARBON-MONOXIDE; RECIPIENTS; SMOKERS; HEART	Tobacco use after lung transplantation is associated with adverse outcome. Therefore, active smoking is regarded as a contraindication for lung transplantation and should be excluded prior to placement on the waiting list. The aim of the study was to compare self-reporting with a systematic cotinine based screening approach to identify patients with active nicotine abuse. Nicotine use was systematically assessed by interviews and cotinine test in all lung transplant candidates at every visit in our center. Patients were classified according to the stage prior to transplantation and cotinine test results were compared to self-reports and retrospectively analyzed until June 2019. Of 620 lung transplant candidates, 92 patients (14.8%) had at least one positive cotinine test. COPD as underlying disease (OR 2.102, CI 1.110-3.981; p = 0.023), number of pack years (OR 1.014, CI 1.000-1.028; p = 0.047) and a time of cessation less than one year (OR 2.413, CI 1.410-4.128; p = 0.001) were associated with a positive cotinine test in multivariable regression analysis. The majority of non-COPD patients (n = 13, 72.2%) with a positive test had a cessation time of less than one year. 78 patients (84.7%) falsely declared not consuming any nicotine-based products prior to the test. Finally, all never smokers were test negative. In conclusion, our data demonstrate that active nicotine use is prevalent in transplant candidates with a high prevalence of falsely declaring nicotine abstinence. COPD was the main diagnosis in affected patients. Short cessation time and a high number of pack years are risk factors for continued nicotine abuse.	[Veit, Tobias; Munker, Dieter; Leuschner, Gabriela; Muemmler, Carlo; Barton, Juergen; Milger, Katrin; Behr, Juergen; Kneidinger, Nikolaus] Univ Munich, German Ctr Lung Res DZL, Dept Internal Med 5, Comprehens Pneumol Ctr CPC M, Munich, Germany; [Sisic, Alma; Meiser, Bruno] Univ Munich, Transplant Ctr, Munich, Germany; [Kauke, Teresa; Schneider, Christian] Univ Munich, Dept Thorac Surg, Munich, Germany; [Irlbeck, Michael] Univ Munich, Dept Anaesthesiol, LMU, Munich, Germany; [Michel, Sebastian] Univ Munich, LMU, Clin Cardiac Surg, Munich, Germany; [Eser-Valerie, Daniela; Huber, Maximilian] Univ Munich, Dept Psychiat & Psychotherapy, LMU, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich; University of Munich	Kneidinger, N (corresponding author), Univ Munich, German Ctr Lung Res DZL, Dept Internal Med 5, Comprehens Pneumol Ctr CPC M, Munich, Germany.	nikolaus.kneidinger@med.uni-muenchen.de	Milger, Katrin/AFI-3881-2022	Milger, Katrin/0000-0003-2914-8773; Schneider, Christian/0000-0003-4501-3094	German Center for Lung Research (Deutsches Zentrum fur Lungenforschung, DZL)	German Center for Lung Research (Deutsches Zentrum fur Lungenforschung, DZL)	The study was supported by the German Center for Lung Research (Deutsches Zentrum fur Lungenforschung, DZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anis KH, 2019, AM J MED, V132, P413, DOI 10.1016/j.amjmed.2018.11.005; [Anonymous], 2016, PREV CHRONIC DIS, V13, pE40; [Anonymous], 2016, STUDIES ROMANTICISM, V55, P29; Bauldoff GS, 2015, J CARDIOPULM REHABIL, V35, P147, DOI 10.1097/HCR.0000000000000096; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Berastegui C, 2017, TRANSPL P, V49, P2285, DOI 10.1016/j.transproceed.2017.09.043; Chambers DC, 2019, J HEART LUNG TRANSPL, V38, P1042, DOI 10.1016/j.healun.2019.08.001; Chang CM, 2017, CANCER EPIDEM BIOMAR, V26, P291, DOI 10.1158/1055-9965.EPI-16-0675; Duerinckx N, 2016, TRANSPLANTATION, V100, P2252, DOI 10.1097/TP.0000000000001335; Hellemons ME, 2011, AM J TRANSPLANT, V11, P2490, DOI 10.1111/j.1600-6143.2011.03701.x; Hofmann P, 2019, TRANSPLANTATION, V103, P1260, DOI 10.1097/TP.0000000000002576; Hofmann P, 2018, J THORAC DIS, V10, P4609, DOI 10.21037/jtd.2018.07.16; JAFFE JH, 1981, ADDICT BEHAV, V6, P337, DOI 10.1016/0306-4603(81)90049-6; JARVIS MJ, 1987, AM J PUBLIC HEALTH, V77, P1435, DOI 10.2105/AJPH.77.11.1435; Le Cook B, 2014, JAMA-J AM MED ASSOC, V311, P172, DOI 10.1001/jama.2013.284985; Maurer J R, 1998, Transplantation, V66, P951; Ruttens D, 2014, EUR RESPIR J, V43, P300, DOI 10.1183/09031936.00141113; Sozen F, 2016, EXP CLIN TRANSPLANT, V14, P95, DOI 10.6002/ect.tondtdtd2016.P35; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Stelmach R, 2015, J BRAS PNEUMOL, V41, P124, DOI 10.1590/S1806-37132015000004526; STITZER ML, 1982, ADDICT BEHAV, V7, P403, DOI 10.1016/0306-4603(82)90010-7; Triplette M, 2019, AM J TRANSPLANT, V19, P1478, DOI 10.1111/ajt.15181; Weig T, 2016, ANN THORAC SURG, V101, P1318, DOI 10.1016/j.athoracsur.2015.10.041; Weill D, 2018, J THORAC DIS, V10, P4574, DOI 10.21037/jtd.2018.06.141; WOODWARD M, 1992, EUR HEART J, V13, P160, DOI 10.1093/oxfordjournals.eurheartj.a060140	25	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234808	10.1371/journal.pone.0234808	http://dx.doi.org/10.1371/journal.pone.0234808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555678	Green Published, gold			2022-12-27	WOS:000543273200043
J	Roudnicky, P; Patesil, D; Zdrahal, Z; Gelnar, M; Kasny, M				Roudnicky, Pavel; Patesil, David; Zdrahal, Zbynek; Gelnar, Milan; Kasny, Martin			Laser capture microdissection in combination with mass spectrometry: Approach to characterization of tissue-specific proteomes ofEudiplozoon nipponicum(Monogenea, Polyopisthocotylea)	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; FLATWORMS PLATYHELMINTHES; MONOGENEA; PARASITE; ULTRASTRUCTURE; SCHISTOSOMES; MICROSCOPY	Eudiplozoon nipponicum(Goto, 1891) is a hematophagous monogenean ectoparasite which inhabits the gills of the common carp (Cyprinus carpio). Heavy infestation can lead to anemia and in conjunction with secondary bacterial infections cause poor health and eventual death of the host. This study is based on an innovative approach to protein localization which has never been used in parasitology before. Using laser capture microdissection, we dissected particular areas of the parasite body without contaminating the samples by surrounding tissue and in combination with analysis by mass spectrometry obtained tissue-specific proteomes of tegument, intestine, and parenchyma of our model organism,E.nipponicum. We successfully verified the presence of certain functional proteins (e.g. cathepsin L) in tissues where their presence was expected (intestine) and confirmed that there were no traces of these proteins in other tissues (tegument and parenchyma). Additionally, we identified a total of 2,059 proteins, including 72 peptidases and 33 peptidase inhibitors. As expected, the greatest variety was found in the intestine and the lowest variety in the parenchyma. Our results are significant on two levels. Firstly, we demonstrated that one can localize all proteins in one analysis and without using laboratory animals (antibodies for immunolocalization of single proteins). Secondly, this study offers the first complex proteomic data on not only theE.nipponicumbut within the whole class of Monogenea, which was from this point of view until recently neglected.	[Roudnicky, Pavel; Gelnar, Milan; Kasny, Martin] Masaryk Univ, Fac Sci, Dept Bot & Zool, Brno, Czech Republic; [Patesil, David; Zdrahal, Zbynek] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Zdrahal, Zbynek] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; Masaryk University Brno	Roudnicky, P (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Brno, Czech Republic.	p.roudnicky@mail.muni.cz	Potesil, David/D-9696-2012	Potesil, David/0000-0003-0390-0904; Zdrahal, Zbynek/0000-0003-3044-5548; Roudnicky, Pavel/0000-0002-6904-7646	Czech Science Foundation [GBP505/12/G112, GAP506/12/1258]; Grant Agency of Masaryk University [MUNI/A/0918/2018]; NCMG research infrastructure (MEYS CR) [LM2018132]; MEYS CR [LM2018127]; project CEITEC 2020, MEYS CR [LQ1601]; project "e-Infrastruktura CZ" [e-INFRA LM2018140]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Masaryk University; NCMG research infrastructure (MEYS CR); MEYS CR; project CEITEC 2020, MEYS CR; project "e-Infrastruktura CZ"	This work was supported by the Czech Science Foundation (GBP505/12/G112, GAP506/12/1258) and Grant Agency of Masaryk University (MUNI/A/0918/2018). We acknowledge the CF Genomics CEITEC MU supported by the NCMG research infrastructure (LM2018132 funded by MEYS CR) for their support with obtaining scientific data presented in this paper. CIISB research infrastructure project LM2018127 funded by MEYS CR is gratefully acknowledged for their financial support of LC-MS/MS measurements at the Proteomics Core Facility. The work was supported by the project CEITEC 2020 (LQ1601), MEYS CR. Computational resources were supplied by the project "e-Infrastruktura CZ" (e-INFRA LM2018140) provided within the program Projects of Large Research, Development, and Innovations Infrastructures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, FARSOTTAFRETTIR, V11, P1, DOI DOI 10.1186/s13071-017-2573-y; [Anonymous], 2006, EUROPEAN CONSTITUTIO, V2, P268; Baeza JA, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3711-5; BERNS MW, 1981, SCIENCE, V213, P505, DOI 10.1126/science.7017933; Bohm M, 1997, AM J PATHOL, V151, P63; Brennan GP, 1996, PARASITOL RES, V82, P638, DOI 10.1007/s004360050178; Clement-Sengewald A, 2000, PATHOBIOLOGY, V68, P232, DOI 10.1159/000055929; Cohen SC, 2001, MEM I OSWALDO CRUZ, V96, P555, DOI 10.1590/S0074-02762001000400019; CONN DB, 1993, T AM MICROSC SOC, V112, P241, DOI 10.2307/3226561; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crecelius AC, 2015, ANALYST, V140, P5806, DOI 10.1039/c5an00990a; CREMER C, 1974, Microscopica Acta, V75, P331; Cubi R, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12735; Datta S, 2015, HISTOL HISTOPATHOL, V30, P1255, DOI 10.14670/HH-11-622; Dilillo M, 2017, J PROTEOME RES, V16, P2993, DOI 10.1021/acs.jproteome.7b00284; Dinguirard N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02773; Dvorak J, 2018, INT J PARASITOL, V48, P333, DOI 10.1016/j.ijpara.2018.01.001; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Fajtova P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003827; Ferreira MS, 2014, J MASS SPECTROM, V49, P86, DOI 10.1002/jms.3308; Glerup S, 2005, J BIOL CHEM, V280, P9823, DOI 10.1074/jbc.M413228200; Gobert GN, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000469; Hahn C, 2014, GENOME BIOL EVOL, V6, P1105, DOI 10.1093/gbe/evu078; Horn M, 2009, CHEM BIOL, V16, P1053, DOI 10.1016/j.chembiol.2009.09.009; Hsu CC, 2015, ANAL CHEM, V87, P11171, DOI 10.1021/acs.analchem.5b03389; Huyse T, 2007, PARASITOLOGY, V134, P739, DOI 10.1017/S0031182006002010; Ilgova J, 2020, MOL BIOCHEM PARASIT, V235, DOI 10.1016/j.molbiopara.2019.111248; Ilgova J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17598-2; Jedlickova L, 2019, INT J PARASITOL, V49, P337, DOI 10.1016/j.ijpara.2018.11.010; Jedlickova L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2666-2; Jedlickova L, 2016, PARASITOLOGY, V143, P494, DOI 10.1017/S0031182015001808; Johann DJ, 2009, J PROTEOME RES, V8, P2310, DOI 10.1021/pr8009403; Jones MK, 2007, EXP PARASITOL, V117, P259, DOI 10.1016/j.exppara.2007.06.004; Jones MK, 2007, INT J BIOCHEM CELL B, V39, P1646, DOI 10.1016/j.biocel.2007.04.017; Kadesch P, 2019, ANAL CHEM, V91, P4520, DOI 10.1021/acs.analchem.8b05440; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kang S, 2012, MITOCHONDR DNA, V23, P176, DOI 10.3109/19401736.2012.668900; Konstanzova V, 2015, PARASITOL RES, V114, P1485, DOI 10.1007/s00436-015-4331-4; Konstanzova V, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2203-8; Lutz HL, 2016, PARASITOL RES, V115, P4503, DOI 10.1007/s00436-016-5237-5; Lyons K.M., 1973, Advances Parasit, V11, P193, DOI 10.1016/S0065-308X(08)60187-6; MONAJEMBASHI S, 1986, EXP CELL RES, V167, P262, DOI 10.1016/0014-4827(86)90223-5; Nawaratna SSK, 2014, MOL BIOCHEM PARASIT, V196, P82, DOI 10.1016/j.molbiopara.2014.08.002; Nawaratna SSK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001043; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Plaisance L, 2007, MOL BIOCHEM PARASIT, V154, P190, DOI 10.1016/j.molbiopara.2007.04.012; Protasio AV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001455; Pshezhetsky AV, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3413, DOI 10.1016/B978-0-12-382219-2.00754-7; Roche L, 1999, MOL BIOCHEM PARASIT, V98, P271, DOI 10.1016/S0166-6851(98)00164-9; Roudnicky P, 2018, PARASITE, V25, DOI 10.1051/parasite/2018062; Roy S, 2007, P NATL ACAD SCI USA, V104, P14472, DOI 10.1073/pnas.0706793104; Salmon CR, 2017, BONE, V101, P219, DOI 10.1016/j.bone.2017.05.014; Schutze K, 2007, METHOD CELL BIOL, V82, P649, DOI 10.1016/S0091-679X(06)82023-6; Shapiro JP, 2012, J PROTEOMICS, V77, P433, DOI 10.1016/j.jprot.2012.09.019; Shawky M, 2007, TRANSPORT RES REC, P11, DOI 10.3141/2012-02; Stilwell JM, 2019, PARASITOL RES, V118, P1639, DOI 10.1007/s00436-019-06295-w; Taverna D, 2015, BONE, V74, P83, DOI 10.1016/j.bone.2015.01.004; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Zhang D, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174214; Zhang D, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2404-1; Zhang J, 2014, MOL BIOL REP, V41, P6583, DOI 10.1007/s11033-014-3542-6; Zhang J, 2012, MOL BIOL REP, V39, P8115, DOI 10.1007/s11033-012-1659-z; Zhang SS, 2018, METHODS MOL BIOL, V1676, P153, DOI 10.1007/978-1-4939-7315-6_9	64	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0231681	10.1371/journal.pone.0231681	http://dx.doi.org/10.1371/journal.pone.0231681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555742	gold, Green Published, Green Submitted			2022-12-27	WOS:000542759600012
J	Santos, MCD; Gabani, FL; Dias, DF; de Andrade, SM; Gonzalez, AD; Loch, MR; Mesas, AE				Santos, Mayara Cristina da Silva; Gabani, Flavia Lopes; Dias, Douglas Fernando; de Andrade, Selma Maffei; Gonzalez, Alberto Duran; Loch, Mathias Roberto; Mesas, Arthur Eumann			Longitudinal associations of changes in physical activity and TV viewing with chronic musculoskeletal pain in Brazilian schoolteachers	PLOS ONE			English	Article							RISK; EXERCISE	This study analyzed the longitudinal association of changes in leisure-time physical activity (LTPA) practice and television viewing (TV viewing) with chronic musculoskeletal pain (CMP). The data about LTPA, TV viewing, and CMP were obtained in 2012 and after 24 months through individual interviews with schoolteachers from elementary and secondary education public schools in a large city in the southern region of Brazil. The statistical analysis was performed using generalized estimating equation regression models adjusted for sex, age, body mass index and depression. A total of 527 schoolteachers were studied, among which 66.6% were women, and the median age was 42 years (interquartile range: 34 to 49). A total of 170 (32.3%) participants reported CMP at baseline and 130 (24.7%) at follow-up. Both LTPA and TV viewing were independently and significantly associated with CMP regardless of all adjustment variables. Concretely, increasing LTPA by 60 minutes/week was associated with a 6.2% lower likelihood of CMP, and increasing TV viewing by 30 minutes/day was associated with a 5.1% higher likelihood of having CMP among the participants. In summary, this study showed that LTPA and TV viewing have independent and opposite relationships with the longitudinal risk of CMP, which suggests that the potential benefits obtained from practicing more LTPA are insufficient to compensate for the potential detrimental effect of viewing TV for longer with respect to the CMP.	[Santos, Mayara Cristina da Silva; Gabani, Flavia Lopes; Dias, Douglas Fernando; de Andrade, Selma Maffei; Gonzalez, Alberto Duran; Loch, Mathias Roberto; Mesas, Arthur Eumann] Univ Estadual Londrina, Dept Publ Hlth, Londrina, Parana, Brazil; [Mesas, Arthur Eumann] Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain	Universidade Estadual de Londrina; Universidad de Castilla-La Mancha	Mesas, AE (corresponding author), Univ Estadual Londrina, Dept Publ Hlth, Londrina, Parana, Brazil.; Mesas, AE (corresponding author), Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain.	arthur.emesas@uclm.es	Mesas, Arthur/AAK-3361-2021; De Andrade, Selma M/B-2822-2008; Gabani, Flavia Lopes/AAW-9258-2020	Mesas, Arthur/0000-0002-0088-8607; De Andrade, Selma M/0000-0001-6843-8330; Gabani, Flavia Lopes/0000-0002-9442-4896; Cristina da Silva Santos, Mayara/0000-0003-1250-0873	CAPES (Coordination for the Improvement of Higher Level Personnel, Ministry of Education, Brazil); Brazilian National Research Council (CNPq)	CAPES (Coordination for the Improvement of Higher Level Personnel, Ministry of Education, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	M.C.S.S. is the recipient of a scholarship from CAPES (Coordination for the Improvement of Higher Level Personnel, Ministry of Education, Brazil) as part of the funding for her dissertation. S. M.A. and A.E.M. are the recipients of research productivity scholarships from the Brazilian National Research Council (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebaw T.-A., 2018, BIOMED J SCI TECH RE, V10, P1, DOI [10.26717/BJSTR.2018.10.001886, DOI 10.26717/BJSTR.2018.10.001886]; Ambrose KR, 2015, BEST PRACT RES CL RH, V29, P120, DOI 10.1016/j.berh.2015.04.022; [Anonymous], 2019, NAT METHODS, V16, P1, DOI 10.1038/s41592-018-0292-8; [Anonymous], 2018, NAT SUSTAIN, V1, P151, DOI 10.1038/s41893-018-0060-x; [Anonymous], 2017, Hosp Case Manag, V25, P1; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2012, AM J TRANSPLANT, V12, P1, DOI 10.1111/j.1600-6143.2011.03886.x; [Anonymous], 2016, CLADISTICS, V32, P1, DOI [10.1111/cla.12, DOI 10.1111/CLA.12]; [Anonymous], 2017, JAP CLASS ES CANC, V14, P1, DOI [DOI 10.1007/s10388-016-0551-7, DOI 10.1093/GERONT/GNY014]; [Anonymous], 2018, U TORONTO LAW J S1, V68, P1, DOI DOI 10.1007/S11881-018-0158-X; [Anonymous], 2016, J GERIATR CARDIOL; Cimas M, 2018, EUR J PAIN, V22, P333, DOI 10.1002/ejp.1123; Cooper L, 2018, OBES REV, V19, P989, DOI 10.1111/obr.12686; de Farias JC, 2010, CAD SAUDE PUBLICA, V26, P1669, DOI 10.1590/S0102-311X2010000900002; Durmus D, 2012, J BACK MUSCULOSKELET, V25, P5, DOI 10.3233/BMR-2012-0304; Gibbs BB, 2018, OCCUP ENVIRON MED, V75, P321, DOI 10.1136/oemed-2017-104732; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Korkmaz NC, 2011, SCI RES ESSAYS, V6, P649; Lee LFR, 2019, MED ENG PHYS, V74, P82, DOI 10.1016/j.medengphy.2019.09.018; Lima LV, 2017, PAIN, V158, P1697, DOI 10.1097/j.pain.0000000000000967; Lima LV, 2017, J PHYSIOL-LONDON, V595, P4141, DOI 10.1113/JP273355; Marchant S., 2012, PHENOMENON PAIN; Mekary RA, 2013, AM J EPIDEMIOL, V178, P474, DOI 10.1093/aje/kws590; Page MG, 2018, J PAIN RES, V11, P237, DOI 10.2147/JPR.S149262; Patterson J, 2017, ENVIRON INNOV SOC TR, V24, P1, DOI 10.1016/j.eist.2016.09.001; Pinto RZ, 2014, EUR J PAIN, V18, P1190, DOI 10.1002/j.1532-2149.2014.00468.x; Polaski AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210418; Santos MCS, 2018, BEHAV MED, V44, P335, DOI 10.1080/08964289.2017.1384358; Shiri R, 2017, BRIT J SPORT MED, V51, P1410, DOI 10.1136/bjsports-2016-097352; Siebra Maiara Mota Rocha, 2017, Rev. dor, V18, P43, DOI 10.5935/1806-0013.20170010; Stamatakis E, 2012, PREV MED, V54, P82, DOI 10.1016/j.ypmed.2011.10.009; van Hecke O, 2013, BRIT J ANAESTH, V111, P13, DOI 10.1093/bja/aet123; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wong JJ, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-1192-4; Zhang YE, 2018, CURR OPIN CELL BIOL, V51, P1, DOI 10.1016/j.ceb.2017.10.001	35	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234609	10.1371/journal.pone.0234609	http://dx.doi.org/10.1371/journal.pone.0234609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555745	Green Published, gold			2022-12-27	WOS:000542759600027
J	Hwang, J; Vu, GT; Tran, BX; Nguyen, THT; Nguyen, BV; Nguyen, LH; Nguyen, HLT; Latkin, CA; Ho, CSH; Ho, RCM				Hwang, Jongnam; Vu, Giang Thu; Tran, Bach Xuan; Nguyen, Thu Hong Thi; Nguyen, Bang Van; Nguyen, Long Hoang; Nguyen, Huong Lan Thi; Latkin, Carl A.; Ho, Cyrus S. H.; Ho, Roger C. M.			Measuring satisfaction with health care services for Vietnamese patients with cardiovascular diseases	PLOS ONE			English	Article							INPATIENT SATISFACTION; VALIDATION; QUESTIONNAIRE; CENTERS	Patient satisfaction is a useful predictor of adherence and outcomes of cardiovascular diseases (CVDs) treatment. This study explored the satisfaction of Vietnamese CVDs inpatients and outpatients using a scale specifically designed for CVDs patients and examined the factors associated with satisfaction towards CVDs treatment services. Interviews of 600 patients at the Hanoi Heart Hospital were conducted. We developed a measurement scale for both inpatient and outpatient services. Multivariate Tobit regression was used to determine the associated factors with patient satisfaction. For inpatients, Cronbach's alpha reported for the domains were in the range of 0.72-0.97, while for outpatients, Cronbach's alpha was within 0.61-0.97. Overall, patients were more satisfied with inpatient services (Mean = 81.8, SD = 5.8) than outpatient services (Mean = 79.7, SD = 5.2, p<0.05). In inpatients, the highest complete satisfaction was in "Attitude of Nurse" item (42.0%), the highest satisfaction score was in "Care and treatment" domain (Mean = 85.6, SD = 9.7) and the lowest in "Hospital facilities" domain (Mean = 78.3; SD = 9.2). Among outpatients, the highest complete satisfaction was in "Attitude of physicians when examining, guiding and explaining to the patient" item (19.7%), the highest satisfaction score was in "Attitude of medical staff" domain (Mean = 82.8; SD = 7.9) and the lowest in "Waiting time" domain (Mean = 76.6; SD = 8.2). People not having health insurances had significantly higher scores in "Waiting time", "Hospital facilities" and "Attitude of staff" domains (for outpatients) and in "Health service accessibility", "Hospital facilities" domains (for inpatients) as well as higher total satisfaction score than those having health insurance. Findings discovered through the application of the newly developed instrument showed low satisfaction regarding hospital facilities for inpatients and waiting time for outpatients, suggesting renovation efforts, while inferiority regarding patient satisfaction of health insurance covered patients compared to those without implied policy reform possibility. Further enhancement and validation of the developed instrument was required.	[Hwang, Jongnam] Wonkwang Univ, Div Social Welf & Hlth Adm, Iksan, South Korea; [Vu, Giang Thu] Nguyen Tat Thanh Univ, Ctr Excellence Evidence based Med, Ho Chi Minh City, Vietnam; [Tran, Bach Xuan] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Tran, Bach Xuan; Latkin, Carl A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Nguyen, Thu Hong Thi] Hanoi Heart Hosp, Hanoi, Vietnam; [Nguyen, Bang Van] Mil Med Univ, Hosp 103, Dept Hematotoxico Radiol & Occupat Dis, Hanoi, Vietnam; [Nguyen, Long Hoang] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam; [Nguyen, Huong Lan Thi] Natl Univ Singapore Hosp, Dept Psychol Med, Singapore, Singapore; [Ho, Cyrus S. H.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore; [Ho, Roger C. M.] Natl Univ Singapore, Inst Hlth Innovat & Technol iHealthtech, Singapore, Singapore	Wonkwang University; Nguyen Tat Thanh University (NTTU); Hanoi Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Duy Tan University; National University of Singapore; National University of Singapore; National University of Singapore	Tran, BX (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam.; Tran, BX (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA.	bach.ipmph@gmail.com	Ho, Roger C./ABD-9061-2021; Hwang, Jongnam/GLQ-6437-2022; Ho, Cyrus SH/AAN-9344-2020; Ho, Roger/ABD-8859-2021	Ho, Roger C./0000-0001-9629-4493; Hwang, Jongnam/0000-0001-7078-9244; Ho, Cyrus SH/0000-0002-7092-9566; 				Aiken Linda H, 2018, BMJ Open, V8, pe019189, DOI 10.1136/bmjopen-2017-019189; Almomani I, 2016, J INFECT PUBLIC HEAL, V9, P734, DOI 10.1016/j.jiph.2016.09.005; Anderson Roger, 2007, J Med Pract Manage, V22, P255; [Anonymous], 2014, AUST LIT STUD, V29, p[128, 33, 3]; [Anonymous], 2017, CARDIOVASCULAR DIS C; [Anonymous], 2012, JOINT ANN HLTH REV 2; [Anonymous], 2002, EREMO SOLITUDINE NEL, VLIV, P493; [Anonymous], 1999, OXFORD REV EDUC, V25, P369; Asadi-Lari Mohsen, 2003, Health Qual Life Outcomes, V1, P57, DOI 10.1186/1477-7525-1-57; Bener A, 2013, NIGER J CLIN PRACT, V16, P285, DOI 10.4103/1119-3077.113448; Bleustein C, 2014, AM J MANAG CARE, V20, P393; Bonett DG, 2015, J ORGAN BEHAV, V36, P3, DOI 10.1002/job.1960; Bujang MA, 2018, MALAYS J MED SCI, V25, P85, DOI 10.21315/mjms2018.25.6.9; Chimatiro GL, 2018, MALAWI MED J, V30, P152, DOI 10.4314/mmj.v30i3.4; Collins K, 2002, J HEALTH PSYCHOL, V7, P615, DOI 10.1177/1359105302007005681; Dang M, 2013, CAND ONLINE CAN 1109; Dawn AG, 2003, AM J MED QUAL, V18, P265, DOI 10.1177/106286060301800607; EuroQol Research, 2015, EQ 5D 5L USER GUIDE; GBD, 2017, LANCET, V390, P1211, DOI [DOI 10.1016/S0140-6736(17)32154-2, 10.1016/S0140-6736(17)32154-2]; Gheorghe A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5806-x; Goel S, 2014, J HEALTH SERV RES PO, V19, P85, DOI 10.1177/1355819613508381; Gonzalez N, 2005, INT J QUAL HEALTH C, V17, P465, DOI 10.1093/intqhc/mzi067; Grogan S, 2000, QUAL HEALTH CARE, V9, P210, DOI 10.1136/qhc.9.4.210; Hoang L, 2019, TUOI TRE ONLINE 0808; Institute of Medicine (US) Committee on Social Security Cardiovascular Disability Criteria, 2010, CARD DIS TRENDS CARD; Kennedy GD, 2014, ANN SURG, V260, P592, DOI 10.1097/SLA.0000000000000932; Kleefstra SM, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.030825; Konerding U, 2016, PATIENT PREFER ADHER, V10, P2083, DOI 10.2147/PPA.S112398; Mai VQ, 2020, QUAL LIFE RES, V29, P1923, DOI 10.1007/s11136-020-02469-7; MARQUIS MS, 1983, MED CARE, V21, P821, DOI 10.1097/00005650-198308000-00006; Martin CM, 2007, CAN FAM PHYSICIAN, V53, P2086; McNeish D, 2018, PSYCHOL METHODS, V23, P412, DOI 10.1037/met0000144; N Le, 2019, VNEXPRESS       0814; Norhayati MN, 2017, PEERJ, V5, DOI 10.7717/peerj.2983; Quintana JM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-102; Sabesan VJ, 2013, J BONE JOINT SURG AM, V95-A, pe82; Sahin B, 2007, J MED SYST, V31, P9, DOI 10.1007/s10916-006-9038-8; Shan LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164366; Siddiqui ZK, 2015, J HOSP MED, V10, P165, DOI 10.1002/jhm.2297; Sixma Herman J., 1998, Health Expect, V1, P82, DOI 10.1046/j.1369-6513.1998.00004.x; Thayaparan AJ, 2013, MED EDUC ONLINE, V18, DOI 10.3402/meo.v18i0.21747; va cs Tran Thj Cam Tu, 2014, TAP CHI HOC THUC HAN, V903, P54; WARTMAN SA, 1983, MED CARE, V21, P886, DOI 10.1097/00005650-198309000-00005; Weidemann RR, 2016, HERZ, V41, P313, DOI 10.1007/s00059-015-4360-x; World Health Organization, 2019, CARD DIS CVD VIET NA; Yusuf S, 2015, LANCET, V386, P399, DOI 10.1016/S0140-6736(15)60265-3	46	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235333	10.1371/journal.pone.0235333	http://dx.doi.org/10.1371/journal.pone.0235333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584904	Green Published, gold			2022-12-27	WOS:000545747200080
J	Nair, ANS; Nair, RVR; Nair, APR; Nair, AS; Thyagarajan, S; Johnson, AJ; Baby, S				Nair, Ajikumaran Nair Sadasivan; Nair, Reshma Vijayakumari Raveendran; Nair, Aroma Prasanna Rajendran; Nair, Akhila Sasikumar; Thyagarajan, Sabu; Johnson, Anil John; Baby, Sabulal			Antidiabetes constituents, cycloartenol and 24-methylenecycloartanol, fromFicus krishnae	PLOS ONE			English	Article							HIGH-FAT DIET; TRITERPENE ALCOHOLS; DIABETES-MELLITUS; MEDICINAL-PLANTS; STEROLS; IDENTIFICATION; PHYTOSTEROLS; MECHANISM	Ficus krishnaestem bark and leaves are used for diabetes treatment in traditional medicines. Stem bark ofF.krishnaewas sequentially extracted with hexane, methanol and water, and these extracts were tested for their antihyperglyceamic activity by oral glucose tolerance test (OGTT) in overnight fasted glucose loaded normal rats. Hexane extract showed significant glucose lowering activity in OGTT, and the triterpene alcohols (cycloartenol+24-methylenecycloartanol) (CA+24-MCA) were isolated together from it by activity guided isolation and characterized by NMR and mass spectroscopy. The ratio of the chemical constituents CA and 24-MCA in (CA+24-MCA) was determined as 2.27:1.00 by chemical derivatization and gas chromatographic quantification. (CA+24-MCA) in high fat diet-streptozotocin induced type II diabetic rats showed significant antidiabetes activity at 1 mg/kg and ameliorated derailed blood glucose and other serum biochemical parameters. Cytoprotective activity of (CA+24-MCA) from glucose toxicity was evaluated in cultured RIN-5F cells by MTT assay and fluorescent microscopy. (CA+24-MCA) inin vitrostudies showed enhanced cell viability in RIN-5F cells and significant protection of beta cells from glucose toxicity. Both inin vivoandin vitrostudies (CA+24-MCA) showed enhancement in insulin release from the beta cells. In short term toxicity studies in mice (CA+24-MCA) did not show any conspicuous toxic symptoms. The combination of the phytosterols (CA+24-MCA) obtained through activity guided isolation of the stem bark ofF.krishnaeshowed significant activity, and therefore is a promising candidate for new generation antidiabetes drug development.	[Nair, Ajikumaran Nair Sadasivan; Nair, Reshma Vijayakumari Raveendran; Nair, Aroma Prasanna Rajendran; Nair, Akhila Sasikumar; Johnson, Anil John; Baby, Sabulal] Jawaharlal Nehru Trop Bot Garden & Res Inst, Phytochem & Phytopharmacol Div, Thiruvananthapuram, Kerala, India; [Thyagarajan, Sabu] Jawaharlal Nehru Trop Bot Garden & Res Inst, Garden Management Div, Thiruvananthapuram, Kerala, India	KSCSTE-Jawaharlal Nehru Tropical Botanic Garden & Research Institute (JNTBGRI); KSCSTE-Jawaharlal Nehru Tropical Botanic Garden & Research Institute (JNTBGRI)	Baby, S (corresponding author), Jawaharlal Nehru Trop Bot Garden & Res Inst, Phytochem & Phytopharmacol Div, Thiruvananthapuram, Kerala, India.	sabulal@gmail.com	Baby, Sabulal/AFK-3415-2022	Baby, Sabulal/0000-0002-4337-9431	Plan Project programme of the Government of Kerala, India [P007]; Science and Engineering Research Board (SERB), Government of India [CRG/2019/000131]	Plan Project programme of the Government of Kerala, India; Science and Engineering Research Board (SERB), Government of India	Authors acknowledge financial support for this study from (i) Plan Project programme (P007) of the Government of Kerala, India and (ii) Core Research Grant (CRG/2019/000131) of Science and Engineering Research Board (SERB), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumaran N. S., 2014, EUR J PHARMACOL, V734, P77; Alvarez-Cilleros D, 2018, FOOD CHEM TOXICOL, V120, P119, DOI 10.1016/j.fct.2018.07.003; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 2019, BRAIN STIMUL MAR; [Anonymous], 2010, B EPIDEMIOLOGICO DEN, V1, P14; APLIN RT, 1967, J CHEM SOC C, P246, DOI 10.1039/j39670000246; Babu V., 2003, Indian Journal of Pharmacology, V35, P290; BENTLEY HR, 1953, J CHEM SOC, P3673, DOI 10.1039/jr9530003673; CARROLL NV, 1956, J BIOL CHEM, V220, P583; Choudhury Hira, 2018, J Tradit Complement Med, V8, P361, DOI 10.1016/j.jtcme.2017.08.012; Deepa P, 2018, J ETHNOPHARMACOL, V215, P210, DOI 10.1016/j.jep.2017.12.045; FEDELI E, 1966, J AM OIL CHEM SOC, V43, P254, DOI 10.1007/BF02641098; Fukuoka D, 2014, J APPL PHYSIOL, V117, P1337, DOI 10.1152/japplphysiol.00268.2014; George S, 2015, J ETHNOPHARMACOL, V168, P158, DOI 10.1016/j.jep.2015.03.060; Gomes AYS, 2005, PLANTA MED, V71, P1025, DOI 10.1055/s-2005-871291; Guan HY, 2017, ACTA PHARM SIN B, V7, P603, DOI 10.1016/j.apsb.2017.07.001; IKEDA I, 1985, J NUTR SCI VITAMINOL, V31, P375, DOI 10.3177/jnsv.31.375; Jam NC, 1986, SCHALMS VET HAEMATOL, P43; Kanjikar AP, 2017, INT J CHEMTECH RES, V10, P220; Khursheed R, 2019, EUR J PHARMACOL, V862, DOI 10.1016/j.ejphar.2019.172625; Kirtikar KR, 2005, INDIAN MED PLANTS, P2312; Lansky EP, 2008, J ETHNOPHARMACOL, V119, P195, DOI 10.1016/j.jep.2008.06.025; Marles RJ, 1995, PHYTOMEDICINE, V2, P137, DOI 10.1016/S0944-7113(11)80059-0; MILON A, 1989, HELV CHIM ACTA, V72, P1, DOI 10.1002/hlca.19890720102; Misawa K, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1412; Nair SA, 2006, J ETHNOPHARMACOL, V106, P192, DOI 10.1016/j.jep.2005.12.020; Nazaruk J, 2015, PHYTOCHEM REV, V14, P675, DOI 10.1007/s11101-014-9369-x; Ohyama K, 2009, P NATL ACAD SCI USA, V106, P725, DOI 10.1073/pnas.0807675106; Okahara F, 2016, MOL NUTR FOOD RES, V60, P1521, DOI 10.1002/mnfr.201500897; Patel D. K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P320, DOI 10.1016/S2221-1691(12)60032-X; Putta S, 2016, CURR TOP MED CHEM, V16, P2532, DOI 10.2174/1568026616666160414123343; REES HH, 1968, BIOCHEM J, V107, P417, DOI 10.1042/bj1070417; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Sheikh Y, 2015, J ETHNOPHARMACOL, V171, P37, DOI 10.1016/j.jep.2015.05.030; Shylesh B. S., 2005, Indian Journal of Pharmacology, V37, P232; Sidhu MC, 2014, INDIAN J PHARM SCI, V76, P323; Sonawane PD, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.205; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Tanaka M, 2006, BIOL PHARM BULL, V29, P1418, DOI 10.1248/bpb.29.1418; TERESA JD, 1987, PHYTOCHEMISTRY, V26, P1767; Tiwari R, 2015, PHYTOTAXA, V192, P169, DOI 10.11646/phytotaxa.192.3.3; Wagner H, 1984, PLANT DRUG ANAL, P197; WANG KC, 1990, TETRAHEDRON LETT, V31, P1283, DOI 10.1016/S0040-4039(00)88786-9; Wang YW, 2011, METABOLISM, V60, P298, DOI 10.1016/j.metabol.2010.02.005; YOSHIDA K, 1989, AGR BIOL CHEM TOKYO, V53, P1901, DOI 10.1080/00021369.1989.10869552; Zhang L, 2010, J ETHNOPHARMACOL, V132, P518, DOI 10.1016/j.jep.2010.08.053; Zhang T, 2020, FOOD FUNCT, V11, P93, DOI [10.1039/c9fo01205b, 10.1039/C9FO01205B]; Zhang Zhong-Lian, 2017, Zhongguo Zhong Yao Za Zhi, V42, P433, DOI 10.19540/j.cnki.cjcmm.20161222.066; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151	51	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235221	10.1371/journal.pone.0235221	http://dx.doi.org/10.1371/journal.pone.0235221			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584888	Green Published, gold			2022-12-27	WOS:000545747200032
J	Richa, S; Herdane, M; Dwaf, A; Khalil, RB; Haddad, F; El Khoury, R; Zarzour, M; Kassab, A; Dagher, R; Brunet, A; El-Hage, W				Richa, Sami; Herdane, Marie; Dwaf, Azzam; Bou Khalil, Rami; Haddad, Fadi; El Khoury, Rhea; Zarzour, Myriam; Kassab, Anthony; Dagher, Ramez; Brunet, Alain; El-Hage, Wissam			Trauma exposure and PTSD prevalence among Yazidi, Christian and Muslim asylum seekers and refugees displaced to Iraqi Kurdistan	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HEALTH CONSEQUENCES; DEPRESSION; TORTURE; WAR	Background There is unreliable, and negligible information on the mental health and trauma-exposure of asylum-seekers and displaced refugees in the Iraqi Kurdistan region. Objectives To evaluate how responsible the ethno-religious origins are, for the prevalence of trauma exposure and post-traumatic stress disorder (PTSD) in displaced Iraqi asylum-seekers and refugees residing in the Iraqi Kurdistan region. Methods Structured interviews with a cross-sectional sample of 150 individuals, comprised of three self-identified ethno-religious groups (50 participants in each): Christians, Muslims, and Yazidis. Results 100% prevalence of trauma exposure and 48.7% of current PTSD among refugees, 70% PTSD rate of Yazidi participants, which is significantly higher (p< 0.01) compared to 44% of Muslim participants and 32% of Christian participants. These findings were corroborated using the self-rated PTSD, DSM-5 Checklist, with more severe PTSD symptom scores (p< 0.001) obtained among Yazidis (43.1;19.7), compared to Muslims (31.3;20.1) and Christians (29.3;17.8). Self-rated depressive symptoms (Patient Health Questionnaire-9) were also higher (p< 0.007) among Yazidis (12.3;8.2) and Muslims (11.7;5.9), compared to Christians (8.1;7).	[Richa, Sami; Herdane, Marie; Dwaf, Azzam; Bou Khalil, Rami; Haddad, Fadi; El Khoury, Rhea; Zarzour, Myriam; Kassab, Anthony; Dagher, Ramez] St Joseph Univ, Fac Med, Hotel Dieu France, Beirut, Lebanon; [Brunet, Alain] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [El-Hage, Wissam] Univ Tours, CHRU Tours, Clin Psychiat Univ, Inserm,UMR 1253,IBrain, Tours, France	McGill University; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Richa, S (corresponding author), St Joseph Univ, Fac Med, Hotel Dieu France, Beirut, Lebanon.	sami.richa@usj.edu.lb	richa, sami/ABF-6036-2020; Bou Khalil, Rami/AAN-4379-2021	Bou Khalil, Rami/0000-0003-1725-4755; richa, sami/0000-0002-3895-1325; EL-HAGE, WISSAM/0000-0003-3877-0855				[Anonymous], IR KURDS WORR ETHN B; Arnetz J, 2013, J NERV MENT DIS, V201, P167, DOI 10.1097/NMD.0b013e3182848afe; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Ceri V, 2016, NEUROPSYCHIATRIE, V30, P145, DOI 10.1007/s40211-016-0195-9; Cetorelli V, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002297; Johnson H, 2008, CLIN PSYCHOL REV, V28, P36, DOI 10.1016/j.cpr.2007.01.017; Khalil RB, 2016, AM J PSYCHIAT, V173, P16, DOI 10.1176/appi.ajp.2015.15070990; Kizilhan JI, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0965-7; Knipscheer J, 2015, BJPSYCH BULL, V39, P178, DOI 10.1192/pb.bp.114.047951; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lecubrier Y., 1998, J CLIN PSYCHIAT S20, V59, P22; LeMaster JW, 2018, AM J ORTHOPSYCHIAT, V88, P38, DOI 10.1037/ort0000240; Levy BS, 2013, LANCET, V381, P949, DOI 10.1016/S0140-6736(13)60254-8; Murthy RS, 2006, WORLD PSYCHIATRY, V5, P25; Nasiroglu S, 2016, NEUROPSYCH DIS TREAT, V12, P2941, DOI 10.2147/NDT.S119506; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Nose M, 2018, J IMMIGR MINOR HEALT, V20, P263, DOI 10.1007/s10903-017-0629-x; Piwowarczyk L, 2007, J NERV MENT DIS, V195, P715, DOI 10.1097/NMD.0b013e318142ca0b; Slewa-Younan S, 2015, J IMMIGR MINOR HEALT, V17, P1231, DOI 10.1007/s10903-014-0046-3; Tam SY, 2017, TRAUMA VIOLENCE ABUS, V18, P377, DOI 10.1177/1524838015622437; Tufan AE, 2013, NORD J PSYCHIAT, V67, P219, DOI 10.3109/08039488.2012.732113; Turrini G, 2017, INT J MENT HEALTH SY, V11, DOI 10.1186/s13033-017-0156-0; Yehuda R, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.57	23	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0233681	10.1371/journal.pone.0233681	http://dx.doi.org/10.1371/journal.pone.0233681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579560	Green Published, gold			2022-12-27	WOS:000545646600044
J	Tanure, A; Rego, FD; Tonelli, GB; Campos, AM; Shimabukuro, PHF; Gontijo, CMF; Paz, GF; Andrade, JD				Tanure, Aline; Rego, Felipe Dutra; Tonelli, Gabriel Barbosa; Campos, Aldenise Martins; Shimabukuro, Paloma Helena Fernandes; Gontijo, Celia Maria Ferreira; Paz, Gustavo Fontes; Andrade-Filho, Jose Dilermando			Diversity of phlebotomine sand flies and molecular detection of trypanosomatids in Brumadinho, Minas Gerais, Brazil	PLOS ONE			English	Article							DIPTERA PSYCHODIDAE PHLEBOTOMINAE; LEISHMANIA VIANNIA BRAZILIENSIS; VISCERAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; KINETOPLASTIDA TRYPANOSOMATIDAE; LUTZOMYIA-MIGONEI; WHITMANI DIPTERA; SP-N; INFECTION; PARASITE	This study aimed to describe the sand fly fauna and detect trypanosomatids in these insects from Casa Branca, state of Minas Gerais, Brazil, an endemic area of both visceral (VL) and tegumentary leishmaniasis (TL). Sand flies were collected bimonthly from May 2013 to July 2014, using automatic light traps exposed for three consecutive nights in peridomiciliary areas of nine houses with previous reports of VL and TL. ITS1-PCR and DNA sequencing were performed for trypanosomatids identification. A total of 16,771 sand flies were collected belonging to 23 species. The most abundant species wasNyssomyia whitmani(Antunes & Coutinho, 1939) (70.9%), followed byLutzomyia longipalpis(Lutz & Neiva, 1912) (15.2%) andMigonemyia migonei(Franca, 1920) (9.1%).Leishmania amazonensisDNA was detected inNy.whitmani(four pools) andLe.braziliensisDNA was detected inPsychodopygus lloydi(one pool). In seven pools ofNy.whitmaniand in one pool ofLu.longipalpispositive forLeishmaniaDNA, the parasite species was not determined due to the low quality of the sequences. Moreover, DNA ofHerpetomonasspp. was detected inNy.whitmani(two pools) and Cortelezzii complex (one pool). DNA ofCrithidiaspp. was detected inNy.whitmaniandPs.lloydi(both one pool). Our results suggest thatNy.whitmanimay be involved in the transmission ofLe.amazonensisin the study area. The molecular detection ofLe.amazonensissuggests the presence of this species in a sylvatic cycle between vertebrate and invertebrate hosts in the region of Casa Branca. Our data also reveal the occurrence of other non-Leishmaniatrypanosomatids in sand flies in Casa Branca District.	[Tanure, Aline; Rego, Felipe Dutra; Tonelli, Gabriel Barbosa; Campos, Aldenise Martins; Shimabukuro, Paloma Helena Fernandes; Gontijo, Celia Maria Ferreira; Paz, Gustavo Fontes; Andrade-Filho, Jose Dilermando] Fiocruz Minas Belo Horizonte, Inst Rene Rachou, Grp Estudos Leishmanioses, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz	Andrade, JD (corresponding author), Fiocruz Minas Belo Horizonte, Inst Rene Rachou, Grp Estudos Leishmanioses, Belo Horizonte, MG, Brazil.	jose.andrade@fiocruz.br	Rêgo, Felipe Dutra/S-6013-2017; Shimabukuro, Paloma Helena Fernandes/AAC-8695-2022; Gontijo, Celia MF/AAU-7736-2020; Rego, Felipe Dutra/V-4646-2019; Andrade Filho, José Dilermando/B-7852-2013	Rêgo, Felipe Dutra/0000-0002-2799-8267; Shimabukuro, Paloma Helena Fernandes/0000-0002-5114-953X; Gontijo, Celia MF/0000-0002-7034-535X; Rego, Felipe Dutra/0000-0002-2799-8267; Andrade Filho, José Dilermando/0000-0002-9754-8464; Barbosa Tonelli, Gabriel/0000-0002-8415-3199; Reis, AlessanRSS/0000-0001-8486-7469	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [302701/2016-8]; Fundacao de Amparo a Pesquisa de Minas Gerais [PPM-00792-18]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [001]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	JDAF - 302701/2016-8 Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) JDAF - PPM-00792-18 Fundacao de Amparo a Pesquisa de Minas Gerais (www.fapemig.br) AT - Finance Code 001 Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229536; Akhoundi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004349; Alexandre J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60600-7; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; AZEVEDO ACR, 1991, MEM I OSWALDO CRUZ, V86, P405, DOI 10.1590/S0074-02761991000400005; Beneke T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007828; [Anonymous], 2005, Rev. Saúde Pública, V39, P137, DOI 10.1590/S0034-89102005000100018; Calzolari M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2597074; Carvalho GML, 2017, J MED ENTOMOL, V54, P1049, DOI 10.1093/jme/tjx051; Carvalho GML, 2017, J MED ENTOMOL, V54, P196, DOI 10.1093/jme/tjw137; Carvalho GML, 2008, VECTOR-BORNE ZOONOT, V8, P407, DOI 10.1089/vbz.2007.0180; Chiurillo MA, 2001, AM J TROP MED HYG, V65, P573; CHRISTENSEN HA, 1972, J PROTOZOOL, V19, P403, DOI 10.1111/j.1550-7408.1972.tb03490.x; Cuvillier A, 2003, CELL MICROBIOL, V5, P717, DOI 10.1046/j.1462-5822.2003.00316.x; da Costa SM, 2007, MEM I OSWALDO CRUZ, V102, P149, DOI 10.1590/S0074-02762007005000016; de Carvalho MR, 2010, ACTA TROP, V116, P108, DOI 10.1016/j.actatropica.2010.03.009; de Pita-Pereira D, 2005, T ROY SOC TROP MED H, V99, P905, DOI 10.1016/j.trstmh.2005.06.019; DELGADO O, 1993, AM J TROP MED HYG, V48, P145, DOI 10.4269/ajtmh.1993.48.145; DEQUEIROZ RG, 1994, AM J TROP MED HYG, V50, P693, DOI 10.4269/ajtmh.1994.50.693; Domagalska MA, 2020, EMERG INFECT DIS, V26, P388, DOI 10.3201/eid2602.191428; dos Santos TV, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219626; Dvorak V., 2018, The leishmaniases: old neglected tropical diseases, P31; El Tai NO, 2000, T ROY SOC TROP MED H, V94, P575, DOI 10.1016/S0035-9203(00)90093-2; Espinosa OA, 2018, PARASITOLOGY, V145, P430, DOI [10.1017/S0031182016002092, 10.1017/s0031182016002092]; Ferreira TD, 2015, REV SOC BRAS MED TRO, V48, P776, DOI 10.1590/0037-8682-0076-2015; Guimaraes VCFV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1444-2; Fonteles RS, 2016, J MED ENTOMOL, V53, P206, DOI 10.1093/jme/tjv143; Franco AMR, 1997, J MED ENTOMOL, V34, P189, DOI 10.1093/jmedent/34.2.189; Galati E.A.B., 2018, BRAZILIAN SAND FLIES, P9, DOI [10.1007/978, 10.1007/978-3-319-75544-1_2]; Ghobakhloo N, 2019, TROP MED INT HEALTH, V24, P116, DOI 10.1111/tmi.13042; Ghosh S, 2012, J CLIN MICROBIOL, V50, P2774, DOI 10.1128/JCM.00966-12; Hayek LC, 1997, SURVEYING NATURAL PO; Kato H, 2011, VECTOR-BORNE ZOONOT, V11, P515, DOI 10.1089/vbz.2010.0138; Kaufer A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2204-7; Pinto MOKM, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4860-z; Kostygov AY, 2017, FOLIA PARASIT, V64, DOI 10.14411/fp.2017.020; Kostygov AY, 2019, TROP MED INT HEALTH, V24, P127, DOI 10.1111/tmi.13168; Kraeva N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005127; KREUTZER RD, 1991, AM J TROP MED HYG, V44, P662, DOI 10.4269/ajtmh.1991.44.662; Lara-Silva FD, 2015, ACTA TROP, V148, P128, DOI 10.1016/j.actatropica.2015.04.002; Lukes J, 2018, TRENDS PARASITOL, V34, P466, DOI 10.1016/j.pt.2018.03.002; Macedo-Silva VP, 2014, J MED ENTOMOL, V51, P237, DOI 10.1603/ME12131; Marcondes CB, 2007, ENTOMOL NEWS, V118, P351, DOI 10.3157/0013-872X(2007)118[351:APOGAS]2.0.CO;2; Margonari C, 2010, J MED ENTOMOL, V47, P1212, DOI 10.1603/ME09248; Maroli M, 2013, MED VET ENTOMOL, V27, P123, DOI 10.1111/j.1365-2915.2012.01034.x; Maruyama SR, 2019, EMERG INFECT DIS, V25, P2088, DOI 10.3201/eid2511.181548; Maslov DA, 2019, PARASITOLOGY, V146, P1, DOI 10.1017/S0031182018000951; Morio F, 2008, J CLIN MICROBIOL, V46, P3845, DOI 10.1128/JCM.01098-08; Rodrigues ACM, 2016, VET PARASITOL, V220, P28, DOI 10.1016/j.vetpar.2016.02.018; Nayduch D, 2009, J ENTOMOL SCI, V44, P141, DOI 10.18474/0749-8004-44.2.141; Nzelu CO, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002630; Machado TDO, 2017, MEM I OSWALDO CRUZ, V112, P681, DOI 10.1590/0074-02760170126; Pacheco RS, 1998, MEM I OSWALDO CRUZ, V93, P531, DOI 10.1590/S0074-02761998000400021; Pereira AA, 2018, J MED ENTOMOL, V55, P989, DOI 10.1093/jme/tjy014; Podlipaev SA, 2004, J EUKARYOT MICROBIOL, V51, P283, DOI 10.1111/j.1550-7408.2004.tb00568.x; Pugedo H, 2005, REV SOC BRAS MED TRO, V38, P70, DOI 10.1590/S0037-86822005000100017; Quaresma PF, 2012, MEM I OSWALDO CRUZ, V107, P480, DOI 10.1590/S0074-02762012000400007; Rangel E.F., 2018, BRAZILIAN SAND FLIES, P341, DOI [10.1007/978-3-319-75544-1_7, DOI 10.1007/978-3-319-75544-1_7]; Rego FD, 2019, J MED ENTOMOL, V56, P519, DOI 10.1093/jme/tjy175; Rego FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122038; ROBERTS DR, 1979, ENVIRON ENTOMOL, V8, P1007, DOI 10.1093/ee/8.6.1007; Rodriguez-Bonfante C, 2003, INFECT GENET EVOL, V3, P119, DOI 10.1016/S1567-1348(03)00012-1; Salomon OD, 2010, ACTA TROP, V113, P84, DOI 10.1016/j.actatropica.2009.08.024; Pereira AAS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187704; Saraiva L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134845; Saraiva L, 2010, MEM I OSWALDO CRUZ, V105, P1033, DOI 10.1590/S0074-02762010000800013; Saraiva L, 2009, J MED ENTOMOL, V46, P1159, DOI 10.1603/033.046.0525; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Seblova V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004060; Srivastava P, 2010, INFECT GENET EVOL, V10, P1145, DOI 10.1016/j.meegid.2010.07.009; Szelag EA, 2018, J MED ENTOMOL, V55, P902, DOI 10.1093/jme/tjy039; Tonelli GB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178628; Votypka J, 2015, TRENDS PARASITOL, V31, P460, DOI 10.1016/j.pt.2015.06.015; 2015, DRUG SAFETY UPDATE, V8, P1	74	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234445	10.1371/journal.pone.0234445	http://dx.doi.org/10.1371/journal.pone.0234445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579586	Green Published, gold			2022-12-27	WOS:000545646600023
J	Senderey, AB; Kornitzer, T; Lawrence, G; Zysman, H; Hallak, Y; Ariely, D; Balicer, R				Berliner Senderey, Adi; Kornitzer, Tamar; Lawrence, Gabriella; Zysman, Hilla; Hallak, Yael; Ariely, Dan; Balicer, Ran			It's how you say it: Systematic A/B testing of digital messaging cut hospital no-show rates	PLOS ONE			English	Article							BEHAVIORAL ECONOMICS; NON-ATTENDANCE; PRIMARY-CARE; APPOINTMENTS; REMINDERS; HEALTH; TELEPHONE	Failure to attend hospital appointments has a detrimental impact on care quality. Documented efforts to address this challenge have only modestly decreased no-show rates. Behavioral economics theory has suggested that more effective messages may lead to increased responsiveness. In complex, real-world settings, it has proven difficult to predict the optimal message composition. In this study, we aimed to systematically compare the effects of several pre-appointment message formats on no-show rates. We randomly assigned members from Clalit Health Services (CHS), the largest payer-provider healthcare organization in Israel, who had scheduled outpatient clinic appointments in 14 CHS hospitals, to one of nine groups. Each individual received a pre-appointment SMS text reminder five days before the appointment, which differed by group. No-show and advanced cancellation rates were compared between the eight alternative messages, with the previously used generic message serving as the control. There were 161,587 CHS members who received pre-appointment reminder messages who were included in this study. Five message frames significantly differed from the control group. Members who received a reminder designed to evoke emotional guilt had a no-show rates of 14.2%, compared with 21.1% in the control group (odds ratio [OR]: 0.69, 95% confidence interval [CI]: 0.67, 0.76), and an advanced cancellation rate of 26.3% compared with 17.2% in the control group (OR: 1.2, 95% CI: 1.19, 1.21). Four additional reminder formats demonstrated significantly improved impact on no-show rates, compared to the control, though not as effective as the best performing message format. Carefully selecting the narrative of pre-appointment SMS reminders can lead to a marked decrease in no-show rates. The process of a/b testing, selecting, and adopting optimal messages is a practical example of implementing the learning healthcare system paradigm, which could prevent up to one-third of the 352,000 annually unattended appointments in Israel.	[Berliner Senderey, Adi; Lawrence, Gabriella; Balicer, Ran] Clalit Hlth Serv, Clalit Res Inst, Tel Aviv, Israel; [Berliner Senderey, Adi] Technion Israel Inst Technol, Fac Ind Engn & Management, Haifa, Israel; [Kornitzer, Tamar; Zysman, Hilla; Ariely, Dan] Kayma Labs, Tel Aviv, Israel; [Lawrence, Gabriella] Hebrew Univ Jerusalem, Braun Sch Publ Hlth, Hadassah Med Ctr, Jerusalem, Israel; [Hallak, Yael; Ariely, Dan] Duke Univ, Fuqua Sch Business, Durham, NC USA; [Balicer, Ran] Ben Gurion Univ Negev, Dept Publ Hlth, Beer Sheva, Israel	Clalit Health Services; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Hadassah University Medical Center; Duke University; Ben Gurion University	Senderey, AB (corresponding author), Clalit Hlth Serv, Clalit Res Inst, Tel Aviv, Israel.; Senderey, AB (corresponding author), Technion Israel Inst Technol, Fac Ind Engn & Management, Haifa, Israel.	adiber3@gmail.com	Berliner Senderey, Adi/AHE-5205-2022	Berliner Senderey, Adi/0000-0002-6235-8177	Israeli Ministry of Finance	Israeli Ministry of Finance	The Israeli Ministry of Finance provided funds to the commercial company "Kayma Labs" to permit the development of the randomization process. No other funds were received by the authors in connection with this study. No funding bodies had any role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript. The authors TK, HZ, and DA are employed by "Kayma Labs", though this company did not fund this research paper.	Barkan R, 2012, J EXP PSYCHOL GEN, V141, P757, DOI 10.1037/a0027588; Barrett LF, 2002, EMO SOC BEH, P1; Budrionis A, 2016, J BIOMED INFORM, V64, P87, DOI 10.1016/j.jbi.2016.09.018; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Christian RC, 2014, J ECON PSYCHOL, V40, P62, DOI 10.1016/j.joep.2012.10.001; Crosby LE, 2009, J PEDIAT HEMATOL ONC, V31, P571, DOI 10.1097/MPH.0b013e3181acd889; Dantas LF, 2018, HEALTH POLICY, V122, P412, DOI 10.1016/j.healthpol.2018.02.002; De Benedetto M.A., 2019, IZA DISCUSSION PAPER; de Jongh T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007459.pub2; Ding XR, 2018, J AM MED INFORM ASSN, V25, P924, DOI 10.1093/jamia/ocy002; Downer Sean R, 2006, Aust Health Rev, V30, P389; Ellis DA, 2017, LANCET PUBLIC HEALTH, V2, pE551, DOI 10.1016/S2468-2667(17)30217-7; Elvira C, 2018, INT J INTERACT MULTI, V4, P29, DOI 10.9781/ijimai.2017.03.004; Frederick S, 2009, J CONSUM RES, V36, P553, DOI 10.1086/599764; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Griskevicius V, 2006, J PERS SOC PSYCHOL, V91, P281, DOI 10.1037/0022-3514.91.2.281; Guy R, 2012, HEALTH SERV RES, V47, P614, DOI 10.1111/j.1475-6773.2011.01342.x; Hallsworth M L.J., 2013, JPOLICYANALMANAG, V32, P718; Hallsworth M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137306; Hasvold PE, 2011, J TELEMED TELECARE, V17, P358, DOI 10.1258/jtt.2011.110707; Haynes LC, 2013, J POLICY ANAL MANAG, V32, P718, DOI 10.1002/pam.21717; Hogg MA, 2006, COMMUN THEOR, V16, P7, DOI 10.1111/j.1468-2885.2006.00003.x; KASSIN SM, 1983, PERS SOC PSYCHOL B, V9, P281, DOI 10.1177/0146167283092013; Kerrison RS, 2015, BRIT J CANCER, V112, P1005, DOI 10.1038/bjc.2015.36; King D, 2013, HEALTH AFFAIR, V32, P661, DOI 10.1377/hlthaff.2012.1348; Knight HE, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-200; Koshy E, 2008, BMC OPHTHALMOL, V8, DOI 10.1186/1471-2415-8-9; Lin CL, 2016, INT J PEDIAT, V2016, DOI 10.1155/2016/8487378; Martin C, 2005, FAM PRACT, V22, P638, DOI 10.1093/fampra/cmi076; McGinnis J.M., 2007, LEARNING HEALTHCARE; McGlone MS, 2017, VACCINE, V35, P4295, DOI 10.1016/j.vaccine.2017.06.080; McLean SM, 2016, PATIENT PREFER ADHER, V10, P479, DOI 10.2147/PPA.S93046; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Neal Richard D, 2005, BMC Fam Pract, V6, P47, DOI 10.1186/1471-2296-6-47; NELSON AH, 2019, NPJ DIGITAL MED, V2, P1; Perron NJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-125; Rice T, 2013, ANNU REV PUBL HEALTH, V34, P431, DOI 10.1146/annurev-publhealth-031912-114353; Richard Thaler CS, 2008, NUDGE IMPROVING DECI; Rosen B, 2015, HEALT SYST TRANSIT, V17, P1; Shapiro JR, 2008, J PERS SOC PSYCHOL, V95, P877, DOI 10.1037/a0011617; Soler Robin E, 2018, Diabetes Spectr, V31, P310, DOI 10.2337/ds18-0022; The Lancet HIV, 2017, LANCET HIV, V4, pe51; van Baar JD, 2006, QUAL SAF HEALTH CARE, V15, P191, DOI 10.1136/qshc.2004.013342; YOUNG KE, 1993, J WILDLIFE DIS, V29, P278, DOI 10.7589/0090-3558-29.2.278; Zellermayer Ofer, 1996, THESIS	45	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234817	10.1371/journal.pone.0234817	http://dx.doi.org/10.1371/journal.pone.0234817			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME9KK	32574181	Green Published, gold			2022-12-27	WOS:000544972400049
J	Yamazaki, A; Nakamura, T; Miyabe-Nishiwaki, T; Hirata, A; Inoue, R; Kobayashi, K; Miyazaki, Y; Hamasaki, Y; Ishigami, A; Nagata, N; Kaneko, A; Koizumi, M; Ohta, H; Okano, HJ; Murata, T				Yamazaki, Arisa; Nakamura, Tatsuro; Miyabe-Nishiwaki, Takako; Hirata, Akihiro; Inoue, Rikako; Kobayashi, Koji; Miyazaki, Yusuke; Hamasaki, Yuta; Ishigami, Akiyo; Nagata, Nanae; Kaneko, Akihisa; Koizumi, Makoto; Ohta, Hiroki; Okano, Hirotaka James; Murata, Takahisa			The profile of lipid metabolites in urine of marmoset wasting syndrome	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ISOPROSTANE PATHWAY; PROSTAGLANDINS; INFLAMMATION; RESOLVINS; COLITIS; WEIGHT	Marmoset wasting syndrome (MWS) is clinically characterized by progressive weight loss. Although morbidity and mortality of MWS are relatively high in captive marmosets, its causes remain unknown. Lipid mediators are bioactive metabolites which are produced from polyunsaturated fatty acids, such as arachidonic acid (AA) and eicosapentaenoic acid. These lipid metabolites regulate a wide range of inflammatory responses and they are excreted into the urine. As urinary lipid profiles reflect systemic inflammatory conditions, we comprehensively measured the levels of 141 types of lipid metabolites in the urines obtained from healthy common marmoset (Callithrix jacchus) (N = 7) or marmosets with MWS (N = 7). We found that 41 types of metabolites were detected in all urine samples of both groups. Among them, AA-derived metabolites accounted for 63% (26/41 types) of all detected metabolites. Notably, the levels of AA-derived prostaglandin (PG) E-2, PGF(2 alpha), thromboxane (TX) B(2)and F-2-isoprostanes significantly increased in the urine samples of marmosets with MWS. In this study, we found some urinary lipid metabolites which may be involved in the development of MWS. Although the cause of MWS remains unclear, our findings may provide some insight into understanding the mechanisms of development of MWS.	[Yamazaki, Arisa; Nakamura, Tatsuro; Inoue, Rikako; Kobayashi, Koji; Miyazaki, Yusuke; Hamasaki, Yuta; Nagata, Nanae; Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan; [Miyabe-Nishiwaki, Takako; Ishigami, Akiyo; Kaneko, Akihisa] Kyoto Univ, Dept Primate Res Inst, Inuyama, Aichi, Japan; [Hirata, Akihiro] Gifu Univ, Dept Anim Expt, Life Sci Res Ctr, Gifu, Japan; [Koizumi, Makoto] Jikei Univ, Dept Lab Anim Facil, Sch Med, Tokyo, Japan; [Ohta, Hiroki; Okano, Hirotaka James] Jikei Univ, Dept Regenerat Med, Sch Med, Tokyo, Japan	University of Tokyo; Kyoto University; Gifu University; Jikei University; Jikei University	Murata, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan.	amurata@mail.ecc.u-tokyo.ac.jp		Murata, Takahisa/0000-0002-3328-0796; Koizumi, Makoto/0000-0002-4662-0382; Okano, Hirotaka James/0000-0003-4611-7098	Cooperative Research Program of Primate Research Institute, Kyoto University; Japan Society for the Promotion of Science; Takeda Science Foundation; Nipponham Foundation; Hoyu Science Foundation; Futaba Foundation	Cooperative Research Program of Primate Research Institute, Kyoto University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Nipponham Foundation; Hoyu Science Foundation; Futaba Foundation	This work was supported by the Cooperative Research Program of Primate Research Institute, Kyoto University, the Japan Society for the Promotion of Science, the Takeda Science Foundation, the Nipponham Foundation, Hoyu Science Foundation, and the Futaba Foundation to T.M.	Arai Y, 2016, DIGESTION, V93, P32, DOI 10.1159/000441665; Araujo A, 2000, INT J PRIMATOL, V21, P317, DOI 10.1023/A:1005433722475; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Bennett M, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0035-2016; BRACK M, 1981, VET PATHOL, V18, P45, DOI 10.1177/0300985881018s0605; BUSSE WW, 1998, AM J RESP CRIT CAR S, V157, pS21; Cabana F, 2018, ZOO BIOL, V37, P98, DOI 10.1002/zoo.21398; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; CHALIFOUX LV, 1982, VET PATHOL, V19, P141, DOI 10.1177/030098588201907s11; Chiabrando C, 1999, J BIOL CHEM, V274, P1313, DOI 10.1074/jbc.274.3.1313; Collins D, 2009, BRIT J PHARMACOL, V158, P1771, DOI 10.1111/j.1476-5381.2009.00464.x; Sousa MBC, 2008, PRIMATES, V49, P283, DOI 10.1007/s10329-008-0105-2; Cracowski JL, 2002, AM J GASTROENTEROL, V97, P99; Duvall MG, 2016, EUR J PHARMACOL, V785, P144, DOI 10.1016/j.ejphar.2015.11.001; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Fu JZ, 2016, ANAL BIOANAL CHEM, V408, P6307, DOI 10.1007/s00216-016-9742-2; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao L, 2003, J BIOL CHEM, V278, P28479, DOI 10.1074/jbc.M303984200; Hirota Y, 2005, J PHARMACOL SCI, V98, P430, DOI 10.1254/jphs.FP0050453; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Logan AC, 1996, TOXICOL PATHOL, V24, P707, DOI 10.1177/019262339602400605; Maeda S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17798-w; Michalak A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00459; Miles EA, 2012, BRIT J NUTR, V107, pS171, DOI 10.1017/S0007114512001560; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Nakashima E, 2013, J VET MED SCI, V75, P1633, DOI 10.1292/jvms.13-0257; Otovic P, 2015, J MED PRIMATOL, V44, P53, DOI 10.1111/jmp.12159; Prossomariti A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07992-1; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; Schwanke RC, 2016, EUR J PHARMACOL, V785, P156, DOI 10.1016/j.ejphar.2015.08.050; Yin HY, 2007, J BIOL CHEM, V282, P329, DOI 10.1074/jbc.M608975200; Yoshimoto T, 2016, COMPARATIVE MED, V66, P468	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234634	10.1371/journal.pone.0234634	http://dx.doi.org/10.1371/journal.pone.0234634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574169	Green Published, gold			2022-12-27	WOS:000544972400007
J	Algredo-Badillo, I; Conde-Mones, JJ; Hernandez-Gracidas, CA; Morin-Castillo, MM; Oliveros-Oliveros, JJ; Feregrino-Uribe, C				Algredo-Badillo, Ignacio; Julio Conde-Mones, Jose; Arturo Hernandez-Gracidas, Carlos; Monserrat Morin-Castillo, Maria; Jacobo Oliveros-Oliveros, Jose; Feregrino-Uribe, Claudia			An FPGA-based analysis of trade-offs in the presence of ill-conditioning and different precision levels in computations	PLOS ONE			English	Article								Several areas, such as physical and health sciences, require the use of matrices as fundamental tools for solving various problems. Matrices are used in real-life contexts, such as control, automation, and optimization, wherein results are expected to improve with increase of computational precision. However, special attention should be paid to ill-conditioned matrices, which can produce unstable systems; an inadequate handling of precision might worsen results since the solution found for data with errors might be too far from the one for data without errors besides increasing other costs in hardware resources and critical paths. In this paper, we make a wake-up call, using 2 x 2 matrices to show how ill-conditioning and precision can affect system design (resources, cost, etc.). We first demonstrate some examples of real-life problems where ill-conditioning is present in matrices obtained from the discretization of the operational equations (ill-posed in the sense of Hadamard) that model these problems. If these matrices are not handled appropriately (i.e., if ill-conditioning is not considered), large errors can result in the computed solutions to the systems of equations in the presence of errors. Furthermore, we illustrate the generated effect in the calculation of the inverse of an ill-conditioned matrix when its elements are approximated by truncation. We present two case studies to illustrate the effects on calculation errors caused by increasing or reducing precision tosdigits. To illustrate the costs, we implemented the adjoint matrix inversion algorithm on different field-programmable gate arrays (FPGAs), namely,Spartan-7,Artix-7,Kintex-7, andVirtex-7, using the full-unrolling hardware technique. The implemented architecture is useful for analyzing trade-offs when precision is increased; this also helps analyze performance, efficiency, and energy consumption. By means of a detailed description of the trade-offs among these metrics, concerning precision and ill-conditioning, we conclude that the need for resources seems to grow not linearly when precision is increased. We also conclude that, if error is to be reduced below a certain threshold, it is necessary to determine an optimal precision point. Otherwise, the system becomes more sensitive to measurement errors and a better alternative would be to choose precision carefully, and/or to apply regularization or preconditioning methods, which would also reduce the resources required.	[Algredo-Badillo, Ignacio] CONACYT INAOE, Comp Sci Dept, Puebla, Mexico; [Julio Conde-Mones, Jose; Jacobo Oliveros-Oliveros, Jose] BUAP, Phys Math Sci Fac, Puebla, Mexico; [Arturo Hernandez-Gracidas, Carlos] CONACYT BUAP, Phys Math Sci Fac, Puebla, Mexico; [Monserrat Morin-Castillo, Maria] BUAP, Elect Sci Fac, Puebla, Mexico; [Feregrino-Uribe, Claudia] INAOE, Comp Sci Dept, Puebla, Mexico	Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla; Instituto Nacional de Astrofisica, Optica y Electronica	Conde-Mones, JJ (corresponding author), BUAP, Phys Math Sci Fac, Puebla, Mexico.; Hernandez-Gracidas, CA (corresponding author), CONACYT BUAP, Phys Math Sci Fac, Puebla, Mexico.; Morin-Castillo, MM (corresponding author), BUAP, Elect Sci Fac, Puebla, Mexico.	juliocondem@hotmail.com; carloshg@fcfm.buap.mx; maria.morin@correo.buap.mx	Algredo-Badillo, Ignacio/HDN-8875-2022; Feregrino, Claudia/AAW-2607-2021	Oliveros Oliveros, Jacobo/0000-0002-1715-3631; Algredo Badillo, Ignacio/0000-0002-4748-3500; Hernandez-Gracidas, Carlos/0000-0003-0267-6306; Conde Mones, Jose Julio/0000-0002-3686-7031	Meritorious Autonomous University of Puebla (BUAP) [VIEP-00174]; National Council of Science and Technology (CONACYT) [882, 278]	Meritorious Autonomous University of Puebla (BUAP); National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	J.J.O. received financial support from the Meritorious Autonomous University of Puebla (BUAP), through project VIEP-00174 (Web page: https://www.buap.mx/).I.A.and C.A.H. are commissioned to their respective institutions through the National Council of Science and Technology (CONACYT) Research Fellows program, by means of projects 882 and 278, respectively (Web page: https://www.conacyt.gob.mx/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A F, 2001, REV MEX FIS, V77, P162; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2002, FRONTIERS APPL MATH; [Anonymous], 2012, P 8 SO C PROGR LOG, P1; [Anonymous], 2002, SPRINGER SERIES OPTI; [Anonymous], 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone.0109970, DOI 10.1371/JOURNAL.PONE.0109970, DOI 10.1371/J0URNAL.P0NE.0109970]; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Defense P. M., 1992, US GAO REPORTS; DIRAC PAM, 1953, PHYSICA, V19, P888, DOI 10.1016/S0031-8914(53)80099-6; Dmytro F, 2008, KARLSRUHE T BIOMEDIC, V4; FEYNMAN RP, 1963, ANN PHYS-NEW YORK, V24, P118, DOI 10.1016/0003-4916(63)90068-X; GUSTAFSSON P., 2012, PLOS ONE, V7, P1; Irturk A, 2009, TECHNICAL REPORT; Kalinin A, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00058; Karkooti M, 2005, 2005 39TH ASILOMAR CONFERENCE ON SIGNALS, SYSTEMS AND COMPUTERS, VOLS 1 AND 2, P1625; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171394; Kirsch A, 2011, INTRO MATH THEORY IN; Kumar GA, 2014, 2014 INTERNATIONAL CONFERENCE ON CONTROL, INSTRUMENTATION, COMMUNICATION AND COMPUTATIONAL TECHNOLOGIES (ICCICCT), P87, DOI 10.1109/ICCICCT.2014.6992935; Kushida N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122331; Mones JJC, 2017, NUMERICAL METHODS PA; Castillo MMM, 2019, ADV DIFFER EQU CONTR, V20, P53, DOI 10.17654/DE020010053; Morin-Castillo M., 2019, REV MEX ING BIOMED, V40, P1; Oliveros J., 2013, FAR E J APPL MATH, V77, P1; Ruan M, 2017, SCALABLE FLOATING PO; Tayyib M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0225397	25	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234293	10.1371/journal.pone.0234293	http://dx.doi.org/10.1371/journal.pone.0234293			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559235	Green Published, gold			2022-12-27	WOS:000543261600039
J	Chien, LC				Chien, Li-Chu			A rank-based normalization method with the fully adjusted full-stage procedure in genetic association studies	PLOS ONE			English	Article							BODY-MASS INDEX; RARE; LOCI; TRANSFORMATIONS; METAANALYSIS; FAMILY	In the area of genetic epidemiology, studies of the genotype-phenotype associations have made significant contributions to human complicated trait genetics. These studies depend on specialized statistical methods for uncover the association between traits and genetic variants, both common and rare variants. Often, in analyzing such studies, potentially confounding factors, such as social and environmental conditions, are required to be involved. Multiple linear regression is the most widely used type of regression analysis when the outcome of interest is quantitative traits. Many statistical tests for identifying genotype-phenotype associations using linear regression rely on the assumption that the traits (or the residuals) of the regression follow a normal distribution. In genomic research, the rank-based inverse normal transformation (INT) is one of the most popular approaches to reach normally distributed traits (or normally distributed residuals). Many researchers believe that applying the INT to the non-normality of the traits (or the non-normality of the residuals) is required for valid inference, because the phenotypic (or residual) outliers and non-normality have the significant influence on both the type I error rate control and statistical power, especially under the situation in rare-variant association testing procedures. Here we propose a test for exploring the association of the rare variant with the quantitative trait by using a fully adjusted full-stage INT. Using simulations we show that the fully adjusted full-stage INT is more appropriate than the existing INT methods, such as the fully adjusted two-stage INT and the INT-based omnibus test, in testing genotype-phenotype associations with rare variants, especially when genotypes are uncorrelated with covariates. The fully adjusted full-stage INT retains the advantages of the fully adjusted two-stage INT and ameliorates the problems of the fully adjusted two-stage INT for analysis of rare variants under non-normality of the trait. We also present theoretical results on these desirable properties. In addition, the two available methods with non-normal traits, the quantile/median regression method and the Yeo-Johnson power transformation, are also included in simulations for comparison with these desirable properties.	[Chien, Li-Chu] Kaohsiung Med Univ, Ctr Fundamental Sci, Kaohsiung, Taiwan	Kaohsiung Medical University	Chien, LC (corresponding author), Kaohsiung Med Univ, Ctr Fundamental Sci, Kaohsiung, Taiwan.	lcchien@kmu.edu.tw			Ministry of Science and Technology, Taiwan, R.O.C [MOST 107-2118-M-037-002, MOST 108-2118-M-037-001-MY2]	Ministry of Science and Technology, Taiwan, R.O.C(Ministry of Science and Technology, Taiwan)	This work is supported by grants MOST 107-2118-M-037-002 and MOST 108-2118-M-037-001-MY2 of Ministry of Science and Technology, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, DTBI S, V1, P1, DOI DOI 10.36811/RJCSE.2019.110001; [Anonymous], 2018, CANC DISCOV, V8, pOF6; ASHTON GC, 1987, BEHAV GENET, V17, P243, DOI 10.1007/BF01065504; Auer PL, 2016, EUR J HUM GENET, V24, P1188, DOI 10.1038/ejhg.2015.270; Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Beyerlein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019057; Bliss CI, 1967, STAT BIOL; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Buzkova P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056976; Che RL, 2012, GENET EPIDEMIOL, V36, P890, DOI 10.1002/gepi.21671; Demissie S, 2011, GENET EPIDEMIOL, V35, P592, DOI 10.1002/gepi.20607; Fox J., 2019, R COMPANION APPL REG, V3; Hoffmann TJ, 2017, NAT GENET, V49, P54, DOI 10.1038/ng.3715; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Koenker R., 2019, QUANTILE REGRESSION; Kozlitina J, 2015, STAT APPL GENET MOL, V14, P443, DOI 10.1515/sagmb-2014-0050; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Lee SS, 2017, SNP SET SEQUENCE KER, DOI [10.1002/gepi.22016, DOI 10.1002/GEPI.22016]; McCaw ZR, 2019, RANK NORMAL TRANSFOR; Nascimento M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190303; Pain O, 2018, EUR J HUM GENET, V26, P1194, DOI 10.1038/s41431-018-0159-6; Peng Bo, 2007, BMC Proc, V1 Suppl 1, pS156; Quinn TP, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz107; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Sofer T, 2019, GENET EPIDEMIOL, V43, P263, DOI 10.1002/gepi.22188; Tajuddin SM, 2016, AM J HUM GENET, V99, P22, DOI 10.1016/j.ajhg.2016.05.003; Tang ZZ, 2015, AM J HUM GENET, V97, P35, DOI 10.1016/j.ajhg.2015.05.001; Wang K, 2002, AM J HUM GENET, V70, P412, DOI 10.1086/338659; Weisberg S, 2001, WORKING PAPER; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu XD, 2002, AM J HUM GENET, V70, P1247, DOI 10.1086/340362; Yeo IK, 2000, BIOMETRIKA, V87, P954, DOI 10.1093/biomet/87.4.954	33	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0233847	10.1371/journal.pone.0233847	http://dx.doi.org/10.1371/journal.pone.0233847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559184	Green Published, gold			2022-12-27	WOS:000543261600049
J	Hanrahan, V; Gillies, K; Biesty, L				Hanrahan, Vivienne; Gillies, Katie; Biesty, Linda			Recruiters' perspectives of recruiting women during pregnancy and childbirth to clinical trials: A qualitative evidence synthesis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; CONSENT; VULNERABILITY; MIDWIVES; BARRIERS; WASTE; TOOL	Introduction Research on research is key to enhancing efficacy in trial methodology. Clinical trials involving women during pregnancy and childbirth are limited, with a paucity of data guiding evidence-based practice. Following a prioritisation exercise that highlighted the top-ten unanswered recruitment questions, this qualitative evidence synthesis was designed specifically to focus on the barriers and enablers for clinicians/healthcare professionals in helping conduct randomised trials within the context of recruitment during pregnancy and childbirth. Methods The synthesis was undertaken using Thomas and Harden's three stage thematic synthesis method and reported following the ENTREQ guidelines. Using a pre-determined SPIDER strategy, we conducted a comprehensive search of databases; Pubmed, CINAHL, PsycINFO, EMBASE, and grey searches for records until January 2019. We included all reports of qualitative data on recruiter's experiences, perceptions, views of recruiting women during pregnancy and childbirth to clinical trials. Altogether 13,401 records were screened, resulting in 31 full-text reviews, of which five were eligible for inclusion. Quality was appraised using CASP. Data were extracted onto a specifically defined form. We used thematic synthesis to identify descriptive and analytical themes, and to interpret and generate theory. Confidence was assessed using GRADE-CERQual. The review protocol is publicly available (OSF). Results Five papers (representing four individual studies) from two different countries were included. All studies focused on the experiences of trial recruiters in the maternity setting. We identified four analytical themes;Recruitment through a clinician's lens,Recruiters judgement on acceptability,From protocol to recruiters lived experience,Framing recruitment in context. These were linked by an overarching theme combining beliefs and power. Conclusion The overarching theme combining beliefs and power links the experiences and perceptions of recruiters. This synthesis shows a gap between the trial design study protocol and the recruiter's lived experience. Strategies such as collaborative trial design, mitigating gatekeeping behaviours, and training may support recruiters in their endeavour.	[Hanrahan, Vivienne; Biesty, Linda] Natl Univ Ireland Galway, Sch Nursing & Midwifery, Galway, Ireland; [Gillies, Katie] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland	Ollscoil na Gaillimhe-University of Galway; University of Aberdeen	Hanrahan, V (corresponding author), Natl Univ Ireland Galway, Sch Nursing & Midwifery, Galway, Ireland.	v.hanrahan1@nuigalway.ie	Hanrahan, Vivienne/AAI-8205-2021; Galvin, Sandra/ABG-6445-2020	Gillies, Katie/0000-0001-7890-2854; Hanrahan, Vivienne/0000-0002-4923-7901	Health Research Board Trial Methodology Research Network (of Ireland)	Health Research Board Trial Methodology Research Network (of Ireland)	This paper forms part of doctorial research project supported by the Health Research Board Trial Methodology Research Network (of Ireland) PhD scholarship awarded to VH. https://www.hrb-tmrn.ie/.The manuscript represents the views of the named authors only. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames HMR, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011787.pub2; [Anonymous], 2016, LANCET ONCOL, V17, P1, DOI 10.1016/S1470-2045(15)00568-9; [Anonymous], 2014, ISMP MSAL, V19, P1; [Anonymous], 2018, CASP QUAL CHECKL; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Bengough T, 2018, COCHRANE DB SYST REV, pCD013115; Benoit C, 2005, SOCIOL HEALTH ILL, V27, P722, DOI 10.1111/j.1467-9566.2005.00471.x; Blehar MC, 2013, WOMEN HEALTH ISS, V23, pE39, DOI 10.1016/j.whi.2012.10.003; Booth A, 2018, J CLIN EPIDEMIOL, V99, P41, DOI 10.1016/j.jclinepi.2018.03.003; Booth A, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0249-x; Butler A, 2016, WORLDV EVID-BASED NU, V13, P241, DOI 10.1111/wvn.12134; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chhoa CY, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1940-5; Cooke A, 2012, QUAL HEALTH RES, V22, P1435, DOI 10.1177/1049732312452938; Daly D, 2019, MIDWIFERY, V74, P14, DOI 10.1016/j.midw.2019.03.011; Donovan JL, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1391-4; Donovan JL, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-5; Elliott D, 2017, EUR UROL, V72, P789, DOI 10.1016/j.eururo.2017.04.036; Fletcher B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000496; Frew PM, 2014, CLIN INFECT DIS, V59, pS400, DOI 10.1093/cid/ciu726; Furber CM, 2010, MIDWIFERY, V26, P232, DOI 10.1016/j.midw.2008.05.003; Harron K, 2015, PEDIATRICS, V136, pE1316, DOI 10.1542/peds.2015-0512; Healy P, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2544-4; Hennessy M, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2964-1; Hernon O, 2020, J CLIN NURS, V29, P667, DOI 10.1111/jocn.15128; Heyrana K, 2018, JAMA-J AM MED ASSOC, V320, P2077, DOI 10.1001/jama.2018.17716; Houghton C, 2017, COCHRANE DB SYST REV, P5, DOI [10.1002/14651858.MR000045.(5), DOI 10.1002/14651858.MR000045.(5)]; Lawton J, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1323-3; Lawton J, 2012, SOC SCI MED, V74, P574, DOI 10.1016/j.socscimed.2011.11.012; Lewin S, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0688-3; Lewin S, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0689-2; McCann S, 2013, J HEALTH SERV RES PO, V18, P233, DOI 10.1177/1355819613483126; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; Minneci PC, 2016, JAMA SURG, V151, P579, DOI 10.1001/jamasurg.2015.4898; Mobbs N., 2018, HUMANISING BIRTH DOE; Mohanna K, 1999, BRIT J OBSTET GYNAEC, V106, P892, DOI 10.1111/j.1471-0528.1999.tb08426.x; Newington Lisa, 2014, J Clin Med Res, V6, P162, DOI 10.14740/jocmr1619w; Noyes J, 2018, J CLIN EPIDEMIOL, V97, P49, DOI 10.1016/j.jclinepi.2017.06.020; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; Ross S, 1999, J CLIN EPIDEMIOL, V52, P1143, DOI 10.1016/S0895-4356(99)00141-9; ROTH JA, 1966, AM SOCIOL, V1, P190; Salman RA, 2014, LANCET, V383, P176, DOI 10.1016/S0140-6736(13)62297-7; Sandelowski M, 2015, NURS INQ, V22, P86, DOI 10.1111/nin.12080; Sharkey K, 2010, J MED ETHICS, V36, P363, DOI 10.1136/jme.2009.031716; Sheppard MK, 2016, J MED ETHICS, V42, P127, DOI 10.1136/medethics-2014-102595; Smith CT, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-32; Snowden A, 2017, NURS OPEN, V4, P187, DOI 10.1002/nop2.83; Stuart J, 2015, MIDWIFERY, V31, P779, DOI 10.1016/j.midw.2015.04.011; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; Tooher Rebecca L, 2008, BMC Pregnancy Childbirth, V8, P36, DOI 10.1186/1471-2393-8-36; Treweek S, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000013.pub6; van der Zande ISE, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2209-7; van der Zande ISE, 2017, J MED ETHICS, V43, P657, DOI 10.1136/medethics-2016-103955; Walters SJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015276	55	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234783	10.1371/journal.pone.0234783	http://dx.doi.org/10.1371/journal.pone.0234783			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559236	Green Published, gold			2022-12-27	WOS:000543261600064
J	Toda, Y; Wakatsuki, H; Aoike, T; Kajiya-Kanegae, H; Yamasaki, M; Yoshioka, T; Ebana, K; Hayashi, T; Nakagawa, H; Hasegawa, T; Iwata, H				Toda, Yusuke; Wakatsuki, Hitomi; Aoike, Toru; Kajiya-Kanegae, Hiromi; Yamasaki, Masanori; Yoshioka, Takuma; Ebana, Kaworu; Hayashi, Takeshi; Nakagawa, Hiroshi; Hasegawa, Toshihiro; Iwata, Hiroyoshi			Predicting biomass of rice with intermediate traits: Modeling method combining crop growth models and genomic prediction models	PLOS ONE			English	Article							LEAF-AREA INDEX; GENETIC DISSECTION; PHOTOPERIOD SENSITIVITY; SELECTION METHODS; NATURAL VARIATION; WIDE PREDICTION; FLOWERING TIME; PEDIGREE; YIELD; TEMPERATURE	Genomic prediction (GP) is expected to become a powerful technology for accelerating the genetic improvement of complex crop traits. Several GP models have been proposed to enhance their applications in plant breeding, including environmental effects and genotype-by-environment interactions (GxE). In this study, we proposed a two-step model for plant biomass prediction wherein environmental information and growth-related traits were considered. First, the growth-related traits were predicted by GP. Second, the biomass was predicted from the GP-predicted values and environmental data using machine learning or crop growth modeling. We applied the model to a 2-year-old field trial dataset of recombinant inbred lines of japonica rice and evaluated the prediction accuracy with training and testing data by cross-validation performed over two years. Therefore, the proposed model achieved an equivalent or a higher correlation between the observed and predicted values (0.53 and 0.65 for each year, respectively) than the model in which biomass was directly predicted by GP (0.40 and 0.65 for each year, respectively). This result indicated that including growth-related traits enhanced accuracy of biomass prediction. Our findings are expected to contribute to the spread of the use of GP in crop breeding by enabling more precise prediction of environmental effects on crop traits.	[Toda, Yusuke; Aoike, Toru; Iwata, Hiroyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan; [Wakatsuki, Hitomi] Natl Agr & Food Res Org NARO, Inst Agroenvironm Sci, Ibaraki, Japan; [Kajiya-Kanegae, Hiromi; Nakagawa, Hiroshi] NARO, Res Ctr Agr Informat Technol, Ibaraki, Japan; [Yamasaki, Masanori; Yoshioka, Takuma] Kobe Univ, Food Resources Educ & Res Ctr, Grad Sch Agr Sci, Kobe, Hyogo, Japan; [Ebana, Kaworu] NARO, Genet Resources Ctr, Ibaraki, Japan; [Hayashi, Takeshi] NARO, Inst Crop Sci, Ibaraki, Japan; [Hasegawa, Toshihiro] NARO, Tohoku Agr Res Ctr, Morioka, Iwate, Japan	University of Tokyo; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Kobe University; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Iwata, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan.	aiwata@mail.ecc.u-tokyo.ac.jp	Kanegae, Hiromi/AFS-0023-2022	Kanegae, Hiromi/0000-0002-5719-7559; Toda, Yusuke/0000-0002-9462-6412; Wakatsuki, Hitomi/0000-0002-9861-5921	Japan Society for the Promotion of Science, KAKENHI [JP25252002, JP16H0458]; Japan Science and Technology Agency, CREST [JPMJCR16O2]	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	Author HI received funding from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/index.html), KAKENHI, grants JP25252002 and JP16H0458. Author HI received funding from the Japan Science and Technology Agency (https://www.jst.go.jp), CREST, grant JPMJCR16O2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asoro FG, 2013, CROP SCI, V53, P1894, DOI 10.2135/cropsci2012.09.0526; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Burgueno J, 2012, CROP SCI, V52, P707, DOI 10.2135/cropsci2011.06.0299; Bustos-Korts D., 2017, CROP SYSTEMS BIOL, P55; Cabrera-Bosquet L, 2012, J INTEGR PLANT BIOL, V54, P312, DOI 10.1111/j.1744-7909.2012.01116.x; Calus MPL, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-26; Cooper M, 2016, CROP SCI, V56, P2141, DOI 10.2135/cropsci2015.08.0512; Corcoles JI, 2013, BIOSYST ENG, V115, P31, DOI 10.1016/j.biosystemseng.2013.02.002; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; Duan SB, 2014, INT J APPL EARTH OBS, V26, P12, DOI 10.1016/j.jag.2013.05.007; Eberhart R., 1995, P MHS 95 P 6 INT S M, P39, DOI DOI 10.1109/MHS.1995.494215; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garcia-Ruiz A, 2016, P NATL ACAD SCI USA, V113, pE3995, DOI 10.1073/pnas.1519061113; Gonzalez-Recio O, 2014, LIVEST SCI, V166, P217, DOI 10.1016/j.livsci.2014.05.036; Grenier C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136594; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Heslot N, 2014, THEOR APPL GENET, V127, P463, DOI 10.1007/s00122-013-2231-5; Holzworth DP, 2014, ENVIRON MODELL SOFTW, V62, P327, DOI 10.1016/j.envsoft.2014.07.009; Hori K, 2013, PLANT J, V76, P36, DOI 10.1111/tpj.12268; Horie T., 1987, Southeast Asian Studies, V25, P62; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Iizumi T, 2009, AGR FOREST METEOROL, V149, P333, DOI 10.1016/j.agrformet.2008.08.015; Jahn CE, 2011, PLANT PHYSIOL, V155, P157, DOI 10.1104/pp.110.165654; Jarquin D, 2014, THEOR APPL GENET, V127, P595, DOI 10.1007/s00122-013-2243-1; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Kang Manjit S., 2002, P221, DOI 10.1079/9780851996011.0221; Khush GS, 2013, PLANT BREEDING, V132, P433, DOI 10.1111/pbr.1991; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Matsubara K, 2012, PLANT CELL PHYSIOL, V53, P709, DOI 10.1093/pcp/pcs028; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-2; Montes JM, 2011, FIELD CROP RES, V121, P268, DOI 10.1016/j.fcr.2010.12.017; Moser G, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-56; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagasaki H, 2010, BREEDING SCI, V60, P648, DOI 10.1270/jsbbs.60.648; Nakagawa H, 2005, THEOR APPL GENET, V110, P778, DOI 10.1007/s00122-004-1905-4; Okada S, 2017, THEOR APPL GENET, V130, P2567, DOI 10.1007/s00122-017-2977-2; Onogi A, 2016, THEOR APPL GENET, V129, P805, DOI 10.1007/s00122-016-2667-5; Onogi A, 2015, THEOR APPL GENET, V128, P41, DOI 10.1007/s00122-014-2411-y; Oraby H, 2007, TRANSGENIC RES, V16, P739, DOI 10.1007/s11248-006-9064-9; PINNSCHMIDT HO, 1995, AGR SYST, V48, P193, DOI 10.1016/0308-521X(94)00012-G; R Core Team, R LANG ENV STAT COMP; Ramirez-Villegas J, 2015, J EXP BOT, V66, P3451, DOI 10.1093/jxb/erv014; Rutkoski J, 2015, PLANT GENOME-US, V8, DOI [10.3835/plantgenome2014.09.0046, 10.3835/plantgenome2014.10.0074]; Rutkoski J, 2016, G3-GENES GENOM GENET, V6, P2799, DOI 10.1534/g3.116.032888; Schulz-Streeck T, 2013, PLANT BREEDING, V132, P532, DOI 10.1111/pbr.12105; Singh U., 1993, USERS GUIDE CERES RI; Soltani A, 2002, MODELING PHYSL CROP; Spindel JE, 2016, HEREDITY, V116, P395, DOI 10.1038/hdy.2015.113; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Sun J, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.11.0111; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Technow F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130855; Timsina J, 2006, AGR SYST, V90, P5, DOI 10.1016/j.agsy.2005.11.007; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Wang X, 2017, HEREDITY, V118, P302, DOI 10.1038/hdy.2016.87; Watanabe K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00421; Xavier A, 2016, THEOR APPL GENET, V129, P1933, DOI 10.1007/s00122-016-2750-y; Xu SH, 2014, P NATL ACAD SCI USA, V111, P12456, DOI 10.1073/pnas.1413750111; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yabe S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00276; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yin XY, 1997, FIELD CROP RES, V51, P189, DOI 10.1016/S0378-4290(96)03456-9; Zhang ZH, 2004, PLANT SCI, V167, P1, DOI 10.1016/j.plantsci.2004.01.007; Zhou Y, 2001, THEOR APPL GENET, V102, P1236, DOI 10.1007/s001220100539	68	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0233951	10.1371/journal.pone.0233951	http://dx.doi.org/10.1371/journal.pone.0233951			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559220	Green Published, gold			2022-12-27	WOS:000543261600022
J	Kyaw, KWY; Kyaw, NTT; Kyi, MS; Aye, S; Harries, AD; Kumar, AMV; Oo, NL; Satyanarayana, S; Aung, ST				Kyaw, Khine Wut Yee; Nang Thu Thu Kyaw; Kyi, Myo Su; Aye, Sandar; Harries, Anthony D.; Kumar, Ajay M., V; Oo, Nay Lynn; Satyanarayana, Srinath; Si Thu Aung			HIV testing uptake and HIV positivity among presumptive tuberculosis patients in Mandalay, Myanmar, 2014-2017	PLOS ONE			English	Article							SUSPECTS; TB; CARE	Introduction The World Health Organization's framework for TB/HIV collaborative activities recommends provider-initiated HIV testing and counselling (PITC) of patients with presumptive TB. In Myanmar, PITC among presumptive TB patients was started at the TB outpatient department (TB OPD) in Mandalay in 2014. In this study, we assessed the uptake of PITC among presumptive TB patients and the number needed to screen to find one additional HIV positive case, stratified by demographic and clinical characteristics. Method This was a cross-sectional study using routinely collected data of presumptive TB patients who registered for PITC services at the TB OPD between August 2014 and December 2017 in Mandalay. Result Among 21,989 presumptive TB patients registered, 9,796 (44.5%) had known HIV status at registration and 2,763 (28.2%) were people already living with HIV (PLHIV). Of the remainder, 85.3% (10,401/12,193) were newly tested for HIV. Patients <55 years old, those registered in 2014, 2015 and 2017, those employed and those having a history of TB contact had higher uptakes of HIV testing. Among 10,401 patients tested for HIV, 213 (2.1%) patients were newly diagnosed with HIV and this included 147 (69.0%) who were not diagnosed as having TB. The overall prevalence of HIV (previously known and newly diagnosed) among presumptive TB patients was 14.8% (2,976/20,119). The number needed to screen to find one additional HIV case was 48: this number was lower (i.e., a higher yield) among patients aged 35-44 years and among those who were divorced or separated. Conclusion Uptake of HIV testing among eligible presumptive TB patients was high with four out of five presumptive TB patients being tested for HIV. This strategy detected many additional HIV-positive persons, and this included those who were not diagnosed with TB. We strongly recommend that this strategy be implemented nationwide in Myanmar.	[Kyaw, Khine Wut Yee; Nang Thu Thu Kyaw; Aye, Sandar; Oo, Nay Lynn] Int Union TB & Lung Dis Union, Mandalay, Myanmar; [Kyaw, Khine Wut Yee; Nang Thu Thu Kyaw; Harries, Anthony D.; Kumar, Ajay M., V; Satyanarayana, Srinath] Int Union TB & Lung Dis Union, Paris, France; [Kyi, Myo Su] Natl TB Programme, Dept Publ Hlth, Nay Pyi Taw, Myanmar; [Harries, Anthony D.] London Sch Hyg & Trop Med, London, England; [Kumar, Ajay M., V] Union South East Asia Off, Int Union TB & Lung Dis, New Delhi, India; [Kumar, Ajay M., V] Yenepoya Deemed Be Univ, Yenepoya Med Coll, Mangaluru, India; [Si Thu Aung] Dept Publ Hlth, Dis Control Div, Nay Pyi Taw, Myanmar	University of London; London School of Hygiene & Tropical Medicine; Yenepoya (Deemed to be University)	Kyaw, KWY (corresponding author), Int Union TB & Lung Dis Union, Mandalay, Myanmar.; Kyaw, KWY (corresponding author), Int Union TB & Lung Dis Union, Paris, France.	dr.khinewutyeekyaw2015@gmail.com	Kyaw, Khine Wut Yee/K-4130-2019	Kyaw, Khine Wut Yee/0000-0003-0709-484X; Kyi, Myo Su/0000-0001-6968-5456; Satyanarayana, Srinath/0000-0002-5420-2551	Department of International Development (DFD), UK; National TB Programme (NTP), TB unit (The Union)	Department of International Development (DFD), UK; National TB Programme (NTP), TB unit (The Union)	We gratefully acknowledge the support of Department of International Development (DFD), UK, National TB Programme (NTP), TB unit (The Union) and all the presumptive TB patients participated in this study.	Achanta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041378; Adjei A A, 2006, West Afr J Med, V25, P38; Ayenew A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009702; Department of Population Ministry of Immigration and Population Republic of the Union of Myanmar, 2015, 2014 MYANM POP HOUS; Deribew A, 2010, INT J TUBERC LUNG D, V14, P1442; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; Dlodlo RA, 2015, PUBLIC HEALTH ACTION, V5, P217, DOI 10.5588/pha.15.0036; Kayigamba FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095459; Kennedy CE, 2013, AIDS BEHAV, V17, P1571, DOI 10.1007/s10461-012-0241-y; Kumar AMV, 2017, J EPIDEMIOL GLOB HEA, V7, P11, DOI 10.1016/j.jegh.2015.12.002; Kumar AMV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156487; MacPherson P, 2011, INT J TUBERC LUNG D, V15, P1390, DOI 10.5588/ijtld.11.0056; Montoy JCC, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6895; Munthali L, 2006, INT J TUBERC LUNG D, V10, P199; Nagai S, 2014, T ROY SOC TROP MED H, V108, P173, DOI 10.1093/trstmh/trt116; Naik B, 2012, J ACQ IMMUN DEF SYND, V59, P72, DOI [10.1097/QAI.0b013e318236bd6f, DOI 10.1097/QAI.0B013E318236BD6F]; National AIDS Programme, 2017, NAT STRAT PLAN HIV A; National AIDS Programme, 2011, GUID CLIN MAN HIV IN; National AIDS Programme, 2014, CLIN MANAGEMENT HIV; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Opollo VS, 2018, INT J TUBERC LUNG D, V22, P1443, DOI 10.5588/ijtld.18.0108; Palanivel C, 2013, PUBLIC HEALTH ACTION, V3, P220, DOI 10.5588/pha.13.0045; Porskrog A, 2011, INT J TUBERC LUNG D, V15, P459, DOI 10.5588/ijtld.10.0353; Rajaram M, 2018, ADV RESPIR MED, V86, P211, DOI 10.5603/ARM.2018.0033; Schatz E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196158; Srikantiah P, 2007, INT J TUBERC LUNG D, V11, P168; Thomas BE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008389; UNAIDS, 2019, GLOB HIV STAT 2018; van Lettow M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141414; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2019, GLOB TUB REP; WHO, 2019, TOB KEY FACTS, P1; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization and Joint United Nations Programme on HIV and AIDS, 2007, GUID PROV IN HIV TES; Yadeta D, 2013, J INFECT PUBLIC HEAL, V6, P222, DOI 10.1016/j.jiph.2013.01.002; Yotebieng Marcel, 2016, Pan Afr Med J, V25, P161, DOI 10.11604/pamj.2016.25.161.8125; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234429	10.1371/journal.pone.0234429	http://dx.doi.org/10.1371/journal.pone.0234429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555731	Green Published, gold			2022-12-27	WOS:000543273200076
J	Langmann, C				Langmann, Caillin			Effect of firearms legislation on suicide and homicide in Canada from 1981 to 2016	PLOS ONE			English	Article							BILL C-17; IMPACT; VIOLENCE; RATES; PREVENTION; CRIME	Canada implemented a series of laws regulating firearms including background and psychological screening, licensing, and training in the years 1991, 1994, and 2001. The effects of this legislation on suicide and homicide rates were examined over the years 1981 to 2016. Models were constructed using difference-in-difference analysis of firearms and non firearms death rates from 1981 to 2016. In addition, negative binomial regression was used to test for an association between rates of suicide by Canadian Province and firearms prevalence, using licensing rates as a proxy for prevalence. No associated benefit from firearms legislation on aggregate rates of male suicide was found. In men aged 45 to 59 an associated shift from firearms suicide after 1991 and 1994 to an increase in hanging resulted in overall rate ratios of 0.994 (95%CI, 0.978,1.010) and 0.993 (95%CI, 0.980,1.005) respectively. In men 60 and older a similar effect was seen after 1991, 1994, and 2001, that resulted in rate ratios of 0.989 (95%CI, 0.971,1.008), 0.994 (95%CI, 0.979,1.010), and 1.010 (95%CI, 0.998,1.022) respectively. In females a similar effect was only seen after 1991, rate ratio 0.983 (95%CI, 0.956,1.010). No beneficial association was found between legislation and female or male homicide rates. There was no association found with firearm prevalence rates per province and provincial suicide rates, but an increased association with suicide rates was found with rates of low income, increased unemployment, and the percentage of aboriginals in the population. In conclusion, firearms legislation had no associated beneficial effect on overall suicide and homicide rates. Prevalence of firearms ownership was not associated with suicide rates. Multifaceted strategies to reduce mortality associated with firearms may be required such as steps to reduce youth gang membership and violence, community-based suicide prevention programs, and outreach to groups for which access to care may be a particular issue, such as Aboriginals.	[Langmann, Caillin] McMaster Univ, Dept Med, Div Emergency Med, Hamilton, ON, Canada	McMaster University	Langmann, C (corresponding author), McMaster Univ, Dept Med, Div Emergency Med, Hamilton, ON, Canada.	caillin.langmann@medportal.ca		Langmann, Caillin/0000-0003-2358-2958				Beattie Sara, 2018, HOMICIDES CANADA 201; Beautrais AL, 1996, AUST NZ J PSYCHIAT, V30, P741, DOI 10.3109/00048679609065040; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bridges FS, 2004, PSYCHOL REP, V94, P819; Caron J, 2008, SUICIDE LIFE-THREAT, V38, P195, DOI 10.1521/suli.2008.38.2.195; Caron Jean, 2004, Arch Suicide Res, V8, P361, DOI 10.1080/13811110490476752; Cheung AH, 2005, CAN J PUBLIC HEALTH, V96, P131, DOI 10.1007/BF03403676; Department of Justice Canada, 2015, FIR ACC DEATHS SUIC; Gagne M, 2010, INJURY PREV, V16, P247, DOI 10.1136/ip.2009.022491; Gilmour S, 2018, AM J PUBLIC HEALTH, V108, P1511, DOI 10.2105/AJPH.2018.304640; Hajizadeh M, 2019, CAN MED ASSOC J, V191, pE325, DOI 10.1503/cmaj.181374; Karp A., 2018, SMALL ARMS SURVEY; Kerr WC, 2017, AM J PREV MED, V52, P469, DOI 10.1016/j.amepre.2016.09.021; Kleck G, 2004, J RES CRIME DELINQ, V41, P3, DOI 10.1177/0022427803256229; Kleck G, 2015, J CRIM JUST, V43, P40, DOI 10.1016/j.jcrimjus.2014.12.002; Knopov A, 2019, AM J PREV MED, V56, P335, DOI 10.1016/j.amepre.2018.10.027; Kral MJ, 2016, CAN J PSYCHIAT, V61, P688, DOI 10.1177/0706743716661329; Langmann C, 2012, J INTERPERS VIOLENCE, V27, P2303, DOI 10.1177/0886260511433515; Lee MJ, 2016, SOCIOL METHOD RES, V45, P134, DOI 10.1177/0049124114566717; Leenaars AA, 2001, J CRIM JUST, V29, P287, DOI 10.1016/S0047-2352(01)00094-0; LESTER D, 1994, PERCEPT MOTOR SKILL, V79, P962, DOI 10.2466/pms.1994.79.2.962; MAUSER GA, 1992, EVALUATION REV, V16, P603, DOI 10.1177/0193841X9201600602; McPhedran S, 2013, VIOLENCE VICTIMS, V28, P875, DOI 10.1891/0886-6708.VV-D-12-00145; Navaneelan T., 2012, HLTH GLANCE SUICIDE; Office of the Auditor General of Canada. Department of Justice-Chapter 10, 2002, DEC 2002 REP AUD GEN, P101, DOI DOI 10.1-10.21; Ohsfeldt R L, 1992, Adv Health Econ Health Serv Res, V13, P65; Owens B, 2019, CAN MED ASSOC J, V191, pE59, DOI 10.1503/cmaj.109-5700; Phillips CD, 2018, AM J PUBLIC HEALTH, V108, P868, DOI 10.2105/AJPH.2018.304462; Santaella-Tenorio J, 2016, EPIDEMIOL REV, V38, P140, DOI 10.1093/epirev/mxv012; Smith-Moncrieffe D, 2013, YOUTH GANG PREVENTIO; Vasiliadis HM, 2015, J MENT HEALTH POLICY, V18, P147	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234457	10.1371/journal.pone.0234457	http://dx.doi.org/10.1371/journal.pone.0234457			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555647	Green Published, gold			2022-12-27	WOS:000543273200052
J	Muhlberger, D; Wenkel, M; Papapostolou, G; Mumme, A; Stucker, M; Reich-Schupke, S; Hummel, T				Muehlberger, Dominic; Wenkel, Martin; Papapostolou, Georg; Mumme, Achim; Stuecker, Markus; Reich-Schupke, Stefanie; Hummel, Thomas			Surgical thrombectomy for iliofemoral deep vein thrombosis: Patient outcomes at 8.5 years	PLOS ONE			English	Article							CLINICAL-PRACTICE-GUIDELINES; POSTTHROMBOTIC SYNDROME; VENOUS THROMBOSIS; VASCULAR-SURGERY; HEMODYNAMICS; SOCIETY; LEG	Introduction Deep vein thrombosis (DVT) is a frequent burden and a post-thrombotic syndrome (PTS) can be a serious long-term consequence. Iliofemoral DVT should be associated with severe forms of PTS. Therefore an early thrombus removal has been recommended in specific conditions. The aim of this study was to find out both, the long-term results after surgical thrombectomy of iliofemoral DVT in respect of the development of PTS as well as the venous hemodynamics after surgery concerning venous reflux and venous obstruction. Methods Sixty-seven patients who underwent surgical thrombectomy between the years 2000 and 2014 were included in this study; iliofemoral DVT was present in 52 of these patients. 35 patients could be reinvestigated after a mean follow-up of 8.5 years. CEAP (Clinical-Etiological-Anatomical-Pathophysiological) and Villalta scores were recorded in order to describe and assess PTS. Follow-up examinations included a detailed duplex mapping. Venous hemodynamics were measured by digital photoplethysmography and venous occlusion plethysmography. Results The primary patency rate of the iliofemoral segment was 88% after 8.5 years. 48% of all patients showed reflux in deep vein segments. Mild or moderate PTS occurred in 57% of all patients. Notably, there was no patient with an active ulcer or severe PTS. The mean venous outflow volume of all patients in the treated legs was 66.1 ml/100ml/min and significantly less than in the controlled contralateral non-treated legs (p<0.05). The mean venous refilling time was 16.3 seconds, while the mean value of the non-treated contralateral legs was 25.6 seconds and therefore significantly higher (p<0.05). Conclusion Even though venous hemodynamics are significantly inferior in the treated legs, this study demonstrates excellent patency rates and good clinical outcome after surgical thrombectomy of iliofemoral veins.	[Muehlberger, Dominic; Wenkel, Martin; Papapostolou, Georg; Mumme, Achim; Hummel, Thomas] Ruhr Univ Bochum, St Josef Hosp Bochum, Dept Vasc Surg, Kathol Klinikum Bochum, Bochum, Germany; [Muehlberger, Dominic; Papapostolou, Georg; Mumme, Achim; Stuecker, Markus; Reich-Schupke, Stefanie; Hummel, Thomas] Kathol Klinikum Bochum, Dept Dermatol & Vasc Surg, Vein Ctr, Bochum, Germany; [Stuecker, Markus; Reich-Schupke, Stefanie] Ruhr Univ Bochum, St Josef Hosp Bochum, Dept Dermatol, Kathol Klinikum Bochum, Bochum, Germany; [Wenkel, Martin] Johannes Gutenberg Univ Mainz, Dept Heart Thorac & Vasc Surg, Mainz, Germany; [Reich-Schupke, Stefanie] Privatpraxis Haut & Gefassmed, Recklinghausen, Germany	Ruhr University Bochum; Ruhr University Bochum; Johannes Gutenberg University of Mainz	Muhlberger, D (corresponding author), Ruhr Univ Bochum, St Josef Hosp Bochum, Dept Vasc Surg, Kathol Klinikum Bochum, Bochum, Germany.; Muhlberger, D (corresponding author), Kathol Klinikum Bochum, Dept Dermatol & Vasc Surg, Vein Ctr, Bochum, Germany.	dominic.muehlberger@gmail.com	Mühlberger, Dominic/AAQ-9390-2021; Reich-Schupke, Stefanie/AAJ-2152-2021	Mühlberger, Dominic/0000-0001-9636-5108; Wenkel, Martin/0000-0002-8569-4288				Attigah N, 2012, ZBL CHIR, V137, P83, DOI 10.1055/s-0030-1247421; Baekgaard N, 2019, EUR J VASC ENDOVASC, V57, P755, DOI 10.1016/j.ejvs.2019.03.017; Broholm R, 2011, J VASC SURG, V54, p18S, DOI 10.1016/j.jvs.2011.06.021; Casey ET, 2012, J VASC SURG, V55, P1463, DOI 10.1016/j.jvs.2011.12.082; Comerota AJ, 2019, CIRCULATION, V139, P1162, DOI 10.1161/CIRCULATIONAHA.118.037425; Delis KT, 2004, ANN SURG, V239, P118, DOI 10.1097/01.sla.0000103067.10695.74; Gohel MS, 2007, EUR J VASC ENDOVASC, V33, P742, DOI 10.1016/j.ejvs.2006.11.039; Haenen JH, 1999, J VASC SURG, V29, P1071, DOI 10.1016/S0741-5214(99)70248-X; Holper P, 2010, EUR J VASC ENDOVASC, V39, P349, DOI 10.1016/j.ejvs.2009.09.028; Kahn SR, 2009, J THROMB HAEMOST, V7, P879, DOI 10.1111/j.1538-7836.2009.03294.x; Kamphausen M, 2005, ZBL CHIR, V130, P454, DOI 10.1055/s-2005-836874; Lindow C, 2010, EUR J VASC ENDOVASC, V40, P134, DOI 10.1016/j.ejvs.2010.02.023; Meissner MH, 2012, J VASC SURG, V55, P1449, DOI 10.1016/j.jvs.2011.12.081; Muhlberger D, 2018, VASOMED, P2; Neglen P, 2003, J VASC SURG, V38, P879, DOI 10.1016/S0741-5214(03)01020-6; Ockert S, 2018, ANN VASC SURG, V46, P314, DOI 10.1016/j.avsg.2017.07.003; Plate G, 1997, EUR J VASC ENDOVASC, V14, P367, DOI 10.1016/S1078-5884(97)80286-9; Rosfors S, 2014, EUR J VASC ENDOVASC, V47, P81, DOI 10.1016/j.ejvs.2013.10.021; Vedantham S, 2017, NEW ENGL J MED, V377, P2240, DOI 10.1056/NEJMoa1615066; Wagenhauser MU, 2018, PHLEBOLOGY, V33, P600, DOI 10.1177/0268355517736437; Wittens C, 2015, EUR J VASC ENDOVASC, V49, P678, DOI 10.1016/j.ejvs.2015.02.007	21	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0235003	10.1371/journal.pone.0235003	http://dx.doi.org/10.1371/journal.pone.0235003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555683	Green Published, gold			2022-12-27	WOS:000543273200017
J	Liu, F; Jones, AYM; Tsang, RCC; Wang, Y; Zhou, J; Zhou, MC; Wang, YL				Liu, Fang; Jones, Alice Y. M.; Tsang, Raymond C. C.; Wang, Yao; Zhou, Jing; Zhou, Mingchao; Wang, Yulong			Noninvasive investigation of the cardiodynamic response to 6MWT in people after stroke using impedance cardiography	PLOS ONE			English	Article							6-MINUTE WALK TEST; VENTRICULAR DIASTOLIC DYSFUNCTION; TEST-RETEST RELIABILITY; CARDIORESPIRATORY FITNESS; CARDIAC-OUTPUT; AMBULATORY ACTIVITY; PHYSICAL-ACTIVITY; EXERCISE; INDIVIDUALS; PERFORMANCE	This is a cross-section observational study that investigated the cardiodynamic response to a 6-minute walk test (6MWT) in patients after stroke using impedance cardiography (ICG). Patients diagnosed with stroke were invited to participate in a 6MWT on consecutive days. Heart rate (HR), cardiac output (CO), stroke volume (SV) and cardiac index (CI) were measured by ICG using the PhysioFlow(R)PF07 Enduro(TM)at 1-second intervals for 10 minutes prior to, during and for 10 minutes after each 6MWT. Oxygen saturation, perceived exertion score (modified Borg scale) and the distance covered at the end of each 6MWT were recorded. Twenty-nine patients (mean age 55.6 +/- 10.9 years) completed the study. The mean duration of stroke after diagnosis was 14.4 +/- 19.1 months. There were no differences in the measured data between the first and second 6MWT (mean intraclass correlation coefficient (ICC) range: 0.87-0.95). The 6 minute walk distance (6WMD) covered in the two 6MWTs was 246 +/- 126 and 255 +/- 130m respectively (p>0.05). Mean measured data for each subject at rest, and at the end of the better performed 6MWT were, respectively: HR 78 +/- 11 and 100 +/- 18 bpm; CO 5.5 +/- 1.2 and 8.9 +/- 2.6 l/min, SV 71.3 +/- 16 and 89.3 +/- 18.6 ml/beat and CI 3.0 +/- 0.6 and 4.9 +/- 1.3 l/min/m(2). After commencement of the 6MWT, the increase in SV took 30 sec before the rise approaching a plateau, whereas HR, CO and CI continued to rise steeply for 90 sec before leveling off to a steady rise. After completion of the 6MWT, all parameters had returned to baseline by a mean of 3.5 min. Sub-group analysis showed that the increase in cardiac output was predominantly contributed by an increase in heart rate in participants diagnosed with stroke for less than 1 year, whereas both stroke volume and heart rate contributed similarly to the increase in cardiac output in participants with diagnosis of stroke for longer than 1 year. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) both returned to baseline within 2 minutes post 6MWT. HR recorded at the end of the 6MWT was 60.8 +/- 10.6% of the predicted maximal heart rate and perceived exertion score was 5 +/- 2. Correlations between 6MWD and HR, and between 6MWD and SV were weak, with correlation coefficients Spearman's rho (r(s)) =0.46, and 0.42, respectively (p<0.05). Correlation between 6MWD and CO and CI were higher (r(s)= 0.66 and 0.63, respectively (p<0.01)). This is the first study to report cardiac responses during a 6MWT in stroke patients. ICG is a reliable, non-invasive, repeatable method of measuring cardiodynamic data in stroke patients.	[Liu, Fang; Wang, Yao; Zhou, Jing; Zhou, Mingchao; Wang, Yulong] Shenzhen Univ, Shenzhen Peoples Hosp 2, Hlth Sci Ctr, Dept Rehabil,Affiliated Hosp 1, Shenzhen, Peoples R China; [Jones, Alice Y. M.] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Jones, Alice Y. M.] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Tsang, Raymond C. C.] MacLehose Med Rehabil Ctr, Dept Physiotherapy, Hong Kong, Peoples R China; [Wang, Yao] Shenzhen Dapeng New Dist Nanao Peoples Hosp, Dept Rehabil, Shenzhen, Peoples R China	Shenzhen University; University of Queensland; University of Sydney	Jones, AYM (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.; Jones, AYM (corresponding author), Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia.	alice.jones@sydney.edu.au	Tsang, Raymond/W-9984-2019	Tsang, Raymond/0000-0002-9251-6236; Jones, Alice YM/0000-0003-3682-619X; Liu, Fang/0000-0003-0363-5389	Sanming Project of Medicine in Shenzhen [SZSM201512011]	Sanming Project of Medicine in Shenzhen	This study was funded by a grant from Sanming Project of Medicine in Shenzhen awarded to YM (No. SZSM201512011).	[Anonymous], 1998, CERCETARI ISTORICE, V17, P101; Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Charloux A, 2000, EUR J APPL PHYSIOL, V82, P313, DOI 10.1007/s004210000226; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; DUNN A, 2015, BMJ-BRIT MED J, V2015, DOI DOI 10.1155/2015/484813; Dunn A, 2019, PHYSIOTHER THEOR PR, V35, P622, DOI 10.1080/09593985.2018.1457746; Eng JJ, 2004, ARCH PHYS MED REHAB, V85, P113, DOI 10.1016/S0003-9993(03)00436-2; Ferreira EM, 2012, CLIN PHYSIOL FUNCT I, V32, P343, DOI 10.1111/j.1475-097X.2012.01135.x; Gonzalez-Represas A, 2020, INT J CARDIOVAS IMAG, V36, P447, DOI 10.1007/s10554-019-01738-y; Gusso S, 2017, DIABETES CARE, V40, P1264, DOI 10.2337/dc16-2347; Harmsen WJ, 2017, TOP STROKE REHABIL, V24, P250, DOI 10.1080/10749357.2016.1260263; Houghton D, 2016, MECH AGEING DEV, V153, P1, DOI 10.1016/j.mad.2015.11.001; Kubo H, 2018, J STROKE CEREBROVASC, V27, P1632, DOI 10.1016/j.jstrokecerebrovasdis.2018.01.017; Mansouri S., 2018, BIOMED RES-TOKYO, V29, P3542, DOI [10.4066/BIOMEDICALRESEARCH.29-17-3479, DOI 10.4066/BIOMEDICALRESEARCH.29-17-3479]; Mayo NE, 1999, DISABIL REHABIL, V21, P258; Michael K, 2007, TOP STROKE REHABIL, V14, P5, DOI 10.1310/tsr1402-5; Michael KM, 2005, ARCH PHYS MED REHAB, V86, P1552, DOI 10.1016/j.apmr.2004.12.026; Muren MA, 2008, TOP STROKE REHABIL, V15, P51, DOI 10.1310/tsr1501-51; Palmieri V, 2006, J AM SOC ECHOCARDIOG, V19, P491, DOI 10.1016/j.echo.2005.12.011; Pang MYC, 2005, CHEST, V127, P495, DOI 10.1378/chest.127.2.495; Park HK, 2016, J STROKE, V18, P195, DOI 10.5853/jos.2015.01697; Parry MJE, 2006, NURS RES, V55, P283, DOI 10.1097/00006199-200607000-00009; Portney LG, 2000, FDN CLIN RES APPL PR; Pradon D, 2013, J REHABIL MED, V45, P105, DOI 10.2340/16501977-1059; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ross RM, 2003, AM J RESP CRIT CARE, V167, P1451, DOI 10.1164/ajrccm.167.10.950; Salbach NM, 2017, J NEUROL PHYS THER, V41, P3, DOI 10.1097/NPT.0000000000000159; Salbach NM, 2014, NEUROREHAB NEURAL RE, V28, P111, DOI 10.1177/1545968313498826; Someya Fujiko, 2015, BMC Res Notes, V8, P355, DOI 10.1186/s13104-015-1331-5; Tang A, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-23; Tang A, 2006, ARCH PHYS MED REHAB, V87, P1100, DOI 10.1016/j.apmr.2006.04.016; Tonelli AR, 2013, CTS-CLIN TRANSL SCI, V6, P474, DOI 10.1111/cts.12090; Tsang RCC, 2014, PHYSIOTHER THEOR PR, V30, P353, DOI 10.3109/09593985.2013.876563; Wang L, 2010, PHYSIOL MEAS, V31, P715, DOI 10.1088/0967-3334/31/5/008; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wheatley CM, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-445	37	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0233000	10.1371/journal.pone.0233000	http://dx.doi.org/10.1371/journal.pone.0233000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555655	Green Published, gold			2022-12-27	WOS:000542759600047
J	Collins, D; Rhea, S; Diallo, BI; Bah, MB; Yattara, F; Keleba, RG; MacDonald, PDM				Collins, Doreen; Rhea, Sarah; Diallo, Boubacar Ibrahima; Bah, Mariama Boubacar; Yattara, Facinet; Keleba, Rachelle Goman; MacDonald, Pia D. M.			Surveillance system assessment in Guinea: Training needed to strengthen data quality and analysis, 2016	PLOS ONE			English	Article								The 2014-2016 Ebola virus disease outbreak revealed the fragility of the Guinean public health infrastructure. As a result, the Guinean Ministry of Health is collaborating with international partners to improve compliance with the International Health Regulations and work toward the Global Health Security Agenda goals, including enhanced case- and community-based disease surveillance. We assessed the case-based disease surveillance system during October 1, 2015-March 31, 2016, in the Boffa prefecture of Guinea. We conducted onsite interviews with public health staff at the peripheral (health center), middle (prefectural), and central (Ministry of Health) levels of the public health system to document leadership structure; methods for maintaining case registers and submitting weekly case reports; disease surveillance feedback; data analysis; and baseline surveillance information on four epidemic-prone diseases (cholera, meningococcal meningitis, measles, and yellow fever). The surveillance system was simple and paper-based at health centers and computer spreadsheet-based at the prefectural and central levels. Surveillance feedback to stakeholders at all levels was infrequent. Data analysis activities were minimal at the peripheral levels and progressively more robust at the prefectural and central levels. Reviewing the surveillance reports from Boffa during the study period, we observed zero reported cases of the four epidemic-prone diseases in the weekly reporting from the peripheral to the central level. Similarly, the national District Health Information System 2 had no reported cases of the four diseases in Boffa but did indicate reported cases among all four neighboring prefectures. Based on the assessment findings, which suggest low sensitivity of the case-based disease surveillance system in Boffa, we recommend additional training and support to improve surveillance data quality and enhance Guinean public health workforce capacity to use these data.	[Collins, Doreen; Rhea, Sarah; Diallo, Boubacar Ibrahima; Bah, Mariama Boubacar; MacDonald, Pia D. M.] RTI Int, Res Triangle Pk, NC 27709 USA; [Diallo, Boubacar Ibrahima; Bah, Mariama Boubacar] RTI Int, Conakry, Guinea; [Yattara, Facinet] Guinea Minist Hlth, Conakry, Guinea; [Keleba, Rachelle Goman] Int Org Migrat, Boffa, Guinea; [MacDonald, Pia D. M.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill	Rhea, S (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	srhea@rti.org		MacDonald, Pia/0000-0003-1340-8905; Rhea, Sarah/0000-0002-6183-1620	U.S. Centers for Disease Control and Prevention Cooperative Agreement [1U19GH001591-01]; International Organization for Migration [1U2GGH001761]	U.S. Centers for Disease Control and Prevention Cooperative Agreement(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); International Organization for Migration	This work was supported by the U.S. Centers for Disease Control and Prevention Cooperative Agreement 1U19GH001591-01 (Doreen Collins, Sarah Rhea, Boubacar Diallo, Mariama Boubacar Bah, Pia D.M. MacDonald) and International Organization for Migration 1U2GGH001761 (Rachelle Keleba Goman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adokiya MN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1397-y; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 2018, WHO VACC PREV DIS MO; [Anonymous], 2016, EVIDENCE, V8, pe1000; [Anonymous], DHIS 2 29 IS HER; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Centers for Disease Control and Prevention, 2017, 2014 2016 EB OUTBR W; Centers for Disease Control and Prevention, 2016, GLOB DIS DET OP CTR; cited January 272020, 2009, EVALUATION CHOLERA S; City Population, 2019, BOFFA PREFECTURE GUI; Global Health Security Agenda, 2018, IMPL GLOB HLTH SEC A; Guinean Ministry of Health, 2015, PLAN REL SYST SANT 2; Guinean Ministry of Health, 2011, GUID TECHN SURV INT; Kruk ME, 2015, LANCET, V385, P1910, DOI 10.1016/S0140-6736(15)60755-3; Ministere de la Sante et de l'Hygiene Publique, 2014, DIR NAT ET HOSP SOIN; Rebaudet S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002898; World Health Organization, 2018, WORLD MAL REP 2018; World Health Organization, 2014, EARL DET ASS RESP AC; World Health Organization, GLOB HLTH OBS DAT RE; World Health Organization, 2010, TECHN GUID INT DIS S; World Health Organization (WHO), 2016, INT HLTH REG 2005	21	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234796	10.1371/journal.pone.0234796	http://dx.doi.org/10.1371/journal.pone.0234796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584846	Green Published, gold			2022-12-27	WOS:000545747200009
J	Luis, VJ; Ortiz, E; Delgadillo-Moya, C; Juarez, D				Jose Luis, Villasenor; Ortiz, Enrique; Delgadillo-Moya, Claudio; Juarez, Diego			The breadth of the Mexican Transition Zone as defined by its flowering plant generic flora	PLOS ONE			English	Article							BIOGEOGRAPHY; AMERICA	Biogeographic regions are defined by taxa with similar distribution patterns. Flowering plants have been widely used to propose biogeographic regionalization schemes because of shared historical or ecological factors that determine their distribution. The Mexican Transition Zone represents the boundary between the Nearctic and Neotropical kingdoms; however, there is no general agreement about the limits and extent of this region. Despite the significance of its role in the history of Mexican biota, no study involving a set of relevant plant taxa validates the magnitude of the Mexican Transition Zone. This work attempts to determine the proportion of flowering plant families and genera that characterize the biogeographic kingdoms and the Mexican Transition Zone. Through identification of distinctive genera it is shown that the Mexican Transition Zone includes the mountains of Mexico, from Oaxaca northwards. The results provide a broad view of the distribution patterns of the flora of Mexico and allow the evaluation of relationships and floristic affinities.	[Jose Luis, Villasenor; Ortiz, Enrique; Delgadillo-Moya, Claudio; Juarez, Diego] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Luis, VJ (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Mexico City, DF, Mexico.	vrios@ib.unam.mx	Villaseñor, José Luis/AAX-9681-2020	Villaseñor, José Luis/0000-0002-0781-8548	Universidad Nacional Autonoma de Mexico - Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [PAPIIT IN209519]	Universidad Nacional Autonoma de Mexico - Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica	Work supported by the Universidad Nacional Autonoma de Mexico - Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT IN209519) to JLV. There was no additional external funding received for this study.	AXELROD DI, 1958, BOT REV, V24, P433, DOI 10.1007/BF02872570; BIRKS HJB, 1976, NEW PHYTOL, V77, P257, DOI 10.1111/j.1469-8137.1976.tb01517.x; BROWN JH, 1983, BIOGEOGRAPHY; Contreras-Medina R, 2007, TAXON, V56, P905, DOI 10.2307/25065872; Cox CB, 2001, J BIOGEOGR, V28, P511; Crisci JV, 2006, AUST SYST BOT, V19, P1, DOI 10.1071/SB05006; Delgadillo-Moya C, 1997, B SOC BOT MEX, V61, P79; Espinosa D., 2008, CAPITAL NATURAL MEXI, VI, P33, DOI DOI 10.32800/ABC.2019.42.0187; Ferro I, 2014, BIOL J LINN SOC, V113, P1, DOI 10.1111/bij.12333; Ferrusquia-Villafranca I., 1990, PROVINCIAS BIOTICAS, VIII; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Halffter Gonzalo, 2017, Dugesiana, V24, P77; Halffter G, 2017, ZOOTAXA, V4226, P1, DOI 10.11646/zootaxa.4226.1.1; LAVIN M, 1993, AM J BOT, V80, P1, DOI 10.2307/2445114; Villasenor JL, 2016, REV MEX BIODIVERS, V87, P559, DOI 10.1016/j.rmb.2016.06.017; Magallon S, 2014, INFLUENCE REGIONAL H, P287; Morrone JJ, 2019, REV MEX BIODIVERS, V90, P1; Morrone JJ, 2010, ECOGRAPHY, V33, P355, DOI 10.1111/j.1600-0587.2010.06266.x; NELSON G, 1978, Journal of the History of Biology, V11, P269, DOI 10.1007/BF00389302; Parenti LR, 2009, COMP BIOGEOGRAPHY; REID N, 1990, FOREST ECOL MANAG, V36, P61, DOI 10.1016/0378-1127(90)90064-I; Rzedowski J., 1990, ATLAS NACL MEXICO, VIII; Rzedowski J., 1978, VEGETACION MEXICO; Takhtajan AL., 1986, FLORISTIC REGIONS WO; Udvardy M.D.F., 1975, IUCN OCCASIONAL PAPE, V18; Villaseñor José Luis, 2014, Rev. Mex. Biodiv., V85, pS134, DOI 10.7550/rmb.31987	26	13	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235267	10.1371/journal.pone.0235267	http://dx.doi.org/10.1371/journal.pone.0235267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584892	gold, Green Published			2022-12-27	WOS:000545747200088
J	Katowah, DF; Mohammed, GI; Al-Eryani, DA; Sobahi, TR; Hussein, MA				Katowah, Dina F.; Mohammed, Gharam I.; Al-Eryani, Dyab A.; Sobahi, Tariq R.; Hussein, Mahmoud A.			Rapid and sensitive electrochemical sensor of cross-linked polyaniline/oxidized carbon nanomaterials core-shell nanocomposites for determination of 2,4-dichlorophenol	PLOS ONE			English	Article							CONDUCTIVE POLYANILINE; EMERALDINE FORM; GRAPHENE; PERFORMANCE; NANOTUBES; COMPOSITES; OXIDATION; ELECTRODE	Nanocomposites (NCs) of crosslinked polyaniline (CPA)-coated oxidized carbon nanomaterials (OXCNMs) were fabricated as a very sensitive and simple electrochemical sensor to be utilized in 2,4-dichlorophenol (2,4-DCPH) detection. CPA/OXCNMs NCs were prepared by chemical copolymerization of polyaniline with triphenylamine and p-phenylenediamine in the presence of OXCNMs. The CPA/GO-OXSWCNTNCs exhibited a higher affinity for the oxidation of chlorophenols compared to the glassy carbon electrode (GCE), CPA/GCE, and other NCs. Cyclic voltammetry was performed to investigate and assess the electrocatalytic oxidation of 2,4-DCPH on the modified GCE. The compound yielded a well-defined voltammetric response in a Britton-Robinson buffer (pH 5) at 0.54 V (vs. silver chloride electrode). Quantitative determination of 2,4-DCPH was performed by differential pulse voltammetry under optimal conditions in the concentration range of 0.05 to 1.2 nmol L-1, and a linear calibration graph was obtained. The detection limit (S/N = 3) was found to be 4.2 nmol L-1. In addition, the results demonstrated that the CPA/GO-OXSWCNTs/GCE sensor exhibited a strong anti-interference ability, reproducibility, and stability. The prepared CPA/GO-OXSWCNTs/GCE sensor was used to rapidly detect 2,4-DCPH with a high degree of sensitivity in fish farm water with proven levels of satisfactory recoveries.	[Katowah, Dina F.; Al-Eryani, Dyab A.; Sobahi, Tariq R.; Hussein, Mahmoud A.] King Abdulaziz Univ, Chem Dept, Fac Sci, Jeddah, Saudi Arabia; [Katowah, Dina F.; Mohammed, Gharam I.] Umm Al Qura Univ, Dept Chem, Fac Sci Appl, Mecca, Saudi Arabia; [Al-Eryani, Dyab A.] Thamar Univ, Dept Chem, Fac Appl Sci, Dhamar, Yemen; [Hussein, Mahmoud A.] Assiut Univ, Chem Dept, Polymer Chem Lab, Fac Sci, Assiut, Egypt	King Abdulaziz University; Umm Al Qura University; Egyptian Knowledge Bank (EKB); Assiut University	Katowah, DF; Hussein, MA (corresponding author), King Abdulaziz Univ, Chem Dept, Fac Sci, Jeddah, Saudi Arabia.; Katowah, DF (corresponding author), Umm Al Qura Univ, Dept Chem, Fac Sci Appl, Mecca, Saudi Arabia.; Hussein, MA (corresponding author), Assiut Univ, Chem Dept, Polymer Chem Lab, Fac Sci, Assiut, Egypt.	dfkatoaah@hotmail.com; maabdo@kau.edu.sa	Abdo, Mahmoud Hussein/H-5762-2012; katowah, dina/AAT-8142-2021	Abdo, Mahmoud Hussein/0000-0002-5128-5136; Katowah, Dina/0000-0003-0081-2917				Al-Qasmi N, 2019, ARAB J CHEM, V12, P946, DOI 10.1016/j.arabjc.2015.08.032; Alfano B., 2015, 2015 18 AISEM ANN C, P1; Ayad M, 2013, CHEM ENG J, V217, P460, DOI 10.1016/j.cej.2012.11.099; Bard A.J., 1980, ELECTROCHEMICAL METH, V2; Bhattacharya P, 2014, RSC ADV, V4, P17039, DOI 10.1039/c4ra00448e; Chaplin BP, 2014, ENVIRON SCI-PROC IMP, V16, P1182, DOI 10.1039/c3em00679d; CHIANG JC, 1986, SYNTHETIC MET, V13, P193, DOI 10.1016/0379-6779(86)90070-6; Dong SY, 2016, SENSOR ACTUAT B-CHEM, V222, P972, DOI 10.1016/j.snb.2015.09.035; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; Eftekhari A, 2017, J POWER SOURCES, V347, P86, DOI 10.1016/j.jpowsour.2017.02.054; Elnaggar EM, 2017, J NANOSTRUCTURE CHEM, V7, P75, DOI 10.1007/s40097-017-0217-6; Farajzadeh MA, 2020, GLOBAL NEST J, V22, P109, DOI 10.30955/gnj.002875; FURUKAWA Y, 1986, SYNTHETIC MET, V16, P189, DOI 10.1016/0379-6779(86)90111-6; Gosser D.K., 1993, CYCLIC VOLTAMMETRY S, V43; Gu ZJ, 2014, MATER LETT, V121, P12, DOI 10.1016/j.matlet.2014.01.133; Hao M, 2016, J SOLID STATE ELECTR, V20, P665, DOI 10.1007/s10008-015-3080-8; He QH, 2018, SENSOR ACTUAT B-CHEM, V271, P367, DOI 10.1016/j.snb.2018.05.101; Holzinger M, 2003, J AM CHEM SOC, V125, P8566, DOI 10.1021/ja029931w; Hong XW, 2015, COMPOS SCI TECHNOL, V117, P215, DOI 10.1016/j.compscitech.2015.06.022; Hu Q, 2019, ACS SUSTAIN CHEM ENG, V7, P5912, DOI 10.1021/acssuschemeng.8b05847; Hussein MA, 2018, RSC ADV, V8, P23555, DOI 10.1039/c8ra03109f; Ibrahim NI, 2019, SYNTHETIC MET, V250, P49, DOI 10.1016/j.synthmet.2019.02.007; Kamel RM, 2020, J MOL LIQ, V297, DOI 10.1016/j.molliq.2019.111798; Kang N, 2019, J ELECTROANAL CHEM, V833, P70, DOI 10.1016/j.jelechem.2018.11.012; Katowah DF, 2019, COMPOS PART B-ENG, V175, DOI 10.1016/j.compositesb.2019.107175; Kumar A, 2018, POLYM COMPOSITE, V39, P3858, DOI 10.1002/pc.24418; Kumaresan N, 2020, J MATER SCI-MATER EL, V31, P3361, DOI 10.1007/s10854-020-02885-y; LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3; Long YZ, 2011, PROG POLYM SCI, V36, P1415, DOI 10.1016/j.progpolymsci.2011.04.001; Lou CQ, 2020, INT J BIOL MACROMOL, V149, P1130, DOI 10.1016/j.ijbiomac.2020.01.248; Lu XF, 2011, PROG POLYM SCI, V36, P671, DOI 10.1016/j.progpolymsci.2010.07.010; Luo JH, 2017, RSC ADV, V7, P36433, DOI 10.1039/c7ra06800j; Ma Y, 2019, POLYMER, V182, DOI 10.1016/j.polymer.2019.121808; Madhankumar A, 2012, SYNTHETIC MET, V162, P176, DOI 10.1016/j.synthmet.2011.11.028; Marinovic S, 2019, J ELECTROANAL CHEM, V848, DOI 10.1016/j.jelechem.2019.113280; Meng X., 2016, FACILE SYNTHESIS SHE; Mitra M, 2015, RSC ADV, V5, P31039, DOI 10.1039/c5ra01794g; Mohammadi G, 2022, IEEE T AFFECT COMPUT, V13, P1127, DOI 10.1109/TAFFC.2020.3028109; Mohammed GI, 2018, MICROCHEM J, V143, P474, DOI 10.1016/j.microc.2018.08.011; Naveen MH, 2017, APPL MATER TODAY, V9, P419, DOI 10.1016/j.apmt.2017.09.001; Pan Y, 2020, MICROPOR MESOPOR MAT, V291, DOI 10.1016/j.micromeso.2019.109703; Ping Z, 1996, J CHEM SOC FARADAY T, V92, P3063, DOI 10.1039/ft9969203063; QUILLARD S, 1994, PHYS REV B, V50, P12496, DOI 10.1103/PhysRevB.50.12496; Rahman MM, 2017, NEW J CHEM, V41, P10761, DOI 10.1039/c7nj01704a; Rahy A, 2008, MATER LETT, V62, P4311, DOI 10.1016/j.matlet.2008.06.057; Ramana GV, 2014, EUR POLYM J, V57, P137, DOI 10.1016/j.eurpolymj.2014.05.018; Rasdi FLM, 2016, RSC ADV, V6, P100186, DOI 10.1039/c6ra19816c; Shahriary L., 2014, INT J RENEW ENERGY E, V2, P58, DOI DOI 10.1016/J.ACA.2014.02.025; Sharma A.K., 2015, AM J POLYM SCI, V1, P1; Shih CJ, 2012, LANGMUIR, V28, P235, DOI 10.1021/la203607w; Tabaraki R, 2019, SPECTROCHIM ACTA A, V215, P405, DOI 10.1016/j.saa.2019.02.060; Vogel AI, 1996, QUANTITATIVE INORGAN; Wang X, 2014, J MATER CHEM A, V2, P12323, DOI 10.1039/c4ta02231a; Wu WQ, 2016, SENSOR ACTUAT B-CHEM, V222, P747, DOI 10.1016/j.snb.2015.09.001; Wu YH, 2004, BIOELECTROCHEMISTRY, V64, P91, DOI 10.1016/j.bioelechem.2004.03.005; Wu Y, 2012, ELECTROPHORESIS, V33, P2911, DOI 10.1002/elps.201250004; Yang JH, 2010, J PHYS CHEM SOLIDS, V71, P448, DOI 10.1016/j.jpcs.2009.12.008; Yang YY, 2011, MACROMOL RAPID COMM, V32, P593, DOI 10.1002/marc.201000806; Yao Q, 2010, ACS NANO, V4, P2445, DOI 10.1021/nn1002562; Yu HB, 2020, J ELECTROANAL CHEM, V869, DOI 10.1016/j.jelechem.2020.114099; Yu LL, 2016, SENSOR ACTUAT B-CHEM, V224, P241, DOI 10.1016/j.snb.2015.10.035; Zengin H, 2002, ADV MATER, V14, P1480, DOI 10.1002/1521-4095(20021016)14:20<1480::AID-ADMA1480>3.0.CO;2-O; Zhang JH, 2015, ANAL METHODS-UK, V7, P3448, DOI 10.1039/c5ay00551e; Zhang ZX, 2018, MAT SCI ENG C-MATER, V92, P77, DOI 10.1016/j.msec.2018.06.029	64	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234815	10.1371/journal.pone.0234815	http://dx.doi.org/10.1371/journal.pone.0234815			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584837	gold, Green Published			2022-12-27	WOS:000545747200028
J	Talhada, D; Goncalves, I; Gomes, JC; Saraiva, MJ; Santos, CR; Ruscher, K				Talhada, Daniela; Goncalves, Isabel; Gomes, Joao Carlos; Saraiva, Maria Joao; Santos, Cecilia Reis; Ruscher, Karsten			Transthyretin expression in the postischemic brain (vol 14, e0221555, 2019)	PLOS ONE			English	Correction									[Gomes, Joao Carlos] Univ Porto, Inst Invest & Inovacao Saude I3S, Porto, Portugal; [Saraiva, Maria Joao] Univ Porto, IBMC Inst Mol & Cell Biol, Mol Neurobiol Unit, Porto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto			Gomes, Joao/D-5115-2011	Gomes, Joao/0000-0002-5710-8819				Talhada D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221555	1	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235527	10.1371/journal.pone.0235527	http://dx.doi.org/10.1371/journal.pone.0235527			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584898	gold, Green Published			2022-12-27	WOS:000545747200004
J	Hernandez, EH; Moreno-Murcia, JA; Espin, J				Huescar Hernandez, Elisa; Moreno-Murcia, Juan Antonio; Espin, Jose			Teachers' interpersonal styles and fear of failure from the perspective of physical education students	PLOS ONE			English	Article							SELF-DETERMINATION; AUTONOMY SUPPORT; INTERVENTION; AMOTIVATION; COMPETENCE; MOTIVATION; SUCCESS	A growing body of research-based knowledge has been generated for the purpose of better understanding the reciprocal and dynamic relationship between teachers' instructional characteristics and students' psychosocial and learning outcomes. This study specifically examined the relationship between teachers' interpersonal styles and fear of failure outcomes in physical education students. Five hundred sixty-two middle school and high school students in Physical Education classes (PE) participated in the study. Students completed questionnaires that assessed instructors' autonomy-supportive and controlling teaching styles and students' own fear of failure. A person-centered analysis was used to test the hypotheses. The results revealed that higher teacher autonomy support was associated with lower student fear of failure. To the contrary, a controlling teaching style was associated with fear of failure in these students. Two profiles emerged in which moderate fear of failure was associated with a stronger perception of a controlling teacher style and lower levels of fear of failure were associated with greater perceived instructor support for autonomy.	[Huescar Hernandez, Elisa] Miguel Hernandez Univ, Hlth Psychol Dept, Elche, Spain; [Moreno-Murcia, Juan Antonio; Espin, Jose] Miguel Hernandez Univ, Sport Res Ctr, Elche, Spain	Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche	Hernandez, EH (corresponding author), Miguel Hernandez Univ, Hlth Psychol Dept, Elche, Spain.	ehuescar@umh.es						Amoura C, 2015, SWISS J PSYCHOL, V74, P141, DOI 10.1024/1421-0185/a000156; [Anonymous], 2017, BASIC, DOI DOI 10.1037/a0032359; Moreno-Murcia JA, 2019, REV ESP ORIENTAC PSI, V30, P116, DOI 10.5944/reop.vol.30.num.1.2019.25197; Moreno-Murcia JA, 2018, EUR J EDUC PSYCHOL, V11, P33, DOI 10.30552/ejep.v11i1.184; Moreno-Murcia JA, 2013, REV ESP ORIENTAC PSI, V24, P8; Bartholomew KJ, 2018, LEARN INSTR, V53, P50, DOI 10.1016/j.learninstruc.2017.07.006; Bartholomew KJ, 2011, PERS SOC PSYCHOL B, V37, P1459, DOI 10.1177/0146167211413125; Bartholomew KJ, 2011, J SPORT EXERCISE PSY, V33, P75, DOI 10.1123/jsep.33.1.75; Cheon SH, 2018, TEACH TEACH EDUC, V69, P43, DOI 10.1016/j.tate.2017.09.022; Cheon SH, 2016, J SPORT EXERCISE PSY, V38, P217, DOI 10.1123/jsep.2015-0236; Cheon SH, 2015, CONTEMP EDUC PSYCHOL, V40, P99, DOI 10.1016/j.cedpsych.2014.06.004; Conroy DE, 2001, J APPL SPORT PSYCHOL, V13, P300, DOI 10.1080/104132001753144428; Conroy DE, 2002, J APPL SPORT PSYCHOL, V14, P76, DOI 10.1080/10413200252907752; Correia Marco, 2016, Motriz: rev. educ. fis., V22, P376, DOI 10.1590/s1980-6574201600040024; Crocker J, 2003, J PERS SOC PSYCHOL, V85, P894, DOI 10.1037/0022-3514.85.5.894; De Castella K, 2013, J EDUC PSYCHOL, V105, P861, DOI 10.1037/a0032464; De Meyer J, 2016, PHYS EDUC SPORT PEDA, V21, P632, DOI 10.1080/17408989.2015.1112777; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Deng XM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42139-4; Escarti A., 1994, ENTRENAMIENTO PSICOL, P61; Haerens L, 2011, QUEST, V63, P321, DOI 10.1080/00336297.2011.10483684; Hair J.F., 1998, MULTIVARIATE DATA AN, V5th ed.; Halliburton AL, 2002, J SPORT EXERCISE PSY, V24, P396, DOI 10.1123/jsep.24.4.396; Jang H, 2016, LEARN INSTR, V43, P27, DOI 10.1016/j.learninstruc.2016.01.002; Jang H, 2010, J EDUC PSYCHOL, V102, P588, DOI 10.1037/a0019682; Lottero-Perdue P. S., 2017, J PRE COLL ENG ED RE, V7, P1, DOI [10.7771/2157-9288.1160, DOI 10.7771/2157-9288.1160]; Maltese AV, 2018, THINK SKILLS CREAT, V30, P116, DOI 10.1016/j.tsc.2018.01.003; Manalo E, 2018, THINK SKILLS CREAT, V30, P1, DOI 10.1016/j.tsc.2018.06.001; Moreno-Murcia J. A., 2011, REV MEX PSICOL, V28, P43; Ng L, 2018, SMALL ENTERP RES, V25, P152, DOI 10.1080/13215906.2018.1480412; Norusis M. J., 1992, SPSS PC PROFESSIONAL; Ntoumanis N, 2004, J SPORT EXERCISE PSY, V26, P197, DOI 10.1123/jsep.26.2.197; Nunez JL, 2015, TEACH TEACH, V21, P191, DOI 10.1080/13540602.2014.928127; Ommundsen Y., 2001, European Physical Education Review, V7, P219, DOI 10.1177/1356336X010073001; Oyama Y, 2018, THINK SKILLS CREAT, V30, P7, DOI 10.1016/j.tsc.2018.01.001; Reeve J, 2016, BUILDING AUTONOMOUS LEARNERS: PERSPECTIVES FROM RESEARCH AND PRACTICE USING SELF-DETERMINATION THEORY, P129, DOI 10.1007/978-981-287-630-0_7; Reeve J, 2011, CONTEMP EDUC PSYCHOL, V36, P257, DOI 10.1016/j.cedpsych.2011.05.002; Reeve J, 2009, EDUC PSYCHOL-US, V44, P159, DOI 10.1080/00461520903028990; Roberts GC., 2001, ADV MOTIVATION SPORT, P1; Ruiz-Sánchez V., 2017, CPD, V17, P55; Martinez JMS, 2007, INVESTIG GEOGR-SPAIN, P33; Shim S, 2005, J EXP EDUC, V73, P333, DOI 10.3200/JEXE.73.4.333-349; Silveira Torregrosa Yolanda, 2015, CPD, V15, P65; Simmons SA, 2014, SMALL BUS ECON, V42, P485, DOI 10.1007/s11187-013-9519-3; Suarez J. M., 2005, REV EDUC, V338, P295; Tulis M, 2011, EDUC PSYCHOL-UK, V31, P779, DOI 10.1080/01443410.2011.608524; Van den Berghe L, 2013, PSYCHOL SPORT EXERC, V14, P650, DOI 10.1016/j.psychsport.2013.04.006; Venner JM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85323; Zuckerman M, 2005, J PERS, V73, P411, DOI 10.1111/j.1467-6494.2005.00314.x	49	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235011	10.1371/journal.pone.0235011	http://dx.doi.org/10.1371/journal.pone.0235011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579576	Green Published, gold			2022-12-27	WOS:000545646600032
J	Liou, D; Kulik, L				Liou, Doreen; Kulik, Lauren			Self-efficacy and psychosocial considerations of obesity risk reduction behaviors in young adult white Americans	PLOS ONE			English	Article							PLANNED BEHAVIOR; FOOD; INTENTIONS; VARIABLES	The obesity epidemic is a pervasive health issue affecting all population groups in developed countries. The purpose of this research was to ascertain obesity risk reduction behaviors and their psychosocial determinants in young adult Americans residing in New Jersey state. A cross-sectional survey design was implemented in which a convenience sample of 174 participants (18 to 40 years) completed a validated online self-administered questionnaire. Nineteen obesity risk reduction behaviors, self-efficacy and psychosocial constructs derived from the Theory of Planned Behavior were measured. Statistical analyses were conducted using frequency distributions, t-tests and regression analysis. Regression analysis indicated that 37.5% of the variance in obesity risk reduction behavior was accounted by self-efficacy alone. T-test comparisons indicated greater frequency of adoption of 17 health behaviors among individuals categorized in the 'high self-efficacy' group (p<0.05). These behaviors included limiting portion sizes of food, eating fruits and vegetables, engaging in physical activity, and monitoring stress and body weight. Nutrition professionals working with young adult Americans need to assess their self-efficacy to engage in obesity risk reduction behaviors. In fostering confidence in adopting these behaviors, executing skill building nutrition interventions is critical for obesity prevention.	[Liou, Doreen; Kulik, Lauren] Montclair State Univ, Dept Nutr & Food Studies, Montclair, NJ 07043 USA	Montclair State University	Liou, D (corresponding author), Montclair State Univ, Dept Nutr & Food Studies, Montclair, NJ 07043 USA.	lioud@montclair.edu						Ahima RS, 2013, SCIENCE, V341, P856, DOI 10.1126/science.1241244; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 2017, FASTSTATS HLTH WHIT; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Arvola A, 2008, APPETITE, V50, P443, DOI 10.1016/j.appet.2007.09.010; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Batsis JA, 2009, APPETITE, V52, P637, DOI 10.1016/j.appet.2009.02.017; BEALE DA, 1991, J APPL SOC PSYCHOL, V21, P409, DOI 10.1111/j.1559-1816.1991.tb00528.x; Blanchard CM, 2009, APPETITE, V52, P15, DOI 10.1016/j.appet.2008.07.001; Brown T.A., 2006, CONFIRMATORY FACTOR, V1st; Bruss MB, 2005, HEALTH COMMUN, V18, P155, DOI 10.1207/s15327027hc1802_4; Cassidy OL, 2012, EAT BEHAV, V13, P174, DOI 10.1016/j.eatbeh.2012.01.003; Cha E, 2014, AM J HEALTH BEHAV, V38, P331, DOI 10.5993/AJHB.38.3.2; Guillaumie L, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-12; Hackman CL, 2014, ADOLESC HEALTH MED T, V5, P101, DOI 10.2147/AHMT.S56207; Holm-Denoma JM, 2008, HEALTH PSYCHOL, V27, pS3, DOI 10.1037/0278-6133.27.1.S3; Kazaks AG, 2013, NUTR OBESITY ASSESSM; Kwan BM, 2010, PSYCHOL SPORT EXERC, V11, P71, DOI 10.1016/j.psychsport.2009.05.010; Liou D, 2001, J NUTR EDUC, V33, P322, DOI 10.1016/S1499-4046(06)60354-0; Liou D., 2018, J FOOD NUTR RES, V6, P168, DOI [10.12691/jfnr-6-3-5, DOI 10.12691/JFNR-6-3-5]; Liou D, 2011, ECOL FOOD NUTR, V50, P486, DOI 10.1080/03670244.2011.620877; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; McAuley E, 2003, PREV MED, V37, P110, DOI 10.1016/S0091-7435(03)00089-6; McEachan RRC, 2011, HEALTH PSYCHOL REV, V5, P97, DOI 10.1080/17437199.2010.521684; Nanakorn S, 1999, Asia Pac J Public Health, V11, P10, DOI 10.1177/101053959901100103; Nutrition Physical Activity and Obesity, 2020, NUTR PHYS ACT OB; Schwarzer R., 1992, SELF EFFICACY THOUGH, P217; Smith KJ, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-29; Stefan E, 2013, HEALTH PROMOT INT, V30, P736; White KM, 2010, APPETITE, V55, P348, DOI 10.1016/j.appet.2010.07.011; World Health Organization, 2017, 10 FACTS OB	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235219	10.1371/journal.pone.0235219	http://dx.doi.org/10.1371/journal.pone.0235219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579592	gold, Green Published			2022-12-27	WOS:000545646600028
J	Schwartz, GL; Jahn, JL				Schwartz, Gabriel L.; Jahn, Jaquelyn L.			Mapping fatal police violence across US metropolitan areas: Overall rates and racial/ethnic inequities, 2013-2017	PLOS ONE			English	Article							BODY-WORN CAMERAS; MATTER; FORCE; DEATH; BLACK; RACE	Background&methods Recent social movements have highlighted fatal police violence as an enduring public health problem in the United States. To solve it, the public requires basic information, such as understanding where rates of fatal police violence are particularly high, and for which groups. Existing mapping efforts, though critically important, often use inappropriate statistical methods and can produce misleading, unstable rates when denominators are small. To fill this gap, we use inverse-variance-weighted multilevel models to estimate overall and race-stratified rates of fatal police violence for all Metropolitan Statistical Areas (MSAs) in the U.S. (2013-2017), as well as racial inequities in these rates. We analyzed the most recent, reliable data from Fatal Encounters, a citizen science initiative that aggregates and verifies media reports. Results Rates of police-related fatalities varied dramatically, with the deadliest MSAs exhibiting rates nine times those of the least deadly. Overall rates in Southwestern MSAs were highest, with lower rates in the northern Midwest and Northeast. Yet this pattern was reversed for Black-White inequities, with Northeast and Midwest MSAs exhibiting the highest inequities nationwide. Our main results excluded deaths that could be considered accidents (e.g., vehicular collisions), but sensitivity analyses demonstrated that doing so may underestimate the rate of fatal police violence in some MSAs by 60%. Black-White and Latinx-White inequities were slightly underestimated nationally by excluding reportedly 'accidental' deaths, but MSA-specific inequities were sometimes severely under- or over-estimated. Conclusions Preventing fatal police violence in different areas of the country will likely require unique solutions. Estimates of the severity of these problems (overall rates, racial inequities, specific causes of death) in any given MSA are quite sensitive to which types of deaths are analyzed, and whether race and cause of death are attributed correctly. Monitoring and mapping these rates using appropriate methods is critical for government accountability and successful prevention.	[Schwartz, Gabriel L.; Jahn, Jaquelyn L.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Schwartz, GL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA.	gabelschwartz@gmail.com		Schwartz, Gabriel/0000-0001-8299-1407				American Public Health Association, 2018, ADDR LAW ENF VIOL PU; [Anonymous], GUARDIAN        0206; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Ariel B, 2015, J QUANT CRIMINOL, V31, P509, DOI 10.1007/s10940-014-9236-3; Banks D, 2016, ARREST RELATED DEATH; Beckett K., 2001, PUNISHMENT SOC, V3, P43, DOI DOI 10.1177/14624740122228249; Bor J, 2018, LANCET, V392, P302, DOI [10.1016/S0140-6736(18)31130-9, 10.1016/s0140-6736(18)31130-9]; Browne WJ, 2003, MCMC ESTIMATION MLWI; Buehler JW, 2017, AM J PUBLIC HEALTH, V107, P295, DOI 10.2105/AJPH.2016.303575; Burghart B, 2019, METHODOLOGY FATAL EN; Coudert F, 2015, COMPUT LAW SECUR REV, V31, P749, DOI 10.1016/j.clsr.2015.09.002; Derenoncourt Ellora, 2019, CAN YOU MOVE OPPORTU; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Edwards F, 2019, P NATL ACAD SCI USA, V116, P16793, DOI 10.1073/pnas.1821204116; Edwards F, 2018, AM J PUBLIC HEALTH, V108, P1241, DOI 10.2105/AJPH.2018.304559; Elinson Zusha, 2018, WALL STREET J; Feldman JM, 2019, AM J PUBLIC HEALTH, V109, P458, DOI 10.2105/AJPH.2018.304851; Feldman JM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002399; Feldman JM, 2017, AM J PUBLIC HEALTH, V107, P1624, DOI 10.2105/AJPH.2017.303940; Hall AV, 2016, AM PSYCHOL, V71, P175, DOI 10.1037/a0040109; Hemenway D, 2019, J URBAN HEALTH, V96, P63, DOI 10.1007/s11524-018-0313-z; Holmes MD, 2019, JUSTICE Q, V36, P751, DOI 10.1080/07418825.2018.1427782; Jacobs D, 1998, AJS; Johnson O, 2019, SOC SCI MED, V220, P226, DOI 10.1016/j.socscimed.2018.11.024; Kelepecz BP, 2015, POLICE CHIEF MAGAZIN; Khan Amina, 2019, L A TIMES; Knox D, 2019, BIAS IS BUILT ADM RE, DOI [10.2139/ssrn.3336338, DOI 10.2139/SSRN.3336338]; Krieger N, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001915; Lai CK, 2016, J EXP PSYCHOL GEN, V145, DOI 10.1037/xge0000179; Leckie G, 2013, J STAT SOFTW, V52, P1; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Peyton K, 2019, P NATL ACAD SCI USA, V116, P19894, DOI 10.1073/pnas.1910157116; Rao JNK, 2015, SMALL AREA ESTIMATIO, P269, DOI [10.1002/9781118735855.ch9, DOI 10.1002/9781118735855.CH9]; Rasbash J, 2015, MLWIN VERSION 2 34; Rice N, 1997, HEALTH ECON, V6, P561, DOI 10.1002/(SICI)1099-1050(199711)6:6<561::AID-HEC288>3.0.CO;2-X; Ross CT, 2018, PALGR COMMUN, V4, DOI 10.1057/s41599-018-0110-z; ROSS CT, 2015, PLOS ONE, V10, DOI [DOI 10.1371/JOURNAL.PONE.0141854, 10.1371/journal.pone.0141854]; Schuetz J, 2017, BROOKINGS; Sethi R., 2019, SHADOWS DOUBT STEREO; Sewell AA, 2016, SOCIOL RACE ETHNIC, V2, P402, DOI 10.1177/2332649215626936; Sewell AA, 2016, SOC SCI MED, V159, P1, DOI 10.1016/j.socscimed.2016.04.024; Sinyangwe S, BP MAPPING POLICE VI; Smith BW, 2003, POLICY STUD J, V31, P147, DOI 10.1111/1541-0072.t01-1-00009; Starr TJ, 2015, WASHINGTON POST; STATA CORP, 2019, STAT REL 16 STAT SOF; StataCorp, 2018, MEP MULT MIX EFF POI; Subramanian Ram., 2018, DIVIDED JUSTICE TREN; Taheri S.A., 2016, CRIMINAL JUSTICE POL, V27, P76, DOI [10.1177/0887403414556289, DOI 10.1177/0887403414556289]; Tate J, 2016, WASHINGTON POST; Umberson D, 2017, J HEALTH SOC BEHAV, V58, P405, DOI 10.1177/0022146517739317; Vock DC, 2019, GOVERNING; Welch K, 2010, TYPIFICATION HISPANI, DOI [10.1016/j.ssresearch.2010.09.012, DOI 10.1016/J.SSRESEARCH.2010.09.012]; Wofford T., 2014, NEWSWEEK; Yokum D., 2017, EVALUATING EFFECTS P	54	34	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0229686	10.1371/journal.pone.0229686	http://dx.doi.org/10.1371/journal.pone.0229686			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579553	gold, Green Published			2022-12-27	WOS:000545646600053
J	Abrams, JA; Castro, B; Gordhandas, S; Grzegorczyk, A; Maxwell, M; Brawner, B; Conserve, DF; Ryan, M				Abrams, Jasmine A.; Castro, Bryan; Gordhandas, Sushmita; Grzegorczyk, Anna; Maxwell, Morgan; Brawner, Bridgette; Conserve, Donaldson F.; Ryan, Mark			Conocimientos de la hipertension: Health beliefs about hypertension in an under-resourced community in the Dominican Republic	PLOS ONE			English	Article							BLOOD-PRESSURE	Understanding health beliefs is important to facilitate health promotion and disease prevention as they influence health behaviors, outcomes, and disease management. Given the rise of hypertension-related diseases in the Dominican Republic, the purpose of our study was to identify hypertension-related health beliefs of Dominicans in order to inform the development of culturally appropriate interventions for hypertension prevention, care, and treatment. Semi-structured interviews were conducted with 20 Dominicans, 15 of whom were receiving treatment for hypertension. Operating within the interpretative paradigmatic framework, we conducted thematic analyses of interview data to identify hypertension-related health beliefs and practices. Iterative data analysis revealed the following themes: 1) Negative emotions are a primary cause of hypertension, 2) Medication is the best treatment but adherence is challenging, 3) Systemic barriers impede treatment access, 4) Hypertension negatively impacts mental and physical well-being, and 5) Lifestyle changes, relaxation, and social support help manage hypertension. Data gathered from member checking validated these findings. This study enhances understanding of the beliefs and experiences of Dominicans and emphasize the importance of implementing culturally competent health programming and care.	[Abrams, Jasmine A.] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA 02215 USA; [Abrams, Jasmine A.] Yale Univ, Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA; [Castro, Bryan] Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA; [Gordhandas, Sushmita] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Grzegorczyk, Anna] Calif Pacific Med Ctr, San Francisco, CA USA; [Maxwell, Morgan] Virginia Polytech Inst & State Univ, Dept Populat Hlth Sci, Blacksburg, VA 24061 USA; [Brawner, Bridgette] Univ Penn, Sch Nursing, Dept Family & Community Hlth, Philadelphia, PA 19104 USA; [Conserve, Donaldson F.] Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC USA; [Ryan, Mark] Virginia Commonwealth Univ, Dept Family Med & Populat Hlth, Richmond, VA USA	Boston University; Yale University; Virginia Commonwealth University; University of Washington; University of Washington Seattle; California Pacific Medical Center; Virginia Polytechnic Institute & State University; University of Pennsylvania; Virginia Commonwealth University	Abrams, JA (corresponding author), Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA 02215 USA.; Abrams, JA (corresponding author), Yale Univ, Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA.	abramsja@bu.edu		Conserve, Donaldson/0000-0001-8193-817X				Arriaza P, 2015, SOC WORK PUBLIC HLTH, V30, P75, DOI 10.1080/19371918.2014.938394; Babington L M, 1999, J Cult Divers, V6, P20; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Burell G, 1979, ELEMENTS SOCIOLOGY C; Burt R.S., 2005, BROKERAGE CLOSURE IN; Campbell MK, 2006, AM BEHAV SCI, V49, P775, DOI 10.1177/0002764205283807; Centers for Disease Control and Prevention, 2019, FAM HIST OTH CHAR IN; Chang C, 2015, J FIELD ACTIONS; Conference Outcome Documents, 2014, HLTH PROMOT INT S1, V29, pi19; Creswell JW, 2016, QUALITATIVE INQUIRY; Dainton C, INT HLTH; DiMatteo MR, 2007, MED CARE, V45, P521, DOI 10.1097/MLR.0b013e318032937e; Florez KR, 2009, J IMMIGR MINOR HEALT, V11, P291, DOI 10.1007/s10903-008-9118-6; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Hawkins J, 2013, J CHRIST NURS, V30, pE1, DOI 10.1097/CNJ.0b013e3182a5f6f7; Hayden J, 2017, INTRO HLTH BEHAV THE, P32; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jesus JE, 2010, ANN EMERG MED, V55, P17, DOI 10.1016/j.annemergmed.2009.07.014; Kennedy Betty M, 2017, Patient Exp J, V4, P29; Landsbergis PA, 2013, AM J PUBLIC HEALTH, V103, pE61, DOI 10.2105/AJPH.2012.301153; Lavigne E, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-5; Legido-Quigley H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122112; Li L, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/5024837; Lupoli CA, 2014, J SUSTAIN TOUR, V22, P898, DOI 10.1080/09669582.2013.879310; Nigenda G, 2001, SALUD PUBLICA MEXICO, V43, P41, DOI 10.1590/S0036-36342001000100006; Niu NN, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-228; O'Connor MK, 2002, SOCIAL WORKERS DESK, P775; Organizacion Panamericana de la Salud, IND BAS SAL REP DOM; Pan American Health Organization, 2014, PLAN ACT PREV CONTR; Pan American Health Organization, 2015, PAHO BAS HLTH IND DA; Roberts CK, 2002, CIRCULATION, V106, P2530, DOI 10.1161/01.CIR.0000040584.91836.0D; Sanon MA, 2016, J TRANSCULT NURS, V27, P147, DOI 10.1177/1043659614543476; Schumacher G, 2010, J TRANSCULT NURS, V21, P93, DOI 10.1177/1043659609357635; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; The Lancet HIV, 2015, LANCET HIV, V2, pe115; Tian ZX, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-56; Tlili F, 2015, INT J PUBLIC HEALTH, V60, pS31, DOI 10.1007/s00038-014-0572-8; Ventres W, 2014, ACAD MED, V89, P529, DOI 10.1097/ACM.0000000000000180; World Health Organization, 2019, HYPERTENSION; Worldbank, 2020, DAT WORLD DEV IND CO	40	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235088	10.1371/journal.pone.0235088	http://dx.doi.org/10.1371/journal.pone.0235088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME9KK	32574228	gold, Green Published			2022-12-27	WOS:000544972400015
J	Kigozi, G; Liu, CM; Park, D; Packman, ZR; Gray, RH; Kaul, R; Tobian, AAR; Abraham, AG; Ssekasanvu, J; Kagaayi, J; Prodger, JL				Kigozi, Godfrey; Liu, Cindy M.; Park, Daniel; Packman, Zoe R.; Gray, Ronald H.; Kaul, Rupert; Tobian, Aaron A. R.; Abraham, Alison G.; Ssekasanvu, Joseph; Kagaayi, Joseph; Prodger, Jessica L.			Foreskin surface area is not associated with sub-preputial microbiome composition or penile cytokines	PLOS ONE			English	Article							RISK HUMAN-PAPILLOMAVIRUS; MALE CIRCUMCISION; HIV ACQUISITION; YOUNG MEN; ORANGE FARM; RAKAI; PREVENTION; PREVALENCE; EXPRESSION; UGANDA	Objective Male circumcision (MC) reduces acquisition of HIV-1 in heterosexual men by at least 60%, but the biological mechanism for this protection is incompletely understood. Previous studies have shown that a larger foreskin size, increased abundance of anaerobic bacteria in the sub-preputial space, and higher levels of pro-inflammatory cytokines on the penis are all prospectively associated with risk of HIV-1 acquisition. Since coverage of the glans on the non-erect penis is dependent on foreskin size, a larger foreskin could result in a less aerobic environment that might preferentially support anaerobic bacterial growth and induce inflammation. We therefore assessed the relationship between foreskin size, penile microbiome composition and local inflammation. Methods This is a retrospective, cross-sectional analysis of 82 HIV-uninfected men who participated in a randomized trial of MC for HIV-1 prevention in Rakai, Uganda between 2003-2006. Sub-preputial swabs were collected prior to MC and assessed for cytokines (multiplexed immunosorbent assay) and bacterial load (qPCR) and taxon abundance (sequencing). Foreskin size was measured immediately after MC. Results Foreskin surface area did not correlate with total bacterial load (rho = 0.05) nor the abundance of key taxa of bacteria previously associated with HIV-1 risk (rho = 0.04-0.25). Foreskin surface area also did not correlate with sub-preputial cytokine concentrations previously associated with HIV-1 risk (IL-8 rho = 0.05). Conclusions Larger foreskin size is not associated with either increased penile anaerobes or pro-inflammatory cytokines. These data suggest that foreskin size does not increase HIV-1 risk through changes in penile microbiome composition or penile inflammation.	[Kigozi, Godfrey; Gray, Ronald H.; Tobian, Aaron A. R.; Ssekasanvu, Joseph; Kagaayi, Joseph] Rakai Hlth Sci Program, Kalisizo, Uganda; [Liu, Cindy M.; Park, Daniel] George Washington Univ, Dept Environm & Occupat Hlth, Milken Inst Sch Publ Hlth, Washington, DC USA; [Packman, Zoe R.; Tobian, Aaron A. R.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Gray, Ronald H.; Abraham, Alison G.; Ssekasanvu, Joseph] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada; [Abraham, Alison G.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Prodger, Jessica L.] Western Univ, Schulich Sch Med & Dent, Dept Microbiol & Immunol, London, ON, Canada; [Prodger, Jessica L.] Western Univ, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada; [Prodger, Jessica L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Rakai Health Sciences Program; George Washington University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Toronto; Johns Hopkins University; Western University (University of Western Ontario); Western University (University of Western Ontario); Johns Hopkins University	Prodger, JL (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Microbiol & Immunol, London, ON, Canada.; Prodger, JL (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada.; Prodger, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	jprodge@uwo.ca	Liu, Cindy/ABF-7427-2020	Kaul, Rupert/0000-0002-1586-4093; Prodger, Jessica/0000-0003-0805-4196	National Institutes of Health [R01AI128779, R01AI123002]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (www.nih.gov), grant numbers R01AI128779 (AT) and R01AI123002 (CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CLIN TRANSL GASTROEN, V4, pe39; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 2009, EUROPEAN J ENDOVASCU, V37, pS1; Arnold KB, 2016, MUCOSAL IMMUNOL, V9, P194, DOI 10.1038/mi.2015.51; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Backes DM, 2012, INT J CANCER, V130, P1888, DOI 10.1002/ijc.26196; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Borgdorff H, 2016, MUCOSAL IMMUNOL, V9, P621, DOI 10.1038/mi.2015.86; Carias AM, 2013, J VIROL, V87, P11388, DOI 10.1128/JVI.01377-13; Fahrbach KM, 2010, MUCOSAL IMMUNOL, V3, P410, DOI 10.1038/mi.2010.18; Gosmann C, 2017, IMMUNITY, V46, P29, DOI 10.1016/j.immuni.2016.12.013; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2010, J INFECT DIS, V201, P1455, DOI 10.1086/652184; Gray RH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000187; Kigozi G, 2009, AIDS, V23, P2209, DOI 10.1097/QAD.0b013e328330eda8; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; McClelland RS, 2018, LANCET INFECT DIS, V18, P554, DOI 10.1016/S1473-3099(18)30058-6; McKinnon LR, 2012, CURR OPIN HIV AIDS, V7, P195, DOI 10.1097/COH.0b013e3283504941; Prodger JL, 2014, MUCOSAL IMMUNOL, V7, P634, DOI 10.1038/mi.2013.83; Prodger JL, 2012, MUCOSAL IMMUNOL, V5, P121, DOI 10.1038/mi.2011.56; Prodger JL, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0167-6; Prodger JL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006025; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; Stieh DJ, 2016, CELL HOST MICROBE, V19, P529, DOI 10.1016/j.chom.2016.03.005; Tobian AAR, 2011, JAMA-J AM MED ASSOC, V306, P1479, DOI 10.1001/jama.2011.1431; 2015, CORSALUD, V6	29	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234256	10.1371/journal.pone.0234256	http://dx.doi.org/10.1371/journal.pone.0234256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574173	Green Published, gold			2022-12-27	WOS:000544972400045
J	Rubio, VJ; Quartiroli, A; Podlog, LW; Olmedilla, A				Rubio, Victor J.; Quartiroli, Alessadro; Podlog, Leslie W.; Olmedilla, Aurelio			Understanding the dimensions of sport-injury related growth: A DELPHI method approach	PLOS ONE			English	Article								Despite the multitude of adverse physical and psychosocial consequences of sports injury, evidence also highlights the potential for positive benefits in the injury aftermath. The purpose of this study is to address this gap by exploring the dimensions of personal growth following a severe sports injury. A 3-rounds e-Delphi method was utilized to develop a consensual understanding of the dimensions of sport-injury related growth. A panel of 24 psychology of sport injury experts participated in the process. The final list of items obtained was subjected to conventional content analysis to identify general themes. The process led to the development of a 5-dimension model capable of describing athletes' experiences of personal growth following a severe sports-related injury: personal strength, improved social life, health benefits, sport benefits, and social support and recognition. The domains of sport-injury related growth identified here are consistent with growth-domains identified in previous personal growth literature. However, they also highlight the importance of contextualizing the experience of growth. We have captured key elements of sport-injury related growth, domains that can be used as the basis for further psychometric testing and for further interventions to increase adjustment and well-being during the rehabilitation process.	[Rubio, Victor J.] Univ Autonoma Madrid, Dept Biol & Hlth Psychol, Madrid, Spain; [Quartiroli, Alessadro] Univ Wisconsin, Dept Psychol, La Crosse, WI 54601 USA; [Podlog, Leslie W.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Olmedilla, Aurelio] Univ Murcia, Dept Personal Evaluat & Psychol Treatment, Murcia, Spain	Autonomous University of Madrid; University of Wisconsin System; Utah System of Higher Education; University of Utah; University of Murcia	Rubio, VJ (corresponding author), Univ Autonoma Madrid, Dept Biol & Hlth Psychol, Madrid, Spain.	victor.rubio@uam.es	Rubio, Victor/B-7568-2011	Rubio, Victor/0000-0002-4943-3865				Almeida PL, 2014, REV PSICOL DEPORTE, V23, P395; Appaneal RN, 2009, J SPORT EXERCISE PSY, V31, P60, DOI 10.1123/jsep.31.1.60; Bauer R, 2009, INJURIES EUROPEAN UN; Bianco T, 1999, RES Q EXERCISE SPORT, V70, P157, DOI 10.1080/02701367.1999.10608033; Chou C, 2002, BRIT J EDUC TECHNOL, V33, P233, DOI 10.1111/1467-8535.00257; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Day MC, 2016, PSYCHOL SPORT EXERC, V22, P131, DOI 10.1016/j.psychsport.2015.07.004; Delbecq AL, 1975, J HUMAN SCI; Heil J, 1993, PSYCHOL SPORT INJURY, P33; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hurley O., 2007, SPORT EXERCISE PSYCH, V3, P14; Keeney S., 2011, DELPHI TECHNIQUE NUR; Ludwig B., 1997, J EXT, V35, P1; Martino J.P., 1983, TECHNOLOGICAL FORECA, V2nd ed.; Miles M.B., 2014, QUALITATIVE DATA ANA, V3rd ed.; Nixdorf I., 2015, Advances in Physical Education, V5, P255, DOI 10.4236/ape.2015.54030; Park C. L., 2006, HDB POSTTRAUMATIC GR, P47; Podlog L, 2014, PHYS MED REH CLIN N, V25, P915, DOI 10.1016/j.pmr.2014.06.011; Pujals C, 2016, REV PSICOL DEPORTE, V25, P271; Salim J, 2016, J APPL SPORT PSYCHOL, V28, P154, DOI 10.1080/10413200.2015.1086448; Salim J, 2015, PSYCHOL SPORT EXERC, V19, P10, DOI 10.1016/j.psychsport.2014.12.004; Schmidt RC, 1997, DECISION SCI, V28, P763, DOI 10.1111/j.1540-5915.1997.tb01330.x; Tamminen KA, 2013, PSYCHOL SPORT EXERC, V14, P28, DOI 10.1016/j.psychsport.2012.07.002; Tedeschi R.G., 1995, TRAUMA TRANSFORMATIO, V1st; Udry E, 1997, J SPORT EXERCISE PSY, V19, P229, DOI 10.1123/jsep.19.3.229; Vaismoradi M, 2016, J NUR ED PR, V6, P100, DOI DOI 10.5430/JNEP.V6N5P100; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Wadey R, 2016, SCAND J MED SCI SPOR, V26, P1132, DOI 10.1111/sms.12579; Wadey R, 2011, J APPL SPORT PSYCHOL, V23, P142, DOI 10.1080/10413200.2010.543119	29	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235149	10.1371/journal.pone.0235149	http://dx.doi.org/10.1371/journal.pone.0235149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME9KK	32574215	gold, Green Published			2022-12-27	WOS:000544972400039
J	Wang, YH; Zhen, C; Zhang, Z; Tao, ZC				Wang, Yanhua; Zhen, Cheng; Zhang, Zhan; Tao, Zhencheng			Corrosion behavior of an AZ91D magnesium alloy under a heterogeneous electrolyte layer	PLOS ONE			English	Article							ATMOSPHERIC CORROSION; MICROSTRUCTURE	The corrosion behavior of an AZ91D magnesium alloy was investigated under a heterogeneous electrolyte layer by using electrochemical methods and surface analysis techniques. Dynamic polarization curves and morphological characterization were obtained at the center and near the edge zones under the electrolyte layer. The influence of the gas/liquid/solid three-phase boundary zone (TPB) on the corrosion behavior of the AZ91D magnesium alloy was discussed. The corrosion rate changed more significantly near the TPB zone than that at the other zones. The AZ91D alloy exhibited the characteristics of filiform corrosion together with shallow pitting corrosion. Different from the randomly distributed shallow pits, the filiform corrosion preferred to initiate near the TPB region and then progressively expanded adjacent to the edge of the electrolyte layer. The TPB zone played a vital role in determining the corrosion location, the corrosion morphologies and the corrosion rate of the magnesium alloy by influencing the mass transport process of carbon dioxide.	[Wang, Yanhua; Zhen, Cheng; Zhang, Zhan] Ocean Univ China, Coll Chem & Chem Engn, Minist Educ, Key Lab Marine Chem Theory & Technol, Qingdao, Peoples R China; [Zhang, Zhan] Ocean Univ China, Lib, Qingdao, Peoples R China; [Tao, Zhencheng] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Tao, Zhencheng] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Tao, Zhencheng] Chinese Acad Sci, Ctr Ocean Mega Sci, Qingdao, Peoples R China	Ocean University of China; Ocean University of China; Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences	Wang, YH (corresponding author), Ocean Univ China, Coll Chem & Chem Engn, Minist Educ, Key Lab Marine Chem Theory & Technol, Qingdao, Peoples R China.; Tao, ZC (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.; Tao, ZC (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.; Tao, ZC (corresponding author), Chinese Acad Sci, Ctr Ocean Mega Sci, Qingdao, Peoples R China.	wyhazz@163.com; taozc@qdio.ac.cn	Wang, Yu/GZL-9655-2022; wang, yan/GSE-6489-2022; Wang, Yuan/HHC-1520-2022; Wang, Yanbo/HFZ-8018-2022; wang, yi/GVT-8516-2022; wangwangwang, yuanyaun/HHN-6432-2022; Wang, Yin/HCI-9352-2022	Zhencheng, TAO/0000-0002-5948-0171	National Natural Science Foundation of China (NSFC) [51131005]; National Key R&D Program of China [2017YFC1404402]; Science & Technology Basic Resources Investigation Program of China [2017FY100803]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Science & Technology Basic Resources Investigation Program of China	This research is supported by the National Natural Science Foundation of China (NSFC) (No. 51131005), the National Key R&D Program of China (No. 2017YFC1404402), and the Science & Technology Basic Resources Investigation Program of China (No. 2017FY100803).	[Anonymous], 2012, J ELECTROCHEM SOC, V159, pA1135; [Anonymous], 2014, J ELECTROCHEM SOC, V161, pF263; Cao FY, 2016, CORROS SCI, V111, P835, DOI 10.1016/j.corsci.2016.05.041; Chen C, 2010, MATER CORROS, V61, P388, DOI 10.1002/maco.200905330; Ding ZY, 2018, J MATER SCI TECHNOL, V34, P1550, DOI 10.1016/j.jmst.2018.05.014; Esmaily M, 2017, PROG MATER SCI, V89, P92, DOI 10.1016/j.pmatsci.2017.04.011; [高璐璐 Gao Lulu], 2013, [材料导报, Materials Review], V27, P31; Jiang J, 2009, ELECTROCHIM ACTA, V54, P1426, DOI 10.1016/j.electacta.2008.09.017; Jonsson M, 2007, CORROS SCI, V49, P1540, DOI 10.1016/j.corsci.2006.08.004; Jonsson M, 2006, CORROS SCI, V48, P1193, DOI 10.1016/j.corsci.2005.05.008; Lindstrom R, 2004, CORROS SCI, V46, P1141, DOI 10.1016/j.corsci.2003.09.010; Lindstrom R, 2002, J ELECTROCHEM SOC, V149, pB103, DOI 10.1149/1.1452115; Liu WJ, 2010, CORROS SCI, V52, P627, DOI 10.1016/j.corsci.2009.10.031; Mordike BL, 2001, MAT SCI ENG A-STRUCT, V302, P37, DOI 10.1016/S0921-5093(00)01351-4; Moulder J. F., 1992, HDB XRAY PHOTOELECTR, P261; Nie LL, 2019, INT J ELECTROCHEM SC, V14, P3095, DOI 10.20964/2019.03.07; Pardo A, 2008, ELECTROCHIM ACTA, V53, P7890, DOI 10.1016/j.electacta.2008.06.001; Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013; Wang YH, 2013, MATER CORROS, V64, P309, DOI 10.1002/maco.201106423; Xiong YL, 2008, APPL GEOCHEM, V23, P1634, DOI 10.1016/j.apgeochem.2007.12.035; Zhang RF, 2009, CORROS SCI, V51, P2820, DOI 10.1016/j.corsci.2009.08.009; Zhang T, 2008, ELECTROCHIM ACTA, V53, P7921, DOI 10.1016/j.electacta.2008.05.074; 2015, APPL SURF SCI, V347, P736	23	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234981	10.1371/journal.pone.0234981	http://dx.doi.org/10.1371/journal.pone.0234981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574186	Green Published, gold			2022-12-27	WOS:000544972400060
J	Mandalaywala, TM; Tai, C; Rhodes, M				Mandalaywala, Tara M.; Tai, Christine; Rhodes, Marjorie			Children's use of race and gender as cues to social status	PLOS ONE			English	Article							POWER; SEX; HEALTH; REPRESENTATION; ASPIRATIONS; STEREOTYPES; PERCEPTIONS; CATEGORIES; PREFERENCE; JUDGMENTS	Social hierarchies are ubiquitous and determine a range of developmental outcomes, yet little is known about when children develop beliefs about status hierarchies in their communities. The present studies (3.5-6.9 years;N= 420) found that children begin to use gender and race as cues to status in early childhood, but that gender and race related to different status dimensions and had different consequences for inter-group attitudes. Children expected boys to hold higher status as defined by access to resources and decision-making power (e.g., having more toys and choosing what other people play with) but did not expect boys to have more wealth overall. Gender-related status beliefs did not relate to gender-related social preferences; instead, children preferred members of their own gender, regardless of their status beliefs. In contrast, children expected White people to be wealthier than Black people, and among some populations of children, the belief that White people were higher status (as defined by access to resources and decision-making power) weakly related to pro-White bias. Children's status-expectations about others were unrelated to beliefs about their own status, suggesting children more readily apply category-based status beliefs to others than to themselves.	[Mandalaywala, Tara M.] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA; [Tai, Christine] Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA; [Rhodes, Marjorie] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Hawaii System; University of Hawaii Manoa; New York University	Mandalaywala, TM (corresponding author), Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA.	tmandalaywala@umass.edu			National Institutes of Health [25-91551-Q1567-F7819]; Eunice Kennedy Shriver National Institute for Child Health and Human Development	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The researchers involved in this project were funded under National Institutes of Health grant number: 25-91551-Q1567-F7819, from the Eunice Kennedy Shriver National Institute for Child Health and Human Development awarded to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahl RE, 2019, DEV PSYCHOL, V55, P303, DOI 10.1037/dev0000643; Ahl RE, 2019, CHILD DEV, V90, P524, DOI 10.1111/cdev.12922; Amir D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226550; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bernard S, 2016, J EXP CHILD PSYCHOL, V152, P307, DOI 10.1016/j.jecp.2016.08.007; Bian L, 2017, SCIENCE, V355, P389, DOI 10.1126/science.aah6524; Bigler RS, 2007, CURR DIR PSYCHOL SCI, V16, P162, DOI 10.1111/j.1467-8721.2007.00496.x; Bigler RS, 2003, DEV PSYCHOL, V39, P572, DOI 10.1037/0012-1649.39.3.572; Boseovski JJ, 2010, CHILD DEV PERSPECT, V4, P212, DOI 10.1111/j.1750-8606.2010.00149.x; Brey E, 2015, CHILD DEV, V86, P276, DOI 10.1111/cdev.12334; Carli LL, 1999, J SOC ISSUES, V55, P81, DOI 10.1111/0022-4537.00106; Charafeddine R, 2015, J COGN DEV, V16, P587, DOI 10.1080/15248372.2014.926269; Cheney DL., 2007, BABOON METAPHYSICS E, DOI [10.7208/chicago/9780226102429.001.0001, DOI 10.7208/CHICAGO/9780226102429.001.0001]; Cimpian A, 2014, BEHAV BRAIN SCI, V37, P461, DOI 10.1017/S0140525X13002197; COWAN G, 1986, SEX ROLES, V14, P211, DOI 10.1007/BF00288250; DeBell M, 2017, POLIT PSYCHOL, V38, P481, DOI 10.1111/pops.12342; Dunham Y, 2016, DEVELOPMENTAL SCI, V19, P781, DOI 10.1111/desc.12321; Dunham Y, 2015, DEVELOPMENTAL SCI, V18, P469, DOI 10.1111/desc.12228; Dunham Y, 2014, SOC COGNITION, V32, P1; Elenbaas L, 2019, J EXP CHILD PSYCHOL, V188, DOI 10.1016/j.jecp.2019.104667; Elenbaas L, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00884; FAGOT BI, 1992, DEV PSYCHOL, V28, P225, DOI 10.1037/0012-1649.28.2.225; Fiske ST, 2012, FACING SOCIAL CLASS: HOW SOCIETAL RANK INFLUENCES INTERACTION, P1; Fiske ST, 2016, CURR OPIN PSYCHOL, V11, P44, DOI 10.1016/j.copsyc.2016.05.012; Ghavami N, 2019, DEV PSYCHOL, V55, P457, DOI 10.1037/dev0000572; Gulgoz S, 2017, CHILD DEV, V88, P946, DOI 10.1111/cdev.12643; Hamilton D., 2015, UMBRELLAS DONT MAKE; JOST JT, 1994, BRIT J SOC PSYCHOL, V33, P1, DOI 10.1111/j.2044-8309.1994.tb01008.x; Kinzler KD, 2010, EUR J SOC PSYCHOL, V40, P581, DOI 10.1002/ejsp.739; KOLBE R, 1981, SOC PSYCHOL QUART, V44, P369, DOI 10.2307/3033906; Kraus MW, 2019, PERSPECT PSYCHOL SCI, V14, P899, DOI 10.1177/1745691619863049; Lei RF, CHILD DEV; Liben LS, 2001, J EXP CHILD PSYCHOL, V79, P346, DOI 10.1006/jecp.2000.2611; LoBue V., 2014, CHILD AFFECTIVE FACI; LoBue Vanessa, 2014, Front Psychol, V5, P1532, DOI 10.3389/fpsyg.2014.01532; Lu LF, 2017, COGN PROCESS, V18, P375, DOI 10.1007/s10339-017-0814-9; Mandalaywala TM, 2019, ENCY EVOLUTIONARY PS, P1, DOI [10.1007/978-3-319-16999-6_2628-1, DOI 10.1007/978-3-319-16999-6_2628-1]; Mandalaywala TM, 2017, BIENN M SOC RES CHIL; Mandalaywala TM, 2020, ADV CHILD DEV BEHAV; Marmot M., 2004, STATUS SYNDROME YOUR; Martin CL, 2002, PSYCHOL BULL, V128, P903, DOI 10.1037//0033-2909.128.6.903; Mascaro O, 2012, P NATL ACAD SCI USA, V109, P6862, DOI 10.1073/pnas.1113194109; Mattan BD, 2017, PERSPECT PSYCHOL SCI, V12, P468, DOI 10.1177/1745691616677828; Mistry RS, 2015, CHILD DEV, V86, P1653, DOI 10.1111/cdev.12407; Newheiser AK, 2014, DEV PSYCHOL, V50, P1081, DOI 10.1037/a0035054; Newheiser AK, 2012, J EXP SOC PSYCHOL, V48, P264, DOI 10.1016/j.jesp.2011.08.011; Olson KR, 2012, CHILD DEV, V83, P1884, DOI 10.1111/j.1467-8624.2012.01819.x; Peterson S.B., 1990, GENDER EDUC, V2, P185, DOI [DOI 10.1080/0954025900020204, https://doi.org/10.1080/0954025900020204]; Pun A, 2017, CHILD DEV PERSPECT, V11, P155, DOI 10.1111/cdep.12235; Raabe T, 2011, CHILD DEV, V82, P1715, DOI 10.1111/j.1467-8624.2011.01668.x; Radke MJ, 1950, J PSYCHOL, V29, P3, DOI 10.1080/00223980.1950.9712770; Rhodes M, 2009, COGNITIVE PSYCHOL, V59, P244, DOI 10.1016/j.cogpsych.2009.05.001; Rivenbark JG, 2019, DEV PSYCHOL, V55, P574, DOI 10.1037/dev0000551; Rose SJ, 2018, STILL AMMANS LABOR M; Shutts K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149360; Shutts K, 2015, CHILD DEV PERSPECT, V9, P262, DOI 10.1111/cdep.12154; Shutts K, 2013, J COGN DEV, V14, P35, DOI 10.1080/15248372.2011.638686; Singh-Manoux A, 2005, PSYCHOSOM MED, V67, P855, DOI 10.1097/01.psy.0000188434.52941.a0; Singh-Manoux A, 2003, SOC SCI MED, V56, P1321, DOI 10.1016/S0277-9536(02)00131-4; Sullivan L, 2015, RACIAL WEALTH GAP WH; Terrizzi BF, 2019, DEV PSYCHOL, V55, P793, DOI 10.1037/dev0000657; Thomas AJ, 2018, NAT HUM BEHAV, V2, P662, DOI 10.1038/s41562-018-0415-3; Thomsen L, 2011, SCIENCE, V331, P477, DOI 10.1126/science.1199198; WEINRAUB M, 1984, CHILD DEV, V55, P1493, DOI 10.2307/1130019; Weisman K, 2015, DEVELOPMENTAL SCI, V18, P1036, DOI 10.1111/desc.12269; WEITZMAN LJ, 1972, AM J SOCIOL, V77, P1125, DOI 10.1086/225261; Zinser O., 1981, MOTIV EMOTION, V5, P179, DOI [10.1007/BF00993896, DOI 10.1007/BF00993896]	67	33	33	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234398	10.1371/journal.pone.0234398	http://dx.doi.org/10.1371/journal.pone.0234398			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569267	gold, Green Published			2022-12-27	WOS:000543547900012
J	Marrero, H; Yagual, SN; Gamez, E; Urrutia, M; Diaz, JM; Beltran, D				Marrero, Hipolito; Yagual, Sara Nila; Gamez, Elena; Urrutia, Mabel; Diaz, Jose Miguel; Beltran, David			Negation interacts with motivational direction in understanding action sentences	PLOS ONE			English	Article							COMPREHENSION; AVOIDANCE	Linguistic negation acts by inhibiting the representation of information under its scope, often leading to the representation of positive alternative states of affairs. Motivational direction refers to approach/avoidance intentionality in our interactions with environmental stimuli expressed by means of verbs (e.g., "accept" vs "reject"). We consider it plausible that negation interacts with direction to represent the true motivation of the protagonist in sentence understanding (e.g., if an approach action is negated it is represented as avoidance). In the first study, we examine this interaction offline by asking participants to judge approach or avoidance meaning of affirmative (e.g., "he/she included/excluded meat") and negative sentences ("he/she did not include/exclude meat"). Results support that negation reversed participants' interpretation of sentence motivational direction. In a further study, we carried out two probe recognition experiments to examine the interaction during sentence comprehension; in both, the critical probe was the word referring to the target of the action (e.g., "meat"). In the first experiment, participants had to recognize the probe word presented 1500 milliseconds after sentence offset, while for the second one, the delay was 500 milliseconds. Results showed that at 1500 ms, target recognition took significantly more time for negated avoidance sentences than for the other conditions. Therefore, representing negated avoidance sentences seems to imply more complex processing, as avoidance verbs would be implicitly negative. By contrast, at the 500 ms delay, negation impaired target recognition for both approach and avoidance sentences, suggesting an unspecific inhibitory effect of negation at that sentence processing stage. Implication of these results for both research on negation and in action understanding are discussed.	[Marrero, Hipolito; Yagual, Sara Nila; Gamez, Elena; Diaz, Jose Miguel; Beltran, David] Univ La Laguna, Dept Psicol Cognit Social & Org, San Cristobal la Laguna, Spain; [Marrero, Hipolito; Yagual, Sara Nila; Gamez, Elena; Urrutia, Mabel; Diaz, Jose Miguel; Beltran, David] Univ La Laguna, Inst Neurociencias, San Cristobal la Laguna, Spain; [Yagual, Sara Nila] Univ Estatal Peninsula Santa Elena, Fac Ciencias Sociales & Salud, La Libertad, Ecuador; [Urrutia, Mabel] Univ Concepcion, Fac Educ, Concepcion, Chile	Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad de la Laguna; Universidad de Concepcion	Marrero, H (corresponding author), Univ La Laguna, Dept Psicol Cognit Social & Org, San Cristobal la Laguna, Spain.; Marrero, H (corresponding author), Univ La Laguna, Inst Neurociencias, San Cristobal la Laguna, Spain.	hmarrero@ull.es	Gámez, Elena/AAO-5466-2021; Marrero, Hipólito/R-2596-2019; Beltrán, David/K-9684-2014; Urrutia, Mabel/L-4282-2014	Marrero, Hipólito/0000-0002-6008-3587; Beltrán, David/0000-0003-1658-5915; Urrutia, Mabel/0000-0002-8475-1383	Spanish Ministry of Economy, Industry and Competitiveness [PSI2017-84527-P]; European Regional Development Funds	Spanish Ministry of Economy, Industry and Competitiveness; European Regional Development Funds(European Commission)	This study was supported by the Spanish Ministry of Economy, Industry and Competitiveness (Grant PSI2017-84527-P), and the European Regional Development Funds.	Amoruso L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00057; Austin K, 2014, DEV PSYCHOL, V50, P2061, DOI 10.1037/a0037179; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 2009, PHILOS T R SOC B, V364, P1281, DOI 10.1098/rstb.2008.0319; Beaupoil-Hourdel P, 2016, LANG COGN MIND, V1, P95, DOI 10.1007/978-3-319-17464-8_5; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; CHASE WG, 1971, BRIT J PSYCHOL, V62, P311, DOI 10.1111/j.2044-8295.1971.tb02042.x; Chen K., 2015, P NAT C UND RES NCUR, P401; Clark E.V., 1978, HUMAN GROWTH DEV, P85; CLARK HH, 1974, MEM COGNITION, V2, P101, DOI 10.3758/BF03197499; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Vega M, 2012, PSICOLOGICA, V33, P157; Dudschig C, 2018, J EXP PSYCHOL HUMAN, V44, P716, DOI 10.1037/xhp0000481; Elliot AJ, 2006, MOTIV EMOTION, V30, P111, DOI 10.1007/s11031-006-9028-7; Farshchi S., 2014, PROCESSING COST NEGA; Ferguson HJ, 2008, BRAIN RES, V1236, P113, DOI 10.1016/j.brainres.2008.07.099; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gamez E, 2001, DISCOURSE PROCESS, V31, P215, DOI 10.1207/S15326950dp31-3_1; Giora R, 2006, J PRAGMATICS, V38, P979, DOI 10.1016/j.pragma.2005.12.007; Giora R, 2005, FIGURATIVE LANGUAGE COMPREHENSION: SOCIAL AND CULTURAL INFLUENCES, P233; Horn L.R., 1989, NATURAL HIST NEGATIO; JUST MA, 1973, J VERB LEARN VERB BE, V12, P21, DOI 10.1016/S0022-5371(73)80057-X; Kaup B, 2003, J EXP PSYCHOL LEARN, V29, P439, DOI 10.1037/0278-7393.29.3.439; Kaup B., 2019, ISSUES PROCESSING NE; Kaup B., 2006, LANGUAGE MEMORY ASPE, P313; Kaup B, 2007, Q J EXP PSYCHOL, V60, P976, DOI 10.1080/17470210600823512; Kaup B, 2006, J PRAGMATICS, V38, P1033, DOI 10.1016/j.pragma.2005.09.012; Khemlani S, 2012, J COGN PSYCHOL, V24, P541, DOI 10.1080/20445911.2012.660913; Kizach J, 2016, J PSYCHOLINGUIST RES, V45, P753, DOI 10.1007/s10936-015-9370-6; Lewin K, 1933, HDB CHILD PSYCHOL, P591; Marrero H, 2017, COGN AFFECT BEHAV NE, V17, P612, DOI 10.3758/s13415-017-0500-5; Marrero H, 2015, CAN J EXP PSYCHOL, V69, P190, DOI 10.1037/cep0000046; OBLER LK, 1991, APPL PSYCHOLINGUIST, V12, P433, DOI 10.1017/S0142716400005865; Orenes I, 2014, J MEM LANG, V74, P36, DOI 10.1016/j.jml.2014.04.001; Peeters G., 1995, PERSPECTIVES NEGATIO, P123; SHERMAN MA, 1976, J VERB LEARN VERB BE, V15, P143, DOI 10.1016/0022-5371(76)90015-3; Tettamanti M, 2008, NEUROIMAGE, V43, P358, DOI 10.1016/j.neuroimage.2008.08.004; Xiang M, 2016, J NEUROLINGUIST, V38, P71, DOI 10.1016/j.jneuroling.2015.11.001; Zhou P, 2014, J EAST ASIAN LINGUIS, V23, P333, DOI 10.1007/s10831-013-9118-y; Zwaan R. A., 2004, PSYCHOL LEARNING MOT	40	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234304	10.1371/journal.pone.0234304	http://dx.doi.org/10.1371/journal.pone.0234304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569322	Green Published, gold			2022-12-27	WOS:000543547900044
J	Monroy-Perez, E; Ceron, AB; Cortes, LRG; Alonso, NN; Dominguez-Trejo, P; Hernandez-Jaimes, T; Bustos-Martinez, J; Hamdan-Partida, A; Jimenez, EAR; Vaca, S; Vaca-Paniagua, F; Paniagua-Contreras, GL				Monroy-Perez, Eric; Ceron, Areli Bautista; Garcia Cortes, Luis Rey; Alonso, Nancy Nolasco; Dominguez-Trejo, Pablo; Hernandez-Jaimes, Tania; Bustos-Martinez, Jaime; Hamdan-Partida, Aida; Rojas Jimenez, Ernesto Arturo; Vaca, Sergio; Vaca-Paniagua, Felipe; Paniagua-Contreras, Gloria Luz			Virulence gene transcription, phylogroups, and antibiotic resistance of cervico-vaginal pathogenicE.coliin Mexico	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAINS; MECHANISMS; EXPRESSION; WOMEN	The pathogenicity ofEscherichia colistrains that cause cervico-vaginal infections (CVI) is due to the presence of several virulence genes. The objective of this study was to define the variability regarding the genotype of antibiotic resistance, the transcription profiles of virulence genes after in vitro infection of the vaginal cell line A431 and the phylogroup composition of a group of cervico-vaginalE.colistrains (CVEC). A total of 200E.colistrains isolated from Mexican women with CVI from two medical units of the Mexican Institute of Social Security were analysed.E.colistrains and antibiotic resistance genes were identified using conventional polymerase chain reaction (PCR), and phylogroups were identified using multiplex PCR. Virulence gene transcription was measured through reverse-transcriptase real-time PCR after infection of the vaginal cell line A431. The most common antibiotic resistance genes among the CVEC strains wereaac(3)II, TEM,dfrA1,sul1, andqnrA. The predominant phylogroup was B2. The genes most frequently transcribed in these strains werefimH,papC,irp2,iroN,kpsMTII,cnf1, andompT, mainly in CVEC strains isolated from chronic and occasional vaginal infections. The strains showed a large diversity of transcription of the virulence genes phenotype and antibiotic resistance genotype, especially in the strains of phylogroups, B2, A, and D. The strains formed 2 large clusters, which contained several subclusters. The genetic diversity of CVEC strains was high. These strains have a large number of transcription patterns of virulence genes, and one-third of them carry three to seven antibiotic resistance genes.	[Monroy-Perez, Eric; Ceron, Areli Bautista; Hernandez-Jaimes, Tania; Vaca, Sergio; Paniagua-Contreras, Gloria Luz] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Tlalnepantla, Estado De Mexic, Mexico; [Garcia Cortes, Luis Rey; Alonso, Nancy Nolasco; Dominguez-Trejo, Pablo] Inst Mexicano Seguro Social, Mexico City, DF, Mexico; [Bustos-Martinez, Jaime; Hamdan-Partida, Aida] Univ Autonoma Metropolitana Xochimilco, Dept Atenc Salud, Mexico City, DF, Mexico; [Rojas Jimenez, Ernesto Arturo; Vaca-Paniagua, Felipe] Univ Nacl Autonoma Mexico, Fa Estudios Super Iztacala, Lab Nacl Salud Diagnost Mol & Efecto Ambiental En, Mexico City, DF, Mexico; [Rojas Jimenez, Ernesto Arturo; Vaca-Paniagua, Felipe] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Unidad Biomed, Mexico City, DF, Mexico; [Vaca-Paniagua, Felipe] Inst Nacl Cancerol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Mexicano del Seguro Social; Universidad Autonoma Metropolitana - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN)	Paniagua-Contreras, GL (corresponding author), Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Tlalnepantla, Estado De Mexic, Mexico.; Vaca-Paniagua, F (corresponding author), Univ Nacl Autonoma Mexico, Fa Estudios Super Iztacala, Lab Nacl Salud Diagnost Mol & Efecto Ambiental En, Mexico City, DF, Mexico.; Vaca-Paniagua, F (corresponding author), Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Unidad Biomed, Mexico City, DF, Mexico.; Vaca-Paniagua, F (corresponding author), Inst Nacl Cancerol, Mexico City, DF, Mexico.	felipe.vaca@gmail.com; mya@unam.mx	Bustos-Martínez, Jaime/AAN-8472-2020; Alonso, Nivaldo/D-2711-2012; Alonso, Nivaldo/AAB-4570-2021	Bustos-Martínez, Jaime/0000-0001-9763-754X; Alonso, Nivaldo/0000-0003-1532-9610; Alonso, Nivaldo/0000-0003-1532-9610; Nolasco-Alonso, Nancy/0000-0002-0175-6235; Rojas-Jimenez, Ernesto/0000-0003-2311-0205; HAMDAN-PARTIDA, AIDA/0000-0002-5827-3576	Universidad Nacional Autonoma de Mexico-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN216517 (UNAM-DGAPA-PAPIIT IN216517)]; Facultad de Estudios Superiores Iztacala-DIP-Programa de Apoyo a Profesores de Carrera-2016-5 [FESI-DIPPAPCA-2016-5]	Universidad Nacional Autonoma de Mexico-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica; Facultad de Estudios Superiores Iztacala-DIP-Programa de Apoyo a Profesores de Carrera-2016-5	This investigation was funded by Universidad Nacional Autonoma de Mexico-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica IN216517 (UNAM-DGAPA-PAPIIT IN216517) and Facultad de Estudios Superiores Iztacala-DIP-Programa de Apoyo a Profesores de Carrera-2016-5 (FESI-DIPPAPCA-2016-5).	Abreu AG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00452; Adamus-Bialek W, 2018, MOL BIOL REP, V45, P1055, DOI 10.1007/s11033-018-4254-0; Al-Agamy MH, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-4; Ali ASM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10445-4; [Anonymous], 2017, CATHOLIC HIST REV, V103, P1, DOI 10.1353/cat.2017.0000; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Bubpamala J, 2018, INFECT DRUG RESIST, V11, P2151, DOI 10.2147/IDR.S174506; Cheng G, 2005, INFECT IMMUN, V73, P1656, DOI 10.1128/IAI.73.3.1656-1663.2005; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Cyoia PS, 2015, J INFECT DEV COUNTR, V9, P1068, DOI 10.3855/jidc.6683; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Domingues Sara, 2012, Mob Genet Elements, V2, P211; Floyd KA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004697; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Blancarte-Lagunas MI, 2020, J INFECT DEV COUNTR, V14, P48, DOI 10.3855/jidc.11940; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Kaczmarek A, 2014, FOLIA MICROBIOL, V59, P419, DOI 10.1007/s12223-014-0315-5; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Paniagua-Contreras GL, 2019, J INFECT CHEMOTHER, V25, P494, DOI 10.1016/j.jiac.2019.02.004; Paniagua-Contreras GL, 2018, PATHOG GLOB HEALTH, V112, P415, DOI 10.1080/20477724.2018.1547542; Molina L, 2011, J INFECT DEV COUNTR, V5, P840; Momtaz H, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-8; Morales-Espinosa R, 2016, J INFECT DEV COUNTR, V10, P317, DOI 10.3855/jidc.6652; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; Ngonzi J, 2018, INT J MICROBIOL, V2018, DOI 10.1155/2018/6579139; Norinder BS, 2011, INFECTION, V39, P571, DOI 10.1007/s15010-011-0199-0; Paniagua-Contreras GL, 2017, J MICROBIOL IMMUNOL, V50, P478, DOI 10.1016/j.jmii.2015.08.005; Raeispour M, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0411-4; Ramirez-Castillo FY, 2018, ANN CLIN MICROB ANTI, V17, DOI 10.1186/s12941-018-0286-5; Ranjit E, 2018, INT J MICROBIOL, V2018, DOI 10.1155/2018/8349601; Rashki A, 2014, MICROB PATHOGENESIS, V75, P29, DOI 10.1016/j.micpath.2014.08.004; Saenz Y, 2004, ANTIMICROB AGENTS CH, V48, P3996, DOI 10.1128/AAC.48.10.3996-4001.2004; Saghafi N, 2018, INT J REPROD BIOMED, V16, P341; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Song Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00949; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Van TTH, 2008, INT J FOOD MICROBIOL, V124, P217, DOI 10.1016/j.ijfoodmicro.2008.03.029; Wang C, 2020, DIAGN MICR INFEC DIS, V96, DOI 10.1016/j.diagmicrobio.2019.114981; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	40	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234730	10.1371/journal.pone.0234730	http://dx.doi.org/10.1371/journal.pone.0234730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569308	Green Published, gold			2022-12-27	WOS:000543547900039
J	Yazdani, A; Hohne, GWH; Misture, ST; Graeve, OA				Yazdani, Arash; Hoehne, Guenther W. H.; Misture, Scott T.; Graeve, Olivia A.			A method to quantify crystallinity in amorphous metal alloys: A differential scanning calorimetry study	PLOS ONE			English	Article							ELECTRON BACKSCATTER DIFFRACTION; STRUCTURAL RELAXATION; GLASS-TRANSITION; CRYSTALLIZATION KINETICS; INITIAL CRYSTALLINITY; SPECIMEN PREPARATION; MICROSTRUCTURE; BEHAVIORS; POLYMERS; LIQUID	We developed and describe a differential scanning calorimetry method for calculating the initial crystallinity, change of crystallinity and crystallinity percentage of amorphous metal alloys as a function of temperature. Using thermodynamic enthalpies of amorphous, crystalline and partially devitrified specimens, our methodology is capable of determining crystallinity percentages as low as a few percent. Moreover, the linear relationship between the set (pre-determined) and calculated crystallinities of experimental samples indicates that there is no need to prepare calibration samples before measuring the crystallinity percentage of target samples. This technique also eliminates the need for expensivein situaccessories, such as those required in electron microscopy. Thus, the technique is highly relevant as a primary technique for characterization of devitrification behavior in amorphous materials.	[Yazdani, Arash; Graeve, Olivia A.] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Hoehne, Guenther W. H.] Univ Ulm, Ulm, Germany; [Misture, Scott T.] Alfred Univ, Kazuo Inamori Sch Engn, Alfred, NY 14802 USA	University of California System; University of California San Diego; Ulm University; State University of New York (SUNY) System; Alfred University	Graeve, OA (corresponding author), Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA.	ograeve@ucsd.edu		Graeve, Olivia/0000-0003-3599-0502	Defense Threat Reduction Agency [HDTRA1-11-1-0067]; TA Instruments, Inc.	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); TA Instruments, Inc.	This work was funded by project HDTRA1-11-1-0067 from the Defense Threat Reduction Agency (https://www.dtra.mil/) awarded to OAG. TA Instruments, Inc. provided technical support. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthanarayanan A, 2011, CRIT REV SOLID STATE, V36, P229, DOI 10.1080/10408436.2011.593643; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; Axinte E, 2011, MATER DESIGN, V32, P1717, DOI 10.1016/j.matdes.2010.11.057; Bennett TD, 2018, NAT REV MATER, V3, P431, DOI 10.1038/s41578-018-0054-3; Biswas D, 2019, J NON-CRYST SOLIDS, V510, P101, DOI 10.1016/j.jnoncrysol.2019.01.013; Bouvard JL, 2009, J ENG MATER-T ASME, V131, DOI 10.1115/1.3183779; Brittain H.G, 1995, PHYS CHARACTERIZATIO, P187; CHEN HS, 1978, J APPL PHYS, V49, P3289, DOI 10.1063/1.325279; Chen YM, 2019, CRYST GROWTH DES, V19, P1103, DOI 10.1021/acs.cgd.8b01608; Cheng IC, 2018, ADV ENG MATER, V20, DOI 10.1002/adem.201800023; Dittmer M, 2012, J BIOMED MATER RES B, V100B, P463, DOI 10.1002/jbm.b.31972; EGAMI T, 1978, MATER RES BULL, V13, P557, DOI 10.1016/0025-5408(78)90178-2; Eggleton BJ, 2011, NAT PHOTONICS, V5, P141, DOI [10.1038/nphoton.2011.309, 10.1038/NPHOTON.2011.309]; European Union, 2016, OFFICIAL J EUROPEAN, DOI DOI 10.2873/84730; Ferrer G, 2017, J ENERGY STORAGE, V11, P1, DOI 10.1016/j.est.2017.02.002; Frankel GS, 2018, MAT DEGRAD, V2, P1, DOI [10.1038/s41529-017-0021-2, DOI 10.1038/s41529-018-0037-2]; Graeve OA, 2008, MATER LETT, V62, P2988, DOI 10.1016/j.matlet.2008.01.092; Greer AL, 1993, STRUCTURAL RELAXATIO; HANCOCK BC, 1995, PHARMACEUT RES, V12, P799, DOI 10.1023/A:1016292416526; Hasegawa R, 2001, J NON-CRYST SOLIDS, V287, P405, DOI 10.1016/S0022-3093(01)00633-0; Hegedus J, 2008, NAT MATER, V7, P399, DOI 10.1038/nmat2157; HERMANS PH, 1950, J POLYM SCI, V5, P269, DOI 10.1002/pol.1950.120050301; HERMANS PH, 1948, J APPL PHYS, V19, P491, DOI 10.1063/1.1698162; Hohne GWH, 2003, DIFFERENTIAL SCANNIN; Hua NB, 2018, J ALLOY COMPD, V745, P111, DOI 10.1016/j.jallcom.2018.02.138; Huang L, 2015, ACTA BIOMATER, V25, P356, DOI 10.1016/j.actbio.2015.07.012; Huang YJ, 2009, J ALLOY COMPD, V479, P121, DOI 10.1016/j.jallcom.2008.12.074; Inoue A, 2005, P JPN ACAD B-PHYS, V81, P172, DOI 10.2183/pjab.81.172; Irifune T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13753; Jafary-Zadeh M, 2018, J FUNCT BIOMATER, V9, DOI 10.3390/jfb9010019; JCGM, 2008, EV MEAS DAT GUID EXP; Johnson WA, 1939, T AM I MIN MET ENG, V135, P416; Johnson WL, 2002, JOM-J MIN MET MAT S, V54, P40, DOI 10.1007/BF02822619; Katrakova D, 2002, PRAKT METALLOGR-PR M, V39, P644; Katrakova D, 2001, PRAKT METALLOGR-PR M, V38, P547; Kelly JP, 2015, JOM-US, V67, P29, DOI 10.1007/s11837-014-1202-x; Lei C, 2013, MICROSYST TECHNOL, V19, P167, DOI 10.1007/s00542-012-1523-z; Leshchyns'ka I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6427537; Lewandowski JJ, 2005, PHIL MAG LETT, V85, P77, DOI 10.1080/09500830500080474; Li JY, 2019, ADV MATER, V31, DOI 10.1002/adma.201802120; Lin CG, 2018, PROG MATER SCI, V93, P1, DOI 10.1016/j.pmatsci.2017.11.001; Loke D, 2012, SCIENCE, V336, P1566, DOI 10.1126/science.1221561; Meagher P, 2016, ADV MATER, V28, P5755, DOI 10.1002/adma.201505347; Novitskaya E, 2018, MAT SCI ENG A-STRUCT, V717, P62, DOI 10.1016/j.msea.2018.01.076; Nowell MM, 2015, MICROSC MICROANAL, V11, P504, DOI [10.1017/s1431927698980485, DOI 10.1017/S1431927698980485]; Nunes C, 2005, PHARM RES-DORDR, V22, P1942, DOI 10.1007/s11095-005-7626-9; Paul T, 2018, J ALLOY COMPD, V753, P679, DOI 10.1016/j.jallcom.2018.04.133; RAY CS, 1991, J AM CERAM SOC, V74, P60, DOI 10.1111/j.1151-2916.1991.tb07297.x; Roura P, 2011, THERMOCHIM ACTA, V522, P161, DOI 10.1016/j.tca.2011.02.014; SALEKIGERHARDT A, 1994, INT J PHARM, V101, P237, DOI 10.1016/0378-5173(94)90219-4; SAUERBRUNN S, 1995, AM LAB, V27, P19; Schawe JEK, 2002, J THERM ANAL CALORIM, V68, P741, DOI 10.1023/A:1016033012403; Schawe JEK, 2017, THERMOCHIM ACTA, V657, P151, DOI 10.1016/j.tca.2017.09.006; Shamblin SL, 1998, PHARMACEUT RES, V15, P1828, DOI 10.1023/A:1011997721086; Sharma E, 2019, PHYSICA B, V562, P100, DOI 10.1016/j.physb.2019.03.019; Slipenyuk A, 2004, SCRIPTA MATER, V50, P39, DOI 10.1016/j.scriptamat.2003.09.038; Smith DS, 2017, NUCL ENG DES, V322, P331, DOI 10.1016/j.nucengdes.2017.07.016; Sreekanth KV, 2019, ADV OPT MATER, V7, DOI 10.1002/adom.201900081; Stephenson GA, 2001, ADV DRUG DELIVER REV, V48, P67, DOI 10.1016/S0169-409X(01)00099-0; Surana R, 2004, PHARM RES-DORDR, V21, P1167, DOI 10.1023/B:PHAM.0000033003.17251.c3; Trexler MM, 2010, PROG MATER SCI, V55, P759, DOI 10.1016/j.pmatsci.2010.04.002; VANDENBEUKEL A, 1990, ACTA METALL MATER, V38, P383, DOI 10.1016/0956-7151(90)90142-4; VANDENBEUKEL A, 1983, ACTA METALL MATER, V31, P419, DOI 10.1016/0001-6160(83)90219-5; Vasic MM, 2018, J NON-CRYST SOLIDS, V500, P326, DOI 10.1016/j.jnoncrysol.2018.08.017; Wang DJ, 2013, MAT SCI ENG A-STRUCT, V560, P841, DOI 10.1016/j.msea.2012.10.067; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Wuttig M, 2007, NAT MATER, V6, P824, DOI 10.1038/nmat2009; Xu YB, 2019, J MATER RES TECHNOL, V8, P2486, DOI 10.1016/j.jmrt.2019.02.007; Yodoshi N, 2014, J ALLOY COMPD, V615, pS61, DOI 10.1016/j.jallcom.2013.12.256; Zhou X, 2013, CORROSION-US, V69, P781, DOI 10.5006/0870; Zhou X, 2018, SOLID EARTH SCI, V3, P16, DOI 10.1016/j.sesci.2017.12.002; Zhukova V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21356-3	73	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234774	10.1371/journal.pone.0234774	http://dx.doi.org/10.1371/journal.pone.0234774			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569283	Green Published, gold			2022-12-27	WOS:000543547900040
J	Hayashi, H; Yamashita, Y; Okabe, H; Imai, K; Higashi, T; Yamamura, K; Chikamoto, A; Beppu, T; Takamori, H; Baba, H				Hayashi, Hiromitsu; Yamashita, Yo-ichi; Okabe, Hirohisa; Imai, Katsunori; Higashi, Takaaki; Yamamura, Kensuke; Chikamoto, Akira; Beppu, Toru; Takamori, Hiroshi; Baba, Hideo			Varied application of intercostal trans-diaphragmatic ports for laparoscopic hepatectomy	PLOS ONE			English	Article							RESECTION; TROCARS	Background The ribcage and diaphragm are mechanical barriers for laparoscopic access during hepatectomy. Here, we introduce the varied application of intercostal trans-diaphragmatic ports during laparoscopic hepatectomy, and describe the management of intercostal ports with key technical points. Methods From January 2013 to December 2017, 180 patients underwent laparoscopic hepatectomy. In 32 of these patients (17.8%), intercostal ports (31 right and one left) were applied, and we analyzed the feasibility and safety of intercostal ports during laparoscopic hepatectomy. Results The main tumor location was segment VII and VIII (78%). The major type of laparoscopic hepatectomy was partial hepatectomy (91%). In the majority of cases (66%) the number and size of intercostal trocars was a single 5-mm port. The median operative time and blood loss were 232 min and 50 mL, respectively. A chest drain was placed via the hole of the intercostal port on the chest wall in two cases (6.3%). The median duration of the post-operative hospital stay was 6 days. There was no conversion, and a pure laparoscopic hepatectomy was achieved in all cases. There was no mortality. As for complications due to the application of intercostal ports, an asymptomatic pneumothorax was detected in only one case, and it was cured by conservative treatment. Conclusions The ribcage and diaphragm could be overcome as barriers to laparoscopic access by the placement of intercostal ports with minimal access during laparoscopic hepatectomy. The use of an intercostal port and proper management allows for a feasible approach and safe resection during laparoscopic hepatectomy.	[Hayashi, Hiromitsu; Yamashita, Yo-ichi; Okabe, Hirohisa; Imai, Katsunori; Higashi, Takaaki; Yamamura, Kensuke; Chikamoto, Akira; Baba, Hideo] Kumamoto Univ, Dept Gastroenterol Surg, Kumamoto, Japan; [Beppu, Toru] Yamaga City Hosp, Dept Surg, Kumamoto, Japan; [Takamori, Hiroshi] Saiseikai Kumamoto Hosp, Imperial Gift Fdn, Dept Surg, Kumamoto, Japan	Kumamoto University; Saiseikai Kumamoto Hospital	Hayashi, H (corresponding author), Kumamoto Univ, Dept Gastroenterol Surg, Kumamoto, Japan.	hhayasi@kumamoto-u.ac.jp		Hayashi, Hiromitsu/0000-0002-1832-4287				[Anonymous], 2015, NICOTINE TOB RES, V17, P299, DOI [10.1093/ntr/ntu144, DOI 10.1093/NTR/NTU144]; [Anonymous], 2014, NYU ENVTL LJ, V21; Ban D, 2014, J HEPATO-BIL-PAN SCI, V21, P745, DOI 10.1002/jhbp.166; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Hirokawa F, 2017, WORLD J SURG, V41, P1340, DOI 10.1007/s00268-016-3867-5; Ichida H, 2017, SURG ENDOSC, V31, P1280, DOI 10.1007/s00464-016-5107-3; Xiao L, 2015, SURG ENDOSC, V29, P2994, DOI 10.1007/s00464-015-4214-x	7	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234919	10.1371/journal.pone.0234919	http://dx.doi.org/10.1371/journal.pone.0234919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559223	Green Published, gold			2022-12-27	WOS:000543261600018
J	Kataria, J; Garner, LJ; Monu, EA; Wang, YF; Morey, A				Kataria, Jasmine; Garner, Laura J.; Monu, Emefa A.; Wang, Yifen; Morey, Amit			Investigating the effects of Functional Ice (FICE) onSalmonella-food safety, microbial spoilage and quality of raw poultry thigh meat during refrigerated storage	PLOS ONE			English	Article							SODIUM LACTATE; LISTERIA-MONOCYTOGENES; SHELF-LIFE; LACTIC-ACID; OBJECTIVE CHARACTERISTICS; BINDING-PROPERTIES; BREAST FILLETS; PERACETIC-ACID; TRIPOLYPHOSPHATE; SALMONELLA	In meat processing, antimicrobial treatment applied during slaughter and deboning may not control pathogens and spoilage organisms during subsequent transportation and storage. "Functional Ice" (FICE), an innovation over traditional ice, was investigated for its effects on food safety, shelf life, and quality of raw poultry thigh meat during refrigerated storage. FICE was prepared by freezing aqueous solutions of sodium tripolyphosphate (STPP) (2.5% and 5% w/v) and sodium lactate-sodium diacetate (SL-SD) (1% and 2.5% v/v). Potable water was used to prepare ice for the control treatment. Thigh meat inoculated withSalmonellaTyphimurium (10(8)CFU/sample) was placed in FICE treatments, stored at 4 degrees C and sampled at 0, 12, 24, 36 and 48 h (n = 375). Weight pick-up was recorded for the uninoculated thighs. Additionally, shelf life and quality were evaluated for 8 days on tray-packed thighs that were stored in FICE treatments for 48 h (STPP 5%, and SL-SD 2.5%). Differences among treatments were determined using ANOVA with LSMeans (p <= 0.05). Results indicated that inoculated thighs stored in individual STPP 5%, and SL-SD 2.5% treatments lead to a significant reduction inSalmonellaTyphimurium compared to the control (p <= 0.05) after 48 h of storage. FICE treated thighs showed higher yields, lower cook loss, and an extended shelf life of 1-2 days, without any color changes. FICE has the potential to improve food safety and shelf life while improving the yields and quality during storage and transportation of raw poultry meat.	[Kataria, Jasmine; Garner, Laura J.; Monu, Emefa A.; Morey, Amit] Auburn Univ, Dept Poultry Sci, Auburn, AL 36849 USA; [Wang, Yifen] Auburn Univ, Dept Biosyst Engn, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Morey, A (corresponding author), Auburn Univ, Dept Poultry Sci, Auburn, AL 36849 USA.	azm0011@auburn.edu		Morey, Amit/0000-0003-4726-8322	Alabama Agricultural Experiment Station (AAES); Hatch program of the National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture	Alabama Agricultural Experiment Station (AAES); Hatch program of the National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture	The research was supported through a grant award to Dr. Amit Morey from the Alabama Agricultural Experiment Station (AAES) and the Hatch program of the National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture. The funding agency did not make any decision or influence any decision on the experiment, experiment design, data collection, and where we can publish the manuscript.; This research was supported by Alabama Agricultural Experiment Station (AAES) and the Hatch program of the National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture.	Alvarado C, 2007, J APPL POULTRY RES, V16, P113, DOI 10.1093/japr/16.1.113; Baptista RC, 2020, FOOD RES INT, V127, DOI 10.1016/j.foodres.2019.108762; Bauermeister LJ, 2008, POULTRY SCI, V87, P2390, DOI 10.3382/ps.2008-00087; Bragg RJ, 2003, SAN ANTONIO EXPRESS, P1; Bunkova L., 2008, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V56, P19; Carroll CD, 2007, POULTRY SCI, V86, P150, DOI 10.1093/ps/86.1.150; Centers for Disease Control and Prevention, 2018, OUTBR SALM INF LINK; Cheng Q, 2008, CRIT REV FOOD SCI, V48, P137, DOI 10.1080/10408390601177647; DICKSON JS, 1992, J FOOD PROTECT, V55, P133, DOI 10.4315/0362-028X-55.2.133; Dominguez SA, 2009, J FOOD PROTECT, V72, P2088, DOI 10.4315/0362-028X-72.10.2088; ELLIOTT RP, 1964, APPL MICROBIOL, V12, P517, DOI 10.1128/AEM.12.6.517-522.1964; Fletcher DL, 2002, WORLD POULTRY SCI J, V58, P131, DOI 10.1079/WPS20020013; FOSTER RD, 1976, J APPL BACTERIOL, V41, P505, DOI 10.1111/j.1365-2672.1976.tb00663.x; Fratamico PM, 2012, J FOOD SCI, V77, pM285, DOI 10.1111/j.1750-3841.2012.02682.x; FRONING GW, 1965, POULTRY SCI, V44, P1104, DOI 10.3382/ps.0441104; Graham J, 1992, ICE FISHERIES; Harvey MS, 2007, United States Patent Application Publication, Patent No. [US 2007/0184155 A1, 20070184155]; Hill J. C., 1988, U.S. Patent, Patent No. [4,770,884., 4770884]; Jeyasekaran G., 2004, Innovative Food Science & Emerging Technologies, V5, P485, DOI 10.1016/j.ifset.2004.06.003; Kin S, 2011, J FOOD SCI, V76, pS242, DOI 10.1111/j.1750-3841.2011.02122.x; LAMBERT AD, 1991, FOOD MICROBIOL, V8, P267, DOI 10.1016/S0740-0020(05)80002-4; Lee N, 2015, POULTRY SCI, V94, P302, DOI 10.3382/ps/peu063; LEE RM, 1994, J FOOD PROTECT, V57, P289, DOI 10.4315/0362-028X-57.4.289; LEE RM, 1994, J FOOD PROTECT, V57, P276, DOI 10.4315/0362-028X-57.4.276; Li B, 2018, IEEE T RELIAB, V67, P1, DOI DOI 10.15585/MMWR.SS6706A1; Mbandi E, 2001, J FOOD PROTECT, V64, P640, DOI 10.4315/0362-028X-64.5.640; Morey A, 2014, J NUTR HLTH FOOD ENG, V1, P25, DOI [10.15406/jnhfe.2014.01.00005, DOI 10.15406/JNHFE.2014.01.00005]; Morey A, 2014, J FOOD SCI, V79, pM54, DOI 10.1111/1750-3841.12220; Nagel GM, 2013, INT J FOOD MICROBIOL, V165, P281, DOI 10.1016/j.ijfoodmicro.2013.05.016; PALUMBO SA, 1986, J FOOD PROTECT, V49, P1003, DOI 10.4315/0362-028X-49.12.1003; PAPADOPOULOS LS, 1991, J FOOD SCI, V56, P341, DOI 10.1111/j.1365-2621.1991.tb05276.x; Pechacek N, 2015, TOXICOL LETT, V233, P45, DOI 10.1016/j.toxlet.2014.12.014; Pintar K, 2007, J FOOD PROTECT, V70, P739, DOI 10.4315/0362-028X-70.3.739; RATHGEBER BM, 1995, J FOOD PROTECT, V58, P530, DOI 10.4315/0362-028X-58.5.530; Rouger A, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030050; Saha A, 2009, POULTRY SCI, V88, P1250, DOI 10.3382/ps.2008-00236; SALMOND CV, 1984, J GEN MICROBIOL, V130, P2845; Shafit HM, 2010, POULTRY SCI, V89, P594, DOI 10.3382/ps.2009-00412; Shekarforoush SS, 2015, INT J BIOL MACROMOL, V76, P303, DOI 10.1016/j.ijbiomac.2015.02.033; SHELEF LA, 1994, J FOOD PROTECT, V57, P445, DOI 10.4315/0362-028X-57.5.445; Smaoui S, 2011, AFR J BIOTECHNOL, V10, P11317; Smith DP, 2007, POULTRY SCI, V86, P2666, DOI 10.3382/ps.2007-00144; Vareltzis K, 1997, FOOD SCI TECHNOL-LEB, V30, P665; Williams SK, 1998, POULTRY SCI, V77, P765, DOI 10.1093/ps/77.5.765; WILLIAMS SK, 1995, J FOOD SCI, V60, P636, DOI 10.1111/j.1365-2621.1995.tb09845.x; Wynveen EJ, 2001, J FOOD SCI, V66, P886, DOI 10.1111/j.1365-2621.2001.tb15191.x; Young LL, 1997, POULTRY SCI, V76, P1587, DOI 10.1093/ps/76.11.1587; YOUNG LL, 1987, J FOOD SCI, V52, P571, DOI 10.1111/j.1365-2621.1987.tb06677.x; ZEITOUN AAM, 1992, INT J FOOD MICROBIOL, V16, P89, DOI 10.1016/0168-1605(92)90001-J; 2000, FED REG, V65, P3121	50	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234781	10.1371/journal.pone.0234781	http://dx.doi.org/10.1371/journal.pone.0234781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559209	gold, Green Published			2022-12-27	WOS:000543261600061
J	Soos, J; Resch, MD; Berko, S; Kovacs, A; Katona, G; Facsko, A; Csanyi, E; Budai-Szucs, M				Soos, Judit; Resch, Miklos D.; Berko, Szilvia; Kovacs, Anita; Katona, Gabor; Facsko, Andrea; Csanyi, Erzsebet; Budai-Szucs, Maria			Comparison of hydrophilic ophthalmic media on silicone oil emulsification	PLOS ONE			English	Article							INTRAOCULAR SILICONE; COMPLICATIONS; REPLACEMENT; EYES	The aim of this study was to investigate whether and how the biological media which are in contact with silicone oil play a role in the silicone emulsification process. Commercially available Oxane 1300 silicone oil and potential hydrophilic phases of the emulsions in the eye (porcine aqueous humor, porcine vitreous and balanced salt solution) were investigated separately and in a mixture or emulsions by means of surface tension, rheological, zeta potential measurements and microscopic investigation. The surface tension of biological media (vitreous and aqueous humor) was significantly lower than that of non-biological media, especially in the case of aqueous humor, which indicates a remarkable emulsification tendency with these phases. The biological media are able to form both oil-in-water and water-in-oil emulsions, which can be observed in the clinical practice as well. It was established that the vitreous has a more expressed emulsification ability compared with the aqueous humor because smaller and more stable droplets can form with silicon oil when the vitreous is still there. It can be concluded that the vitreous has a higher impact on emulsification than the aqueous medium, which can predict that the vitreous remaining after vitrectomy has a key role in emulsion formation in the eye with silicone oil endotamponade.	[Soos, Judit; Facsko, Andrea] Univ Szeged, Dept Ophthalmol, Szeged, Hungary; [Soos, Judit] Univ Szeged, Doctoral Sch Clin Med, Szeged, Hungary; [Resch, Miklos D.] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary; [Berko, Szilvia; Kovacs, Anita; Katona, Gabor; Csanyi, Erzsebet; Budai-Szucs, Maria] Univ Szeged, Dept Pharmaceut Technol & Regulatory Affairs, Szeged, Hungary	Szeged University; Szeged University; Semmelweis University; Szeged University	Csanyi, E (corresponding author), Univ Szeged, Dept Pharmaceut Technol & Regulatory Affairs, Szeged, Hungary.	csanyi@pharm.u-szeged.hu	Berkó, Szilvia/AFM-7458-2022; Katona, Gabor/AFE-0796-2022	Berkó, Szilvia/0000-0002-3842-8876; Katona, Gabor/0000-0003-1564-4813	University of Szeged Open Access Fund [4520]	University of Szeged Open Access Fund	The publication was supported by The University of Szeged Open Access Fund (Fund Ref, Grant No. 4520) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMALY MF, 1962, ARCH OPHTHALMOL-CHIC, V68, P390, DOI 10.1001/archopht.1962.00960030394013; Azen SP, 1998, OPHTHALMOLOGY, V105, P1587, DOI 10.1016/S0161-6420(98)99023-6; Brunner S, 2011, GRAEF ARCH CLIN EXP, V249, P29, DOI 10.1007/s00417-010-1464-0; Chan YK, 2017, ACTA OPHTHALMOL, V95, pE385, DOI 10.1111/aos.13258; Chan YK, 2011, INVEST OPHTH VIS SCI, V52, P9721, DOI 10.1167/iovs.11-8586; CIBIS PA, 1962, ARCH OPHTHALMOL-CHIC, V68, P590; de Silva DJ, 2005, BRIT J OPHTHALMOL, V89, P1348, DOI 10.1136/bjo.2004.063768; FEDERMAN JL, 1988, OPHTHALMOLOGY, V95, P870, DOI 10.1016/s0161-6420(88)33080-0; Halberstadt M, 2006, KLIN MONATSBL AUGENH, V223, P361, DOI 10.1055/s-2006-926594; Hanaor D, 2012, J EUR CERAM SOC, V32, P235, DOI 10.1016/j.jeurceramsoc.2011.08.015; Heidenkummer H-P, 1992, RETINA, V12, P28; HEIDENKUMMER HP, 1991, GRAEF ARCH CLIN EXP, V229, P88, DOI 10.1007/BF00172269; Ichhpujani P, 2009, GRAEF ARCH CLIN EXP, V247, P1585, DOI 10.1007/s00417-009-1155-x; Jonas JB, 2001, J GLAUCOMA, V10, P102, DOI 10.1097/00061198-200104000-00006; Kruglyakov P. M., 2000, HYDROPHILE LIPOPHILE; Lakits A, 1999, OPHTHALMOLOGY, V106, P1091, DOI 10.1016/S0161-6420(99)90261-0; Lu YJ, 2019, ACTA OPHTHALMOL, V97, P313, DOI 10.1111/aos.13982; Mezger TG, 2006, RHEOLOGY HDB, P2; Miller JB, 2014, SEMIN OPHTHALMOL, V29, P312, DOI 10.3109/08820538.2014.962181; NAKAMURA K, 1990, INVEST OPHTH VIS SCI, V31, P647; Partenhauser A, 2017, J BIOMED MATER RES B, V105, P551, DOI 10.1002/jbm.b.33575; REFOJO MF, 1988, OPHTHALMOLOGY, V95, P614; RIEDEL KG, 1990, GRAEF ARCH CLIN EXP, V228, P19, DOI 10.1007/BF02764284; Toklu Y, 2012, RETINA-J RET VIT DIS, V32, P2039, DOI 10.1097/IAE.0b013e3182561f98	24	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0235067	10.1371/journal.pone.0235067	http://dx.doi.org/10.1371/journal.pone.0235067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559226	Green Accepted, gold, Green Published			2022-12-27	WOS:000543261600051
J	Chen, X; Wang, QC; Luo, C; Yang, Y; Jiang, H; Guo, XM; Chen, XP; Yang, JZ; Xu, KJ				Chen, Xi; Wang, Quanchuan; Luo, Cheng; Yang, Yong; Jiang, Hao; Guo, Xiangmei; Chen, Xipeng; Yang, Jiazhong; Xu, Kaijun			Increased functional dynamics in civil aviation pilots: Evidence from a neuroimaging study	PLOS ONE			English	Article							SCALE BRAIN NETWORKS; RISK PERCEPTION; AIRLINE PILOTS; CONNECTIVITY; EXPERIENCE; PATTERNS; STATES	Civil aviation is a distinctive career. Pilots need to monitor the entire system in real time. However, the psychophysiological mechanism of flying is largely unknown. The human brain is a large-scale interconnected organization, and many stable intrinsic large-scale brain networks have been identified. Among them are three core neurocognitive networks: default mode network (DMN), central executive network (CEN), and salience network (SN). These three networks play a critical role in human cognition. This study aims to examine the dynamic properties of the three large-scale brain networks in civil aviation pilots. We collected resting-state functional magnetic resonance imaging data from pilots. Independent component analysis, which is a data-driven approach, was combined with sliding window dynamic functional connectivity analysis to detect the dynamic properties of large-scale brain networks. Our results revealed that pilots exhibit an increased interaction of the CEN with the DMN and the SN along with a decreased interaction within the CEN. In addition, the temporal properties of functional dynamics (number of transitions) increased in pilots compared to healthy controls. In general, pilots exhibited increased between-network functional connectivity, decreased within-network functional connectivity, and a higher number of transitions. These findings suggest that pilots might have better functional dynamics and cognitive flexibility.	[Chen, Xi; Wang, Quanchuan; Yang, Yong; Jiang, Hao; Guo, Xiangmei; Chen, Xipeng; Yang, Jiazhong; Xu, Kaijun] Civil Aviat Flight Univ China, Inst Flight Technol, Guanghan, Peoples R China; [Luo, Cheng] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu, Peoples R China	Civil Aviation Flight University of China; University of Electronic Science & Technology of China	Yang, JZ; Xu, KJ (corresponding author), Civil Aviat Flight Univ China, Inst Flight Technol, Guanghan, Peoples R China.	Jiazhongyang@msn.com; k_j_xu@163.com	Luo, Cheng/A-4647-2015	Luo, Cheng/0000-0003-0524-5886; Jiang, Hao/0000-0002-4520-0394	National Nature Science Foundation of China [U1833130]; Foundation of General Program in Civil Aviation Flight University of China [XM3802]; Foundation of "Research Institute of Flight Training Safety Control and Service" Scientific research innovation team in Civil Aviation Flight University of China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of General Program in Civil Aviation Flight University of China; Foundation of "Research Institute of Flight Training Safety Control and Service" Scientific research innovation team in Civil Aviation Flight University of China	This study was supported by the National Nature Science Foundation of China (No. U1833130) to Xi Chen, Foundation of General Program in Civil Aviation Flight University of China (XM3802), and Foundation of "Research Institute of Flight Training Safety Control and Service" Scientific research innovation team in Civil Aviation Flight University of China (Grant No. JG2019-15).	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Buckner RL, 2019, NAT REV NEUROSCI, V20, P593, DOI 10.1038/s41583-019-0212-7; Cao WF, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00070; Chen F, 2019, TUNN UNDERGR SP TECH, V92, DOI 10.1016/j.tust.2019.103034; Chen P, 2018, TRANS RES BOARD 97 A; Chen X, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01406; Chen X, 2016, PSYCHIAT RES-NEUROIM, V256, P26, DOI 10.1016/j.pscychresns.2016.09.006; Damaraju E, 2014, NEUROIMAGE-CLIN, V5, P298, DOI 10.1016/j.nicl.2014.07.003; Du YH, 2018, NEUROIMAGE, V180, P632, DOI 10.1016/j.neuroimage.2017.10.022; Fiorenzato E, 2019, BRAIN, V142, P2860, DOI 10.1093/brain/awz192; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gu S, 2015, P NATL ACAD SCI USA, V112, P13681, DOI 10.1073/pnas.1502829112; Jenkins JC, 2008, AVIAT SPACE ENVIR MD, V79, P397, DOI 10.3357/ASEM.2195.2008; Ji M, 2018, J SAFETY RES, V66, P161, DOI 10.1016/j.jsr.2018.07.005; Jiang YC, 2017, PROG NEURO-PSYCHOPH, V79, P302, DOI 10.1016/j.pnpbp.2017.07.007; Kearney P, 2019, ERGONOMICS, V62, P305, DOI 10.1080/00140139.2018.1493151; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Laboratoire de Microbiologie d'Actalia Cecalait, 2015, NEW FOOD MAGAZINE, V16, P55; Lee WH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16789-1; Manoliu A, 2014, SCHIZOPHRENIA BULL, V40, P428, DOI 10.1093/schbul/sbt037; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Navarro J, 2018, NEUROSCI BIOBEHAV R, V95, P464, DOI 10.1016/j.neubiorev.2018.10.016; Nomi JS, 2017, NEUROIMAGE, V147, P861, DOI 10.1016/j.neuroimage.2016.10.026; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Ryali S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005138; Satterthwaite TD, 2015, CEREB CORTEX, V25, P2383, DOI 10.1093/cercor/bhu036; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; You XQ, 2013, ACCIDENT ANAL PREV, V57, P131, DOI 10.1016/j.aap.2013.03.036; Zalesky A, 2015, NEUROIMAGE, V114, P466, DOI 10.1016/j.neuroimage.2015.03.047	36	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234790	10.1371/journal.pone.0234790	http://dx.doi.org/10.1371/journal.pone.0234790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555721	Green Published, gold			2022-12-27	WOS:000543273200013
J	Hu, XJ; Qu, HY; Houser, SH; Ding, JM; Chen, HL; Zhang, XZ; Yu, M				Hu, Xuejun; Qu, Haiyan; Houser, Shannon H.; Ding, Jingmei; Chen, Huoliang; Zhang, Xianzhi; Yu, Min			Exploring association between certified EHRs adoption and patient experience in US psychiatric hospitals	PLOS ONE			English	Article							ELECTRONIC HEALTH RECORD; INFORMATION-TECHNOLOGY; MEDICAL-RECORD; MEANINGFUL-USE; SATISFACTION; IMPACT; CARE; QUALITY; IMPLEMENTATION; COMMUNICATION	Objective Certified Electronic Health Records (EHR) have been shown to improve the health service quality in some health settings, but there is scant evidence related to its adoption in psychiatric hospitals. This paper aimed to examine the relationship between certified EHR adoption and patient experience across psychiatric hospitals in the United States. Methods A cross-sectional study design compared the difference in patient experience measures between psychiatric hospitals with and without certified EHR. Data were drawn from the American Hospital Association (AHA) Annual Survey Database and Hospital Compare datasets. Eleven publicly reported measures for patient experience from the Consumer Assessment of Healthcare Providers and Systems Hospital Survey (HCAHPS) were applied for analysis. Independent relationship of certified EHR adoption and patient experience was explored with multiple linear regression models adjusted for hospital organizational characteristics. Results Positive associations were identified between certified EHR adoption and five patient perception measures-"recommend hospital" (beta = 0.66, 95% CI = [0.16,1.16]; t = 2.68, p = 0.010), "overall hospital rating" (beta = 0.39, 95% CI = [0.03,0.75]; t = 2.11, p = 0.035), "discharge information" (beta = 0.45, 95% CI = [0.03,0.86]; t = 2.09, p = 0.037), "care transition" (beta = 0.44, 95% CI = [0.14, 0.75]; t = 2.84, p = 0.005), and "responsiveness of hospital staff" (beta = 0.47, 95% CI = [0.04, 0.90]; t = 2.13, p = 0.033). Conclusion Our results suggest the positive association between certified EHR adoption and patient experience. More studies are needed to explore impacts of certified EHR adoption and potential improvement in patient experience to quality of care.	[Hu, Xuejun; Ding, Jingmei; Chen, Huoliang; Zhang, Xianzhi] Air Force Med Univ, Dept Hlth Serv Adm, Xian, Peoples R China; [Hu, Xuejun; Qu, Haiyan; Houser, Shannon H.] Univ Alabama Birmingham, Dept Hlth Serv Adm, Birmingham, AL USA; [Yu, Min] Acad Mil Med Sci, Dept Hlth Serv Adm, Beijing, Peoples R China	Air Force Military Medical University; University of Alabama System; University of Alabama Birmingham; Academy of Military Medical Sciences - China	Yu, M (corresponding author), Acad Mil Med Sci, Dept Hlth Serv Adm, Beijing, Peoples R China.	yumin@bmi.ac.cn		Qu, Haiyan/0000-0002-0044-589X	China Scholarship Council [201703170149]	China Scholarship Council(China Scholarship Council)	Xuejun Hu was supported by a scholarship from the China Scholarship Council (NO. 201703170149). https://www.csc.edu.cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkureishi MA, 2016, J GEN INTERN MED, V31, P548, DOI 10.1007/s11606-015-3582-1; [Anonymous], 2015, CRIT CARE S1, V19, pP1; [Anonymous], TECHN NOT HCAHPS STA; Batbaatar E, 2017, PERSPECT PUBLIC HEAL, V137, P89, DOI 10.1177/1757913916634136; Boyer L, 2010, ENCEPHALE, V36, P236, DOI 10.1016/j.encep.2009.05.004; Boyer L, 2010, INT J PSYCHIAT CLIN, V14, P223, DOI 10.3109/13651501003717243; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Bruns EJ, 2018, J MED INTERNET RES, V20, DOI 10.2196/10197; Busch AB, 2018, NEW ENGL J MED, V378, P1665, DOI 10.1056/NEJMp1800465; Carroll T, 2017, J NURS ADMIN, V47, P558, DOI 10.1097/NNA.0000000000000543; CMS HHS. Medicare and Medicaid Programs, 2015, FED REGISTER, V80, P62761; Duarte JG, 2017, INT J MED INFORM, V102, P80, DOI 10.1016/j.ijmedinf.2017.03.007; Ediyattumangalam R, 2012, THESIS; Elliott MN, 2010, HEALTH AFFAIR, V29, P2061, DOI 10.1377/hlthaff.2009.0876; Elliott MN, 2010, MED CARE RES REV, V67, P56, DOI 10.1177/1077558709339066; Farber NJ, 2015, J FAM PRACTICE, V64, P687; Gerard M, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7212; Harle CA, 2016, AM J MANAG CARE, V22, pE403; Henry J, ADOPTION ELECT HLTH, V35, P1; Holmgren AJ, 2017, J HOSP MED, V12, P193, DOI 10.12788/jhm.2704; Iqbal E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134208; Irani JS, 2009, J AM BOARD FAM MED, V22, P553, DOI 10.3122/jabfm.2009.05.080259; Jarvis B, 2013, ACAD MED, V88, P1471, DOI 10.1097/ACM.0b013e3182a36cab; Jones SS, 2014, ANN INTERN MED, V160, P48, DOI 10.7326/M13-1531; Kaufman Kenneth R, 2005, J Psychiatr Pract, V11, P200, DOI 10.1097/00131746-200505000-00008; Kazley AS, 2012, HEALTH CARE MANAGE R, V37, P23, DOI 10.1097/HMR.0b013e3182307bd3; Kazley AS., 2015, J HOSP ADM, V4, P40, DOI 10.5430/jha.v4n4p40; Krishna R, 2017, CHILD ADOL PSYCH CL, V26, P67, DOI 10.1016/j.chc.2016.07.007; Lee TY, 2018, STUD HEALTH TECHNOL, V250, P192, DOI 10.3233/978-1-61499-872-3-192; Lehrman WG, 2010, MED CARE RES REV, V67, P38, DOI 10.1177/1077558709341323; Dal Sasso GTM, 2013, REV ESC ENFERM USP, V47, P238, DOI 10.1590/S0080-62342013000100031; Marmor RA, 2018, APPL CLIN INFORM, V9, P11, DOI 10.1055/s-0037-1620263; McGregor B, 2015, PSYCHIAT SERV, V66, P985, DOI 10.1176/appi.ps.201400095; Meyerhoefer CD, 2018, J AM MED INFORM ASS; Mitchell JP, 2016, J HEALTHC QUAL, V38, P296, DOI 10.1097/01.JHQ.0000462678.02018.92; Payne TH, 2016, HEART, V102, P1782, DOI 10.1136/heartjnl-2015-308724; Peters TE, 2017, CHILD ADOL PSYCH CL, V26, P55, DOI 10.1016/j.chc.2016.07.003; Raleigh VS, 2012, BMJ QUAL SAF, V21, P381, DOI 10.1136/bmjqs-2011-000588; Riahi S, 2017, JMIR MED INF, V5, DOI 10.2196/medinform.6512; Rose D, 2014, J AM ASSOC NURSE PRA, V26, P674, DOI 10.1002/2327-6924.12170; Rumshisky A, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.182; Salomon RM, 2010, J AM MED INFORM ASSN, V17, P54, DOI 10.1197/jamia.M3341; Ser G, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102623, 10.1371/journal.pone.0077669]; Shield RR, 2010, ANN FAM MED, V8, P316, DOI 10.1370/afm.1136; Stewart RF, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-3; Strudwick G, 2015, ARCH PSYCHIAT NURS, V29, P238, DOI 10.1016/j.apnu.2015.03.007; Tsai TC, 2015, ANN SURG, V261, P2, DOI 10.1097/SLA.0000000000000765; Tverdal CB, 2018, J REHABIL MED, V50, P505, DOI 10.2340/16501977-2332; Walker D, 2016, HEALTH AFFAIR, V35, P495, DOI 10.1377/hlthaff.2015.0924; West JC, 2016, PSYCHIAT SERV, V67, P1292, DOI 10.1176/appi.ps.201500536; Wolf L, 2012, HEALTH AFFAIR, V31, P505, DOI 10.1377/hlthaff.2011.0351	51	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234607	10.1371/journal.pone.0234607	http://dx.doi.org/10.1371/journal.pone.0234607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555623	Green Published, gold			2022-12-27	WOS:000542759600031
J	Shalizi, A; Wiegers, TN; Maamar, H				Shalizi, Aryaman; Wiegers, Toni N.; Maamar, Hedia			Click-to-Capture: A method for enriching viableStaphylococcus aureus using bio-orthogonal labeling of surface proteins	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; EPIDEMIOLOGY; CHEMISTRY; SEPSIS	Staphylococcus aureusis one of the principal causative agents of bacteremia which can progress to sepsis. Rapid diagnostic tests for identification and antibiotic resistance profiling ofS.aureuswould improve patient outcomes and antibiotic stewardship, but existing methods require a lengthy culture step to obtain enough material for testing. Complexity of the host matrix, where pathogenic microbes are often present, also interferes with many diagnostic methods. Here, we describe a straightforward and rapid method for enriching viableS.aureususing bio-orthogonal, or "click," chemistry methods. Bacteria labeled in this manner can potentially be cultured, interrogated using molecular methods for pathogen identification, or used to test antibiotic susceptibility.	[Shalizi, Aryaman; Wiegers, Toni N.; Maamar, Hedia] Talis Biomed Corp, Dept Assay Dev, Menlo Pk, CA 94025 USA		Maamar, H (corresponding author), Talis Biomed Corp, Dept Assay Dev, Menlo Pk, CA 94025 USA.	hmaamar@talisbio.com		Shalizi, Aryaman/0000-0001-9226-0800	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health [R01AI139005]; Talis Biomedical corporation; Talis Biomedical Corporation	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Talis Biomedical corporation; Talis Biomedical Corporation	Research reported in this publication was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number R01AI139005. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. It was also supported by Talis Biomedical corporation. Talis Biomedical Corporation provided support in the form of salaries for authors [AS, TW and HM] and therefor was involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section'.	[Anonymous], 2017, LANCET HIV, V2, pe115; Baboo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099346; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Cartwright M, 2016, EBIOMEDICINE, V9, P217, DOI 10.1016/j.ebiom.2016.06.014; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; Fratila RM, 2017, NEW J CHEM, V41, P10835, DOI 10.1039/c7nj01822c; Fugier E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127700; Gerlach D, 2018, NATURE, V563, P705, DOI 10.1038/s41586-018-0730-x; Hilmi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096416; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Khanna S, 2016, EXPERT REV GASTROENT, V10, P1145, DOI 10.1586/17474124.2016.1158097; Kopp BJ, 2004, ANN PHARMACOTHER, V38, P1377, DOI 10.1345/aph.1E028; Lallana E, 2011, ANGEW CHEM INT EDIT, V50, P8794, DOI 10.1002/anie.201101019; Lamy B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00697; Mahla RS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00248; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; Metan G, 2005, J HOSP INFECT, V61, P93, DOI 10.1016/j.jhin.2005.02.020; Monaco M, 2017, CURR TOP MICROBIOL, V409, P21, DOI 10.1007/82_2016_3; O'Neill J, 2015, RAPID DIAGNOSTICS ST; ONeill J., 2016, TACKLING DRUG RESIST; Opota O, 2015, CLIN MICROBIOL INFEC, V21, P323, DOI 10.1016/j.cmi.2015.02.005; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Reddy Prakash Narayana, 2017, Infect Dis (Auckl), V10, p1179916117703999, DOI 10.1177/1179916117703999; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Shorr AF, 2007, PHARMACOECONOMICS, V25, P751, DOI 10.2165/00019053-200725090-00004; van Belkum A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01437; Wang MC, 2015, J MICROBIOL IMMUNOL, V48, P419, DOI 10.1016/j.jmii.2013.10.006; Wypych TP, 2018, TRENDS IMMUNOL, V39, P697, DOI 10.1016/j.it.2018.02.008; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990; Zhang SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136082	32	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234542	10.1371/journal.pone.0234542	http://dx.doi.org/10.1371/journal.pone.0234542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555702	Green Published, gold			2022-12-27	WOS:000542759600061
J	Gervais, A; Courtois, E; Fournier, V; Belisle, M				Gervais, Amelie; Courtois, Eve; Fournier, Valerie; Belisle, Marc			Landscape composition and local floral resources influence foraging behavior but not the size ofBombus impatiensCresson (Hymenoptera: Apidae) workers	PLOS ONE			English	Article							BEE COLONY GROWTH; BUMBLE-BEES; BODY-SIZE; BOMBUS-TERRESTRIS; POLLEN LOADS; NEONICOTINOID PESTICIDE; HABITAT FRAGMENTATION; POLLINATOR BEHAVIOR; NUTRITIONAL INTAKE; FLOWER CONSTANCY	Bumble bee communities are strongly disrupted worldwide through the population decline of many species; a phenomenon that has been generally attributed to landscape modification, pesticide use, pathogens, and climate change. The mechanisms by which these causes act on bumble bee colonies are, however, likely to be complex and to involve many levels of organization spanning from the community down to the least understood individual level. Here, we assessed how the morphology, weight and foraging behavior of individual workers are affected by their surrounding landscape. We hypothesized that colonies established in landscapes showing high cover of intensive crops and low cover of flowering crops, as well as low amounts of local floral resources, would produce smaller workers, which would perform fewer foraging trips and collect pollen loads less constant in species composition. We tested these predictions with 80 colonies of commercially rearedBombus impatiensCresson placed in 20 landscapes spanning a gradient of agricultural intensification in southern Quebec, Canada. We estimated weekly rate at which workers entered and exited colonies and captured eight workers per colony over a period of 14 weeks during the spring and summer of 2016. Captured workers had their wing, thorax, head, tibia, and dry weight measured, as well as their pollen load extracted and identified to the lowest possible taxonomic level. We did not detect any effect of landscape habitat composition on worker morphology or body weight, but found that foraging activity decreased with intensive crops. Moreover, higher diversity of local floral resources led to lower pollen constancy in intensively cultivated landscapes. Finally, we found a negative correlation between the size of workers and the diversity of their pollen load. Our results provide additional evidence that conservation actions regarding pollinators in arable landscapes should be made at the landscape rather than at the farm level.	[Gervais, Amelie; Fournier, Valerie] Univ Laval, Ctr Rech & Innovat Vegetaux CRIV, Dept Phytol, Quebec City, PQ, Canada; [Courtois, Eve; Belisle, Marc] Univ Sherbrooke, Ctr Etud Foret CEF, Dept Biol, Sherbrooke, PQ, Canada	Laval University; University of Sherbrooke	Gervais, A (corresponding author), Univ Laval, Ctr Rech & Innovat Vegetaux CRIV, Dept Phytol, Quebec City, PQ, Canada.	amelie.gervais.bio@gmail.com		Courtois, Eve/0000-0003-4597-5605; Belisle, Marc/0000-0003-0657-6724	NSERC; Centre-Seve	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre-Seve	MB: NSERC, Discovery Grand Program. https://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp VF: Centre-Seve, New Initiatives ProgramInterinstitutional project. https://centreseve.recherche.usherbrooke.ca/en/node/205 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari S, 2019, AGR ECOSYST ENVIRON, V270, P9, DOI 10.1016/j.agee.2018.10.010; Arbetman MP, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0204; Arce AN, 2017, J APPL ECOL, V54, P1199, DOI 10.1111/1365-2664.12792; Barbosa WF, 2015, ECOTOXICOLOGY, V24, P130, DOI 10.1007/s10646-014-1365-9; Baron GL, 2017, NAT ECOL EVOL, V1, P1308, DOI 10.1038/s41559-017-0260-1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beil M, 2008, APIDOLOGIE, V39, P456, DOI 10.1051/apido:2008021; Belanger L, 2002, ENVIRON CONSERV, P495; Belisle M, 2005, ECOLOGY, V86, P1988, DOI 10.1890/04-0923; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bernauer OM, 2015, INSECTS, V6, P478, DOI 10.3390/insects6020478; Birmingham AL, 2004, CAN J ZOOL, V82, P52, DOI 10.1139/Z03-201; Bosch J, 2002, ECOL ENTOMOL, DOI [10.1046/j.1365-2311.2002.00446.x, DOI 10.1046/J.1365-2311.2002.00446.X]; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; CANE JH, 1987, J KANSAS ENTOMOL SOC, V60, P145; Cane JH, 2003, AM J BOT, V90, P1425, DOI 10.3732/ajb.90.10.1425; Carvell C, 2017, NATURE, V543, P547, DOI 10.1038/nature21709; Carvell C, 2015, BASIC APPL ECOL, V16, P519, DOI 10.1016/j.baae.2015.05.006; Chittka L, 1997, BEHAV ECOL, V8, P239, DOI 10.1093/beheco/8.3.239; CNAANI J, 1994, INSECT SOC, V41, P301, DOI 10.1007/BF01242301; CORBET SA, 1993, ECOL ENTOMOL, V18, P17, DOI 10.1111/j.1365-2311.1993.tb01075.x; Couvillon MJ, 2009, P ROY SOC B-BIOL SCI, V276, P2411, DOI 10.1098/rspb.2009.0172; Cresswell JE, 1997, OIKOS, V78, P546, DOI 10.2307/3545616; Desjardins EC, 2006, J ECON ENTOMOL, V99, P443, DOI 10.1603/0022-0493-99.2.443; Diaz-Forero I, 2013, J INSECT CONSERV, V17, P113, DOI 10.1007/s10841-012-9490-3; Ellis C, 2017, ENVIRON SCI TECHNOL, V51, P1727, DOI 10.1021/acs.est.6b04791; Fauser-Misslin A, 2014, J APPL ECOL, V51, P450, DOI 10.1111/1365-2664.12188; Forsman A, 2015, HEREDITY, V115, P276, DOI 10.1038/hdy.2014.92; Frier SD, 2016, AGR ECOSYST ENVIRON, V219, P42, DOI 10.1016/j.agee.2015.12.011; Gegear RJ, 2005, ANIM BEHAV, V69, P939, DOI 10.1016/j.anbehav.2004.06.029; Gill RJ, 2014, FUNCT ECOL, V28, P1459, DOI 10.1111/1365-2435.12292; Girard M, 2014, OUVRAGE REFERENCE PH; Girard M, 2012, BOTANY, V90, P545, DOI [10.1139/B2012-049, 10.1139/b2012-049]; Giroux I, 2015, PRESENCE PESTICIDES; GOLDBLATT JW, 1987, CAN J ZOOL, V65, P2349, DOI 10.1139/z87-354; Gomez-Escobar E, 2018, J ECON ENTOMOL, V111, P1711, DOI 10.1093/jee/toy152; Goulson D, 2002, ANIM BEHAV, V64, P123, DOI 10.1006/anbe.2002.3041; Goulson D, 2002, OECOLOGIA, V130, P267, DOI 10.1007/s004420100803; Goulson D, 2018, ECOL ENTOMOL, V43, P168, DOI 10.1111/een.12482; Goulson D, 2015, PEERJ, V3, DOI 10.7717/peerj.854; Goulson Dave, 2010, P415; Goulson D, 2009, J INSECT CONSERV, V13, P177, DOI 10.1007/s10841-008-9140-y; Goverde M, 2002, BIOL CONSERV, V104, P293, DOI 10.1016/S0006-3207(01)00194-X; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Greenleaf SS, 2006, BIOL CONSERV, V133, P81, DOI 10.1016/j.biocon.2006.05.025; Gruter Christoph, 2011, Communicative & Integrative Biology, V4, P633; Hagen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019997; Hanley ME, 2011, OIKOS, V120, P1618, DOI 10.1111/j.1600-0706.2011.19233.x; HARDER LD, 1983, OECOLOGIA, V57, P274, DOI 10.1007/BF00379591; Harmon-Threatt AN, 2015, ECOL ENTOMOL, V40, P471, DOI 10.1111/een.12211; Haroune L, 2015, ANAL CHIM ACTA, V891, P160, DOI 10.1016/j.aca.2015.07.031; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Henry M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5359; Herrmann JD, 2018, ECOL ENTOMOL, V43, P458, DOI 10.1111/een.12517; Herrmann JD, 2017, APIDOLOGIE, V48, P545, DOI 10.1007/s13592-017-0499-1; Ings TC, 2006, J APPL ECOL, V43, P940, DOI 10.1111/j.1365-2664.2006.01199.x; Jacobson MM, 2018, BIOL CONSERV, V217, P437, DOI 10.1016/j.biocon.2017.11.026; Jha S, 2013, ECOL ENTOMOL, V38, P570, DOI 10.1111/een.12056; Jobin B, 2005, BIODIVERS CONSERV, V14, P81, DOI 10.1007/s10531-005-4052-6; Kapustjanskij A, 2007, FUNCT ECOL, V21, P1130, DOI 10.1111/j.1365-2435.2007.01329.x; Kenna D, 2019, ECOL EVOL, V9, P5637, DOI 10.1002/ece3.5143; Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031; Kerr NZ, 2019, FUNCT ECOL, V33, P467, DOI 10.1111/1365-2435.13251; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Kunin W, 1996, THEOR POPUL BIOL, V49, P232, DOI 10.1006/tpbi.1996.0013; LAVERTY TM, 1988, ANIM BEHAV, V36, P733, DOI 10.1016/S0003-3472(88)80156-8; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LOUVEAUX J, 1978, BEE WORLD, V59, P139, DOI 10.1080/0005772X.1978.11097714; Marchand P, 2015, ECOL MODEL, V313, P41, DOI 10.1016/j.ecolmodel.2015.06.019; Milano NJ, 2019, AGR ECOSYST ENVIRON, V284, DOI 10.1016/j.agee.2019.106594; Moisan-Deserres J, 2014, J ECON ENTOMOL, V107, P1156, DOI 10.1603/EC13229; Montiel-Leon JM, 2019, ENVIRON POLLUT, V250, P29, DOI 10.1016/j.envpol.2019.03.125; Nooten SS, 2020, BIODIVERS CONSERV, V29, P451, DOI 10.1007/s10531-019-01893-7; O'Neill RP, 2011, APIDOLOGIE, V42, P223, DOI 10.1051/apido/2010057; Oksanen J., 2016, VEGAN COMMUNITY ECOL; Park MG, 2016, APIDOLOGIE, V47, P145, DOI 10.1007/s13592-015-0383-9; Persson AS, 2011, BASIC APPL ECOL, V12, P695, DOI 10.1016/j.baae.2011.10.002; Persson AS, 2013, AGR ECOSYST ENVIRON, DOI [10.1016/j.agee.2013.01.014, DOI 10.1016/J.AGEE.2013.01.014]; Persson AS, 2015, BIODIVERS CONSERV, DOI [10.1007/s10531-015-0859-y, DOI 10.1007/S10531-015-0859-Y]; PLOWRIGHT RC, 1977, CAN J ZOOL, V55, P1133, DOI 10.1139/z77-146; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; QGIS Development Team, 2019, QGIS GEOGR INF SYST; R Development Core Team, 2009, R LANG ENV STAT COMP; Redhead JW, 2016, ECOL APPL, V26, P726, DOI 10.1890/15-0546; Reininghaus H, LOCAL LANDSCAPE EFFE; Samuelson AE, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0807; SCHMIDHEMPEL P, 1988, J ANIM ECOL, V57, P509, DOI 10.2307/4921; Siviter H, 2018, J APPL ECOL, V55, P2812, DOI 10.1111/1365-2664.13193; Spaethe J, 2003, J EXP BIOL, V206, P3447, DOI 10.1242/jeb.00570; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; Spiesman BJ, 2017, BIOL CONSERV, V206, P217, DOI 10.1016/j.biocon.2016.12.008; Stanley DA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08752-x; Stanley DA, 2016, J APPL ECOL, V53, P1440, DOI 10.1111/1365-2664.12689; Stanley DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16508; SUTCLIFFE GH, 1988, CAN ENTOMOL, V120, P1051, DOI 10.4039/Ent1201051-12; Szigeti V, 2016, ECOL ENTOMOL, V41, P231, DOI 10.1111/een.12298; TAYLOR PD, 1995, OIKOS, V73, P43, DOI 10.2307/3545723; Vaudo AD, 2018, ECOL EVOL, V8, P5765, DOI 10.1002/ece3.4115; Vaudo AD, 2016, P NATL ACAD SCI USA, V113, pE4035, DOI 10.1073/pnas.1606101113; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Warzecha D, 2016, LANDSCAPE ECOL, V31, P1449, DOI 10.1007/s10980-016-0349-y; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507; Westphal C, 2009, J APPL ECOL, V46, P187, DOI 10.1111/j.1365-2664.2008.01580.x; Westphal C, 2006, OECOLOGIA, V149, P289, DOI 10.1007/s00442-006-0448-6; Westphal C, 2006, ECOL ENTOMOL, V31, P389, DOI 10.1111/j.1365-2311.2006.00801.x; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams NM, 2012, ECOLOGY, V93, P1049, DOI 10.1890/11-1006.1; Wu-Smart J, 2018, ENVIRON ENTOMOL, V47, P55, DOI 10.1093/ee/nvx175	110	5	5	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234498	10.1371/journal.pone.0234498	http://dx.doi.org/10.1371/journal.pone.0234498			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584843	Green Published, gold			2022-12-27	WOS:000545747200038
J	Merrill, KG; Campbell, JC; Decker, MR; McGready, J; Burke, VM; Mwansa, JK; Miti, S; Frimpong, C; Kennedy, CE; Denison, JA				Merrill, Katherine G.; Campbell, Jacquelyn C.; Decker, Michele R.; McGready, John; Burke, Virginia M.; Mwansa, Jonathan K.; Miti, Sam; Frimpong, Christiana; Kennedy, Caitlin E.; Denison, Julie A.			Prevalence of physical and sexual violence and psychological abuse among adolescents and young adults living with HIV in Zambia	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; GENDER-BASED VIOLENCE; POSITIVE ADOLESCENTS; SOUTH-AFRICA; CAPE-TOWN; WOMEN; VICTIMIZATION; OUTCOMES; IMPACT; TRIAL	Background Little is known about violence against HIV-positive adolescents and young adults (AYA) in sub-Saharan Africa. This analysis examines experiences of violence victimization, and the perpetrators of this violence, among AYA living with HIV, aged 15-24 years, in Zambia. Methods We analyzed baseline data from 272 AYA (60.1% female, 71.0% perinatally infected) enrolled in Project YES! (Youth Engaging for Success), a randomized controlled trial conducted in four HIV clinics in Ndola, Zambia. Violence measures were adapted from the ICAST-C and the WHO Multi-Country Study on Women's Health and Domestic Violence. Youth could report up to 12 perpetrator types for past-year experiences of violence. We estimated lifetime and past-year prevalence of physical violence, psychological abuse, and forced sex, disaggregated by sex and age group. Estimates were weighted using sex and age data from the 2013-14 Zambian Demographic and Health Survey to be representative of HIV-positive AYA in Zambia. Results Estimated lifetime prevalence of any violence victimization was 78.2%. Past-year prevalence was 72.0% among males and 74.5% among females. Almost half of AYA (46.1%) had ever experienced polyvictimization (2+ types of violence). Psychological abuse was most common (70.4% lifetime, 65.3% past-year), followed by physical violence (50.8% lifetime, 44.7% past-year) and forced sex (10.4% lifetime, 4.7% past-year). Among past-year victims, males experienced more violence than females from a friend/peer (74.3% vs. 45.1%, p<0.001); females experienced more violence than males from a romantic partner (33.3% vs. 5.0%, p<0.001), parent/caregiver (32.4% vs. 17.6%, p = 0.02), and stranger (19.7% vs. 5.2%, p<0.001). Conclusion The widespread and overlapping prevalence of multiple types of violence highlights the critical need for prevention and response efforts that are tailored to youths' sex and the perpetrator type. Future research should explore violence victimization and HIV outcomes, and the measurement of psychological abuse and sexual violence, among HIV-positive AYA in the region.	[Merrill, Katherine G.; Burke, Virginia M.; Kennedy, Caitlin E.; Denison, Julie A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Campbell, Jacquelyn C.] Johns Hopkins Sch Nursing, Dept Community Publ Hlth, Baltimore, MD USA; [Decker, Michele R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [McGready, John] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Mwansa, Jonathan K.; Miti, Sam; Frimpong, Christiana] Arthur Davison Childrens Hosp, Ndola, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Merrill, KG (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.	kgmerrill@jhu.edu		Denison, Julie/0000-0002-4670-093X; Merrill, Katherine Gannett/0000-0001-5308-4154	Project SOAR - U.S. President's Emergency Plan for AIDS Relief; U.S. Agency for International Development [AID-OAA-A-14-00060]; Johns Hopkins Center for AIDS Research [P30AI094189]; National Institute of Mental Health of the National Institutes of Health [F31MH116821-01A1]	Project SOAR - U.S. President's Emergency Plan for AIDS Relief; U.S. Agency for International Development(United States Agency for International Development (USAID)); Johns Hopkins Center for AIDS Research; National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was provided by Project SOAR, a five-year cooperative agreement funded by the U.S. President's Emergency Plan for AIDS Relief and the U.S. Agency for International Development (Agreement No. AID-OAA-A-14-00060) and the Johns Hopkins Center for AIDS Research (P30AI094189). KGM was supported by the National Institute of Mental Health of the National Institutes of Health under Award Number F31MH116821-01A1. The content is solely the responsibility of the authors and does not necessarily represent the official views of PEPFAR, USAID, or the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, VIOLENCE CHILDREN YO; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2015, ZAMBIA DEMOGRAPHIC H; [Anonymous], 2016, SENSORS, V16, pC1, DOI 10.1109/JSEN.2016.2517933; [Anonymous], 2012, ZAMB 2010 CENS POP H; Campbell JC, 2008, INT J INJ CONTROL SA, V15, P221, DOI 10.1080/17457300802423224; Christofides N, 2010, AIDS CARE, V22, P279, DOI 10.1080/09540120903193617; Cluver L, 2018, AIDS, V32, P975, DOI 10.1097/QAD.0000000000001795; Cluver LD, 2017, RES SOCIAL WORK PRAC, V27, P758, DOI 10.1177/1049731516628647; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Decker MR, 2015, J ADOLESCENT HEALTH, V56, P188, DOI 10.1016/j.jadohealth.2014.09.003; Denison J BV, 2018, PROJECT YES YOUTH EN; Devries KM, 2015, LANCET GLOB HEALTH, V3, pE378, DOI 10.1016/S2214-109X(15)00060-1; Dow DE, 2016, AIDS CARE, V28, P825, DOI 10.1080/09540121.2016.1139043; Dunkle KL, 2013, AM J REPROD IMMUNOL, V69, P20, DOI 10.1111/aji.12039; Earnshaw VA, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3426; Edwards KM, 2015, PSYCHOL VIOLENCE, V5, P112, DOI 10.1037/a0038656; Exner-Cortens D, 2012, PEDIATRICS, V131; Hatcher AM, 2015, AIDS, V29, P2183, DOI 10.1097/QAD.0000000000000842; Hatcher AM, 2012, AIDS BEHAV, V16, P1295, DOI 10.1007/s10461-011-0065-1; Heise L., 2017, MEASURING INTIMATE P; Heise L, 2019, SSM-POPUL HLTH, V9, DOI 10.1016/j.ssmph.2019.100377; Hillis S, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4079; ICAST-C, 2006, ICAST C ISPCAN CHILD; Iliyasu Zubairu, 2011, Afr J Reprod Health, V15, P41; Jewkes R, 2010, LANCET, V376, P851, DOI 10.1016/S0140-6736(10)61079-3; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Maeri I, 2016, AIDS CARE, V28, P59, DOI 10.1080/09540121.2016.1168917; Mahlangu P, 2014, S AFRICAN CHILD GAUG; McGarlane J, 1992, JAMA-J AM MED ASSOC, V267, P3176; Meinck F, 2018, CHILD ABUSE NEGLECT, V82, P45, DOI 10.1016/j.chiabu.2018.05.022; Meinck F, 2016, J EPIDEMIOL COMMUN H, V70, P910, DOI 10.1136/jech-2015-205860; Murray LK, 2006, J NERV MENT DIS, V194, P610, DOI 10.1097/01.nmd.0000230662.01953.bc; Pantelic M, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21771; Perkins HW, 2011, GROUP PROCESS INTERG, V14, P703, DOI 10.1177/1368430210398004; Reed E, 2015, AIDS BEHAV, V19, P192, DOI 10.1007/s10461-014-0820-1; S3-Leitlinie, 2017, SOMNOLOGIE, V20, pS97 S180; Sanders RA, 2013, PEDIATR REV, V34, P354, DOI 10.1542/pir.34-8-354; Smith CA, 2005, CHILD ABUSE NEGLECT, V29, P1099, DOI 10.1016/j.chiabu.2005.02.011; StataCorp, 2015, STAT; Turanovic JJ, 2015, J PEDIATR-US, V166, P1062, DOI 10.1016/j.jpeds.2014.12.059; UNAIDS, 2013, GLOBAL REPORT UNAIDS; Under the Same Sun, 2014, CHILDR ALB VIOL DISP; UNICEF, 2017, CHILDREN AIDS STAT U; UNICEF, 2011, VIOL CHILDR TANZ FIN; UNICEF, 2016, TURN TID AIDS WILL R; UNICEF, 2018, VIOL CHILDR ZAMB FIN; United Nations Children's Fund (UNICEF), 2012, VIOL CHILDR KEN FIND; Watt MH, 2017, AIDS BEHAV, V21, P3209, DOI 10.1007/s10461-016-1617-1; WHO Department of Gender Women and Health, 2001, PUTT WOM 1 ETH SAF R; Woollett N, 2017, J CHILD ADOLESC MENT, V29, P11, DOI 10.2989/17280583.2017.1283320; World Health Organization, 2005, WHO MULT STUD WOM HL	53	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235203	10.1371/journal.pone.0235203	http://dx.doi.org/10.1371/journal.pone.0235203			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584889	gold, Green Published			2022-12-27	WOS:000545747200067
J	Woodward, SF; Reiss, D; Magnasco, MO				Woodward, Sean F.; Reiss, Diana; Magnasco, Marcelo O.			Learning to localize sounds in a highly reverberant environment: Machine-learning tracking of dolphin whistle-like sounds in a pool	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; TURSIOPS-TRUNCATUS; ACOUSTIC LOCALIZATION; SIGNATURE WHISTLES; SPERM-WHALE; IDENTIFICATION; COMMUNICATION; INFORMATION; REPERTOIRES; DELPHINIDAE	Tracking the origin of propagating wave signals in an environment with complex reflective surfaces is, in its full generality, a nearly intractable problem which has engendered multiple domain-specific literatures. We posit that, if the environment and sensor geometries are fixed, machine learning algorithms can "learn" the acoustical geometry of the environment and accurately track signal origin. In this paper, we propose the first machine-learning-based approach to identifying the source locations of semi-stationary, tonal, dolphin-whistle-like sounds in a highly reverberant space, specifically a half-cylindrical dolphin pool. Our algorithm works by supplying a learning network with an overabundance of location "clues", which are then selected under supervised training for their ability to discriminate source location in this particular environment. More specifically, we deliver estimated time-difference-of-arrivals (TDOA's) and normalized cross-correlation values computed from pairs of hydrophone signals to a random forest model for high-feature-volume classification and feature selection, and subsequently deliver the selected features into linear discriminant analysis, linear and quadratic Support Vector Machine (SVM), and Gaussian process models. Based on data from 14 sound source locations and 16 hydrophones, our classification models yielded perfect accuracy at predicting novel sound source locations. Our regression models yielded better accuracy than the established Steered-Response Power (SRP) method when all training data were used, and comparable accuracy along the pool surface when deprived of training data at testing sites; our methods additionally boast improved computation time and the potential for superior localization accuracy in all dimensions with more training data. Because of the generality of our method we argue it may be useful in a much wider variety of contexts.	[Woodward, Sean F.; Magnasco, Marcelo O.] Rockefeller Univ, Ctr Studies Phys & Biol, Lab Integrat Neurosci, 1230 York Ave, New York, NY 10021 USA; [Reiss, Diana] CUNY Hunter Coll, Dept Psychol, 695 Pk Ave, New York, NY 10021 USA	Rockefeller University; City University of New York (CUNY) System; Hunter College (CUNY)	Woodward, SF (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, Lab Integrat Neurosci, 1230 York Ave, New York, NY 10021 USA.	sf.woodward@gmail.com		Woodward, Sean/0000-0002-8783-1039	National Science Foundation [1530544, 1607280]	National Science Foundation(National Science Foundation (NSF))	MO Magnasco, DR Reiss Awards 1530544, 1607280 National Science Foundation https://www.nsf.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2000, J ACOUST SOC AM, V108, P1353, DOI 10.1121/1.1287841; alente D. L., 2011, J ACOUST SOC AM, V130, pEL32; [Anonymous], 2016, NUCL ACIDS RES, V44, pD7; AU WWL, 1986, J ACOUST SOC AM, V80, P688, DOI 10.1121/1.394012; Au WWL, 2000, HEARING WHALES DOLPH; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Belgiu M, 2016, ISPRS J PHOTOGRAMM, V114, P24, DOI 10.1016/j.isprsjprs.2016.01.011; BELL BM, 1986, IEEE T ACOUST SPEECH, V34, P1029, DOI 10.1109/TASSP.1986.1164940; Branstetter BK, 2012, J ACOUST SOC AM, V131, P1613, DOI 10.1121/1.3676694; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1984, CLASSIFICATION REGRE; Caldwell M.C., 1990, P199; CALDWELL MC, 1965, NATURE, V207, P434, DOI 10.1038/207434a0; Charif RA, 2001, MAR MAMMAL SCI, V17, P751, DOI 10.1111/j.1748-7692.2001.tb01297.x; Clark CW, 2000, J ACOUST SOC AM, V107, P3509, DOI 10.1121/1.429421; Connor RC, 2001, P ROY SOC B-BIOL SCI, V268, P263, DOI 10.1098/rspb.2000.1357; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cummings WC., 1994, J ACOUST SOC AM, V95, P2853, DOI DOI 10.1121/1.409514; DELGROSS.VA, 1974, J ACOUST SOC AM, V56, P1084, DOI 10.1121/1.1903388; Di Claudio ED, 2003, IEEE T SIGNAL PROCES, V51, P338, DOI 10.1109/TSP.2002.806866; DiBiase JH., 2000, HIGH ACCURACY LOW LA; Do H, 2007, INT CONF ACOUST SPEE, P121; DREHER JJ, 1961, J ACOUST SOC AM, V33, P1799, DOI 10.1121/1.1908584; FREITAG LE, 1993, J ACOUST SOC AM, V93, P2197, DOI 10.1121/1.406681; Gero S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150372; Giraudet P, 2006, APPL ACOUST, V67, P1106, DOI 10.1016/j.apacoust.2006.05.003; Greensted A, 2012, TYPE; GRUN F, 1967, B SCHWEIZ AKAD MED, V23, P384; Isaacs JT, 2009, IEEE DECIS CONTR P, P7878, DOI 10.1109/CDC.2009.5399478; Janik VM, 2013, J COMP PHYSIOL A, V199, P479, DOI 10.1007/s00359-013-0817-7; Janik VM, 2013, MAR MAMMAL SCI, V29, P109, DOI 10.1111/j.1748-7692.2011.00549.x; Janik VM, 2000, MAR MAMMAL SCI, V16, P437, DOI 10.1111/j.1748-7692.2000.tb00935.x; KNAPP CH, 1976, IEEE T ACOUST SPEECH, V24, P320, DOI 10.1109/TASSP.1976.1162830; Kotsiantis SB, 2006, ARTIF INTELL REV, V26, P159, DOI [10.1007/s10462-007-9052-3, 10.1007/S10462-007-9052-3]; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Krutzen M, 2003, P ROY SOC B-BIOL SCI, V270, P497, DOI 10.1098/rspb.2002.2229; Kusel ET, 2017, OCEAN SCI, V13, P273, DOI 10.5194/os-13-273-2017; Li X, 2014, SCI REPORTS, V4, P668; Li XY, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4947001; LILLY JC, 1961, SCIENCE, V134, P1873, DOI 10.1126/science.134.3493.1873; Lin C, PROCEDIA ENG, V15, P4912; Lopez-Rivas RM, 2010, APPL ACOUST, V71, P1057, DOI 10.1016/j.apacoust.2010.05.006; Mallawaarachchi A, 2008, J ACOUST SOC AM, V124, P1159, DOI 10.1121/1.2945711; McCowan B, 1999, ANIM BEHAV, V57, P409, DOI 10.1006/anbe.1998.1000; MCCOWAN B, 1995, ETHOLOGY, V100, P177; MCCOWAN B, 1995, ETHOLOGY, V100, P194, DOI 10.1111/j.1439-0310.1995.tb00325.x; McCowan B., 1998, Aquatic Mammals, V24, P27; McCowan B, 2001, ANIM BEHAV, V62, P1151, DOI 10.1006/anbe.2001.1846; MCCOWAN B, 1995, J COMP PSYCHOL, V109, P242, DOI 10.1037/0735-7036.109.3.242; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Michalopoulou ZH, 2011, J ACOUST SOC AM, P2924; Navidi W, 1998, COMPUT STAT DATA AN, V27, P209, DOI 10.1016/S0167-9473(97)00053-4; Nosal EM, 2006, APPL ACOUST, V67, P1187, DOI 10.1016/j.apacoust.2006.05.005; Nosal EM, 2013, J ACOUST SOC AM, V134, P2383, DOI 10.1121/1.4816549; Oppenheim A.V, 1999, DISCRETE TIME SIGNAL; Reiss D, 2001, P NATL ACAD SCI USA, V98, P5937, DOI 10.1073/pnas.101086398; Rendell LE, 1999, J ZOOL, V249, P403, DOI 10.1017/S0952836999009875; Sargeant BL, 2005, CAN J ZOOL, V83, P1400, DOI 10.1139/Z05-136; Sayigh LS, 2007, ANIM BEHAV, V74, P1631, DOI 10.1016/j.anbehav.2007.02.018; Shirihai H., 2006, WHALES DOLPHINS OTHE; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Smith J David, 2010, Int J Comp Psychol, V23, P401; SMITH JO, 1987, IEEE J OCEANIC ENG, V12, P246, DOI 10.1109/JOE.1987.1145217; Spiesberger JL, 1998, J ACOUST SOC AM, V104, P300, DOI 10.1121/1.423257; Spiesberger JL, 1999, J ACOUST SOC AM, V106, P837, DOI 10.1121/1.427100; Stafford KM, 1998, J ACOUST SOC AM, V104, P3616, DOI 10.1121/1.423944; STEINER WW, 1981, BEHAV ECOL SOCIOBIOL, V9, P241, DOI 10.1007/BF00299878; Thode A, 2005, J ACOUST SOC AM, V118, P3575, DOI 10.1121/1.2049068; Thomas RE, 2002, J ACOUST SOC AM, V112, P1692, DOI 10.1121/1.1494805; TYACK P, 1985, J ACOUST SOC AM, V78, P1892, DOI 10.1121/1.392777; TYACK P, 1986, BEHAV ECOL SOCIOBIOL, V18, P251, DOI 10.1007/BF00300001; Van Veen BD, 1998, IEEE ASSP MAGAZINE, P1; WAHBA G., 1990, SPLINE MODELS OBSERV, V59, DOI [10.1137/1.9781611970128, DOI 10.1137/1.9781611970128]; WATKINS WA, 1974, J MAMMAL, V55, P319, DOI 10.2307/1379001; Watwood SL, 2005, ANIM BEHAV, V69, P1373, DOI 10.1016/j.anbehav.2004.08.019; Wei Meng, 2012, 2012 15th International Conference on Information Fusion (FUSION 2012), P1897; White PR, 2006, APPL ACOUST, V67, P1074, DOI 10.1016/j.apacoust.2006.05.002; Williams NJ, 1998, HEAD AND NECK CANCER, P89; Yack TM, 2013, J ACOUST SOC AM, V134, P2589, DOI 10.1121/1.4816585; Yang B, 2007, INT CONF ACOUST SPEE, P1093; Zimmer WM., 2011, PASSIVE ACOUSTIC MON, DOI 10.1017/CBO9780511977107; 2005, EUROPEAN HEART J SB, V7	83	2	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235155	10.1371/journal.pone.0235155	http://dx.doi.org/10.1371/journal.pone.0235155			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584861	Green Published, gold			2022-12-27	WOS:000545747200095
J	Yang, YM; Wan, HS; Yang, F; Xiao, C; Li, J; Ye, MJ; Chen, CX; Deng, GM; Wang, Q; Li, AL; Mao, L; Yang, WY; Zhou, YH				Yang, Yumin; Wan, Hongshen; Yang, Fan; Xiao, Chun; Li, Jun; Ye, Meijin; Chen, Chunxiu; Deng, Guangmin; Wang, Qin; Li, Aili; Mao, Long; Yang, Wuyun; Zhou, Yonghong			Mapping QTLs for enhancing early biomass derived fromAegilops tauschiiin synthetic hexaploid wheat	PLOS ONE			English	Article							AEGILOPS-TAUSCHII; SEGREGATION DISTORTION; MOLECULAR MARKERS; TRITICUM-AESTIVUM; EARLY VIGOR; GENETIC-IMPROVEMENT; GENOMIC REGIONS; HYBRID NECROSIS; TRAIT LOCI; RESISTANCE	Strong early vigour plays a crucial role in wheat yield improvement by enhancing resource utilization efficiency. Synthetic hexaploid wheat (SHW) combines the elite genes of tetraploid wheat withAegilops tauschiiand has been widely used in wheat genetic improvement for its abundant genetic variation. The two SHWs Syn79 and Syn80 were derived from the crossing of the same tetraploid wheat DOY1 with two differentAe.tauschiiaccessions, AT333 and AT428, respectively. The Syn80 possessed better early vigour traits than Syn79, theretically caused by their D genome fromAe.tauschii. To dissect their genetic basis in a hexaploid background, 203 recombinant inbred lines (RILs) derived from the cross of Syn79 x Syn80 were developed to detect quantitative trait loci (QTL) for four early biomass related traits: plant height (PH), tiller number (TN), shoot fresh weight (SFW) and shoot dry weight (SDW) per plant, under five different environmental conditions. Determined from the data of SNP markers, two genome regions on 1DS and 7D were stably associated with the four early biomass related traits showing pleiotropic effects. Four stable QTLsQPh.saas-1DS,QTn.saas-1DS,QSfw.saas-1DSandQSdw.saas-1DSexplaining 7.92, 15.34, 9.64 and 10.15% of the phenotypic variation, respectively, were clustered in the region of 1DS fromAX-94812958toAX-110910133. Meanwhile,QPh.saas-7D,QTn.saas-7D,QSfw.saas-7DandQSdw.saas-7Dwere flanked byAX-109917900andAX-110605376on 7D, explaining 16.12, 24.35, 15.25 and 13.37% of the phenotypic variation on average, respectively. Moreover, these genomic QTLs on 1DS and 7D enhancing biomass in the parent Syn80 were fromAe.tauschiiAT428. These findings suggest that these two QTLs fromAe.tauschiican be expressed stably in a hexaploid background at the jointing stage and be used for wheat improvement.	[Yang, Yumin; Yang, Fan; Ye, Meijin; Zhou, Yonghong] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Peoples R China; [Yang, Yumin; Xiao, Chun; Chen, Chunxiu; Deng, Guangmin] Sichuan Acad Agr Sci, Soil & Fertilizer Res Inst, Chengdu, Peoples R China; [Yang, Yumin; Wan, Hongshen; Li, Jun; Wang, Qin; Yang, Wuyun] Minist Agr & Rural Areas, Key Lab Wheat Biol & Genet Improvement SouthWeste, Chengdu, Peoples R China; [Wan, Hongshen; Li, Jun; Yang, Wuyun] Sichuan Acad Agr Sci, Crop Res Inst, Chengdu, Peoples R China; [Li, Aili; Mao, Long] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China	Sichuan Agricultural University; Sichuan Academy of Agricultural Sciences (SAAS); Sichuan Academy of Agricultural Sciences (SAAS); Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhou, YH (corresponding author), Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Peoples R China.; Yang, WY (corresponding author), Minist Agr & Rural Areas, Key Lab Wheat Biol & Genet Improvement SouthWeste, Chengdu, Peoples R China.; Yang, WY (corresponding author), Sichuan Acad Agr Sci, Crop Res Inst, Chengdu, Peoples R China.	yangwuyun@126.com; zhouyhdavid@126.com	YANG, FAN/F-2603-2015	YANG, FAN/0000-0002-0355-3044	National Natural Science Foundation of China [31661143007, 31401383]; Department of Science and Technology of Sichuan Province [2017JY0077, 2017JY0286, 2020YJ0469]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province	This work was financially supported by National Natural Science Foundation of China (Grant No. 31661143007, 31401383) and Department of Science and Technology of Sichuan Province (Grant No. 2017JY0077, 2017JY0286, 2020YJ0469).	[Anonymous], 2017, Drug Ther Bull, V55, P33, DOI 10.1136/dtb.2017.3.0463; Ayalew H, 2018, PLANT MOL BIOL REP, V36, P399, DOI 10.1007/s11105-018-1093-z; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Botwright TL, 2002, AUST J AGR RES, V53, P1137, DOI 10.1071/AR02007; Bultynck L, 2004, ANN BOT-LONDON, V94, P99, DOI 10.1093/aob/mch110; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Cao TingJie, 2015, Acta Agronomica Sinica, V41, P197; Das MK, 2016, GENET RESOUR CROP EV, V63, P1285, DOI 10.1007/s10722-015-0312-9; Deng S.H., 2005, J SICHUAN NORMAL U S, V32, P125; Dubcovsky J, 2006, PLANT MOL BIOL, V60, P469, DOI 10.1007/s11103-005-4814-2; Dvorak J, 1998, GENETICS, V148, P423; Dvorak J, 1998, THEOR APPL GENET, V97, P657, DOI 10.1007/s001220050942; Dvorak J, 2012, J HERED, V103, P426, DOI 10.1093/jhered/esr152; El Bouhssini M, 2013, GENET RESOUR CROP EV, V60, P621, DOI 10.1007/s10722-012-9861-3; Genc Y, 2010, THEOR APPL GENET, V121, P877, DOI 10.1007/s00122-010-1357-y; Goloenko IM, 2002, RUSS J GENET+, V38, P791, DOI 10.1023/A:1016343705826; Gororo NN, 2001, ANN BOT-LONDON, V88, P947, DOI 10.1006/anbo.2001.1531; Guo Y, 2012, THEOR APPL GENET, V124, P851, DOI 10.1007/s00122-011-1749-7; Harushima Y, 1996, THEOR APPL GENET, V92, P145, DOI 10.1007/BF00223368; Harushima Y, 2002, GENETICS, V160, P313; He P, 2001, CROP SCI, V41, P1240, DOI 10.2135/cropsci2001.4141240x; KIHARA H, 1944, AGR HORTIC, V19, P889, DOI DOI 10.1016/J.JGG.2011.07.002; Landjeva S, 2008, BIOL PLANTARUM, V52, P259, DOI 10.1007/s10535-008-0056-x; Landjeva S, 2010, EUPHYTICA, V171, P129, DOI 10.1007/s10681-009-0016-3; Li AL, 2018, ENGINEERING-PRC, V4, P552, DOI 10.1016/j.eng.2018.07.001; Li AL, 2014, PLANT CELL, V26, P1878, DOI 10.1105/tpc.114.124388; Li ChaoSu, 2016, Acta Agronomica Sinica, V42, P803; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li J, 2014, J SYST EVOL, V52, P735, DOI 10.1111/jse.12110; [刘易科 Liu Yike], 2020, [作物学报, Acta Agronomica Sinica], V46, P307; LUBBERS EL, 1991, GENOME, V34, P354, DOI 10.1139/g91-057; Luo MC, 2007, THEOR APPL GENET, V114, P947, DOI 10.1007/s00122-006-0474-0; Luo MC, 2017, NATURE, V551, P498, DOI 10.1038/nature24486; Matsuda R, 2012, GENES GENET SYST, V87, P137, DOI 10.1266/ggs.87.137; Matsuoka Y, 2007, THEOR APPL GENET, V115, P509, DOI 10.1007/s00122-007-0584-3; MCFADDEN ES, 1946, J HERED, V37, P81, DOI 10.1093/oxfordjournals.jhered.a105590; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; Mizuno N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011326; Mizuno N, 2010, MOL ECOL, V19, P999, DOI 10.1111/j.1365-294X.2010.04537.x; MujeebKazi A, 1996, GENET RESOUR CROP EV, V43, P129, DOI 10.1007/BF00126756; Mulki MA, 2013, MOL BREEDING, V31, P299, DOI 10.1007/s11032-012-9790-z; NAKAI Y, 1979, JPN J GENET, V54, P175, DOI 10.1266/jjg.54.175; Ni Zhong-Fu, 2002, Acta Genetica Sinica, V29, P542; NISHIKAWA K, 1962, JPN J GENET, V37, P227, DOI 10.1266/jjg.37.227; Nishikawa K., 1973, Proceedings of the fourth international wheat genetics symposium. Biochemical and physiological genetics., P851; Passioura JB, 1996, PLANT GROWTH REGUL, V20, P79, DOI 10.1007/BF00024003; Rashid MR, 2013, ASIAN J AGR BIO, V1, P91; Rebetzke GJ, 2005, PLANT SOIL, V272, P87, DOI 10.1007/s11104-004-4040-8; Ryan PR, 2015, J EXP BOT, V66, P7089, DOI 10.1093/jxb/erv403; Su JY, 2009, PLANT SCI, V176, P824, DOI 10.1016/j.plantsci.2009.03.006; Takumi S, 2013, GENETICA, V141, P463, DOI 10.1007/s10709-013-9745-2; [汤永禄 Tang Yonglu], 2010, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V49, P86; ter Steege MW, 2005, PLANT PHYSIOL, V139, P1078, DOI 10.1104/pp.105.063263; Van Ginkel M, 2007, DEV PLANT BREED, V12, P383; Wan HS, 2015, EUPHYTICA, V205, P275, DOI 10.1007/s10681-015-1457-5; Wang JR, 2013, NEW PHYTOL, V198, P925, DOI 10.1111/nph.12164; Wang YongJun, 2004, Acta Agronomica Sinica, V30, P413; Xu Y, 1997, MOL GEN GENET, V253, P535, DOI 10.1007/s004380050355; Yang WY, 2009, J GENET GENOMICS, V36, P539, DOI 10.1016/S1673-8527(08)60145-9; Yang WY, 1998, GENET RESOUR CROP EV, V45, P395, DOI 10.1023/A:1008651901159; [杨玉敏 Yang Yumin], 2015, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V21, P1123; Yoshida T, 2010, THEOR APPL GENET, V120, P543, DOI 10.1007/s00122-009-1174-3; Zhao Bing, 2006, Acta Genetica Sinica, V33, P449, DOI 10.1016/S0379-4172(06)60072-3; Zhao GY, 2017, NAT PLANTS, V3, P946, DOI 10.1038/s41477-017-0067-8	64	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234882	10.1371/journal.pone.0234882	http://dx.doi.org/10.1371/journal.pone.0234882			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584908	gold, Green Published			2022-12-27	WOS:000545747200082
J	Lanyero, H; Eriksen, J; Obua, C; Lundborg, CS; Nanzigu, S; Katureebe, A; Kalyango, JN; Ocan, M				Lanyero, Hindum; Eriksen, Jaran; Obua, Celestino; Stalsby Lundborg, Cecilia; Nanzigu, Sarah; Katureebe, Agaba; Kalyango, Joan N.; Ocan, Moses			Use of antibacterials in the management of symptoms of acute respiratory tract infections among children under five years in Gulu, northern Uganda: Prevalence and determinants	PLOS ONE			English	Article							ANTIBIOTIC USE; HEALTH-CARE; KNOWLEDGE; PNEUMONIA; ATTITUDES; BEHAVIOR; BELIEFS; ILLNESS; UNDER-5	Inappropriate use of antibacterials is a major public health challenge as it can promote emergence of resistance, wastage of financial resources, morbidity and mortality. In this study, we determined the prevalence and factors associated with antibacterial use in managing symptoms of acute respiratory tract infections (ARIs) in households in rural communities of Gulu district, northern Uganda. A cross-sectional study was conducted among households selected using multi-stage sampling. Data were collected through interviews with care-givers of children under five years, using a structured interviewer administered questionnaire. Out of the 856 children who had symptoms of ARIs, 515 (60.2%; CI: 54.5%-65.6%) were treated with antibacterials. The most commonly used antibacterials were amoxicillin (55.2%, n = 358), cotrimoxazole (15.4%, n = 100) and metronidazole (11.4%, n = 74). The determinants of antibacterial use included; getting treatment from a health facility (AOR: 1.85, CI: 1.34-2.56,P< 0.001), households located in peri-urban area (AOR: 2.54, CI: 1.34-4.84,P= 0.005), and a child having cough (AOR: 7.02, CI: 4.36-11.31,P< 0.001). The prevalence of antibacterial use among children under five years with symptoms of ARIs is high in communities of Gulu district, northern Uganda. Getting treatment from a health facility, if a household was located in a peri-urban area and having a cough are positive predictors of antibacterial use. There is need for targeted education on appropriate antibacterial use in rural communities and hospital settings where over prescription is most likely especially in treating symptoms of ARIs among children under five years.	[Lanyero, Hindum; Nanzigu, Sarah; Ocan, Moses] Makerere Univ, Dept Pharmacol & Therapeut, Coll Hlth Sci, Kampala, Uganda; [Eriksen, Jaran; Stalsby Lundborg, Cecilia] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Eriksen, Jaran] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Obua, Celestino] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Katureebe, Agaba] Infect Dis Res Collaborat, Kampala, Uganda; [Kalyango, Joan N.] Makerere Univ, Dept Pharm, Coll Hlth Sci, Kampala, Uganda; [Kalyango, Joan N.] Makerere Univ, Clin Epidemiol Unit, Coll Hlth Sci, Kampala, Uganda	Makerere University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Mbarara University of Science & Technology; Makerere University; Makerere University	Lanyero, H (corresponding author), Makerere Univ, Dept Pharmacol & Therapeut, Coll Hlth Sci, Kampala, Uganda.	lhindum@gmail.com		Stalsby Lundborg, Cecilia/0000-0001-6525-1861; Lanyero, Hindum/0000-0002-2798-1107; Ocan, Moses/0000-0002-8852-820X; Eriksen, Jaran/0000-0003-1146-5615	Makerere University -SIDA collaboration (Sida) [PI0010]	Makerere University -SIDA collaboration (Sida)	Makerere University -SIDA collaboration (Sida PI0010) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisa R, 2018, AFR HEALTH SCI, V18, P1189, DOI 10.4314/ahs.v18i4.40; Al-Shawi MM, 2018, J FAM COMMUNITY MED, V25, P5, DOI 10.4103/jfcm.JFCM_46_17; Alanazi AA, 2013, J PHARM BIOMEDICAL S, V29, P801; [Anonymous], 2016, J LARGE SCALE RES FA, V2, pA49; Arnold BF, 2013, AM J EPIDEMIOL, V177, P361, DOI 10.1093/aje/kws281; Arroll B, 2005, RESP MED, V99, P255, DOI 10.1016/j.rmed.2004.11.004; Bbosa G. S., 2014, Health, V6, P171, DOI 10.4236/health.2014.62027; Bhuyan GS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174488; Bjornstad E, 2014, PAEDIATR INT CHILD H, V34, P29, DOI 10.1179/2046905513Y.0000000070; Nga DTT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-6; Ekambi GAE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212875; Eriksen J, 2005, TROP MED INT HEALTH, V10, P1038, DOI 10.1111/j.1365-3156.2005.01486.x; Flores-Hernandez S, 1999, Gac Med Mex, V135, P121; Goldman N, 1998, INT J EPIDEMIOL, V27, P505, DOI 10.1093/ije/27.3.505; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Gonzales R, 2001, ANN EMERG MED, V37, P690, DOI 10.1067/S0196-0644(01)70087-X; Gwimile JJ, 2012, PAN AFR MED J, V12; Hoa NQ, 2009, TROP MED INT HEALTH, V14, P546, DOI 10.1111/j.1365-3156.2009.02267.x; Kibuule D, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.12918; Kibuule D, 2016, EXPERT REV ANTI-INFE, V14, P863, DOI 10.1080/14787210.2016.1206468; Kish L, 1995, SCI 1995; Lee PH, 2014, J EPIDEMIOL; MENGISTU A., 2014, DRUG SAFETY, V1, P1; Mengistu Assegid, 2013, J Pharm Policy Pract, V6, P4, DOI 10.1186/2052-3211-6-4; Ministry of Health U, 2002, UG NAT DRUG POL; Moses O, 2016, ANTIMICROBIAL SELF M; Nambiar S, 2002, ARCH PEDIAT ADOL MED, V156, P621, DOI 10.1001/archpedi.156.6.621; Nepal G, 2018, CUREUS, V10, DOI 10.7759/cureus.2428; Nguyen Quynh H, 2010, HIGH ANTIBIOTIC USE; Nyquist AC, 1988, JAMA-J AM MED ASSOC, V279, P875; O'Connor R, 2018, IRISH J MED SCI, V187, P969, DOI 10.1007/s11845-018-1774-5; Ocan M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4770-1; OFORIASENSO R, 2016, PHARMACY, V4, P61295, DOI [DOI 10.3390/pharmacy4040035, DOI 10.3390/PHARMACY4040035]; Pan DST, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0547-3; Pavyde E, 2015, INT J ENV RES PUB HE, V12, P7002, DOI 10.3390/ijerph120607002; Rashid MM, 2017, PATIENT PREFER ADHER, V11, P1335, DOI 10.2147/PPA.S140002; S BE, 2018, J CROHNS COLITIS, V12, pS049; Serisier DJ, 2013, LANCET RESP MED, V1, P262, DOI 10.1016/S2213-2600(13)70038-9; Skinner C.J., 2014, PROBABILITY PROPORTI, P1, DOI [10.1002/9781118445112.stat03346, DOI 10.1002/9781118445112.STAT03346]; Togoobaatar G, 2010, B WORLD HEALTH ORGAN, V88, P930, DOI 10.2471/BLT.10.079004; Uganda Bureau of Statistics, 2016, NAT POP HOUS CENS 20; Vialle-Valentin CE, 2012, TROP MED INT HEALTH, V17, P211, DOI 10.1111/j.1365-3156.2011.02895.x; Wutzke SE, 2007, HEALTH PROMOT INT, V22, P53, DOI 10.1093/heapro/dal034; Zoorob R, 2012, AM FAMILY PHYS, V86	44	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235164	10.1371/journal.pone.0235164	http://dx.doi.org/10.1371/journal.pone.0235164			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574206	gold, Green Published			2022-12-27	WOS:000544972400016
J	Schmitt, CA; Bergey, CM; Jasinska, AJ; Ramensky, V; Burt, F; Svardal, H; Jorgensen, MJ; Freimer, NB; Grobler, JP; Turner, TR				Schmitt, Christopher A.; Bergey, Christina M.; Jasinska, Anna J.; Ramensky, Vasily; Burt, Felicity; Svardal, Hannes; Jorgensen, Matthew J.; Freimer, Nelson B.; Grobler, J. Paul; Turner, Trudy R.			ACE2 and TMPRSS2 variation in savanna monkeys (Chlorocebus spp.): Potential risk for zoonotic/anthroponotic transmission of SARS-CoV-2 and a potential model for functional studies	PLOS ONE			English	Article							CORONAVIRUS SPIKE PROTEIN; SARS-CORONAVIRUS; VERVET MONKEYS; COVID-19; REHABILITATION; CONSERVATION; ACTIVATION; HUMANS; GENOME; GREEN	The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has devastated health infrastructure around the world. Both ACE2 (an entry receptor) and TMPRSS2 (used by the virus for spike protein priming) are key proteins to SARS-CoV-2 cell entry, enabling progression to COVID-19 in humans. Comparative genomic research into critical ACE2 binding sites, associated with the spike receptor binding domain, has suggested that African and Asian primates may also be susceptible to disease from SARS-CoV-2 infection. Savanna monkeys (Chlorocebusspp.) are a widespread non-human primate with well-established potential as a bi-directional zoonotic/anthroponotic agent due to high levels of human interaction throughout their range in sub-Saharan Africa and the Caribbean. To characterize potential functional variation in savanna monkeyACE2andTMPRSS2, we inspected recently published genomic data from 245 savanna monkeys, including 163 wild monkeys from Africa and the Caribbean and 82 captive monkeys from the Vervet Research Colony (VRC). We found several missense variants. One missense variant inACE2(X:14,077,550; Asp30Gly), common inCh.sabaeus, causes a change in amino acid residue that has been inferred to reduce binding efficiency of SARS-CoV-2, suggesting potentially reduced susceptibility. The remaining populations appear as susceptible as humans, based on these criteria for receptor usage. All missense variants observed in wildCh.sabaeuspopulations are also present in the VRC, along with two splice acceptor variants (at X:14,065,076) not observed in the wild sample that are potentially disruptive to ACE2 function. The presence of these variants in the VRC suggests a promising model for SARS-CoV-2 infection and vaccine and therapy development. In keeping with a One Health approach, characterizing actual susceptibility and potential for bi-directional zoonotic/anthroponotic transfer in savanna monkey populations may be an important consideration for controlling COVID-19 epidemics in communities with frequent human/non-human primate interactions that, in many cases, may have limited health infrastructure.	[Schmitt, Christopher A.] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Bergey, Christina M.] Rutgers State Univ, Dept Genet, New Brunswick, NJ USA; [Jasinska, Anna J.; Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Jasinska, Anna J.] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Jasinska, Anna J.] Eye Primates, Los Angeles, CA USA; [Ramensky, Vasily] Minist Healthcare Russian Federat, Fed State Inst Natl Med Res Ctr Therapy & Prevent, Moscow, Russia; [Burt, Felicity] Natl Hlth Lab Serv, Div Med Virol, Bloemfontein, Free State, South Africa; [Burt, Felicity] Univ Free State, Div Virol, Fac Hlth Sci, Bloemfontein, Free State, South Africa; [Svardal, Hannes] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Svardal, Hannes] Nat Biodivers Ctr, Leiden, Netherlands; [Jorgensen, Matthew J.] Wake Forest Sch Med, Dept Pathol, Comparat Med Sect, Winston Salem, NC 27101 USA; [Grobler, J. Paul; Turner, Trudy R.] Univ Free State, Dept Genet, Bloemfontein, Free State, South Africa; [Turner, Trudy R.] Univ Wisconsin, Dept Anthropol, Milwaukee, WI 53201 USA	Boston University; Rutgers State University New Brunswick; University of California System; University of California Los Angeles; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; National Medical Research Center for Therapy & Preventive Medicine; University of the Free State; University of Antwerp; Naturalis Biodiversity Center; Wake Forest University; University of the Free State; University of Wisconsin System; University of Wisconsin Milwaukee	Schmitt, CA (corresponding author), Boston Univ, Dept Anthropol, Boston, MA 02215 USA.	caschmit@bu.edu	Burt, Felicity/AAB-6993-2020; Bergey, Christina/ADV-1840-2022	Burt, Felicity/0000-0002-7238-7799; Bergey, Christina/0000-0001-8336-8078; Jasinska, Anna/0000-0002-1897-4570; Svardal, Hannes/0000-0001-7866-7313; Grobler, Paul/0000-0002-5913-7031; Turner, Trudy/0000-0001-8615-442X	Boston University; NSF [SOC 74-24166, BNS 770-3322, BCS 0938969]; NIH [R01RR0163009, R01RR016300, R01OD010980]; University of WisconsinMilwaukee; University of the Free State, South Africa; University of Limpopo, South Africa; Coriell Institute; Austrian Ministry of Science and Research; National Institute of Neurological Disorders and Stroke (NINDS) Informatics Center for Neurogenetics and Neurogenomics [P30 NS062691]	Boston University; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of WisconsinMilwaukee; University of the Free State, South Africa; University of Limpopo, South Africa; Coriell Institute; Austrian Ministry of Science and Research; National Institute of Neurological Disorders and Stroke (NINDS) Informatics Center for Neurogenetics and Neurogenomics	This work was supported by funding from Boston University, to C.A.S., http://www.bu.edu.There was no additional external funding received for this study. Original data collection was supported by funding from NSF (SOC 74-24166, BNS 770-3322, BCS 0938969) to T.R.T., http://www.nsf.gov; NIH (R01RR0163009) to N.B.F., and to N.B.F. for the UCLA Systems Biology Sample Repository (R01RR016300 and R01OD010980), http://www.nih.gov; the University of WisconsinMilwaukee to T.R.T., http://www.uwm.edu; The University of the Free State, South Africa, to J.P.G., http://www.ufs.ac.za; the University of Limpopo, South Africa, to J.P.G., http://www.ul.ac.za; Coriell Institute, to T.R.T., http://www.coriell.org; the Austrian Ministry of Science and Research, to H.S, https://www.bmbwf.gv.at/.We acknowledge the support of the National Institute of Neurological Disorders and Stroke (NINDS) Informatics Center for Neurogenetics and Neurogenomics (P30 NS062691), to N.B.F., http://www.ninds.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r For the generation of this data, the authors gratefully acknowledge assistance in the field by Jennifer Danzy Cramer, Oliver "Pess" Morton, Yoon Jung, Stephanie Groman, David Jentsch, Eugene Redmond and the St. Kitts Biomedical Research Foundation in St. Kitts; veterinarians Lizanne Meiring, Murray Stokoe and numerous field assistants in South Africa including especially Gabriel Coetzer, Magali Jacquier, Helene DeNys, JD Pampush, Elzet Answegen, Tegan Gaetano, Dewald DuPlessis, Micah Beller, David Beller and Pess Morton; the University of Limpopo and the University of the Free State; and Mamkumba Sanneh, Katie Camfield, Michel Dione, Martin Antonio and the Medical Research Council in the Gambia. Collections of these data were conducted under permits and permissions issued by the following: Ethiopian Wildlife Conservation Authority; Gambia Department of Parks and Wildlife Management; Ministry of Tourism and Wildlife, Kenya; in South Africa the Department of Economic Development and Environmental Affairs, Eastern Cape; Department of Tourism, Environmental and Economic Affairs, Free State Province; Ezemvelo KZN Wildlife; Department of Economic Development, Environment and Tourism, Limpopo; the Department of Agriculture, Conservation and Environment, Mpumalanga and the Department of Environment and Nature Conservation, Northern Cape, as well as the South African National Department of Environmental Affairs.	Afar DEH, 2001, CANCER RES, V61, P1686; American Veterinary Medical Association, COVID 19 FAQS PET OW; Anderson CJ, 2017, SOUTHEAST NAT, V16, P19, DOI 10.1656/058.016.0103; Bao L., 2020, REINFECTION COULD NO, DOI [10.1101/2020.03.13.990226, DOI 10.1101/2020.03.13.990226V1]; Benavides J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031290; Blaszczyk MB, 2017, ANIM BEHAV, V123, P91, DOI 10.1016/j.anbehav.2016.10.017; Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1; Centers for Disease Control and Prevention, YOU HAV AN; Clark NL, 2005, PLOS GENET, V1, P335, DOI 10.1371/journal.pgen.0010035; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Denham WW, 1982, J BARBADOS MUSEUM HI, V36, P211; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dore KM, 2018, FOLIA PRIMATOL, V89, P63, DOI 10.1159/000479064; Gaetano TJ, 2014, S AFR J WILDL RES, V44, P56, DOI 10.3957/056.044.0105; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Gillespie TR, 2008, YEARB PHYS ANTHROPOL, V51, P53, DOI 10.1002/ajpa.20949; GROBLER P., 2006, ECOLOGICAL ENV ANTHR, V2, P12; Groves C.P., 2001, PRIMATE TAXONOMY; Healy A, 2014, ANIM WELFARE, V23, P353, DOI 10.7120/09627286.23.3.353; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hopman J, 2020, JAMA-J AM MED ASSOC, V323, P1549, DOI 10.1001/jama.2020.4169; Huang X, 2019, BIOINFORMATICS, DOI [10.1093/bioinformatics/btz926.36, DOI 10.1093/BIOINFORMATICS/BTZ926.36]; Jasinska AJ, 2013, ILAR J, V54, P122, DOI 10.1093/ilar/ilt049; Jia HP, 2006, ADV EXP MED BIOL, V581, P479; Karczewski K.J., 2019, GENOMICS, DOI [10.1101/531210, DOI 10.1101/531210]; Kelly TR, 2020, ONE HEALTH OUTLOOK, V2, DOI 10.1186/s42522-019-0007-9; Leendertz SAJ, 2017, MAMMAL REV, V47, P98, DOI 10.1111/mam.12082; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li R, 2020, J INFECTION, V80, P469, DOI 10.1016/j.jinf.2020.02.013; Liu ZX, 2020, J MED VIROL, V92, P595, DOI 10.1002/jmv.25726; Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; McAuliffe J, 2004, VIROLOGY, V330, P8, DOI 10.1016/j.virol.2004.09.030; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Melin Amanda D, 2020, bioRxiv, DOI 10.1101/2020.04.09.034967; Mikula P, 2018, BEHAV PROCESS, V147, P21, DOI 10.1016/j.beproc.2017.12.011; Nasiri MJ, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00459; Ramensky V, 2019, BIORXIV, DOI [10.1101/784132, DOI 10.1101/784132]; Saj TL, 2001, AFR J ECOL, V39, P195, DOI 10.1046/j.0141-6707.2000.00299.x; Schmitt C.A., 2020, ANTHROPOGENIC FOOD E, DOI [10.1101/2020.04.18.048314, DOI 10.1101/2020.04.18.048314]; Senghore M, 2016, APPL ENVIRON MICROB, V82, P5910, DOI 10.1128/AEM.01496-16; Shan C, 2020, RES SQUARE, DOI [10.21203/rs.2.25200/v1, DOI 10.21203/RS.2.25200/V1]; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2013, ANTIVIR RES, V100, P605, DOI 10.1016/j.antiviral.2013.09.028; South African Government, REG GUID COR COV 19; Svardal H, 2017, NAT GENET, V49, P1705, DOI 10.1038/ng.3980; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HEALTH, V8, pe545; Turner TR, 2019, SAVANNA MONKEYS: THE GENUS CHLOROCEBUS, P1, DOI 10.1017/9781139019941; Turner TR, 2018, AM J PHYS ANTHROPOL, V166, P682, DOI 10.1002/ajpa.23459; Warren WC, 2015, GENOME RES, V25, P1921, DOI 10.1101/gr.192922.115; Wimberger K, 2010, ANIM WELFARE, V19, P481; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; Wu C., 2020, SILICO ANAL INTERMED, DOI [10.26434/chemrxiv.12057996.v1, DOI 10.26434/CHEMRXIV.12057996.V1]; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yu P, 2020, ANIM MODEL EXP MED, V3, P93, DOI 10.1002/ame2.12108; Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9; Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022	61	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235106	10.1371/journal.pone.0235106	http://dx.doi.org/10.1371/journal.pone.0235106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574196	Green Published, Green Submitted, gold			2022-12-27	WOS:000544972400038
J	von der Esch, E; Kohles, AJ; Anger, PM; Hoppe, R; Niessner, R; Elsner, M; Ivleva, NP				von der Esch, Elisabeth; Kohles, Alexander J.; Anger, Philipp M.; Hoppe, Roland; Niessner, Reinhard; Elsner, Martin; Ivleva, Natalia P.			TUM-ParticleTyper: A detection and quantification tool for automated analysis of (Microplastic) particles and fibers	PLOS ONE			English	Article							NILE RED; FILTER SUBSTRATE; IDENTIFICATION; FTIR; MICROSPECTROSCOPY; MICROSCOPY; FALLOUT; WATER; MP	TUM-ParticleTyperis a novel program for the automated detection, quantification and morphological characterization of fragments, including particles and fibers, in images from optical, fluorescence and electron microscopy (SEM). It can be used to automatically select targets for subsequent chemical analysis, e.g., Raman microscopy, or any other single particle identification method. The program was specifically developed and validated for the analysis of microplastic particles on gold coated polycarbonate filters. Our method development was supported by the design of a filter holder that minimizes filter roughness and facilitates enhanced focusing for better images and Raman measurements. TheTUM-ParticleTypersoftware is tunable to the user's specific sample demands and can extract the morphological characteristics of detected objects (coordinates, Feret's diameter min / max, area and shape). Results are saved in csv-format and contours of detected objects are displayed as an overlay on the original image. Additionally, the program can stitch a set of images to create a full image out of several smaller ones. An additional useful feature is the inclusion of a statistical process to calculate the minimum number of particles that must be chemically identified to be representative of all particles localized on the substrate. The program performance was evaluated on genuine microplastic samples. TheTUM-ParticleTypersoftware localizes particles using an adaptive threshold with results comparable to the "gold standard" method (manual localization by an expert) and surpasses the commonly usedOtsuthresholding by doubling the rate of true positive localizations. This enables the analysis of a statistically significant number of particles on the filter selected by random sampling, measured via single point approach. This extreme reduction in measurement points was validated by comparison to chemical imaging, applying both procedures to the same area at comparable processing times. The single point approach was both faster and more accurate proving the applicability of the presented program.	[von der Esch, Elisabeth; Kohles, Alexander J.; Anger, Philipp M.; Hoppe, Roland; Niessner, Reinhard; Elsner, Martin; Ivleva, Natalia P.] Tech Univ Munich, Inst Hydrochem, Chair Analyt Chem & Water Chem, Munich, Germany	Technical University of Munich	Ivleva, NP (corresponding author), Tech Univ Munich, Inst Hydrochem, Chair Analyt Chem & Water Chem, Munich, Germany.	natalia.ivleva@tum.de	Elsner, Martin/J-4637-2012; Ivleva, Natalia/AAQ-9987-2020	Elsner, Martin/0000-0003-4746-9052; Ivleva, Natalia/0000-0002-7685-5166	Bayerische Forschungsstiftung [AZ-1258-16]; German Federal Ministry of Education and Research [02WRS1378C]; German Research Foundation (DFG); Technical University of Munich, within the funding program Open Access Publishing	Bayerische Forschungsstiftung; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich, within the funding program Open Access Publishing	Funding by the Bayerische Forschungsstiftung (https://www.forschungsstiftung.de/) for the Project MiPaq "Microparticles in the aquatic environment and in foodstuffs" are biodegradable polymers a conceivable solution to the "microplastic problem"?, AZ-1258-16 is gratefully acknowledged. Funding by the German Federal Ministry of Education and Research https://www.bmbf.de/for the Project MiWa -Microplastic in the water cycle, 02WRS1378C is gratefully acknowledged. Furthermore, this work was supported by the German Research Foundation (DFG, https://www.dfg.de/) and the Technical University of Munich, within the funding program Open Ac-cess Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anger PM, 2018, TRAC-TREND ANAL CHEM, V109, P214, DOI 10.1016/j.trac.2018.10.010; Anger PM, 2019, ANAL METHODS; [Anonymous], 2006, AM J KIDNEY DIS, V2006, pS176; [Anonymous], 2016, IM THRESH; Bassan P, 2010, ANALYST, V135, P268, DOI 10.1039/b921056c; Bittrich L., 2018, GEPARD GEPARD ENABLE; Cabernard L, 2018, ENVIRON SCI TECHNOL, V52, P13279, DOI 10.1021/acs.est.8b03438; Catarino AI, 2018, ENVIRON POLLUT, V237, P675, DOI 10.1016/j.envpol.2018.02.069; Chae Y, 2018, ENVIRON POLLUT, V240, P387, DOI 10.1016/j.envpol.2018.05.008; Dris R, 2016, MAR POLLUT BULL, V104, P290, DOI 10.1016/j.marpolbul.2016.01.006; Eerkes-Medrano D, 2015, WATER RES, V75, P63, DOI 10.1016/j.watres.2015.02.012; Erni-Cassola G, 2017, ENVIRON SCI TECHNOL, V51, P13641, DOI 10.1021/acs.est.7b04512; Huppertsberg S, 2018, ANAL BIOANAL CHEM, V410, P6343, DOI 10.1007/s00216-018-1210-8; Imhof HK, 2016, WATER RES, V98, P64, DOI 10.1016/j.watres.2016.03.015; Ivleva NP, 2017, ANGEW CHEM INT EDIT, V56, P1720, DOI 10.1002/anie.201606957; Kappler A, 2016, ANAL BIOANAL CHEM, V408, P8377, DOI 10.1007/s00216-016-9956-3; Kappler A, 2015, ANAL BIOANAL CHEM, V407, P6791, DOI 10.1007/s00216-015-8850-8; Kohles A.J., 2020, TUM PARTICLETYPER SO; Maes T, 2017, SCI REP-UK, V7, DOI 10.1038/srep44501; Ossmann BE, 2018, WATER RES, V141, P307, DOI 10.1016/j.watres.2018.05.027; Ossmann BE, 2017, ANAL BIOANAL CHEM, V409, P4099, DOI 10.1007/s00216-017-0358-y; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Prata JC, 2019, SCI TOTAL ENVIRON, V690, P1277, DOI 10.1016/j.scitotenv.2019.07.060; Primpke S, 2019, ANAL METHODS-UK, V11, P2138, DOI 10.1039/c9ay00126c; Primpke S, 2017, ANAL METHODS-UK, V9, P1499, DOI 10.1039/c6ay02476a; Renner Gerrit, 2018, Current Opinion in Environmental Science & Health, V1, P55, DOI 10.1016/j.coesh.2017.11.001; Schymanski D, 2018, WATER RES, V129, P154, DOI 10.1016/j.watres.2017.11.011; Shim WJ, 2016, MAR POLLUT BULL, V113, P469, DOI 10.1016/j.marpolbul.2016.10.049; Simon M, 2018, WATER RES, V142, P1, DOI 10.1016/j.watres.2018.05.019; Tagg AS, 2015, ANAL CHEM, V87, P6032, DOI 10.1021/acs.analchem.5b00495; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; Udupa JK, 2006, COMPUT MED IMAG GRAP, V30, P75, DOI 10.1016/j.compmedimag.2005.12.001; von der Esch E, 2020, FRONT CHEM, V8, DOI 10.3389/fchem.2020.00169	33	12	12	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234766	10.1371/journal.pone.0234766	http://dx.doi.org/10.1371/journal.pone.0234766			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574195	Green Published, gold			2022-12-27	WOS:000544972400022
J	Huang, J; Cui, Z; Gu, QH; Zhang, YM; Qu, Z; Wang, X; Wang, F; Cheng, XY; Meng, LQ; Liu, G; Zhao, MH				Huang, Jing; Cui, Zhao; Gu, Qiu-hua; Zhang, Yi-miao; Qu, Zhen; Wang, Xin; Wang, Fang; Cheng, Xu-yang; Meng, Li-qiang; Liu, Gang; Zhao, Ming-hui			Complement activation profile of patients with primary focal segmental glomerulosclerosis	PLOS ONE			English	Article							UROKINASE RECEPTOR; MICE; IGM; CONTRIBUTES; INJURY; DAMAGE; ROLES	Background Studies on adriamycin mice model suggest complement system is activated and together with IgM contributes to the glomerular injury of primary focal segmental glomerulosclerosis (FSGS). We recently reported primary FSGS patients with IgM and C3 deposition showed unfavorable therapeutic responses and worse renal outcomes. Here we examined the plasma and urinary complement profile of patients with primary FSGS, aiming to investigate the complement participation in FSGS pathogenesis. Methods Seventy patients with biopsy-proven primary FSGS were enrolled. The plasma and urinary levels of C3a, C5a, soluble C5b-9, C4d, C1q, MBL, and Bb were determined by commercial ELISA kits. Results The levels of C3a, C5a and C5b-9 in plasma and urine of FSGS patients were significantly higher than those in normal controls. The plasma and urinary levels of C5b-9 were positively correlated with urinary protein, renal dysfunction and interstitial fibrosis. The plasma C5a levels were positively correlated with the proportion of segmental sclerotic glomeruli. The urinary levels of Bb were elevated, positively correlated with C3a and C5b-9 levels, renal dysfunction, and interstitial fibrosis. The plasma C1q level was significantly decreased, and negatively correlated with urinary protein excretion. Urinary Bb level was a risk factor for no remission (HR = 3.348, 95% CI 1.264-8.870, P = 0.015) and ESRD (HR = 2.323, 95% CI 1.222-4.418, P = 0.010). Conclusion In conclusion, our results identified the systemic activation of complement in human primary FSGS, possibly via the classical and alternative pathway. The activation of complement system was partly associated with the clinical manifestations, kidney pathological damage, and renal outcomes.	[Huang, Jing; Cui, Zhao; Gu, Qiu-hua; Zhang, Yi-miao; Qu, Zhen; Wang, Xin; Wang, Fang; Cheng, Xu-yang; Meng, Li-qiang; Liu, Gang; Zhao, Ming-hui] Peking Univ, Div Renal, Hosp 1, Beijing, Peoples R China; [Huang, Jing; Cui, Zhao; Gu, Qiu-hua; Zhang, Yi-miao; Qu, Zhen; Wang, Xin; Wang, Fang; Cheng, Xu-yang; Meng, Li-qiang; Liu, Gang; Zhao, Ming-hui] Peking Univ, Inst Nephrol, Beijing, Peoples R China; [Huang, Jing; Cui, Zhao; Gu, Qiu-hua; Zhang, Yi-miao; Qu, Zhen; Wang, Xin; Wang, Fang; Cheng, Xu-yang; Meng, Li-qiang; Liu, Gang; Zhao, Ming-hui] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China; [Huang, Jing; Cui, Zhao; Gu, Qiu-hua; Zhang, Yi-miao; Qu, Zhen; Wang, Xin; Wang, Fang; Cheng, Xu-yang; Meng, Li-qiang; Liu, Gang; Zhao, Ming-hui] Minist Educ China, Key Lab CKD Prevent & Treatment, Beijing, Peoples R China; [Zhao, Ming-hui] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University; Ministry of Education, China	Cui, Z (corresponding author), Peking Univ, Div Renal, Hosp 1, Beijing, Peoples R China.; Cui, Z (corresponding author), Peking Univ, Inst Nephrol, Beijing, Peoples R China.; Cui, Z (corresponding author), Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China.; Cui, Z (corresponding author), Minist Educ China, Key Lab CKD Prevent & Treatment, Beijing, Peoples R China.	cuizhao@bjmu.edu.cn	Cui, Zhao/ABZ-9262-2022	Cui, Zhao/0000-0002-5837-1926	National Natural Science Foundation of China (NSFC) [81621092, 81330020, 81500542, 81622009]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (NSFC) to the Innovation Research Group (81621092) and other NSFC programs (81330020, 81500542, 81622009).	Addis-Lieser E, 2005, J IMMUNOL, V175, P1894, DOI 10.4049/jimmunol.175.3.1894; Cofiell R, 2015, BLOOD, V125, P3253, DOI 10.1182/blood-2014-09-600411; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; EMBER JA, 1998, HUMAN COMPLEMENT SYS, P241; Hillebrandt S, 2005, NAT GENET, V37, P835, DOI 10.1038/ng1599; Huang J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-81; Huang J, 2013, KIDNEY INT, V84, P366, DOI 10.1038/ki.2013.55; Lenderink AM, 2007, AM J PHYSIOL-RENAL, V293, pF555, DOI 10.1152/ajprenal.00403.2006; Mastellos D, 2001, J IMMUNOL, V166, P2479, DOI 10.4049/jimmunol.166.4.2479; Morita Y, 2000, J AM SOC NEPHROL, V11, P700, DOI 10.1681/ASN.V114700; Panzer SE, 2015, KIDNEY INT, V88, P528, DOI 10.1038/ki.2015.120; Rangan GK, 2004, KIDNEY INT, V66, P1838, DOI 10.1111/j.1523-1755.2004.00957.x; SCHWARTZ MM, 1995, AM J KIDNEY DIS, V25, P845, DOI 10.1016/0272-6386(95)90566-9; Schwartz MM, 2007, HEPINSTALLS PATHOLOG, V2, P156; Sorman A, 2014, MOL IMMUNOL, V61, P79, DOI 10.1016/j.molimm.2014.06.010; Strassheim D, 2013, J AM SOC NEPHROL, V24, P393, DOI 10.1681/ASN.2012020187; Thurman JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136558; Turnberg D, 2006, J IMMUNOL, V177, P4094, DOI 10.4049/jimmunol.177.6.4094; Vivarelli M, 2014, SEMIN THROMB HEMOST, V40, P472, DOI 10.1055/s-0034-1375299; Wada T, 2013, KIDNEY INT, V84, P441, DOI 10.1038/ki.2013.134; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; YAMAMOTO T, 1993, LUPUS, V2, P261, DOI 10.1177/096120339300200410; Yu F, 2010, KIDNEY INT, V77, P820, DOI 10.1038/ki.2010.13; Zhang YM, 2016, CLIN J AM SOC NEPHRO, V11, P1582, DOI 10.2215/CJN.01190216; 2003, SEMICOND SCI TECHNOL, V18, pVI45	26	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234934	10.1371/journal.pone.0234934	http://dx.doi.org/10.1371/journal.pone.0234934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569286	Green Published, gold			2022-12-27	WOS:000543547900035
J	Ananthapavan, J; Sacks, G; Brown, V; Moodie, M; Nguyen, P; Veerman, L; Herrera, AMM; Lal, A; Peeters, A; Carter, R				Ananthapavan, Jaithri; Sacks, Gary; Brown, Vicki; Moodie, Marj; Nguyen, Phuong; Veerman, Lennert; Herrera, Ana Maria Mantilla; Lal, Anita; Peeters, Anna; Carter, Rob			Priority-setting for obesity prevention-The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study	PLOS ONE			English	Article							INTERVENTIONS; ADOLESCENTS; CHILDREN; LIFE	The aim of the ACE-Obesity Policy study was to assess the economic credentials of a suite of obesity prevention policies across multiple sectors and areas of governance for the Australian setting. The study aimed to place the cost-effectiveness results within a broad decision-making context by providing an assessment of the key considerations for policy implementation. The Assessing Cost-Effectiveness (ACE) approach to priority-setting was used. Systematic literature reviews were undertaken to assess the evidence of intervention effectiveness on body mass index and/or physical activity for selected interventions. A standardised evaluation framework was used to assess the cost-effectiveness of each intervention compared to a 'no intervention' comparator, from a limited societal perspective. A multi-state life table Markov cohort model was used to estimate the long-term health impacts (quantified as health adjusted life years (HALYs)) and health care cost-savings resulting from each intervention. In addition to the technical cost-effectiveness results, qualitative assessments of implementation considerations were undertaken. All 16 interventions evaluated were found to be cost-effective (using a willingness-to-pay threshold of AUD50,000 per HALY gained). Eleven interventions were dominant (health promoting and cost-saving). The incremental cost-effectiveness ratio for the non-dominant interventions ranged from AUD1,728 to 28,703 per HALY gained. Regulatory interventions tended to rank higher on their cost-effectiveness results, driven by lower implementation costs. However, the program-based policy interventions were generally based on higher quality evidence of intervention effectiveness. This comparative analysis of the economic credentials of obesity prevention policies for Australia indicates that there are a broad range of policies that are likely to be cost-effective, although policy options vary in strength of evidence for effectiveness, affordability, feasibility, acceptability to stakeholders, equity impact and sustainability. Implementation of these policies will require sustained co-ordination across jurisdictions and multiple government sectors in order to generate the predicted health benefits for the Australian population.	[Ananthapavan, Jaithri; Brown, Vicki; Moodie, Marj; Nguyen, Phuong; Lal, Anita; Carter, Rob] Deakin Univ, Sch Hlth & Social Dev, Inst Hlth Transformat, Deakin Hlth Econ, Geelong, Vic, Australia; [Ananthapavan, Jaithri; Sacks, Gary; Brown, Vicki; Moodie, Marj; Nguyen, Phuong; Lal, Anita; Peeters, Anna] Deakin Univ, Global Obes Ctr, Sch Hlth & Social Dev, Inst Hlth Transformat, Geelong, Vic, Australia; [Veerman, Lennert] Griffith Univ, Sch Med, Gold Coast, Australia; [Herrera, Ana Maria Mantilla] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Herrera, Ana Maria Mantilla] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Herrera, Ana Maria Mantilla] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Deakin University; Deakin University; Griffith University; Queensland Centre for Mental Health Research; University of Queensland; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Ananthapavan, J (corresponding author), Deakin Univ, Sch Hlth & Social Dev, Inst Hlth Transformat, Deakin Hlth Econ, Geelong, Vic, Australia.; Ananthapavan, J (corresponding author), Deakin Univ, Global Obes Ctr, Sch Hlth & Social Dev, Inst Hlth Transformat, Geelong, Vic, Australia.	jaithri.ananthapavan@deakin.edu.au	; Veerman, Lennert/A-9973-2011	Carter, Rob/0000-0002-1586-5619; PEETERS, ANNA/0000-0003-4340-9132; Veerman, Lennert/0000-0002-3206-8232; Ananthapavan, Jaithri/0000-0002-5957-6931	National Health and Medical Research Council (NHMRC) [APP1041020]; Australian Research Council [DE160100307]; National Heart Foundation of Australia [102035]; Deakin University	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Heart Foundation of Australia(National Heart Foundation of Australia); Deakin University	This research activity was supported by the National Health and Medical Research Council (NHMRC) funded Centre of Research Excellence in Obesity Policy and Food Systems (APP1041020). GS was supported by an Australian Research Council Discovery Early Career Researcher Award (DE160100307) and a National Heart Foundation of Australia Future Leader Fellowship (102035). VB and AL were supported by a Deakin University Postgraduate Research Scholarship. AL was supported by a Deakin University Dean's Postdoctoral Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ananthapavan J, 2019, INT J OBESITY, V43, P1102, DOI 10.1038/s41366-019-0341-0; Ananthapavan J, 2014, INT J ENV RES PUB HE, V11, P4007, DOI 10.3390/ijerph110404007; [Anonymous], 2014, CHOICES CHILDH OB IN; Australian Bureau of Statistics, 2011, 3101 0 AUSTR DEM STA; Australian Bureau of Statistics, 2015, AUSTR HLTH SURV 2011; Australian Bureau of Statistics, 2015, 63060DO011 201405 EM; Australian Government Department of Health, 2019, OV OB CAMB; Australian Institute of Health and Welfare, 2016, HLTH EXP AUSTR 2014; Australian Institute of Health and Welfare, 2017, PICTURE OVERWEIGHT O; Barendregt JJ, 2010, J EPIDEMIOL COMMUN H, V64, P209, DOI 10.1136/jech.2009.090274; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Brown V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4271-2; Brown V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050622; Carter R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-419; Carter Rob, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P593, DOI 10.1586/14737167.8.6.593; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chen G, 2014, PEDIATRICS, V133, pE868, DOI 10.1542/peds.2013-0622; Clarke B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3639-z; Cobiac L, 2010, AUST NZ J PUBL HEAL, V34, P240, DOI 10.1111/j.1753-6405.2010.00520.x; Crino M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090983; Dunford E, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3230; Epigear International, 2016, ERS BRISB; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Food Standards Australia and New Zealand, 2016, NUTR TABL US AUSTR N; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Gao L, 2018, SCAND J WORK ENV HEA, V44, P503, DOI 10.5271/sjweh.3740; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Global Burden of Disease Collaborative Network, 2021, GLOBAL BURDEN DIS ST; Haby MM, 2006, INT J OBESITY, V30, P1463, DOI 10.1038/sj.ijo.0803469; Hall KD, 2013, LANCET DIABETES ENDO, V1, P97, DOI 10.1016/S2213-8587(13)70051-2; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Huse O, 2020, INT J OBESITY, V44, P1011, DOI 10.1038/s41366-019-0495-9; Husereau D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1049; Institute for Physcial Activity and Nutrition, 2019, TRANSF US; Kumanyika SK, 2010, BRIDGING THE EVIDENCE GAP IN OBESITY PREVENTION: A FRAMEWORK TO INFORM DECISION MAKING, P1; Lal A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002326; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; New South Wales Government, 2018, PREM PRIOR 2015 2019; North Caucasus Analysis, 2005, N CAUCASUS ANAL, V6, P23; Obesity Policy Coalition GLOBE, 2017, TIPP SCAL; Organisation for Economic Co- operation and Development, 2017, OB UPD; Price Waterhouse Coopers (PwC), 2015, WEIGH COST OB CAS AC; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; Robinson E, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030603; Sacks G, 2009, OBES REV, V10, P76, DOI 10.1111/j.1467-789X.2008.00524.x; Sacks G., 2019, POLICIES TACKLING OB; Sacks G, 2020, CURR OBES REP, V9, P150, DOI 10.1007/s13679-020-00376-z; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Shiell A, 2018, HEALTH PROMOT J AUST, V29, P7, DOI 10.1002/hpja.165; Snowdon W, 2011, FOOD POLICY, V36, P597, DOI 10.1016/j.foodpol.2011.06.001; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Veerman L., 2010, ASSESSING COST EFFEC; WHO, 1997, GLOB DAT CHILD GROWT; World Health Organisation, 2018, OB OV KEY FACTS; World Health Organization, 2019, WHO EUR APPR OB; World Health Organization, 2017, REP COMM END CHILDH; Zapata-Diomedi B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184799; 2018, CURR OPIN TOXICOL, V10	59	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234804	10.1371/journal.pone.0234804	http://dx.doi.org/10.1371/journal.pone.0234804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559212	Green Published, gold			2022-12-27	WOS:000543261600027
J	Barros-Santos, T; Silva, KSO; Libarino-Santos, M; Cata-Preta, EG; Reis, HS; Tamura, EK; de Oliveira-Lima, AJ; Berro, LF; Uetanabaro, APT; Marinho, EAV				Barros-Santos, Thaisa; Oliveira Silva, Kallyane Santos; Libarino-Santos, Matheus; Cata-Preta, Elisangela Gouveia; Reis, Henrique Sousa; Tamura, Eduardo Koji; de Oliveira-Lima, Alexandre Justo; Berro, Lais Fernanda; Trovatti Uetanabaro, Ana Paula; Villela Marinho, Eduardo Ary			Effects of chronic treatment with new strains of Lactobacillus plantarumon cognitive, anxiety- and depressive-like behaviors in male mice	PLOS ONE			English	Article							KYNURENINE PATHWAY; BACTERIA; FERMENTATION; MOUSE	Psychobiotics correspond to a class of probiotics, mainly of the genusLactobacillusandBifidobacterium, capable of producing neuroactive substances, such as gamma-aminobutyric acid (GABA) and serotonin, which exert effects on the brain-gut axis. Evidence suggests that psychobiotics can have a beneficial effect on mood, anxiety and cognition. The present study evaluated the effects of chronic administration of two new strains ofLactobacillus plantarum,L.plantarum286 (Lp 286) andL.plantarum81 (Lp 81) isolated from the fermentation of cocoa (Theobroma cacaoL.) and cupuacu (Theobroma grandiflorum), respectively, on cognitive, anxiety- and depressive-like behaviors in male Swiss mice. Different groups of animals were administered (oral gavage) solutions of vehicle (0.85% saline plus 15% skim milk), Lp 286 (10(9)/0.1 ml CFU) or Lp 81 (10(9)/0.1 ml CFU) for 30 days, and animals were tested for general locomotor activity, depressive-like behavior in the forced swim test, and learning/memory and anxiety-like behavior in the plus-maze discriminative avoidance task. Treatment with the strains Lp 286 and Lp 81 did not interfere with locomotor activity or learning and memory. The Lp 286 strain exerted anti-depressant- and anxiolytic-like effects under our experimental conditions. Our findings add to the current body of evidence suggesting that probiotics from the genusLactobacillusmay exert psychobiotic potential and introduce a new strain, Lp 286, as a potential candidate in the prevention or as therapeutic adjuvant in the treatment of mental disorders.	[Barros-Santos, Thaisa; Oliveira Silva, Kallyane Santos; Libarino-Santos, Matheus; Trovatti Uetanabaro, Ana Paula] Univ Estadual Santa Cruz, Dept Biol Sci, Ilheus, BA, Brazil; [Cata-Preta, Elisangela Gouveia; Reis, Henrique Sousa; Tamura, Eduardo Koji; de Oliveira-Lima, Alexandre Justo; Berro, Lais Fernanda; Villela Marinho, Eduardo Ary] Univ Estadual Santa Cruz, Dept Hlth Sci, Ilheus, BA, Brazil; [Berro, Lais Fernanda] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA	Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz; University of Mississippi; University of Mississippi Medical Center	Berro, LF; Marinho, EAV (corresponding author), Univ Estadual Santa Cruz, Dept Hlth Sci, Ilheus, BA, Brazil.; Berro, LF (corresponding author), Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA.	lberro@umc.edu; eavmarinho@uesc.br	Berro, Laís F/D-9710-2014; Marinho, Eduardo Ary Villela/D-7223-2013; Lima, Alexandre Justo Oliveira-/AAU-4084-2020; Avaliação, PPGCS/ABF-2467-2020; Marinho, Eduardo/AGK-8589-2022; Tamura, Eduardo Koji/F-7068-2012	Berro, Laís F/0000-0003-4841-4117; Marinho, Eduardo Ary Villela/0000-0002-3179-2819; Lima, Alexandre Justo Oliveira-/0000-0003-1414-4761; Tamura, Eduardo Koji/0000-0002-6105-7452; Uetanabaro, Ana Paula/0000-0003-3992-8474	Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) [DTE 0034/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES) [407278/2013-3]; Universidade Estadual de Santa Cruz	Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Universidade Estadual de Santa Cruz	Funding for this study was provided by grants from Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB), grant DTE 0034/2013; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES), grant 407278/2013-3; and by intramural funding from Universidade Estadual de Santa Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, J PROSTHET DENT, V11, pe1; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2009, OXFORD CRITICAL CULT, V1, P6; Barrett E, 2012, J APPL MICROBIOL, V113, P411, DOI 10.1111/j.1365-2672.2012.05344.x; Benton D, 2007, EUR J CLIN NUTR, V61, P355, DOI 10.1038/sj.ejcn.1602546; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Claes S, 2011, PSYCHIAT RES, V188, P355, DOI 10.1016/j.psychres.2011.03.012; Dinan TG, 2013, BIOL PSYCHIAT, V74, P720, DOI 10.1016/j.biopsych.2013.05.001; FAO/WHO, 2002, GUIDELINES EVALUATIO; Gibney SM, 2013, BRAIN BEHAV IMMUN, V28, P170, DOI 10.1016/j.bbi.2012.11.010; Holmes A, 2000, PHYSIOL BEHAV, V71, P509, DOI 10.1016/S0031-9384(00)00373-5; Kopp MV, 2008, CLIN EXP ALLERGY, V38, P602, DOI 10.1111/j.1365-2222.2007.02911.x; Kubera N, 2001, J CLIN PSYCHOPHARM, V21, P199, DOI 10.1097/00004714-200104000-00012; Liang S, 2015, NEUROSCIENCE, V310, P561, DOI 10.1016/j.neuroscience.2015.09.033; Liu WH, 2016, BEHAV BRAIN RES, V298, P202, DOI 10.1016/j.bbr.2015.10.046; Lyte M, 2011, BIOESSAYS, V33, P574, DOI 10.1002/bies.201100024; Marin IA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43859; Marinho EAV, 2015, PROG NEURO-PSYCHOPH, V58, P22, DOI 10.1016/j.pnpbp.2014.11.010; Marschalek J, 2017, BREAST CARE, V12, P335, DOI 10.1159/000478994; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Navarro-Lopez V, 2018, JAMA DERMATOL, V154, P37, DOI 10.1001/jamadermatol.2017.3647; Porsolt RD, 1977, NATURE, V21, P266; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Saarela M, 2000, J BIOTECHNOL, V84, P197, DOI 10.1016/S0168-1656(00)00375-8; Ornellas RMS, 2017, ADV EXP MED BIOL, V973, P1, DOI 10.1007/5584_2017_5; Santos TT, 2016, LWT-FOOD SCI TECHNOL, V73, P259, DOI 10.1016/j.lwt.2016.06.003; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Silva RH, 2000, J NEUROSCI METH, V102, P117, DOI 10.1016/S0165-0270(00)00289-2; Singh PK, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01861.x; Vecsei L, 2013, NAT REV DRUG DISCOV, V12, P64, DOI 10.1038/nrd3793; Wei CL, 2019, BRAIN RES, V1711, P202, DOI 10.1016/j.brainres.2019.01.025	32	19	20	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234037	10.1371/journal.pone.0234037	http://dx.doi.org/10.1371/journal.pone.0234037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559185	Green Published, gold			2022-12-27	WOS:000543261600014
J	Cole, CL; Beck, CA; Robinson, D; Ye, J; Mills, B; Gerber, SA; Schwarz, EM; Linehan, D				Cole, Calvin L.; Beck, Christopher A.; Robinson, Deja; Ye, Jian; Mills, Bradley; Gerber, Scott A.; Schwarz, Edward M.; Linehan, David			Dual Energy X-ray Absorptiometry (DEXA) as a longitudinal outcome measure of cancer-related muscle wasting in mice	PLOS ONE			English	Article							PANCREATIC-CANCER; TREATMENT OPTIONS; ECHOMRI-AH; SARCOPENIA; CACHEXIA; OBESITY; DXA	Introduction Pancreatic ductal adenocarcinoma (PDAC) is notorious for its associated skeletal muscle wasting (SMW) and mortality. Currently, the relationships between PDAC, SMW, and survival are poorly understood. Thus, there is great need for a faithful small animal model with quantitative longitudinal outcome measures that recapitulate clinical PDAC, to define SMW onset and assess progression. Therefore, we aimed to validate dual energy X-ray absorptiometry (DEXA) as a longitudinal measure of lean mass, and demonstrate its utility to quantify SMW in the KCKO murine model of PDAC. Methods In vivo body composition of: 1) untreated mice at 5, 8, 12, 18, and 22 weeks of age (n = 4) and 2) a cohort of mice with (n = 5) and without PDAC (n = 5), was determined via DEXA and lean mass of the lower hind limbs was predicted via a region of interest analysis by two-independent observers. Total body weight was determined. Tibialis anterior (TA) muscles were weighed and processed for histomorphometry immediately post-mortem. Statistical differences between groups were assessed using ANOVA and Student's t-tests. Linear regression models and correlation analysis were used to measure the association between TA and DEXA mass, and reproducibility of DEXA was quantified via the intraclass correlation coefficient (ICC). Results Lean mass in growing untreated mice determined by DEXA correlated with TA mass (r(2)= 0.94; p <0.0001) and body weight (r(2)= 0.89; p <0.0001). DEXA measurements were highly reproducible between observers (ICC = 0.95; 95% CI: 0.89-0.98). DEXA and TA mass also correlated in the PDAC cohort (r(2)= 0.76; p <0.0001). Significant SMW in tumor-bearing mice was detected within 38 days of implantation, by DEXA, TA mass, and histomorphometry. Conclusions DEXA is a longitudinal outcome measure of lean mass in mice. The KCKO syngeneic model is abona fidemodel of PDAC associated SMW that can be quantified with longitudinal DEXA.	[Cole, Calvin L.; Robinson, Deja; Schwarz, Edward M.] Univ Rochester, Med Ctr, Dept Orthopaed, Rochester, NY 14642 USA; [Cole, Calvin L.; Robinson, Deja; Schwarz, Edward M.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Cole, Calvin L.; Ye, Jian; Mills, Bradley; Gerber, Scott A.; Linehan, David] Univ Rochester, Med Ctr, Dept Surg, Rochester, NY 14642 USA; [Cole, Calvin L.] Univ Rochester, Med Ctr, Canc Control, Rochester, NY 14642 USA; [Beck, Christopher A.] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Beck, Christopher A.] Univ Rochester, Med Ctr, Dept Orthpaed, Rochester, NY 14642 USA; [Gerber, Scott A.] Univ Rochester, Med Ctr, Dept Microbiol, Rochester, NY 14642 USA; [Gerber, Scott A.] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA; [Schwarz, Edward M.; Linehan, David] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Cole, CL (corresponding author), Univ Rochester, Med Ctr, Dept Orthopaed, Rochester, NY 14642 USA.; Cole, CL (corresponding author), Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA.; Cole, CL (corresponding author), Univ Rochester, Med Ctr, Dept Surg, Rochester, NY 14642 USA.; Cole, CL (corresponding author), Univ Rochester, Med Ctr, Canc Control, Rochester, NY 14642 USA.	Calvin_Cole@urmc.rochester.edu		Schwarz, Edward/0000-0002-4854-9698	National Institutes of Health [P30 AR069955]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the National Institutes of Health (P30 AR069955) (CLC) www.nih.gov The funders had no role in study design, data collection and analysis, decisition to publish, or preparation of the manuscript.	Bachman JF, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.167197; Bergqvist J, 2017, ACTA ONCOL, V56, P1168, DOI 10.1080/0284186X.2017.1327719; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Bozzetti F, 2017, ANN ONCOL, V28, P2107, DOI 10.1093/annonc/mdx271; Bredella MA, 2010, OBESITY, V18, P2227, DOI 10.1038/oby.2010.5; Cole C., 2018, J CACHEXIA SARCOPENI, V3, P19; Costamagna D, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/805172; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, DOI 10.1093/ageing/afz046; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2010, HPB, V12, P323, DOI 10.1111/j.1477-2574.2010.00178.x; Galgani JE, 2011, INT J OBESITY, V35, P1241, DOI 10.1038/ijo.2010.268; Gargiulo S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/253067; Guglielmi G, 2016, AGING CLIN EXP RES, V28, P1047, DOI 10.1007/s40520-016-0589-3; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Lee SJ, 2017, CANCER NURS, V40, P479, DOI 10.1097/NCC.0000000000000454; Marlatt KL, 2017, EUR J CLIN NUTR, V71, P558, DOI 10.1038/ejcn.2016.236; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Michaelis KA, 2017, J CACHEXIA SARCOPENI, V8, P824, DOI 10.1002/jcsm.12225; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Ninomiya G., PANCREATOLOGY, V16, pS91; Nywening TM, 2018, GUT, V67, P1112, DOI 10.1136/gutjnl-2017-313738; Pasetto L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198089; Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Romanick M, 2013, BBA-MOL BASIS DIS, V1832, P1410, DOI 10.1016/j.bbadis.2013.03.011; Ryan AM, 2016, P NUTR SOC, V75, P199, DOI 10.1017/S002966511500419X; Sandini M, 2018, JAMA SURG, V153, P809, DOI 10.1001/jamasurg.2018.0979; Shukla SK, 2015, ONCOTARGET, V6, P41146, DOI 10.18632/oncotarget.5843; Shukla SK, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-18; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Takagi K, 2017, INT J SURG OPEN, V6, P12, DOI 10.1016/j.ijso.2016.12.002; Wang SL, 2016, ANN SURG ONCOL, V23, P556, DOI 10.1245/s10434-015-4887-3; Zhang XM, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6645-6	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0230695	10.1371/journal.pone.0230695	http://dx.doi.org/10.1371/journal.pone.0230695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559188	gold, Green Published, Green Submitted			2022-12-27	WOS:000543261600045
J	Lawless, SP; Cohen, ND; Lawhon, SD; Chamoun-Emanuelli, AM; Wu, J; Rivera-Velez, A; Weeks, BR; Whitfield-Cargile, CM				Lawless, Shauna P.; Cohen, Noah D.; Lawhon, Sara D.; Chamoun-Emanuelli, Ana M.; Wu, Jing; Rivera-Velez, Andres; Weeks, Brad R.; Whitfield-Cargile, Canaan M.			Effect of gallium maltolate on a model of chronic, infected equine distal limb wounds	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL ACTIVITY; NITRIC-OXIDE; IFN-GAMMA; IN-VIVO; HORSES; NITRATE; SUPPRESSION; EXPRESSION; EFFICACY	Distal limb wounds are common injuries sustained by horses and their healing is fraught with complications due to equine anatomy, prevalence of infection, and challenges associated with wound management. Gallium is a semi-metallic element that has been shown to possess antimicrobial properties and aid in wound healing in various preclinical models. The effects of Gallium have not been studied in equine wound healing. Therefore, the objective of this study was to compare healing rates between gallium-treated and untreated wounds of equine distal limbs and to demonstrate the antimicrobial effects of gallium on wounds inoculated withS.aureus. Using an established model of equine wound healing we demonstrated beneficial effects of 0.5% topical gallium maltolate on equine wound healing. Specifically we documented reduced healing times, reduced bioburden, and reduced formation of exuberant granulation tissue in wounds treated with gallium maltolate as compared with untreated wounds. Gallium appeared to exert its beneficial effects via its well-described antimicrobial actions as well as by altering the expression of specific genes known to be involved in wound healing of horses and other animals. Specifically, gallium maltolate appeared to increase expression of transforming growth factor-beta in both infected and un-infected wounds. Further work is needed to document the effects of gallium on naturally occurring equine wounds and to compare the effects of gallium with other wound treatment options. These data, however, suggest that gallium may be an attractive and novel means of improving equine distal limb wound healing.	[Lawless, Shauna P.; Cohen, Noah D.; Chamoun-Emanuelli, Ana M.; Rivera-Velez, Andres; Whitfield-Cargile, Canaan M.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA; [Lawhon, Sara D.; Weeks, Brad R.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA; [Wu, Jing] Texas A&M Univ, Vet Med Teaching Hosp, Coll Vet Med & Biomed Sci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Whitfield-Cargile, CM (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA.	cwhitfield@cvm.tamu.edu	Lawhon, Sara D./G-5147-2011	Lawhon, Sara D./0000-0001-9154-8909; Chamoun-Emanuelli, Ana/0000-0001-5314-7266; Weeks, Brad/0000-0002-5509-5719; Whitfield-Cargile, Canaan/0000-0002-9743-8783; Cohen, Noah/0000-0002-0384-2903	Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas AM University; Link Equine Research Endowment, College of Veterinary Medicine, Texas AM University	Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas AM University; Link Equine Research Endowment, College of Veterinary Medicine, Texas AM University	SPL, CMW, NDC: Research and Graduate Studies Trainee Grant, Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University. NDC: Link Equine Research Endowment, College of Veterinary Medicine, Texas A&M University	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2019, INTEL 64 IA 32 ARCHI, V3; [Anonymous], 2003, REV ETUD ITAL, V49, P1; [Anonymous], 2008, TS, V69, P144, DOI [10.1177/004056390806900108, DOI 10.1177/004056390806900108]; Arnold CE, 2012, VET MICROBIOL, V155, P389, DOI 10.1016/j.vetmic.2011.09.009; Baldoni D, 2010, ANTIMICROB AGENTS CH, V54, P157, DOI 10.1128/AAC.00700-09; Bill T J, 2001, Ostomy Wound Manage, V47, P34; Bischofberger AS, 2011, VET SURG, V40, P898, DOI 10.1111/j.1532-950X.2011.00886.x; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; Carricajo A, 2001, J CLIN MICROBIOL, V39, P2581, DOI 10.1128/JCM.39.7.2581-2583.2001; Caston SS, 2012, VET CLIN N AM-EQUINE, V28, P83, DOI 10.1016/j.cveq.2012.01.001; Celeste CJ, 2013, VET SURG, V42, P147, DOI 10.1111/j.1532-950X.2012.00966.x; Chaffin MK, 2011, AM J VET RES, V72, P945, DOI 10.2460/ajvr.72.7.945; Cirioni O, 2013, J MED MICROBIOL, V62, P1552, DOI 10.1099/jmm.0.057414-0; CLARK RAF, 1993, AM J MED SCI, V306, P42, DOI 10.1097/00000441-199307000-00011; Collery P, 2002, CRIT REV ONCOL HEMAT, V42, P283, DOI 10.1016/S1040-8428(01)00225-6; Dart AJ, 2009, AUST VET J, V87, P215, DOI 10.1111/j.1751-0813.2009.00428.x; Dart AJ, 2002, VET SURG, V31, P309, DOI 10.1053/jvet.2002.33585; Dart AJ, 2002, VET SURG, V31, P314, DOI 10.1053/jvet.2002.33589; Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x; DeLeon K, 2009, ANTIMICROB AGENTS CH, V53, P1331, DOI 10.1128/AAC.01330-08; ENONEN, 1995, FALL SCH ANAL, V68, P1; Fecteau ME, 2011, AM J VET RES, V72, P1243, DOI 10.2460/ajvr.72.9.1243; Freeman K, 2009, CAN J MICROBIOL, V55, P197, DOI [10.1139/w08-115, 10.1139/W08-115]; Goncalves J, 2002, J SURG RES, V103, P134, DOI 10.1006/jsre.2001.6347; GREENE SA, 1986, AM J VET RES, V47, P2364; Greenlee-Wacker MC, 2017, J LEUKOCYTE BIOL, V101, P751, DOI 10.1189/jlb.4A1215-565RR; Hanson RR, 2008, VET CLIN N AM-EQUINE, V24, P663, DOI 10.1016/j.cveq.2008.10.005; Harrington JR, 2006, J VET PHARMACOL THER, V29, P121, DOI 10.1111/j.1365-2885.2006.00723.x; Ishida Y, 2004, J IMMUNOL, V172, P1848, DOI 10.4049/jimmunol.172.3.1848; JACOBS KA, 1984, VET SURG, V13, P83, DOI 10.1111/j.1532-950X.1984.tb00765.x; Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783; Kelson AB, 2013, CURR OPIN PHARMACOL, V13, P707, DOI 10.1016/j.coph.2013.07.001; KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X; Krecic-Shepard ME, 1999, LIFE SCI, V65, P1359, DOI 10.1016/S0024-3205(99)00375-6; Laato M, 2001, ANN CHIR GYNAECOL, V90, P19; Lazaro JL, 2016, J WOUND CARE, V25, P277, DOI 10.12968/jowc.2016.25.5.277; Lefebvre-Lavoie J, 2005, PHYSIOL GENOMICS, V22, P157, DOI 10.1152/physiolgenomics.00018.2005; Lepault E, 2005, WOUND REPAIR REGEN, V13, P520, DOI 10.1111/j.1067-1927.2005.00073.x; Makkonen N, 1995, INFLAMM RES, V44, P523, DOI 10.1007/BF01757356; Nijhuis RHT, 2014, J CLIN MICROBIOL, V52, P2861, DOI 10.1128/JCM.00808-14; Olakanmi O, 2010, ANTIMICROB AGENTS CH, V54, P244, DOI 10.1128/AAC.00655-09; Olczak T, 2012, ARCH MICROBIOL, V194, P719, DOI 10.1007/s00203-012-0804-3; Panagakos FS, 2000, BIOCHIMIE, V82, P147, DOI 10.1016/S0300-9084(00)00384-9; Pierezan F, 2016, VET DERMATOL, V27, P332, DOI 10.1111/vde.12366; Samra Z, 2004, DIAGN MICR INFEC DIS, V49, P243, DOI 10.1016/j.diagmicrobio.2004.02.009; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Stick, 2012, EQUINE SURG, P47; Theoret C., 2008, EQUINE WOUND MANAGEM; Theoret CL, 2013, WOUND REPAIR REGEN, V21, P365, DOI 10.1111/wrr.12018; Theoret CL, 2002, VET SURG, V31, P266, DOI 10.1053/jvet.2002.32394; Toth T, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-45; Van den Boom R, 2002, WOUND REPAIR REGEN, V10, P188, DOI 10.1046/j.1524-475X.2002.10608.x; Van den Eede A, 2009, VET MICROBIOL, V133, P138, DOI 10.1016/j.vetmic.2008.06.021; Weese JS, 2005, JAVMA-J AM VET MED A, V226, P580, DOI 10.2460/javma.2005.226.580; Westgate SJ, 2011, VET MICROBIOL, V150, P152, DOI 10.1016/j.vetmic.2011.01.003; WHITACRE C, 1992, J NEUROIMMUNOL, V39, P175, DOI 10.1016/0165-5728(92)90186-O; Wilmink JM, 2003, EQUINE VET J, V35, P561, DOI 10.2746/042516403775467234; Wilmink JM, 2002, EQUINE VET J, V34, P270, DOI 10.2746/042516402776186047; Wilmink JM, 1999, EQUINE VET J, V31, P61, DOI 10.1111/j.2042-3306.1999.tb03792.x; Wilmink JM, 1999, EQUINE VET J, V31, P53, DOI 10.1111/j.2042-3306.1999.tb03791.x; Xu ZR, 2017, RSC ADV, V7, P52266, DOI 10.1039/c7ra10265h	64	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0235006	10.1371/journal.pone.0235006	http://dx.doi.org/10.1371/journal.pone.0235006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559258	Green Published, gold			2022-12-27	WOS:000543261600007
J	Kendrick, N; Powers, G; Johansen, J; Hoelter, M; Koll, A; Carlson, S; Channaveerappa, D; Darie, CC				Kendrick, Nancy; Powers, Ginny; Johansen, Jon; Hoelter, Matt; Koll, Andrew; Carlson, Sofia; Channaveerappa, Devika; Darie, Costel C.			Preparation of a phosphotyrosine-protein standard for use in semiquantitative western blotting with enhanced chemiluminescence	PLOS ONE			English	Article							RESOLUTION 2-DIMENSIONAL ELECTROPHORESIS; LYMPHOMA KINASE ALK; SPECIFICITY	Protein tyrosine phosphorylation is key to activation of receptor tyrosine kinases (RTK) that drive development of some cancers. One challenge of RTK-targeted therapy is identification of those tumors that express non-mutated but activated RTKs. Phosphotyrosine (pTyr) RTK levels should be more predictive of the latter than expressed total protein. Western blotting (WB) with a pTyr antibody and enhanced chemiluminescence (ECL) detection is sufficiently sensitive to detect pTyr-RTKs in human tumor homogenates. Presentation of results by comparing WB images, however, is wanting. Here we describe the preparation of a new pTyr-protein standard, pTyr-ALK48-SB (pA), derived from a commercial anaplastic lymphoma kinase (ALK) recombinant fragment, and its use to quantify pTyr-epidermal growth factor receptor (pTyr-EGFR) in commercial A431 cell lysates. Linearity of one-dimensional (1D) WB plots of pA band density versus load as well as its lower level of detection (0.1 ng, 2 fmole) were determined for standardized conditions. Adding pA to two lots of A431 cell lysates with high and low pTyr-EGFR allowed normalization and quantification of the latter by expressing results as density ratios for both 1D and 2D WB. This approach is semi-quantitative because unknown RTKs may be outside the linear range of detection. Semiquantitative ratios are an improvement over comparisons of images without a reference standard and facilitate comparisons between samples.	[Kendrick, Nancy; Powers, Ginny; Johansen, Jon; Hoelter, Matt; Koll, Andrew; Carlson, Sofia] Kendrick Labs Inc, Madison, WI 53713 USA; [Channaveerappa, Devika; Darie, Costel C.] Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, Potsdam, NY 13699 USA	Clarkson University	Kendrick, N (corresponding author), Kendrick Labs Inc, Madison, WI 53713 USA.; Darie, CC (corresponding author), Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, Potsdam, NY 13699 USA.	nancy@kendricklabs.com; cdarie@clarkson.edu		Carlson, Sofia/0000-0002-3959-768X; Darie, Costel C./0000-0001-6402-2311; Kendrick, Nancy/0000-0002-0282-4906	Kendrick Labs, Inc.	Kendrick Labs, Inc.	Funding for this research was provided by Kendrick Labs, Inc. NK and JJ are officers, board members, and stockholders of Kendrick Labs. Kendrick Labs provided support in the form of salaries for employees NK, JJ, GP, MH, AD and SC. The specific roles of these authors are articulated in the 'author contributions' section. All studies were conceived and performed by Kendrick Labs employees except for mass spectrometry studies which were conceived and performed by CCD and DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria-Schaffer A, 2009, METHOD ENZYMOL, V463, P573, DOI 10.1016/S0076-6879(09)63033-0; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; ANDERSON L, 1977, P NATL ACAD SCI USA, V74, P5421, DOI 10.1073/pnas.74.12.5421; Awasthi S, 2018, J PROTEOMICS; Awasthi S, 2018, DATA BRIEF, V19, P424, DOI 10.1016/j.dib.2018.04.086; Bainor A, 2011, ANAL BIOCHEM, V410, P310, DOI 10.1016/j.ab.2010.11.015; Boersema PJ, 2009, J MASS SPECTROM, V44, P861, DOI 10.1002/jms.1599; BURGESSCASSLER A, 1989, CLIN CHEM, V35, P2297; Chang YC, 2018, PEERJ, V6, DOI 10.7717/peerj.4719; Channaveerappa D, 2017, J CELL MOL MED, V21, P2223, DOI 10.1111/jcmm.13145; Degasperi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087293; Donella-Deana A, 2005, BIOCHEMISTRY-US, V44, P8533, DOI 10.1021/bi0472954; Du ZF, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0782-4; Finotello F, 2018, CANCER IMMUNOL IMMUN, V67, P1031, DOI 10.1007/s00262-018-2150-z; Fosang AJ, 2015, J BIOL CHEM, V290, P29692, DOI 10.1074/jbc.E115.000002; Gajiwala KS, 2013, PROTEIN SCI, V22, P995, DOI 10.1002/pro.2283; Genova C, 2016, ONCOTARGETS THER, V9, P5427, DOI 10.2147/OTT.S114039; Gorg A, 2009, ELECTROPHORESIS, V30, pS122, DOI 10.1002/elps.200900051; Johnson H, 2012, SEMIN CELL DEV BIOL, V23, P854, DOI 10.1016/j.semcdb.2012.05.008; Kendrick N, 2019, ADV EXP MED BIOL, V1140, P563, DOI 10.1007/978-3-030-15950-4_33; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lopez-Coral A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31426-1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Rabilloud T, 2009, ELECTROPHORESIS, V30, pS174, DOI 10.1002/elps.200900050; Rodrigues JG, 2018, CELL IMMUNOL, V333, P46, DOI 10.1016/j.cellimm.2018.03.007; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sattu K, 2013, FEBS J, V280, P5269, DOI 10.1111/febs.12453; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Tinti M, 2012, NEW BIOTECHNOL, V29, P571, DOI 10.1016/j.nbt.2011.12.001; Trivedi MV, 2009, CURR PROTEIN PEPT SC, V10, P614, DOI 10.2174/138920309789630534; Weinberg RA, 2014, BIOLOGY OF CANCER, SECOND EDITION, P1; Zhen YJ, 2003, BIOCHEMISTRY-US, V42, P5478, DOI 10.1021/bi027101p	32	2	2	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234645	10.1371/journal.pone.0234645	http://dx.doi.org/10.1371/journal.pone.0234645			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555693	gold, Green Published			2022-12-27	WOS:000543273200023
J	Wulczyn, E; Steiner, DF; Xu, ZY; Sadhwani, A; Wang, HW; Flament-Auvigne, I; Mermel, CH; Chen, PHC; Liu, Y; Stumpe, MC				Wulczyn, Ellery; Steiner, David F.; Xu, Zhaoyang; Sadhwani, Apaar; Wang, Hongwu; Flament-Auvigne, Isabelle; Mermel, Craig H.; Chen, Po-Hsuan Cameron; Liu, Yun; Stumpe, Martin C.			Deep learning-based survival prediction for multiple cancer types using histopathology images	PLOS ONE			English	Article								Providing prognostic information at the time of cancer diagnosis has important implications for treatment and monitoring. Although cancer staging, histopathological assessment, molecular features, and clinical variables can provide useful prognostic insights, improving risk stratification remains an active research area. We developed a deep learning system (DLS) to predict disease specific survival across 10 cancer types from The Cancer Genome Atlas (TCGA). We used a weakly-supervised approach without pixel-level annotations, and tested three different survival loss functions. The DLS was developed using 9,086 slides from 3,664 cases and evaluated using 3,009 slides from 1,216 cases. In multivariable Cox regression analysis of the combined cohort including all 10 cancers, the DLS was significantly associated with disease specific survival (hazard ratio of 1.58, 95% CI 1.28-1.70, p<0.0001) after adjusting for cancer type, stage, age, and sex. In a per-cancer adjusted subanalysis, the DLS remained a significant predictor of survival in 5 of 10 cancer types. Compared to a baseline model including stage, age, and sex, the c-index of the model demonstrated an absolute 3.7% improvement (95% CI 1.0-6.5) in the combined cohort. Additionally, our models stratified patients within individual cancer stages, particularly stage II (p = 0.025) and stage III (p<0.001). By developing and evaluating prognostic models across multiple cancer types, this work represents one of the most comprehensive studies exploring the direct prediction of clinical outcomes using deep learning and histopathology images. Our analysis demonstrates the potential for this approach to provide significant prognostic information in multiple cancer types, and even within specific pathologic stages. However, given the relatively small number of cases and observed clinical events for a deep learning task of this type, we observed wide confidence intervals for model performance, thus highlighting that future work will benefit from larger datasets assembled for the purposes for survival modeling.	[Wulczyn, Ellery; Steiner, David F.; Xu, Zhaoyang; Sadhwani, Apaar; Wang, Hongwu; Mermel, Craig H.; Chen, Po-Hsuan Cameron; Liu, Yun; Stumpe, Martin C.] Google LLC, Google Hlth, Palo Alto, CA USA; [Flament-Auvigne, Isabelle] Adv Clin, Chicago, IL USA; [Stumpe, Martin C.] Tempus Labs Inc, Chicago, IL USA		Liu, Y (corresponding author), Google LLC, Google Hlth, Palo Alto, CA USA.	liuyun@google.com	Mermel, Craig/AAZ-7322-2020	Mermel, Craig/0000-0002-0816-3395; Sadhwani, Apaar/0000-0002-9272-2574; Liu, Yun/0000-0003-4079-8275	Google LLC	Google LLC(Google Incorporated)	This study was funded by Google LLC. All authors contributed to this work while employed at or performing work at Google. Most authors own Alphabet stock. Google did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of each author is articulated in the `author contributions' section.	Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; BRESLOW N, 1974, BIOMETRICS, V30, P89, DOI 10.2307/2529620; Bychkov D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21758-3; Cancer Genome Atlas N., 2015, CELL, V161, P1681, DOI [10.1016/j.cell.2015.05.044, DOI 10.1016/J.CELL.2015.05.044]; Cooper LAD, 2018, J PATHOL, V244, P512, DOI 10.1002/path.5028; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; COX DR, 1975, BIOMETRIKA, V62, P269, DOI 10.2307/2335362; COX DR, 1972, J R STAT SOC B, V34, P187; Davidson-Pilon C, 2019, CAMDAVIDSONPILON LIF, DOI [10.5281/zenodo.3240536, DOI 10.5281/ZENODO.3240536]; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Howard A.G., 2017, MOBILENETS EFFICIENT; Kather JN, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002730; LeCun Y., 2015, NATURE, V521, P436, DOI [10.1038/nature14539, DOI 10.1038/nmeth.3707, DOI 10.1038/nature14539, DOI 10.1038/NATURE14539]; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Liu Y, 2019, ARCH PATHOL LAB MED, V143, P859, DOI 10.5858/arpa.2018-0147-OA; Mobadersany P, 2018, P NATL ACAD SCI USA, V115, pE2970, DOI 10.1073/pnas.1717139115; Nagpal K, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0112-2; Rakha EA, 2008, J CLIN ONCOL, V26, P3153, DOI 10.1200/JCO.2007.15.5986; Saltz J, 2018, CELL REP, V23, P181, DOI 10.1016/j.celrep.2018.03.086; Sparano JA, 2018, NEW ENGL J MED, V379, P111, DOI 10.1056/NEJMoa1804710; Sparano JA, 2019, NEW ENGL J MED, V380, P2395, DOI 10.1056/NEJMoa1904819; Steck H., 2008, ADV NEURAL INFORM PR, V20, P1209; Tieleman T, 2012, COURSERA NEURAL NETW, V4, P26; Wang C, 2013, J AM MED INFORM ASSN, V20, P680, DOI 10.1136/amiajnl-2012-001538; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Weiser MR, 2011, J CLIN ONCOL, V29, P4796, DOI 10.1200/JCO.2011.36.5080; Yu KH, 2017, CELL SYST, V5, P620, DOI 10.1016/j.cels.2017.10.014; Yu KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12474; Zhu XL, 2017, PROC CVPR IEEE, P6855, DOI 10.1109/CVPR.2017.725	32	72	73	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0233678	10.1371/journal.pone.0233678	http://dx.doi.org/10.1371/journal.pone.0233678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555646	Green Published, gold, Green Submitted			2022-12-27	WOS:000542759600019
J	Baur, M; Weber, B; Lackner, I; Gebhard, F; Pfeifer, R; Cinelli, P; Halvachizadeh, S; Teuben, M; Lipiski, M; Cesarovic, N; Pape, HC; Kalbitz, M				Baur, Meike; Weber, Birte; Lackner, Ina; Gebhard, Florian; Pfeifer, Roman; Cinelli, Paolo; Halvachizadeh, Sascha; Teuben, Michel; Lipiski, Miriam; Cesarovic, Nikola; Pape, Hans-Christoph; Kalbitz, Miriam			Structural alterations and inflammation in the heart after multiple trauma followed by reamed versus non-reamed femoral nailing	PLOS ONE			English	Article							BLUNT CARDIAC INJURY; TROPONIN-I; FRACTURES; CARDIOMYOPATHY; STIMULATION; EXPRESSION; CONDUCTION; RECEPTOR; ALPHA; DEATH	Background Approximately 30,000 patients with blunt cardiac trauma are recorded each year in the United States. Blunt cardiac injuries after trauma are associated with a longer hospital stay and a poor overall outcome. Organ damage after trauma is linked to increased systemic release of pro-inflammatory cytokines and damage-associated molecular patterns. However, the interplay between polytrauma and local cardiac injury is unclear. Additionally, the impact of surgical intervention on this process is currently unknown. This study aimed to determine local cardiac immunological and structural alterations after multiple trauma. Furthermore, the impact of the chosen fracture stabilization strategy (reamed versus non-reamed femoral nailing) on cardiac alterations was studied. Experimental approach 15 male pigs were either exposed to multiple trauma (blunt chest trauma, laparotomy, liver laceration, femur fracture and haemorrhagic shock) or sham conditions. Blood samples as well as cardiac tissue were analysed 4 h and 6 h after trauma. Additionally, murine HL-1 cells were exposed to a defined polytrauma-cocktail, mimicking the pro-inflammatory conditions after multiple traumain vitro. Results After multiple trauma, cardiac structural changes were observed in the left ventricle. More specifically, alterations in the alpha-actinin and desmin protein expression were found. Cardiac structural alterations were accompanied by enhanced local nitrosative stress, increased local inflammation and elevated systemic levels of the high-mobility group box 1 protein. Furthermore, cardiac alterations were observed predominantly in pigs that were treated by non-reamed intramedullary reaming. The polytrauma-cocktail impaired the viability of HL-1 cellsin vitro, which was accompanied by a release of troponin I and HFABP. Discussion Multiple trauma induced cardiac structural alterationsin vivo, which might contribute to the development of early myocardial damage (EMD). This study also revealed that reamed femoral nailing (reamed) is associated with more prominent immunological cardiac alterations compared to nailing without reaming (non-reamed). This suggests that the choice of the initial fracture treatment strategy might be crucial for the overall outcome as well as for any post-traumatic cardiac consequences.	[Baur, Meike; Weber, Birte; Lackner, Ina; Gebhard, Florian; Kalbitz, Miriam] Univ Ulm, Dept Traumatol Hand Plastic & Reconstruct Surg, Ctr Surg, Ulm, Germany; [Pfeifer, Roman; Cinelli, Paolo; Halvachizadeh, Sascha; Teuben, Michel; Pape, Hans-Christoph] Univ Hosp Zurich, Dept Trauma, Zurich, Switzerland; [Teuben, Michel] Rhein Westfal TH Aachen, Dept Orthopaed Trauma, Aachen, Germany; [Lipiski, Miriam; Cesarovic, Nikola] Univ Hosp Zurich, Dept Surg Res, Zurich, Switzerland; [Cesarovic, Nikola] Swiss Fed Inst Technol, Dept Hlth Sci, Translat Cardiovasc Technol, Zurich, Switzerland	Ulm University; University of Zurich; University Zurich Hospital; RWTH Aachen University; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kalbitz, M (corresponding author), Univ Ulm, Dept Traumatol Hand Plastic & Reconstruct Surg, Ctr Surg, Ulm, Germany.	miriam.kalbitz@uniklinik-ulm.de		Cesarovic, Nikola/0000-0001-6744-2928; Lackner, Ina/0000-0001-6410-9222; Pape, Hans-Christoph/0000-0002-2059-4980; Cinelli, Paolo/0000-0002-0163-9055; Weber, Birte/0000-0001-7779-9816	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [CRC 1149, 251293561]; AO Grant [S-16-133T]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); AO Grant	This work was conducted in the framework of the CRC 1149 funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Project number 251293561. This work was also funded by the AO Grant S-16-133T: 'Effects of standard reaming and RIA techniques on local soft tissue and systemic homeostasis in a porcine trauma model'.	Afanasyeva M, 2004, AUTOIMMUN REV, V3, P476, DOI 10.1016/j.autrev.2004.08.009; Agullo-Pascual E, 2014, FEBS LETT, V588, P1322, DOI 10.1016/j.febslet.2014.02.008; Amann EM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216862; [Anonymous], 2014, Hosp Case Manag, V22, P9; Asavarut Paladd, 2013, Acta Anaesthesiol Taiwan, V51, P28, DOI 10.1016/j.aat.2013.03.007; Ballard-Croft C, 2004, J APPL PHYSIOL, V97, P1470, DOI 10.1152/japplphysiol.01149.2003; Bertsch T, 2000, EXP TOXICOL PATHOL, V52, P157; Braun CK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187327; Decavele M, 2018, BRIT J ANAESTH, V120, P1158, DOI 10.1016/j.bja.2018.03.010; Duan X, 2011, ARCH ORTHOP TRAUM SU, V131, P1445, DOI 10.1007/s00402-011-1311-8; Duncan DJ, 2010, CELL CALCIUM, V47, P378, DOI 10.1016/j.ceca.2010.02.002; Elie MC, 2006, MT SINAI J MED, V73, P542; Foertsch S, 2019, BRAIN BEHAV IMMUN, V80, P667, DOI 10.1016/j.bbi.2019.05.013; Gard JJ, 2005, CARDIOVASC RES, V67, P539, DOI 10.1016/j.cardiores.2005.04.004; Giannoudis PV, 2006, INJURY, V37, pS50, DOI 10.1016/j.injury.2006.08.040; Giannoudis PV, 1999, J BONE JOINT SURG BR, V81B, P356, DOI 10.1302/0301-620X.81B2.8988; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Hartsock LA, 2010, INJURY, V41, pS94, DOI 10.1016/S0020-1383(10)70018-8; Horst K, 2016, SCI REP-UK, V6, DOI 10.1038/srep39659; Hou YC1, 2009, AM J PHYSIOL-LUNG C, V296, pL288; Husebye EE, 2011, INJURY, V42, P630, DOI 10.1016/j.injury.2010.06.025; Jin HL, 2018, J PHYSIOL SCI, V68, P77, DOI 10.1007/s12576-016-0509-5; Kalbitz M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18088-1; Kalbitz M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187270; Kalbitz M, 2017, WORLD J SURG, V41, P162, DOI 10.1007/s00268-016-3650-7; Kalbitz M, 2016, J IMMUNOL, V197, P2353, DOI 10.4049/jimmunol.1600091; Kalbitz M, 2015, FASEB J, V29, P2185, DOI 10.1096/fj.14-268730; Kanakaris NK, 2017, INJURY, V48, pS10, DOI 10.1016/j.injury.2017.04.017; Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949; Lackner I, 2019, SHOCK AUGUSTA GA, DOI [10.1097/shk.0000000000001400, DOI 10.1097/SHK.0000000000001400MEDLINE:31313740]; Lackner I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01920; Lackner I, 2020, SHOCK, V53, P620, DOI 10.1097/SHK.0000000000001400; Lasanianos NG, 2011, INJURY, V42, P617, DOI 10.1016/j.injury.2011.02.011; Li AB, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004248; Meng XY, 2016, INT J CARDIOL, V206, P42, DOI 10.1016/j.ijcard.2016.01.014; Mersmann J, 2010, CRIT CARE MED, V38, P1927, DOI 10.1097/CCM.0b013e3181ef455b; Monnerat G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13344; Morley JR, 2008, J BONE JOINT SURG BR, V90B, P393, DOI 10.1302/0301-620X.90B3.19688; Muller SC, 2018, IEEE T SMART GRID, V9, P14, DOI 10.1109/TSG.2016.2542824; Panagopoulou P, 2008, J CELL BIOL, V181, P761, DOI 10.1083/jcb.200710049; PAPE HC, 1993, J TRAUMA, V34, P540, DOI 10.1097/00005373-199304000-00010; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; RADY MY, 1992, BRIT J SURG, V79, P65, DOI 10.1002/bjs.1800790123; Ramspacher C, 2015, CELL REP, V11, P1564, DOI 10.1016/j.celrep.2015.05.010; Robinson CM, 2001, J BONE JOINT SURG BR, V83B, P963, DOI 10.1302/0301-620X.83B7.11593; Severs NJ, 2001, MICROSC RES TECHNIQ, V52, P301, DOI 10.1002/1097-0029(20010201)52:3<301::AID-JEMT1015>3.0.CO;2-Q; Skinner DL, 2015, INJURY, V46, P66, DOI 10.1016/j.injury.2014.08.051; Skioldebrand E, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00406; Sun KX, 2019, CLINICS, V74, DOI 10.6061/clinics/2019/e729; Tatsumi T, 2004, J MOL CELL CARDIOL, V37, P775, DOI 10.1016/j.yjmcc.2004.06.014; Vaden KI, 2016, EXP AGING RES, V42, P86, DOI 10.1080/0361073X.2016.1108784; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; van Spaendonck-Zwarts KY, 2011, CLIN GENET, V80, P354, DOI 10.1111/j.1399-0004.2010.01512.x; Weber B, 2019, PEDIATR RES, V86, P709, DOI 10.1038/s41390-019-0505-6; Weninger P, 2007, J TRAUMA, V62, P692, DOI 10.1097/01.ta.0000243203.38466.e0; Xia LH, 2014, ORTHOPEDICS, V37, pE332, DOI 10.3928/01477447-20140401-52; Yasui K, 2000, CARDIOVASC RES, V48, P68, DOI 10.1016/S0008-6363(00)00145-0	57	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235220	10.1371/journal.pone.0235220	http://dx.doi.org/10.1371/journal.pone.0235220			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584885	Green Published, Green Accepted, gold			2022-12-27	WOS:000545747200034
J	De Meyer, V; Abramowicz, D; De Meester, J; Collart, F; Bosmans, JL; Cools, W; Wissing, KM				De Meyer, Vicky; Abramowicz, Daniel; De Meester, Johan; Collart, Frederic; Bosmans, Jean-Louis; Cools, Wilfried; Wissing, Karl Martin			Variability in the incidence of renal replacement therapy over time in Western industrialized countries: A retrospective registry analysis	PLOS ONE			English	Article							COMPARATIVE SURVIVAL; ELDERLY-PATIENTS; KIDNEY FAILURE; DISEASE; AUSTRALIA; DIALYSIS; ERA; MANAGEMENT; INITIATION; OUTCOMES	Introduction A growing number of patients started renal replacement therapy (RRT) in Western industrialized countries between 1980 an early 2000s. Thereafter reports from national and international registries suggest a trend towards stabilization and sometimes a decrease in the incidence rate. Aim To investigate the differences in overall and age-specific incidence rates between industrialized countries from 1998 until 2013. Secondly, to investigate changes in incidence rates over time and their association with specific age categories. Method We extracted the unadjusted overall incidence of RRT and age-specific incidence rates from renal registry reports in Europe, the United States, Canada, Australia and New Zealand. Time trends in the incidence rate by country and age categories were analyzed by Joinpoint regression analysis. Results The incidence rate in 2013 ranged from 89 per million population (pmp) in Finland to 363 pmp in the US. Incidence rates in the lower age categories (20-64 year) were similar between countries and remained stable over time. Higher incidence countries were characterized by higher numbers of patients in both the 65-74 and >= 75 year categories starting RRT. Joinpoint analysis confirmed that most countries had significant reductions in the incidence rate at the end of the study period. These reductions were explained by lower numbers of older patients starting RRT and were observed also in countries with lower overall incidence rates. Conclusion This study confirmed different incidence rates of RRT between industrialized countries worldwide. Countries with the highest overall incidence rates also had the highest incidence rates in the oldest age categories. Since the early 2000's the number of older patients starting RRT is either stabilizing or even decreasing in most countries. This reduction is universal and is also observed in countries with previously low incidence rates.	[De Meyer, Vicky; Wissing, Karl Martin] Vrije Univ Brussel VUB, Univ Ziekenhuis Brussel, Dept Hypertens & Nephrol, Brussels, Belgium; [Abramowicz, Daniel; Bosmans, Jean-Louis] Univ Ziekenhuis Antwerpen, Dept Nephrol, Antwerp, Belgium; [Abramowicz, Daniel] Univ Antwerp, Lab Med & Pediat, Antwerp, Belgium; [De Meester, Johan] AZ Nikolaas, Dept Nephrol, St Niklaas, Belgium; [Collart, Frederic] CHU Brugmann, Dept Nephrol, Brussels, Belgium; [Cools, Wilfried] Vrije Univ Brussel VUB, Interfac Ctr Data Proc & Stat, Brussels, Belgium	University Hospital Brussels; Vrije Universiteit Brussel; University of Antwerp; University of Antwerp; Vrije Universiteit Brussel	De Meyer, V (corresponding author), Vrije Univ Brussel VUB, Univ Ziekenhuis Brussel, Dept Hypertens & Nephrol, Brussels, Belgium.	vicky.demeyer@uzbrusssel.be	cools, wilfried/AAE-4534-2019	cools, wilfried/0000-0002-3458-0336; De Meyer, Vicky/0000-0001-5408-798X; Collart, Frederic/0000-0003-1673-5450				[Anonymous], 2016, ERA EDTA REG ANN REP; Brown EA, 2011, NAT REV NEPHROL, V7, P591, DOI 10.1038/nrneph.2011.113; Canadian Institute for Health Information, 2014, CAN ORG REPL REG ANN; Canadian Institute for Health Information, 2016, CAN ORG REPL REF ANN; Caskey FJ, 2011, NEPHROL DIAL TRANSPL, V26, P2604, DOI 10.1093/ndt/gfq781; Chandna SM, 2011, NEPHROL DIAL TRANSPL, V26, P1608, DOI 10.1093/ndt/gfq630; Clayton P, 2015, 36 ANZDATA; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Couchoud C, 2012, NEPHROL DIAL TRANSPL, V27, P2312, DOI 10.1093/ndt/gfr639; Couchoud C, 2010, NEPHROL DIAL TRANSPL, V25, P1576, DOI 10.1093/ndt/gfp675; De Vecchi AF, 1999, NEPHROL DIAL TRANSPL, V14, P31, DOI 10.1093/ndt/14.suppl_6.31; Eggers PW, 2011, CURR OPIN NEPHROL HY, V20, P241, DOI 10.1097/MNH.0b013e3283454319; Grace BS, 2012, NEPHROLOGY, V17, P76, DOI 10.1111/j.1440-1797.2011.01512.x; Helve J, 2018, NEPHROL DIAL TRANSPL, V33, P1428, DOI 10.1093/ndt/gfy056; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Hemmelgarn BR, 2012, JAMA-J AM MED ASSOC, V307, P2507, DOI 10.1001/jama.2012.6455; Kramer A, 2009, NEPHROL DIAL TRANSPL, V24, P3557, DOI 10.1093/ndt/gfp519; Moranne O, 2018, NEPHROL DIAL TRANSPL, V33, P2182, DOI 10.1093/ndt/gfy046; Murtagh FEM, 2007, NEPHROL DIAL TRANSPL, V22, P1955, DOI 10.1093/ndt/gfm153; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; Pippias M, 2016, NEPHROL DIAL TRANSPL, V31, P831, DOI 10.1093/ndt/gfv327; Rosansky SJ, 2019, KIDNEY INT, V95, P1273, DOI 10.1016/j.kint.2019.02.008; Rosansky SJ, 2013, J AM SOC NEPHROL, V24, P1367, DOI 10.1681/ASN.2013050458; Sparke C, 2013, AM J KIDNEY DIS, V61, P413, DOI 10.1053/j.ajkd.2012.10.012; Tamura MK, 2009, NEW ENGL J MED, V361, P1539, DOI 10.1056/NEJMoa0904655; United States Renal Data System, 2015, UN STAT REN DAT SYST; United States Renal Data System, 2013, UN STAT REN DAT SYST; van de Luijtgaarden MWM, 2013, NEPHROL DIAL TRANSPL, V28, P2604, DOI 10.1093/ndt/gft287; Verberne WR, 2016, CLIN J AM SOC NEPHRO, V11, P633, DOI 10.2215/CJN.07510715; Visser A, 2012, NEPHROL DIAL TRANSPL, V27, P338, DOI 10.1093/ndt/gfr346; Wanner C, 2018, NAT REV NEPHROL, V14, P78, DOI 10.1038/nrneph.2017.182	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235004	10.1371/journal.pone.0235004	http://dx.doi.org/10.1371/journal.pone.0235004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584849	gold, Green Published			2022-12-27	WOS:000545747200010
J	Pyrih, J; Raskova, V; Skodova-Sverakova, I; Panek, T; Lukes, J				Pyrih, Jan; Raskova, Vendula; Skodova-Sverakova, Ingrid; Panek, Tomas; Lukes, Julius			ZapE/Afg1 interacts with Oxa1 and its depletion causes a multifaceted phenotype	PLOS ONE			English	Article							RESPIRATORY-CHAIN; INNER-MEMBRANE; BIOTIN LIGASE; COMPLEX; LOCALIZATION; PREDICTION; GENOMICS; DIVISION; NETWORK	ZapE/Afg1 is a component of the inner cell membrane of some eubacteria and the inner mitochondrial membrane of eukaryotes. This protein is involved in FtsZ-dependent division of eubacteria. In the yeast and human mitochondrion, ZapE/Afg1 likely interacts with Oxa1 and facilitates the degradation of mitochondrion-encoded subunits of respiratory complexes. Furthermore, the depletion of ZapE increases resistance to apoptosis, decreases oxidative stress tolerance, and impacts mitochondrial protein homeostasis. It remains unclear whether ZapE is a multifunctional protein, or whether some of the described effects are just secondary phenotypes. Here, we have analyzed the functions of ZapE inTrypanosoma brucei, a parasitic protist, and an important model organism. Using a newly developed proximity-dependent biotinylation approach (BioID2), we have identified the inner mitochondrial membrane insertase Oxa1 among three putative interacting partners of ZapE, which is present in two paralogs. RNAi-mediated depletion of both ZapE paralogs likely affected the function of respiratory complexes I and IV. Consistently, we show that the distribution of mitochondrial ZapE is restricted only to organisms with Oxa1, respiratory complexes, and a mitochondrial genome. We propose that the evolutionarily conserved interaction of ZapE with Oxa1, which is required for proper insertion of many inner mitochondrial membrane proteins, is behind the multifaceted phenotype caused by the ablation of ZapE.	[Pyrih, Jan; Raskova, Vendula; Skodova-Sverakova, Ingrid; Lukes, Julius] Czech Acad Sci, Inst Parasitol, Biol Ctr, Ceske Budejovice, Czech Republic; [Raskova, Vendula; Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Skodova-Sverakova, Ingrid] Comenius Univ, Fac Sci, Bratislava, Slovakia; [Panek, Tomas] Univ Ostrava, Fac Sci, Ostrava, Czech Republic; [Pyrih, Jan] Charles Univ Prague, Fac Sci, Biocev, Vestec, Czech Republic; [Panek, Tomas] Charles Univ Prague, Fac Sci, Prague, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Comenius University Bratislava; University of Ostrava; Charles University Prague; Charles University Prague	Pyrih, J; Lukes, J (corresponding author), Czech Acad Sci, Inst Parasitol, Biol Ctr, Ceske Budejovice, Czech Republic.; Lukes, J (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.; Pyrih, J (corresponding author), Charles Univ Prague, Fac Sci, Biocev, Vestec, Czech Republic.	jula@paru.cas.cz; jan.pyrih@gmail.com	Pánek, Tomáš/AAS-4567-2021; Pánek, Tomáš/S-8539-2017; Rašková, Vendula/AAX-1211-2020; Sveráková, Ingrid/AAE-2756-2019; Lukes, Julius/H-6760-2012	Pánek, Tomáš/0000-0002-1738-8430; Rašková, Vendula/0000-0002-1746-1482; Sveráková, Ingrid/0000-0002-4004-3377; Lukes, Julius/0000-0002-0578-6618; Pyrih, Jan/0000-0003-0715-2448	Czech Science Foundation [18-18699S, 18-15962S]; ERC [CZ LL1601]; ERD Funds project OPVVV [0000759]; Grant Agency of the Slovak Ministry of Education; Academy of Sciences [1/0387/17]; Slovak Research and Development Agency [APVV-0286-12]	Czech Science Foundation(Grant Agency of the Czech Republic); ERC(European Research Council (ERC)European Commission); ERD Funds project OPVVV; Grant Agency of the Slovak Ministry of Education; Academy of Sciences(Egyptian Academy of Scientific Research & Technology (ASRT)); Slovak Research and Development Agency(Slovak Research and Development Agency)	This work was supported by the Czech Science Foundation grant 18-15962S, ERC CZ LL1601, and the ERD Funds project OPVVV 0000759, Czech Science Foundation grant 18-18699S, and the Grant Agency of the Slovak Ministry of Education and the Academy of Sciences 1/0387/17, and Slovak Research and Development Agency grant APVV-0286-12.	Acestor N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006908; Armenteros JJA, 2017, BIOINFORMATICS, V33, P3387, DOI 10.1093/bioinformatics/btx431; Benz C, 2016, INT J PARASITOL, V46, P641, DOI 10.1016/j.ijpara.2016.04.006; Branon TC, 2018, NAT BIOTECHNOL, V36, P880, DOI 10.1038/nbt.4201; Cai K, 2018, J INORG BIOCHEM, V183, P107, DOI 10.1016/j.jinorgbio.2018.03.007; Cerna M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12021-2; Cesnekova J, 2016, ONCOTARGET, V7, P47687, DOI 10.18632/oncotarget.9959; Cesnekova J, 2016, BIOCHEM J, V473, P797, DOI 10.1042/BJ20151029; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dang HQ, 2017, MBIO, V8, DOI [10.1128/mBio.02120-16, 10.1128/mbio.02120-16]; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Downey N, 2005, EUKARYOT CELL, V4, P765, DOI 10.1128/EC.4.4.765-774.2005; Eddy SR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000069; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Germany EM, 2018, J CELL SCI, V131, DOI 10.1242/jcs.219956; Herrmann JM, 2004, J BIOL CHEM, V279, P2507, DOI 10.1074/jbc.M310468200; Horvathova L, 2019, ANCESTRAL MITOCHONDR, DOI [10.1101/790865, DOI 10.1101/790865]; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Katoh K, 2016, BIOINFORMATICS, V32, P1933, DOI 10.1093/bioinformatics/btw108; Kaurov I, 2018, CURR BIOL, V28, P3393, DOI 10.1016/j.cub.2018.09.008; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Kim DI, 2016, MOL BIOL CELL, V27, P1188, DOI 10.1091/mbc.E15-12-0844; Kolli R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020641; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Kwong JQ, 2007, J CELL BIOL, V179, P1163, DOI 10.1083/jcb.200704059; Leger MM, 2015, P NATL ACAD SCI USA, V112, P10239, DOI 10.1073/pnas.1421392112; Long S, 2008, P NATL ACAD SCI USA, V105, P13468, DOI 10.1073/pnas.0806762105; Lukes J, 2002, EUKARYOT CELL, V1, P495, DOI 10.1128/EC.1.4.495-502.2002; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Marteyn BS, 2014, MBIO, V5, DOI 10.1128/mBio.00022-14; McAllaster MR, 2016, MOL BIOCHEM PARASIT, V210, P13, DOI 10.1016/j.molbiopara.2016.08.001; Morriswood B, 2013, EUKARYOT CELL, V12, P356, DOI 10.1128/EC.00326-12; Paris Z, 2010, J BIOL CHEM, V285, P22394, DOI 10.1074/jbc.M109.083774; Peikert CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15272; Pena-Diaz P, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006310; Poon SK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110037; Read LK, 2016, WIRES RNA, V7, P33, DOI 10.1002/wrna.1313; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Smith DR, 2015, P NATL ACAD SCI USA, V112, P10177, DOI 10.1073/pnas.1422049112; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stiller SB, 2016, CELL METAB, V23, P901, DOI 10.1016/j.cmet.2016.04.005; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Verner Z, 2015, INT REV CEL MOL BIO, V315, P73, DOI 10.1016/bs.ircmb.2014.11.001; Verner Z, 2014, MOL BIOCHEM PARASIT, V193, P55, DOI 10.1016/j.molbiopara.2014.02.003; Verner Z, 2011, MOL BIOCHEM PARASIT, V175, P196, DOI 10.1016/j.molbiopara.2010.11.003; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Widmer G, 2012, PARASITE IMMUNOL, V34, P61, DOI 10.1111/j.1365-3024.2011.01301.x; Zikova A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006679	53	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234918	10.1371/journal.pone.0234918	http://dx.doi.org/10.1371/journal.pone.0234918			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579605	Green Published, gold			2022-12-27	WOS:000545646600019
J	Furfaro, LL; Payne, MS; Chang, BJ				Furfaro, Lucy L.; Payne, Matthew S.; Chang, Barbara J.			Host range, morphological and genomic characterisation of bacteriophages with activity against clinicalStreptococcus agalactiaeisolates	PLOS ONE			English	Article							GROUP-B STREPTOCOCCI; MULTIPLEX PCR ASSAY; MOLECULAR CHARACTERIZATION; IDENTIFICATION; ENUMERATION; RESISTANCE; PHAGE; IA	Streptococcus agalactiaeor Group B Streptococcus (GBS) is a leading cause of sepsis in neonates. As a preventative measure prophylactic antibiotic administration is common in pregnant women colonised with GBS, but antibiotic-resistance and adverse effects on neonatal microbiomes may result. Use of bacteriophages (phages) is one option for targeted therapy. To this end, four phages (LF1 -LF4) were isolated from wastewater. They displayed lytic activityin vitroagainstS.agalactiaeisolates collected from pregnant women and neonates, with 190/246 isolates (77.2%) and 10/10 (100%) isolates susceptible to at least one phage, respectively. Phage genomes ranged from 32,205-44,768 bp and all phages were members of theSiphoviridaefamily. High nucleotide identity (99.9%) was observed between LF1 and LF4, which were closely related to a putative prophage ofS.agalactiae. The genome organisation of LF2 differed, and it showed similarity to a differentS.agalactiaeprophage, while LF3 was more closely related to aStreptococcus pyogenesphage. Lysogenic gene presence (integrase, repressor and regulatory modules), was suggestive of temperate phages. In a therapeutic context, temperate phages are not ideal candidates, however, the broad host range activity of these phages observed on clinical isolatesin vitrois promising for future therapeutic approaches including bioengineered phage or lysin applications.	[Furfaro, Lucy L.; Payne, Matthew S.] Univ Western Australia, Sch Med, Div Obstet & Gynaecol, Crawley, Australia; [Chang, Barbara J.] Univ Western Australia, Sch Biomed Sci, Marshall Ctr Infect Dis Res & Training, Crawley, Australia	University of Western Australia; University of Western Australia	Furfaro, LL (corresponding author), Univ Western Australia, Sch Med, Div Obstet & Gynaecol, Crawley, Australia.	lucy.furfaro@uwa.edu.au	; Furfaro, Lucy/H-5569-2018	Chang, Barbara/0000-0002-6077-1646; Furfaro, Lucy/0000-0001-7652-0713	Channel 7 Telethon Trust Fund; Australian Government Research Training Program Scholarship; Professor Gordon King Postgraduate Scholarship by the Women's and Infants' Research Foundation; NHMRC [1144040]	Channel 7 Telethon Trust Fund; Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Professor Gordon King Postgraduate Scholarship by the Women's and Infants' Research Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the Channel 7 Telethon Trust Fund to MSP. LLF is supported by the Australian Government Research Training Program Scholarship and the Professor Gordon King Postgraduate Scholarship provided by the Women's and Infants' Research Foundation. MSP is also supported by an NHMRC Project Grant [1144040].	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Aloisio I, 2016, APPL MICROBIOL BIOT, V100, P5537, DOI 10.1007/s00253-016-7410-2; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Back EE, 2012, ANTIMICROB AGENTS CH, V56, P739, DOI 10.1128/AAC.05794-11; Bai Qinqin, 2016, Weishengwu Xuebao, V56, P317; Bai QQ, 2013, ARCH VIROL, V158, P1733, DOI 10.1007/s00705-013-1667-x; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BETRIU C, 1994, ANTIMICROB AGENTS CH, V38, P2183, DOI 10.1128/AAC.38.9.2183; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Cheng Q, 2005, ANTIMICROB AGENTS CH, V49, P111, DOI 10.1128/AAC.49.1.111-117.2005; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Domelier AS, 2009, J BACTERIOL, V191, P4776, DOI 10.1128/JB.00426-09; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Furfaro LL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223256; Furfaro LL, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02660; Furfaro LL, 2017, DIAGN MICR INFEC DIS, V89, P7, DOI 10.1016/j.diagmicrobio.2017.06.003; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Imperi M, 2010, J MICROBIOL METH, V80, P212, DOI 10.1016/j.mimet.2009.11.010; Jacobs-Sera D, 2012, VIROLOGY, V434, P187, DOI 10.1016/j.virol.2012.09.026; Kimura K, 2008, ANTIMICROB AGENTS CH, V52, P2890, DOI 10.1128/AAC.00185-08; Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Mazzocco Amanda, 2009, V501, P81, DOI 10.1007/978-1-60327-164-6_9; Mcshan WM, 1997, MOL MICROBIOL, V23, P719, DOI 10.1046/j.1365-2958.1997.2591616.x; Nale JY, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7010013; NCBI Resource Coordinators, 2018, NUCLEIC ACIDS RES, V46, pD8; Nobrega FL, 2015, TRENDS MICROBIOL, V23, P185, DOI 10.1016/j.tim.2015.01.006; Russell NJ, 2017, CLIN INFECT DIS, V65, pS100, DOI 10.1093/cid/cix658; Salloum M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020256; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seki T, 2015, J ANTIMICROB CHEMOTH, V70, P2725, DOI 10.1093/jac/dkv203; Simioni J, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0724-5; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; Wommack K. Eric, 2009, V501, P3, DOI 10.1007/978-1-60327-164-6_1; 2016, CANC DISCOV, V6	37	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235002	10.1371/journal.pone.0235002	http://dx.doi.org/10.1371/journal.pone.0235002			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574197	Green Published, gold			2022-12-27	WOS:000544972400020
J	Kadler, S; Vural, O; Rosowski, J; Reiners-Schramm, L; Lauster, R; Rosowski, M				Kadler, Shirin; Vural, Oezlem; Rosowski, Jennifer; Reiners-Schramm, Luzia; Lauster, Roland; Rosowski, Mark			Effects of 5-aza-2 '-deoxycytidine on primary human chondrocytes from osteoarthritic patients	PLOS ONE			English	Article							MESENCHYMAL STEM-CELL; DNA METHYLATION; PROGENITOR CELLS; CARTILAGE; TISSUE; DEDIFFERENTIATION; EXPRESSION; DIFFERENTIATION; DEMETHYLATION; 5-AZACYTIDINE	Chondrocytes, comparable to many cells from the connective tissue, dedifferentiate and end up in a similar fibroblastoid cell type, marked by the loss of the specific expression pattern. Here, chondrocytes isolated from osteoarthritic (OA) patients were investigated. The OA chondrocytes used in this work were not affected by the loss of specific gene expression upon cell culture. The mRNA levels of known cartilage markers, such as SOX5, SOX6, SOX9, aggrecan and proteoglycan 4, remained unchanged. Since chondrocytes from OA and healthy tissue show different DNA methylation patterns, the underlying mechanisms of cartilage marker maintenance were investigated with a focus on the epigenetic modification by DNA methylation. The treatment of dedifferentiated chondrocytes with the DNA methyltransferase inhibitor 5-aza-2 '-deoxycytidine (5-aza-dC) displayed no considerable impact on the maintenance of marker gene expression observed in the dedifferentiated state, while the chondrogenic differentiation capacity was compromised. On the other hand, the pre-cultivation with 5-aza-dC improved the osteogenesis and adipogenesis of OA chondrocytes. Contradictory to these effects, the DNA methylation levels were not reduced after treatment for four weeks with 1 mu M 5-aza-dC. In conclusion, 5-aza-dC affects the differentiation capacity of OA chondrocytes, while the global DNA methylation level remains stable. Furthermore, dedifferentiated chondrocytes isolated from late-stage OA patients represent a reliable cell source forin vitrostudies and disease models without the need for additional alterations.	[Kadler, Shirin; Vural, Oezlem; Rosowski, Jennifer; Reiners-Schramm, Luzia; Lauster, Roland; Rosowski, Mark] Tech Univ Berlin, Inst Biotechnol, Dept Med Biotechnol, Berlin, Germany	Technical University of Berlin	Kadler, S (corresponding author), Tech Univ Berlin, Inst Biotechnol, Dept Med Biotechnol, Berlin, Germany.	shirin.kadler@tu-berlin.de		Kadler, Shirin/0000-0001-9281-4770	German Research Foundation; Open Access Publication Fund of TU Berlin	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Fund of TU Berlin	We acknowledge support by the German Research Foundation and the Open Access Publication Fund of TU Berlin.	Ahmed TAE, 2014, HISTOL HISTOPATHOL, V29, P669, DOI 10.14670/HH-29.669; Alvarez-Garcia O, 2016, ARTHRITIS RHEUMATOL, V68, P1876, DOI 10.1002/art.39643; Avgustinova A, 2016, NAT REV MOL CELL BIO, V17, P643, DOI 10.1038/nrm.2016.76; Barter MJ, 2012, OSTEOARTHR CARTILAGE, V20, P339, DOI 10.1016/j.joca.2011.12.012; Bonin CA, 2016, GENE, V576, P312, DOI 10.1016/j.gene.2015.10.037; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Decker RS, 2014, MATRIX BIOL, V39, P5, DOI 10.1016/j.matbio.2014.08.006; Demoor M, 2014, BBA-GEN SUBJECTS, V1840, P2414, DOI 10.1016/j.bbagen.2014.02.030; Doran PM, 2015, METHODS MOL BIOL, V1340, P3, DOI 10.1007/978-1-4939-2938-2_1; Duan L, 2017, J CELL PHYSIOL, V232, P1708, DOI 10.1002/jcp.25486; Duan L, 2015, AM J TRANSL RES, V7, P194; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Goldring SR, 2016, NAT REV RHEUMATOL, V12, P632, DOI 10.1038/nrrheum.2016.148; Hagemann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017388; Hashimoto K, 2009, ARTHRITIS RHEUM-US, V60, P3303, DOI 10.1002/art.24882; Ikegami K, 2009, INT J DEV BIOL, V53, P203, DOI 10.1387/ijdb.082741ki; Im GI, 2013, EXPERT OPIN BIOL TH, V13, P713, DOI 10.1517/14712598.2013.764410; Jiang YZ, 2015, NAT REV RHEUMATOL, V11, P206, DOI 10.1038/nrrheum.2014.200; Khan IM, 2009, CELL STEM CELL, V4, P282, DOI 10.1016/j.stem.2009.03.007; Kim HJ, 2016, BIOTECHNOL LETT, V38, P167, DOI 10.1007/s10529-015-1949-3; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Komashko Vitalina M, 2010, Epigenetics, V5, P229; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; La Noce M, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0978-x; Liang X, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/7028901; Lin Z, 2008, J ORTHOP RES, V26, P1230, DOI 10.1002/jor.20523; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Ma B, 2013, OSTEOARTHR CARTILAGE, V21, P599, DOI 10.1016/j.joca.2013.01.014; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; Oda T, 2016, BIOCHEM BIOPH RES CO, V479, P469, DOI 10.1016/j.bbrc.2016.09.085; Pohlig F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150020; Rosowski M, 2006, ARTIF ORGANS, V30, P775, DOI 10.1111/j.1525-1594.2006.00300.x; Stellavato A, 2016, J CELL BIOCHEM, V117, P2158, DOI 10.1002/jcb.25556; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Unterberger A, 2006, MOL CELL BIOL, V26, P7575, DOI 10.1128/MCB.01887-05; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Yamada Y, 2014, STEM CELL TRANSL MED, V3, P1182, DOI 10.5966/sctm.2014-0090; Zhang W, 2016, BONE RES, V4, DOI 10.1038/boneres.2015.40	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234641	10.1371/journal.pone.0234641	http://dx.doi.org/10.1371/journal.pone.0234641			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574164	Green Published, gold			2022-12-27	WOS:000544972400033
J	Lin, LT; Chen, JT; Lu, DW; Tai, MC; Liang, CM; Chen, CL; Pao, SI; Hsu, CK; Chen, YH				Lin, Le-Tien; Chen, Jiann-Torng; Lu, Da-Wen; Tai, Ming-Cheng; Liang, Chang-Min; Chen, Ching-Long; Pao, Shu-, I; Hsu, Chih-Kang; Chen, Yi-Hao			Antifibrotic role of low-dose mitomycin-c-induced cellular senescence in trabeculectomy models	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; INDUCED PREMATURE SENESCENCE; REPLICATIVE SENESCENCE; RISK-FACTORS; TGF-BETA; FIBROSIS; FIBROBLASTS; MECHANISMS; CELLS; DIFFERENTIATION	Purpose We assessed whether mitomycin-C (MMC) has different antifibrotic mechanisms in trabeculectomy wound healing. Methods We identified 2 concentrations of MMC as "low-dose" by using WST-1 assay, Lactic dehydrogenase assay, and fluorescence-activated cell sorting flow cytometry. Senescence-associated beta-galactosidase (SA-beta-gal) and fibrotic gene expression was examined through immunocytochemistry, flow cytometry, real-time quantitative reverse transcription polymerase chain reaction, Western blotting, zymography, and modified scratch assay in vitro. In vivo, 0.1 mL of MMC or normal saline was injected to Tenon's capsule before trabeculectomy in a rabbit model. SA-beta-gal expression, apoptotic cell death, and collagen deposition in sites treated and not treated with MMC were evaluated using terminal dUTP nick end labeling assay and histochemical staining. Bleb function and intraocular pressure (IOP) levels were examined 3, 7, 14, 21, 28, and 35 days after trabeculectomy. Results In vitro, human Tenon's fibroblast (HTF) senescence was confirmed by observing cell morphologic change, SA-beta-gal accumulation, formation of senescence-associated heterochromatin, increased p16(INK4a)and p21(CIP1/WAF1)expression, lower percentage of Ki-67-positive cells, and decreased COL1A1 release. Increased expression of alpha-SMA,COL1A1, and Smad2 signaling in TGF-beta 1-induced stress fibers were passivated in senescent HTFs. In addition, cellular migration enhanced by TGF-beta 1was inactivated. In vivo, histological examination indicated increased SA-beta-gal accumulation, lower apoptosis ratios, and looser collagen deposition in sites treated with 0.2 mu M MMC. Low-dose MMC-induced cellular senescence prolonged trabeculectomy bleb survival and reduced IOP levels in a rabbit model. Conclusion Low-dose MMC-induced cellular senescence is involved in the antifibrotic mechanism of trabeculectomy wound healing.	[Lin, Le-Tien; Hsu, Chih-Kang] Tri Serv Gen Hosp, Dept Ophthalmol, Natl Def Med Ctr, Songshan Branch, Taipei, Taiwan; [Lin, Le-Tien; Chen, Jiann-Torng; Lu, Da-Wen; Tai, Ming-Cheng; Liang, Chang-Min; Chen, Ching-Long; Chen, Yi-Hao] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Le-Tien; Chen, Jiann-Torng; Lu, Da-Wen; Tai, Ming-Cheng; Liang, Chang-Min; Chen, Ching-Long; Pao, Shu-, I; Hsu, Chih-Kang; Chen, Yi-Hao] Tri Serv Gen Hosp, Dept Ophthalmol, Natl Def Med Ctr, Taipei, Taiwan; [Liang, Chang-Min] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Chen, YH (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Chen, YH (corresponding author), Tri Serv Gen Hosp, Dept Ophthalmol, Natl Def Med Ctr, Taipei, Taiwan.	doc30879@mail.ndmctsgh.edu.tw			Ministry of Science and Technology, Taiwan [107-2314-B-016-032]; National Defense Medical Center, Tri-Service General Hospital, Taiwan [C108-124]; National Defense Medical Center, Tri-Service General Hospital Songshan Branch, Taiwan [108-23, 108-38]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Defense Medical Center, Tri-Service General Hospital, Taiwan; National Defense Medical Center, Tri-Service General Hospital Songshan Branch, Taiwan	This study was funded by the Ministry of Science and Technology, Taiwan to YHC (grant no. 107-2314-B-016-032), National Defense Medical Center, Tri-Service General Hospital, Taiwan to YHC (grant no. C108-124), and National Defense Medical Center, Tri-Service General Hospital Songshan Branch, Taiwan to LTL and CKH (grant no. 108-23 and 108-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Broadway DC, 2001, J GLAUCOMA, V10, P237, DOI 10.1097/00061198-200106000-00017; Bruno CA, 2007, EXPERT REV OPHTHALMO, V2, P79, DOI 10.1586/17469899.2.1.79; CAIRNS JE, 1968, AM J OPHTHALMOL, V66, P673, DOI 10.1016/0002-9394(68)91288-9; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Caprioli J, 2011, AM J OPHTHALMOL, V152, P340, DOI 10.1016/j.ajo.2011.05.029; Chen CZC, 2009, FIBROGENESIS TISSUE, V2, DOI 10.1186/1755-1536-2-7; Chen YH, 2013, ACTA OPHTHALMOL, V91, pE506, DOI 10.1111/aos.12160; Cicinnati VR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-350; Classen L, 1996, AM J OPHTHALMOL, V122, P205, DOI 10.1016/S0002-9394(14)72011-2; Cordeiro M F, 2000, Curr Opin Ophthalmol, V11, P121, DOI 10.1097/00055735-200004000-00010; Cordeiro MF, 2003, CLIN SCI, V104, P181, DOI 10.1042/CS20020150; Crowston JG, 1998, INVEST OPHTH VIS SCI, V39, P449; Daniels JT, 2003, INVEST OPHTH VIS SCI, V44, P1104, DOI 10.1167/iovs.02-0412; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DESMOULIERE A, 1995, J HEPATOL, V22, P61; Deva NC, 2012, INFLAMMATION, V35, P1276, DOI 10.1007/s10753-012-9439-4; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Ederer F, 2004, OPHTHALMOLOGY, V111, P651, DOI 10.1016/j.ophtha.2003.09.025; Ekinci M, 2014, J GLAUCOMA, V23, P372, DOI 10.1097/IJG.0000000000000052; Esson DW, 2004, INVEST OPHTH VIS SCI, V45, P4450, DOI 10.1167/iovs.04-0375; Fontana H, 2006, OPHTHALMOLOGY, V113, P930, DOI 10.1016/j.ophtha.2006.01.062; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Giannandrea M, 2014, DIS MODEL MECH, V7, P193, DOI 10.1242/dmm.012062; Gossrau R, 1991, GLYCOSIDASE HISTOCHE, P241; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hackbarth H, 2000, LAB ANIM-UK, V34, P91, DOI 10.1258/002367700780578055; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hoyles RK, 2008, ARTHRITIS RHEUM-US, V58, P1175, DOI 10.1002/art.23379; Huang WT, 2015, EXP GERONTOL, V61, P62, DOI 10.1016/j.exger.2014.11.018; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Jurikova M, 2016, ACTA HISTOCHEM, V118, P544, DOI 10.1016/j.acthis.2016.05.002; KARSENTY G, 1991, BIOCHEM BIOPH RES CO, V177, P538, DOI 10.1016/0006-291X(91)92017-E; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Krieg T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2188; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leask A, 2008, J CELL COMMUN SIGNAL, V2, P49, DOI 10.1007/s12079-008-0029-z; Leng F, 2011, CURR EYE RES, V36, P301, DOI 10.3109/02713683.2010.547648; Liang CM, 2011, ACTA OPHTHALMOL, V89, pE505, DOI 10.1111/j.1755-3768.2011.02147.x; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin XC, 2009, INVEST OPHTH VIS SCI, V50, P3763, DOI 10.1167/iovs.08-2815; Maier AB, 2007, ANN NY ACAD SCI, V1100, P323, DOI 10.1196/annals.1395.035; Mawal-Dewan M, 2002, J BIOL CHEM, V277, P7857, DOI 10.1074/jbc.M104515200; McKenna E, 2012, CELL CYCLE, V11, P3132, DOI 10.4161/cc.21506; Mellone M, 2017, AGING-US, V9, P128, DOI 10.18632/aging.101127; Mietz H, 1996, GRAEF ARCH CLIN EXP, V234, P364, DOI 10.1007/BF00190712; Mohan R, 2002, J BIOL CHEM, V277, P2065, DOI 10.1074/jbc.M107611200; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Perkins TW, 2002, ARCH OPHTHALMOL-CHIC, V120, P941, DOI 10.1001/archopht.120.7.941; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Pinilla I, 1998, OPHTHALMOLOGICA, V212, P306, DOI 10.1159/000027313; Pratt WB, 1994, THE ANTICANCER DRUGS, P124; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Razeghinejad MR, 2012, SURV OPHTHALMOL, V57, P1, DOI 10.1016/j.survophthal.2011.07.005; SAPPINO AP, 1990, LAB INVEST, V63, P144; Sarrazy V, 2011, WOUND REPAIR REGEN, V19, pS10, DOI 10.1111/j.1524-475X.2011.00708.x; Sethi A, 2011, INVEST OPHTH VIS SCI, V52, P5240, DOI 10.1167/iovs.11-7287; Shi SR, 2008, AM J CLIN PATHOL, V129, P358, DOI 10.1309/7CXUYXT23E5AL8KQ; Shin DM, 2004, PLAST RECONSTR SURG, V113, P633, DOI 10.1097/01.PRS.0000101530.33096.5B; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; Toussaint O, 2002, BIOCHEM PHARMACOL, V64, P1007, DOI 10.1016/S0006-2952(02)01170-X; Verhaegen PDHM, 2009, WOUND REPAIR REGEN, V17, P649, DOI 10.1111/j.1524-475X.2009.00533.x; Walton KL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00461; Wang L, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9365950; Wong TTL, 2003, INVEST OPHTH VIS SCI, V44, P1097, DOI 10.1167/iovs.02-0366; Yanai H, 2015, AGING-US, V7, P664, DOI 10.18632/aging.100807; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	74	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234706	10.1371/journal.pone.0234706	http://dx.doi.org/10.1371/journal.pone.0234706			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574191	Green Published, gold			2022-12-27	WOS:000544972400003
J	Nwaozuru, U; Blackstone, S; Obiezu-Umeh, C; Conserve, DF; Mason, S; Uzoaru, F; Gbajabiamila, T; Ezechi, O; Iwelunmor, P; Ehiri, JE; Iwelunmor, J				Nwaozuru, Ucheoma; Blackstone, Sarah; Obiezu-Umeh, Chisom; Conserve, Donaldson F.; Mason, Stacey; Uzoaru, Florida; Gbajabiamila, Titi; Ezechi, Oliver; Iwelunmor, Patricia; Ehiri, John E.; Iwelunmor, Juliet			Psychosocial correlates of safe sex self-efficacy among in-school adolescent girls in Lagos, Nigeria	PLOS ONE			English	Article							CONDOM-USE; AFRICAN-AMERICAN; RISK BEHAVIOR; HIV; FUTURE; PREDICTORS; KNOWLEDGE; ORIENTATION; PERCEPTIONS; VALIDATION	Background Adolescent girls in Nigeria are at heightened risk for HIV and other sexually transmitted infections. However, there are limited studies on psychosocial factors that are associated with safe sex intentions among this population. Self-efficacy has been established as an important correlate of behavioral intentions and the actual behavior. The objective of this research was to examine how key psychosocial factors such as social support, parental monitoring, and future orientation influence perceived safe sex self-efficacy among in-school adolescent girls in Nigeria. Furthermore, we assessed the associations between these psychosocial factors and HIV-related knowledge and safe sex self-efficacy. Methods A self-administered questionnaire was distributed to 426 adolescent girls attending public and private school systems in Lagos, Nigeria. Multiple linear regression was used to evaluate the influence of psychosocial and demographic factors on safe sex self-efficacy. Further, stratified analysis was conducted to compare the estimates between participants attending public schools (n = 272) and those attending private schools (n = 154). Findings Results from the study show that future orientation (beta = 0.17; p < 0.05), participants age (beta = 0.14; p < 0.05), and HIV knowledge accuracy (beta = 0.17; p < 0.05) were associated with safe sex self-efficacy. Future orientation remained statistically significant in the sub-group analysis among participants attending public (beta = 0.13; p < 0.05) and private schools (beta = 0.24; p < 0.05). Among participants attending public schools, HIV accuracy (beta = 0.2; p < 0.05) remained a significant correlate of safe sex self-efficacy while this association dissipated among private school attendees. Conclusions These findings point to the importance of including future orientation strategies in interventions developed for in-school adolescent girls in Nigeria. School-based interventions that increase positive future orientation outcomes may be beneficial to improve safe sex intentions among adolescent girls in Nigeria.	[Nwaozuru, Ucheoma; Obiezu-Umeh, Chisom; Mason, Stacey; Uzoaru, Florida; Iwelunmor, Juliet] St Louis Univ, Dept Behav Sci & Hlth Educ, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA; [Blackstone, Sarah] James Madison Univ, Dept Hlth Profess & Hlth Sci, Harrisonburg, VA 22807 USA; [Conserve, Donaldson F.] Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Gbajabiamila, Titi; Ezechi, Oliver] Nigerian Inst Med Res, Yaba, Lagos State, Nigeria; [Iwelunmor, Patricia] Morning Star Hlth & Human Dev Fdn, Festac Town, Lagos State, Nigeria; [Ehiri, John E.] Univ Arizona, Dept Hlth Promot Sci, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA	Saint Louis University; James Madison University; University of South Carolina System; University of South Carolina Columbia; University of Arizona	Nwaozuru, U (corresponding author), St Louis Univ, Dept Behav Sci & Hlth Educ, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA.	nwaozur2@gmail.com		Conserve, Donaldson/0000-0001-8193-817X; Obiezu-umeh, Chisom/0000-0003-3881-9313; Uzoaru, Florida/0000-0001-7507-6809; Nwaozuru, Ucheoma/0000-0002-0680-0928				Adedimeji AA, 2009, SOCIAL FACTORS SOCIA; Adedimeji Adebola A, 2008, East Afr J Public Health, V5, P215; Ajayi AI, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7310-3; Ankomah A, 2011, ADOLESC HEALTH MED T, V2, P75, DOI 10.2147/AHMT.S23649; Arricau-Bouvery N, 2005, VET RES, V36, P327, DOI 10.1051/vetres:2005010; Auerbach J, 2009, HEALTH AFFAIR, V28, P1655, DOI 10.1377/hlthaff.28.6.1655; Baker J G, 1999, J Pediatr Adolesc Gynecol, V12, P17, DOI 10.1016/S1083-3188(00)86615-2; BASENENGQUIST K, 1992, HEALTH EDUC QUART, V19, P263, DOI 10.1177/109019819201900209; Bella-Awusah T, 2016, CHILD ADOL MENT H-UK, V21, P44, DOI 10.1111/camh.12104; Bolland JM, 2007, AM J COMMUN PSYCHOL, V40, P230, DOI 10.1007/s10464-007-9132-1; Bourdeau B, 2008, J SEX RES, V45, P71, DOI 10.1080/00224490701845185; Bryan A, 2004, J APPL SOC PSYCHOL, V34, P912, DOI 10.1111/j.1559-1816.2004.tb02577.x; Burns MJ, 2005, J BLACK PSYCHOL, V31, P172, DOI 10.1177/0095798404268288; Cabrera P., 2009, J CHILD ADOLESCENT T, V2, P271, DOI [10.1080/19361520903317311, DOI 10.1080/19361520903317311]; Cha ES, 2008, ARCH SEX BEHAV, V37, P641, DOI 10.1007/s10508-007-9187-y; Closson K, 2018, AIDS BEHAV, V22, P671, DOI 10.1007/s10461-017-1950-z; Cluver LD, 2015, J INT AIDS SOC, V18, P73, DOI 10.7448/IAS.18.7.20260; de Vries H, 1988, HLTH ED RES, V3, P273, DOI [10.1093/her/3.3.273, DOI 10.1093/HER/3.3.273]; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; DiClemente RJ, 2008, PSYCHOSOM MED, V70, P598, DOI 10.1097/PSY.0b013e3181775edb; DICLEMENTE RJ, 1993, J ADOLESCENT HEALTH, V14, P231, DOI 10.1016/1054-139X(93)90011-D; DiClemente RJ, 2001, PEDIATRICS, V107, P1363, DOI 10.1542/peds.107.6.1363; Fishbein M., 2011, PREDICTING CHANGING, DOI [10.4324/9780203838020, DOI 10.4324/9780203838020]; Folayan MO, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-83; Grimley DM, 1996, AM J HEALTH BEHAV, V20, P406; Hampanda K, 2014, AIDS CARE, V26, P1209, DOI 10.1080/09540121.2014.894612; JEMMOTT JB, 1992, J ADOLESCENT HEALTH, V13, P512, DOI 10.1016/1054-139X(92)90016-5; Johnson Sarah R Lindstrom, 2014, Int J Adolesc Med Health, V26, P459, DOI 10.1515/ijamh-2013-0333; KELLY JA, 1989, J BEHAV THER EXP PSY, V20, P227, DOI 10.1016/0005-7916(89)90027-X; Kerpelman JL, 2008, J YOUTH ADOLESCENCE, V37, P997, DOI 10.1007/s10964-007-9201-7; Kuponiyi Olugbenga Temitope, 2016, BMC Res Notes, V9, P203, DOI 10.1186/s13104-016-2006-6; Mahat G, 2016, J PEDIATR NURS, V31, pE63, DOI 10.1016/j.pedn.2015.06.015; McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4; Miller BC, 2002, J SEX RES, V39, P22, DOI 10.1080/00224490209552115; NACA. National Agency for the Control of AIDS, 2016, NAT AG CONTR AIDS NA; National Agency for the Control of AIDS, 2019, REV NAT HIV AIDS STR; NDHS. National Population Commision, 2013, NIG DEM HLTH SURV RE; Omoyeni S. T., 2014, African Population Studies, V27, P331; Parsons JT, 2000, J ADOLESCENCE, V23, P377, DOI 10.1006/jado.2000.0326; Robbins RN, 2004, J ADOLESCENT RES, V19, P428, DOI 10.1177/0743558403258860; Rotheram-Borus MJ, 2018, CURR OPIN PEDIATR, V30, P131, DOI 10.1097/MOP.0000000000000580; Rothspan S, 1996, HEALTH PSYCHOL, V15, P131, DOI 10.1037/0278-6133.15.2.131; Sayles JN, 2006, JAIDS-J ACQ IMM DEF, V43, P226, DOI 10.1097/01.qai.0000230527.17459.5c; Shobe M., 2001, J SOCIOL SOC WELFARE, V28; Slap GB, 2003, BMJ-BRIT MED J, V326, P15, DOI 10.1136/bmj.326.7379.15; Smith SJ, 2017, SOC WORK PUBLIC HLTH, V32, P176, DOI 10.1080/19371918.2016.1215278; Ssewamala FM, 2010, AM J PUBLIC HEALTH, V100, P483, DOI 10.2105/AJPH.2008.158840; Statistics NBo, 2018, NIG DAT STAT 2018; Stewart RC, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-180; STLAWRENCE JS, 1993, J CONSULT CLIN PSYCH, V61, P104, DOI 10.1037/0022-006X.61.1.104; Toma BO, 2015, EVALUATION SCH HLTH; UNAIDS, HIV PREV AD GIRLS YO; UNAIDS, 2019, WOM HIV SPOTL AD GIR; UNAIDS, 2019, UNAIDS DAT 2019; UNAIDS/UNICEF, 2013, HIV NIG; Van Campen KS, 2012, FAM RELAT, V61, P548, DOI 10.1111/j.1741-3729.2012.00721.x; Whitaker DJ, 2000, FAM PLANN PERSPECT, V32, P111, DOI 10.2307/2648159; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; Zaleski Z., 1994, PSYCHOL FUTURE ORIEN	59	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234788	10.1371/journal.pone.0234788	http://dx.doi.org/10.1371/journal.pone.0234788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME9KK	32574187	Green Published, gold			2022-12-27	WOS:000544972400050
J	Oka, S; Sabry, AD; Horiuchi, AK; Cawley, KM; O'Very, SA; Zaitsev, MA; Shankar, TS; Byun, J; Mukai, R; Xu, XY; Torres, NS; Kumar, A; Yazawa, M; Ling, J; Taleb, I; Saijoh, Y; Drakos, SG; Sadoshima, J; Warren, JS				Oka, Shin-ichi; Sabry, Amira D.; Horiuchi, Amanda K.; Cawley, Keiko M.; O'Very, Sean A.; Zaitsev, Maria A.; Shankar, Thirupura S.; Byun, Jaemin; Mukai, Risa; Xu, Xiaoyong; Torres, Natalia S.; Kumar, Anil; Yazawa, Masayuki; Ling, Jing; Taleb, Iosif; Saijoh, Yukio; Drakos, Stavros G.; Sadoshima, Junichi; Warren, Junco S.			Perm1 regulates cardiac energetics as a downstream target of the histone methyltransferase Smyd1	PLOS ONE			English	Article							RECEPTOR-GAMMA COACTIVATOR-1-ALPHA; ACTIVATED PROTEIN-KINASE; MITOCHONDRIAL BIOGENESIS; OXIDATIVE CAPACITY; GENE-EXPRESSION; ERR-ALPHA; TRANSCRIPTION; HYPERTROPHY; FAMILY; STIMULATION	The transcriptional regulatory machinery in mitochondrial bioenergetics is complex and is still not completely understood. We previously demonstrated that the histone methyltransferase Smyd1 regulates mitochondrial energetics. Here, we identifiedPerm1(PPARGC-1 andESRR-inducedregulator,muscle specific1) as a downstream target of Smyd1 through RNA-seq. Chromatin immunoprecipitation assay showed that Smyd1 directly interacts with the promoter of Perm1 in the mouse heart, and this interaction was significantly reduced in mouse hearts failing due to pressure overload for 4 weeks, where Perm1 was downregulated (24.4 +/- 5.9% of sham, p<0.05). Similarly, the Perm1 protein level was significantly decreased in patients with advanced heart failure (55.2 +/- 13.1% of donors, p<0.05). Phenylephrine (PE)-induced hypertrophic stress in cardiomyocytes also led to downregulation of Perm1 (55.7 +/- 5.7% of control, p<0.05), and adenovirus-mediated overexpression of Perm1 rescued PE-induced downregulation of estrogen-related receptor alpha (ERR alpha), a key transcriptional regulator of mitochondrial energetics, and its target gene,Ndufv1(Complex I). Pathway enrichment analysis of cardiomyocytes in whichPerm1was knocked-down by siRNA (siPerm1), revealed that the most downregulated pathway was metabolism. Cell stress tests using the Seahorse XF analyzer showed that basal respiration and ATP production were significantly reduced in siPerm1 cardiomyocytes (40.7% and 23.6% of scrambled-siRNA, respectively, both p<0.05). Luciferase reporter gene assay further revealed that Perm1 dose-dependently increased the promoter activity of theERR alpha gene and known target of ERR alpha, Ndufv1 (Complex I). Overall, our study demonstrates that Perm1 is an essential regulator of cardiac energetics through ERR alpha, as part of the Smyd1 regulatory network.	[Oka, Shin-ichi; Byun, Jaemin; Mukai, Risa; Xu, Xiaoyong; Sadoshima, Junichi] Rutgers New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ USA; [Sabry, Amira D.; Horiuchi, Amanda K.; Cawley, Keiko M.; O'Very, Sean A.; Zaitsev, Maria A.; Shankar, Thirupura S.; Torres, Natalia S.; Ling, Jing; Taleb, Iosif; Drakos, Stavros G.; Warren, Junco S.] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA; [Xu, Xiaoyong] Lihuili Hosp, Dept Cardiol, Ningbo Med Ctr, Ningbo, Zhejiang, Peoples R China; [Kumar, Anil] Univ Utah, Metab Phenotyping Core Facil, Salt Lake City, UT USA; [Yazawa, Masayuki] Columbia Univ, Columbia Stem Cell Initiat Rehabil & Regenerat Me, New York, NY USA; [Yazawa, Masayuki] Columbia Univ, Pharmacol, New York, NY USA; [Taleb, Iosif; Drakos, Stavros G.; Warren, Junco S.] Univ Utah, Sch Med, Dept Internal Med, Div Cardiovasc Med, Salt Lake City, UT 84112 USA; [Saijoh, Yukio] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Warren, Junco S.] Kumamoto Univ, Inst Resource Dev & Anal, Kumamoto, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Columbia University; Columbia University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Kumamoto University	Warren, JS (corresponding author), Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA.; Warren, JS (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Div Cardiovasc Med, Salt Lake City, UT 84112 USA.; Warren, JS (corresponding author), Kumamoto Univ, Inst Resource Dev & Anal, Kumamoto, Japan.	junco.warren@utah.edu		Mukai, Risa/0000-0003-4669-4100; O'Very, Sean/0000-0003-2885-6962; Torres, Natalia/0000-0002-8192-2562	Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research [51005911]; University of Utah Research Initiative Seed Grant Program; Nora Eccles Treadwell Foundation; American Heart Association [17GRNT33440031]; American Heart Association Transformational Project Award [19TPA34850170]; New Jersey Health Foundation (NJHF) [PC56-16 PC80-17]; University of Utah Undergraduate Research Opportunity Program; American Heart Association Heart Failure Strategically Focused Research Network [16SFRN290200000]; NHLBI [R01 HL132067-01A1, R01 HL135121-01]; National Cancer Institute of the National Institutes of Health [P30CA042014]	Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research; University of Utah Research Initiative Seed Grant Program; Nora Eccles Treadwell Foundation; American Heart Association(American Heart Association); American Heart Association Transformational Project Award(American Heart Association); New Jersey Health Foundation (NJHF); University of Utah Undergraduate Research Opportunity Program; American Heart Association Heart Failure Strategically Focused Research Network; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research #51005911 (J.S. W.)(https://hria.org/tmf/geneen/), University of Utah Research Initiative Seed Grant Program (J.S. W)(https://research.utah.edu/funding/1U4U-targeted-research-seed-grant.php), the Nora Eccles Treadwell Foundation (J.S.W., S.D.)(https://www.tides.org/project/tenant/nora-eccles-treadwell-foundation/), American Heart Association Grant in Aid 17GRNT33440031 (S.O.)(URL n/a), American Heart Association Transformational Project Award 19TPA34850170 (S.O.) (https://professional.heart.org/professional/ResearchPrograms/UCM_ 497208_Transformational-Project-Award.jsp), New Jersey Health Foundation (NJHF) research grants PC56-16 PC80-17 (S.O.)(https://www.njhealthfoundation.org/research-grant-program), University of Utah Undergraduate Research Opportunity Program (A.H.)(https://our.utah.edu/urop/), American Heart Association Heart Failure Strategically Focused Research Network 16SFRN290200000 (S. D.)(https://professional.heart.org/professional/ResearchPrograms/StrategicallyFocusedResearchPrograms/UCM_ 454438_Strategically-Focused-ResearchNetworks.jsp), NHLBI R01 HL135121-01 (S.D.), NHLBI R01 HL132067-01A1 (S.D.)(https://www.nhlbi.nih.gov/grants-and-training/fundingopportunities-and-contacts), and the National Cancer Institute of the National Institutes of Health under Award Number P30CA042014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, AM J PHYSIOL-RENAL, V307, pF891; Berkholz J, 2015, EXP CELL RES, V336, P182, DOI 10.1016/j.yexcr.2015.06.019; Bhat S, 2019, CIRC-HEART FAIL, V12, DOI 10.1161/CIRCHEARTFAILURE.118.005529; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cho Y, 2019, MOL METAB, V23, P88, DOI 10.1016/j.molmet.2019.02.009; Cho Y, 2016, FASEB J, V30, P674, DOI 10.1096/fj.15-276360; Cho Y, 2013, J BIOL CHEM, V288, P25207, DOI 10.1074/jbc.M113.489674; Diakos Nikolaos A, 2016, JACC Basic Transl Sci, V1, P432, DOI 10.1016/j.jacbts.2016.06.009; Diakos NA, 2014, J AM COLL CARDIOL, V64, P1602, DOI 10.1016/j.jacc.2014.05.073; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Franklin S, 2016, AM J PHYSIOL-HEART C, V311, pH1234, DOI 10.1152/ajpheart.00235.2016; Hu XL, 2011, HYPERTENSION, V58, P696, DOI 10.1161/HYPERTENSIONAHA.111.174128; Hur B, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3302-7; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Kam Y JN, 2017, NORMALIZATION AGILEN; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Karkkainen O, 2019, CARDIOVASC RES, V115, P107, DOI 10.1093/cvr/cvy155; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Liu D, 2005, J MOL ENDOCRINOL, V34, P473, DOI 10.1677/jme.1.01586; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Oka S, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00002; Oka SI, 2020, CARDIOVASC RES, V116, P1742, DOI 10.1093/cvr/cvz251; Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001; Pereira RO, 2014, FASEB J, V28, P3691, DOI 10.1096/fj.14-253823; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; SIMPSON P, 1985, CIRC RES, V56, P884, DOI 10.1161/01.RES.56.6.884; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Tracy CM, 2018, CURR OPIN PHYSIOL, V1, P140, DOI 10.1016/j.cophys.2017.10.001; Warren JS, 2018, P NATL ACAD SCI USA, V115, pE7871, DOI 10.1073/pnas.1800680115; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Zhao M, 1999, MOL CELL BIOL, V19, P21	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234913	10.1371/journal.pone.0234913	http://dx.doi.org/10.1371/journal.pone.0234913			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574189	Green Published, gold			2022-12-27	WOS:000544972400011
J	Murcia, H; Diaz, GJ				Murcia, Hansen; Diaz, Gonzalo J.			Dealing with aflatoxin B(1)dihydrodiol acute effects: Impact of aflatoxin B-1-aldehyde reductase enzyme activity in poultry species tolerant to AFB(1)toxic effects	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; ALDEHYDE REDUCTASE; RAT-LIVER; METABOLISM; KEGG; HYDROLYSIS; ETHOXYQUIN; DIALDEHYDE; MECHANISM; OXIDATION	Aflatoxin B(1)aldehyde reductase (AFAR) enzyme activity has been associated to a higher resistance to the aflatoxin B-1(AFB(1)) toxicity in ethoxyquin-fed rats. However, no studies about AFAR activity and its relationship with tolerance to AFB(1)have been conducted in poultry. To determine the role of AFAR in poultry tolerance, the hepaticin vitroenzymatic activity of AFAR was investigated in liver cytosol from four commercial poultry species (chicken, quail, turkey and duck). Specifically, the kinetic parameters V-max, K(m)and intrinsic clearance (CLint) were determined for AFB(1)dialdehyde reductase (AFB(1)-monoalcohol production) and AFB(1)monoalcohol reductase (AFB(1)-dialcohol production). In all cases, AFB(1)monoalcohol reductase activity saturated at the highest aflatoxin B(1)dialdehyde concentration tested (66.4 mu M), whereas AFB(1)dialdehyde reductase did not. Both activities were highly and significantly correlated and therefore are most likely catalyzed by the same AFAR enzyme. However, it appears that production of the AFB(1)monoalcohol is favored over the AFB(1)dialcohol. The production of alcohols from aflatoxin dialdehyde showed the highest enzymatic efficiency (highest CL(int)value) in chickens, a species resistant to AFB(1); however, it was also high in the turkey, a species with intermediate sensitivity; further, CL(int)values were lowest in another tolerant species (quail) and in the most sensitive poultry species (the duck). These results suggest that AFAR activity is related to resistance to the acute toxic effects of AFB(1)only in chickens and ducks. Genetic selection of ducks for high AFAR activity could be a means to control aflatoxin sensitivity in this poultry species.	[Murcia, Hansen; Diaz, Gonzalo J.] Univ Nacl Colombia, Fac Med Vet & Zootecnia, Lab Toxicol, Bogota, Colombia	Universidad Nacional de Colombia	Murcia, H (corresponding author), Univ Nacl Colombia, Fac Med Vet & Zootecnia, Lab Toxicol, Bogota, Colombia.	hwmurciag@unal.edu.co		Diaz, Gonzalo/0000-0002-9858-0845; Murcia, Hansen/0000-0003-0545-9307	Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS; Departamento de Salud Animal, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional de Colombia, Bogota D.C., Colombia	Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Departamento de Salud Animal, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional de Colombia, Bogota D.C., Colombia	HM, Convocatoria 647, Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS, https://www.colciencias.gov.co/convocatorias/2014/doctorados-nacionales-2014, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GD, Departamento de Salud Animal, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional de Colombia, Bogota D.C., Colombia, http://medicinaveterinariaydezootecnia.bogota.unal.edu.co/la-facultad/departamentos/, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; BAERTSCHI SW, 1989, CHEM RES TOXICOL, V2, P114, DOI 10.1021/tx00008a008; Budavari S, 1996, THE MERK INDEX; Diaz GJ., 2020, TOXICOLOGIA MICOTOXI; Diaz GJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44515-6; EATON DL, 1994, ANNU REV PHARMACOL, V34, P135, DOI 10.1146/annurev.pa.34.040194.001031; Ellis EM, 2003, CARCINOGENESIS, V24, P727, DOI 10.1093/carcin/bgg016; ELLIS EM, 1993, P NATL ACAD SCI USA, V90, P10350, DOI 10.1073/pnas.90.21.10350; FRINGUELLI F, 1989, SYNTHETIC COMMUN, V19, P1939, DOI 10.1080/00397918908052586; Guengerich FP, 2002, CHEM RES TOXICOL, V15, P780, DOI 10.1021/tx010156s; Guengerich FP, 1998, MUTAT RES-FUND MOL M, V402, P121, DOI 10.1016/S0027-5107(97)00289-3; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P727, DOI 10.1021/tx010005p; Hetzel D. J. S., 1984, Singapore Veterinary Journal, V8, P6; Johnson WW, 1996, J AM CHEM SOC, V118, P8213, DOI 10.1021/ja960525k; JUDAH DJ, 1993, BIOCHEM J, V292, P13, DOI 10.1042/bj2920013; Kakkar T, 1999, DRUG METAB DISPOS, V27, P756; Kakkar T, 2000, J PHARMACOL EXP THER, V293, P861; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kelly VP, 2002, BIOCHEM J, V366, P847, DOI 10.1042/BJ20020342; Kelly VP, 2000, BIOCHEM J, V348, P389, DOI 10.1042/0264-6021:3480389; KENSLER TW, 1986, CANCER RES, V46, P3924; Klein PJ, 2002, COMP BIOCHEM PHYS C, V132, P193, DOI 10.1016/S1532-0456(02)00065-0; Marangoni AG, 2003, ENZYME KINETICS MODE; MCLELLAN LI, 1994, BIOCHEM J, V300, P117, DOI 10.1042/bj3000117; NEAL GE, 1981, TOXICOL APPL PHARM, V58, P431, DOI 10.1016/0041-008X(81)90095-8; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; REDINBAUGH MG, 1986, ANAL BIOCHEM, V153, P267, DOI 10.1016/0003-2697(86)90091-6; SAS Institute Inc, 2013, BAS SAS 9 4 PROC GUI; Seibert E, 2014, ENZYME KINETICS DRUG; SIU GM, 1982, LIPIDS, V17, P349, DOI 10.1007/BF02535193; SWENSON DH, 1973, BIOCHEM BIOPH RES CO, V53, P1260, DOI 10.1016/0006-291X(73)90601-3; Tulayakul P, 2005, TOXICON, V46, P204, DOI 10.1016/j.toxicon.2005.03.023	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235061	10.1371/journal.pone.0235061	http://dx.doi.org/10.1371/journal.pone.0235061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569334	gold, Green Published			2022-12-27	WOS:000543547900027
J	Simon, N; Guichard, N; Odou, P; Decaudin, B; Bonnabry, P; Fleury-Souverain, S				Simon, Nicolas; Guichard, Nicolas; Odou, Pascal; Decaudin, Bertrand; Bonnabry, Pascal; Fleury-Souverain, Sandrine			Efficiency of four solutions in removing 23 conventional antineoplastic drugs from contaminated surfaces	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; CLEANING SOLUTIONS; DECONTAMINATION EFFICACY; GUIDELINES; NURSES	Background Residual contamination by intravenous conventional antineoplastic drugs (ICAD) is still a daily issue in hospital facilities. This study aimed to compare the efficiency (Eff(Q)) of 4 different solutions to remove 23 widely used ICADs from surfaces. Method and findings A solution containing 23 ICADs (4 alkylating agents, 8 antimetabolites, 2 topo-I inhibitors, 6 topo-II inhibitors and 3 spindle poisons) was spread over 100 cm(2)stainless steel. After drying, decontamination was carried out using 10x10 cm wipes moistened with 300 mu L of one of the following solutions: 70% isopropanol (S1); ethanol-hydrogen peroxide 91.6-50.0 mg/g (S2); 10(-2)M sodium dodecyl sulphate/isopropanol 80/20 (S3) or 0.5% sodium hypochlorite (S4). Six tests were performed for each decontamination solution. Two modalities were tested: a single wipe motion from top to bottom or vigorous wiping (n = 6 for each modality). Residual contamination was measured with a validated liquid chromatography with tandem mass spectrometry detection method. Solution efficiency (in %) was computed as follows: Eff(Q)= 1-(quantity after decontamination/quantity before decontamination), as median (min-max) for the 23 ICADs. The overall decontamination efficiency (Eff(Q)) of the 4 solutions was compared by a Kruskall-Wallis test. Decontamination modalities were compared for each solution and per ICAD with a Mann-Whitney test (p<0.05). Eff(Q)were significantly different from one solution to the next for single wipe motion decontamination: 79.9% (69.3-100), 86.5% (13.0-100), 85.4% (56.5-100) and 100% (52.9-100) for S1, S2, S3 and S4 (p<0.0001), respectively. Differences were also significant for vigorous decontamination: Eff(Q)of 84.3% (66.0-100), 92.3% (68.7-100), 99.6% (84.8-100) and 100% (82.9-100) for S1, S2, S3 and S4, respectively (p<0.0001). Generally, vigorous decontamination increased Eff(Q)for all tested solutions and more significantly for the surfactant. Conclusion Decontamination efficiency depended on the solution used but also on the application modality. An SDS admixture seems to be a good alternative to sodium hypochlorite, notably after vigorous chemical decontamination with no hazard either to materials or workers.	[Simon, Nicolas; Guichard, Nicolas; Bonnabry, Pascal; Fleury-Souverain, Sandrine] Geneva Univ Hosp, Pharm, Geneva, Switzerland; [Simon, Nicolas; Guichard, Nicolas; Bonnabry, Pascal; Fleury-Souverain, Sandrine] Univ Geneva, Inst Pharmaceut Sci Western Switzerland, Geneva, Switzerland; [Simon, Nicolas; Odou, Pascal; Decaudin, Bertrand] Univ Lille, CHU Lille, ULR 7365, GRITA, Lille, France	University of Geneva; University of Geneva; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Simon, N (corresponding author), Geneva Univ Hosp, Pharm, Geneva, Switzerland.; Simon, N (corresponding author), Univ Geneva, Inst Pharmaceut Sci Western Switzerland, Geneva, Switzerland.; Simon, N (corresponding author), Univ Lille, CHU Lille, ULR 7365, GRITA, Lille, France.	nicolas.simon@univ-lille.fr	Decaudin, Bertrand/E-5828-2010; SIMON, Nicolas/G-4328-2016; GUICHARD, Nicolas/K-4504-2016	Decaudin, Bertrand/0000-0001-8267-5594; SIMON, Nicolas/0000-0001-5257-440X; GUICHARD, Nicolas/0000-0002-6228-2379	French Society of Clinical Pharmacy; Fondation pour la Recherche en Pharmacie Hospitaliere; AstraZeneca laboratories	French Society of Clinical Pharmacy; Fondation pour la Recherche en Pharmacie Hospitaliere; AstraZeneca laboratories(AstraZeneca)	NS received a grant from French Society of Clinical Pharmacy, by la Fondation pour la Recherche en Pharmacie Hospitaliere, AstraZeneca laboratories for his post-doctoral position in the University Hospital of Geneva. The specific roles of this author is articulated in the 'author contributions' section. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade A, 2017, CAN J HOSP PHARM, V70, P407; Alexander K, 2018, VET COMP ONCOL, V16, P385, DOI 10.1111/vco.12390; American Society of Health-System Pharmacists, 2006, AM J HEALTH-SYST PH, V63, P1172, DOI DOI 10.2146/AJHP050529; Anastasi M, 2015, ANN OCCUP HYG, V59, P895, DOI 10.1093/annhyg/mev031; [Anonymous], 2007, J ONCOL PHARM PRACT, V13, P1; Berthod F, 2020, J ONCOL PHARM PRACT, V26, P853, DOI 10.1177/1078155219875504; Bohlandt A, 2017, INT J HYG ENVIR HEAL, V220, P757, DOI 10.1016/j.ijheh.2017.03.005; Bohlandt Antje, 2015, J Occup Environ Hyg, V12, P384, DOI 10.1080/15459624.2015.1009985; Boiano JM, 2015, J OCCUP ENVIRON HYG, V12, P588, DOI 10.1080/15459624.2015.1029610; Centers for Disease Control and Prevention, NAT I OCC SAF HLTH H; Connor TH, 2014, J OCCUP ENVIRON MED, V56, P901, DOI 10.1097/JOM.0000000000000249; European parliament, PREV OCC EXP CYT OTH; European Pharmacopeia, 2019, MON PAR; FALCK K, 1979, LANCET, V1, P1250; GERPAC-Europharmat Workgroup, 2007, PREP ADM DRUGS RISK; Guichard N, 2019, EUR J HOSP PHARM; Guichard N, 2019, J PHARMACEUT BIOMED, V172, P139, DOI 10.1016/j.jpba.2019.04.042; Guichard N, 2019, J PHARMACEUT BIOMED, V164, P395, DOI 10.1016/j.jpba.2018.11.014; HARRISON BR, 1981, AM J HOSP PHARM, V38, P1686, DOI 10.1093/ajhp/38.11.1686; Hedmer M, 2008, INT ARCH OCC ENV HEA, V81, P899, DOI 10.1007/s00420-007-0284-y; Hon CY, 2014, J ONCOL PHARM PRACT, V20, P210, DOI 10.1177/1078155213497070; Lamerie TQ, 2013, ANN OCCUP HYG, V57, P456, DOI 10.1093/annhyg/mes087; Lee Su-Gil, 2009, Journal of Pharmacy Practice and Research, V39, P181; Le LMM, 2013, INT ARCH OCC ENV HEA, V86, P333, DOI 10.1007/s00420-012-0769-1; Martin Susan, 2003, Oncol Nurs Forum, V30, P575, DOI 10.1188/03.ONF.575-581; McDiarmid M, 1998, J OCCUP MED, V30, P984; Occupational Safety and Health Administration, 1996, AM J HEALTH-SYST PH, V53, P1669, DOI DOI 10.1093/AJHP/53.14.1669; Power Luci A, 2018, Am J Health Syst Pharm, V75, P1996, DOI 10.2146/ajhp180564; Sessink Paul J M, 2013, Hosp Pharm, V48, P204, DOI 10.1310/hpj4803-204; SESSINK PJM, 1994, INT ARCH OCC ENV HEA, V65, P401, DOI 10.1007/BF00383251; Simon N, 2020, ANN WORK EXPOS HEAL, V64, P114, DOI 10.1093/annweh/wxz093; Simon N, 2019, J ONCOL PHARM PRACT, V25, P929, DOI 10.1177/1078155219831427; Simon N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159052; Touzin K, 2010, ANN OCCUP HYG, V54, P351, DOI 10.1093/annhyg/meq004; United States Pharmacopeia, USP GEN HAZ DRUGS HA; VALANIS BG, 1993, CANCER NURS, V16, P288; VALANIS BG, 1993, AM J HOSP PHARM, V50, P455, DOI 10.1093/ajhp/50.3.455; Vasseur M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201335; Villarini M, 2016, MUTAT RES-REV MUTAT, V770, P35, DOI 10.1016/j.mrrev.2016.05.001; ZELLMER WA, 1981, AM J HOSP PHARM, V38, P1679, DOI 10.1093/ajhp/38.11.1679; ZIMMERMAN PF, 1981, AM J HOSP PHARM, V38, P1693, DOI 10.1093/ajhp/38.11.1693; 1986, AM J HOSP PHARM, V43, P1193	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235131	10.1371/journal.pone.0235131	http://dx.doi.org/10.1371/journal.pone.0235131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569333	gold, Green Published			2022-12-27	WOS:000543547900025
J	Lynch, EE; Meier, HCS				Lynch, Emily E.; Meier, Helen C. S.			The intersectional effect of poverty, home ownership, and racial/ethnic composition on mean childhood blood lead levels in Milwaukee County neighborhoods	PLOS ONE			English	Article							GEOGRAPHIC ANALYSIS; HEALTH DISPARITIES; CHILDREN BORN; BIRTH-WEIGHT; CONSEQUENCES; DIVERSITY; EXPOSURE; SEPARATE	Environmental conditions that contribute to childhood lead exposure are spatially patterned. Socioeconomic and racial inequities in childhood lead exposure have been well documented, however childhood lead exposure in Milwaukee is understudied. As a segregated rustbelt metropolitan area with childhood lead exposure concerns, Milwaukee is uniquely positioned to evaluate the synergistic effects of racial and economic drivers of childhood lead exposure. Using surveillance data from the Wisconsin Department of Health Services, Division of Public Health and the US Census Bureau, this cross-sectional study determined the intersectional effect of poverty, home ownership, and racial/ethnic composition on childhood lead exposure in Milwaukee County neighborhoods using linear regression adjusting for average census tract housing age and number of children. The final analytical sample consisted of 48,393 individual childhood blood lead levels aggregated to 215 Milwaukee County census tracts. Census tracts with mean childhood blood lead levels greater than or equal to 5 mu g/dL were predominantly low home ownership, high poverty, and majority non-White census tracts. The effects of low home ownership, high poverty, and majority non-White census tracts were synergistic, producing 1.78 (95% CI: 1.44, 2.11) mu g/dL higher mean childhood blood lead level than high home ownership, low poverty, and majority White census tracts (referent). This research reveals that social determinants at the neighborhood level co-occur and interact to produce inequities in childhood lead exposure. Lead prevention efforts should align with equity-focused housing and economic policies that target primary prevention in neighborhoods disproportionately burdened by childhood lead exposure.	[Lynch, Emily E.; Meier, Helen C. S.] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Meier, HCS (corresponding author), Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA.	meierh2@uwm.edu	Meier, Helen/AAD-3381-2020	Meier, Helen/0000-0003-4400-0216	Shaw Scientist Award; Greater Milwaukee Foundation	Shaw Scientist Award; Greater Milwaukee Foundation	This work was supported by the Shaw Scientist Award to HM from the Greater Milwaukee Foundation https://www.greatermilwaukeefoundation.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Garcia D, 2008, HEALTH AFFAIR, V27, P321, DOI 10.1377/hlthaff.27.2.321; Acevedo-Garcia D, 2008, AM J EPIDEMIOL, V168, P1255, DOI 10.1093/aje/kwn290; Advisory Committee on Childhood Lead Poisoning Prevention of the Centers for Disease Control and Prevention, 2012, LOW LEV LEAD EXP HAR; [Anonymous], 2016, PEDIATRICS, V138; Ayoob M, 2008, EVALUATION CITY ROCH; Brink LA, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/8791686; Cantor AG, 2019, SCREENING ELEVATED B; Centers for Disease Control and Prevention, 2009, 4 CDCP; Christensen K, 2017, P0120216 WISC DEP HL; City of Milwaukee Health Department, 2007, CHILDH LEAD POIS DAS; City of Milwaukee Health Department, 2018, CHILDH LEAD POIS PRE; Farrell CR, 2011, SOC SCI RES, V40, P1108, DOI 10.1016/j.ssresearch.2011.04.003; Greene SK, 2015, AM J PUBLIC HEALTH, V105, pE27, DOI 10.2105/AJPH.2015.302741; Haley VB, 2004, ENVIRON HEALTH PERSP, V112, P1577, DOI 10.1289/ehp.7053; Handler P, 2012, INT J ENV RES PUB HE, V9, P3934, DOI 10.3390/ijerph9113934; Jacobs DE, 2002, ENVIRON HEALTH PERSP, V110, pA599, DOI 10.1289/ehp.021100599; Korfmacher KS, 2012, ENVIRON HEALTH PERSP, V120, P309, DOI 10.1289/ehp.1103606; Krieger N, 2006, J URBAN HEALTH, V83, P355, DOI 10.1007/s11524-006-9040-y; Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186; Langhoff KK, 2001, LANDLORDS NEED HELP, P84; Lanphear BP, 1998, PEDIATRICS, V101, P264, DOI 10.1542/peds.101.2.264; Lanphear BP, 2005, PUBLIC HEALTH REP, V120, P305, DOI 10.1177/003335490512000315; Miranda ML, 2011, ENVIRON HEALTH PERSP, V119, P1513, DOI 10.1289/ehp.1003231; Moody H, 2016, SOCIOL RACE ETHNIC, V2, P200, DOI 10.1177/2332649215608873; Moody HA, 2016, J URBAN HEALTH, V93, P820, DOI 10.1007/s11524-016-0071-8; Muller C, 2018, ANNU REV SOCIOL, V44, P263, DOI 10.1146/annurev-soc-073117-041222; National Toxicology Program, 2012, NTP MON HLTH EFF LOW; NORC at the University of Chicago, 2012, WISC PROM PRACT COOR; Ohri-Vachaspati P, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16132354; Osypuk TL, 2009, URBAN AFF REV, V45, P25, DOI 10.1177/1078087408331119; Oyana TJ, 2007, ARCH ENVIRON OCCUP H, V62, P93, DOI 10.3200/AEOH.62.2.93-104; Oyana TJ, 2010, PROF GEOGR, V62, P46, DOI 10.1080/00330120903375894; President's Task Force on Environmental Health Risks and Safety Risks to Children, 2016, KEY FED PROGR RED CH; Stults B, 2011, PERSISTENCE SEGREGAT; Taggert E, 2019, J ENVIRON HEALTH, V82, P18; Thornton, 2018, POVERTY INCOMES RACE; Toprani A, 2013, SELECTING APPL STAND; U. S. Census Bureau, 2012 2016 AM COMM SU; U.S. Census Bureau, DEC CENS 2010 TABL P; United States Environmental Protection Agency, 2018, INT SCI ASS ISA LEAD; US Census Bureau, 2014, CENSUS BUREAU REPORT; Vaidyanathan A, 2009, J PEDIATR-US, V154, P409, DOI 10.1016/j.jpeds.2008.09.027; Vang ZM, 2013, SOC SCI MED, V97, P56, DOI 10.1016/j.socscimed.2013.07.013; Wisconsin Department of Health Services, 2019, WISC LOC HLTH DEP MI; Wisconsin Department of Health Services, 2010, P44535B WISC DEP HLT	45	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234995	10.1371/journal.pone.0234995	http://dx.doi.org/10.1371/journal.pone.0234995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559243	Green Published, gold			2022-12-27	WOS:000543261600005
J	Jacobs-Sera, D; Abad, LA; Alvey, RM; Anders, KR; Aull, HG; Bhalla, SS; Blumer, LS; Bollivar, DW; Bonilla, JA; Butela, KA; Coomans, RJ; Cresawn, SG; D'Elia, T; Diaz, A; Divens, AM; Edgington, NP; Frederick, GD; Gainey, MD; Garlena, RA; Grant, KW; Gurney, SMR; Hendrickson, HL; Hughes, LE; Kenna, MA; Klyczek, KK; Kotturi, H; Mavrich, TN; McKinney, AL; Merkhofer, EC; Parker, JM; Molloy, SD; Monti, DL; Pape-Zambito, DA; Pollenz, RS; Pope, WH; Reyna, NS; Rinehart, CA; Russell, DA; Shaffer, CD; Sivanathan, V; Stoner, TH; Stukey, J; Sunnen, CN; Tolsma, SS; Tsourkas, PK; Wallen, JR; Ware, VC; Warner, MH; Washington, JM; Westover, KM; Whitefleet-Smith, JL; Wiersma-Koch, HI; Williams, DC; Zack, KM; Hatfull, GF				Jacobs-Sera, Deborah; Abad, Lawrence A.; Alvey, Richard M.; Anders, Kirk R.; Aull, Haley G.; Bhalla, Suparna S.; Blumer, Lawrence S.; Bollivar, David W.; Bonilla, J. Alfred; Butela, Kristen A.; Coomans, Roy J.; Cresawn, Steven G.; D'Elia, Tom; Diaz, Arturo; Divens, Ashley M.; Edgington, Nicholas P.; Frederick, Gregory D.; Gainey, Maria D.; Garlena, Rebecca A.; Grant, Kenneth W.; Gurney, Susan M. R.; Hendrickson, Heather L.; Hughes, Lee E.; Kenna, Margaret A.; Klyczek, Karen K.; Kotturi, Hari; Mavrich, Travis N.; McKinney, Angela L.; Merkhofer, Evan C.; Parker, Jordan Moberg; Molloy, Sally D.; Monti, Denise L.; Pape-Zambito, Dana A.; Pollenz, Richard S.; Pope, Welkin H.; Reyna, Nathan S.; Rinehart, Claire A.; Russell, Daniel A.; Shaffer, Christopher D.; Sivanathan, Viknesh; Stoner, Ty H.; Stukey, Joseph; Sunnen, C. Nicole; Tolsma, Sara S.; Tsourkas, Philippos K.; Wallen, Jamie R.; Ware, Vassie C.; Warner, Marcie H.; Washington, Jacqueline M.; Westover, Kristi M.; Whitefleet-Smith, JoAnn L.; Wiersma-Koch, Helen, I; Williams, Daniel C.; Zack, Kira M.; Hatfull, Graham F.			Genomic diversity of bacteriophages infecting Microbacterium spp	PLOS ONE			English	Article							TRANSFER-RNA GENES; SP-NOV.; PERITONEAL-DIALYSIS; 1ST REPORT; BACTERIUM; SEQUENCE; PROGRAM; AMMONIAPHILUM; SYSTEM; PHAGE	The bacteriophage population is vast, dynamic, old, and genetically diverse. The genomics of phages that infect bacterial hosts in the phylum Actinobacteria show them to not only be diverse but also pervasively mosaic, and replete with genes of unknown function. To further explore this broad group of bacteriophages, we describe here the isolation and genomic characterization of 116 phages that infectMicrobacteriumspp. Most of the phages are lytic, and can be grouped into twelve clusters according to their overall relatedness; seven of the phages are singletons with no close relatives. Genome sizes vary from 17.3 kbp to 97.7 kbp, and their G+C% content ranges from 51.4% to 71.4%, compared to similar to 67% for theirMicrobacteriumhosts. The phages were isolated on five differentMicrobacteriumspecies, but typically do not efficiently infect strains beyond the one on which they were isolated. TheseMicrobacteriumphages contain many novel features, including very large viral genes (13.5 kbp) and unusual fusions of structural proteins, including a fusion of VIP2 toxin and a MuF-like protein into a single gene. These phages and their genetic components such as integration systems, recombineering tools, and phage-mediated delivery systems, will be useful resources for advancingMicrobacteriumgenetics.	[Jacobs-Sera, Deborah; Abad, Lawrence A.; Aull, Haley G.; Butela, Kristen A.; Divens, Ashley M.; Garlena, Rebecca A.; Mavrich, Travis N.; Pope, Welkin H.; Russell, Daniel A.; Stoner, Ty H.; Warner, Marcie H.; Zack, Kira M.; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Alvey, Richard M.; Bollivar, David W.] Illinois Wesleyan Univ, Dept Biol, Bloomington, IL 61701 USA; [Anders, Kirk R.] Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA; [Bhalla, Suparna S.; Merkhofer, Evan C.] Mt St Mary Coll, Dept Nat Sci, Newburgh, NY USA; [Blumer, Lawrence S.] Morehouse Coll, Dept Biol, Atlanta, GA USA; [Bonilla, J. Alfred; Klyczek, Karen K.] Univ Wisconsin, Dept Biol, River Falls, WI 54022 USA; [Coomans, Roy J.] North Carolina A&T State Univ, Dept Biol, Greensboro, NC USA; [Cresawn, Steven G.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA; [D'Elia, Tom; Wiersma-Koch, Helen, I] Indian River State Coll, Dept Biol Sci, Ft Pierce, FL USA; [Diaz, Arturo] La Sierra Univ, Dept Biol, Riverside, CA USA; [Edgington, Nicholas P.] Southern Connecticut State Univ, Dept Biol, New Haven, CT USA; [Frederick, Gregory D.] LeTourneau Univ, Dept Biol & Kinesiol, Longview, TX USA; [Gainey, Maria D.; Wallen, Jamie R.] Western Carolina Univ, Dept Chem & Phys, Cullowhee, NC 28723 USA; [Grant, Kenneth W.] Wake Forest Baptist Hlth, Dept Pathol, Winston Salem, NC USA; [Gurney, Susan M. R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Hendrickson, Heather L.] Massey Univ, Sch Nat & Computat Sci, Auckland, New Zealand; [Hughes, Lee E.] Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA; [Kenna, Margaret A.; Ware, Vassie C.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Kotturi, Hari] Univ Cent Oklahoma, Dept Biol, Edmond, OK USA; [McKinney, Angela L.] Nebraska Wesleyan Univ, Dept Biol, Lincoln, NE USA; [Parker, Jordan Moberg] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Molloy, Sally D.] Univ Maine, Dept Mol & Biomed Sci, Orono, ME USA; [Monti, Denise L.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Pape-Zambito, Dana A.] Univ Sci Philadelphia, Dept Biol Sci, Philadelphia, PA USA; [Pollenz, Richard S.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Reyna, Nathan S.] Ouachita Baptist Univ, Dept Biol, Arkadelphia, AR USA; [Rinehart, Claire A.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA; [Shaffer, Christopher D.] Univ Washington St Louis, Dept Biol, St Louis, MO USA; [Sivanathan, Viknesh] Howard Hughes Med Inst, Chevy Chase, MD USA; [Stukey, Joseph] Hope Coll, Biol Dept, Holland, MI 49423 USA; [Sunnen, C. Nicole] Univ Sci, Dept Biol Sci, Philadelphia, PA USA; [Tolsma, Sara S.] Northwestern Coll, Biol Dept, Orange City, IA USA; [Tsourkas, Philippos K.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Washington, Jacqueline M.] Nyack Coll, Dept Nat Sci, Nyack, NY USA; [Westover, Kristi M.] Winthrop Univ, Dept Biol, Rock Hill, SC 29733 USA; [Whitefleet-Smith, JoAnn L.] Worcester Polytech Inst, Dept Biol & Biotechnol, Worcester, MA 01609 USA; [Williams, Daniel C.] Coastal Carolina Univ, Dept Biol, Conway, SC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Illinois Wesleyan University; Gonzaga University; Morehouse College; University of Wisconsin System; University of North Carolina; North Carolina A&T State University; James Madison University; Connecticut State University System; Southern Connecticut State University; University of North Carolina; Western Carolina University; Wake Forest University; Wake Forest Baptist Medical Center; Drexel University; Massey University; University of North Texas System; University of North Texas Denton; Lehigh University; University of Central Oklahoma; University of California System; University of California Los Angeles; University of Maine System; University of Maine Orono; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of South Florida; Western Kentucky University; Howard Hughes Medical Institute; Hope College; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Worcester Polytechnic Institute; Coastal Carolina University	Hatfull, GF (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	gfh@pitt.edu		Divens, Ashley/0000-0003-4793-4129; Butela, Kristen/0000-0003-1463-5288; Reyna, Nathan/0000-0003-3430-0282; Moberg Parker, Jordan/0000-0003-1445-9587; Bollivar, David/0000-0002-9378-3408	National Institutes of Health [GM116884, GM131729]; Howard Hughes Medical Institute [54308198, GT12053]; Provost Internal Support grant from Western Carolina University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Provost Internal Support grant from Western Carolina University	This work was supported by grants from the National Institutes of Health (GM116884 and GM131729; https://www.nih.gov/) and Howard Hughes Medical Institute (54308198 and GT12053; https://www.hhmi.org) to GFH. Work performed by M.D.G and J.R.W was supported by a Provost Internal Support grant from Western Carolina University. HHMI supported the SEA-PHAGES program that generated the data and analyses (data collection and analysis), and supported a workshop where genomic data was analyzed for manuscript preparation.	Akimkina T, 2007, RES MICROBIOL, V158, P582, DOI 10.1016/j.resmic.2007.06.005; Ali N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57224-x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amano J, 2019, J INFECT CHEMOTHER, V25, P806, DOI 10.1016/j.jiac.2019.03.013; [Anonymous], 2004, HUMAN RIGHTS WATCH, V16, P11; [Anonymous], 2005, NUCLEIC ACIDS RES, V33, pe80; [Anonymous], 2017, J PEDIAT REHAB MED, V10, ps1; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Behrendt U, 2001, INT J SYST EVOL MICR, V51, P1267, DOI 10.1099/00207713-51-4-1267; Borodovsky Mark, 2011, Curr Protoc Bioinformatics, VChapter 4, DOI [10.1002/0471250953.bi0406s35, 10.1002/0471250953.bi0405s35]; Cheng L, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1159-y; Cresawn SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118725; Cresawn SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-395; Davydova EK, 2003, METHOD ENZYMOL, V370, P83; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hanauer DI, 2017, P NATL ACAD SCI USA, V114, P13531, DOI 10.1073/pnas.1718188115; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hatfull GF, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.GPP3-0026-2018; Hatfull GF, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0032-2013; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jacobs-Sera D, 2012, VIROLOGY, V434, P187, DOI 10.1016/j.virol.2012.09.026; Kageyama A, 2007, INT J SYST EVOL MICR, V57, P2355, DOI 10.1099/ijs.0.65038-0; Kageyama A, 2007, J GEN APPL MICROBIOL, V53, P1, DOI 10.2323/jgam.53.1; Kageyama A, 2006, INT J SYST EVOL MICR, V56, P2113, DOI 10.1099/ijs.0.64236-0; Klyczek KK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180517; Knowles B, 2016, NATURE, V531, P466, DOI 10.1038/nature17193; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Laffineur K, 2003, J CLIN MICROBIOL, V41, P2242, DOI 10.1128/JCM.41.5.2242-2246.2003; Lam PW, 2018, PERITON DIALYSIS INT, V38, P9, DOI 10.3747/pdi.2017.00121; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lassmann T, 2020, BIOINFORMATICS, V36, P1928, DOI 10.1093/bioinformatics/btz795; Liu J, 2005, INT J SYST EVOL MICR, V55, P661, DOI 10.1099/ijs.0.63265-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marinelli LJ, 2012, MBIO, V3, DOI 10.1128/mBio.00279-12; Mavrich TN, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.112; MCLEAN RA, 1953, J BACTERIOL, V65, P428, DOI 10.1128/JB.65.4.428-433.1953; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Petrovski S, 2012, J VIROL, V86, P358, DOI 10.1128/JVI.05460-11; Pope WH, 2015, ELIFE, V4, DOI 10.7554/eLife.06416; Pope WH, 2018, METHODS MOL BIOL, V1681, P217, DOI 10.1007/978-1-4939-7343-9_16; Pope WH, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.01143-16; Pope WH, 2017, MBIO, V8, DOI 10.1128/mBio.01069-17; Pope WH, 2014, MBIO, V5, DOI 10.1128/mBio.02145-14; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026750; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Russell DA, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.01467-18; Russell DA, 2018, METHODS MOL BIOL, V1681, P109, DOI 10.1007/978-1-4939-7343-9_9; Russell DA, 2017, BIOINFORMATICS, V33, P784, DOI 10.1093/bioinformatics/btw711; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkis GJ, 1998, METH MOL B, V101, P145, DOI 10.1385/0-89603-471-2:145; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma P, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-97; Sharma P, 2012, J BACTERIOL, V194, P4785, DOI 10.1128/JB.01088-12; STRIEBEL HM, 1990, GENE, V91, P95, DOI 10.1016/0378-1119(90)90167-P; Striebel HM, 1996, GENE, V172, P41, DOI 10.1016/0378-1119(96)00189-8; Sun WH, 2019, J HAZARD MATER, V370, P225, DOI 10.1016/j.jhazmat.2018.02.003; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tanaka N, 2011, J BIOL CHEM, V286, P7727, DOI 10.1074/jbc.C111.219022; The Lancet Haematology, 2018, LANCET HAEMATOL, V5, pe127; Yusuf E, 2016, J MICROBIOL IMMUNOL, V49, P464, DOI 10.1016/j.jmii.2014.03.008; Zakhia F, 2006, MICROB ECOL, V51, P375, DOI 10.1007/s00248-006-9025-0; Zamani I, 2014, ARCH VIROL, V159, P2537, DOI 10.1007/s00705-014-2092-5; Zlamala C, 2002, INT J SYST EVOL MICR, V52, P1229, DOI [10.1099/ijs.0.02013-0, 10.1099/00207713-52-4-1229]	68	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234636	10.1371/journal.pone.0234636	http://dx.doi.org/10.1371/journal.pone.0234636			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555720	Green Published, gold			2022-12-27	WOS:000543273200010
J	Vilpert, S; Borrat-Besson, C; Borasio, GD; Maurer, J				Vilpert, Sarah; Borrat-Besson, Carmen; Domenico Borasio, Gian; Maurer, Juergen			Associations of end-of-life preferences and trust in institutions with public support for assisted suicide: Evidence from nationally representative survey data of older adults in Switzerland (vol 15, e0232109, 2020)	PLOS ONE			English	Correction																		Vilpert S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232109	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234954	10.1371/journal.pone.0234954	http://dx.doi.org/10.1371/journal.pone.0234954			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555749	gold, Green Published			2022-12-27	WOS:000543273200006
J	Sacristan, JA; Dilla, T; Diaz-Cerezo, S; Gabas-Rivera, C; Aceituno, S; Lizan, L				Antonio Sacristan, Jose; Dilla, Tatiana; Diaz-Cerezo, Silvia; Gabas-Rivera, Clara; Aceituno, Susana; Lizan, Luis			Patient-physician discrepancy in the perception of immune-mediated inflammatory diseases: rheumatoid arthritis, psoriatic arthritis and psoriasis. A qualitative systematic review of the literature	PLOS ONE			English	Review							GLOBAL ASSESSMENTS; SELF-REPORT; DISCORDANCE; JOINT; REMISSION; DETERMINANTS; SATISFACTION; MULTICENTER; SEVERITY; TIME	Introduction Recommendations on chronic diseases management emphasise the need to consider patient perspectives and shared decision-making. Discrepancies between patients and physicians' perspectives on treatment objectives, disease activity, preferences and treatment have been described for immune-mediate inflammatory diseases. These differences could result on patient dissatisfaction and negatively affect outcomes. Objective To describe the degree of patient-physician discrepancy in three chronic immune-mediated inflammatory diseases (rheumatoid arthritis [RA], psoriatic arthritis [PsA] and psoriasis [Ps]), identifying the main areas of discrepancy and possible predictor factors. Methods Qualitative systematic review of the available literature on patient and physician discrepancies in the management of RA, PsA and Ps. The search was performed in international (Medline/PubMed, Cochrane Library, ISI-WOK) and Spanish electronic databases (MEDES, IBECS), including papers published from April 1, 2008 to April 1, 2018, in English or Spanish, and conducted in European or North American populations. Study quality was assessed by the Oxford Centre for Evidence-Based Medicine criteria. Results A total of 21 studies were included (13 RA; 3 PsA; 4 Ps; 1 RA, Ps, and Axial Spondyloarthritis). A significant and heterogeneous degree of discrepancy between patients and physicians was found, regarding disease activity, treatment, clinical expectations, remission concept, and patient-physician relationship. In RA and PsA, studies were mainly focused on the evaluation of disease activity, which is perceived as higher from the patient's than the physician's perspective, with the discrepancy determined by factors such as patient's perception of pain and fatigue. In Ps, studies were focused on treatment satisfaction and patient-physician relationship, showing a lower degree of discrepancy in the satisfaction regarding these aspects. Conclusions There is a significant degree of patient-physician discrepancy regarding the management of RA, PA, and Ps, what can have a major impact on shared decision-making. Future research may help to show whether interventions considering discrepancy improve shared decision-making.	[Antonio Sacristan, Jose; Diaz-Cerezo, Silvia] Lilly Spain, Med Dept, Madrid, Spain; [Dilla, Tatiana] Lilly Int, Global Patient Outcomes & Real World Evidence, Madrid, Spain; [Gabas-Rivera, Clara; Aceituno, Susana; Lizan, Luis] Outcomes10, Castellon De La Plana, Spain; [Lizan, Luis] Jaume I Univ, Dept Med, Castellon De La Plana, Spain	Universitat Jaume I	Lizan, L (corresponding author), Outcomes10, Castellon De La Plana, Spain.; Lizan, L (corresponding author), Jaume I Univ, Dept Med, Castellon De La Plana, Spain.	lizan@outcomes10.com	Sacristán, José Antonio/ABG-7160-2020	Diaz-Cerezo, Silvia/0000-0001-6351-818X	Lilly	Lilly(Eli Lilly)	This study was sponsored by Lilly. The funders had a role in the preparation of the manuscript, revising the content of the manuscript, but had no role in study design, data collection and analysis or decision to publish. Lilly also provided support in the form of salaries for authors JAS, TD, and SDC. Outcomes'10, an independent research organization, provided support in the form of salary for authors CGR, SA, and LL. The specific roles of these authors are articulated in the `author contributions' section.	Acebes C, 2017, CLIN EXP RHEUMATOL, V35, P816; Akhavan P, 2014, ANN RHEUM DIS, V71, P340; [Anonymous], 2017, INT J RES HUMANITIES, V46, P1; [Anonymous], 2016, BIOL BLOOD MARROW TR, V22, pS1; Barton JL, 2010, ARTHRIT CARE RES, V62, P857, DOI 10.1002/acr.20132; Barton JL, 2009, J RHEUMATOL, V36, P2635, DOI 10.3899/jrheum.090569; Challa DN, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1419-5; Chaudhry SR, 2013, RHEUMATOLOGY, V52, P705, DOI 10.1093/rheumatology/kes355; Dauden E, 2011, ACTAS DERMO-SIFILOGR, V102, P270, DOI 10.1016/j.ad.2010.04.018; Davis JM, 2014, ACR ARHP ANN M; De Mits S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166607; Desthieux C, 2017, ARTHRIT CARE RES, V69, P1606, DOI 10.1002/acr.23172; Desthieux C, 2016, ARTHRIT CARE RES, V68, P1767, DOI 10.1002/acr.22902; Diaz-correa L, DISCORDANCE PATIENT; Eder L, 2015, ARTHRIT CARE RES, V67, P264, DOI 10.1002/acr.22401; Egholm CL, 2015, J RHEUMATOL, V42, P1781, DOI 10.3899/jrheum.150007; Feinberg B, 2015, VALUE HEAL, pPHS86; French T, 2013, MUSCULOSKELET CARE, V11, P229, DOI 10.1002/msc.1046; Furst DE, 2017, CLIN RHEUMATOL, V36, P2045, DOI 10.1007/s10067-017-3578-9; Gonzalez JM, 2017, BRIT J DERMATOL, V176, P777, DOI 10.1111/bjd.14798; Griffiths C, 2017, J AM ACAD DERMATOL, V76, pAB102; Ha JF, 2010, OCHSNER J, V10, P38; Herzog R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-154; Janta I, 2013, RHEUMATOLOGY, V52, P2243, DOI 10.1093/rheumatology/ket297; Kaneko Y, 2014, J RHEUMATOL, V41, P1061, DOI 10.3899/jrheum.131468; Karpouzas GA, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2017-000551; Khan NA, 2012, ARTHRIT CARE RES, V64, P206, DOI 10.1002/acr.20685; Kuek A, 2007, POSTGRAD MED J, V83, P251, DOI 10.1136/pgmj.2006.052688; Kvrgic Z, 2017, ARTHRITIS CARE RES H; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Markenson JA, 2013, JCR-J CLIN RHEUMATOL, V19, P317, DOI 10.1097/RHU.0b013e3182a2164f; Michelsen B, 2016, ANN RHEUM DIS, V75, P2108, DOI 10.1136/annrheumdis-2015-208806; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Nelson PA, 2013, BRIT J DERMATOL, V168, P354, DOI 10.1111/j.1365-2133.2012.11217.x; Okubo Y, 2018, ANAL TREATMENT GOAL, P606; Oxford Centre for Evidence-Based Medicine (OCEBM), 2009, LEVELS EVIDENCE; Pincus T, 2005, CLIN EXP RHEUMATOL, V23, pS1; Pincus T, 2004, CLIN EXP RHEUMATOL, V22, pS26; Pincus T, 2003, ARTHRITIS RHEUM, V48, P625, DOI 10.1002/art.10824; Sears ED, 2015, PLAST RECONSTR SURG, V136, p775E, DOI 10.1097/PRS.0000000000001778; Smolen JS, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1004-3; Tascilar K, 2016, ANN RHEUM DIS S2, V75; Uhlenhake EE, 2010, J DERMATOL TREAT, V21, P6, DOI 10.3109/09546630903085328; Walter MJM, 2017, QUAL LIFE RES, V26, P291, DOI 10.1007/s11136-016-1369-4; Ward MM, 2017, ARTHRIT CARE RES, V69, P1260, DOI 10.1002/acr.23103; Watanabe T, 2013, ANN RHEUM DIS, V72; Wells G, 2000, NEWCASTLE OTTAWA SCA; Wen HY, 2012, INT J RHEUM DIS, V15, P380, DOI 10.1111/j.1756-185X.2012.01752.x; Whiting P, 2016, J CLIN EPIDEMIOL, V69, P225, DOI 10.1016/j.jclinepi.2015.06.005; Wolfe F, 2009, J RHEUMATOL, V36, P930, DOI 10.3899/jrheum.080947	50	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234705	10.1371/journal.pone.0234705	http://dx.doi.org/10.1371/journal.pone.0234705			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555708	Green Published, gold			2022-12-27	WOS:000542759600054
J	Bhowmick, R; Sarkar, RR				Bhowmick, Rupa; Sarkar, Ram Rup			Differential suitability of reactive oxygen species and the role of glutathione in regulating paradoxical behavior in gliomas: A mathematical perspective	PLOS ONE			English	Article							OXIDATIVE STRESS; GLIOBLASTOMA CELLS; HYDROGEN-PEROXIDE; REDOX REGULATION; CANCER; ROS; PROLIFERATION; RATIO; MITOCHONDRIA; CONNECTION	Manipulative strategies of ROS in cancer are often exhibited as changes in the redox and thiol ratio of the cells. Cellular responses to oxidative insults are generated in response to these changes which are triggered due to the rerouting of the metabolic framework to maintain survival under stress. However, mechanisms of these metabolic re-routing are not clearly understood and remained debatable. In the present work, we have designed a context-based dynamic metabolic model to establish that the coordinated functioning of glutathione peroxidase (GTHP), glutathione oxidoreductase (GTHO) and NADPH oxidase (NOX) is crucial in determining cancerous transformation, specifically in gliomas. Further, we propose that the puzzling duality of ROS (represented by changes inh(2)o(2)in the present model) in exhibiting varying cellular fates can be determined by considering simultaneous changes innadph/nadp(+)andgsh/gssgthat occur during the reprogramming of metabolic reactions. This will be helpful in determining the pro-apoptotic or anti-apoptotic fate of gliomas and can be useful in designing effective pro-oxidant and/or anti-oxidant therapeutic approaches against gliomas.	[Bhowmick, Rupa; Sarkar, Ram Rup] CSIR Natl Chem Lab, Chem Engn & Proc Dev Div, Pune, Maharashtra, India; [Bhowmick, Rupa; Sarkar, Ram Rup] Acad Sci & Innovat Res AcSIR, Ghaziabad, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Academy of Scientific & Innovative Research (AcSIR)	Sarkar, RR (corresponding author), CSIR Natl Chem Lab, Chem Engn & Proc Dev Div, Pune, Maharashtra, India.; Sarkar, RR (corresponding author), Acad Sci & Innovat Res AcSIR, Ghaziabad, India.	rr.sarkar@ncl.res.in		Bhowmick, Rupa/0000-0001-5812-0513; SARKAR, RAM RUP/0000-0001-7115-163X	SERB, Department of Science and Technology, Govt. of India [EMR/2016/000516, DST/ICPS/EDA/2018]; Council of Scientific & Industrial Research (CSIR)	SERB, Department of Science and Technology, Govt. of India(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); Council of Scientific & Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	We thank SERB, Department of Science and Technology, Govt. of India (File No. EMR/2016/000516) and (DST/ICPS/EDA/2018), for providing financial support to Ram Rup Sarkar. Rupa Bhowmick acknowledges the Council of Scientific & Industrial Research (CSIR) for the Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agledal L, 2010, REDOX REP, V15, P2, DOI 10.1179/174329210X12650506623122; Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2015, ALZHEIMERS DEMENTI S, V11, pP121; Aoyama K, 2013, INT J MOL SCI, V14, P21021, DOI 10.3390/ijms141021021; Aquilano K, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00196; Aylett SB, 2013, NEUROCHEM INT, V63, P750, DOI 10.1016/j.neuint.2013.10.002; Bansal A, 2018, J CELL BIOL, V217, P2291, DOI 10.1083/jcb.201804161; Bhowmick Rupa, 2015, Syst Synth Biol, V9, P159, DOI 10.1007/s11693-015-9183-9; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Blacker TS, 2016, FREE RADICAL BIO MED, V100, P53, DOI 10.1016/j.freeradbiomed.2016.08.010; Blanchetot C, 2008, CRIT REV EUKAR GENE, V18, P35, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.30; Blanco A., 2017, MED BIOCH, P413; Borbely G, 2010, J MED CHEM, V53, P6758, DOI 10.1021/jm1004368; Dokic I, 2012, GLIA, V60, P1785, DOI 10.1002/glia.22397; Galadari S, 2017, FREE RADICAL BIO MED, V104, P144, DOI 10.1016/j.freeradbiomed.2017.01.004; Galanis A, 2008, CANCER LETT, V266, P12, DOI 10.1016/j.canlet.2008.02.028; Gali RR, 1997, BIOCHEM J, V321, P207, DOI 10.1042/bj3210207; Gould RL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051056; Haack F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004106; Halliwell B, 2000, LANCET, V355, P1179, DOI 10.1016/S0140-6736(00)02075-4; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Hole PS, 2013, BLOOD, V122, P3322, DOI 10.1182/blood-2013-04-491944; Hosios AM, 2018, J BIOL CHEM, V293, P7490, DOI 10.1074/jbc.TM117.000239; Huster D, 2000, NEUROCHEM INT, V36, P461, DOI 10.1016/S0197-0186(99)00149-7; Janes KA, 2013, J CELL SCI, V126, P1913, DOI 10.1242/jcs.112045; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kong Q, 2000, MED HYPOTHESES, V55, P29, DOI 10.1054/mehy.1999.0982; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Liao BR, 1996, ARCH BIOCHEM BIOPHYS, V327, P53, DOI 10.1006/abbi.1996.0092; Lim JKM, 2019, P NATL ACAD SCI USA, V116, P9433, DOI 10.1073/pnas.1821323116; Maldonado EN, 2014, MITOCHONDRION, V19, P78, DOI 10.1016/j.mito.2014.09.002; Martin KR, 2002, HUM EXP TOXICOL, V21, P71, DOI 10.1191/0960327102ht213oa; MEIER B, 1989, BIOCHEM J, V263, P539, DOI 10.1042/bj2630539; MORIKOFERZWEZ S, 1989, BIOCHEM J, V259, P117; Pereira EJ, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00457; PIERCE GB, 1991, DIFFERENTIATION, V46, P181, DOI 10.1111/j.1432-0436.1991.tb00880.x; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Qu Y, 2011, J CLIN INVEST, V121, P212, DOI 10.1172/JCI43144; Raftos JE, 2010, J BIOL CHEM, V285, P23557, DOI 10.1074/jbc.M109.067017; Rao GM, 2000, CLIN CHIM ACTA, V296, P203, DOI 10.1016/S0009-8981(00)00219-9; Ren JG, 2014, SCI REP-UK, V4, DOI 10.1038/srep05414; Rinaldi M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060984; Ruiz-Gines JA, 2000, J CARDIOVASC PHARM, V35, P109, DOI 10.1097/00005344-200001000-00014; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Sharma P, 2008, IMMUNITY, V29, P551, DOI 10.1016/j.immuni.2008.07.019; Sheeran FL, 2010, BBA-BIOENERGETICS, V1797, P1138, DOI 10.1016/j.bbabio.2010.04.002; Shono T, 2008, INT J CANCER, V123, P787, DOI 10.1002/ijc.23569; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Smith GR, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-41; Stankova J, 2008, CURR PHARM DESIGN, V14, P1143, DOI 10.2174/138161208784246171; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Tedeschi PM, 2016, CLIN CANCER RES, V22, P5189, DOI 10.1158/1078-0432.CCR-16-1129; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wang YP, 2016, MOL CELL, V64, P673, DOI 10.1016/j.molcel.2016.09.028; Ye ZC, 1999, CANCER RES, V59, P4383; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999; Zhang HY, 2009, TOXICOL SCI, V110, P376, DOI 10.1093/toxsci/kfp101; Zhong WX, 1999, FREE RADICAL BIO MED, V27, P1334, DOI 10.1016/S0891-5849(99)00181-1; Zhu ZL, 2018, J NEUROCHEM, V144, P93, DOI 10.1111/jnc.14250; Zitka O, 2012, ONCOL LETT, V4, P1247, DOI 10.3892/ol.2012.931	63	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235204	10.1371/journal.pone.0235204	http://dx.doi.org/10.1371/journal.pone.0235204			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584884	Green Published, gold			2022-12-27	WOS:000545747200066
J	Bloodhart, B; Balgopal, MM; Casper, AMA; McMeeking, LBS; Fischer, EV				Bloodhart, Brittany; Balgopal, Meena M.; Casper, Anne Marie A.; McMeeking, Laura B. Sample; Fischer, Emily V.			Outperforming yet undervalued: Undergraduate women in STEM	PLOS ONE			English	Article							STUDENT PERFORMANCE; GENDER-DIFFERENCES; MATH; STEREOTYPES; EXPERIENCES; PREJUDICE; SCIENCE; MALLEABILITY; PERCEPTIONS; MOTIVATION	In spite of efforts to increase gender diversity across many science fields, women continue to encounter beliefs that they lack ability and talent. Undergraduate education is a critical time when peer influence may alter choice of majors and careers for women interested in science. Even in life science courses, in which women outnumber men, gender biases that emerge in peer-to-peer interactions during coursework may detract from women's interest and progress. This is the first study of which we are aware to document that women are outperforming men in both physical and life science undergraduate courses at the same institution, while simultaneously continuing to be perceived as less-able students. This is problematic because undergraduate women may not be able to escape gender-ability stereotypes even when they are outperforming men, which has important implications for 1) the recognition of women's achievements among their peers in undergraduate education and 2) retention of women in STEM disciplines and careers.	[Bloodhart, Brittany] Calif State Univ San Bernardino, Dept Psychol, San Bernardino, CA 92407 USA; [Balgopal, Meena M.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Casper, Anne Marie A.] Colorado State Univ, Dept Civil & Environm Engn, Ft Collins, CO 80523 USA; [McMeeking, Laura B. Sample] Colorado State Univ, STEM Ctr, Ft Collins, CO 80523 USA; [Fischer, Emily V.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA	California State University System; California State University San Bernardino; Colorado State University; Colorado State University; Colorado State University; Colorado State University	Balgopal, MM (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	Meena.Balgopal@colostate.edu	; Fischer, Emily/K-7330-2015	Casper, A.M. Aramati/0000-0001-6557-4425; Balgopal, Meena/0000-0002-3846-9256; Fischer, Emily/0000-0001-8298-3669	Office of the Vice Provost for Research, Colorado State University	Office of the Vice Provost for Research, Colorado State University	The authors received partial funding from the Office of the Vice Provost for Research, Colorado State University, to conduct this study. Our institution did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2015, DABIQ, V8, P19; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Atadero RA, 2015, J ENG EDUC, V104, P55, DOI 10.1002/jee.20063; Beede D.N., 2011, WOMEN STEM GENDER GA, P4, DOI [DOI 10.2139/SSRN.1964782, 10.2139/ssrn.1964782]; Bobo Lawrence, 2001, AM BECOMING RACIAL T, P262, DOI DOI 10.17226/9599; Botella C, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21010030; Campbell LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079147; Cheryan S, 2000, PSYCHOL SCI, V11, P399, DOI 10.1111/1467-9280.00277; Cheryan S, 2017, PSYCHOL BULL, V143, P1, DOI 10.1037/bul0000052; Corbett C., 2015, SOLVING EQUATION VAR; Dasgupta N, 2001, J PERS SOC PSYCHOL, V81, P800, DOI 10.1037/0022-3514.81.5.800; Dasgupta N., 2014, POLICY INSIGHTS BEH, V1, P21, DOI [10.1177/2372732214549471, DOI 10.1177/2372732214549471]; Ding N, 2006, J SCI EDUC TECHNOL, V15, P331, DOI DOI 10.1007/S10956-006-9021-7; Dovidio JR, 2003, GROUP PROCESS INTERG, V6, P5, DOI 10.1177/1368430203006001009; EAGLY AH, 1984, J PERS SOC PSYCHOL, V46, P735, DOI 10.1037/0022-3514.46.4.735; Felder R. M., 1995, J ENG EDUC, V84, P151, DOI DOI 10.1002/J.2168-9830.1995.TB00162.X; Felder R. M., 1998, J ENG EDUC, V87, P469, DOI DOI 10.1002/J.2168-9830.1998.TB00381.X; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; Garcia-Retamero R, 2006, SEX ROLES, V55, P51, DOI 10.1007/s11199-006-9068-1; Gayles JG, 2014, J HIGH EDUC, V85, P439, DOI 10.1353/jhe.2014.0022; Grunspan DZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148405; Heilman ME, 2005, J APPL PSYCHOL, V90, P905, DOI 10.1037/0021-9010.90.5.905; Hyde JS, 2008, SCIENCE, V321, P494, DOI 10.1126/science.1160364; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; KIMBALL MM, 1989, PSYCHOL BULL, V105, P198, DOI 10.1037/0033-2909.105.2.198; LaCosse J, 2016, PSYCHOL WOMEN QUART, V40, P378, DOI 10.1177/0361684316630965; Leaper C, 2019, PSYCHOL WOMEN QUART, V43, P165, DOI 10.1177/0361684318806302; Leaper C, 2012, J YOUTH ADOLESCENCE, V41, P268, DOI 10.1007/s10964-011-9693-z; Lewin Tamar, 2006, NY TIMES, V9; Lorenzo M, 2006, AM J PHYS, V74, P118, DOI 10.1119/1.2162549; McGee EO, 2017, COGNITION INSTRUCT, V35, P265, DOI 10.1080/07370008.2017.1355211; Miller DI, 2015, J EDUC PSYCHOL, V107, P631, DOI 10.1037/edu0000005; Moss-Racusin CA, 2018, SEX ROLES, V79, P651, DOI 10.1007/s11199-018-0902-z; Murphy MC, 2007, PSYCHOL SCI, V18, P879, DOI 10.1111/j.1467-9280.2007.01995.x; National Research Council, 2012, FRAM K 12 SCI ED PRA; O'Brien LT, 2015, CULT DIVERS ETHN MIN, V21, P169, DOI 10.1037/a0037944; Ong M, 2018, J RES SCI TEACH, V55, P206, DOI 10.1002/tea.21417; Pollock SJ, 2007, PHYS REV SPEC TOP-PH, V3, DOI 10.1103/PhysRevSTPER.3.010107; Rainey K, 2018, INT J STEM EDUC, V5, DOI 10.1186/s40594-018-0115-6; Riegle-Crumb C, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00329; Rudman LA, 2004, J PERS SOC PSYCHOL, V87, P157, DOI 10.1037/0022-3514.87.2.157; Rudman LA, 2001, J PERS SOC PSYCHOL, V81, P856, DOI 10.1037/0022-3514.81.5.856; Shen H, 2013, NATURE, V495, P22, DOI [10.1038/495022a, 10.1038/495021a]; SHIELDS SA, 1982, SIGNS, V7, P769, DOI 10.1086/493921; Smith MK, 2009, SCIENCE, V323, P122, DOI 10.1126/science.1165919; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; STANGOR C, 1988, PERS SOC PSYCHOL B, V14, P694, DOI 10.1177/0146167288144005; Steele J, 2002, PSYCHOL WOMEN QUART, V26, P46, DOI 10.1111/1471-6402.00042; Stoet G, 2018, PSYCHOL SCI, V29, P581, DOI 10.1177/0956797617741719; Stout JG, 2011, J PERS SOC PSYCHOL, V100, P255, DOI 10.1037/a0021385; SWIM JK, 1995, J PERS SOC PSYCHOL, V68, P199, DOI 10.1037/0022-3514.68.2.199; Swim JK, 1996, PERS SOC PSYCHOL B, V22, P507, DOI 10.1177/0146167296225008; Tanner Kimberly, 2003, Cell Biol Educ, V2, P1, DOI 10.1187/cbe.03-03-0010; Tonso Karen L., 1996, J ENG EDUC, V85, P143, DOI DOI 10.1002/J.2168-9830.1996.TB00223.X; Voyer D, 2014, PSYCHOL BULL, V140, P1174, DOI 10.1037/a0036620; Wang MT, 2017, EDUC PSYCHOL REV, V29, P119, DOI 10.1007/s10648-015-9355-x; WEBER R, 1983, J PERS SOC PSYCHOL, V45, P961, DOI 10.1037/0022-3514.45.5.961; Wu LL, 2011, ISSUES SCI TECHNOL, V28, P82	58	21	22	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234685	10.1371/journal.pone.0234685	http://dx.doi.org/10.1371/journal.pone.0234685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584838	gold, Green Published			2022-12-27	WOS:000545747200023
J	Burguin, A; Furrer, D; Ouellette, G; Jacob, S; Diorio, C; Durocher, F				Burguin, Anna; Furrer, Daniela; Ouellette, Genevieve; Jacob, Simon; Diorio, Caroline; Durocher, Francine			Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE ACTIVATION; ADJUVANT TRASTUZUMAB; EFFICACY; HER-2/NEU; OVEREXPRESSION; AMPLIFICATION; CHEMOTHERAPY; MECHANISMS; EXPRESSION	The breast cancer (BC) biomarker HER2 (Human Epidermal Receptor 2) is overexpressed in 25% of BC. Only patients with HER2-positive tumors receive HER2-targeting therapies, like trastuzumab (Herceptin). However, some women with a HER2-negative BC could benefit from trastuzumab. This could be explained by the activation/phosphorylation of HER2 that can be recognized by trastuzumab. The aim of this study is to examine trastuzumab effects on HER2 phosphorylation at tyrosine Y877 (pHER2(Y877)). HER2 and pHER2(Y877)status were evaluated in a cohort of BC patients representative of molecular subtypes distribution (n = 497) and in a series of BC cell lines (n = 7). Immunohistochemistry against pHER2(Y877)was performed on tissue micro arrays. Cellular proliferation assays were performed on BC cell lines presenting different combinations of HER2 and pHER2(Y877)status and treated with increasing doses of trastuzumab (0-150 mu g/ml). The prevalence of pHER2(Y877)in this cohort was 6%. Nearly 5% of patients with HER2-negative tumors (n = 406, 82%) overexpressed pHER2(Y877). Among triple negative BC patients (n = 39, 8%), 7.7% expressed pHER2(Y877). Trastuzumab treatment decreased cell proliferation in HER2-/pHER2(Y877)+ BC cell lines, to an extent comparable to what occurs in HER2+ cell lines, but did not affect HER2-/pHER2(Y877)- cell lines. Trastuzumab sensitivity in HER2-/pHER2(Y877)+ cell line is specific to HER2 tyrosine 877 phosphorylation. Hence, with further confirmation in a bigger cohort, trastuzumab treatment could be envisaged as a treatment option to women presenting with HER2-/pHER2+ tumors, representing more than 1000 BC women in Canada in 2019.	[Burguin, Anna; Furrer, Daniela; Ouellette, Genevieve; Diorio, Caroline; Durocher, Francine] Univ Laval, Ctr Rech Canc, Ctr Rech CHU Quebec, Quebec City, PQ, Canada; [Burguin, Anna; Ouellette, Genevieve; Durocher, Francine] Univ Laval, Fac Med, Dept Med Mol, Quebec City, PQ, Canada; [Furrer, Daniela; Diorio, Caroline] Univ Laval, Fac Med, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Jacob, Simon] Univ Laval, CHU Quebec, Hop St Sacrement, Lab Pathol, Quebec City, PQ, Canada; [Jacob, Simon; Diorio, Caroline] Hop St Sacrement, Ctr Malad Sein, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University; Laval University	Durocher, F (corresponding author), Univ Laval, Ctr Rech Canc, Ctr Rech CHU Quebec, Quebec City, PQ, Canada.; Durocher, F (corresponding author), Univ Laval, Fac Med, Dept Med Mol, Quebec City, PQ, Canada.	francine.durocher@crchudequebec.ulaval.ca		Diorio, Caroline/0000-0001-5355-7345; Durocher, Francine/0000-0001-8012-4641	Canadian Institute of Health Research (CIHR); Fondation du cancer du sein du Quebec; Banque de tissus et donnees of the Reseau de recherche sur le cancer of the Fonds de recherche du Quebec Sante (FRQS); Canadian Tumor Repository Network (CTRNet); FRQS	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fondation du cancer du sein du Quebec; Banque de tissus et donnees of the Reseau de recherche sur le cancer of the Fonds de recherche du Quebec Sante (FRQS); Canadian Tumor Repository Network (CTRNet); FRQS	This project was supported by the Canadian Institute of Health Research (CIHR) and the tumor banking was supported by the Fondation du cancer du sein du Quebec and the Banque de tissus et donnees of the Reseau de recherche sur le cancer of the Fonds de recherche du Quebec Sante (FRQS), associated with the Canadian Tumor Repository Network (CTRNet). AB holds a Bourse de formation Desjardins pour la recherche et l'innovation-CHU de Quebec and a Bourse d'excellence aux etudes graduees du Centre de recherche sur le cancer. CD holds a Senior Investigator Award from the FRQS.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2001, PROCESS CONDUCTING A, VIII, P385; [Anonymous], 2013, VACCINE S2, V31, pB5; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Cabioglu N, 2005, CANCER RES, V65, P6493, DOI 10.1158/0008-5472.CAN-04-1303; Cicenas J, 2006, EUR J CANCER, V42, P636, DOI 10.1016/j.ejca.2005.11.012; Dai XF, 2016, J CANCER, V7, P1281, DOI 10.7150/jca.13141; DiGiovanna MP, 2005, J CLIN ONCOL, V23, P1152, DOI 10.1200/JCO.2005.09.055; Dokmanovic M, 2014, CANCER BIOL THER, V15, P1029, DOI 10.4161/cbt.29171; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; Frogne T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2230; Fulford LG, 2006, HISTOPATHOLOGY, V49, P22, DOI 10.1111/j.1365-2559.2006.02453.x; Furrer D, 2017, ANTICANCER RES, V37, P3323, DOI 10.21873/anticanres.11701; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Ginestier C, 2007, ONCOGENE, V26, P7163, DOI 10.1038/sj.onc.1210528; Giuliani R, 2007, EUR J CANCER, V43, P725, DOI 10.1016/j.ejca.2006.11.019; Gyawali B, 2017, CANCER TREAT REV, V60, P18, DOI 10.1016/j.ctrv.2017.08.001; Haas S, 2009, ONCOL REP, V21, P299, DOI 10.3892/or_00000221; Hudelist G, 2006, INT J CANCER, V118, P1126, DOI 10.1002/ijc.21492; Hudelist G, 2003, BRIT J CANCER, V89, P983, DOI 10.1038/sj.bjc.6601160; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kalimutho M, 2015, TRENDS PHARMACOL SCI, V36, P822, DOI 10.1016/j.tips.2015.08.009; Kawaguchi Y, 2007, BRIT J CANCER, V97, P494, DOI 10.1038/sj.bjc.6603885; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; Landberg G, 1997, APMIS, V105, P575, DOI 10.1111/j.1699-0463.1997.tb05056.x; Larsen MS, 2012, BREAST, V21, P662, DOI 10.1016/j.breast.2012.07.005; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; Montgomery RB, 2005, CANCER RES, V65, P650; Paik S, 2008, NEW ENGL J MED, V358, P1409, DOI 10.1056/NEJMc0801440; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pignatelli M, 2001, J CELL SCI, V114, P4117; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Ramic S, 2013, ANTICANCER RES, V33, P2509; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V319, P1, DOI 10.1016/j.bbrc.2004.04.150; Roskoski R, 2014, PHARMACOL RES, V87, P42, DOI 10.1016/j.phrs.2014.06.001; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Singer CF, 2009, J CANCER RES CLIN, V135, P807, DOI 10.1007/s00432-008-0516-x; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spears M, 2012, BREAST CANCER RES TR, V134, P701, DOI 10.1007/s10549-012-2076-7; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tanner M, 2004, MOL CANCER THER, V3, P1585; Telesco Shannon E, 2011, Cancer Res J, V4, P1; Thakur V, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1443-1; Thor AD, 2000, J CLIN ONCOL, V18, P3230, DOI 10.1200/JCO.2000.18.18.3230; Tseng LM, 2017, BREAST CANCER RES TR, V163, P241, DOI 10.1007/s10549-017-4195-7; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wulfkuhle JD, 2018, PRECIS ONCOL, V2, P1, DOI DOI 10.1200/P0.18.00024; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	51	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234991	10.1371/journal.pone.0234991	http://dx.doi.org/10.1371/journal.pone.0234991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584853	gold, Green Published			2022-12-27	WOS:000545747200070
J	Rao, M; van Pelt, M; LoGerfo, J; Steinman, LE; Heang, H; Fitzpatrick, AL				Rao, Mayuree; van Pelt, Maurits; LoGerfo, James; Steinman, Lesley E.; Heang, Hen; Fitzpatrick, Annette L.			Utilization of diabetes management health care services and its association with glycemic control among patients participating in a peer educator-based program in Cambodia	PLOS ONE			English	Article							SELF-MANAGEMENT; WORKERS; INTERVENTION; PREVENTION; OUTCOMES; SUPPORT; MIDDLE	Background Substantial evidence supports the effectiveness of peer educator programs for diabetes management in low- and middle-income countries. However, little is known about peer educators' impact relative to other treatment components such as medication and physician consultation. In Cambodia, the non-governmental organization MoPoTsyo organizes four services for people with diabetes: self-management training through peer educator visits, lab tests, physician consultations, and low-cost medicines. Our aims were to 1) quantify MoPoTsyo participant utilization of each program service and 2) define the relationship between each program service and glycemic control. Methods We conducted a retrospective cohort study among 4,210 MoPoTsyo participants, using data collected by MoPoTsyo from 2006-2016. Independent variables assessed were medication adherence, number of peer educator visits, number of physician consultations, and number of lab tests. A multiple logistic regression model was used to evaluate the association between these disease management services and glycemic control-fasting plasma glucose <= 130 mg/dl or post-prandial glucose <= 180 mg/dl-based on most recent glucose level. The model was adjusted for baseline demographic and disease characteristics. Findings Participants with 12 or more peer educator visits per year had a 35% higher odds of glycemic control relative to participants with 4 or fewer visits (odds ratio 1.35, 95% CI: 1.08-1.69; p = 0.009), after adjustment for utilization of other treatment components (medication adherence, number of physician visits, number of lab tests), follow-up time, and demographic and disease characteristics. Better adherence to medications and a greater number of lab tests per year were also associated with a higher odds of glycemic control after adjustment. Number of physician consultations was not associated with glycemic control after adjustment. Conclusions This study demonstrates a positive association between peer educator utilization and glycemic control incremental to other elements of diabetes management. These results suggest that peer educators may be a valuable addition to comprehensive diabetes management programs in low- and middle-income countries even when other health care services are accessible. The associations identified in this research warrant further prospective studies to explore the causal impact of peer educators on glycemic control relative to other disease management components.	[Rao, Mayuree] VA Puget Sound Hlth Care Syst, Gen Med Serv, Seattle, WA 98108 USA; [Rao, Mayuree; LoGerfo, James; Heang, Hen] Univ Washington, Dept Med, Seattle, WA 98195 USA; [van Pelt, Maurits] MoPoTsyo Patient Informat Ctr, Phnom Penh, Cambodia; [LoGerfo, James; Fitzpatrick, Annette L.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Steinman, Lesley E.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Fitzpatrick, Annette L.] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Fitzpatrick, Annette L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rao, M (corresponding author), VA Puget Sound Hlth Care Syst, Gen Med Serv, Seattle, WA 98108 USA.; Rao, M (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	mayuree@uw.edu		Rao, Mayuree/0000-0002-0874-8238				Alaofe H, 2017, ANN GLOB HEALTH, V83, P661, DOI 10.1016/j.aogh.2017.10.009; Ali MK, 2017, CARDIOVASCULAR RESP; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS55, DOI 10.2337/dc18-S006; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 2019, PROP DAYS COV PDC 3; Balagopal P, 2012, DIABETES EDUCATOR, V38, P822, DOI 10.1177/0145721712459890; Bigdeli M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146147; CEIC, 2019, CAMB 2019; DePue JD, 2013, DIABETES CARE, V36, P1947, DOI 10.2337/dc12-1969; Egbujie BA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198424; Farzadfar F, 2012, LANCET, V379, P47, DOI 10.1016/S0140-6736(11)61349-4; Fisher EB, 2014, ANNU REV PUBL HEALTH, V35, P363, DOI 10.1146/annurev-publhealth-032013-182450; Fisher EB, 2012, HEALTH AFFAIR, V31, P130, DOI 10.1377/hlthaff.2011.0914; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Jacob V, 2019, AM J PREV MED, V56, pE95, DOI 10.1016/j.amepre.2018.10.009; Jeet G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180640; Less LA, 2010, FAM PRACT, V27, pI46, DOI 10.1093/fampra/cmp085; Micikas M, 2015, HEALTH PROMOT PRACT, V16, P601, DOI 10.1177/1524839914557033; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Pharmacy Quality Alliance, PQA ADH MEAS; Rao MvPM, 2018, ANN CONS U GLOB HLTH; Suy S, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001787; Taniguchi D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181582; van Olmen Josefien, 2016, J Pharm Policy Pract, V9, P1, DOI 10.1186/s40545-016-0050-1; Van Olmen J, 2015, PRIM CARE DIABETES, V9, P196, DOI 10.1016/j.pcd.2014.09.001; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	26	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235037	10.1371/journal.pone.0235037	http://dx.doi.org/10.1371/journal.pone.0235037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584854	Green Published, gold			2022-12-27	WOS:000545747200097
J	Wheat, W; Chow, L; Rozo, V; Herman, J; Brooks, KS; Colbath, A; Hunter, R; Dow, S				Wheat, William; Chow, Lyndah; Rozo, Vanessa; Herman, Julia; Still Brooks, Kelly; Colbath, Aimee; Hunter, Randy; Dow, Steven			Non-specific protection from respiratory tract infections in cattle generated by intranasal administration of an innate immune stimulant	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PNEUMONIC INFECTION; ANTITUMOR-ACTIVITY; EVOLVING VIEWS; DISEASE; IMMUNIZATION; PATHOGENS; RESPONSES; IMMUNOTHERAPY; ACTIVATION	Alternatives to antibiotics for prevention of respiratory tract infections in cattle are urgently needed given the increasing public and regulatory pressure to reduce overall antibiotic usage. Activation of local innate immune defenses in the upper respiratory tract is one strategy to induce non-specific protection against infection with the diverse array of viral and bacterial pathogens associated with bovine respiratory disease complex (BRDC), while avoiding the use of antibiotics. Our prior studies in rodent models demonstrated that intranasal administration of liposome-TLR complexes (LTC) as a non-specific immune stimulant generated high levels of protection against lethal bacterial and viral pathogens. Therefore, we conducted studies to assess LTC induction of local immune responses and protective immunity to BRDC in cattle. In vitro, LTC were shown to activate peripheral blood mononuclear cells in cattle, which was associated with secretion of INF gamma and IL-6. Macrophage activation with LTC triggered intracellular killing ofMannheimia hemolyticaand several other bacterial pathogens. In studies in cattle, intranasal administration of LTC demonstrated dose-dependent activation of local innate immune responses in the nasopharynx, including recruitment of monocytes and prolonged upregulation (at least 2 weeks) of innate immune cytokine gene expression by nasopharyngeal mucosal cells. In a BRDC challenge study, intranasal administration of LTC prior to pathogen exposure resulted in significant reduction in both clinical signs of infection and disease-associated euthanasia rates. These findings indicate that intranasal administration of a non-specific innate immune stimulant can be an effective method of rapidly generating generalized protection from mixed viral and bacterial respiratory tract infections in cattle.	[Wheat, William; Chow, Lyndah; Rozo, Vanessa; Herman, Julia; Still Brooks, Kelly; Colbath, Aimee; Dow, Steven] Colorado State Univ, Coll Vet Med & Biomed Sci, Ctr Immune & Regenerat Med, Dept Clin Sci, Ft Collins, CO 80523 USA; [Hunter, Randy] Hunter Cattle Co, Wheatland, WY USA	Colorado State University	Dow, S (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Ctr Immune & Regenerat Med, Dept Clin Sci, Ft Collins, CO 80523 USA.	sdow@colostate.edu		Herman, Julia/0000-0002-7766-4337; Wheat, William/0000-0003-4229-3617	State of Colorado Office of Economic Development and International Translation (OEDIT) [1011]; Colorado State University Research Council (CRC) [COLV 2018-06]; OEDIT	State of Colorado Office of Economic Development and International Translation (OEDIT); Colorado State University Research Council (CRC); OEDIT	These studies were supported by grant 1011 from the State of Colorado Office of Economic Development and International Translation (OEDIT) and by grant COLV 2018-06 from Colorado State University Research Council (CRC) to SD. The OEDIT funding is provided to support the state of Colorado bioscience industry and funds were used to supply materials and salary support, including sample collection, research supplies, data analysis and publication costs. OEDIT and CRC funds supplied salary support for WWbut the study sponsors did not have any additional role in the study design, data collection analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of the author's salary and/or research materials. Animal BRDC challenge studies were performed by Elanco, Inc. Elanco Inc covered the costs associated with animal procurement, animal boarding, and costs associated with the completing the animal challenge studies and assisted with data collection and analysis. The Hunter Cattle Company provided healthy cattle and blood samples for testing the immunological effects of LTC administration. Neither of these two commercial entities (i.e., Elanco Inc or Hunter Cattle Co.) had a role in supplying salary support, decisions to publish, or preparation of the manuscript. Elanco Inc did however design the animal challenge studies, in collaboration with other study investigators. The specific roles of each study author are articulated in the "author contributions" section.	Alving CR, 2012, EXPERT REV VACCINES, V11, P733, DOI [10.1586/ERV.12.35, 10.1586/erv.12.35]; Bal SM, 2011, VACCINE, V29, P1045, DOI 10.1016/j.vaccine.2010.11.061; Berghuis L, 2014, VET RES, V45, DOI 10.1186/s13567-014-0105-8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Contreras ET, 2019, J VET INTERN MED, V33, P831, DOI 10.1111/jvim.15427; Dhama K, 2015, INT J PHARMACOL, V11, P253, DOI 10.3923/ijp.2015.253.290; Diaz AM, 2018, BENEF MICROBES, V9, P553, DOI 10.3920/BM2017.0081; Dow SW, 2008, EXPERT OPIN DRUG DEL, V5, P11, DOI 10.1517/17425247.5.1.11; Dow SW, 1999, J IMMUNOL, V163, P1552; Drevets Douglas A, 2015, Curr Protoc Immunol, V109, DOI 10.1002/0471142735.im1406s109; Dubrovsky SA, 2020, J DAIRY SCI, V103, P1583, DOI 10.3168/jds.2018-15501; Dubrovsky SA, 2019, J DAIRY SCI, V102, P7320, DOI 10.3168/jds.2018-15463; Dufour S, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.00133-19; DYER RM, 1982, COMP CONT EDUC PRACT, V4, pS296; Earley B, 2017, ANIMAL, V11, P486, DOI 10.1017/S1751731116001622; Enomoto R., 2013, ADV BIOL CHEM SCI RE, V03, P556, DOI [10.4236/abc.2013.36064, DOI 10.4236/ABC.2013.36064]; FDA, 2017, VET FEED DIR VFD; FRANK GH, 1986, AM J VET RES, V47, P1704; Fura JM, 2017, CURR TOP MED CHEM, V17, P290, DOI 10.2174/1568026616666160829160707; Goodyear A, 2009, INFECT IMMUN, V77, P1579, DOI 10.1128/IAI.01384-08; Gorski A, 2019, FUTURE MICROBIOL, V14, P1171, DOI 10.2217/fmb-2019-0222; Hammerbeck DM, 2007, ANTIVIR RES, V73, P1, DOI 10.1016/j.antiviral.2006.07.011; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Henderson A, 2011, VACCINE, V29, P5304, DOI 10.1016/j.vaccine.2011.05.009; Ilg T, 2017, MOL IMMUNOL, V90, P182, DOI 10.1016/j.molimm.2017.07.013; Ito S, 2005, J IMMUNOL, V174, P777, DOI 10.4049/jimmunol.174.2.777; Jacobs P, 1996, INFECT IMMUN, V64, P44, DOI 10.1128/IAI.64.1.44-49.1996; Jones A, 2010, VACCINE, V28, P5924, DOI 10.1016/j.vaccine.2010.06.020; Jones GJ, 2013, VACCINE, V31, P5250, DOI 10.1016/j.vaccine.2013.08.051; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kamstock D, 2006, CANCER GENE THER, V13, P306, DOI 10.1038/sj.cgt.7700895; Karnowski A, 2012, J EXP MED, V209, P2049, DOI 10.1084/jem.20111504; Kiser JN, 2017, J ANIM SCI, V95, P2726, DOI 10.2527/jas.2017.1548; Logue CH, 2010, ANTIVIR RES, V87, P195, DOI 10.1016/j.antiviral.2010.04.013; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McRae G, 2019, AMPLIMUNE ADM CALVES; Mitani H, 2000, BRIT J HAEMATOL, V109, P288, DOI 10.1046/j.1365-2141.2000.02020.x; Murray GM, 2016, VET J, V217, P95, DOI 10.1016/j.tvjl.2016.09.012; Murray GM, 2016, VET J, V217, P78, DOI 10.1016/j.tvjl.2016.09.013; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Nickell J. S., 2016, Bovine Practitioner, V50, P9; Nijnik A, 2013, CURR OPIN MICROBIOL, V16, P590, DOI 10.1016/j.mib.2013.06.011; Panciera RJ, 2010, VET CLIN N AM-FOOD A, V26, P191, DOI 10.1016/j.cvfa.2010.04.001; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Propst KL, 2010, ANTIMICROB AGENTS CH, V54, P1785, DOI 10.1128/AAC.01513-09; ROOK GAW, 1991, BIOTHERAPY, V3, P167, DOI 10.1007/BF02172089; Sabet M, 2006, FEMS IMMUNOL MED MIC, V47, P369, DOI 10.1111/j.1574-695X.2006.00096.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Snowder GD, 2006, J ANIM SCI, V84, P1999, DOI 10.2527/jas.2006-046; Thomas AC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48007-5; Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621; Troyer RM, 2009, VACCINE, V27, P4424, DOI 10.1016/j.vaccine.2009.05.041; Tucker CB, 2015, ANIM HEALTH RES REV, V16, P107, DOI 10.1017/S1466252315000171; Tuvim MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030596; Van Engen NK, 2018, ANIM HEALTH RES REV, V19, P142, DOI 10.1017/S1466252318000075; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Velazquez-Salinas L, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01057; WANG JM, 1990, IMMUNOLOGY, V71, P364; Wang M, 2018, JAVMA-J AM VET MED A, V253, P624, DOI 10.2460/javma.253.5.624; Welsh RD, 2004, J VET DIAGN INVEST, V16, P426, DOI 10.1177/104063870401600510; Wheat W, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2073-8; Wheat W, 2019, J VET INTERN MED, V33, P838, DOI 10.1111/jvim.15426; WHITELEY LO, 1992, J VET INTERN MED, V6, P11, DOI 10.1111/j.1939-1676.1992.tb00980.x; Wolfger B, 2015, VET CLIN N AM-FOOD A, V31, P351, DOI 10.1016/j.cvfa.2015.05.005; Woolums AR, 2019, J ANIM SCI, V97, P111, DOI 10.1093/jas/sky392; Wynn JL, 2008, BLOOD, V112, P1750, DOI 10.1182/blood-2008-01-130500; Zaks K, 2006, J IMMUNOL, V176, P7335, DOI 10.4049/jimmunol.176.12.7335; Zeineldin M, 2019, TRENDS MICROBIOL, V27, P753, DOI 10.1016/j.tim.2019.04.005; Zeineldin M, 2018, MICROB PATHOGENESIS, V124, P106, DOI 10.1016/j.micpath.2018.08.038	70	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235422	10.1371/journal.pone.0235422	http://dx.doi.org/10.1371/journal.pone.0235422			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584899	Green Published, gold			2022-12-27	WOS:000545747200087
J	Kamara, FM; Mokuwa, EY; Richards, P				Kamara, Foday Mamoud; Mokuwa, Esther Yei; Richards, Paul			How villagers in central Sierra Leone understand infection risks under threat of Covid-19	PLOS ONE			English	Article								Background Concern has been expressed over how well Africa is prepared to cope with the pandemic of Covid-19. Will rural populations with low levels of education know how to apply community-based infection control? We undertook fieldwork in two villages in central Sierra Leone to gain insight into how rural people faced with Covid-19 assess epidemic infection risks. Methods Two communities were selected based on prior contrasted exposure to Ebola Virus Disease-one with substantial number of cases and the other having resisted infection through strong community sequestration measures. We assessed understanding of infection risks via an experimental game. This asked players to express a preference for one of two diseases, one resembling Ebola with lower risk of infection and the other resembling Covid-19 with lower risk of death. Players were not told the identity of the diseases. Results In total 107 adult villagers played the game (58% women). Half (52%) preferred the disease model with lower risk of infection, 29% preferred the model with lower risk of death, while 21% saw the combined risk of infection and death as being equivalent. Differences in reactions between the two locations were small despite different experiences of Ebola. Asked to explain their choices 48% of players cited information on infection risks modelled by the game and 31% stated that their choices reflected awareness of the need for personal action and respect for local regulations. We concluded that villagers thoughtfully assess disease risks and that some are good intuitive statisticians. Conclusions Results suggest rural people in Sierra Leone retain the lessons of experience from the Ebola outbreak of 2014-15 and will be able to apply these lessons to a new infectious disease for which have no prior practical experience. Our expectation is that rural populations will understand Covid-19 control measures, thus reducing need for draconian enforcement.	[Kamara, Foday Mamoud; Mokuwa, Esther Yei; Richards, Paul] Njala Univ, Mokonde, Sierra Leone	Njala University	Richards, P (corresponding author), Njala Univ, Mokonde, Sierra Leone.	prichards@njala.edu.sl		Richards, Paul/0000-0001-5813-0228	Wellcome Trust [212536/Z/18/Z.]	Wellcome Trust(Wellcome TrustEuropean Commission)	The Wellcome Trust grant is the only source of funding. The grant number is 212536/Z/18/Z. All three authors receive some honoraria from this source.	[Anonymous], 1982, JUDGMENT UNCERTAINTY; Cosmides L, 1996, COGNITION, V58, P1, DOI 10.1016/0010-0277(95)00664-8; Gay J., 1967, NEW MATH OLD CULTURE; Gigerenzer G., 2007, GUT FEELINGS; Lave Jean., 2011, APPRENTICESHIP CRITI; Richards P, 2020, PLOS ONE; Richards P., 2016, EBOLA PEOPLES SCI HE; Shaw Rosalind, 2002, MEMORIES SLAVE TRADE	8	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235108	10.1371/journal.pone.0235108	http://dx.doi.org/10.1371/journal.pone.0235108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579602	Green Published, gold			2022-12-27	WOS:000545646600039
J	Mulinari, S; Vilhelmsson, A; Rickard, E; Ozieranski, P				Mulinari, Shai; Vilhelmsson, Andreas; Rickard, Emily; Ozieranski, Piotr			Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs	PLOS ONE			English	Article							ADVOCACY ORGANIZATIONS; EUROPE; DISCLOSURE	Background Many patient organisations collaborate with drug companies, resulting in concerns about commercial agendas influencing patient advocacy. We contribute to an international body of knowledge on patient organisation-industry relations by considering payments reported in the industry's centralised 'collaboration database' in Sweden. We also investigate possible commercial motives behind the funding by assessing its association with drug commercialisation. Methods Our primary data source were 1,337 payment reports from 2014-2018. After extraction and coding, we analysed the data descriptively, calculating the number, value and distribution of payments for various units of analysis, e.g. individual companies, diseases and payment goals. The association between drug commercialisation and patient organisation funding was assessed by, first, the concordance between leading companies marketing drugs in specific diseases and their funding of corresponding patient organisations and, second, the correlation between new drugs in broader condition areas and payments to corresponding patient organisations. Results 46 companies reported paying euro6,449.224 (median euro2,411; IQR euro1,024-4,569) to 77 patient organisations, but ten companies provided 67% of the funding. Small payments dominated, many of which covered costs of events organised by patient organisations. An association existed between drug commercialisation and industry funding. Companies supported patient organisations in diseases linked to their drug portfolios, with the top 3 condition areas in terms of funding-cancer; endocrine, nutritional and metabolic disorders; and infectious and parasitic disorders-accounting for 63% of new drugs and 56% of the funding. Conclusion This study reveals close and widespread ties between patient organisations and drug companies. A relatively few number of companies dominated the funding landscape by supporting patient organisations in disease areas linked to their drug portfolios. This commercially motivated funding may contribute to inequalities in resource and influence between patient organisations. The association between drug commercialisation and industry funding is also worrying because of the therapeutic uncertainty of many new drugs. Our analysis benefited from the existence of a centralised database of payments-which should be adopted by other countries too-but databases should be downloadable in an analysable format to permit efficient and independent analysis.	[Mulinari, Shai; Vilhelmsson, Andreas] Lund Univ, Dept Sociol, Lund, Sweden; [Rickard, Emily; Ozieranski, Piotr] Univ Bath, Dept Social & Policy Sci, Claverton Down, Bath, Avon, England	Lund University; University of Bath	Mulinari, S (corresponding author), Lund Univ, Dept Sociol, Lund, Sweden.	shai.mulinari@soc.lu.se	Vilhelmsson, Andreas/D-3879-2018	Vilhelmsson, Andreas/0000-0002-6635-8182; Ozieranski, Piotr/0000-0002-2023-3288; Mulinari, Shai/0000-0001-8773-9796; Rickard, Emily/0000-0003-2251-0127	Swedish Research Council for Health, Working Life and Welfare [201600875]; Crafoord Foundation	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Crafoord Foundation	This work was supported by grants from the Swedish Research Council for Health, Working Life and Welfare (www.forte.se) (FORTE #201600875 to SM (PI) and PO) and the Crafoord Foundation (www.crafoord.se) (to SM (PI) and PO and AV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abola MV, 2016, MAYO CLIN PROC, V91, P1668, DOI 10.1016/j.mayocp.2016.08.015; Abraham J., 2000, REGULATING MED EUROP; Baggott R, 2008, HEALTH EXPECT, V11, P85, DOI 10.1111/j.1369-7625.2007.00472.x; Ball DE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-201; Batt S, 2017, PHARM FUNDING CHANGE; Colombo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034974; Davis C., 2013, UNHEALTHY PHARM REGU, V1st ed; Davis C, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4530; di Priolo SL, 2012, PATIENT, V5, P127, DOI 10.2165/11589210-000000000-00000; EFPIA, 2011, EFPIA COD PRACT REL; Fabbri A, 2019, INT J HEALTH SERV, V49, P273, DOI 10.1177/0020731418823376; Fabbri A, 2018, INT J HEALTH POLICY, V7, P504, DOI 10.15171/ijhpm.2018.20; Ferrario A, 2015, SOC SCI MED, V124, P39, DOI 10.1016/j.socscimed.2014.11.003; Grundy Q, 2018, HEALTH POLICY, V122, P509, DOI 10.1016/j.healthpol.2018.03.015; Haerry D, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00230; Hemminki E, 2010, SOC SCI MED, V70, P1171, DOI 10.1016/j.socscimed.2010.01.005; Hoekman J, 2019, SOC SCI MED, V222, P76, DOI 10.1016/j.socscimed.2018.12.025; Hughes David, 2013, Healthc Policy, V9, P52; Institute for Health Metrics and Evaluation (IHME), 2018, SWED PROF; Kang SY, 2019, AM J PUBLIC HEALTH, V109, P559, DOI 10.2105/AJPH.2018.304946; Kent A, 2007, BRIT MED J, V334, P934, DOI 10.1136/bmj.39185.461968.AD; Lau E, 2019, AUST HEALTH REV, V43, P474, DOI 10.1071/AH17288; Lexchin J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212399; Li DG, 2019, JAMA DERMATOL, V155, P460, DOI 10.1001/jamadermatol.2018.5102; LIF, 2020, ETH RUL PHARM IND SW; LIF, SAM; Lofgren H, 2011, DEMOCRATIZING HEALTH: CONSUMER GROUPS IN THE POLICY PROCESS, P1; Mandeville KL, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5300; McCoy MS, 2017, NEW ENGL J MED, V376, P880, DOI 10.1056/NEJMsr1610625; Menon D, 2011, EXPERT REV PHARM OUT, V11, P75, DOI 10.1586/ERP.10.82; Mulinari S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023094; Mulinari S, 2016, J PUBLIC HEALTH POL, V37, P149, DOI 10.1057/jphp.2016.6; Mulinari S, 2013, SOCIOL HEALTH ILL, V35, P761, DOI 10.1111/j.1467-9566.2012.01528.x; Myndigheten for Vardanalys, 2015, 20154 MYND VARD; Naci H, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5221; Ozieranski P, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6253; Ozieranski P, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1806; Parker L, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6694; Pearcy J, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l740; Perehudoff SK, 2011, PATIENT CONSUMER VOI; Pontes C, 2020, APPL HEALTH ECON HEA, V18, P5, DOI 10.1007/s40258-019-00527-x; Prasad V, 2015, JAMA INTERN MED, V175, P1389, DOI 10.1001/jamainternmed.2015.2829; Rickard E, 2019, HEALTH POLICY, V123, P1244, DOI 10.1016/j.healthpol.2019.08.007; Rose SL, 2017, JAMA INTERN MED, V177, P344, DOI 10.1001/jamainternmed.2016.8443; Rothman SM, 2011, AM J PUBLIC HEALTH, V101, P602, DOI 10.2105/AJPH.2010.300027; Taylor J, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1251; The Institute for Health Metrics and Evaluation (IHME), GLOB HLTH DAT EXCH G; Tibau A, 2018, JAMA ONCOL, V4, P1610, DOI 10.1001/jamaoncol.2018.4300; Wehling P., 2014, PUBLIC SHAPING MED R; Zetterqvist AV, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001785	50	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235021	10.1371/journal.pone.0235021	http://dx.doi.org/10.1371/journal.pone.0235021			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579571	Green Published, gold			2022-12-27	WOS:000545646600045
J	Adu-Oppong, B; Mangan, SA; Stein, C; Catano, CP; Myers, JA; Dantas, G				Adu-Oppong, Boahemaa; Mangan, Scott A.; Stein, Claudia; Catano, Christopher P.; Myers, Jonathan A.; Dantas, Gautam			Prairie plants harbor distinct and beneficial root-endophytic bacterial communities	PLOS ONE			English	Article							SOIL FEEDBACK; RHIZOSPHERE MICROBIOME; DIVERSITY; POPULATION; DYNAMICS; BIOTA; ANTIBIOTICS; PRODUCTIVITY; BIODIVERSITY; BIOGEOGRAPHY	Plant-soil feedback studies attempt to understand the interplay between composition of plant and soil microbial communities. A growing body of literature suggests that plant species can coexist when they interact with a subset of the soil microbial community that impacts plant performance. Most studies focus on the microbial community in the soil rhizosphere; therefore, the degree to which the bacterial community within plant roots (root-endophytic compartment) influences plant-microbe interactions remains relatively unknown. To determine if there is an interaction between conspecific vs heterospecific soil microbes and plant performance, we sequenced root-endophytic bacterial communities of five tallgrass-prairie plant species, each reciprocally grown with soil microbes from each hosts' soil rhizosphere. We found evidence of plant-soil feedbacks for some pairs of plant hosts; however, the strength and direction of feedbacks varied substantially across plant species pairs-from positive to negative feedbacks. Additionally, each plant species harbored a unique subset of root-endophytic bacteria. Conspecifics that hosted similar bacterial communities were more similar in biomass than individuals that hosted different bacterial communities, suggesting an important functional link between root-endophytic bacterial community composition and plant fitness. Our findings suggest a connection between an understudied component of the root-endophytic microbiome and plant performance, which may have important implications in understanding plant community composition and coexistence.	[Adu-Oppong, Boahemaa; Dantas, Gautam] Washington Univ, Sch Med, Edison Family Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA; [Mangan, Scott A.; Catano, Christopher P.; Myers, Jonathan A.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Mangan, Scott A.; Catano, Christopher P.; Myers, Jonathan A.] Washington Univ, Tyson Res Ctr, St Louis, MO 63110 USA; [Stein, Claudia] Auburn Univ, Dept Biol & Environm Sci, Montgomery, AL 36117 USA; [Catano, Christopher P.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Dantas, Gautam] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Dantas, Gautam] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Dantas, Gautam] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Auburn University System; Auburn University; Michigan State University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Dantas, G (corresponding author), Washington Univ, Sch Med, Edison Family Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA.; Dantas, G (corresponding author), Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Dantas, G (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Dantas, G (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA.	dantas@wustl.edu	Stein, Claudia/AAV-8970-2020	Adu-Oppong, Boahemaa/0000-0002-1185-6598	NIH Director's New Innovator Award; National Institute of Diabetes and Digestive and Kidney Diseases [DP2DK098089]; National Institute of General Medical Sciences [R01GM099538]; National Science Foundation [DGE1143945]	NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF))	G.D. from the NIH Director's New Innovator Award, the National Institute of Diabetes and Digestive and Kidney Diseases (DP2DK098089) and the National Institute of General Medical Sciences (R01GM099538). B.A. was supported by National Science Foundation graduate research fellow (award number DGE1143945). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank Mike Dryer, Darlene Branson, Khadine Gomez, Max Herzog, Kevin Stiles, and the undergraduates of the Mangan Lab for their assistance in the greenhouse, Jessica Hoisington-Lopez, Eric Martin, and Brian Koebbe for next-generation sequencing and high-throughput computing support at the Edison Family Center for Genome Sciences and Systems Biology at Washington University in St Louis School of Medicine, and members of the Dantas lab for insightful discussions of the results and conclusions.	[Anonymous], 2015, ANN ONCOL S5, V26, pv174; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 1996, PRAIRIE CONSERVATION; [Anonymous], 2013, PSYCHIAT SERV, V64, pe10; Batten KM, 2008, MICROB ECOL, V55, P220, DOI 10.1007/s00248-007-9269-3; Bennett JA, 2017, SCIENCE, V355, P181, DOI 10.1126/science.aai8212; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bever JD, 2015, ANNU REV ECOL EVOL S, V46, P305, DOI 10.1146/annurev-ecolsys-112414-054306; Bever JD, 2013, ECOL LETT, V16, P167, DOI 10.1111/ele.12024; Bever JD, 2012, ANNU REV MICROBIOL, V66, P265, DOI 10.1146/annurev-micro-092611-150107; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Bonanomi G, 2005, OIKOS, V111, P311, DOI 10.1111/j.0030-1299.2005.13975.x; Brinkman EP, 2010, J ECOL, V98, P1063, DOI 10.1111/j.1365-2745.2010.01695.x; Brun S, 2001, EUR J CLIN MICROBIOL, V20, P718, DOI 10.1007/s100960100577; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Burns JH, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv030; Callaway RM, 2004, ECOLOGY, V85, P1062, DOI 10.1890/02-0775; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaparro JM, 2014, ISME J, V8, P790, DOI 10.1038/ismej.2013.196; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; Coleman-Derr D, 2016, NEW PHYTOL, V209, P798, DOI 10.1111/nph.13697; Cumming JR, 2007, J TORREY BOT SOC, V134, P63, DOI 10.3159/1095-5674(2007)134[63:PVIISA]2.0.CO;2; Du L, 2012, AGRON SUSTAIN DEV, V32, P309, DOI DOI 10.1007/s13593-011-0062-9; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Eppinga MB, 2018, NAT ECOL EVOL, V2, P1403, DOI 10.1038/s41559-018-0622-3; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; Faisal M, 2006, LETT APPL MICROBIOL, V43, P461, DOI 10.1111/j.1472-765X.2006.01977.x; Fitzpatrick CR, 2018, P NATL ACAD SCI; Gornish ES, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163930; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Gustafson DJ, 2004, PLANT SOIL, V259, P9, DOI 10.1023/B:PLSO.0000020936.56786.a4; Hacquard S, 2016, NEW PHYTOL, V209, P454, DOI 10.1111/nph.13760; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Hammesfahr U, 2008, SOIL BIOL BIOCHEM, V40, P1583, DOI 10.1016/j.soilbio.2008.01.010; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hartnett DC, 2002, PLANT SOIL, V244, P319, DOI 10.1023/A:1020287726382; Hervu M., 2015, RVAIDEMEMOIRE DIVERS; Hu LF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05122-7; Kaisermann A, 2017, NEW PHYTOL, V215, P1413, DOI 10.1111/nph.14661; Keymer DP, 2017, J ECOL, V105, P816, DOI 10.1111/1365-2745.12716; Kim H, 1998, J APPL MICROBIOL, V85, P731, DOI 10.1111/j.1365-2672.1998.00586.x; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kourtev PS, 2003, SOIL BIOL BIOCHEM, V35, P895, DOI 10.1016/S0038-0717(03)00120-2; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Larsson DGJ, 2014, UPSALA J MED SCI, V119, P108, DOI 10.3109/03009734.2014.896438; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; Leebens-Mack Y., 2012, GENOME BIOL, V13, pR3; Leff JW, 2017, NEW PHYTOL, V214, P412, DOI 10.1111/nph.14323; Lesk C, 2016, NATURE, V529, P84, DOI 10.1038/nature16467; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luby E, 2016, J ENVIRON QUAL, V45, P441, DOI 10.2134/jeq2015.07.0367; Martinez JL, 2009, ENVIRON POLLUT, V157, P2893, DOI 10.1016/j.envpol.2009.05.051; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Majeed A, 2018, PLANT CELL REP, V37, P1599, DOI 10.1007/s00299-018-2341-2; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meisner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031596; Naylor D, 2017, ISME J, V11, P2691, DOI 10.1038/ismej.2017.118; Oksanen J, 2013, R PACKAGE, V2, P9; Paredes SH, 2016, FUNCT ECOL, V30, P1043, DOI 10.1111/1365-2435.12684; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Prober SM, 2015, ECOL LETT, V18, P85, DOI 10.1111/ele.12381; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Reinhart KO, 2004, ECOL APPL, V14, P1737, DOI 10.1890/03-5204; Reinhart KO, 2003, ECOL LETT, V6, P1046, DOI 10.1046/j.1461-0248.2003.00539.x; Reinhart KO, 2010, NEW PHYTOL, V186, P484, DOI 10.1111/j.1469-8137.2009.03159.x; Reinhold-Hurek B, 2015, ANNU REV PHYTOPATHOL, V53, P403, DOI 10.1146/annurev-phyto-082712-102342; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Semedo M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02121; Shakya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076382; Shannon S, 2012, OECOLOGIA, V169, P235, DOI 10.1007/s00442-011-2195-6; Stockwell VO, 2012, REV SCI TECH OIE, V31, P199; Stringlis IA, 2018, P NATL ACAD SCI USA, V115, pE5213, DOI 10.1073/pnas.1722335115; Suding KN, 2013, J ECOL, V101, P298, DOI 10.1111/1365-2745.12057; Thiele-Bruhn S, 2005, CHEMOSPHERE, V59, P457, DOI 10.1016/j.chemosphere.2005.01.023; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; van der Heijden MGA, 2006, FEMS MICROBIOL ECOL, V56, P178, DOI 10.1111/j.1574-6941.2006.00086.x; van Grunsven RHA, 2007, J ECOL, V95, P1050, DOI 10.1111/j.1365-2745.2007.01282.x; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wagner MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12151; Walters WA, 2018, P NATL ACAD SCI USA, V115, P7368, DOI 10.1073/pnas.1800918115; Wassermann B, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0723-5; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Whitaker BK, 2017, ECOL LETT, V20, P1064, DOI 10.1111/ele.12805; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wohlwend MR, 2019, RESTOR ECOL, V27, P1307, DOI 10.1111/rec.13006; Wolfe BE, 2005, BIOSCIENCE, V55, P477, DOI 10.1641/0006-3568(2005)055[0477:BNGSCA]2.0.CO;2; Zhalnina K, 2018, NAT MICROBIOL, V3, P470, DOI 10.1038/s41564-018-0129-3; Zuppinger-Dingley D, 2014, NATURE, V515, P108, DOI 10.1038/nature13869	102	0	0	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234537	10.1371/journal.pone.0234537	http://dx.doi.org/10.1371/journal.pone.0234537			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574172	Green Published, gold			2022-12-27	WOS:000544972400040
J	Ihmig, FR; Gogeascoechea, HA; Neurohr-Parakenings, F; Schafer, SK; Lass-Hennemann, J; Michael, T				Ihmig, Frank R.; Gogeascoechea, Antonio H.; Neurohr-Parakenings, Frank; Schaefer, Sarah K.; Lass-Hennemann, Johanna; Michael, Tanja			On-line anxiety level detection from biosignals: Machine learning based on a randomized controlled trial with spider-fearful individuals	PLOS ONE			English	Article							REALITY EXPOSURE THERAPY; STRESS; METAANALYSIS; AGREEMENT; PHOBIA	We present performance results concerning the validation for anxiety level detection based on trained mathematical models using supervised machine learning techniques. The model training is based on biosignals acquired in a randomized controlled trial. Wearable sensors were used to collect electrocardiogram, electrodermal activity, and respiration from spider-fearful individuals. We designed and applied ten approaches for data labeling considering individual biosignals as well as subjective ratings. Performance results revealed a selection of trained models adapted for two-level (low and high) and three-level (low, medium and high) classification of anxiety using a minimal set of six features. We obtained a remarkable accuracy of 89.8% for the two-level classification and of 74.4% for the three-level classification using a short time window length of ten seconds when applying the approach that uses subjective ratings for data labeling.Bagged Treesproved to be the most suitable classifier type among the classification models studied. The trained models will have a practical impact on the feasibility study of an augmented reality exposure therapy based on a therapeutic game for the treatment of arachnophobia.	[Ihmig, Frank R.; Neurohr-Parakenings, Frank] Fraunhofer Inst Biomed Tech IBMT, Dept Biomed Microsyst, Sulzbach, Germany; [Gogeascoechea, Antonio H.] Univ Twente, Fac Elect Engn Math & Comp Sci, Enschede, Netherlands; [Schaefer, Sarah K.; Lass-Hennemann, Johanna; Michael, Tanja] Saarland Univ, Dept Psychol, Div Clin Psychol & Psychotherapy, Saarbrucken, Germany	Fraunhofer Gesellschaft; University of Twente; Saarland University	Ihmig, FR (corresponding author), Fraunhofer Inst Biomed Tech IBMT, Dept Biomed Microsyst, Sulzbach, Germany.	frank.ihmig@ibmt.fraunhofer.de			German Federal Ministry of Education and Research through an applied research grant [13GW0158B, 13GW0158C]	German Federal Ministry of Education and Research through an applied research grant	This research is funded by the German Federal Ministry of Education and Research through an applied research grant (contract numbers 13GW0158B and 13GW0158C) within the program "Medical technology solutions for the digital healthcare". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alom MZ, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8030292; [Anonymous], 2015, DIABET CARE S1, V38, pS4, DOI DOI https://doi.org/10.2337/dc15-S005; Barua S, 2015, STUD HEALTH TECHNOL, V211, P241, DOI 10.3233/978-1-61499-516-6-241; Ben-David A, 2008, EXPERT SYST APPL, V34, P825, DOI 10.1016/j.eswa.2006.10.022; Bishop C. M., 2006, SPRINGER; Braithwaite Watson, 2013, TECHNICAL REPORT; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CACIOPPO JT, 1980, AM J PSYCHOL, V93, P173, DOI 10.2307/1422117; Camm AJ, 1996, CIRCULATION, V93, P1043; Cardos RAI, 2017, COMPUT HUM BEHAV, V72, P371, DOI 10.1016/j.chb.2017.03.007; Carl E, 2019, J ANXIETY DISORD, V61, P27, DOI 10.1016/j.janxdis.2018.08.003; Chen LL, 2017, EXPERT SYST APPL, V85, P279, DOI 10.1016/j.eswa.2017.01.040; Choi J, 2010, IEEE SENSOR, P150, DOI 10.1109/ICSENS.2010.5690677; Christy T, 2014, GSTF J COMPUT, V3, P29; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Deterding S., 2011, P 15 INT ACAD MINDTR, P9; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; El Khayat GA, 2012, 2012 17TH INTERNATIONAL CONFERENCE ON COMPUTER GAMES (CGAMES), P30, DOI 10.1109/CGames.2012.6314547; Emmelkamp PMG, 2005, PSYCHOTHER PSYCHOSOM, V74, P336, DOI 10.1159/000087780; Fodor LA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28113-6; Fu WJJ, 2005, BIOINFORMATICS, V21, P1979, DOI 10.1093/bioinformatics/bti294; Gevirtz R., 2013, BIOFEEDBACK, V41, P110, DOI [10.5298/1081-5937-41.3.01, DOI 10.5298/1081-5937-41.3.01]; Giannakakis G, 2019, IEEE T AFFECTIVE COM, P1; GROSSMAN P, 1983, PSYCHOPHYSIOLOGY, V20, P284, DOI 10.1111/j.1469-8986.1983.tb02156.x; Hammad M, 2019, FUTURE GENER COMP SY, V101, P180, DOI 10.1016/j.future.2019.06.008; Hammad M, 2018, MEASUREMENT, V125, P634, DOI 10.1016/j.measurement.2018.05.033; Handouzi W, 2013, IEEE SYS MAN CYBERN, P3145, DOI 10.1109/SMC.2013.536; Healey JA, 2005, IEEE T INTELL TRANSP, V6, P156, DOI 10.1109/TITS.2005.848368; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Kampmann IL, 2016, BEHAV RES THER, V77, P147, DOI 10.1016/j.brat.2015.12.016; Keshan N, 2015, PROCEEDINGS 2015 IEEE INTERNATIONAL CONFERENCE ON BIG DATA, P2661, DOI 10.1109/BigData.2015.7364066; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu Y, 2018, BEHAV BRAIN RES, V341, P50, DOI 10.1016/j.bbr.2017.12.021; LYKKEN DT, 1966, PSYCHOL BULL, V66, P481, DOI 10.1037/h0023922; McDuff D, 2014, IEEE ENG MED BIO, P2957, DOI 10.1109/EMBC.2014.6944243; Mclay RN, 2017, CYBERPSYCH BEH SOC N, V20, P218, DOI 10.1089/cyber.2016.0554; Morina N, 2015, BEHAV RES THER, V74, P18, DOI 10.1016/j.brat.2015.08.010; Nemcova A, 2016, C PAPER EEICT, P543; Newman MG, 2011, CLIN PSYCHOL REV, V31, P89, DOI 10.1016/j.cpr.2010.09.008; Olatunji BO, 2009, COGN BEHAV PRACT, V16, P172, DOI 10.1016/j.cbpra.2008.07.003; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Picard RW, 2001, IEEE T PATTERN ANAL, V23, P1175, DOI 10.1109/34.954607; Rothbaum BO, 2000, J CONSULT CLIN PSYCH, V68, P1020, DOI 10.1037/0022-006X.68.6.1020; Rothbaurn BO, 2010, ANN NY ACAD SCI, V1208, P126, DOI 10.1111/j.1749-6632.2010.05691.x; Schafer SK, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2554-2; Sedghamiz H., 2014, MATLAB IMPLEMENTATIO; Shiban Y, 2015, BEHAV RES THER, V71, P45, DOI 10.1016/j.brat.2015.05.014; Siegel EH, 2018, PSYCHOL BULL, V144, P343, DOI 10.1037/bul0000128; SPITZER L, 1989, ANNU REV ASTRON ASTR, V27, P1; Wardenaar KJ, 2017, PSYCHOL MED, V47, P1744, DOI [10.1017/S0033291717000174, 10.1017/s0033291717000174]; Wolitzky-Taylor KB, 2008, CLIN PSYCHOL REV, V28, P1021, DOI 10.1016/j.cpr.2008.02.007	51	17	18	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0231517	10.1371/journal.pone.0231517	http://dx.doi.org/10.1371/journal.pone.0231517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME9KK	32574167	Green Published, gold			2022-12-27	WOS:000544972400002
J	Roland, MCP; Lekva, T; Godang, K; Bollerslev, J; Henriksen, T				Roland, Marie Cecilie Paasche; Lekva, Tove; Godang, Kristin; Bollerslev, Jens; Henriksen, Tore			Changes in maternal blood glucose and lipid concentrations during pregnancy differ by maternal body mass index and are related to birthweight: A prospective, longitudinal study of healthy pregnancies	PLOS ONE			English	Article							MODIFIABLE DETERMINANTS; OVERWEIGHT; OBESITY; GAIN	Background Maternal obesity is increasing worldwide but the consequences for maternal physiology and fetal growth are not fully understood. Objective To study whether changes in glucose and lipid metabolism during pregnancy differ between women with normal weight and overweight/obesity, and investigate which of these metabolic factors are associated with birthweight. Design Prospective, longitudinal study. Setting Department of Obstetrics, Oslo University Hospital, Rikshospitalet. Population 1031 healthy pregnant women with singleton pregnancies. Methods Blood samples from early and late pregnancy were analyzed for fasting glucose, insulin and lipids (total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides). Associations between metabolic factors and birthweight (z-scores) were explored by linear regression models. Main Outcome Measures: Group-dependent longitudinal changes in glucose and lipids and their association with birthweight (z-scores). Results Compared to women with normal weight (BMI < 25), women with overweight (BMI 25-29.9) and obesity (BMI > 30) had significantly higher fasting glucose (4.54, 4.68 and 4.84 mmol/l), insulin (23, 33 and 50 pmol/l), total cholesterol (4.85, 4.99 and 5.14 mmol/l), LDL-C (2.49, 2.66 and 2.88 mmol/l) and triglycerides (1.10, 1.28 and 1.57 mmol/l), but lower HDL-C (1.86, 1.75 and 1.55 mmol/l). BMI (B 0.05, 95% CI 0.03-0.06, p<0.001), gestational weight gain (GWG) (B 0.06, 0.05-0.08, p<0.001) and an increase in fasting glucose (B 0.30, 0.16-0.43, p<0.001) were positively associated with birthweight, whereas a decrease in HDL-C (B -0.72, -0.96- -0.53, p<0.001) had a negative association with birthweight. Conclusions Overweight/obesity was associated with an unfavorable metabolic profile in early pregnancy which was associated with increased birthweight. However, modifiable factors like gestational weight gain and an increase in fasting glucose were identified and can be targeted for interventions.	[Roland, Marie Cecilie Paasche] Oslo Univ Hosp, Dept Obstet, Oslo, Norway; [Roland, Marie Cecilie Paasche] Oslo Univ Hosp, Natl Advisory Unit Womens Hlth, Oslo, Norway; [Lekva, Tove] Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway; [Godang, Kristin; Bollerslev, Jens] Oslo Univ Hosp, Dept Endocrinol, Oslo, Norway; [Bollerslev, Jens; Henriksen, Tore] Univ Oslo, Dept Clin Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Roland, MCP (corresponding author), Oslo Univ Hosp, Dept Obstet, Oslo, Norway.; Roland, MCP (corresponding author), Oslo Univ Hosp, Natl Advisory Unit Womens Hlth, Oslo, Norway.	mcpaasche@hotmail.com		Lekva, Tove/0000-0002-7962-4726	National Advisory Unit for Women's Health after external peer review for scientific quality	National Advisory Unit for Women's Health after external peer review for scientific quality	MCPR was awarded a 3 years postdoctoral grant from the National Advisory Unit for Women's Health after external peer review for scientific quality. The funding body has played no role in conducting the research or writing the paper.	Barbour LA, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1008-2; Barker DJP, 2013, CLIN OBSTET GYNECOL, V56, P511, DOI 10.1097/GRF.0b013e31829cb9ca; Bozkurt L, 2016, SCI REP-UK, V6, DOI 10.1038/srep29971; Bringhenti I, 2016, NUTRITION, V32, P1138, DOI 10.1016/j.nut.2016.03.001; CATALANO PM, 1992, AM J OBSTET GYNECOL, V167, P913, DOI 10.1016/S0002-9378(12)80011-1; CATALANO PM, 1991, AM J OBSTET GYNECOL, V165, P1667, DOI 10.1016/0002-9378(91)90012-G; Farias D, 2015, BJOG; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friedman JE, 1999, DIABETES, V48, P1807, DOI 10.2337/diabetes.48.9.1807; Friis CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057467; Geraghty AA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1543-x; Langer O, 2015, J MATERN-FETAL NEO M, P1, DOI DOI 10.3109/14767058; McIntyre HD, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0098-8; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Metzger Be Fau-Lowe LP, HYPERGLYCEMIA ADVERS, P1533; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; Poston L, 2012, CURR OPIN CLIN NUTR, V15, P252, DOI 10.1097/MCO.0b013e3283527cf2; Qvigstad E, 2010, EUR J ENDOCRINOL, V162, P67, DOI 10.1530/EJE-09-0416; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Roland MCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087303; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Schaefer-Graf UM, 2008, DIABETES CARE, V31, P1858, DOI 10.2337/dc08-0039; Scifres CM, 2014, OBESITY, V22, P932, DOI 10.1002/oby.20576; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Sommer C, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0512-5; Voldner N, 2008, ACTA OBSTET GYN SCAN, V87, P423, DOI 10.1080/00016340801989825; Voldner N, 2009, ACTA OBSTET GYN SCAN, V88, P550, DOI 10.1080/00016340902818162	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0232749	10.1371/journal.pone.0232749	http://dx.doi.org/10.1371/journal.pone.0232749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574162	gold, Green Published			2022-12-27	WOS:000544972400037
J	Bhargava, M; Bhargava, A; Ghate, SD; Rao, RSP				Bhargava, Madhavi; Bhargava, Anurag; Ghate, Sudeep D.; Rao, R. Shyama Prasad			Nutritional status of Indian adolescents (15-19 years) from National Family Health Surveys 3 and 4: Revised estimates using WHO 2007 Growth reference	PLOS ONE			English	Article							ACTION GROUP EAG; THINNESS; CHILDREN; GIRLS; PREVALENCE; TRANSITION; OVERWEIGHT	Background The National Family Health Surveys (NFHS) in India apply adult cutoffs of nutritional status for the estimation of undernutrition/overweight in the 15-19 age group. The prevalence of thinness in boys and girls thus estimated is 58.1% and 46.8% in NFHS-3, and 45% and 42% in NFHS-4 respectively. But the WHO recommends using age and sex-specific reference for adolescents. We reanalyzed the nutritional status of the adolescents using the WHO 2007 Growth Reference to obtain revised estimates of thinness, overweight and stunting across states, rural-urban residence, and wealth quintiles. Methods and findings Demographic information, anthropometric data, and wealth index were accessed from the Demographic and Health Survey (DHS) database. We re-analyzed the anthropometric data using WHO AnthroPlus software which uses the WHO 2007 Growth reference. The revised estimates of thinness assessed by BMI-for-age z-scores in boys and girls was 22.3% (95%CI: 21.6, 23.0) and 9.9% (95%CI: 9.5, 10.3) in NFHS-3 and 16.5% (95%CI: 16.0,17.0) and 9% (95%CI: 8.9, 9.2) in NFHS-4 respectively. Stunting was found to be 32.2% (95% CI: 31.6, 32.9) in boys and 34.4% (95% CI: 34.2, 34.7) in girls in NFHS-4. This was higher than that in NFHS-3; 25.2% (95% CI: 24.4, 26) in boys and 31.2 (95% CI: 30.6, 31.8) in girls. There was a clear socioeconomic gradient as there were higher thinness and stunting in rural areas. There was wide variation among the states with pockets of a double burden of malnutrition. Conclusion Using the adult cutoffs significantly overestimates thinness in adolescents in the age group of 15-19 years old in India. Stunting, which is an indicator of long term nutrition is also widely prevalent in them. Future editions of DHS and NFHS should consider adolescents as a separate age group for nutritional assessment for a better understanding of nutritional transition in the population.	[Bhargava, Madhavi] Yenepoya Med Coll, Dept Community Med, Mangalore, Karnataka, India; [Bhargava, Madhavi; Bhargava, Anurag] Yenepoya Deemed Be Univ, Ctr Nutr Studies, Mangalore, Karnataka, India; [Ghate, Sudeep D.] Yenepoya Med Coll, Dept Gen Med, Mangalore, Karnataka, India; [Rao, R. Shyama Prasad] Yenepoya Deemed Be Univ, Yenepoya Res Ctr, Mangalore, Karnataka, India	Yenepoya (Deemed to be University); Yenepoya (Deemed to be University); Yenepoya (Deemed to be University); Yenepoya (Deemed to be University)	Bhargava, M (corresponding author), Yenepoya Med Coll, Dept Community Med, Mangalore, Karnataka, India.; Bhargava, M (corresponding author), Yenepoya Deemed Be Univ, Ctr Nutr Studies, Mangalore, Karnataka, India.	madhavibhargava4@gmail.com	Ghate, Sudeep/GPX-0141-2022; Rao, R Shyama Prasad/E-5434-2011	Rao, R Shyama Prasad/0000-0002-2285-6788; Bhargava, Madhavi/0000-0001-7480-566X	United Nations Children's Fund (UNICEF) [SSFA/2019/07]	United Nations Children's Fund (UNICEF)	MB received grant from The United Nations Children's Fund (UNICEF) SSFA/2019/07. URL of the website available at: https://unicef.in/Karnataka.The funders did not play any role in the design, analysis and preparation of the manuscript.	[Anonymous], 2006, Prescrire Int, V15, P64; [Anonymous], 2016, J AM SOC ECHOCARDIOG, V29, pA19; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2015, 201516 DHS; [Anonymous], 2017, POLICY BRIEF; [Anonymous], 2017, INT J SCI REIJSR, V6, P513, DOI [10.21275/art20178761, DOI 10.21275/ART20178761]; Arokiasamy P, 2013, J BIOSOC SCI, V45, P167, DOI 10.1017/S0021932012000211; Auslander P, 2006, PAJ, P1; Bhargava M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156283; Bulbul T, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-86; Bundy DAP, 2018, LANCET, V391, P687, DOI 10.1016/S0140-6736(17)32417-0; Caleyachetty R, 2018, AM J CLIN NUTR, V108, P414, DOI 10.1093/ajcn/nqy105; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Corsi DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025120; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Department of Health and Human Services, CDC GROWTH CHARTS US; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Engidaw MT, 2019, CONFL HEALTH, V13, DOI 10.1186/s13031-019-0203-3; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fanzo J., 2019, 2018 GLOBAL NUTR REP; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Ghosh Ayan, 2015, J Family Med Prim Care, V4, P84, DOI 10.4103/2249-4863.152261; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; International Obesity Task Force, 1998, OB PREV MAN GLOB EP; Kapoor SK, 2002, J EPIDEMIOL COMMUN H, V56, P804, DOI 10.1136/jech.56.11.804; Khadilkar VV, 2007, INDIAN PEDIATR, V44, P187; Kumar V, 2016, NATL MED J INDIA, V29, P267; Laxmaiah A, 2007, OBESITY, V15, P1384, DOI 10.1038/oby.2007.165; Lukito Widjaja, 2006, Asia Pac J Clin Nutr, V15 Suppl, P21; Maehara M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221273; Mamidi RS, 2016, FOOD NUTR BULL, V37, P425, DOI 10.1177/0379572116647579; Mansur D I, 2015, Kathmandu Univ Med J (KUMJ), V13, P146; Melaku YA, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0093-9; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Office of Registrar General and Census Commissioner India, 2015, POP EN DAT FIN POP; Partap U, 2019, GLOB HEALTH EPIDEM G, V4, DOI 10.1017/gheg.2019.1; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Popkin BM, 2020, LANCET, V395, P65, DOI 10.1016/S0140-6736(19)32497-3; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Rah JH, 2009, PUBLIC HEALTH NUTR, V12, P2400, DOI 10.1017/S1368980009005345; Rohilla Ravi, 2014, J Family Med Prim Care, V3, P404, DOI 10.4103/2249-4863.148127; Sethi V, 2019, PUBLIC HEALTH NUTR, V22, P2189, DOI 10.1017/S1368980019000594; Shahabuddin A.K.M., 2000, Indian Journal of Pediatrics, V67, P93, DOI 10.1007/BF02726173; Soliman Ashraf, 2014, Indian J Endocrinol Metab, V18, pS39, DOI 10.4103/2230-8210.145073; Spears D, 2012, ECON HUM BIOL, V10, P210, DOI 10.1016/j.ehb.2011.08.005; Story M., 1992, TXB ADOLESCENT MED, P75; Suguitan Jr AL, 2011, PLOS ONE, V6; Tanner J M, 1987, Acta Paediatr Jpn, V29, P96; Tumilowicz A, 2019, ADV NUTR, V10, P563, DOI 10.1093/advances/nmy133; UNICEF, 2019, AD DEM UNICEF DATA; United Nations Department of Economic and Social Affairs, 2019, WORLD POP PROSP 2019; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO, 2009, WHO ANTHR PER COMP S; World Health Organization, 2001, 2 DEC IMPR AD HLTH D	58	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234570	10.1371/journal.pone.0234570	http://dx.doi.org/10.1371/journal.pone.0234570			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569312	Green Published, gold			2022-12-27	WOS:000543547900037
J	Ito, A; Wang, TS; Nakahara, R; Kawai, H; Nishitani, K; Aoyama, T; Kuroki, H				Ito, Akira; Wang, Tianshu; Nakahara, Ryo; Kawai, Hideki; Nishitani, Kohei; Aoyama, Tomoki; Kuroki, Hiroshi			Ultrasound therapy with optimal intensity facilitates peripheral nerve regeneration in rats through suppression of pro-inflammatory and nerve growth inhibitor gene expression	PLOS ONE			English	Article							SCIATIC-NERVE; PULSED ULTRASOUND; FUNCTIONAL RECOVERY; ELECTRICAL-STIMULATION; NEUROTROPHINS; NEURONS; CELLS; DIFFERENTIATION; PARAMETERS; GSK-3-BETA	Background Therapeutic ultrasound (US) is a promising physical therapy modality for peripheral nerve regeneration. However, it is necessary to identify the most effective US parameters and clarify the underlying mechanisms before its clinical application. The intensity of US is one of the most important parameters. However, the optimum intensity for the promotion of peripheral nerve regeneration has yet to be determined. Objectives To identify the optimum intensity of US necessary for the promotion of peripheral nerve regeneration after crush injuries in rats and to clarify the underlying mechanisms of US by mRNA expression analysis. Methods We inflicted sciatic nerve crush injuries on adult Lewis rats and performed ultrasound irradiation using 4 different US intensities: 0 (sham stimulation), 30, 140, and 250 mW/cm(2)with frequency (5 days/week) and duration (5 min/day). We evaluated peripheral nerve regeneration by quantitative real-time PCR one week after injury. Histomorphometric analyses and motor function analysis were evaluated 3 weeks after injury. Results US stimulation enhanced re-myelination as well as sprouting of axons, especially at an intensity of 140 mW/cm(2). mRNA expression revealed that US suppressed the expression of the inflammatory cytokines TNF and IL-6 and the axonal growth inhibitors SEMA3A and GSK3 beta. Conclusions An intensity of 140 mW/cm(2)was optimal to support regeneration of the sciatic nerve after a crush injury in rats by, in part, the suppression of pro-inflammatory and nerve growth inhibitor gene expression.	[Ito, Akira; Nakahara, Ryo; Kawai, Hideki; Kuroki, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Motor Funct Anal, Human Hlth Sci, Kyoto, Japan; [Wang, Tianshu; Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Dept Dev & Rehabil Motor Funct, Human Hlth Sci, Kyoto, Japan; [Nishitani, Kohei] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University	Kuroki, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Motor Funct Anal, Human Hlth Sci, Kyoto, Japan.	hiroshi.kuroki.6s@kyoto-u.ac.jp	Ito, Akira/AAA-4872-2021; Nishitani, Kohei/ABB-1788-2021	Ito, Akira/0000-0002-9645-9777; Nishitani, Kohei/0000-0002-8327-3826	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP19K19793, JP18H03129, JP18K19739]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/index.html) KAKENHI Grant, Number JP19K19793 to AI, and Number JP18H03129 and JP18K19739 to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhlaghi Zhamak, 2012, Iranian Biomedical Journal, V16, P107, DOI 10.6091/IBJ.942.2012; Altland OD, 2004, J THROMB HAEMOST, V2, P637, DOI 10.1111/j.1538-7836.2004.00655.x; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arslantunali D, 2014, MED DEVICES-EVID RES, V7, P405, DOI 10.2147/MDER.S59124; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Bosse F, 2012, CELL TISSUE RES, V349, P5, DOI 10.1007/s00441-012-1389-5; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Chen WZ, 2010, ULTRASOUND MED BIOL, V36, P1109, DOI 10.1016/j.ultrasmedbio.2010.04.014; Chung JI, 2012, OSTEOARTHR CARTILAGE, V20, P314, DOI 10.1016/j.joca.2012.01.005; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Crisci AR, 2002, ULTRASOUND MED BIOL, V28, P1335, DOI 10.1016/S0301-5629(02)00576-8; Daeschler SC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01057; Daeschler SC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21540-5; DINNO MA, 1989, ULTRASOUND MED BIOL, V15, P461, DOI 10.1016/0301-5629(89)90099-9; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; HONG CZ, 1988, ARCH PHYS MED REHAB, V69, P410; Huang JH, 2010, NEUROREHAB NEURAL RE, V24, P736, DOI 10.1177/1545968310368686; Ito A, 2019, NEURAL REGEN RES, V14, P2077, DOI 10.4103/1673-5374.262581; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jiang WL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22773; Kato K, 2010, J NEUROSCI RES, V88, P360, DOI 10.1002/jnr.22202; Khanna A, 2009, BRIT MED BULL, V89, P169, DOI 10.1093/bmb/ldn040; Kim JR, 2013, TISSUE ENG PT A, V19, P2674, DOI [10.1089/ten.tea.2012.0735, 10.1089/ten.TEA.2012.0735]; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Lv YG, 2015, BIOTECHNOL LETT, V37, P2497, DOI 10.1007/s10529-015-1939-5; Lv YG, 2013, BIOTECHNOL LETT, V35, P2201, DOI 10.1007/s10529-013-1313-4; MORTIMER AJ, 1988, ULTRASOUND MED BIOL, V14, P499, DOI 10.1016/0301-5629(88)90111-1; Mourad PD, 2001, NEUROSURGERY, V48, P1136, DOI 10.1097/00006123-200105000-00035; Munoz-Montano Juan Ramon, 1999, J Alzheimers Dis, V1, P361; Nadeau S, 2011, J NEUROSCI, V31, P12533, DOI 10.1523/JNEUROSCI.2840-11.2011; Nakayama T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19834-9; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Ni XJ, 2017, ULTRASOUND MED BIOL, V43, P461, DOI 10.1016/j.ultrasmedbio.2016.09.017; Omoto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047716; Raso VVM, 2005, J NEUROSCI METH, V142, P185, DOI 10.1016/j.jneumeth.2004.08.016; Ren C, 2010, BIOMED ENVIRON SCI, V23, P244, DOI 10.1016/S0895-3988(10)60059-1; SCHNEIDERSCHAULIES J, 1991, NEURON, V7, P995, DOI 10.1016/0896-6273(91)90344-Y; Syed YA, 2011, J NEUROSCI, V31, P3719, DOI 10.1523/JNEUROSCI.4930-10.2011; VENTIMIGLIA R, 1995, EUR J NEUROSCI, V7, P213, DOI 10.1111/j.1460-9568.1995.tb01057.x; Wang TS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208985; Watanabe Y, 2010, J ORTHOP TRAUMA, V24, pS56, DOI 10.1097/BOT.0b013e3181d2efaf; Willand MP, 2016, NEUROREHAB NEURAL RE, V30, P490, DOI 10.1177/1545968315604399; Yang M, 2011, J RECONSTR MICROSURG, V27, P451, DOI 10.1055/s-0031-1281526; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yurie H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171448; Zhang H, 2009, MICROSURG, V29, P479, DOI 10.1002/micr.20644	47	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234691	10.1371/journal.pone.0234691	http://dx.doi.org/10.1371/journal.pone.0234691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555658	gold, Green Published			2022-12-27	WOS:000542759600045
J	Song, LR; Lu, HC; Yin, JD				Song, Lirong; Lu, Hecheng; Yin, Jiandong			Preliminary study on discriminating HER2 2+amplification status of breast cancers based on texture features semi-automatically derived from pre-, post-contrast, and subtraction images of DCE-MRI	PLOS ONE			English	Article							MOLECULAR SUBTYPES; NEOADJUVANT CHEMOTHERAPY; TUMOR HETEROGENEITY; ENHANCED MRI; PREDICTION; RECEPTOR; WOMEN; CLASSIFICATION; EXPRESSION; RADIOMICS	Objective To investigate whether texture features extracted from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) are associated with human epidermal growth factor receptor type 2 (HER2) 2+ status of breast cancer. Materials and methods 92 MRI cases including 52 HER2 2+ positive and 40 negative patients confirmed by fluorescencein situhybridization were retrospectively selected. The lesion area was semi-automatically delineated, and a total of 488 texture features were respectively extracted from precontrast, postcontrast, and subtraction images. The Student'st-test or Mann-WhitneyUtest was performed to identify statistically significant features between different HER2 2+ amplification groups. Least absolute shrinkage and selection operator (LASSO) was used to search for the optimal feature subsets. Three machine learning classifiers, logistic regression analysis (LRA), quadratic discriminant analysis (QDA), and support vector machine (SVM), were used with a leave-one-out cross validation method to establish the classification models of HER2 2+ status. Classification performance was evaluated by receiver operating characteristic (ROC) analysis. Results Based on the texture analysis with SVM model, the areas under the ROC curve (AUCs) were 0.890 for subtraction images, 0.736 for postcontrast images, and 0.672 for precontrast images, respectively. For LRA model, the AUCs were 0.884, 0.733, and 0.623, respectively. For QDA model, the AUCs were 0.831, 0.726, and 0.568, respectively. LRA and the SVM model with subtraction images reached significantly better performance than the QDA model (P= 0.0227 andP= 0.0088, respectively). Conclusion Texture features of breast cancer extracted from DCE-MRI are associated with HER2 2+ status. Additional studies are necessary to confirm the present preliminary findings.	[Song, Lirong; Yin, Jiandong] China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Liaoning, Peoples R China; [Lu, Hecheng] Northeastern Univ, Coll Med & Biol Informat Engn, Shenyang, Liaoning, Peoples R China	China Medical University; Northeastern University - China	Yin, JD (corresponding author), China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Liaoning, Peoples R China.	jiandongyin@sina.com			Research and development (R&D) foundation for major Science and Technology from Shenyang [19-112-4105]; Big data foundation for health care from China Medical University [HMB201902105]; Natural Fund Guidance Plan [2019-ZD0743]	Research and development (R&D) foundation for major Science and Technology from Shenyang; Big data foundation for health care from China Medical University; Natural Fund Guidance Plan	this study is supported by Research and development (R&D) foundation for major Science and Technology from Shenyang (No. 19-112-4105), Big data foundation for health care from China Medical University (No. HMB201902105) and Natural Fund Guidance Plan (No. 2019-ZD0743).	Berg WA, 2012, JAMA-J AM MED ASSOC, V307, P1394, DOI 10.1001/jama.2012.388; Blaschke E, 2015, J MAGN RESON IMAGING, V42, P920, DOI 10.1002/jmri.24884; Braman N, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2561; Chamming's F, 2018, RADIOLOGY, V286, P412, DOI 10.1148/radiol.2017170143; Chang RF, 2016, MAGN RESON IMAGING, V34, P809, DOI 10.1016/j.mri.2016.03.001; Chaudhury B, 2015, J MAGN RESON IMAGING, V42, P1421, DOI 10.1002/jmri.24921; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; Fan M, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1199-8; Fan M, 2017, EUR J RADIOL, V94, P140, DOI 10.1016/j.ejrad.2017.06.019; Field A., 2013, DISCOVERING STAT USI; Fleeman N, 2011, HEALTH TECHNOL ASSES, V15, pXIII, DOI 10.3310/hta15330; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Grimm LJ, 2017, BREAST J, V23, P579, DOI 10.1111/tbj.12799; Hatt M, 2019, J NUCL MED, V60, p38S, DOI 10.2967/jnumed.118.220582; Herlidou-Meme S, 2003, MAGN RESON IMAGING, V21, P989, DOI 10.1016/S0730-725X(03)00212-1; Holli-Helenius K, 2017, BMC MED IMAGING, V17, DOI 10.1186/s12880-017-0239-z; Imbriaco M, 2018, RADIOLOGY, V286, P421, DOI 10.1148/radiol.2017172454; Jeong JH, 2017, CLIN COLORECTAL CANC, V16, pE147, DOI 10.1016/j.clcc.2017.01.005; Karahaliou A, 2010, BRIT J RADIOL, V83, P296, DOI 10.1259/bjr/50743919; Kim JH, 2017, RADIOLOGY, V282, P665, DOI 10.1148/radiol.2016160261; Kuhl CK, 2007, LANCET, V370, P485, DOI 10.1016/S0140-6736(07)61232-X; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Lehman Constance D., 2010, Journal of the National Cancer Institute Monographs, P150, DOI 10.1093/jncimonographs/lgq030; Li H, 2016, NPJ BREAST CANCER, V2, DOI 10.1038/npjbcancer.2016.12; Liu ZH, 2019, BREAST CANCER RES TR, V175, P51, DOI 10.1007/s10549-019-05148-5; Loibl S, 2017, LANCET, V389, P2415, DOI 10.1016/S0140-6736(16)32417-5; Ma W, 2018, CLIN RADIOL, V73, DOI 10.1016/j.crad.2018.05.027; Mao N, 2019, J COMPUT ASSIST TOMO, V43, P93, DOI 10.1097/RCT.0000000000000793; Nam KJ, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015871; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ozturk M, 2017, J BREAST HEALTH, V13, P27, DOI 10.5152/tjbh.2016.3247; Park JE, 2020, EUR RADIOL, V30, P523, DOI 10.1007/s00330-019-06360-z; Press MF, 2016, J CLIN ONCOL, V34, P3518, DOI 10.1200/JCO.2016.66.6693; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Sardanelli F, 2007, RADIOLOGY, V242, P698, DOI 10.1148/radiol.2423051965; Schick U, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20190105; Srivastava S, 2007, J MACH LEARN RES, V8, P1277; Sun XR, 2018, J COMPUT ASSIST TOMO, V42, P531, DOI 10.1097/RCT.0000000000000738; Sutton EJ, 2015, J MAGN RESON IMAGING, V42, P1398, DOI 10.1002/jmri.24890; Teruel JR, 2014, NMR BIOMED, V27, P887, DOI 10.1002/nbm.3132; Thibault G, 2017, TOMOGRAPHY, V3, P23, DOI 10.18383/j.tom.2016.00241; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; van der Velden BHM, 2019, EUR J RADIOL, V121, DOI 10.1016/j.ejrad.2019.108705; Wang LJ, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1537-9; Wong TT, 2015, PATTERN RECOGN, V48, P2839, DOI 10.1016/j.patcog.2015.03.009; Wu MX, 2019, EUR J RADIOL, V114, P175, DOI 10.1016/j.ejrad.2019.03.015; Yeh AC, 2019, CANCER IMAGING, V19, DOI 10.1186/s40644-019-0233-5; Yin JD, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0140-y; Yoon HH, 2012, CLIN CANCER RES, V18, P546, DOI 10.1158/1078-0432.CCR-11-2272; Yuan CR, 2019, J MED SYST, V43, DOI 10.1007/s10916-019-1197-5; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147	52	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234800	10.1371/journal.pone.0234800	http://dx.doi.org/10.1371/journal.pone.0234800			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555662	Green Published, gold			2022-12-27	WOS:000542759600018
J	Cella, A; De Luca, A; Squeri, V; Parodi, S; Vallone, F; Giorgeschi, A; Senesi, B; Zigoura, E; Guerrero, KLQ; Siri, G; De Michieli, L; Saglia, J; Sanfilippo, C; Pilotto, A				Cella, Alberto; De Luca, Alice; Squeri, Valentina; Parodi, Sara; Vallone, Francesco; Giorgeschi, Angela; Senesi, Barbara; Zigoura, Ekaterini; Quispe Guerrero, Katerin Leslie; Siri, Giacomo; De Michieli, Lorenzo; Saglia, Jody; Sanfilippo, Carlo; Pilotto, Alberto			Development and validation of a robotic multifactorial fall-risk predictive model: A one-year prospective study in community-dwelling older adults	PLOS ONE			English	Article							BALANCE; MORTALITY; MOBILITY; POSTUROGRAPHY; RELIABILITY; PREVENTION; PEOPLE; LIMITS; TOOLS; SPEED	Background Falls in the elderly are a major public health concern because of their high incidence, the involvement of many risk factors, the considerable post-fall morbidity and mortality, and the health-related and social costs. Given that many falls are preventable, the early identification of older adults at risk of falling is crucial in order to develop tailored interventions to prevent such falls. To date, however, the fall-risk assessment tools currently used in the elderly have not shown sufficiently high predictive validity to distinguish between subjects at high and low fall risk. Consequently, predicting the risk of falling remains an unsolved issue in geriatric medicine. This one-year prospective study aims to develop and validate, by means of a cross-validation method, a multifactorial fall-risk model based on clinical and robotic parameters in older adults. Methods Community-dwelling subjects aged >= 65 years were enrolled. At the baseline, all subjects were evaluated for history of falling and number of drugs taken daily, and their gait and balance were evaluated by means of the Timed "Up & Go" test (TUG), Gait Speed (GS), Short Physical Performance Battery (SPPB) and Performance-Oriented Mobility Assessment (POMA). They also underwent robotic assessment by means of thehunovarobotic device to evaluate the various components of balance. All subjects were followed up for one-year and the number of falls was recorded. The models that best predicted falls-on the basis of: i) only clinical parameters; ii) only robotic parameters; iii) clinical plus robotic parameters-were identified by means of a cross-validation method. Results Of the 100 subjects initially enrolled, 96 (62 females, mean age 77.17 +/-.49 years) completed the follow-up and were included. Within one year, 32 participants (33%) experienced at least one fall ("fallers"), while 64 (67%) did not ("non-fallers"). The best classifier model to emerge from cross-validated fall-risk estimation included eight clinical variables (age, sex, history of falling in the previous 12 months, TUG, Tinetti, SPPB, Low GS, number of drugs) and 20 robotic parameters, and displayed an area under the receiver operator characteristic (ROC) curve of 0.81 (95% CI: 0.72-0.90). Notably, the model that included only three of these clinical variables (age, history of falls and low GS) plus the robotic parameters showed similar accuracy (ROC AUC 0.80, 95% CI: 0.71-0.89). In comparison with the best classifier model that comprised only clinical parameters (ROC AUC: 0.67; 95% CI: 0.55-0.79), both models performed better in predicting fall risk, with an estimated Net Reclassification Improvement (NRI) of 0.30 and 0.31 (p = 0.02), respectively, and an estimated Integrated Discrimination Improvement (IDI) of 0.32 and 0.27 (p<0.001), respectively. The best model that comprised only robotic parameters (the 20 parameters identified in the final model) achieved a better performance than the clinical parameters alone, but worse than the combination of both clinical and robotic variables (ROC AUC: 0.73, 95% CI 0.63-0.83). Conclusion A multifactorial fall-risk assessment that includes clinical andhunovarobotic variables significantly improves the accuracy of predicting the risk of falling in community-dwelling older people. Our data suggest that combining clinical and robotic assessments can more accurately identify older people at high risk of falls, thereby enabling personalized fall-prevention interventions to be undertaken.	[Cella, Alberto; Vallone, Francesco; Giorgeschi, Angela; Senesi, Barbara; Zigoura, Ekaterini; Quispe Guerrero, Katerin Leslie; Siri, Giacomo; Pilotto, Alberto] EO Galliera Hosp, Dept Geriatr Care Orthogeriatr & Rehabil, Genoa, Italy; [De Luca, Alice; Squeri, Valentina; Parodi, Sara; Saglia, Jody; Sanfilippo, Carlo] Movendo Technol Srl, Genoa, Italy; [De Michieli, Lorenzo] IIT, Genoa, Italy; [Pilotto, Alberto] Univ Bari, Interdisciplinary Med, Bari, Italy	Ente Ospedaliero Ospedali Galliera; Istituto Italiano di Tecnologia - IIT; Universita degli Studi di Bari Aldo Moro	Pilotto, A (corresponding author), EO Galliera Hosp, Dept Geriatr Care Orthogeriatr & Rehabil, Genoa, Italy.; Pilotto, A (corresponding author), Univ Bari, Interdisciplinary Med, Bari, Italy.	alberto.pilotto@galliera.it	Parodi, Sara/AHE-2718-2022	Parodi, Sara/0000-0002-6265-0661; zigoura, ekaterini/0000-0001-5825-8520; Cella, Alberto/0000-0001-6234-6320; De Michieli, Lorenzo/0000-0001-7158-3002				Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Barla A, 2008, P ESANN 2008, P83; Bigelow KE, 2011, J GERONTOL A-BIOL, V66, P228, DOI 10.1093/gerona/glq202; Bohannon RW, 2006, PERCEPT MOTOR SKILL, V103, P215, DOI 10.2466/PMS.103.1.215-222; Buatois S, 2006, GERONTOLOGY, V52, P345, DOI 10.1159/000094983; Cella A, 2020, AGING CLIN EXP RES, V32, P491, DOI 10.1007/s40520-019-01395-0; Clark S, 1997, ARCH PHYS MED REHAB, V78, P1078, DOI 10.1016/S0003-9993(97)90131-3; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Drover D, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17061321; Fardin P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-474; Florence CS, 2018, J AM GERIATR SOC, V66, P693, DOI 10.1111/jgs.15304; Ghahramani M, 2019, MED BIOL ENG COMPUT, V57, P533, DOI 10.1007/s11517-018-1901-5; GIBSON MJ, 1987, DAN MED BULL, V34, P1; Greene BR, 2017, IEEE J BIOMED HEALTH, V21, P725, DOI 10.1109/JBHI.2016.2539098; Greene BR, 2012, GERONTOLOGY, V58, P472, DOI 10.1159/000337259; Grossman DC, 2018, JAMA-J AM MED ASSOC, V319, P1696, DOI 10.1001/jama.2018.3097; Guideline for the prevention of falls in older persons, 2001, J AM GERIATR SOC, V49, P664, DOI DOI 10.1046/J.1532-5415.2001.49115.X; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hartholt KA, 2019, JAMA-J AM MED ASSOC, V321, P2131, DOI 10.1001/jama.2019.4185; Hastie T., 2001, ELEMENTS STAT LEARNI, P193, DOI DOI 10.1007/978-0-387-21606-5_7; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Howcroft J, 2017, IEEE T NEUR SYS REH, V25, P1812, DOI 10.1109/TNSRE.2017.2687100; Howcroft J, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0255-9; Howcroft J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172398; Lafond D, 2004, ARCH PHYS MED REHAB, V85, P896, DOI 10.1016/j.apmr.2003.08.089; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; MAHONEY F I, 1965, Md State Med J, V14, P61; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Marchesi G, 2019, INT C REHAB ROBOT, P570, DOI 10.1109/ICORR.2019.8779387; Marschollek M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-48; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Nardone A, 2010, EUR J PHYS REHAB MED, V46, P221; Nardone A, 2007, CLIN NEUROPHYSIOL, V118, P538, DOI 10.1016/j.clinph.2006.11.012; Nguyen USDT, 2012, ARTHRIT CARE RES, V64, P1895, DOI 10.1002/acr.21783; Pahor M, 2019, JAMA-J AM MED ASSOC, V321, P2080, DOI 10.1001/jama.2019.6569; Paillard T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/891390; Palumbo P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146247; Park SH, 2018, AGING CLIN EXP RES, V30, P1, DOI 10.1007/s40520-017-0749-0; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Pickerill ML, 2011, J ATHL TRAINING, V46, P600; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Richards J., 2018, COMPREHENSIVE TXB CL; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Saglia JA, 2019, IEEE INT C REH ROB 2; Sibley KM, 2015, ARCH PHYS MED REHAB, V96, P122, DOI 10.1016/j.apmr.2014.06.021; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Sun RP, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0706-6; Tiedemann A, 2010, J GERONTOL A-BIOL, V65, P893, DOI 10.1093/gerona/glq067; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; World Health Organization, 2018, FACT SHEET FALLS; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhao P, 2006, J MACH LEARN RES, V7, P2541; ZWEIG MH, 1993, CLIN CHEM, V39, P561	56	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234904	10.1371/journal.pone.0234904	http://dx.doi.org/10.1371/journal.pone.0234904			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584912	gold, Green Published			2022-12-27	WOS:000545747200064
J	Deschepper, M; Waegeman, W; Vogelaers, D; Eeckloo, K; Orueta, JF				Deschepper, Mieke; Waegeman, Willem; Vogelaers, Dirk; Eeckloo, Kristof; Orueta, Juan F.			Using structured pathology data to predict hospital-wide mortality at admission	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; IMPROVE RISK-ADJUSTMENT; INPATIENT MORTALITY; ICD-9-CM; MODELS	Early prediction of in-hospital mortality can improve patient outcome. Current prediction models for in-hospital mortality focus mainly on specific pathologies. Structured pathology data is hospital-wide readily available and is primarily used for e.g. financing purposes. We aim to build a predictive model at admission using the International Classification of Diseases (ICD) codes as predictors and investigate the effect of the self-evident DNR ("Do Not Resuscitate") diagnosis codes and palliative care codes. We compare the models using ICD-10-CM codes with Risk of Mortality (RoM) and Charlson Comorbidity Index (CCI) as predictors using the Random Forests modeling approach. We use the Present on Admission flag to distinguish which diagnoses are present on admission. The study is performed in a single center (Ghent University Hospital) with the inclusion of 36 368 patients, all discharged in 2017. Our model at admission using ICD-10-CM codes (AUCROC = 0.9477) outperforms the model using RoM (AUCROC = 0.8797 and CCI (AUCROC = 0.7435). We confirmed that DNR and palliative care codes have a strong impact on the model resulting in a decrease of 7% for the ICD model (AUCROC = 0.8791) at admission. We therefore conclude that a model with a sufficient predictive performance can be derived from structured pathology data, and if real-time available, can serve as a prerequisite to develop a practical clinical decision support system for physicians.	[Deschepper, Mieke; Orueta, Juan F.] Ghent Univ Hosp, Strateg Policy Cell, Ghent, Belgium; [Waegeman, Willem] Univ Ghent, Dept Data Anal & Math Modelling, Ghent, Belgium; [Vogelaers, Dirk] Ghent Univ Hosp, Gen Internal Med, Ghent, Belgium; [Vogelaers, Dirk] Univ Ghent, Dept Internal Med, Ghent, Belgium; [Eeckloo, Kristof] Univ Ghent, Dept Publ Hlth & Primary Care, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University Hospital	Deschepper, M (corresponding author), Ghent Univ Hosp, Strateg Policy Cell, Ghent, Belgium.	Mieke.deschepper@uzgent.be		Deschepper, Mieke/0000-0001-6797-3147	Flemish Government under the "Onderzoeksprogramma Artificiele Intelligentie (AI) Vlaanderen" programme	Flemish Government under the "Onderzoeksprogramma Artificiele Intelligentie (AI) Vlaanderen" programme	For this work Willem Waegeman received funding from the Flemish Government under the "Onderzoeksprogramma Artificiele Intelligentie (AI) Vlaanderen" programme.	Allyn J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169772; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2018, IEEE T SYSTEMS MAN C, P1, DOI DOI 10.2861/86313; Awad A, 2017, INT J MED INFORM, V108, P185, DOI 10.1016/j.ijmedinf.2017.10.002; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clermont G, 2001, CRIT CARE MED, V29, P291, DOI 10.1097/00003246-200102000-00012; CMS, ICD 10 CM OFF GUID C; Couronne R, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2264-5; Deschepper M, 2019, COMPUT METH PROG BIO, V173, P177, DOI 10.1016/j.cmpb.2019.02.007; Kim S, 2011, HEALTHC INFORM RES, V17, P232, DOI 10.4258/hir.2011.17.4.232; Lau BT., 2008, INT J COMPUTING ICT, V2, P19; McCormick PJ, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-0936-3; Novack V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012184; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Pine M, 2009, MED DECIS MAKING, V29, P69, DOI 10.1177/0272989X08323297; Provost F, 2001, MACH LEARN, V42, P203, DOI 10.1023/A:1007601015854; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Sahni N, 2018, J GEN INTERN MED, V33, P921, DOI 10.1007/s11606-018-4316-y; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; Sakhnini A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007284; Schwartz N, 2018, INTERN EMERG MED, V13, P205, DOI 10.1007/s11739-017-1784-8; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Taylor RA, 2016, ACAD EMERG MED, V23, P269, DOI 10.1111/acem.12876; Toson B, 2015, J CLIN EPIDEMIOL, V68, P44, DOI 10.1016/j.jclinepi.2014.09.017; van der Hoek W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1472-6963-11-57	26	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235117	10.1371/journal.pone.0235117	http://dx.doi.org/10.1371/journal.pone.0235117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584872	gold, Green Published			2022-12-27	WOS:000545747200047
J	Hendrix, P; Sofoluke, N; Adams, M; Kunaprayoon, S; Zand, R; Kolinovsky, AN; Person, TN; Gupta, M; Goren, O; Kirchner, HL; Schirmer, CM; Rost, NS; Faber, JE; Griessenauer, CJ				Hendrix, Philipp; Sofoluke, Nelson; Adams, Matthew; Kunaprayoon, Saran; Zand, Ramin; Kolinovsky, Amy N.; Person, Thomas N.; Gupta, Mudit; Goren, Oded; Kirchner, H. Lester; Schirmer, Clemens M.; Rost, Natalia S.; Faber, James E.; Griessenauer, Christoph J.			Matrix Gla protein polymorphism rs1800801 associates with recurrence of ischemic stroke	PLOS ONE			English	Article							RISK SCORE; CALCIFICATION; PREDICT; ATTACK; TRIAL	The MGP single nucleotide polymorphism (SNP) rs1800801 has previously been associated with recurrent ischemic stroke in a Spanish cohort. Here, we tested for association of this SNP with ischemic stroke recurrence in a North American Caucasian cohort. Acute ischemic stroke patients admitted between 10/2009 and 12/2016 at three hospitals within a large healthcare system in the northeastern United States that were enrolled in a healthcare system-wide exome sequencing program were retrospectively reviewed. Patients with recurrent stroke within 1 year after index event were compared to those without recurrence. Of 9,348 suspected acute ischemic strokes admitted between 10/2009 and 12/2016, 1,727 (18.5%) enrolled in the exome-sequencing program. Among those, 1,068 patients had exome sequencing completed and were eligible for inclusion. Recurrent stroke within the first year of stroke was observed in 79 patients (7.4%). In multivariable analysis, stroke prior to the index stroke (OR 9.694, 95% CI 5.793-16.224, p <= 0.001), pro-coagulant status (OR = 3.563, 95% CI 1.504-8.443, p = 0.004) and the AA genotype of SNP rs1800801 (OR = 2.408, 95% CI 1.079-4.389, p = 0.004) were independently associated with recurrent stroke within the first year. The AA genotype of the MGP SNP rs1800801 is associated with recurrence within the first year after ischemic stroke in North American Caucasians. Study of stroke subtypes and additional populations will be required to determine if incorporation of allelic status at this SNP into current risk scores improves prediction of recurrent ischemic stroke.	[Hendrix, Philipp; Sofoluke, Nelson; Schirmer, Clemens M.; Griessenauer, Christoph J.] Geisinger, Dept Neurosurg, Danville, PA 17822 USA; [Hendrix, Philipp; Goren, Oded] Saarland Univ, Med Ctr, Dept Neurosurg, Homburg, Germany; [Hendrix, Philipp; Goren, Oded] Saarland Univ, Fac Med, Homburg, Germany; [Adams, Matthew; Kunaprayoon, Saran] Geisinger Commonwealth Sch Med, Scranton, PA USA; [Zand, Ramin] Geisinger, Dept Neurol, Danville, PA USA; [Kolinovsky, Amy N.; Person, Thomas N.; Gupta, Mudit] Geisinger Hlth Syst Phen Analyt & Clin Data Core, Danville, PA USA; [Kirchner, H. Lester] Geisinger Hlth Syst, Biomed & Translat Informat, Danville, PA USA; [Rost, Natalia S.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Faber, James E.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Griessenauer, Christoph J.] Paracelsus Med Univ, Res Inst Neurointervent, Salzburg, Austria	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Geisinger Health System; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill; Paracelsus Private Medical University	Griessenauer, CJ (corresponding author), Geisinger, Dept Neurosurg, Danville, PA 17822 USA.; Griessenauer, CJ (corresponding author), Paracelsus Med Univ, Res Inst Neurointervent, Salzburg, Austria.	christoph.griessenauer@gmail.com		Adams, Matthew/0000-0002-4311-5057; Zand, Ramin/0000-0002-9477-0094; Schirmer, Clemens/0000-0003-1743-8781	NINDS NIH HHS [R01 NS083633] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Achterberg S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119203; Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ataman O V, 2013, Tsitol Genet, V47, P33; Ay H, 2010, NEUROLOGY, V74, P128, DOI 10.1212/WNL.0b013e3181ca9cff; Bjorklund G, 2020, CURR MED CHEM, V27, P1647, DOI 10.2174/0929867325666180716104159; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Fernandez-Cadenas I, 2017, STROKE, V48, P1147, DOI 10.1161/STROKEAHA.116.014322; Fitzek S, 2011, CEREBROVASC DIS, V31, P400, DOI 10.1159/000323226; Garbuzova V Yu, 2015, Fiziol Zh, V61, P19; Giles MF, 2010, STROKE, V41, P667, DOI 10.1161/STROKEAHA.109.571174; Harbuzova V Iu, 2012, Fiziol Zh, V58, P14; Harbuzova V Iu, 2011, Fiziol Zh, V57, P16; Hendrix P, 2019, STROKE, V50, P1074, DOI 10.1161/STROKEAHA.118.023917; Herrmann SM, 2000, ARTERIOSCL THROM VAS, V20, P2386, DOI 10.1161/01.ATV.20.11.2386; Kernan WN, 2000, STROKE, V31, P456, DOI 10.1161/01.STR.31.2.456; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Schwartz MLB, 2018, AM J HUM GENET, V103, P328, DOI 10.1016/j.ajhg.2018.07.009; Sheng KX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09328-5; Spence JD, 2001, NEUROEPIDEMIOLOGY, V20, P16, DOI 10.1159/000054753; Thompson DD, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-58; van Wijk I, 2005, LANCET, V365, P2098, DOI 10.1016/S0140-6736(05)66734-7; Weimar C, 2008, J NEUROL NEUROSUR PS, V79, P1339, DOI 10.1136/jnnp.2008.146092	24	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235122	10.1371/journal.pone.0235122	http://dx.doi.org/10.1371/journal.pone.0235122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584873	Green Published, gold			2022-12-27	WOS:000545747200005
J	Reed, LI; Meyer, AK; Okun, SJ; Best, CK; Hooley, JM				Reed, Lawrence Ian; Meyer, Ashley K.; Okun, Sara J.; Best, Cheryl K.; Hooley, Jill M.			In smiles we trust? Smiling in the context of antisocial and borderline personality pathology	PLOS ONE			English	Article							COOPERATION; CHARACTERS	Research suggests that people behave more cooperatively towards those who smile and less cooperatively towards those with personality pathology. Here, we integrated these two lines of research to model the combined effects of smiles and personality pathology on trust. In two experiments, participants read vignettes portraying a person with either borderline personality disorder, antisocial personality disorder, or no personality pathology. These portrayals were paired with a brief video clip that showed a person with either a neutral expression or a smile. Participants then played a Trust game with the "person" presented using each vignette and video clip combination. In Experiment 1, rates of trust were lower in response to the borderline and antisocial personality disorder vignettes compared with the control vignette. Interestingly, the effect of smiles was dependent upon personality. Although participants were more trusting of smiling confederates portrayed as having borderline personality disorder or no pathology, they were less trusting of confederates portrayed as having antisocial personality disorder if they smiled. In Experiment 2, run with a second set of personality vignettes, rates of trust were lower in response to both personality disorder vignettes and higher in response to smiles with no significant interaction. Together, these results suggest that information regarding both the current emotional state as well as the personality traits of a partner are important for creating trust.	[Reed, Lawrence Ian; Okun, Sara J.] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Reed, Lawrence Ian] Harvard Med Sch, McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA; [Meyer, Ashley K.] Massachusetts Gen Hosp, Dept Psychiat, Depress Clin & Res Program DCRP, Boston, MA 02114 USA; [Best, Cheryl K.; Hooley, Jill M.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA	New York University; Harvard University; McLean Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Reed, LI (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	lr113@nyu.edu		Meyer, Ashley/0000-0001-6565-3510				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2011, NAT NEUROSCI, V14, P399, DOI 10.1038/nn0411-399; [Anonymous], 1988, MAURITIUS LAW REV, V1, P1; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Brown WM, 2002, SMILE ASYMMETRIES RE; Brulhart M, 2012, ECON LETT, V115, P20, DOI 10.1016/j.econlet.2011.11.039; Buhrmester M, 2011, AMAZONS MECH TURK NE; Cohn J. F., 2005, NEW HDB METHODS NONV, P9; Cox JC, 2004, GAME ECON BEHAV, V46, P260, DOI 10.1016/S0899-8256(03)00119-2; Ekman P., 2002, A HUMAN FACE, P77; Ekman P., 1978, FACIAL ACTION CODING; King-Casas B, 2008, SCIENCE, V321, P806, DOI 10.1126/science.1156902; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mehu M., 2007, J EVOLUT PSYCHOL, V5, P183, DOI [DOI 10.1556/JEP.2007.1011, 10.1556/JEP.2007.1011]; Mehu M, 2007, EVOL HUM BEHAV, V28, P415, DOI 10.1016/j.evolhumbehav.2007.05.010; Millon T, 2012, PERSONALITY DISORDER; Mokros A, 2008, J ABNORM PSYCHOL, V117, P406, DOI 10.1037/0021-843X.117.2.406; Oda R, 2009, HUM NATURE-INT BIOS, V20, P331, DOI 10.1007/s12110-009-9070-8; Race M, 2014, MENTAL ILLNESS WORK; Reed LI, 2019, PERS INDIV DIFFER, V140, P65, DOI 10.1016/j.paid.2018.05.035; Reed LI, 2018, EVOL PSYCHOL-US, V16, DOI 10.1177/1474704918814400; Reed LI, 2018, PERS INDIV DIFFER, V126, P33, DOI 10.1016/j.paid.2018.01.008; Reed LI, 2012, EVOL HUM BEHAV, V33, P200, DOI 10.1016/j.evolhumbehav.2011.09.003; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Scharlemann JPW, 2001, J ECON PSYCHOL, V22, P617, DOI 10.1016/S0167-4870(01)00059-9; Unoka Z, 2009, J PERS DISORD, V23, P399, DOI 10.1521/pedi.2009.23.4.399; 2003, DIABETES CARE S1, V1	27	0	0	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234574	10.1371/journal.pone.0234574	http://dx.doi.org/10.1371/journal.pone.0234574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584836	gold, Green Published			2022-12-27	WOS:000545747200091
J	Bravi, F; Flacco, ME; Carradori, T; Volta, CA; Cosenza, G; De Togni, A; Martellucci, CA; Parruti, G; Mantovani, L; Manzoli, L				Bravi, Francesca; Flacco, Maria Elena; Carradori, Tiziano; Volta, Carlo Alberto; Cosenza, Giuseppe; De Togni, Aldo; Acuti Martellucci, Cecilia; Parruti, Giustino; Mantovani, Lorenzo; Manzoli, Lamberto			Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens	PLOS ONE			English	Article							UP-REGULATION; ACE2; EXPRESSION	Aims This retrospective case-control study was aimed at identifying potential independent predictors of severe/lethal COVID-19, including the treatment with Angiotensin-Converting Enzyme inhibitors (ACEi) and/or Angiotensin II Receptor Blockers (ARBs). Methods and results All adults with SARS-CoV-2 infection in two Italian provinces were followed for a median of 24 days. ARBs and/or ACEi treatments, and hypertension, diabetes, cancer, COPD, renal and major cardiovascular diseases (CVD) were extracted from clinical charts and electronic health records, up to two years before infection. The sample consisted of 1603 subjects (mean age 58.0y; 47.3% males): 454 (28.3%) had severe symptoms, 192 (12.0%) very severe or lethal disease (154 deaths; mean age 79.3 years; 70.8% hypertensive, 42.2% with CVD). The youngest deceased person aged 44 years. Among hypertensive subjects (n = 543), the proportion of those treated with ARBs or ACEi were 88.4%, 78.7% and 80.6% among patients with mild, severe and very severe/lethal disease, respectively. At multivariate analysis, no association was observed between therapy and disease severity (Adjusted OR for very severe/lethal COVID-19: 0.87; 95% CI: 0.50-1.49). Significant predictors of severe disease were older age (with AORs largely increasing after 70 years of age), male gender (AOR: 1.76; 1.40-2.23), diabetes (AOR: 1.52; 1.05-2.18), CVD (AOR: 1.88; 1.32-2.70) and COPD (AOR: 1.88; 1.11-3.20). Only gender, age and diabetes also predicted very severe/lethal disease. Conclusion No association was found between COVID-19 severity and treatment with ARBs and/or ACEi, supporting the recommendation to continue medication for all patients unless otherwise advised by their physicians.	[Bravi, Francesca; Carradori, Tiziano; Volta, Carlo Alberto; Manzoli, Lamberto] St Anna Univ Hosp Ferrara, Ferrara, Italy; [Flacco, Maria Elena; Manzoli, Lamberto] Univ Ferrara, Dept Med Sci, Ferrara, Italy; [Volta, Carlo Alberto] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Cosenza, Giuseppe; De Togni, Aldo] Local Hlth Author Ferrara, Ferrara, Italy; [Acuti Martellucci, Cecilia] Univ Marche Reg, Dept Biomed Sci & Publ Hlth, Ancona, Italy; [Parruti, Giustino] Local Hlth Author Pescara, Cerveteri, Italy; [Mantovani, Lorenzo] Univ Milano Bicocca, Ctr Publ Hlth Res, Milan, Italy; [Mantovani, Lorenzo] IRCCS Multimed, Sesto San Giovanni, Italy	University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; University of Ferrara; University of Milano-Bicocca; IRCCS Multimedica	Manzoli, L (corresponding author), St Anna Univ Hosp Ferrara, Ferrara, Italy.; Manzoli, L (corresponding author), Univ Ferrara, Dept Med Sci, Ferrara, Italy.	lmanzoli@post.harvard.edu	Mantovani, Lorenzo Giovanni/AAC-4263-2021; Martellucci, Cecilia/GQI-2453-2022; Martellucci, Cecilia Acuti/AAW-5903-2020; Flacco, Maria Elena/E-3306-2017; Manzoli, Lamberto/K-1895-2018	Martellucci, Cecilia Acuti/0000-0002-4308-2144; Flacco, Maria Elena/0000-0003-1404-4314; Manzoli, Lamberto/0000-0002-8129-9344				American Hearth A, 2020, PAT TAK ACE I ARBS W; [Anonymous], 2020, COVID 19 COR OUTBR; Aronson JK, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1313; Bavishi C, 2020, JAMA CARDIOL, V5, P745, DOI 10.1001/jamacardio.2020.1282; Cascella M, 2020, STATPEARLS; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082; Esler M, 2020, J HYPERTENS, V38, P781, DOI 10.1097/HJH.0000000000002450; European Medicines A, 2020, EMA ADV CONT US MED; European Society of C, 2020, POS STAT ESC COUNC H; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Furuhashi M, 2015, AM J HYPERTENS, V28, P15, DOI 10.1093/ajh/hpu086; Gallagher PE, 2008, AM J PHYSIOL-CELL PH, V295, pC1169, DOI 10.1152/ajpcell.00145.2008; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hou YC1, 2009, AM J PHYSIOL-LUNG C, V296, pL288; Igase M, 2005, AM J PHYSIOL-HEART C, V289, pH1013, DOI 10.1152/ajpheart.00068.2005; Ishiyama Y, 2004, HYPERTENSION, V43, P970, DOI 10.1161/01.HYP.0000124667.34652.1a; Italian Institute of Statistics (ISTAT), 2020, ASP DAIL LIF HLTH ST; Jarcho JA, 2020, NEW ENGL J MED, V382, P2462, DOI 10.1056/NEJMe2012924; Jordan Rachel E, 2020, BMJ, V368, pm1198, DOI 10.1136/bmj.m1198; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuster GM, 2020, EUR HEART J, V41, P1857, DOI 10.1093/eurheartj/ehaa335; Kuster GM, 2020, EUR HEART J, V41, P1801, DOI 10.1093/eurheartj/ehaa235; Li JY, 2020, JAMA CARDIOL, V5, P825, DOI 10.1001/jamacardio.2020.1624; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Luque M, 1996, J HYPERTENS, V14, P799, DOI 10.1097/00004872-199606000-00017; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; Mehta N, 2020, JAMA CARDIOL, V5, P1020, DOI 10.1001/jamacardio.2020.1855; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Patel AB, 2020, JAMA-J AM MED ASSOC, V323, P1769, DOI 10.1001/jama.2020.4812; Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975; Sommerstein R, 2020, BMJ, V368, pm810, DOI [DOI 10.1016/S0140-6736(20)30185-9, 10.1136/bmj.m810]; Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760; Williamson E, 2020, MEDRXIV, V7, P1, DOI [10.1101/2020.05.06.20092999v1, 10.1101/2020.05.06.20092999]; World Health Organzation (WHO), 2020, LAB TESTING CORONAVI; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhang JJ, 2020, ALLERGY, V75, P1809, DOI 10.1111/all.14316; Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134; Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5; Zisman LS, 2003, CIRCULATION, V108, P1707, DOI 10.1161/01.CIR.0000094734.67990.99	43	55	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235248	10.1371/journal.pone.0235248	http://dx.doi.org/10.1371/journal.pone.0235248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579597	Green Published, gold, Green Submitted			2022-12-27	WOS:000545646600010
J	Joshi, SR; Jagtap, S; Basu, B; Deobagkar, DD; Ghosh, P				Joshi, Suraj R.; Jagtap, Surabhi; Basu, Bhakti; Deobagkar, Deepti D.; Ghosh, Payel			Construction, analysis and validation of co-expression network to understand stress adaptation inDeinococcus radioduransR1	PLOS ONE			English	Article							BACTERIUM DEINOCOCCUS-RADIODURANS; PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; RADIATION; RESISTANCE; PROTEINS; GENOME; FAMILY; ROLES; PHOSPHORYLATION	Systems biology based approaches have been effectively utilized to mine high throughput data. In the current study, we have performed system-level analysis forDeinococcus radioduransR1 by constructing a gene co-expression network based on several microarray datasets available in the public domain. This condition-independent network was constructed by Weighted Gene Co-expression Network Analysis (WGCNA) with 61 microarray samples from 9 different experimental conditions. We identified 13 co-expressed modules, of which, 11 showed functional enrichments of one or more pathway/s or biological process. Comparative analysis of differentially expressed genes and proteins from radiation and desiccation stress studies with our co-expressed modules revealed the association of cyan with radiation response. Interestingly, two modules viz darkgreen and tan was associated with radiation as well as desiccation stress responses. The functional analysis of these modules showed enrichment of pathways important for adaptation of radiation or desiccation stress. To decipher the regulatory roles of these stress responsive modules, we identified transcription factors (TFs) and then calculated a Biweight mid correlation between modules hub gene and the identified TFs. We obtained 7 TFs for radiation and desiccation responsive modules. The expressions of 3 TFs were validated in response to gamma radiation using qRT-PCR. Along with the TFs, selected close neighbor genes of two important TFs, viz., DR_0997 (CRP) and DR_2287 (AsnC family transcriptional regulator) in the darkgreen module were also validated. In our network, among 13 hub genes associated with 13 modules, the functionality of 5 hub genes which are annotated as hypothetical proteins (hypothetical hub genes) inD.radioduransgenome has been revealed. Overall the study provided a better insight of pathways and regulators associated with relevant DNA damaging stress response inD.radiodurans.	[Joshi, Suraj R.; Jagtap, Surabhi; Ghosh, Payel] Savitribai Phule Pune Univ, Bioinformat Ctr, Pune, Maharashtra, India; [Joshi, Suraj R.; Deobagkar, Deepti D.] Savitribai Phule Pune Univ, Dept Zool, Mol Biol Res Lab, Pune, Maharashtra, India; [Joshi, Suraj R.; Basu, Bhakti] Bhabha Atom Res Ctr, Div Mol Biol, Mumbai, Maharashtra, India; [Deobagkar, Deepti D.] Savitribai Phule Pune Univ, ISRO Space Technol Cell, Pune, Maharashtra, India	Savitribai Phule Pune University; Savitribai Phule Pune University; Bhabha Atomic Research Center (BARC); Savitribai Phule Pune University	Ghosh, P (corresponding author), Savitribai Phule Pune Univ, Bioinformat Ctr, Pune, Maharashtra, India.	pghosh@unipune.ac.in	Joshi, Suraj/AAI-7094-2021	Joshi, Suraj/0000-0002-6843-7167	SPPU-BARC collaborative PhD Programme	SPPU-BARC collaborative PhD Programme	SRJ thanks SPPU-BARC collaborative PhD Programme for financial support. All authors thank Dept. of Zoology and Bioinformatics centre, SPPU Pune and MBD, BARC for providing all the resources. DDD and SRJ thank Ministry of Earth Sciences (MOES) and DST-Purse for consumables.	[Anonymous], 2014, J HEADACHE PAIN, V15, P3; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2005, CANC BIOL THERAPY, V4, pv; [Anonymous], 2019, DTBI S, V1, P1, DOI DOI 10.36811/RJCSE.2019.110001; [Anonymous], 2008, IEEE J OCEANIC ENG, V33, P133; [Anonymous], 2013, FOCUS CATAL, V6, P2, DOI [10.1016/S1351-4180(13)70179-X, DOI 10.1016/S1351-4180(13)70179-X]; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Basu B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011734; Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Beiki H, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3176-2; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Chang XA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012126; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Das AD, 2011, MICROBIOL-SGM, V157, P2196, DOI 10.1099/mic.0.040436-0; Deng WY, 2011, J CELL BIOCHEM, V112, P2655, DOI 10.1002/jcb.23193; Desai SS, 2011, MICROBIOL-SGM, V157, P2974, DOI 10.1099/mic.0.049361-0; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fisher David I., 2004, BMC Biochemistry, V5, P7, DOI 10.1186/1471-2091-5-7; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harris DR, 2008, J BACTERIOL, V190, P6475, DOI 10.1128/JB.01165-07; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Hosseinkhan N, 2018, GENE, V639, P1, DOI 10.1016/j.gene.2017.10.005; Hua XT, 2011, SCI CHINA LIFE SCI, V54, P854, DOI 10.1007/s11427-011-4209-3; Iancu OD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-585; Im Seong Hun, 2012, SHER NEW ORL US 34 S; Im S, 2013, RES MICROBIOL, V164, P923, DOI 10.1016/j.resmic.2013.07.005; Jaffe EK, 2003, CHEM BIOL, V10, P25, DOI 10.1016/S1074-5521(02)00296-X; Jiang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28422; Joe MH, 2011, J MICROBIOL BIOTECHN, V21, P438, DOI 10.4014/jmb.1012.12021; Joelsson A, 2007, APPL ENVIRON MICROB, V73, P3742, DOI 10.1128/AEM.02804-06; Krisko A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012765; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Levican G, 2007, P NATL ACAD SCI USA, V104, P3135, DOI 10.1073/pnas.0611611104; Lin L, 2016, MOL MICROBIOL, V100, P527, DOI 10.1111/mmi.13331; Liu W, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7030019; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Loraine AE, 2015, METHODS MOL BIOL, V1284, P481, DOI 10.1007/978-1-4939-2444-8_24; Mahler N, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006402; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Maurya GK, 2019, MICROBIOL RES, V223, P22, DOI 10.1016/j.micres.2019.03.005; Maurya GK, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00325-18; Mumford JA, 2010, NEUROIMAGE, V52, P1465, DOI 10.1016/j.neuroimage.2010.05.047; Nilsson EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011637; Obiero J, 2010, J BACTERIOL, V192, P494, DOI 10.1128/JB.01046-09; Ortet P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-628; Rajpurohit YS, 2016, J BIOL CHEM, V291, P16672, DOI 10.1074/jbc.M116.736389; Rajpurohit YS, 2013, INT J BIOCHEM CELL B, V45, P2541, DOI 10.1016/j.biocel.2013.08.011; Rajpurohit YS, 2013, J BASIC MICROB, V53, P518, DOI 10.1002/jobm.201100650; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Tang HM, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00088; The Lancet Global Health, 2016, LANCET GLOB HEALTH, V4, pe427; Timmins J, 2016, COMPUT STRUCT BIOTEC, V14, P168, DOI 10.1016/j.csbj.2016.04.001; Ujaoney AK, 2017, BBA-PROTEINS PROTEOM, V1865, P1215, DOI 10.1016/j.bbapap.2017.06.014; van Dam S, 2018, BRIEF BIOINFORM, V19, P575, DOI 10.1093/bib/bbw139; Wang H, 2012, MICROBIOL-SGM, V158, P936, DOI 10.1099/mic.0.053702-0; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Yang S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155010; Ye ZM, 2019, WORLD J SURG ONCOL, V17, DOI 10.1186/s12957-019-1605-9; Zhang HY, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2073-c1; Zinkgraf M, 2017, NEW PHYTOL, V214, P1464, DOI 10.1111/nph.14492; Zou XY, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020119	68	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234721	10.1371/journal.pone.0234721	http://dx.doi.org/10.1371/journal.pone.0234721			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579573	Green Published, gold			2022-12-27	WOS:000545646600024
J	Sarkes, A; Fu, HT; Feindel, D; Harding, M; Feng, J				Sarkes, Alian; Fu, Heting; Feindel, David; Harding, Michael; Feng, Jie			Development and evaluation of a loop-mediated isothermal amplification (LAMP) assay for the detection ofTomato brown rugose fruit virus(ToBRFV)	PLOS ONE			English	Article							RUGOSE FRUIT VIRUS; TOMATO	Tomato brown rugose fruit virus(ToBRFV) is a member ofTobamovirusinfecting tomato and pepper. Within North America, both the United States and Mexico consider ToBRFV to be a regulated pest. In Canada, the presence of ToBRFV has been reported, but an efficient diagnostic system has not yet been established. Here, we describe the development and assessment of a loop-mediated isothermal amplification (LAMP)-based assay to detect ToBRFV. The LAMP test was efficient and robust, and results could be obtained within 35 min with an available RNA sample. Amplification was possible when either water bath or oven were used to maintain the temperature at isothermal conditions (65 degrees C), and results could be read by visual observation of colour change. Detection limit of the LAMP was eight target RNA molecules. Under the experimental conditions tested, LAMP was as sensitive as qPCR and 100 times more sensitive than the currently used RT-PCR. We recommend this sensitive, efficient LAMP protocol to be used for routine lab testing of ToBRFV.	[Sarkes, Alian; Fu, Heting; Feindel, David; Feng, Jie] Alberta Agr & Forestry, Alberta Plant Hlth Lab, Crop Div Ctr North, Edmonton, AB, Canada; [Harding, Michael] Alberta Agr & Forestry, Crop Diversificat Ctr South, Brooks, AB, Canada		Feng, J (corresponding author), Alberta Agr & Forestry, Alberta Plant Hlth Lab, Crop Div Ctr North, Edmonton, AB, Canada.; Harding, M (corresponding author), Alberta Agr & Forestry, Crop Diversificat Ctr South, Brooks, AB, Canada.	michael.harding@gov.ab.ca; jie.feng@gov.ab.ca			Canadian Agricultural Partnership [601322]	Canadian Agricultural Partnership	This study was supported by a grant from the Canadian Agricultural Partnership (no. 601322) to JF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAFC, 2017, CROP PROF GREENH TOM; Alkowni R, 2019, J PLANT PATHOL, V101, P719, DOI 10.1007/s42161-019-00240-7; Baswaraj Raigond, 2019, Indian Phytopathology, V72, P321, DOI 10.1007/s42360-019-00147-4; Davidson K, 2019, TOMATO BROWN RUGOSE; Fidan H., 2019, New Disease Reports, V39, DOI 10.5197/j.2044-0588.2019.039.018; Foolad MR, 2012, CRIT REV PLANT SCI, V31, P93, DOI 10.1080/07352689.2011.616057; Forootan Amin, 2017, Biomol Detect Quantif, V12, P1, DOI 10.1016/j.bdq.2017.04.001; Hanssen IM, 2010, MOL PLANT MICROBE IN, V23, P539, DOI 10.1094/MPMI-23-5-0539; Kogovsek P, 2017, EUR J PLANT PATHOL, V148, P75, DOI 10.1007/s10658-016-1070-z; Ling KS, 2019, PLANT DIS, V103, P1439, DOI 10.1094/PDIS-11-18-1959-PDN; Liu H, 2019, J VIROL METHODS, V270, P150, DOI 10.1016/j.jviromet.2019.05.009; Luria N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170429; Cambrón-Crisantos José Manuel, 2019, Rev. mex. fitopatol, V37, P185, DOI [10.18781/R.MEX.FIT.1810-5, 10.18781/r.mex.fit.1810-5]; Menzel W., 2019, New Disease Reports, V39, DOI 10.5197/j.2044-0588.2019.039.001; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Okiro LA, 2019, PLANT DIS, V103, P959, DOI 10.1094/PDIS-03-18-0489-RE; Oladokun JO, 2019, PLANT PATHOL, V68, P1579, DOI 10.1111/ppa.13096; Panno S, 2019, PLANT DIS, V103, P1443, DOI 10.1094/PDIS-12-18-2254-PDN; Panno S, 2019, PEERJ, V7, DOI 10.7717/peerj.7928; Puente M, 2019, COMMUNICATION   1030; Raigond B, 2019, POTATO RES, P1; Romero JL, 2019, ARCH VIROL, V164, P1453, DOI 10.1007/s00705-019-04207-y; Salem N, 2016, ARCH VIROL, V161, P503, DOI 10.1007/s00705-015-2677-7; Spadoro J., 1998, GENE QUANTIFICATION, P31; Tahzima R, 2019, J VIROL METHODS, V265, P91, DOI 10.1016/j.jviromet.2018.12.019; Tiberini A, 2019, J VIROL METHODS, V271, DOI 10.1016/j.jviromet.2019.113680; USDA, 2019, FED ORD US IMP TOM S; Wang KL, 2019, CROP PROT, V119, P38, DOI 10.1016/j.cropro.2018.11.024; Yan HW, 2019, PEERJ, V7, DOI 10.7717/peerj.7766; Zhang L, 2019, PLANT DIS, V103, P12, DOI 10.1094/PDIS-01-18-0093-RE; Zwart MP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002122	31	18	19	7	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0230403	10.1371/journal.pone.0230403	http://dx.doi.org/10.1371/journal.pone.0230403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579552	Green Published, Green Submitted, gold			2022-12-27	WOS:000545646600025
J	Zheng, YL; Zhang, LP; Zhu, XX; Guo, G				Zheng, Yanling; Zhang, Liping; Zhu, XiXun; Guo, Gang			A comparative study of two methods to predict the incidence of hepatitis B in Guangxi, China	PLOS ONE			English	Article							CRASH FREQUENCY; NEURAL-NETWORK; DISEASE; MODEL; POPULATION	In recent years, the incidence of hepatitis B (HB) in Guangxi is higher than that of the national level; it has been increasing, so it is urgent to do a good predictive research of HB incidence, which can help analyze the early warning of hepatitis B in Guangxi, China. In the study, the feasibility of predicting HB incidence in Guangxi by autoregressive integrated moving average (ARIMA) model method and Elman neural network (ElmanNN) method was discussed respectively, and the prediction accuracy of the two models was compared. Finally, we established the ARIMA (0, 1, 1) model and ElmanNN with 8 neurons. Both ARIMA (0, 1, 1) model and ElmanNN model had good performance, and their prediction accuracy were high. The fitting and prediction root-mean-square error (RMSE) and mean absolute error (MAE) of ElmanNN were smaller than those of ARIMA (0, 1, 1) model, which indicated that ElmanNN was superior to ARIMA (0, 1, 1) model in predicting the incidence of hepatitis B in Guangxi. Based on the ElmanNN, the HB incidence from September 2019 to December 2020 in Guangxi was predicted, the predicted results showed that the incidence of HB in 2020 was slightly higher than that in 2019 and the change trend was similar to that in 2019, for 2021 and beyond, the ElmanNN model could be used to continue the predictive analysis.	[Zheng, Yanling; Zhang, Liping] Xinjiang Med Univ, Coll Med Engn & Technol, Urumqi, Peoples R China; [Zhu, XiXun] Jingchu Univ Technol, Sch Comp Engn, Jingmen, Peoples R China; [Guo, Gang] Xinjiang Med Univ, State Key Lab Pathogenesis Prevent & Treatment Hi, Clin Med Inst, Affiliated Hosp 1, Urumqi, Peoples R China	Xinjiang Medical University; Jingchu University of Technology; Xinjiang Medical University	Zheng, YL (corresponding author), Xinjiang Med Univ, Coll Med Engn & Technol, Urumqi, Peoples R China.; Guo, G (corresponding author), Xinjiang Med Univ, State Key Lab Pathogenesis Prevent & Treatment Hi, Clin Med Inst, Affiliated Hosp 1, Urumqi, Peoples R China.	zhengyl_math@sina.cn; zhub168_math@sina.com			Natural science funding of Xinjiang Uygur Autonomous Region [2017D01C189]	Natural science funding of Xinjiang Uygur Autonomous Region	This work was supported by the Natural science funding of Xinjiang Uygur Autonomous Region (2017D01C189), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhasawneh MS, 2019, ARAB J SCI ENG, V44, P9209, DOI 10.1007/s13369-019-03829-3; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; [Anonymous], 2020, LANCET INFECT DIS, V20, P192, DOI [10.1016/S1473-3099(20)30483-7, DOI 10.1016/S1473-3099(20)30483-7, DOI 10.1056/NEJMoa2021756]; [Anonymous], 2018, J AMBIENT INTELLIGEN; [Anonymous], 2019, IMMUNE NETW, V19, pe34; Berecibar M, 2019, NATURE, V568, P325, DOI 10.1038/d41586-019-01138-1; Brittin J, 2015, J SIMUL, V9, P140, DOI 10.1057/jos.2014.16; Chunli Wang, 2017, INT J ENV RES PUB HE, V14, P559; Dusheiko G, 2018, LANCET GASTROENTEROL, V3, P372, DOI 10.1016/S2468-1253(18)30093-1; Haapamaki J, 2009, QUAL LIFE RES, V18, P961, DOI 10.1007/s11136-009-9514-y; Hasan A., 2017, COMP ANAL BAYESIAN N; Heathfield L, 2013, EUR J HUM GENET, V21, P1173, DOI 10.1038/ejhg.2013.92; Kelo S, 2012, INT J ELEC POWER, V43, P1063, DOI 10.1016/j.ijepes.2012.06.009; Khakban A, 2017, AM J RESP CRIT CARE, V195, P287, DOI 10.1164/rccm.201606-1162PP; Kneifel J, 2016, APPL ENERG, V178, P468, DOI 10.1016/j.apenergy.2016.06.013; Kulkarni GE, 2018, MODEL EARTH SYST ENV, V4, P1435, DOI 10.1007/s40808-018-0493-2; Lelieveld J, 2019, EUR HEART J, V40, P1590, DOI 10.1093/eurheartj/ehz135; Li Q, 2014, APPL MECH MATER, V505-506, P1023, DOI 10.4028/www.scientific.net/AMM.505-506.1023; Lin W, 2018, MATH PROBLEMS ENG 2, V2018, P90138391; Ling Song SH, 2013, SYST BIOMED, V1, P261; Liu H, 2015, APPL ENERG, V157, P183, DOI 10.1016/j.apenergy.2015.08.014; Mohd Danish Khan Hong Ha Thi Vu, 2019, INT J ENV RES PUB HE, V16, P2799; Orva N L V, 2018, J PHYS C SERIES, P1025; Razavi-Shearer D, 2018, LANCET GASTROENTEROL, V3, P383, DOI 10.1016/S2468-1253(18)30056-6; Silva JD, 2018, PROCESS BIOCHEM, V74, P61, DOI 10.1016/j.procbio.2018.07.010; Simoes EAF, 2003, J PEDIATR-US, V143, pS118, DOI 10.1067/S0022-3476(03)00511-0; Tomaskova H, 2016, NEUROPSYCH DIS TREAT, V12, P1589, DOI 10.2147/NDT.S107969; Wang J, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/6138251; WHO, 2017, GLOB HEP REP; Yang XB, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011787; Yazdani Charati Jamshid, 2018, Gastroenterol Hepatol Bed Bench, V11, P110; Zeng Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082768; Zeng Q, 2016, ACCIDENT ANAL PREV, V97, P87, DOI 10.1016/j.aap.2016.08.017; Zeng Q, 2016, ANAL METHODS ACCID R, V10, P12, DOI 10.1016/j.amar.2016.03.002; Zheng RS, 2018, CHINESE J CANCER RES, V30, P571, DOI 10.21147/j.issn.1000-9604.2018.06.01; Zuin M, 2017, EUR J CLIN MICROBIOL, V36, P479, DOI 10.1007/s10096-016-2821-7; 2019, J CROHNS COLITIS S1, V13; 2018, WORLDS LATEST MED IN, V18, P39	41	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234660	10.1371/journal.pone.0234660	http://dx.doi.org/10.1371/journal.pone.0234660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579598	Green Published, gold			2022-12-27	WOS:000545646600063
J	Li, JL; Chattopadhyay, K; Xu, M; Chen, YS; Hu, FF; Chu, JP; Li, L				Li, Jialin; Chattopadhyay, Kaushik; Xu, Miao; Chen, Yanshu; Hu, Fangfang; Chu, Jianping; Li, Li			Prevalence and associated factors of vascular complications among inpatients with type 2 diabetes: A retrospective database study at a tertiary care department, Ningbo, China	PLOS ONE			English	Article							MICROVASCULAR COMPLICATIONS; CARDIOVASCULAR EVENTS; GLYCEMIC CONTROL; RISK-FACTORS; MELLITUS; MORTALITY; DIAGNOSIS; HEALTH; IMPACT; PREDICTOR	To determine the prevalence of vascular complications among inpatients with type 2 diabetes mellitus (T2DM) and factors independently associated with vascular complications in a tertiary care department in Ningbo, China, the authors conducted a cross-sectional study using an existing computerised medical records database. A total of 3370 adult patients with T2DM were admitted to this tertiary care department for the first time between 2012 and 2017. Patients were categorised as those (1) with at least one vascular complication, (2) with at least one microvascular complication, and (3) with at least one macrovascular complication. Over 5 years, the prevalence of vascular, microvascular, and macrovascular complications among inpatients with T2DM was 73.2%, 57.5%, and 51.4%, respectively. The odds of vascular, microvascular, and macrovascular complications increased with age and were higher in patients with hypertension. The odds of vascular and microvascular complications were higher in single, divorced, or widowed patients, patients with T2DM for a long time, and patients on advanced T2DM therapeutic regimen. The odds of vascular and macrovascular complications were lower in women. The odds of microvascular complications decreased with education. The odds of macrovascular complications were higher in smokers. In conclusion, in the tertiary care department, more than half of inpatients with T2DM had vascular complications, and factors independently associated with vascular complications were identified. The study findings could be used in future interventional studies to prevent and manage vascular complications among these patients.	[Li, Jialin; Xu, Miao; Chen, Yanshu; Hu, Fangfang; Chu, Jianping; Li, Li] Ningbo First Hosp, Dept Endocrinol & Metab, Ningbo, Peoples R China; [Chattopadhyay, Kaushik] Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Nottingham, England	University of Nottingham	Li, L (corresponding author), Ningbo First Hosp, Dept Endocrinol & Metab, Ningbo, Peoples R China.	lilyningbo@163.com	Li, Jialin/B-3046-2018; li, jia/GVT-7587-2022	Li, Jialin/0000-0001-6930-9530; 				Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Agrawal R P, 2014, J Assoc Physicians India, V62, P504; Ankush, 2016, J CLIN DIAGN RES, V10, pOC15, DOI 10.7860/JCDR/2016/15268.7583; [Anonymous], 1995, Diabetes, V44, P1249; [Anonymous], 1985, Diabetologia, V28 Suppl, P615; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2011, CHIN J HYPERTENS; [Anonymous], 2001, OFF J EUR COMMUNITIE, V44, pL307; Blomster JI, 2017, DIABETES RES CLIN PR, V127, P212, DOI 10.1016/j.diabres.2017.03.015; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Cai L, 2016, DIABETES RES CLIN PR, V121, P9, DOI 10.1016/j.diabres.2016.07.032; Cavalot F, 2011, DIABETES CARE, V34, P2237, DOI 10.2337/dc10-2414; Cerebral vascular disease group of neurology branch of Chinese Medical Association, 2015, CHIN J NEUROL, V48, P246, DOI DOI 10.3760/cma.j.issn.1006-7876.2015.04.002; China International Exchange and Promotive Association for Medical and Health Care Diabetic Foot Association, 2017, NATL MED J CHINA, V97, P251; Chinese Diabetes Society, 2014, CHIN J ENDOCRINOL ME, V30, P893; Chinese Society of Endocrinology, 2016, CHIN J DIABETES, V32, P623, DOI 10.3760/cma.j.issn. 1000-6699.2016.08.001; Clarke PM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000236; Davis TME, 1997, DIABETES CARE, V20, P1435, DOI 10.2337/diacare.20.9.1435; Dong YH, 2017, DIABETES VASC DIS RE, V14, P24, DOI 10.1177/1479164116675489; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gedebjerg A, 2018, J DIABETES COMPLICAT, V32, P34, DOI 10.1016/j.jdiacomp.2017.09.010; Health and Family Planning Commission of Ningbo Municipality, PREV TREATM CHRON DI; Huang YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159297; International Diabetes Federation, 2019, IDF DIABETES ATLAS, V9th; Ji LN, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.02.035; Kamuhabwa AR, 2014, DRUG HEALTHC PATIENT, V6, P155, DOI 10.2147/DHPS.S68786; Khalil SA, 2019, CURR DIABETES REV, V15, P74, DOI 10.2174/1573399814666180125100917; Li JL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019697; Liu ZL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-62; Margolis R, 2013, J HEALTH SOC BEHAV, V54, P353, DOI 10.1177/0022146513489312; Maric-Bilkan C, 2017, CLIN SCI, V131, P833, DOI 10.1042/CS20160998; Ministry of Health of the People's Republic of China, 2010, DIAGN CRIT COR ATH; Ministry of Health of the People's Republic of China, 1989, MEAS ADM HOSP GRAD; Morgan CL, 2000, DIABETIC MED, V17, P146, DOI 10.1046/j.1464-5491.2000.00222.x; Ningbo Municipal Human Resources and Social Security Bureau, CAT DRUGS BAS MED IN; Pan A, 2015, CIRCULATION, V132, P1795, DOI 10.1161/CIRCULATIONAHA.115.017926; Pan S, 2017, PSYCHIAT RES, V258, P177, DOI 10.1016/j.psychres.2017.07.050; Parajuli Janaki, 2014, BMC Res Notes, V7, P758, DOI 10.1186/1756-0500-7-758; Phillips P, 1998, INT J EPIDEMIOL, V27, P853, DOI 10.1093/ije/27.5.853; Pradeepa R, 2010, DIABETES TECHNOL THE, V12, P755, DOI 10.1089/dia.2010.0069; Pratley RE, 2013, AM J MED, V126, pS2, DOI 10.1016/j.amjmed.2013.06.007; Rawshani A, 2016, JAMA INTERN MED, V176, P1146, DOI 10.1001/jamainternmed.2016.2940; Ross SA, 2013, AM J MED, V126, pS38, DOI 10.1016/j.amjmed.2013.06.012; Santos AD, 2015, CIENC SAUDE COLETIVA, V20, P761, DOI 10.1590/1413-81232015203.12182014; Sharma Niharikaa, 2015, Indian J Endocrinol Metab, V19, P775, DOI 10.4103/2230-8210.167552; Shiraiwa T, 2005, DIABETES CARE, V28, P2806, DOI 10.2337/diacare.28.11.2806; Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18; Sosale Aravind, 2014, Indian J Endocrinol Metab, V18, P355, DOI 10.4103/2230-8210.131184; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; The National People's Congress of the People's Republic of China, REG PEOPL REP CHIN R; The Public Health Service Platform of Ningbo, NINGB 1 HOSP; Tracey ML, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5975903; Wandell PE, 2004, DIABETES RES CLIN PR, V63, P195, DOI 10.1016/j.diabres.2003.08.011; Wang WB, 2009, VALUE HEALTH, V12, P923, DOI 10.1111/j.1524-4733.2009.00561.x; World Health Organization, RAT DIAB CHIN EXPL; [向红丁 Xiang Hongding], 2003, [中国糖尿病杂志, Chinese Journal of Diabetes], V11, P232; Yamazaki D, 2018, HYPERTENS RES, V41, P147, DOI 10.1038/s41440-017-0008-y; Yao DZ., 2016, MOD PRACT MED, V28, P1343; Zhu P, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0903-2; Zoungas S, 2014, DIABETOLOGIA, V57, P2465, DOI 10.1007/s00125-014-3369-7	61	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235161	10.1371/journal.pone.0235161	http://dx.doi.org/10.1371/journal.pone.0235161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574208	Green Published, gold			2022-12-27	WOS:000544972400001
J	Salian, SR; Uppangala, S; Cheredath, A; D'Souza, F; Kalthur, G; Nayak, VC; Anderson, RA; Adiga, SK				Salian, Sujith Raj; Uppangala, Shubhashree; Cheredath, Aswathi; D'Souza, Fiona; Kalthur, Guruprasad; Nayak, Vinod C.; Anderson, Richard A.; Adiga, Satish Kumar			Early prepubertal cyclophosphamide exposure in mice results in long-term loss of ovarian reserve, and impaired embryonic development and blastocyst quality	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; CHILDHOOD-CANCER; FEMALE SURVIVORS; YOUNG-WOMEN; MOUSE; FAILURE; CHEMOTHERAPY; CHECKPOINT; FERTILITY; TOXICITY	Background Due to improved treatment, there is an increasing focus on the reproductive potential of survivors of childhood cancer. Cytotoxic chemotherapy accelerates the decline in the number of primordial follicles within the mammalian ovary at all ages, but effects on the developmental potential of remaining oocytes following prepubertal cancer treatment are unclear. Objectives To investigate whether cyclophosphamide (CY) exposure in the prepubertal period in female mice influences ovarian function and the functional competence of oocytes in adulthood. Methods This study used Swiss albino mice as the experimental model. Female mice were treated with 200 mg/kg CY on either postnatal day 14 (CY14), 21 (CY21) or 28 (CY28) i.e at a prepubertal and 2 young postpubertal ages. At 14 weeks of life, ovarian function, functional competence of oocytes, and embryo quality were assessed. Results The number of primordial follicles decreased significantly in CY14 and CY21 groups compared to control (p < 0.01). The number of oocytes from superovulated was 8.5 +/- 1.4, 24.1 +/- 2.9 and 26.8 +/- 2.1 in CY14, CY21 and CY28 respectively which was significantly lower than control (50.2 +/- 3.2; p < 0.001).In vitroculture of CY14 embryos demonstrated only 55.4% blastocyst formation (p < 0.0001) and reduced ability of inner cell mass (ICM) to proliferatein vitro(p < 0.05) at 120 and 216 h post insemination respectively. On the other hand, ICM proliferation was unaltered in 2 young postpubertal ages. Conclusion Our results indicate long-term effects on the developmental competence of oocytes exposed to CY in early but not adult life. These data provide a mechanism whereby long-term fertility can be impaired after chemotherapy exposure, despite the continuing presence of follicles within the ovary, and support the need for fertility preservation in prepubertal girls before alkylating agent exposure.	[Salian, Sujith Raj; Uppangala, Shubhashree; Cheredath, Aswathi; D'Souza, Fiona; Kalthur, Guruprasad; Adiga, Satish Kumar] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Clin Embryol, Manipal, India; [Nayak, Vinod C.] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Forens Med, Manipal, India; [Anderson, Richard A.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; University of Edinburgh	Adiga, SK (corresponding author), Manipal Acad Higher Educ, Kasturba Med Coll, Dept Clin Embryol, Manipal, India.	satish.adiga@manipal.edu	Adiga, Satish Kumar/AAU-4386-2020; Uppangala, Shubhashree/AAA-4965-2021	Adiga, Satish Kumar/0000-0002-2897-4697; Nayak, Vinod/0000-0002-4614-235X	Manipal Academy of Higher Education; MRC [MR/N022556/1, G1100357] Funding Source: UKRI	Manipal Academy of Higher Education; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was partly funded by Manipal Academy of Higher Education intramural support to SRS towards integrated PhD course fellowship. This funder did not play a role in study design, data collection, analysis, or decision to publish the manuscript.	Adiga SK, 2007, ONCOGENE, V26, P6141, DOI 10.1038/sj.onc.1210444; Adiga SK, 2010, FERTIL STERIL, V93, P2486, DOI 10.1016/j.fertnstert.2009.06.015; Anderson RA, 2014, HUM REPROD, V29, P97, DOI 10.1093/humrep/det388; [Anonymous], 2013, J THORAC DIS S2, V5, pS168; Barton SE, 2013, LANCET ONCOL, V14, P873, DOI 10.1016/S1470-2045(13)70251-1; Bath LE, 2003, HUM REPROD, V18, P2368, DOI 10.1093/humrep/deg473; Brougham MFH, 2012, J CLIN ENDOCR METAB, V97, P2059, DOI 10.1210/jc.2011-3180; Chang EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144245; Comish PB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093311; Connors T., 1975, ANTINEOPLASTIC IMM 2, P18; Cui W, 2016, SCI REP-UK, V6, DOI 10.1038/srep37396; D'Souza F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35342-2; D'Souza F, 2016, SCI REP-UK, V6, DOI 10.1038/srep37291; Fong SL, 2009, HUM REPROD, V24, P982, DOI 10.1093/humrep/den487; Gada RP, 2012, FERTIL STERIL, V98, P863, DOI 10.1016/j.fertnstert.2012.06.012; Green DM, 2009, J CLIN ONCOL, V27, P2374, DOI 10.1200/JCO.2008.21.1839; Green DM, 2009, J CLIN ONCOL, V27, P2677, DOI 10.1200/JCO.2008.20.1541; HIMELSTEINBRAW R, 1978, BRIT J CANCER, V38, P82, DOI 10.1038/bjc.1978.166; Jaroudi S, 2007, MUTAT RES-REV MUTAT, V635, P53, DOI 10.1016/j.mrrev.2006.09.002; KOYAMA H, 1977, CANCER, V39, P1403, DOI 10.1002/1097-0142(197704)39:4<1403::AID-CNCR2820390408>3.0.CO;2-8; Letourneau JM, 2012, CANCER-AM CANCER SOC, V118, P1933, DOI 10.1002/cncr.26403; Luan Y, 2019, J ENDOCRINOL, V240, P243, DOI 10.1530/JOE-18-0370; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; MILLER JJ, 1971, AM J MED, V50, P530, DOI 10.1016/0002-9343(71)90341-X; Nguyen QN, 2019, MOL HUM REPROD, V25, P433, DOI 10.1093/molehr/gaz020; PETERS H, 1969, ACTA ENDOCRINOL-COP, V62, P98, DOI 10.1530/acta.0.0620098; PLOWCHALK DR, 1992, REPROD TOXICOL, V6, P411, DOI 10.1016/0890-6238(92)90004-D; Salian SR, 2019, J ASSIST REPROD GEN, V36, P255, DOI 10.1007/s10815-018-1323-1; Shimura T, 2002, MOL CELL BIOL, V22, P2220, DOI 10.1128/MCB.22.7.2220-2228.2002; Shimura T, 2002, RADIAT RES, V158, P735, DOI 10.1667/0033-7587(2002)158[0735:TNSMOT]2.0.CO;2; Spears N, 2019, HUM REPROD UPDATE, V25, P673, DOI 10.1093/humupd/dmz027; Uppangala S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119735; van Dorp W, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2017.76.3441; Wallace WHB, 2005, LANCET ONCOL, V6, P209, DOI 10.1016/S1470-2045(05)70092-9; Winship AL, 2018, HUM REPROD UPDATE, V24, P119, DOI 10.1093/humupd/dmy002	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235140	10.1371/journal.pone.0235140	http://dx.doi.org/10.1371/journal.pone.0235140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574203	Green Published, Green Submitted, gold			2022-12-27	WOS:000544972400036
J	Venkataraman, GR; Pineda, AL; Bear, OJ; Zehnder, AM; Ayyar, S; Page, RL; Bustamante, CD; Rivas, MA				Venkataraman, Guhan Ram; Pineda, Arturo Lopez; Bear, Oliver J.; Zehnder, Ashley M.; Ayyar, Sandeep; Page, Rodney L.; Bustamante, Carlos D.; Rivas, Manuel A.			FasTag: Automatic text classification of unstructured medical narratives	PLOS ONE			English	Article							EXTRACTION SYSTEM; DIAGNOSIS; COVERAGE; ANIMALS; HISTORY; RECORDS; CANCER; TERMS; CT	Unstructured clinical narratives are continuously being recorded as part of delivery of care in electronic health records, and dedicated tagging staff spend considerable effort manually assigning clinical codes for billing purposes. Despite these efforts, however, label availability and accuracy are both suboptimal. In this retrospective study, we aimed to automate the assignment of top-level International Classification of Diseases version 9 (ICD-9) codes to clinical records from human and veterinary data stores using minimal manual labor and feature curation. Automating top-level annotations could in turn enable rapid cohort identification, especially in a veterinary setting. To this end, we trained long short-term memory (LSTM) recurrent neural networks (RNNs) on 52,722 human and 89,591 veterinary records. We investigated the accuracy of both separate-domain and combined-domain models and probed model portability. We established relevant baseline classification performances by training Decision Trees (DT) and Random Forests (RF). We also investigated whether transforming the data using MetaMap Lite, a clinical natural language processing tool, affected classification performance. We showed that the LSTM-RNNs accurately classify veterinary and human text narratives into top-level categories with an average weighted macro F1 score of 0.74 and 0.68 respectively. In the "neoplasia" category, the model trained on veterinary data had a high validation accuracy in veterinary data and moderate accuracy in human data, with F1 scores of 0.91 and 0.70 respectively. Our LSTM method scored slightly higher than that of the DT and RF models. The use of LSTM-RNN models represents a scalable structure that could prove useful in cohort identification for comparative oncology studies. Digitization of human and veterinary health information will continue to be a reality, particularly in the form of unstructured narratives. Our approach is a step forward for these two domains to learn from and inform one another.	[Venkataraman, Guhan Ram; Pineda, Arturo Lopez; Ayyar, Sandeep; Bustamante, Carlos D.; Rivas, Manuel A.] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Bear, Oliver J.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Biomed Informat, New York, NY USA; [Zehnder, Ashley M.] Fauna Bio, San Francisco, CA USA; [Page, Rodney L.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA; [Bustamante, Carlos D.] Chan Zuckerberg Biohub, San Francisco, CA USA	Stanford University; Columbia University; Colorado State University	Rivas, MA (corresponding author), Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA.	mrivas@stanford.edu	Rivas, Manuel/ABE-8173-2020; Lopez Pineda, Arturo/B-1610-2015	Rivas, Manuel/0000-0003-1457-9925; Bustamante, Carlos D./0000-0002-4187-7920; Lopez Pineda, Arturo/0000-0002-3409-1815	Stanford University; National Institute of Health center for Multi and Trans-ethnic Mapping of Mendelian and Complex Diseases grant [5U01 HG009080]; National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) [R01HG010140]	Stanford University(Stanford University); National Institute of Health center for Multi and Trans-ethnic Mapping of Mendelian and Complex Diseases grant; National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	M.A.R. is supported by Stanford University and a National Institute of Health center for Multi and Trans-ethnic Mapping of Mendelian and Complex Diseases grant (5U01 HG009080). This work was supported by National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) under awards R01HG010140. C.D.B. is a Chan Zuckerberg Biohub Investigator. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, ARXIV PREPRINT; Abraha I, 2016, VALIDITY OF ICD 9 CM; Agibetov A, 2018, FAST SCALABLE NEURAL; Anholt RM, 2014, PREV VET MED, V113, P417, DOI 10.1016/j.prevetmed.2014.01.017; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Banerjee I, 2019, ARTIF INTELL MED, V97, P79, DOI 10.1016/j.artmed.2018.11.004; Barros JM, 2018, J BIOMED SEMANT, V9, DOI 10.1186/s13326-018-0186-9; Benesch C, 1997, NEUROLOGY, V49, P660, DOI 10.1212/WNL.49.3.660; Berndorfer S, 2017, STUD HEALTH TECHNOL, V235, P201, DOI 10.3233/978-1-61499-753-5-201; Burton JH, 2018, CLIN CANCER RES, V24, P5830, DOI 10.1158/1078-0432.CCR-18-1498; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chapman BE, 2011, J BIOMED INFORM, V44, P728, DOI 10.1016/j.jbi.2011.03.011; Chen MC, 2018, RADIOLOGY, V286, P845, DOI 10.1148/radiol.2017171115; Christensen L.M., 2002, P ACL 02 WORKSH NAT, P29, DOI DOI 10.3115/1118149.1118154; Christensen LM, 2009, ONYX; Cummings KJ, 2014, VECTOR-BORNE ZOONOT, V14, P496, DOI 10.1089/vbz.2013.1467; Demner-Fushman D, 2017, METAMAP LITE EVALUAT; Denny Joshua C, 2003, AMIA Annu Symp Proc, P195; Du YP, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2534-2; Elkin PL, 2006, MAYO CLIN PROC, V81, P741, DOI 10.4065/81.6.741; Field K, 2007, ILAR J, V48, P37; Fisher BT, 2014, ESTABLISHMENT 11 YEA; Friedlin Jeff, 2010, AMIA Annu Symp Proc, V2010, P237; Friedman C, 2000, J AM MED INFORM ASSN, P270; FRIEDMAN C, 1994, J AM MED INFORM ASSN, V1, P161, DOI 10.1136/jamia.1994.95236146; Friedman C, 2002, 2 BIOMEDICAL SUBLANG; Garden OA, 2018, VET J, V240, P6, DOI 10.1016/j.tvjl.2018.08.008; Gehrmann S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192360; German Robert R, 2011, J Registry Manag, V38, P75; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Griffith JE, 2012, AUST VET J, V90, P457, DOI 10.1111/j.1751-0813.2012.00963.x; Gundlapalli AV, 2015, MAXIMIZING CLIN COHO; Hanauer DA, 2014, APPLYING METAMAP MED; Harkema H, 2009, CONTEXT ALGORITHM DE; Jackson MSc Richard G, 2014, AMIA Annu Symp Proc, V2014, P729; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Kim SC, 2013, PHARMACOEPIDEM DR S, V22, P1239, DOI 10.1002/pds.3520; Koopman B, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0174-2; Krone LM, 2014, JAVMA-J AM VET MED A, V245, P324, DOI 10.2460/javma.245.3.324; LeBlanc AK, 2016, CLIN CANCER RES, V22, P2133, DOI 10.1158/1078-0432.CCR-15-2347; Lee Hee-Jin, 2016, P 10 INT WORKSH SEM, P1292; Liu Kaihong, 2005, AMIA Annu Symp Proc, P460; Lustgarten JL, 2020, VET INFORMATICS FORG; Maccabe AT, 2015, J VET MED EDUC, V42, P395, DOI 10.3138/jvme.0615-089R; Mikolov T., 2013, ADV NEURAL INFORM PR, V26, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Moar KK, 2012, BRIT J ORAL MAX SURG, V50, P85, DOI 10.1016/j.bjoms.2011.01.005; Moriyama IM, 2011, HIST STAT CLASSIFICA; Nadkarni PM, 2011, J AM MED INFORM ASSN, V18, P544, DOI 10.1136/amiajnl-2011-000464; Nie A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0067-8; Paoloni M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090028; Pascanu T., 2013, INT C MACH LEARN, P1310; Paviot BT, 2011, METHOD INFORM MED, V50, P124, DOI 10.3414/ME09-01-0064; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pennington Jeffrey, 2014, PROC 2014 C EMPIRICA, P1532, DOI [DOI 10.3115/V1/D14-1162, 10.3115/v1/D14-1162]; Pham T, 2016, DEEPCARE DEEP DYNAMI; Polednak Anthony P, 2014, J Registry Manag, V41, P190; Poppe John L, 2013, US Army Med Dep J, P5; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Robinson Timothy P, 2014, PLoS One, V9, pe96084, DOI 10.1371/journal.pone.0096084; Saba C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149194; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Segura-Bedmar I, 2018, PREDICTING ANAPHYLAX; Shalev Moshe, 2003, Lab Anim (NY), V32, P16; Shivade C, 2014, J AM MED INFORM ASSN, V21, P221, DOI 10.1136/amiajnl-2013-001935; Sohn S, 2018, J AM MED INFORM ASSN, V25, P353, DOI 10.1093/jamia/ocx138; Stetson PD, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P742; Tseytlin E, 2016, NOBLE FLEXIBLE CONCE; Tran T, 2017, J BIOMED INFORM, V75, pS138, DOI 10.1016/j.jbi.2017.06.010; Virginia-Maryland Regional College of Veterinary Medicine, 1993, RESEARCH RESOURCES V; Wagner Michael, 2011, Online J Public Health Inform, V3, DOI 10.5210/ojphi.v3i3.3798; Wang YS, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-018-0723-6; Weng WH, 2017, MEDICAL SUBDOMAIN CL; Witte CL, 2013, J ZOO WILDLIFE MED, V44, P634, DOI 10.1638/2012-0183R.1; Wu Y, 2016, LONG JOURNEY SHORT A; Xu H, 2010, J AM MED INFORM ASSN, V17, P19, DOI 10.1197/jamia.M3378; Ye Y, 2017, STUDY TRANSFERABILIT; Yu ZG, 2016, J BIOMED INFORM, V61, P77, DOI 10.1016/j.jbi.2016.03.013; Zeng Qing T, 2006, BMC Med Inform Decis Mak, V6, P30, DOI 10.1186/1472-6947-6-30; Zhang YY, 2015, J AM MED INFORM ASSN, V22, P967, DOI 10.1093/jamia/ocu048	79	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234647	10.1371/journal.pone.0234647	http://dx.doi.org/10.1371/journal.pone.0234647			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569327	gold, Green Published			2022-12-27	WOS:000543547900023
J	Jones, A; Bronskill, SE; Seow, H; Junek, M; Feeny, D; Costa, AP				Jones, Aaron; Bronskill, Susan E.; Seow, Hsien; Junek, Mats; Feeny, David; Costa, Andrew P.			Associations between continuity of primary and specialty physician care and use of hospital-based care among community-dwelling older adults with complex care needs	PLOS ONE			English	Article							MINIMUM DATA SET; INTERPERSONAL CONTINUITY; VALIDATION; MULTIMORBIDITY; WORKFORCE; OUTCOMES; DISEASE; BURDEN; SCALE; RISK	Objective While research suggests that higher continuity of primary and specialty physician care can improve patient outcomes, their effects have rarely been examined and compared concurrently. We investigated associations between continuity of primary and specialty physician care and emergency department visits and hospital admissions among community-dwelling older adults with complex care needs. Methods We conducted a retrospective cohort study of home care patients in Ontario, Canada, from October 2014 to September 2016. We measured continuity of primary and specialty physician care over the two years prior to a home care assessment and categorized them into low, medium, and high groups using terciles of the distribution. We used Cox regression models to concurrently test the associations between continuity of primary and specialty care and risk of an emergency department visit and hospital admission within six months of assessment, controlling for potential confounders. We examined interactions between continuity of care and count of chronic conditions, count of physician specialties seen, functional impairment, and cognitive impairment. Results Of 178,686 participants, 49% had an emergency department visit during follow-up and 27% had a hospital admission. High vs. low continuity of primary care was associated with a reduced risk of an emergency department visit (HR = 0.90 (0.89-0.92)) as was continuity of specialty care (HR = 0.93 (0.91-0.95)). High vs. low continuity of primary care was associated also with a reduced risk of a hospital admission (HR = 0.94 (0.92-0.96)) as was continuity of specialty care (HR = 0.92 (0.90-0.94)). The effect of continuity of specialty care was moderately stronger among patients who saw four or more physician specialties. Conclusion Higher continuity of primary physician and specialty physician care had independent, protective effects of similar magnitude against emergency department use and hospital admissions. Improving continuity of specialty care should be a priority alongside improving continuity of primary care in complex, older adult populations with significant specialist use.	[Jones, Aaron; Seow, Hsien; Junek, Mats; Costa, Andrew P.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Bronskill, Susan E.] ICES, Toronto, ON, Canada; [Bronskill, Susan E.] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Seow, Hsien] McMaster Univ, Dept Oncol, Hamilton, ON, Canada; [Feeny, David] McMaster Univ, Dept Econ, Hamilton, ON, Canada; [Costa, Andrew P.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; University of Toronto; University of Toronto; McMaster University; McMaster University; McMaster University	Jones, A (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.	jonesa13@mcmaster.ca	Seow, Hsien/AAQ-1438-2021; Jones, Aaron/AAG-1427-2020	Seow, Hsien/0000-0001-6701-1714; Jones, Aaron/0000-0002-6282-3614; Junek, Mats/0000-0001-8416-3955	Canadian Institutes of Health Research [148933]; ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	AC received a grant for this research from the Canadian Institutes of Health Research (148933) (https://cihr-irsc.gc.ca/e/193.html).This study was supported by ICES (www.ices.on.ca), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The analyses, conclusions, opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred. Parts of this material are based on data and/or information compiled and provided by the Canadian Institute for Health Information (CIHI)(www.cihi.ca).However, the analyses, conclusions, opinions and statements expressed in the material are those of the authors, and not necessarily those of CIHI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres C, 2016, CAN FAM PHYSICIAN, V62, P116; [Anonymous], ADV PROF CONT CAR; [Anonymous], 2014, DIABETES CARE, V1, pS14; Bauman M., 2017, MULTIPLE CHRONIC CON; Bayliss EA, 2015, ANN FAM MED, V13, P123, DOI 10.1370/afm.1739; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; Blecker S, 2014, INT J QUAL HEALTH C, V26, P530, DOI 10.1093/intqhc/mzu065; Bodenheimer T, 2009, HEALTH AFFAIR, V28, P64, DOI 10.1377/hlthaff.28.1.64; Chen LM, 2014, JAMA INTERN MED, V174, P749, DOI 10.1001/jamainternmed.2013.14331; Costa AP, 2015, J AM GERIATR SOC, V63, P763, DOI 10.1111/jgs.13336; Dall TM, 2013, HEALTH AFFAIR, V32, P2013, DOI 10.1377/hlthaff.2013.0714; Dufour I, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1197-9; Emond M, 2017, CAN GERIATR J, V20, P10, DOI 10.5770/cgj.20.246; Engamba SA, 2019, BRIT J GEN PRACT, V69, P92, DOI 10.3399/bjgp19X701201; Foebel AD, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-457; Gray DP, 2003, J ROY SOC MED, V96, P160, DOI 10.1258/jrsm.96.4.160; Gray E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017593; Haggerty JL, 2012, ANN FAM MED, V10, P443, DOI 10.1370/afm.1378; Haggerty JL, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5915; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; HARTMAIER SL, 1995, J GERONTOL A-BIOL, V50, pM128, DOI 10.1093/gerona/50A.2.M128; Hirdes JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-277; HOENIG HM, 1991, J AM GERIATR SOC, V39, P220, DOI 10.1111/j.1532-5415.1991.tb01632.x; Hoertel N, 2014, EUR PSYCHIAT, V29, P358, DOI 10.1016/j.eurpsy.2013.12.001; Hwang U, 2013, HEALTH AFFAIR, V32, P2116, DOI 10.1377/hlthaff.2013.0670; Justiniano CF, 2017, DIS COLON RECTUM, V60, P1147, DOI 10.1097/DCR.0000000000000919; Kuluski K, 2017, INT J INTEGR CARE, V17, DOI 10.5334/ijic.2944; Lancet Global Health, 2019, LANCET GLOB HEALTH, V7, pe1; Landi F, 2000, MED CARE, V38, P1184, DOI 10.1097/00005650-200012000-00005; McWhinney I R, 1975, J Fam Pract, V2, P373; Milenkovic M, 2006, HEALTHCARE COST UTIL; Mondor L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002249; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; National Prevention Council, 2016, HLTH AG ACT ADV NAT; Nguyen Hai, 2019, J Comorb, V9, p2235042X19870934, DOI 10.1177/2235042X19870934; Nutting Paul A, 2003, Ann Fam Med, V1, P149, DOI 10.1370/afm.63; Nyweide DJ, 2013, JAMA INTERN MED, V173, P1879, DOI 10.1001/jamainternmed.2013.10059; Palmer W, 2018, IMPROVING ACCESS CON; Pefoyo AJK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1733-2; Pollack CE, 2016, MED CARE, V54, pE30, DOI 10.1097/MLR.0000000000000018; Poss J W, 2008, Healthc Manage Forum, V21, P33; Price M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-309; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Saultz JW, 2005, ANN FAM MED, V3, P159, DOI 10.1370/afm.285; Saultz JW, 2004, ANN FAM MED, V2, P445, DOI 10.1370/afm.91; Schiotz Michaela L, 2016, J Comorb, V6, P95, DOI 10.15256/joc.2016.6.81; Starfleld B, 2005, ANN FAM MED, V3, P215, DOI 10.1370/afm.307; van Walraven C, 2010, J EVAL CLIN PRACT, V16, P947, DOI 10.1111/j.1365-2753.2009.01235.x; Vetrano DL, 2019, J GERONTOL A-BIOL, V74, P659, DOI 10.1093/gerona/gly110; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176; Weir DL, 2016, MED CARE, V54, P386, DOI 10.1097/MLR.0000000000000493; WHO, 2018, CONT COORD CAR PRACT; Wu S-Y, 2000, PROJECTION CHRONIC I, P18	53	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234205	10.1371/journal.pone.0234205	http://dx.doi.org/10.1371/journal.pone.0234205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559214	gold, Green Published			2022-12-27	WOS:000543261600020
J	Lin, HP; Lynk, N; Moore, LL; Cabral, HJ; Heffernan, KS; Dumas, AK; Hruska, B; Zajdel, RA; Gump, BB; Spartano, NL				Lin, Hsuan-Ping; Lynk, Nicole; Moore, Lynn L.; Cabral, Howard J.; Heffernan, Kevin S.; Dumas, Amy K.; Hruska, Bryce; Zajdel, Rachel A.; Gump, Brooks B.; Spartano, Nicole L.			A pragmatic approach to the comparison of wrist-based cutpoints of physical activity intensity for the MotionWatch8 accelerometer in children	PLOS ONE			English	Article							CALIBRATION; VALIDATION; ACTIGRAPH; MONITORS; OBESITY	Background A variety of wearable monitors are available for objectively assessing physical activity but there is a lack of established values for the activity intensity of MotionWatch8 (MW8) and a similar lack of studies on comparability across devices. Our study aimed to establish activity intensity cutpoints for the MW8 accelerometer in children, which are necessary to determine whether they are meeting physical activity guidelines. Methods Children (n = 39, ages 9-13 years) were asked to wear two different accelerometers (MW8 and ActiGraph) simultaneously on the same dominant wrist as they performed different activities designed to mimic activities of variable intensity that a child might perform in a free-living environment. Linear regression and receiver operating characteristic (ROC) curves were performed to assess sensitivity and specificity of the identified MW8 intensity cutpoints compared to established ActiGraph cutpoints. Results Mean values for each activity were positively correlated using the MW8 and ActiGraph monitors (r = 0.85, p<0.001). The optimal cutpoints for differentiating sedentary from light physical activity, light from moderate, and moderate from vigorous activity were <= 32 counts, >= 371.5 counts, and >= 859.5 counts per 30 seconds, respectively. Conclusions Our study demonstrated the ability of MW8 to discriminate different intensity activities and provided the first cutoff values for researchers using the MW8 to measure physical activity patterns among children.	[Lin, Hsuan-Ping; Moore, Lynn L.] Boston Univ, Sch Med, Dept Med Preventat Med & Epidemiol, Boston, MA 02118 USA; [Lynk, Nicole; Dumas, Amy K.; Hruska, Bryce; Zajdel, Rachel A.; Gump, Brooks B.] Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, Syracuse, NY USA; [Cabral, Howard J.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Heffernan, Kevin S.] Syracuse Univ, Dept Exercise Sci, Syracuse, NY USA; [Spartano, Nicole L.] Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet Nutr & Weight Management, Boston, MA 02118 USA	Boston University; Syracuse University; Boston University; Syracuse University; Boston University	Spartano, NL (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet Nutr & Weight Management, Boston, MA 02118 USA.	spartano@bu.edu	; Spartano, Nicole/Y-3344-2018	Hruska, Bryce/0000-0002-8651-5827; Dumas, Amy/0000-0003-0561-4979; Heffernan, Kevin/0000-0002-3499-1477; Spartano, Nicole/0000-0002-0724-8629	National Institutes of Health [R15-ES15619, R01-ES023252, T32-HL07224]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this study was provided by the National Institutes of Health, which had no role in collection, analysis, or interpretation of the data, nor did they have a right to approve/disapprove publication of the final manuscript: R15-ES15619 (BBG), R01-ES023252 (BBG) and T32-HL07224 (NLS).	Adamo KB, 2009, INT J PEDIATR OBES, V4, P2, DOI 10.1080/17477160802315010; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; BERK RA, 1976, J EXP EDUC, V45, P4, DOI 10.1080/00220973.1976.11011567; Crouter SE, 2015, MED SCI SPORT EXER, V47, P944, DOI 10.1249/MSS.0000000000000502; Dishman RK, 2001, QUEST, V53, P295, DOI 10.1080/00336297.2001.10491746; Dollman J, 2009, J SCI MED SPORT, V12, P518, DOI 10.1016/j.jsams.2008.09.007; Fairclough SJ, 2016, MED SCI SPORT EXER, V48, P245, DOI 10.1249/MSS.0000000000000771; Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Gump BB, 2017, ENVIRON RES, V158, P576, DOI 10.1016/j.envres.2017.06.033; Hanggi JM, 2013, J SCI MED SPORT, V16, P40, DOI 10.1016/j.jsams.2012.05.012; Janssen X, 2015, MEAS PHYS EDUC EXERC, V19, P116, DOI 10.1080/1091367X.2015.1045908; JEQUIER E, 1987, ANNU REV NUTR, V7, P187, DOI 10.1146/annurev.nu.07.070187.001155; Johansson E, 2015, PEDIATR OBES, V10, P1, DOI 10.1111/j.2047-6310.2013.00213.x; Karnik S, 2012, INT J PREVENTIVE MED, V3, P1; Kelly Louise A, 2013, BMC Med Phys, V13, P5, DOI 10.1186/1756-6649-13-5; Landry GJ, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00165; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID AM; Preiser JC, 2014, BRIT J ANAESTH, V113, P945, DOI 10.1093/bja/aeu187; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Rideout V.J., 2010, HENRY J KAIS FAM FOU; Schaefer CA, 2014, J PHYS ACT HEALTH, V11, P604, DOI 10.1123/jpah.2011-0411; Schrack JA, 2016, J GERONTOL A-BIOL, V71, P1039, DOI 10.1093/gerona/glw026; Sirard JR, 2001, SPORTS MED, V31, P439, DOI 10.2165/00007256-200131060-00004; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Trost SG, 2007, AM J LIFESTYLE MED, V1, P299, DOI 10.1177/1559827607301686; Van Remoortel H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-84; Westerterp KS, 1999, MED SCI SPORT EXER, V31, pS522, DOI 10.1097/00005768-199911001-00006; ZWEIG MH, 1993, CLIN CHEM, V39, P561; 2014, REG ANESTH PAIN MED, V9	32	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234725	10.1371/journal.pone.0234725	http://dx.doi.org/10.1371/journal.pone.0234725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559207	gold, Green Published			2022-12-27	WOS:000543261600030
J	Pathak, S; Stewart, WCL; Burd, CE; Hester, ME; Greenberg, DA				Pathak, Shilpa; Stewart, William C. L.; Burd, Christin E.; Hester, Mark E.; Greenberg, David A.			Brd2haploinsufficiency extends lifespan and healthspan in C57B6/J mice	PLOS ONE			English	Article							BROMODOMAIN INHIBITOR OTX015; DOSE-ESCALATION; PROTEIN BRD2; SIRT1; GENE; INFLAMMATION; AGE; TRANSCRIPTION; DISRUPTION; EXPRESSION	Aging in mammals is the gradual decline of an organism's physical, mental, and physiological capacity. Aging leads to increased risk for disease and eventually to death. Here, we show thatBrd2haploinsufficiency (Brd2+/-) extends lifespan and increases healthspan in C57B6/J mice. InBrd2+/- mice, longevity is increased by 23% (p<0.0001), and, relative to wildtype animals (Brd2+/+), cancer incidence is reduced by 43% (p<0.001). In addition, relative to age-matched wildtype mice,Brd2heterozygotes show healthier aging including: improved grooming, extended period of fertility, and lack of age-related decline in kidney function and morphology. Our data support a role for haploinsufficiency ofBrd2in promoting healthy aging. We hypothesize that Brd2 affects aging by protecting against the accumulation of molecular and cellular damage. Given the recent advances in the development of BET inhibitors, our research provides impetus to test drugs that target BRD2 as a way to understand and treat/prevent age-related diseases.	[Pathak, Shilpa; Stewart, William C. L.; Greenberg, David A.] Nationwide Childrens Hosp, Battelle Ctr Math Med, Abigail Wexner Res Inst, Columbus, OH 43205 USA; [Stewart, William C. L.; Greenberg, David A.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Stewart, William C. L.] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Burd, Christin E.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Burd, Christin E.] Ohio State Univ, Dept Mol Biol & Canc Genet, Columbus, OH 43210 USA; [Hester, Mark E.] Nationwide Childrens Hosp, Steve & Cindy Rasmussen Inst Genom Med, Abigail Wexner Res Inst, Columbus, OH USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Greenberg, DA (corresponding author), Nationwide Childrens Hosp, Battelle Ctr Math Med, Abigail Wexner Res Inst, Columbus, OH 43205 USA.; Greenberg, DA (corresponding author), Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA.	David.Greenberg@NationwideChildrens.org	Pathak, Shilpa/AAX-4833-2021; Hester, Mark/AAY-8611-2020	Pathak, Shilpa/0000-0001-6341-089X; 				Amorim S, 2016, LANCET HAEMATOL, V3, pE196, DOI 10.1016/S2352-3026(16)00021-1; Andrieu Guillaume, 2016, Drug Discov Today Technol, V19, P45, DOI 10.1016/j.ddtec.2016.06.004; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2011, CANC DISCOV; Arai Y, 2015, EBIOMEDICINE, V2, P1549, DOI 10.1016/j.ebiom.2015.07.029; Belkina AC, 2014, J LEUKOCYTE BIOL, V95, P451, DOI 10.1189/jlb.1112588; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Berthon C, 2016, LANCET HAEMATOL, V3, pE186, DOI 10.1016/S2352-3026(15)00247-1; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103; Chachua T, 2014, GENES BRAIN BEHAV, V13, P702, DOI 10.1111/gbb.12160; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Eischen C.M., 2016, COLD SPRING HARB PER, V6, P6; Erol A, 2007, PPAR RES, V2007, DOI 10.1155/2007/39654; Flurkey K., 2007, MOUSE BIOMEDICAL RES; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gomes P, 2009, OXID MED CELL LONGEV, V2, P138, DOI 10.4161/oxim.2.3.8819; GREENBERG DA, 1988, GENET EPIDEMIOL, V5, P81, DOI 10.1002/gepi.1370050204; Greenwald RJ, 2004, BLOOD, V103, P1475, DOI 10.1182/blood-2003-06-2116; Guan Y, 2016, KIDNEY DIS-BASEL, V1, P258, DOI 10.1159/000440967; Gyuris A, 2009, BBA-GENE REGUL MECH, V1789, P413, DOI 10.1016/j.bbagrm.2009.03.005; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Herskovits AZ, 2014, NEURON, V81, P471, DOI 10.1016/j.neuron.2014.01.028; Hnilicova J, 2013, MOL BIOL CELL, V24, P3557, DOI 10.1091/mbc.E13-06-0303; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Jahagirdar R, 2017, MOL PHARMACOL, V92, P694, DOI 10.1124/mol.117.110379; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kokkola T, 2015, CHEMBIOCHEM, V16, P1997, DOI 10.1002/cbic.201500272; Lenburg ME, 2007, J BIOL CHEM, V282, P4803, DOI 10.1074/jbc.M605870200; Li XL, 2011, INT J BIOL SCI, V7, P575, DOI 10.7150/ijbs.7.575; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Liao CY, 2012, CELL RES, V22, P1215, DOI 10.1038/cr.2012.62; Loganathan SN, 2016, ONCOTARGET, V7, P43504, DOI 10.18632/oncotarget.9762; Marx JO, 2013, J AM ASSOC LAB ANIM, V52, P782; Mercken EM, 2014, AGING CELL, V13, P193, DOI 10.1111/acel.12151; Michaeloudes C, 2014, J IMMUNOL, V192, P4913, DOI 10.4049/jimmunol.1301984; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Moskalev AA, 2014, CELL CYCLE, V13, P1063, DOI 10.4161/cc.28433; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Pal DK, 2003, AM J HUM GENET, V73, P261, DOI 10.1086/377006; Petkovich DA, 2017, CELL METAB, V25, P954, DOI 10.1016/j.cmet.2017.03.016; Porcher C, 2015, BLOOD, V125, P2739, DOI 10.1182/blood-2015-03-630830; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Shang EY, 2009, DEV DYNAM, V238, P908, DOI 10.1002/dvdy.21911; Velisek L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023656; Wang FN, 2010, BIOCHEM J, V425, P71, DOI 10.1042/BJ20090928; Watroba M, 2016, ADV MED SCI-POLAND, V61, P52, DOI 10.1016/j.advms.2015.09.003; Wu CY, 2012, HUM MOL GENET, V21, P3956, DOI 10.1093/hmg/dds210; Yang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yuan R, 2011, ILAR J, V52, P4, DOI 10.1093/ilar.52.1.4; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883; Zou D, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-1094-z	62	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234910	10.1371/journal.pone.0234910	http://dx.doi.org/10.1371/journal.pone.0234910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559200	gold, Green Published			2022-12-27	WOS:000543261600003
J	Schwab, F; Gastmeier, P; Hoffmann, P; Meyer, E				Schwab, Frank; Gastmeier, Petra; Hoffmann, Peter; Meyer, Elisabeth			Summer, sun and sepsis-The influence of outside temperature on nosocomial bloodstream infections: A cohort study and review of the literature	PLOS ONE			English	Review							SURGICAL SITE INFECTIONS; SEASONAL-VARIATION; ESCHERICHIA-COLI; GUT MICROBIOME; BACTEREMIA; EPIDEMIOLOGY; ASSOCIATION; VARIABILITY	Background The incidence of many infections is seasonal e.g. surgical site infections, urinary tract infection and bloodstream infections. We questioned whether there is seasonal variation even in climate-controlled hospitalized patients, and analyzed the influence of climate parameters on nosocomial bloodstream infections. Methods and findings The retrospective cohort study is based on two databases: The German national surveillance system for nosocomial infections in intensive care units (ICU-KISS) from 2001 to 2015 and aggregated monthly climate data. Primary bloodstream infection (PBSI) is defined as a positive blood culture with one (or more) pathogen(s) which are not related to an infection on another site and which were not present at admission. Monthly infection data were matched with postal code, calendar month and corresponding monthly climate and weather data. All analyses were exploratory in nature. 1,196 ICUs reported data on PBSI to KISS. The ICUs were located in 779 hospitals and in 728 different postal codes in Germany. The majority of the 19,194 PBSI were caused by gram-positive bacteria. In total, the incidence density of BSI was 17% (IRR 1.168, 95%CI 1.076-1.268) higher in months with high temperatures (>= 20 degrees C) compared to months with low temperatures (<5 degrees C). The effect was most prominent for gram-negatives; more than one third (38%) higher followed by gram-positives with 13%. Fungi reached their highest IRR at moderately warm temperatures between 15-20 degrees C. At such temperatures fungi showed an increase of 33% compared to temperatures below 5 degrees C. PBSI spiked in summer with a peak in July and August. PBSI differed by pathogen: The majority of bacteria increased with rising temperatures. Enterococci showed no seasonality.S.pneumoniaereached a peak in winter time. The association of the occurrence of PBSI and temperatures >= 20 degrees C was stronger when the mean monthly temperature in the month prior to the occurrence of BSI was considered instead of the temperature in the month of the occurrence of BSI. High average temperatures >= 20 degrees C increased the risk of the development of a PBSI by 16% compared with low temperatures Conclusions Most nosocomial infections are endogenous in nature; the microbiome plays a crucial role in host health. If gut and skin microbiome varies with season, environmental parameters will contribute to the observed incidence patterns. Similarly, the impact of global warming on both local weather patterns and extreme weather events may influence the acquisition of pathogens. A better understanding of the etiology of these infections is needed to provide guidance for future infection control strategies.	[Schwab, Frank; Gastmeier, Petra; Meyer, Elisabeth] Charite Univ Med Berlin, Berlin, Germany; [Schwab, Frank; Gastmeier, Petra; Meyer, Elisabeth] Free Univ Berlin, Berlin, Germany; [Schwab, Frank; Gastmeier, Petra; Meyer, Elisabeth] Humboldt Univ, Berlin, Germany; [Schwab, Frank; Gastmeier, Petra; Meyer, Elisabeth] Berlin Inst Hlth, Inst Hyg & Environm Med, Berlin, Germany; [Schwab, Frank; Gastmeier, Petra; Meyer, Elisabeth] Charite Univ Med Berlin, Natl Reference Ctr Surveillance Nosocomial Infect, Berlin, Germany; [Hoffmann, Peter] Potsdam Inst Climate Impact Res, Potsdam, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Potsdam Institut fur Klimafolgenforschung	Schwab, F (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Schwab, F (corresponding author), Free Univ Berlin, Berlin, Germany.; Schwab, F (corresponding author), Humboldt Univ, Berlin, Germany.; Schwab, F (corresponding author), Berlin Inst Hlth, Inst Hyg & Environm Med, Berlin, Germany.; Schwab, F (corresponding author), Charite Univ Med Berlin, Natl Reference Ctr Surveillance Nosocomial Infect, Berlin, Germany.	frank.schwab@charite.de		Meyer, Elisabeth/0000-0001-5590-2421; Schwab, Frank/0000-0002-6666-725X	Federal Ministry for Education and Research (BMBF)	Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was funded by InfectControl 2020 within the scope of the funding programme "Zwanzig20 - Partnerschaft fur Innovation" headed by the Federal Ministry for Education and Research (BMBF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hasan MN, 2009, CLIN MICROBIOL INFEC, V15, P947, DOI 10.1111/j.1469-0691.2009.02877.x; Al-Hasan MN, 2010, MAYO CLIN PROC, V85, P139, DOI 10.4065/mcp.2009.0410; Alcorn K, 2013, AM J INFECT CONTROL, V41, P1205, DOI 10.1016/j.ajic.2013.05.019; Anderson DJ, 2008, J INFECT DIS, V197, P752, DOI 10.1086/527486; Anthony CA, 2018, J ARTHROPLASTY, V33, P510, DOI 10.1016/j.arth.2017.10.043; Anthony CA, 2017, INFECT CONT HOSP EP, V38, P809, DOI 10.1017/ice.2017.84; Brown PT, 2017, NATURE, V552, P45, DOI 10.1038/nature24672; Cabrera-Perez J, 2017, EXP BIOL MED, V242, P127, DOI 10.1177/1535370216669610; Caldeira SM, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005438; Cassini A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002150; Chazan B, 2011, CLIN MICROBIOL INFEC, V17, P851, DOI 10.1111/j.1469-0691.2010.03327.x; Dandoy CE, 2016, BIOL BLOOD MARROW TR, V22, P1671, DOI 10.1016/j.bbmt.2016.06.002; Davenport ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090731; Deeny SR, 2015, CLIN MICROBIOL INFEC, V21, P924, DOI 10.1016/j.cmi.2015.06.023; Deutscher Wetterdienst, 2020, CLIM DAT TR CDC OBS; (DGEpi) DGfE, 2019, LEITL EMPF SICH GUT; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Eber MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025298; Fisman D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0114548, 10.1371/currents.outbreaks.89c0d3783f36958d96ebbae97348d571]; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Freeman JT, 2013, INFECT CONT HOSP EP, V34, P89, DOI 10.1086/668431; Goncalves-Pereira J, 2013, CLIN MICROBIOL INFEC, V19, P242, DOI 10.1111/j.1469-0691.2012.03776.x; Gradel KO, 2016, INFECT CONT HOSP EP, V37, P946, DOI 10.1017/ice.2016.89; Hoffmann P, 2018, WARNSIGNAL KLIMA EXT; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kato K, 2014, EUR J CLIN MICROBIOL, V33, P1371, DOI 10.1007/s10096-014-2083-1; Liang L, 2017, ENVIRON INT, V103, P99, DOI 10.1016/j.envint.2017.03.011; McDonald D, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00199-16; Menz C, 2019, DOKUMENTATION INTERP; Nash AK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0373-4; Rosello A, 2018, EPIDEMIOL INFECT, V146, P37, DOI 10.1017/S095026881700259X; Schroder C, 2015, INT J MED MICROBIOL, V305, P799, DOI 10.1016/j.ijmm.2015.08.034; Schwab F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194210; Schwab F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091105; See I, 2013, INFECT CONT HOSP EP, V34, P769, DOI 10.1086/671281; Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834; Tvedebrink T, 2008, CLIN MICROBIOL INFEC, V14, P1183, DOI 10.1111/j.1469-0691.2008.02114.x; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	38	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234656	10.1371/journal.pone.0234656	http://dx.doi.org/10.1371/journal.pone.0234656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559761	Green Published, gold			2022-12-27	WOS:000543261600043
J	Aljumaah, MR; Alkhulaifi, MM; Abudabos, AM; Aljumaah, RS; Alsaleh, AN; Stanley, D				Aljumaah, Mashael R.; Alkhulaifi, Manal M.; Abudabos, Alaeldein M.; Aljumaah, Riyadh S.; Alsaleh, Asma N.; Stanley, Dragana			Bacillus subtilisPB6 based probiotic supplementation plays a role in the recovery after the necrotic enteritis challenge	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; ANTIMICROBIAL GROWTH PROMOTERS; BROILER-CHICKENS; CLOSTRIDIUM-PERFRINGENS; GASTROINTESTINAL-TRACT; INTESTINAL HEALTH; GUT MICROBIOTA; BUTYRIC-ACID; ANIMAL FEED; PERFORMANCE	In poultry production, birds are raised under intensive conditions, which can enable rapid spread of infections, withClostridium perfringens-caused necrotic enteritis (NE) being one of the most devastating for the industry. The current investigation was conducted to evaluate the effectiveness ofBacillus subtilisPB6 probiotic supplementation on bird's post NE recovery, based on chicken performance, cecal microbiota composition, ileum histomorphometric measurements, and short-chain fatty acid production in the cecum of the birds that were challenged with NE mid-production. Birds were split into four groups, including a negative control, positive control challenged withC.perfringens, group supplemented withB.subtilisprobiotic, and NE challenged birds supplemented withB.subtilisprobiotic. Following NE challenge birds were allowed to reach the end of production time at 40 days, and samples were collected to estimate if probiotic supplementation resulted in better post-NE recovery. Intestinal lesion score across the duodenum, jejunum, and ileum indicated that at the end of production timeline NE challenged birds supplemented withB.subtilisprobiotic had lower intestinal lesion scores compared to NE challenged birds without probiotic supplementation implying improved recovery. Probiotic supplementation improved performance of NE challenged birds only in the post-NE recovery stage. NE challenged birds had a significant increase in cecal propionic acid, which was not observed in NE challenged birds supplemented withB.subtilus. BothB.subtilissupplemented groups (challenged and unchanged) were characterized by a significant rise in cecal acetic and butyric acid. Our results demonstrate thatB.subtilissupplementation can assist the birds in dealing with NE outbreak and long term recovery.	[Aljumaah, Mashael R.; Alkhulaifi, Manal M.; Alsaleh, Asma N.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia; [Abudabos, Alaeldein M.; Aljumaah, Riyadh S.] King Saud Univ, Coll Food & Agr Sci, Dept Anim Prod, Riyadh, Saudi Arabia; [Stanley, Dragana] Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld, Australia	King Saud University; King Saud University; Central Queensland University	Stanley, D (corresponding author), Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld, Australia.	D.Stanley@cqu.edu.au	Abudabos, Alaeldein M/E-7222-2014; Alsaleh, Asma/ABD-1640-2020	Abudabos, Alaeldein M/0000-0001-7998-0344; Stanley, Dragana/0000-0001-7019-4726	Deanship of scientific research through the initiative of DSR Graduate Students Research Support (GSR)	Deanship of scientific research through the initiative of DSR Graduate Students Research Support (GSR)	This project was supported by the Deanship of scientific research through the initiative of DSR Graduate Students Research Support (GSR).	Abudabos AM, 2013, INT J AGRIC BIOL, V15, P978; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Baptista DF, 2007, HYDROBIOLOGIA, V575, P83, DOI 10.1007/s10750-006-0286-x; Bbosa G. S., 2014, Health, V6, P410, DOI 10.4236/health.2014.65059; Butaye P, 2003, CLIN MICROBIOL REV, V16, P175, DOI 10.1128/CMR.16.2.175-188.2003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104; Craven SE, 2001, AVIAN DIS, V45, P887, DOI 10.2307/1592868; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dongarra ML, 2013, CURR ALLERGY ASTHM R, V13, P19, DOI 10.1007/s11882-012-0313-0; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Dunkley KD, 2007, POULTRY SCI, V86, P801, DOI 10.1093/ps/86.5.801; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Gaggia F, 2010, INT J FOOD MICROBIOL, P141, DOI [10.1016/j.ijfoodmicro.2010.09.011, DOI 10.1016/J.IJFOODMICRO.2010.09.011]; Gharib-Naseri K, 2019, POULTRY SCI, V98, P6422, DOI 10.3382/ps/pez480; Gholamiandehkordi AR, 2007, AVIAN PATHOL, V36, P375, DOI 10.1080/03079450701589118; Harrison C., 2010, QUANTIFICATION SHORT; Hassan H.M.A., 2018, INT J POULT SCI, V17, P255; Havenstein GB, 2003, POULTRY SCI, V82, P1500, DOI 10.1093/ps/82.10.1500; He LQ, 2018, J CHROMATOGR B, V1092, P359, DOI 10.1016/j.jchromb.2018.06.028; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Hoving LR, 2018, METHODS MOL BIOL, V1730, P247, DOI 10.1007/978-1-4939-7592-1_17; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Jayaraman S, 2013, POULTRY SCI, V92, P370, DOI 10.3382/ps.2012-02528; Johnson JR, 2006, J INFECT DIS, V194, P71, DOI 10.1086/504921; Kloos DP, 2014, RAPID COMMUN MASS SP, V28, P1507, DOI 10.1002/rcm.6923; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Landoni MF, 2015, VET J, V205, P21, DOI 10.1016/j.tvjl.2015.04.016; Lee K, 2010, J POULT SCI, V47, P106, DOI 10.2141/jpsa.009096; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; M'Sadeq SA, 2015, ANIM NUTR, V1, P1, DOI 10.1016/j.aninu.2015.02.004; Montagne L, 2003, ANIM FEED SCI TECH, V108, P95, DOI 10.1016/S0377-8401(03)00163-9; Montassier E, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0301-4; MOORE PR, 1946, J BIOL CHEM, V165, P437; Panda AK, 2009, ASIAN AUSTRAL J ANIM, V22, P1026, DOI 10.5713/ajas.2009.80298; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Redondo LM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00118; Rehman HU, 2007, ARCH ANIM NUTR, V61, P319, DOI 10.1080/17450390701556817; Roberts T, 2015, J APPL POULTRY RES, V24, P257, DOI 10.3382/japr/pfv023; Samanya M, 2002, COMP BIOCHEM PHYS A, V133, P95, DOI 10.1016/S1095-6433(02)00121-6; Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892; Shareef AM, 2009, IRAQI J VET SCI, V23, P45; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Teo AYL, 2006, J APPL POULTRY RES, V15, P229, DOI 10.1093/japr/15.2.229; Timbermont L, 2010, AVIAN PATHOL, V39, P117, DOI 10.1080/03079451003610586; Torres-Rodriguez A, 2005, J APPL POULTRY RES, V14, P665, DOI 10.1093/japr/14.4.665; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; van der Wielen PWJJ, 2000, APPL ENVIRON MICROB, V66, P2536, DOI 10.1128/AEM.66.6.2536-2540.2000; Wegener HC, 2003, CURR OPIN MICROBIOL, V6, P439, DOI 10.1016/j.mib.2003.09.009; Willis WL, 2007, POULTRY SCI, V86, P1856, DOI 10.1093/ps/86.9.1856; Xue GD, 2018, POULTRY SCI, V97, P1334, DOI 10.3382/ps/pex444; Yang Y, 2009, WORLD POULTRY SCI J, V65, P97, DOI 10.1017/S0043933909000008; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; 2016, INT J PHYS MED REHAB, V4, p3S	60	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0232781	10.1371/journal.pone.0232781	http://dx.doi.org/10.1371/journal.pone.0232781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555739	Green Published, gold			2022-12-27	WOS:000543273200039
J	Cinelli, M; Cresci, S; Galeazzi, A; Quattrociocchi, W; Tesconi, M				Cinelli, Matteo; Cresci, Stefano; Galeazzi, Alessandro; Quattrociocchi, Walter; Tesconi, Maurizio			The limited reach of fake news on Twitter during 2019 European elections	PLOS ONE			English	Article								The advent of social media changed the way we consume content, favoring a disintermediated access to, and production of information. This scenario has been matter of critical discussion about its impact on society, magnified in the case of the Arab Springs or heavily criticized during Brexit and the 2016 U.S. elections. In this work we explore information consumption on Twitter during the 2019 European Parliament electoral campaign by analyzing the interaction patterns of official news outlets, disinformation outlets, politicians, people from the showbiz and many others. We extensively explore interactions among different classes of accounts in the months preceding the elections, held between 23rd and 26th of May, 2019. We collected almost 400,000 tweets posted by 863 accounts having different roles in the public society. Through a thorough quantitative analysis we investigate the information flow among them, also exploiting geolocalized information. Accounts show the tendency to confine their interaction within the same class and the debate rarely crosses national borders. Moreover, we do not find evidence of an organized network of accounts aimed at spreading disinformation. Instead, disinformation outlets are largely ignored by the other actors and hence play a peripheral role in online political discussions.	[Cinelli, Matteo] ISC CNR, Rome, Italy; [Cresci, Stefano; Tesconi, Maurizio] IIT CNR, Pisa, Italy; [Galeazzi, Alessandro] Univ Brescia, Brescia, Italy; [Quattrociocchi, Walter] Ca Foscari Univ Venice, Venice, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Informatica e Telematica (IIT-CNR); University of Brescia; Universita Ca Foscari Venezia	Galeazzi, A (corresponding author), Univ Brescia, Brescia, Italy.	a.galeazzi002@unibs.it	Cresci, Stefano/Q-4031-2018; TESCONI, MAURIZIO/P-2441-2016; Quattrociocchi, Walter/L-4550-2016	Cresci, Stefano/0000-0003-0170-2445; TESCONI, MAURIZIO/0000-0001-8228-7807; Galeazzi, Alessandro/0000-0001-6859-0391; Quattrociocchi, Walter/0000-0002-4374-9324; Cinelli, Matteo/0000-0003-3899-4592	CNR-PNR National Project [DFM.AD004.027 289, P0000326]	CNR-PNR National Project	MC acknowledges the support from CNR-PNR National Project DFM.AD004.027 289 "Crisis-Lab" and P0000326 project AMOFI (Analysis and Models OF social medIa).	Allcott H, 2017, J ECON PERSPECT, V31, P211, DOI 10.1257/jep.31.2.211; Bakir V, 2018, DIGIT JOURNAL, V6, P154, DOI 10.1080/21670811.2017.1345645; Bessi A., 2016, 1 MONDAY, V21, P11, DOI [DOI 10.5210/FM.V21I11.7090, 10.5210/fm.v21i11.7090]; Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118093; Bovet A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07761-2; Cresci S, 2019, ACM T WEB, V13, DOI 10.1145/3313184; Cresci S, 2017, WWW'17 COMPANION: PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P963, DOI 10.1145/3041021.3055135; Del Vicario M, 2019, ACM T WEB, V13, DOI 10.1145/3316809; Del Vicario M, 2017, PR INT CONF DATA SC, P648, DOI 10.1109/DSAA.2017.33; Del Vicario M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37825; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Fourney A, 2017, CIKM'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P2071, DOI 10.1145/3132847.3133147; Grinberg N, 2019, SCIENCE, V363, P374, DOI 10.1126/science.aau2706; Mele N, 2017, COMBATING FAKE NEWS; Pierri F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227821; Quattrociocchi W, 2017, SCI AM, V316, P60, DOI 10.1038/scientificamerican0417-60; Quattrociocchi W, 2014, SCI REP-UK, V4, DOI 10.1038/srep04938; Ruths D, 2019, SCIENCE, V363, P348, DOI 10.1126/science.aaw1315; Scheufele DA, 2019, P NATL ACAD SCI USA, V116, P7662, DOI 10.1073/pnas.1805871115; Schmidt AL, 2017, P NATL ACAD SCI USA, V114, P3035, DOI 10.1073/pnas.1617052114; Stella M, 2018, P NATL ACAD SCI USA, V115, P12435, DOI 10.1073/pnas.1803470115; Vicario MD, 2016, ABS161006809 CORR; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; Wald Randall, 2013, 2013 IEEE 14th International Conference on Information Reuse & Integration (IRI), P6, DOI 10.1109/IRI.2013.6642447; Zollo F, 2018, COMPUT SOC SCI, P177, DOI 10.1007/978-3-319-77332-2_10	25	18	20	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234689	10.1371/journal.pone.0234689	http://dx.doi.org/10.1371/journal.pone.0234689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555659	Green Published, gold, Green Submitted			2022-12-27	WOS:000543273200024
J	Sayans, MP; Quintanilla, JAS; Petronacci, CMC; Penaranda, JMS; Jornet, PL; Garcia, FG; Sanchez, YG				Perez Sayans, Mario; Suarez Quintanilla, Juan A.; Chamorro Petronacci, Cintia M.; Suarez Penaranda, Jose M.; Lopez Jornet, Pia; Gomez Garcia, Francisco; Guerrero Sanchez, Yolanda			Volumetric study of the maxillary sinus in patients with sinus pathology	PLOS ONE			English	Article							3-DIMENSIONAL ANALYSIS; COMPUTED-TOMOGRAPHY	Objectives The aim of this study is 1) to obtain the area and volumes of the maxillary sinuses in patients affected by clinically unilateral sinus pathology by comparing the results to the contralateral sinus and 2) to determine the importance of the volumetric measures when diagnosing the percentage of sinus obliteration. Materials and methods A single-centre observational retrospective clinical study was conducted in 214 patients with clinically unilateral sinus pathologies. Linear (mm), area (mm2) and volume (mm3) measurements were taken from Cone Beam Computed Tomography (CBCT) images of the affected sinus as well as from the contralateral ones. Histopathological study was performed using haematoxylin/eosin and PAS or Groccot stains. The lesions were classified into non-specific sinusitis, polyps, inverted papilloma, fungal sinusitis, cysts, mucocele and other lesions. Chi-squared test, ANOVA for independent samples and Pearson test were used for the statistical analysis. Results A total of 100 sinuses were measured in 50 patients (28 men and 22 women, with an age of 43.6 years (SD = 18.3), 50 pathological and 50 healthy contralateral sinuses. The three-dimensional occupation volume of the affected sinuses was 97.1 mm(3)(62.5%) vs. 40.6 mm(3)(22.8%) in the healthy ones (p<0.0001). The medial-lateral width of the sinus in the frontal plane was significantly higher in the cysts group (32.4 mm, CI: 23-41.8 mm). Conclusion In medical terms, the global percentage of occupation determined using the classic manual determination method does not differ from the three-dimensional percentage calculated using specific complex software.	[Perez Sayans, Mario] Univ Santiago de Compostela, Fac Med & Dent, Oral Surg & Implantol Unit, Oral Med,MedOralRes Grp, Santiago De Compostela, Spain; [Perez Sayans, Mario; Chamorro Petronacci, Cintia M.] Fdn Santiago FIDIS, Hlth Res Inst, Santiago De Compostela, Spain; [Suarez Quintanilla, Juan A.] Univ Santiago de Compostela, Fac Med & Dent, Area Human Anat & Embryol, Santiago De Compostela, Spain; [Suarez Penaranda, Jose M.] Univ Hosp Complex Santiago CHUS, Pathol Anat Serv, Santiago De Compostela, Spain; [Lopez Jornet, Pia; Gomez Garcia, Francisco] Univ Murcia, Res Virgen de la Arrixaca Clin Univ Hosp, Clin Odontol, Sch Dent,Fac Med,Univ Hosp Morales Meseguer,IMIB, Murcia, Spain; [Guerrero Sanchez, Yolanda] Univ Murcia, Area Oh Human Anat & Psychobiol, Murcia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University of Murcia; University of Murcia	Sayans, MP (corresponding author), Univ Santiago de Compostela, Fac Med & Dent, Oral Surg & Implantol Unit, Oral Med,MedOralRes Grp, Santiago De Compostela, Spain.; Sayans, MP (corresponding author), Fdn Santiago FIDIS, Hlth Res Inst, Santiago De Compostela, Spain.	perezsayans@gmail.com	Sayáns, Mario Pérez/L-1345-2014; Gómez García, Francisco José/ABE-5240-2021; Petronacci, Cintia Chamorro/F-4267-2019; SUAREZ-PENARANDA, JOSE MANUEL/D-2688-2009	Sayáns, Mario Pérez/0000-0003-2196-9868; Gómez García, Francisco José/0000-0001-6795-1028; Petronacci, Cintia Chamorro/0000-0002-5637-9908; SUAREZ-PENARANDA, JOSE MANUEL/0000-0003-4033-3638; Lopez Jornet, Pia/0000-0002-3314-8613				ANAGNOSTOPOULOU S, 1991, ANAT ANZEIGER, V173, P121; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2019, BRAIN STIMUL MAR; Ariji Y, 1996, DENTOMAXILLOFAC RAD, V25, P19, DOI 10.1259/dmfr.25.1.9084281; Brook I, 2006, OTOLARYNG HEAD NECK, V135, P349, DOI 10.1016/j.otohns.2005.10.059; Butaric LN, 2010, AM J PHYS ANTHROPOL, V143, P426, DOI 10.1002/ajpa.21331; Evteev AA, 2019, AM J PHYS ANTHROPOL, V169, P513, DOI 10.1002/ajpa.23841; Fernandes CL, 2004, J LARYNGOL OTOL, V118, P877, DOI 10.1258/0022215042703705; Galletti B, 2019, AURIS NASUS LARYNX, V46, P520, DOI 10.1016/j.anl.2018.11.004; Giacomini G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190770; Gulec M, 2020, FOLIA MORPHOL, V79, P557, DOI 10.5603/FM.a2019.0106; Hamdy RM, 2014, J ADV RES, V5, P387, DOI 10.1016/j.jare.2013.06.006; Hopkins C, 2007, OTOLARYNG HEAD NECK, V137, P555, DOI 10.1016/j.otohns.2007.02.004; Jun BC, 2005, OTOLARYNG HEAD NECK, V132, P429, DOI 10.1016/j.otohns.2004.11.012; Lee KC, 2010, YONSEI MED J, V51, P932, DOI 10.3349/ymj.2010.51.6.932; Likness MM, 2014, OTOLARYNG HEAD NECK, V150, P305, DOI 10.1177/0194599813513881; Lo Giudice Antonino, 2018, J Clin Exp Dent, V10, pe484, DOI 10.4317/jced.54745; Luz J, 2018, INT J IMPLANT DENT, V4, DOI 10.1186/s40729-018-0128-4; Mehra P, 2009, CURR ALLERGY ASTHM R, V9, P238, DOI 10.1007/s11882-009-0035-0; Milonski Jaroslaw, 2014, Otolaryngol Pol, V68, P83, DOI 10.1016/j.otpol.2013.07.002; Mohlhenrich SC, 2015, J CRANIOFAC SURG, V26, pE723, DOI 10.1097/SCS.0000000000002226; Oksayan R, 2017, ACTA ODONTOL SCAND, V75, P345, DOI 10.1080/00016357.2017.1310294; Paknahad M, 2017, J FORENSIC SCI, V62, P395, DOI 10.1111/1556-4029.13272; Prabhat Mukul, 2016, J Forensic Dent Sci, V8, P40, DOI 10.4103/0975-1475.176950; Przystanska A, 2018, ANN ANAT, V215, P47, DOI 10.1016/j.aanat.2017.09.010; Saccucci M, 2015, EUR REV MED PHARMACO, V19, P185; Sahlstrand-Johnson P, 2011, BMC MED IMAGING, V11, DOI 10.1186/1471-2342-11-8; Schriber M, 2019, CLIN ORAL INVEST, V23, P1349, DOI 10.1007/s00784-018-2552-5; Simuntis R, 2019, AM J RHINOL ALLERGY, V33, P44, DOI 10.1177/1945892418804975; Timmenga N, 2002, ORAL SURG ORAL MED O, V93, P103, DOI 10.1067/moe.2002.120056; Uchida Y, 1998, INT J ORAL MAX IMPL, V13, P811; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; Valtonen O, 2018, ANN OTO RHINOL LARYN, V127, P931, DOI 10.1177/0003489418801386; Velasco-Torres M, 2017, IMPLANT DENT, V26, P288, DOI 10.1097/ID.0000000000000551; Yeung Andy Wai Kan, 2019, Swiss Dent J, V129, P562	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234915	10.1371/journal.pone.0234915	http://dx.doi.org/10.1371/journal.pone.0234915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555640	Green Published, gold			2022-12-27	WOS:000543273200022
J	Berl, REW; Samarasinghe, AN; Jordan, FM; Gavin, MC				Berl, Richard E. W.; Samarasinghe, Alarna N.; Jordan, Fiona M.; Gavin, Michael C.			The Position-Reputation-Information (PRI) scale of individual prestige	PLOS ONE			English	Article							OCCUPATIONAL PRESTIGE; SOCIAL RANK; ATTAINMENT; DYNAMICS; DOMINANCE; EDUCATION; ABILITY; MODEL	Prestige is a key concept across the social and behavioral sciences and has been implicated as an important driver in the processes governing human learning and behavior and the evolution of culture. However, existing scales of prestige fail to account for the full breadth of its potential determinants or focus only on collective social institutions rather than the individual-level perceptions that underpin everyday social interactions. Here, we use open, extensible methods to unite diverse theoretical ideas into a common measurement tool for individual prestige. Participants evaluated the perceived prestige of regional variations in accented speech using a pool of candidate scale items generated from free-listing tasks and a review of published scales. Through exploratory and confirmatory factor analyses, we find that our resulting 7-item scale, composed of dimensions we term position, reputation, and information ("PRI"), exhibits good model fit, scale validity, and scale reliability. The PRI scale of individual prestige contributes to the integration of existing lines of theory on the concept of prestige, and the scale's application in Western samples and its extensibility to other cultural contexts serves as a foundation for new theoretical and experimental trajectories across the social and behavioral sciences.	[Berl, Richard E. W.; Gavin, Michael C.] Colorado State Univ, Dept Human Dimens Nat Resources, Ft Collins, CO 80523 USA; [Samarasinghe, Alarna N.; Jordan, Fiona M.] Univ Bristol, Dept Anthropol & Archaeol, Bristol, Avon, England; [Jordan, Fiona M.; Gavin, Michael C.] Max Planck Inst Sci Human Hist, Jena, Germany	Colorado State University; University of Bristol	Berl, REW (corresponding author), Colorado State Univ, Dept Human Dimens Nat Resources, Ft Collins, CO 80523 USA.	rewberl@colostate.edu	Berl, Richard/AAF-6172-2021	Berl, Richard/0000-0002-4154-1319; Gavin, Michael/0000-0002-2169-4668	Max Planck Institute for the Science of Human History	Max Planck Institute for the Science of Human History	This work was supported by a grant from the Max Planck Institute for the Science of Human History (http://www.shh.mpg.de/) to MCG and FMJ. The funders provided advisement for the work but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, RES METHODS ANTHR; ASCH SE, 1948, PSYCHOL REV, V55, P250, DOI 10.1037/h0057270; BAJEMA CJ, 1968, SOCIOL EDUC, V41, P317, DOI 10.2307/2111879; BARKOW JH, 1975, CURR ANTHROPOL, V16, P553, DOI 10.1086/201619; BARRINGER HR, 1990, SOCIOL EDUC, V63, P27, DOI 10.2307/2112895; Bishop Hywel, 2005, ACTA LINGUIST HAF, V37, P131, DOI DOI 10.1080/03740463.2005.10416087; BLAIKIE NWH, 1977, AUST NZ J SOCIOL, V13, P102; Boyd R., 1985, CULTURE EVOLUTIONARY; Chapais B, 2015, HUM NATURE-INT BIOS, V26, P161, DOI 10.1007/s12110-015-9227-6; Cheng H, 2012, J VOCAT BEHAV, V81, P218, DOI 10.1016/j.jvb.2012.07.005; Cheng JT, 2013, J PERS SOC PSYCHOL, V104, P103, DOI 10.1037/a0030398; Cheng JT, 2010, EVOL HUM BEHAV, V31, P334, DOI 10.1016/j.evolhumbehav.2010.02.004; Coupland N, 2007, J SOCIOLING, V11, P74, DOI 10.1111/j.1467-9841.2007.00311.x; Crawley D, 2014, SAGE OPEN, V4, DOI 10.1177/2158244013518923; Cronk L, 2005, SOC SCI INFORM, V44, P603, DOI 10.1177/0539018405058203; D'Aveni RA, 1990, ORGAN SCI, V1, P121, DOI 10.1287/orsc.1.2.121; Davis K, 1945, AM SOCIOL REV, V10, P242, DOI 10.2307/2085643; Deeter-Schmelz D.R., 2000, J MARK THEORY PRACT, V8, P43, DOI DOI 10.1080/10696679.2000.11501879; Duncan O. D., 1961, OCCUPATIONS SOCIAL S, P109; Fuertes JN, 2012, EUR J SOC PSYCHOL, V42, P120, DOI 10.1002/ejsp.862; GANZEBOOM HBG, 1992, SOC SCI RES, V21, P1, DOI 10.1016/0049-089X(92)90017-B; GILES H, 1970, EDUC REV, V22, P211, DOI 10.1080/0013191700220301; Goldthorpe J. H., 1972, ANAL SOCIAL MOBILITY, P19; Goyder J, 2005, CAN REV SOC ANTHROP, V42, P1; GUPPY N, 1984, SOC FORCES, V62, P709, DOI 10.2307/2578707; GUSFIELD JR, 1963, AM SOCIOL REV, V28, P265, DOI 10.2307/2090613; Hair J.F., 2010, MULTIVARIATE DATA AN; Harbaugh WT, 1998, AM ECON REV, V88, P277; Hauser RM, 1997, SOCIOL METHODOL, V27, P177, DOI 10.1111/1467-9531.271028; Haynes SN, 1995, PSYCHOL ASSESSMENT, V7, P238, DOI 10.1037/1040-3590.7.3.238; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Henrich J, 2001, AM ANTHROPOL, V103, P992, DOI 10.1525/aa.2001.103.4.992; Henrich J., 2002, J COGNITION CULTURE, V2, P87, DOI DOI 10.1163/156853702320281836; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; INKELES A, 1956, AM J SOCIOL, V61, P329, DOI 10.1086/221764; KAHANE H, 1986, LANGUAGE, V62, P495, DOI 10.2307/415474; Kaufman HF, 1945, SOCIOMETRY, V8, P199, DOI 10.2307/2785239; Kitchin R, 2014, BIG DATA SOC, V1, DOI 10.1177/2053951714528481; KROCH AS, 1978, LANG SOC, V7, P17, DOI 10.1017/S0047404500005315; MAEL F, 1992, J ORGAN BEHAV, V13, P103, DOI 10.1002/job.4030130202; Mazzocchi F, 2015, EMBO REP, V16, P1250, DOI 10.15252/embr.201541001; Nakao K, 1992, 1989 SOCIOECONOMIC I; NILSON LB, 1979, SOCIETY, V16, P57, DOI 10.1007/BF02701599; Redhead D, 2019, EVOL HUM BEHAV, V40, P222, DOI 10.1016/j.evolhumbehav.2018.12.001; Reyes-Garcia V, 2008, EVOL HUM BEHAV, V29, P275, DOI 10.1016/j.evolhumbehav.2008.02.002; Rhoads JK, 2010, CRITICAL ISSUES SOCI; Richerson P. J., 2005, NOT GENES ALONE CULT; Samarasinghe AN, 2019, EVALUATIONS ACCENTS; SELIGSON MA, 1977, AM J SOCIOL, V83, P632, DOI 10.1086/226597; SEWELL WH, 1969, AM SOCIOL REV, V34, P82, DOI 10.2307/2092789; Shenkar O, 1997, HUM RELAT, V50, P1361, DOI 10.1177/001872679705001102; Smidts A, 2001, ACAD MANAGE J, V44, P1051, DOI 10.2307/3069448; Steenkamp JBEM, 2003, J INT BUS STUD, V34, P53, DOI 10.1057/palgrave.jibs.8400002; Svalastoga Kaare, 1959, PRESTIGE CLASS MOBIL; Treiman D. J., 1977, OCCUPATIONAL PRESTIG; Vigneron F., 1999, ACAD MARK SCI REV, V1, P1, DOI DOI 10.4018/978-1-59140-327-2.CH001; Vigneron F., 2004, BRAND MANAGEMENT, V11, P484, DOI [10.1057/palgrave.bm.2540194, DOI 10.1057/PALGRAVE.BM.2540194]; von Rueden C, 2008, EVOL HUM BEHAV, V29, P402, DOI 10.1016/j.evolhumbehav.2008.05.001; Weber M., 1946, M WEBER ESSAYS SOCIO; Weber Max, 1972, WIRTSCHAFT GESELLSCH; WEGENER B, 1992, ANNU REV SOCIOL, V18, P253; William Labov, 1966, SOCIAL STRATIFICATIO	62	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234428	10.1371/journal.pone.0234428	http://dx.doi.org/10.1371/journal.pone.0234428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584829	Green Submitted, Green Published, gold			2022-12-27	WOS:000545747200049
J	Dreijer, AR; Kruip, MJHA; Diepstraten, J; Polinder, S; Brouwer, R; Mol, PGM; Croles, FN; Kragten, E; Leebeek, FWG; van den Bemt, PMLA				Dreijer, Albert R.; Kruip, Marieke J. H. A.; Diepstraten, Jeroen; Polinder, Suzanne; Brouwer, Rolf; Mol, Peter G. M.; Croles, F. Nanne; Kragten, Esther; Leebeek, Frank W. G.; van den Bemt, Patricia M. L. A.			Effect of antithrombotic stewardship on the efficacy and safety of antithrombotic therapy during and after hospitalization	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; BLEEDING COMPLICATIONS; VENOUS THROMBOEMBOLISM; WARFARIN; ANTICOAGULATION; DEFINITION; MANAGEMENT; APIXABAN; COST	Background Although the benefits of antithrombotic drugs are indisputable to reduce thrombotic events, they carry a high risk of compromising patient safety. No previous studies investigated the implementation and (cost-) effectiveness of a hospital-based multidisciplinary antithrombotic team on bleeding and thrombotic outcomes. The primary aim of this study was to compare the proportion of patients with a composite end point consisting of one or more bleeding episodes or one or more thrombotic event from hospitalization until three months after hospitalization. Methods and findings A prospective, multicenter before-after intervention study was conducted in two Dutch hospitals. Adult patients hospitalized between October 2015 and December 2017 treated with anticoagulant therapy were included. The primary aim was to estimate the proportion of patients with a composite end point consisting of one or more bleeding episodes or one or more thrombotic event from hospitalization until three months after hospitalization. The intervention was the implementation of a multidisciplinary antithrombotic team focusing on education, medication reviews by pharmacists, implementing of local anticoagulant therapy guidelines based on national guidelines, patient counselling and medication reconciliation at admission and discharge. The primary endpoint was analysed using segmented linear regression. We obtained data for 1,886 patients: 941 patients were included in the usual care period and 945 patients in the intervention period. The S-team study showed that implementation of a multidisciplinary antithrombotic team over time significantly reduced the composite end point consisting of one or more bleeding episodes or one or more thrombotic event from hospitalization until three months after hospitalization in patients using anticoagulant drugs (-1.83% (-2.58% to -1.08%) per 2 month period). Conclusions This study shows that implementation of a multidisciplinary antithrombotic team over time significantly reduces the composite end point consisting of one or more bleeding episodes or one or more thrombotic event from hospitalization until three months after hospitalization in patients using anticoagulant drugs.	[Dreijer, Albert R.] Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands; [Dreijer, Albert R.; Diepstraten, Jeroen] Reinier Graaf Hosp, Dept Hosp Pharm, Delft, Netherlands; [Kruip, Marieke J. H. A.; Croles, F. Nanne; Leebeek, Frank W. G.] Erasmus MC, Dept Hematol, Rotterdam, Netherlands; [Kruip, Marieke J. H. A.] Thrombosis Serv STAR SHL, Rotterdam, Netherlands; [Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Brouwer, Rolf; Kragten, Esther] Reinier Graaf Hosp, Dept Hematol, Delft, Netherlands; [Mol, Peter G. M.; van den Bemt, Patricia M. L. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Reinier de Graaf Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Reinier de Graaf Hospital; University of Groningen	Dreijer, AR (corresponding author), Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands.; Dreijer, AR (corresponding author), Reinier Graaf Hosp, Dept Hosp Pharm, Delft, Netherlands.	a.dreijer@treant.nl		Van den Bemt, Patricia/0000-0003-1418-5520	Stichting Phoenix Schiedam; Daiichi Sankyo; Boehringer Ingelheim; Bayer; Pfizer; Scientific Committee Reinier de Graaf Gasthuis	Stichting Phoenix Schiedam; Daiichi Sankyo(Daiichi Sankyo Company Limited); Boehringer Ingelheim(Boehringer Ingelheim); Bayer(Bayer AG); Pfizer(Pfizer); Scientific Committee Reinier de Graaf Gasthuis	Stichting Phoenix Schiedam, the pharmaceutical companies (Daiichi Sankyo, Boehringer Ingelheim, Bayer and Pfizer) and the Scientific Committee Reinier de Graaf Gasthuis provided financial support for this study in the form of unrestricted grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageno W, 2013, J THROMB HAEMOST, V11, P1597, DOI 10.1111/jth.12301; [Anonymous], 2004, DIONYSIUS, V22, P29; Bajorek BV, 2005, J AM GERIATR SOC, V53, P1912, DOI 10.1111/j.1532-5415.2005.53564.x; Bond CA, 2004, PHARMACOTHERAPY, V24, P953, DOI 10.1592/phco.24.11.953.36133; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Deitelzweig SB, 2013, CLIN THER, V35, P1536, DOI 10.1016/j.clinthera.2013.08.013; Dreijer AR, 2019, INT J CLIN PHARM-NET, V41, P691, DOI 10.1007/s11096-019-00834-2; Dreijer AR, 2019, EUR J INTERN MED, V62, P17, DOI 10.1016/j.ejim.2019.01.008; Dreijer AR, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011537; DURBIN J, 1950, BIOMETRIKA, V37, P409, DOI 10.1093/biomet/37.3-4.409; Ewen EF, 2009, J INTERV CARDIOL, V22, P266, DOI 10.1111/j.1540-8183.2009.00431.x; Fernandez MM, 2015, CLINICOECONOMIC OUTC, V7, P451, DOI 10.2147/CEOR.S85635; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Gomez-Outes Antonio, 2013, Thrombosis, V2013, P640723, DOI 10.1155/2013/640723; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hakkaart-van Roijen L, 2010, HANDLEIDING KOSTENON, P1; Hylek EM, 2014, J AM COLL CARDIOL, V63, P2141, DOI 10.1016/j.jacc.2014.02.549; Lopez-de-Andres A, 2010, BMC HEALTH SERV RES, V10, DOI [10.1186/1472-6963-10-59, 10.1186/1472-6963-10-287]; Maynard G, 2014, AM J HEALTH-SYST PH, V71, P305, DOI 10.2146/ajhp130108; Padron Maria, 2015, J Pharm Pract, V28, P93, DOI 10.1177/0897190013514091; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Reardon DP, 2015, J THROMB THROMBOLYS, V40, P379, DOI 10.1007/s11239-015-1189-3; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Schillig J, 2011, J HOSP MED, V6, P322, DOI 10.1002/jhm.910; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; Sellier E, 2006, ARCH INTERN MED, V166, P2065, DOI 10.1001/archinte.166.19.2065; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; van der Hulle T, 2014, J THROMB HAEMOST, V12, P320, DOI 10.1111/jth.12485; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235048	10.1371/journal.pone.0235048	http://dx.doi.org/10.1371/journal.pone.0235048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584857	Green Published, gold			2022-12-27	WOS:000545747200069
J	Li, Y; Wang, MM; Li, QF; Gao, YX; Li, Q; Li, JG; Cao, YF				Li, Yan; Wang, Meimei; Li, Qiufeng; Gao, Yanxia; Li, Qian; Li, Jianguo; Cao, Yufeng			Transcriptome profiling oflongissimus lumborumin Holstein bulls and steers with different beef qualities	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; MUSCULUS-LONGISSIMUS-DORSI; MEAT QUALITY; INTRAMUSCULAR FAT; CARCASS CHARACTERISTICS; LIPID-METABOLISM; CATTLE; EXPRESSION; PERFORMANCE	Previous research regarding Holstein cows has mainly focused on increasing milk yield. However, in order to maximize the economical profits of Holstein cattle farming, it is necessary to fully take advantage of Holstein bulls to produce high-grade beef. The present study aims to investigate different transcriptomic profiling of Holstein bulls and steers, via high-throughput RNA-sequencing (RNA-seq). The growth and beef quality traits of Holstein steers and bulls were characterized via assessment of weight, rib eye area, marbling score, shear force and intramuscular fat percentage of thelongissimus lumborum(LL) muscle. The results indicated that castration improved the meat quality, yet reduced the meat yield. Subsequently, RNA-seq of the LL muscle from Holstein steers and bulls revealed a total of 56 differentially expressed genes (DEGs). We performed the functional enrichment analysis in Gene Ontology (GO) annotations of the DEGs using GOseq R package software and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis using KOBAS tool. Through the integrated analysis of DEGs with reported QTLs and SNPs, seven promising candidate genes potentially affecting the beef quality of LL muscle following castration were discovered, including muscle structural protein coding genes (MYH1,MYH4,MYH10) and functional protein coding genes (GADL1,CYP2R1,EEPD1,SHISA3). Among them,MYH10,GADL1,CYP2R1,EEPD1andSHISA3were novel candidate genes associated with beef quality traits. Notably,EEPD1was associated with both meat quality and reproduction traits, thus indicating its overlapping role in responding to hormone change, and subsequently inducing beef quality improvement. Our findings provide a complete dataset of gene expression profile of LL in Holstein bulls and steers, and will aid in understanding how castration influence meat yield and quality.	[Li, Yan] Hebei Agr Univ, Coll Vet Med, Baoding, Hebei, Peoples R China; [Wang, Meimei; Li, Qiufeng; Gao, Yanxia; Li, Jianguo; Cao, Yufeng] Hebei Agr Univ, Coll Anim Sci & Technol, Baoding, Hebei, Peoples R China; [Li, Qian] Hebei Anim Husb & Vet Inst, Baoding, Hebei, Peoples R China	Hebei Agricultural University; Hebei Agricultural University	Li, JG; Cao, YF (corresponding author), Hebei Agr Univ, Coll Anim Sci & Technol, Baoding, Hebei, Peoples R China.	jgli@hebau.edu.cn; caoyufeng@hebau.edu.cn			China Agriculture Research System [CARS-37]; Hebei Agricultural University [ZD201608]; Hebei Provincial Department of Human Resources and Social Security [CN201604]	China Agriculture Research System; Hebei Agricultural University; Hebei Provincial Department of Human Resources and Social Security	This work was funded by the China Agriculture Research System (http://www.beefsys.com/post_works1.html), with the grant number CARS-37; Hebei Agricultural University (www.hebau.edu.cn), with the grant number ZD201608; Hebei Provincial Department of Human Resources and Social Security (https://rst.hebei.gov.cn/index.html), with the grant number CN201604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht E, 2016, GENOM DATA, V7, P109, DOI 10.1016/j.gdata.2015.12.014; Allais S, 2014, J ANIM SCI, V92, P4329, DOI 10.2527/jas.2014-7868; Andersen HJ, 2005, MEAT SCI, V70, P543, DOI 10.1016/j.meatsci.2004.07.015; [Anonymous], 2007, AGILENT TECHNOLOGIES, V1; [Anonymous], 2014, LANCET ONCOL, V15, pe475; Ashwell MS, 2004, J DAIRY SCI, V87, P468, DOI 10.3168/jds.S0022-0302(04)73186-0; Baik M, 2014, LIVEST SCI, V168, P168, DOI 10.1016/j.livsci.2014.08.013; Bernard C, 2007, J AGR FOOD CHEM, V55, P5229, DOI 10.1021/jf063372l; Chagas LM, 2007, J DAIRY SCI, V90, P4022, DOI 10.3168/jds.2006-852; Chen CC, 2014, AM J RESP CRIT CARE, V190, P433, DOI 10.1164/rccm.201312-2256OC; Chen D, 2015, ASIAN AUSTRAL J ANIM, V28, P158, DOI 10.5713/ajas.14.0394; Doran AG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-837; Esmailizadeh AK, 2011, ANIM GENET, V42, P592, DOI 10.1111/j.1365-2052.2011.02197.x; FIELD RA, 1971, J ANIM SCI, V32, P849; Gutierrez-Gil B, 2008, ANIM GENET, V39, P51, DOI 10.1111/j.1365-2052.2007.01682.x; Hausman GJ, 2009, J ANIM SCI, V87, P1218, DOI 10.2527/jas.2008-1427; Jeong J, 2013, J ANIM SCI, V91, P4692, DOI 10.2527/jas.2012-6089; Jeong JY, 2013, ANIM GENET, V44, P627, DOI 10.1111/age.12061; Ji B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-441; Jiang JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168946; Jones G, 2014, J LIPID RES, V55, P13, DOI 10.1194/jlr.R031534; Joo ST, 2013, MEAT SCI, V95, P828, DOI 10.1016/j.meatsci.2013.04.044; Karges K, 2001, J ANIM SCI, V79, P2844; Kee HJ, 2008, MOL CELLS, V25, P428; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kim HS, 2017, J BIOL CHEM, V292, P2795, DOI 10.1074/jbc.M116.758235; Komolka K, 2016, GENOM DATA, V7, P131, DOI 10.1016/j.gdata.2015.12.023; Lee SH, 2014, LIVEST SCI, V165, P27, DOI 10.1016/j.livsci.2014.04.006; Liu PY, 2012, J BIOL CHEM, V287, P40898, DOI 10.1074/jbc.M112.393728; Magalhaes AFB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157845; Marti S, 2017, MEAT SCI, V126, P36, DOI 10.1016/j.meatsci.2016.11.013; McClure MC, 2012, ANIM GENET, V43, P662, DOI 10.1111/j.1365-2052.2012.02323.x; Mei CG, 2018, MOL BIOL EVOL, V35, P688, DOI 10.1093/molbev/msx322; Minelli G, 2013, ITAL J ANIM SCI, V12, DOI 10.4081/ijas.2013.e52; Nalaila SM, 2012, J ANIM BREED GENET, V129, P107, DOI 10.1111/j.1439-0388.2011.00954.x; NEBEL RL, 1993, J DAIRY SCI, V76, P3257, DOI 10.3168/jds.S0022-0302(93)77662-6; Nelson JK, 2017, ARTERIOSCL THROM VAS, V37, P423, DOI 10.1161/ATVBAHA.116.308434; Nian YQ, 2018, J SCI FOOD AGR, V98, P4339, DOI 10.1002/jsfa.8960; Ovilo C, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-413, 10.1186/s12863-014-0148-x]; Peters SO, 2012, J ANIM SCI, V90, P3398, DOI [10.2527/jas.2011-4507, 10.2527/jas.2012-4507]; Ribeiro ELDA, 2004, MEAT SCI, V68, P285, DOI 10.1016/j.meatsci.2004.03.008; Sanchez-Escalante A, 2001, MEAT SCI, V58, P421, DOI 10.1016/S0309-1740(01)00045-6; Venkata Reddy B, 2015, ANIM SCI J, V86, P1, DOI 10.1111/asj.12266; Wang BW, 2016, ANIM NUTR, V2, P312, DOI 10.1016/j.aninu.2016.07.005; Warren HE, 2008, MEAT SCI, V78, P270, DOI 10.1016/j.meatsci.2007.06.007; WHEELER TL, 1994, J ANIM SCI, V72, P3145, DOI 10.2527/1994.72123145x; Wu F, 2015, GENET MOL RES, V14, P7873, DOI 10.4238/2015.July.14.13; Yamada T, 2014, ANIM SCI J, V85, P349, DOI 10.1111/asj.12179; Zhang YY, 2011, LIVEST SCI, V135, P76, DOI 10.1016/j.livsci.2010.06.070; Zhao CP, 2014, LIVEST SCI, V161, P201, DOI 10.1016/j.livsci.2013.11.030; Zhou ZK, 2011, MOL BIOL REP, V38, P5307, DOI 10.1007/s11033-011-0680-y	51	12	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235218	10.1371/journal.pone.0235218	http://dx.doi.org/10.1371/journal.pone.0235218			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584890	Green Published, gold			2022-12-27	WOS:000545747200073
J	Ngow, Z; Chynoweth, RJ; Gunnarsson, M; Rolston, P; Buddenhagen, CE				Ngow, Zachary; Chynoweth, Richard J.; Gunnarsson, Matilda; Rolston, Phil; Buddenhagen, Christopher E.			A herbicide resistance risk assessment for weeds in wheat and barley crops in New Zealand	PLOS ONE			English	Article							EVOLUTION; RYEGRASS; POPULATIONS; BROMUS; SPP.	We estimated the risk of selecting for herbicide resistance in 101 weed species known to occur in wheat and barley crops on farms in New Zealand. A protocol was used that accounts for both the risk that different herbicides will select for resistance and each weed's propensity to develop herbicide resistance based on the number of cases worldwide. To provide context we documented current herbicide use patterns. Most weeds (55) were low-risk, 30 were medium-risk and 16 high-risk. The top ten scored weeds wereEchinochloa crus-galli,Poa annua,Lolium multiflorum,Erigeron sumatrensis,Raphanus raphanistrum,Lolium perenne,Erigeron bonariensis,Avena fatua,Avena sterilisandDigitaria sanguinalis. Seven out of ten high-risk weeds were grasses. The most used herbicides were synthetic auxins, an enolpyruvylshikimate-phosphate synthase inhibitor, acetolactate synthase (ALS) inhibitors, carotenoid biosynthesis inhibitors, and long-chain fatty acid inhibitors. ALS-inhibitors were assessed as posing the greatest risk for more species than other modes-of-action. Despite pre-emergence herbicides being known to delay resistance, New Zealand farmers only applied flufenacet and terbuthlazine with high frequency. Based on our analysis, surveys for herbicide-resistant species should focus on the high-risk species we identified. Farmer extension efforts in New Zealand should address resistance evolution in cropping weeds.	[Ngow, Zachary; Buddenhagen, Christopher E.] AgResearch Ltd, Hamilton, New Zealand; [Chynoweth, Richard J.; Gunnarsson, Matilda; Rolston, Phil] Fdn Arable Res, Christchurch, New Zealand	AgResearch - New Zealand	Ngow, Z; Buddenhagen, CE (corresponding author), AgResearch Ltd, Hamilton, New Zealand.	zacharyngow@gmail.com; chris.buddenhagen@agresearch.co.nz	Ngow, Zachary/GNP-6179-2022; Buddenhagen, Christopher/J-3942-2019	Ngow, Zachary/0000-0002-2435-2321; Buddenhagen, Christopher/0000-0002-3016-1054	Ministry of Business, Innovation and Employment [C10X1806]	Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	All the authors worked under the Ministry of Business, Innovation and Employment [grant number C10X1806] to AgResearch Ltd.: "Improved weed control and vegetation management to minimize future herbicide resistance." AgResearch Ltd is a crown owned research institution doing science research businesses but owned by the Crown (i.e. the Government) in New Zealand. The funding agency is also the main public science funding organization in New Zealand and provided financial support in the form of authors' [ZN and CEB] salaries and/or research materials. They did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, B OEPP EPPO, V45, P371, DOI [10.1111/epp.12246, DOI 10.1111/EPP.12246]; [Anonymous], 1986, DETAILS PATTERNS PES; Baucom RS, 2016, AM J BOT, V103, P181, DOI 10.3732/ajb.1500510; Beckie HJ, 2002, CAN J PLANT SCI, V82, P463, DOI 10.4141/P01-067; Beckie HJ, 2006, WEED TECHNOL, V20, P793, DOI 10.1614/WT-05-084R1.1; Bourdot G. W., 1996, P81; Bourdot GW, 1998, NEW ZEAL J CROP HORT, V26, P233, DOI 10.1080/01140671.1998.9514059; Breitwieser I. P.J., 2010, FLORA NZ ONLINE; Broster J. C., 2010, 17th Australasian weeds conference. New frontiers in New Zealand: together we can beat the weeds. Christchurch, New Zealand, 26-30 September, 2010, P274; Broster J. C., 2012, Plant Protection Quarterly, V27, P36; Broster J. C., 2011, Plant Protection Quarterly, V26, P22; Buddenhagen CE, 2020, NEW ZEAL J AGR RES, V63, P430, DOI 10.1080/00288233.2019.1636829; Busi R, 2020, PEST MANAG SCI, V76, P487, DOI 10.1002/ps.5534; Darling W, 2015, HIGHEST BARLEY YIELD; Ghanizadeh H, 2021, NEW ZEAL J AGR RES, V64, P471, DOI 10.1080/00288233.2019.1705863; Gunnarsson M., 2017, New Zealand Plant Protection, V70, P165, DOI 10.30843/nzpp.2017.70.45; Hampton JG, 2012, AGRON NZ, P12; Harrington KC., 2014, N Z PLANT PROTECT, V67, P331; HOLLAND PT, 1999, REV TRENDS AGR PESTI; HRAC, 2020, GLOB CLASS LOOK; Jasieniuk M, 1996, WEED SCI, V44, P176, DOI 10.1017/S0043174500093747; Kon K. F., 2007, New Zealand Plant Protection, V60, P174; Manktelow D, 2005, REP MINIST ENV PROJ; Menchari Y, 2006, NEW PHYTOL, V171, P861, DOI 10.1111/j.1469-8137.2006.01788.x; Millner JP, 2013, ECOSYSTEM SERVICES IN NEW ZEALAND: CONDITIONS AND TRENDS, P102; Moss S, 2019, CROP PROT, V115, P13, DOI 10.1016/j.cropro.2018.09.005; New Zealand ACVM Group, 1999, ACVM REG INF REQ PRO; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Owen MJ, 2015, CROP PASTURE SCI, V66, P1079, DOI 10.1071/CP15063; Owen MJ, 2015, CROP PASTURE SCI, V66, P466, DOI 10.1071/CP14293; Owen MJ, 2012, PEST MANAG SCI, V68, P1077, DOI 10.1002/ps.3270; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; ProductionWise, 2020, PRODUCTIONWISE GRAIN; R Core Team, 2020, R LANG ENV STAT COMP; Rolston MP, 2003, N Z PLANT PROTECT-SE, V56, P220, DOI 10.30843/nzpp.2003.56.6095; Stephenson GR, 2000, PESTICIDE USE WORLD, P9, DOI [10.1021/bk-2003-0853.ch015, DOI 10.1021/BK-2003-0853.CH015]; Thorne ME, 2003, J SOIL WATER CONSERV, P9; Watson E, 2017, HIGHEST WHEAT YIELD; Wickham H., 2016, GGPLOT2 ELEGANT GRAP	39	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234771	10.1371/journal.pone.0234771	http://dx.doi.org/10.1371/journal.pone.0234771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584914	Green Published, gold			2022-12-27	WOS:000545747200040
J	Raisner, R; Bainer, R; Haverty, PM; Benedetti, KL; Gascoigne, KE				Raisner, Ryan; Bainer, Russell; Haverty, Peter M.; Benedetti, Kelli L.; Gascoigne, Karen E.			Super-enhancer acquisition drives oncogene expression in triple negative breast cancer	PLOS ONE			English	Article							CELL IDENTITY; SUBTYPES	Triple Negative Breast Cancer (TNBC) is a heterogeneous disease lacking known molecular drivers and effective targeted therapies. Cytotoxic chemotherapy remains the mainstay of treatment for TNBCs, which have significantly poorer survival rates compared to other breast cancer subtypes. In addition to changes within the coding genome, aberrant enhancer activity is a well-established contributor to tumorigenesis. Here we use H3K27Ac chromatin immunoprecipitation followed by sequencing (ChIP-Seq) to map the active cis-regulatory landscape in TNBC. We identify distinct disease subtypes associated with specific enhancer activity, and over 2,500 unique superenhancers acquired by tumor cells but absent from normal breast tissue. To identify potential actionable disease drivers, we probed the dependency on genes that associate with tumor-specific enhancers by CRISPR screening. In this way we identify a number of tumor-specific dependencies, including a previously uncharacterized dependency on the TGF beta pseudo-receptor BAMBI.	[Raisner, Ryan; Gascoigne, Karen E.] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA; [Bainer, Russell] Maze Therapeut, San Francisco, CA USA; [Haverty, Peter M.] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Benedetti, Kelli L.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California San Francisco	Gascoigne, KE (corresponding author), Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA.	gascoigne.karen@gene.com		Gascoigne, Karen/0000-0002-9407-2982	Genentech; Canadian Institutes of Health Research (CIHR); Genome BC; Genome Canada; Genome Quebec	Genentech(Roche HoldingGenentech); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome BC; Genome Canada(Genome Canada); Genome Quebec	Funding for this study was provided by Genentech. The funder provided support in the form of salaries for authors [RR, PMH, KEG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.' The results published here are in whole or part based upon data generated by The Canadian Epigenetics, Epigenomics, Environment and Health Research Consortium (CEEHRC) initiative funded by the Canadian Institutes of Health Research (CIHR), Genome BC, Genome Canada and Genome Quebec. Information about CEEHRC and the participating investigators and institutions can be found at http://www.epigenomes.ca/.	[Anonymous], 2018, FORENSIC SCI INT GEN, V34, pe18; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2018, IEEE T SYSTEMS MAN C, P1, DOI DOI 10.2861/86313; Callow MG, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0301-y; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Corces MR, 2018, SCIENCE, V362, P420, DOI 10.1126/science.aav1898; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Franco HL, 2018, GENOME RES, V28, P159, DOI 10.1101/gr.226019.117; Haverty PM, 2016, NATURE, V533, P333, DOI 10.1038/nature17987; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; McKeown MR, 2017, CANCER DISCOV, V7, P1136, DOI 10.1158/2159-8290.CD-17-0399; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Pellacani D, 2016, CELL REP, V17, P2060, DOI 10.1016/j.celrep.2016.10.058; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	20	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235343	10.1371/journal.pone.0235343	http://dx.doi.org/10.1371/journal.pone.0235343			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584896	Green Published, gold			2022-12-27	WOS:000545747200041
J	Steinemann, ST; Geelan, BJ; Zaehringer, S; Mutuura, K; Wolkow, E; Frasseck, L; Opwis, K				Steinemann, Sharon T.; Geelan, Benjamin J.; Zaehringer, Stephan; Mutuura, Kamalatharsi; Wolkow, Ewgenij; Frasseck, Lars; Opwis, Klaus			Potentials and pitfalls of increasing prosocial behavior and self-efficacy over time using an online personalized platform	PLOS ONE			English	Article							CONCEPTUAL-FRAMEWORK; FEEDBACK; INTERVENTIONS; TECHNOLOGY	Background This longitudinal mixed methods experimental study aimed to better understand the interplay between digital technology exposure over time, self-efficacy, and prosocial behavior in everyday contexts. Methods 66 psychology students tracked their daily prosocial behavior over three weeks. Additionally, half of the participants were randomly assigned to receive access to an online platform, which made personalized suggestions for prosocial actions to complete. Qualitative post-study interviews complemented quantitative measures. Results Platform exposure had no measurable impact beyond that of tracking over time on either prosocial behavior or self-efficacy. Tracking increased self-efficacy to perform everyday prosocial actions, but did not affect self-efficacy to impact change. Prosocial behavior was predicted by self-efficacy to impact change. Enjoyment of the platform predicted completing higher numbers of suggested prosocial actions and was related to a higher likelihood to continue using the platform in the future. Avenues for increasing platform effectiveness include context-specific action personalization, an effective reminder system, and better support for the development of self-efficacy to impact change through meaningful actions. Conclusion Technology for prosocial behavior should be enjoyable, capable of being seamlessly integrated into everyday life, and ensure that suggested actions are perceived as meaningful in order to support the sustainable development of self-efficacy and prosocial behavior over time.	[Steinemann, Sharon T.; Geelan, Benjamin J.; Zaehringer, Stephan; Mutuura, Kamalatharsi; Wolkow, Ewgenij; Frasseck, Lars; Opwis, Klaus] Univ Basel, Fac Psychol, Dept Gen Psychol & Methodol, Basel, Switzerland	University of Basel	Steinemann, ST (corresponding author), Univ Basel, Fac Psychol, Dept Gen Psychol & Methodol, Basel, Switzerland.	sharon.steinemann@unibas.ch		OPWIS, KLAUS/0000-0003-0509-8070	Freie Akademische Gesellschaft Basel	Freie Akademische Gesellschaft Basel	STS was supported by the Freie Akademische Gesellschaft Basel (https://www.fagbasel.ch/). The funder played no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abras Chadia, 2004, BAINBRIDGE ENCY HUMA, V37, P445; Adams AT, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP 2015), P719, DOI 10.1145/2750858.2805843; Akin-Little A, 2019, EFFECT EXTRINSIC REI; Aknin LB, 2015, J EXPT PSYCHOL GEN, V144; All A, 2015, COMPUT EDUC, V88, P29, DOI 10.1016/j.compedu.2015.04.012; [Anonymous], 2013, Pract Midwife, V16, P7; [Anonymous], 2000, INT J NONPROFIT VOLU, DOI DOI 10.1002/(ISSN)1479-103X; BANDURA A, 1990, EVAL PROGRAM PLANN, V13, P9, DOI 10.1016/0149-7189(90)90004-G; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Bandura A., 1997, SELF EFFICACY EXERCI; Batson C.D., 2003, ALTRUISM PROSOCIAL B, DOI [10.1002/0471264385.wei0519, DOI 10.1002/0471264385.WEI0519]; Bekkers R, 2011, NONPROF VOLUNT SEC Q, V40, P924, DOI 10.1177/0899764010380927; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Brown Valerie A., 2010, TACKLING WICKED PROB; Calvo RA, 2014, POSITIVE COMPUTING: TECHNOLOGY FOR WELLBEING AND HUMAN POTENTIAL, P1; Caprara GV, 2008, J EDUC PSYCHOL, V100, P525, DOI 10.1037/0022-0663.100.3.525; Chen G, 2001, ORGAN RES METHODS, V4, P62, DOI 10.1177/109442810141004; Direito A, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4568; Du Honglu, 2014, P WIR HLTH 2014 NAT, P1, DOI DOI 10.1145/2668883.2668887; Eisenberg N., 2014, PROSOCIAL DEV MULTID, P17, DOI [10.1093/acprof:oso/9780199964772.003.0002, DOI 10.1093/ACPROF:OSO/9780199964772.003.0002]; Feng L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126090; Field A., 2012, DISCOVERING STAT USI, DOI DOI 10.1111/INSR.12011_21; Finstad K, 2010, INTERACT COMPUT, V22, P323, DOI 10.1016/j.intcom.2010.04.004; Fogg B.J., 2009, P 4 INT C PERSUASIVE, P1, DOI [10.1145/1541948.1541999, DOI 10.1145/1541948.1541999]; Fogg BJ., 2003, PERSUASIVE TECHNOLOG; Fugard AJB, 2015, INT J SOC RES METHOD, V18, P669, DOI 10.1080/13645579.2015.1005453; Gardner B, 2016, HEALTH PSYCHOL REV, V10, P89, DOI 10.1080/17437199.2015.1082146; Geelan B., 2016, P 28 AUSTR C COMP HU, P542; Glisczinski D, 2018, J TRANSFORM EDUC, V16, P175, DOI 10.1177/1541344618777367; Domingo MG, 2016, COMPUT HUM BEHAV, V56, P21, DOI 10.1016/j.chb.2015.11.023; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hamari J, 2014, P ANN HICSS, P3025, DOI 10.1109/HICSS.2014.377; Hermsen S, 2016, COMPUT HUM BEHAV, V57, P61, DOI 10.1016/j.chb.2015.12.023; Huang HP, 2016, J BUS RES, V69, P2206, DOI 10.1016/j.jbusres.2015.12.031; Iacoviello Brian M, 2017, JMIR Mhealth Uhealth, V5, pe56, DOI 10.2196/mhealth.7226; Koivisto J, 2019, GAMIFIN C; Konrath S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137585; Kowalski RM, 2019, AGGRESS VIOLENT BEH, V45, P20, DOI 10.1016/j.avb.2018.02.009; Kreis R, 2017, DISCOURSE COMMUN, V11, P498, DOI 10.1177/1750481317714121; Layous K, 2017, J POSIT PSYCHOL, V12, P385, DOI 10.1080/17439760.2016.1198924; Luo Y, 2019, J ENVIRON MANAGE, V232, P445, DOI 10.1016/j.jenvman.2018.11.061; Michie S., 2014, BEHAV CHANGE WHEEL B; Munson S. A., 2012, 2012 6th International Conference on Pervasive Computing Technologies for Healthcare, P25, DOI 10.4108/icst.pervasivehealth.2012.248691; Nafcha O, 2016, PROG BRAIN RES, V229, P49, DOI 10.1016/bs.pbr.2016.06.008; Nelson SK, 2016, EMOTION, V16, P850, DOI 10.1037/emo0000178; Nichols S, 2017, SYNTHESE, V194, P809, DOI 10.1007/s11229-015-0893-z; O'Brien HL, 2008, J AM SOC INF SCI TEC, V59, P938, DOI 10.1002/asi.20801; OECD/OCDE, OECD GUIDELINE TESTI, DOI [10.1787/9789264091016-en, DOI 10.1787/9789264091016-EN]; Oliver MB, 2010, HUM COMMUN RES, V36, P53, DOI 10.1111/j.1468-2958.2009.01368.x; Orji R, 2018, HEALTH INFORM J, V24, P66, DOI 10.1177/1460458216650979; Patrick RB, 2018, J GENET PSYCHOL, V179, P231, DOI 10.1080/00221325.2018.1491472; Petersen JM, 2019, J MED INTERNET RES, V21, DOI 10.2196/12687; Pollak JP, 2010, IEEE PERVAS COMPUT, V9, P21, DOI 10.1109/MPRV.2010.41; Pushkar D, 2010, PSYCHOL RES PROG, P11; R Development Core Team, 2009, R LANG ENV STAT COMP; Rapp A, 2017, COMPUT HUM BEHAV, V71, P455, DOI 10.1016/j.chb.2015.02.048; Reinecke L, 2016, ROUTLEDGE HDB MEDIA, P106; Rosenberg RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055003; Roth C, 2012, CYBERPSYCH BEH SOC N, V15, P378, DOI 10.1089/cyber.2011.0437; S BE, 2018, J CROHNS COLITIS, V12, pS049; Sargeant A, 2006, J BUS RES, V59, P155, DOI 10.1016/j.jbusres.2005.04.006; Shin J, 2018, J MORAL EDUC, V47, P159, DOI 10.1080/03057240.2017.1419943; Shriram K., 2017, SOCIAL SIGNAL PROCES, P304, DOI DOI 10.1017/9781316676202.022; Spohr SA, 2015, J SUBST ABUSE TREAT, V56, P1, DOI 10.1016/j.jsat.2015.01.011; Stawarz K, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P2653, DOI 10.1145/2702123.2702230; Steinemann S.T., 2015, P 2015 ANN S COMP HU, P319, DOI DOI 10.1145/2793107.2793125; Steinemann ST, 2017, J MEDIA PSYCHOL-GER, V29, P54, DOI 10.1027/1864-1105/a000211; Street TD, 2017, GAMES HEALTH J, V6, P136, DOI 10.1089/g4h.2016.0102; Tannenbaum PH, 1981, PLAY IT AGAIN SAM RE; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; Ubhi HK, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3479; Velazquez-Perez L, 2001, REV NEUROLOGIA, V32, P71, DOI 10.33588/rn.3201.2000283; Weinstein N, 2010, J PERS SOC PSYCHOL, V98, P222, DOI 10.1037/a0016984; Weiser P., 2015, TAXONOMY MOTIVATIONA; White K, 2012, J MARKETING, V76, P103, DOI 10.1509/jm.09.0581; Wood W, 2016, ANNU REV PSYCHOL, V67, P289, DOI 10.1146/annurev-psych-122414-033417	77	0	0	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234422	10.1371/journal.pone.0234422	http://dx.doi.org/10.1371/journal.pone.0234422			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584828	gold, Green Published			2022-12-27	WOS:000545747200056
J	Teng, KT; McGreevy, PD; Toribio, JALML; Dhand, NK				Teng, Kendy T.; McGreevy, Paul D.; Toribio, Jenny-Ann L. M. L.; Dhand, Navneet K.			Positive attitudes towards feline obesity are strongly associated with ownership of obese cats	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; CONDITION SCORE; LIFE-SPAN; OVERWEIGHT; PREVALENCE; DISEASE; DOGS; HEALTH; PERIODONTITIS	Overweight and obesity (O&O) is a risk factor for several health conditions and can result in a shorter lifespan for cats. The objectives of this study were to investigate (a) cat owners' attitudes towards feline O&O and their associations with O&O in their cats; and (b) the risk factors for feline O&O and underweight, particularly those involving owner practice. An online survey comprising questions related to cat owners' attitudes towards feline O&O, owner-reported body weight and body condition of their cat, and potential risk factors for feline O&O was conducted. Primarily targeting the Australian population, the survey attracted 1,390 valid responses. In response to ten attitude-related questions, more participants (percentage range among the ten questions: 39.1-76.6%) held a disapproving attitude towards feline O&O than a neutral (17.1-31.9%) or approving attitude (3.9-27.7%). A greater proportion of participants had a more disapproving attitude towards obesity than towards overweight. Cats belonging to owners with an approving attitude towards O&O were more likely to be overweight or obese than cats belonging to owners with a disapproving attitude towards O&O. The cats had particularly high odds of overweight or obesity if their owner agreed that 'being chubby says that the cat has a quality life' (OR: 3.75, 95% CI: 2.41-5.82) and 'being fat says that the cat has a quality life' (OR: 4.98, 95%CI: 2.79-8.91). This study revealed, for the first time, that begging for food was a risk factor for O&O in cats. Other important feline risk factors for O&O identified included being middle-aged, being mixed-breed, dry food as the major diet, the amount of feed not being quantified, and frequently spending time indoors. Being over 11 years, receiving no dry food and receiving measured amounts of feed were associated with an increased odds of underweight in cats. As specific attitudes often lead to certain behaviours, reducing approving attitudes towards feline O&O may potentially reduce the frequency of O&O and the risks of O&O-related disorders in cats.	[Teng, Kendy T.; McGreevy, Paul D.; Toribio, Jenny-Ann L. M. L.; Dhand, Navneet K.] Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Camperdown, NSW, Australia; [Teng, Kendy T.] Univ Complutense Madrid, VISAVET Hlth Surveillance Ctr, Madrid, Spain	University of Sydney; Complutense University of Madrid	Teng, KT (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Camperdown, NSW, Australia.; Teng, KT (corresponding author), Univ Complutense Madrid, VISAVET Hlth Surveillance Ctr, Madrid, Spain.	kendy.t.teng@gmail.com	Toribio, Jenny-Ann LML/B-5032-2011	Dhand, Navneet/0000-0002-4362-3596; Teng, Kendy/0000-0003-3200-1545	Royal Society for the Prevention of Cruelty to Animals (RSPCA) Australia	Royal Society for the Prevention of Cruelty to Animals (RSPCA) Australia	KTT has received 2015 RSPCA Australia Alan White Scholarship for Animal Welfare from Royal Society for the Prevention of Cruelty to Animals (RSPCA) Australia to conduct the current study. The RSPCA Australia plays no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRTUM (Italian Association of Cancer Registries), 2016, EPIDEMIOL PREV S2, V40, P1; AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; Allan FJ, 2000, PREV VET MED, V46, P183, DOI 10.1016/S0167-5877(00)00147-1; Animal Medicines Australia Pty Ltd, 2016, PET OWN AUSTR; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2017, RESOURCE SELECTION P; [Anonymous], 2000, GRBS, V41, P12; Aune D, 2015, EUR J EPIDEMIOL, V30, P1009, DOI 10.1007/s10654-015-0081-y; Australian Bureau of Statistics, 2017, 2071 0 CENS POP HOUS; Barratt DG, 1998, WILDLIFE RES, V25, P475, DOI 10.1071/WR97026; BROUSSARD JD, 1995, J AM VET MED ASSOC, V206, P302; Cat Owner Club, CAT BREEDS 2017; Cave NJ, 2012, PREV VET MED, V107, P121, DOI 10.1016/j.prevetmed.2012.05.006; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; Coffey LT, 2010, TODAY; Colliard L, 2009, J FELINE MED SURG, V11, P135, DOI 10.1016/j.jfms.2008.07.002; Corbee RJ, 2014, J ANIM PHYSIOL AN N, V98, P1075, DOI 10.1111/jpn.12176; Courcier EA, 2012, VET REC, V171, P560, DOI 10.1136/vr.100953; Courcier EA, 2010, J FELINE MED SURG, V12, P746, DOI 10.1016/j.jfms.2010.05.011; de Moura-Grec PG, 2014, CIENC SAUDE COLETIVA, V19, P1763, DOI 10.1590/1413-81232014196.13482013; Donoghue S., 1998, J NUTR, V128, P2776; Eastland-Jones RC, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.25; Edwards S, THIS PHOTOGRAPHER TA; Eibl-Eibesfeldt I., 1970, ETHOLOGY BIOL BEHAV; Fox J., 2019, R COMPANION APPL REG, V.; Genosko G, 2005, NATURES CULTURES CUT; Greenebaum J, 2004, SOC ANIM, V12, P117, DOI 10.1163/1568530041446544; Harper EJ, 2001, J SMALL ANIM PRACT, V42, P433, DOI 10.1111/j.1748-5827.2001.tb02496.x; Hills A.M., 1993, SOC ANIM, V1, P111, DOI [10.1163/156853093X00028, DOI 10.1163/156853093X00028]; Hosmer D. W., 2013, APPL LOGISTIC REGRES; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; KELLERT SR, 1987, WILDLIFE SOC B, V15, P363; Kienzle E, 2006, J NUTR, V136, p1947S, DOI 10.1093/jn/136.7.1947S; Kronfeld D. S., 1994, J NUTR, V124, p2683S, DOI 10.1093/jn/124.suppl_12.2683s; Laflamme D, 2014, VET CLIN N AM-SMALL, V44, P761, DOI 10.1016/j.cvsm.2014.03.001; Lorenz Konrad, 1981, FDN ETHOLOGY; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Lund E. M., 2005, International Journal of Applied Research in Veterinary Medicine, V3, P88; Marston LC, 2009, J APPL ANIM WELF SCI, V12, P189, DOI 10.1080/10888700902955948; McGreevy P., 2011, CARROTS STICKS PRINC; McGreevy PD, 2005, VET REC, V156, P695, DOI 10.1136/vr.156.22.695; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Mhurchu CN, 2006, ASIA PAC J CLIN NUTR, V15, P287; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Musher-Eizenman DR, 2007, OBESITY, V15, P2095, DOI 10.1038/oby.2007.249; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nagayasu A, 1999, ADV DRUG DELIVER REV, V40, P75, DOI 10.1016/S0169-409X(99)00041-1; Nascimento GG, 2015, J CLIN PERIODONTOL, V42, P495, DOI 10.1111/jcpe.12417; Ohlund M, 2018, ACTA VET SCAND, V60, DOI 10.1186/s13028-018-0359-7; Park M, 2014, PREV MED, V65, P13, DOI 10.1016/j.ypmed.2014.03.027; Paul ES, 2000, VET REC, V146, P269, DOI 10.1136/vr.146.10.269; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rand JS, 2013, VET CLIN N AM-SMALL, V43, P221, DOI 10.1016/j.cvsm.2013.01.003; Revelle W, 2017, **DATA OBJECT**; Rochlitz I., 2005, THE WELFARE OF CATS; Rosen Howard, 2014, Mo Med, V111, P104; Rowe EC, 2017, PREV VET MED, V143, P39, DOI 10.1016/j.prevetmed.2017.05.010; Rowe E, 2015, PREV VET MED, V121, P273, DOI 10.1016/j.prevetmed.2015.07.011; Salt C, 2019, J VET INTERN MED, V33, P89, DOI 10.1111/jvim.15367; Scarlett J. M., 1996, Veterinary Clinical Nutrition, V3, P128; Scarlett JM, 1998, J AM VET MED ASSOC, V212, P1725; SCARLETT JM, 1994, INT J OBESITY, V18, pS22; SLOTH C, 1992, J SMALL ANIM PRACT, V33, P178, DOI 10.1111/j.1748-5827.1992.tb01111.x; Summers JF, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1902-0; Taylor EJ, 1995, P NUTR SOC, V54, P645, DOI 10.1079/PNS19950064; Teng KT, 2018, J SMALL ANIM PRACT, V59, P603, DOI 10.1111/jsap.12905; Teng KT, 2018, J FELINE MED SURG, V20, P1110, DOI [10.1177/1098612X17752198, 10.1177/1098612x17752198]; Teng KT, 2017, PREV VET MED, V144, P102, DOI 10.1016/j.prevetmed.2017.05.021; The Prospect Shop, AUSTR WID POSTC BREA; Thomas RL, 2014, URBAN ECOSYST, V17, P911, DOI 10.1007/s11252-014-0360-5; Toribio JALM, 2009, J FELINE MED SURG, V11, P449, DOI 10.1016/j.jfms.2008.06.010; Turner W., 2001, QUAL REP, V6, P1, DOI [10.46743/2160-3715/2001.2009, DOI 10.46743/2160-3715/2001.2009]; Venables WN., 2002, MODERN APPL STAT S; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Woods M, 2003, MAMMAL REV, V33, P174, DOI 10.1046/j.1365-2907.2003.00017.x; Worthing KA, 2012, J FELINE MED SURG, V14, P405, DOI 10.1177/1098612X12441875; Zhang A, 2015, J AM ACAD DERMATOL, V72, P606, DOI 10.1016/j.jaad.2014.12.013; Zhang Y., 2008, PLOS ONE, V3, pe3933	79	3	3	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234190	10.1371/journal.pone.0234190	http://dx.doi.org/10.1371/journal.pone.0234190			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584825	Green Published, gold			2022-12-27	WOS:000545747200061
J	Escoubet, J; Kenigsberg, M; Derock, M; Yaligara, V; Bock, MD; Roche, S; Massey, F; de Foucauld, H; Bettembourg, C; Olivier, A; Berthemy, A; Capdevielle, J; Legoux, R; Perret, E; Buzy, A; Chardenot, P; Destelle, V; Leroy, A; Cahours, C; Teixeira, S; Juvet, P; Gauthier, P; Leguet, M; Rocheteau-Beaujouan, L; Chatoux, MA; Deshayes, W; Clement, M; Kabiri, M; Orsini, C; Mikol, V; Didier, M; Guillemot, JC				Escoubet, Johanna; Kenigsberg, Mireille; Derock, Murielle; Yaligara, Veeranagouda; Bock, Marie-Dominique; Roche, Sandrine; Massey, Florence; de Foucauld, Helene; Bettembourg, Charles; Olivier, Anne; Berthemy, Antoine; Capdevielle, Joel; Legoux, Richard; Perret, Eric; Buzy, Armelle; Chardenot, Pascale; Destelle, Valerie; Leroy, Aurelie; Cahours, Christophe; Teixeira, Sandrine; Juvet, Patrick; Gauthier, Pascal; Leguet, Michael; Rocheteau-Beaujouan, Laurence; Chatoux, Marie-Agnes; Deshayes, Willy; Clement, Margerie; Kabiri, Mostafa; Orsini, Cecile; Mikol, Vincent; Didier, Michel; Guillemot, Jean-Claude			ABHD11, a new diacylglycerol lipase involved in weight gain regulation	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; RAT; IDENTIFICATION; BIOSYNTHESIS; MITOCHONDRIA; INHIBITION; PHYSIOLOGY; ENZYME; ALPHA	Obesity epidemic continues to spread and obesity rates are increasing in the world. In addition to public health effort to reduce obesity, there is a need to better understand the underlying biology to enable more effective treatment and the discovery of new pharmacological agents. Abhydrolase domain-containing protein 11 (ABHD11) is a serine hydrolase enzyme, localized in mitochondria, that can synthesize the endocannabinoid 2-arachidonoyl glycerol (2AG) in vitro. In vivo preclinical studies demonstrated that knock-out ABHD11 mice have a similar 2AG level as WT mice and exhibit a lean metabolic phenotype. Such mice resist to weight gain in Diet Induced Obesity studies (DIO) and display normal biochemical plasma parameters. Metabolic and transcriptomic analyses on serum and tissues of ABHD11 KO mice from DIO studies show a modulation in bile salts associated with reduced fat intestinal absorption. These data suggest that modulating ABHD11 signaling pathway could be of therapeutic value for the treatment of metabolic disorders.	[Escoubet, Johanna; Kenigsberg, Mireille; Derock, Murielle; Yaligara, Veeranagouda; Bock, Marie-Dominique; Roche, Sandrine; Massey, Florence; de Foucauld, Helene; Bettembourg, Charles; Olivier, Anne; Buzy, Armelle; Juvet, Patrick; Gauthier, Pascal; Leguet, Michael; Rocheteau-Beaujouan, Laurence; Chatoux, Marie-Agnes; Deshayes, Willy; Clement, Margerie; Orsini, Cecile; Mikol, Vincent; Didier, Michel; Guillemot, Jean-Claude] Sanofi Res & Dev, Chilly Mazarin, France; [Berthemy, Antoine; Perret, Eric] Evotec, Toulouse, France; [Capdevielle, Joel; Legoux, Richard; Perret, Eric] Sanofi Res & Dev, Toulouse, France; [Chardenot, Pascale; Destelle, Valerie; Leroy, Aurelie; Cahours, Christophe; Teixeira, Sandrine] Sanofi Res & Dev, Montpellier, France; [Kabiri, Mostafa] Sanofi Res & Dev, Ind Pk Hochst, Frankfurt, Germany	Sanofi-Aventis; Sanofi France; Evotec; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France	Escoubet, J (corresponding author), Sanofi Res & Dev, Chilly Mazarin, France.	Johanna.escoubet@sanofi.com		escoubet, johanna/0000-0003-4669-7766; /0000-0001-7372-1528	Sanofi	Sanofi	The work was funded by Sanofi. Sanofi provided support in the form of salaries for all Sanofi authors [J.E., M.Ke., M.De., V.Y., M.D.B., S. R., F.M., H.d.F., C.B., A.O., J.C., R.L., E.P., A.Bu., P. C., V.D., A.L., C.C., S.T., P.J., P.G., M.L., L.R.B., M. A.C., W.D., M.C., M.Ka., C.O., V.M., M.Di., J.C.G.]. The funder had a role in the decision to publish but no role in the study design, data collection and analysis or preparation of the manuscript. The specific roles of the authors are articulated in the `author contribution' section.	Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]; Araki M, 2016, J BIOCHEM, V160, P269, DOI 10.1093/jb/mvw034; Arya M, 2017, BIOCHEM BIOPH RES CO, V487, P875, DOI 10.1016/j.bbrc.2017.04.145; Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Belleau F, 2008, J BIOMED INFORM, V41, P706, DOI 10.1016/j.jbi.2008.03.004; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 1999, BIOCHEM BIOPH RES CO, V256, P377, DOI 10.1006/bbrc.1999.0254; Bisogno T, 2013, BRIT J PHARMACOL, V169, P784, DOI 10.1111/bph.12013; Catanzaro G, 2009, BIOCHEM BIOPH RES CO, V388, P439, DOI 10.1016/j.bbrc.2009.08.037; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Di Marzo V, 2009, NAT REV ENDOCRINOL, V5, P633, DOI 10.1038/nrendo.2009.197; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; FAROOQUI AA, 1989, ANN NY ACAD SCI, V559, P25; Palacios-Verdu MG, 2015, J MED GENET, V52, P248, DOI 10.1136/jmedgenet-2014-102713; Garnier X., 2017, JOBIM 2017 JOURN OUV, P1; Grober J, 1999, J BIOL CHEM, V274, P29749, DOI 10.1074/jbc.274.42.29749; Hofmann AF, 2010, J LIPID RES, V51, P226, DOI 10.1194/jlr.R000042; Kaplan AS, 1998, J PEDIATR-US, V132, P223, DOI 10.1016/S0022-3476(98)70435-4; Lancet Global Health, 2019, LANCET GLOBAL HLTH, V7, pe1; LEE MW, 1995, BBA-LIPID LIPID MET, V1254, P311, DOI 10.1016/0005-2760(94)00193-3; Lefort N, 2009, J PROTEOMICS, V72, P1046, DOI 10.1016/j.jprot.2009.06.011; Martinez-Augustin O, 2008, WORLD J GASTROENTERO, V14, P5630, DOI 10.3748/wjg.14.5630; Massa F, 2005, J MOL MED, V83, P944, DOI 10.1007/s00109-005-0698-5; McPartland JM, 2006, GENE, V370, P64, DOI 10.1016/j.gene.2005.11.004; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mechoulam R., 2005, MILESTONES DRUG THER; Navia-Paldanius D, 2016, EUR J PHARM SCI, V93, P253, DOI 10.1016/j.ejps.2016.08.031; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Pertwee RG, 2001, GUT, V48, P859, DOI 10.1136/gut.48.6.859; Pircher PC, 2003, J BIOL CHEM, V278, P27703, DOI 10.1074/jbc.M302128200; Qi YP, 2015, BBA-MOL CELL BIOL L, V1851, P19, DOI 10.1016/j.bbalip.2014.04.008; Reisenberg M, 2012, PHILOS T R SOC B, V367, P3264, DOI 10.1098/rstb.2011.0387; Rimmerman N, 2008, BRIT J PHARMACOL, V153, P380, DOI 10.1038/sj.bjp.0707561; Rosenberger TA, 2007, LIPIDS, V42, P187, DOI 10.1007/s11745-007-3019-7; Schubert C, 2009, CELL MOL LIFE SCI, V66, P1178, DOI 10.1007/s00018-008-8401-y; Siegmund SV, 2007, FASEB J, V21, P2798, DOI 10.1096/fj.06-7717com; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Silvestri C, 2012, EXPERT OPIN INV DRUG, V21, P1309, DOI 10.1517/13543784.2012.704019; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Smith KB, 2016, PRIMARY CARE, V43, P121, DOI 10.1016/j.pop.2015.10.001; Suarez J, 2011, NEUROSCIENCE, V192, P112, DOI 10.1016/j.neuroscience.2011.06.062; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; SUTHERLAND CA, 1982, J BIOL CHEM, V257, P4006; Thomas A, 2009, RAPID COMMUN MASS SP, V23, P629, DOI 10.1002/rcm.3918; Ueda N, 2011, BIOFACTORS, V37, P1, DOI 10.1002/biof.131; Wiedl T, 2011, J PROTEOMICS, V74, P1884, DOI 10.1016/j.jprot.2011.04.030; World Health Organization, OB OV FACT SHEET	49	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234780	10.1371/journal.pone.0234780	http://dx.doi.org/10.1371/journal.pone.0234780			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579589	gold, Green Published			2022-12-27	WOS:000545646600061
J	Abildgaard, J; Tingstedt, J; Zhao, YA; Hartling, HJ; Pedersen, AT; Lindegaard, B; Nielsen, SD				Abildgaard, Julie; Tingstedt, Jeanette; Zhao, Yanan; Hartling, Hans Jakob; Pedersen, Anette Tonnes; Lindegaard, Birgitte; Dam Nielsen, Susanne			Increased systemic inflammation and altered distribution of T-cell subsets in postmenopausal women	PLOS ONE			English	Article							SENESCENCE; MENOPAUSE; OBESITY; PROLIFERATION; NORMALIZATION; RESPONSES; ESTROGEN; MICE	Aim To investigate markers of systemic inflammation in pre- and postmenopausal women and identify possible predictors of systemic inflammation with menopause. Methods Cross-sectional study of 69 healthy women between 45- and 60 years. Blood samples were collected to assess leukocyte subsets and plasma cytokines. MRI and DXA scans were performed to assess body composition. Through uni- and multivariate analyses, follicle-stimulating hormone (FSH), visceral fat mass and age were evaluated as predictors of systemic inflammation in relation to menopause. Results Postmenopausal women tended to have higher leukocyte counts (5.4 x10(9)vs. 4.9 x10(9)cells/l, p = 0.05) reflected in increased total lymphocytes (1.8 x10(9)vs. 1.6 x10(9)cells/l, p = 0.01) and monocytes (0.5 x10(9)vs. 0.4 x10(9)cells/l, p = 0.02), compared to premenopausal women. Increased visceral fat mass was a strong predictor of high leukocyte subsets. Postmenopausal women had higher plasma TNF-alpha (2.24 vs. 1.91 pg/ml, p = 0.01) and IL-6 (0.45 vs. 0.33 pg/ml, p = 0.004) compared to premenopausal women and high FSH was a significant predictor of increased plasma TNF-alpha, IL-1 beta and IL-6. Menopause was further associated with increased T-cells (1,336 vs. 1,128 cells/mu l, p = 0.04) reflected in significantly higher counts of exhausted-, senescent-, and memory CD4+ T-cell subsets. Conclusions Menopause is associated with increased systemic inflammation as well as exhausted- and senescent T-cells. We suggest, that both increased visceral fat mass and declining sex hormone levels might contribute to postmenopausal systemic inflammation and calls for further large-scale studies to confirm these findings.	[Abildgaard, Julie; Lindegaard, Birgitte] Univ Copenhagen, Ctr Inflammat & Metab, Rigshosp, Copenhagen O, Denmark; [Abildgaard, Julie; Lindegaard, Birgitte] Univ Copenhagen, Ctr Phys Act Res, Rigshosp, Copenhagen O, Denmark; [Tingstedt, Jeanette; Zhao, Yanan; Hartling, Hans Jakob; Dam Nielsen, Susanne] Univ Copenhagen, Viroimmunol Res Unit, Rigshosp, Dept Infect Dis, Copenhagen O, Denmark; [Tingstedt, Jeanette] Statens Serum Inst, Virus Res & Dev, Dept Virol & Special Microbial Diagnost, Copenhagen O, Denmark; [Pedersen, Anette Tonnes] Univ Copenhagen, Dept Gynaecol, Rigshosp, Copenhagen O, Denmark; [Lindegaard, Birgitte] Nordsjaellands Hosp, Dept Pulm & Infect Dis, Hillerod, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Statens Serum Institut; Rigshospitalet; University of Copenhagen	Abildgaard, J (corresponding author), Univ Copenhagen, Ctr Inflammat & Metab, Rigshosp, Copenhagen O, Denmark.; Abildgaard, J (corresponding author), Univ Copenhagen, Ctr Phys Act Res, Rigshosp, Copenhagen O, Denmark.	julie.abildgaard.01@regionh.dk	Lindegaard, Birgitte/AGY-9629-2022; Abildgaard, Julie/ABB-2325-2020	Abildgaard, Julie/0000-0003-1317-7051; Lindegaard, Birgitte/0000-0002-5236-8427; Tingstedt, Jeanette Linnea/0000-0001-6005-0518; Nielsen, Susanne Dam/0000-0001-6391-7455	TrygFonden [101390, 20045]; Danish National Research Foundation [DNRF55]	TrygFonden; Danish National Research Foundation(Danmarks Grundforskningsfond)	The Centre for Physical Activity Research (CFAS) is supported by TrygFonden (grants ID 101390 and ID 20045). During the study period, the Centre of Inflammation and Metabolism (CIM) was supported by a grant from the Danish National Research Foundation (DNRF55). The funding sources were not involved in the conduction of the study or interpretation of the results.	Abildgaard J, 2013, AM J PHYSIOL-ENDOC M, V304, pE1227, DOI 10.1152/ajpendo.00492.2012; Abildgaard J, 2018, J CLIN ENDOCRINOL ME; Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Cenci S, 2003, P NATL ACAD SCI USA, V100, P10405, DOI 10.1073/pnas.1533207100; Cioffi M, 2002, MATURITAS, V41, P187, DOI 10.1016/S0378-5122(01)00286-9; Dong CH, 2018, CLIN BIOCHEM, V52, P131, DOI 10.1016/j.clinbiochem.2017.11.008; Engelmann F, 2011, AGE, V33, P275, DOI 10.1007/s11357-010-9178-0; Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; GIGLIO T, 1994, LIFE SCI, V54, P1305, DOI 10.1016/0024-3205(94)00508-7; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kullo IJ, 2002, AM J CARDIOL, V89, P1441, DOI 10.1016/S0002-9149(02)02366-4; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Parish ST, 2009, J IMMUNOL, V182, P4237, DOI 10.4049/jimmunol.0803449; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Pawelec G, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-15; Potter VJV, 2012, ENDOCRINOLOGY, V153, P4266, DOI 10.1210/en.2011-2006; Randolph JF, 2011, J CLIN ENDOCR METAB, V96, P746, DOI 10.1210/jc.2010-1746; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Schmidt FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121971; Sjoholm A, 2006, DIABETES-METAB RES, V22, P4, DOI 10.1002/dmrr.568; Stubelius A, 2017, IMMUNOBIOLOGY, V222, P878, DOI 10.1016/j.imbio.2017.05.007; Tyagi AM, 2012, OSTEOPOROSIS INT, V23, P1151, DOI 10.1007/s00198-011-1650-x; van Benthem BHB, 2002, AIDS, V16, P919, DOI 10.1097/00002030-200204120-00012; van der Weerd K, 2012, DIABETES, V61, P401, DOI 10.2337/db11-1065; Veronelli A, 2004, DIABETES CARE, V27, P2501, DOI 10.2337/diacare.27.10.2501; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yasui T, 2007, MATURITAS, V56, P396, DOI 10.1016/j.maturitas.2006.11.002	35	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235174	10.1371/journal.pone.0235174	http://dx.doi.org/10.1371/journal.pone.0235174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574226	gold, Green Published			2022-12-27	WOS:000544972400031
J	Feyrer, LJ; Zhao, ST; Whitehead, H; Matthews, CJD				Feyrer, Laura Joan; Zhao, Shu Ting; Whitehead, Hal; Matthews, Cory J. D.			Prolonged maternal investment in northern bottlenose whales alters our understanding of beaked whale reproductive life history	PLOS ONE			English	Article							MESOPLODON-DENSIROSTRIS; HYPEROODON-AMPULLATUS; ZIPHIUS-CAVIROSTRIS; PARENTAL INVESTMENT; DIVING BEHAVIOR; SEX-DIFFERENCES; FEEDING-HABITS; WEANING AGE; CARBON; DELTA-N-15	Nursing and weaning periods are poorly understood in cetaceans due to the difficulty of assessing underwater behaviour in the wild. However, the onset and completion of weaning are critical turning points for individual development and survival, with implications for a species' life history including reproductive potential. delta N-15 and delta C-13 deposited in odontocete teeth annuli provide a lifetime record of diet, offering an opportunity to investigate variation and trends in fundamental biology. While available reproductive parameters for beaked whales have largely been inferred from single records of stranded or hunted animals and extrapolated across species, here we examine the weaning strategy and nursing duration in northern bottlenose whales (Hyperoodon ampullatus) by measuring stable isotopes deposited in dentine growth layer groups (GLGs). Using a collection ofH.ampullatusteeth taken from whales killed during the whaling era (N = 48) and from two stranded specimens, we compared ontogenetic variation of delta N-15 and delta C-13 found in annual GLGs across all individuals, by sex and by region. We detected age-based trends in both delta N-15 and delta C-13 that are consistent across regions and males and females, and indicate that nursing is prolonged and weaning does not conclude until whales are 3-4 years old, substantially later than previous estimates of 1 year. Incorporating a prolonged period of maternal care intoH.ampullatuslife history significantly reduces their reproductive potential, with broad implications for models of beaked whale life history, energetics and the species' recovery from whaling.	[Feyrer, Laura Joan; Whitehead, Hal] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Zhao, Shu Ting; Matthews, Cory J. D.] Fisheries & Oceans Canada, Arctic Aquat Res Div, Winnipeg, MB, Canada	Dalhousie University; Fisheries & Oceans Canada	Feyrer, LJ (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	ljfeyrer@dal.ca	Feyrer, Laura Joan/H-5144-2016	Feyrer, Laura Joan/0000-0002-9300-1947	Fisheries and Oceans Species at Risk program; Natural Sciences and Engineering Research Council of Canada; Killam Trusts	Fisheries and Oceans Species at Risk program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Killam Trusts	LJF, HW and CJDM received funding from Fisheries and Oceans Species at Risk program (https://www.dfo-mpo.gc.ca/speciesespeces/sara-lep/index-eng.html) for this work. In addition, LJF received funding from the Natural Sciences and Engineering Research Council of Canada and Killam Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the contributions of the GG Hatch Lab to the analysis of these samples, and support of Dr. Steve Ferguson, DFO. Teeth specimens from whaled animals were contributed by Nils Oien, Institute of Marine Research Norway. Samples from stranded whales were generously contributed by Wayne Ledwell, of the Newfoundland Stranding network.	AHLQUIST DA, 1984, J COMP PHYSIOL B, V155, P75, DOI 10.1007/BF00688794; [Anonymous], 2020, PROLONGED MATERNAL I, DOI [10.5061/dryad.k98sf7m3j, DOI 10.5061/DRYAD.K98SF7M3J]; [Anonymous], 2015, DTSCH VIERTELJAHRESS, V89, P41; [Anonymous], 2017, REPROD MAMM FEM; Baird R.W., 2019, ETHOLOGY BEHAVIOURAL, P1, DOI [10.1007/978-3-030-16663-2_14, DOI 10.1007/978-3-030-16663-2_14]; Barley J, 2007, VET REC, V160, P452, DOI 10.1136/vr.160.13.452-a; Bates D, LME4 LINEAR MIXED EF; Benjaminsen T., 1979, Behavior of Marine Animals, V3, P143; BENJAMINSEN T, 1972, Norwegian Journal of Zoology, V20, P233; Best P.B., 1984, Reports of the International Whaling Commission Special Issue, P51; CHRISTENSEN I, 1973, Norwegian Journal of Zoology, V21, P331; Clutton-Brock T., 2016, MAMMAL SOC; CLUTTONBROCK TH, 1981, NATURE, V289, P487, DOI 10.1038/289487a0; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; EFSA J, 2010, EFSA J, V8, P1; Einfeldt AL, 2019, J MAMMAL, V100, P1671, DOI 10.1093/jmammal/gyz131; Ellis R, 2017, BEAKED WHALES: A COMPLETE GUIDE TO THEIR BIOLOGY AND CONSERVATION, P1; English PA, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00014; Evacitas FC, 2017, MAR MAMMAL SCI, V33, P748, DOI 10.1111/mms.12396; Feyrer LJ, 2019, ECOL EVOL, V9, P13567, DOI 10.1002/ece3.5813; Gero S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1113; Goldbogen JA, 2017, ANNU REV MAR SCI, V9, P367, DOI 10.1146/annurev-marine-122414-033905; Gowans S, 2001, ANIM BEHAV, V62, P369, DOI 10.1006/anbe.2001.1756; Gowans SE, 1999, SOCIAL ORG POPULATIO, P1; Grove T, 2020, MAR MAMMAL SCI, V36, P1033, DOI 10.1111/mms.12689; Hooker SK, 2019, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00514; Hooker SK, 2009, RESP PHYSIOL NEUROBI, V167, P235, DOI 10.1016/j.resp.2009.04.023; Hooker SK, 1999, P ROY SOC B-BIOL SCI, V266, P671, DOI 10.1098/rspb.1999.0688; Hooker SK, 2001, CAN J ZOOL, V79, P1442, DOI 10.1139/cjz-79-8-1442; Huang SL, 2011, MAR MAMMAL SCI, V27, P182, DOI 10.1111/j.1748-7692.2010.00392.x; Klevezal G.A., 1996, RECORDING STRUCTURES; LEE PC, 1991, J ZOOL, V225, P99, DOI 10.1111/j.1469-7998.1991.tb03804.x; Luque Sebastian P., 2007, Aquatic Mammals, V33, P241, DOI 10.1578/AM.33.2.2007.241; Magozzi S, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1763; Matthews CJD, 2015, J MAMMAL, V96, P425, DOI 10.1093/jmammal/gyv046; MAYNARDSMITH J, 1980, BEHAV ECOL SOCIOBIOL, V7, P247; McSweeney DJ, 2007, MAR MAMMAL SCI, V23, P666, DOI 10.1111/j.1748-7692.2007.00135.x; Mendes S, 2007, OECOLOGIA, V151, P605, DOI 10.1007/s00442-006-0612-z; New LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068725; Newsome SD, 2006, MAR MAMMAL SCI, V22, P556, DOI 10.1111/j.1748-7692.2006.00043.x; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Newsome SD, 2009, MAR ECOL PROG SER, V374, P229, DOI 10.3354/meps07747; Oftedal OT, 1997, J MAMMARY GLAND BIOL, V2, P205, DOI 10.1023/A:1026328203526; Perrin W.F., 1984, Reports of the International Whaling Commission Special Issue, P97; Pierce K.V., 1980, International Whaling Commission Report of the Commission, P99; Quay P, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001817; Read F. L., 2018, NAMMCO SCI PUBLICATI, V10, P1; Rendell L, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0066; Riofrio-Lazo M, 2012, MAR ECOL PROG SER, V450, P229, DOI 10.3354/meps09562; Rossman S, 2015, OECOLOGIA, V178, P415, DOI 10.1007/s00442-015-3241-6; Scheffer V.B., 1980, International Whaling Commission Report of the Commission, P51; Simonis AE, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.0070; Smithi KJ, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00388; Tonnesen P, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2570-y; TRIVERS RL, 1974, AM ZOOL, V14, P249; Trivers RL., 1972, SEXUAL SELECTION DES; Trueman CN, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0669; Trueman CN, 2019, PEERJ, V7, DOI 10.7717/peerj.7912; Trueman CN, 2018, TRACKING ANIMAL MIGR, P137; Whitehead H., 2000, CETACEAN SOC FIELD S	62	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235114	10.1371/journal.pone.0235114	http://dx.doi.org/10.1371/journal.pone.0235114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574188	gold, Green Published			2022-12-27	WOS:000544972400055
J	Mauer, K; Hellmann, SL; Groth, M; Frobius, AC; Zischler, H; Hankeln, T; Herlyn, H				Mauer, Katharina; Hellmann, Soeren Lukas; Groth, Marco; Froebius, Andreas C.; Zischler, Hans; Hankeln, Thomas; Herlyn, Holger			The genome, transcriptome, and proteome of the fish parasitePomphorhynchus laevis(Acanthocephala)	PLOS ONE			English	Article							POMPHORHYNCHUS-LAEVIS ACANTHOCEPHALA; COMPLETE MITOCHONDRIAL GENOME; COLOSSOMA-MACROPOMUM CUVIER; NUCLEAR-DNA CONTENT; PHYLOGENETIC-RELATIONSHIPS; ENDOPARASITIC ACANTHOCEPHALA; DEGENERATE TETRAPLOIDY; HELMINTH-PARASITES; DEFINITIVE HOST; RAINBOW-TROUT	Thorny-headed worms (Acanthocephala) are endoparasites exploiting Mandibulata (Arthropoda) and Gnathostomata (Vertebrata). Despite their world-wide occurrence and economic relevance as a pest, genome and transcriptome assemblies have not been published before. However, such data might hold clues for a sustainable control of acanthocephalans in animal production. For this reason, we present the first draft of an acanthocephalan nuclear genome, besides the mitochondrial one, using the fish parasitePomphorhynchus laevis(Palaeacanthocephala) as a model. Additionally, we have assembled and annotated the transcriptome of this species and the proteins encoded. A hybrid assembly of long and short reads resulted in a near-completeP.laevisdraft genome of ca. 260 Mb, comprising a large repetitive portion of ca. 63%. Numbers of transcripts and translated proteins (35,683) were within the range of other members of the Rotifera-Acanthocephala clade. Our data additionally demonstrate a significant reorganization of the acanthocephalan gene repertoire. Thus, more than 20% of the usually conserved metazoan genes were lacking inP.laevis. Ontology analysis of the retained genes revealed many connections to the incorporation of carotinoids. These are probably taken up via the surface together with lipids, thus accounting for the orange coloration ofP.laevis. Furthermore, we found transcripts and protein sequences to be more derived inP.laevisthan in rotifers from Monogononta and Bdelloidea. This was especially the case in genes involved in energy metabolism, which might reflect the acanthocephalan ability to use the scarce oxygen in the host intestine for respiration and simultaneously carry out fermentation. Increased plasticity of the gene repertoire through the integration of foreign DNA into the nuclear genome seems to be another underpinning factor of the evolutionary success of acanthocephalans. In any case, energy-related genes and their proteins may be considered as candidate targets for the acanthocephalan control.	[Mauer, Katharina; Zischler, Hans; Herlyn, Holger] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut iomE, Anthropol, Mainz, Germany; [Hellmann, Soeren Lukas; Hankeln, Thomas] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut iomE, Mol Genet & Genom Anal Grp, Mainz, Germany; [Groth, Marco] Fritz Lipmann Inst, CF DNA Sequencing, Leibniz Inst Aging, Jena, Germany; [Froebius, Andreas C.] Justus Liebig Univ Giessen, Biomed Res Ctr Seltersberg BFS, Mol Androl, Giessen, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Justus Liebig University Giessen	Mauer, K; Herlyn, H (corresponding author), Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut iomE, Anthropol, Mainz, Germany.	kamauer@uni-mainz.de; herlyn@uni-mainz.de		Hellmann, Lukas/0000-0003-4958-1419; Zischler, Hans/0000-0002-3440-8376	Johannes Gutenberg University Mainz	Johannes Gutenberg University Mainz	The only funding resource involved in this project was a so-called Stufe 1 funding by Johannes Gutenberg University Mainz to Holger Herlyn, as declared already. This funding was internal and has no extra number. It is just "Stufe 1". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no additional specific funding for this work.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Abrusan G, 2009, BIOINFORMATICS, V25, P1329, DOI 10.1093/bioinformatics/btp084; Ahlrichs WH, 1997, ZOOMORPHOLOGY, V117, P41, DOI 10.1007/s004350050028; Amin OM, 2013, COMP PARASITOL, V80, P39, DOI 10.1654/4562.1; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2015, ENERGY MALAYSIA, V6, P5; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; [Anonymous], 2010, J CLIN APHERESIS, V25, P1, DOI DOI 1671-8755(2010)04-0001-04; Arkhipova IR, 2005, P NATL ACAD SCI USA, V102, P11781, DOI 10.1073/pnas.0505333102; Bakker TCM, 1997, ECOLOGY, V78, P1098, DOI 10.1890/0012-9658(1997)078[1098:PICIBA]2.0.CO;2; BARRETT J, 1973, EXPERIENTIA, V29, P651, DOI 10.1007/BF01944752; BARRETT J, 1968, COMP BIOCHEM PHYSIOL, V27, P575, DOI 10.1016/0010-406X(68)90254-5; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bininda-Emonds Olaf R. P., 2016, Life-Basel, V6, P38, DOI 10.3390/life6030038; Blommaert J, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5859-y; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boschetti C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003035; Brand T.von., 1940, Journal of Parasitology Urbana, V26, P301, DOI 10.2307/3272103; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; BULLOCK W. L., 1969, Problems in systematics of parasites., P9; BULLOCK WL, 1949, J MORPHOL, V84, P201, DOI 10.1002/jmor.1050840203; CALUMPANG SMF, 1995, B ENVIRON CONTAM TOX, V55, P494, DOI 10.1007/BF00196027; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cevrimel DS, 2017, SU URUN DERG, V34, P255, DOI 10.12714/egejfas.2017.34.3.02; Chakraborty M, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw654; Choi CJ, 2010, KOREAN J PARASITOL, V48, P139, DOI 10.3347/kjp.2010.48.2.139; Cobbs C, 2013, MOL PHYLOGENET EVOL, V68, P221, DOI 10.1016/j.ympev.2013.03.012; Coghlan A, 2019, NAT GENET, V51, P163, DOI 10.1038/s41588-018-0262-1; CROMPTON DW, 1967, NATURE, V215, P964, DOI 10.1038/215964b0; Cushion MT, 2004, J EUKARYOT MICROBIOL, V51, P30, DOI 10.1111/j.1550-7408.2004.tb00158.x; de la Cruz CPP, 2012, ASIA LIFE SCI, V21, P287; de Matos LV, 2017, PARASITOL RES, V116, P1029, DOI 10.1007/s00436-017-5384-3; Costa CMD, 2018, REV BRAS PARASITOL V, V27, P562, DOI [10.1590/S1984-296120180079, 10.1590/s1984-296120180079]; Diaz Cosin D.J., 1972, Boletin R Soc esp Hist nat (Biol), V70, P239; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dunagan T.T., 1991, P299; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Evans DW, 2001, J FISH BIOL, V59, P166, DOI 10.1111/j.1095-8649.2001.tb02346.x; Eyres I, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0202-9; Eyres I, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-148; Ferraz de Lima CLB., 1990, B TEC CEPTA, V2, P43; Flot JF, 2013, NATURE, V500, P453, DOI 10.1038/nature12326; Fontaneo D, 2015, HDB ZOOLOGY, P2017; Fortmann Michel, 2001, REV INT STRATEGIQUE, V44, P41; Franch-Gras L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34188-y; Frobius AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004004; Frobius AC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00020-w; Garcia-Varela M, 2005, J PARASITOL, V91, P1401, DOI 10.1645/GE-523R.1; Garcia-Varela M, 2006, MOL PHYLOGENET EVOL, V40, P61, DOI 10.1016/j.ympev.2006.02.010; Garey JR, 1996, J MOL EVOL, V43, P287, DOI 10.1007/BF02338837; Gazi M, 2016, ZOOL SCR, V45, P437, DOI 10.1111/zsc.12160; Gazi M, 2015, PARASITOL INT, V64, P64, DOI 10.1016/j.parint.2015.01.009; Gazi M, 2012, PARASITOL INT, V61, P307, DOI 10.1016/j.parint.2011.12.001; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Goater TM, 2014, PARASITISM: THE DIVERSITY AND ECOLOGY OF ANIMAL PARASITES, 2ND EDITION, P1; Goubert C, 2015, GENOME BIOL EVOL, V7, P1192, DOI 10.1093/gbe/evv050; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRAFF D, 1963, J PARASITOL, V49, P204, DOI 10.2307/3275984; Gribble KE, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3540-x; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hackl T, 2014, BIOINFORMATICS, V30, P3004, DOI 10.1093/bioinformatics/btu392; Haffner K. v., 1950, Zoologischer Anzeiger Erganzungsb, V145, P243; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hamann O, 1891, JENA Z NATURW, V1, P113; HAMMOND RA, 1966, J EXP BIOL, V45, P203; Han J, 2019, AQUAT TOXICOL, V214, DOI 10.1016/j.aquatox.2019.105230; Herlyn H, 1997, ZOOMORPHOLOGY, V117, P135, DOI 10.1007/s004350050038; Herlyn H, 2003, MOL PHYLOGENET EVOL, V26, P155, DOI 10.1016/S1055-7903(02)00309-3; Herlyn H, 2017, ZOOMORPHOLOGY, V136, P425, DOI 10.1007/s00435-017-0369-4; Herlyn H, 2017, PARASITOL RES, V116, P1207, DOI 10.1007/s00436-017-5398-x; HINE PM, 1974, J FISH BIOL, V6, P521, DOI 10.1111/j.1095-8649.1974.tb04569.x; Hoff KJ, 2013, NUCLEIC ACIDS RES, V41, pW123, DOI 10.1093/nar/gkt418; HORVATH K, 1971, J PARASITOL, V57, P132, DOI 10.2307/3277767; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hubley R., 2013, REPEATMASKER OPEN 40; Hur JH, 2009, MOL BIOL EVOL, V26, P375, DOI 10.1093/molbev/msn260; Jeronimo GT, 2017, AQUACULTURE, V469, P124, DOI 10.1016/j.aquaculture.2016.11.027; Juhling F, 2012, NUCLEIC ACIDS RES, V40, P2833, DOI 10.1093/nar/gkr1131; Kado T, 2018, GENOME BIOL EVOL, V10, P3196, DOI 10.1093/gbe/evy219; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Kaldonski N, 2009, P ROY SOC B-BIOL SCI, V276, P169, DOI 10.1098/rspb.2008.0798; Kayis S, 2009, ISR J AQUACULT-BAMID, V61, P93; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keen NT, 1998, P NATL ACAD SCI USA, V95, P4789, DOI 10.1073/pnas.95.9.4789; KENNEDY CR, 1978, J FISH BIOL, V13, P265, DOI 10.1111/j.1095-8649.1978.tb03434.x; Kennedy CR, 1999, FOLIA PARASIT, V46, P111; KENNEDY CR, 1989, J FISH BIOL, V34, P607, DOI 10.1111/j.1095-8649.1989.tb03339.x; Kennedy CR, 2006, ECOLOGY OF THE ACANTHOCEPHALA, P1, DOI 10.2277/ 0521850088; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kim HS, 2018, MOL ECOL RESOUR, V18, P646, DOI 10.1111/1755-0998.12768; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; KORTING W, 1972, J PARASITOL, V58, P45, DOI 10.2307/3278239; Kriventseva EV, 2003, TRENDS GENET, V19, P124, DOI 10.1016/S0168-9525(03)00023-4; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; LAURIE JOHN S., 1959, EXPTL PARASITOL, V8, P188, DOI 10.1016/0014-4894(59)90018-9; Le TH, 2002, TRENDS PARASITOL, V18, P206, DOI 10.1016/S1471-4922(02)02252-3; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Mabuchi K, 2006, AQUACULTURE, V257, P68, DOI 10.1016/j.aquaculture.2006.03.040; Malta Jose Celso de Oliveira, 2001, Acta Amazonica, V31, P133, DOI 10.1590/1809-43922001311143; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Marijic VF, 2013, SCI TOTAL ENVIRON, V463, P772, DOI 10.1016/j.scitotenv.2013.06.041; Marinho RGB, 2013, ARQ BRAS MED VET ZOO, V65, P1192, DOI 10.1590/S0102-09352013000400035; Marletaz F, 2006, CURR BIOL, V16, pR577, DOI 10.1016/j.cub.2006.07.016; Martins M. L., 2001, Brazilian Journal of Biology, V61, P517, DOI 10.1590/S1519-69842001000300022; Mathison BA, 2016, CLIN INFECT DIS, V63, P1357, DOI 10.1093/cid/ciw543; Mehlhorn H, 2012, PARASITEN TIERE; MEYER A., 1931, ZOOL JAHRB ABT SYST OKOL U GEOGR TIERE, V62, P53; Miquelis A, 2000, CR ACAD SCI III-VIE, V323, P925, DOI 10.1016/S0764-4469(00)01230-0; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Mounsey KE, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-3; Muller A, 2017, BIOINFORMATICS, V33, P3740, DOI 10.1093/bioinformatics/btx520; Nagayasu E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058458; Near TJ, 2002, INTEGR COMP BIOL, V42, P668, DOI 10.1093/icb/42.3.668; Near TJ, 1998, MOL PHYLOGENET EVOL, V10, P287, DOI 10.1006/mpev.1998.0569; Nikishin VP, 2004, BIOL BULL+, V31, P598, DOI 10.1023/B:BIBU.0000049733.16236.79; Nowell RW, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004830; O'Mahony EM, 2004, PARASITOLOGY, V129, P341, DOI 10.1017/S0031182004005748; Oliveira LCD, 2019, J FISH DIS, V42, P765, DOI 10.1111/jfd.12980; Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978; Pan TS, 2013, FOLIA PARASIT, V60, P181, DOI 10.14411/fp.2013.021; Pan TingShuang, 2014, Acta Hydrobiologica Sinica, V38, P351; Park JC, 2020, AQUAT TOXICOL, V221, DOI 10.1016/j.aquatox.2020.105443; Pereira JN, 2018, ACTA AMAZON, V48, P42, DOI 10.1590/1809-4392201702411; Perrot-Minnot MJ, 2011, INT J PARASITOL, V41, P173, DOI 10.1016/j.ijpara.2010.08.006; Petrochenko VI, 1971, ACANTHOCEPHALA WILD, V1; Poulin R, 2000, J ZOOL, V250, P551, DOI 10.1017/S0952836900004118; Poulin R, 2007, BIOL J LINN SOC, V90, P637, DOI 10.1111/j.1095-8312.2006.00754.x; Poulin R, 2015, PARASITOLOGY, V142, P791, DOI 10.1017/S0031182014001917; Poulin R, 2015, PARASITOLOGY, V142, pS6, DOI 10.1017/S0031182013001674; Reier S, 2019, INT J PARASITOL-PAR, V8, P145, DOI 10.1016/j.ijppaw.2019.01.009; Riegerl RM, 2009, INVERTEBR BIOL, V114, P186; ROGERS WP, 1949, AUST J SCI RES SER B, V2, P157, DOI 10.1071/BI9490157; Roncalli V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186794; Rosny HS., 2016, INT J FISH AQUAT, V4, P188, DOI [10.22271/fish.2016.v4.i3c.746, DOI 10.22271/FISH.2016.V4.I3C.746]; Ruckert S, 2008, J APPL ICHTHYOL, V24, P321, DOI 10.1111/j.1439-0426.2008.01064.x; SANFORD SE, 1978, CAN VET J, V19, P234; SAZ HJ, 1981, ANNU REV PHYSIOL, V43, P323, DOI 10.1146/annurev.ph.43.030181.001543; Schell T, 2017, GENOME BIOL EVOL, V9, P585, DOI 10.1093/gbe/evx032; SCHMIDT GD, 1971, J PARASITOL, V57, P582, DOI 10.2307/3277920; Sielaff M, 2016, MOL PHYLOGENET EVOL, V96, P79, DOI 10.1016/j.ympev.2015.11.017; Silva-Gomes AL, 2017, LAT AM J AQUAT RES, V45, P496, DOI 10.3856/vol45-issue2-fulltext-25; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smit AFA., REPEATMODELER OPEN 1; Soler-Jimenez LC, 2017, J HELMINTHOL, V91, P110, DOI 10.1017/S0022149X16000833; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Starling J.A., 1985, P125; Steinauer ML, 2005, J MOL EVOL, V60, P706, DOI 10.1007/s00239-004-0159-8; Steinstraesser W, 1936, Z FISCHEREI, P177; Stelzer CP, 2011, HYDROBIOLOGIA, V662, P77, DOI 10.1007/s10750-010-0487-1; Struck TH, 2014, MOL BIOL EVOL, V31, P1833, DOI 10.1093/molbev/msu143; Suga K, 2008, MOL BIOL EVOL, V25, P1129, DOI 10.1093/molbev/msn058; Sures B, 2000, INT J PARASITOL, V30, P1071, DOI 10.1016/S0020-7519(00)00094-1; Sures B, 2002, INT J PARASITOL, V32, P1117, DOI 10.1016/S0020-7519(02)00083-8; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Taraschewski H, 2000, ADV PARASIT, V46, P1, DOI 10.1016/S0065-308X(00)46008-2; TARASCHEWSKI H, 1990, PARASITOL RES, V76, P619, DOI 10.1007/BF00932573; TARASCHEWSKI H, 1991, PARASITOL RES, V77, P536, DOI 10.1007/BF00928423; TARASCHEWSKI H, 1991, PARASITOL RES, V77, P247, DOI 10.1007/BF00930867; Taraschewski H, 2015, HBK ZOOL, P301; TIELENS AGM, 1994, PARASITOL TODAY, V10, P346, DOI 10.1016/0169-4758(94)90245-3; Tielens AGM, 2010, INT J PARASITOL, V40, P387, DOI 10.1016/j.ijpara.2009.12.006; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Urry L.A., 2017, CAMPBELL BIOL; Vurture GW, 2017, BIOINFORMATICS, V33, P2202, DOI 10.1093/bioinformatics/btx153; Wallace RL, 2002, INTEGR COMP BIOL, V42, P660, DOI 10.1093/icb/42.3.660; Wang XZ, 2012, SCI CHINA LIFE SCI, V55, P761, DOI 10.1007/s11427-012-4366-z; Wang Y, 2015, NUCLEIC ACIDS RES, V43, pW78, DOI 10.1093/nar/gkv487; WARD HL, 1952, J PARASITOL, V38, P493, DOI 10.2307/3273932; Weber M, 2000, J ZOO WILDLIFE MED, V31, P503, DOI 10.1638/1042-7260(2000)031[0503:IATOMC]2.0.CO;2; Weber M, 2013, MOL PHYLOGENET EVOL, V66, P182, DOI 10.1016/j.ympev.2012.09.017; Welch DBM, 2008, P NATL ACAD SCI USA, V105, P5145, DOI 10.1073/pnas.0800972105; Welch DBM, 2000, INVERTEBR BIOL, V119, P17; Welch DBM, 2003, BIOL J LINN SOC, V79, P85, DOI 10.1046/j.1095-8312.2003.00180.x; Wey-Fabrizius AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088618; Wey-Fabrizius AR, 2013, MOL PHYLOGENET EVOL, V69, P365, DOI 10.1016/j.ympev.2012.12.015; Wiecaszek B, 2019, ACTA ICHTHYOL PISCAT, V49, P65, DOI 10.3750/AIEP/02392; WINNEPENNINCKX B, 1995, MOL BIOL EVOL, V12, P1132; Witek A, 2009, MOL PHYLOGENET EVOL, V53, P1037, DOI 10.1016/j.ympev.2009.07.031; Witek A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-345; Woo PTK, 2012, FISH PARASITES: PATHOBIOLOGY AND PROTECTION, P1, DOI 10.1079/9781845938062.0000; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wurmbach H., 1937, FISCH HILFSWISS, V35, P217; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yamaguti S, 1963, SYSTEMA HELMINTHUM, VV; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yasumoto S, 1996, FISH PATHOL, V31, P235, DOI 10.3147/jsfp.31.235; Ye CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep19688; Ye J, 2018, NUCLEIC ACIDS RES, V46, pW71, DOI 10.1093/nar/gky400; Zhang JZ, 2006, NAT GENET, V38, P819, DOI 10.1038/ng1812; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140; Ziolkowska Marta, 2003, Acta Ichthyologica et Piscatoria, V33, P37	196	8	8	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0232973	10.1371/journal.pone.0232973	http://dx.doi.org/10.1371/journal.pone.0232973			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574180	gold, Green Published			2022-12-27	WOS:000544972400009
J	Freire, IT; Moulin-Frier, C; Sanchez-Fibla, M; Arsiwalla, XD; Verschure, PFMJ				Freire, Ismael T.; Moulin-Frier, Clement; Sanchez-Fibla, Marti; Arsiwalla, Xerxes D.; Verschure, Paul F. M. J.			Modeling the formation of social conventions from embodied real-time interactions	PLOS ONE			English	Article							COMMUNICATION; COOPERATION; ARCHITECTURE; RECIPROCITY; EVOLUTION; FRAMEWORK; SYSTEMS; BRAIN; GAMES	What is the role of real-time control and learning in the formation of social conventions? To answer this question, we propose a computational model that matches human behavioral data in a social decision-making game that was analyzed both in discrete-time and continuous-time setups. Furthermore, unlike previous approaches, our model takes into account the role of sensorimotor control loops in embodied decision-making scenarios. For this purpose, we introduce the Control-based Reinforcement Learning (CRL) model. CRL is grounded in the Distributed Adaptive Control (DAC) theory of mind and brain, where low-level sensorimotor control is modulated through perceptual and behavioral learning in a layered structure. CRL follows these principles by implementing a feedback control loop handling the agent's reactive behaviors (pre-wired reflexes), along with an Adaptive Layer that uses reinforcement learning to maximize long-term reward. We test our model in a multi-agent game-theoretic task in which coordination must be achieved to find an optimal solution. We show that CRL is able to reach human-level performance on standard game-theoretic metrics such as efficiency in acquiring rewards and fairness in reward distribution.	[Freire, Ismael T.; Arsiwalla, Xerxes D.; Verschure, Paul F. M. J.] Inst Bioengn Catalonia, SPECS Lab, Barcelona, Spain; [Moulin-Frier, Clement] INRIA, Flowers Team, Bordeaux, France; [Moulin-Frier, Clement] Ensta ParisTech, Bordeaux, France; [Sanchez-Fibla, Marti] Univ Pompeu Fabra, ETIC, AI ML Grp, Barcelona, Spain; [Verschure, Paul F. M. J.] Barcelona Inst Sci & Technol BIST, Barcelona, Spain; [Verschure, Paul F. M. J.] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Inria; Institut Polytechnique de Paris; Pompeu Fabra University; ICREA	Freire, IT (corresponding author), Inst Bioengn Catalonia, SPECS Lab, Barcelona, Spain.	ifreire@ibecbarcelona.eu	Sanchez Fibla, Marti/I-6604-2016	Sanchez Fibla, Marti/0000-0001-5725-1984	European Union's Horizon 2020 research and innovation programme [820742, 641321];  [INSOCO-DPI2016-80116-P]	European Union's Horizon 2020 research and innovation programme; 	PFMJV. This project has received funding from the European Union's Horizon 2020 research and innovation programme, ID:820742 and ID:641321. MSF and CMF. This project has been supported by INSOCO-DPI2016-80116-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcott H, 2011, J PUBLIC ECON, V95, P1082, DOI 10.1016/j.jpubeco.2011.03.003; Arsiwalla Xerxes D., 2017, Biomimetic and Biohybrid Systems. 6th International Conference, Living Machines 2017. Proceedings: LNAI 10384, P509, DOI 10.1007/978-3-319-63537-8_43; Arsiwalla XD, 2017, ABS170511190; Arsiwalla XD, 2016, FRONT ARTIF INTEL AP, V288, P233, DOI 10.3233/978-1-61499-696-5-233; Baker B., 2019, ARXIV190907528; Barr DJ, 2004, COGNITIVE SCI, V28, P937, DOI 10.1016/j.cogsci.2004.07.002; Bigoni M, 2015, ECONOMETRICA, V83, P587, DOI 10.3982/ECTA11380; Binmore K, 2005, NATURAL JUSTICE; Botvinick M, 2019, TRENDS COGN SCI, P31003893; Braitenberg V., 1986, VEHICLES EXPT SYNTHE; BROOKS RA, 1991, ARTIF INTELL, V47, P139, DOI 10.1016/0004-3702(91)90053-M; BROOKS RA, 1986, IEEE T ROBOTIC AUTOM, V2, P14, DOI 10.1109/JRA.1986.1087032; Bruelisauer M, 2019, SSRN ELECT J; Busoniu L, 2008, IEEE T SYST MAN CY C, V38, P156, DOI 10.1109/TSMCC.2007.913919; Camerer CF, 2004, Q J ECON, V119, P861, DOI 10.1162/0033553041502225; Claus C, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P746; CLEMENTS KC, 1995, ANIM BEHAV, V50, P527, DOI 10.1006/anbe.1995.0267; CONNOR RC, 1995, TRENDS ECOL EVOL, V10, P84, DOI 10.1016/S0169-5347(00)88988-0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; David Lewis, 1969, CONVENTION PHILOS ST; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Friedman D, 2012, AM ECON REV, V102, P337, DOI 10.1257/aer.102.1.337; Fudenberg D., 1991, GAME THEORY, V1; Gasparrini Marco Jerome, 2018, FRONTIERS ARTIFICIAL, V308, P307; Hawkins RXD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151670; Hawkins RXD, 2015, BEHAV RES METHODS, V47, P966, DOI 10.3758/s13428-014-0515-6; Hawkins RX, 2018, TRENDS COGN SCI, P30522867; Herreros I., 2016, ADV NEURAL INFORM PR, P3828; Jaderberg M, 2019, SCIENCE, V364, P859, DOI 10.1126/science.aau6249; JANSEN ASP, 1995, SCIENCE, V270, P644, DOI 10.1126/science.270.5236.644; Jaynes E.T., 2003, PROBABILITY THEORY L; Kephart C, 2015, J ECON SCI ASSOC-JES, V1, P132, DOI 10.1007/s40881-015-0009-z; Kleiman-Weiner M, 2016, COORDINATE COOPERATE; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; LAIRD JE, 1987, ARTIF INTELL, V33, P1, DOI 10.1016/0004-3702(87)90050-6; Lakoff G., 1999, PHILOS FLESH; Leibo JZ, 2017, AAMAS'17: PROCEEDINGS OF THE 16TH INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS AND MULTIAGENT SYSTEMS, P464; Lerer A, 2017, ABS17070 ARXIV; Miller N, 2013, P NATL ACAD SCI USA, V110, P5263, DOI 10.1073/pnas.1217513110; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; MONTAGUE PR, 1994, LEARN MEMORY, V1, P1; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morgenstern O., 1944, GAME THEORY EC BEHAV; Moulin-Frier C, 2017, ARXIV170401407; Moulin-Frier C, 2016, P WORKSH COGN COMP 3; Moulin-Frier C, 2016, PHYS LIFE REV, V16, P88, DOI 10.1016/j.plrev.2016.01.019; Moulin-Frier C, 2015, 5TH INTERNATIONAL CONFERENCE ON DEVELOPMENT AND LEARNING AND ON EPIGENETIC ROBOTICS (ICDL-EPIROB), P188, DOI 10.1109/DEVLRN.2015.7346139; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; Muro C, 2011, BEHAV PROCESS, V88, P192, DOI 10.1016/j.beproc.2011.09.006; Newell A, 1994, UNIFIED THEORIES COG; Noe R, 2006, ANIM BEHAV, V71, P1, DOI 10.1016/j.anbehav.2005.03.037; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Oprea R, 2014, J ECON BEHAV ORGAN, V108, P212, DOI 10.1016/j.jebo.2014.09.012; Oprea R, 2011, J ECON THEORY, V146, P2206, DOI 10.1016/j.jet.2011.10.014; Perolat J., 2017, ADV NEURAL INFORM PR, P3646; Peysakhovich A, 2017, ABS17100 ARXIV; Peysakhovich A, 2017, ABS17090 ARXIV; Riehl C, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0090; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Steels L, 2003, TRENDS COGN SCI, V7, P308, DOI 10.1016/S1364-6613(03)00129-3; Steels L, 2001, IEEE INTELL SYST, V16, P16, DOI 10.1109/5254.956077; Taborsky M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0084; van Doorn GS, 2014, J THEOR BIOL, V356, P1, DOI 10.1016/j.jtbi.2014.03.019; Verschure PFMJ, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0448; Verschure PFMJ, 2003, NATURE, V425, P620, DOI 10.1038/nature02024; Verschure PFMJ, 2014, BIOL SCI, V369, P1655, DOI DOI 10.1098/RSTB.2013.0483; Weitzenfeld A., 2006, IEEE 3 LAT AM ROB S, P120, DOI DOI 10.1109/LARS.2006.334327; Xiao E, 2016, J CONFLICT RESOLUT, V60, P670, DOI 10.1177/0022002714564426; Young HP, 2015, ANNU REV ECON, V7, P359, DOI 10.1146/annurev-economics-080614-115322; 2015, GYNECOLOGICAL SURG, V12	73	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234434	10.1371/journal.pone.0234434	http://dx.doi.org/10.1371/journal.pone.0234434			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569266	Green Published, Green Submitted, gold			2022-12-27	WOS:000543547900004
J	Gropper, H; John, JM; Sudeck, G; Thiel, A				Gropper, Hannes; John, Jannika M.; Sudeck, Gorden; Thiel, Ansgar			The impact of life events and transitions on physical activity: A scoping review	PLOS ONE			English	Review							HEALTH BEHAVIORS; MARITAL TRANSITIONS; SEDENTARY BEHAVIOR; ACTIVITY PATTERNS; HIGH-SCHOOL; ACTIVITY TRAJECTORIES; LONGITUDINAL CHANGES; ENERGY-EXPENDITURE; STYLE BEHAVIORS; ACTIVITY LEVEL	Background Physical activity (PA) is a fluctuating behavior and prone to change across the life course. Changes in PA may be particularly due to the experience of life events and transitions. For well-timed and successful PA interventions, it is important to understand when and why individuals take up or terminate PA. Objectives This scoping review aims to examine the extent, range, and nature of research on the impact of life events and transitions on PA and to summarize key findings. Methods A systematic literature search was conducted in PubMed, PsycINFO, PsycARTICLES, SPORTDiscus, and Web of Science. Articles were included if they had been published in peer-reviewed journals between 1998 and 2020 and assessed the impact of at least one life event or transition on PA. Results 107 studies that assessed 72 distinct life events and transitions were included and summarized in ten categories. Events and transitions that are primarily associated with decreases in PA were starting cohabitation, getting married, pregnancy, evolving parenthood, and the transitions from kindergarten to primary school, from primary to secondary school, and from high school to college or into the labor market. Retirement was associated with increases in PA; yet, long-term trajectories across retirement indicated a subsequent drop in activity levels. Divorce was associated with no changes in PA. No trends could be identified for changing work conditions, quitting or losing a job, starting a new relationship, widowhood, moving, and diagnosis of illness. Conclusion Life events and transitions can be conceptualized as natural interventions that occur across the life course and that are oftentimes associated with changes in PA behavior. Our study indicates that, despite some emerging trends, similar events do not necessarily have similar impacts on PA across individuals. It also shows that the research landscape is characterized by a lack of conceptual clarity and by disparate methodologies, making it difficult to synthesize results across studies.	[Gropper, Hannes; John, Jannika M.; Sudeck, Gorden; Thiel, Ansgar] Eberhard Karls Univ Tubingen, Inst Sports Sci, Tubingen, Germany; [Gropper, Hannes; John, Jannika M.; Sudeck, Gorden; Thiel, Ansgar] Eberhard Karls Univ Tubingen, Interfac Res Inst Sport & Phys Act, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Gropper, H (corresponding author), Eberhard Karls Univ Tubingen, Inst Sports Sci, Tubingen, Germany.; Gropper, H (corresponding author), Eberhard Karls Univ Tubingen, Interfac Res Inst Sport & Phys Act, Tubingen, Germany.	hannes.gropper@uni-tuebingen.de	John, Jannika/GLU-0671-2022	John, Jannika Maria/0000-0002-7777-6064	iReAct graduate school - Ministry of Research, Science, and the Arts of Baden-Wurttemberg; State Postgraduate Fellowship Program, Germany; University of Tubingen	iReAct graduate school - Ministry of Research, Science, and the Arts of Baden-Wurttemberg; State Postgraduate Fellowship Program, Germany; University of Tubingen	The authors HG, GS, and AT acknowledge financial support from the iReAct graduate school, which is funded by the Ministry of Research, Science, and the Arts of Baden-Wurttemberg; State Postgraduate Fellowship Program, Germany (https://uni-tuebingen.de/en/research/support/research-funding/researchfunding-baden-wuerttemberg/state-postgraduate-fellowship-programme/).Moreover, we acknowledge support by Open Access Publishing Fund of University of Tubingen (https://unituebingen.de/en/facilities/university-library/publishing-research/open-access/open-accesspublikationsfonds/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron DJ, 2005, WORLD REV NUTR DIET, V94, P36, DOI 10.1159/000088204; Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Albright CL, 2005, WOMEN HEALTH, V42, P95, DOI 10.1300/J013v42n03_06; Allender S, 2008, HEALTH PROMOT INT, V23, P160, DOI 10.1093/heapro/dan012; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2016, PREV CHRONIC DIS, V13, pE40; [Anonymous], 2015, GYNECOLOGICAL SURG; Arksey, 2005, INT J SOC RES METHOD, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Barnett Inka, 2014, J Epidemiol Community Health, V68, P747, DOI 10.1136/jech-2013-203225; Barnett I, 2012, AM J PREV MED, V43, P329, DOI 10.1016/j.amepre.2012.05.026; Barnett TA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-57; Barr-Anderson DJ, 2017, J ADOLESCENT HEALTH, V61, P562, DOI 10.1016/j.jadohealth.2017.05.007; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Beal SJ, 2016, CHILD DEV, V87, P1106, DOI 10.1111/cdev.12539; Bell S, 2005, INT J BEHAV MED, V12, P227, DOI 10.1207/s15327558ijbm1204_3; Bellows-Riecken KH, 2008, PREV MED, V46, P99, DOI 10.1016/j.ypmed.2007.08.003; Berger U, 2005, AGEING SOC, V25, P181, DOI 10.1017/S0144686X04002739; Blanchard CM, 2003, AM J HEALTH BEHAV, V27, P246, DOI 10.5993/AJHB.27.3.6; Bray SR, 2004, J AM COLL HEALTH, V52, P181, DOI 10.3200/JACH.52.4.181-188; Bray SR, 2007, RES Q EXERCISE SPORT, V78, P61, DOI 10.1080/02701367.2007.10599404; Brown WJ, 2009, ANN BEHAV MED, V37, P294, DOI 10.1007/s12160-009-9099-2; Brown WJ, 2003, AM J PREV MED, V25, P140, DOI 10.1016/S0749-3797(03)00119-3; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cerimagic S, 2015, INT J HUM RIGHTS HEA, V8, P110, DOI 10.1108/IJHRH-10-2014-0027; Chong KH, 2020, J SCI MED SPORT, V23, P498, DOI 10.1016/j.jsams.2019.12.002; Chung S, 2009, AM J PREV MED, V36, P422, DOI 10.1016/j.amepre.2009.01.026; Clark AJ, 2015, INT J EPIDEMIOL, V44, P1027, DOI 10.1093/ije/dyv063; Colley K, 2019, LEISURE SCI, V41, P186, DOI 10.1080/01490400.2017.1349696; Condello G, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0510-2; Cooper AR, 2012, MED SCI SPORT EXER, V44, P1890, DOI 10.1249/MSS.0b013e31825a3a1e; Corder K, 2020, OBES REV, V21, DOI 10.1111/obr.12959; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Cramp AG, 2009, RES Q EXERCISE SPORT, V80, P403; Crane JR, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5100131; D'Alisera J, 2001, J MAT CULT, V6, P91, DOI 10.1177/135918350100600105; D'Haese S, 2015, HEALTH PLACE, V33, P132, DOI 10.1016/j.healthplace.2015.03.004; Dai SL, 2014, AM J PREV MED, V47, P123, DOI 10.1016/j.amepre.2014.04.003; Daudt HML, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-48; De Meester F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-261; Deforche B, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0173-9; Diehl K, 2016, SCI SPORT, V31, P223, DOI 10.1016/j.scispo.2016.04.012; Ding D, 2016, AM J PREV MED, V51, P170, DOI 10.1016/j.amepre.2016.01.019; Downs DS, 2004, J MIDWIFERY WOM HEAL, V49, P138, DOI 10.1016/j.jmwh.2003.11.009; Duval K, 2013, EUR J CLIN NUTR, V67, P407, DOI 10.1038/ejcn.2013.33; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Eng PM, 2005, J EPIDEMIOL COMMUN H, V59, P56, DOI 10.1136/jech.2004.020073; Engberg E, 2012, SPORTS MED, V42, P433, DOI 10.2165/11597610-000000000-00000; European Commission, 2018, SPEC EUR 472 SPORT P, DOI 10.2875/92205; Evenson KR, 2002, AM J EPIDEMIOL, V155, P692, DOI 10.1093/aje/155.8.692; Ezendam NPM, 2019, ACTA ONCOL, V58, P700, DOI 10.1080/0284186X.2018.1557342; Feng XQ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3253-0; Filipp S-H, 1995, KRITISCHE LEBENSEREI, P3; Flake J. K., 2019, MEASUREMENT SCHMEASU, DOI [10.31234/osf.io/hs7wm, DOI 10.31234/OSF.IO/HS7WM]; Forss KS, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00294; Gabriel KKP, 2012, J PHYS ACT HEALTH, V9, pS11, DOI 10.1123/jpah.9.s1.s11; Gao J, 2019, TRANSPORT RES D-TR E, V77, P243, DOI 10.1016/j.trd.2019.11.006; Garcia AW, 1998, J ADOLESCENT HEALTH, V22, P394, DOI 10.1016/S1054-139X(97)00259-0; Grace SL, 2006, WOMEN HEALTH, V43, P51, DOI 10.1300/J013v43n02_04; Hamilton K, 2010, PSYCHOL SPORT EXERC, V11, P275, DOI 10.1016/j.psychsport.2010.02.006; Han JL, 2008, AM J HEALTH EDUC, V39, P194, DOI 10.1080/19325037.2008.10599038; Henkens K, 2008, EUR J PUBLIC HEALTH, V18, P644, DOI 10.1093/eurpub/ckn095; Henning G, 2021, AGING MENT HEALTH, V25, P621, DOI 10.1080/13607863.2019.1709156; Hinton P S, 2001, Matern Child Health J, V5, P7, DOI 10.1023/A:1011315616694; Hirvensalo M, 2011, EUR REV AGING PHYS A, V8, P13, DOI 10.1007/s11556-010-0076-3; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Holstila A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4455-9; Hull EE, 2015, J PHYS ACT HEALTH, V12, P782, DOI 10.1123/jpah.2013-0412; Hull EE, 2010, J PHYS ACT HEALTH, V7, P577, DOI 10.1123/jpah.7.5.577; Humpel N, 2007, SUPPORT CARE CANCER, V15, P621, DOI 10.1007/s00520-006-0207-6; Jago R, 2012, MED SCI SPORT EXER, V44, P111, DOI 10.1249/MSS.0b013e318229df6e; Jauregui A, 2011, SALUD PUBLICA MEXICO, V53, P228; John JM, 2019, PSYCHOL SPORT EXERC, V45, DOI 10.1016/j.psychsport.2019.101565; Jones Sydney A, 2018, Prev Med Rep, V11, P221, DOI 10.1016/j.pmedr.2018.07.002; Jones SA, 2018, AM J PREV MED, V54, P786, DOI 10.1016/j.amepre.2018.02.022; Josefsson K, 2018, SOC SCI MED, V209, P152, DOI 10.1016/j.socscimed.2018.03.006; Kampfen F, 2016, J HEALTH ECON, V45, P91, DOI 10.1016/j.jhealeco.2015.12.001; Kenter EJ, 2015, PSYCHOL HEALTH, V30, P627, DOI 10.1080/08870446.2014.934687; King AC, 1998, ANN BEHAV MED, V20, P64, DOI 10.1007/BF02884450; Kirk MA, 2012, PSYCHOL HEALTH MED, V17, P551, DOI 10.1080/13548506.2011.647700; Koeneman MA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-147; Kostamo K, 2019, PSYCHOL SPORT EXERC, V45, DOI 10.1016/j.psychsport.2019.101564; Kutob RM, 2017, J WOMENS HEALTH, V26, P313, DOI 10.1089/jwh.2016.5925; Larouche R, 2012, J PHYS ACT HEALTH, V9, P516, DOI 10.1123/jpah.9.4.516; Lee S, 2005, INT J EPIDEMIOL, V34, P69, DOI 10.1093/ije/dyh258; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Li KG, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3368-3; Li KK, 2013, J GERONTOL B-PSYCHOL, V68, P794, DOI 10.1093/geronb/gbt068; Littman AJ, 2015, J PHYS ACT HEALTH, V12, P666, DOI 10.1123/jpah.2013-0260; Lovejoy JC, 2008, INT J OBESITY, V32, P949, DOI 10.1038/ijo.2008.25; Luhmann M, 2012, J PERS SOC PSYCHOL, V102, P592, DOI 10.1037/a0025948; Malina RM, 1996, RES Q EXERCISE SPORT, V67, pS48, DOI 10.1080/02701367.1996.10608853; Marks J, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0218-0; McDonald S, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0623-7; McIntyre CA, 2009, WOMEN HEALTH, V49, P66, DOI 10.1080/03630240802690853; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moilanen JM, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-8; Molina-Garcia J, 2015, J PHYS ACT HEALTH, V12, P1414, DOI 10.1123/jpah.2014-0412; Morgan AJ, 2013, J EXERCISE PHYSL ONL, V16, P64; Morseth B, 2011, MED SCI SPORT EXER, V43, P1229, DOI 10.1249/MSS.0b013e3182084562; Muller T, 2018, J HEALTH ECON, V57, P45, DOI 10.1016/j.jhealeco.2017.10.005; NIH Public Access Author Manuscript, 2011, J PHYS ACT HLTH, V8, pS257; Oshio T, 2017, PREV MED, V100, P287, DOI 10.1016/j.ypmed.2017.04.007; Owens CS, 2014, J PUBLIC HEALTH-UK, V36, P599, DOI 10.1093/pubmed/fdt123; Paluch AE, 2018, J PHYS ACT HEALTH, V15, P374, DOI 10.1123/jpah.2017-0304; Parra-Saldias M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16010053; Pate RR, 2019, AM J PREV MED, V56, pE65, DOI 10.1016/j.amepre.2018.10.012; Perales F, 2015, INT J PUBLIC HEALTH, V63, P301, DOI 10.1007/s00038-015-0653-3; Pereira MA, 2007, AM J PREV MED, V32, P312, DOI 10.1016/j.amepre.2006.12.017; Physical Activity Guidelines Advisory Committee, 2018, PHYS ACT GUID ADV CO; Pot N., 2016, MED REP, V4, P121, DOI [10.1016/j.pmedr.2016.05.01827413672, DOI 10.1016/J.PMEDR.2016.05.018, DOI 10.1016/j.pmedr.2016.05.018]; PubMed, 1977, LIF CHANG EV MESH SU; Pullman AW, 2009, APPL PHYSIOL NUTR ME, V34, P162, DOI 10.1139/H09-007; Rauner A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1731-4; Regan K, 2016, CAN J AGING, V35, P526, DOI 10.1017/S0714980816000593; Reiner M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-813; Rhodes RE, 2014, J BEHAV MED, V37, P533, DOI 10.1007/s10865-013-9508-7; Richards EA, 2019, HEALTH EDUC BEHAV, V46, P398, DOI 10.1177/1090198118822712; Ridley K, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16244959; Rovio SP, 2018, SCAND J MED SCI SPOR, V28, P1073, DOI 10.1111/sms.12988; Rutten C, 2014, J PHYS ACT HEALTH, V11, P1607, DOI 10.1123/jpah.2012-0465; Salin K, 2019, SCAND J PUBLIC HEALT, V47, P722, DOI 10.1177/1403494818807558; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Satia JA, 2004, CANCER EPIDEM BIOMAR, V13, P1022; SCHLOSSBERG NK, 1981, COUNS PSYCHOL, V9, P2, DOI 10.1177/001100008100900202; Schonbach JK, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111356; Shang BR, 2018, EUR J SPORT SCI, V18, P266, DOI 10.1080/17461391.2017.1417486; Shaw BA, 2010, J GERONTOL B-PSYCHOL, V65, P756, DOI 10.1093/geronb/gbq073; Shull ER, 2020, J SCI MED SPORT, V23, P385, DOI 10.1016/j.jsams.2019.10.017; Sigmund E, 2009, CHILD CARE HLTH DEV, V35, P376, DOI 10.1111/j.1365-2214.2009.00945.x; Simons D, 2015, PREV MED, V72, P30, DOI 10.1016/j.ypmed.2014.12.039; Sjosten N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000522; Slingerland AS, 2007, AM J EPIDEMIOL, V165, P1356, DOI 10.1093/aje/kwm053; Sprod J, 2017, MATURITAS, V100, P70, DOI 10.1016/j.maturitas.2017.02.018; Stahl ST, 2014, J BEHAV MED, V37, P806, DOI 10.1007/s10865-013-9532-7; Stults-Kolehmainen MA, 2014, SPORTS MED, V44, P81, DOI 10.1007/s40279-013-0090-5; Swinbourne R, 2018, SPORTS, V6, DOI 10.3390/sports6020042; Taylor RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081567; Taymoori P, 2012, HEALTH EDUC J, V71, P631, DOI 10.1177/0017896911419341; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244; Thiel A, 2018, EUR J SPORT SOC, V15, P1, DOI 10.1080/16138171.2018.1437689; Touvier M, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-14; Treuth MS, 2005, MED SCI SPORT EXER, V37, P832, DOI 10.1249/01.MSS.0000161749.38453.02; Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850; Ullrich-French S, 2013, SPORT EXERC PERFORM, V2, P90, DOI 10.1037/a0030632; Van Dyck D, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3792-4; Van Dyck D, 2015, INT J BEHAV MED, V22, P178, DOI 10.1007/s12529-014-9424-4; van Houten JMA, 2019, EUR J SPORT SOC, V16, P44, DOI 10.1080/16138171.2019.1603832; van Houten JMA, 2017, INT REV SOCIOL SPORT, V52, P858, DOI 10.1177/1012690215619204; Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024; Wilcox S, 2003, HEALTH PSYCHOL, V22, P513, DOI 10.1037/0278-6133.22.5.513; Winpenny EM, 2020, OBES REV, V21, DOI 10.1111/obr.12962; Zhou PL, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5408-7	152	38	38	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234794	10.1371/journal.pone.0234794	http://dx.doi.org/10.1371/journal.pone.0234794			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569282	Green Published, gold			2022-12-27	WOS:000543547900011
J	Jung, JY; Ro, H; Chang, JH; Kim, AJ; Lee, HH; Han, SH; Yoo, TH; Lee, KB; Kim, YH; Kim, SW; Park, SK; Chae, DW; Oh, KH; Ahn, C; Chung, W				Jung, Ji Yong; Ro, Han; Chang, Jae Hyun; Kim, Ae Jin; Lee, Hyun Hee; Han, Seung Hyeok; Yoo, Tae-Hyun; Lee, Kyu-Beck; Kim, Yeong Hoon; Kim, Soo Wan; Park, Sue Kyung; Chae, Dong-Wan; Oh, Kook-Hwan; Ahn, Curie; Chung, Wookyung			Mediation of the relationship between proteinuria and serum phosphate: Insight from the KNOW-CKD study	PLOS ONE			English	Article							PHOSPHORUS HOMEOSTASIS; SOLUBLE KLOTHO; ALBUMIN; FGF23; MICROALBUMINURIA; HYPOPHOSPHATEMIA; REABSORPTION; PARAMETERS; DISEASE; FGF-23	Proteinuria and hyperphosphatemia are risk factors for cardiovascular disease in patients with chronic kidney disease (CKD). Although the interaction between proteinuria and the serum phosphate level is well established, the mechanistic link between the two, particularly the extent to which this interaction is mediated by phosphate-regulating factors, remains poorly understood. In this study, we examined the association between proteinuria and the serum phosphate level, as well as potential mediators, including circulating fibroblast growth factor (FGF23)/klotho, the 24-h urinary phosphate excretion rate to glomerular filtration rate ratio (EP/GFR), and the 24-h tubular phosphate reabsorption rate to GFR ratio (TRP/GFR). The analyses were performed with data from 1793 patients in whom 24-h urine protein and phosphate, serum phosphate, FGF23, and klotho levels were measured simultaneously, obtained from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD). Multivariable linear regression and mediation analyses were performed. Total, direct, and indirect effects were also estimated. Patients with high serum phosphate levels were found to be more likely to exhibit greater proteinuria, higher FGF23 levels, and lower klotho levels. The 24-h EP/GFR increased and the 24-h TRP/GFR decreased with increasing proteinuria and CKD progression. Simple mediation analyses showed that 15.4% and 67.9% of the relationship between proteinuria and the serum phosphate level were mediated by the FGF23/klotho ratio and 24-h EP/GFR, respectively. Together, these two factors accounted for 73.1% of the relationship between serum markers. These findings suggest that proteinuria increases the 24-h EP/GFR via the FGF23/klotho axis as a compensatory mechanism for the increased phosphate burden well before the reduction in renal function is first seen.	[Jung, Ji Yong; Ro, Han; Chang, Jae Hyun; Kim, Ae Jin; Lee, Hyun Hee; Chung, Wookyung] Gachon Univ, Dept Internal Med, Gil Med Ctr, Incheon, South Korea; [Jung, Ji Yong; Ro, Han; Chang, Jae Hyun; Kim, Ae Jin; Lee, Hyun Hee; Chung, Wookyung] Gachon Univ, Coll Med, Incheon, South Korea; [Han, Seung Hyeok; Yoo, Tae-Hyun] Yonsei Univ, Inst Kidney Dis Res, Dept Internal Med, Coll Med, Seoul, South Korea; [Lee, Kyu-Beck] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Sch Med, Seoul, South Korea; [Kim, Yeong Hoon] Inje Univ, Busan Paik Hosp, Dept Internal Med, Coll Med, Busan, South Korea; [Kim, Soo Wan] Chonnam Natl Univ, Dept Internal Med, Sch Med, Gwangju, South Korea; [Park, Sue Kyung] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Chae, Dong-Wan] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seoul, South Korea; [Oh, Kook-Hwan; Ahn, Curie] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea	Gachon University; Gachon University; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Inje University; Chonnam National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Jung, JY (corresponding author), Gachon Univ, Dept Internal Med, Gil Med Ctr, Incheon, South Korea.; Jung, JY (corresponding author), Gachon Univ, Coll Med, Incheon, South Korea.	jyjung@gachon.ac.kr	; Han, Seung Hyeok/K-4559-2018	Yoo, Tae-Hyun/0000-0002-9183-4507; Jung, Ji Yong/0000-0003-1271-8012; Han, Seung Hyeok/0000-0001-7923-5635	Korea Centers for Disease Control and Prevention [2011E3300300, 2012E3301100, 2013E3301600, 2013E3301601, 2013E3301602, 2016E3300200, 2016E3300201, 2016E3300202, 2019E320100]	Korea Centers for Disease Control and Prevention	This work was supported by the Research Program funded by the Korea Centers for Disease Control and Prevention (2011E3300300, 2012E3301100, 2013E3301600, 2013E3301601, 2013E3301602, 2016E3300200, 2016E3300201, 2016E3300202, and 2019E320100).	Bachmann S, 2004, J AM SOC NEPHROL, V15, P892, DOI 10.1097/01.ASN.0000120389.09938.21; Chang AR, 2017, AM J KIDNEY DIS, V69, P200, DOI 10.1053/j.ajkd.2016.08.029; de Seigneux S, 2015, J AM SOC NEPHROL, V26, P1608, DOI 10.1681/ASN.2014010104; Dermaku-Sopjani M, 2011, CELL PHYSIOL BIOCHEM, V28, P251, DOI 10.1159/000331737; Di Iorio BR, 2013, NEPHROL DIAL TRANSPL, V28, P632, DOI 10.1093/ndt/gfs477; Feinstein S, 2006, PEDIATR NEPHROL, V21, P1406, DOI 10.1007/s00467-006-0195-2; Fernandez-Fernandez B, 2018, NEPHROL DIAL TRANSPL, V33, P1712, DOI 10.1093/ndt/gfx376; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Gekle M, 1998, NEWS PHYSIOL SCI, V13, P5; Hayes A. F., 2018, INTRO MEDIATION MODE; Ide N, 2018, AM J PHYSIOL-RENAL, V315, pF1261, DOI 10.1152/ajprenal.00650.2017; Ide N, 2016, KIDNEY INT, V90, P348, DOI 10.1016/j.kint.2016.04.009; Karalliedde J, 2013, CLIN J AM SOC NEPHRO, V8, P1899, DOI 10.2215/CJN.02700313; Kawasaki T, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0118-1; Kim H, 2020, NEPHROL DIAL TRANSPL, V35, P438, DOI 10.1093/ndt/gfy403; Kim JH, 2017, J AM SOC NEPHROL, V28, P140, DOI 10.1681/ASN.2015080888; Kuro-o M, 2019, NAT REV NEPHROL, V15, P27, DOI 10.1038/s41581-018-0078-3; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Kuro-o M, 2010, PEDIATR NEPHROL, V25, P583, DOI 10.1007/s00467-009-1260-4; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lim SC, 2014, J RENIN-ANGIO-ALDO S, V15, P487, DOI 10.1177/1470320313475905; Lundberg S, 2012, CLIN J AM SOC NEPHRO, V7, P727, DOI 10.2215/CJN.10331011; MARONI BJ, 1985, KIDNEY INT, V27, P58, DOI 10.1038/ki.1985.10; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Mathew S, 2008, J AM SOC NEPHROL, V19, P1092, DOI 10.1681/ASN.2007070760; Miyagawa A, 2018, KIDNEY INT, V93, P1073, DOI 10.1016/j.kint.2017.11.022; Nomura K, 2014, J AM SOC NEPHROL, V25, P761, DOI 10.1681/ASN.2013060569; Oh KH, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-80; Ozeki M, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-147; Phelps KR, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050427; Phelps KR, 2015, CLIN NEPHROL, V83, P208, DOI 10.5414/CN108380; Phelps KR, 2015, CLIN NEPHROL, V83, P167, DOI 10.5414/CN108367; Phelps KR, 2012, CLIN NEPHROL, V77, P484, DOI 10.5414/CN107298; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Scialla JJ, 2014, NAT REV NEPHROL, V10, P268, DOI 10.1038/nrneph.2014.49; Silva AP, 2017, INT UROL NEPHROL, V49, P1809, DOI 10.1007/s11255-017-1646-3; Smith ER, 2012, J CLIN ENDOCR METAB, V97, P3357, DOI 10.1210/jc.2012-1811; Sophie D, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14509; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Tan SJ, 2017, CLIN KIDNEY J, V10, P397, DOI 10.1093/ckj/sfw146; Tenten V, 2013, J AM SOC NEPHROL, V24, P1966, DOI 10.1681/ASN.2013010018; Vervloet MG, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-20; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yilmaz MI, 2014, AM J NEPHROL, V40, P208, DOI 10.1159/000366169	47	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235077	10.1371/journal.pone.0235077	http://dx.doi.org/10.1371/journal.pone.0235077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569271	Green Published, gold			2022-12-27	WOS:000543547900053
J	Laws, MB; Lee, YJ; Rogers, WS; Taubin, T; Wilson, IB				Laws, M. Barton; Lee, Yoojin; Rogers, William S.; Taubin, Tatiana; Wilson, Ira B.			An instrument to assess HIV-related knowledge and adjustment to HIV plus status, and their association with anti-retroviral adherence	PLOS ONE			English	Article							INTERACTIVE TOXICITY BELIEFS; FUNCTIONAL HEALTH LITERACY; SELF-EFFICACY; THERAPY; IDENTITY; NEED; ALCOHOL; STIGMA; ACCESS; CARE	Background Findings on the association between health literacy and anti-retroviral (ARV) adherence are inconsistent. Health literacy is usually operationalized with simple tests of basic literacy, but more complex conceptions of health literacy include content knowledge. People living with chronic illness also conceptualize and experience illness in ways other than biomedical or mechanistic models of disease. Objective There are no instruments that comprehensively assess knowledge of people living with HIV concerning HIV disease and treatment; or psychological adjustment to being HIV+. Little is known about the relationship between factual knowledge, or positive identification as HIV+, and anti-retroviral (ARV) adherence. Methods Formative work with in-depth semi-structured interviews, and cognitive testing, to develop a structured instrument assessing HIV-related knowledge, and personal meanings of living with HIV. Pilot administration of the instrument to a convenience sample of 101 respondents. Key results Respondents varied considerably in their expressed need for in-depth knowledge, the accuracy of their understanding of relevant scientific concepts and facts about ARV treatment, and psychological adjustment and acceptance of HIV+ status. Most knowledge domains were not significantly related to self-reported ARV adherence, but accurate knowledge specifically about ARV treatment was (r = 0.25, p = .02), as was an adapted version of the Need for Cognition scale (r = .256, p = .012). Negative feelings about living with HIV (r = .33, p = .0012), and medication taking (r = .276, p = .008) were significantly associated with non-adherence. Conclusion The instrument may be useful in diagnosing addressable reasons for non-adherence, as a component of psychoeducational interventions, and for evaluation of such interventions.	[Laws, M. Barton; Lee, Yoojin; Taubin, Tatiana; Wilson, Ira B.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Rogers, William S.] Tufts Univ, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	Brown University; Tufts University	Laws, MB (corresponding author), Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA.	Michael_Barton_Laws@brown.edu			National Institute of Mental Health [5R21MH092781-02]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by a grant from the National Institute of Mental Health, Grant #5R21MH092781-02, to MBL. https://www.nimh.nih.gov/index.shtml The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner LM, 2007, QUAL HEALTH RES, V17, P919, DOI 10.1177/1049732307305881; BECKER MH, 1975, MED CARE, V13, P10, DOI 10.1097/00005650-197501000-00002; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; CACIOPPO JT, 1984, J PERS ASSESS, V48, P306, DOI 10.1207/s15327752jpa4803_13; Cacioppo JT, 1996, PSYCHOL BULL, V119, P197, DOI 10.1037/0033-2909.119.2.197; Caplan A. L., 2004, HLTH DIS ILLNESS CON; Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512; Colbert AM, 2013, J ADV NURS, V69, P295, DOI 10.1111/j.1365-2648.2012.06007.x; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Davis T C, 1993, Fam Med, V25, P391; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fowler FJ, 2014, FIELD METHOD; Glass TR, 2008, ANTIVIR THER, V13, P77; Goffman E., 1963, BEHAV PUBLIC PLACES, P3; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Kalichman SC, 1999, J GEN INTERN MED, V14, P267, DOI 10.1046/j.1525-1497.1999.00334.x; Kalichman SC, 2012, J ASSOC NURSE AIDS C, V23, P511, DOI 10.1016/j.jana.2011.11.005; Kalichman Seth C, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P317, DOI 10.1177/1545109708328130; Kalichman SC, 2009, AIDS PATIENT CARE ST, V23, P449, DOI 10.1089/apc.2008.0184; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Kleinman A., 1981, PATIENTS HEALERS CON; Kralik D, 2003, J ADV NURS, V42, P11, DOI 10.1046/j.1365-2648.2003.02505.x; Laws MB, 2015, AIDS BEHAV, V19, P635, DOI 10.1007/s10461-014-0931-8; Laws MB, 2016, AIDS BEHAV; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Murphy DA, 2010, PATIENT EDUC COUNS, V79, P25, DOI 10.1016/j.pec.2009.07.014; Osborn CY, 2007, AM J PREV MED, V33, P374, DOI 10.1016/j.amepre.2007.07.022; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Paasche-Orlow MK, 2006, J GEN INTERN MED, V21, P835, DOI 10.1111/j.1525-1497.2006.00527.x; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Petty R.E., 2009, HDB INDIVIDUAL DIFFE, P318; Soubelet A, 2017, ASSESSMENT, V24, P987, DOI 10.1177/1073191116636449; Stryker S, 2000, SOC PSYCHOL QUART, V63, P284, DOI 10.2307/2695840; Waite KR, 2008, J GEN INTERN MED, V23, P1367, DOI 10.1007/s11606-008-0662-5; Wilson IB, 2016, AIDS BEHAV; Wilson IB, 2014, AIDS BEHAV, V18, P2349, DOI 10.1007/s10461-013-0610-1; Wilson IB, 2010, JAIDS-J ACQ IMM DEF, V53, P338, DOI 10.1097/QAI.0b013e3181c7a245; Wolf MS, 2007, PATIENT EDUC COUNS, V65, P253, DOI 10.1016/j.pec.2006.08.006	40	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0227722	10.1371/journal.pone.0227722	http://dx.doi.org/10.1371/journal.pone.0227722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569272	Green Published, Green Submitted, gold			2022-12-27	WOS:000543547900017
J	Bagnaresi, P; Cattivelli, L				Bagnaresi, Paolo; Cattivelli, Luigi			Ab initioGO-based mining for non-tandem-duplicated functional clusters in three model plant diploid genomes	PLOS ONE			English	Article							METABOLIC GENE CLUSTERS; IDENTIFICATION; PREDICTION; EVOLUTION; BIOSYNTHESIS; ANNOTATION; SYNTHASE; RICE	A functional Non-Tandem Duplicated Cluster (FNTDC) is a group of non-tandem-duplicated genes that are located closer than expected by mere chance and have a role in the same biological function. The identification of secondary-compounds-related FNTDC has gained increased interest in recent years, but littleab-initioattempts aiming to the identification of FNTDCs covering all biological functions, including primary metabolism compounds, have been carried out. We report an extensive FNTDC dataset accompanied by a detailed assessment on parameters used for genome scanning and their impact on FNTDC detection. We propose 70% identity and 70% alignment coverage as intermediate settings to exclude tandem duplicated genes and a dynamic scanning window of 24 genes. These settings were applied to rice, arabidopsis and grapevine genomes to call for FNTDCs. Besides the best-known secondary metabolism clusters, we identified many FNTDCs associated to primary metabolism ranging from macromolecules synthesis/editing, TOR signalling, ubiquitination, proton and electron transfer complexes. Using the intermediate FNTDC setting parameters (atP-value1e(-6)), 130, 70 and 140 candidate FNTDCs were called in rice, arabidopsis and grapevine, respectively, and 20 to 30% of GO tags associated to called FNTDC were common among the 3 genomes. The datasets developed along with this work provide a rich framework for pinpointing candidate FNTDCs reflecting all GO-BP tags covering both primary and secondary metabolism with large macromolecular complexes/metabolons as the most represented FNTDCs. Noteworthy, several FNTDCs are tagged with GOs referring to organelle-targeted multi-enzyme complex, a finding that suggest the migration of endosymbiont gene chunks towards nuclei could be at the basis of these class of candidate FNTDCs. Most FNTDC appear to have evolved prior of genome duplication events. More than one-third of genes interspersed/adjacent to called FNTDCs lacked any functional annotation; however, their co-localization may provide hints towards a candidate biological role.	[Bagnaresi, Paolo; Cattivelli, Luigi] CREA Res Ctr Genom & Bioinformat, Fiorenzuola Darda, Italy		Bagnaresi, P (corresponding author), CREA Res Ctr Genom & Bioinformat, Fiorenzuola Darda, Italy.	paolo.bagnaresi@crea.gov.it	cattivelli, luigi/AAE-7046-2020	cattivelli, luigi/0000-0002-6067-4600; Bagnaresi, Paolo/0000-0001-8466-4805				Blin K, 2017, NUCLEIC ACIDS RES, V45, pW36, DOI 10.1093/nar/gkx319; Bodenhofer U, 2015, BIOINFORMATICS, V31, P3997, DOI 10.1093/bioinformatics/btv494; Boycheva S, 2014, TRENDS PLANT SCI, V19, P447, DOI 10.1016/j.tplants.2014.01.013; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Field B, 2011, P NATL ACAD SCI USA, V108, P16116, DOI 10.1073/pnas.1109273108; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Ghanbarian AT, 2015, MOL BIOL EVOL, V32, P1748, DOI 10.1093/molbev/msv053; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hiscock SJ, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-reviews1004; Jonczyk R, 2008, PLANT PHYSIOL, V146, P1053, DOI 10.1104/pp.107.111237; Kautsar SA, 2017, NUCLEIC ACIDS RES, V45, pW55, DOI 10.1093/nar/gkx305; Kurotani A, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu176; Ling QH, 2015, BBA-BIOENERGETICS, V1847, P939, DOI 10.1016/j.bbabio.2015.02.017; Ling QH, 2012, SCIENCE, V338, P655, DOI 10.1126/science.1225053; Maccaferri M, 2019, NAT GENET, V51, P885, DOI 10.1038/s41588-019-0381-3; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Matsuba Y, 2013, PLANT CELL, V25, P2022, DOI 10.1105/tpc.113.111013; Niehaus TD, 2015, PLANT PHYSIOL, V169, P1436, DOI 10.1104/pp.15.00959; Nintemann SJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02028; Nutzmann HW, 2014, CURR OPIN BIOTECH, V26, P91, DOI 10.1016/j.copbio.2013.10.009; Nutzmann HW, 2018, ANNU REV GENET, V52, P159, DOI 10.1146/annurev-genet-120417-031237; Nutzmann HW, 2016, NEW PHYTOL, V211, P771, DOI 10.1111/nph.13981; Schlapfer P, 2017, PLANT PHYSIOL, V173, P2041, DOI 10.1104/pp.16.01942; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Takos AM, 2011, PLANT J, V68, P273, DOI 10.1111/j.1365-313X.2011.04685.x; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Topfer N, 2017, NUCLEIC ACIDS RES, V45, P7049, DOI 10.1093/nar/gkx404; von Rad U, 2001, PLANT J, V28, P633, DOI 10.1046/j.1365-313x.2001.01161.x; Wada M, 2012, GENE, V503, P56, DOI 10.1016/j.gene.2012.04.043; Wilderman PR, 2007, J AM CHEM SOC, V129, P15736, DOI 10.1021/ja074977g; Wilderman PR, 2004, PLANT PHYSIOL, V135, P2098, DOI 10.1104/pp.104.045971; Yi G, 2007, BIOINFORMATICS, V23, P1053, DOI 10.1093/bioinformatics/btl673; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu N, 2016, NUCLEIC ACIDS RES, V44, P2255, DOI 10.1093/nar/gkw100; Zerbe P, 2015, TRENDS BIOTECHNOL, V33, P419, DOI 10.1016/j.tibtech.2015.04.006	37	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234782	10.1371/journal.pone.0234782	http://dx.doi.org/10.1371/journal.pone.0234782			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559249	Green Published, gold			2022-12-27	WOS:000543261600063
J	Hasegawa, R; Ebina, T; Tanaka, YR; Kobayashi, K; Matsuzaki, M				Hasegawa, Ryota; Ebina, Teppei; Tanaka, Yasuhiro R.; Kobayashi, Kenta; Matsuzaki, Masanori			Structural dynamics and stability of corticocortical and thalamocortical axon terminals during motor learning	PLOS ONE			English	Article							DENDRITIC SPINES; LONG-TERM; SYNAPTIC PLASTICITY; THALAMIC NUCLEI; LAYER 1; NEURONS; CORTEX; REORGANIZATION; ORGANIZATION; PROJECTIONS	Synaptic plasticity is the cellular basis of learning and memory. When animals learn a novel motor skill, synaptic modifications are induced in the primary motor cortex (M1), and new postsynaptic dendritic spines relevant to motor memory are formed in the early stage of learning. However, it is poorly understood how presynaptic axonal boutons are formed, eliminated, and maintained during motor learning, and whether long-range corticocortical and thalamocortical axonal boutons show distinct structural changes during learning. In this study, we conducted two-photon imaging of presynaptic boutons of long-range axons in layer 1 (L1) of the mouse M1 during the 7-day learning of an accelerating rotarod task. The training-period-averaged rate of formation of boutons on axons projecting from the secondary motor cortical area increased, while the average rate of elimination of those from the motor thalamus (thalamic boutons) decreased. In particular, the elimination rate of thalamic boutons during days 4-7 was lower than that in untrained mice, and the fraction of pre-existing thalamic boutons that survived until day 7 was higher than that in untrained mice. Our results suggest that the late stabilization of thalamic boutons in M1 contributes to motor skill learning.	[Hasegawa, Ryota; Ebina, Teppei; Tanaka, Yasuhiro R.; Matsuzaki, Masanori] Natl Inst Basic Biol, Div Brain Circuits, Okazaki, Aichi, Japan; [Hasegawa, Ryota] Natl Inst Basic Biol, Div Behav Neurobiol, Okazaki, Aichi, Japan; [Hasegawa, Ryota; Matsuzaki, Masanori] SOKENDAI Grad Univ Adv Studies, Dept Basic Biol, Okazaki, Aichi, Japan; [Hasegawa, Ryota; Ebina, Teppei; Tanaka, Yasuhiro R.; Matsuzaki, Masanori] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo, Japan; [Tanaka, Yasuhiro R.] Tamagawa Univ, Brain Sci Inst, Tokyo, Japan; [Kobayashi, Kenta] Natl Inst Physiol Sci, Sect Viral Vector Dev, Okazaki, Aichi, Japan; [Matsuzaki, Masanori] RIKEN Ctr Brain Sci, Brain Funct Dynam Collaborat Lab, Saitama, Japan; [Matsuzaki, Masanori] Univ Tokyo, Int Res Ctr Neurointelligence WPI IRCN, Inst Adv Study, Tokyo, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); RIKEN; University of Tokyo	Matsuzaki, M (corresponding author), Natl Inst Basic Biol, Div Brain Circuits, Okazaki, Aichi, Japan.; Matsuzaki, M (corresponding author), SOKENDAI Grad Univ Adv Studies, Dept Basic Biol, Okazaki, Aichi, Japan.; Matsuzaki, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo, Japan.; Matsuzaki, M (corresponding author), RIKEN Ctr Brain Sci, Brain Funct Dynam Collaborat Lab, Saitama, Japan.; Matsuzaki, M (corresponding author), Univ Tokyo, Int Res Ctr Neurointelligence WPI IRCN, Inst Adv Study, Tokyo, Japan.	mzakim@m.u-tokyo.ac.jp		Ebina, Teppei/0000-0002-3097-0513; Matsuzaki, Masanori/0000-0003-3872-4322	Ministry of Education, Culture, Sports, Science, and Technology, Japan [17H06309, 19H01037]; AMED [JP18dm0207027, JP19dm0107150]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (17H06309 to M.M.) and for Scientific Research (A) (19H01037 to M.M.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; AMED (JP18dm0207027 and JP19dm0107150 to M.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Aoki S, 2019, ELIFE, V8, DOI 10.7554/eLife.49995; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Biane JS, 2016, NEURON, V89, P1173, DOI 10.1016/j.neuron.2016.02.001; Bopp R, 2017, J NEUROSCI, V37, P2435, DOI 10.1523/JNEUROSCI.2557-16.2017; Cao VY, 2015, NEURON, V86, P1385, DOI 10.1016/j.neuron.2015.05.022; Chen SX, 2015, NAT NEUROSCI, V18, P1109, DOI 10.1038/nn.4049; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; FRIEDLANDER MJ, 1991, J NEUROSCI, V11, P3268; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Gala R, 2017, ELIFE, V6, DOI 10.7554/eLife.29315; Gong WK, 2020, NEUROBIOL LEARN MEM, V168, DOI 10.1016/j.nlm.2019.107156; Grillo FW, 2013, P NATL ACAD SCI USA, V110, pE1514, DOI 10.1073/pnas.1218731110; Harms KJ, 2008, J NEUROSCI, V28, P5686, DOI 10.1523/JNEUROSCI.0584-08.2008; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hayashi-Takagi A, 2015, NATURE, V525, P333, DOI 10.1038/nature15257; Hira R, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00055; Hira R, 2013, J NEUROSCI, V33, P1377, DOI 10.1523/JNEUROSCI.2550-12.2013; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Hooks BM, 2013, J NEUROSCI, V33, P748, DOI 10.1523/JNEUROSCI.4338-12.2013; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; IRIKI A, 1989, SCIENCE, V245, P1385, DOI 10.1126/science.2551038; Jejeli M, 2003, NEUROSCI RES, V47, P309, DOI 10.1016/S0168-0102(03)00224-4; Johnson CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10785; Kaneda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018452; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kobayashi K, 2016, NEUROSCI LETT, V630, P45, DOI 10.1016/j.neulet.2016.07.020; Kubota Y, 2007, J NEUROSCI, V27, P1139, DOI 10.1523/JNEUROSCI.3846-06.2007; Kuramoto E, 2015, CEREB CORTEX, V25, P221, DOI 10.1093/cercor/bht216; Kuramoto E, 2011, EUR J NEUROSCI, V33, P95, DOI 10.1111/j.1460-9568.2010.07481.x; Kuramoto E, 2009, CEREB CORTEX, V19, P2065, DOI 10.1093/cercor/bhn231; Liston C, 2013, NAT NEUROSCI, V16, P698, DOI 10.1038/nn.3387; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Masamizu Y, 2014, NAT NEUROSCI, V17, P987, DOI 10.1038/nn.3739; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; Paxinos G, 2013, PAXINOS FRANKLINS MO; Qiao Q, 2016, DEV NEUROBIOL, V76, P252, DOI 10.1002/dneu.22311; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shibata H, 2005, BRAIN RES, V1059, P93, DOI 10.1016/j.brainres.2005.08.025; Sun YJ, 2019, P NATL ACAD SCI USA, V116, P21812, DOI 10.1073/pnas.1914661116; Suter BA, 2015, J NEUROSCI, V35, P2959, DOI 10.1523/JNEUROSCI.4287-14.2015; Tanaka YH, 2018, NEURON, V100, P244, DOI 10.1016/j.neuron.2018.08.016; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Ueta Y, 2014, CEREB CORTEX, V24, P2362, DOI 10.1093/cercor/bht088; Wang XH, 2017, CELL, V171, P440, DOI 10.1016/j.cell.2017.08.014; WHITE EL, 1987, J COMP NEUROL, V262, P13, DOI 10.1002/cne.902620103; Wright NF, 2013, J COMP NEUROL, V521, P2966, DOI 10.1002/cne.23325; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yamawaki N, 2014, ELIFE, V3, DOI 10.7554/eLife.05422; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yang Y, 2016, NAT NEUROSCI, V19, P1348, DOI 10.1038/nn.4370; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; 1993, ADVERSE REACTIONS PL, V10, P1	69	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234930	10.1371/journal.pone.0234930	http://dx.doi.org/10.1371/journal.pone.0234930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559228	Green Submitted, Green Published, gold			2022-12-27	WOS:000543261600047
J	Ortiz-Comino, L; Fernandez-Lao, C; Speksnijder, CM; Lozano-Lozano, M; Tovar-Martin, I; Arroyo-Morales, M; Martin-Martin, L				Ortiz-Comino, Lucia; Fernandez-Lao, Carolina; Speksnijder, Caroline M.; Lozano-Lozano, Mario; Tovar-Martin, Isabel; Arroyo-Morales, Manuel; Martin-Martin, Lydia			Upper body motor function and swallowing impairments and its association in survivors of head and neck cancer: A cross-sectional study	PLOS ONE			English	Article							SHOULDER FUNCTION; DISSECTION; RELIABILITY; TRISMUS; DYSFUNCTION; CARCINOMA; MOTION; RANGE	Background Upper body motor function and swallowing may be affected after curative treatment for head and neck cancer. The aims of this study are to compare maximum mouth opening (MMO), temporomandibular dysfunction (TMD), cervical and shoulder active range of motion (AROM) and strength, and swallowing difficulty between survivors of head and neck cancer (sHNC) and healthy matched controls (HMC) and to examine the correlations between these outcomes in sHNC. Methods Thirty-two sHNC and 32 HMC participated on the study. MMO, TMD, cervical and shoulder AROM, cervical and shoulder strength, the SPADI shoulder pain and disability indices, the Eating Assessment Tool (EAT-10) score, swallowing difficulty as determined using a visual analogue scale (VAS), and the location of disturbances in swallowing, were recorded. Results MMO and cervical and shoulder AROM and strength were significantly lower in sHNC, whereas FAI, SPADI score, EAT-10 and VAS were higher. The MMO, TMD, cervical and shoulder AROM, and cervical shoulder strength values showed significant correlations (some direct, others inverse) with one another. Swallowing difficulty was inversely associated with the MMO, cervical AROM and shoulder strength. Conclusion Compared with controls, sHNC present smaller MMO, lower cervical and shoulder AROM, lower cervical and shoulder strength and higher perception of TMD, shoulder pain and disability and swallowing difficulty. sHNC suffer impaired swallowing related to lower MMO, presence of TMD, cervical AROM and shoulder strength values. Improving these variables via physiotherapy may reduce the difficulty in swallowing experienced by some sHNC.	[Ortiz-Comino, Lucia] Univ Granada, Dept Phys Therapy, Granada, Spain; [Fernandez-Lao, Carolina; Arroyo-Morales, Manuel] Univ Granada, Inst Biosanitario Granada IBS Granada, Inst Mixto Deporte & Salud iMUDS, Dept Phys Therapy, Granada, Spain; [Speksnijder, Caroline M.] Univ Utrecht, Univ Med Ctr Utrecht, Canc Ctr, Dept Head & Neck Surg Oncol, Utrecht, Netherlands; [Speksnijder, Caroline M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Oral & Maxillofacial Surg & Special Dent Car, Utrecht, Netherlands; [Speksnijder, Caroline M.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Lozano-Lozano, Mario; Martin-Martin, Lydia] Univ Granada, Inst Biosanitario Granada IBS Granada, Dept Phys Therapy, Granada, Spain; [Tovar-Martin, Isabel] Virgen de las Nieves Univ Hosp, Radiat Oncol Dept, Granada, Spain	University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Hospital Universitario Virgen de las Nieves	Fernandez-Lao, C (corresponding author), Univ Granada, Inst Biosanitario Granada IBS Granada, Inst Mixto Deporte & Salud iMUDS, Dept Phys Therapy, Granada, Spain.	carolinafl@ugr.es	Speksnijder, Caroline/C-7921-2009; Martin-Martin, Lydia M/L-8955-2014; Lozano-Lozano, Mario/G-2564-2016	Speksnijder, Caroline/0000-0003-0540-3741; Lozano-Lozano, Mario/0000-0001-5854-3567; Fernandez Lao, Carolina/0000-0002-9392-1532	Fondos Estructurales de la Union Europea (FEDER); Unit of Excellence on Exercise and Health (UCEES), University of Granada	Fondos Estructurales de la Union Europea (FEDER); Unit of Excellence on Exercise and Health (UCEES), University of Granada	This research was supported by the Fondos Estructurales de la Union Europea (FEDER) and Unit of Excellence on Exercise and Health (UCEES), University of Granada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, LANCET ONCOL, V18, P1, DOI 10.1016/S1470-2045(16)30642-8; [Anonymous], 2006, J AM ACAD ORTHOP S1, V15, p104S; Baggi F, 2014, ACTA OTORHINOLARYNGO, V34, P230; Belafsky PC, 2008, ANN OTO RHINOL LARYN, V117, P919, DOI 10.1177/000348940811701210; Bensadoun RJ, 2010, SUPPORT CARE CANCER, V18, P1033, DOI 10.1007/s00520-010-0847-4; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; da Fonseca DM, 1994, RGO REV GAUC ODONTOL, V42, P23; Membrilla-Mesa MD, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0397-z; Domenech MA, 2011, PM&R, V3, P105, DOI 10.1016/j.pmrj.2010.10.023; Douma JAJ, 2020, ACTA ONCOL, V59, P342, DOI 10.1080/0284186X.2019.1675906; Duncan M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015860; Felten DL, 2016, NETTERS ATLAS NEUROS, VThird, P153, DOI [10.1016/B978-0-323-26511-9.00009-6, DOI 10.1016/B978-0-323-26511-9.00009-6]; Gane EM, 2017, EJSO-EUR J SURG ONC, V43, P1199, DOI 10.1016/j.ejso.2016.10.026; Gane EM, 2019, OTOLARYNG HEAD NECK, V160, P1009, DOI 10.1177/0194599818821885; Ghiam MK, 2017, SUPPORT CARE CANCER, V25, P2085, DOI 10.1007/s00520-017-3603-1; Giordano L, 2012, ACTA OTORHINOLARYNGO, V32, P376; Giraldi L, 2017, ANN ONCOL, V28, P2843, DOI 10.1093/annonc/mdx486; Harris KD, 2005, PHYS THER, V85, P1349, DOI 10.1093/ptj/85.12.1349; Hauer-Jensen M, 2004, CRIT CARE MED, V32, pS325, DOI 10.1097/01.CCM.0000126358.15697.75; Heijnen BJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6086894; Hislop H., 2013, DANIELS WORTHINGHAMS; Logemann JA, 2018, BRAIN INJ MED, V26, P203, DOI [10.1891/9781617050572.0066, DOI 10.1891/9781617050572.0066]; Maghami E, 2018, MULTIDISCIPLINARY CA, V174, DOI [10.1007/978-3-319-65421-8_5, DOI 10.1007/978-3-319-65421-8_5]; McNeely ML, 2004, HEAD NECK-J SCI SPEC, V26, P518, DOI 10.1002/hed.20010; Mullaney Michael J., 2010, Physiotherapy Theory and Practice, V26, P327, DOI 10.3109/09593980903094230; Namaki S, 2011, J PLAST SURG HAND SU, V45, P136, DOI 10.3109/2000656X.2011.569198; Norkin C., 2006, GONIOMETRIA EVALUACI; Okeson J., 2012, MANAGEMENT TEMPOROMA; Ortigara GB, 2019, OR SURG OR MED OR PA, V128, P235, DOI 10.1016/j.oooo.2019.05.009; Oz B, 2009, EUR J CANCER CARE, V18, P179, DOI 10.1111/j.1365-2354.2008.00950.x; Pauli N, 2019, HEAD NECK-J SCI SPEC, V41, P3570, DOI 10.1002/hed.25878; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Rapidis AD, 2015, CLIN OTOLARYNGOL, V40, P516, DOI 10.1111/coa.12488; Riekki R, 2002, ARCH DERMATOL RES, V294, P178, DOI 10.1007/s00403-002-0306-2; Robbins KT, 2002, ARCH OTOLARYNGOL, V128, P751, DOI 10.1001/archotol.128.7.751; Roy JS, 2009, ARTHRIT RHEUM-ARTHR, V61, P623, DOI 10.1002/art.24396; Shah J, 2019, HEAD NECK SURG ONCOL; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sobin L., 2009, TNM CLASSIFICATION M, V7th edn; Soldatova L, 2019, ANN OTO RHINOL LARYN, V128, P802, DOI 10.1177/0003489419842256; Speksnijder CM, 2013, HEAD NECK-J SCI SPEC, V35, P1303, DOI 10.1002/hed.23131; Tashiro M, 2017, GERIATR GERONTOL INT, V17, P2565, DOI 10.1111/ggi.13097; van der Geer SJ, 2019, HEAD NECK-J SCI SPEC, V41, P64, DOI 10.1002/hed.25369; van Hinte G, 2019, SUPPORT CARE CANCER, V27, P2553, DOI 10.1007/s00520-018-4534-1; von Piekartz H, 2016, MANUAL THER, V26, P208, DOI 10.1016/j.math.2016.09.001; Wetzels JWGH, 2014, HEAD NECK-J SCI SPEC, V36, P1754, DOI 10.1002/hed.23534; Yokogawa N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109838; Young D, 2015, ORAL ONCOL, V51, P727, DOI 10.1016/j.oraloncology.2015.03.015	48	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234467	10.1371/journal.pone.0234467	http://dx.doi.org/10.1371/journal.pone.0234467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559241	Green Published, gold			2022-12-27	WOS:000543261600054
J	Khoshnevis, M; Carozzo, C; Brown, R; Bardies, M; Bonnefont-Rebeix, C; Belluco, S; Nennig, C; Maroon, L; Tillement, O; Gehan, H; Louis, C; Zahi, I; Buronfosse, T; Roger, T; Ponce, F				Khoshnevis, Mehrdad; Carozzo, Claude; Brown, Richard; Bardies, Manuel; Bonnefont-Rebeix, Catherine; Belluco, Sara; Nennig, Christophe; Maroon, Lionel; Tillement, Olivier; Gehan, Helene; Louis, Cedric; Zahi, Ilyes; Buronfosse, Thierry; Roger, Thierry; Ponce, Frederique			Feasibility of intratumoral (165)Holmium siloxane delivery to induced U87 glioblastoma in a large animal model, the Yucatan minipig	PLOS ONE			English	Article							RADIOTHERAPY PLUS CONCOMITANT; MALIGNANT GLIOMAS; RADIATION-THERAPY; TEMOZOLOMIDE; BRACHYTHERAPY; MICROSPHERES; SURVIVAL; CHEMOTHERAPY; MECHANISMS; XENOGRAFT	Glioblastoma is the most aggressive primary brain tumor leading to death in most of patients. It comprises almost 50-55% of all gliomas with an incidence rate of 2-3 per 100,000. Despite its rarity, overall mortality of glioblastoma is comparable to the most frequent tumors. The current standard treatment combines surgical resection, radiotherapy and chemotherapy with temozolomide. In spite of this aggressive multimodality protocol, prognosis of glioblastoma is poor and the median survival remains about 12-14.5 months. In this regard, new therapeutic approaches should be developed to improve the life quality and survival time of the patient after the initial diagnosis. Before switching to clinical trials in humans, all innovative therapeutic methods must be studied first on a relevant animal model in preclinical settings. In this regard, we validated the feasibility of intratumoral delivery of a holmium (Ho) microparticle suspension to an induced U87 glioblastoma model. Among the different radioactive beta emitters,Ho-166 emits high-energy beta(-) radiation and low-energy gamma radiation. beta(-) radiation is an effective means for tumor destruction and gamma rays are well suited for imaging (SPECT) and consequent dosimetry. In addition, the paramagnetic Ho nucleus is a good asset to perform MRI imaging. In this study, five minipigs, implanted with our glioblastoma model were used to test the injectability of(165)Ho (stable) using a bespoke injector and needle. The suspension was produced in the form of Ho microparticles and injected inside the tumor by a technique known as microbrachytherapy using a stereotactic system. At the end of this trial, it was found that the(165)Ho suspension can be injected successfully inside the tumor with absence or minimal traces of Ho reflux after the injections. This injection technique and the use of the(165)Ho suspension needs to be further assessed with radioactive(166)Ho in future studies.	[Khoshnevis, Mehrdad; Carozzo, Claude; Bonnefont-Rebeix, Catherine; Belluco, Sara; Roger, Thierry; Ponce, Frederique] Univ Lyon1, UPSP 2016 A104, VetAgro Sup, ICE Interact Cellules Environm, Marcy Letoile, France; [Brown, Richard; Bardies, Manuel] INSERM, UMR1037, CRCT, Toulouse, France; [Nennig, Christophe] EVEON, Montbonnot St Martin, France; [Maroon, Lionel; Tillement, Olivier] UCBL, Inst Lumiere Matiere, UMR CNRS 5306, Campus LyonTech La Doua, Villeurbanne, France; [Gehan, Helene; Louis, Cedric] NanoH SAS, St Quentin Fallavier, France; [Zahi, Ilyes] Adv Accelerator Applicat, St Genis Pouilly, France; [Buronfosse, Thierry] Univ Lyon1, Dept Endocrinol, VetAgro Sup, Marcy Letoile, France; [Ponce, Frederique] Univ Lyon1, Clin Oncol Unit, VetAgro Sup, Marcy Letoile, France; [Khoshnevis, Mehrdad] INSERM, BrainTech Lab U1205, Grenoble, France	VetAgro Sup; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; VetAgro Sup; Institut National de la Sante et de la Recherche Medicale (Inserm)	Khoshnevis, M (corresponding author), Univ Lyon1, UPSP 2016 A104, VetAgro Sup, ICE Interact Cellules Environm, Marcy Letoile, France.; Khoshnevis, M (corresponding author), INSERM, BrainTech Lab U1205, Grenoble, France.	dvm.khoshnevis@gmail.com	Bardies, Manuel/L-3136-2014	Bardies, Manuel/0000-0002-1766-727X; Marcon, Lionel/0000-0002-3190-3224; Brown, Richard/0000-0001-6989-9200; Khoshnevis, Mehrdad/0000-0003-0609-0898	BPifrance [ISI 2013-2018]	BPifrance	This work was supported by the BPifrance [ISI 2013-2018]. The funder provided support in the form of salaries for authors [Christophe Nennig, Lionel Marcon, Olivier Tillement, Helene Gehan, Cedric Louis, Ilyes Zahi], and did have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alifieris C, 2015, PHARMACOL THERAPEUT, V152, P63, DOI 10.1016/j.pharmthera.2015.05.005; Amelio Dante, 2012, Cancers (Basel), V4, P257, DOI 10.3390/cancers4010257; AMMIRATI M, 1987, NEUROSURGERY, V21, P201, DOI 10.1227/00006123-198708000-00012; Barbarite E, 2017, NEUROSURG REV, V40, P195, DOI 10.1007/s10143-016-0727-6; Beauchesne P, 2010, NEURO-ONCOLOGY, V12, P595, DOI 10.1093/neuonc/noq008; BRANDES A, 1991, ANTICANCER RES, V11, P719; Brandes AA, 2008, NEURO-ONCOLOGY, V10, P361, DOI 10.1215/15228517-2008-008; Brown K, 2017, INTED PROC, P450; Bult W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052178; Buonerba C, 2011, CRIT REV ONCOL HEMAT, V80, P54, DOI 10.1016/j.critrevonc.2010.09.001; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Castro BA, 2014, NEURO-ONCOLOGY, V16, P4, DOI 10.1093/neuonc/not233; Chang Julie E, 2007, Clin Adv Hematol Oncol, V5, P894; Chen L, 2013, BBA-REV CANCER, V1836, P158, DOI 10.1016/j.bbcan.2013.04.003; Chen MY, 1999, J NEUROSURG, V90, P315, DOI 10.3171/jns.1999.90.2.0315; Collingridge DR, 1999, RADIOTHER ONCOL, V53, P127, DOI 10.1016/S0167-8140(99)00121-8; Davis ME, 2016, CLIN J ONCOL NURS, V20, P2, DOI 10.1188/16.CJON.S1.2-8; Dempsey JF, 1998, INT J RADIAT ONCOL, V42, P421, DOI 10.1016/S0360-3016(98)00215-6; Faramarz-Allandini, 2010, WORLD NEUROSURG, V73, P128, DOI 10.1016/j.wneu.2009.06.001; Fisher JL, 2007, NEUROL CLIN, V25, P867, DOI 10.1016/j.ncl.2007.07.002; Gilbert MR, 2013, J CLIN ONCOL, V31, P4085, DOI 10.1200/JCO.2013.49.6968; Gzell C, 2017, CLIN ONCOL-UK, V29, P15, DOI 10.1016/j.clon.2016.09.015; Hong YD, 2002, NUCL MED BIOL, V29, P833, DOI 10.1016/S0969-8051(02)00329-3; Hottinger AF, 2014, CHIN J CANCER, V33, P32, DOI 10.5732/cjc.013.10207; Howells DW, 2010, J CEREBR BLOOD F MET, V30, P1412, DOI 10.1038/jcbfm.2010.66; Huh R, 2005, YONSEI MED J, V46, P51, DOI 10.3349/ymj.2005.46.1.51; Jacobs VL, 2011, ASN NEURO, V3, DOI 10.1042/AN20110014; Kelley K, 2016, CANCERS, V8, DOI 10.3390/cancers8040042; Kesari S, 2011, SEMIN ONCOL, V38, pS2, DOI 10.1053/j.seminoncol.2011.09.005; Khoshnevis M, 2017, J NEUROSCI METH, V282, P61, DOI 10.1016/j.jneumeth.2017.03.007; Knisely JPS, 2002, NEUROIMAG CLIN N AM, V12, P525, DOI 10.1016/S1052-5149(02)00032-1; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Lee CY, 2017, ONCOTARGETS THER, V10, P265, DOI 10.2147/OTT.S120662; Lee YH., 1998, J KOREAN SOC RADIOL, V38, P83, DOI [10.3348/jkrs.1998.38.1.83, DOI 10.3348/JKRS.1998.38.1.83]; Marcon L, 2017, J NANOMED NANOTECHNO, V8, P460; Miller IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095885; Minniti G, 2010, RADIOTHER ONCOL, V97, P377, DOI 10.1016/j.radonc.2010.08.020; Mujokoro B, 2016, MAT SCI ENG C-MATER, V69, P1092, DOI 10.1016/j.msec.2016.07.080; Nijsen JFW, 2004, RADIOLOGY, V231, P491, DOI 10.1148/radiol.2312030594; Nupponen N. N., 2006, CURRENT DIAGNOSTIC P, V12, P394; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Patel S, 2000, NEUROSURGERY, V46, P1123, DOI 10.1097/00006123-200005000-00019; Plowman PN, 1999, BRIT J NEUROSURG, V13, P256, DOI 10.1080/02688699943655; SALAZAR OM, 1979, INT J RADIAT ONCOL, V5, P1733, DOI 10.1016/0360-3016(79)90554-6; Selek L, 2014, J NEUROSCI METH, V221, P159, DOI 10.1016/j.jneumeth.2013.10.002; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Srinivas N., 1994, Evolutionary Computation, V2, P221, DOI 10.1162/evco.1994.2.3.221; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suzuki M, 2003, JPN J CLIN ONCOL, V33, P271, DOI 10.1093/jjco/hyg053; Suzuki YS, 1998, J NUCL MED, V39, P2161; Tatter SB, 2003, J NEUROSURG, V99, P297, DOI 10.3171/jns.2003.99.2.0297; Thomas AA, 2012, CANCER J, V18, P59, DOI 10.1097/PPO.0b013e3182431a73; Tso CL, 2006, CANCER RES, V66, P159, DOI 10.1158/0008-5472.CAN-05-0077; Tysnes BB, 2001, J NEURO-ONCOL, V53, P129; Urbanska K, 2014, WSPOLCZESNA ONKOL, V18, P307, DOI 10.5114/wo.2014.40559; van Nimwegen SA, 2018, VET COMP ONCOL, V16, P114, DOI 10.1111/vco.12319; van Tellingen O, 2015, DRUG RESIST UPDATE, V19, P1, DOI 10.1016/j.drup.2015.02.002; Vente MAD, 2010, EUR RADIOL, V20, P862, DOI 10.1007/s00330-009-1613-1; Villa S, 2014, CHIN J CANCER, V33, P25, DOI 10.5732/cjc.013.10216; Walid Mohammad Sami, 2008, Perm J, V12, P45; WALKER MD, 1978, J NEUROSURG, V49, P333, DOI 10.3171/jns.1978.49.3.0333; WALKER MD, 1979, INT J RADIAT ONCOL, V5, P1725, DOI 10.1016/0360-3016(79)90553-4; Waters JD, 2013, J NEURO-ONCOL, V113, P467, DOI 10.1007/s11060-013-1139-x; Weathers SP, 2014, F1000PRIME REP, V6; Weiss T, 2016, EXPERT REV ANTICANC, V16, P1087, DOI 10.1080/14737140.2016.1229600; Zielhuis SW, 2007, BIOMATERIALS, V28, P4591, DOI 10.1016/j.biomaterials.2007.07.012	67	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234772	10.1371/journal.pone.0234772	http://dx.doi.org/10.1371/journal.pone.0234772			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555746	Green Published, gold			2022-12-27	WOS:000543273200066
J	Sosa-Moreno, A; Comstock, SS; Sugino, KY; Ma, TF; Paneth, N; Davis, Y; Olivero, R; Schein, R; Maurer, J; Zhang, LX				Sosa-Moreno, Andrea; Comstock, Sarah S.; Sugino, Kameron Y.; Ma, Teng F.; Paneth, Nigel; Davis, Yelena; Olivero, Rosemary; Schein, Rebecca; Maurer, Joel; Zhang, Lixin			Perinatal risk factors for fecal antibiotic resistance gene patterns in pregnant women and their infants	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GUT MICROBIOME; 1ST YEAR; RESISTOME; PREVALENCE; DIVERSITY	Perinatal factors can shape fecal microbiome patterns among pregnant women and their infants. However, there is scarce information about the effect of maternal demographics and perinatal exposures on antibiotic resistance genes (ARG) and mobile genetic element (MGE) patterns in pregnant women and infants. We examined fecal samples from pregnant women during their third trimester of pregnancy (n = 51) and 6-month-old infants (n = 40). Of the 91 participants, 72 represented 36 maternal-infant dyads, 15 were additional pregnant women, and 4 were additional infants. We assessed the effects of demographics, pre-pregnancy BMI, smoking and parity in the pregnancy resistome and the effects of demographics, delivery mode, feeding habits and prenatal antibiotic treatment on the infancy resistome. ARG and MGE richness and abundance were assessed using a SmartChip qPCR-array. Alpha diversity (Shannon and Inverse Simpson index) and beta diversity (Sorensen and Bray-Curtis index) were calculated. The Wilcoxon and the Kruskal non-parametric test were used for comparisons. There is a high variability in shared resistome patterns between pregnant women and their infants. An average of 29% of ARG and 24% of MGE were shared within dyads. Infants had significantly greater abundance and higher diversity of ARG and MGE compared to pregnant women. Pregnancy and infancy samples differed in ARG and MGE gene composition and structure. Composition of the fecal resistome was significantly associated with race in pregnant women, with non-white women having different patterns than white women, and, in infants, with extent of solid food consumption. Our data showed that the pregnancy and infancy resistome had different structure and composition patterns, with maternal race and infant solid food consumption as possible contributors to ARG. By characterizing resistome patterns, our results can inform the mechanism of antibiotic resistome development in pregnant women and their infants.	[Sosa-Moreno, Andrea; Ma, Teng F.; Paneth, Nigel; Zhang, Lixin] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Comstock, Sarah S.; Sugino, Kameron Y.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Davis, Yelena; Maurer, Joel] Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, E Lansing, MI 48824 USA; [Davis, Yelena; Olivero, Rosemary] Helen DeVos Childrens Hosp Spectrum Hlth, Grand Rapids, MI USA; [Olivero, Rosemary; Schein, Rebecca] Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, E Lansing, MI 48824 USA; [Sosa-Moreno, Andrea] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Michigan State University College of Human Medicine; University of Michigan System; University of Michigan	Zhang, LX (corresponding author), Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.	lxzhang@msu.edu	Moreno, Andrea Sosa/ABG-2370-2020	Moreno, Andrea Sosa/0000-0002-4687-426X	Environmental influences on Child Health Outcomes (ECHO) - National Institutes of Health (NIH); Office of the Director [UG3 OD023285, UH3OD023285]; Offices of Vice Presidents for Research (Michigan State University) within the Child Health Advances from Research with Mothers Coalition (CHARM); Offices of Vice Presidents for Research (University of Michigan) within the Child Health Advances from Research with Mothers Coalition (CHARM); Offices of Vice Presidents for Research (Wayne State University) within the Child Health Advances from Research with Mothers Coalition (CHARM); Blue Cross Blue Shield of Michigan Foundation [002789]	Environmental influences on Child Health Outcomes (ECHO) - National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director(National Science Foundation (NSF)NSF - Office of the Director (OD)); Offices of Vice Presidents for Research (Michigan State University) within the Child Health Advances from Research with Mothers Coalition (CHARM); Offices of Vice Presidents for Research (University of Michigan) within the Child Health Advances from Research with Mothers Coalition (CHARM); Offices of Vice Presidents for Research (Wayne State University) within the Child Health Advances from Research with Mothers Coalition (CHARM); Blue Cross Blue Shield of Michigan Foundation	This research was financially supported by funds provided to NP by the Environmental influences on Child Health Outcomes (ECHO), which is a nationwide research program supported by the National Institutes of Health (NIH); Office of the Director to enhance child health (UG3 OD023285 and UH3OD023285) as well as an investigator grant awarded to SSC and LZ from the Offices of Vice Presidents for Research from three universities (Michigan State University, the University of Michigan and Wayne State University) within the Child Health Advances from Research with Mothers Coalition (CHARM); and Blue Cross Blue Shield of Michigan Foundation ((grant number: 002789) (https://www.bcbsm.com/foundation/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; [Anonymous], ANT RES THREATS US 2; [Anonymous], 2012, NUCLEIC ACIDS RES, V41, pD43; Arboleya S, 2015, J PEDIATR-US, V166, P538, DOI 10.1016/j.jpeds.2014.09.041; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Broe A, 2014, BJOG-INT J OBSTET GY, V121, P988, DOI 10.1111/1471-0528.12806; Brooks AW, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006842; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; de Vries LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021644; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Feng J, 2018, ENVIRON MICROBIOL, V20, P355, DOI 10.1111/1462-2920.14009; Gardete S, 2014, J CLIN INVEST, V124, P2836, DOI 10.1172/JCI68834; Gasparrini AJ, 2016, GUT MICROBES, V7, P443, DOI 10.1080/19490976.2016.1218584; Gibson MK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.24, 10.1038/nmicrobiol.2016.24]; Gomez-Arango LF, 2017, SCI REP-UK, V7, DOI 10.1038/srep43481; Gosalbes MJ, 2016, J DEV ORIG HLTH DIS, V7, P35, DOI 10.1017/S2040174415001506; Greenwood C, 2014, J PEDIATR-US, V165, P23, DOI 10.1016/j.jpeds.2014.01.010; Guo XP, 2018, ENVIRON SCI TECHNOL, V52, P8165, DOI 10.1021/acs.est.8b01667; Hasperhoven G, 2020, BJOG-INT J OBSTET GY, V127, P1039, DOI 10.1111/1471-0528.16251; Hollister EB, 2014, GASTROENTEROLOGY, V146, P1449, DOI 10.1053/j.gastro.2014.01.052; Hu YF, 2016, APPL ENVIRON MICROB, V82, P6672, DOI 10.1128/AEM.01802-16; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Johnson CL, 2012, PEDIATRICS, V129, P950, DOI 10.1542/peds.2011-2736; Karami N, 2006, ANTIMICROB AGENTS CH, V50, P156, DOI 10.1128/AAC.50.1.156-161.2006; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kuperman A, 2020, BJOG-INT J OBSTET GY, V127, P159, DOI 10.1111/1471-0528.15896; Laursen MF, 2017, FRONT MICROBIOL, P8, DOI 10.3389/fmicb.2017.00356/full 28144237; Li B, 2015, ISME J, V9, P2490, DOI 10.1038/ismej.2015.59; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Moore AM, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0090-9; Moore RE, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190128; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Oldenburg CE, 2020, CLIN INFECT DIS, V70, P525, DOI 10.1093/cid/ciz455; Olesen J, 2018, CEPHALALGIA, V38, P1, DOI 10.1177/0333102417738202; Parnanen K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06393-w; Qin SS, 2012, ANTIMICROB AGENTS CH, V56, P5332, DOI 10.1128/AAC.00809-12; Ravi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep15317; Rose G, 2017, PEERJ, V5, DOI 10.7717/peerj.2928; Stearns JC, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0421-5; Stedtfeld RD, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy130; Steinke D, 2001, CLIN INFECT DIS, V33, pS193, DOI 10.1086/321848; Su JQ, 2015, ENVIRON SCI TECHNOL, V49, P7356, DOI 10.1021/acs.est.5b01012; Sugino KY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213733; Wang SC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01406; Werner G, 2001, ANTIMICROB AGENTS CH, V45, P3267, DOI 10.1128/AAC.45.11.3267-3269.2001; WHO (WorldHealthOrganization), 2018, WHO FACT SHEETS; World Health Organization, 2016, ANTIMICROBIAL RESIST; Xi CW, 2009, APPL ENVIRON MICROB, V75, P5714, DOI 10.1128/AEM.00382-09; Yang R, 2019, PHYSIOL GENOMICS, V51, P368, DOI 10.1152/physiolgenomics.00026.2019; Yassour M, 2018, CELL HOST MICROBE, V24, P146, DOI 10.1016/j.chom.2018.06.007; Zhu YG, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.270	55	9	9	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234751	10.1371/journal.pone.0234751	http://dx.doi.org/10.1371/journal.pone.0234751			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555719	Green Published, gold			2022-12-27	WOS:000543273200014
J	McGetrick, J; Brucks, D; Marshall-Pescini, S; Range, F				McGetrick, Jim; Brucks, Desiree; Marshall-Pescini, Sarah; Range, Friederike			No evidence for a relationship between breed cooperativeness and inequity aversion in dogs	PLOS ONE			English	Article							CANIS-FAMILIARIS; GRAY WOLVES; MONKEYS; EVOLUTION; CHIMPANZEES; BEHAVIOR; SEX; RECIPROCATION; AGGRESSION; TOLERANCE	Inequity aversion, the resistance to inequitable outcomes, has been demonstrated in a wide variety of animal species. Inequity aversion was hypothesised to have co-evolved with cooperation but only limited evidence supports this. Dogs provide a suitable model species to test this hypothesis as dogs were previously shown to be inequity averse and dog breeds vary in the extent to which they were selected for cooperativeness. Here, we compared the response of 12 individuals of "cooperative worker" breeds with that of 12 individuals of "independent worker" breeds in the "paw task" previously used to demonstrate inequity aversion in dogs. We also compared the two breed groups' subsequent social behaviours in a food tolerance test and free interaction session. Although subjects in both breed groups were inequity averse, we found no considerable difference between the groups in the extent of the negative response to inequity or in the impact of the inequity on subsequent social behaviours. However, we found differences between the breed groups in the response to reward omission with cooperative breeds tending to work for longer than independent breeds. Additionally, in the free interaction session, individuals of cooperative breeds spent more time in proximity to their partner in the baseline condition than individuals of independent breeds. Overall, our results do not provide support for the hypothesis that inequity aversion and cooperation co-evolved. However, they illuminate potential differences in selection pressures experienced by cooperative worker and independent worker dog breeds throughout their evolutionary history.	[McGetrick, Jim; Marshall-Pescini, Sarah; Range, Friederike] Univ Vet Med, Konrad Lorenz Inst Ethol, Domesticat Lab, Vienna, Austria; [McGetrick, Jim; Brucks, Desiree; Marshall-Pescini, Sarah; Range, Friederike] Med Univ Vienna, Univ Vet Med, Messerli Res Inst, Comparat Cognit Unit, Vienna, Austria; [McGetrick, Jim; Brucks, Desiree; Marshall-Pescini, Sarah; Range, Friederike] Univ Vienna, Vienna, Austria; [Brucks, Desiree] Swiss Fed Inst Technol, Inst Agr Sci, Zurich, Switzerland	University of Veterinary Medicine Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; Swiss Federal Institutes of Technology Domain; ETH Zurich	McGetrick, J (corresponding author), Univ Vet Med, Konrad Lorenz Inst Ethol, Domesticat Lab, Vienna, Austria.; McGetrick, J (corresponding author), Med Univ Vienna, Univ Vet Med, Messerli Res Inst, Comparat Cognit Unit, Vienna, Austria.; McGetrick, J (corresponding author), Univ Vienna, Vienna, Austria.	Jim.McGetrick@vetmeduni.ac.at	Brucks, Désirée/AAF-6788-2020	McGetrick, Jim/0000-0001-5468-934X; Range, Friederike/0000-0003-3127-5536; Brucks, Desiree/0000-0003-3146-5110	DOC fellowship of the Austrian Academy of Sciences at the Messerli Research Institute; Austrian Science Fund (FWF) [W1262-B29]; European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant [311870]	DOC fellowship of the Austrian Academy of Sciences at the Messerli Research Institute; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant	JMcG was funded by a DOC fellowship of the Austrian Academy of Sciences at the Messerli Research Institute, and by the Austrian Science Fund (FWF) number W1262-B29. DB and SMP were funded by the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement n. [311870]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2003, BEHAVIOUR, V140, P519, DOI 10.1163/156853903322127968; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Boesch C, 2002, HUM NATURE-INT BIOS, V13, P27, DOI 10.1007/s12110-002-1013-6; BOINSKI S, 1987, BEHAV ECOL SOCIOBIOL, V21, P13, DOI 10.1007/BF00324430; Boinski S, 2002, BEHAVIOUR, V139, P227, DOI 10.1163/156853902760102663; Brauer J, 2006, P ROY SOC B-BIOL SCI, V273, P3123, DOI 10.1098/rspb.2006.3693; Brauer J, 2009, AM J PRIMATOL, V71, P175, DOI 10.1002/ajp.20639; Brosnan SF, 2016, BEHAVIOUR, V153, P1267, DOI 10.1163/1568539X-00003355; Brosnan SF, 2014, SCIENCE, V346, P314, DOI 10.1126/science.1251776; Brosnan SF, 2013, P NATL ACAD SCI USA, V110, P10416, DOI 10.1073/pnas.1301194110; Brosnan SF, 2011, FOLIA PRIMATOL, V82, P56, DOI 10.1159/000328142; Brosnan SF, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00043; Brosnan SF, 2010, ANIM BEHAV, V79, P1229, DOI 10.1016/j.anbehav.2010.02.019; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Brosnan SF, 2002, HUM NATURE-INT BIOS, V13, P129, DOI 10.1007/s12110-002-1017-2; Brucks D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00270; Brucks D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153799; Bshary R, 2008, J EVOLUTION BIOL, V21, P405, DOI 10.1111/j.1420-9101.2007.01482.x; Cassidy KA, 2017, BEHAV PROCESS, V136, P64, DOI 10.1016/j.beproc.2017.01.011; Cassidy KA, 2016, ANIM COGN, V19, P939, DOI 10.1007/s10071-016-0994-1; Cassidy KA, 2015, BEHAV ECOL, V26, P1352, DOI 10.1093/beheco/arv081; Chalmeau R, 1997, INT J PRIMATOL, V18, P23, DOI 10.1023/A:1026337006136; CONNOR RC, 1995, BIOL REV, V70, P427, DOI 10.1111/j.1469-185X.1995.tb01196.x; Connor RC, 2010, PHILOS T R SOC B, V365, P2687, DOI 10.1098/rstb.2010.0150; Coppinger R, 1995, EVOLUTION WORKING DO; Crockford C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2765; Cronin KA, 2008, ANIM BEHAV, V75, P245, DOI 10.1016/j.anbehav.2007.04.032; Dale R, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2339-8; Dale R, 2017, CURR ZOOL, V63, P323, DOI 10.1093/cz/zow111; de Waal F. B. M., 1977, Zeitschrift Tierpsychol, V44, P225; DEWAAL FBM, 1993, AM J PRIMATOL, V29, P73, DOI 10.1002/ajp.1350290108; Dufour V, 2009, BIOL LETTERS, V5, P172, DOI 10.1098/rsbl.2008.0644; Dugatkin L.A., 1997, COOPERATION ANIMALS; Essler JL, 2017, CURR BIOL, V27, P1861, DOI 10.1016/j.cub.2017.05.061; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; Gamer M, 2012, IRR VARIOUS COEFFICI; Gilby IC, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0005; Gilby IC, 2013, BEHAV ECOL SOCIOBIOL, V67, P373, DOI 10.1007/s00265-012-1457-6; Gumert MD, 2008, PRIMATES, V49, P176, DOI 10.1007/s10329-008-0089-y; Gumert MD, 2007, ANIM BEHAV, V74, P1655, DOI 10.1016/j.anbehav.2007.03.009; Hart Benjamin L., 1995, P65; Heaney M, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160461; Heaney M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169799; Heberlein MTE, 2017, J COMP PSYCHOL, V131, P19, DOI 10.1037/com0000050; Horowitz A, 2012, SOC JUSTICE RES, V25, P195, DOI 10.1007/s11211-012-0158-7; IZAWA K, 1980, Primates, V21, P443, DOI 10.1007/BF02373834; Jahn-Eimermacher A, 2011, BEHAV BRAIN RES, V221, P271, DOI 10.1016/j.bbr.2011.03.007; Jakovcevic A, 2010, BEHAV PROCESS, V84, P602, DOI 10.1016/j.beproc.2010.04.003; Jelbert SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133253; Kaburu SSK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20634; Kassambara A, 2018, SURVMINER DRAWING SU; Krasheninnikova A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52780-8; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Langergraber KE, 2017, P NATL ACAD SCI USA, V114, P7337, DOI 10.1073/pnas.1701582114; LEHMAN N, 1992, BEHAV ECOL SOCIOBIOL, V30, P83; Machanda ZP, 2014, ANIM BEHAV, V87, P165, DOI 10.1016/j.anbehav.2013.10.028; MacNulty DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112884; Massen JJM, 2019, NEUROSCI BIOBEHAV R, V107, P370, DOI 10.1016/j.neubiorev.2019.09.027; Massen JJM, 2012, AM J PRIMATOL, V74, P145, DOI 10.1002/ajp.21014; McAuliffe K, 2015, ANIM BEHAV, V103, P65, DOI 10.1016/j.anbehav.2015.02.014; McAuliffe K, 2014, ANIM COGN, V17, P1289, DOI 10.1007/s10071-014-0764-x; McGetrick J, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00413; McGetrick J, 2018, LEARN BEHAV, V46, P479, DOI 10.3758/s13420-018-0338-x; Mech L.D., 2015, WOLVES HUNT BEHAV WO; Mehrkam LR, 2014, APPL ANIM BEHAV SCI, V155, P12, DOI 10.1016/j.applanim.2014.03.005; MITCHELL CL, 1994, BEHAVIOUR, V130, P169, DOI 10.1163/156853994X00514; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Oberliessen L, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00133; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Passalacqua C, 2011, ANIM BEHAV, V82, P1043, DOI 10.1016/j.anbehav.2011.07.039; R Development Core Team, 2009, R LANG ENV STAT COMP; Raihani NJ, 2012, ANIM BEHAV, V84, P665, DOI 10.1016/j.anbehav.2012.06.023; Range F, 2009, P NATL ACAD SCI USA, V106, P340, DOI 10.1073/pnas.0810957105; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Romero T, 2019, PHYSIOL BEHAV, V201, P104, DOI 10.1016/j.physbeh.2018.12.023; Samuni L, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1643; Samuni L, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0142-3; Schino G, 2009, ETHOLOGY, V115, P70, DOI 10.1111/j.1439-0310.2008.01581.x; Schino G, 2009, AM J PRIMATOL, V71, P101, DOI 10.1002/ajp.20627; Schwing R, 2016, ANIM COGN, V19, P1093, DOI 10.1007/s10071-016-1017-y; Skinner BF., 1953, SCI HUMAN BEHAV; Surbeck M, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22641; Therneau T., 2015, PACKAGE SURVIVAL ANA; Therneau TM, 2000, MODELING SURVIVAL DA; Udell MAR, 2014, ANIM BEHAV, V89, P99, DOI 10.1016/j.anbehav.2013.12.012; Ulber J, 2017, J EXP CHILD PSYCHOL, V155, P48, DOI 10.1016/j.jecp.2016.10.013; van Leeuwen EJC, 2011, BIOL LETTERS, V7, P39, DOI 10.1098/rsbl.2010.0482; Van Noordwijk MA, 2001, BEHAVIOUR, V138, P359, DOI 10.1163/15685390152032505; van Wolkenten M, 2007, P NATL ACAD SCI USA, V104, P18854, DOI 10.1073/pnas.0707182104; Venables W.N., 2002, MODERN APPL STAT S, VFourth; Volter CJ, 2015, ANIM BEHAV, V100, P126, DOI 10.1016/j.anbehav.2014.11.025; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; West Eberhard M.J., 1975, Quarterly Review of Biology, V50, P1; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willis MB, 1995, DOMESTIC DOG ITS EVO, P21; Wilsson E, 1997, APPL ANIM BEHAV SCI, V53, P279, DOI 10.1016/S0168-1591(96)01174-4; Wittig RM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3096; Zeileis A., 2002, P NATL ACAD SCI USA, V2, P7, DOI [DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/, DOI 10.1073/pnas.2022376118]	105	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0233067	10.1371/journal.pone.0233067	http://dx.doi.org/10.1371/journal.pone.0233067			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555709	Green Published, gold			2022-12-27	WOS:000542759600015
J	Zawiah, M; Yousef, AM; Khan, AH; AL-Ashwal, FY; Matar, A; ALKhawaldeh, B; Nassar, R; Abduljabbar, R; Ahmed, AAA				Zawiah, Mohammed; Yousef, Al-Motassem; Khan, Amer Hayat; AL-Ashwal, Fahmi Y.; Matar, Amal; ALKhawaldeh, Batool; Nassar, Rand; Abduljabbar, Rami; Ahmed, Abdullah Abdulmajid Abdo			Food-drug interactions: Knowledge among pharmacists in Jordan	PLOS ONE			English	Article							HEALTH-CARE; WARFARIN; THERAPY; INHIBITOR; CAFFEINE	Background Pharmacists have crucial role in providing drug information and medication counseling to patients. This survey aimed to benchmark the current knowledge of the pharmacists concerning food-drug interactions (FDIs) in Jordan. Methods A cross-sectional study was conducted in Amman, the capital and largest city of Jordan, using a validated questionnaire. It was distributed to pharmacists working in community and hospital pharmacies using a convenience sampling technique. Descriptive and inferential statistics were performed in this study. Results A total of 340 questionnaires distributed, 300 (88%) pharmacists responded. Over 50% of pharmacists claimed that they have sufficient knowledge regarding FDI. Virtually, the overall median (interquartile range) knowledge score was 18 (15-21), approximately 60%. The highest knowledge scores were for alcohol-drug interactions section (66.6%) followed by both common food-drug interactions and the timing of drug intake to food consumption sections with a score of (58.3%) for each, reflecting a suboptimal knowledge of FDIs among the pharmacists. Conclusion Pharmacists had unsatisfactory knowledge about common FDIs, with no significant difference between hospital and community pharmacists. Therefore, more attention and efforts should be played to improve awareness about potential food-drug interactions.	[Zawiah, Mohammed; Khan, Amer Hayat; AL-Ashwal, Fahmi Y.] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Yousef, Al-Motassem; Matar, Amal; ALKhawaldeh, Batool; Nassar, Rand] Univ Jordan, Sch Pharm, Dept Biopharmaceut & Clin Pharm, Amman, Jordan; [Abduljabbar, Rami] Yemeni Univ Sci & Technol, Coll Pharm, Taizz, Yemen; [Ahmed, Abdullah Abdulmajid Abdo] Int Islamic Univ, Dept Pharm Practice, Kulliyyah Pharm, Gombak, Malaysia	Universiti Sains Malaysia; University of Jordan	Yousef, AM (corresponding author), Univ Jordan, Sch Pharm, Dept Biopharmaceut & Clin Pharm, Amman, Jordan.	ayousef@ju.edu.jo	Zawiah, Mohammed/AAE-7309-2020; Khan, Amer Hayat/O-5310-2018; Al-Ashwal, Fahmi/AAX-5385-2021; Yousef, Al-Motassem/F-1781-2015	Zawiah, Mohammed/0000-0002-3325-1442; Khan, Amer Hayat/0000-0003-4802-6181; Al-Ashwal, Fahmi/0000-0003-2076-0771; Yousef, Al-Motassem/0000-0002-3841-4132	Institute of post graduate studies of Universiti Sains Malaysia	Institute of post graduate studies of Universiti Sains Malaysia	We would like to thank Institute of post graduate studies of Universiti Sains Malaysia for providing fellowship during the course of doctoral studies of Mr. Mohammed Hussein.	Abbasinazari M, 2011, IRAN J PHARM RES, V10, P173; Abdollahi M, 2018, EVID BASED CARE, V8, P27; Agosti S, 2012, AM J EMERG MED, V30, DOI 10.1016/j.ajem.2010.08.031; [Anonymous], 2009, MED LETT DRUGS THER, V51, P65; Ansari Ja, 2010, J Young Pharm, V2, P326, DOI 10.4103/0975-1483.66807; Bailey DG, 2013, CAN MED ASSOC J, V185, P309, DOI 10.1503/cmaj.120951; Benni JM, 2012, INT J PHARM CLIN SCI, V1, P97; Bonner L, 2017, PHARM TODAY, V23, P18; BRUCE M, 1992, ARCH GEN PSYCHIAT, V49, P867; Cooper M, 2004, PSYCHOL REP, V95, P183, DOI 10.2466/PR0.95.5.183-191; Couris RR, 2000, J AM COLL NUTR, V19, P439, DOI 10.1080/07315724.2000.10718944; Deng JY, 2017, DRUGS, V77, P1833, DOI 10.1007/s40265-017-0832-z; Dixit A, 2019, ANN CARD ANAESTH, V22, P162, DOI 10.4103/aca.ACA_65_18; El Lassy RBM, EFFECT FOOD DRUG INT; Enwerem NM, 2015, INT J NURS STUD, V2, P1; Enwerem NM, 2017, INT J HIGHER ED, V6, P122; Flisch R., 2009, AGRARFORSCHUNG, V16, P1; de Carvalho REFL, 2013, ACTA PAUL ENFERM, V26, P150, DOI 10.1590/S0103-21002013000200008; Genser D, 2008, ANN NUTR METAB, V52, P29, DOI 10.1159/000115345; Hourani HA, 2011, FOOD NUTR PROFILE JO; Johnson Bankole A, 2014, Handb Clin Neurol, V125, P543, DOI 10.1016/B978-0-444-62619-6.00031-8; Joint Commission on Accreditation of Health Care Organizations (PF1.5), 1986, JCAH PERSP, P1994; Kinoshita Y, 2018, J NEUROGASTROENTEROL, V24, P182, DOI 10.5056/jnm18001; Lenz TL, 2013, AM J LIFESTYLE MED, V7, P250, DOI 10.1177/1559827613483956; LEWIS CW, 1995, J AM DIET ASSOC, V95, P309, DOI 10.1016/S0002-8223(95)00079-8; Macedo R, 2013, PROCEEDINGS OF 2013 INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND SYSTEMS MANAGEMENT (IEEE-IESM 2013), P19; Mallhi TH, 2015, TROP J PHARM RES, V14, P1927, DOI 10.4314/tjpr.v14i10.27; Mazokopakis EE, 2008, INTERN MED J, V38, P364, DOI 10.1111/j.1445-5994.2007.01550.x; Moore Alison A, 2007, Am J Geriatr Pharmacother, V5, P64, DOI 10.1016/j.amjopharm.2007.03.006; Nazer LH, 2017, CAN J HOSP PHARM, V70, P150; Nelson ML, 2011, ANN NY ACAD SCI, V1241, P17, DOI 10.1111/j.1749-6632.2011.06354.x; Neves S. J. F., 2016, Journal of Chemical and Pharmaceutical Research, V8, P965; Ngo ASY, 2010, J MED TOXICOL, V6, P431, DOI 10.1007/s13181-010-0101-y; Nutescu EA, 2006, EXPERT OPIN DRUG SAF, V5, P433, DOI 10.1517/14740338.5.3.433; Quadra GR, 2020, ENVIRON POLLUT, V256, DOI 10.1016/j.envpol.2019.113343; Radwan A, 2018, INT J CLIN PHARM-NET, V40, P668, DOI 10.1007/s11096-018-0640-x; Roberts GW., 2004, AUST PRESCR, V27, P75, DOI [10.18773/austprescr.2004.061, DOI 10.18773/AUSTPRESCR.2004.061]; Roth JA, 2015, PHARMACOEPIDEM DR S, V24, P619, DOI 10.1002/pds.3769; Schmidt LE, 2002, DRUGS, V62, P1481, DOI 10.2165/00003495-200262100-00005; Sorensen JM, 2002, J ALTERN COMPLEM MED, V8, P293, DOI 10.1089/10755530260127989; Stargrove M.B, 2008, HERB DRUG INTERACTIO, P487; Teodoro AJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3765986; Trailokya Abhijit, 2017, J Assoc Physicians India, V65, P100; Virmani Tuhin, 2016, J Clin Mov Disord, V3, P8, DOI 10.1186/s40734-016-0036-9; Wenzler E, 2018, DRUG INTERACTIONS IN, P87; Won CS, 2012, PHARMACOL THERAPEUT, V136, P186, DOI 10.1016/j.pharmthera.2012.08.001	46	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234779	10.1371/journal.pone.0234779	http://dx.doi.org/10.1371/journal.pone.0234779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555684	Green Published, gold			2022-12-27	WOS:000542759600042
J	Addepalli, A; Kalyani, S; Singh, M; Bandyopadhyay, D; Mohan, KN				Addepalli, Aditya; Kalyani, Sakhare; Singh, Minali; Bandyopadhyay, Debashree; Naga Mohan, K.			CalPen (Calculator ofPenetrance), a web-based tool to estimate penetrance in complex genetic disorders (vol 15, e0228156, 2020)	PLOS ONE			English	Correction													Bandyopadhyay, Debashree/AAL-9043-2021; Mohan, Kommu Naga/HIK-1746-2022					Addepalli A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228156	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235547	10.1371/journal.pone.0235547	http://dx.doi.org/10.1371/journal.pone.0235547			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584917	Green Published, gold			2022-12-27	WOS:000545747200084
J	Galpern, EA; Freiberger, MI; Ferreiro, DU				Galpern, Ezequiel A.; Freiberger, Maria I.; Ferreiro, Diego U.			Large Ankyrin repeat proteins are formed with similar and energetically favorable units	PLOS ONE			English	Article							FOLDING KINETICS; DOMAIN REPEATS; EVOLUTION	Ankyrin containing proteins are one of the most abundant repeat protein families present in all extant organisms. They are made with tandem copies of similar amino acid stretches that fold into elongated architectures. Here, we built and curated a dataset of 200 thousand proteins that contain 1.2 million Ankyrin regions and characterize the abundance, structure and energetics of the repetitive regions in natural proteins. We found that there is a continuous roughly exponential variety of array lengths with an exceptional frequency at 24 repeats. We described that individual repeats are seldom interrupted with long insertions and accept few deletions, in line with the known tertiary structures. We found that longer arrays are made up of repeats that are more similar to each other than shorter arrays, and display more favourable folding energy, hinting at their evolutionary origin. The array distributions show that there is a physical upper limit to the size of an array of repeats of about 120 copies, consistent with the limit found in nature. The identity patterns within the arrays suggest that they may have originated by sequential copies of more than one Ankyrin unit.	[Galpern, Ezequiel A.; Freiberger, Maria I.; Ferreiro, Diego U.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, IQUIBICEN,CONICE,Prot Physiol Lab,Inst Quim Biol, Buenos Aires, DF, Argentina	University of Buenos Aires	Ferreiro, DU (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, IQUIBICEN,CONICE,Prot Physiol Lab,Inst Quim Biol, Buenos Aires, DF, Argentina.	ferreiro@qb.fcen.uba.ar		Ferreiro, Diego/0000-0002-7869-4247	DUF; Universidad de Buenos Aires-UBACYT [20020170100540BA]; Agencia Nacional de Promocion Cienctifica y Tecnologica [PICT2016-1467]	DUF; Universidad de Buenos Aires-UBACYT(University of Buenos Aires); Agencia Nacional de Promocion Cienctifica y Tecnologica	DUF; Universidad de Buenos Aires-UBACYT 2018 - 20020170100540BA. http://www.uba.ar DUF; Agencia Nacional de Promocion Cienctifica y Tecnologica -PICT2016-1467 https://www.argentina.gob.ar/ciencia/agencia The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksel T, 2014, BIOPHYS J, V107, P220, DOI 10.1016/j.bpj.2014.04.058; Aksel T, 2011, STRUCTURE, V19, P349, DOI 10.1016/j.str.2010.12.018; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Barrick D, 2008, CURR OPIN STRUC BIOL, V18, P27, DOI 10.1016/j.sbi.2007.12.004; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Bjorklund AK, 2010, J MOL BIOL, V402, P38, DOI 10.1016/j.jmb.2010.07.011; Boutet Emmanuel, 2007, V406, P89; DeVries I, 2011, J MOL BIOL, V408, P163, DOI 10.1016/j.jmb.2011.02.021; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Espada R, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005584; Espada R, 2015, BIOCHEM SOC T, V43, P844, DOI 10.1042/BST20150083; Ferreiro DU, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000070; Ferreiro DU, 2008, P NATL ACAD SCI USA, V105, P9853, DOI 10.1073/pnas.0805287105; Ferreiro DU, 2007, J MOL BIOL, V365, P1201, DOI 10.1016/j.jmb.2006.11.044; Ferreiro DU, 2005, J MOL BIOL, V354, P679, DOI 10.1016/j.jmb.2005.09.078; Hagai T, 2012, BIOPHYS J, V103, P1555, DOI 10.1016/j.bpj.2012.08.018; Hutton RD, 2015, J AM CHEM SOC, V137, P14610, DOI 10.1021/jacs.5b07370; Jernigan KK, 2014, PEERJ, V2, DOI 10.7717/peerj.264; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Marchi J, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007282; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; MICHAELY P, 1993, J BIOL CHEM, V268, P22703; Mora T, 2011, J STAT PHYS, V144, P268, DOI 10.1007/s10955-011-0229-4; Paladin L, 2017, NUCLEIC ACIDS RES, V45, pD308, DOI 10.1093/nar/gkw1136; Paques F, 1998, MOL CELL BIOL, V18, P2045, DOI 10.1128/MCB.18.4.2045; Parra RG, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004659; Persi E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13570; Reshef D, 2010, TRENDS GENET, V26, P383, DOI 10.1016/j.tig.2010.06.003; Rowling PJE, 2015, BIOCHEM SOC T, V43, P881, DOI 10.1042/BST20150099; Schuler A, 2016, MOL BIOL EVOL, V33, P3170, DOI 10.1093/molbev/msw194; Street TO, 2007, P NATL ACAD SCI USA, V104, P4907, DOI 10.1073/pnas.0608756104; Street TO, 2009, PROTEIN SCI, V18, P58, DOI 10.1002/pro.9; Tamaskovic R, 2012, METHOD ENZYMOL, V503, P101, DOI 10.1016/B978-0-12-396962-0.00005-7; Tang KS, 1999, J MOL BIOL, V285, P1869, DOI 10.1006/jmbi.1998.2420; Wang C, 2014, ELIFE, V3, DOI 10.7554/eLife.04353; Werbeck ND, 2008, P NATL ACAD SCI USA, V105, P9982, DOI 10.1073/pnas.0705300105; Wolynes PG, 2015, BIOCHIMIE, V119, P218, DOI 10.1016/j.biochi.2014.12.007; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195	41	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0233865	10.1371/journal.pone.0233865	http://dx.doi.org/10.1371/journal.pone.0233865			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579546	Green Published, gold, Green Submitted			2022-12-27	WOS:000545646600008
J	Herrero-Tejedor, TR; Soler, FA; Medina, SLC; Cabrera, MRD; Romero, JLM				Herrero-Tejedor, Tomas Ramon; Arques Soler, Francisco; Lopez-Cuervo Medina, Serafin; Cabrera, Manuel Rodrigo de la O.; Martin Romero, Juan Luis			Documenting a cultural landscape using point-cloud 3d models obtained with geomatic integration techniques. The case of the El Encin atomic garden, Madrid (Spain)	PLOS ONE			English	Article							UAV PHOTOGRAMMETRY; FOREST; AIRBORNE; LIDAR; TERRAIN; SYSTEMS; SURFACE; TREES; GIS	A country's cultural landscapes are an important part of its heritage. The growing need to identify, catalogue and preserve these resources has led to a rapid change in the management and inventorying of heritage in general and of cultural landscapes in particular. The main aim of this work is to develop and apply an updated and integrated methodology for capturing and processing geo-information for the digital documentation of cultural heritage. The proposed case study is the atomic garden in the Finca El Encin (Madrid), a singular space with unique biogeographical features created over 60 years ago. The results of the case study validate the method, consisting of an unmanned aerial platform equipped with sensors to obtain point clouds and aerial images in conjunction with point clouds and images captured with a terrestrial laser scanner.	[Herrero-Tejedor, Tomas Ramon; Martin Romero, Juan Luis] Univ Politecn Madrid, Dept Agroforestry Engn, Madrid, Spain; [Arques Soler, Francisco] Univ Politecn Madrid, Dept Architectural Design, Madrid, Spain; [Lopez-Cuervo Medina, Serafin] Univ Politecn Madrid, Dept Surveying & Cartog Engn, Madrid, Spain; [Cabrera, Manuel Rodrigo de la O.] Univ Politecn Madrid, Dept Architectural Composit, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Universidad Politecnica de Madrid	Herrero-Tejedor, TR (corresponding author), Univ Politecn Madrid, Dept Agroforestry Engn, Madrid, Spain.	tomas.herrero.tejedor@upm.es	Medina, Serafin Lopez-Cuervo/L-4082-2017; DE LA O CABRERA, MANUEL RODRIGO/M-6203-2019; Herrero-Tejedor, Tomas Ramon/A-9600-2012	Medina, Serafin Lopez-Cuervo/0000-0003-2396-7815; DE LA O CABRERA, MANUEL RODRIGO/0000-0001-9869-8766; Herrero-Tejedor, Tomas Ramon/0000-0002-4827-1403	SENSE-SCAPES R&D Project, Ministerio de Economia y Competitividad [HAR2015-64762-P]; LABPACM R&D Program, Comunidad de Madrid [H2019/HUM-5692]	SENSE-SCAPES R&D Project, Ministerio de Economia y Competitividad; LABPACM R&D Program, Comunidad de Madrid	This investigation was carried out with the funds from SENSE-SCAPES R&D Project, Ministerio de Economia y Competitividad, HAR2015-64762-P (research tasks) and LABPACM R&D Program, Comunidad de Madrid, H2019/HUM-5692 (dissemination task). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicardi I, 2018, J CULT HERIT, V32, P257, DOI 10.1016/j.culher.2017.11.006; Aicardi I, 2017, IFOREST, V10, P41, DOI [1, 10.3832/ifor1780-009]; Alexander C, 2018, INT J APPL EARTH OBS, V72, P86, DOI 10.1016/j.jag.2018.05.024; Anderson K, 2018, LANDSCAPE URBAN PLAN, V178, P248, DOI 10.1016/j.landurbplan.2018.05.024; [Anonymous], 2009, RESEARCHGATE, V40, P5; [Anonymous], 2017, INSTALLATION DKZ, V9, P26; [Anonymous], 2015, REC TECN DOC PAIS IN; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; [Anonymous], 2017, EPLASTY, V17, pic25; Arques Soler F, 2017, ECLAS C 2017 CREAT R, P101; Bandarin F, 2003, CULTURAL LANDSCAPES; Bielanski M, 2018, APPL GEOGR, V96, P51, DOI 10.1016/j.apgeog.2018.05.008; Brabyn L, 2011, APPL GEOGR, V31, P1115, DOI 10.1016/j.apgeog.2011.03.003; Council of Europe Recommendation CM/Rec, 2008, REC COMM MIN MEMB ST; FRANCES CUESTA A, 2016, PROYECTO ARQUITECTUR; Gheyle W, 2018, APPL GEOGR, V90, P55, DOI 10.1016/j.apgeog.2017.11.011; Grubesic TH, 2018, LANDSCAPE URBAN PLAN, V169, P148, DOI 10.1016/j.landurbplan.2017.09.001; Gruszczynski W, 2017, ISPRS J PHOTOGRAMM, V126, P168, DOI 10.1016/j.isprsjprs.2017.02.015; Gupta S, 2018, APPL GEOGR, V98, P156, DOI 10.1016/j.apgeog.2018.07.012; Hayek UW, 2016, LANDSCAPE URBAN PLAN, V156, P59, DOI 10.1016/j.landurbplan.2016.05.015; Herrero T, 2015, SURV REV, V47, P202, DOI 10.1179/1752270614Y.0000000104; Kumazaki R, INT ARCH PHOTOGRAMME, P233; Langhammer J, 2018, APPL GEOGR, V98, P9, DOI 10.1016/j.apgeog.2018.07.001; Liang XL, 2016, ISPRS J PHOTOGRAMM, V115, P63, DOI 10.1016/j.isprsjprs.2016.01.006; Lin E., 2016, POINT CLOUDS REPRESE; Luo LH, 2019, MEASUREMENT, V131, P513, DOI 10.1016/j.measurement.2018.09.020; Madden M, 2015, P PHOTOGRAMM WEEK; McClelland, 1990, BULLETIN, V30, P1; Moudry V, 2019, APPL GEOGR, V104, P32, DOI 10.1016/j.apgeog.2019.02.002; National Plan for Cultural Landscape, 2012, NAT PLAN CULT LANDSC; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Page Robert R., 1998, GUIDE CULTURAL LANDS; Panagiotidis D, 2017, INT J REMOTE SENS, V38, P2392, DOI 10.1080/01431161.2016.1264028; Parker PL, 1990, NATL REGISTER B DEP; Pelzer P, 2014, COMPUT ENVIRON URBAN, V48, P16, DOI 10.1016/j.compenvurbsys.2014.05.002; Perez-Martin E, 2011, APPL GEOGR, V31, P941, DOI 10.1016/j.apgeog.2011.01.006; Rodrigo Camara JM, 2017, DOCUMENTACION PAISAJ; ROSSLER M., 1998, PAISAJES CULTURALES, P17; Ruiz-Labourdette D, WIT T ECOLOGY ENV; Schmitz MF, 2017, LAND DEGRAD DEV, V28, P833, DOI 10.1002/ldr.2659; Sparrow AH, 1959, RADIACIONES IONIZANT; Steinitz C., 2012, FRAMEWORK GEODESIGN; Stichelbaut B, 2016, APPL GEOGR, V66, P64, DOI 10.1016/j.apgeog.2015.11.020; Turner D, 2015, REMOTE SENS-BASEL, V7, P1736, DOI 10.3390/rs70201736; Uysal M, 2015, MEASUREMENT, V73, P539, DOI 10.1016/j.measurement.2015.06.010; Van Eetvelde V, 2009, LAND USE POLICY, V26, P901, DOI 10.1016/j.landusepol.2008.11.001; Vukomanovic J, 2018, LANDSCAPE URBAN PLAN, V170, P169, DOI 10.1016/j.landurbplan.2017.10.010; Weligepolage K, 2012, INT J APPL EARTH OBS, V14, P192, DOI 10.1016/j.jag.2011.08.014; Werbrouck I, 2009, EUROPEAN LANDSCAPES; Xu ZH, 2014, REMOTE SENS-BASEL, V6, P10413, DOI 10.3390/rs61110413; Zaragoza IME, 2017, GEOMAT NAT HAZ RISK, V8, P1492, DOI 10.1080/19475705.2017.1345796	51	4	4	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235169	10.1371/journal.pone.0235169	http://dx.doi.org/10.1371/journal.pone.0235169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579596	Green Published, gold			2022-12-27	WOS:000545646600016
J	Ito, A; Maruyama-Inoue, M; Kitajima, Y; Sato, S; Inoue, T; Yamane, S; Kadonosono, K				Ito, Arisa; Maruyama-Inoue, Maiko; Kitajima, Yoko; Sato, Shimpei; Inoue, Tatsuya; Yamane, Shin; Kadonosono, Kazuaki			Comparison of one-year results of photodynamic therapy combined with ranibizumab or aflibercept for treating polypoidal choroidal vasculopathy	PLOS ONE			English	Article							MACULAR DEGENERATION; INTRAVITREAL RANIBIZUMAB; VERTEPORFIN; BEVACIZUMAB; EFFICACY	Purpose To compare the 1-year visual outcomes and anatomical responses of patients who received photodynamic therapy (PDT) combined with intravitreal ranibizumab (IVR) injections with those of patients who received PDT combined with intravitreal aflibercept (IVA) injections for treating polypoidal choroidal vasculopathy (PCV). Methods We retrospectively studied all treatment-naive patients with PCV who received PDT combined with either IVR or IVA. Best-corrected visual acuity (BCVA), central macular thickness (CMT), central choroidal thickness (CCT), the number of additional injections, and the presence of polypoidal lesions, as indicated by indocyanine green angiography (ICGA), during 1 year were evaluated. Results Forty-four eyes were assessed at the 1-year follow-up examination. Of these, 23 were treated with PDT combined with IVR (PDT/IVR group), and 21 were treated with PDT combined with IVA (PDT/IVA group). In both groups, BCVA was shown to be significantly improved 1 year after the initial treatment. CMT and CCT were also significantly decreased after 1 year. There were no significant differences in the changes in BCVA or CMT between the two groups. However, the change in CCT in the PDT/IVA group was significantly larger than that of the PDT/IVR group (P< 0.001). The mean number of additional injections was 0.78 +/- 0.21 in the PDT/IVR group and 0.57 +/- 0.21 in the PDT/IVA group with no significant difference between the two groups (P= 0.45). The polyp regression rate at 12 months was 78.2% in the PDT/IVR group and 78.9% in the PDT/IVA group with no significant difference between the two groups. Conclusions PDT combined with either IVR or IVA was well tolerated and appeared to improve both vision and anatomy in patients with PCV. PDT/IVA may have a more pronounced effect on macular choroidal thickness at 1-year follow-up.	[Ito, Arisa; Maruyama-Inoue, Maiko; Inoue, Tatsuya; Yamane, Shin; Kadonosono, Kazuaki] Yokohama City Univ, Dept Ophthalmol, Med Ctr, Yokohama, Kanagawa, Japan; [Kitajima, Yoko; Sato, Shimpei] Kanto Rosai Hosp, Dept Ophthalmol, Kawasaki, Kanagawa, Japan	Yokohama City University	Maruyama-Inoue, M (corresponding author), Yokohama City Univ, Dept Ophthalmol, Med Ctr, Yokohama, Kanagawa, Japan.	maicoo@urahp.yokohama-cu.ac.jp						[Anonymous], 1999, Arch Ophthalmol, V117, P1329; Chan WM, 2004, OPHTHALMOLOGY, V111, P1576, DOI 10.1016/j.ophtha.2003.12.056; Choi EY, 2020, OPHTHALMOLOGICA, V243, P136, DOI 10.1159/000501724; Gomi F, 2008, BRIT J OPHTHALMOL, V92, P70, DOI 10.1136/bjo.2007.122283; Gomi F, 2008, OPHTHALMOLOGY, V115, P141, DOI 10.1016/j.ophtha.2007.02.031; Hatz K, 2014, BRIT J OPHTHALMOL, V98, P188, DOI 10.1136/bjophthalmol-2013-303444; Hikichi T, 2012, AM J OPHTHALMOL, V154, P117, DOI 10.1016/j.ajo.2011.12.019; Honda S, 2009, OPHTHALMOLOGICA, V223, P333, DOI 10.1159/000221837; Inoue M, 2016, RETINA-J RET VIT DIS, V36, P1527, DOI 10.1097/IAE.0000000000000933; Kikushima W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16476-1; Kikushima W, 2017, JPN J OPHTHALMOL, V61, P61, DOI 10.1007/s10384-016-0479-4; Kim JH, 2016, BRIT J OPHTHALMOL, V100, P1634, DOI 10.1136/bjophthalmol-2015-308074; Koh A, 2017, JAMA OPHTHALMOL, V135, P1206, DOI 10.1001/jamaophthalmol.2017.4030; Koh AHC, 2013, RETINA-J RET VIT DIS, V33, P686, DOI 10.1097/IAE.0b013e3182852446; Lai TYY, 2008, BRIT J OPHTHALMOL, V92, P661, DOI 10.1136/bjo.2007.135103; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Maruko I, 2011, AM J OPHTHALMOL, V151, P594, DOI 10.1016/j.ajo.2010.10.030; Maruyama-Inoue M, 2018, RETINA-J RET VIT DIS, V38, P2001, DOI 10.1097/IAE.0000000000001818; Matsumiya W, 2017, GRAEF ARCH CLIN EXP, V255, P541, DOI 10.1007/s00417-016-3500-1; Oishi A, 2013, AM J OPHTHALMOL, V156, P644, DOI 10.1016/j.ajo.2013.05.024; Saito M, 2013, GRAEF ARCH CLIN EXP, V251, P2099, DOI 10.1007/s00417-013-2323-6; Sakurada Y, 2013, J OCUL PHARMACOL TH, V29, P832, DOI 10.1089/jop.2013.0044; Takada K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181598; Yannuzzi LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P478, DOI 10.1001/archopht.1997.01100150480005; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001	25	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235213	10.1371/journal.pone.0235213	http://dx.doi.org/10.1371/journal.pone.0235213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579608	Green Published, gold			2022-12-27	WOS:000545646600034
J	Ogaki, Y; Fukuma, M; Shimizu, N				Ogaki, Yusuke; Fukuma, Miki; Shimizu, Noriaki			Repeat induces not only gene silencing, but also gene activation in mammalian cells	PLOS ONE			English	Article							REPLICATION INITIATION REGION; MATRIX ATTACHMENT REGION; EPISOMAL TRANSGENE EXPRESSION; RNA INTERFERENCE; DNA; HETEROCHROMATIN; AMPLIFICATION; METHYLATION; MAINTENANCE; BEARING	Repeat-induced gene silencing (RIGS) establishes the centromere structure, prevents the spread of transposons and silences transgenes, thereby limiting recombinant protein production. We previously isolated a sequence (B-3-31) that alleviates RIGS from the human genome. Here, we developed an assay system for evaluating the influence of repeat sequences on gene expression, based onin vitroligation followed by our original gene amplification technology in animal cells. Using this assay, we found that the repeat of B-3-31, three core sequences of replication initiation regions (G5, C12, and D8) and two matrix attachment regions (AR1 and 32-3), activated the co-amplified plasmid-encodedd2EGFPgene in both human and hamster cell lines. This upregulation effect persisted for up to 82 days, which was confirmed to be repeat-induced, and was thus designated as a repeat-induced gene activation (RIGA). In clear contrast, the repeat of three bacterial sequences (lambda-phage, Amp, and ColE1) and three human retroposon sequences (Alu, 5'-untranslated region, and ORF1 of a long interspersed nuclear element) suppressed gene expression, thus reflecting RIGS. RIGS was CpG-independent. We suggest that RIGA might be associated with replication initiation. The discovery of RIGS and RIGA has implications for the repeat in mammalian genome, as well as practical value in recombinant production.	[Ogaki, Yusuke; Fukuma, Miki; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima, Japan	Hiroshima University	Shimizu, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima, Japan.	shimizu@hiroshima-u.ac.jp		Shimizu, Noriaki/0000-0002-7979-897X	Japan Society for the Promotion of Science [16K081]; AMED [JP19ae0101054]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); AMED	Japan Society for the Promotion of Science, Grant/Award Number: a Grant-in-Aid for Scientific Research (C) (16K081) to N.S. in part. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was supported by AMED under Grant Number JP19ae0101054	Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006; Araki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041787; CHAN CSM, 1980, P NATL ACAD SCI-BIOL, V77, P6329, DOI 10.1073/pnas.77.11.6329; Chen ZY, 2008, MOL THER, V16, P548, DOI 10.1038/sj.mt.6300399; Chen ZY, 2004, GENE THER, V11, P856, DOI 10.1038/sj.gt.3302231; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Fu HQ, 2006, NAT BIOTECHNOL, V24, P572, DOI 10.1038/nbt1202; Fukuma M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153338; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Harada S, 2009, J BIOL CHEM, V284, P24320, DOI 10.1074/jbc.M109.008128; Harraghy N, 2008, CURR GENE THER, V8, P353, DOI 10.2174/156652308786071032; Hashizume T, 2007, J CELL BIOCHEM, V101, P552, DOI 10.1002/jcb.21210; He HJ, 2016, CELL REP, V14, P1018, DOI 10.1016/j.celrep.2016.01.006; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Hiro-Oka H., 2012, BIOMED OPT EXPRESS, V3, P3067, DOI DOI 10.1364/B0E.3.003067; Ho SCL, 2015, MOL BIOTECHNOL, V57, P138, DOI 10.1007/s12033-014-9809-2; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Ishak CA, 2016, MOL CELL, V64, P1074, DOI 10.1016/j.molcel.2016.10.021; Kondo Y, 2003, J BIOL CHEM, V278, P27658, DOI 10.1074/jbc.M304072200; Majocchi S, 2014, NUCLEIC ACIDS RES, V42, P193, DOI 10.1093/nar/gkt880; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; McBurney MW, 2002, EXP CELL RES, V274, P1, DOI 10.1006/excr.2001.5443; Mesner LD, 2003, P NATL ACAD SCI USA, V100, P3281, DOI 10.1073/pnas.0437791100; Mitsuda SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161288; Noguchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052990; Ohsaki K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175585; Okada N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077350; Oobatake Y, 2020, GENE CHROMOSOME CANC, V59, P133, DOI 10.1002/gcc.22810; Ortega JM, 1998, J CELL SCI, V111, P3663; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Porokhovnik LN, 2019, CHROMOSOME RES, V27, P5, DOI 10.1007/s10577-018-9587-y; Reddy BD, 2011, GENE DEV, V25, P214, DOI 10.1101/gad.1993611; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Takahashi Y, 2017, SCIENCE, V356, P503, DOI 10.1126/science.aag3260; Tanaka SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103439; TSUTSUI K, 1993, J BIOL CHEM, V268, P12886; Utani KI, 2007, MOL CANCER RES, V5, P695, DOI 10.1158/1541-7786.MCR-07-0031; Utani K, 2009, NUCLEIC ACIDS RES, V37, P393, DOI 10.1093/nar/gkn970; VONHOFF DD, 1988, P NATL ACAD SCI USA, V85, P4804; Wang FW, 2006, MOL CELL BIOL, V26, P4028, DOI 10.1128/MCB.02189-05; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Yoshimura H, 2011, PROTEIN EXPRES PURIF, V80, P41, DOI 10.1016/j.pep.2011.05.009; Zhang WL, 2008, PLANT CELL, V20, P25, DOI 10.1105/tpc.107.057083	49	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235127	10.1371/journal.pone.0235127	http://dx.doi.org/10.1371/journal.pone.0235127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579599	Green Published, gold			2022-12-27	WOS:000545646600011
J	Mravcakova, D; Kisidayova, S; Kopcakova, A; Pristas, P; Pisarcikova, J; Bryszak, M; Cieslak, A; Varady, M; Varadyova, Z				Mravcakova, Dominika; Kisidayova, Svetlana; Kopcakova, Anna; Pristas, Peter; Pisarcikova, Jana; Bryszak, Magda; Cieslak, Adam; Varady, Marian; Varadyova, Zora			Can the foregut nematodeHaemonchus contortusand medicinal plants influence the fecal microbial community of the experimentally infected lambs?	PLOS ONE			English	Article							HAEMONCHUS-CONTORTUS; ANTHELMINTIC RESISTANCE; FERMENTATION; IMPACT; SHEEP; RUMEN; PARAMETERS; NEMATODES; PARASITES; MODEL	The abomasal parasitic nematodeHaemonchus contortuscan influence the abomasal microbiome of the host. On the other hand, no information occurs on the influence of the parasite on the hindgut microbiome of the host. We evaluated the impact ofHaemonchus contortuson the fecal microbial community of the experimentally infected lambs treated with a mixture of medicinal herbs to ameliorate the haemonchosis. Twenty-four female lambs were divided into four groups: infected animals (Inf), infected animals supplemented with a blend of medicinal herbs (Inf+Herb), uninfected control animals (Control), and uninfected animals supplemented with medicinal herbs (C+Herb). Inf and Inf+Herb lambs were infected orally with approximately 5000 L3 larvae of a strain ofH.contortussusceptible to anthelmintics (MHco1). Herb blend (Herbmix) consisted of dry medicinal plants ofAlthaea officinalis,Petasites hybridus,Inula helenium,Malva sylvestris,Chamomilla recutita,Plantago lanceolata,Rosmarinus officinalis,Solidago virgaurea,Fumaria officinalis,Hyssopus officinalis,Melisa officinalis,Foeniculum vulgare, andArtemisia absinthium. Each animal was fed meadow hay and a commercial concentrate (600 + 350 g DM/d). Inf+Herb and C+Herb lambs were fed Herbmix (100 g DM/d and animal). Treatment lasted for 50 days. The fecal microbial fermentation parameters (short-chain fatty acids, ammonia, and pH) were evaluated at intervals of 0, 20, 32, and 50 days. The fecal eubacterial populations were evaluated by denaturing gradient gel electrophoresis (DGGE) at day 32 whenH.contortusinfection was the highest. No substantial effects of theH.contortusinfection and the herbal treatment on fecal microbial fermentation parameters and fecal eubacterial populations were observed. Evaluation of DGGE patterns by Principal component analysis pointed to the tendency to branch the C+Herb group from the other experimental groups on Day 32. The results indicate that hindgut microbial activity was not disturbed byH.contortusinfection and herbal treatment.	[Mravcakova, Dominika; Kisidayova, Svetlana; Kopcakova, Anna; Pristas, Peter; Pisarcikova, Jana; Varadyova, Zora] Slovak Acad Sci, Inst Anim Physiol, Ctr Biosci, Kosice, Slovakia; [Bryszak, Magda; Cieslak, Adam] Poznan Univ Life Sci, Dept Anim Nutr, Poznan, Poland; [Varady, Marian] Slovak Acad Sci, Inst Parasitol, Kosice, Slovakia	Slovak Academy of Sciences; Poznan University of Life Sciences; Slovak Academy of Sciences	Kisidayova, S (corresponding author), Slovak Acad Sci, Inst Anim Physiol, Ctr Biosci, Kosice, Slovakia.	kisiday@saske.sk	Várady, Marián/AAN-6094-2020; Pristas, Peter/K-7512-2016; Kopcakova Vandzurova, Anna/GZH-1902-2022; Kišidayová, Svetlana/B-7652-2008; Batťányi, Dominika/AFV-4822-2022; Varadyova, Zora/P-2806-2016	Várady, Marián/0000-0001-6589-8219; Pristas, Peter/0000-0002-7948-2617; Kopcakova Vandzurova, Anna/0000-0002-3054-7010; Kišidayová, Svetlana/0000-0001-6608-4903; Batťányi, Dominika/0000-0002-9070-0558; Varadyova, Zora/0000-0003-3675-8641; Cieslak, Adam/0000-0001-7518-579X	Slovak Research and Development Agency [APVV 140169, APVV 18-0131]; Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic [VEGA 2/0069/17]; Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Academy of Sciences [VEGA 2/0069/17]	Slovak Research and Development Agency(Slovak Research and Development Agency); Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Academy of Sciences	The funding sources were: Slovak Research and Development Agency (APVV 140169): ZV Slovak Research and Development Agency (APVV 18-0131): MV Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences (VEGA 2/0069/17): SK The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, OBSTET GYNECOL, V13, pe49; AOAC, 1996, OFFICIAL METHODS ANA, V16th; Bashir MEH, 2002, J IMMUNOL, V169, P3284, DOI 10.4049/jimmunol.169.6.3284; Besier RB, 2016, ADV PARASIT, V93, P95, DOI 10.1016/bs.apar.2016.02.022; Besier RB, 2003, AUST J EXP AGR, V43, P1383, DOI 10.1071/EA02229; Cantacessi C, 2014, J INFECT DIS, V210, P1431, DOI 10.1093/infdis/jiu256; Cortes A, 2018, TRENDS PARASITOL, V34, P640, DOI 10.1016/j.pt.2018.05.009; Domke AVM, 2012, PARASITOL RES, V111, P185, DOI 10.1007/s00436-012-2817-x; Durmic Z, 2012, ANIM FEED SCI TECH, V176, P150, DOI 10.1016/j.anifeedsci.2012.07.018; El-Ashram S, 2017, VET RES COMMUN, V41, P263, DOI 10.1007/s11259-017-9698-5; El-Ashram S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00171-2; Green SJ, 2010, HDB HYDROCARBON LIPI, P4137, DOI DOI 10.1007/978-3-540-77587-4_323; Harris EV, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007891; HONDE C, 1982, EXP PARASITOL, V54, P371, DOI 10.1016/0014-4894(82)90046-7; Hoste H, 2015, VET PARASITOL, V212, P5, DOI 10.1016/j.vetpar.2015.06.026; Hunter MM, 2005, J IMMUNOL, V174, P7368, DOI 10.4049/jimmunol.174.11.7368; Leung JM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00843; Li RW, 2016, SCI REP-UK, V6, DOI 10.1038/srep20606; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Loisel P, 2006, ENVIRON MICROBIOL, V8, P720, DOI 10.1111/j.1462-2920.2005.00950.x; Maizels RM, 2005, CURR OPIN IMMUNOL, V17, P656, DOI 10.1016/j.coi.2005.09.001; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Mravcakova D, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2050-2; Nubel U, 1996, J BACTERIOL, V178, P5636; Odhaib KJ, 2018, TROP ANIM HEALTH PRO, V50, P1011, DOI 10.1007/s11250-018-1525-7; Patra A, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0145-9; Peachey LE, 2018, INT J PARASITOL, V48, P403, DOI 10.1016/j.ijpara.2017.11.003; Plieskatt JL, 2013, FASEB J, V27, P4572, DOI 10.1096/fj.13-232751; Rapin A, 2018, TRENDS IMMUNOL, V39, P724, DOI 10.1016/j.it.2018.06.002; Rashid S, 2020, J HELMINTHOL, V94, DOI 10.1017/S0022149X19000117; Rook Graham A. W., 2013, Evolution Medicine and Public Health, P46, DOI 10.1093/emph/eot004; Schallig HDFH, 2000, PARASITOLOGY, V120, pS63, DOI 10.1017/S003118209900579X; Slapeta J, 2015, INT J PARASITOL, V45, P585, DOI 10.1016/j.ijpara.2015.04.001; Spiegler V, 2017, NAT PROD REP, V34, P627, DOI 10.1039/c6np00126b; Suguitan Jr AL, 2011, PLOS ONE, V6; Szulc P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231516; Tirabassi AH, 2016, SEMIN-CIENC AGRAR, V37, P4097, DOI 10.5433/1679-0359.2016v37n6p4097; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Varadyova Z, 2017, SMALL RUMINANT RES, V151, P124, DOI 10.1016/j.smallrumres.2017.04.023; Varadyova Z, 2018, EXP PARASITOL, V195, P71, DOI 10.1016/j.exppara.2018.10.009; Varadyova Z, 2018, J ANIM PHYSIOL AN N, V102, P1131, DOI 10.1111/jpn.12940; Varadyova Z, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1405-4; Walshe N, 2019, INT J PARASITOL, V49, P489, DOI 10.1016/j.ijpara.2019.02.003; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wencelova M, 2016, CZECH J ANIM SCI, V61, P551, DOI 10.17221/17/2016-CJAS; Wencelova M, 2015, SMALL RUMINANT RES, V125, P64, DOI 10.1016/j.smallrumres.2015.01.028; Wencelova M, 2014, J ANIM PLANT SCI, V24, P1388; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010	48	1	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235072	10.1371/journal.pone.0235072	http://dx.doi.org/10.1371/journal.pone.0235072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574178	gold, Green Published			2022-12-27	WOS:000544972400047
J	Schwarze, J; Theil, C; Gosheger, G; Dieckmann, R; Moellenbeck, B; Ackmann, T; Schmidt-Braekling, T				Schwarze, Jan; Theil, Christoph; Gosheger, Georg; Dieckmann, Ralf; Moellenbeck, Burkhard; Ackmann, Thomas; Schmidt-Braekling, Tom			Promising results of revision total hip arthroplasty using a hexagonal, modular, tapered stem in cases of aseptic loosening	PLOS ONE			English	Article							FEMORAL BONE LOSS; TITANIUM STEMS; UNITED-STATES; FOLLOW-UP; COMPONENT; FEMUR; CLASSIFICATIONS; MANAGEMENT; FRACTURES; INFECTION	Background Modular stems are widely used in revision total hip arthroplasty (THA) with aseptic loosening being a common reason for revision. Despite the good results reported on the use of modular stem designs, there are only few studies focusing on aseptic revisions and few studies on a hexagonal stem design. The goal of this study is to determine stem survival, clinical and functional outcome along with possible risk factors for implant failure in aseptic revision THA. Methods We retrospectively identified 53 patients with aseptic THA revision using a modular hexagonal stem with a minimum follow-up of two years. Femoral bone loss, radiographic and clinical outcomes as well as function measured using the Harris Hip Score (HHS) was assessed. Patients' previous medical history was analyzed for comorbidities and the body mass index. Stem survival was calculated using the Kaplan-Meier method. Possible risk factors for implant failure were analyzed using the log-rank test. The median age at revision was 69 (IQR 62-73) with a median follow up of 74 months. Results Implant survival rates amounted to 90.4% at 3 and 5 years. The median HHS improved by 47 points (34 (IQR 22-47) vs 81 (IQR 59-90) p<0.001). There was a reduced implant survival after 5 years when the revision stem was used following a previous cemented stem (83.4% vs 100%, p = 0.04). Conclusion A modular, hexagonal stem can be successfully used in aseptic revision THA with remarkable functional results and excellent survivorship. Revision of a cemented stem using this implant might result in reduced survival which must be considered when planning treatment.	[Schwarze, Jan; Theil, Christoph; Gosheger, Georg; Moellenbeck, Burkhard; Ackmann, Thomas; Schmidt-Braekling, Tom] Muenster Univ Hosp, Dept Orthoped & Tumor Orthoped, Albert Schweitzer Campus, Munster, Germany; [Dieckmann, Ralf] Krankenhaus Barmherzigen Bruder Trier, Dept Orthoped, Nordallee, Germany	University of Munster	Schwarze, J (corresponding author), Muenster Univ Hosp, Dept Orthoped & Tumor Orthoped, Albert Schweitzer Campus, Munster, Germany.	jan.schwarze@ukmuenster.de		Schwarze, Jan/0000-0001-6793-1844	Open Access Publication Fund of the University of Muenster	Open Access Publication Fund of the University of Muenster	The author received support from the Open Access Publication Fund of the University of Muenster. This funding had no influence on the author's or coauthors' work.	Abdel MP, 2017, J BONE JOINT SURG AM, V99, P873, DOI 10.2106/JBJS.16.00423; Aribindi R, 1998, ORTHOP CLIN N AM, V29, P319, DOI 10.1016/S0030-5898(05)70330-8; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cnudde PHJ, 2017, BONE JOINT J, V99B, P27, DOI 10.1302/0301-620X.99B4.BJJ-2016-1222.R1; Dieckmann R, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-398; Duncan CP, 1995, AAOS INSTR COURS LEC, V44, P293; Dzaja I, 2014, J ARTHROPLASTY, V29, P1594, DOI 10.1016/j.arth.2014.02.035; ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45, DOI 10.1302/0301-620X.69B1.3818732; Fink Bernd, 2018, Arthroplast Today, V4, P306, DOI 10.1016/j.artd.2018.03.002; Gaski GE, 2011, CLIN ORTHOP RELAT R, V469, P1507, DOI 10.1007/s11999-010-1532-0; Gosheger G, 2006, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000223978.36831.39; Gravius S, 2011, ORTHOPADE, V40, P1084, DOI 10.1007/s00132-011-1844-0; Grimberg A, 2017, ENDOPROTHESENREGISTE; Gwam CU, 2017, J ARTHROPLASTY, V32, P2088, DOI 10.1016/j.arth.2017.02.046; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Hoberg M, 2015, INT ORTHOP, V39, P1709, DOI 10.1007/s00264-015-2699-5; Hoell S, 2015, BONE JOINT J, V97B, P71, DOI 10.1302/0301-620X.97B1.33802; Houdek MT, 2015, J ARTHROPLASTY, V30, P435, DOI 10.1016/j.arth.2014.08.012; Huang Y, 2017, J ARTHROPLASTY, V32, P3108, DOI 10.1016/j.arth.2017.05.021; Ibrahim DA, 2017, CLIN ORTHOP RELAT R, V475, P917, DOI 10.1007/s11999-016-5012-z; Jacobs AME, 2017, BONE JOINT J, V99B, P1482, DOI [10.1302/0301-620X.99B11.BJJ-2016-0655.R2, 10.1302/0301-620x.99b11.bjj-2016-0655.r2]; Jibodh SR, 2013, J ARTHROPLASTY, V28, P1167, DOI 10.1016/j.arth.2012.07.031; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Konan S, 2016, BONE JOINT J, V98B, P50, DOI 10.1302/0301-620X.98B1.36442; Krishnamurthy AB, 1997, J ARTHROPLASTY, V12, P839, DOI 10.1016/S0883-5403(97)90152-2; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Lakstein D, 2011, J BONE JOINT SURG AM, V93A, P57, DOI 10.2106/JBJS.I.01589; Lakstein D, 2010, HIP INT, V20, P136, DOI 10.1177/112070001002000202; Mariconda M, 2011, BMC MUSCULOSKEL DIS, V12, P1, DOI 10.1186/1471-2474-12-1; Moreta Jesus, 2018, Eur J Orthop Surg Traumatol, V28, P1327, DOI 10.1007/s00590-018-2213-z; Nawabi DH, 2016, J BONE JOINT SURG AM, V98, P40, DOI 10.2106/JBJS.N.01121; Oakes DA, 2006, J AM ACAD ORTHOP SUR, V14, P620, DOI 10.5435/00124635-200610000-00004; Parvizi J, 2018, J ARTHROPLASTY, V33, P1309, DOI 10.1016/j.arth.2018.02.078; Parvizi J, 2011, CLIN ORTHOP RELAT R, V469, P1401, DOI 10.1007/s11999-011-1822-1; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Restrepo C, 2011, CLIN ORTHOP RELAT R, V469, P476, DOI 10.1007/s11999-010-1561-8; Rieger B, 2018, HIP INT, V28, P84, DOI 10.5301/hipint.5000522; Sakellariou VI, 2014, WORLD J ORTHOP, V5, P614, DOI 10.5312/wjo.v5.i5.614; Sandiford NA, 2017, BONE JOINT J, V99B, P199, DOI 10.1302/0301-620X.99B2.BJJ-2016-0076.R1; Sculco PK, 2015, HIP INT, V25, P380, DOI 10.5301/hipint.5000272; Sheth NP, 2013, J AM ACAD ORTHOP SUR, V21, P601, DOI 10.5435/JAAOS-21-10-601; Smith MA, 2016, J ARTHROPLASTY, V31, P446, DOI 10.1016/j.arth.2015.08.029; Srinivasan A, 2012, J AM ACAD ORTHOP SUR, V20, P214, DOI 10.5435/JAAOS-20-04-214; Su SL, 2017, J ARTHROPLASTY, V32, P2301, DOI 10.1016/j.arth.2017.02.016; Wimmer MD, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-19; Wirtz DC, 1997, Z ORTHOP GRENZGEB, V135, P270, DOI 10.1055/s-2008-1039388	47	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0233035	10.1371/journal.pone.0233035	http://dx.doi.org/10.1371/journal.pone.0233035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574168	Green Published, gold			2022-12-27	WOS:000544972400032
J	MacIntosh, A; Desailly, E; Vignais, N; Vigneron, V; Biddiss, E				MacIntosh, Alexander; Desailly, Eric; Vignais, Nicolas; Vigneron, Vincent; Biddiss, Elaine			A biofeedback-enhanced therapeutic exercise video game intervention for young people with cerebral palsy: A randomized single-case experimental design feasibility study	PLOS ONE			English	Article							INTERACTIVE COMPUTER PLAY; ASSISTING HAND ASSESSMENT; INDUCED MOVEMENT THERAPY; GROSS MOTOR FUNCTION; UPPER EXTREMITY; MANUAL ABILITY; BLOCK TEST; CHILDREN; REHABILITATION; RELIABILITY	Importance/Background Movement-controlled video games have potential to promote home-based practice of therapy activities. The success of therapy gaming interventions depends on the quality of the technology usedandthe presence of effective support structures. Aim This study assesses the feasibility of a novel intervention that combines a co-created gaming technology integrating evidence-based biofeedback and solution-focused coaching (SFC) strategies to support therapy engagement and efficacy at home. Methods Following feasibility and single-case reporting standards (and), this was a non-blind, randomized, multiple-baseline, AB, design. Nineteen (19) young people with cerebral palsy (8-18 years old) completed the 4-week home-based intervention in France and Canada. Participant motivations, personalized practice goals, and relevance of the intervention to daily activities were discussed in a Solution Focused Coaching-style conversation pre-, post-intervention and during weekly check-ins. Participants controlled a video game by completing therapeutic gestures (wrist extension, pinching) detected via electromyography and inertial sensors on the forearm (Myo Armband and custom software). Process feasibilitysuccess criteria for recruitment response, completion and adherence rates, and frequency of technical issues were establisheda priori.Scientific feasibility,effect size estimates and variance were determined for Body Functionoutcome measures: active wrist extension, grip strength and Box and Blocks Test; and forActivities and Participationmeasures: Assisting Hand Assessment (AHA), Canadian Occupational Performance Measure (COPM) and Self-Reported Experiences of Activity Settings (SEAS). Results Recruitment response (31%) and assessment completion (84%) rates were good and 74% of participants reached self-identified practice goals. As 17% of technical issues required external support to resolve, the intervention was graded asfeasible with modifications. No adverse events were reported. Moderate effects were observed in Body Function measures (active wrist extension: SMD = 1.82, 95%CI = 0.85-2.78; Grip Strength: SMD = 0.63, 95%CI = 0.65-1.91; Box and Blocks: Hedge's g = 0.58, 95%CI = -0.11-1.27) and small-moderate effects in Activities and Participation measures (AHA: Hedge's g = 0.29, 95%CI = -0.39-0.97, COPM: r = 0.60, 95%CI = 0.13-0.82, SEAS: r = 0.24, 95%CI = -0.25-0.61). Conclusion A definitive RCT to investigate the effectiveness of this novel intervention is warranted. Combining SFC-style coaching with high-quality biofeedback may positively engage youth in home rehabilitation to complement traditional therapy.	[MacIntosh, Alexander; Biddiss, Elaine] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [MacIntosh, Alexander; Biddiss, Elaine] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [MacIntosh, Alexander; Vignais, Nicolas] Univ Paris Saclay, Complexite Innovat Act Motrices & Sport, Sci Sport Mot & Mouvement Humain, Orsay, France; [Desailly, Eric] Fdn Ellen Poidatz, Rech & Innovat, St Fargeau Ponthierry, France; [Vignais, Nicolas] Univ Orleans, Complexite Innovat Act Motrices & Sport, Orleans, France; [Vigneron, Vincent] Univ Evry Val Essonne, Informat Bioinformat & Syst Complexes, Evry, France	University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; University of Toronto; UDICE-French Research Universities; Universite Paris Saclay; Universite de Orleans; UDICE-French Research Universities; Universite Paris Saclay	MacIntosh, A (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada.; MacIntosh, A (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.; MacIntosh, A (corresponding author), Univ Paris Saclay, Complexite Innovat Act Motrices & Sport, Sci Sport Mot & Mouvement Humain, Orsay, France.	alexander.macintosh@mail.utoronto.ca	; vigneron, vincent/C-4719-2017	Desailly, Eric/0000-0003-3910-3755; vigneron, vincent/0000-0001-5917-6041; Vignais, Nicolas/0000-0002-7267-0236	Canadian Institutes of Health Research [RN304779 - 379428]; Campus France Eiffel Excellence Scholarship [895191H]; Mitacs GobaLink program [IT10648]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Campus France Eiffel Excellence Scholarship; Mitacs GobaLink program	This work was supported by the Canadian Institutes of Health Research [funding reference number RN304779 - 379428, Author AM], the Campus France Eiffel Excellence Scholarship [895191H, Author AM], and the Mitacs GobaLink program [IT10648, Author AM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts PB, 2011, RES DEV DISABIL, V32, P271, DOI 10.1016/j.ridd.2010.10.008; Abraham C, 2009, PSYCHOL HEALTH MED, V14, P1, DOI 10.1080/13548500802537903; [Anonymous], 2020, NAT METHODS, V17, P1, DOI 10.1038/s41592-019-0703-5; [Anonymous], 2012, KIDNEY INT, V2, ps1; Arnould C, 2004, NEUROLOGY, V63, P1045, DOI 10.1212/01.WNL.0000138423.77640.37; Arnould C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00048; Baldwin P, 2013, PHYS OCCUP THER PEDI, V33, P467, DOI 10.3109/01942638.2013.784718; Biddiss E, 2021, DISABIL REHABIL, V43, P133, DOI 10.1080/09638288.2019.1613681; Bilde PE, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-32; Bulte I, 2012, METHODOLOGY-EUR, V8, P104, DOI 10.1027/1614-2241/a000042; Chen CL, 2012, RES DEV DISABIL, V33, P1087, DOI 10.1016/j.ridd.2012.01.017; Chiu HC, 2014, CLIN REHABIL, V28, P1015, DOI 10.1177/0269215514533709; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cup EHC, 2003, CLIN REHABIL, V17, P402, DOI 10.1191/0269215503cr635oa; Eldridge Sandra M, 2016, Pilot Feasibility Stud, V2, P64, DOI 10.1136/bmj.i5239; Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; Elvrum AKG, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-91; Faraone Stephen V, 2008, P T, V33, P700; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garzon LC, 2018, J REHABIL ASSIST TER, V5, DOI 10.1177/2055668318768402; Glazier JN, 1997, DEV MED CHILD NE S75, V39, P33, DOI [10.1111/j.1469-8749.1997.tb07505.x;SP:16, DOI 10.1111/J.1469-8749.1997.TB07505.X]; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Howcroft J, 2012, ARCH PHYS MED REHAB, V93, P1448, DOI 10.1016/j.apmr.2012.02.033; James S, 2016, PHYS OCCUP THER PEDI, V36, P343, DOI 10.3109/01942638.2015.1076560; James S, 2015, DEV MED CHILD NEUROL, V57, P530, DOI 10.1111/dmcn.12705; Jelsma J, 2013, DEV NEUROREHABIL, V16, P27, DOI 10.3109/17518423.2012.711781; Jong PD, 2012, INTERVIEWING SOLUTIO; Keller JW, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0293-3; King G, 2016, RES DEV DISABIL, V55, P242, DOI 10.1016/j.ridd.2016.04.014; King G, 2014, INT J DISABIL DEV ED, V61, P44, DOI 10.1080/1034912X.2014.878542; Klingels K, 2010, DISABIL REHABIL, V32, P409, DOI 10.3109/09638280903171469; Kratochwill T.R., 2010, ED510743; Kratochwill TR, 2010, WHAT WORKS CLGH; Law M, 1990, Can J Occup Ther, V57, P82; Levin I, 2017, PEDIATR PHYS THER, V29, P138, DOI 10.1097/PEP.0000000000000362; Louwers A, 2017, DEV MED CHILD NEUROL, V59, P926, DOI 10.1111/dmcn.13465; Louwers A, 2016, DEV MED CHILD NEUROL, V58, P1303, DOI 10.1111/dmcn.13168; MacIntosh A, 2019, DISABIL REHABIL, V41, P2369, DOI 10.1080/09638288.2018.1468933; Manolov R, 2014, NEUROPSYCHOL REHABIL, V24, P634, DOI 10.1080/09602011.2014.903199; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Mayring P., 2004, COMPANION QUALITATIV, V1, P159; McColl Mary Ann, 2005, Can J Occup Ther, V72, P298; McPherson AC, 2018, DEV NEUROREHABIL, V21, P121, DOI 10.1080/17518423.2017.1289271; Mutlu A, 2007, MED SCI MONITOR, V13, pCR323; ODRISCOLL SW, 1992, J HAND SURG-AM, V17A, P169, DOI 10.1016/0363-5023(92)90136-D; Olama KA, 2012, EGYPTIAN J MED HUMAN, V13, P183, DOI [10.1016/j.ejmhg.2012.03.005, DOI 10.1016/J.EJMHG.2012.03.005]; Oskoui M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8949; Park ES, 2013, YONSEI MED J, V54, P516, DOI 10.3349/ymj.2013.54.2.516; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Pustejovsky J. E., 2017, SINGLECASEES CALCULA; Ramstrand N, 2012, TECHNOL HEALTH CARE, V20, P531, DOI 10.3233/THC-2012-0696; Ratner H., 2012, SOLUTION FOCUSED BRI; Ravi DK, 2017, PHYSIOTHERAPY, V103, P245, DOI 10.1016/j.physio.2016.08.004; Rios DC, 2013, DEV NEUROREHABIL, V16, P398, DOI 10.3109/17518423.2013.766818; Rone-Adams Shari A, 2004, Pediatr Phys Ther, V16, P140, DOI 10.1097/01.PEP.0000136006.13449.DC; Rosenbaum Peter, 2004, Semin Pediatr Neurol, V11, P5, DOI 10.1016/j.spen.2004.01.002; Sandlund M, 2009, DEV MED CHILD NEUROL, V51, P173, DOI 10.1111/j.1469-8749.2008.03184.x; Sanger TD, 2006, PEDIATRICS, V118, P2159, DOI 10.1542/peds.2005-3016; Schiariti V, 2014, EUR J PAEDIATR NEURO, V18, P609, DOI 10.1016/j.ejpn.2014.04.009; Sevick M, 2016, BEHAV SCI, V6, DOI 10.3390/bs6020010; Shadish WR, 2014, J SCHOOL PSYCHOL, V52, P123, DOI 10.1016/j.jsp.2013.11.005; Shikako-Thomas K, 2015, DEV NEUROREHABIL, V18, P234, DOI 10.3109/17518423.2013.794166; Silva SM, 2015, BRAZ J PHYS THER, V19, P137, DOI 10.1590/bjpt-rbf.2014.0081; Solanas A, 2010, BEHAV MODIF, V34, P195, DOI 10.1177/0145445510363306; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Tate R.L., 2016, ARCH SCI PSYCHOL, V4, P10, DOI [10.1037/arc0000027, DOI 10.1037/ARC0000027]; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; van Dijk H, 2005, J REHABIL MED, V37, P202, DOI 10.1080/16501970510030165; Wagner LV, 2012, CLIN ORTHOP RELAT R, V470, P1257, DOI 10.1007/s11999-011-2065-x; Wood KC, 2013, IEEE T NEUR SYS REH, V21, P300, DOI 10.1109/TNSRE.2012.2227804; Xu KS, 2012, DISABIL REHABIL, V34, P337, DOI 10.3109/09638288.2011.607213	71	9	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234767	10.1371/journal.pone.0234767	http://dx.doi.org/10.1371/journal.pone.0234767			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569284	Green Published, gold			2022-12-27	WOS:000543547900018
J	Ouyang, JB; Yang, MH; Gong, T; Ou, JL; Tan, YN; Zhang, Z; Li, S				Ouyang, Jiabi; Yang, Mohui; Gong, Tian; Ou, Jinlai; Tan, Yani; Zhang, Zhen; Li, Sha			Doxorubicin-loading core-shell pectin nanocell: A novel nanovehicle for anticancer agent delivery with multidrug resistance reversal	PLOS ONE			English	Article							BREAST-CANCER CELLS; DRUG-DELIVERY; LIGAND MODIFICATION; NANOPARTICLES; LIPOSOMES; ENCAPSULATION; COMBINATION; STRATEGIES; EFFICACY; ACID	Tumor is a prevalent great threat to public health worldwide and multidrug resistance (MDR) of tumor is a leading cause of chemotherapy failure. Nanomedicine has shown prospects in overcoming the problem. Doxorubicin (DOX), a broad-spectrum anticancer drug, showed limited efficacy due to MDR. Herein, a doxorubicin containing pectin nanocell (DOX-PEC-NC) of core-shell structure, a pectin nanoparticle encapsulated with liposome-like membrane was developed. The DOX-PEC-NC, spheroid in shape and sized around 150 nm, exerted better sustained release behavior than doxorubicin loading pectin nanoparticle (DOX-PEC-NP) or liposome (DOX-LIP).In vitroanticancer study showed marked accumulation of doxorubicin in different tumor cells as well as reversal of MDR in HepG2/ADR cells and MCF-7/ADR cells caused by treatment of DOX-PEC-NC. In H(22)tumor-bearing mice, DOX-PEC-NC showed higher anticancer efficacy and lower toxicity than doxorubicin. DOX-PEC-NC can improve anticancer activity and reduce side effect of doxorubicin due to increased intracellular accumulation and reversal of MDR in tumor cells, which may be a promising nanoscale drug delivery vehicle for chemotherapeutic agents.	[Ouyang, Jiabi; Yang, Mohui; Gong, Tian; Ou, Jinlai; Tan, Yani; Zhang, Zhen; Li, Sha] Jinan Univ, Coll Pharm, Guangzhou, Peoples R China; [Li, Sha] Jinan Univ, Int Cooperat Lab Tradit Chinese Med Modernizat &, Chinese Minist Educ, Coll Pharm, Guangzhou, Peoples R China; [Li, Sha] Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Peoples R China	Jinan University; Jinan University	Li, S (corresponding author), Jinan Univ, Coll Pharm, Guangzhou, Peoples R China.; Li, S (corresponding author), Jinan Univ, Int Cooperat Lab Tradit Chinese Med Modernizat &, Chinese Minist Educ, Coll Pharm, Guangzhou, Peoples R China.; Li, S (corresponding author), Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Peoples R China.	tlisha@jnu.edu.cn			projects of Science and Technology Program of Guangzhou, China [201704020087, 201704020198]; Natural Science Foundation of Guangdong Province [2020A1515010990]	projects of Science and Technology Program of Guangzhou, China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was financially supported by projects of Science and Technology Program of Guangzhou, China (No. 201704020087 and No. 201704020198) and Natural Science Foundation of Guangdong Province (No. 2020A1515010990) to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak MI, 2016, INT J PHARMACEUT, V506, P201, DOI 10.1016/j.ijpharm.2016.04.050; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Arias JL, 2008, MOLECULES, V13, P2340, DOI 10.3390/molecules13102340; Bahrami B, 2017, IMMUNOL LETT, V190, P64, DOI 10.1016/j.imlet.2017.07.015; Betancourt T, 2007, NANOMEDICINE-UK, V2, P219, DOI 10.2217/17435889.2.2.219; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Carmona-Ribeiro AM, 1999, COLLOID SURFACE A, V153, P355, DOI 10.1016/S0927-7757(98)00532-9; Deng ZT, 2014, J CONTROL RELEASE, V174, P109, DOI 10.1016/j.jconrel.2013.11.018; Devendiran RM, 2016, RSC ADV, V6, P29757, DOI 10.1039/c6ra01698g; Gautier J, 2013, J CONTROL RELEASE, V169, P48, DOI 10.1016/j.jconrel.2013.03.018; Gong T, 2016, J PHARM BIOMED SCI, V6, P338, DOI DOI 10.3109/02652048.2011.559286; Gu YJ, 2012, NANOMED-NANOTECHNOL, V8, P204, DOI 10.1016/j.nano.2011.06.005; Gungor-Ordueri NE, 2019, PHARMACOL REP, V71, P591, DOI 10.1016/j.pharep.2019.02.018; Injac R, 2009, BIOMATERIALS, V30, P1184, DOI 10.1016/j.biomaterials.2008.10.060; Khames A, 2017, EUR J PHARMACOL, V805, P118, DOI 10.1016/j.ejphar.2017.02.046; Khanniri E, 2016, CRIT REV FOOD SCI, V56, P484, DOI 10.1080/10408398.2013.779571; Kibria G, 2014, ARCH PHARM RES, V37, P4, DOI 10.1007/s12272-013-0276-2; Klemetsrud T, 2013, COLLOID SURFACE B, V103, P158, DOI 10.1016/j.colsurfb.2012.10.012; Kumar A, 2019, EUR J MED CHEM, V176, P268, DOI 10.1016/j.ejmech.2019.05.027; Li L, 2018, INT J PHARMACEUT, V536, P450, DOI 10.1016/j.ijpharm.2017.12.018; Liu LS, 2003, BIOMATERIALS, V24, P3333, DOI 10.1016/S0142-9612(03)00213-8; Maeki M, 2018, ADV DRUG DELIVER REV, V128, P84, DOI 10.1016/j.addr.2018.03.008; Mastria EM, 2018, J CONTROL RELEASE, V269, P364, DOI 10.1016/j.jconrel.2017.11.021; Moya S, 2000, MACROMOLECULES, V33, P4538, DOI 10.1021/ma9914974; [欧金来 Ou Jinlai], 2014, [暨南大学学报. 自然科学与医学版, Journal of Jinan University. Natural Science & Medicine Edition], V35, P330; Renu K, 2018, EUR J PHARMACOL, V818, P241, DOI 10.1016/j.ejphar.2017.10.043; Rodrigues ARO, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11010010; Seidi K, 2018, J CONTROL RELEASE, V275, P142, DOI 10.1016/j.jconrel.2018.02.020; Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smistad G, 2012, CARBOHYD POLYM, V90, P1337, DOI 10.1016/j.carbpol.2012.07.002; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tao JY, 2019, MOL PHARMACEUT, V16, P786, DOI 10.1021/acs.molpharmaceut.8b01056; Thakkar S, 2020, ACTA BIOMATER, V101, P43, DOI 10.1016/j.actbio.2019.09.009; Wen ShaoHong, 2015, Journal of Pharmaceutical and Biomedical Sciences, V5, P385; Wilhelm S, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.14; Xia YQ, 2017, COLLOID SURFACE B, V159, P427, DOI 10.1016/j.colsurfb.2017.08.011; Ying XY, 2011, J MAGN MAGN MATER, V323, P1088, DOI 10.1016/j.jmmm.2010.12.019; Zahednezhad F, 2019, J CONTROL RELEASE, V305, P194, DOI 10.1016/j.jconrel.2019.05.030; Zhang YX, 2015, CARBOHYD POLYM, V133, P31, DOI 10.1016/j.carbpol.2015.06.102; Zheng WP, 2018, BIOMED PHARMACOTHER, V108, P565, DOI 10.1016/j.biopha.2018.09.039; Zhou XT, 2015, INT J PHARMACEUT, V479, P391, DOI 10.1016/j.ijpharm.2014.12.068; Zhu JZ, 2019, FOOD HYDROCOLLOID, V95, P562, DOI 10.1016/j.foodhyd.2018.04.042; Zong L, 2019, J PHARMACEUT BIOMED, V165, P268, DOI 10.1016/j.jpba.2018.11.057	44	3	3	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235090	10.1371/journal.pone.0235090	http://dx.doi.org/10.1371/journal.pone.0235090			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569270	Green Published, gold			2022-12-27	WOS:000543547900014
J	de Carvalho, P; Bonecker, M; Tello, G; Abanto, J; Oliveira, LB; Braga, MM				de Carvalho, Patricia; Bonecker, Marcelo; Tello, Gustavo; Abanto, Jenny; Oliveira, Luciana Butini; Braga, Mariana Minatel			Inclusion of initial caries lesions in a population-based sample of Brazilian preschool children: Impact on estimates and treatment needs	PLOS ONE			English	Article							ASSESSMENT SYSTEM ICDAS; DENTAL-CARIES; EPIDEMIOLOGIC SURVEYS; INTERNATIONAL CARIES; PREVALENCE; TRENDS; INJURIES; KAPPA; RISK	This study aimed to assess changes in epidemiological estimates and treatment needed when initial caries lesions are included in a population-based survey of preschool children. A cross-sectional survey was conducted in a Brazilian municipality, collecting data of preschool children in 16 health centers. Caries detection used the merged codes (epi-codes) for ICDAS/ICCMS. An option for treatment, according to ICCMS, was chosen during the examination. Caries experience (dmft/dmfs) and prevalence were estimated considering three thresholds (A- initial, moderate, and severe lesions, B- only moderate and severe lesions and C- severe lesions). Incremental need for non-operative care was also verified. The sample consisted of 663 children aged 2-4 years (response rate of 99.85%). Including initial lesions, a 2-fold increase in dmft was observed (A: 3.36, B: 1.02, p<0.001). With the inclusion, the caries prevalence increased to 75% compared to threshold B only (28%). The majority (76%) of children who required any intervention (56%) should be scheduled for non-operative care. We suggest that including initial caries lesions in an epidemiological survey may significantly impact assessment of population caries experience.	[de Carvalho, Patricia; Bonecker, Marcelo; Tello, Gustavo; Abanto, Jenny; Braga, Mariana Minatel] Univ Sao Paulo, Sch Dent, Dept Orthodont & Pediat Dent, Sao Paulo, Brazil; [Oliveira, Luciana Butini] Fac Sao Leopoldo Mand, Div Pediat Dent, Campinas, Brazil	Universidade de Sao Paulo; Faculdade Sao Leopoldo Mandic	de Carvalho, P (corresponding author), Univ Sao Paulo, Sch Dent, Dept Orthodont & Pediat Dent, Sao Paulo, Brazil.	patcarvalho@usp.br	Bonecker, Marcelo/I-9393-2012	Bonecker, Marcelo/0000-0001-9786-6473; Carvalho, Patricia/0000-0001-8263-5314; Tello, Gustavo/0000-0003-0120-6388	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [400736/2014-4, 309817/2015-3, 304319/2018-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (400736/2014-4), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (309817/2015-3, 304319/2018-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanto J, 2015, INT J PAEDIATR DENT, V25, P18, DOI 10.1111/ipd.12092; Assaf AV, 2006, COMMUNITY DENT ORAL, V34, P213, DOI 10.1111/j.1600-0528.2006.00278.x; Bonecker M, 2010, INT J PAEDIATR DENT, V20, P125, DOI 10.1111/j.1365-263X.2009.01030.x; Bonecker M, 2002, Int J Paediatr Dent, V12, P183; Braga MM, 2009, CARIES RES, V43, P245, DOI 10.1159/000217855; Cadavid Alexandra Saldarriaga, 2010, Braz. oral res., V24, P211, DOI 10.1590/S1806-83242010000200014; Cortes A, 2017, ACTA ODONTOL SCAND, V75, P12, DOI 10.1080/00016357.2016.1242154; Pinto-Sarmento TCD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150116; Bonini GADC, 2009, DENT TRAUMATOL, V25, P594, DOI 10.1111/j.1600-9657.2009.00826.x; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Gimenez T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164903; Guedes RS, 2018, CARIES RES, V52, P32, DOI 10.1159/000479824; Guedes RS, 2016, INT J PAEDIATR DENT, V26, P116, DOI 10.1111/ipd.12166; Gulliford MC, 2005, J CLIN EPIDEMIOL, V58, P246, DOI 10.1016/j.jclinepi.2004.08.012; IBGE, IND SOC MUN 2010 INC; Ismail AI, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/1472-6831-15-S1-S9; Martignon Stefania, 2018, Braz. Dent. J., V29, P374, DOI 10.1590/0103-6440201801949; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Murakami C, 2016, INT J PAEDIATR DENT, V26, P60, DOI 10.1111/ipd.12159; Oliveira LB, 2008, EUR J ORAL SCI, V116, P37, DOI 10.1111/j.1600-0722.2007.00507.x; Piovesan C, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-49; Piovesan C, 2013, COMMUNITY DENT ORAL, V41, P204, DOI 10.1111/cdoe.12004; Pitchika V, 2016, COMMUNITY DENT ORAL, V44, P354, DOI 10.1111/cdoe.12219; Pitts NB, 2013, COMMUNITY DENT ORAL, V41, pe41, DOI 10.1111/cdoe.12025; Pitts NB, ICCMSTM GUIDE PRACTI; Pitts Nigel, 2004, Community Dent Health, V21, P193; [SB Brasil Ministerio da Saude. Secretaria de AtencAo a Saude. Secretaria de Vigilancia em Saude], 2012, PESQ NAC SAUD BUC; Sim J, 2005, PHYS THER, V85, P257; Tello G, 2016, DENT TRAUMATOL, V32, P274, DOI 10.1111/edt.12255; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Xie ZJ, 2007, ORAL SURG ORAL MED O, V103, pE44, DOI 10.1016/j.tripleo.2006.12.028	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234122	10.1371/journal.pone.0234122	http://dx.doi.org/10.1371/journal.pone.0234122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559191	Green Published, gold			2022-12-27	WOS:000543261600037
J	Aguirre, CG; Stolyarova, A; Das, K; Kolli, S; Marty, V; Ray, L; Spigelman, I; Izquierdo, A				Aguirre, Claudia G.; Stolyarova, Alexandra; Das, Kanak; Kolli, Saisriya; Marty, Vincent; Ray, Lara; Spigelman, Igor; Izquierdo, Alicia			Sex-dependent effects of chronic intermittent voluntary alcohol consumption on attentional, not motivational, measures during probabilistic learning and reversal	PLOS ONE			English	Article							CONDITIONED TASTE-AVERSION; MEDIAL PREFRONTAL CORTEX; BRAIN REGIONAL VOLUMES; ETHANOL EXPOSURE; LONG-EVANS; COGNITIVE FLEXIBILITY; ORBITOFRONTAL CORTEX; BINGE DRINKING; ANIMAL-MODELS; RATS	Background Forced alcohol (ethanol, EtOH) exposure has been shown to cause significant impairments on reversal learning, a widely-used assay of cognitive flexibility, specifically on fully-predictive, deterministic versions of this task. However, previous studies have not adequately considered voluntary EtOH consumption and sex effects on probabilistic reversal learning. The present study aimed to fill this gap in the literature. Methods Male and female Long-Evans rats underwent either 10 weeks of voluntary intermittent 20% EtOH access or water only (H2O) access. Rats were then pretrained to initiate trials and learn stimulus-reward associations via touchscreen response, and subsequently required to select between two visual stimuli, rewarded with probability 0.70 or 0.30. In the final phase, reinforcement contingencies were reversed. Results We found significant sex differences on several EtOH-drinking variables, with females reaching a higher maximum EtOH consumption, exhibiting more high-drinking days, and escalating their EtOH at a quicker rate compared to males. During early abstinence, EtOH drinkers (and particularly EtOH-drinking females) made more initiation omissions and were slower to initiate trials than H2O drinking controls, especially during pretraining. A similar pattern in trial initiations was also observed in discrimination, but not in reversal learning. EtOH drinking rats were unaffected in their reward collection and stimulus response times, indicating intact motivation and motor responding. Although there were sex differences in discrimination and reversal phases, performance improved over time. We also observed sex-independent drinking group differences in win-stay and lose-shift strategies specific to the reversal phase. Conclusions Females exhibit increased vulnerability to EtOH effects in early learning: there were sex-dependent EtOH effects on attentional measures during pretraining and discrimination phases. We also found sex-independent EtOH effects on exploration strategies during reversal. Future studies should aim to uncover the neural mechanisms for changes in attention and exploration in both acute and prolonged EtOH withdrawal.	[Aguirre, Claudia G.; Stolyarova, Alexandra; Das, Kanak; Kolli, Saisriya; Ray, Lara; Izquierdo, Alicia] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Marty, Vincent; Ray, Lara; Spigelman, Igor; Izquierdo, Alicia] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Marty, Vincent; Spigelman, Igor] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Ray, Lara; Izquierdo, Alicia] Univ Calif Los Angeles, Integrat Ctr Addict, Los Angeles, CA 90095 USA; [Izquierdo, Alicia] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Aguirre, CG; Izquierdo, A (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.; Izquierdo, A (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA.; Izquierdo, A (corresponding author), Univ Calif Los Angeles, Integrat Ctr Addict, Los Angeles, CA 90095 USA.; Izquierdo, A (corresponding author), Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA.	cgaguirre@ucla.edu; aizquie@psych.ucla.edu		Izquierdo, Alicia/0000-0001-9897-2091	UCLA's Division of Life Sciences Recruitment and Retention fund [R01 DA047870, R01 AA024527]; NSF Graduate Research Fellowship; Nancy M. Biram Research Fund in Life Sciences Award; UCLA's Dissertation Year Fellowship; Charles E. and Sue K. Young Graduate Student Fellowship	UCLA's Division of Life Sciences Recruitment and Retention fund; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Nancy M. Biram Research Fund in Life Sciences Award; UCLA's Dissertation Year Fellowship; Charles E. and Sue K. Young Graduate Student Fellowship	This work was supported by UCLA's Division of Life Sciences Recruitment and Retention fund (Izquierdo), R01 DA047870 (Izquierdo), and R01 AA024527 (Spigelman). We acknowledge UCLA's Graduate Division Graduate Summer Research Mentorship and Graduate Research Mentorship programs (Aguirre) and the NSF Graduate Research Fellowship (Aguirre). We also acknowledge Nancy M. Biram Research Fund in Life Sciences Award (Stolyarova), UCLA's Dissertation Year Fellowship (Stolyarova) and Charles E. and Sue K. Young Graduate Student Fellowship (Stolyarova).	Amitai N, 2010, BIOL PSYCHIAT, V68, P5, DOI 10.1016/j.biopsych.2010.03.004; Amodeo LR, 2017, NEUROSCIENCE, V345, P27, DOI 10.1016/j.neuroscience.2016.03.034; [Anonymous], 2017, IBM SPSS STAT; Asinof SK, 2014, JOVE-J VIS EXP, DOI 10.3791/51574; Bacon Francis, 2012, EARLY SCI MED, V17, P132; Badanich KA, 2016, PSYCHOPHARMACOLOGY, V233, P3615, DOI 10.1007/s00213-016-4395-6; Badanich KA, 2011, BEHAV NEUROSCI, V125, P879, DOI 10.1037/a0025922; Barker JM, 2010, J NEUROSCI, V30, P9140, DOI 10.1523/JNEUROSCI.0548-10.2010; Bayless DW, 2012, BEHAV BRAIN RES, V235, P48, DOI 10.1016/j.bbr.2012.07.028; Becker HC, 2014, ALCOHOL, V48, P205, DOI 10.1016/j.alcohol.2014.04.001; Boutros N, 2017, PSYCHOPHARMACOLOGY, V234, P1549, DOI 10.1007/s00213-017-4555-3; Bruinsma B, 2019, PSYCHOPHARMACOLOGY, V236, P2015, DOI 10.1007/s00213-019-05189-0; Bryce CA, 2015, BEHAV BRAIN RES, V278, P21, DOI 10.1016/j.bbr.2014.09.027; Brys I, 2014, INT J DEV NEUROSCI, V38, P161, DOI 10.1016/j.ijdevneu.2014.08.007; Bushnell PJ, 2009, FRONT NEUROSCI, P119; Cailhol S, 2002, J STUD ALCOHOL, V63, P91; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Carnicella S, 2014, ALCOHOL, V48, P243, DOI 10.1016/j.alcohol.2014.01.006; Coleman LG, 2011, ALCOHOL CLIN EXP RES, V35, P671, DOI 10.1111/j.1530-0277.2010.01385.x; Coleman LG, 2014, PHARMACOL BIOCHEM BE, V116, P142, DOI 10.1016/j.pbb.2013.11.021; Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, 2019, LANCET, V6, pe105; Committee for the Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016, 2017, JJAAM, V28, ps1; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Dajani DR, 2015, TRENDS NEUROSCI, V38, P571, DOI 10.1016/j.tins.2015.07.003; Dalton GL, 2016, J NEUROSCI, V36, P1996, DOI 10.1523/JNEUROSCI.3366-15.2016; Depoy L, 2013, P NATL ACAD SCI USA, V110, P14783, DOI 10.1073/pnas.1308198110; Evans KL, 2015, BRAIN COGNITION, V93, P42, DOI 10.1016/j.bandc.2014.11.006; Fernandez GM, 2017, NEUROSCIENCE, V348, P324, DOI 10.1016/j.neuroscience.2017.02.045; Fernandez GM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149987; George O, 2012, P NATL ACAD SCI USA, V109, P18156, DOI 10.1073/pnas.1116523109; Givens B, 1997, PSYCHOPHARMACOLOGY, V129, P135, DOI 10.1007/s002130050173; Grissom NM, 2019, NEUROPSYCHOPHARMACOL, V44, P86, DOI 10.1038/s41386-018-0179-5; Guidi M, 2015, J NEUROSCI, V35, P3966, DOI 10.1523/JNEUROSCI.3523-14.2015; Guo L., 2010, INT J ROBUST NONLIN, V15, P109; Houston RJ, 2014, ADDICT BEHAV, V39, P345, DOI 10.1016/j.addbeh.2013.09.032; Hwa LS, 2011, ALCOHOL CLIN EXP RES, V35, P1938, DOI 10.1111/j.1530-0277.2011.01545.x; Irimia C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109948; Irimia C, 2015, ADDICT BIOL, V20, P263, DOI 10.1111/adb.12119; Izquierdo A, 2017, NEUROSCIENCE, V345, P12, DOI 10.1016/j.neuroscience.2016.03.021; Izquierdo A, 2017, J NEUROSCI, V37, P10529, DOI 10.1523/JNEUROSCI.1678-17.2017; Izquierdo A, 2010, NEUROPSYCHOPHARMACOL, V35, P505, DOI 10.1038/npp.2009.155; Knapp DJ, 2012, METHODS MOL BIOL, V829, P205, DOI 10.1007/978-1-61779-458-2_13; Kroener S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037541; de la Torre ML, 2015, PHARMACOL BIOCHEM BE, V137, P7, DOI 10.1016/j.pbb.2015.07.011; Lukkes JL, 2016, DEV PSYCHOBIOL, V58, P231, DOI 10.1002/dev.21368; Marbach F, 2017, SELF INITIATED 2 ALT, V073783; Marquardt K, 2017, NEUROBIOL LEARN MEM, V139, P179, DOI 10.1016/j.nlm.2017.01.006; Martin TJ, 2015, J NEUROSCI METH, V241, P37, DOI 10.1016/j.jneumeth.2014.12.007; MATLAB and Statistics Toolbox, 2013, MATLAB STAT TOOLB; Morales M, 2015, PHARMACOL BIOCHEM BE, V139, P67, DOI 10.1016/j.pbb.2015.10.016; Nixon K, 2008, NEUROBIOL DIS, V31, P218, DOI 10.1016/j.nbd.2008.04.009; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; O'Neill J, 2001, ALCOHOL CLIN EXP RES, V25, P1673; Obernier JA, 2002, PHARMACOL BIOCHEM BE, V72, P521, DOI 10.1016/S0091-3057(02)00715-3; Overman WH, 2004, BRAIN COGNITION, V55, P134, DOI 10.1016/s0278-2626(03)00279-3; Palanza P, 2001, PHYSIOL BEHAV, V72, P255, DOI 10.1016/S0031-9384(00)00406-6; Piano MR, 2005, ALCOHOL, V35, P113, DOI 10.1016/j.alcohol.2005.03.002; Piantadosi PT, 2019, LEARN MEMORY, V26, P24, DOI 10.1101/lm.048264.118; Planeta CS, 2013, REV BRAS PSIQUIATR, V35, pS140, DOI 10.1590/1516-4446-2013-1149; Priddy BM, 2017, PHARMACOL BIOCHEM BE, V152, P61, DOI 10.1016/j.pbb.2016.08.001; Ray MH, 2018, PHYSIOL BEHAV, V196, P176, DOI 10.1016/j.physbeh.2018.08.021; Remmelink E, 2017, SCI REP-UK, V7, DOI 10.1038/srep42519; Robbins TW, 2019, PSYCHOPHARMACOLOGY, V236, P2295, DOI 10.1007/s00213-019-05302-3; Rosenbloom MJ, 2007, PSYCHIAT RES-NEUROIM, V155, P91, DOI 10.1016/j.pscychresns.2006.12.019; Rosenwasser AM, 2013, ADDICT BIOL, V18, P496, DOI 10.1111/j.1369-1600.2012.00481.x; Sanchez-Roige S, 2014, NEUROPSYCHOPHARMACOL, V39, P2919, DOI 10.1038/npp.2014.151; Sanchez-Roige S, 2014, ALCOHOL CLIN EXP RES, V38, P2579, DOI 10.1111/acer.12535; Schramm-Sapyta NL, 2014, PSYCHOPHARMACOLOGY, V231, P1831, DOI 10.1007/s00213-013-3319-y; Sherrill LK, 2011, BEHAV BRAIN RES, V225, P104, DOI 10.1016/j.bbr.2011.07.003; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Stolyarova A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12725-1; Stolyarova A, 2017, ELIFE, V6, P1, DOI 10.7554/eLife.27483; Stolyarova A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00115; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Torres OV, 2014, ALCOHOL CLIN EXP RES, V38, P108, DOI 10.1111/acer.12213; Tudor MJ, 2006, MEASUREMENT SCI TECH, V17, pR175; Turner KM, 2016, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00370; Verharen JPH, 2020, PSYCHOPHARMACOLOGY, V237, P1267, DOI 10.1007/s00213-020-05454-7; Vetter-O'Hagen C, 2009, ALCOHOL ALCOHOLISM, V44, P547, DOI 10.1093/alcalc/agp048; Vetter-O'Hagen CS, 2011, ALCOHOL CLIN EXP RES, V35, P2039, DOI 10.1111/j.1530-0277.2011.01555.x; Wallin-Miller KG, 2017, DRUG ALCOHOL DEPEN, V174, P137, DOI 10.1016/j.drugalcdep.2017.01.023; Wilhelm CJ, 2016, BRAIN PATHOL, V26, P433, DOI 10.1111/bpa.12276; Worthy DA, 2014, J MATH PSYCHOL, V59, P41, DOI 10.1016/j.jmp.2013.10.001; 2014, REG ANESTH PAIN MED, V9, pE1006	84	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234729	10.1371/journal.pone.0234729	http://dx.doi.org/10.1371/journal.pone.0234729			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555668	Green Published, Green Submitted, gold			2022-12-27	WOS:000543273200046
J	Chu, PL; Liu, HS; Wang, CK; Lin, CY				Chu, Pei-Lun; Liu, Hui-Shan; Wang, Chikang; Lin, Chien-Yu			Association between acrylamide exposure and sex hormones in males: NHANES, 2003-2004	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ANTI-MULLERIAN HORMONE; BINDING GLOBULIN; BODY-COMPOSITION; INHIBIN B; MEN; AGE; NEUROTOXICITY; TESTOSTERONE; ADDUCTS	Introduction Acrylamide is widely present in heat-processed food, cigarette smoke and environment. Reproductive toxicity was reported in animals treated with acrylamide, particularly in males. The reproductive toxicity of acrylamide and its active metabolite, glycidamide, was reported to be mainly mediated through DNA damage in spermatocytes. However, the effect of acrylamide on sex hormones in men is unknown. Methods There were 468 male subjects (age >= 12 years) enrolled to determine the relationships between hemoglobin adducts of acrylamide (HbAA) and hemoglobin adducts of glycidamide (HbGA) with several sex hormones using the National Health and Nutrition Examination Survey (NHANES), 2003 to 2004. All potential confounding variables in the data set were properly adjusted. Results We found that one unit increase in the natural log-transformed HbAA level was associated with an increase in natural log transformed serum inhibin B level by 0.10 (SE = 0.05;P= 0.046), and natural log transformed serum sex hormone binding globulin (SHBG) by 0.15 (SE = 0.15;P= 0.036). With respect to HbGA, one unit increase in the natural log-transformed HbGA level was associated with an increase in natural log transformed serum anti-Mullerian Hormone (AMH) level by 0.31 (SE = 0.00;P= 0.003). Conclusion In this representative cohort, we identified positive associations between acrylamide exposure and several sex hormones in men. The HbAA is positively associated with inhibin B and SHBG, and HbGA is positively associated with AMH. Other than genotoxicity, our findings suggested that altered sex hormones might also play a role in acrylamide-related reproductive toxicity in males.	[Chu, Pei-Lun; Lin, Chien-Yu] Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan; [Chu, Pei-Lun] Fu Jen Catholic Univ, Fu Jen Catholic Univ Hosp, Dept Internal Med, New Taipei, Taiwan; [Liu, Hui-Shan] Hsinchu Cathay Gen Hosp, Dept Gynecol & Obstet, Hsinchu, Taiwan; [Wang, Chikang; Lin, Chien-Yu] Yuanpei Univ Med Technol, Dept Environm Engn & Hlth, Hsinchu, Taiwan; [Lin, Chien-Yu] En Chu Kong Hosp, Dept Internal Med, New Taipei, Taiwan	Fu Jen Catholic University; Fu Jen Catholic University; Fu Jen Catholic University Hospital; Cathay General Hospital	Lin, CY (corresponding author), Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan.; Lin, CY (corresponding author), Yuanpei Univ Med Technol, Dept Environm Engn & Hlth, Hsinchu, Taiwan.; Lin, CY (corresponding author), En Chu Kong Hosp, Dept Internal Med, New Taipei, Taiwan.	lin7010@mail2000.com.tw			Fu Jen Catholic University Hospital [PL-201705006-V]	Fu Jen Catholic University Hospital	The study was partly supported by the Fu Jen Catholic University Hospital, PL-201705006-V to Pei-Lun Chu. The funder plays no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ahmed EA, 2009, BIOL REPROD, V80, P1084, DOI 10.1095/biolreprod.108.071662; Andersson AM, 1997, J CLIN ENDOCR METAB, V82, P3976, DOI 10.1210/jc.82.12.3976; [Anonymous], 2017, CANCER DISCOV, V7, pOF12; [Anonymous], 2003, J PAIN PALLIAT CARE, V17, P1; [Anonymous], 2008, NHANES 2003 2004; [Anonymous], 2005, AN REP GUID; Bjellaas T, 2007, TOXICOL SCI, V98, P110, DOI 10.1093/toxsci/kfm091; El-Halawaty S, 2011, GYNECOL ENDOCRINOL, V27, P401, DOI 10.3109/09513590.2010.495433; Exon J H, 2006, J Toxicol Environ Health B Crit Rev, V9, P397, DOI 10.1080/10937400600681430; Gates MA, 2013, J CLIN ENDOCR METAB, V98, P2442, DOI 10.1210/jc.2012-2582; Goulis DG, 2008, GYNECOL ENDOCRINOL, V24, P158, DOI 10.1080/09513590701672314; Hamdy SM, 2012, HUM EXP TOXICOL, V31, P483, DOI 10.1177/0960327111417267; He ZH, 2018, INT J OBESITY, V42, P1366, DOI 10.1038/s41366-018-0033-1; Hogervorst JG, 2013, CANCER EPIDEM BIOMAR, V22, P2024, DOI 10.1158/1055-9965.EPI-13-0509; Klingmuller D, 1997, HUM REPROD, V12, P2376, DOI 10.1093/humrep/12.11.2376; Le TN, 2012, TRENDS ENDOCRIN MET, V23, P32, DOI 10.1016/j.tem.2011.09.005; Lin CY, 2009, DIABETES CARE, V32, P2206, DOI 10.2337/dc09-0309; Mannaa F, 2006, J APPL TOXICOL, V26, P198, DOI 10.1002/jat.1128; Mojska Hanna, 2013, Rocz Panstw Zakl Hig, V64, P173; Nagata C, 2018, AM J EPIDEMIOL, V187, P75, DOI 10.1093/aje/kwx197; Nagata C, 2015, CANCER EPIDEM BIOMAR, V24, P249, DOI 10.1158/1055-9965.EPI-14-0935; Rougier C, 2019, ANN ENDOCRINOL-PARIS, V80, P234, DOI 10.1016/j.ando.2019.06.002; Song Hong-Xiu, 2008, Zhonghua Nan Ke Xue, V14, P406; Tyl RW, 2000, REPROD TOXICOL, V14, P147, DOI 10.1016/S0890-6238(00)00066-6; US EPA, 2010, TOX REV ACR; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wallace IR, 2013, CLIN ENDOCRINOL, V78, P321, DOI 10.1111/cen.12086; Weitzman M, 2005, CIRCULATION, V112, P862, DOI 10.1161/CIRCULATIONAHA.104.520650; WHO, 2018, GLOB DAT CHILD GROWT; Wirfalt E, 2008, EUR J CLIN NUTR, V62, P314, DOI 10.1038/sj.ejcn.1602704; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yilmaz BO, 2017, HUM EXP TOXICOL, V36, P1225, DOI 10.1177/0960327116686818; ZENICK H, 1986, J TOXICOL ENV HEALTH, V17, P457, DOI 10.1080/15287398609530840	33	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234622	10.1371/journal.pone.0234622	http://dx.doi.org/10.1371/journal.pone.0234622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555690	Green Published, gold			2022-12-27	WOS:000543273200074
J	Park, J; Choi, JY; Shin, A; Lee, SA; Lee, M; Choi, J; Lee, JK; Kang, D				Park, JooYong; Choi, Ji-Yeob; Shin, Aesun; Lee, Sang-Ah; Lee, Miyoung; Choi, Jaesung; Lee, Jong-koo; Kang, Daehee			Patterns of leisure time and household physical activity and the risk of mortality among middle-aged Korean adults	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; HEALTH-BENEFITS; OLDER-ADULTS; METAANALYSIS; ASSOCIATION; PREVALENCE; COHORT; WORK	Background Although many studies have focused on leisure time physical activity (LTPA), household physical activity (HPA) can contribute to health benefits. This study aimed to compare LTPA and HPA patterns and to examine the association of these types of activities with the risk of mortality in Korea. Methods A total of 125,299 participants 40 to 69 years old and enrolled in the Health Examinees (HEXA) study from 2004 to 2012 were included in this study. The sex-specific LTPA and HPA categories were defined based on a questionnaire. A multinomial logistic regression was used to examine the LTPA and HPA correlates. Hazard ratios (HR) with 95% confidence intervals (95% CIs) of all-cause mortality were estimated using the Cox proportional hazard model. Results Overall, the LTPA and HPA patterns differed by age, income, and history of chronic diseases. LTPA reduced the risk of death, and lower risks were observed in more time spent engaged in or a vigorous LTPA intensity. The subjects who participated only in HPA and were not involved in LTPA also had lower risks of mortality (HR = 0.72, 95% CIs: 0.60-0.85 for men, and HR = 0.84, 95% CIs: 0.69-1.02 for women) than those who did not participate in both LTPA and HPA. Conclusions HPA reduced the risks of mortality in middle-aged Korean adults and could even decrease the risk of death in those who did not participate in LTPA.	[Park, JooYong; Choi, Ji-Yeob; Choi, Jaesung; Kang, Daehee] Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea; [Park, JooYong; Choi, Ji-Yeob; Choi, Jaesung] BK21plus Biomed Sci Project, Seoul, South Korea; [Choi, Ji-Yeob; Shin, Aesun; Kang, Daehee] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Choi, Ji-Yeob; Shin, Aesun; Kang, Daehee] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Lee, Sang-Ah] Kangwon Natl Univ, Dept Prevent Med, Sch Med, Chuncheon Si, South Korea; [Lee, Miyoung] Kookmin Univ, Coll Phys Educ & Sport Sci, Seoul, South Korea; [Lee, Jong-koo] Seoul Natl Univ, JW Lee Ctr Global Med, Coll Med, Seoul, South Korea; [Lee, Jong-koo] Seoul Natl Univ, Dept Family Med, Coll Med, Seoul, South Korea; [Kang, Daehee] Seoul Natl Univ, Inst Environm Med, Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Kookmin University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choi, JY (corresponding author), Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea.; Choi, JY (corresponding author), BK21plus Biomed Sci Project, Seoul, South Korea.; Choi, JY (corresponding author), Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.; Choi, JY (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul, South Korea.	jiyeob.choi@gmail.com		Lee, Jong-koo/0000-0003-4833-1178; Kang, Daehee/0000-0003-4031-5878	National Research Foundation of Korea - Korea government [NRF-2018R1A2A3075397]; Seoul National University Hospital; Korea Centers for Disease Control and Prevention [2004-E71004-00, 2005-E71011-00, 2005-E71009-00];  [2006-E71001-00];  [2006-E71004-00];  [2006-E71010-00];  [2006-E71003-00];  [2007-E71004-00];  [2007-E71006-00];  [2008-E71006-00];  [2008-E71008-00];  [2009-E71009-00];  [2010-E71006-00];  [2011-E71006-00];  [2012-E71001-00];  [2013-E71009-00];  [2014-E71008-00];  [2014-E71008-01]	National Research Foundation of Korea - Korea government(National Research Foundation of KoreaKorean Government); Seoul National University Hospital; Korea Centers for Disease Control and Prevention; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	This work was supported by the Research Program that is funded by the Korea Centers for Disease Control and Prevention (2004-E71004-00, 2005-E71011-00, 2005-E71009-00, 2006-E71001-00, 2006-E71004-00, 2006-E71010-00, 2006-E71003-00, 2007-E71004-00, 2007-E71006-00, 2008-E71006-00, 2008-E71008-00, 2009-E71009-00, 2010-E71006-00, 2011-E71006-00, 2012-E71001-00, 2013-E71009-00, 2014-E71008-00, and 2014-E71008-01), by the National Research Foundation of Korea grant funded by the Korea government (NRF-2018R1A2A3075397), and by the Seoul National University Hospital (2019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Aijo M, 2016, J SPORT HEALTH SCI, V5, P437, DOI 10.1016/j.jshs.2015.09.008; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; [Anonymous], 2015, ASIAN PAC J CANCER P, V16, P1591, DOI DOI 10.7314/APJCP.2015.16.4.1591; [Anonymous], 2010, DRUG DISCOV TODAY TE, V7, pe1; Arrieta A, 2008, ANN EPIDEMIOL, V18, P889, DOI 10.1016/j.annepidem.2008.09.007; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Chen LJ, 2012, ASIA-PAC J PUBLIC HE, V24, P795, DOI 10.1177/1010539511404397; Choi J, 2019, J EPIDEMIOL, V29, P125, DOI 10.2188/jea.JE20170296; Choi J, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4255-2; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Csizmadi I, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-110; Engberg E, 2012, SPORTS MED, V42, P433, DOI 10.2165/11597610-000000000-00000; Eyler AE, 2002, J WOMEN HEALTH GEN-B, V11, P239, DOI 10.1089/152460902753668448; Gebel K, 2015, JAMA INTERN MED, V175, P970, DOI 10.1001/jamainternmed.2015.0541; Gillum RF, 2010, ANN EPIDEMIOL, V20, P251, DOI 10.1016/j.annepidem.2010.01.005; Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002; Hosmer DW, 2000, APPL LOGISTIC REGRES, P274; Jurj AL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-213; Kim Y, 2017, INT J EPIDEMIOL, V46, P1350, DOI 10.1093/ije/dyx105; Kirk MA, 2011, AM J PREV MED, V40, P476, DOI 10.1016/j.amepre.2010.12.015; Koeneman MA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-142; Koolhaas CM, 2018, INT J EPIDEMIOL, V47, P1705, DOI 10.1093/ije/dyy058; Ku PW, 2006, PREV MED, V43, P454, DOI 10.1016/j.ypmed.2006.04.011; Lahti J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101548; Lawlor DA, 2002, J EPIDEMIOL COMMUN H, V56, P473, DOI 10.1136/jech.56.6.473; Liu Y, 2018, INT J EPIDEMIOL, V47, P771, DOI 10.1093/ije/dyy024; Livingstone MBE, 2001, PUBLIC HEALTH NUTR, V4, P1107, DOI 10.1079/PHN2001192; Huerta JM, 2016, PREV MED, V85, P106, DOI 10.1016/j.ypmed.2016.02.009; Martinez-Gomez D, 2014, PREV MED, V61, P14, DOI 10.1016/j.ypmed.2014.01.006; Nang EEK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-644; National Institute of Agricultural Sciences, 2013, KOR STAND FOOD COMP; Ng SW, 2012, OBES REV, V13, P659, DOI 10.1111/j.1467-789X.2011.00982.x; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Norman A, 2002, INT J OBESITY, V26, P670, DOI 10.1038/sj.ijo.0801955; Ottenbacher AJ, 2012, J AM GERIATR SOC, V60, P1085, DOI 10.1111/j.1532-5415.2012.03995.x; Peters TM, 2010, MED SCI SPORT EXER, V42, P2222, DOI 10.1249/MSS.0b013e3181e1fcd5; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Rhodes RE, 1999, SPORTS MED, V28, P397, DOI 10.2165/00007256-199928060-00003; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Shi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14901; Sobal J., 2010, INT J SOCIOL FAM, V36, P181, DOI [10.2307/23028828, DOI 10.2307/23028828]; Stamatakis E, 2007, AM J PREV MED, V32, P320, DOI 10.1016/j.amepre.2006.12.020; Teh CH, 2014, PUBLIC HEALTH, V128, P416, DOI 10.1016/j.puhe.2013.10.008; Trinh OTH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-204; Venous Forum of the Royal Society of Medicine, 2011, PHLEBOLOGY, V26, P91; Warburton DER, 2017, CURR OPIN CARDIOL, V32, P541, DOI 10.1097/HCO.0000000000000437; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; West SL, 2010, AHRQ METHODS EFFECTI; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Zhou Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep39939	53	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234852	10.1371/journal.pone.0234852	http://dx.doi.org/10.1371/journal.pone.0234852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555644	gold, Green Published			2022-12-27	WOS:000543273200050
J	Steiner, BL; Alonso, N; Grillas, P; Jorda, C; Piques, G; Tillier, M; Rovira, N				Steiner, Bigna L.; Alonso, Natalia; Grillas, Patrick; Jorda, Christophe; Piques, Gael; Tillier, Margaux; Rovira, Nuria			Languedoc lagoon environments and man: Building a modern analogue botanical macroremain database for understanding the role of water and edaphology in sedimentation dynamics of archaeobotanical remains at the Roman port ofLattara(Lattes, France)	PLOS ONE			English	Article							EASTERN-CENTRAL EUROPE; SEED BANK; SPATIAL-DISTRIBUTION; STANDING VEGETATION; SURFACE SEDIMENTS; ASSEMBLAGES; DELTA; LAKE; DUNG; LIVESTOCK	A new method to evaluate archaeological wetland sites in a more objective way was tested. Different wetland environments have been sampled in areas of a nature reserve and their macroremain content analysed to build a modern analogue dataset. This dataset was then used to characterise archaeological samples from a navigation channel from the Roman port cityLattara. In the modern analogue samples, the different wetland types (saline/brackish or fresh water) could be differentiated in the correspondence analysis. Within these groups, the sampled area of the littoral (submerged, shoreline, unsubmerged) could also be differentiated. This dataset can therefore provide a basis for the interpretation of the nature and degree of aquatic influence and layer formation processes in archaeobotanical records of coastal sites. In the tested archaeological samples from the navigation channel ofLattara, changes in space and time could be tracked using the modern analogue dataset and geoarchaeological information. The channel lost its fresh water supply and silted up over a short period of time (approx. 100 years).	[Steiner, Bigna L.] Univ Basel, Integrat Prehist & Archaeol Sci IPAS, Dept Environm Sci, Basel, Switzerland; [Steiner, Bigna L.; Jorda, Christophe; Piques, Gael; Tillier, Margaux; Rovira, Nuria] Paul Valery Univ Montpellier, UMR5140, CNRS, Archeol Soc Mediterraneennes ASM, Montpellier, France; [Alonso, Natalia] Univ Lleida, Grp Invest Prehist, Dept Hist, Lleida, Catalonia, Spain; [Grillas, Patrick] Res Inst Conservat Mediterranean Wetlands, Tour du Valet, Arles, France; [Jorda, Christophe] Inrap Mediterranee, Parc Actipolis, Villeneuve Les Beziers, France; [Tillier, Margaux] Inst Sci Evolut Montpellier ISEM, Montpellier, France	University of Basel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universitat de Lleida; Universite de Montpellier	Steiner, BL (corresponding author), Univ Basel, Integrat Prehist & Archaeol Sci IPAS, Dept Environm Sci, Basel, Switzerland.; Steiner, BL (corresponding author), Paul Valery Univ Montpellier, UMR5140, CNRS, Archeol Soc Mediterraneennes ASM, Montpellier, France.	bigna.steiner@unibas.ch	Alonso, Natàlia/ABI-5269-2020	Rovira, Nuria/0000-0001-8139-7000	Swiss National Science Foundation [P2BSP1_178658]; LabEx ARCHIMEDE from "Investissement d'Avenir" program [ANR-11-LABX-0032-01]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); LabEx ARCHIMEDE from "Investissement d'Avenir" program(French National Research Agency (ANR))	This research was funded by the Swiss National Science Foundation (http://www.snf.ch/; early postdoc mobility grant to BLS, project nr. P2BSP1_178658) and supported by the LabEx ARCHIMEDE from "Investissement d'Avenir" program ANR-11-LABX-0032-01 (https://archimede.cnrs.fr/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeret o, 2000, THESIS; Alagich R, 2018, J ARCHAEOL SCI, V93, P135, DOI 10.1016/j.jas.2018.03.006; Alonso N., 2008, GALLIA, V65, P193; Alonso N, 2016, VEG HIST ARCHAEOBOT, V25, P323, DOI 10.1007/s00334-015-0553-8; [Anonymous], 1989, DET REF STAT, V2; [Anonymous], 1992, ACT UP LA NEWS, V5, P9; [Anonymous], LATTARA; [Anonymous], 1998, INDEX BOT ECOLOGIQUE; Antolin F, 2017, J ARCHAEOL SCI-REP, V12, P323, DOI 10.1016/j.jasrep.2017.02.008; Antolin F, 2015, J ARCHAEOL SCI, V61, P36, DOI 10.1016/j.jas.2015.04.019; Auderset Joye D., 2012, ROTE LISTE ARMLEUCHT; Azuara J, 2015, CLIM PAST, V11, P1769, DOI 10.5194/cp-11-1769-2015; Bagan G, 2010, QUATERNAIRE, V21, P85, DOI 10.4000/quaternaire.5470; Balbo AL, 2017, WIRES WATER, V4, DOI 10.1002/wat2.1238; Banas D, 2005, HYDROBIOLOGIA, V551, P3, DOI 10.1007/s10750-005-4446-1; Bogaard A, 2016, VEG HIST ARCHAEOBOT, V25, P57, DOI 10.1007/s00334-015-0524-0; Bollinger T, 1981, THESIS; Bullock P, 1990, HDB SOIL THIN SECTIO; BUXO R, 1991, LATTARA, V4, P101; Cappers R.T., 2012, DIGITALE ZADENATLAS, V4th ed.; Cappers R. T. J., 2005, PALAEOHISTORIA, V47, P429; Cappers RTJ, 1995, VEG HIST ARCHAEOBOT, V4, P249; Cappers RTJ, 1993, VEG HIST ARCHAEOBOT, P173, DOI DOI 10.1007/8F00198588; Carrion JS, 2002, REV PALAEOBOT PALYNO, V120, P217, DOI 10.1016/S0034-6667(02)00073-8; Chabal L, 2003, LATTARA, V16, P219; Charles M, 2003, LEVANT, V35, P213, DOI DOI 10.1179/lev.2003.35.1.213; Cheiron A, 2018, RAPPORT ACTIVITE 201; Court-Picon M, 2005, REV PALAEOBOT PALYNO, V135, P13, DOI 10.1016/j.revpalbo.2005.02.003; Cui LJ, 2016, ECOL ENG, V96, P45, DOI 10.1016/j.ecoleng.2016.03.040; Dieffenbacher-Krall AC, 2000, J PALEOLIMNOL, V24, P213, DOI 10.1023/A:1008164614818; Edgeworth M., 2011, FLUID PASTS ARCHAEOL; Friesem DE, 2017, QUATERNARY SCI REV, V171, P85, DOI 10.1016/j.quascirev.2017.07.002; Friesem DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164185; Gardeisen A, 2008, GALLIA, V65, P185; Goman M, 2001, J PALEOLIMNOL, V26, P393, DOI 10.1023/A:1012687113269; GRILLAS P, 1993, OECOLOGIA, V94, P1, DOI 10.1007/BF00317293; Grillas P, 2000, AQ SCI M AM SOC LIMN; Grillas P, 2016, ADAPTATION GRILLES D; Grillas P, 2010, ETUDE PILOTE EVALUAT; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hannon GE, 1997, J PALEOLIMNOL, V18, P15, DOI 10.1023/A:1007958511729; Hillman GC., 1984, PLANTS ANCIENT MAN S, P1; Hodder I., 2012, ENTANGLED ARCHAEOLOG; HOLYOAK DT, 1984, NEW PHYTOL, V98, P405, DOI 10.1111/j.1469-8137.1984.tb02750.x; Homeier J, 2017, FOR ECOSYST, V4, DOI 10.1186/s40663-017-0097-8; Hopfensperger KN, 2007, OIKOS, V116, P1438, DOI [10.1111/j.2007.0030-1299.15818.x, 10.1111/j.0030-1299.2007.15818.x]; Hosch S, 2003, J ARCHAEOL SCI, V30, P849, DOI 10.1016/S0305-4403(02)00263-7; Jacomet S., 2013, OXFORD HDB WETLAND A, P497; Jacomet S, 1985, BOT MAKRORESTE SEDIM; Jones G, 2010, J ARCHAEOL SCI, V37, P70, DOI 10.1016/j.jas.2009.08.017; Jones GEM., 1990, CIRCAEA, V6, P91; Jorda C., 2008, GALLIA, V65, P11, DOI DOI 10.3406/GALIA.2008.3328; Jutila HM, 2002, ANN BOT FENN, V39, P49; KAUTSKY L, 1990, HOLARCTIC ECOL, V13, P143; KEDDY PA, 1986, J GREAT LAKES RES, V12, P25, DOI 10.1016/S0380-1330(86)71697-3; Knorzer K-H, 1996, DECHENIANA, V149, P81; Koff Tiiu, 2008, Estonian Journal of Ecology, V57, P5, DOI 10.3176/eco.2008.1.01; Kreuz A, 2002, VEG HIST ARCHAEOBOT, V11, P177, DOI 10.1007/s003340200019; Kunes P, 2008, J BIOGEOGR, V35, P2223, DOI 10.1111/j.1365-2699.2008.01974.x; Kuster H, 1991, MODELLING ECOLOGICAL, P17; Liu GH, 2006, FRESHWATER BIOL, V51, P1862, DOI 10.1111/j.1365-2427.2006.01621.x; Lorber D, 2007, CONTRIBUTION ANAL FO; Magyari EOK, 2014, QUATERNARY SCI REV, V95, P60, DOI 10.1016/j.quascirev.2014.04.020; Verges JM, 2016, QUATERN INT, V414, P304, DOI 10.1016/j.quaint.2016.01.032; Menotti F., 2015, END LAKE DWELLINGS C; Menotti F., 2013, OXFORD HDB WETLAND A; Mesleard F, 1996, MEDWET SERIES CONSER, V6; Molinier R., 1970, PRODROME UNITES PHYT; Mouronval J.-B., 2010, PLANTES AQUATIQUES C; Nilsson C, 2002, ECOLOGY, V83, P2878, DOI 10.1890/0012-9658(2002)083[2878:DIRFBR]2.0.CO;2; Oberdorfer E., 2001, PFLANZENSOZIOLOGISCH; ODUM WE, 1988, ANNU REV ECOL SYST, V19, P147, DOI 10.1146/annurev.es.19.110188.001051; Paczyski A, 1992, ACTA SOC BOT POL, V61, P115; Persat H, 1996, ADV LIF SCI-SERIES, P321; Petit L. Garcia, 1999, LATTARA, V12, P609; Picon B., 2006, GESTION RISQUE INOND; Picon B, 1979, REV ECOL, P31; Piques G, 2010, LATTARA, V21, P387; Piques G, 2016, LATTARA LATTES HERAU; Piques G, 2018, ZONE PORTUAIRE LATTA; Piques G, 2019, ZONE PORTUAIRE LATTA; Piques G, 2017, ZONE PORTUAIRE LATTA; Puertas O, 1998, LATTARA, P11; Py M, 1993, GALLIA, P1; Py M., 2009, LATTARA LATTES HERAU; Py M, 1997, LATTARA, V10; Rovira N, 2017, ZONE PORTUAIRE LATTA; Rovira N, 2010, PLANTS SNAILS; Rovira N, 2018, ZONE PORTUAIRE LATTA; Rovira N, 2016, LATTARA LATTES HERAU; Rovira N, 2018, VEG HIST ARCHAEOBOT, V27, P85, DOI 10.1007/s00334-017-0619-x; Sabatier F., 2003, GEOMORPHOLOGIE, V4, P283, DOI DOI 10.3406/M0RF0.2003.1191; Salel Tiphaine, 2016, Revue de Micropaleontologie, V59, P425, DOI 10.1016/j.revmic.2016.09.001; Schaal C, 2018, REV SCI BOURGOGNE FR, V16, P29; Schepers M, 2015, ENVIRON ARCHAEOL, V20, P66, DOI 10.1179/1749631414Y.0000000030; Schepers M, 2013, VEG HIST ARCHAEOBOT, V22, P243, DOI 10.1007/s00334-012-0370-2; Schnitzler A., 2006, FORET MEDITERRANEENN, VXXVII, P43; Schnitzler-Lenoble A, 2007, FORETS ALLUVIALES DE; Seabloom EW, 1998, PLANT ECOL, V138, P203, DOI 10.1023/A:1009711919757; Steiner BL, 2018, VEG HIST ARCHAEOBOT, V27, P45, DOI 10.1007/s00334-017-0613-3; Steiner BL, 2015, J ARCHAEOL SCI-REP, V2, P310, DOI 10.1016/j.jasrep.2015.02.012; Steinhardt T, 2007, ESTUAR COAST SHELF S, V74, P205, DOI 10.1016/j.ecss.2007.04.004; Styring AK, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.76; Tillier M, 2019, THESIS; Tillier M, 2013, THESIS; TisoN J.-M., 2014, FLORA GALLICA; Tison J.-M., 2014, FLORE FRANCE MEDITER; Tolar T, 2010, VEG HIST ARCHAEOBOT, V19, P53, DOI 10.1007/s00334-009-0221-y; Vandorpe P, 2007, ENVIRON ARCHAEOL, V12, P207, DOI 10.1179/174963107x226462; VAQUER A, 1989, Annales de Limnologie, V25, P25; Vassio E, 2012, PALAIOS, V27, P779, DOI 10.2110/palo.2012.p12-050r; Vella C, 2005, MAR GEOL, V222, P235, DOI 10.1016/j.margeo.2005.06.028; Walsh K, 2014, ARCHAEOLOGY OF MEDITERRANEAN LANDSCAPES: HUMAN-ENVIRONMENT INTERACTION FROM THE NEOLITHIC TO THE ROMAN PERIOD, P1; Weisskopf A, 2018, QUATERN INT, V489, P80, DOI 10.1016/j.quaint.2016.09.028; Weisskopf A, 2014, J ARCHAEOL SCI, V51, P43, DOI 10.1016/j.jas.2013.04.026; Wiemann P., 2012, J WETLAND ARCHAEOLOG, V12, P58, DOI DOI 10.1179/JWA.2012.12.1.004; Willm L, 2018, RIPISYLVE TOURTOULEN; Willm L, 2003, RIPISYLVE TOURTOULEN; Yuan LY, 2007, PLANT ECOL, V189, P127, DOI 10.1007/s11258-006-9170-z; Zanon M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00253; Zibulski P., 2010, HORGENZEITLICHE SIED, P236	121	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234853	10.1371/journal.pone.0234853	http://dx.doi.org/10.1371/journal.pone.0234853			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555679	Green Published, gold			2022-12-27	WOS:000543273200051
J	Collis, RM; Biggs, PJ; Midwinter, AC; Browne, AS; Wilkinson, DA; Irshad, H; French, NP; Brightwell, G; Cookson, AL				Collis, Rose M.; Biggs, Patrick J.; Midwinter, Anne C.; Browne, A. Springer; Wilkinson, David A.; Irshad, Hamid; French, Nigel P.; Brightwell, Gale; Cookson, Adrian L.			Genomic epidemiology and carbon metabolism of Escherichia coli serogroup O145 reflect contrasting phylogenies	PLOS ONE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; MULTISTATE OUTBREAK; AGAR MEDIA; O157; INFECTIONS; INTIMIN; O26; O111; O103; VIRULENCE	Shiga toxin-producing Escherichia coli (STEC) are a leading cause of foodborne outbreaks of human disease, but they reside harmlessly as an asymptomatic commensal in the ruminant gut. STEC serogroup O145 are difficult to isolate as routine diagnostic methods are unable to distinguish non-O157 serogroups due to their heterogeneous metabolic characteristics, resulting in under-reporting which is likely to conceal their true prevalence. In light of these deficiencies, the purpose of this study was a twofold approach to investigate enhanced STEC O145 diagnostic culture-based methods: firstly, to use a genomic epidemiology approach to understand the genetic diversity and population structure of serogroup O145 at both a local (New Zealand) (n = 47) and global scale (n = 75) and, secondly, to identify metabolic characteristics that will help the development of a differential media for this serogroup. Analysis of a subset of E.coli serogroup O145 strains demonstrated considerable diversity in carbon utilisation, which varied in association witheaesubtype and sequence type. Several carbon substrates, such as D-serine and D-malic acid, were utilised by the majority of serogroup O145 strains, which, when coupled with current molecular and culture-based methods, could aid in the identification of presumptive E.coli serogroup O145 isolates. These carbon substrates warrant subsequent testing with additional serogroup O145 strains and non-O145 strains. Serogroup O145 strains displayed extensive genetic heterogeneity that was correlated with sequence type andeaesubtype, suggesting these genetic markers are good indicators for distinct E.coli phylogenetic lineages. Pangenome analysis identified a core of 3,036 genes and an open pangenome of >14,000 genes, which is consistent with the identification of distinct phylogenetic lineages. Overall, this study highlighted the phenotypic and genotypic heterogeneity within E.coli serogroup O145, suggesting that the development of a differential media targeting this serogroup will be challenging.	[Collis, Rose M.; Brightwell, Gale; Cookson, Adrian L.] Massey Univ, AgResearch Ltd, Hopkirk Res Inst, Palmerston North, New Zealand; [Collis, Rose M.; Biggs, Patrick J.; Midwinter, Anne C.; Browne, A. Springer; Wilkinson, David A.; French, Nigel P.; Cookson, Adrian L.] Massey Univ, Mol Epidemiol & Vet Publ Hlth Lab EpiLab, Infect Dis Res Ctr, Sch Vet Sci, Palmerston North, New Zealand; [Biggs, Patrick J.] Massey Univ, Sch Fundamental Sci, Palmerston North, New Zealand; [Wilkinson, David A.; French, Nigel P.; Brightwell, Gale] Massey Univ, New Zealand Food Safety Sci & Res Ctr, Palmerston North, New Zealand; [Irshad, Hamid] Natl Agr Res Ctr, Anim Hlth Programme, Islamabad, Pakistan	AgResearch - New Zealand; Massey University; Massey University; Massey University; Massey University; National Agricultural Research Council - Pakistan	Cookson, AL (corresponding author), Massey Univ, AgResearch Ltd, Hopkirk Res Inst, Palmerston North, New Zealand.; Cookson, AL (corresponding author), Massey Univ, Mol Epidemiol & Vet Publ Hlth Lab EpiLab, Infect Dis Res Ctr, Sch Vet Sci, Palmerston North, New Zealand.	Adrian.Cookson@agresearch.co.nz	Biggs, Patrick Jon/H-3355-2014; Brightwell, Gale/AAL-9620-2021	Biggs, Patrick Jon/0000-0002-0285-4101; Midwinter, Anne/0000-0001-5731-3233; Brightwell, Gale/0000-0002-3980-4108; Cookson, Adrian/0000-0002-8197-3386	AgResearch Food Provenance and Assurance Strategic Science Investment (SSI) Fund programme; Massey University School of Veterinary Science post-graduate research fund Massey University; Palmerston North Medical Research Foundation	AgResearch Food Provenance and Assurance Strategic Science Investment (SSI) Fund programme; Massey University School of Veterinary Science post-graduate research fund Massey University; Palmerston North Medical Research Foundation	This research was supported by the AgResearch Food Provenance and Assurance Strategic Science Investment (SSI) Fund programme awarded to GB, the Massey University School of Veterinary Science post-graduate research fund Massey University awarded to RMC and the Palmerston North Medical Research Foundation awarded to ALC. The funder AgResearch Ltd provided support in the form of salaries for the authors ALC and GB, but AgResearch Ltd and other Funders did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Almeida C, 2013, APPL ENVIRON MICROB, V79, P6293, DOI 10.1128/AEM.01009-13; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2019, ANIM BEHAV, V147, pI; [Anonymous], 2014, J APPL ECOL, DOI DOI 10.1111/1365-2664.12306; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; Bettelheim KA, 2000, J APPL MICROBIOL, V88, p38S, DOI 10.1111/j.1365-2672.2000.tb05331.x; Beutin L, 1998, EMERG INFECT DIS, V4, P635, DOI 10.3201/eid0404.980415; Bibbal D, 2014, APPL ENVIRON MICROB, V80, P1177, DOI 10.1128/AEM.03161-13; Bielaszewska M, 2014, INT J MED MICROBIOL, V304, P521, DOI 10.1016/j.ijmm.2014.05.005; Bielaszewska M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003797; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Biggs PJ, 2016, QCTOOL; Brandal LT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1017-6; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Browne AS, 2019, EMERG INFECT DIS, V25, P489, DOI 10.3201/eid2503.180899; Browne AS, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00481-18, 10.1128/aem.00481-18]; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carter MQ, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.00418-18; Carter MQ, 2016, APPL ENVIRON MICROB, V82, P1090, DOI 10.1128/AEM.03172-15; Center for Genomic Epidemiology, 2011, OV SERV DENM; Conrad CC, 2014, J MICROBIOL METH, V105, P22, DOI 10.1016/j.mimet.2014.06.020; Cooper KK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-17; De Rauw K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199968; Dewsbury DM, 2015, FOODBORNE PATHOG DIS, V12, P726, DOI 10.1089/fpd.2015.1987; Durso LM, 2004, APPL ENVIRON MICROB, V70, P6466, DOI 10.1128/AEM.70.11.6466-6472.2004; Friesema I, 2014, EUROSURVEILLANCE, V19, P26, DOI 10.2807/1560-7917.ES2014.19.17.20787; Gill A, 2014, J MICROBIOL METH, V96, P6, DOI 10.1016/j.mimet.2013.10.022; Girard F, 2005, INFECT IMMUN, V73, P6005, DOI 10.1128/IAI.73.9.6005-6016.2005; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Haugum K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111788; Hillerton JE, 2017, NEW ZEAL VET J, V65, P71, DOI 10.1080/00480169.2016.1171736; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iguchi A, 2012, J CLIN MICROBIOL, V50, P2894, DOI 10.1128/JCM.00789-12; Jaros P, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-450; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Jolley KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/mic.0.055459-0; Jores J, 2004, INT J MED MICROBIOL, V294, P103, DOI 10.1016/j.ijmm.2004.06.024; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kerangart S, 2018, INT J FOOD MICROBIOL, V266, P324, DOI 10.1016/j.ijfoodmicro.2017.10.018; Koutsoumanis K, 2020, EFSA J, V18, DOI 10.2903/j.efsa.2020.5967; Kozlov AM, 2019, BIOINFORMATICS, V35, P4453, DOI 10.1093/bioinformatics/btz305; Kruger A, 2015, MICROBIOL-SGM, V161, P451, DOI 10.1099/mic.0.000003; Kwon T, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0156-2; Lacher DW, 2006, FEMS MICROBIOL LETT, V261, P80, DOI 10.1111/j.1574-6968.2006.00328.x; Larsen MV, 2014, J CLIN MICROBIOL, V52, P1529, DOI 10.1128/JCM.02981-13; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lin A, 2011, FOOD MICROBIOL, V28, P478, DOI 10.1016/j.fm.2010.10.007; Lucas A, 2019, CTC CLUSTER TREE CON; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Nakamura K, 2020, MICROB GENOMICS, V6, DOI 10.1099/mgen.0.000323; Noll LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135446; Nyholm O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135936; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Phillips AD, 2000, J INFECT DIS, V181, P1496, DOI 10.1086/315404; Posse B, 2008, J APPL MICROBIOL, V105, P227, DOI 10.1111/j.1365-2672.2008.03739.x; Prager R, 2009, INT J MED MICROBIOL, V299, P343, DOI 10.1016/j.ijmm.2008.10.008; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rivas M, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0002-2013; Robins-Browne RM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/tcimb.2016.00141; Sabarly V, 2011, J EVOLUTION BIOL, V24, P1559, DOI 10.1111/j.1420-9101.2011.02287.x; Schmidt H, 2000, APPL ENVIRON MICROB, V66, P1205, DOI 10.1128/AEM.66.3.1205-1208.2000; Schrijver K. de, 2008, Eurosurveillance, V13, P8041; Seemann T., 2016, SNIPPY; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Stanford K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159866; Taylor EV, 2013, J FOOD PROTECT, V76, P939, DOI 10.4315/0362-028X.JFP-12-503; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Tillman GE, 2012, J FOOD PROTECT, V75, P1548, DOI 10.4315/0362-028X.JFP-12-110; Tozzoli R, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00080; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; U.S. Department of Agriculture FSIS, 2012, RISK PROF PATH NON 0; United States Department of Agriculture Food Safety and Inspection Service, 2011, FED REGISTER, V76; Vaas LAI, 2013, BIOINFORMATICS, V29, P1823, DOI 10.1093/bioinformatics/btt291; Verhaegen B, 2015, INT J ENV RES PUB HE, V12, P6965, DOI 10.3390/ijerph120606965; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; 2017, ANTHROPOL TODAY, V17, P15	87	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235066	10.1371/journal.pone.0235066	http://dx.doi.org/10.1371/journal.pone.0235066			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584859	Green Published, gold			2022-12-27	WOS:000545747200033
J	Wolf, TE; Mangwiro, N; Fasina, FO; Ganswindt, A				Wolf, Tanja E.; Mangwiro, Norbert; Fasina, Folorunso O.; Ganswindt, Andre			Non-invasive monitoring of adrenocortical function in female domestic pigs using saliva and faeces as sample matrices	PLOS ONE			English	Article							GLUCOCORTICOID METABOLITES; CORTISOL METABOLITES; STRESS; EXCRETION; HORMONES; WELFARE; CORTICOSTERONE; INDICATORS; URINARY; SHEEP	Intensive pig management involves in a commercial setting the housing and implementation of certain procedures, such as castration and tail docking, which may be stressful for the animal. Good farming practices include the reduction of stress due to management processes, but assessing the level of stress perceived entirely through behavioural observations can be challenging. The monitoring stress-related physiological markers, like glucocorticoids (GC), can be an accurate alternative that would presumably be more objective. In order to avoid an additional stressor by taking blood, a non-invasive approach is advisable. We used an adrenocorticotropic hormone (ACTH) stimulation test and the effect of transport to examine the suitability of different enzyme immunoassays (EIAs) for monitoring adrenocortical function in domestic pigs using saliva and faeces as sample matrices. An assay measuring faecal glucocorticoid metabolites (fGCMs) with a 3ss,11ss-diol group has proven suited to determine adrenocortical activity, showing an overall increase of 180% in fGCM concentrations related to ACTH administration and of 70% related to transport, respectively. A cortisol EIA was used to detect salivary glucocorticoid (sGC) concentrations, revealing a 1100% increase in sGC concentrations after ACTH administration. The stability of fGCM concentrations post-defecation was determined to assess possible changes in measured fGCM concentrations in unpreserved faecal material over time, with fGCM concentrations being relatively stable (maximal 12% change) under natural conditions for approximately two days after defecation. This implicates that untreated faecal material from pigs can be analysed for up to two days after collection without appreciable level of depreciation in fGCM concentrations. Being able to assess the physiological stress response of domestic pigs non-invasively can help to improve the well-being of commercially reared pigs.	[Wolf, Tanja E.; Ganswindt, Andre] Univ Pretoria, Mammal Res Inst, Fac Nat & Agr Sci, Pretoria, South Africa; [Mangwiro, Norbert; Fasina, Folorunso O.] Univ Pretoria, Dept Prod Anim Studies, Fac Vet Sci, Pretoria, South Africa; [Fasina, Folorunso O.] ECTAD, Food & Agr Org United Nations, Pretoria, Tanzania; [Ganswindt, Andre] Univ Pretoria, Dept Anat & Physiol, Endocrine Res Lab, Fac Vet Sci, Pretoria, South Africa	University of Pretoria; University of Pretoria; University of Pretoria	Wolf, TE (corresponding author), Univ Pretoria, Mammal Res Inst, Fac Nat & Agr Sci, Pretoria, South Africa.; Mangwiro, N (corresponding author), Univ Pretoria, Dept Prod Anim Studies, Fac Vet Sci, Pretoria, South Africa.	tanja.wolf@tuks.co.za; mangwiron@yahoo.com	; Ganswindt, Andre/G-9856-2014	Wolf, Tanja/0000-0003-4040-8425; Ganswindt, Andre/0000-0002-1474-7602	National Research Foundation	National Research Foundation	Funding for this work was provided partly by the National Research Foundation Incentive funding for Rated Researchers (2016) provided to Fasina FO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ECON POLIT WEEKLY, V47, P9; BARNETT JL, 1981, GEN COMP ENDOCR, V44, P219, DOI 10.1016/0016-6480(81)90251-3; Beehner JC, 2004, PHYSIOL BEHAV, V82, P269, DOI 10.1016/j.physbeh.2004.03.012; Bradshaw RH, 1996, ANIM SCI, V63, P507, DOI 10.1017/S135772980001540X; Broom D.M., 2015, DOMESTIC ANIMAL BEHA, VFifth; Bushong DM, 2000, LAB ANIM-UK, V34, P171, DOI 10.1258/002367700780457482; Cook NJ, 1997, J AGR FOOD CHEM, V45, P395, DOI 10.1021/jf960619d; FAO, 2005, FAO AGR SER, V36, P211, DOI DOI 10.18356/7EE6B494-EN; Fiess M, 1999, GEN COMP ENDOCR, V115, P76, DOI 10.1006/gcen.1999.7287; Ganswindt A, 2002, ZOO BIOL, V21, P27, DOI 10.1002/zoo.10034; Ganswindt SB, 2014, COMP BIOCHEM PHYS A, V177, P11, DOI 10.1016/j.cbpa.2014.07.013; Hameenoja P, 2002, ACTA VET SCAND, V43, P33; Hodges Keith, 2010, P447; JANSSENS CJJG, 1995, DOMEST ANIM ENDOCRIN, V12, P167, DOI 10.1016/0739-7240(94)00018-V; Johnson K.G., 1993, STRESS ANIMAL WELFAR, P87, DOI [DOI 10.1007/978-94-024-0980-2, 10.1007/978-94-024-0980-2]; Khonmee Jaruwan, 2018, Vet Med Int, V2018, P2762153, DOI 10.1155/2018/2762153; Kittawornrat A, 2010, VIRUS RES, V154, P170, DOI 10.1016/j.virusres.2010.07.025; Kleinsasser C, 2010, WIEN TIERARZTL MONAT, V97, P259; Lexen E, 2008, WIEN TIERARZTL MONAT, V95, P64; McGlone J. J., 2013, Professional Animal Scientist, V29, P189; McGlone John J, 2013, Animals (Basel), V3, P401, DOI 10.3390/ani3020401; Merlot E, 2011, PHYSIOL BEHAV, V102, P259, DOI 10.1016/j.physbeh.2010.11.009; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Mostl E, 1999, J VET MED A, V46, P621, DOI 10.1046/j.1439-0442.1999.00256.x; Mostl E, 2002, VET RES COMMUN, V26, P127, DOI 10.1023/A:1014095618125; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Palme R, 2012, ANIM WELFARE, V21, P331, DOI 10.7120/09627286.21.3.331; Palme R, 1996, ANIM REPROD SCI, V43, P43, DOI 10.1016/0378-4320(95)01458-6; Palme R, 1997, Z SAUGETIERKD, V62, P192; Palme R, 2019, PHYSIOL BEHAV, V199, P229, DOI 10.1016/j.physbeh.2018.11.021; Peeters M, 2011, EQUINE VET J, V43, P487, DOI 10.1111/j.2042-3306.2010.00294.x; R Core Team, 2013, R LANG ENV STAT COMP; Ruis MAW, 1997, PHYSIOL BEHAV, V62, P623, DOI 10.1016/S0031-9384(97)00177-7; Salak-Johnson JL, 2007, J ANIM SCI, V85, pE81, DOI 10.2527/jas.2006-538; Sapolsky RM, 2000, NEUROBIOL DIS, V7, P540, DOI 10.1006/nbdi.2000.0350; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; Turner AI, 2005, DOMEST ANIM ENDOCRIN, V29, P398, DOI 10.1016/j.domaniend.2005.02.031; Van Putten, 2000, P 2 NAHWOA WORKSH; WARRISS PD, 1994, MEAT SCI, V38, P329, DOI 10.1016/0309-1740(94)90121-X; Webster AB, 2018, AFR ZOOL, V53, P53, DOI 10.1080/15627020.2018.1467280; Yates D., 2008, P AM SOC AN SCI IND, V59, P261	45	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234971	10.1371/journal.pone.0234971	http://dx.doi.org/10.1371/journal.pone.0234971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584863	Green Published, gold			2022-12-27	WOS:000545747200086
J	Ghazi, IM; El Nekidy, WS; Asay, R; Fimognari, P; Knarr, A; Awad, M				Ghazi, Islam M.; El Nekidy, Wasim S.; Asay, Regan; Fimognari, Paul; Knarr, Anthony; Awad, Mina			Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach (vol 15, e0233335, 2020)	PLOS ONE			English	Correction													El Nekidy, Wasim S./I-6814-2019; Ghazi, Islam/X-6108-2019	El Nekidy, Wasim S./0000-0003-3109-0590; Ghazi, Islam/0000-0003-1108-7706				Ghazi IM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233335	1	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0235405	10.1371/journal.pone.0235405	http://dx.doi.org/10.1371/journal.pone.0235405			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579614	Green Published, gold			2022-12-27	WOS:000545646600007
J	Zhang, PQ; Bai, JD; Liu, YJ; Meng, YP; Yang, Z; Liu, T				Zhang, Pengqian; Bai, Jiade; Liu, Yanju; Meng, Yuping; Yang, Zheng; Liu, Tian			Drought resistance of ten ground cover seedling species during roof greening	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; ASCORBATE PEROXIDASE; OXIDATIVE STRESS; ACTIVE OXYGEN; TOLERANCE; PLANTS; PERMEABILITY; EXPRESSION; ENZYMES	Roof greening is an important national policy for maintaining the hydrological balance in China; however, plant growth is limited by drought stress. This study aims to identify strong drought resistant plant species for roof greening from ten common species:Paeonia lactiflora,Hemerocallis dumortieri,Meehania urticifolia,Iris lacteavar.chinensis,Hylotelephium erythrostictum,Sedum lineare,Iris germanica,Cosmos bipinnata,Hosta plantaginea, andDianthus barbatus. By controlling the soil relative water content (RWC), we designed three treatments: moderate drought stress (40 +/- 2% < RWC < 45 +/- 2%), severe drought stress (RWC < 30 +/- 2%) and well-watered control (RWC > 75 +/- 2%). After the seedlings were provided different levels of water, their membrane permeability (MP), chlorophyll concentration (Chl), and superoxide dismutase (SOD), peroxidase (POD) and ascorbate peroxidase (APX) activity were measured. Finally, the membership function method was used to assess the drought resistance of these species. The results showed thatC.bipinnataandM.urticifoliawere not suitable for moderate or severe drought stress and did not survive. The other species presented variations in physiological and biochemical parameters. The MP ofHe.dumortieri,I.lacteaandHo.plantagineashowed minor changes between the well-watered control and drought stress. Most of the species showed reduced SOD activity under moderate drought stress but increased activity under severe stress. All of the plant species showed decreases in the protective enzymes POD and APX with increasing drought stress. The membership function method was applied to calculate the plant species' drought resistance, and the following order of priority of the roof-greening plant species was suggested:He.dumortieri > I.germanica > I.lactea > D.barbatus > Hy.erythrostictum > S.lineare > Ho.plantaginea > P.lactiflora.	[Zhang, Pengqian; Bai, Jiade; Meng, Yuping; Yang, Zheng; Liu, Tian] Beijing Biodivers Conservat Res Ctr, Beijing, Peoples R China; [Zhang, Pengqian] Beijing Gardening & Greening Bur, Beijing, Peoples R China; [Liu, Yanju] Beijing Ctr Phys & Chem Anal, Beijing, Peoples R China		Liu, YJ (corresponding author), Beijing Ctr Phys & Chem Anal, Beijing, Peoples R China.	liuyanju@hotmail.com	Zhang, Peng-qian/AAN-9134-2021	Liu, Yanju/0000-0002-3002-6469	Young Core Plan of the Beijing Academy of Science and Technology (BJAST) [201528]; Beijing Natural Science Foundation [8142017]; National Natural Science Foundation of China [41475133]	Young Core Plan of the Beijing Academy of Science and Technology (BJAST); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Young Core Plan of the Beijing Academy of Science and Technology (BJAST) (No. 201528), the Beijing Natural Science Foundation (No. 8142017) and the National Natural Science Foundation of China (No. 41475133).; The authors thank the anonymous reviewers and editor Saddam Hussain for valuable comments, and Fen Qin (a business development manager for the China office from Power Systems Research) for helping with the manuscript preparation.	Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Anjum NA, 2016, ENVIRON SCI POLLUT R, V23, P19002, DOI 10.1007/s11356-016-7309-6; [Anonymous], 2007, J CONTRACT LAW, V23, P105; [Anonymous], 2006, AIDS, V20, pW1; [Anonymous], 2006, OSTEOARTHRITIS CARTI, V14, p859e; [Anonymous], 2018, J ORTHOP TRAUMA, V32, pS141; [Anonymous], 1996, J ORTHOP TRAUMA, V32, pS49; [Anonymous], 2009, SHADOW PHENOMENOLOGY; [Anonymous], 2015, STRATEG DIR, V31, P13; [Anonymous], 2019, IMMUNE NETW, V19, pe34; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Bahari A. A., 2015, Cercetari Agronomice in Moldova, V48, P57; Bai JingJing, 2015, Journal of South China Agricultural University, V36, P85; Bai LP, 2006, PEDOSPHERE, V16, P326, DOI 10.1016/S1002-0160(06)60059-3; Baik JJ, 2012, ATMOS ENVIRON, V61, P48, DOI 10.1016/j.atmosenv.2012.06.076; BAUM JA, 1979, DIFFERENTIATION, V13, P133, DOI 10.1111/j.1432-0436.1979.tb01576.x; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beijing Municipal Administration of Quality and Technology Supervision, 2005, DB11T2812005 BEIJ MU; [卜令铎 BU Lingduo], 2010, [生态学报, Acta Ecologica Sinica], V30, P1184; Cai JunHuo, 2018, Journal of Nanjing Forestry University (Natural Sciences Edition), V42, P55; Chang QingShan, 2018, Journal of Nanjing Forestry University (Natural Sciences Edition), V42, P44; Chen JiYu, 2019, Scientia Agricultura Sinica, V52, P3773, DOI 10.3864/j.issn.0578-1752.2019.21.006; Chen RM, 2002, J AGR U HEBEI, V25, P7; Chen Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00128; Chen ZhiHua, 2014, Journal of Yunnan Agricultural University, V29, P223; Croft H, 2020, REMOTE SENS ENVIRON, V236, DOI 10.1016/j.rse.2019.111479; Dai Gao-Xing, 2006, Zhongguo Shuidao Kexue, V20, P557; DEVOS CHR, 1989, J PLANT PHYSIOL, V135, P164, DOI 10.1016/S0176-1617(89)80171-3; Ding YanFang, 2015, Southwest China Journal of Agricultural Sciences, V28, P2746; Dong QiQi, 2020, Journal of Shenyang Agricultural University, V51, P18; Du P.B., 2019, SEED, V38, P120, DOI [10.16590/j.cnki.1001-4705.2019.08.120, DOI 10.16590/J.CNKI.1001-4705.2019.08.120]; Du RunFeng, 2012, Acta Prataculturae Sinica, V21, P51; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; [付宝春 Fu Baochun], 2017, [分子植物育种, Molecular Plant Breeding], V15, P1096; Gao Xue, 2018, Journal of Southern Agriculture, V49, P1736; Ghozlene I., 2014, Annual Research & Review in Biology, V4, P1241, DOI 10.9734/ARRB/2014/5321; He XueYin, 2008, Southwest China Journal of Agricultural Sciences, V21, P52; [贺亚川 He Yachuan], 2010, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V19, P127; [黄秋婵 HUANG Qiu-chan], 2009, [湖北农业科学, Hubei Agricultural Sciences], V48, P1923; Humanism, 2009, REPUBLICS LETT J STU, V1, P1, DOI DOI 10.1111/j.1728-4457.2009.00312.x; Jian LC, 2009, PLANT STRESS BIOL, P123; Jovanovic Aleksandra A., 2019, Tehnika, V74, P493, DOI 10.5937/tehnika1904493J; Kohler M, 2013, GREEN ROOFS ECOLOGIC; Li Yun, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P451; Li Ze-Qin, 2013, Yichuan, V35, P45, DOI 10.3724/SP.J.1005.2013.00045; [柳燕兰 Liu Yanlan], 2018, [水土保持学报, Journal of Soil and Water Conservation], V32, P339; Liu ZJ, 2018, J SHANXI AGR SCI, V46, P548; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mohammadi MHS, 2017, PLANT PHYSIOL BIOCH, V111, P129, DOI 10.1016/j.plaphy.2016.11.014; Molina-Rueda JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056421; Monclus R, 2006, NEW PHYTOL, V169, P765, DOI 10.1111/j.1469-8137.2005.01630.x; Mork-Jansson AE, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-018-0385-5; Nahar K, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv069; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Ondimu SN, 2007, BIOSYST ENG, V96, P541, DOI 10.1016/j.biosystemseng.2006.12.007; OPARKA KJ, 1994, NEW PHYTOL, V126, P571, DOI 10.1111/j.1469-8137.1994.tb02952.x; Paulsen H, 2008, HEME CHLOROPHYLL BIL, DOI [10.1385/1-59259-243-0:235, DOI 10.1385/1-59259-243-0:235]; Peng LLH, 2015, URBAN FOR URBAN GREE, V14, P554, DOI 10.1016/j.ufug.2015.05.006; Perera RS, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8070227; Perkins R, 2017, J AM CHEM SOC, V139, P14388, DOI 10.1021/jacs.7b09219; Qin P., 2002, HEILONGJIANG AGR SCI, V1, P31; Qin Peng, 2005, Chinese Tobacco Science, P28; RiliBak, 2015, J LAB MED, V39, P26, DOI DOI 10.1515/LABMED-2014-0046; Rulcova J, 2001, BIOL PLANTARUM, V44, P75, DOI 10.1023/A:1017922421606; Ruppenthal V, 2016, SEMIN-CIENC AGRAR, V37, P3941, DOI 10.5433/1679-0359.2016v37n6p3941; Sanchez-Rodriguez E, 2010, PLANT SCI, V178, P30, DOI 10.1016/j.plantsci.2009.10.001; Shang RX, 2019, J GANSU AGR U, V12, P39; Sharma P, 2005, PLANT GROWTH REGUL, V46, P209, DOI 10.1007/s10725-005-0002-2; Shen Man, 2005, Acta Horticulturae Sinica, V32, P141; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; Sivan V, 2012, C OPTOELECTR MICRO, P213, DOI 10.1109/COMMAD.2012.6472436; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Taj MJRJ, 2018, ASIAN J PSYCHIATR, V38, P65, DOI 10.1016/j.ajp.2017.10.014; Tian G. Z., 2001, J WUHAN PLANT RES, V19, P332; Tuggy D, 2003, RELIG STUD, V39, P165, DOI 10.1017/S0034412503006437; United Nations Children's Fund (UNICEF), 2011, IDD NEWSL, V39, P8; Verein Deutscher Ingenieure Dusseldorf, 2007, 3957 VDI, P6; Wan ML, 2020, PALAEOWORLD, V29, P117, DOI 10.1016/j.palwor.2019.06.002; Wang JF, 2020, CHINESE J APPL ECOLO; WHITE JA, 1987, BIOCHIM BIOPHYS ACTA, V926, P16, DOI 10.1016/0304-4165(87)90178-4; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; Wu JC, 2017, GUIZHOU AGR SCI, V45, P25; Wu Q. S., 2006, FRONT CHIN, V1, P312, DOI [10.1007/s11461-006-0035-3, DOI 10.1007/S11461-006-0035-3]; Wu XL, 2016, IND CROP PROD, V94, P385, DOI 10.1016/j.indcrop.2016.08.041; [徐琨 Xu Kun], 2012, [生态学报, Acta Ecologica Sinica], V32, P215; [徐小玉 Xu Xiaoyu], 2014, [东北农业大学学报, Journal of Northeast Agricultural University], V45, P55; Yang Feng, 2020, Journal of Northwest A & F University - Natural Science Edition, V48, P119, DOI 10.13207/j.cnki.jnwafu.2020.08.015; [杨鹏辉 Yang peng hui], 2003, [干旱地区农业研究, Agricultural Research in the Arid Areas], V21, P127; [杨小英 Yang Xiaoying], 2019, [玉米科学, Journal of Maize Science], V27, P25; Yao LN, 2005, EDUC CHEM, V5, P58; Zang ZQ, 2019, SUGAR CROPS CHINA, V41, P54; Zhang GuiLian, 2006, Acta Agronomica Sinica, V32, P1306; Zhang M. S., 2001, SEED, V21, P23, DOI DOI 10.3969/J.ISSN.1001-4705.2001.04.010; Zhang MingSheng, 2003, Scientia Agricultura Sinica, V36, P13; Zhang PQ, 2016, ECOTOX ENVIRON SAFE, V132, P212, DOI 10.1016/j.ecoenv.2016.06.003; Zhang SQ, 2011, EXPT TECHNIQUE PHYTO, V191-193, P203; Zhu Minghao, 2016, Huanjing Huaxue-Environmental Chemistry, V35, P208, DOI 10.7524/j.issn.0254-6108.2016.01.2015070803; Zuo YM., 2016, CROPS, V2016, P84	101	5	6	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0220598	10.1371/journal.pone.0220598	http://dx.doi.org/10.1371/journal.pone.0220598			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579545	Green Submitted, Green Published, gold			2022-12-27	WOS:000545646600051
J	Herrera, AL; Van Hove, C; Hanson, M; Dale, JB; Tweten, RK; Huber, VC; Diel, D; Chaussee, MS				Herrera, Andrea L.; Van Hove, Christopher; Hanson, Mary; Dale, James B.; Tweten, Rodney K.; Huber, Victor C.; Diel, Diego; Chaussee, Michael S.			Immunotherapy targeting theStreptococcus pyogenesM protein or streptolysin O to treat or prevent influenza A superinfection	PLOS ONE			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSINS; POLYSPECIFIC IMMUNOGLOBULIN-G; STREPTOCOCCAL M-PROTEIN; TOXIC-SHOCK-SYNDROME; INTRAVENOUS IMMUNOGLOBULIN; NEUTRALIZING ANTIBODIES; NECROTIZING FASCIITIS; IMMUNE-RESPONSES; VACCINE; INFECTION	Viral infections complicated by a bacterial infection are typically referred to as coinfections or superinfections.Streptococcus pyogenes, the group A streptococcus (GAS), is not the most common bacteria associated with influenza A virus (IAV) superinfections but did cause significant mortality during the 2009 influenza pandemic even though all isolates are susceptible to penicillin. One approach to improve the outcome of these infections is to use passive immunization targeting GAS. To test this idea, we assessed the efficacy of passive immunotherapy using antisera against either the streptococcal M protein or streptolysin O (SLO) in a murine model of IAV-GAS superinfection. Prophylactic treatment of mice with antiserum to either SLO or the M protein decreased morbidity compared to mice treated with non-immune sera; however, neither significantly decreased mortality. Therapeutic use of antisera to SLO decreased morbidity compared to mice treated with non-immune sera but neither antisera significantly reduced mortality. Overall, the results suggest that further development of antibodies targeting the M protein or SLO may be a useful adjunct in the treatment of invasive GAS diseases, including IAV-GAS superinfections, which may be particularly important during influenza pandemics.	[Herrera, Andrea L.; Van Hove, Christopher; Hanson, Mary; Huber, Victor C.; Chaussee, Michael S.] Univ South Dakota, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD 57069 USA; [Dale, James B.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Div Infect Dis, Memphis, TN 38163 USA; [Tweten, Rodney K.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Diel, Diego] South Dakota State Univ, Dept Vet & Biomed Sci, Brookings, SD 57007 USA; [Diel, Diego] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Anim Hlth Diagnost Ctr, Ithaca, NY 14853 USA	University of South Dakota; University of Tennessee System; University of Tennessee Health Science Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; South Dakota State University; Cornell University	Chaussee, MS (corresponding author), Univ South Dakota, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD 57069 USA.	michael.chaussee@usd.edu	Diel, Diego G./ABC-6242-2021	Diel, Diego G./0000-0003-3237-8940	NIH/NIAID [5R21AI115087, 5R01AI132117]; South Dakota Center for Biologics Research & Commercialization (SD-CBRC) from the SD GOED Governors Research Center	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); South Dakota Center for Biologics Research & Commercialization (SD-CBRC) from the SD GOED Governors Research Center	Funding for the project was provided by NIH/NIAID grants 5R21AI115087 (M.S.C) and 5R01AI132117 (J.B.D.) and the South Dakota Center for Biologics Research & Commercialization (SD-CBRC) from the SD GOED Governors Research Center (M.S.C, D.D, and V.C.H.).	Alejandria MM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001090.pub2; Ashbaugh CD, 1998, J CLIN INVEST, V102, P550, DOI 10.1172/JCI3065; Basma H, 1998, INFECT IMMUN, V66, P2279, DOI 10.1128/IAI.66.5.2279-2283.1998; Batzloff MR, 2003, J INFECT DIS, V187, P1598, DOI 10.1086/374800; BESSEN D, 1988, J EXP MED, V167, P1945, DOI 10.1084/jem.167.6.1945; BHAKDI S, 1985, INFECT IMMUN, V47, P52; Brandt ER, 2000, INFECT IMMUN, V68, P6587, DOI 10.1128/IAI.68.12.6587-6594.2000; BRONZE MS, 1992, J IMMUNOL, V148, P888; Cawley MJ, 1999, PHARMACOTHERAPY, V19, P1094, DOI 10.1592/phco.19.13.1094.31589; Chaussee MS, 2011, VACCINE, V29, P3773, DOI 10.1016/j.vaccine.2011.03.031; Chiarot E, 2013, MBIO, V4, DOI 10.1128/mBio.00387-12; Courtney HS, 2006, MOL MICROBIOL, V59, P936, DOI 10.1111/j.1365-2958.2005.04977.x; Dale JB, 1999, VACCINE, V17, P193, DOI 10.1016/S0264-410X(98)00150-9; Dale JB, 2002, INFECT IMMUN, V70, P2166, DOI 10.1128/IAI.70.4.2166-2170.2002; Darenberg J, 2004, CLIN INFECT DIS, V38, P836, DOI 10.1086/381979; de Gier B, 2019, INFLUENZA OTHER RESP, V13, P453, DOI 10.1111/irv.12658; Farrand S, 2008, BIOCHEMISTRY-US, V47, P7097, DOI 10.1021/bi8005835; Fernandes MHV, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00363; Fiorillo F, 2002, J MAGN MAGN MATER, V242, P257, DOI 10.1016/S0304-8853(01)01271-9; Hall MA, 2004, INFECT IMMUN, V72, P2507, DOI 10.1128/IAI.72.5.2507-2512.2004; Herrera AL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29714-x; Herrera AL, 2017, MICROBIOL-SGM, V163, P1445, DOI 10.1099/mic.0.000532; Herrera AL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00342; HOLM SE, 1992, J INFECT DIS, V166, P31, DOI 10.1093/infdis/166.1.31; HOLMES SJ, 1992, J INFECT DIS, V165, pS121, DOI 10.1093/infdis/165-Supplement_1-S121; Hotze EM, 2013, INFECT IMMUN, V81, P216, DOI 10.1128/IAI.00927-12; Huang YS, 2011, J INFECT DIS, V203, P1595, DOI 10.1093/infdis/jir149; Huber VC, 2009, VACCINE, V27, P1192, DOI 10.1016/j.vaccine.2008.12.023; Jean C, 2010, CLIN INFECT DIS, V50, pE59, DOI 10.1086/652291; Kadri SS, 2017, CLIN INFECT DIS, V64, P877, DOI 10.1093/cid/ciw871; Kaul R, 1999, CLIN INFECT DIS, V28, P800, DOI 10.1086/515199; Kawabata S, 2001, INFECT IMMUN, V69, P924, DOI 10.1128/IAI.69.2.924-930.2001; Klonoski JM, 2018, VIRAL IMMUNOL, V31, P457, DOI 10.1089/vim.2017.0193; Klonoski JM, 2014, VACCINE, V32, P5241, DOI 10.1016/j.vaccine.2014.06.093; Kotloff KL, 2004, JAMA-J AM MED ASSOC, V292, P709, DOI 10.1001/jama.292.6.709; LANCEFIELD RC, 1962, J IMMUNOL, V89, P307; Lannergard J, 2011, CELL HOST MICROBE, V10, P147, DOI 10.1016/j.chom.2011.06.011; Limbago B, 2000, INFECT IMMUN, V68, P6384, DOI 10.1128/IAI.68.11.6384-6390.2000; Liu MY, 2007, INFECT IMMUN, V75, P3651, DOI 10.1128/IAI.00038-07; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; Mehta S, 2006, CHEST, V130, P1679, DOI 10.1016/S0012-3692(15)50887-8; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Muller MP, 2003, ARCH INTERN MED, V163, P467, DOI 10.1001/archinte.163.4.467; Norrby-Teglund A, 1998, CLIN INFECT DIS, V26, P631, DOI 10.1086/514588; NorrbyTeglund A, 1996, J IMMUNOL, V156, P3057; NorrbyTeglund A, 1996, INFECT IMMUN, V64, P5395, DOI 10.1128/IAI.64.12.5395-5398.1996; NORRBYTEGLUND A, 1994, J INFECT DIS, V170, P585, DOI 10.1093/infdis/170.3.585; Okamoto S, 2004, INFECT IMMUN, V72, P6068, DOI 10.1128/IAI.72.10.6068-6075.2004; Okamoto S, 2004, VACCINE, V22, P2887, DOI 10.1016/j.vaccine.2003.12.024; Okamoto S, 2003, J VIROL, V77, P4104, DOI 10.1128/JVI.77.7.4104-4112.2003; Okamoto S, 2018, MICROBIOL IMMUNOL, V62, P141, DOI 10.1111/1348-0421.12577; Oligbu G, 2016, VACCINE, V34, P6126, DOI 10.1016/j.vaccine.2016.10.050; Olive C, 2002, INFECT IMMUN, V70, P2734, DOI 10.1128/IAI.70.5.2734-2738.2002; Olsen RJ, 2010, MICROB PATHOGENESIS, V49, P336, DOI 10.1016/j.micpath.2010.06.012; Pandey M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005147; Park HS, 2005, INFECT IMMUN, V73, P7878, DOI 10.1128/IAI.73.12.7878-7886.2005; Parks T, 2018, CLIN INFECT DIS, V67, P1434, DOI 10.1093/cid/ciy401; Penfound TA, 2010, VACCINE, V28, P5017, DOI 10.1016/j.vaccine.2010.05.018; Poland GA, 2018, EXPERT REV VACCINES, V17, P495, DOI 10.1080/14760584.2018.1484284; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reglinski M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15825; Rivera-Hernandez T, 2019, MBIO, V10, DOI 10.1128/mBio.00693-19; Saeland E, 2003, J IMMUNOL, V170, P6158, DOI 10.4049/jimmunol.170.12.6158; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Scaber J, 2011, EUROSURVEILLANCE, V16, P2; Shapiro SZ, 2019, VACCINE, V37, P3400, DOI 10.1016/j.vaccine.2019.04.005; SVENSON M, 1993, J CLIN INVEST, V92, P2533, DOI 10.1172/JCI116862; Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200; Tweten RK, 2015, ANNU REV MICROBIOL, V69, P323, DOI 10.1146/annurev-micro-091014-104233; Weeks-Gorospe JN, 2012, J VIROL, V86, P9035, DOI 10.1128/JVI.00369-12; Zabriskie JB, 1997, ADV EXP MED BIOL, V418, P917; Zeppa JJ, 2017, P NATL ACAD SCI USA, V114, P10226, DOI 10.1073/pnas.1700858114	74	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235139	10.1371/journal.pone.0235139	http://dx.doi.org/10.1371/journal.pone.0235139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574205	Green Published, gold			2022-12-27	WOS:000544972400026
J	Roberts, K; Thom, O; Eley, R; Cabilan, CJ; Vallmuur, K				Roberts, Kym; Thom, Ogilvie; Eley, Rob; Cabilan, C. J.; Vallmuur, Kirsten			Long term impact of ladder-related injuries as measured by the AQoL instrument	PLOS ONE			English	Article							QUALITY-OF-LIFE; EMERGENCY-DEPARTMENT; POPULATION NORMS; FALL INJURIES; HEALTH; EPIDEMIOLOGY; OUTCOMES	Introduction Ladder-related falls are a common cause of patients presenting to emergency departments (ED) with serious injury. The impacts of ladder-related injuries were assessed at six-months post-injury using the quality of life, AQoL 4D Basic (AQoL) instrument. Materials and methods This was a prospective observational study, conducted and reported according to the STROBE statement. All adult patients with ladder-related injuries who presented to two EDs in southeast Queensland, Australia between October 2015 and October 2016 were approached. Initial participant interviews took place at the time of ED presentation or shortly thereafter, with follow-up telephone interview at six-months. Results There were 177 enrolments, 43 (24%) were lost to follow up. There were statistically significant changes post-injury for three of the four AQoL dimensions: independence, social relationships and psychological wellbeing, as well as the global AQoL. Twenty-four (18%) participants reported a clinically significant deterioration in independence, 26 (20%) participants reported a clinically significant deterioration in their social relationships, and 34 participants (40%) reporting a clinically significant deterioration in their psychological wellbeing. Nine of the twelve individual items (in AQoL dimension) deteriorated after injury, there was no change in two items (vision and hearing) and an improvement reported in one (communication). The largest changes (> 25% of participants) were reported with sleeping, anxiety worry and depression, and pain. Across the global AQoL dimension, 65 (49%) participants reported a clinically significant deterioration. The severity of injury as measured by the ISS was an independent predictor of the change in AQoL scores (p<0.001). Conclusions Injuries related to falls from ladders continue to have a profound impact on patients at six-months post-injury as measured using the AQoL instrument. This adds to previous research which has demonstrated considerable morbidity and mortality at the time of injury. Prevention Older males using ladders at home are at high risk for serious long-term injury. Injury prevention strategies and the safety instructions packaged with the ladder need to be targeted to this at-risk community group. There may also be a role for regulatory bodies to mandate a stabilising device to be included with the ladder at the time of purchase.	[Roberts, Kym; Thom, Ogilvie] Sunshine Coast Hosp & Hlth Serv, Dept Emergency Med, Birtinya, Qld, Australia; [Eley, Rob; Cabilan, C. J.] Princess Alexandra Hosp, Dept Emergency Med, Woolloongabba, Qld, Australia; [Eley, Rob] Univ Queensland, St Lucia, Qld, Australia; [Vallmuur, Kirsten] Queensland Univ Technol, Australian Ctr Hlth Serv Innovat, Brisbane, Qld, Australia; [Vallmuur, Kirsten] Brisbane & Womens Hosp, Jamieson Trauma Inst, Metro North Hosp & Hlth Serv Royal, Herston, Qld, Australia	University of Queensland; Queensland University of Technology (QUT); Royal Brisbane & Women's Hospital	Roberts, K (corresponding author), Sunshine Coast Hosp & Hlth Serv, Dept Emergency Med, Birtinya, Qld, Australia.	kym.roberts@health.qld.gov.au	Cabilan, C.J./ABA-8691-2020; Eley, Rob/A-8121-2011; Vallmuur, Kirsten/AAL-9526-2021	Cabilan, C.J./0000-0001-8465-8026; Eley, Rob/0000-0003-0856-4313; Vallmuur, Kirsten/0000-0002-3760-0822; Roberts, Kym/0000-0001-5012-7534	Emergency Medicine Foundation (Australasia) Queensland Program [EMTR100R23-2015]	Emergency Medicine Foundation (Australasia) Queensland Program	This research was supported by a grant from the Emergency Medicine Foundation (Australasia) Queensland Program, EMTR100R23-2015. (OT) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland HM, 2016, INJURY, V47, P1109, DOI 10.1016/j.injury.2015.12.016; Ashby K, 2007, INJURY PREV, V13, P328, DOI 10.1136/ip.2006.012328; Bedi HS, 2008, J TRAUMA, V64, P1608, DOI 10.1097/TA.0b013e31804aa444; Bradley C., 2007, LADDER RELATED FALL; Cabilan CJ, 2018, EMERG MED AUSTRALAS, V30, P95, DOI 10.1111/1742-6723.12854; Chung MC, 2009, INT J GERIATR PSYCH, V24, P955, DOI 10.1002/gps.2201; Commission ACaC, 2016, LADD SAF MATT; Con J, 2014, J SURG RES, V191, P262, DOI 10.1016/j.jss.2014.05.072; D'Souza AL, 2007, AM J PREV MED, V32, P413, DOI 10.1016/j.amepre.2007.01.012; Diggs BS, 2005, ACAD EMERG MED, V12, P267, DOI 10.1197/j.aem.2004.10.028; Hawthorne G, 2013, AUST NZ J PUBL HEAL, V37, P7, DOI 10.1111/1753-6405.12004; Hsiao H, 2008, INT J IND ERGONOM, V38, P959, DOI 10.1016/j.ergon.2008.01.011; Jayasinghe N, 2014, GEN HOSP PSYCHIAT, V36, P669, DOI 10.1016/j.genhosppsych.2014.08.003; Kent Alison, 2006, Emerg Med Australas, V18, P23, DOI 10.1111/j.1742-6723.2006.00800.x; Lombardi DA, 2011, SCAND J WORK ENV HEA, V37, P525, DOI 10.5271/sjweh.3174; Mitra B, 2007, MED J AUSTRALIA, V186, P31, DOI 10.5694/j.1326-5377.2007.tb00785.x; Miu J, 2016, MED J AUSTRALIA, V204, P302, DOI 10.5694/mja15.01245; Nosaka N, 2015, ACTA MED OKAYAMA, V69, P275; O'Sullivan J, 2004, INJURY, V35, P429, DOI 10.1016/S0020-1383(03)00265-1; Osborne RH, 2003, J CLIN EPIDEMIOL, V56, P138, DOI 10.1016/S0895-4356(02)00601-7; Osoba D, 2005, EUR J CANCER, V41, P280, DOI 10.1016/j.ejca.2004.10.017; Oxley J, 2014, REPORT REDUCTION MAJ; Rainey EE, 2014, AM J SURG, V208, P517, DOI 10.1016/j.amjsurg.2014.05.016; Richardson JRJ, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-38; Richmond TS, 2006, AM J CRIT CARE, V15, P158; Vallmuur K, 2016, AUST NZ J PUBL HEAL, V40, P559, DOI 10.1111/1753-6405.12592; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Watson WL, 2007, INJURY PREV, V13, P45, DOI 10.1136/ip.2005.010157; Whitehurst DGT, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-50; Wiseman TA, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0109-z	30	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235092	10.1371/journal.pone.0235092	http://dx.doi.org/10.1371/journal.pone.0235092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME9KK	32574183	gold, Green Published			2022-12-27	WOS:000544972400021
J	Scott, S; Arrieta, A; Kumar, N; Menon, P; Quisumbing, A				Scott, Samuel; Arrieta, Alejandra; Kumar, Neha; Menon, Purnima; Quisumbing, Agnes			Multidimensional predictors of common mental disorders among Indian mothers of 6-to 24-month-old children living in disadvantaged rural villages with women's self-help groups: A cross-sectional analysis	PLOS ONE			English	Article							MATERNAL DEPRESSION; HEALTH; POVERTY; ILLNESS; STRESS; ODISHA; RISK	Common mental disorders (CMD) among mothers cause disability, negatively affect child development, and have high long-term economic costs. Little is known about how factors across multiple life dimensions, modeled together, are differentially related to maternal mental health in high poverty contexts. Further, there is limited evidence on determinants of CMD in areas where self-help groups (SHGs) exist to promote women's wellbeing. Filling this evidence gap is important given the high prevalence of CMD and the rapid expansion of SHGs in rural India. Cross-sectional data were collected from 1644 mother-infant pairs living in disadvantaged rural villages across five Indian states-Jharkhand, Madhya Pradesh, West Bengal, Odisha, and Chhattisgarh-surveyed in the Women Improving Nutrition through Group-based Strategies study. CMD were assessed using the 20-item Self Reporting Questionnaire (SRQ). We examined 31 factors across four life dimensions: work (work type, time spent in labor, domestic and caretaking activities), agency (SHG membership, decision-making, gender attitudes), health/nutrition (underweight, fertility, diet diversity, child illness), and household/environment (dependency ratio, wealth, food security, shocks, water, sanitation). Survey-adjusted multivariate logistic and ordinary least squares regression models were fit to examine predictors of CMD or SRQ score. On average, mothers were 26 (range 18-46) years old and their children were 15 (range 6-24) months old. CMD defined as >= 8 positive SRQ responses were reported by 262 women (16%). Protective factors included being engaged in agricultural labor as a main occupation relative to being a housewife (AOR 0.18, 95% CI 0.10-0.32), more time working (0.85, 0.77-0.93), higher decision-making (0.33, 0.16-0.69), SHG membership (0.73, 0.56-0.96), and having an improved toilet (0.49, 0.33-0.72). Risk factors included food insecurity (1.13, 1.07-1.20) and shocks to non-farm livelihoods (2.04, 1.10-3.78). Practitioners and policymakers should aim to improve food security, economic wellbeing and social capital, such as that created through SHG membership, to improve maternal mental health. Future research should aim to understand why working outside the home, albeit in agricultural work, appears to protect maternal mental health in this context.	[Scott, Samuel; Arrieta, Alejandra; Kumar, Neha; Menon, Purnima; Quisumbing, Agnes] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA; [Scott, Samuel; Menon, Purnima] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, New Delhi, India	CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Food Policy Research Institute (IFPRI)	Scott, S (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA.; Scott, S (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, New Delhi, India.	samuel.scott@cgiar.org	Kumar, Neha/GSI-5286-2022		Bill & Melinda Gates Foundation [OPP1132181]; CGIAR Research Program on Agriculture for Nutrition and Health	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); CGIAR Research Program on Agriculture for Nutrition and Health(CGIAR)	This work was supported by the Bill & Melinda Gates Foundation, Grant Number: OPP1132181 and the CGIAR Research Program on Agriculture for Nutrition and Health.	4World Health Organization and Calouste Gulbenkian Foundation, 2014, SOC DET MENT HLTH; [Anonymous], 2015, J INT ASS PROVIDE S1, V14, pS3; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Balaji AB, 2007, J WOMENS HEALTH, V16, P1386, DOI 10.1089/jwh.2007.CDC10; Beusenberg M., 1994, WHOMNHPSF948; Brody C., 2015, CAMPBELL SYST REV, V2015, P19, DOI [DOI 10.4073/CSR.2015.19, 10.4073/csr.2015.19]; de Hoop T, 2014, FEM ECON, V20, P103, DOI 10.1080/13545701.2014.893388; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; FAO and FHI 360, 2016, MIN DIET DIV WOM GUI; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Harpham T, 2005, J EPIDEMIOL COMMUN H, V59, P1060, DOI 10.1136/jech.2005.039180; Herba CM, 2016, LANCET PSYCHIAT, V3, P983, DOI 10.1016/S2215-0366(16)30148-1; Hjelm L, 2017, SOC SCI MED, V177, P110, DOI 10.1016/j.socscimed.2017.01.023; Khan AM, 2017, INT J MENT HEALTH SY, V11, DOI 10.1186/s13033-017-0129-3; Lund C, 2018, LANCET PSYCHIAT, V5, P357, DOI 10.1016/S2215-0366(18)30060-9; Malhotra S, 2015, INDIAN J PSYCHIAT, V57, pS205, DOI 10.4103/0019-5545.161479; Ministry of Health and Family Welfare, 2018, DEM NO 42; Ministry of Rural Development, 2019, SHG COUNT; Mohindra KS, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-2; Nguyen PH, 2014, PUBLIC HEALTH NUTR, V17, P1318, DOI 10.1017/S1368980013001043; Patel V, 2008, PSYCHOL MED, V38, P221, DOI 10.1017/S0033291707002334; Patel V, 1999, SOC SCI MED, V49, P1461, DOI 10.1016/S0277-9536(99)00208-7; Patel V, 2006, BRIT J PSYCHIAT, V189, P547, DOI 10.1192/bjp.bp.106.022558; Nguyen PH, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12621; PLOS Medicine Editors, 2007, PLOS MED, V3, pe380; Prost A, 2012, J AFFECT DISORDERS, V138, P277, DOI 10.1016/j.jad.2012.01.029; Rahman A, 2007, ARCH DIS CHILD, V92, P24, DOI 10.1136/adc.2005.086579; ROSENZWEIG MR, 1989, J POLIT ECON, V97, P905, DOI 10.1086/261633; Ruducha J, 2018, SOCIETIES, V8, DOI 10.3390/soc8040092; Sahoo KC, 2015, SOC SCI MED, V139, P80, DOI 10.1016/j.socscimed.2015.06.031; Shankardass M., 2018, INDIAN J PSYCHIAT NU, V15, P58, DOI [10.4103/2231-1505.262509, DOI 10.4103/2231-1505.262509]; Soni A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010834; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; Upadhyay RP, 2017, B WORLD HEALTH ORGAN, V95, P706, DOI 10.2471/BLT.17.192237; Vigo DV, 2019, LANCET PUBLIC HEALTH, V4, pE89, DOI 10.1016/S2468-2667(18)30203-2; World Health Organization, 2018, DEPRESSION	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0233418	10.1371/journal.pone.0233418	http://dx.doi.org/10.1371/journal.pone.0233418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME9KK	32574218	gold, Green Published			2022-12-27	WOS:000544972400054
J	Shim, GH; Kim, SY; Cheung, PY; Lee, TF; O'Reilly, M; Schmolzer, GM				Shim, Gyu-Hong; Kim, Seung Yeun; Cheung, Po-Yin; Lee, Tze-Fun; O'Reilly, Megan; Schmolzer, Georg M.			Effects of sustained inflation pressure during neonatal cardiopulmonary resuscitation of asphyxiated piglets	PLOS ONE			English	Article							DELIVERY ROOM RESUSCITATION; BIRTH-WEIGHT INFANTS; CHEST COMPRESSIONS; PORCINE MODEL; RESPIRATORY SUPPORT; VENTILATION RATIO; PRETERM INFANTS; TIDAL VOLUME; RECOVERY; SURVIVAL	Background Sustained inflation (SI) during chest compression (CC = CC+SI) has been recently shown as an alternative method during cardiopulmonary resuscitation in neonates. However, the optimal peak inflation pressure (PIP) of SI during CC+SI to improve ROSC and hemodynamic recovery is unknown. Objective To examine if different PIPs of SI during CC+SI will improve ROSC and hemodynamic recovery in severely asphyxiated piglets. Methods Twenty-nine newborn piglets (1-3 days old) were anesthetized, intubated, instrumented and exposed to 30-min normocapnic hypoxia followed by asphyxia. Piglets were randomized into four groups: CC+SI with a PIP of 10 cmH(2)O (CC+SI_PIP_10, n = 8), a PIP of 20 cmH(2)O (CC+SI_PIP_20, n = 8), a PIP of 30 cmH(2)O (CC+SI_PIP_30, n = 8), and a sham-operated control group (n = 5). Heart rate, arterial blood pressure, carotid blood flow, cerebral oxygenation, and respiratory parameters were continuously recorded throughout the experiment. Results Baseline parameters were similar between all groups. There was no difference in asphyxiation (duration and degree) between intervention groups. PIP correlated positively with tidal volume (V-T) and inversely with exhaled CO(2)during cardiopulmonary resuscitation. Time to ROSC and rate of ROSC were similar between piglets resuscitated with CC+SI_PIP_10, CC+SI_PIP_20, and CC+SI_PIP_30 cmH(2)O: median (IQR) 75 (63-193) sec, 94 (78-210) sec, and 85 (70-90) sec; 5/8 (63%), 7/8 (88%), and 3/8 (38%) (p = 0.56 and p = 0.12, respectively). All piglets that achieved ROSC survived to four hours post-resuscitation. Piglets resuscitated with CC+SI_PIP_30 cmH(2)O exhibited increased concentrations of pro-inflammatory cytokines interleukin-1 beta and tumour necrosis factor-alpha in the frontoparietal cerebral cortex (both p<0.05 vs. sham-operated controls). Conclusion In asphyxiated term newborn piglets resuscitated by CC+SI, the use of different PIPs resulted in similar time to ROSC, but PIP at 30 cmH(2)O showed a larger V(T)delivery, lower exhaled CO(2)and increased tissue inflammatory markers in the brain.	[Shim, Gyu-Hong; Kim, Seung Yeun; Cheung, Po-Yin; Lee, Tze-Fun; O'Reilly, Megan; Schmolzer, Georg M.] Royal Alexandra Hosp, Neonatal Res Unit, Ctr Studies Asphyxia & Resuscitat, Edmonton, AB, Canada; [Shim, Gyu-Hong] Inje Univ, Dept Pediat, Sanggye Paik Hosp, Seoul, South Korea; [Kim, Seung Yeun] Eulji Univ Hosp, Dept Pediat, Daejeon, South Korea; [Cheung, Po-Yin; Lee, Tze-Fun; O'Reilly, Megan; Schmolzer, Georg M.] Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB, Canada	Royal Alexandra Hospital; Inje University; Eulji University; University of Alberta	Schmolzer, GM (corresponding author), Royal Alexandra Hosp, Neonatal Res Unit, Ctr Studies Asphyxia & Resuscitat, Edmonton, AB, Canada.; Schmolzer, GM (corresponding author), Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB, Canada.	georg.schmoelzer@me.com	Schmölzer, Georg M/E-7883-2010	Schmölzer, Georg M/0000-0001-9798-2415; Shim, Gyu Hong/0000-0001-5805-8764; Kim, Seung Yeon/0000-0002-7004-4821	SickKids Foundation; Canadian Institutes of Health Research (CIHR -Institute of Human Development, Child and Youth Health (IHDCYH)), New Investigator Research Grant Program [NI17-033]; Stollery Children's Hospital Foundation	SickKids Foundation; Canadian Institutes of Health Research (CIHR -Institute of Human Development, Child and Youth Health (IHDCYH)), New Investigator Research Grant Program(Canadian Institutes of Health Research (CIHR)); Stollery Children's Hospital Foundation	We would like to thank the public for donating money to our funding agencies: GMS is a recipient of the Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation, a National New Investigator of the Heart and Stroke Foundation Canada and an Alberta New Investigator of the Heart and Stroke Foundation Alberta. The study was supported by a Grant from the SickKids Foundation in partnership with the Canadian Institutes of Health Research (CIHR -Institute of Human Development, Child and Youth Health (IHDCYH)), New Investigator Research Grant Program (Grant number -No. NI17-033). This research has been facilitated by the Women and Children's Health Research Institute through the generous support of the Stollery Children's Hospital Foundation.	Andersen CC, 2011, J APPL PHYSIOL, V111, P775, DOI 10.1152/japplphysiol.00214.2011; [Anonymous], 2015, CIRCULATION S2, V132, pS414; [Anonymous], 2015, CIRCULATION S2, V132, pS414; Aziz K, 2008, RESUSCITATION, V79, P444, DOI 10.1016/j.resuscitation.2008.08.004; Barton SK, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00097; Chalak LF, 2011, PEDIATR RES, V69, P401, DOI 10.1203/PDR.0b013e3182125f7f; Cheung PY, 2011, JOVE-J VIS EXP, DOI 10.3791/3166; Dammann O, 2001, PEDIATR RES, V49, P388, DOI 10.1203/00006450-200103000-00013; DeMauro SB, 2011, J PEDIATR-US, V159, P546, DOI 10.1016/j.jpeds.2011.03.025; Finer NN, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e40; Garcia-Hidalgo C, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00400; Harrington DJ, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.877; Kapadia V, 2012, CLIN PERINATOL, V39, P833, DOI 10.1016/j.clp.2012.09.011; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kirpalani H, 2019, JAMA-J AM MED ASSOC, V321, P1165, DOI 10.1001/jama.2019.1660; Klingenberg C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003666.pub4; Li ES, 2017, NEONATOLOGY, V112, P337, DOI 10.1159/000477998; Li ES, 2015, ARCH DIS CHILD-FETAL, V100, pF530, DOI 10.1136/archdischild-2015-308363; Mian Q, 2019, ARCH DIS CHILD-FETAL, V104, pF57, DOI 10.1136/archdischild-2017-313864; Mustofa J, 2018, RESUSCITATION, V129, P82, DOI 10.1016/j.resuscitation.2018.06.013; Pasquin MP, 2018, NEONATOLOGY, V114, P37, DOI 10.1159/000487988; Pichler G, 2013, J PEDIATR-US, V163, P1558, DOI 10.1016/j.jpeds.2013.07.007; Polglase GR, 2014, PEDIATR RES, V75, P682, DOI 10.1038/pr.2014.40; Polglase GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039535; Polglase GR, 2012, J APPL PHYSIOL, V112, P481, DOI 10.1152/japplphysiol.00995.2011; Schmolzer GM, 2014, RESUSCITATION, V85, P270, DOI 10.1016/j.resuscitation.2013.10.011; Schmolzer GM, 2013, CIRCULATION, V128, P2495, DOI 10.1161/CIRCULATIONAHA.113.002289; Schmolzer GM, 2010, ARCH DIS CHILD-FETAL, V95, pF295, DOI 10.1136/adc.2009.165878; Schmolzer GM, 2008, J PEDIATR-US, V153, P741, DOI 10.1016/j.jpeds.2008.08.016; Schmolzer GM, 2019, JACC-BASIC TRANSL SC, V4, P116, DOI 10.1016/j.jacbts.2018.12.004; Schmolzer GM, 2018, ARCH DIS CHILD-FETAL, V103, pF455, DOI 10.1136/archdischild-2017-313037; Shah PS, 2009, J PERINATOL, V29, P693, DOI 10.1038/jp.2009.70; Shah PS, 2009, J PERINATOL, V29, P655, DOI 10.1038/jp.2009.71; SK AZ, 2016, DIABETOL STOFFWECHS, V11, pS01; Sobotka KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146574; Solevag AL, 2017, ARCH DIS CHILD-FETAL, V102, pF85, DOI 10.1136/archdischild-2016-311043; Solevag AL, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00003; Solevag AL, 2016, RESUSCITATION, V106, P7, DOI 10.1016/j.resuscitation.2016.06.014; Solevag AL, 2016, ARCH DIS CHILD-FETAL, V101, pF272, DOI 10.1136/archdischild-2015-309761; Tracy M, 2004, ARCH DIS CHILD-FETAL, V89, pF84, DOI 10.1136/fn.89.1.F84; Tsui BCH, 2015, RESUSCITATION, V92, P148, DOI 10.1016/j.resuscitation.2015.02.021; van Os S, 2014, ACTA PAEDIATR, V103, P796, DOI 10.1111/apa.12650; Wyckoff M, 2000, PEDIATRICS, V106, P618, DOI 10.1542/peds.106.3.618; Wyckoff MH, 2012, J PEDIATR-US, V160, P239, DOI 10.1016/j.jpeds.2011.07.041	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0228693	10.1371/journal.pone.0228693	http://dx.doi.org/10.1371/journal.pone.0228693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574159	Green Submitted, gold, Green Published			2022-12-27	WOS:000544972400023
J	Zhou, J; Yang, Q; Zhu, XC; Lin, T; Hao, DD; Xu, J				Zhou, Jing; Yang, Qi; Zhu, Xiaochen; Lin, Tong; Hao, Dongdong; Xu, Jing			Antioxidant activities ofClerodendrum cyrtophyllumTurcz leaf extracts and their major components	PLOS ONE			English	Article							RADICAL SCAVENGING ACTIVITY; PHENOLIC-COMPOUNDS; DIFFERENT FRACTIONS; OXIDATIVE STRESS; HYDROLYSATE; CAPACITY; ETHANOL	This study was designed to investigate the antioxidant properties of the extracts and subfractions of various polarities fromClerodendrum cyrtophyllumTurcz leaves and the related phenolic compound profiles. The ethyl acetate fraction (EAF) showed the most potent radical-scavenging activity for DPPH radicals, ABTS radicals, and superoxide anion (O-2(center dot-)) radicals as well as the highest reducing power of the fractions tested; then-butyl alcohol fraction (BAF) was the most effective in scavenging hydroxyl radical (OH center dot), and the dichloromethane fraction (DMF) exhibited the highest ferrous ion chelating activity. Twelve phenolic components were identified from the EAF ofC.cyrtophyllum. Additionally, acteoside (1) was found to be a major component (0.803 g, 0.54%) and show DPPH and ABTS radical scavenging activities with IC(50)values of 79.65 +/- 3.4 and 23.00 +/- 1.5 mu g/ml, indicating it is principally responsible for the significant total antioxidant effect ofC.cyrtophyllum. Our work offers a theoretical basis for further utilization of C.cyrtophyllumas a potential source of natural, green antioxidants derived from plants.	[Zhou, Jing; Zhu, Xiaochen; Lin, Tong; Hao, Dongdong; Xu, Jing] Hainan Univ, Sch Chem Engn & Technol, Key Lab Adv Mat Trop Isl Resources, Minist Educ, Haikou, Hainan, Peoples R China; [Zhou, Jing; Xu, Jing] Hainan Univ, Sch Life & Pharmaceut Sci, Haikou, Hainan, Peoples R China; [Yang, Qi] Hainan Univ, Sch Ecol & Environm, Haikou, Hainan, Peoples R China	Hainan University; Hainan University; Hainan University	Xu, J (corresponding author), Hainan Univ, Sch Chem Engn & Technol, Key Lab Adv Mat Trop Isl Resources, Minist Educ, Haikou, Hainan, Peoples R China.; Xu, J (corresponding author), Hainan Univ, Sch Life & Pharmaceut Sci, Haikou, Hainan, Peoples R China.	happyjing3@163.com	徐, 静/HDM-6882-2022		National Natural Science Foundation of China [81973229, 81660584]; Key Research and Development Program of Hainan Province [ZDYF2017099]; Key Project of Education Department of Hainan Province [Hnky2019ZD-6]; Research initiation fund project of Hainan University [KYQD(ZR)20001]; High-level Talents Programs of Hainan Province [2019RC006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Hainan Province; Key Project of Education Department of Hainan Province; Research initiation fund project of Hainan University; High-level Talents Programs of Hainan Province	This work was financially supported by the National Natural Science Foundation of China (No. 81973229/81660584), Key Research and Development Program of Hainan Province (ZDYF2017099), Key Project of Education Department of Hainan Province (Hnky2019ZD-6) and Research initiation fund project of Hainan University (No.KYQD(ZR)20001).This work was financially supported by the High-level Talents Programs of Hainan Province (No. 2019RC006).	Ahmed MI, 2020, J FOOD MEAS CHARACT, V14, P799, DOI 10.1007/s11694-019-00328-9; Alu'datt MH, 2017, FOOD CHEM, V218, P99, DOI 10.1016/j.foodchem.2016.09.057; [Anonymous], 2015, NAT METHODS, V12, P1; Awah FM, 2010, FOOD CHEM, V119, P1409, DOI 10.1016/j.foodchem.2009.09.020; Banjarnahor SDS, 2014, MED J INDONES, V23, P239, DOI 10.13181/mji.v23i4.1015; Barizao EO, 2016, FOOD RES INT, V86, P24, DOI 10.1016/j.foodres.2016.05.007; Carocho M, 2013, FOOD CHEM TOXICOL, V51, P15, DOI 10.1016/j.fct.2012.09.021; Chiang CJ, 2013, LWT-FOOD SCI TECHNOL, V51, P417, DOI 10.1016/j.lwt.2012.11.014; Fatima M, 2017, CHEM NAT COMPD+, V53, P432, DOI 10.1007/s10600-017-2016-1; Gouthamchandra K, 2010, ENVIRON TOXICOL PHAR, V30, P11, DOI 10.1016/j.etap.2010.03.005; Guo T, 2011, FOOD CHEM, V127, P1634, DOI 10.1016/j.foodchem.2011.02.030; Khan SA, 2013, ASIAN J CHEM, V25, P7457, DOI 10.14233/ajchem.2013.14831; Kim NM, 2000, ARCH PHARM RES, V23, P237, DOI 10.1007/BF02976451; Li DL, 2016, J ETHNOPHARMACOL, V194, P358, DOI 10.1016/j.jep.2016.07.050; Li HB, 2007, FOOD CHEM, V102, P771, DOI 10.1016/j.foodchem.2006.06.022; Lushchak VI, 2014, CHEM-BIOL INTERACT, V224, P164, DOI 10.1016/j.cbi.2014.10.016; Pernin A, 2018, J SCI FOOD AGR, V98, P5401, DOI 10.1002/jsfa.9082; Priyankar Dey, 2012, International Journal of Pharma and Bio Sciences, V3, pP; Qian ZJ, 2008, BIORESOURCE TECHNOL, V99, P1690, DOI 10.1016/j.biortech.2007.04.005; Rehecho S, 2011, LWT-FOOD SCI TECHNOL, V44, P875, DOI 10.1016/j.lwt.2010.11.035; s NA, 2018, LANCET INFECT DIS, V18, pe228; Salla S, 2016, LWT-FOOD SCI TECHNOL, V66, P293, DOI 10.1016/j.lwt.2015.09.008; Santos JS, 2017, FOOD CHEM, V214, P515, DOI 10.1016/j.foodchem.2016.07.091; SASAKI H, 1989, PHYTOCHEMISTRY, V28, P875, DOI 10.1016/0031-9422(89)80134-7; Shi YT, 2015, CURR ORG CHEM, V19, P1935, DOI 10.2174/1385272819666150709165210; Thoo YY, 2010, FOOD CHEM, V120, P290, DOI 10.1016/j.foodchem.2009.09.064; Tian Y, 2017, FOOD CHEM, V220, P266, DOI 10.1016/j.foodchem.2016.09.145; Tiwari OP, 2007, FOOD CHEM, V100, P1170, DOI 10.1016/j.foodchem.2005.10.069; Wang B, 2012, PEPTIDES, V36, P240, DOI 10.1016/j.peptides.2012.05.013; Wang T, 2009, FOOD CHEM, V116, P240, DOI 10.1016/j.foodchem.2009.02.041; Wojdyo A, FOOD CHEM, V105, P940; Wong CC, 2006, FOOD CHEM, V97, P705, DOI 10.1016/j.foodchem.2005.05.049; Yang XB, 2015, FLORA OF HAINAN, V11, P350; Yokozawa T, 1998, BIOCHEM PHARMACOL, V56, P213, DOI 10.1016/S0006-2952(98)00128-2; Zhou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068392	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234435	10.1371/journal.pone.0234435	http://dx.doi.org/10.1371/journal.pone.0234435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574221	Green Published, gold			2022-12-27	WOS:000544972400010
J	Nichols, PH; Pan, Y; May, B; Pavlicova, M; Rausch, JC; Mencin, AA; Thaker, VV				Nichols, Presley H.; Pan, Yue; May, Benjamin; Pavlicova, Martina; Rausch, John C.; Mencin, Ali A.; Thaker, Vidhu V.			Effect of TSH on Non-Alcoholic Fatty Liver Disease (NAFLD) independent of obesity in children of predominantly Hispanic/Latino ancestry by causal mediation analysis	PLOS ONE			English	Article							SUBCLINICAL HYPOTHYROIDISM; PEDIATRIC GASTROENTEROLOGY; HEART-DISEASE; RISK; ADOLESCENTS; CHILDHOOD; DIAGNOSIS; GROWTH; SAS	Background Nonalcoholic Fatty Liver Disease (NAFLD) is a common co-morbidity of obesity. Elevated TSH levels (eTSH), also associated with obesity, may contribute to the dysmetabolic state that predisposes to NAFLD. Objective To assess the relationship between TSH levels and NAFLD in children with biopsy-proven NAFLD compared to controls. Design and methods In this retrospective study of children with biopsy-proven NAFLD and age-matched controls, the association of eTSH with NAFLD was investigated and the role of TSH as a mediator between obesity and NAFLD was assessed. Results Sixty-six cases and 4067 controls (69.7 vs 59% Hispanic/Latino ancestry, p = 0.1) of the same age range seen in the same time duration at an urban Children's Hospital were studied. Children with NAFLD were more likely to be male (74.6 vs 39.4%, p < 0.001), have higher modified BMI-z scores (median 2.4 (IQR 1.7) vs 1.9 (IQR 1.7), p < 0.001), and abnormal metabolic parameters (TSH, ALT, HDL-C, non-HDL-C, and TG). Multivariate analyses controlling for age, sex and severity of obesity showed significant association between the 4(th)quartile of TSH and NAFLD. Causal mediation analysis demonstrates that TSH mediates 33.8% of the effect of modified BMI-z score on NAFLD. This comprises of 16.0% (OR = 1.1, p = 0.002) caused by the indirect effect of TSH and its interaction with modified BMI-z, and 17.7% (OR = 1.1, p = 0.05) as an autonomous effect of TSH on NAFLD. Overall, 33.8% of the effect can be eliminated by removing the mediator, TSH (p = 0.001). Conclusions The association of eTSH and biopsy-proven NAFLD is demonstrated in children of Hispanic/Latino ancestry. Further, a causal mediation analysis implicates an effect of TSH on NAFLD, independent of obesity.	[Nichols, Presley H.; Rausch, John C.] New York Presbyterian Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY USA; [Pan, Yue; Pavlicova, Martina] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [May, Benjamin] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, New York, NY USA; [Rausch, John C.; Mencin, Ali A.; Thaker, Vidhu V.] Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10027 USA	NewYork-Presbyterian Hospital; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Thaker, VV (corresponding author), Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10027 USA.	vvt2114@cumc.columbia.edu		Rausch, John/0000-0002-1916-641X; Thaker, Vidhu/0000-0002-3537-2782	NIH-NIDDK, National Institutes of Diabetes and Digestive and Kidney Diseases [K23 DK 110539]; Irving Institute for Clinical and Translational Medicine at Columbia University Medical Center - National Center for Advancing Translational Sciences, NIH [UL1TR001873]	NIH-NIDDK, National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Irving Institute for Clinical and Translational Medicine at Columbia University Medical Center - National Center for Advancing Translational Sciences, NIH	VVT received funding from NIH-NIDDK K23 DK 110539, National Institutes of Diabetes and Digestive and Kidney Diseases, https://www.niddk.nih.gov/.The statistical analysis was supported by the Irving Institute for Clinical and Translational Medicine at Columbia University Medical Center supported by the the National Center for Advancing Translational Sciences, NIH, through Grant Number UL1TR001873. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterio A, 2014, HORM RES PAEDIAT, V82, P283, DOI 10.1159/000365192; Anderson EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140908; Aypak C, 2013, J PEDIATR ENDOCR MET, V26, P703, DOI 10.1515/jpem-2012-0384; Bilgin H, 2014, J CLIN RES PEDIATR E, V6, P152, DOI [10.4274/Jcrpe.1488, 10.4274/jcrpe.1488]; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; BURMAN KD, 1980, J CLIN ENDOCR METAB, V51, P106, DOI 10.1210/jcem-51-1-106; Centers for Disease Control and Prevention, 2016, SAS PROGRAM 2000 CDC; Cerbone M, 2014, J CLIN ENDOCR METAB, V99, P2697, DOI 10.1210/jc.2014-1761; Cerbone M, 2011, EUR J ENDOCRINOL, V164, P591, DOI 10.1530/EJE-10-0979; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Dahl M, 2017, J CLIN RES PEDIATR E, V9, P8, DOI 10.4274/jcrpe.3319; Denzer C, 2013, EUR J ENDOCRINOL, V168, P601, DOI 10.1530/EJE-12-0703; Fernandes DM, 2018, J PEDIATR-US, V200, P174, DOI 10.1016/j.jpeds.2018.04.047; Ferrandino G, 2017, P NATL ACAD SCI USA, V114, pE9172, DOI 10.1073/pnas.1707797114; Freedman DS, 2017, OBESITY, V25, P739, DOI 10.1002/oby.21782; Gao N, 2013, ATHEROSCLEROSIS, V227, P18, DOI 10.1016/j.atherosclerosis.2012.10.070; Gencer B, 2012, CIRCULATION, V126, P1040, DOI 10.1161/CIRCULATIONAHA.112.096024; Gulati AK, 2012, PEDIATRICS, V130, P1136, DOI 10.1542/peds.2012-0596; Guo ZQ, 2018, DIGEST LIVER DIS, V50, P1153, DOI 10.1016/j.dld.2018.08.012; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Kaltenbach TEM, 2017, PEDIATR OBES, V12, P67, DOI 10.1111/ijpo.12110; Lee MK, 2019, ENDOCRINE, V65, P608, DOI 10.1007/s12020-019-01942-9; Licenziati MR, 2019, J CLIN ENDOCR METAB, V104, P2757, DOI 10.1210/jc.2018-02399; Monzani A, 2013, EUR J ENDOCRINOL, V168, pR1, DOI 10.1530/EJE-12-0656; Nobili V, 2015, JAMA PEDIATR, V169, P170, DOI 10.1001/jamapediatrics.2014.2702; PACIFICO L, 2013, INT J ENDOCRINOL, DOI DOI 10.1155/2013/381014; Radetti G, 2006, J PEDIATR-US, V149, P827, DOI 10.1016/j.jpeds.2006.08.045; Razvi S, 2010, J CLIN ENDOCR METAB, V95, P1734, DOI 10.1210/jc.2009-1749; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Salerno M, 2016, NAT REV ENDOCRINOL, V12, P734, DOI 10.1038/nrendo.2016.100; Schwimmer JB, 2013, ALIMENT PHARM THER, V38, P1267, DOI 10.1111/apt.12518; Sert A, 2013, PEDIATR CARDIOL, V34, P1166, DOI 10.1007/s00246-013-0638-z; Sinha RA, 2018, NAT REV ENDOCRINOL, V14, P259, DOI 10.1038/nrendo.2018.10; Song YF, 2015, J HEPATOL, V62, P1171, DOI 10.1016/j.jhep.2014.12.006; Torun E, 2014, J CLIN RES PEDIATR E, V6, P34, DOI 10.4274/Jcrpe.1155; Valeri L, 2015, EPIDEMIOLOGY, V26, pE23, DOI 10.1097/EDE.0000000000000253; Valeri L, 2013, PSYCHOL METHODS, V18, P137, DOI 10.1037/a0031034; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P749, DOI 10.1097/EDE.0000000000000121; Vos MB, 2017, J PEDIATR GASTR NUTR, V64, P319, DOI 10.1097/MPG.0000000000001482; Wang XL, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1249630; Wasniewska M, 2009, EUR J ENDOCRINOL, V160, P417, DOI 10.1530/EJE-08-0625; Yan F, 2014, J HEPATOL, V61, P1358, DOI 10.1016/j.jhep.2014.06.037; Zhang W, 2009, J CELL MOL MED, V13, P4636, DOI 10.1111/j.1582-4934.2008.00670.x; Zhang XJ, 2015, J LIPID RES, V56, P963, DOI 10.1194/jlr.M047654	45	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234985	10.1371/journal.pone.0234985	http://dx.doi.org/10.1371/journal.pone.0234985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569304	gold, Green Published			2022-12-27	WOS:000543547900049
J	Yadav, C; Smith, ML; Yack, JE				Yadav, Chanchal; Smith, Myron L.; Yack, Jayne E.			Transcriptome analysis of a social caterpillar,Drepana arcuata: De novo assembly, functional annotation and developmental analysis	PLOS ONE			English	Article							GENE-EXPRESSION; MEDIATED TERRITORIALITY; BEHAVIOR; CATERPILLAR; EVOLUTION; BRAIN	The masked birch caterpillar,Drepana arcuata, provides an excellent opportunity to study mechanisms mediating developmental changes in social behaviour. Larvae transition from being social to solitary during the 3(rd)instar, concomitant with shifts in their use of acoustic communication. In this study we characterize the transcriptome ofD.arcuatato initiate sociogenomic research of this lepidopteran insect. We assembled and annotated the combined larval transcriptome of "social" early and "solitary" late instars using next generation Illumina sequencing, and used this transcriptome to conduct differential gene expression analysis of the two behavioural phenotypes. A total of 211,012,294 reads generated by RNA sequencing were assembled into 231,348 transcripts and 116,079 unigenes for the functional annotation of the transcriptome. Expression analysis revealed 3300 transcripts that were differentially expressed between early and late instars, with a large proportion associated with development and metabolic processes. We independently validated differential expression patterns of selected transcripts using RT-qPCR. The expression profiles of social and solitary larvae revealed differentially expressed transcripts coding for gene products that have been previously reported to influence social behaviour in other insects (e.g. cGMP- and cAMP- dependent kinases, and bioamine receptors). This study provides the first transcriptomic resources for a lepidopteran species belonging to the superfamily Drepanoidea, and gives insight into genetic factors mediating grouping behaviour in insects.	[Yadav, Chanchal; Smith, Myron L.; Yack, Jayne E.] Carleton Univ, Dept Biol, Ottawa, ON, Canada	Carleton University	Yack, JE (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.	jayneyack@cunet.carleton.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [201405947, 2014-05436]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/index_eng.asp) Discovery grant numbers: 201405947 to JEY and 2014-05436 to MLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002596; [Anonymous], 2017, Hepatol Int, V11, P1, DOI 10.1007/s12072-016-9783-9; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; [Anonymous], 2017, PHARMACOEPIDEMIO SS2, V26, P1, DOI DOI 10.1007/s11665-016-2478-5; [Anonymous], GENOMICS PHYSL BEHAV; [Anonymous], 2012, P NATL ACAD SCI USA, V109, pE1377; [Anonymous], 2015, HLTH PROT REP, V9, P1, DOI DOI 10.1186/1752-4458-9-1; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Anstey LJ, 2002, CAN ENTOMOL, V134, P529, DOI 10.4039/Ent134529-4; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028110; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Berens AJ, 2015, MOL BIOL EVOL, V32, P690, DOI 10.1093/molbev/msu330; Bloch G, 2001, J BIOL RHYTHM, V16, P444, DOI 10.1177/074873001129002123; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borzoui E, 2018, J ECON ENTOMOL, V111, P942, DOI 10.1093/jee/tox360; Bowen JL, 2008, PHYSIOL ENTOMOL, V33, P238, DOI 10.1111/j.1365-3032.2008.00627.x; Bryant DM, 2017, CELL REP, V18, P762, DOI 10.1016/j.celrep.2016.12.063; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Costa J., 2006, OTHER INSECT SOC; Costa JT, 2018, CURR OPIN INSECT SCI, V28, P40, DOI 10.1016/j.cois.2018.04.008; Costa James T., 1997, P407; Cremer Sylvia, 2018, Annual Review of Entomology, V63, P105, DOI 10.1146/annurev-ento-020117-043110; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Despland E, 2007, ENTOMOL EXP APPL, V122, P181, DOI 10.1111/j.1570-7458.2006.00512.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; Goldstein PZ, 2017, INSECT BIODIVERSITY: SCIENCE AND SOCIETY, VOL I, 2ND EDITION, P463; Gospocic J, 2017, CELL, V170, P748, DOI 10.1016/j.cell.2017.07.014; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guedes RNC, 2012, J COMP PHYSIOL A, V198, P325, DOI 10.1007/s00359-012-0711-8; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Hewlett SE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205686; Hill DS, 1983, AGR INSECT PESTS TRO, P551; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kato T, 2006, PIGM CELL RES, V19, P337, DOI 10.1111/j.1600-0749.2006.00316.x; Kocher SD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06824-8; Kucharski R, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0007; Leonhardt SD, 2016, CELL, V164, P1277, DOI 10.1016/j.cell.2016.01.035; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu XN, 2006, PESTIC BIOCHEM PHYS, V84, P127, DOI 10.1016/j.pestbp.2005.06.002; Ma ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08036; Markert MJ, 2016, G3-GENES GENOM GENET, V6, P905, DOI 10.1534/g3.116.027029; McClure M, 2011, NATURWISSENSCHAFTEN, V98, P425, DOI 10.1007/s00114-011-0788-x; Minet Joel, 1999, Handbuch der Zoologie (Berlin), V4, P301; Miura T, 2004, ECOL RES, V19, P141, DOI 10.1111/j.1440-1703.2003.00618.x; Mougenot F, 2012, ANIM BEHAV, V84, P391, DOI 10.1016/j.anbehav.2012.05.008; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; OECD/OCDE, OECD GUIDELINE TESTI, DOI [10.1787/9789264091016-en, DOI 10.1787/9789264091016-EN]; Okamoto S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-396; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Pearce SL, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0402-6; Peterson B, 2019, GENE, V710, P387, DOI 10.1016/j.gene.2019.05.048; Ratchford SG, 1998, ANIM BEHAV, V56, P1027, DOI 10.1006/anbe.1998.0869; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scott JL, 2012, EUR J ENTOMOL, V109, P411, DOI 10.14411/eje.2012.053; Scott JL, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.5401; Scott Jessica R., 2012, THESIS; Sen Zeng R, 2007, J CHEM ECOL, V33, P449, DOI 10.1007/s10886-006-9238-1; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Surlykke A, 2003, J EXP BIOL, V206, P2653, DOI 10.1242/jeb.00469; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Triant DA, 2018, CURR OPIN INSECT SCI, V25, P99, DOI 10.1016/j.cois.2017.12.004; Trible W, 2017, CELL, V170, P727, DOI 10.1016/j.cell.2017.07.001; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wada-Katsumata A, 2011, J EXP BIOL, V214, P1707, DOI 10.1242/jeb.051565; Wallbank RWR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002353; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; WILSON EO, 1985, SCIENCE, V228, P1489, DOI 10.1126/science.228.4707.1489; WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 17 STUDY GROUP, 2017, Amyotroph Lateral Scler Frontotemporal Degener, V18, P20, DOI 10.1080/21678421.2017.1362000; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yack JE, 2014, ETHOLOGY, V120, P354, DOI 10.1111/eth.12210; Yack JE, 2001, P NATL ACAD SCI USA, V98, P11371, DOI 10.1073/pnas.191378898; Yadav C, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2280-x; Yan H, 2017, CELL, V170, P736, DOI 10.1016/j.cell.2017.06.051	76	6	6	8	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234903	10.1371/journal.pone.0234903	http://dx.doi.org/10.1371/journal.pone.0234903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569288	gold, Green Published			2022-12-27	WOS:000543547900050
J	Jamaloddin, M; Rani, CVD; Swathi, G; Anuradha, C; Vanisri, S; Rajan, CPD; Raju, SK; Bhuvaneshwari, V; Jagadeeswar, R; Laha, GS; Prasad, MS; Satyanarayana, PV; Cheralu, C; Rajani, G; Ramprasad, E; Sravanthi, P; Kumar, NAP; Kumari, KA; Yamini, KN; Mahesh, D; Rao, DS; Sundaram, RM; Madhav, MS				Jamaloddin, Md; Rani, Ch V. Durga; Swathi, G.; Anuradha, Ch; Vanisri, S.; Rajan, C. P. D.; Raju, S. Krishnam; Bhuvaneshwari, V; Jagadeeswar, R.; Laha, G. S.; Prasad, M. S.; Satyanarayana, P., V; Cheralu, C.; Rajani, G.; Ramprasad, E.; Sravanthi, P.; Kumar, N. Arun Prem; Kumari, K. Aruna; Yamini, K. N.; Mahesh, D.; Rao, D. Sanjeev; Sundaram, R. M.; Madhav, M. Sheshu			Marker Assisted Gene Pyramiding (MAGP) for bacterial blight and blast resistance into mega rice variety "Tellahamsa"	PLOS ONE			English	Article							SELECTION; IDENTIFICATION; LOCUS	Bacterial blight (BB) and fungal blast diseases are the major biotic constraints that limit rice productivity. To sustain yield improvement in rice, it is necessary to developed yield potential of the rice varieties by incorporation of biotic stress resistance genes. Tellahamsa is a well-adapted popular high yielding rice variety in Telangana state, India. However, the variety is highly susceptible to BB and blast. In this study, simultaneous stepwise transfer of genes through marker-assisted backcross breeding (MABB) strategy was used to introgress two major BB (Xa21andxa13) and two major blast resistance genes (Pi54andPi1) into Tellahamsa. In each generation (from F(1)to ICF3) foreground selection was done using gene-specific markers viz., pTA248 (Xa21),xa13prom(xa13),Pi54MAS(Pi54) and RM224 (Pi1). Two independent BC(2)F(1)lines of Tellahamsa/ISM (Cross-I) and Tellahamsa/NLR145 (Cross-II) possessing 92% and 94% recurrent parent genome (RPG) respectively were intercrossed to develop ICF1-ICF(3)generations. These gene pyramided lines were evaluated for key agro-morphological traits, quality, and resistance against blast at three different hotspot locations as well as BB at two locations. Two ICF(3)gene pyramided lines viz., TH-625-159 and TH-625-491 possessing four genes exhibited a high level of resistance to BB and blast. In the future, these improved Tellahamsa lines could be developed as mega varieties for different agro-climatic zones and also as potential donors for different pre-breeding rice research.	[Jamaloddin, Md; Rani, Ch V. Durga; Swathi, G.; Anuradha, Ch; Vanisri, S.; Cheralu, C.; Rajani, G.; Ramprasad, E.; Sravanthi, P.; Kumar, N. Arun Prem; Kumari, K. Aruna; Yamini, K. N.; Mahesh, D.] PJTSAU, Inst Biotechnol IBT, Hyderabad, India; [Jamaloddin, Md] Int Rice Res Inst IRRI, Los Banos, Philippines; [Rajan, C. P. D.] ANGRAU, Agr Res Stn ARS, Nellore, India; [Raju, S. Krishnam; Bhuvaneshwari, V; Satyanarayana, P., V] ANGRAU, Andhra Pradesh Rice Res Inst APRRI, West Godavari, India; [Jagadeeswar, R.] PJTSAU, Agr Res Inst ARI, Hyderabad, India; [Laha, G. S.; Prasad, M. S.; Rao, D. Sanjeev; Sundaram, R. M.; Madhav, M. Sheshu] Indian Inst Rice Res ICAR IIRR, Hyderabad, India	CGIAR; International Rice Research Institute (IRRI); Acharya N. G. Ranga Agricultural University; Acharya N. G. Ranga Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Rice Research	Rani, CVD (corresponding author), PJTSAU, Inst Biotechnol IBT, Hyderabad, India.; Madhav, MS (corresponding author), Indian Inst Rice Res ICAR IIRR, Hyderabad, India.	ranivenkata2@gmail.com; sheshu24@gmail.com		Vutukuri, Bhuvaneswari/0000-0002-0399-1183	Department of Biotechnology (DBT), Government of India [BT/PR11705/AGR/02/646/2008]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	The authors would like to acknowledge Department of Biotechnology (DBT), Government of India, for the financial support to conduct research on rice breeding through the grant BT/PR11705/AGR/02/646/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Department of Biotechnology (DBT), Government of India, for the financial support to conduct research on rice breeding. The authors would like to acknowledge Professor Jayashankar Telangana State Agricultural University (PJTSAU) for providing necessary facilities and also like to acknowledge ANGRAU and IIRR for extending facilities to screen the breeding material.	[Anonymous], 2013, B CONSTITUTIONAL CAS, V2, P308; Arunakumari K, 2016, RICE SCI, V23, P306, DOI 10.1016/j.rsci.2016.04.005; Babujee L, 2000, CURR SCI INDIA, V78, P248; Balachiranjeevi CH, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0348-8; Bao JS, 2006, STARCH-STARKE, V58, P259, DOI 10.1002/star.200500469; Basavaraj SH, 2009, INDIAN J GENET PL BR, V69, P10; Das G, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00985; Devi SJSR, 2020, RICE, V13, DOI 10.1186/s12284-020-00378-4; Divya B, 2014, EUPHYTICA, V200, P61, DOI 10.1007/s10681-014-1146-9; Ellur RK, 2015, PLANT SCI, DOI [10.1016/j.linesci.2015.08.020, DOI 10.1016/J.LINESCI.2015.08.020]; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Flores A, 2008, AGR RES, P22; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; Hua LX, 2012, THEOR APPL GENET, V125, P1047, DOI 10.1007/s00122-012-1894-7; Huang N, 1997, THEOR APPL GENET, V95, P313, DOI 10.1007/s001220050565; IRRI (International rice research institute), 1996, STAND EV SYST RIC; Jiang HC, 2012, MOL BREEDING, V30, P1679, DOI 10.1007/s11032-012-9751-6; Joseph M, 2004, MOL BREEDING, V13, P377, DOI 10.1023/B:MOLB.0000034093.63593.4c; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Khan GH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22246-4; Khanna A, 2015, THEOR APPL GENET, V128, P1243, DOI 10.1007/s00122-015-2502-4; Kumar VA, 2016, J PLANT BIOCHEM BIOT, V25, P400, DOI 10.1007/s13562-016-0352-z; Laha GS, 2009, DRR TECHNICAL B, V41; Liu WD, 2014, ANNU REV PHYTOPATHOL, V52, P213, DOI 10.1146/annurev-phyto-102313-045926; Madhavi KR, 2012, INDIAN J PLANT PROT, V40, P52; Ni DH, 2015, FIELD CROP RES, V184, P1, DOI 10.1016/j.fcr.2015.07.018; Ou SH, 1985, RICE DIS; Pandey P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01348; Patroti P, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2487-1; Pradhan SK, 2015, RICE, V8, DOI 10.1186/s12284-015-0051-8; Prasad MS, 2011, USDA TECHNICAL B; Ramkumar G, 2011, MOL BREEDING, V27, P129, DOI 10.1007/s11032-010-9538-6; Ratna M K, 2011, IND J PLANT PROT, V39, P124; RONALD PC, 1992, MOL GEN GENET, V236, P113, DOI 10.1007/BF00279649; RoyChowdhury M, 2012, PHYTOPATHOLOGY, V102, P700, DOI 10.1094/PHYTO-02-12-0026-R; Shanti M. L., 2010, International Journal of Plant Pathology, V1, P58; Singh S, 2001, THEOR APPL GENET, V102, P1011, DOI 10.1007/s001220000495; Singh VK, 2013, PLANT BREEDING, V132, P486, DOI 10.1111/pbr.12077; Srikanth S., 2017, INT J DEV RES, V06, P8366; Subudhi H. N., 2012, Journal of Agricultural Science (Toronto), V4, P269; Sundaram RM, 2008, EUPHYTICA, V160, P411, DOI 10.1007/s10681-007-9564-6; Swathi G, 2019, MOL BREEDING, V39, DOI 10.1007/s11032-019-0950-2; Tabien RE, 2002, THEOR APPL GENET, V105, P313, DOI 10.1007/s00122-002-0940-2; Tanweer FA, 2015, CR BIOL, V338, P321, DOI 10.1016/j.crvi.2015.03.001; van Berloo R, 1999, J HERED, V90, P328, DOI 10.1093/jhered/90.2.328; Vanisree S., 2012, INT S 100 YEARS RIC, V1, P108; Vasudevan K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00505; Vikal Y., 2017, ADV INT RICE RES, DOI [10.5772/67361, DOI 10.5772/67361]; Yugander A, 2017, EUR J PLANT PATHOL, V149, P171, DOI 10.1007/s10658-017-1176-y; Yugander A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198260; Zheng K., 1995, IRRI DISCUSSION PAPE; 2012, J I CHINESE LIT PHIL, V22, P5	53	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234088	10.1371/journal.pone.0234088	http://dx.doi.org/10.1371/journal.pone.0234088			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559183	Green Published, gold			2022-12-27	WOS:000543261600031
J	Lim, SL; Xu, L; Han, BC; Shyamsunder, P; Chng, WJ; Koeffler, HP				Lim, Su-Lin; Xu, Liang; Han, Bing-Chen; Shyamsunder, Pavithra; Chng, Wee-Joo; Koeffler, H. Phillip			Multiple myeloma: Combination therapy of BET proteolysis targeting chimeric molecule with CDK9 inhibitor	PLOS ONE			English	Article							TRANSCRIPTION	Cyclin Dependent Kinase 9 (CDK9) associates with Bromodomain and Extra-Terminal Domain (BET) proteins to promote transcriptional elongation by phosphorylation of serine 2 of RNAP II C-terminal domain. We examined the therapeutic potential of selective CDK9 inhibitors (AZD 4573 and MC180295) against human multiple myeloma cellsin vitro. Short-hairpin RNA silencing of CDK9 in Multiple Myeloma (MM) cell lines reduced cell viability compared to control cells showing the dependency of MM cells on CDK9. In order to explore synergy with the CDK9 inhibitor, proteolysis targeting chimeric molecule (PROTAC) ARV 825 was added. This latter drug causes ubiquitination of BET proteins resulting in their rapid and efficient degradation. Combination treatment of MM cells with ARV 825 and AZD 4573 markedly reduced their protein expression of BRD 2, BRD 4, MYC and phosphorylated RNA pol II as compared to each single agent alone. Combination treatment synergistically inhibited multiple myeloma cells bothin vitroandin vivowith insignificant weight loss. The combination also resulted in marked increase of apoptotic cells at low dose compared to single agent alone. Taken together, our studies show for the first time that the combination of a BET PROTAC (ARV 825) plus AZD 4573 (CDK9 inhibitor) is effective against MM cells.	[Lim, Su-Lin; Han, Bing-Chen; Koeffler, H. Phillip] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Xu, Liang; Shyamsunder, Pavithra; Chng, Wee-Joo; Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore	Cedars Sinai Medical Center; National University of Singapore	Lim, SL (corresponding author), Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.	sulin_lim_86@hotmail.com	Xu, Liang/I-9877-2014	Xu, Liang/0000-0002-2700-4840; Lim, Su Lin/0000-0001-6885-2451	Aaron Eshman and Melmed family, Morgan Stanley Inc.; Leukemia and Lymphoma Society (LLS) [9002-16]; Department of Defense (DoD) Award [W81XWH-17-1-0093]; UCLA Clinical and Translational Institute (CTSI) voucher V159; National Research Foundation Singapore under Singapore Translational Research (STaR) [NMRC/STaR/0021/2014]; RNA Biology Center at the Cancer Science Institute of Singapore, NUS, Singapore Ministry of Education's Tier 3 grants [MOE2014-T3-1-006]	Aaron Eshman and Melmed family, Morgan Stanley Inc.; Leukemia and Lymphoma Society (LLS)(Leukemia and Lymphoma Society); Department of Defense (DoD) Award; UCLA Clinical and Translational Institute (CTSI) voucher V159; National Research Foundation Singapore under Singapore Translational Research (STaR); RNA Biology Center at the Cancer Science Institute of Singapore, NUS, Singapore Ministry of Education's Tier 3 grants(Ministry of Education, SingaporeNational University of Singapore)	The sources of funding for this study are as follows: 1. Aaron Eshman and Melmed family, Morgan Stanley Inc. Recipient: H.P.K. 2. Leukemia and Lymphoma Society (LLS) Grant ID: 9002-16. Recipient: H.P.K. 3. Department of Defense (DoD) Award W81XWH-17-1-0093. Recipient: H.P.K. 4. UCLA Clinical and Translational Institute (CTSI) voucher V159. Recipient: H.P.K. 5. National Research Foundation Singapore under Singapore Translational Research (STaR). Investigator Award (NMRC/STaR/0021/2014) and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), the NMRC Centre. Grant awarded to National University Cancer Institute of Singapore, the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centers of Excellence initiatives. Recipient: H.P.K. 6. RNA Biology Center at the Cancer Science Institute of Singapore, NUS, Singapore Ministry of Education's Tier 3 grants, grant number MOE2014-T3-1-006. Recipient: H.P.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boffo S, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0704-8; Chou TC, 2005, COMPUSYN DRUG COMBIN; Cidado J, 2018, CANC RES, V78; Conroy A, 2009, CANCER CHEMOTH PHARM, V64, P723, DOI 10.1007/s00280-008-0921-5; Dai Y, 2003, CURR OPIN PHARMACOL, V3, P362, DOI 10.1016/S1471-4892(03)00079-1; Dai Y, 2009, BLOOD, V114, P125; Gerlach D, 2018, ONCOGENE, V37, P2687, DOI 10.1038/s41388-018-0150-2; Hofmeister CC, 2015, BLOOD, V126, P3052; Kazandjian D, 2016, SEMIN ONCOL, V43, P676, DOI 10.1053/j.seminoncol.2016.11.004; Lim SL, 2019, HAEMATOLOGICA, V104, P1209, DOI 10.3324/haematol.2018.201483; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lu HS, 2015, ELIFE, V4, DOI 10.7554/eLife.06535; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Ma HZ, 2019, EBIOMEDICINE, V39, P182, DOI 10.1016/j.ebiom.2018.12.022; Morales F, 2016, CELL CYCLE, V15, P519, DOI 10.1080/15384101.2016.1138186; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rule S., 2018, J CLIN ONCOL, V36, pTPS7588; Shu SK, 2016, COLD SH Q B, V81, P123, DOI 10.1101/sqb.2016.81.030908; Zhang HH, 2018, CELL, V175, P1244, DOI 10.1016/j.cell.2018.09.051; Zhang XH, 2018, LEUKEMIA, V32, P2224, DOI 10.1038/s41375-018-0044-x; Zhang Y, 2017, ONCOTARGET, V8, P59476, DOI 10.18632/oncotarget.19761	21	5	5	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0232068	10.1371/journal.pone.0232068	http://dx.doi.org/10.1371/journal.pone.0232068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559187	Green Published, gold, Green Submitted			2022-12-27	WOS:000543261600035
J	Loiselle, AR; de Kleine, E; van Dijk, P; Jansonius, NM				Loiselle, Allison R.; de Kleine, Emile; van Dijk, Pim; Jansonius, Nomdo M.			Intraocular and intracranial pressure in glaucoma patients taking acetazolamide	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; PRODUCT OTOACOUSTIC EMISSIONS; NORMAL-TENSION GLAUCOMA; HYPERTENSION; POSTURE	The alternative mechanical theory of glaucoma, in which an increased pressure difference across the lamina cribrosa (difference between intraocular and intracranial pressure; IOP and ICP), rather than solely an elevated IOP, leads to structural and functional vision loss, is still controversial. If the theory is true, a drug that simultaneously lowers both the IOP and ICP may be ineffective. The aim of this study was to determine how acetazolamide (AAZ; a drug prescribed in glaucoma that aims to lower the IOP) affects both IOP and ICP in glaucoma patients and to compare the magnitude and time course of the induced pressure changes with those of healthy subjects not taking AAZ. IOP and noninvasive ICP (measured through emissions from the ear) were measured in 20 glaucoma patients taking 125 mg of AAZ twice daily. Measurements were taken for 30 minutes before taking the drug and for 2 hours post-ingestion. Comparisons were made with 13 age-similar controls. After 12 hours with no anti-glaucoma medication, AAZ did not further reduce IOP in glaucoma patients compared to controls (P = 0.58) but did reduce ICP compared to controls (P = 0.035), by approximately 4 mmHg. Our findings suggest that there are periods during the day when the pressure difference across the lamina cribrosa is larger in case of AAZ use. Future studies should focus on improving the noninvasive ICP testing, different doses and dosing schedules of AAZ, and the time course of IOP in glaucoma patients not taking AAZ.	[Loiselle, Allison R.; Jansonius, Nomdo M.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [de Kleine, Emile; van Dijk, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Groningen, Netherlands	University of Groningen; University of Groningen	Jansonius, NM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	n.m.jansonius@umcg.nl	Van Dijk, Pim/E-8019-2010; de Kleine, Emile/P-2350-2014	Van Dijk, Pim/0000-0002-8023-7571; de Kleine, Emile/0000-0001-9525-3032; Jansonius, Nomdo/0000-0002-6495-6568; Loiselle, Allison/0000-0003-2686-0634	European Union (EU) Horizon 2020 grant European Glaucoma Research Training Program (EGRET) [661883]; Uitzicht grant (ANVVB) [2015-11]; Uitzicht grant (Glaucoomfonds) [2015-11]; Uitzicht grant (LSBS) [2015-11]; Uitzicht grant (Novartisfonds) [2015-11]; Uitzicht grant (Oogfonds) [2015-11]; Uitzicht grant (Stichting Blinden-Penning) [2015-11]	European Union (EU) Horizon 2020 grant European Glaucoma Research Training Program (EGRET); Uitzicht grant (ANVVB); Uitzicht grant (Glaucoomfonds); Uitzicht grant (LSBS); Uitzicht grant (Novartisfonds); Uitzicht grant (Oogfonds); Uitzicht grant (Stichting Blinden-Penning)	N.M. Jansonius received the funding for this study from the European Union (EU) Horizon 2020 grant No 661883 European Glaucoma Research Training Program (EGRET) and by Uitzicht grant No 2015-11 (ANVVB, Glaucoomfonds, LSBS, Novartisfonds, Oogfonds, Stichting Blinden-Penning). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALM A, 1982, ACTA OPHTHALMOL, V60, P24; [Anonymous], 1955, BMJ-BRIT MED J, V2, P479; Avan P, 2011, HEARING RES, V277, P88, DOI 10.1016/j.heares.2011.03.006; BECKER B, 1954, AM J OPHTHALMOL, V37, P13, DOI 10.1016/0002-9394(54)92027-9; BECKER B, 1954, AM J OPHTHALMOL, V38, P109, DOI 10.1016/0002-9394(54)90051-3; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bershad EM, 2014, NEUROSURGERY, V75, P445, DOI 10.1227/NEU.0000000000000449; Buki B, 2000, HEARING RES, V140, P202, DOI 10.1016/S0378-5955(99)00202-6; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Chaaban MR, 2013, INT FORUM ALLERGY RH, V3, P718, DOI 10.1002/alr.21188; Costagliola C, 2009, EXPERT OPIN PHARMACO, V10, P2859, DOI 10.1517/14656560903300129; DAVID R, 1992, BRIT J OPHTHALMOL, V76, P280, DOI 10.1136/bjo.76.5.280; ELVIDGE AR, 1957, J NEUROSURG, V14, P628, DOI 10.3171/jns.1957.14.6.0628; FRIEDLAND BR, 1977, ARCH OPHTHALMOL-CHIC, V95, P1809; Friedman DI, 2014, J NEURO-OPHTHALMOL, V34, P107, DOI 10.1097/WNO.0000000000000114; Heeg GP, 2005, ACTA OPHTHALMOL SCAN, V83, P46, DOI 10.1111/j.1600-0420.2005.00423.x; Jonas JB, 2015, PROG BRAIN RES, V221, P33, DOI 10.1016/bs.pbr.2015.06.002; KASS MA, 1982, ARCH OPHTHALMOL-CHIC, V100, P941, DOI 10.1001/archopht.1982.01030030949010; KATAVISTO MARTTI, 1964, ACTA OPHTHALMOL, P1; Kattah JC, 2015, J NEUROL, V262, P2271, DOI 10.1007/s00415-015-7838-9; Linden C, 2018, OPHTHALMOLOGY, V125, P361, DOI 10.1016/j.ophtha.2017.09.022; Loiselle AR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204939; Lusthaus J, 2019, MED J AUSTRALIA, V210, P180, DOI 10.5694/mja2.50020; MACDONALD MJ, 1977, BRIT J OPHTHALMOL, V61, P345, DOI 10.1136/bjo.61.5.345; Maus TL, 1997, ARCH OPHTHALMOL-CHIC, V115, P45, DOI 10.1001/archopht.1997.01100150047008; Pircher A, 2017, ACTA OPHTHALMOL, V95, pE524, DOI 10.1111/aos.13302; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; RUBIN RC, 1966, J NEUROSURG, V25, P430, DOI 10.3171/jns.1966.25.4.0430; Stamper RL, 2009, BECKER SHAFFER S DIA, P407, DOI [10.1016/b978-0-323-02394-8.00026-7, DOI 10.1016/B978-0-323-02394-8.00026-7]; Supuran CT, 2015, EXPERT REV NEUROTHER, V15, P851, DOI 10.1586/14737175.2015.1066675; van Gestel A, 2010, VALUE HEALTH, V13, P358, DOI 10.1111/j.1524-4733.2009.00678.x; Voss SE, 2010, HEARING RES, V263, P43, DOI 10.1016/j.heares.2010.03.003; Williams MA, 2016, AEROSP MED HUM PERF, V87, P844, DOI 10.3357/AMHP.4572.2016; Zinkernagel MS, 2009, J OCUL PHARMACOL TH, V25, P141, DOI 10.1089/jop.2008.0077	35	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234690	10.1371/journal.pone.0234690	http://dx.doi.org/10.1371/journal.pone.0234690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555666	Green Published, gold			2022-12-27	WOS:000543273200060
J	Ronsley, C; Nolan, S; Knight, R; Hayashi, K; Klimas, J; Walley, A; Wood, E; Fairbairn, N				Ronsley, Claire; Nolan, Seonaid; Knight, Rod; Hayashi, Kanna; Klimas, Jano; Walley, Alex; Wood, Evan; Fairbairn, Nadia			Treatment of stimulant use disorder: A systematic review of reviews	PLOS ONE			English	Review							METHADONE-MAINTENANCE TREATMENT; RELAPSE-PREVENTION TREATMENT; TREATING COCAINE ADDICTION; STREET-INVOLVED YOUTH; CONTINGENCY-MANAGEMENT; DOUBLE-BLIND; HEPATITIS-C; METHAMPHETAMINE; NALTREXONE; DEPENDENCE	Aims Stimulant use disorder contributes to a substantial worldwide burden of disease, although evidence-based treatment options are limited. This systematic review of reviews aims to: (i) synthesize the available evidence on both psychosocial and pharmacological interventions for the treatment of stimulant use disorder; (ii) identify the most effective therapies to guide clinical practice, and (iii) highlight gaps for future study. Methods A systematic database search was conducted to identify systematic reviews and meta-analyses. Eligible studies were those that followed standard systematic review methodology and assessed randomized controlled trials focused on the efficacy of interventions for stimulant use disorder. Articles were critically appraised using an assessment tool adapted from Palmeteer et al. and categorized for quality as 'core' or 'supplementary' reviews. Evidence from the included reviews were further synthesized according to pharmacological or non-pharmacological management themes. Results Of 476 identified records, 29 systematic reviews examining eleven intervention modalities were included. The interventions identified include: contingency management, cognitive behavioural therapy, acupuncture, antidepressants, dopamine agonists, antipsychotics, anticonvulsants, disulfiram, opioid agonists, N-Acetylcysteine, and psychostimulants. There was sufficient evidence to support the efficacy of contingency management programs for treatment of stimulant use disorder. Psychostimulants, n-acetylcysteine, opioid agonist therapy, disulfiram and antidepressant pharmacological interventions were found to have insufficient evidence to support or discount their use. Results of this review do not support the use of all other treatment options. Conclusions The results of this review supports the use of contingency management interventions for the treatment of stimulant use disorder. Although evidence to date is insufficient to support the clinical use of psychostimulants, our results demonstrate potential for future research in this area. Given the urgent need for effective pharmacological treatments for stimulant use disorder, high-quality primary research focused on the role of psychostimulant medications for the treatment of stimulant use disorder is needed.	[Ronsley, Claire; Nolan, Seonaid; Knight, Rod; Hayashi, Kanna; Klimas, Jano; Wood, Evan; Fairbairn, Nadia] British Columbia Ctr Subst Use, Vancouver, BC, Canada; [Ronsley, Claire; Nolan, Seonaid; Knight, Rod; Wood, Evan; Fairbairn, Nadia] Univ British Columbia, St Pauls Hosp, Dept Med, Vancouver, BC, Canada; [Hayashi, Kanna] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Klimas, Jano] Univ Coll Dublin, Sch Med, Dublin, Ireland; [Walley, Alex] Boston Med Ctr, Dept Gen Internal Med, Boston, MA USA; [Walley, Alex] Boston Univ, Sch Med, Boston, MA 02118 USA	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Simon Fraser University; University College Dublin; Boston Medical Center; Boston University	Fairbairn, N (corresponding author), British Columbia Ctr Subst Use, Vancouver, BC, Canada.; Fairbairn, N (corresponding author), Univ British Columbia, St Pauls Hosp, Dept Med, Vancouver, BC, Canada.	nadia.fairbairn@bccsu.ubc.ca	Klimas, Jan/ABG-2669-2020	Klimas, Jan/0000-0002-5179-0052	MSFHR/St. Paul's Foundation Scholar Award; Tier 1 Canada Research Chair in Addiction Medicine; CIHR New Investigator Award [MSH-141971]; Michael Smith Foundation for Health Research (MSFHR) Scholar Award; St. Paul's Hospital Foundation; MSFHR [701698]; University of British Columbia's Steven Diamond Professorship in Addiction Care Innovation; Canadian Institutes of Health Research [671 397968, 422332]	MSFHR/St. Paul's Foundation Scholar Award; Tier 1 Canada Research Chair in Addiction Medicine; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR) Scholar Award(Michael Smith Foundation for Health Research); St. Paul's Hospital Foundation; MSFHR(Michael Smith Foundation for Health Research); University of British Columbia's Steven Diamond Professorship in Addiction Care Innovation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was undertaken, in part, thanks to funding from a MSFHR/St. Paul's Foundation Scholar Award which supports Dr. Nadia Fairbairn. Evan Wood is supported by a Tier 1 Canada Research Chair in Addiction Medicine. Kanna Hayashi is supported by a CIHR New Investigator Award (MSH-141971), a Michael Smith Foundation for Health Research (MSFHR) Scholar Award, and the St. Paul's Hospital Foundation. Dr. Seonaid Nolan is supported by the MSFHR and the University of British Columbia's Steven Diamond Professorship in Addiction Care Innovation. Rod Knight is supported by a Scholar Award from MSFHR. A European Commission grant (701698) and Canadian Institutes of Health Research (671 397968, 422332) grants support Dr. Klimas.	Alvarez Y, 2013, J SUBST ABUSE TREAT, V45, P1, DOI 10.1016/j.jsat.2012.12.013; Alvarez Y, 2010, J SUBST ABUSE TREAT, V38, P66, DOI 10.1016/j.jsat.2009.07.001; Alves P, 2017, DRUG ALCOHOL DEPEN, V179, P299, DOI 10.1016/j.drugalcdep.2017.05.049; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2019, WORLD DRUG REP 2018; [Anonymous], 2018, NAT GUID CLIN MAN OP; [Anonymous], 2002, PATIENT ED MANAGEMEN, V9, pSS1; Benishek LA, 2014, ADDICTION, V109, P1426, DOI 10.1111/add.12589; Bhatt M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0370-x; Castells X, EFFICACY OPIATE MAIN; Castells X, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007380.pub4; Castells X, 2009, AM J DRUG ALCOHOL AB, V35, P339, DOI 10.1080/00952990903108215; Chan B, 2019, J GEN INTERN MED; Chan B, 2019, ADDICTION, V114, P2122, DOI 10.1111/add.14755; Ciccarone D, 2011, PRIMARY CARE, V38, P41, DOI 10.1016/j.pop.2010.11.004; Cohen-Barak O, 2015, J CLIN PHARMACOL, V55, P573, DOI 10.1002/jcph.450; Comer SD, 2013, NEUROPSYCHOPHARMACOL, V38, P2427, DOI 10.1038/npp.2013.143; Connor JP, 2014, CURR OPIN PSYCHIATR, V27, P269, DOI 10.1097/YCO.0000000000000069; Cunningham EB, 2015, DRUG ALCOHOL DEPEN, V152, P272, DOI 10.1016/j.drugalcdep.2015.04.005; Darke S, 2017, ADDICTION; Darke S, 2010, ADDICTION, V105, P916, DOI 10.1111/j.1360-0443.2009.02872.x; De Crescenzo F, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002715; Dursteler KM, 2015, SUBST ABUSE REHABIL, V6, P61, DOI 10.2147/SAR.S50807; Elkashef A, 2012, ADDICTION, V107, P1297, DOI 10.1111/j.1360-0443.2011.03771.x; Elliott L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225273; Ellis S., 2003, HIV PREVENTION REV R; Farronato NS, 2013, J ADDICT DIS, V32, P274, DOI 10.1080/10550887.2013.824328; Garcia-Rodriguez O, 2009, EXP CLIN PSYCHOPHARM, V17, P131, DOI 10.1037/a0015963; Gates S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005192.pub2; Harada T, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011315.pub2; Hartmann-Boyce J, 2014, ADDICTION, V109, P1414, DOI 10.1111/add.12633; Hoelen DWM, 2009, NEW ENGL J MED, V360, P308, DOI 10.1056/NEJMc0804248; Indave BI, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006306.pub3; Johnson BA, 2013, JAMA PSYCHIAT, V70, P1338, DOI 10.1001/jamapsychiatry.2013.2295; Kiluk BD, 2016, DRUG ALCOHOL DEPEN, V158, P1, DOI 10.1016/j.drugalcdep.2015.11.004; Kim YH, 2005, J ADDICT DIS, V24, P115, DOI 10.1300/J069v24n04_09; Kirby KC, 2006, DRUG ALCOHOL DEPEN, V85, P19, DOI 10.1016/j.drugalcdep.2006.03.010; Kishi T, 2013, J CLIN PSYCHIAT, V74, pE1169, DOI 10.4088/JCP.13r08525; Lee NK, 2008, DRUG ALCOHOL REV, V27, P309, DOI 10.1080/09595230801919494; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; Miller ML, 2015, DRUG ALCOHOL DEPEN, V153, P29, DOI 10.1016/j.drugalcdep.2015.06.014; Mills Edward J, 2005, Harm Reduct J, V2, P4, DOI 10.1186/1477-7517-2-4; Minozzi S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003352.pub4; Minozzi S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005064.pub3; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Murphy SM, 2015, DRUG ALCOHOL DEPEN, V153, P293, DOI 10.1016/j.drugalcdep.2015.05.004; NIDA, 2011, TREATM STAT; Echevarria MA, 2017, PSYCHIAT RES, V251, P197, DOI 10.1016/j.psychres.2017.02.024; Operskalski EA, 2008, J CLIN VIROL, V41, P255, DOI 10.1016/j.jcv.2007.08.021; Oslin DW, 1999, J SUBST ABUSE TREAT, V16, P163, DOI 10.1016/S0740-5472(98)00039-7; Palmateer N, 2010, ADDICTION, V105, P844, DOI 10.1111/j.1360-0443.2009.02888.x; Palmer RS, 2009, SUBST USE MISUSE, V44, P1021, DOI 10.1080/10826080802495237; Pani PP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007024.pub2; Pani PP, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002950.pub3; Peirce JM, 2006, ARCH GEN PSYCHIAT, V63, P201, DOI 10.1001/archpsyc.63.2.201; Perez-Mana C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009695.pub2; Perez-Mana C, 2011, J SUBST ABUSE TREAT, V40, P109, DOI 10.1016/j.jsat.2010.08.012; Pettinati HM, 2008, ADDICT BEHAV, V33, P651, DOI 10.1016/j.addbeh.2007.11.011; Ray LA, 2015, NEUROPSYCHOPHARMACOL, V40, P2347, DOI 10.1038/npp.2015.83; Roberts-Wolfe DJ, 2015, CNS NEUROL DISORD-DR, V14, P745, DOI 10.2174/1871527314666150529144655; Roozen HG, 2004, DRUG ALCOHOL DEPEN, V74, P1, DOI 10.1016/j.drugalcdep.2003.12.006; Runarsdottir V, 2017, J ADDICT MED, V11, P197, DOI 10.1097/ADM.0000000000000297; Saddichha S, 2015, INT J OFFENDER THER, V59, P1487, DOI 10.1177/0306624X14541661; Schierenberg Alwin, 2012, Curr Drug Abuse Rev, V5, P320; Schmitz JM, 2001, ADDICT BEHAV, V26, P167, DOI 10.1016/S0306-4603(00)00098-8; Schumacher JE, 2007, J CONSULT CLIN PSYCH, V75, P823, DOI 10.1037/0022-006X.75.5.823; Sinclair JMA, 2016, DRUG SAFETY, V39, P627, DOI 10.1007/s40264-016-0416-y; Singh M, 2016, ADDICTION, V111, P1337, DOI 10.1111/add.13328; Smith V, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-15; Strickland JC, 2019, DRUG ALCOHOL DEPEN, V204, DOI 10.1016/j.drugalcdep.2019.107592; Torrens M, 2005, DRUG ALCOHOL DEPEN, V78, P1, DOI 10.1016/j.drugalcdep.2004.09.004; U.S. Department of Justice DEA Diversion Control Division. National Forensic Laboratory Information System (NFLIS), 2015, NAT FOR LAB INF SYST; Uhlmann S, 2014, AM J ADDICTION, V23, P393, DOI 10.1111/j.1521-0391.2014.12123.x; Umbricht A, 2014, DRUG ALCOHOL DEPEN, V140, P92, DOI 10.1016/j.drugalcdep.2014.03.033; Willyard C, 2015, NATURE, V522, pS53, DOI 10.1038/522S53a; Winhusen TM, 2014, J CLIN PSYCHIAT, V75, P757, DOI 10.4088/JCP.13m08862; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364	77	46	46	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234809	10.1371/journal.pone.0234809	http://dx.doi.org/10.1371/journal.pone.0234809			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555667	Green Published, gold			2022-12-27	WOS:000543273200047
J	Asemahagn, MA				Asemahagn, Mulusew Andualem			Epidemiology of hepatitis B and C virus infections among patients who booked for surgical procedures at Felegehiwot referral hospital, Northwest Ethiopia	PLOS ONE			English	Article							PREVALENCE	Background Hepatitis B virus(HBV) and hepatitis C virus(HCV) are the main causes of cirrhosis, liver cancer, and death. This study aimed to determine the seroprevalence and associated factors of HBV surface antigen(HBsAg) and anti-HCV among patients screened for surgery at Felegehiwot referral hospital, Northwest Ethiopia. Methods A hospital-based cross-sectional study was conducted among 433 patients in 2018. Data on socio-demographic and risk factors were collected by an exit interview using a pretested structured questionnaire. A venous blood sample of 5ml was collected from each participant, and serum was tested for HBsAg and anti-HCV using one-step rapid test kits and enzyme-linked immunosorbent assay. Multivariable logistic regression analysis was computed to identify factors associated with HBV and HCV infections. The odds ratio with 95%CI was used to describe the strength of association and statistical significance. Results A total of 422 patients gave data and included in the analysis. The mean age of patients was 36 +/- 5 years. About two-thirds, 269(64%) and 274(65%) patients were males, and from rural areas, respectively. The seroprevalence of HBsAg was 34(8%) followed by 18(4.3%) anti-HCV and 4(0.9%) co-infections. Being single(AOR = 1.96, 95%CI = 1.12-3.10), rural residence (AOR = 2.68, 95%CI = 1.28-5.61), ever heard about HBV (AOR = 2.41, 95%CI = 1.18-5.20), having multiple sexual partners(AOR = 2.85, 95%CI = 1.30-5.58), HIV positive(AOR = 3.14, 95%CI = 1.31-7.61), history of tooth extraction(AOR = 3.0, 95%CI = 1.40-6.56), hospitalization history(AOR = 2.95, 95%CI = 1.26-5.81), sharing of sharp instruments (AOR = 3.86, 95%CI = 1.82-8.79), and had blood contact(AOR = 2.64, 95%CI = 1.14-5.42) were statistically significant factors to HBV infection. Similarly, sharing of sharp instruments(AOR = 4.65, 95%CI = 1.32-15.1), tooth extraction practice(AOR = 2.81, 95%CI = 1.12-6.56), surgical history (AOR = 3.68, 95%CI = 1.64-9.82), hospitalization history(AOR = 4.51, 95%CI = 1.62-8.35) and had blood contact(AOR = 3.2, 95%CI = 1.56-8.51) were significant factors to HCV infection. Conclusion The seroprevalence of HBsAg and ant-HCV was high compared to WHO and previous study findings. Giving special attention to awareness creation, rural settings, improving personal behaviors, infection prevention activities of health facilities, quality of healthcare procedures is crucial to prevent viral hepatitis infection.	[Asemahagn, Mulusew Andualem] Bahir Dar Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Bahir Dar, Ethiopia	Bahir Dar University	Asemahagn, MA (corresponding author), Bahir Dar Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	muler.hi@gmail.com			Bahir Dar University	Bahir Dar University	Bahir Dar University covered the budget, but it has no technical role in the research processes.	Ameha Z, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4727-9; [Anonymous], 2018, 2018 AMH REG HLTH BU; [Anonymous], 2017, WHO GLOB HEP REP 201; [Anonymous], 2017, ONCOGENESIS, V6, pe345; [Anonymous], 2019, IMMUNE NETW, V19, pe34; [Anonymous], 2018, J WOMENS HLTH CARE; Ayele AG, 2013, ISRN TROPICAL MED, V2013, P7, DOI DOI 10.1155/2013/563821; Badawi MM, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1060-1; Bafa TA, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312119900870; Binder A, 2013, DOUBLE ANTIBODY SAND, P4; Chernet Asrat, 2017, BMC Res Notes, V10, P418, DOI 10.1186/s13104-017-2702-x; Chisenga CC, 2018, J CLIN VIROL, V98, P5, DOI [10.1016/j.jcv.2017.11.005, 10.101]; Dabsu R, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4792584; Ejeta E, 2019, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00366; Ethiopian Public Health Institute, 2016, ETH PUBL HLTH I NAT; European Centre for Disease Prevention and Control, 2018, HEP B C EP SEL POP G; Ford DA, 2014, ASSOC OPER ROOM NURS, V99, P107, DOI 10.1016/j.aorn.2013.11.013; Hofstraat SHI, 2017, EPIDEMIOL INFECT, V145, P2873, DOI [10.1017/S0950268817001947, 10.1017/s0950268817001947]; Iklaki C. U., 2015, British Journal of Medicine and Medical Research, V8, P324, DOI 10.9734/BJMMR/2015/16397; Javed K, 2006, BLOOD TRANSFUS, V50, P32; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Liu WC, 2014, WORLD J GASTROENTERO, V20, P6252, DOI 10.3748/wjg.v20.i20.6252; Mele A, 2001, J HEPATOL, V35, P284, DOI 10.1016/S0168-8278(01)00111-8; Metaferia Y, 2016, EPIDEMIOLOGY HLTH, V38, P7; Saravanan S, 2009, J MICROBIOL IMMUNOL, V42, P122; Shiferaw E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214755; Taye M, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4456-0; Tsatsralt-Od B, 2005, J MED VIROL, V77, P491, DOI 10.1002/jmv.20482; WHO, 1990, PROT ASS PREV HEP B; WHO, 2013, GLOB POL REP PREV CO, P536289; WHO, 2017, WHO HEP; WHO, 2017, GUID HEP B C VIR TES; Woldegiorgis AE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226890; World Health Organization, 2016, GLOB HLTH SECT STRAT	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234822	10.1371/journal.pone.0234822	http://dx.doi.org/10.1371/journal.pone.0234822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555634	gold, Green Published			2022-12-27	WOS:000542759600050
J	Fearon, E; Tenza, S; Mokoena, C; Moodley, K; Smith, AD; Bourne, A; Weatherburn, P; Palanee-Phillips, T				Fearon, Elizabeth; Tenza, Siyanda; Mokoena, Cecilia; Moodley, Kerushini; Smith, Adrian D.; Bourne, Adam; Weatherburn, Peter; Palanee-Phillips, Thesla			HIV testing, care and viral suppression among men who have sex with men and transgender individuals in Johannesburg, South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TREATMENT CASCADE; PREVENTION; HIV/AIDS; COVERAGE; NETWORK; WORKERS; TRENDS; LOAD	Introduction Men who have sex with men and transgender individuals (MSM/TG) carry a disproportionately high burden of HIV, including in South Africa. However, there are few empirical population-representative estimates of viral suppression and the HIV care cascade including HIV testing among this population, nor of factors associated with these outcomes. Methods We conducted a respondent driven sampling (RDS) survey among 301 MSM/TG in Johannesburg in 2017. Participants gave blood samples for HIV testing and viral load. Participants self-completed a survey including sociodemographics, HIV testing history, and engagement in care. We calculated RDS-II weighted estimates of the percentage of HIV-negative MSM/TG reporting HIV testing in the previous 6 months, their testing experience and preferences. Among those HIV-positive, we estimated the percentage status-aware, on ART, and virally suppressed (<50 viral copies/ml plasma). We conducted RDS-weighted robust Poisson regression to obtain weighted prevalence ratios of factors associated with 1) HIV testing among those HIV-negative; and 2) viral suppression among those HIV-positive. Results There were 118/300 HIV-positive MSM/TG, (37.5%). Of the HIV-negative MSM/TG, 61.5% reported that they had tested for HIV in the previous 6 months, which was associated with selling sex to men (Prevalence Ratio = 1.67, 95% CI 1.36-2.05). There were 76/118 HIV-positive MSM/TG (56.5%) who reported having previously tested positive for HIV and 39/118 (30.0%) who reported current ART. There were 58/118 HIV-positive MSM/TG with viral loads <50 copies/ml plasma (46.9%). Viral suppression was associated with older age (adjusted PR = 1.03, 95% CI 1.00-1.06 for each year), neighbourhood, and having bought sex from men (adjusted PR = 1.53, 95% CI 1.12-2.08). Conclusions HIV prevalence was very high. Viral suppression among those HIV-positive was similar to the general male population in South Africa, but remains far short of national and international targets. A majority of HIV-negative MSM/TG had HIV tested in the previous 6 months, though there is room for improvement.	[Fearon, Elizabeth] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Tenza, Siyanda; Mokoena, Cecilia; Moodley, Kerushini; Palanee-Phillips, Thesla] Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Smith, Adrian D.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Bourne, Adam] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Weatherburn, Peter] London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; La Trobe University; University of London; London School of Hygiene & Tropical Medicine	Fearon, E (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England.	Elizabeth.Fearon@lshtm.ac.uk	Palanee-Phillips, Thesla/ABD-2449-2020	Weatherburn, Peter/0000-0002-4950-6163; Smith, Adrian/0000-0003-0036-1490; Palanee-Phillips, Thesla/0000-0002-0052-5830; Fearon, Elizabeth/0000-0001-5574-251X	Evidence for HIV prevention in Southern Africa (EHPSA) programme - UK aid from the Department for International Development, and Sweden, through the Swedish International Development Agency (SIDA) [MM/EHPSA/WHC/0116029]	Evidence for HIV prevention in Southern Africa (EHPSA) programme - UK aid from the Department for International Development, and Sweden, through the Swedish International Development Agency (SIDA)	This study was funded through the Evidence for HIV prevention in Southern Africa (EHPSA) programme (http://www.ehpsa.org/, grant number MM/EHPSA/WHC/0116029, PI Thesla Palanee-Phillips) funded by UK aid from the Department for International Development, and Sweden, through the Swedish International Development Agency (SIDA), mandated to represent the Norwegian Agency for Development Cooperation (Norad), and managed by Mott Macdonald. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDSinfo, 2018, COUNTR FACTSH S AFR; [Anonymous], 2018, DEV COGN NEUROSCI, V21, DOI 10.1016/S1878-9293(18)30129-4; [Anonymous], 2014, ARTHRITIS RHEUM S, V66, pS690; [Anonymous], 2013, AM J KIDNEY DIS    S, V63, pe1; Babor T.F., 1992, AUDIT ALCOHOL USE DI; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Beyrer C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002154; Beyrer C, 2016, LANCET, V388, P198, DOI 10.1016/S0140-6736(16)30781-4; Charurat ME, 2015, JAIDS-J ACQ IMM DEF, V68, pS114, DOI 10.1097/QAI.0000000000000439; Chen WS, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0519-5; Cloete A., 2014, S AFRICAN MARANG MEN; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cowan FM, 2017, JAIDS-J ACQ IMM DEF, V74, P375, DOI 10.1097/qai.0000000000001255; Fearon E, 2019, U NAIR COLL M HIV ST; Fogel JM, 2018, AIDS BEHAV; Friedman MR, 2015, AIDS, V29, P1087, DOI 10.1097/QAD.0000000000000657; Gile KJ, 2015, J R STAT SOC A STAT, V178, P241, DOI 10.1111/rssa.12059; Hakim AJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207363; Handcock MS, 2019, RDS RESPONDENT DRIVE; Hermans LE, 2018, LANCET INFECT DIS, V18, P188, DOI 10.1016/S1473-3099(17)30681-3; Hladik W, 2017, AIDS BEHAV, V21, P1478, DOI 10.1007/s10461-016-1535-2; Hoots BE, 2019, AIDS, V33, P913, DOI 10.1097/QAD.0000000000002147; Jobson G, 2018, AIDS CARE, V30, P1421, DOI 10.1080/09540121.2018.1465175; Johnson LF, 2018, EPIDEMIOL INFECT, V146, P1036, DOI 10.1017/S0950268818000961; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Lane T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111063; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Lippman SA, 2018, JAIDS-J ACQ IMM DEF, V77, P279, DOI [10.1097/QAI.0000000000001601, 10.1097/qai.0000000000001601]; Lumley T., 2018, SURVEY ANAL COMPLEX; Makusha T, 2017, PUBLIC HEALTH, V143, P1, DOI 10.1016/j.puhe.2016.10.017; Mooney AC, 2018, AIDS BEHAV; National Department of Health Republic of South Africa, 2019, 2019 ART CLIN GUID M; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Rees K, 2017, SEX TRANSM DIS, V44, P768, DOI 10.1097/OLQ.0000000000000679; Reniers G, 2014, AIDS, V28, pS533, DOI 10.1097/QAD.0000000000000496; Risher K, 2015, CURR OPIN HIV AIDS, V10, P420, DOI 10.1097/COH.0000000000000200; Rodger AJ, 2019, LANCET; Sabin KM, 2014, CURR OPIN HIV AIDS, V9, P101, DOI 10.1097/COH.0000000000000046; Scheibe A, 2018, AIDS BEHAV, V22, P853, DOI 10.1007/s10461-017-1773-y; Shaver John, 2017, J Int Assoc Provid AIDS Care, V16, P562, DOI 10.1177/2325957417736611; Siegler AJ, 2015, AIDS CARE, V27, P229, DOI 10.1080/09540121.2014.947914; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Solomon SS, 2016, LANCET HIV, V3, pE183, DOI 10.1016/S2352-3018(16)00019-9; South African Demographic Health Survey, 2017, S AFR DEM HLTH SURV, P1; South African National AIDS Council, 2017, LET OUR ACT COUNT S; Stannah J, 2019, LANCET HIV, V6, pE769, DOI 10.1016/S2352-3018(19)30239-5; StataCorp, 2011, STAT STAT SOFTW REL; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Team RC., 2013, R LANG ENV STAT COMP; UNAIDS, 2014, UND FAST TRACK ACC A; UNAIDS, 2018, FACT SHEET HIV MEN S; University of California San Francisco, 2015, REP S AFR MEN WHO HA; Volz E, 2008, J OFF STAT, V24, P79; WHO, 2018, FOC KEY POP NAT HIV; Witzel TC, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4370-0; Zahn R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147156	57	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234384	10.1371/journal.pone.0234384	http://dx.doi.org/10.1371/journal.pone.0234384			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555703	Green Published, gold			2022-12-27	WOS:000542759600057
J	Perez, AR; Queiro, R; Seoane-Mato, D; Graell, E; Chamizo, E; Chaparro, LC; Herrera, SR; Dolset, JP; Ostariz, MAP; Garrido, SRA; Macia-Villa, C; Cruz-Valenciano, A; Gomez, MLG; Sanchez-Piedra, C; Diaz-Gonzalez, F; Bustabad-Reyes, S				Romero Perez, Antonio; Queiro, Ruben; Seoane-Mato, Daniel; Graell, Eduard; Chamizo, Eugenio; Chaves Chaparro, Lara; Rojas Herrera, Sara; Pons Dolset, Jordi; Polo Ostariz, Miguel A.; Ruiz-Alejos Garrido, Susana; Macia-Villa, Cristina; Cruz-Valenciano, Ana; Gonzalez Gomez, Maria L.; Sanchez-Piedra, Carlos; Diaz-Gonzalez, Federico; Bustabad-Reyes, Sagrario		Proyecto EPISER2016 Working Grp	Higher prevalence of psoriatic arthritis in the adult population in Spain? A population-based cross-sectional study	PLOS ONE			English	Article							CLINICAL-FEATURES; NONRESPONSE RATES; EPIDEMIOLOGY; BIAS	Objective The prevalence of psoriatic arthritis (PsA) is very heterogeneous. There are no data on its frequency in the general population in Spain. The aim of EPISER2016 study was to estimate the prevalence of PsA in people aged >= 20 years in Spain. Methods Cross-sectional multicenter population-based study. Subjects from all the autonomous communities in Spain were randomly selected using multistage stratified cluster sampling. Participants in each of the municipalities randomly selected for the study were administered a telephone-based questionnaire to screen for the study diseases. If the participant reported being previously diagnosed, rheumatologists from the participant's reference hospital confirmed the diagnosis based on a review of the clinical history. Subjects not previously diagnosed but whose screening result was positive based on symptoms received a second telephone call from the investigating rheumatologist in order to evaluate the suspicion. If the suspicion remained, an appointment was made at the reference hospital to complete the diagnostic confirmation process according to CASPAR criteria. To calculate the prevalence and its 95% confidence interval (CI), the sample design was taken into account and weighing was calculated considering age, sex and geographic origin. Results The sample comprised 4916 subjects. The prevalence of PsA was 0.58% (95%CI: 0.38-0.87). All but 1 of the 27 cases (96.30%) had been diagnosed prior to EPISER2016. Conclusion The prevalence of PsA in Spain was among the highest reported to date, only below that reported in Norway (0.67%) and slightly higher than that reported in Italy (0.42%).	[Romero Perez, Antonio] Complejo Hosp Jaen, Dept Rheumatol, Jaen, Spain; [Queiro, Ruben] Hosp Univ Cent Asturias, Dept Rheumatol, Oviedo, Asturias, Spain; [Seoane-Mato, Daniel; Sanchez-Piedra, Carlos] Spanish Soc Rheumatol, Res Unit, Madrid, Spain; [Graell, Eduard] Hosp Univ Parc Tauli, Dept Rheumatol, Barcelona, Spain; [Chamizo, Eugenio; Chaves Chaparro, Lara; Rojas Herrera, Sara] Hosp Merida, Dept Rheumatol, Badajoz, Spain; [Pons Dolset, Jordi; Polo Ostariz, Miguel A.; Ruiz-Alejos Garrido, Susana] Fdn Hosp Calahorra, Dept Rheumatol, Calahorra, La Rioja, Spain; [Macia-Villa, Cristina; Cruz-Valenciano, Ana] Hosp Univ Severo Ochoa, Dept Rheumatol, Madrid, Spain; [Gonzalez Gomez, Maria L.] Hosp El Escorial, Dept Rheumatol, Madrid, Spain; [Diaz-Gonzalez, Federico] Univ La Laguna, San Cristobal la Laguna, Santa Cruz De T, Spain; [Diaz-Gonzalez, Federico; Bustabad-Reyes, Sagrario] Hosp Univ Canarias, Dept Rheumatol, San Cristobal la Laguna, Santa Cruz De T, Spain	Complejo Hospitalario de Jaen; Central University Hospital Asturias; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Severo Ochoa University Hospital; Universidad de la Laguna; Universidad de la Laguna	Seoane-Mato, D (corresponding author), Spanish Soc Rheumatol, Res Unit, Madrid, Spain.; Bustabad-Reyes, S (corresponding author), Hosp Univ Canarias, Dept Rheumatol, San Cristobal la Laguna, Santa Cruz De T, Spain.	daniel.seoane@ser.es; sagrario.bustabad@gmail.com	Silva, Rúben/GYE-3599-2022; Queiro, Rubén/D-5358-2016	Queiro, Rubén/0000-0002-8418-7145; Macia-Villa, Cristina/0000-0002-6822-6730	Celgene; Gebro Pharma; Merck Sharp Dohme in Spain; Pfizer; Sanofi-Aventis	Celgene(Bristol-Myers SquibbCelgene Corporation); Gebro Pharma; Merck Sharp Dohme in Spain; Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis)	EPISER2016 was financially supported by Celgene (https://www.celgene.com/), Gebro Pharma (https://www.gebro.com/en/), Merck Sharp & Dohme in Spain (https://www.msd.es/), Pfizer (https://www.pfizer.com/) and Sanofi-Aventis/https://www.sanofi.com/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomaviciute D, 2008, SCAND J RHEUMATOL, V37, P113, DOI 10.1080/03009740701774966; [Anonymous], 2017, PEW RES CTR; Burgos-Pol R, 2016, ACTAS DERMO-SIFILOGR, V107, P577, DOI 10.1016/j.ad.2016.04.018; Cakir N, 2012, RHEUMATOL INT, V32, P895, DOI 10.1007/s00296-010-1699-4; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Donmez S, 2015, CLIN RHEUMATOL, V34, P1091, DOI 10.1007/s10067-014-2746-4; Eder L, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-017-1497-4; Ferrandiz C, 2014, ACTAS DERMO-SIFILOGR, V105, P504, DOI 10.1016/j.ad.2013.12.008; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gelfand JM, 2005, J AM ACAD DERMATOL, V53, P573, DOI 10.1016/j.jaad.2005.03.046; Gratacos J, 2014, REUMATOL CLIN, V10, P25, DOI 10.1016/j.reuma.2013.05.006; Groves RM, 2008, PUBLIC OPIN QUART, V72, P167, DOI 10.1093/poq/nfn011; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Halbesleben JRB, 2013, HEALTH SERV RES, V48, P913, DOI 10.1111/1475-6773.12002; Hoff M, 2015, ANN RHEUM DIS, V74, P60, DOI 10.1136/annrheumdis-2013-203862; Li R, 2012, RHEUMATOLOGY, V51, P721, DOI 10.1093/rheumatology/ker370; Estebaranz JLL, 2015, EUR J DERMATOL, V25, P57, DOI 10.1684/ejd.2014.2449; Madland TM, 2005, J RHEUMATOL, V32, P1918; Ogdie A, 2013, RHEUMATOLOGY, V52, P568, DOI 10.1093/rheumatology/kes324; Salaffi F, 2005, CLIN EXP RHEUMATOL, V23, P819; Scotti L, 2018, SEMIN ARTHRITIS RHEU, V48, P28, DOI 10.1016/j.semarthrit.2018.01.003; Seoane-Mato D., 2019, EPISER 2016 study, descriptive analysis of fieldwork and characteristics of the sample; Seoane-Mato D, 2019, REUMATOL CLIN, V15, P90, DOI 10.1016/j.reuma.2017.06.009; Sewerin P, 2019, ANN RHEUM DIS, V78, P286, DOI 10.1136/annrheumdis-2018-214065; Soriano ER, 2011, RHEUMATOLOGY, V50, P729, DOI 10.1093/rheumatology/keq369; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Vallance JK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-486; Wilson FC, 2009, J RHEUMATOL, V36, P361, DOI 10.3899/jrheum.080691	28	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234556	10.1371/journal.pone.0234556	http://dx.doi.org/10.1371/journal.pone.0234556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555622	gold, Green Published			2022-12-27	WOS:000542759600004
J	Klak, M; Gomolka, M; Dobrzanski, T; Tymicki, G; Cywoniuk, P; Kowalska, P; Kosowska, K; Bryniarski, T; Berman, A; Dobrzyn, A; Idaszek, J; Swieszkowski, W; Wszola, M				Klak, M.; Gomolka, M.; Dobrzanski, T.; Tymicki, G.; Cywoniuk, P.; Kowalska, P.; Kosowska, K.; Bryniarski, T.; Berman, A.; Dobrzyn, A.; Idaszek, J.; swieszkowski, W.; Wszola, M.			Irradiation with 365 nm and 405 nm wavelength shows differences in DNA damage of swine pancreatic islets	PLOS ONE			English	Article							COMET ASSAY; HIGH-INTENSITY; STRAND BREAKS; BLUE-LIGHT; UV; REPAIR; ULTRAVIOLET; ARCHITECTURE; FIBROBLASTS; RADIATION	Introduction 3D printing is being used more extensively in modern biomedicine. One of the problems is selecting a proper crosslinking method of bioprinted material. Amongst currently used techniques we can distinguish: physical crosslinking (e.g. Ca(2+)and Sr2+) and chemical crosslinking-the UV light crosslinking causing the biggest discussion. UV radiation is selectively absorbed by DNA, mainly in the UV-B region but also (to some extent) in UV-A and UV-C regions. DNA excitement results in typical photoproducts. The amount of strand breaks may vary depending on the period of exposition, it can also differ when cells undergo incubation after radiation. Aim The aim of this study was to show whether and how the time of irradiation with 405 nm and 365 nm wavelengths affect DNA damage in cell lines and micro-organs (pancreatic islets). Materials and methods The degree of DNA damage caused by different wavelengths of radiation (405 nm and 365 nm) was evaluated by a comet assay. The test was performed on fibroblasts, alpha cells, beta cells and porcine pancreatic islets after 24 hours incubation period. Samples without radiation treatment were selected as a control group. Results analysis consisted of determining the percent of cells with damaged DNA and the tail intensity evaluation. Results The degree of DNA damage in pancreatic islets after exposure to 405 nm wavelength oscillated between 2% and 6% depending on the tested time period (10 - 300 seconds). However, treating islets using 365 nm wavelength resulted in damage up to 50%. This clearly shows significantly less damage when using 405 nm wavelength. Similar results were obtained for the tested cell lines. Conclusions Crosslinking with 405 nm is better for pancreatic islets than crosslinking with 365 nm UV light.	[Klak, M.; Gomolka, M.; Dobrzanski, T.; Tymicki, G.; Cywoniuk, P.; Kowalska, P.; Kosowska, K.; Bryniarski, T.; Berman, A.; Wszola, M.] Fdn Res & Sci Dev, Warsaw, Poland; [Dobrzyn, A.] Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland; [Idaszek, J.; swieszkowski, W.] Warsaw Univ Technol, Fac Mat Sci & Engn, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Warsaw University of Technology	Wszola, M (corresponding author), Fdn Res & Sci Dev, Warsaw, Poland.	michal.wszola@fundacjabirn.pl	Berman, Andrzej/GRX-4747-2022; Gomółka, Magdalena/AAL-5101-2021; Dobrzyn, Agnieszka/R-4073-2016	Gomółka, Magdalena/0000-0002-7067-5252; Swieszkowski, Wojciech/0000-0003-4216-9974; Kowalska, Patrycja/0000-0003-0635-7214; Cywoniuk, Piotr/0000-0003-1827-5283; Dobrzyn, Agnieszka/0000-0002-6331-9460; Wszola, Michal/0000-0001-5920-4065; Klak, Marta/0000-0003-3901-586X	National Centre for Research and Development [STRATEGMED3/305813/2/NCBR/2017]	National Centre for Research and Development(National Centre for Research & Development, Poland)	This study was financially supported by The National Centre for Research and Development. Grant no. STRATEGMED3/305813/2/NCBR/2017 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock C, 1998, MUTAT RES-DNA REPAIR, V408, P111, DOI 10.1016/S0921-8777(98)00023-8; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Chimene D, 2016, ANN BIOMED ENG, V44, P2090, DOI 10.1007/s10439-016-1638-y; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Edstrom DW, 2001, PHOTODERMATOL PHOTO, V17, P66, DOI 10.1034/j.1600-0781.2001.017002066.x; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Garcia O, 2004, MUTAT RES-FUND MOL M, V556, P25, DOI 10.1016/j.mrfmmm.2004.06.035; Grskovic B, 2013, CROAT MED J, V54, P263, DOI 10.3325/cmj.2013.54.263; Hoeijmakers JHJ, 2009, DNA DAMAGE AGING CAN, P1475; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; Ilieva A, 1999, J ENDOCRINOL, V161, P357, DOI 10.1677/joe.0.1610357; Kawada A, 2002, J DERMATOL SCI, V30, P129, DOI 10.1016/S0923-1811(02)00068-3; Kielbassa C, 1997, CARCINOGENESIS, V18, P811, DOI 10.1093/carcin/18.4.811; Kleinpenning MM, 2010, PHOTODERMATOL PHOTO, V26, P16, DOI 10.1111/j.1600-0781.2009.00474.x; Lankinen MH, 1996, MUTAT RES-FUND MOL M, V352, P31, DOI 10.1016/0027-5107(95)00172-7; Mandrycky C, 2016, BIOTECHNOL ADV, V34, P422, DOI 10.1016/j.biotechadv.2015.12.011; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Pati F, 2016, ANGEW CHEM INT EDIT, V55, P4650, DOI 10.1002/anie.201505062; Patton WP, 1999, INVEST OPHTH VIS SCI, V40, P3268; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; ROSENSTEIN BS, 1983, PHOTOCHEM PHOTOBIOL, V38, P51, DOI 10.1111/j.1751-1097.1983.tb08365.x; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Skardal A, 2015, ANN BIOMED ENG, V43, P730, DOI 10.1007/s10439-014-1207-1; Smith S, 2009, IFMBE PROC, V23, P1352; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815; Wang ZJ, 2016, RSC ADV, V6, P21099, DOI 10.1039/c5ra24910d; Wang ZJ, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/4/045009	28	6	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235052	10.1371/journal.pone.0235052	http://dx.doi.org/10.1371/journal.pone.0235052			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584858	Green Published, gold			2022-12-27	WOS:000545747200071
J	Knuff-Janzen, K; Tupin, A; Yurist-Doutsch, S; Rowland, JL; Finlay, BB				Knuff-Janzen, Katelyn; Tupin, Audrey; Yurist-Doutsch, Sophie; Rowland, Jennifer L.; Finlay, B. Brett			MultipleSalmonella-pathogenicity island 2 effectors are required to facilitate bacterial establishment of its intracellular niche and virulence	PLOS ONE			English	Article							III SECRETION SYSTEM; ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA-CONTAINING VACUOLES; ENDOSOMAL SYSTEM; TRANSLOCATED EFFECTORS; MEMBRANE DYNAMICS; INDUCED FILAMENTS; LYSOSOME FUSION; SIFA; PROTEINS	The pathogenesis ofSalmonellaTyphimurium depends on the bacterium's ability to survive and replicate within host cells. The formation and maintenance of a unique membrane-bound compartment, termed theSalmonella-containing vacuole (SCV), is essential forS. Typhimurium pathogenesis. SCV-boundS. Typhimurium induces formation of filamentous tubules that radiate outwards from the SCV, termedSalmonella-induced filaments (SIFs). SIF formation is concomitant with the onset of replication within host epithelial cells. SIF biogenesis, formation and maintenance of the SCV, and the intracellular positioning of the SCV within the host cell requires translocation of bacterial proteins (effectors) into the host cell. Effectors secreted by the type III secretion system encoded onSalmonellapathogenicity island 2 (T3SS2) function to interfere with host cellular processes and promote both intracellular survival and replication ofS. Typhimurium. Seven T3SS2-secreted effectors, SifA, SopD2, PipB2, SteA, SseJ, SseF, and SseG have previously been implicated to play complementary, redundant, and/or antagonistic roles with respect to SIF biogenesis, intracellular positioning of the SCV, and SCV membrane dynamics modulation during infection. We undertook a systematic study to delineate the contribution of each effector to these processes by (i) deleting all seven of these effectors in a singleS. Typhimurium strain; and (ii) deleting combinations of multiple effectors based on putative effector function. Using this deletion mutant library, we show that each of SIF biogenesis, intracellular SCV localization, intramacrophage replication, colonization, and virulence depends on the activities of multiple effectors. Together, our data demonstrates the complex interplay between these seven effectors and highlights the necessity to study T3SS2-secreted effectors as groups, rather than studies of individual effectors.	[Knuff-Janzen, Katelyn; Tupin, Audrey; Yurist-Doutsch, Sophie; Rowland, Jennifer L.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Knuff-Janzen, Katelyn; Tupin, Audrey; Yurist-Doutsch, Sophie; Rowland, Jennifer L.; Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Finlay, B. Brett] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Finlay, BB (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada.; Finlay, BB (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada.; Finlay, BB (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada.	bfinlay@msl.ubc.ca		Finlay, Brett/0000-0001-5303-6128; Rowland, Jennifer/0000-0002-5560-9943	Canadian Institutes of Health Research [FDN-15993]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Research reported in this publication was supported by the Canadian Institutes of Health Research under the award number FDN-15993 (B. B.F). The funders had no role in study design, data collection, and analysis, decisions to publish, or preparation of the manuscript.	Abrahams GL, 2006, TRAFFIC, V7, P950, DOI 10.1111/j.1600-0854.2006.00454.x; [Anonymous], 2011, J ANCIENT JUDAISM, V2, P208; Auweter SD, 2011, J BIOL CHEM, V286, P24023, DOI 10.1074/jbc.M111.224600; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Birmingham CL, 2005, INFECT IMMUN, V73, P1204, DOI 10.1128/IAI.73.2.1204-1208.2005; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Brumell JH, 2001, TRAFFIC, V2, P643, DOI 10.1034/j.1600-0854.2001.20907.x; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; BUCHMEIER NA, 1991, INFECT IMMUN, V59, P2232, DOI 10.1128/IAI.59.7.2232-2238.1991; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Deiwick J, 2006, INFECT IMMUN, V74, P6965, DOI 10.1128/IAI.00648-06; Diacovich L, 2009, J BIOL CHEM, V284, P33151, DOI 10.1074/jbc.M109.034975; Domingues L, 2014, INFECT IMMUN, V82, P2923, DOI 10.1128/IAI.01385-13; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Drecktrah D, 2008, TRAFFIC, V9, P2117, DOI 10.1111/j.1600-0854.2008.00830.x; Dumont A, 2010, TRAFFIC, V11, P899, DOI 10.1111/j.1600-0854.2010.01069.x; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Eswarappa SM, 2010, INFECT IMMUN, V78, P68, DOI 10.1128/IAI.00668-09; Ferrieres L, 2010, J BACTERIOL, V192, P6418, DOI 10.1128/JB.00621-10; Fierer J, 2012, INFECT IMMUN, V80, P3360, DOI 10.1128/IAI.00404-12; Figueira R, 2013, MBIO, V4, DOI 10.1128/mBio.00065-13; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; Freeman JA, 2003, INFECT IMMUN, V71, P418, DOI 10.1128/IAI.71.1.418-427.2003; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; Garvis SG, 2001, CELL MICROBIOL, V3, P731, DOI 10.1046/j.1462-5822.2001.00153.x; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Harrison RE, 2004, MOL BIOL CELL, V15, P3146, DOI 10.1091/mbc.E04-02-0092; Hashim S, 2000, J BIOL CHEM, V275, P16281, DOI 10.1074/jbc.275.21.16281; Henry T, 2006, CELL MICROBIOL, V8, P23, DOI 10.1111/j.1462-5822.2005.00649.x; Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jennings E, 2017, CELL HOST MICROBE, V22, P217, DOI 10.1016/j.chom.2017.07.009; Jiang XJ, 2004, MOL MICROBIOL, V54, P1186, DOI 10.1111/j.1365-2958.2004.04344.x; Kaniuk NA, 2011, CELL MICROBIOL, V13, P1812, DOI 10.1111/j.1462-5822.2011.01663.x; Knodler LA, 2005, MOL BIOL CELL, V16, P4108, DOI 10.1091/mbc.e05-04-0367; Krieger V, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004374; Kuhle V, 2006, TRAFFIC, V7, P716, DOI 10.1111/j.1600-0854.2006.00422.x; Kuhle V, 2002, CELL MICROBIOL, V4, P813, DOI 10.1046/j.1462-5822.2002.00234.x; LaRock DL, 2015, NAT REV MICROBIOL, V13, P191, DOI 10.1038/nrmicro3420; LaRock DL, 2012, J BIOL CHEM, V287, P29654, DOI 10.1074/jbc.M112.363598; LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470; Liss V, 2017, CELL HOST MICROBE, V21, P390, DOI 10.1016/j.chom.2017.02.005; Liss V, 2015, CELL MICROBIOL, V17, P639, DOI 10.1111/cmi.12441; Marsman M, 2004, MOL BIOL CELL, V15, P2954, DOI 10.1091/mbc.E03-08-0614; Matsuda S, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00872-18; McEwan DG, 2015, MOL CELL, V57, P39, DOI 10.1016/j.molcel.2014.11.006; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Miao EA, 2003, MOL MICROBIOL, V48, P401, DOI 10.1046/j.1365-2958.2003.t01-1-03456.x; Moest T, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12951; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Pfeifer CG, 1999, INFECT IMMUN, V67, P5690, DOI 10.1128/IAI.67.11.5690-5698.1999; Popp J, 2015, INFECT IMMUN, V83, P4466, DOI 10.1128/IAI.00624-15; Rajashekar R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115423; Rajashekar R, 2008, TRAFFIC, V9, P2100, DOI 10.1111/j.1600-0854.2008.00821.x; Ramsden AE, 2007, TRENDS MICROBIOL, V15, P516, DOI 10.1016/j.tim.2007.10.002; Ramsden AE, 2007, CELL MICROBIOL, V9, P2517, DOI 10.1111/j.1462-5822.2007.00977.x; Reinicke AT, 2005, J BIOL CHEM, V280, P14620, DOI 10.1074/jbc.M500076200; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Schroeder N, 2011, TRENDS MICROBIOL, V19, P268, DOI 10.1016/j.tim.2011.01.006; Schroeder N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001002; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Smith AC, 2005, J BIOL CHEM, V280, P24634, DOI 10.1074/jbc.M500358200; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Szeto J, 2009, INFECT IMMUN, V77, P996, DOI 10.1128/IAI.01275-08; Wasylnka JA, 2008, INFECT IMMUN, V76, P2722, DOI 10.1128/IAI.00152-08; Zhao WD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12979	78	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235020	10.1371/journal.pone.0235020	http://dx.doi.org/10.1371/journal.pone.0235020			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584855	Green Published, gold			2022-12-27	WOS:000545747200085
J	Kontopoulos, I; Penkman, K; Mullin, VE; Winkelbach, L; Unterlander, M; Scheu, A; Kreutzer, S; Hansen, HB; Margaryan, A; Teasdale, MD; Gehlen, B; Street, M; Lynnerup, N; Liritzis, I; Sampson, A; Papageorgopoulou, C; Allentoft, ME; Burger, J; Bradley, DG; Collins, MJ				Kontopoulos, Ioannis; Penkman, Kirsty; Mullin, Victoria E.; Winkelbach, Laura; Unterlaender, Martina; Scheu, Amelie; Kreutzer, Susanne; Hansen, Henrik B.; Margaryan, Ashot; Teasdale, Matthew D.; Gehlen, Birgit; Street, Martin; Lynnerup, Niels; Liritzis, Ioannis; Sampson, Adamantios; Papageorgopoulou, Christina; Allentoft, Morten E.; Burger, Joachim; Bradley, Daniel G.; Collins, Matthew J.			Screening archaeological bone for palaeogenetic and palaeoproteomic studies	PLOS ONE			English	Article							AMINO-ACID RACEMIZATION; ANCIENT DNA; PRESERVATION; COLLAGEN; DIAGENESIS; IDENTIFICATION; DEGRADATION; CARBON; SITES; DECAY	The recovery and analysis of ancient DNA and protein from archaeological bone is time-consuming and expensive to carry out, while it involves the partial or complete destruction of valuable or rare specimens. The fields of palaeogenetic and palaeoproteomic research would benefit greatly from techniques that can assess the molecular quality prior to sampling. To be relevant, such screening methods should be effective, minimally-destructive, and rapid. This study reports results based on spectroscopic (Fourier-transform infrared spectroscopy in attenuated total reflectance [FTIR-ATR]; n = 266), palaeoproteomic (collagen content; n = 226), and palaeogenetic (endogenous DNA content; n = 88) techniques. We establish thresholds for three different FTIR indices, a) the infrared splitting factor [IRSF] that assesses relative changes in bioapatite crystals' size and homogeneity; b) the carbonate-to-phosphate [C/P] ratio as a relative measure of carbonate content in bioapatite crystals; and c) the amide-to-phosphate ratio [Am/P] for assessing the relative organic content preserved in bone. These thresholds are both extremely reliable and easy to apply for the successful and rapid distinction between well- and poorly-preserved specimens. This is a milestone for choosing appropriate samples prior to genomic and collagen analyses, with important implications for biomolecular archaeology and palaeontology.	[Kontopoulos, Ioannis] Univ York, Dept Archaeol, BioArCh, York, N Yorkshire, England; [Penkman, Kirsty] Univ York, Dept Chem, BioArCh, York, N Yorkshire, England; [Mullin, Victoria E.; Teasdale, Matthew D.; Bradley, Daniel G.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Mullin, Victoria E.] Nat Hist Museum, Dept Earth Sci, London, England; [Winkelbach, Laura; Unterlaender, Martina; Scheu, Amelie; Kreutzer, Susanne; Burger, Joachim] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut iomE, Palaeogenet Grp, Mainz, Germany; [Unterlaender, Martina; Papageorgopoulou, Christina] Democritus Univ Thrace, Dept Hist & Ethnol, Lab Phys Anthropol, Komotini, Greece; [Unterlaender, Martina] German Fed Criminal Police Off, Wiesbaden, Germany; [Kontopoulos, Ioannis; Hansen, Henrik B.; Margaryan, Ashot; Allentoft, Morten E.] Univ Copenhagen, GLOBE Inst, Ctr GeoGenet, Copenhagen, Denmark; [Teasdale, Matthew D.; Collins, Matthew J.] Univ Cambridge, McDonald Inst Archaeol Res, Dept Archaeol, Cambridge, England; [Gehlen, Birgit] Cologne Univ, Collaborat Res Ctr, Project D4, Cologne, Germany; [Street, Martin] RGZM Leibniz Res Inst Archaeol, MONREPOS Archaeol Res Ctr, Neuwied, Germany; [Street, Martin] RGZM Leibniz Res Inst Archaeol, Museum Human Behav Evolut, Neuwied, Germany; [Lynnerup, Niels] Univ Copenhagen, Dept Forens Med, Unit Forens Anthropol, Copenhagen, Denmark; [Liritzis, Ioannis] Univ Aegean, Dept Mediterranean Studies, Lab Archaeometry, Rhodes, Greece; [Liritzis, Ioannis] Henan Univ, Key Res Inst Yellow River Civilizat & Sustainable, Ctr Yellow River Civilizat Henan Prov, Kaifeng, Peoples R China; [Sampson, Adamantios] Univ Aegean, Dept Mediterranean Studies, Rhodes, Greece; [Collins, Matthew J.] Univ Copenhagen, Globe Inst, Ctr Evogenom, Copenhagen, Denmark	University of York - UK; University of York - UK; Trinity College Dublin; Natural History Museum London; Johannes Gutenberg University of Mainz; Democritus University of Thrace; University of Copenhagen; University of Cambridge; University of Cologne; University of Copenhagen; University of Aegean; Henan University; University of Aegean; University of Copenhagen	Kontopoulos, I (corresponding author), Univ York, Dept Archaeol, BioArCh, York, N Yorkshire, England.	ioanniskontopoulos1@gmail.com	LIRITZIS, IOANNIS/A-9444-2013; Kontopoulos, Ioannis/AAY-6367-2020	Kontopoulos, Ioannis/0000-0001-5591-8917; papageorgopoulou, Christina/0000-0002-4145-950X; Margaryan, Ashot/0000-0002-2576-2429; Street, Martin/0000-0002-1707-604X; Allentoft, Morten/0000-0003-4424-3568; Teasdale, Matthew David/0000-0002-7376-9975; Kreutzer, Susanne/0000-0001-6286-534X; LIRITZIS, IOANNIS/0000-0003-3079-1336	Onassis Foundation [F ZL 047-1/2015-2016]; Leventis Foundation; Greek Archaeological Committee UK (GACUK); Leverhulme Trust [PLP-2012-116]; DNRF [DNRF 128]; EU Social Fund; Greek national funds research program ARISTEIA II; Villum Foundation (Young Investigator Programme) [10120]; Sino-Hellenic Academic Project, from the Key Research Institute of the Yellow River Civilization and Sustainable Development and Collaborative Innovation Center on the Yellow River Civilization of Henan Province, Henan University, Kaifeng, China; ERC [295729-CodeX]	Onassis Foundation; Leventis Foundation; Greek Archaeological Committee UK (GACUK); Leverhulme Trust(Leverhulme Trust); DNRF; EU Social Fund; Greek national funds research program ARISTEIA II; Villum Foundation (Young Investigator Programme)(Villum Fonden); Sino-Hellenic Academic Project, from the Key Research Institute of the Yellow River Civilization and Sustainable Development and Collaborative Innovation Center on the Yellow River Civilization of Henan Province, Henan University, Kaifeng, China; ERC(European Research Council (ERC)European Commission)	IK is grateful to Onassis Foundation (Grant no. F ZL 047-1/2015-2016), Leventis Foundation and the Greek Archaeological Committee UK (GACUK). KP thanks the Leverhulme Trust (PLP-2012-116), MJC thanks the DNRF for the award of a Niels Bohr Professorship (DNRF 128), and MJC and DGB thank the ERC Investigator grant 295729-CodeX. MU and CP were cofinanced by the EU Social Fund and the Greek national funds research funding program ARISTEIA II. MEA was funded by The Villum Foundation (Young Investigator Programme, grant no. 10120). IL is thankful for the partial funding support for this work, which is part of the Sino-Hellenic Academic Project, from the Key Research Institute of the Yellow River Civilization and Sustainable Development and Collaborative Innovation Center on the Yellow River Civilization of Henan Province, Henan University, Kaifeng, China.	Adler CJ, 2011, J ARCHAEOL SCI, V38, P956, DOI 10.1016/j.jas.2010.11.010; Alexander MM, 2019, ARCHAEOL ANTHROP SCI, V11, P3875, DOI 10.1007/s12520-019-00810-x; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Bada JL, 1999, PHILOS T ROY SOC B, V354, P77, DOI 10.1098/rstb.1999.0361; Bocherens H, 2005, ANTHROPOLOGIE, V109, P557, DOI 10.1016/j.anthro.2005.06.005; Botigue LR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16082; Bouwrnan AS, 2008, J ARCHAEOL SCI, V35, P2580, DOI 10.1016/j.jas.2008.04.010; Brandt E, 2002, INT J OSTEOARCHAEOL, V12, P307, DOI 10.1002/oa.624; Brock F, 2010, J ARCHAEOL SCI, V37, P855, DOI 10.1016/j.jas.2009.11.015; Brock F, 2012, RADIOCARBON, V54, P879, DOI 10.1017/S0033822200047524; Brown T, 2011, P 2011 PART ACC C; Burger J, 1999, ELECTROPHORESIS, V20, P1722; Campos PF, 2012, ANN ANAT, V194, P7, DOI 10.1016/j.aanat.2011.07.003; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Chadefaux C., 2009, E PRESERVATION SCI, V6, P129, DOI DOI 10.1016/J.SAA.2019.118006; Collins MJ, 2009, P ROY SOC B-BIOL SCI, V276, P2971, DOI 10.1098/rspb.2009.0563; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; COLLINS MJ, 1995, J ARCHAEOL SCI, V22, P175, DOI 10.1006/jasc.1995.0019; Demarchi B, 2016, ELIFE, V5, DOI 10.7554/eLife.17092; DENIRO MJ, 1988, GEOCHIM COSMOCHIM AC, V52, P2197, DOI 10.1016/0016-7037(88)90122-6; Deviese T, 2018, RAPID COMMUN MASS SP, V32, P373, DOI 10.1002/rcm.8047; Dickinson MR, 2019, QUAT GEOCHRONOL, V50, P29, DOI 10.1016/j.quageo.2018.11.005; Ermini L, 2015, J HUM EVOL, V79, P4, DOI 10.1016/j.jhevol.2014.06.015; Frantz LAF, 2016, SCIENCE, V352, P1228, DOI 10.1126/science.aaf3161; Gotherstrom A, 2002, ARCHAEOMETRY, V44, P395, DOI 10.1111/1475-4754.00072; Gourion-Arsiquaud Samuel, 2008, V455, P293, DOI 10.1007/978-1-59745-104-8_20; Gravlund P, 2012, ANN ANAT, V194, P103, DOI 10.1016/j.aanat.2011.10.011; Grunenwald A, 2014, APPL SURF SCI, V292, P867, DOI 10.1016/j.apsusc.2013.12.063; GRUPE G, 1995, J ARCHAEOL SCI, V22, P193, DOI 10.1006/jasc.1995.0021; Guarino FM, 2000, BIOTECH HISTOCHEM, V75, P110, DOI 10.3109/10520290009066488; Hansen HB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170940; Harvey VL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150650; Haynes S, 2002, J ARCHAEOL SCI, V29, P585, DOI 10.1006/jasc.2001.0731; Hofmanova Z, 2016, P NATL ACAD SCI USA, V113, P6886, DOI 10.1073/pnas.1523951113; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hollund HI, 2016, INT J OSTEOARCHAEOL; Huls MC, 2007, RADIOCARBON, V49, P193, DOI 10.1017/S0033822200042119; Jiao YF, 2006, MAT SCI ENG C-BIO S, V26, P648, DOI 10.1016/j.msec.2005.08.038; Kaya M, 2005, INT J BIOL MACROMOL, V35, P39, DOI 10.1016/j.ijbiomac.2004.11.005; Kendall C, 2018, PALAEOGEOGR PALAEOCL, V491, P21, DOI 10.1016/j.palaeo.2017.11.041; Kitamura H, 1997, INT J BIOL MACROMOL, V20, P241, DOI 10.1016/S0141-8130(97)00021-4; Kontopoulos I, 2019, ARCHAEOL ANTHROP SCI, V11, P5213, DOI 10.1007/s12520-019-00853-0; Kontopoulos I, 2019, PALAEOGEOGR PALAEOCL, V518, P143, DOI 10.1016/j.palaeo.2019.01.005; Kontopoulos I, 2018, VIB SPECTROSC, V99, P167, DOI 10.1016/j.vibspec.2018.09.004; Kontopoulos I, 2015, MEDITERR ARCHAEOL AR, V15, P97, DOI 10.5281/zenodo.18361; Lebon M, 2016, RADIOCARBON, V58, P131, DOI 10.1017/RDC.2015.11; Leskovar T, 2020, FORENSIC SCI INT-GEN, V44, DOI 10.1016/j.fsigen.2019.102196; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Margaryan A, 2018, ECOL EVOL, V8, P3534, DOI 10.1002/ece3.3924; Matisoo-Smith E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190169; Mittnik A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163019; Ni M, 2008, SURF INTERFACE ANAL, V40, P1356, DOI 10.1002/sia.2904; Nielsen-Marsh C.M., 2000, HUMAN OSTEOLOGY ARCH, P439; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Parsons T, 2006, FORENSIC TAPHONOMY P, P109; Pinhasi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129102; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; Pruvost M, 2008, PALAEOGEOGR PALAEOCL, V266, P211, DOI 10.1016/j.palaeo.2008.03.041; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Ramsey CB, 2004, RADIOCARBON, V46, P155, DOI 10.1017/S0033822200039473; Rhee SH, 2000, J AM CERAM SOC, V83, P2890; Richter KK, 2011, J ARCHAEOL SCI, V38, P1502, DOI 10.1016/j.jas.2011.02.014; Roberts C, 2008, INT J OSTEOARCHAEOL, V18, P600, DOI 10.1002/oa.966; Schroeder H, 2019, P NATL ACAD SCI USA, V116, P10705, DOI 10.1073/pnas.1820210116; Schwarz C, 2009, NUCLEIC ACIDS RES, V37, P3215, DOI 10.1093/nar/gkp159; Sealy J, 2014, J ARCHAEOL SCI, V47, P64, DOI 10.1016/j.jas.2014.04.011; Skoglund P, 2013, J ARCHAEOL SCI, V40, P4477, DOI 10.1016/j.jas.2013.07.004; Sosa C, 2013, AM J PHYS ANTHROPOL, V151, P102, DOI 10.1002/ajpa.22262; Sponheimer M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50443-2; Susini A., 1988, RIV ANTROPOL, V66, P35; Trueman CN, 2008, PALAEOGEOGR PALAEOCL, V266, P160, DOI 10.1016/j.palaeo.2008.03.038; Trueman CNG, 2004, J ARCHAEOL SCI, V31, P721, DOI 10.1016/j.jas.2003.11.003; URRY DW, 1971, P NATL ACAD SCI USA, V68, P810, DOI 10.1073/pnas.68.4.810; Verdugo MP, 2019, SCIENCE, V365, P173, DOI 10.1126/science.aav1002; Vullo C, 2019, FORENS SCI INT-GEN S, V7, P760, DOI 10.1016/j.fsigss.2019.10.167; WEINER S, 1990, J ARCHAEOL SCI, V17, P187, DOI 10.1016/0305-4403(90)90058-D; Wright LE, 1996, J ARCHAEOL SCI, V23, P933, DOI 10.1006/jasc.1996.0087	80	22	22	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235146	10.1371/journal.pone.0235146	http://dx.doi.org/10.1371/journal.pone.0235146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584871	Green Published, Green Accepted, gold			2022-12-27	WOS:000545747200089
J	Mahalak, KK; Firrman, J; Lee, JJ; Bittinger, K; Nunez, A; Mattei, LM; Zhang, HJ; Fett, B; Bobokalonov, J; Arango-Argoty, G; Zhang, LQ; Zhang, GD; Liu, LS				Mahalak, Karley K.; Firrman, Jenni; Lee, Jung-Jin; Bittinger, Kyle; Nunez, Alberto; Mattei, Lisa M.; Zhang, Huanjia; Fett, Bryton; Bobokalonov, Jamshed; Arango-Argoty, Gustavo; Zhang, Liqing; Zhang, Guodong; Liu, Lin Shu			Triclosan has a robust, yet reversible impact on human gut microbial compositionin vitro	PLOS ONE			English	Article							EMERGING CONCERN; ACID; RESISTANCE; CONTAMINANTS; METABOLISM; ABSORPTION; MECHANISM; EXPOSURE; MILK	The recent ban of the antimicrobial compound triclosan from use in consumer soaps followed research that showcased the risk it poses to the environment and to human health. Triclosan has been found in human plasma, urine and milk, demonstrating that it is present in human tissues. Previous work has also demonstrated that consumption of triclosan disrupts the gut microbial community of mice and zebrafish. Due to the widespread use of triclosan and ubiquity in the environment, it is imperative to understand the impact this chemical has on the human body and its symbiotic resident microbes. To that end, this study is the first to explore how triclosan impacts the human gut microbial communityin vitroboth during and after treatment. Through ourin vitrosystem simulating three regions of the human gut; the ascending colon, transverse colon, and descending colon regions, we found that treatment with triclosan significantly impacted the community structure in terms of reduced population, diversity, and metabolite production, most notably in the ascending colon region. Given a 2 week recovery period, most of the population levels, community structure, and diversity levels were recovered for all colon regions. Our results demonstrate that the human gut microbial community diversity and population size is significantly impacted by triclosan at a high dosein vitro, and that the community is recoverable within this system.	[Mahalak, Karley K.; Firrman, Jenni; Nunez, Alberto; Bobokalonov, Jamshed; Liu, Lin Shu] ARS, USDA, Dairy & Funct Foods Res Unit, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA; [Lee, Jung-Jin; Bittinger, Kyle; Mattei, Lisa M.; Zhang, Huanjia; Fett, Bryton] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Arango-Argoty, Gustavo; Zhang, Liqing] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA; [Zhang, Guodong] Univ Massachusetts, Dept Food Sci, Amherst, MA 01003 USA; [Zhang, Guodong] Univ Massachusetts, Mol & Cellular Biol Grad Program, Amherst, MA 01003 USA	United States Department of Agriculture (USDA); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Virginia Polytechnic Institute & State University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Liu, LS (corresponding author), ARS, USDA, Dairy & Funct Foods Res Unit, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA.	linshu.liu@usda.gov	Bobokalonov, Jamshed/AAD-4293-2020; Bittinger, Kyle/ABG-2342-2020	Bobokalonov, Jamshed/0000-0002-0829-9364; Fett, Bryton/0000-0001-9017-7771; Zhang, Guodong/0000-0001-7780-5470; Liu, LinShu/0000-0003-3962-290X; Mattei, Lisa/0000-0002-2238-0281	US Congress	US Congress	This work was supported by funds from the US Congress. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson-Erici M, 2002, CHEMOSPHERE, V46, P1485, DOI 10.1016/S0045-6535(01)00255-7; Allmyr M, 2006, ANAL CHEM, V78, P6542, DOI 10.1021/ac060666x; [Anonymous], 2017, J ENDOCRINOL METAB D, V22, pS1; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2017, HEMONC TODAY, V18, P46; ARIES V, 1970, BIOCHIM BIOPHYS ACTA, V202, P535, DOI 10.1016/0005-2760(70)90124-4; Bagley DM, 2000, AM J DENT, V13, P148; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P303, DOI 10.1289/ehp.10768; Chedgzoy P, 2002, INT J PHARM, V235, P229, DOI 10.1016/S0378-5173(01)00992-9; Ciusa ML, 2012, INT J ANTIMICROB AG, V40, P210, DOI 10.1016/j.ijantimicag.2012.04.021; Emiola A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07240-8; Fair PA, 2009, ENVIRON POLLUT, V157, P2248, DOI 10.1016/j.envpol.2009.04.002; Fang JL, 2016, ENVIRON TOXICOL, V31, P609, DOI 10.1002/tox.22074; Firrman J, 2019, JOVE-J VIS EXP, DOI 10.3791/59054; Food and Drug Adminnistration HHS, 2016, Fed Regist, V81, P61106; Gaulke CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154632; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Khan R, 2016, SCI REP-UK, V6, DOI 10.1038/srep32322; Lawrence JR, 2015, AQUAT TOXICOL, V161, P253, DOI 10.1016/j.aquatox.2015.02.012; Lin YJ, 2000, AM J DENT, V13, P215; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; McNamara PJ, 2014, ENVIRON SCI TECHNOL, V48, P7393, DOI 10.1021/es501388v; McNamara PJ, 2013, FEMS MICROBIOL LETT, V344, P48, DOI 10.1111/1574-6968.12153; Meador JP, 2016, ENVIRON POLLUT, V213, P254, DOI 10.1016/j.envpol.2016.01.088; MIDTVEDT T, 1974, AM J CLIN NUTR, V27, P1341, DOI 10.1093/ajcn/27.11.1341; Moss T, 2000, FOOD CHEM TOXICOL, V38, P361, DOI 10.1016/S0278-6915(99)00164-7; Olaniyan LWB, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3287-x; Poole AC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00056-15; Queckenberg C, 2010, ANTIMICROB AGENTS CH, V54, P570, DOI 10.1128/AAC.00615-09; Quince C, 2015, AM J GASTROENTEROL, V110, P1718, DOI 10.1038/ajg.2015.357; Ribado JV, 2017, EMBO MOL MED, V9, P1732, DOI 10.15252/emmm.201707882; Rudel H, 2013, CHEMOSPHERE, V91, P1517, DOI 10.1016/j.chemosphere.2012.12.030; Russell AD, 2004, J ANTIMICROB CHEMOTH, V53, P693, DOI 10.1093/jac/dkh171; Sanidad KZ, 2019, GUT MICROBES, V10, P434, DOI 10.1080/19490976.2018.1546521; Shim JO, 2019, PEDIATR GASTROENTERO, V22, P41, DOI 10.5223/pghn.2019.22.1.41; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Suller MTE, 2000, J ANTIMICROB CHEMOTH, V46, P11, DOI 10.1093/jac/46.1.11; Suller MTE, 1999, J HOSP INFECT, V43, P281, DOI 10.1016/S0195-6701(99)90424-3; Syed AK, 2014, MBIO, V5, DOI 10.1128/mBio.01015-13; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10; Weatherly LM, 2017, J TOXICOL ENV HEAL B, V20, P447, DOI 10.1080/10937404.2017.1399306; Westfall C, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.02312-18, 10.1128/aac.02312-18]; Yang HX, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan4116; Yeh A, 2017, AQUAT TOXICOL, V190, P21, DOI 10.1016/j.aquatox.2017.06.011	49	4	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234046	10.1371/journal.pone.0234046	http://dx.doi.org/10.1371/journal.pone.0234046			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32585680	gold, Green Published			2022-12-27	WOS:000545747200024
J	Petsnik, C; Vorauer, JD				Petsnik, Corey; Vorauer, Jacquie D.			Do dominant group members have different emotional responses to observing dominant-on-dominant versus dominant-on-disadvantaged ostracism? Some evidence for heightened reactivity to potentially discriminatory ingroup behavior	PLOS ONE			English	Article							WITNESSING PEER REJECTION; IN-GROUP IDENTIFICATION; NEURAL RESPONSES; SOCIAL IDENTITY; SELF-ESTEEM; DESPISED OUTGROUP; MORAL JUDGMENTS; HE SAID; EMPATHY; EXCLUSION	The importance of social connection to well-being is underscored by individuals' reactivity to events highlighting the potential for rejection and exclusion, which extends even to observing the social exclusion of others ("vicarious ostracism"). Because responses to vicarious ostracism depend at least in part on empathy with the target, and individuals tend to empathize less readily with outgroup than ingroup members, the question arises as to whether there is a boundary condition on vicarious ostracism effects whereby individuals are relatively immune to observing ingroup-on-outgroup ostracism. Of particular interest is the case where members of a dominant ethnic group observe fellow ingroup members ostracize a member of a disadvantaged ethnic minority group, as here there is a compelling potential alternative: Perceived violation of contemporary social norms condemning prejudice and discrimination might instead lead dominant group members to be especially upset by "dominant-on-disadvantaged" ostracism. Accordingly, the present research examines, across four studies and 4413 participants, individuals' affective reactions to observing dominant-on-disadvantaged versus dominant-on-dominant ostracism. In each study, dominant group members (White/Europeans) observed dominant group members include or ostracize a fellow dominant group member or a disadvantaged ethnic minority group member (a Black individual) in an online Cyberball game. Results revealed that dominant group members felt more guilt, anger, and sadness after observing severe ostracism of a disadvantaged as opposed to dominant group member. Although no direct effects emerged on behavioral outcomes, exploratory analyses suggested that observing ostracism of a disadvantaged (versus dominant) group member had indirect effects on behavior via increased feelings of anger. These results suggest that observing ostracism may be a sufficiently potent and relatable experience that when it occurs across group boundaries it awakens individuals' sensitivity to injustice and discrimination.	[Petsnik, Corey; Vorauer, Jacquie D.] Univ Manitoba, Dept Psychol, Winnipeg, MB, Canada	University of Manitoba	Petsnik, C (corresponding author), Univ Manitoba, Dept Psychol, Winnipeg, MB, Canada.	umpetsni@myumanitoba.ca		Petsnik, Corey/0000-0002-5985-5658	Canada Graduate Scholarship from the Social Sciences and Humanities Research Council of Canada; Tri Council Master's Supplement Award from the University of Manitoba; Social Sciences and Humanities Research Council of Canada [435-2012-0348]	Canada Graduate Scholarship from the Social Sciences and Humanities Research Council of Canada; Tri Council Master's Supplement Award from the University of Manitoba; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was supported by a Canada Graduate Scholarship from the Social Sciences and Humanities Research Council of Canada (https://www.sshrc-crsh.gc.ca) and a Tri Council Master's Supplement Award from the University of Manitoba (http://umanitoba.ca) awarded to Corey Petsnik as well as a Social Sciences and Humanities Research Council of Canada grant (grant number 435-2012-0348) awarded to Jacquie D. Vorauer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpin S. N., 2017, COMPREHENSIVE RESULT, V2, P143, DOI [10.1080/23743603.2017.1358477, DOI 10.1080/23743603.2017.1358477]; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; BATSON CD, 1987, J PERS, V55, P19, DOI 10.1111/j.1467-6494.1987.tb00426.x; BATSON CD, 1983, J PERS SOC PSYCHOL, V45, P706, DOI 10.1037//0022-3514.45.3.706; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Beeney JE, 2011, SOC NEUROSCI-UK, V6, P369, DOI 10.1080/17470919.2011.557245; Bernstein MJ, 2010, PERS SOC PSYCHOL B, V36, P999, DOI 10.1177/0146167210376059; BLANCHARD FA, 1994, J APPL PSYCHOL, V79, P993, DOI 10.1037/0021-9010.79.6.993; Borenstein M, 2009, INTRO META ANAL; BRANSCOMBE NR, 1994, EUR J SOC PSYCHOL, V24, P641, DOI 10.1002/ejsp.2420240603; Bruneau EG, 2017, SOC PSYCHOL PERS SCI, V8, P934, DOI 10.1177/1948550617693064; Castano E, 2006, J PERS SOC PSYCHOL, V90, P804, DOI 10.1037/0022-3514.90.5.804; Cikara M, 2011, CURR DIR PSYCHOL SCI, V20, P149, DOI 10.1177/0963721411408713; Crandall CS, 2002, J PERS SOC PSYCHOL, V82, P359, DOI 10.1037//0022-3514.82.3.359; Crandall CS, 2003, PSYCHOL BULL, V129, P414, DOI 10.1037/0033-2909.129.3.414; Crosby JR, 2015, J HOMOSEXUAL, V62, P957, DOI 10.1080/00918369.2015.1008284; Doosje B, 1998, J PERS SOC PSYCHOL, V75, P872, DOI 10.1037/0022-3514.75.4.872; Fayant MP, 2014, SOC PSYCHOL-GERMANY, V45, P489, DOI 10.1027/1864-9335/a000209; Fein S, 1997, J PERS SOC PSYCHOL, V73, P31, DOI 10.1037/0022-3514.73.1.31; FENIGSTEIN A, 1984, J PERS SOC PSYCHOL, V47, P860, DOI 10.1037/0022-3514.47.4.860; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Forbes H, 2020, J PSYCHOL, V154, P15, DOI 10.1080/00223980.2019.1642839; Giesen A, 2018, PERS SOC PSYCHOL B, V44, P550, DOI 10.1177/0146167217744524; Glasford DE, 2009, PERS SOC PSYCHOL B, V35, P415, DOI 10.1177/0146167208329216; Godwin A, 2014, BEHAV RES METHODS, V46, P660, DOI 10.3758/s13428-013-0408-0; Goh JX, 2016, SOC PERSONAL PSYCHOL, V10, P535, DOI 10.1111/spc3.12267; Gonsalkorale K, 2007, EUR J SOC PSYCHOL, V37, P1176, DOI 10.1002/ejsp.392; Guroglu B., 2013, INT J DEV SCI, V7, P13, DOI [10.3233/dev-1312117, DOI 10.3233/DEV-1312117, 10.3233/DEV-1312117]; Gutsell JN, 2012, SOC COGN AFFECT NEUR, V7, P596, DOI 10.1093/scan/nsr035; Gutsell JN, 2010, J EXP SOC PSYCHOL, V46, P841, DOI 10.1016/j.jesp.2010.03.011; Hartley C, 2015, SCI REP-UK, V5, DOI 10.1038/srep12519; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsueh M, 2015, HUM COMMUN RES, V41, P557, DOI 10.1111/hcre.12059; Iyer A, 2007, PERS SOC PSYCHOL B, V33, P572, DOI 10.1177/0146167206297402; Iyer A, 2009, J SOC ISSUES, V65, P791, DOI 10.1111/j.1540-4560.2009.01625.x; Karmali F, 2017, J EXP PSYCHOL GEN, V146, P1073, DOI 10.1037/xge0000304; Kawakami K, 2009, SCIENCE, V323, P276, DOI 10.1126/science.1164951; Krill Austen, 2009, Front Evol Neurosci, V1, P1, DOI 10.3389/neuro.18.001.2009; LANZETTA JT, 1989, J PERS SOC PSYCHOL, V56, P543, DOI 10.1037/0022-3514.56.4.543; Leach C, 2001, POISONING CONSCIENCE, P136; Leach CW, 2006, PERS SOC PSYCHOL B, V32, P1232, DOI 10.1177/0146167206289729; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; Mackie DM, 2008, SOC PERSONAL PSYCHOL, V2, P1866, DOI 10.1111/j.1751-9004.2008.00130.x; Masten CL, 2013, CHILD DEV, V84, P1338, DOI 10.1111/cdev.12056; Masten CL, 2011, NEUROIMAGE, V55, P381, DOI 10.1016/j.neuroimage.2010.11.060; Masten CL, 2010, SOC NEUROSCI-UK, V5, P496, DOI 10.1080/17470919.2010.490673; MAYER JD, 1988, J PERS SOC PSYCHOL, V55, P102, DOI 10.1037/0022-3514.55.1.102; McGregor I, 2001, J PERS SOC PSYCHOL, V80, P472, DOI 10.1037//0022-3514.80.3.472; Meyer ML, 2013, SOC COGN AFFECT NEUR, V8, P446, DOI 10.1093/scan/nss019; Miron AM, 2006, GROUP PROCESS INTERG, V9, P163, DOI 10.1177/1368430206062075; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Over H, 2016, J PERS SOC PSYCHOL, V110, P710, DOI 10.1037/pspi0000050; Paolini D, 2017, SOC INFLUENCE, V12, P117, DOI 10.1080/15534510.2017.1377107; Pew Research Center, 2019, RAC AM 2019; PRENTICE DA, 1992, PSYCHOL BULL, V112, P160, DOI 10.1037/0033-2909.112.1.160; R Core Team, 2018, R LANG ENV STAT COMP; Rasinski HM, 2013, PERS SOC PSYCHOL B, V39, P856, DOI 10.1177/0146167213484769; Richard FD, 2003, REV GEN PSYCHOL, V7, P331, DOI 10.1037/1089-2680.7.4.331; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Rudert SC, 2020, EUR J SOC PSYCHOL, V50, P376, DOI 10.1002/ejsp.2606; Rudert SC, 2018, J PERS SOC PSYCHOL, V115, P31, DOI 10.1037/pspa0000122; Rudert SC, 2017, J EXP SOC PSYCHOL, V68, P101, DOI 10.1016/j.jesp.2016.06.005; Saguy T, 2013, EUR J SOC PSYCHOL, V43, P292, DOI 10.1002/ejsp.1948; Schaafsma J, 2012, J EXP SOC PSYCHOL, V48, P829, DOI 10.1016/j.jesp.2012.02.015; Schwarzer G., 2007, R NEWS, V7, P40; Shelton J.N., 2006, EUR REV SOC PSYCHOL, V17, P321, DOI [DOI 10.1080/10463280601095240, 10.1080/10463280601095240]; Smith A, 2004, GROUP DYN-THEOR RES, V8, P291, DOI 10.1037/1089-2699.8.4.291; Sommers SR, 2006, GROUP PROCESS INTERG, V9, P117, DOI 10.1177/1368430206059881; Spaans JP, 2019, J RES ADOLESCENCE, V29, P508, DOI 10.1111/jora.12401; Stangor C, 2001, PERS SOC PSYCHOL B, V27, P486, DOI 10.1177/0146167201274009; Steiger JH, 2004, PSYCHOL METHODS, V9, P164, DOI 10.1037/1082-989X.9.2.164; Tarrant M, 2012, J EXP SOC PSYCHOL, V48, P513, DOI 10.1016/j.jesp.2011.10.017; Thomas EF, 2009, PERS SOC PSYCHOL REV, V13, P310, DOI 10.1177/1088868309343290; van der Meulen M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159045; Veldhuis TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095421; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vorauer JD, 2003, PERS SOC PSYCHOL B, V29, P498, DOI 10.1177/0146167202250917; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D., 1994, PANAS X MANUAL POSIT, DOI [10.17077/48vtm4t2, DOI 10.17077/48VTM4T2, DOI 10.13072/MIDSS.438]; Wesselmann E., 2014, HUMAN ETHOLOGY B, V29, P82; Wesselmann ED, 2015, J SOC PSYCHOL, V155, P483, DOI 10.1080/00224545.2015.1060935; Wesselmann ED, 2013, SOC PSYCHOL PERS SCI, V4, P108, DOI 10.1177/1948550612443386; Wesselmann ED, 2009, J EXP SOC PSYCHOL, V45, P1308, DOI 10.1016/j.jesp.2009.08.003; Will GJ, 2013, DEV PSYCHOL, V49, P2236, DOI 10.1037/a0032299; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams Kipling S., 2012, CYBERBALL VERSION 4; Xu XJ, 2009, J NEUROSCI, V29, P8525, DOI 10.1523/JNEUROSCI.2418-09.2009; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006; Zhou HT, 2016, J PERS SOC PSYCHOL, V111, P493, DOI 10.1037/pspa0000056; ZUCKERMAN M, 1983, J PERS, V51, P621, DOI 10.1111/j.1467-6494.1983.tb00869.x; ZUCKERMAN M, 1983, PERS SOC PSYCHOL B, V9, P578, DOI 10.1177/0146167283094007	93	1	1	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234540	10.1371/journal.pone.0234540	http://dx.doi.org/10.1371/journal.pone.0234540			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584831	Green Published, gold			2022-12-27	WOS:000545747200058
J	Tian, DA; Yu, NM; Li, ZP; Li, SJ; Li, N				Tian, Dian; Yu, Ningmei; Li, Zhengpeng; Li, Shuaijun; Li, Na			A super-resolution scanning algorithm for lensless microfluidic imaging using the dual-line array image sensor	PLOS ONE			English	Article							MICROSCOPY	The lensless optical fluid microscopy is of great significance to the miniaturization, portability and low cost development of cell detection instruments. However, the resolution of the cell image collected directly is low, because the physical pixel size of the image sensor is the same order of magnitude as the cell size. To solve this problem, this paper proposes a super-resolution scanning algorithm using a dual-line array sensor and a microfluidic chip. For dual-line array sensor images, the multi-group velocity and acceleration of cells flowing through the line array sensor are calculated. Then the reconstruction model of the super-resolution image is constructed with variable acceleration. By changing the angle between the line array image sensor and the direction of cell flow, the super-resolution image scanning and reconstruction are achieved in both horizontal and vertical directions. In addition, it is necessary to study the row by row extraction algorithm for cell foreground image. In this paper, the dual-line array sensor is implemented by adjusting the acquisition window of the image sensor with a pixel size of 2.2 mu m. When the tilt angle is 21 degrees, the equivalent pixel size is 0.79 mu m, improved 2.8 times, and after de-diffraction its average size error was 3.249%. As the angle decreases, the image resolution is higher, but the amount of information is less. This super-resolution scanning algorithm can be integrated on the chip and used with a microfluidic chip to realize on-chip instrument.	[Tian, Dian; Yu, Ningmei; Li, Zhengpeng; Li, Shuaijun; Li, Na] Xian Univ Technol, Sch Automat & Informat Engn, Xian, Shaanxi, Peoples R China	Xi'an University of Technology	Yu, NM (corresponding author), Xian Univ Technol, Sch Automat & Informat Engn, Xian, Shaanxi, Peoples R China.	yunm@xaut.edu.cn		Tian, Dian/0000-0002-8626-0561	National Natural Science Foundation of China [61771388]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 61771388). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; [Anonymous], 2020, LANCET INFECT DIS, V20, P192, DOI [10.1016/S1473-3099(20)30483-7, DOI 10.1016/S1473-3099(20)30483-7, DOI 10.1056/NEJMoa2021756]; [Anonymous], 2018, TEXTILE INFORM MELLI, V7, P66; Coskun AF, 2011, ANALYST, V136, P3512, DOI 10.1039/c0an00926a; Cui XQ, 2006, PROC SPIE, V6095, DOI 10.1117/12.640328; Fang YK, 2018, 2018 IEEE INTERNATIONAL MAGNETIC CONFERENCE (INTERMAG); Gao MJ, 2018, INFRARED PHYS TECHN, V95, P46, DOI 10.1016/j.infrared.2018.10.013; Heng X, 2006, LAB CHIP, V6, P1274, DOI 10.1039/b604676b; Lee LM, 2009, BIOMED MICRODEVICES, V11, P951, DOI 10.1007/s10544-009-9312-x; Ma X, 2018, 2018 IEEE 3RD INTERNATIONAL CONFERENCE ON IMAGE, VISION AND COMPUTING (ICIVC), P369; Mudanyali O, 2011, OPT EXPRESS, V19, P17378, DOI 10.1364/OE.19.017378; Ouyang W, 2018, NAT BIOTECHNOL, V36, P460, DOI 10.1038/nbt.4106; SEE CW, 1986, ELECTRON LETT, V22, P961, DOI 10.1049/el:19860655; SHEPPARD CJR, 1980, ELECTRON POWER, V26, P166, DOI 10.1049/ep.1980.0088; Suguitan Jr AL, 2011, PLOS ONE, V6; Wang HD, 2019, NAT METHODS, V16, P103, DOI 10.1038/s41592-018-0239-0; Zhang JL, 2018, OPT LETT, V43, P3714, DOI 10.1364/OL.43.003714; Zhang JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11715-x; Zheng GA, 2011, I S BIOMED IMAGING, P1362, DOI 10.1109/ISBI.2011.5872653; Zheng GA, 2010, LAB CHIP, V10, P3125, DOI [10.1039/c01c00213e, 10.1039/c0lc00213e]; Zuo C, 2015, OPT EXPRESS, V23, P14314, DOI 10.1364/OE.23.014314	21	1	1	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235111	10.1371/journal.pone.0235111	http://dx.doi.org/10.1371/journal.pone.0235111			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584867	gold, Green Published			2022-12-27	WOS:000545747200050
J	Ciacci, A; Sueshige, T; Takayasu, H; Christensen, K; Takayasu, M				Ciacci, Alberto; Sueshige, Takumi; Takayasu, Hideki; Christensen, Kim; Takayasu, Misako			The microscopic relationships between triangular arbitrage and cross-currency correlations in a simple agent based model of foreign exchange markets	PLOS ONE			English	Article							STATISTICAL PROPERTIES; PRICE; FLUCTUATIONS; LAW	Foreign exchange rates movements exhibit significant cross-correlations even on very short time-scales. The effect of these statistical relationships become evident during extreme market events, such as flash crashes. Although a deep understanding of cross-currency correlations would be clearly beneficial for conceiving more stable and safer foreign exchange markets, the microscopic origins of these interdependencies have not been extensively investigated. This paper introduces an agent-based model which describes the emergence of cross-currency correlations from the interactions between market makers and an arbitrager. The model qualitatively replicates the time-scale vs. cross-correlation diagrams observed in real trading data, suggesting that triangular arbitrage plays a primary role in the entanglement of the dynamics of different foreign exchange rates. Furthermore, the model shows how the features of the cross-correlation function between two foreign exchange rates, such as its sign and value, emerge from the interplay between triangular arbitrage and trend-following strategies. In particular, the interaction of these trading strategies favors certain combinations of price trend signs across markets, thus altering the probability of observing two foreign exchange rates drifting in the same or opposite direction. Ultimately, this entangles the dynamics of foreign exchange rate pairs, leading to cross-correlation functions that resemble those observed in real trading data.	[Ciacci, Alberto; Christensen, Kim] Imperial Coll London, Blackett Lab, London, England; [Ciacci, Alberto; Christensen, Kim] Imperial Coll London, Ctr Complex Sci, London, England; [Sueshige, Takumi] Tokyo Inst Technol, Sch Comp, Dept Math & Comp Sci, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa, Japan; [Takayasu, Hideki; Takayasu, Misako] Tokyo Inst Technol, Inst Innovat Res, Nagatsuta Cho, Yokohama, Kanagawa, Japan; [Takayasu, Hideki] Sony Comp Sci Labs, Shinagawa Ku, Tokyo, Japan	Imperial College London; Imperial College London; Tokyo Institute of Technology; Tokyo Institute of Technology	Ciacci, A (corresponding author), Imperial Coll London, Blackett Lab, London, England.; Ciacci, A (corresponding author), Imperial Coll London, Ctr Complex Sci, London, England.; Takayasu, M (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Nagatsuta Cho, Yokohama, Kanagawa, Japan.	alberto.ciacci16@imperial.ac.uk; takayasu.m.aa@m.titech.ac.jp	; Takayasu, Misako/H-9890-2014	Christensen, Kim/0000-0002-7648-7332; Takayasu, Misako/0000-0002-2467-614X; Ciacci, Alberto/0000-0002-1514-2162	JSPS KAKENHI [17J10781]; EPSRC [EP/L015129/1]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study is partially supported by the JSPS KAKENHI (Grant Numbers 17J10781 to TS), EPSRC (Grant Numbers EP/L015129/1 to AC), the Joint Collaborative Research Laboratory for MUFG AI Financial Market Analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other commercial affiliations mentioned in the'competing interest statement' (Sony Computer Science Laboratories, Inc and FNA) provide unrelated salaries to HT and AC. However, these commercial affiliations neither provided any financial support to this study nor influenced study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `Author Contributions' section.	Aiba Y, 2002, PHYSICA A, V310, P467, DOI 10.1016/S0378-4371(02)00799-9; Aiba Y, 2006, PHYSICA A, V371, P572, DOI 10.1016/j.physa.2006.05.046; Ait-Sahalia Y, 2011, J ECONOMETRICS, V160, P160, DOI 10.1016/j.jeconom.2010.03.028; Alfonsi A, 2010, QUANT FINANC, V10, P143, DOI 10.1080/14697680802595700; Almgren R., 2001, J RISK, V3, P5, DOI [10.21314/JOR.2001.041, DOI 10.21314/JOR.2001.041]; Anderson P., 1988, EC EVOLVING COMPLEX; [Anonymous], 2018, WORLD NEUROSURG, V120, pe153; [Anonymous], 2010, MODEL LIMIT ORDER BO; Bank for International Settlements (BIS), 2018, MON FAST PAC E UNPUB; Bertsimas D., 1998, J FINANC MARK, V10, P1, DOI [DOI 10.1016/S1386-4181(97)00012-8, 10.1016/S1386-4181(97)00012-8]; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Bonart J, 2018, PHYSICA A, V503, P698, DOI 10.1016/j.physa.2018.03.002; Bouchaud JP, 2004, QUANT FINANC, V4, P176, DOI 10.1088/1469-7688/4/2/007; Buchanan M, 2012, NAT PHYS, V8, P2, DOI 10.1038/nphys2191; Chakraborti A, 2011, QUANT FINANC, V11, P991, DOI 10.1080/14697688.2010.539248; CHAKRAVARTY S, 1995, J FINANC INTERMED, V4, P213, DOI 10.1006/jfin.1995.1010; Challet D, 2003, QUANT FINANC, V3, P155, DOI 10.1088/1469-7688/3/3/301; Chiarella C., 2002, Quantitative Finance, V2, P346, DOI 10.1088/1469-7688/2/5/303; CME Group, 2019, EBS; CME Group, 2019, EBS PLATF; Cocco L, 2017, J ECON INTERACT COOR, V12, P345, DOI 10.1007/s11403-015-0168-2; Cont R, 2000, MACROECON DYN, V4, P170; Cont R., 2005, FRACTALS ENG; Cont R., 2007, LONG MEMORY EC, P289, DOI [10.1007/978-3-540-34625-8_10, DOI 10.1007/978-3-540-34625-8_10]; Cont R, 2001, QUANT FINANC, V1, P223, DOI [10.1080/713665670, 10.1088/1469-7688/1/2/304]; Farmer JD, 2005, PHYS TODAY, V58, P37, DOI 10.1063/1.2117821; Fenn DJ, 2009, INT J THEOR APPL FIN, V12, P1105, DOI 10.1142/S0219024909005609; Foucault T., 1999, J FINANCIAL MARKETS, V2, P99, DOI DOI 10.1016/S1386-4181(98)00012-3; Foucault T, 2017, REV FINANC STUD, V30, P1053, DOI 10.1093/rfs/hhw103; GLOSTEN LR, 1985, J FINANC ECON, V14, P71, DOI 10.1016/0304-405X(85)90044-3; Goettler R, 2006, MICROSTRUCTURE EFFEC; Gopikrishnan P, 1998, EUR PHYS J B, V3, P139, DOI 10.1007/s100510050292; Gould MD, 2013, QUANT FINANC, V13, P1709, DOI 10.1080/14697688.2013.803148; Gu GF, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/48002; Han MF, 2019, ANATOMY SUDDEN YEN A; Kozhan R, 2012, MANAGE SCI, V58, P2131, DOI 10.1287/mnsc.1120.1541; KYLE AS, 1985, ECONOMETRICA, V53, P1315, DOI 10.2307/1913210; Lee S, 2015, J OPEN INNOV TECHNOL, P1, DOI [10.1186/s40852-015-0013-9, DOI 10.1186/S40852-015-0013-9]; Lillo F, 2007, EUR PHYS J B, V55, P453, DOI 10.1140/epjb/e2007-00067-9; Lillo F, 2004, STUD NONLINEAR DYN E, V8; Liu YH, 1997, PHYSICA A, V245, P437, DOI 10.1016/S0378-4371(97)00368-3; Mahmoodzadeh S, 2014, TICK SIZE CHANGE WHO; Marshall B, 2008, AM FIN ASS ANN M NEW; Mizuno T, 2004, APPLICATION OF ECONOPHYSICS, PROCEEDINGS, P24; Obizhaeva AA, 2013, J FINANC MARK, V16, P1, DOI 10.1016/j.finmar.2012.09.001; Parlour CA, 1998, REV FINANC STUD, V11, P789, DOI 10.1093/rfs/11.4.789; Parlour CA, 2008, HANDB FINANC, P63, DOI 10.1016/B978-044451558-2.50007-6; Ramos-Requena JP, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8020261; Plerou V, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.037101; Preis T, 2006, EUROPHYS LETT, V75, P510, DOI 10.1209/epl/i2006-10139-0; Preis T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016108; Rime D., 2013, BIS Q REV; Rosu I, 2010, LIQUIDITY INFORM ORD; Rosu I, 2009, REV FINANC STUD, V22, P4601, DOI 10.1093/rfs/hhp011; Sato AH, 1998, PHYSICA A, V250, P231, DOI 10.1016/S0378-4371(97)00569-4; Stanley HE, 2008, PHYSICA A, V387, P3967, DOI 10.1016/j.physa.2008.01.093; TAKAYASU H, 1992, PHYSICA A, V184, P127, DOI 10.1016/0378-4371(92)90161-I; Wang GJ, 2013, ENTROPY-SWITZ, V15, P1643, DOI 10.3390/e15051643; Yamada K, 2007, PHYSICA A, V382, P340, DOI 10.1016/j.physa.2007.02.027; Yamada K, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051120; Zovko I., 2002, Quantitative Finance, V2, P387, DOI 10.1088/1469-7688/2/5/308	61	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234709	10.1371/journal.pone.0234709	http://dx.doi.org/10.1371/journal.pone.0234709			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579583	Green Published, gold			2022-12-27	WOS:000545646600006
J	Geith, MA; Eckmann, JD; Haspinger, DC; Agrafiotis, E; Maier, D; Szabo, P; Sommer, G; Schratzenstaller, TG; Holzapfel, GA				Geith, Markus A.; Eckmann, Jakob D.; Haspinger, Daniel Ch.; Agrafiotis, Emmanouil; Maier, Dominik; Szabo, Patrick; Sommer, Gerhard; Schratzenstaller, Thomas G.; Holzapfel, Gerhard A.			Experimental and mathematical characterization of coronary polyamide-12 balloon catheter membranes	PLOS ONE			English	Article							BEHAVIOR; STRAIN; ANGIOPLASTY; MORPHOLOGY; STRENGTH	The experimental quantification and modeling of the multiaxial mechanical response of polymer membranes of coronary balloon catheters have not yet been carried out. Due to the lack of insights, it is not shown whether isotropic material models can describe the material response of balloon catheter membranes expanded with nominal or higher, supra-nominal pressures. Therefore, for the first time, specimens of commercial polyamide-12 balloon catheters membranes were investigated during uniaxial and biaxial loading scenarios. Furthermore, the influence of kinematic effects on the material response was observed by comparing results from quasi-static and dynamic biaxial extension tests. Novel clamping techniques are described, which allow to test even tiny specimens taken from the balloon membranes. The results of this study reveal the semi-compliant, nonlinear, and viscoelastic character of polyamide-12 balloon catheter membranes. Above nominal pressure, the membranes show a pronounced anisotropic mechanical behavior with a stiffer response in the circumferential direction. The anisotropic feature intensifies with an increasing strain-rate. A modified polynomial model was applied to represent the realistic mechanical response of the balloon catheter membranes during dynamic biaxial extension tests. This study also includes a compact set of constitutive model parameters for the use of the proposed model in future finite element analyses to perform more accurate simulations of expanding balloon catheters.	[Geith, Markus A.; Eckmann, Jakob D.; Haspinger, Daniel Ch.; Agrafiotis, Emmanouil; Maier, Dominik; Szabo, Patrick; Sommer, Gerhard; Holzapfel, Gerhard A.] Graz Univ Technol, Inst Biomech, Fac Comp Sci & Biomed Engn, Graz, Austria; [Geith, Markus A.] Kings Coll London, Biomed Engn Dept, London, England; [Schratzenstaller, Thomas G.] Tech Univ Appl Sci Regensburg, Regensburg Ctr Biomed Engn, Med Device Lab, Regensburg, Germany; [Holzapfel, Gerhard A.] Norwegian Univ Sci & Technol NTNU, Dept Struct Engn, Trondheim, Norway	Graz University of Technology; University of London; King's College London; Norwegian University of Science & Technology (NTNU)	Geith, MA; Holzapfel, GA (corresponding author), Graz Univ Technol, Inst Biomech, Fac Comp Sci & Biomed Engn, Graz, Austria.; Geith, MA (corresponding author), Kings Coll London, Biomed Engn Dept, London, England.; Holzapfel, GA (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Struct Engn, Trondheim, Norway.	markus.geith@TUGraz.at; holzapfel@TUGraz.at		Haspinger, Daniel/0000-0003-1558-2878	Bavarian Research Foundation [PIZ-225-18]; project "LAESIO" of Austrian Science Fund (FWF) [P 32713]	Bavarian Research Foundation; project "LAESIO" of Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was funded by the Bavarian Research Foundation within the project PIZ-225-18 and partly financed from the project "LAESIO" (P 32713) of the Austrian Science Fund (FWF).	Aggarwal S.L., 1959, J APPL POLYM SCI, V1, P91, DOI [10.1002/app.1959.070010115, DOI 10.1002/APP.1959.070010115]; Bukala J, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2890; Coulon G, 1999, POLYMER, V40, P95, DOI 10.1016/S0032-3861(98)00221-3; Davarpanah MA, 2017, J MANUF SCI E-T ASME, V139, DOI 10.1115/1.4034036; Fu XL, 2017, LECT NOTES ARTIF INT, V10464, P808, DOI 10.1007/978-3-319-65298-6_72; GARRAMONE S., 2001, STRUCTURE PROPERTY R; Gasser TC, 2007, COMPUT MECH, V40, P47, DOI 10.1007/s00466-006-0081-6; Geith MA, 2019, INT J NUMER METH BIO, V35, DOI 10.1002/cnm.3249; Gervaso F, 2008, J BIOMECH, V41, P1206, DOI 10.1016/j.jbiomech.2008.01.027; Ghahremanpour M, 2012, FUTURE TRENDS PRODUC, P275; HOLMES DR, 1953, NATURE, V171, P1104, DOI 10.1038/1711104b0; Holzapfel G., 2001, NONLINEAR SOLID MECH; Holzapfel GA, 2001, COMPUT METHOD APPL M, V190, P4379, DOI 10.1016/S0045-7825(00)00323-6; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Humphrey JD., 2002, CARDIOVASCULAR SOLID; Mabry E., 2008, EXTRUDED TUBING DESI; McFerran NLA, 2006, PLAST RUBBER COMPOS, V35, P310, DOI 10.1179/174328906X143886; Menary GH, 2006, PLAST RUBBER COMPOS, V35, P348, DOI 10.1179/174328906X143877; Meyer RW, 2001, POLYMER, V42, P5293, DOI 10.1016/S0032-3861(00)00626-1; Mortier P, 2010, ANN BIOMED ENG, V38, P88, DOI 10.1007/s10439-009-9836-5; Rangari VK, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/24/245703; Rangari VK, 2009, MAT SCI ENG A-STRUCT, V500, P92, DOI 10.1016/j.msea.2008.09.014; Rhee S, 2002, J POLYM SCI POL PHYS, V40, P1189, DOI 10.1002/polb.10181; Richeton J, 2006, INT J SOLIDS STRUCT, V43, P2318, DOI 10.1016/j.ijsolstr.2005.06.040; RIVLIN RS, 1951, PHILOS TR R SOC S-A, V243, P251, DOI 10.1098/rsta.1951.0004; Sauerteig K, 1998, MED PLAST BIOMAT MAY, P46; Schulze-Bauer CAJ, 2003, J BIOMECH ENG-T ASME, V125, P395, DOI 10.1115/1.1574331; Sommer G, 2016, J BIOMECH, V49, P2374, DOI 10.1016/j.jbiomech.2016.02.042; Sommer G, 2013, ACTA BIOMATER, V9, P9036, DOI 10.1016/j.actbio.2013.06.011; WALLEY SM, 1991, J PHYS III, V1, P1889, DOI 10.1051/jp3:1991240; Wiesent L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224026; Zahedmanesh H, 2010, J BIOMECH, V43, P2126, DOI 10.1016/j.jbiomech.2010.03.050	32	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234340	10.1371/journal.pone.0234340	http://dx.doi.org/10.1371/journal.pone.0234340			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579587	gold, Green Published			2022-12-27	WOS:000545646600062
J	Zhou, GL; Li, CG; Zhang, J				Zhou, Guolei; Li, Chenggu; Zhang, Jing			Identification of urban functions enhancement and weakening based on urban land use conversion: A case study of Changchun, China	PLOS ONE			English	Article							PATTERNS; SPRAWL; GROWTH; EXPLORATION; IMAGES; CITY; SAR	A deep understanding of urban functions is the basis for the optimization of urban spatial structure and for the sustainable development of urban space. Previous research mainly focused on the identification and classification of urban functions using a variety of data and methods; however, little attention has been paid to the quantitative measurement of changes in urban functions, and to their temporal and spatial evolution. With the help of urban land use maps, we used the overlay analysis and the transition matrix to quantitatively measure the enhancement and weakening of urban functions and their spatial differences, by analyzing the relationship between urban land development and redevelopment. Accordingly, the change state of urban function enhancement and weakening could be divided into six categories. Moreover, the results of research on residential, commercial, public service, and industrial functions show that changes in different urban functions have different temporal and spatial characteristics. Our findings on the enhancement and weakening of urban functions in the central city of Changchun provide theoretical support for the sustainable development of urban space in the future.	[Zhou, Guolei; Li, Chenggu; Zhang, Jing] Northeast Normal Univ, Sch Geog Sci, Changchun, Jilin, Peoples R China	Northeast Normal University - China	Zhou, GL; Li, CG (corresponding author), Northeast Normal Univ, Sch Geog Sci, Changchun, Jilin, Peoples R China.	z19870219@126.com; lcg6010@nenu.edu.cn	Zhou, Guolei/GVS-5186-2022	Zhou, Guolei/0000-0001-6726-8093	Fundamental Research Funds for the Central Universities [2412018QD017]; National Natural Science Foundation of China	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Fundamental Research Funds for the Central Universities, grant number 2412018QD017 (Guolei Zhou) and the National Natural Science Foundation of China, grant number (Chenggu Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnsley MJ, 1996, PHOTOGRAMM ENG REM S, V62, P949; Burger M, 2012, URBAN STUD, V49, P1127, DOI 10.1177/0042098011407095; Carlucci M, 2019, ENVIRON PLANN B, V0, P1; Catalan B, 2008, LANDSCAPE URBAN PLAN, V85, P174, DOI 10.1016/j.landurbplan.2007.11.004; Chen XH, 2018, CHINESE GEOGR SCI, V28, P584, DOI 10.1007/s11769-018-0976-0; Chen YM, 2020, CITIES, V97, DOI 10.1016/j.cities.2019.102563; China City Statistical Yearbook, 2016, CHIN CIT STAT YB; Colantoni A, 2015, REND LINCEI-SCI FIS, V26, pS615, DOI 10.1007/s12210-015-0394-5; Crooks A, 2015, INT J GEOGR INF SCI, V29, P720, DOI 10.1080/13658816.2014.977905; EI Rahman SA, 2015, 2015 5 INT C E LEARN; Frondoni R, 2011, LANDSCAPE URBAN PLAN, V100, P117, DOI 10.1016/j.landurbplan.2010.12.002; Fuentes C., 2000, J BORDERLANDS STUDIE, V15, P25, DOI [10.1080/08865655.2000.9695554, DOI 10.1080/08865655.2000.9695554]; Gao QK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215656; Gao S, 2017, T GIS, V21, P446, DOI 10.1111/tgis.12289; Gong ZY, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11226424; Guo AD, 2020, SUSTAIN CITIES SOC, V53, DOI 10.1016/j.scs.2019.101972; Guo ZQ, 2018, INT GEOSCI REMOTE SE, P5061; Henderson FM, 1997, IEEE T GEOSCI REMOTE, V35, P79, DOI 10.1109/36.551936; Hirt S, 2012, J PLAN LIT, V27, P375, DOI 10.1177/0885412212451029; Jin SH, 2020, TOURISM MANAGE, V78, DOI 10.1016/j.tourman.2019.104070; Kroll F, 2012, POPUL SPACE PLACE, V18, P260, DOI 10.1002/psp.653; Markusen A, 2006, URBAN STUD, V43, P1301, DOI 10.1080/00420980600776392; Myint SW, 2008, APPL GEOGR, V28, P168, DOI 10.1016/j.apgeog.2008.02.005; Salvati L, 2019, LETT SPAT RESOUR SCI, V12, P19, DOI 10.1007/s12076-018-00221-x; Seto KC, 2005, LANDSCAPE ECOL, V20, P871, DOI 10.1007/s10980-005-5238-8; Talen E, 2006, J PLAN LIT, V20, P233, DOI 10.1177/0885412205283104; Terzi F, 2009, EUR PLAN STUD, V17, P1559, DOI 10.1080/09654310903141797; Tian GJ, 2010, HABITAT INT, V34, P249, DOI 10.1016/j.habitatint.2009.09.010; Tu W, 2017, INT J GEOGR INF SCI, V31, P2331, DOI 10.1080/13658816.2017.1356464; Wang HM, 2019, J IND ECOL, V23, P1425, DOI 10.1111/jiec.12933; Wang YH, 2018, ISPRS INT J GEO-INF, V7, DOI 10.3390/ijgi7020042; Xing HF, 2020, ECOL INDIC, V108, DOI 10.1016/j.ecolind.2019.105722; Xing HF, 2018, COMPUT ENVIRON URBAN, V72, P134, DOI 10.1016/j.compenvurbsys.2018.06.005; Xue B, 2016, J STRUCT ENG, V142, DOI 10.1061/(ASCE)ST.1943-541X.0001485; Yang J, 2019, URBAN CLIM, V28, DOI 10.1016/j.uclim.2019.100458; Yi DS, 2019, ISPRS INT GEO-INF, V8, DOI 10.3390/ijgi8120555; Zambon I, 2017, GEOGR ANN B, V99, P319, DOI 10.1080/04353684.2017.1294857; Zhang HS, 2018, INT J APPL EARTH OBS, V64, P87, DOI 10.1016/j.jag.2017.08.013; Zhang XY, 2017, ISPRS J PHOTOGRAMM, V132, P170, DOI 10.1016/j.isprsjprs.2017.09.007; Zhong C, 2014, COMPUT ENVIRON URBAN, V48, P124, DOI 10.1016/j.compenvurbsys.2014.07.004; Zhou GL, 2016, HABITAT INT, V56, P20, DOI 10.1016/j.habitatint.2016.04.002; [周国磊 Zhou Guolei], 2015, [地理学报, Acta Geographica Sinica], V70, P539; Zhou ZG, 2018, J VISUAL LANG COMPUT, V48, P169, DOI 10.1016/j.jvlc.2018.08.009	43	5	5	9	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234522	10.1371/journal.pone.0234522	http://dx.doi.org/10.1371/journal.pone.0234522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MF9GS	32579615	gold, Green Published			2022-12-27	WOS:000545646600022
J	Van Remoortel, H; Scheers, H; De Buck, E; Haenen, W; Vandekerckhove, P				Van Remoortel, Hans; Scheers, Hans; De Buck, Emmy; Haenen, Winne; Vandekerckhove, Philippe			Prediction modelling studies for medical usage rates in mass gatherings: A systematic review	PLOS ONE			English	Review							PATIENT VOLUME; HALF-MARATHON; HEALTH; RISK; WEATHER; QUALITY; EVENTS; GRADE	Background Mass gathering manifestations attended by large crowds are an increasingly common feature of society. In parallel, an increased number of studies have been conducted that developed and/or validated a model to predict medical usage rates at these manifestations. Aims To conduct a systematic review to screen, analyse and critically appraise those studies that developed or validated a multivariable statistical model to predict medical usage rates at mass gatherings. To identify those biomedical, psychosocial and environmental predictors that are associated with increased medical usage rates and to summarise the predictive performance of the models. Method We searched for relevant prediction modelling studies in six databases. The predictors from multivariable regression models were listed for each medical usage rate outcome (i.e. patient presentation rate (PPR), transfer to hospital rate (TTHR) and the incidence of new injuries). The GRADE methodology (Grades of Recommendation, Assessment, Development and Evaluation) was used to assess the certainty of evidence. Results We identified 7,036 references and finally included 16 prediction models which were developed (n = 13) or validated (n = 3) in the USA (n = 8), Australia (n = 4), Japan (n = 1), Singapore (n = 1), South Africa (n = 1) and The Netherlands (n = 1), with a combined audience of >48 million people in >1700 mass gatherings. Variables to predict medical usage rates were biomedical (i.e. age, gender, level of competition, training characteristics and type of injury) and environmental predictors (i.e. crowd size, accommodation, weather, free water availability, time of the manifestation and type of the manifestation) (low-certainty evidence). Evidence from 3 studies indicated that using Arbon's or Zeitz' model in other contexts significantly over- or underestimated medical usage rates (from 22% overestimation to 81% underestimation). Conclusions This systematic review identified multivariable models with biomedical and environmental predictors for medical usage rates at mass gatherings. Since the overall certainty of the evidence is low and the predictive performance is generally poor, proper development and validation of a context-specific model is recommended.	[Van Remoortel, Hans; Scheers, Hans; De Buck, Emmy] Belgian Red Cross, Ctr Evidence Based Practice, Mechelen, Belgium; [De Buck, Emmy; Vandekerckhove, Philippe] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Fac Med, Leuven, Belgium; [De Buck, Emmy] Cochrane First Aid, Mechelen, Belgium; [Haenen, Winne] Fed Publ Serv Hlth Food Chain Safety & Environm, Brussels, Belgium; [Vandekerckhove, Philippe] Belgian Red Cross, Mechelen, Belgium	KU Leuven	Van Remoortel, H (corresponding author), Belgian Red Cross, Ctr Evidence Based Practice, Mechelen, Belgium.	hans.vanremoortel@cebap.org			Foundation for Scientific Research of the Belgian Red Cross	Foundation for Scientific Research of the Belgian Red Cross(Fonds de la Recherche Scientifique - FNRS)	This work was made possible through funding from the Foundation for Scientific Research of the Belgian Red Cross. One of the activities of the Belgian Red Cross is providing first aid training to laypeople.	Aitsi-Selmi A, 2016, INT J INFECT DIS, V47, P101, DOI 10.1016/j.ijid.2016.04.006; Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Arbon P, 2001, Prehosp Disaster Med, V16, P150; Arbon Paul, 2004, Prehosp Disaster Med, V19, P208; Arbon P, 2018, PREHOSP DISASTER MED, V33, P362, DOI 10.1017/S1049023X18000493; Baird MB, 2010, AM J EMERG MED, V28, P224, DOI 10.1016/j.ajem.2008.10.034; BOWDISH GE, 1992, ANN EMERG MED, V21, P1200, DOI 10.1016/S0196-0644(05)81746-9; De Buck E, 2014, INT J EVID-BASED HEA, V12, P39, DOI 10.1097/01.XEB.0000444637.88465.a3; Evans J, 1996, STRAIGHT FORWARD STA, V1st; FitzGibbon KM, 2017, PREHOSP DISASTER MED, V32, P563, DOI 10.1017/S1049023X1700663X; Grange JT, 1999, ACAD EMERG MED, V6, P202, DOI 10.1111/j.1553-2712.1999.tb00156.x; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hartman N, 2009, AM J EMERG MED, V27, P337, DOI 10.1016/j.ajem.2008.03.042; Kman NE, 2007, PREHOSP EMERG CARE, V11, P453, DOI 10.1080/00207450701537043; Nieto PL, 2017, EMERGENCIAS, V29, P257; Locoh-Donou S, 2016, INTERN EMERG MED, V11, P745, DOI 10.1007/s11739-015-1387-1; Memish ZA, 2019, LANCET, V393, P2073, DOI 10.1016/S0140-6736(19)30501-X; Memish ZA, 2014, LANCET, V383, P2030, DOI 10.1016/S0140-6736(14)60225-7; Milsten Andrew M, 2003, Prehosp Disaster Med, V18, P334; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moher David, 2009, Open Med, V3, pe123; Moons KGM, 2019, ANN INTERN MED, V170, pW1, DOI 10.7326/M18-1377; Moore R, 2011, AM J EMERG MED, V29, P1217, DOI 10.1016/j.ajem.2010.07.018; Morimura Naoto, 2004, Prehosp Disaster Med, V19, P278; Murad M Hassan, 2017, Evid Based Med, V22, P85, DOI 10.1136/ebmed-2017-110668; Nable JV, 2014, PREHOSP DISASTER MED, V29, P608, DOI 10.1017/S1049023X14001046; Schwabe K, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093472; Selig B, 2013, J EMERG NURS, V39, pE39, DOI 10.1016/j.jen.2011.10.002; Shiker MAK, 2012, BRIT J SCI, V6, P55; Steenkamp M, 2016, PREHOSP DISASTER MED, V31, P443, DOI 10.1017/S1049023X1600042X; Tam JS, 2012, LANCET INFECT DIS, V12, P231, DOI 10.1016/S1473-3099(11)70353-X; Tan CM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1109; van Poppel D, 2016, SCAND J MED SCI SPOR, V26, P226, DOI 10.1111/sms.12424; Wasserstein RL, 2019, AM STAT, V73, P1, DOI 10.1080/00031305.2019.1583913; Westrol MS, 2017, PREHOSP DISASTER MED, V32, P289, DOI 10.1017/S1049023X17000085; Woodall J, 2010, PREHOSP DISASTER MED, V25, P442, DOI 10.1017/S1049023X00008542; World Health Organization, 2015, PUBL HLTH MASS GATH; World Health Organization (WHO), 2016, IS WHOS ROL MASS GAT; Zeitz KM, 2005, PREHOSPITAL DISASTER, V20, P164, DOI 10.1017/S1049023X00002399; Zeitz Kathryn M, 2002, Prehosp Disaster Med, V17, P147	41	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234977	10.1371/journal.pone.0234977	http://dx.doi.org/10.1371/journal.pone.0234977			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574190	Green Published, gold			2022-12-27	WOS:000544972400041
J	de Faria, FR; Miranda, VPN; Howe, CA; Sasaki, JE; Amorim, PRD				de Faria, Fernanda Rocha; Neves Miranda, Valter Paulo; Howe, Cheryl A.; Sasaki, Jeffer Eidi; dos Santos Amorim, Paulo Roberto			Behavioral classes related to physical activity and sedentary behavior on the evaluation of health and mental outcomes among Brazilian adolescents	PLOS ONE			English	Article							LATENT CLASS ANALYSIS; PATTERNS; CHILDREN; OBESITY; SLEEP	Latent Class Analysis can assist researchers interested in a better understanding of behavioral patterns and their association with health outcomes. This study aimed to identify lifestyle latent classes related to distinct domains of physical activity (PA) and sedentary behavior (SB) among adolescents and their association with health outcomes. This cross-sectional study included 217 Brazilian adolescents (15 to 18 years old, 49.3% female). The classes were based on moderate-to-vigorous physical activity (MVPA), light physical activity (LPA), number of steps, sedentary behavior (SB), and screen time (ST). To assess these behaviors, participants wore an accelerometer for one week. ST, demographic characteristics, socioeconomic status, and signs of common mental disorders (CMD) were evaluated through questionnaires. Latent Class Analysis was used to identify lifestyle classes. Three classes were recognized: "Active-Non-sedentary" (class 1) with 28.1% of adolescents; "Inactive-Non-sedentary" (class 2), 48.85%; and "Inactive-Sedentary" (class 3), 23.04%. Sex and signs of CMD were associated with the prevalence of the classes. Female adolescents presented 4.48 (95% CI 2.04-9.77) times more chance of belonging to the "Inactive-Sedentary" (class 3). Adolescents who presented CMD had 11.35 (95% CI 3.45-101.1) times more chance of belonging to the "Inactive-Non-sedentary" (class 2). The interaction between sex and signs of CMD showed that girls with signs of CMD were 9.20 (95% CI 1.17-71.52) more likely to belong to the Inactive-Sedentary class than the "Active-Non-sedentary". Results indicate that sex and signs of CMD can affect the prevalence of the classes. Our findings highlight that physical inactivity and SB can be associated with signs of CMD, especially in female adolescents.	[de Faria, Fernanda Rocha; Neves Miranda, Valter Paulo; dos Santos Amorim, Paulo Roberto] Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil; [Howe, Cheryl A.] Ohio Univ, Sch Appl Hlth Sci & Wellness, Athens, OH 45701 USA; [Sasaki, Jeffer Eidi] Univ Fed Triangulo Mineiro, Dept Sports Sci, Uberaba, MG, Brazil	Universidade Federal de Vicosa; University System of Ohio; Ohio University; Universidade Federal do Triangulo Mineiro	de Faria, FR (corresponding author), Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil.	frfaria.ef@gmail.com	Howe, Cheryl/ABC-1936-2020					Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; Champion KE, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00135; Chaput JP, 2017, OBES REV, V18, P7, DOI 10.1111/obr.12508; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; Council on Communications and Media, 2011, Pediatrics, V128, P201, DOI 10.1542/peds.2011-1066; Cureau FV, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S01518-8787.2016050006683, 10.1590/s01518-8787.2016050006683]; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Evenson K. R., 2016, International Journal of Behavioral Nutrition and Physical Activity, V13; Fleary SA, 2017, J SCHOOL HEALTH, V87, P182, DOI 10.1111/josh.12481; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Huh J, 2011, OBESITY, V19, P652, DOI 10.1038/oby.2010.228; Iannotti RJ, 2013, J ADOLESCENT HEALTH, V53, P280, DOI 10.1016/j.jadohealth.2013.03.007; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Jenkins GP, 2017, MED SCI SPORT EXER, V49, P1826, DOI 10.1249/MSS.0000000000001310; Kim Y, 2016, J EPIDEMIOL, V26, P137, DOI 10.2188/jea.JE20150068; Kongsted Alice, 2017, J Physiother, V63, P55, DOI 10.1016/j.jphys.2016.05.018; Kremer P, 2014, J SCI MED SPORT, V17, P183, DOI 10.1016/j.jsams.2013.03.012; Krokstad S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3993-x; Lavie CJ, 2019, CIRC RES, V124, P799, DOI 10.1161/CIRCRESAHA.118.312669; Linzer DA, 2011, J STAT SOFTW, V42, P1, DOI 10.18637/jss.v042.i10; Lohman T.G., 1988, ANTHROPOMETRIC STAND; Lopes CS, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S01518-8787.2016050006690, 10.1590/s01518-8787.2016050006690]; Malachias M V B, 2016, Arq Bras Cardiol, V107, P7, DOI 10.5935/abc.20160152; MARI JD, 1985, PSYCHOL MED, V15, P651; Martinez-Gonzalez M., 2009, BIOESTADISTICA AMIGA, V2, P373; Miranda VPN, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6488-8; Oliveira Juliana Souza, 2016, Rev. Saúde Pública, V50, p7s, DOI 10.1590/s01518-8787.2016050006680; Paruthi S, 2016, J CLIN SLEEP MED, V12, P785, DOI 10.5664/jcsm.5866; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; R Code Team and R Development Code Team, 2014, LANG ENV STAT COMP; Romanzini M, 2014, EUR J SPORT SCI, V14, P91, DOI 10.1080/17461391.2012.732614; Tenório Maria Cecília Marinho, 2010, Rev. bras. epidemiol., V13, P105, DOI 10.1590/S1415-790X2010000100010; Thivel D, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00288; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-78; Ussher MH, 2007, SOC PSYCH PSYCH EPID, V42, P851, DOI 10.1007/s00127-007-0232-x; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2008, WAIST CIRCUMFERENCE	41	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234374	10.1371/journal.pone.0234374	http://dx.doi.org/10.1371/journal.pone.0234374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569320	Green Published, gold			2022-12-27	WOS:000543547900036
J	Piruzyan, M; Shitanda, I; Shimauchi, Y; Okita, G; Tsurekawa, Y; Moriuchi, M; Nakano, Y; Teramoto, K; Suico, MA; Shuto, T; Kai, HR				Piruzyan, Mariam; Shitanda, Ihori; Shimauchi, Yuichiro; Okita, Go; Tsurekawa, Yu; Moriuchi, Masataka; Nakano, Yoshio; Teramoto, Keisuke; Suico, Mary Ann; Shuto, Tsuyoshi; Kai, Hirofumi			A novel condition of mild electrical stimulation exerts immunosuppression via hydrogen peroxide production that controls multiple signaling pathway	PLOS ONE			English	Article							NF-KAPPA-B; T-LYMPHOCYTES; HYPERTHERMIA; CYCLOSPORINE; EXPRESSION; PROTEINS; ARREST; INJURY; CELLS	Different modes of exogenous electrical stimulation at physiological strength has been applied to various diseases. Previously, we extensively demonstrated the usability of mild electrical stimulation (MES) with low frequency pulse current at 55 pulses per second (MES55) for several disease conditions. Here we found that MES with high frequency pulse-current (5500 pulse per second; MES5500) suppressed the overproduction of pro-inflammatory cytokines induced by phorbol myristate acetate/ionomycin in Jurkat T cells and primary splenocytes. MES(5500)also suppressed the overproduction of inflammatory cytokines, improved liver damage and reduced mouse spleen enlargement in concanavalin-A-treated BALB/c mice. The molecular mechanism underlying these effects included the ability of MES(5500)to induce modest amount of hydrogen peroxide and control multiple signaling pathways important for immune regulation, such as NF-kappa B, NFAT and NRF2. In the treatment of various inflammatory and immune-related diseases, suppression of excessive inflammatory cytokines is key, but because immunosuppressive drugs used in the clinical setting have serious side effects, development of safer methods of inhibiting cytokines is required. Our finding provides evidence that physical medicine in the form of MES(5500)may be considered as a novel therapeutic tool or as adjunctive therapy for inflammatory and immune-related diseases.	[Piruzyan, Mariam; Shitanda, Ihori; Shimauchi, Yuichiro; Okita, Go; Tsurekawa, Yu; Moriuchi, Masataka; Nakano, Yoshio; Teramoto, Keisuke; Suico, Mary Ann; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto, Japan; [Piruzyan, Mariam; Tsurekawa, Yu; Moriuchi, Masataka; Nakano, Yoshio; Teramoto, Keisuke; Kai, Hirofumi] Kumamoto Univ, Program Leading Grad Sch HIGO Hlth Life Sci Inter, Kumamoto, Japan	Kumamoto University; Kumamoto University	Kai, HR (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto, Japan.; Kai, HR (corresponding author), Kumamoto Univ, Program Leading Grad Sch HIGO Hlth Life Sci Inter, Kumamoto, Japan.	hirokai@gpo.kumamoto-u.ac.jp		Shuto, Tsuyoshi/0000-0003-1275-4988	Japan Society for the Promotion Science (JSPS) KAKENHI [JP26460098, JP17K08309]; JSPS Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers [S2803]	Japan Society for the Promotion Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers	Funding was provided by the Japan Society for the Promotion Science (JSPS) KAKENHI (Grant Nos. JP26460098 and JP17K08309 (to M.A.S.)), and JSPS Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (Grant No. S2803 (to H.K.)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2015, FREE RADICAL BIO MED, V79, P28, DOI 10.1016/j.freeradbiomed.2014.11.014; AEBI H, 1968, BIOCHEM GENET, V2, P245, DOI 10.1007/BF01474764; [Anonymous], 2014, EURASIAN CARDIOLOGIC, V1, P80; Antoniv TT, 2011, IMMUNOLOGY, V132, P567, DOI 10.1111/j.1365-2567.2010.03402.x; Avrahami R, 2015, WOUNDS, V27, P199; Busquets-Cortes C, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121920; Bussel B, 2015, ANN PHYS REHABIL MED, V58, P198, DOI 10.1016/j.rehab.2015.04.008; Doerfler Maria, 2015, SYRIAC ENCOUNTERS PA, V20, P259; Du PH, 2016, CHEMOSPHERE, V144, P1674, DOI 10.1016/j.chemosphere.2015.10.038; Fukuda R, 2016, J AM SOC NEPHROL, V27, P144, DOI 10.1681/ASN.2014111109; Fukuda R, 2013, J BIOL CHEM, V288, P16117, DOI 10.1074/jbc.M112.442442; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Heymann F, 2015, LAB ANIM-UK, V49, P12, DOI 10.1177/0023677215572841; Hoorn EJ, 2011, NAT MED, V17, P1304, DOI 10.1038/nm.2497; Horiba M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42208; Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x; Huang JH, 2013, EUR J NEUROSCI, V38, P3691, DOI 10.1111/ejn.12370; Kai H, 2009, INT J HYPERTHER, V25, P655, DOI 10.3109/02656730903039605; Kitahara K, 2007, CURR OPIN RHEUMATOL, V19, P238, DOI 10.1097/BOR.0b013e328099af80; Koga T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043852; Kondo T, 2012, DIABETES, V61, P838, DOI 10.2337/db11-1098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsuyama S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114690; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Morino S, 2008, J PHARMACOL SCI, V108, P222, DOI 10.1254/jphs.08180SC; Morino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004068; Morzadec C, 2014, FREE RADICAL BIO MED, V71, P133, DOI 10.1016/j.freeradbiomed.2014.03.006; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Oba M, 2010, J SURG RES, V162, P213, DOI 10.1016/j.jss.2009.03.093; Odell RH, 2008, PAIN PHYSICIAN, V11, P891; Pandey AN, 2014, BIORESEARCH OPEN ACC, V3, P183, DOI 10.1089/biores.2014.0013; ROSS R, 1994, P NATL ACAD SCI USA, V91, P2879, DOI 10.1073/pnas.91.8.2879; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Schmitt J, 2007, J EUR ACAD DERMATOL, V21, P606, DOI 10.1111/j.1468-3083.2006.02023.x; Sies H, 2017, REDOX BIOL, V11, P613, DOI 10.1016/j.redox.2016.12.035; Suico MA, 2014, J BIOL CHEM, V289, P26143, DOI 10.1074/jbc.M114.580209; Sultana ST, 2015, SCI REP-UK, V5, DOI 10.1038/srep14908; Tsurekawa Y, 2018, EXP DERMATOL, V27, P1092, DOI 10.1111/exd.13720; Wollbold J, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0101-7; Yano S, 2011, J PHARMACOL SCI, V115, P94, DOI 10.1254/jphs.10185SC; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	45	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234867	10.1371/journal.pone.0234867	http://dx.doi.org/10.1371/journal.pone.0234867			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569300	Green Published, gold			2022-12-27	WOS:000543547900051
J	Browne, MA; Ros, M; Johnston, EL				Browne, Mark Anthony; Ros, Macarena; Johnston, Emma L.			Pore-size and polymer affect the ability of filters for washing-machines to reduce domestic emissions of fibres to sewage	PLOS ONE			English	Article							MICROPLASTICS; RELEASE	When clothes are worn and washed, they emit fibres into the ecosystem via discharges of sewage that have been linked to the global dispersion of clothing fibres. Facilities that treat sewage divert some fibres from sewage effluent to sludge, but no current methods of filtration eliminate their environmental release. While filters for washing-machines are sold to consumers with the argument they will reduce the emissions of fibres from clothes to the environment, there is insufficient scientific peer-reviewed evidence assessing their ability to retain fibres from washed clothes and reduce environmental contamination. To improve our understanding and develop more realistic methods to assess the efficiency of filters, we washed replicate cotton and polyester garments in replicate domestic front-loaded washing-machines with and without replicate filters (micro- and milli-meter-sized pores), and then quantified the masses of the fibres retained by the filters and those released in the effluent. Here we show micrometer-sized filters significantly reduced the mass of cotton by 67% (F-2,F-6= 11.69, P<0.01) compared to effluent from appliances with no filters, whilst filters in general reduced polyester fibres in their effluent by more than 65% (micrometer-sized pores) and 74% (millimeter-sized pores) compared to effluent from appliances with no filters (F-2,F-12= 5.20, P<0.05). While filters with micrometer-sized pores caught larger masses and total proportions of fibres than filters with millimeter-sized pores, the differences were only significant for the total proportions of cotton (t = 4.799 df = 4, P<0.01). For tests with garments of either types of polymer, the filtered effluent still contained up to a third of the original masses of fibres released from the garments. Given the diversity of clothes, polymers, appliances and filters currently sold to consumers, our work shows the value of increasing the rigour (e.g. more levels of replication) when testing filters and the need for further studies that test an even greater diversity of materials and methods in order to meet the growing demand for knowledge from governments, industry and the public.	[Browne, Mark Anthony; Johnston, Emma L.] Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Ros, Macarena] Univ Cadiz, Fac Ciencias Mar & Ambientales, Dept Biol, Puerto Real, Spain	University of New South Wales Sydney; Universidad de Cadiz	Browne, MA (corresponding author), Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	m.browne@unsw.edu.au	Johnston, Emma/AAC-2878-2022; Ros, Macarena/AAD-4589-2021	Johnston, Emma/0000-0002-2117-366X; Ros, Macarena/0000-0001-8074-0778; Browne, Mark Anthony/0000-0002-7508-1015	Eileen Fisher; Mosman Council; NSW EPA (Waste Less, Recycle More initiative from waste-levy); Australian Research Council [DP150103272, LP170100313]; Spanish Government fellowship [CAS17/00482]	Eileen Fisher; Mosman Council; NSW EPA (Waste Less, Recycle More initiative from waste-levy); Australian Research Council(Australian Research Council); Spanish Government fellowship	MAB received funding in the form of a grant from Eileen Fisher (www.eileenfisher.com).MAB and ELJ received funding from Mosman Council (www.mosman.nsw.gov.au), NSW EPA (Waste Less, Recycle More initiative funded from waste-levy; https://www.epa.nsw.gov.au/yourenvironment/recycling-and-reuse/waste-less-recycle-more), Australian Research Council (DP150103272, LP170100313; www.arc.gov.au).MR received funding from Spanish Government fellowship (Jose Castillejo CAS17/00482; www.mecd.gob.es).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 00 The manuscript was written through contributions of all authors reflected by the order of authorship. All authors approved the final version of the manuscript. We thank B. Jollimore (at Environmental Enhancements for providing all filters for free), N. Garg, A. Bugnot, M. Gil, M. Mayer-Pinto, E. Marzinelli, L. Martin (for the use of their homes/appliances), M.Todesco (microscopic observations of the physical construction of the garments) and R. Stamminger (for advice and helpful comments). This work was supported by grants from Eileen Fisher, Mosman Council, NSW EPA (Waste Less, Recycle More initiative funded from waste-levy) and the Australian Research Council (DP150103272, LP170100313) to MAB, ELJ and a Spanish Government fellowship to MR (Jose Castillejo CAS17/00482). Sources of funding and Environmental Enhancements were not involved in the collection, analysis and interpretation of data, in report-writing or the decision to submit for publication.	Almroth BMC, 2018, ENVIRON SCI POLLUT R, V25, P1191, DOI 10.1007/s11356-017-0528-7; [Anonymous], 2019, FABR; [Anonymous], 2011, 604562011 EN; Australian Competition and Consumer Commission, 2019, GREEN MARK AUSTR CON; Browne MA, 2015, NY TIMES; Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a; Browne MA, 2015, MARINE ANTHROPOGENIC LITTER, P229, DOI 10.1007/978-3-319-16510-3_9; Browne MA, 2015, ENVIRON SCI TECHNOL, V49, P7082, DOI 10.1021/es5060572; Browne MA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2929; Browne MA, 2013, CURR BIOL, V23, P2388, DOI 10.1016/j.cub.2013.10.012; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Carmichael A, 2019, MAN MADE FIBRES CONT; De Falco F, 2018, ENVIRON POLLUT, V236, P916, DOI 10.1016/j.envpol.2017.10.057; El Backly RM, 2013, TISSUE ENG PT A, V19, P152, DOI [10.1089/ten.tea.2012.0357, 10.1089/ten.TEA.2012.0357]; Fisher R.A., 1930, IMPERIAL BUREAU SOIL, V10, P437; Gatoo MA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/498420; Gosney ML, 1979, IND RELATION LAW J, V3, P102, DOI 10.15779/Z38N03T; Halstead JE, 2018, ENVIRON POLLUT, V234, P552, DOI 10.1016/j.envpol.2017.11.085; Hartline NL, 2016, ENVIRON SCI TECHNOL, V50, P11532, DOI 10.1021/acs.est.6b03045; Hernandez E, 2017, ENVIRON SCI TECHNOL, V51, P7036, DOI 10.1021/acs.est.7b01750; Hsiao IL, 2011, SCI TOTAL ENVIRON, V409, P1219, DOI 10.1016/j.scitotenv.2010.12.033; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Hussain N, 2001, ADV DRUG DELIVER REV, V50, P107, DOI 10.1016/S0169-409X(01)00152-1; Lusher AL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14947; McIlwraith HK, 2019, MAR POLLUT BULL, V139, P40, DOI 10.1016/j.marpolbul.2018.12.012; Murphy F, 2016, ENVIRON SCI TECHNOL, V50, P5800, DOI 10.1021/acs.est.5b05416; Murray F, 2011, MAR POLLUT BULL, V62, P1207, DOI 10.1016/j.marpolbul.2011.03.032; Muthu SS, 2017, TEXT INST BOOK SER, pXV; Napper IE, 2016, MAR POLLUT BULL, V112, P39, DOI 10.1016/j.marpolbul.2016.09.025; Oerlikon, 2009, FIBR YEAR 2008 09 WO; Oner E, 2019, FIBER POLYM, V20, P2416, DOI 10.1007/s12221-019-9119-1; Pirc U, 2016, ENVIRON SCI POLLUT R, V23, P22206, DOI 10.1007/s11356-016-7703-0; Senate Environment and Communications References Committee, TOX TID THREAT MAR P; Sillanpaa M, 2017, ENVIRON SCI POLLUT R, V24, P19313, DOI 10.1007/s11356-017-9621-1; Stamminger R, 2018, RESOUR CONSERV RECY, V131, P206, DOI 10.1016/j.resconrec.2017.11.014; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Underwood AJ, 2017, ANAL METHODS-UK, V9, P1332, DOI 10.1039/c6ay02641a; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Woodall LC, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140317	39	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234248	10.1371/journal.pone.0234248	http://dx.doi.org/10.1371/journal.pone.0234248			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559201	Green Published, gold			2022-12-27	WOS:000543261600023
J	Chang, J; Oh, SH; Park, SK				Chang, Jiwon; Oh, Seung-Ha; Park, Su-Kyoung			Comparison of newborn hearing screening results between well babies and neonates admitted to the neonatal intensive care unit for more than 5 days: Analysis based on the national database in Korea for 9 years	PLOS ONE			English	Article							RISK-FACTORS; INFANTS	Objective The purpose of this cohort study is to compare newborn hearing screening (NHS) results between healthy newborns and neonates who were admitted to the neonate intensive care unit (NICU) for more than 5 days based on the national database for 9 years. Ultimately, we've tried to analyze the associated factors necessary to manage the national NHS program according to the group, which would help to establish policy to effectively detect and support hearing impaired children and which would help to control qualities. Methods The Ministry of Health and Welfare (MHW) introduced a nationwide coupon-mediated program for the low-income class since 2009. The coupon consisted of two parts, the screening part and the confirming parts with the same unique number, and the MHW supported the cost of one screening test and one diagnostic auditory brainstem response (ABR) test for infants who did not pass from the screening test. We have analyzed the screening test performing rate, the referral rate according to the screening methods or institutions, the prevalence of hearing loss, and the average age of hearing loss diagnosis. Hearing loss was defined as any hearing impairment either unilateral or bilateral with the hearing threshold >= 40 dB nHL on the diagnostic ABR test, irrespective of its etiology. Results A total of 524,371 newborns were enrolled in the study, and 506,634 (96.6%) neonates were in the "well-baby group (WBG)", while 17,737 (3.4%) were in the "high-risk group (HRG)". The referral rate of the screening test was 1.5% in average, 1.3% in the WBG, and 7.5% in the HRG. The referral rates varied according to the screening methods and screening institutions. The adjusted prevalence of HL was 5.6/1,000 in average, 4.6/1,000 in the WBC, and 28.8/1,000 in the HRG. The screening tests were performed 4.3 +/- 6.7 days after birth and the diagnostic tests were done 62.7 +/- 37.5 days after birth in WBG. In HRG, dates were 17.7 +/- 19.3 days and 97.6 +/- 51.4 days, respectively. Conclusions The prevalence of hearing loss in infants who were hospitalized in NICU for more than 5 days was about seven times higher than that in healthy newborns. However, different referral rates were noted depending on both institutions and the screening methods. These differences need to be addressed in order to improve our program and ensure that all neonates with hearing loss, especially neonates with high risk factor, are detected and appropriately referred for the treatment.	[Chang, Jiwon; Park, Su-Kyoung] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Oh, Seung-Ha] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Hallym University; Hallym University	Park, SK (corresponding author), Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	ashock@daum.net		Park, Su-Kyoung/0000-0002-2274-2799	Hallym University Research Fund [HURF-2017-17]	Hallym University Research Fund	This research was supported by Hallym University Research Fund 2017 (HURF-2017-17). The funder played no role in the study design, data collection or analysis, the decision to publish, or preparation of the manuscript.	[Anonymous], 2000, Am J Audiol, V9, P9; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Barker MJ, 2013, J PAEDIATR CHILD H, V49, pE74, DOI 10.1111/j.1440-1754.2012.02472.x; Boone RT, 2005, INT J PEDIATR OTORHI, V69, P393, DOI 10.1016/j.ijporl.2004.11.006; Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333; Connolly JL, 2005, LARYNGOSCOPE, V115, P232, DOI 10.1097/01.mlg.0000154724.00787.49; Dalla-Favera R., 2014, CANC CELL, V25, pe131; Erenberg A, 1999, PEDIATRICS, V103, P527; Health WSDo, 2018, PROT NEWB HEAR SCREE; Hille ETM, 2007, ACTA PAEDIATR, V96, P1155, DOI 10.1111/j.1651-2227.2007.00398.x; Korean Statistical Information Service (KOSIS), 2020, NAT LIV BIRTHS; Korres S, 2005, OTOL NEUROTOL, V26, P1186, DOI 10.1097/01.mao.0000184602.94677.41; Martinez-Cruz CF, 2008, ARCH MED RES, V39, P686, DOI 10.1016/j.arcmed.2008.06.004; Mason JA, 1998, PEDIATRICS, V101, P221, DOI 10.1542/peds.101.2.221; Ravi R, 2016, INT J PEDIATR OTORHI, V90, P29, DOI 10.1016/j.ijporl.2016.08.016; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Statistics Korea, 2021, BIRTH STAT 2020; The Korean Audiological Society, 2018, KOR NEWB HEAR SCREEN, V2nd; Thompson DC, 2001, JAMA-J AM MED ASSOC, V286, P2000, DOI 10.1001/jama.286.16.2000; van Dommelen P, 2011, ACTA PAEDIATR, V100, P1097, DOI 10.1111/j.1651-2227.2011.02230.x; van Dommelen P, 2010, ACTA PAEDIATR, V99, P344, DOI 10.1111/j.1651-2227.2009.01614.x; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161	22	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0235019	10.1371/journal.pone.0235019	http://dx.doi.org/10.1371/journal.pone.0235019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559227	Green Published, gold			2022-12-27	WOS:000543261600021
J	Maharani, A; Dawes, P; Nazroo, J; Tampubolon, G; Pendleton, N				Maharani, Asri; Dawes, Piers; Nazroo, James; Tampubolon, Gindo; Pendleton, Neil		SENSE-Cog WP1 Grp	Trajectories of recall memory as predictive of hearing impairment: A longitudinal cohort study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MINI-MENTAL STATE; PHYSICAL-ACTIVITY; OLDER-ADULTS; RISK-FACTORS; DEMENTIA; DECLINE; AGE; HEALTH; INTELLIGENCE	Objectives Accumulating evidence points to a relationship between hearing function and cognitive ability in later life. However, the exact mechanisms of this relationship are still unclear. This study aimed to characterise latent cognitive trajectories in recall memory and identify their association with subsequent risk of hearing impairment. Methods We analysed data from the English Longitudinal Study of Ageing Wave 1 (2002/03) until Wave 7 (2014/15). The study population consisted of 3,615 adults aged 50+ who participated in the first wave of the English Longitudinal Study of Ageing, who had no self-reported hearing impairment in Wave 1, and who underwent a hearing test in Wave 7. Respondents were classified as having hearing impairment if they failed to hear tones quieter than 35 dB HL in the better ear. Results The trajectories of recall memory scores were grouped using latent class growth mixture modelling and were related to the presence of hearing impairment in Wave 7. Models estimating 1-class through 5-class recall memory trajectories were compared and the best-fitting models were 4-class trajectories. The different recall memory trajectories represent different starting points and mean of the memory scores. Compared to respondents with the highest recall memory trajectory, other trajectories were increasingly likely to develop later hearing impairment. Conclusions Long-term changes in cognitive ability predict hearing impairment. Further research is required to identify the mechanisms explaining the association between cognitive trajectories and hearing impairment, as well as to determine whether intervention for maintenance of cognitive function also give benefit on hearing function among older adults.	[Maharani, Asri; Pendleton, Neil] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Neurosci & Expt Psychol, Manchester, Lancs, England; [Dawes, Piers] Univ Manchester, Div Human Commun Dev & Hearing, Manchester, Lancs, England; [Nazroo, James; Tampubolon, Gindo] Univ Manchester, Cathie Marsh Inst Social Res, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Maharani, A (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Neurosci & Expt Psychol, Manchester, Lancs, England.	asri.maharani@manchester.ac.uk	Delcourt, Cecile/I-2627-2013; Pendleton, Neil/F-2333-2015; Maharani, Asri/U-7663-2017	Delcourt, Cecile/0000-0002-2099-0481; Dawes, Piers/0000-0003-3180-9884; Pendleton, Neil/0000-0003-0794-2386; Tampubolon, Gindo/0000-0002-9081-2349; Maharani, Asri/0000-0002-5931-8692	Horizon 2020 Framework Programme [633491, 668648]; UK National Institute for Health Research [01A1-CSPP04-014]	Horizon 2020 Framework Programme; UK National Institute for Health Research(National Institute for Health Research (NIHR))	SENSE-Cog project has received funding from the Horizon 2020 Framework Programme (633491) research and innovation programme under grant agreement No 668648. PD is supported by the UK National Institute for Health Research (01A1-CSPP04-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimoni C, 2010, AUDIOL NEURO-OTOL, V15, P111, DOI 10.1159/000231636; Amieva H, 2015, J AM GERIATR SOC, V63, P2099, DOI 10.1111/jgs.13649; Anstey KJ, 2003, PSYCHOL AGING, V18, P714, DOI 10.1037/0882-7974.18.4.714; Anstey KJ, 2001, J GERONTOL B-PSYCHOL, V56, pP3, DOI 10.1093/geronb/56.1.P3; Armstrong NM, 2020, J GERONTOL A-BIOL, V75, P574, DOI 10.1093/gerona/gly268; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Bakk Z, 2013, SOCIOL METHODOL, V43, P272, DOI 10.1177/0081175012470644; Baloyannis SJ, 2005, J NEUROL SCI, V229, P51, DOI 10.1016/j.jns.2004.11.025; Baloyannis SJ, 2011, ACTA OTO-LARYNGOL, V131, P610, DOI 10.3109/00016489.2010.539626; Baloyannis SJ, 2011, ACTA OTO-LARYNGOL, V131, P359, DOI 10.3109/00016489.2010.539267; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Benova L, 2015, J GERONTOL B-PSYCHOL, V70, P443, DOI 10.1093/geronb/gbu024; Bizley JK, 2013, NAT REV NEUROSCI, V14, P693, DOI 10.1038/nrn3565; Buschkuehl M, 2008, PSYCHOL AGING, V23, P743, DOI 10.1037/a0014342; Davies HR, 2017, J AM GERIATR SOC, V65, P2074, DOI 10.1111/jgs.14986; DAVIS AC, 1989, INT J EPIDEMIOL, V18, P911, DOI 10.1093/ije/18.4.911; Deary IJ, 1997, TRENDS NEUROSCI, V20, P365, DOI 10.1016/S0166-2236(97)01070-9; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Golob EJ, 2007, BRAIN, V130, P740, DOI 10.1093/brain/awl375; GordonSalant S, 1997, J SPEECH LANG HEAR R, V40, P423, DOI 10.1044/jslhr.4002.423; Griffiths TD, 2004, NAT REV NEUROSCI, V5, P887, DOI 10.1038/nrn1538; Gurgel RK, 2014, OTOL NEUROTOL, V35, P775, DOI 10.1097/MAO.0000000000000313; Heinrich A, 2020, EAR HEARING, V41, P907, DOI 10.1097/AUD.0000000000000812; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Hull RH, 2010, AM J AUDIOL, V19, P9, DOI 10.1044/1059-0889(2010/08-0040); Inst Med, 2015, COGNITIVE AGING: PROGRESS IN UNDERSTANDING AND OPPORTUNITIES FOR ACTION, P1; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kiely KM, 2012, J GERONTOL A-BIOL, V67, P997, DOI 10.1093/gerona/gls066; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2012, JAMA-J AM MED ASSOC, V307, P1147, DOI 10.1001/jama.2012.321; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Lindenberger U, 2009, PSYCHOL AGING, V24, P1, DOI 10.1037/a0014986; Maharani A, 2020, J GERONTOL B-PSYCHOL, V75, P1230, DOI 10.1093/geronb/gbz043; Maharani A, 2018, AGE AGEING, V47, P575, DOI 10.1093/ageing/afy061; Marmot M., 2015, ENGLISH LONGITUDINAL, DOI [10.5255/UKDA-SN-5050-10., DOI 10.5255/UKDA-SN-5050-10, http://dx.doi.org/10.5255/UKDA-SN-5050-10]; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; McGarrigle R, 2014, INT J AUDIOL, V53, P433, DOI 10.3109/14992027.2014.890296; Miles L, 2007, NUTR BULL, V32, P314, DOI 10.1111/j.1467-3010.2007.00668.x; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1161/CIRCULATIONAHA.107.185650; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Nondahl DM, 1998, AUDIOLOGY, V37, P295; Parving A., 2008, AUDIOLOGICAL MED, V6, P115, DOI DOI 10.1080/16513860801995633; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rosenberg A, 2018, ALZHEIMERS DEMENT, V14, P263, DOI 10.1016/j.jalz.2017.09.006; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Schneider B. A., 2000, IMPLICATIONS PERCEPT; Scholes S, 2014, HLTH SURV ENGL; Society for Endocrinology MaDoSAS, 2017, J ENDOCRINOL METAB D, V21, pS1; Spiby J, 2014, EXTERNAL REV PROGRAM; Sun R., 2006, COGNITION MULTIAGENT, P79; Tampubolon G, 2017, EUR GERIATR MED, V8, P454, DOI 10.1016/j.eurger.2017.08.001; Twamley EW, 2006, J INT NEUROPSYCH SOC, V12, P707, DOI 10.1017/S1355617706060863; UHLMANN RF, 1989, J AM GERIATR SOC, V37, P223, DOI 10.1111/j.1532-5415.1989.tb06811.x; Wayne RV, 2015, AGEING RES REV, V23, P154, DOI 10.1016/j.arr.2015.06.002; Wickett JC, 2000, PERS INDIV DIFFER, V29, P1095, DOI 10.1016/S0191-8869(99)00258-5; Wilson BS, 2017, LANCET, V390, P2503, DOI 10.1016/S0140-6736(17)31073-5; Wingfield A, 1996, J Am Acad Audiol, V7, P175	62	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234623	10.1371/journal.pone.0234623	http://dx.doi.org/10.1371/journal.pone.0234623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555743	gold, Green Published			2022-12-27	WOS:000543273200072
J	Ping, WW; Zheng, JZ; Niu, XH; Guo, CZ; Zhang, JF; Yang, H; Shi, Y				Ping, Weiwei; Zheng, Jianzhong; Niu, Xiaohong; Guo, Chongzheng; Zhang, Jinfang; Yang, Hui; Shi, Yan			Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic	PLOS ONE			English	Article							GENERAL-POPULATION; QUESTIONNAIRE; VALIDITY; EUROQOL; ADULTS; SF-12	Objective Since December 2019, an increasing number of cases of the 2019 novel coronavirus disease (COVID-19) infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been identified in Wuhan, Hubei Province, China. Now, more cases have been reported in 200 other countries and regions. The pandemic disease not only affects physical health who suffered it, but also affects the mental health of the general population. This study aims to know about the impact of the COVID-19 epidemic on the health-related quality of life (HRQOL) of living using EQ-5D in general population in China. Methods An online-based survey was developed and participants were recruited via social media. The questionnaires included demographic and socioeconomic data, health status, the condition epidemic situation and EQ-5D scale. The relationships of all factors and the scores of EQ-5D were analyzed. Logistic regression model were used to the five health dimensions. Results The respondents obtained a mean EQ-5D index score of 0.949 and a mean VAS score of 85.52.The most frequently reported problem were pain/discomfort (19.0%) and anxiety/depression (17.6%). Logistic regression models showed that the risk of pain/discomfort and anxiety/depression among people with aging, with chronic disease, lower income, epidemic effects, worry about get COVID-19 raised significantly. Conclusion The article provides important evidence on HRQOL during the COVID-19 pandemic. The risk of pain/discomfort and anxiety/depression in general population in China raised significantly with aging, with chronic disease, lower income, epidemic effects, worried about get COVID-19 during the COVID-19 pandemic. The results from each categorical data can be used for future healthcare measures among general population.	[Ping, Weiwei; Zheng, Jianzhong; Guo, Chongzheng; Yang, Hui; Shi, Yan] Changzhi Med Coll, Dept Prevent Med, Changzhi, Shanxi, Peoples R China; [Niu, Xiaohong; Zhang, Jinfang] Changzhi Med Coll, Heji Hosp, Changzhi, Shanxi, Peoples R China	Changzhi Medical College; Changzhi Medical College	Ping, WW (corresponding author), Changzhi Med Coll, Dept Prevent Med, Changzhi, Shanxi, Peoples R China.	weiweip@czmc.edu.cn			Soft Science Project of Shanxi of China [2018041033-1, 2017041040-4]; prevention and control COVID-19 project of Changzhi Medical College [XG202004]	Soft Science Project of Shanxi of China; prevention and control COVID-19 project of Changzhi Medical College	The study was funded by the Soft Science Project of Shanxi of China (2017041040-4), the Soft Science Project of Shanxi of China (2018041033-1) to WP, and by the prevention and control COVID-19 project of Changzhi Medical College by XN (XG202004).	Abdin E, 2013, QUAL LIFE RES, V22, P2983, DOI 10.1007/s11136-013-0405-x; Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; [Anonymous], 2020, LANCET INFECT DIS, V20, P192, DOI [10.1016/S1473-3099(20)30483-7, DOI 10.1016/S1473-3099(20)30483-7, DOI 10.1056/NEJMoa2021756]; Burstrom K, 2001, QUAL LIFE RES, V10, P621, DOI 10.1023/A:1013171831202; Chang TJ, 2007, J FORMOS MED ASSOC, V106, P1023, DOI 10.1016/S0929-6646(08)60078-9; Chinese Center for Disease Control and Prevention, HLTH TOP INF DIS COR; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; Fujikawa Ai, 2011, Environmental Health and Preventive Medicine, V16, P25, DOI 10.1007/s12199-010-0162-1; Golicki D, 2010, POL ARCH MED WEWN, V120, P276, DOI 10.20452/pamw.945; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Huang WD, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030224; Jelsma J, 2004, B WORLD HEALTH ORGAN, V82, P206; JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437; Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048; Johnson JA, 1998, QUAL LIFE RES, V7, P155, DOI 10.1023/A:1008809610703; Johnson JA, 2000, MED CARE, V38, P115, DOI 10.1097/00005650-200001000-00013; Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Kontodimopoulos N, 2008, VALUE HEALTH, V11, P1162, DOI 10.1111/j.1524-4733.2008.00356.x; Liu GG, 2014, VALUE HEALTH, V17, P597, DOI 10.1016/j.jval.2014.05.007; Liu XH, 2012, COMPR PSYCHIAT, V53, P15, DOI 10.1016/j.comppsych.2011.02.003; Luo N, 2005, MED CARE, V43, P1078, DOI 10.1097/01.mlr.0000182493.57090.c1; National Bureau of Statistics of China, NAT DAT; National Health Commission of the People`s Republic of China, COR DIS COVID 19 PAN; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Sorensen J, 2009, SCAND J PUBLIC HEALT, V37, P467, DOI 10.1177/1403494809105286; SPRANGERS MAG, 1993, QUAL LIFE RES, V2, P287, DOI 10.1007/BF00434800; Su M, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0868-0; Sun S, 2011, QUAL LIFE RES, V20, P309, DOI 10.1007/s11136-010-9762-x; Tan XD, 2019, GLOB HEALTH PROMOT, V26, P96, DOI 10.1177/1757975917743533; Taylor S, 2020, J ANXIETY DISORD, V72, DOI 10.1016/j.janxdis.2020.102232; Teris Cheung, COVID 19 SARS CLOUD, DOI [10.1111/JPM.12639, DOI 10.1111/JPM.12639]; Wang H, 2005, QUAL LIFE RES, V14, P119, DOI 10.1007/s11136-004-0612-6; Wong ELY, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032544; World Health Organization, COR DIS COVID 19 PAN; Yu ST, 2015, QUAL LIFE RES, V24, P2541, DOI 10.1007/s11136-015-0978-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zhuang Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229652; 2014, REG ANESTH PAIN MED, V9	39	106	106	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234850	10.1371/journal.pone.0234850	http://dx.doi.org/10.1371/journal.pone.0234850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555642	Green Published, gold			2022-12-27	WOS:000543273200062
J	Rhee, KY; Chawla, R; Lele, PP				Rhee, Kathy Y.; Chawla, Ravi; Lele, Pushkar P.			Protein expression-independent response of intensity-based pH-sensitive fluorophores inEscherichia coli	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; CYTOPLASMIC PH; INTRACELLULAR PH; BACTERIA; HOMEOSTASIS; ADAPTATION; SURVIVAL; STRESS; LIGHT	Fluorescent proteins that modulate their emission intensities when protonated serve as excellent probes of the cytosolic pH. Since the total fluorescence output fluctuates significantly due to variations in the fluorophore levels in cells, eliminating the dependence of the signal on protein concentration is crucial. This is typically accomplished with the aid of ratiometric fluorescent proteins such as pHluorin. However, pHluorin is excited by blue light, which can complicate pH measurements by adversely impacting bacterial physiology. Here, we characterized the response of intensity-based, pH-sensitive fluorescent proteins that excite at longer wavelengths where the blue light effect is diminished. The pH-response was interpreted in terms of an analytical model that assumed two emission states for each fluorophore: a low intensity protonated state and a high intensity deprotonated state. The model suggested a scaling to eliminate the dependence of the signal on the expression levels as well as on the illumination and photon-detection settings. Experiments successfully confirmed the scaling predictions. Thus, the internal pH can be readily determined with intensity-based fluorophores with appropriate calibrations irrespective of the fluorophore concentration and the signal acquisition setup. The framework developed in this work improves the robustness of intensity-based fluorophores for internal pH measurements inE.coli, potentially extending their applications.	[Rhee, Kathy Y.; Chawla, Ravi; Lele, Pushkar P.] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA; [Chawla, Ravi] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Texas A&M University System; Texas A&M University College Station; Scripps Research Institute	Lele, PP (corresponding author), Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA.	plele@tamu.edu	Chawla, Ravi/GMX-1615-2022	Chawla, Ravi/0000-0003-1867-9528	National Institute of General Medical Sciences [R01-GM123085]; DOD ACC-APG-RTP Division [W911NF1810353]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOD ACC-APG-RTP Division	PPL acknowledges support from the National Institute of General Medical Sciences (R01-GM123085) and the DOD ACC-APG-RTP Division (W911NF1810353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1967, J GEN MICROBIOL, V46, P175, DOI 10.1099/00221287-46-2-175; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Awaji T, 2001, BIOCHEM BIOPH RES CO, V289, P457, DOI 10.1006/bbrc.2001.6004; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Beales N, 2004, COMPR REV FOOD SCI F, V3, P1, DOI 10.1111/j.1541-4337.2004.tb00057.x; Bednarska NG, 2013, MICROBIOL-SGM, V159, P1795, DOI 10.1099/mic.0.069575-0; Bencina M, 2013, SENSORS-BASEL, V13, P16736, DOI 10.3390/s131216736; BENJAMIN MM, 1995, APPL ENVIRON MICROB, V61, P1669, DOI 10.1128/AEM.61.4.1669-1672.1995; Booth I. R., 1989, MECH ACTION FOOD PRE, P119; BOOTH IR, 1983, BIOCHEM SOC T, V11, P70, DOI 10.1042/bst0110070; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; BULTHUIS BA, 1993, ANTON LEEUW INT J G, V63, P1, DOI 10.1007/BF00871725; Campbell Tessa N., 2001, Molecular Biology Today, V2, P1; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Chawla R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05521-8; Chen JS, 2011, MICROBIOL-SGM, V157, P3150, DOI 10.1099/mic.0.049619-0; Dai TH, 2012, DRUG RESIST UPDATE, V15, P223, DOI 10.1016/j.drup.2012.07.001; dos Anjos C, 2019, PHOTODIAGN PHOTODYN, V27, P51, DOI 10.1016/j.pdpdt.2019.05.014; Fallingborg J, 1999, DAN MED BULL, V46, P183; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; FOSTER JW, 1995, ANNU REV MICROBIOL, V49, P145, DOI 10.1146/annurev.micro.49.1.145; Hall H K, 1995, Adv Microb Physiol, V37, P229, DOI 10.1016/S0065-2911(08)60147-2; Hanson GT, 2002, BIOCHEMISTRY-US, V41, P15477, DOI 10.1021/bi026609p; Hughes BS, 2007, EVOLUTION, V61, P1725, DOI 10.1111/j.1558-5646.2007.00139.x; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Lele PP, 2015, BIOPHYS J, V108, P1275, DOI 10.1016/j.bpj.2015.02.004; Lele PP, 2012, P NATL ACAD SCI USA, V109, P20018, DOI 10.1073/pnas.1212327109; Li H, 2011, MOL MICROBIOL, V80, P886, DOI 10.1111/j.1365-2958.2011.07557.x; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Lipovsky A, 2010, LASER SURG MED, V42, P467, DOI 10.1002/lsm.20948; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Lund P, 2014, FEMS MICROBIOL REV, V38, P1091, DOI 10.1111/1574-6976.12076; Maclean M, 2009, APPL ENVIRON MICROB, V75, P1932, DOI 10.1128/AEM.01892-08; Martinez KA, 2012, APPL ENVIRON MICROB, V78, P3706, DOI 10.1128/AEM.00354-12; Martynov VI, 2018, BBA-GEN SUBJECTS, V1862, P2924, DOI 10.1016/j.bbagen.2018.09.013; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Olsen KN, 2002, APPL ENVIRON MICROB, V68, P4145, DOI 10.1128/AEM.68.8.4145-4147.2002; PADAN E, 1981, BIOCHIM BIOPHYS ACTA, V650, P151, DOI 10.1016/0304-4157(81)90004-6; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; Shen Y, 2014, J CELL BIOL, V207, P419, DOI 10.1083/jcb.201404107; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; SLONCZEWSKI JL, 1982, J BACTERIOL, V152, P384; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; SMITH JJ, 1994, APPL ENVIRON MICROB, V60, P2977, DOI 10.1128/AEM.60.8.2977-2984.1994; Stijlemans B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003561; Strauber H, 2010, CYTOM PART A, V77A, P623, DOI 10.1002/cyto.a.20920; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; VanEngelenburg SB, 2008, CURR OPIN CHEM BIOL, V12, P60, DOI 10.1016/j.cbpa.2008.01.020; Vorob'eva LI, 2004, APPL BIOCHEM MICRO+, V40, P217, DOI 10.1023/B:ABIM.0000025941.11643.19; Wang YiQian, 2017, Chinese Journal of Zoonoses, V33, P1; WARD WW, 1982, PHOTOCHEM PHOTOBIOL, V35, P803, DOI 10.1111/j.1751-1097.1982.tb02651.x; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Yang JY, 2020, P NATL ACAD SCI USA, V117, P6114, DOI 10.1073/pnas.1916974117; Young B, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-27; Yuan JH, 2012, NATURE, V484, P233, DOI 10.1038/nature10964; ZILBERSTEIN D, 1984, J BACTERIOL, V158, P246, DOI 10.1128/JB.158.1.246-252.1984	59	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234849	10.1371/journal.pone.0234849	http://dx.doi.org/10.1371/journal.pone.0234849			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555627	gold, Green Published			2022-12-27	WOS:000543273200044
J	Beaumont, A; Lelard, T; Mouras, H; Granon, S				Beaumont, Anais; Lelard, Thierry; Mouras, Harold; Granon, Sylvie			Evoked pleasure and approach-avoidance in response to pollution	PLOS ONE			English	Article							LANDSCAPE ECOLOGY	From year-to-year, environment is becoming one of the major concerns of human societies. Few studies have investigated the biological processes involved in environmental scene perception. Here, we initiate a line of research by beginning to study emotional processes involved in this perception. Our results demonstrate a clear distinction between "Clean" and "Polluted" environments according to the pleasure and approach desire ratings they induced. Moreover, women expressed higher pleasure in the "Clean" condition, as did older participants. Finally, rural scenes induced higher pleasure in participants than urban ones.	[Beaumont, Anais; Mouras, Harold] Ctr Univ Rech Sante, UR UPJV LNFP 4559, Lab Neurosci Fonct & Pathol, Amiens, France; [Beaumont, Anais; Granon, Sylvie] Inst Neurosci Paris Saclay, Ctr Natl Rech Sci, Equipe Neurobiol Prise Decis, Gif Sur Yvette, France; [Lelard, Thierry] Univ Picardie Jules Verne, UFR Sci Sport, UR UPJV APERE 3300, Adaptat Physiol Exercice & Readaptat Effort, Allee P Grousset, Amiens, France	Centre National de la Recherche Scientifique (CNRS); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Mouras, H (corresponding author), Ctr Univ Rech Sante, UR UPJV LNFP 4559, Lab Neurosci Fonct & Pathol, Amiens, France.	harold.mouras@u-picardie.fr	Mouras, Harold/L-8117-2019		Vinci Autoroutes Foundation	Vinci Autoroutes Foundation	We would like to thank the Vinci Autoroutes Foundation, which provided the funding for the experiments we conducted. (grant CNRSFondation Vinci Autoroutes no187783).	[Anonymous], 2020, LANCET INFECT DIS, V20, P192, DOI [10.1016/S1473-3099(20)30483-7, DOI 10.1016/S1473-3099(20)30483-7, DOI 10.1056/NEJMoa2021756]; Antrop M, 2000, AGR ECOSYST ENVIRON, V77, P17, DOI 10.1016/S0167-8809(99)00089-4; Bennett NJ, 2016, CONSERV BIOL, V30, P582, DOI 10.1111/cobi.12681; Berleant A., 1992, AESTHETICS ENV; Borgomaneri S, 2014, SOC COGN AFFECT NEUR, V9, P1451, DOI 10.1093/scan/nst139; Brown TC., 1987, J ENVIRON PSYCHOL, V7, P233, DOI [DOI 10.1016/S0272-4944(87)80032-4, https://doi.org/10.1016/S0272-4944(87)80032-4]; Coombes SA, 2012, CEREB CORTEX, V22, P616, DOI 10.1093/cercor/bhr141; Daniel T.C., 1983, HUMAN BEHAV ENV, P39; DANIEL TC, 1990, AM PSYCHOL, V45, P633, DOI 10.1037/0003-066X.45.5.633; Darwin C., 1872, P374; Dewey J., 1948, J AESTHETICS ART CRI, V6, P203, DOI [10.2307/426476, DOI 10.2307/426476]; Fini C, 2015, COGNITION, V134, P50, DOI 10.1016/j.cognition.2014.08.014; Fini C., 2020, SUPPORT TMS MEP STUD, DOI [10.31234/osf.io/semv8, DOI 10.31234/0SF.I0/SEMV8]; Fini C, 2017, ACTA PSYCHOL, V172, P77, DOI 10.1016/j.actpsy.2016.11.006; Fini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114719; HODGSON RW, 1980, LANDSCAPE PLAN, V7, P171, DOI 10.1016/0304-3924(80)90014-3; HULL RB, 1989, J ENVIRON PSYCHOL, V9, P177, DOI 10.1016/S0272-4944(89)80033-7; Hunziker M., 2007, CHANGING WORLD CHALL, P47, DOI [DOI 10.1007/978-1-4020-4436-6_5, 10.1007/978-1-4020-4436-6, DOI 10.1007/978-1-4020-4436-6]; Husserl E., 1913, IDEAS GEN INTRO PURE; Kaplan R., 1975, LANDSCAPE ASSESSMENT, P118; Kaplan S, 1976, ENV KNOWING, P32; Lang P.J., 2008, INT AFFECTIVE PICTUR; Lelard T, 2019, NEUROPHYSIOL CLIN, V49, P109, DOI 10.1016/j.neucli.2019.01.005; Lelard T, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02012; Lelard T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00004; Levine J, 2015, ECOL ECON, V114, P22, DOI 10.1016/j.ecolecon.2015.03.010; Meinig D., 1979, INTERPRETATION ORDIN, V66; Menatti L, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00159; Merleau-Ponty M., 1962, PHENOMENOL PERCEPT, DOI [10.4324/9780203981139, DOI 10.4324/9780203981139]; Michalak J, 2009, PSYCHOSOM MED, V71, P580, DOI 10.1097/PSY.0b013e3181a2515c; Moon K, 2014, CONSERV BIOL, V28, P1167, DOI 10.1111/cobi.12326; Mouras H, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00277; Mouras H, 2016, BEHAV BRAIN SCI, V39, DOI 10.1017/S0140525X15001880; Munhall P. L., 2008, SAGE ENCY QUAL RES M, P607, DOI [10.4135/9781412963909, DOI 10.4135/9781412963909]; Nassauer JI, 2011, LANDSCAPE URBAN PLAN, V100, P321, DOI 10.1016/j.landurbplan.2011.02.022; Naugle KM, 2011, EMOTION, V11, P267, DOI 10.1037/a0022577; Naveh Z, 2000, LANDSCAPE URBAN PLAN, V50, P7, DOI 10.1016/S0169-2046(00)00077-3; Naveh Z, 2007, LANDSCAPE ECOL, V22, P1437, DOI 10.1007/s10980-007-9171-x; Pitt D. G., 1987, HDB ENV PSYCHOL, P1009; PURCELL AT, 1994, J ENVIRON PSYCHOL, V14, P195, DOI 10.1016/S0272-4944(94)80056-1; Satterfield T, 2009, NAT NANOTECHNOL, V4, P883; Schmidt L, 2009, J NEUROSCI, V29, P9450, DOI 10.1523/JNEUROSCI.1951-09.2009; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Tveit M, 2006, LANDSCAPE RES, V31, P229, DOI 10.1080/01426390600783269; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; Varela F. J., 1991, EMBODIED MIND COGNIT, pxx	46	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234210	10.1371/journal.pone.0234210	http://dx.doi.org/10.1371/journal.pone.0234210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584844	Green Published, gold			2022-12-27	WOS:000545747200090
J	Pirlar, RF; Emaneini, M; Beigverdi, R; Banar, M; van Leeuwen, WB; Jabalameli, F				Fanaei Pirlar, Rima; Emaneini, Mohammad; Beigverdi, Reza; Banar, Maryam; van Leeuwen, B. Willem; Jabalameli, Fereshteh			Combinatorial effects of antibiotics and enzymes against dual-speciesStaphylococcus aureusandPseudomonas aeruginosabiofilms in the wound-like medium	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; STAPHYLOCOCCUS-AUREUS BIOFILMS; IN-VITRO; PSEUDOMONAS-AERUGINOSA; SYNERGISTIC INTERACTIONS; ANTIMICROBIAL EFFICACY; MULTISPECIES BIOFILMS; DNASE I; MATRIX; REMOVAL	Bacterial biofilms are one of the major issues in the treatment of chronic infections such as chronic wounds, where biofilms are typically polymicrobial. The synergy between species can occur during most polymicrobial infections, where antimicrobial resistance enhances as a result. Furthermore, self-produced extracellular polymeric substance (EPS) in biofilms results in a high tolerance to antibiotics that complicates wound healing. Since most antibiotics fail to remove biofilms in chronic infections, new therapeutic modalities may be required. Disruption of EPS is one of the effective approaches for biofilm eradication. Therefore, degradation of EPS using enzymes may result in improved chronic wounds healing. In the current study, we investigated the efficacy of trypsin, beta-glucosidase, and DNase I enzymes on the degradation of dual-species biofilms ofPseudomonas aeruginosaandStaphylococcus aureusin a wound-like medium. These species are the two most common bacteria associated with biofilm formation in chronic wounds. Moreover, the reduction of minimum biofilm eradication concentration (MBEC) of meropenem and amikacin was evaluated when combined with enzymes. The minimum effective concentrations of trypsin, beta-glucosidase, and DNase I enzymes to degrade biofilms were 1 mu g/ml, 8 U/ml, and 150 U/ml, respectively. Combination of 0.15 mu g/ml trypsin and 50 U/ml DNase I had a significant effect onS.aureus-P.aeruginosabiofilms which resulted in the dispersal and dissolution of all biofilms. In the presence of the enzymatic mixture, MBECs of antibiotics showed a significant decrease (p <0.05), at least 2.5 fold. We found that trypsin/DNase I mixture can be used as an anti-biofilm agent against dual-species biofilms ofS.aureus-P.aeruginosa.	[Fanaei Pirlar, Rima; Emaneini, Mohammad; Beigverdi, Reza; Banar, Maryam; Jabalameli, Fereshteh] Univ Tehran Med Sci, Sch Med, Dept Microbiol, Tehran, Iran; [van Leeuwen, B. Willem] Univ Appl Sci Leiden, Leiden Ctr Appl Biosci, Leiden, Netherlands	Tehran University of Medical Sciences	Jabalameli, F (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Microbiol, Tehran, Iran.	jabalamf@tums.ac.ir	Fanaei Pirlar, Rima/GLU-9688-2022; Emaneini, Mohammad/AAB-1003-2019; Emaneini, Mohammad/K-3545-2016	Emaneini, Mohammad/0000-0002-0208-7264; Emaneini, Mohammad/0000-0002-0208-7264	Tehran University of Medical Sciences [97-01-30-38032]	Tehran University of Medical Sciences(Tehran University of Medical Sciences)	This work was supported by Tehran University of Medical Sciences under 97-01-30-38032.	[Anonymous], 2017, PERF STAND ANT SUSC; Araujo JC, 2003, J ELECTRON MICROSC, V52, P429, DOI 10.1093/jmicro/52.4.429; Bales PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067950; Banar M, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1662-9; Banar M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164622; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Bjarnsholt T, 2013, APMIS, V121, P1, DOI 10.1111/apm.12099; Brackman G, 2016, ADV EXP MED BIOL, V897, P15, DOI 10.1007/5584_2015_5002; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y; Clinton L, 2015, LABMEDICINE, V46, P277, DOI 10.1309/LMBNSWKUI4JPN7SO; Connolly KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018984; Craigen Bradford, 2011, Open Microbiol J, V5, P21, DOI 10.2174/1874285801105010021; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; Darouiche RO, 2009, J ANTIMICROB CHEMOTH, V64, P88, DOI 10.1093/jac/dkp158; Das T, 2013, ENV MICROBIOL REP, V5, P778, DOI 10.1111/1758-2229.12085; Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x; Davis SC, 2010, ADV WOUND CARE-SER, V1, P535, DOI 10.1089/awc.2009.0166; DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14; Fleming D, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5020015; Fleming D, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01998-16; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gawande PV, 2014, CURR MICROBIOL, V68, P635, DOI 10.1007/s00284-014-0519-6; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hendricks KJ, 2001, J BONE JOINT SURG AM, V83A, P855, DOI 10.2106/00004623-200106000-00006; Hobley L, 2015, FEMS MICROBIOL REV, V39, P649, DOI 10.1093/femsre/fuv015; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Jiao YQ, 2010, APPL ENVIRON MICROB, V76, P2916, DOI 10.1128/AEM.02289-09; Johansen C, 1997, APPL ENVIRON MICROB, V63, P3724, DOI 10.1128/AEM.63.9.3724-3728.1997; Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004; Lasa I, 2006, RES MICROBIOL, V157, P99, DOI 10.1016/j.resmic.2005.11.003; Lequette Y, 2010, BIOFOULING, V26, P421, DOI 10.1080/08927011003699535; Macia MD, 2014, CLIN MICROBIOL INFEC, V20, P981, DOI 10.1111/1469-0691.12651; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Marcato-Romain CE, 2012, BIOFOULING, V28, P305, DOI 10.1080/08927014.2012.673122; Molobela IP, 2010, AFR J MICROBIOL RES, V4, P1515; Motallebi M, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0501-y; Nemoto K, 2003, CHEMOTHERAPY, V49, P121, DOI 10.1159/000070617; Niazi SA, 2014, INT ENDOD J, V47, P756, DOI 10.1111/iej.12214; Rhoads DD, 2012, INT J MOL SCI, V13, P2535, DOI 10.3390/ijms13032535; Roder HL, 2016, TRENDS MICROBIOL, V24, P503, DOI 10.1016/j.tim.2016.02.019; Saggu SK, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00192; Speziale P, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00171; Sun Y, 2008, WOUND REPAIR REGEN, V16, P805, DOI 10.1111/j.1524-475X.2008.00434.x; Tetz GV, 2009, ANTIMICROB AGENTS CH, V53, P1204, DOI 10.1128/AAC.00471-08; Tetz VV, 2010, DNA CELL BIOL, V29, P399, DOI 10.1089/dna.2009.1011; Thallinger B, 2013, BIOTECHNOL J, V8, P97, DOI 10.1002/biot.201200313; Trizna E, 2019, BIONANOSCIENCE, V9, P48, DOI 10.1007/s12668-018-0581-9; Tsiaprazi-Stamou A, 2019, BIOFOULING, V35, P883, DOI 10.1080/08927014.2019.1666108; Waryah CB, 2017, MICROB DRUG RESIST, V23, P384, DOI 10.1089/mdr.2016.0100; Watters CM, 2016, INFECT DRUG RESIST, V9, P71, DOI 10.2147/IDR.S103101; Wei Q, 2013, INT J MOL SCI, V14, P20983, DOI 10.3390/ijms141020983; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wingender J, 2001, METHOD ENZYMOL, V336, P302, DOI 10.1016/S0076-6879(01)36597-7; Xavier JB, 2005, MICROBIOL-SGM, V151, P3817, DOI 10.1099/mic.0.28165-0	56	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235093	10.1371/journal.pone.0235093	http://dx.doi.org/10.1371/journal.pone.0235093			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584878	Green Published, gold			2022-12-27	WOS:000545747200014
J	Polivka, CM; Mihaljevic, JR; Dwyer, G				Polivka, Carlos M.; Mihaljevic, Joseph R.; Dwyer, Greg			Use of a mechanistic growth model in evaluating post-restoration habitat quality for juvenile salmonids	PLOS ONE			English	Article							CHINOOK SALMON; RIVER RESTORATION; FISH-HABITAT; SELECTION; CONSERVATION; ABUNDANCE; DENSITY; IDAHO; TROUT; RECRUITMENT	Individual growth data are useful in assessing relative habitat quality, but this approach is less common when evaluating the efficacy of habitat restoration. Furthermore, available models describing growth are infrequently combined with computational approaches capable of handling large data sets. We apply a mechanistic model to evaluate whether selection of restored habitat can affect individual growth. We used mark-recapture to collect size and growth data on sub-yearling Chinook salmon and steelhead in restored and unrestored habitat in five sampling years (2009, 2010, 2012, 2013, 2016). Modeling strategies differed for the two species: For Chinook, we compared growth patterns of individuals recaptured in restored habitat over 15-60 d with those not recaptured regardless of initial habitat at marking. For steelhead, we had enough recaptured fish in each habitat type to use the model to directly compare habitats. The model generated spatially explicit growth parameters describing size of fish over the growing season in restored vs. unrestored habitat. Model parameters showed benefits of restoration for both species, but that varied by year and time of season, consistent with known patterns of habitat partitioning among them. The model was also supported by direct measurement of growth rates in steelhead and by known patterns of spatio-temporal partitioning of habitat between these two species. Model parameters described not only the rate of growth, but the timing of size increases, and is spatially explicit, accounting for habitat differences, making it widely applicable across taxa. The model usually supported data on density differences among habitat types in Chinook, but only in a couple of cases in steelhead. Modeling growth can thus prevent overconfidence in distributional data, which are commonly used as the metric of restoration success.	[Polivka, Carlos M.] US Forest Serv, Pacific Northwest Res Stn, USDA, Wenatchee, WA USA; [Mihaljevic, Joseph R.; Dwyer, Greg] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA; [Mihaljevic, Joseph R.] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA	United States Department of Agriculture (USDA); United States Forest Service; University of Chicago; Northern Arizona University	Polivka, CM (corresponding author), US Forest Serv, Pacific Northwest Res Stn, USDA, Wenatchee, WA USA.	carlos.polivka@usda.gov	Dwyer, Greg/L-1134-2015; Polivka, Carlos/AAG-7759-2021	Dwyer, Greg/0000-0002-7387-2075; Polivka, Carlos/0000-0001-9021-240X; Mihaljevic, Joseph/0000-0003-2320-5773	Bonneville Power Administration [2003-017-00]; American Recovery and Re-investment Act; U.S. Bureau of Reclamation; US Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) Postdoctoral Fellowship [2014-67012-22272]	Bonneville Power Administration; American Recovery and Re-investment Act; U.S. Bureau of Reclamation; US Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) Postdoctoral Fellowship	Early portions of this work (2009-2010) were funded by Bonneville Power Administration (Project No. 2003-017-00), and by the American Recovery and Re-investment Act enacted by President B. Obama. The later activities (2012-2016) were funded by the U.S. Bureau of Reclamation. JRM was funded by a US Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) Postdoctoral Fellowship (2014-67012-22272).	Achord S, 2007, T AM FISH SOC, V136, P142, DOI 10.1577/T05-308.1; Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; [Anonymous], R LANG ENV STAT COMP; Bartz KK, 2006, CAN J FISH AQUAT SCI, V63, P1578, DOI 10.1139/F06-055; Beckman Brian R., 1998, North American Journal of Fisheries Management, V18, P537, DOI 10.1577/1548-8675(1998)018<0537:ROFSAG>2.0.CO;2; Beechie TJ, 2005, T AM FISH SOC, V134, P717, DOI 10.1577/T04-062.1; Birch CPD, 1999, ANN BOT-LONDON, V83, P713, DOI 10.1006/anbo.1999.0877; Bjorndal KA, 2000, ECOL APPL, V10, P269, DOI 10.2307/2641001; Carran Spencer, 2019, U S Forest Service Pacific Northwest Research Station Research Note PNW-RN; Croak BM, 2013, J APPL ECOL, V50, P432, DOI 10.1111/1365-2664.12040; Davies AB, 2016, BEHAV ECOL, V27, P1869, DOI 10.1093/beheco/arw124; Dibner RR, 2017, ECOL EVOL, V7, P5692, DOI 10.1002/ece3.3131; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ELLIOTT JM, 1975, J ANIM ECOL, V44, P805, DOI 10.2307/3720; EVEREST FH, 1972, J FISH RES BOARD CAN, V29, P91, DOI 10.1139/f72-012; Flitcroft RL, 2016, FOREST ECOL MANAG, V359, P126, DOI 10.1016/j.foreco.2015.09.049; Flores L, 2017, ECOL ENG, V106, P116, DOI 10.1016/j.ecoleng.2017.05.036; Gelman A., 2021, BAYESIAN DATA ANAL; Grote J, 2016, JUVENILE SALMONID OU; Hilderbrand RH, 1997, CAN J FISH AQUAT SCI, V54, P931, DOI 10.1139/cjfas-54-4-931; HILLMAN TW, 1987, T AM FISH SOC, V116, P185, DOI 10.1577/1548-8659(1987)116<185:SAWHSB>2.0.CO;2; Hockendorff S, 2017, CONSERV BIOL, V31, P1098, DOI 10.1111/cobi.12908; Honea JM, 2009, FRESHWATER BIOL, V54, P1576, DOI 10.1111/j.1365-2427.2009.02208.x; Irwin LL, 2015, FOREST ECOL MANAG, V354, P232, DOI 10.1016/j.foreco.2015.06.009; James JJ, 2011, J APPL ECOL, V48, P961, DOI 10.1111/j.1365-2664.2011.02009.x; Johnson CJ, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2622; Jorgensen JC, 2009, FRESHWATER BIOL, V54, P1560, DOI 10.1111/j.1365-2427.2009.02207.x; Karkach AS, 2006, DEMOGR RES, V15, P348; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Lake P.S., 2001, ECOLOGICAL MANAGEMEN, V2, P110, DOI [DOI 10.1046/J.1442-8903.2001.00074.X, 10.1046/j.1442-8903.2001.00074.x]; LaRue EA, 2017, RESTOR ECOL, V25, P19, DOI 10.1111/rec.12458; Link WA, 2012, METHODS ECOL EVOL, V3, P112, DOI 10.1111/j.2041-210X.2011.00131.x; MacPherson MP, 2018, BIOL CONSERV, V226, P215, DOI 10.1016/j.biocon.2018.08.001; Marco-Rius F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045528; Morris W. F., 2002, QUANTITATIVE CONSERV; Mosser A, 2009, ECOL LETT, V12, P1050, DOI 10.1111/j.1461-0248.2009.01359.x; Nicieza AG, 1997, ECOLOGY, V78, P2385, DOI 10.1890/0012-9658(1997)078[2385:GCIJAS]2.0.CO;2; Oele DL, 2019, ECOL FRESHW FISH, V28, P285, DOI 10.1111/eff.12453; Pfister CA, 2002, ECOLOGY, V83, P59; Polivka CM, 2020, N AM J FISH MANAGE, V40, P446, DOI 10.1002/nafm.10421; Polivka CM, ECOSPHERE; Polivka KM, 2015, CAN J FISH AQUAT SCI, V72, P166, DOI 10.1139/cjfas-2014-0228; Polivka KM, 2005, CAN J FISH AQUAT SCI, V62, P913, DOI 10.1139/F04-235; Polivka KM, 2010, UPP COL REG TECHN TE, P48; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; Railsback SF, 1999, ECOL MODEL, V123, P73, DOI 10.1016/S0304-3800(99)00124-6; Railsback SF, 2005, ECOLOGY, V86, P947, DOI 10.1890/04-1178; Railsback SF, 2002, ECOLOGY, V83, P1817, DOI 10.2307/3071767; Reeves G. H., 2014, CANADIAN J FISHERIES, V72, P304; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Rodriguez MA, 2002, ECOLOGY, V83, P1; Roni P, 2002, N AM J FISH MANAGE, V22, P1, DOI 10.1577/1548-8675(2002)022&lt;0001:AROSRT&gt;2.0.CO;2; Roni P, 2008, N AM J FISH MANAGE, V28, P856, DOI 10.1577/M06-169.1; Roni Philip, 2015, V78, P73; Rosenfeld J, 2003, T AM FISH SOC, V132, P953, DOI 10.1577/T01-126; Rosenfeld JS, 2005, CAN J FISH AQUAT SCI, V62, P1691, DOI [10.1139/f05-072, 10.1139/F05-072]; Rosenfeld JS, 2001, CAN J FISH AQUAT SCI, V58, P585, DOI 10.1139/cjfas-58-3-585; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Scheuerell MD, 2006, CAN J FISH AQUAT SCI, V63, P1596, DOI 10.1139/F06-056; SCHNUTE JT, 1990, CAN J FISH AQUAT SCI, V47, P24, DOI 10.1139/f90-003; Schultz CB, 2015, J APPL ECOL, V52, P1111, DOI 10.1111/1365-2664.12450; Sievers M, 2017, FRESHWATER BIOL, V62, P445, DOI 10.1111/fwb.12888; Sivakoff FS, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1522; Smokorowski KE, 2007, ENVIRON REV, V15, P15, DOI [10.1139/A06-007, 10.1139/a06-007]; Stan Development Team, 2018, STAN MOD LANG US GUI; Stan Development Team, 2017, RSTAN R INT STAN; Stranko SA, 2012, RESTOR ECOL, V20, P747, DOI 10.1111/j.1526-100X.2011.00824.x; Street GM, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00383.1; Tarkan AS, 2016, AQUAT CONSERV, V26, P212, DOI 10.1002/aqc.2580; Taylor BL, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P96; Theuerkauf SJ, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00064; Tiffan KF, 2015, N AM J FISH MANAGE, V35, P845, DOI 10.1080/02755947.2015.1052163; Tjorve KMC, 2010, ZOOLOGY, V113, P326, DOI 10.1016/j.zool.2010.05.003; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Whiteway SL, 2010, CAN J FISH AQUAT SCI, V67, P831, DOI 10.1139/F10-021; Wood KA, 2018, ANIM CONSERV, V21, P87, DOI 10.1111/acv.12371; Young KA, 2004, ECOLOGY, V85, P134, DOI 10.1890/02-0402; Young TP, 2005, ECOL LETT, V8, P662, DOI 10.1111/j.1461-0248.2005.00764.x	80	3	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2020	15	6							e0234072	10.1371/journal.pone.0234072	http://dx.doi.org/10.1371/journal.pone.0234072			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF9GS	32579548	Green Published, Green Submitted, gold			2022-12-27	WOS:000545646600001
J	Selvaratnam, RJ; Davey, MA; Wallace, EM				Selvaratnam, Roshan John; Davey, Mary-Ann; Wallace, Euan Morrison			The pitfalls of using birthweight centile charts to audit care	PLOS ONE			English	Article							FETAL-GROWTH RESTRICTION; GESTATIONAL-AGE; STANDARDS; PERCENTILES; PREGNANCY; OBESITY; MOTHER; TRENDS; RATIO; SEX	Objectives Timely delivery of fetal growth restriction (FGR) is important in reducing stillbirth. However, targeted earlier delivery of FGR preferentially removes smaller babies from later gestations, thereby right-shifting the distribution of birthweights at term. This artificially increases the birthweight cutoffs defining the lower centiles and redefines normally grown babies as small by population-based birthweight centiles. Our objective was to compare updated Australian national population-based birthweight centile charts over time with the prescriptive INTERGROWTH-21(st)standard. Methods A retrospective descriptive study of all singleton births >= 34 weeks' gestation in Victoria, Australia in five two-year epochs: 1983-84, 1993-94, 2003-04, 2013-14, and 2016-17. The birthweight cutoffs defining the 3(rd)and 10(th)centile from three Australian national population-based birthweight centile charts, for births in 1991-1994, in 1998-2007, and 2004-2013 respectively, were applied to each epoch to calculate the proportion of babies with birthweight <3(rd)and <10(th)centile. The same analysis was done using the INTERGROWTH-21(st)birthweight standard. To assess change over gestation, proportions were also calculated at preterm, early term and late term gestations. Results From 1983-84 to 2016-17, the proportion of babies with birthweight <3(rd)fell across all birthweight centile charts, from 3.1% to 1.7% using the oldest Australian chart, from 3.9% to 1.9% using the second oldest Australian chart, from 4.3% to 2.2% using the most recent Australian chart, and from 2.0% to 0.9% using the INTERGROWTH-21(st)standard. A similar effect was evident for the <10(th)centile. The effect was most obvious at term gestations. Updating the Australian population birthweight chart progressively right-shifted the birthweight distribution, changing the definition of small over time. The birthweight distribution of INTERGROWTH-21(st)was left-shifted compared to the Australian charts. Conclusions Locally-derived population-based birthweight centiles are better for clinical audit of care but should not be updated. Prescriptive birthweight standards are less useful in defining 'small' due to their significant left-shift.	[Selvaratnam, Roshan John; Davey, Mary-Ann; Wallace, Euan Morrison] Monash Univ, Ritchie Ctr, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Selvaratnam, Roshan John; Davey, Mary-Ann; Wallace, Euan Morrison] Victorian Govt, Safer Care Victoria, Dept Hlth & Human Serv, Melbourne, Vic, Australia; [Selvaratnam, Roshan John; Davey, Mary-Ann; Wallace, Euan Morrison] Monash Univ, Monash Med Ctr, Dept Obstet & Gynaecol, Ritchie Ctr, Level 5, Clayton, Vic, Australia	Monash University; Monash University	Selvaratnam, RJ (corresponding author), Monash Univ, Ritchie Ctr, Dept Obstet & Gynaecol, Melbourne, Vic, Australia.; Selvaratnam, RJ (corresponding author), Victorian Govt, Safer Care Victoria, Dept Hlth & Human Serv, Melbourne, Vic, Australia.	roshan.selvaratnam@monash.edu		Selvaratnam, Roshan/0000-0003-4240-5594	National Health and Medical Research Council (NHMRC) [APP1113902]; Australian Government Research Training Program (RTP) Scholarship from Monash University; national Stillbirth Centre of Research Excellence (CRE)	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Research Training Program (RTP) Scholarship from Monash University; national Stillbirth Centre of Research Excellence (CRE)	This work was undertaken as part of a National Health and Medical Research Council (NHMRC) funded Program Grant (APP1113902) to EMW. RJS received an Australian Government Research Training Program (RTP) Scholarship from Monash University and a top-up scholarship from the national Stillbirth Centre of Research Excellence (CRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Consultative Council on Obstetric and Paediatric Mortality and Morbidity (CCOPMM) for providing access to the data used for this project and for the assistance of the staff at the Consultative Councils Unit, Safer Care Victoria. The views expressed in this paper do not necessarily reflect those of CCOPMM.	Ananth CV, 2019, AM J OBSTET GYNECOL, V220, P293, DOI 10.1016/j.ajog.2019.02.060; Ananth CV, 2009, EARLY HUM DEV, V85, P653, DOI 10.1016/j.earlhumdev.2009.09.004; Ananth CV, 2002, SEMIN PERINATOL, V26, P260, DOI 10.1053/sper.2002.34772; Anderson NH, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.10.931; Australian Institute of Health Welfare, 2019, AUSTR MOTH BAB 2017; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331; Flenady V, 2016, LANCET, V387, P691, DOI 10.1016/S0140-6736(15)01020-X; Francis A, 2018, AM J OBSTET GYNECOL, V218, pS692, DOI 10.1016/j.ajog.2017.12.013; Gaccioli F, 2018, LANCET CHILD ADOLESC, V2, P569, DOI 10.1016/S2352-4642(18)30129-9; Gardosi J, 2018, AM J OBSTET GYNECOL, V218, pS609, DOI 10.1016/j.ajog.2017.12.011; GEIRSSON RT, 1991, BRIT J OBSTET GYNAEC, V98, P108, DOI 10.1111/j.1471-0528.1991.tb10323.x; Ghosh RE, 2018, ARCH DIS CHILD-FETAL, V103, pF264, DOI 10.1136/archdischild-2016-311790; Healthcare Improvement Scotland, 2018, SCOTT PAT SAF PROGR; Hoftiezer L, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2018.12.023; Hunt R., 2019, VICTORIAN PERINATAL; Hutcheon JA, 2008, BJOG-INT J OBSTET GY, V115, P1397, DOI 10.1111/j.1471-0528.2008.01870.x; Hutcheon JA, 2011, PAEDIATR PERINAT EP, V25, P11, DOI 10.1111/j.1365-3016.2010.01155.x; Iliodromiti S, 2020, ULTRASOUND OBST GYN, V55, P599, DOI 10.1002/uog.21999; Kiserud T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002220; Kramer MS, 2019, PAEDIATR PERINAT EP, V33, P57, DOI 10.1111/ppe.12528; Liu SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172910; Marchi J, 2015, OBES REV, V16, P621, DOI 10.1111/obr.12288; Ministry of Health, 2019, NZ MAT CLIN IND 2017; NMPA Project Team, 2019, NAT MAT PER AUD CLIN; Papageorghiou AT, 2018, AM J OBSTET GYNECOL, V218, pS630, DOI 10.1016/j.ajog.2018.01.011; Pritchard N, 2020, J MATERN-FETAL NEO M, V33, P961, DOI 10.1080/14767058.2018.1511696; Pritchard NL, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002923; Roberts CL, 1999, MED J AUSTRALIA, V170, P114, DOI 10.5694/j.1326-5377.1999.tb127678.x; Selvaratnam RJ, 2020, BJOG-INT J OBSTET GY, V127, P1074, DOI 10.1111/1471-0528.16215; Selvaratnam RJ, 2020, BJOG-INT J OBSTET GY, V127, P581, DOI 10.1111/1471-0528.16038; Sovio U, 2020, NAT MED, V26, P348, DOI 10.1038/s41591-020-0804-9; Sovio U, 2018, AM J OBSTET GYNECOL, V218, pS738, DOI 10.1016/j.ajog.2017.11.563; Surkan PJ, 2004, OBSTET GYNECOL, V104, P720, DOI 10.1097/01.AOG.0000141442.59573.cd; Vieira MC, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002902; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6	36	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235113	10.1371/journal.pone.0235113	http://dx.doi.org/10.1371/journal.pone.0235113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574213	Green Published, gold			2022-12-27	WOS:000544972400058
J	Clausen, LPW; Hansen, OFH; Oturai, NB; Syberg, K; Hansen, SF				Clausen, Lauge Peter Westergaard; Hansen, Oliver Foss Hessner; Oturai, Nikoline Bang; Syberg, Kristian; Hansen, Steffen Foss			Stakeholder analysis with regard to a recent European restriction proposal on microplastics	PLOS ONE			English	Article							EU; POLICY; SUCCESS	Stakeholder involvement is pivotal EU governance. In this paper, we complete a stakeholder analysis of the European Chemicals Agency's recent Annex XV restriction proposal process on intentionally added microplastics. The aim of this study is to map the interests, influence and importance of active stakeholders in order to understand the arguments being put forward by different stakeholders and provide recommendations to policy-makers on how to ensure a balanced consideration of all stakeholder perspectives. Stakeholders were identified through niche media analysis and by scrutinising comments from the public consultation on the restriction proposal. Their importance and influence were mapped using three approaches: "scale from low to high", "psychometric scale" and "qualitative ranking". We identified 205 different stakeholders out of which 77 were industry and trade associations, 25 were large companies and only four were small and medium-sized enterprises. National authorities and researchers did not comment on the restriction proposal, whilst large companies were very active providing comments. Industry trade associations and sports-related non-governmental organizations articulated anxiety about the costs associated with the implementation of the restriction proposal. Among environmental non-governmental organizations, there was consensus that plastics should be handled like other substances under EU's chemical regulation. Primary stakeholders identified exhibited high importance, but varying degrees of influence, while the opposite applied to the major European institutions. Based on our analysis, we recommend that: The European Chemicals Agency implement measures to include "silent" stakeholders and invite guest experts to participate in their committees on Risk Assessment and Socio-Economic Analysis; Researchers should be more active in the public consultation; and that special emphasis should be put on helping small and medium-sized enterprises. With regards to stakeholder consultation, we find that media analysis is a good supplement to stakeholder analysis and that a more objective top-down measure of stakeholder importance and influence is needed.	[Clausen, Lauge Peter Westergaard; Hansen, Oliver Foss Hessner; Hansen, Steffen Foss] Tech Univ Denmark, Dept Environm Engn, Lyngby, Denmark; [Oturai, Nikoline Bang; Syberg, Kristian] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark	Technical University of Denmark; Roskilde University	Clausen, LPW (corresponding author), Tech Univ Denmark, Dept Environm Engn, Lyngby, Denmark.	lpwc@env.dtu.dk	Foss Hansen, Steffen/L-8182-2019; Clausen, Lauge Peter Westergaard/G-6370-2019	Foss Hansen, Steffen/0000-0003-4342-7779; Clausen, Lauge Peter Westergaard/0000-0001-9710-2588	Velux Foundation [25084]	Velux Foundation(Velux Fonden)	We acknowledge MarinePlastic, a Danish Centre for research in marine plastic pollution, sponsored by the Velux Foundation, grant number 25084, for providing the funding for this research.	Achterkamp Marjolein C., 2008, International Journal of Project Management, V26, P749, DOI 10.1016/j.ijproman.2007.10.001; [Anonymous], 1996, CONTAGION J VIOLENCE; [Anonymous], 2003, EUR J CARDIOVASC S1, V10, pS1; [Anonymous], 1998, AOAC OFFICIAL METHOD, V1; Backhaus T, 2020, GLOB CHALL, V4, DOI 10.1002/gch2.201900022; Brugha R, 2000, HEALTH POLICY PLANN, V15, P239, DOI 10.1093/heapol/15.3.239; Crosby B., 1992, STAKEHOLDER ANAL VIT; Cuspedes-Lorente J., 2003, SCAND J MANAG, V19, P333, DOI [10.1016/S0956-5221(02)00034-9, DOI 10.1016/S0956-5221(02)00034-9]; D'AGOSTINO M., 2013, SCRIPTA, V6, P41; Dreser A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1051; Dur A, 2008, EUR UNION POLIT, V9, P559, DOI 10.1177/1465116508095151; Dur A, 2008, WEST EUR POLIT, V31, P1212, DOI 10.1080/01402380802372662; Dur Andreas., 2007, J PUBLIC POLICY, V27, P79, DOI DOI 10.1017/S0143814X0700061X; Eden C, 2013, MAKING STRATEGY JOUR; European Commission, 2019, CIRC EC PLAST INS RE, DOI [10.2777/269031, DOI 10.2777/269031]; European Commission, 2018, SWD201816 EUR COMM; European Commission, 2001, COM2001428; Eurostat, 2018, SMALL MED SIZ ENT OV; Fassin Y, 2009, J BUS ETHICS, V84, P113, DOI 10.1007/s10551-008-9677-4; Freeman E., 1984, J MANAGE STUD; Frooman J, 1999, ACAD MANAGE REV, V24, P191; Galbraith J. K., 1983, CHALLENGE, V26, P26; Hansen SF, 2015, NANOETHICS, V9, P297, DOI 10.1007/s11569-015-0245-y; Ielite I, 2015, 2015 IEEE SEVENTH INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTING AND INFORMATION SYSTEMS (ICICIS), P251, DOI 10.1109/IntelCIS.2015.7397229; Jones TM, 2018, ACAD MANAGE REV, V43, P371, DOI 10.5465/amr.2016.0111; Junk WM, 2016, J EUR PUBLIC POLICY, V23, P236, DOI 10.1080/13501763.2015.1041416; Kluver H, 2011, EUR UNION POLIT, V12, P483, DOI 10.1177/1465116511413163; Maguire B, 2012, MAR POLICY, V36, P246, DOI 10.1016/j.marpol.2011.05.012; Manowong E., 2010, CONSTRUCTION STAKEHO, P121, DOI [10.1002/9781444315349.ch8, DOI 10.1002/9781444315349.CH8]; Norwegian Environmental Agency, 2019, ANN 15 RSTR REP PROS; Olander S., 2005, International Journal of Project Management, V23, P321, DOI 10.1016/j.ijproman.2005.02.002; Orach K, 2017, ENVIRON SCI POLICY, V76, P90, DOI 10.1016/j.envsci.2017.06.010; Padhyoti Y., 2018, Journal of Agriculture and Environment, V19, P80; Pesendorfer D, 2006, ENVIRON POLIT, V15, P95, DOI 10.1080/09644010500418803; Pomeroy R, 2008, MAR POLICY, V32, P816, DOI 10.1016/j.marpol.2008.03.017; Reed MS, 2009, J ENVIRON MANAGE, V90, P1933, DOI 10.1016/j.jenvman.2009.01.001; Roed M, 2018, JCMS-J COMMON MARK S, V56, P1446, DOI 10.1111/jcms.12754; Sabatier PA, 1998, J EUR PUBLIC POLICY, V5, P98, DOI 10.1080/13501768880000051; Sabatier PA, 2007, ADVOCACY COALITION F, P189; Selin H, 2007, GLOBAL ENVIRON POLIT, V7, P63, DOI 10.1162/glep.2007.7.3.63; Van den Brande L, 2017, REACHING OUT EU CITI; van Straalen NM, 2018, SCIENCE, V360, P958, DOI 10.1126/science.aat0567; Varvasovszky Z, 2000, HEALTH POLICY PLANN, V15, P338, DOI 10.1093/heapol/15.3.338; Walker D. H. T., 2005, MANAG DECIS, V43, P649, DOI DOI 10.1108/00251740510597680; Xanthos D, 2017, MAR POLLUT BULL, V118, P17, DOI 10.1016/j.marpolbul.2017.02.048; Zhang Wen-liang, 2007, Proceedings of the CSEE, V27, P1	80	7	8	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235062	10.1371/journal.pone.0235062	http://dx.doi.org/10.1371/journal.pone.0235062			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569303	Green Published, gold			2022-12-27	WOS:000543547900026
J	Madewell, ZJ; Lopez, MR; Espinosa-Bode, A; Brouwer, KC; Sanchez, CG; McCracken, JP				Madewell, Zachary J.; Lopez, Maria Renee; Espinosa-Bode, Andres; Brouwer, Kimberly C.; Sanchez, Cesar G.; McCracken, John P.			Inverse association between dengue, chikungunya, and Zika virus infection and indicators of household air pollution in Santa Rosa, Guatemala: A case-control study, 2011-2018	PLOS ONE			English	Article							RISK-FACTORS; ANOPHELES-GAMBIAE; GUINEA-BISSAU; MALARIA; WOODSMOKE; SEROPREVALENCE; TRANSMISSION; SENSITIVITY; MOSQUITOS; CHILDREN	Background Dengue, chikungunya, and Zika viruses are increasingly important public health problems. Burning vegetation, leaves, and other plant products have been shown to be effective mosquito repellents for their vector,Aedes spp., but there has been scant research on whether firewood cooking smoke in households influences mosquito populations or mosquito-borne diseases. About 2.9 billion people worldwide use biomass fuel for household cooking and heating, resulting in an estimated 1.6 million deaths annually from household air pollution (HAP)-related diseases. Global health agencies now encourage households to transition from biomass to clean fuels, but it is unclear whether such interventions may actually increase risk for mosquito-borne diseases. This retrospective case-control study evaluated associations between arboviral infections and cooking with firewood in Santa Rosa, Guatemala. Method Vigilancia Integrada Comunitaria(VICo) was a prospective public health surveillance system for bacterial, parasitic, and viral causes of diarrheal, neurological, respiratory, and febrile illnesses in hospitals and clinics in the department of Santa Rosa, Guatemala. Enrolled VICo in-patients and out-patients during 2011-2018 were interviewed using standardized questionnaires on demographics and household characteristics. Blood and stool specimens were collected and tested to identify the etiologies presenting symptoms. Cases were defined as laboratory-positive for dengue, chikungunya, or Zika virus infections. Controls were laboratory-positive for bacterial and viral diarrheal illnesses (e.g.,Salmonella,Shigella,Campylobacter,Escherichia coli, rotavirus, norovirus, sapovirus, or astrovirus). Cooking with firewood, kitchen location, stove type, and firewood cooking frequency were the independent exposure variables. Logistic regression models were used to analyze unadjusted and adjusted associations between arboviral infections and exposures of interest. Result There were 311 arboviral cases and 1,239 diarrheal controls. Arboviral infections were inversely associated with cooking with firewood in the main house (AOR: 0.22; 95% CI: 0.08-0.57), cooking with firewood on an open hearth (AOR: 0.50; 95% CI: 0.33-0.78), and cooking with firewood >= 5 times per week (AOR: 0.54; 95% CI: 0.36-0.81), adjusting for age, sex, ethnicity, socioeconomic status index, number of people per household, community population density, community elevation, recruitment location, season, and admission year. Conclusion Several primary determinants of HAP exposure were inversely associated with arboviral infections. Additional studies are needed to understand whether interventions to reduce HAP might actually increase risk for mosquito-borne infectious diseases, which would warrant improved education and mosquito control efforts in conjunction with fuel interventions.	[Madewell, Zachary J.; Lopez, Maria Renee; McCracken, John P.] Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala; [Madewell, Zachary J.] Univ Calif San Diego, PhD Program Publ Hlth Epidemiol, San Diego, CA 92103 USA; [Madewell, Zachary J.] San Diego State Univ, San Diego, CA 92182 USA; [Espinosa-Bode, Andres] Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA USA; [Brouwer, Kimberly C.] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Global Hlth, San Diego, CA 92103 USA; [Sanchez, Cesar G.] Minist Salud Publ & Asistencia Social, Guatemala City, Guatemala	Universidad del Valle de Guatemala; University of California System; University of California San Diego; California State University System; San Diego State University; Centers for Disease Control & Prevention - USA; University of California System; University of California San Diego	Madewell, ZJ (corresponding author), Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala.; Madewell, ZJ (corresponding author), Univ Calif San Diego, PhD Program Publ Hlth Epidemiol, San Diego, CA 92103 USA.; Madewell, ZJ (corresponding author), San Diego State Univ, San Diego, CA 92182 USA.	zmadewel@ucsd.edu	Madewell, Zachary/AAM-4921-2020	Madewell, Zachary/0000-0002-5667-9660	Global Disease Detection initiative of the Center for Global Health, Centers for Disease Control and Prevention; Universidad del Valle de Guatemala (UVG) Centro de Estudios En Salud [1U01GH000028-01, 1U01GH00100301]; Fogarty International Center of the National Institutes of Health (NIH) [D43TW009343]; University of California Global Health Institute (UCGHI)	Global Disease Detection initiative of the Center for Global Health, Centers for Disease Control and Prevention; Universidad del Valle de Guatemala (UVG) Centro de Estudios En Salud; Fogarty International Center of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of California Global Health Institute (UCGHI)	This study was funded by the Global Disease Detection initiative of the Center for Global Health, Centers for Disease Control and Prevention. Funds for field activities were provided through Cooperative Agreements with the Universidad del Valle de Guatemala (UVG) Centro de Estudios En Salud (1U01GH000028-01 and 1U01GH00100301). ZM was supported by the Fogarty International Center of the National Institutes of Health (NIH) under Award Number D43TW009343 and the University of California Global Health Institute (UCGHI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the CDC, UVG, NIH, or UCGHI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmonem A.A.., 2019, PRACTICAL MULTIVARIA, V6; Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135; Alpern JD, 2016, MED CLIN N AM, V100, P303, DOI 10.1016/j.mcna.2015.08.019; [Anonymous], 2019, LANCET DIGITAL HLTH; [Anonymous], 2016, CHINA, V3, P30; [Anonymous], 2016, MICROB BIOTECHNOL, V9, P527; [Anonymous], CHIK INF HEALTHC PRO; [Anonymous], 2013, CRIT CARE, V17, pR76; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Barnard D.R., 2006, INSECT REPELLENTS PR; Benoit SR, 2014, J EPIDEMIOL GLOB HEA, V4, P51, DOI 10.1016/j.jegh.2013.10.001; Biran A, 2007, T ROY SOC TROP MED H, V101, P1065, DOI 10.1016/j.trstmh.2007.07.010; BOCKARIE MJ, 1994, ACTA TROP, V57, P337, DOI 10.1016/0001-706X(94)90080-9; Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586; Centers for Disease Control and Prevention, KEY MESS ZIK VIR DIS; Centers for Disease Control and Prevention, 2018, MAL AN MOSQ 2018; Centers for Disease Control and Prevention, 2018, MAL BIOL 2018; Centers for Disease Control and Prevention, 2012, DENG AED AE MOSQ 201; Che-Mendoza A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006283; Climate-Data, 2019, CLIM SANT ROS 2019; Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023; Consortium for Spatial Information (CGIAR-CSI), 2018, SRTM30 EL DAT 2018; Cortes J, 2012, TROP MED INT HEALTH, V17, P254, DOI 10.1111/j.1365-3156.2011.02911.x; DAVIS EE, 1994, J AM MOSQUITO CONTR, V10, P316; Diaz-Menendez M, 2017, ZIKA VIRUS INFECT RI; Dube FF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-375; Engle PL, 1997, HUM ORGAN, V56, P408, DOI 10.17730/humo.56.4.d125333382k63v83; Estevez A, 2013, J MED VIROL, V85, P1293, DOI 10.1002/jmv.23578; Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002; Gama Z. P., 2013, Open Journal of Animal Sciences, V3, P11; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Global Alliance for Clean Cookstoves, 2013, GUAT COOKST FUELS MA; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Health Effects Institute, 2019, STAT GLOB AIR 2019; Hiscox A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062769; Instituto Nacional de Estadistica, 2019, GUAT EST POBL TOT PE; JAENSON TGT, 1994, T ROY SOC TROP MED H, V88, P620, DOI 10.1016/0035-9203(94)90197-X; Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011; Jarquin C, 2016, AM J TROP MED HYG, V94, P912, DOI 10.4269/ajtmh.15-0555; Kelly FJ, 2003, OCCUP ENVIRON MED, V60, P612, DOI 10.1136/oem.60.8.612; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; LINDSAY SW, 1990, ANN TROP MED PARASIT, V84, P553, DOI 10.1080/00034983.1990.11812510; Lipsett M, 1997, ENVIRON HEALTH PERSP, V105, P216, DOI 10.2307/3433245; Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X; Lorono-Pino MA, 2018, J TROP MED-US, V2018, DOI 10.1155/2018/4054501; Mansournia MA, 2013, INT J EPIDEMIOL, V42, P860, DOI 10.1093/ije/dyt083; Mengist Hylemariam Mihiretie, 2018, BMC Res Notes, V11, P276, DOI 10.1186/s13104-018-3380-z; Ministerio de Salud Publica Instituto Nacional de Estadistica, 2017, 6 ENC NAC SAL MAT IN; Ministerio de Salud Publica y Asistencia Social, 2018, SIT EP ARB GUAT NO 3; Naeher LP, 2007, INHAL TOXICOL, V19, P67, DOI 10.1080/08958370600985875; Nagao Y, 2003, TROP MED INT HEALTH, V8, P650, DOI 10.1046/j.1365-3156.2003.01075.x; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530; Palsson K, 1999, ACTA TROP, V72, P39, DOI 10.1016/S0001-706X(98)00083-7; Pan American Health Organization, CHIK DAT MAPS STAT 2; Pan American Health Organization, 2018, ZIK SUSP CONF CAS RE; Paru R., 1995, Papua New Guinea Medical Journal, V38, P215; Pearce N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i969; Ramos-De La Medina A, 2011, GASTROENT HEPAT-BARC, V34, P243, DOI 10.1016/j.gastrohep.2011.01.012; Seyoum A, 2002, T ROY SOC TROP MED H, V96, P225, DOI 10.1016/S0035-9203(02)90084-2; Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8; Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; Smith KR, 2010, J EXPO SCI ENV EPID, V20, P406, DOI 10.1038/jes.2009.30; SNOW RW, 1987, ANN TROP MED PARASIT, V81, P449, DOI 10.1080/00034983.1987.11812143; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Takken W., 1990, ENV MEASURES MALARIA; Thavara U, 2001, J VECTOR ECOL, V26, P172; Velasco-Salas ZI, 2014, AM J TROP MED HYG, V91, P1039, DOI 10.4269/ajtmh.14-0127; Ventura VH, 2014, ENERGY EFFICIENCY CE; Verani JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083600; Vernede Raoul, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P771; Vicenti- Gonzalez MF, 2017, PLOS NEGLECT TROP D, V11, P1; WEBER R, 1991, J CLIN MICROBIOL, V29, P1323, DOI 10.1128/JCM.29.7.1323-1327.1991; Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035; WHO, DENG SEV DENG 2019; World Health Organisation, HOUS AIR POLL HLTH 2; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2019, HOUS AIR POLL HLTH I; World Health Organization (WHO), DENG SEV DENG 2018; WorldPop, 2015, GUAT 100M POP 2015 M; Yung CF, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1662-4	83	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234399	10.1371/journal.pone.0234399	http://dx.doi.org/10.1371/journal.pone.0234399			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559225	Green Published, gold			2022-12-27	WOS:000543261600013
J	Maffei, V; Indovina, I; Mazzarella, E; Giusti, MA; Macaluso, E; Lacquaniti, F; Viviani, P				Maffei, Vincenzo; Indovina, Iole; Mazzarella, Elisabetta; Giusti, Maria Assunta; Macaluso, Emiliano; Lacquaniti, Francesco; Viviani, Paolo			Sensitivity of occipito-temporal cortex, premotor and Broca's areas to visible speech gestures in a familiar language	PLOS ONE			English	Article							HUMAN EXTRASTRIATE CORTEX; AUDIOVISUAL SPEECH; VISUAL SPEECH; AUDITORY-CORTEX; BIOLOGICAL MOTION; HEARING LIPS; HUMAN BRAIN; FMRI GROUP; PERCEPTION; FACE	When looking at a speaking person, the analysis of facial kinematics contributes to language discrimination and to the decoding of the time flow of visual speech. To disentangle these two factors, we investigated behavioural and fMRI responses to familiar and unfamiliar languages when observing speech gestures with natural or reversed kinematics. Twenty Italian volunteers viewed silent video-clips of speech shown as recorded (Forward, biological motion) or reversed in time (Backward, non-biological motion), in Italian (familiar language) or Arabic (non-familiar language). fMRI revealed that language (Italian/Arabic) and time-rendering (Forward/Backward) modulated distinct areas in the ventral occipito-temporal cortex, suggesting that visual speech analysis begins in this region, earlier than previously thought. Left premotor ventral (superior subdivision) and dorsal areas were preferentially activated with the familiar language independently of time-rendering, challenging the view that the role of these regions in speech processing is purely articulatory. The left premotor ventral region in the frontal operculum, thought to include part of the Broca's area, responded to the natural familiar language, consistent with the hypothesis of motor simulation of speech gestures.	[Maffei, Vincenzo; Indovina, Iole; Mazzarella, Elisabetta; Lacquaniti, Francesco; Viviani, Paolo] IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Maffei, Vincenzo; Giusti, Maria Assunta; Lacquaniti, Francesco; Viviani, Paolo] Univ Roma Tor Vergata, Ctr Space BioMed, Rome, Italy; [Maffei, Vincenzo; Giusti, Maria Assunta; Lacquaniti, Francesco; Viviani, Paolo] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Maffei, Vincenzo] Poste Italiane, DOT Technol, Data Lake & BI, Rome, Italy; [Indovina, Iole] St Camillus Int Univ Hlth & Med Sci, Dept Fac Med & Surg, Rome, Italy; [Macaluso, Emiliano] Lyon Neurosci Res Ctr, ImpAct Team, Lyon, France; [Macaluso, Emiliano] IRCCS Santa Lucia Fdn, Lab Neuroimaging, Rome, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); IRCCS Santa Lucia	Indovina, I (corresponding author), IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy.; Indovina, I (corresponding author), St Camillus Int Univ Hlth & Med Sci, Dept Fac Med & Surg, Rome, Italy.	i.indovina@hsantalucia.it		maffei, vincenzo/0000-0003-0957-6615	Italian Ministry of Health (Ricerca corrente, IRCCS Fondazione Santa Lucia) [PE-2013-02355372]; Italian Ministry of University and Research [2017CBF8NJ_005]; Italian Space Agency [I/006/06/0, 2019-11-U.0]	Italian Ministry of Health (Ricerca corrente, IRCCS Fondazione Santa Lucia); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Space Agency(Agenzia Spaziale Italiana (ASI))	This work was supported by the Italian Ministry of Health (Ricerca corrente, IRCCS Fondazione Santa Lucia and PE-2013-02355372), Italian Ministry of University and Research (PRIN grant 2017CBF8NJ_005), Italian Space Agency (I/006/06/0 grant and 2019-11-U.0).	Abercrombie D, 1971, ELEMENTS GEN PHONETI; Amunts K, 2012, TRENDS COGN SCI, V16, P418, DOI 10.1016/j.tics.2012.06.005; [Anonymous], 1996, ELAPHE, V4, P58, DOI DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Balestrucci P, 2017, EXP BRAIN RES, V235, P1999, DOI 10.1007/s00221-017-4942-3; Basile A, 2017, CURRENT TRENDS AND FUTURE DEVELOPMENTS ON (BIO-) MEMBRANES: SILICA MEMBRANES: PREPARATION, MODELLING, APPLICATION, AND COMMERCIALIZATION, P1; Berner LA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00395; Bernstein L. E., 1986, J ACOUSTICAL SOC S1, V80, pS78; Bernstein LE, 2000, PERCEPT PSYCHOPHYS, V62, P233, DOI 10.3758/BF03205546; Bernstein LE, 2008, NEUROIMAGE, V39, P423, DOI 10.1016/j.neuroimage.2007.08.035; Bernstein LE, 2011, HUM BRAIN MAPP, V32, P1660, DOI 10.1002/hbm.21139; Bhat J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00173; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bobick AF, 1997, PHILOS T ROY SOC B, V352, P1257, DOI 10.1098/rstb.1997.0108; Borowiak K, 2018, NEUROIMAGE-CLIN, V20, P1078, DOI 10.1016/j.nicl.2018.09.019; Callan DE, 2003, NEUROREPORT, V14, P2213, DOI 10.1097/00001756-200312020-00016; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Calvert GA, 2003, READING SPEECH STILL, P57; Campbell CS, 1997, PERCEPTION, V26, P627, DOI 10.1068/p260627; Campbell R, 2001, COGNITIVE BRAIN RES, V12, P233, DOI 10.1016/S0926-6410(01)00054-4; Campbell R, 2008, PHILOS T R SOC B, V363, P1001, DOI 10.1098/rstb.2007.2155; Campbell R, 2011, BRIT J PSYCHOL, V102, P704, DOI 10.1111/j.2044-8295.2011.02021.x; Capek CM, 2008, NEUROPSYCHOLOGIA, V46, P1233, DOI 10.1016/j.neuropsychologia.2007.11.026; CARAMAZZA A, 1976, BRAIN LANG, V3, P572, DOI 10.1016/0093-934X(76)90048-1; Cerri G, 2015, HUM BRAIN MAPP, V36, P1010, DOI 10.1002/hbm.22682; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cross ES, 2012, HUM BRAIN MAPP, V33, P2238, DOI 10.1002/hbm.21361; Dale A, 1997, HUM BRAIN MAPP; Daselaar SM, 2003, BRAIN, V126, P43, DOI 10.1093/brain/awg005; Dias JW, 2016, ATTEN PERCEPT PSYCHO, V78, P317, DOI 10.3758/s13414-015-0982-6; Downing PE, 2011, COGN NEUROSCI-UK, V2, P186, DOI 10.1080/17588928.2011.582945; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Egner T, 2010, J NEUROSCI, V30, P16601, DOI 10.1523/JNEUROSCI.2770-10.2010; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; ERBER NP, 1975, J SPEECH HEAR DISORD, V40, P481, DOI 10.1044/jshd.4004.481; Fedorenko E, 2016, ANN NY ACAD SCI, V1369, P132, DOI 10.1111/nyas.13046; Fedorenko E, 2012, CURR BIOL, V22, P2059, DOI 10.1016/j.cub.2012.09.011; Fedorenko E, 2012, BRAIN LANG, V120, P187, DOI 10.1016/j.bandl.2011.01.001; Flinker A, 2015, P NATL ACAD SCI USA, V112, P2871, DOI 10.1073/pnas.1414491112; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Fridriksson J, 2008, NEUROIMAGE, V41, P605, DOI 10.1016/j.neuroimage.2008.02.046; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Friston KJ, 1997, HUM BRAIN MAPP, P1; Fuertinger S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002209; Furl N, 2010, CEREB CORTEX, V20, P694, DOI 10.1093/cercor/bhp140; Galantucci B, 2006, PSYCHON B REV, V13, P742, DOI 10.3758/BF03193990; Gardner T, 2015, J NEUROSCI, V35, P1561, DOI 10.1523/JNEUROSCI.2942-14.2015; Ghazali S, 2004, P INT 2004, P1613; Gonzalez-Franco M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04201-x; GRACCO VL, 1988, J NEUROSCI, V8, P4628; GREEN KP, 1987, PERCEPT PSYCHOPHYS, V42, P587, DOI 10.3758/BF03207990; Grill-Spector K, 2014, NAT REV NEUROSCI, V15, P536, DOI 10.1038/nrn3747; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Hagoort P, 2014, CURR OPIN NEUROBIOL, V28, P136, DOI 10.1016/j.conb.2014.07.013; Hasson U, 2007, NEURON, V56, P1116, DOI 10.1016/j.neuron.2007.09.037; Hauswald A, 2018, CURR BIOL, V28, P1453, DOI 10.1016/j.cub.2018.03.044; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Henson R., 2006, STAT PARAMETRIC MAPP, P193; Hickok G, 2011, J COGNITIVE NEUROSCI, V23, P2629, DOI 10.1162/jocn_a_00044; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jastorff J, 2009, J NEUROSCI, V29, P7315, DOI 10.1523/JNEUROSCI.4870-08.2009; Jeffers J., 1971, SPEECHREADING LIPREA; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Koster-Hale J, 2013, NEURON, V79, P836, DOI 10.1016/j.neuron.2013.08.020; Lemon R, 2015, BRAIN, V138, P2109, DOI DOI 10.1093/BRAIN/AWV131; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Lindquist MA, 2008, STAT SCI, V23, P439, DOI 10.1214/09-STS282; Lingnau A, 2015, TRENDS COGN SCI, V19, P268, DOI 10.1016/j.tics.2015.03.006; Macmillan NA., 1991, DETECTION THEORY USE; Maffei V, 2015, CEREB CORTEX, V25, P2022, DOI 10.1093/cercor/bhu008; Maffei V, 2015, NEUROIMAGE, V104, P221, DOI 10.1016/j.neuroimage.2014.10.006; Mahon BZ, 2011, TRENDS COGN SCI, V15, P97, DOI 10.1016/j.tics.2011.01.004; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Mikl M, 2008, MAGN RESON IMAGING, V26, P490, DOI 10.1016/j.mri.2007.08.006; Murphy K, 2004, NEUROIMAGE, V21, P219, DOI 10.1016/j.neuroimage.2003.09.016; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Negri GAL, 2007, COGN NEUROPSYCHOL, V24, P795, DOI 10.1080/02643290701707412; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; OSTRY DJ, 1989, ARCH ORAL BIOL, V34, P685, DOI 10.1016/0003-9969(89)90074-5; Paulesu E, 2003, J NEUROPHYSIOL, V90, P2005, DOI 10.1152/jn.00926.2002; Pekkola J, 2005, NEUROREPORT, V16, P125, DOI 10.1097/00001756-200502080-00010; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; Pike K., 1945, INTONATION AM ENGLIS, DOI DOI 10.HTTPS://D0I.0RG/10.1111/J.1360-6441; Pinsk MA, 2009, J NEUROPHYSIOL, V101, P2581, DOI 10.1152/jn.91198.2008; Ponton CW, 2009, BRAIN TOPOGR, V21, P207, DOI 10.1007/s10548-009-0094-5; Pritchett BL, 2018, J NEUROPHYSIOL, V120, P2555, DOI 10.1152/jn.00222.2018; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Ramus F, 1999, COGNITION, V73, P265, DOI 10.1016/S0010-0277(99)00058-X; Ramus F, 1999, J ACOUST SOC AM, V105, P512, DOI 10.1121/1.424522; Ramus F., 2002, ANN REV LANGUAGE ACQ, V2, P85, DOI [10.1075/arla.2.05ram, DOI 10.1075/ARLA.2.05RAM]; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Reinl M, 2014, NEUROIMAGE, V102, P407, DOI 10.1016/j.neuroimage.2014.08.011; Reisberg D., 1987, HEARING EYE PSYCHOL, P97; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, LANGUAGE OUR GRASP, V2236, P1667, DOI [10.1016/S0166-2236(98)01260-0, DOI 10.1016/S0166-2236(98)01260-0]; Rogalsky C, 2011, J COGNITIVE NEUROSCI, V23, P1664, DOI 10.1162/jocn.2010.21530; Ronquest RE, 2010, ATTEN PERCEPT PSYCHO, V72, P1601, DOI 10.3758/APP.72.6.1601; Rosenblum LD, 1996, J EXP PSYCHOL HUMAN, V22, P318, DOI 10.1037/0096-1523.22.2.318; Ruytjens L, 2006, EUR J NEUROSCI, V24, P1835, DOI 10.1111/j.1460-9568.2006.05072.x; Santi A, 2003, J COGNITIVE NEUROSCI, V15, P800, DOI 10.1162/089892903322370726; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shapiro KA, 2001, J COGNITIVE NEUROSCI, V13, P713, DOI 10.1162/08989290152541386; Skipper JI, 2007, CEREB CORTEX, V17, P2387, DOI 10.1093/cercor/bhl147; Skipper JI, 2005, NEUROIMAGE, V25, P76, DOI 10.1016/j.neuroimage.2004.11.006; Soto-Faraco S, 2007, PERCEPT PSYCHOPHYS, V69, P218, DOI 10.3758/BF03193744; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Sunaert S, 1999, EXP BRAIN RES, V127, P355, DOI 10.1007/s002210050804; Tajima K, 1999, P 14 ICPHS SAN FRANC, P3; Turner TH, 2009, NEUROREPORT, V20, P492, DOI 10.1097/WNR.0b013e32832940a0; VANSON N, 1994, J ACOUST SOC AM, V96, P1341, DOI 10.1121/1.411324; Venezia JH, 2016, NEUROIMAGE, V126, P196, DOI 10.1016/j.neuroimage.2015.11.038; Venezia JH, 2009, LANG LINGUIST COMPAS, V3, P1403, DOI 10.1111/j.1749-818x.2009.00169.x; Venezia JH, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00157; Viviani P, 2002, ATTENTION PERFORM, V19, P406; Viviani P, 2011, EXP BRAIN RES, V215, P141, DOI 10.1007/s00221-011-2883-9; Viviani P, 2011, EXP BRAIN RES, V214, P93, DOI 10.1007/s00221-011-2809-6; Watkins KE, 2003, NEUROPSYCHOLOGIA, V41, P989, DOI 10.1016/S0028-3932(02)00316-0; Weikum WM, 2007, SCIENCE, V316, P1159, DOI 10.1126/science.1137686; Weiner KS, 2013, PSYCHOL RES-PSYCH FO, V77, P74, DOI 10.1007/s00426-011-0392-x; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Wu T, 2011, HUM BRAIN MAPP, V32, P1443, DOI 10.1002/hbm.21118; Wurm MF, 2015, J NEUROSCI, V35, P7727, DOI 10.1523/JNEUROSCI.0188-15.2015; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119; Zhu LL, 2017, J NEUROSCI, V37, P2697, DOI 10.1523/JNEUROSCI.2914-16.2017; 2014, FRONT PSYCHOL, V5, P1	137	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234695	10.1371/journal.pone.0234695	http://dx.doi.org/10.1371/journal.pone.0234695			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559213	gold, Green Published			2022-12-27	WOS:000543261600053
J	Dargin, JS; Mostafavi, A				Dargin, Jennifer S.; Mostafavi, Ali			Human-centric infrastructure resilience: Uncovering well-being risk disparity due to infrastructure disruptions in disasters	PLOS ONE			English	Article							MENTAL-HEALTH; LESSONS; FRAMEWORK; EVENTS	The objective of this paper is to empirically examine the impacts of infrastructure service disruptions on the well-being of vulnerable populations during disasters. There are limited studies that empirically evaluate the extent to which disruptions in infrastructure system services impact subpopulation groups differently and how these impacts relate to the wellbeing of households. Being able to systematically capture the differential experiences of sub-populations in a community due to infrastructure disruptions is necessary to highlight the differential needs and inequities that households have. In order to address this knowledge gap, this study derives an empirical relationship between sociodemographic factors of households and their subjective well-being impacts due to disruptions in various infrastructure services during and immediately after Hurricane Harvey. Statistical analysis driven by spearman-rank order correlations and fisher-z tests indicated significant disparities in well-being due to service disruptions among vulnerable population groups. The characterization of subjective well-being is used to explain to what extent infrastructure service disruptions influence different subpopulations. The results show that: (1) disruptions in transportation, solid waste, food, and water infrastructure services resulted in more significant well-being impact disparities as compared to electricity and communication services; (2) households identifying as Black and African American experienced well-being impact due to disruptions in food, transportation, and solid waste services; and (3) households were more likely to feel helpless, difficulty doing daily tasks and feeling distance from their community as a result of service disruptions. The findings present novel insights into understanding the role of infrastructure resilience in household well-being and highlights why it is so important to use approaches that consider various factors. Infrastructure resilience models tend to be monolithic. The results provide empirical and quantitative evidence of the inequalities in well-being impacts across various sub-populations. The research approach and findings enable a paradigm shift towards a more human-centric approach to infrastructure resilience.	[Dargin, Jennifer S.; Mostafavi, Ali] Texas A&M Univ, Zachry Dept Environm & Civil Engn, College Stn, TX 77845 USA	Texas A&M University System; Texas A&M University College Station	Dargin, JS (corresponding author), Texas A&M Univ, Zachry Dept Environm & Civil Engn, College Stn, TX 77845 USA.	jenniferdsara@tamu.edu			National Science Foundation [1846069]; National Academies' Gulf Research Program Early Career Research Fellowship; University Libraries; Office of the Vice President for Research	National Science Foundation(National Science Foundation (NSF)); National Academies' Gulf Research Program Early Career Research Fellowship; University Libraries; Office of the Vice President for Research	The authors would like to acknowledge the funding support from the National Science Foundation under grant number 1846069 (https://www.nsf.gov/awardsearch/showAward?AWD_ID= 1846069&HistoricalAwards=false)(AM) and the National Academies' Gulf Research Program Early Career Research Fellowship (AM) (http://www.nationalacademies.org/gulf/fellowships/earlycareer/index.htm).The open access publishing fees for this article have been covered by the Texas A&M University Open Access to Knowledge Fund (OAKFund), supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adeola F.O, 2003, 162 U COL NAT HAZ RE; Aitsi-Selmi A, 2015, INT J DISAST RISK SC, V6, P164, DOI 10.1007/s13753-015-0050-9; Akoglu H, 2018, TURK J EMERG MED, V18, P91, DOI 10.1016/j.tjem.2018.08.001; Alderson DL, 2015, RISK ANAL, V35, P562, DOI 10.1111/risa.12333; Andrulis DP, 2011, DISASTER MED PUBLIC, V5, P227, DOI 10.1001/dmp.2011.72; [Anonymous], 2015, CORSALUD; [Anonymous], WORLD HLTH REPORT 20; [Anonymous], 2009, KIDNEY INT, V6, pS1; [Anonymous], 2015, CANC DISCOV, V5, pOF2; [Anonymous], 2005, DISASTER SAFETY REV; Badland H, 2014, SOC SCI MED, V111, P64, DOI 10.1016/j.socscimed.2014.04.003; Baggio S., 2007, CAHIERS INT PSYCHOL, V74, P19, DOI [10.3917/cips.074.0019, DOI 10.3917/cips.074.0019]; Barrett C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045406; Blunt K, 2017, HOUSTON CHRONICLE; Boehm JK, 2012, PSYCHOL BULL, V138, P655, DOI 10.1037/a0027448; Brown C, 2011, WASTE MANAGE, V31, P1085, DOI 10.1016/j.wasman.2011.01.027; Brown K, 2011, ANNU REV ENV RESOUR, V36, P321, DOI 10.1146/annurev-environ-052610-092905; Bruneau M, 2003, EARTHQ SPECTRA, V19, P733, DOI 10.1193/1.1623497; Bubenik T., 2017, POWER OUTAGES WERE L; Burrus R.T., 2002, NAT HAZARDS REV, DOI [DOI 10.1061/(ASCE)1527-6988(2002)3:3(118), 10.1061/(asce)1527-6988(2002)3:3(118)]; Capic T., 2016, WUSTR UNITY WELLBE A; Centers for Disease Control and Prevention, 2018, WELL BEING CONC; Chang S.E., 2016, SOCIOECONOMIC IMPACT, DOI [10.1093/acrefore/9780199389407.013.6, DOI 10.1093/ACREFORE/9780199389407.013.6]; Cleland Claire, 2016, BMC Res Notes, V9, P470; Czaja SJ, 2006, PSYCHOL AGING, V21, P333, DOI 10.1037/0882-7974.21.2.333; DIEDENHOFEN B, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0121945; Diener E, 2002, SOC INDIC RES, V57, P119, DOI 10.1023/A:1014411319119; Doorn N, 2019, SUSTAIN RESIL INFRAS, V4, P112, DOI 10.1080/23789689.2018.1428162; Esmalian A, 2019, COMPUTING IN CIVIL ENGINEERING 2019: SMART CITIES, SUSTAINABILITY, AND RESILIENCE, P16; Falco GJ, 2015, PROCEDIA ENGINEER, V118, P1008, DOI 10.1016/j.proeng.2015.08.542; Federal Communications Commission (FCC), 2017, REP 2019 ATL HURR SE; Few R, 2006, FLOOD HAZARDS HLTH R; Flanagan BE, 2011, J HOMEL SECUR EMERG, V8, DOI 10.2202/1547-7355.1792; Foa EB, 2013, PSYCHOL SCI PUBL INT, V14, P65, DOI 10.1177/1529100612468841; Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017; Hay A.G-P., RESILIENCE AND RISK; HCFCD, 2018, IMP RESP HARR COUNT; Helliwell J., 2014, WORLD HAPPINESS REPO; HORLEY J, 1995, SOC INDIC RES, V34, P275, DOI 10.1007/BF01079200; Institute of Medicine, 2015, HLTH RES SYST COMM D; Institute of Medicine, 2015, HLTH RESILIENT SUSTA, P504; International Wellbeing Group, 2013, PERS WELLB IND MAN 5; Kelley J, 2017, SOC SCI RES, V62, P1, DOI 10.1016/j.ssresearch.2016.04.020; Kellezi B, 2009, APPL PSYCHOL-INT REV, V58, P59, DOI 10.1111/j.1464-0597.2008.00382.x; Keppel Kenneth, 2005, Vital Health Stat 2, P1; Kessler RC, 1996, BRIT J PSYCHIAT, V168, P17, DOI 10.1192/S0007125000298371; Keyes CLM, 2003, CROSS CONT, P477; Khumalo IP, 2012, SOC INDIC RES, V105, P419, DOI 10.1007/s11205-010-9777-2; Kirmayer LJ, 2009, INT J INDIG HEALTH, V5, P62; Lin S, 2016, DISASTER MED PUBLIC, V10, P314, DOI 10.1017/dmp.2016.51; Lindell MK, 2008, RISK ANAL, V28, P539, DOI 10.1111/j.1539-6924.2008.01032.x; Linkov I., 2017, RESILIENCE RISK NATO; Linkov I, 2014, NAT CLIM CHANGE, V4, P407, DOI 10.1038/nclimate2227; Martuzzi M, 2010, EUR J PUBLIC HEALTH, V20, P21, DOI 10.1093/eurpub/ckp216; McDonald J. H., 2014, HDB BIOL STAT, P209; Michalos AC, 2010, SOC INDIC RES, V98, P403, DOI 10.1007/s11205-009-9554-2; Miles SB, 2015, ENVIRON HAZARDS-UK, V14, P103, DOI 10.1080/17477891.2014.999018; Mohai P, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/11/115008; Morrow Hearn, 1997, HURRICANE ANDREW ETH; Mostafavi A., RISK ANAL; MYERS DG, 1995, PSYCHOL SCI, V6, P10, DOI 10.1111/j.1467-9280.1995.tb00298.x; Nateghi R, 2011, RISK ANAL, V31, P1897, DOI 10.1111/j.1539-6924.2011.01618.x; National Research Council, 2012, DIRENAT IMP, DOI DOI 10.17226/13457; National Research Council (NRC), 2012, DIRENAT IMP, DOI 10.17226/13457; NIST, 2016, COMM RES PLANN GUID; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Nozhati S., 2018, 9 INT C ENV MOD SOFT; Nyamwanza AM, 2012, JAMBA-J DISASTER RIS, V4, DOI 10.4102/jamba.v4i1.55; OECD, 2013, OECD GUID MEAS SUBJ; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Per Di Qua, 2011, RIV ITAL NUTR PARENT, V29, pS2; Rand K, 2020, INT J DISAST RISK RE, V42, DOI 10.1016/j.ijdrr.2019.101310; Rasoulkhani K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207674; Reeskens T, 2017, J HAPPINESS STUD, V18, P41, DOI 10.1007/s10902-016-9716-2; Roman MO, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218883; Rose D, 2011, AM J PUBLIC HEALTH, V101, P482, DOI 10.2105/AJPH.2010.196659; RTI International, 2014, SCIENCEDAILY; Sangha KK, 2015, GLOB ECOL CONSERV, V4, P445, DOI 10.1016/j.gecco.2015.09.001; Santos JR, 2014, RISK ANAL, V34, P1056, DOI 10.1111/risa.12183; Schimmack U, 2005, J PERS SOC PSYCHOL, V89, P395, DOI 10.1037/0022-3514.89.3.395; Sen A., 1999, COMMODITIES CAPABILI; Serulle Urena, 2014, TRANSPORT RES REC, V2459, P72, DOI [10.3141/2459-09, DOI 10.3141/2459-09]; Shear MK, 2011, DEPRESS ANXIETY, V28, P648, DOI 10.1002/da.20865; Siamak S., 2018, NIST SPECIAL PUBLICA, V1224, P95, DOI [10.6028/NIST.SP.1224, DOI 10.6028/NIST.SP.1224]; Silverman WK., 2002, CHILDREN EXPERIENCIN, P11, DOI [10.1037/10454-001, DOI 10.1037/10454-001]; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Song JL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190701; Stewart-Brown S, 2015, BRIT J PSYCHIAT, V206, P461, DOI 10.1192/bjp.bp.114.147280; Stiglitz J.E., 2010, INOPERABILITY INPUT; Stone A.A., 2013, COMMITTEE NATL STAT; Uchida Y, 2014, J HAPPINESS STUD, V15, P207, DOI 10.1007/s10902-013-9463-6; UNDRR, SEND FRAM DIS RISK R; Ursano R.J., 2007, TXB DISASTER PSYCHIA, DOI [10.1080/20008198.2018.1468711, DOI 10.1080/20008198.2018.1468711]; *US DEP HHS, 2000, UND IMPR HLTH OBJ IM; Vaportzis E, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01687; Walker D. T., 2017, 2017 HURRICANE SEASO; WFAA, 2017, MAND EV ORD SOM COAS; Wiersma Hinkle W., 2003, APPL STAT BEHAV SCI, Vfifth; Zemba V, 2019, SAFETY SCI, V120, P603, DOI 10.1016/j.ssci.2019.07.042	100	23	24	8	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234381	10.1371/journal.pone.0234381	http://dx.doi.org/10.1371/journal.pone.0234381			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555741	Green Published, gold			2022-12-27	WOS:000543273200067
J	Foster, E; Malloy, MJ; Jokubaitis, VG; Wrede, CDH; Butzkueven, H; Sasadeusz, J; Van Doornum, S; Macrae, F; Unglik, G; Brotherton, JML; van der Walt, A				Foster, Emma; Malloy, Michael J.; Jokubaitis, Vilija G.; Wrede, C. David H.; Butzkueven, Helmut; Sasadeusz, Joe; Van Doornum, Sharon; Macrae, Finlay; Unglik, Gary; Brotherton, Julia M. L.; van der Walt, Anneke			Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; WOMEN; RESPONSES; NEOPLASIA; CANCER	Background Autoimmune conditions (AICs) and/or their treatment may alter risk of human papilloma virus (HPV) infection and females with AICs are therefore at an increased risk of cervical dysplasia. However, inclusion of these at-risk populations in cervical cancer screening and HPV-vaccination guidelines, are mostly lacking. This study aimed to determine the prevalence of cervical dysplasia in a wide range of AICs and compare that to HIV and immunocompetent controls to support the optimisation of cervical cancer preventive health measures. Methods Data linkage was used to match cervical screening episodes to emergency department records of females with AICs or HIV to immunocompetent controls over a 14-year period. The primary outcome was histologically confirmed high-grade cervical disease. Results, measured as rates by cytology and histology classification per 1,000 females screened, were analysed per disease group, and intergroup comparisons were performed. Results Females with inflammatory bowel disease (2,683), psoriatic and enteropathic arthropathies (1,848), multiple sclerosis (MS) (1,426), rheumatoid arthritis (1,246), systemic lupus erythematosus and/or mixed connective tissue disease (SLE/MCTD) (702), HIV (44), and 985,383 immunocompetent controls were included. SLE/MCTD and HIV groups had greater rates of high-grade histological and cytological abnormalities compared to controls. Increased rates of low-grade cytological abnormalities were detected in all females with AICs, with the exception of the MS group. Conclusions Females with SLE/MCTD or HIV have increased rates of high-grade cervical abnormalities. The increased low-grade dysplasia rate seen in most females with AICs is consistent with increased HPV infection. These findings support expansion of cervical cancer preventative programs to include these at-risk females.	[Foster, Emma; Jokubaitis, Vilija G.; Butzkueven, Helmut; van der Walt, Anneke] Alfred Hlth, Dept Neurol MS & Neuroimmunol Serv, Melbourne, Vic, Australia; [Foster, Emma; Jokubaitis, Vilija G.; Butzkueven, Helmut; van der Walt, Anneke] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Foster, Emma; van der Walt, Anneke] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia; [Malloy, Michael J.; Brotherton, Julia M. L.] VCS Fdn, VCS Populat Hlth, Victorian Cerv Screening Registry, Melbourne, Vic, Australia; [Malloy, Michael J.; Brotherton, Julia M. L.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Wrede, C. David H.] Royal Women S Hosp, Dept Oncol & Dysplasia, Melbourne, Vic, Australia; [Wrede, C. David H.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Sasadeusz, Joe] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia; [Van Doornum, Sharon] Royal Melbourne Hosp, Rheumatol Dept, Melbourne, Vic, Australia; [Van Doornum, Sharon] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Macrae, Finlay] Royal Melbourne Hosp, Colorectal Med & Genet, Melbourne, Vic, Australia; [Unglik, Gary] Royal Melbourne Hosp, Dept Clin Immunol & Allergy, Melbourne, Vic, Australia	Monash University; Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; Royal Melbourne Hospital	van der Walt, A (corresponding author), Alfred Hlth, Dept Neurol MS & Neuroimmunol Serv, Melbourne, Vic, Australia.; van der Walt, A (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia.; van der Walt, A (corresponding author), Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia.; Brotherton, JML (corresponding author), VCS Fdn, VCS Populat Hlth, Victorian Cerv Screening Registry, Melbourne, Vic, Australia.; Brotherton, JML (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.	jbrother@vcs.org.au; anneke.vanderwalt@monash.edu			Victorian Department of Health and Human Services	Victorian Department of Health and Human Services	The data linkage for this study was funded by the Victorian Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW NCSP, 2017, CANC SERIES, V105; Allegretti JR, 2015, INFLAMM BOWEL DIS, V21, P1089, DOI 10.1097/MIB.0000000000000338; [Anonymous], 2011, 1269 0 STANDARD AUST; [Anonymous], 2011, 1270055006 AUSTR BUR; [Anonymous], 2017, VICT CERV CYT REG ST; [Anonymous], 2018, HOSP ADM EM DEP VIS; Australian Bureau of Statistics, 2016, SOC IND AR SEIFA CAT; Australian Bureau of Statistics, 2006, 32350 AUSTR BUR STAT; Bossingham D, 2003, LUPUS, V12, P327, DOI 10.1191/0961203303lu381xx; Brotherton JML, 2016, MED J AUSTRALIA, V204, P184, DOI 10.5694/mja15.01038; Cancer Council Australia, 2014, CERV CANC PREV POL C; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Dugue PA, 2015, INT J CANCER, V136, pE711, DOI 10.1002/ijc.29209; Garland SM, 2017, PAPILLOMAVIRUS RES, V4, P35, DOI 10.1016/j.pvr.2017.06.002; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hall MT, 2019, LANCET PUBLIC HEALTH, V4, pE19, DOI 10.1016/S2468-2667(18)30183-X; Hemmer B, 2015, LANCET NEUROL, V14, P406, DOI 10.1016/S1474-4422(14)70305-9; Kelly HA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174117; Liu HL, 2011, RHEUMATOLOGY, V50, P343, DOI 10.1093/rheumatology/keq304; Mackie FE, 2015, LUPUS, V24, P66, DOI 10.1177/0961203314552118; Marrie RA, 2015, MULT SCLER J, V21, P294, DOI 10.1177/1352458514564489; Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699; Reusser NM, 2015, J CLIN MED, V4, P260, DOI 10.3390/jcm4020260; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Schmidt RE, 2018, NAT REV RHEUMATOL, V14, P7, DOI 10.1038/nrrheum.2017.198; Stanley M, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0268; Stanley MA, 2012, CLIN MICROBIOL REV, V25, P215, DOI 10.1128/CMR.05028-11; Velentzis LS, CLIMACTERIC, V2019, P1; Wadstrom H, 2016, ANN RHEUM DIS, V75, P1272, DOI 10.1136/annrheumdis-2015-208263; Wheeler CM, 2008, OBSTET GYN CLIN N AM, V35, P519, DOI 10.1016/j.ogc.2008.09.006; World Hlth Org, 2017, VACCINE, V35, P5753, DOI 10.1016/j.vaccine.2017.05.069	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234813	10.1371/journal.pone.0234813	http://dx.doi.org/10.1371/journal.pone.0234813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555638	Green Published, gold			2022-12-27	WOS:000543273200057
J	Palmucci, A; Liao, H; Napoletano, A; Zaccaria, A				Palmucci, Andrea; Liao, Hao; Napoletano, Andrea; Zaccaria, Andrea			Where is your field going? A machine learning approach to study the relative motion of the domains of physics	PLOS ONE			English	Article							TECHNOLOGY; SCIENCE	We propose an original approach to describe the scientific progress in a quantitative way. Using innovative Machine Learning techniques we create a vector representation for the PACS codes and we use them to represent the relative movements of the various domains of Physics in a multi-dimensional space. This methodology unveils about 25 years of scientific trends, enables us to predict innovative couplings of fields, and illustrates how Nobel Prize papers and APS milestones drive the future convergence of previously unrelated fields.	[Palmucci, Andrea; Napoletano, Andrea] Sapienza Univ Rome, Dept Phys, Rome, Italy; [Liao, Hao] Shenzhen Univ, Coll Comp Sci & Software Engn, Guangdong Prov Key Lab Popular High Performance C, Shenzhen, Peoples R China; [Napoletano, Andrea; Zaccaria, Andrea] UOS Sapienza, Inst Complex Syst, Rome, Italy	Sapienza University Rome; Shenzhen University; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Napoletano, A (corresponding author), Sapienza Univ Rome, Dept Phys, Rome, Italy.; Napoletano, A (corresponding author), UOS Sapienza, Inst Complex Syst, Rome, Italy.	andrea.napoletano1990@gmail.com		Napoletano, Andrea/0000-0003-1289-6548	CNR Progetto di Interesse CRISIS LAB; National Natural Science Foundation of China [61803266, 61703281, 91846301, 71790615]; Guangdong Province Natural Science Foundation [2019A1515011173, 2019A1515011064, 2017B030314073]; Shenzhen Fundamental Research-general project [JCYJ20190808162601658]	CNR Progetto di Interesse CRISIS LAB; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Shenzhen Fundamental Research-general project	The authors acknowledge support from CNR Progetto di Interesse CRISIS LAB, the National Natural Science Foundation of China (Grant Nos. 61803266, 61703281, 91846301, 71790615), Guangdong Province Natural Science Foundation (Grant Nos. 2019A1515011173, 2019A1515011064, 2017B030314073), Shenzhen Fundamental Research-general project (JCYJ20190808162601658).	[Anonymous], [No title captured]; ARTHUR W. BRIAN, 2009, NATURE TECHNOLOGY WH; Battiston F, 2019, NAT REV PHYS, V1, P89, DOI 10.1038/s42254-018-0005-3; Borner K, 2018, P NATL ACAD SCI USA, V115, P12573, DOI 10.1073/pnas.1818750115; Bottou L., 2008, ADV NEURAL INFORM PR, V20, P161, DOI DOI 10.7751/mitpress/8996.003.0015; Chavalarias D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054847; Chinazzi M, 2019, EPJ DATA SCI, V8, DOI 10.1140/epjds/s13688-019-0210-z; Cimini G, 2016, J INFORMETR, V10, P200, DOI 10.1016/j.joi.2016.01.002; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fortunato S, 2018, SCIENCE, V359, DOI 10.1126/science.aao0185; Gerlach M., 2018, SCI ADV; Gutmann Michael, 2010, P 13 INT C ART INT S, P297, DOI DOI 10.1145/3292500.3330651; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HASTIE T, 2009, SPRINGER SERIES STAT; Herrera M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010355; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jia T, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0078; Ma YF, 2018, P NATL ACAD SCI USA, V115, P12608, DOI 10.1073/pnas.1800485115; Manning C, 1999, FDN STAT NATURAL LAN; Martinez W, 2018, P NATL ACAD SCI USA, V115, P12624, DOI 10.1073/pnas.1803216115; Mikolov Tomas, 2013, DISTRIBUTED REPRESEN; Mryglod O, 2016, SCIENTOMETRICS, V106, P1151, DOI 10.1007/s11192-015-1820-2; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Ram Y, 2019, P NATL ACAD SCI USA, V116, P14698, DOI 10.1073/pnas.1902217116; Rauber P.E., 2016, EUR C VIS EUROVIS; Reichert J, 2000, PHYS REV LETT, V84, P3232, DOI 10.1103/PhysRevLett.84.3232; Robbins H., 1985, HERBERT ROBBINS SELE, P111; Rong X., 2014, ARXIV; Shneiderman B, 2018, P NATL ACAD SCI USA, V115, P12590, DOI 10.1073/pnas.1802918115; Sinatra R, 2016, SCIENCE, V354, DOI 10.1126/science.aaf5239; Sun X., 2016, J INFORMETRICS, V10; Szanto-Varnagy A, 2014, NATL SCI REV, V1, P343, DOI 10.1093/nsr/nwu027; Tacchella A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230107; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Weinberg S., 2015, EXPLAIN WORLD DISCOV; Wu L, 2017, ARXIV170903856; Zeng An, 2017, PHYS REPORTS, V714-715	38	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0233997	10.1371/journal.pone.0233997	http://dx.doi.org/10.1371/journal.pone.0233997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555661	Green Published, gold, Green Submitted			2022-12-27	WOS:000543273200026
J	Qiao, CC; Qian, HY; Wang, J; Zhao, TT; Ma, PY; Wang, SC; Zhang, T; Liu, XS				Qiao, Chuchu; Qian, Hongyan; Wang, Jue; Zhao, Tingting; Ma, Pengyu; Wang, Sicen; Zhang, Tao; Liu, Xinshe			PD173074 blocks G1/S transition via CUL3-mediated ubiquitin protease in HepG2 and Hep3B cells	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR RECEPTOR-4; CONTROLS S-PHASE; TARGETS CYCLIN-E; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; CANCER; EXPRESSION; BINDING; PROLIFERATION	Fibroblast growth factor receptors (FGFRs) are frequently altered in a variety of human cancer cells and are overexpressed in hepatocellular carcinoma (HCC). Several literatures have proven that they are efficacious for HCC therapy, however, the underlying mechanism remains unclear. Here, we found FGFR4 was overexpressed in HCC cell lines HepG2 and Hep3B and we used PD173074, an FGFR4 inhibitor, to explore the role of FGFR4 and its underlying mechanism in these cell lines. The results showed that PD173074 significantly arrested HepG2 and Hep3B cells in G1 phase and inhibited cell proliferation. Furthermore, Western blot analysis revealed that PD173074 decreased the levels of P-FRS2 alpha, P-ERK, CDK2, cyclin E and NF-kappa B (p65) in the nucleus while it increased the levels of ubiquitin and CUL3, an E3 ubiquitin ligase which involves in cyclin E degradation. Meanwhile, the data from RT-qPCR showed that PD173074 also decreased miR-141 level. In conclusion, these results suggest that FGFR4 is involved in HCC by ERK/CUL3/cyclin E signaling pathway, and the finding may provide a potential theoretical basis for treatment by targeting FGFR4 in HCC.	[Qiao, Chuchu; Wang, Jue; Zhao, Tingting; Ma, Pengyu; Wang, Sicen; Zhang, Tao] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Xian, Shaanxi, Peoples R China; [Qian, Hongyan; Liu, Xinshe] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Forens Sci & Med, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Zhang, T (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Xian, Shaanxi, Peoples R China.; Liu, XS (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Forens Sci & Med, Xian, Shaanxi, Peoples R China.	lxins@xjtu.edu.cn; taozhang@xjtu.edu.cn	Wang, Jue/GVU-0480-2022		National Natural Science Foundation of China [81471818, 81430048, 81202495, 81230079]; Natural Science Foundation of Shaanxi Province [2017JM8098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	This work was supported by the National Natural Science Foundation of China (No. 81471818, 81430048, 81202495, 81230079) and the Natural Science Foundation of Shaanxi Province (No. 2017JM8098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZX, 2013, INT J MED SCI, V10, P1868, DOI 10.7150/ijms.6868; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; Ezzat S, 2005, CLIN CANCER RES, V11, P1336; Helsten T, 2016, CLIN CANCER RES, V22, P259, DOI 10.1158/1078-0432.CCR-14-3212; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Ho HK, 2009, J HEPATOL, V50, P118, DOI 10.1016/j.jhep.2008.08.015; Icard P, 2019, TRENDS BIOCHEM SCI, V44, P490, DOI 10.1016/j.tibs.2018.12.007; Ito Y, 1999, HEPATOLOGY, V30, P90, DOI 10.1002/hep.510300114; Jeon YJ, 2015, P NATL ACAD SCI USA, V112, pE3355, DOI 10.1073/pnas.1504630112; Keenan SM, 2001, J BIOL CHEM, V276, P22404, DOI 10.1074/jbc.M100409200; Kim J, 2019, FEBS J, V286, P4443, DOI 10.1111/febs.14946; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Koziczak M, 2004, J BIOL CHEM, V279, P50004, DOI 10.1074/jbc.M404252200; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Liu Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.64; Masaki T, 2003, HEPATOLOGY, V37, P534, DOI 10.1053/jhep.2003.50112; McEvoy JD, 2007, MOL CELL BIOL, V27, P3651, DOI 10.1128/MCB.00720-06; Mo J, 2020, CANCER RES TREAT, V52, P74, DOI 10.4143/crt.2019.062; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nguyen PT, 2013, BRIT J CANCER, V109, P2248, DOI 10.1038/bjc.2013.550; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; POON RYC, 1995, SCIENCE, V270, P90, DOI 10.1126/science.270.5233.90; Porta R, 2017, CRIT REV ONCOL HEMAT, V113, P256, DOI 10.1016/j.critrevonc.2017.02.018; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Scheffner M, 1998, UBIQUITIN CONJUGATIO; Shi XP, 2020, FOOD CHEM TOXICOL, V136, DOI 10.1016/j.fct.2019.110960; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Suguitan Jr AL, 2011, PLOS ONE, V6; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang WB, 2013, CELL PHYSIOL BIOCHEM, V32, P1655, DOI 10.1159/000356601; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; VAINIKKA S, 1994, J BIOL CHEM, V269, P18320; van Jaarsveld MTM, 2013, ONCOGENE, V32, P4284, DOI 10.1038/onc.2012.433; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wu AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017868	38	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234708	10.1371/journal.pone.0234708	http://dx.doi.org/10.1371/journal.pone.0234708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555680	Green Published, gold			2022-12-27	WOS:000543273200001
J	Panahi, B; Hejazi, MA				Panahi, Bahman; Hejazi, Mohammad Amin			Integrative analysis of gene expression and alternative splicing in microalgae grown under heterotrophic condition	PLOS ONE			English	Article							DESATURASE GENE; EVENTS; TOOL	Heterotrophic cultures are the most effective approach to overcome low growth rate challenge in the most commercial microalgae. However, the mechanism through which heterotrophic condition regulates algae metabolism are not completely clear. Alternative Splicing (AS) is a common posttranscriptional process by which transcriptome and proteome plasticity increases at different environmental conditions. To identify and characterize of AS events inAuxenochlorella protothecoidesmicroalga grown in autotrophic and heterotrophic, RNA-Seq data were analysed. We found that AS increased with the transition from autotrophic to heterotrophic condition. 705 and 660 differentially expressed (DEG) and spliced (DAS) genes were identified forA.protothecoideswas transferred from autotrophic to heterotrophic condition, respectively. Moreover, there was slight coverage between DEG and DAS genes. Furthermore, functional analysis showed that the DAS genes are most frequently related to ion binding and stimulus response. The results also indicated that prevalence of Intron retention is associated with down-regulation of the genes involved in carotenoid biosynthesis. This study provides valuable insights into transcriptional and posttranscriptional plasticity of microalgae during growth mode change.	[Panahi, Bahman] Agr Res Educ & Extens Org AREEO, Dept Genom, Branch Northwest & West Reg, Agr Biotechnol Res Inst Iran ABRII, Tabriz, Iran; [Hejazi, Mohammad Amin] Agr Res Educ & Extens Org AREEO, Dept Food Biotechnol, Branch Northwest & West Reg, Agr Biotechnol Res Inst Iran ABRII, Tabriz, Iran		Panahi, B (corresponding author), Agr Res Educ & Extens Org AREEO, Dept Genom, Branch Northwest & West Reg, Agr Biotechnol Res Inst Iran ABRII, Tabriz, Iran.	panahibahman@ymail.com	Panahi, Bahman/HHN-6671-2022	Panahi, Bahman/0000-0001-8523-994X				Akubude V. C., 2019, Materials Science for Energy Technologies, V2, P216, DOI 10.1016/j.mset.2018.12.006; Alvarez D, 2016, PLANT PHYSIOL, V172, P2314, DOI 10.1104/pp.16.01262; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2019, PROG RETIN EYE RES; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Foissac S, 2007, NUCLEIC ACIDS RES, V35, pW297, DOI 10.1093/nar/gkm311; GLADUE RM, 1994, J APPL PHYCOL, V6, P131, DOI 10.1007/BF02186067; Harun R, 2010, RENEW SUST ENERG REV, V14, P1037, DOI 10.1016/j.rser.2009.11.004; Huang BR, 2015, CROP SCI, V55, P1405, DOI 10.2135/cropsci2014.07.0508; Huang JC, 2008, J PHYCOL, V44, P684, DOI 10.1111/j.1529-8817.2008.00511.x; James AB, 2012, PLANT CELL, V24, P961, DOI 10.1105/tpc.111.093948; Kianianmomeni A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1117; Klamczynska B, 2017, SUSTAINABLE PROTEIN SOURCES, P327, DOI 10.1016/B978-0-12-802778-3.00020-2; Li RJ, 2017, PLANT SCI, V262, P39, DOI 10.1016/j.plantsci.2017.05.014; Ling Y, 2017, PLANT J, V89, P291, DOI 10.1111/tpj.13383; Liu J, 2016, CHIN J OCEANOL LIMN, V34, P405, DOI 10.1007/s00343-015-4321-5; Lodato P, 2003, APPL ENVIRON MICROB, V69, P4676, DOI 10.1128/AEM.69.8.4676-4682.2003; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Panahi B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0225677; Panahi B, 2015, FEBS LETT, V589, P3564, DOI 10.1016/j.febslet.2015.09.023; Panahi B, 2014, PHYSIOL MOL BIOL PLA, V20, P323, DOI 10.1007/s12298-014-0245-3; Pimentel H, 2016, NUCLEIC ACIDS RES, V44, P838, DOI 10.1093/nar/gkv1168; Santelia D, 2005, FEBS LETT, V579, P5399, DOI 10.1016/j.febslet.2005.08.061; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Shang XD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020432; Xiao YB, 2018, MAR DRUGS, V16, DOI 10.3390/md16080283; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yun S, 2015, IEEE ANTENN WIREL PR, V14, P36, DOI 10.1109/LAWP.2014.2354517	31	3	3	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234710	10.1371/journal.pone.0234710	http://dx.doi.org/10.1371/journal.pone.0234710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555718	gold, Green Published			2022-12-27	WOS:000542759600006
J	Ransom, CJ; Jolley, VD; Blair, TA; Sutton, LE; Hopkins, BG				Ransom, Curtis J.; Jolley, Von D.; Blair, Trenton A.; Sutton, Lloyd E.; Hopkins, Bryan G.			Nitrogen release rates from slow- and controlled-release fertilizers influenced by placement and temperature	PLOS ONE			English	Article							POLYMER-COATED UREA; NUTRIENT RELEASE; SOIL; EFFICIENCY; PATTERNS; MOISTURE; SYSTEM; YIELD; MODEL	Controlled-release and slow-release fertilizers can effectively supply nitrogen (N) while mitigating N loss. To determine the suitability of these fertilizers for plants in semi-arid environments, these fertilizers need to be evaluated under varying placement and temperature conditions. Several urea fertilizers were evaluated, including: uncoated, sulfur-coated (SCU), polymer-coated-sulfur-coated (PCSCU), and polymer-coated (PCU) with projected release timings between 45 and 180 d. Nitrogen release was measured under daily fluctuating or static temperatures applied either to the surface or buried in the soil. A second experiment consisted of two PCU sources and added a hanging bag placement comparison and low and high soil moisture treatments. For the first Experiment, the N in uncoated urea released shortly after application. The SCU and PCSCU treatments released > 80% of the N before the first sampling date. With fluctuating temperatures, the PCU 45, 75, 120, and 180 incorporated into the soil released N within +9, +9, -22, and -68 d of their expected timing. However, they released their N within 35 d when surface applied. Conversely, with static temperatures, PCU products released slowly, releasing under 80% for the entire study. The second experiment verified these results and showed no difference between low and high moisture and minimal release with fertilizer not in contact with soil. Each coated fertilizer in these studies exhibited slow/control release properties, but the PCU (surface applied) and SCU/PCSCU (surface applied or incorporated in soil) release was much more rapid than expected. Our research suggests that, although the SCU and PCSCU showed minimal slow-release properties (regardless of placement), the PCU fertilizers incorporated in the soil do have a controlled release approximate to what is expected, but have a much more rapid release when surface applied.	[Ransom, Curtis J.; Jolley, Von D.; Blair, Trenton A.; Sutton, Lloyd E.; Hopkins, Bryan G.] Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA; [Ransom, Curtis J.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA	Brigham Young University; University of Missouri System; University of Missouri Columbia	Ransom, CJ (corresponding author), Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA.; Ransom, CJ (corresponding author), Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA.	curtisransom@gmail.com	Hopkins, Bryan G./F-3670-2011	Hopkins, Bryan G./0000-0001-7313-055X; Ransom, Curtis/0000-0002-1268-7247	Brigham Young University	Brigham Young University	Funding for this project came from Brigham Young University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 2013, J PLANT NUTR SOIL SC, V176, P76, DOI 10.1002/jpln.201200156; budras Corinna, 2008, FRANKFURTER ALLGEMEI, V7, pC5; Buss J, 2016, POLYM COATED UREA KE; Cameron KC, 2013, ANN APPL BIOL, V162, P145, DOI 10.1111/aab.12014; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; Carroll DA, 2017, IRRIGATION SCI, V35, P549, DOI 10.1007/s00271-017-0558-4; Carson LC, 2012, HORTTECHNOLOGY, V22, P20, DOI 10.21273/HORTTECH.22.1.20; CHRISTIANSON CB, 1988, FERT RES, V16, P273, DOI 10.1007/BF01051376; Du CW, 2006, J POLYM ENVIRON, V14, P223, DOI 10.1007/s10924-006-0025-4; Ellison E., 2013, P 2013 W NUTRIENT MA, P17; Fernandez FG, 2015, J ENVIRON QUAL, V44, P415, DOI 10.2134/jeq2013.12.0496; Fujinuma R, 2009, SOIL SCI SOC AM J, V73, P2043, DOI 10.2136/sssaj2009.0085; Geary B, 2015, J PLANT NUTR, V38, P41, DOI 10.1080/01904167.2014.912323; Golden B, 2011, COMMUN SOIL SCI PLAN, V42, P1809, DOI 10.1080/00103624.2011.587568; Halvorson AD, 2014, AGRON J, V106, P681, DOI 10.2134/agronj2013.0001; Halvorson AD, 2014, AGRON J, V106, P715, DOI 10.2134/agronj2013.0081; HASHIMOTO I, 1979, SOIL SCI SOC AM J, V43, P1165, DOI 10.2136/sssaj1979.03615995004300060021x; Hopkins BG, 2020, ACHIEVING SUSTAINABL; Hopkins BG, 2007, AM J POTATO RES, V84, P19, DOI 10.1007/BF02986295; Huett DO, 2000, COMMUN SOIL SCI PLAN, V31, P959, DOI 10.1080/00103620009370490; Husby CE, 2003, HORTSCIENCE, V38, P387, DOI 10.21273/HORTSCI.38.3.387; JARRELL WM, 1979, SOIL SCI SOC AM J, V43, P1044, DOI 10.2136/sssaj1979.03615995004300050046x; Kissel DE, 1988, MANAGEMENT UREA FERT; KOCHBA M, 1990, SOIL SCI, V149, P339, DOI 10.1097/00010694-199006000-00004; LeMonte JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204090; LeMonte JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146761; Lenth R. V, 2022, EMMEANS ESTIMATED MA; Liu YH, 2008, POWDER TECHNOL, V183, P88, DOI 10.1016/j.powtec.2007.11.022; LUNT O. R., 1962, SOIL SCI SOC AMER PROC, V26, P584; Milesi C, 2005, ENVIRON MANAGE, V36, P426, DOI 10.1007/s00267-004-0316-2; Mulvaney RL, 2009, J ENVIRON QUAL, V38, P2295, DOI 10.2134/jeq2008.0527; Nash PR, 2012, AGRON J, V104, P1074, DOI 10.2134/agronj2011.0235; Nelson KA, 2014, J AGRON CROP SCI, V200, P54, DOI 10.1111/jac.12040; Olson BM, 2009, J ENVIRON QUAL, V38, P2218, DOI 10.2134/jeq2008.0519; Ransom CJ, 2014, NITROGEN USE EFFICIE; Shen YZ, 2015, APPL ENG AGRIC, V31, P247; SHOJI S, 1991, SOIL SCI SOC AM J, V55, P1468, DOI 10.2136/sssaj1991.03615995005500050045x; Stevens WB, 2007, AGRON J, V99, P1252, DOI 10.2134/agronj2006.0357; Tong X, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010119; Trenkel M.E., 2010, SLOWAND CONTROLLED R; Trenkel ME, 1997, CONTROLLED RELEASE S; Wilson ML, 2009, HORTSCIENCE, V44, P492, DOI 10.21273/HORTSCI.44.2.492; Zhang YS, 2011, J ENVIRON MANAGE, V92, P480, DOI 10.1016/j.jenvman.2010.09.018; Zvomuya F, 2003, J ENVIRON QUAL, V32, P480, DOI 10.2134/jeq2003.0480	44	21	21	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234544	10.1371/journal.pone.0234544	http://dx.doi.org/10.1371/journal.pone.0234544			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555670	gold, Green Published			2022-12-27	WOS:000542759600051
J	Soltesz, B; Piko, P; Sandor, J; Kosa, Z; Adany, R; Fiatal, S				Soltesz, Beata; Piko, Peter; Sandor, Janos; Kosa, Zsigmond; Adany, Roza; Fiatal, Szilvia			The genetic risk for hypertension is lower among the Hungarian Roma population compared to the general population	PLOS ONE			English	Article							METABOLIC SYNDROME; BLOOD-PRESSURE; MINORITY POPULATION; MOLECULAR-GENETICS; ASSOCIATION; PREVALENCE; HEALTH; POLYMORPHISMS; PREDICTION; DISEASE	Estimating the prevalence of cardiovascular diseases (CVDs) and risk factors among the Roma population, the largest minority in Europe, and investigating the role of genetic or environmental/behavioral risk factors in CVD development are important issues in countries where they are significant minority. This study was designed to estimate the genetic susceptibility of the Hungarian Roma (HR) population to essential hypertension (EH) and compare it to that of the general (HG) population. Twenty EH associated SNPs (inAGT,FMO3,MTHFR-NPPB,NPPA,NPPA-AS1,AGTR1,ADD1,NPR3-C5orf23,NOS3,CACNB2,PLCE1,ATP2B1,GNB3,CYP1A1-ULK3,UMODandGNAS-EDN3) were genotyped using DNA samples obtained from HR (N = 1176) and HG population (N = 1178) subjects assembled by cross-sectional studies. Allele frequencies and genetic risk scores (unweighted and weighted genetic risk scores (GRS and wGRS, respectively) were calculated for the study groups and compared to examine the joint effects of the SNPs. The susceptibility alleles were more frequent in the HG population, and both GRS and wGRS were found to be higher in the HG population than in the HR population (GRS: 18.98 +/- 3.05 vs. 18.25 +/- 2.97, p<0.001; wGRS: 1.4 [IQR: 0.93-1.89] vs. 1.52 [IQR: 0.99-2.00], p<0.01). Twenty-seven percent of subjects in the HR population were in the bottom fifth (GRS <= 16) of the risk allele count compared with 21% of those in the HG population. Thirteen percent of people in the HR group were in the top fifth (GRS >= 22) of the GRS compared with 21% of those in the HG population (p<0.001), i.e., the distribution of GRS was found to be left-shifted in the HR population compared to the HG population. The Roma population seems to be genetically less susceptible to EH than the general one. These results support preventive efforts to lower the risk of developing hypertension by encouraging a healthy lifestyle.	[Soltesz, Beata] Univ Debrecen, Fac Publ Hlth, Doctoral Sch Hlth Sci, Dept Prevent Med, Debrecen, Hungary; [Piko, Peter; Adany, Roza] Univ Debrecen, Hungarian Acad Sci, MTA DE Publ Hlth Res Grp, Fac Publ Hlth, Debrecen, Hungary; [Sandor, Janos; Adany, Roza; Fiatal, Szilvia] Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, Debrecen, Hungary; [Sandor, Janos; Adany, Roza; Fiatal, Szilvia] Univ Debrecen, Fac Publ Hlth, WHO Collaborating Ctr Vulnerabil & Hlth, Dept Prevent Med, Debrecen, Hungary; [Kosa, Zsigmond] Univ Debrecen, Fac Hlth, Dept Hlth Visitor Methodol & Publ Hlth, Nyiregyhaza, Hungary	University of Debrecen; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Hungarian Academy of Sciences; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Fiatal, S (corresponding author), Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, Debrecen, Hungary.; Fiatal, S (corresponding author), Univ Debrecen, Fac Publ Hlth, WHO Collaborating Ctr Vulnerabil & Hlth, Dept Prevent Med, Debrecen, Hungary.	fiatal.szilvia@sph.unideb.hu	Dr Fiatal, Szilvia/GQH-2653-2022; Piko, Peter/AAG-5784-2021	Piko, Peter/0000-0001-5539-907X; Fiatal, Szilvia/0000-0002-2797-9621	TAMOP 'Social Renewal Operational Programme - IGEN-HUNGARIAN' [4.2.2.A-11/1/KONV-2012-0031]; European Union; European Regional Development Fund;  [GINOP-2.3.2-15-2016-00005]	TAMOP 'Social Renewal Operational Programme - IGEN-HUNGARIAN'; European Union(European Commission); European Regional Development Fund(European Commission); 	This research was supported by the TAMOP 4.2.2.A-11/1/KONV-2012-0031 'Social Renewal Operational Programme - IGEN-HUNGARIAN' and the GINOP-2.3.2-15-2016-00005 project. The projects were co-financed by the European Union and the European Regional Development Fund.	Adany Roza, 2013, Eur J Public Health, V23, P529, DOI 10.1093/eurpub/ckt095; Babinska I, 2013, INT J PUBLIC HEALTH, V58, P417, DOI 10.1007/s00038-013-0463-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benjafield AV, 1998, HYPERTENSION, V32, P1094, DOI 10.1161/01.HYP.32.6.1094; Bushueva O, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/712169; Carrasco-Garrido P, 2011, EUR J PUBLIC HEALTH, V21, P793, DOI 10.1093/eurpub/ckq153; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Che Ronglin, 2013, Frontiers in Genetics, V4, P138, DOI 10.3389/fgene.2013.00138; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; Cusi D, 1997, LANCET, V349, P1353, DOI 10.1016/S0140-6736(97)01029-5; de Courten BV, 2003, DIABETES RES CLIN PR, V62, P95, DOI 10.1016/S0168-8227(03)00162-1; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Enache G., 2016, Romanian Journal of Diabetes Nutrition and Metabolic Diseases, V23, P27; European Commission, 2011, COMM COMM EUR PARL C; Fiatal S, 2019, THROMB RES, V179, P37, DOI 10.1016/j.thromres.2019.04.031; Fiatal S, 2018, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00358; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Gualdi-Russo E, 2009, J TRAVEL MED, V16, P88, DOI 10.1111/j.1708-8305.2008.00280.x; Helis E, 2011, EUR J CARDIOV PREV R, V18, P347, DOI 10.1177/1741826710389361; Humphries SE, 2008, CURR OPIN LIPIDOL, V19, P128, DOI 10.1097/MOL.0b013e3282f5283e; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Johnson AD, 2010, BIOINFORMATICS, V26, P1386, DOI 10.1093/bioinformatics/btq098; Johnson T., 2012, EFFICIENT CALCULATIO; Kosa Z, 2015, EUR J PUBLIC HEALTH, V25, P299, DOI 10.1093/eurpub/cku157; Krajcovicova-Kudlackova M, 2004, Bratisl Lek Listy, V105, P256; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; MIALL WE, 1963, BRIT MED J, P75; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Penzes J., 2018, TER LETI STATISZTIKA, V58, P3, DOI [10.15196/TS580101, DOI 10.15196/TS580101]; Per Di Qua, 2011, RIV ITAL NUTR PARENT, V29, pS2; Pereira TV, 2008, HYPERTENSION, V51, P778, DOI 10.1161/HYPERTENSIONAHA.107.100370; Piko P, 2019, GENE, V686, P187, DOI 10.1016/j.gene.2018.11.067; Piko P, 2017, ATHEROSCLEROSIS, V263, P119, DOI 10.1016/j.atherosclerosis.2017.05.028; Salvi E, 2012, HYPERTENSION, V59, P248, DOI 10.1161/HYPERTENSIONAHA.111.181990; Sebastiani Paola, 2012, Frontiers in Genetics, V3, P26, DOI 10.3389/fgene.2012.00026; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh M, 2016, CLIN EXP HYPERTENS, V38, P268, DOI 10.3109/10641963.2015.1116543; Snieder H, 2000, HYPERTENSION, V35, P574, DOI 10.1161/01.HYP.35.2.574; Szeles G, 2005, EUR J PUBLIC HEALTH, V15, P26, DOI 10.1093/eurpub/cki107; Szigethy E, 2012, PUBLIC HEALTH, V126, P143, DOI 10.1016/j.puhe.2011.11.003; Talmud PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4838; Tanira M, 2005, J HUM HYPERTENS, V19, P7, DOI 10.1038/sj.jhh.1001780; Templeton GF, 2011, COMMUN ASSOC INF SYS, V28, P41; Timberlake DS, 2001, CURR OPIN NEPHROL HY, V10, P71, DOI 10.1097/00041552-200101000-00012; Wang WYS, 1997, CLIN GENET, V51, P31; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; World Health Organization Rotary International Centers for Disease Control and Prevention and UNICEF, 2013, GLOBAL ACTION PLAN P; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zeljko H, 2008, COLLEGIUM ANTROPOL, V32, P667; Zeljko HM, 2013, ECON HUM BIOL, V11, P326, DOI 10.1016/j.ehb.2012.02.007; Zheng J, 2015, APPL INFORM, V2, P10, DOI [10.1186/s40535-015-0013-7, DOI 10.1186/S40535-015-0013-7]	58	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234547	10.1371/journal.pone.0234547	http://dx.doi.org/10.1371/journal.pone.0234547			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555714	Green Published, gold			2022-12-27	WOS:000542759600049
J	Boecking, B; von Sass, J; Sieveking, A; Schaefer, C; Brueggemann, P; Rose, M; Mazurek, B				Boecking, Benjamin; von Sass, Josephine; Sieveking, Antonia; Schaefer, Christina; Brueggemann, Petra; Rose, Matthias; Mazurek, Birgit			Tinnitus-related distress and pain perceptions in patients with chronic tinnitus - Do psychological factors constitute a link?	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; GENERALIZED ANXIETY DISORDER; STRESS QUESTIONNAIRE PSQ; VISUAL ANALOG SCALE; QUALITY-OF-LIFE; EMOTION REGULATION; MAJOR DEPRESSION; NEUROPATHIC PAIN; PANIC DISORDER; ASSOCIATION	Objective To investigate the co-occurrence of tinnitus-related distress and pain experiences alongside psychological factors that may underlie their association. Method Patients with chronic tinnitus (N= 1238) completed a questionnaire battery examining tinnitus-related distress and affective and sensory pain perceptions. A series of simple, parallel- and serial multiple mediator models examined indirect effects of psychological comorbidities as well as -process variables including depressivity, perceived stress and coping attitudes. Moderator and moderated mediation analyses examined differential relational patterns in patients with decompensated vs. compensated tinnitus. Results There were significant associations between tinnitus-related distress and pain perceptions. These were partially mediated by most specified variables. Psychological comorbidities appeared to influence tinnitus-pain associations through their impact on depressivity, perceived stress, and coping attitudes. Some specific differences in affective vs. sensory pain perception pathways emerged. Patients with decompensated tinnitus yielded significantly higher symptom burden across all measured indices. Tinnitus decompensation was associated with heightened associations between [1] tinnitus-related distress and pain perceptions, depressivity and negative coping attitudes; and [2] most psychological comorbidities and sensory, but not affective pain perception. Moderated mediation analyses revealed stronger indirect effects of depressivity and anxiety in mediating affective-, and anxiety in mediating sensory pain perception in patients with decompensated tinnitus. Conclusion Psychological constructs mediate the co-occurrence of tinnitus- and pain-related symptoms across different levels of tinnitus-related distress. Psychological treatment approaches should conceptualize and address individualised interactions of common cognitive-emotional processes in addressing psychosomatic symptom clusters across syndromatic patients with varying distress levels.	[Boecking, Benjamin; von Sass, Josephine; Sieveking, Antonia; Schaefer, Christina; Brueggemann, Petra; Mazurek, Birgit] Charite Univ Med Berlin, Tinnitus Ctr, Berlin, Germany; [Rose, Matthias] Charite Univ Med Berlin, Div Psychosomat Med, Dept Med, Berlin, Berlin, Germany; [Mazurek, Birgit] Charite Univ Med Berlin, Tinnituszentrum, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mazurek, B (corresponding author), Charite Univ Med Berlin, Tinnitus Ctr, Berlin, Germany.; Mazurek, B (corresponding author), Charite Univ Med Berlin, Tinnituszentrum, Berlin, Germany.	birgit.mazurek@charite.de						Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Affleck G., 2001, OPTIMISM PESSIMISM I, V147, P168; Andersson G, 2002, CLIN PSYCHOL REV, V22, P977, DOI 10.1016/S0272-7358(01)00124-6; Andersson G, 1996, PSYCHOL HEALTH, V11, P697, DOI 10.1080/08870449608404998; Angst J, 2001, J AFFECT DISORDERS, V62, P7, DOI 10.1016/S0165-0327(00)00346-3; Asmundson GJG, 2009, DEPRESS ANXIETY, V26, P888, DOI 10.1002/da.20600; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Banks SM, 1996, PSYCHOL BULL, V119, P95, DOI 10.1037/0033-2909.119.1.95; Basten-Gunther J, 2019, BEHAV MED, V45, P323, DOI 10.1080/08964289.2018.1517242; Berube M, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0583-7; Biesinger E, 1998, HNO, V46, P157, DOI 10.1007/s001060050215; Brenner R., 2001, J AGRAR CHANGE, V1, P169, DOI DOI 10.1111/1471-0366.00007; Bruggemann P, 2018, HNO, V66, pS34, DOI 10.1007/s00106-017-0463-4; Bujak BK, 2019, PAIN MANAG, V9, P417, DOI 10.2217/pmt-2018-0087; Burke ALJ, 2015, BRIT J CLIN PSYCHOL, V54, P345, DOI 10.1111/bjc.12078; Buscemi V., 2019, J PAIN; Calderon PD, 2012, J APPL ORAL SCI, V20, P170, DOI 10.1590/S1678-77572012000200008; Chawla N, 2007, J CLIN PSYCHOL, V63, P871, DOI 10.1002/jclp.20400; Chen YK, 2019, PLOS ONE, V14, DOI [10.1371/journal.pone.0219837, 10.1371/journal.pone.0211625]; Cima RF, 2017, TINNITUS STRESS INTE, P139; Cima RFF, 2012, LANCET, V379, P1951, DOI 10.1016/S0140-6736(12)60469-3; Ciminelli Patricia, 2018, Clin Pract Epidemiol Ment Health, V14, P264, DOI 10.2174/1745017901814010264; Clark David A., 2009, Cognitive Behaviour Therapy, V38, P29, DOI 10.1080/16506070902980745; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Dimova V, 2015, J PAIN, V16, P791, DOI 10.1016/j.jpain.2015.05.004; Dudley R, 2011, CLIN PSYCHOL REV, V31, P213, DOI 10.1016/j.cpr.2010.07.005; Eggermont JJ, 2005, DRUG DISCOV TODAY, V10, P1283, DOI 10.1016/S1359-6446(05)03542-7; ERLANDSSON SI, 1992, AUDIOLOGY, V31, P168; Feliu-Soler A, 2018, J PAIN RES, V11, P2145, DOI 10.2147/JPR.S144631; Fergus TA, 2014, J OBSESS-COMPULS REL, V3, P243, DOI 10.1016/j.jocrd.2014.06.001; Fernandes G, 2014, BRAZ ORAL RES, V28, P95, DOI 10.1590/1807-3107BOR-2014.vol28.0003; Fernandez E., 1994, CLIN J PAIN; Fischer HF, 2010, PSYCHOTHER PSYCH MED, V60, P307, DOI 10.1055/s-0029-1214419; Fishbain DA, 1999, MED CLIN N AM, V83, P737, DOI 10.1016/S0025-7125(05)70132-2; Fishbain DA, 2009, PAIN PRACT, V9, P449, DOI 10.1111/j.1533-2500.2009.00309.x; Fitzgerald PJ, 2013, J AFFECT DISORDERS, V151, P418, DOI 10.1016/j.jad.2013.06.045; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; Fliege H, 2001, DIAGNOSTICA, V47, P142, DOI 10.1026//0012-1924.47.3.142; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Geissner E, 1996, SCHMERZEMPFINDUNGSSK; Gellatly R, 2016, COGNITIVE THER RES, V40, P441, DOI 10.1007/s10608-016-9763-3; Geocze L, 2013, BRAZ J OTORHINOLAR, V79, P106, DOI 10.5935/1808-8694.20130018; Gerhards F, 2004, VERHALTENSTHERAPIE, V14, P265, DOI 10.1159/000082836; Goebel G., 1998, TINNITUS FRAGEBOGEN, DOI [10.1007/s00106-013-2798-9, DOI 10.1007/S00106-013-2798-9]; Guichard E, 2016, HEADACHE, V56, P987, DOI 10.1111/head.12845; Hammen C, 2009, DEPRESS ANXIETY, V26, P718, DOI 10.1002/da.20571; Han K.-M., 2018, J PSYCHIAT RES; Harvey A.G., 2004, COGNITIVE BEHAV PROC; Hautzinger M., 2012, PSYCHIAT PRAX, V2nd, DOI DOI 10.1055/S-0032-1326702; Hayes A.F., 2013, INTRO MEDIATION MODE; Hesser H, 2011, CLIN PSYCHOL REV, V31, P545, DOI 10.1016/j.cpr.2010.12.006; Hiller W, 1997, J PSYCHOSOM RES, V43, P613, DOI 10.1016/S0022-3999(97)00188-8; HILLER W, 1994, BRIT J CLIN PSYCHOL, V33, P231, DOI 10.1111/j.2044-8260.1994.tb01117.x; Isaacson JE, 2003, OTOLARYNG HEAD NECK, V128, P706, DOI 10.1016/S0194-5998(03)00227-4; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Jeanmonod D, 1996, BRAIN, V119, P363, DOI 10.1093/brain/119.2.363; Johnstone L, 2018, J HUMANIST PSYCHOL, V58, P30, DOI 10.1177/0022167817722230; JUDD CM, 1981, EVALUATION REV, V5, P602, DOI 10.1177/0193841X8100500502; Kahl C, 2005, PHYS THER REV, V10, P123, DOI 10.1179/108331905X55776; Kazantzis N, 2018, COGNITIVE THER RES, V42, P349, DOI 10.1007/s10608-018-9920-y; Keogh E, 2002, J PAIN, V3, P320, DOI 10.1054/jpai.2002.125182; Khedr EM, 2010, NEUROEPIDEMIOLOGY, V35, P45, DOI 10.1159/000306630; Knoerl R, 2016, WESTERN J NURS RES, V38, P596, DOI 10.1177/0193945915615869; Koechlin H, 2018, J PSYCHOSOM RES, V107, P38, DOI 10.1016/j.jpsychores.2018.02.002; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lane RD, 2000, PSYCHOSOM MED, V62, P492, DOI 10.1097/00006842-200007000-00007; Langguth B, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00440; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; LANGLEY GB, 1985, RHEUMATOL INT, V5, P145, DOI 10.1007/BF00541514; Langlois F, 2000, BEHAV RES THER, V38, P157, DOI 10.1016/S0005-7967(99)00027-3; Lenhard W., 2016, PSYCHOMETRICA; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Linton SJ, 2013, J APPL BIOBEHAV RES, V18, P82, DOI 10.1111/jabr.12007; Liu RT, 2010, CLIN PSYCHOL REV, V30, P582, DOI 10.1016/j.cpr.2010.04.010; Malouff JM, 2017, J POSIT PSYCHOL, V12, P594, DOI 10.1080/17439760.2016.1221122; Mansell W, 2008, INT J COGN THER, V1, P181, DOI 10.1680/ijct.2008.1.3.181; Marek A, 2015, LARYNGO RHINO OTOL, V94, P72; McCormack A, 2015, INT J AUDIOL, V54, P599, DOI 10.3109/14992027.2015.1014577; Miranda R, 2007, COGNITIVE THER RES, V31, P71, DOI 10.1007/s10608-006-9063-4; Mohr C, 2014, PSYCHOPATHOLOGY, V47, P235, DOI 10.1159/000356398; Moller AR, 1997, AM J OTOL, V18, P577; Muller E, 2008, THESIS; Newby JM, 2015, CLIN PSYCHOL REV, V40, P91, DOI 10.1016/j.cpr.2015.06.002; Norton PJ, 2003, BEHAV THER, V34, P17, DOI 10.1016/S0005-7894(03)80019-9; Pilgramm M, 1999, HNO AKTUELL, V7, P261; Pincus T, 2001, PSYCHOL BULL, V127, P599, DOI 10.1037//0033-2909.127.5.599; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Pinto PCL, 2014, J LARYNGOL OTOL, V128, P660, DOI 10.1017/S0022215114001030; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Salviati M, 2014, NEUROPSYCH DIS TREAT, V10, P267, DOI 10.2147/NDT.S49425; Scheier M. F., 2001, OPTIMISM PESSIMISM I, V1, P189, DOI DOI 10.1037/10385-009; Schmidt NB, 1997, J CONSULT CLIN PSYCH, V65, P214, DOI 10.1037/0022-006X.65.2.214; Scholler G, 1999, PSYCHOTHER PSYCH MED, V49, P275; Sergeant S, 2014, J CONSULT CLIN PSYCH, V82, P263, DOI 10.1037/a0035536; Son Hyo Jung, 2011, Korean J Anesthesiol, V61, P162, DOI 10.4097/kjae.2011.61.2.162; Stern MR, 2014, J OBSESS-COMPULS REL, V3, P109, DOI 10.1016/j.jocrd.2014.02.005; Stobik C, 2005, INT J AUDIOL, V44, P370, DOI 10.1080/14992020500147557; Sullivan MJL, 2005, PAIN, V113, P310, DOI 10.1016/j.pain.2004.11.003; Talkovsky AM, 2014, J ANXIETY DISORD, V28, P919, DOI 10.1016/j.janxdis.2014.09.017; Tominaga T, 2014, NEUROPSYCH DIS TREAT, V10, P55, DOI 10.2147/NDT.S55956; TONNDORF J, 1987, HEARING RES, V28, P271, DOI 10.1016/0378-5955(87)90054-2; Trevis KJ, 2018, CLIN PSYCHOL REV, V60, P62, DOI 10.1016/j.cpr.2017.12.006; Tritt K., 2007, ENTWICKLUNG FRAGEBOG; Turk DC, 2002, J CONSULT CLIN PSYCH, V70, P678, DOI 10.1037//0022-006X.70.3.678; Tyler R. S., 2000, TINNITUS HDB; van Hecke O, 2014, PAIN, V155, P654, DOI 10.1016/j.pain.2013.11.013; Visted E, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00756; Vollmann M, 2014, PSYCHOL HEALTH, V29, P81, DOI 10.1080/08870446.2013.828294; Vowles KE, 2008, HEALTH PSYCHOL, V27, pS136, DOI 10.1037/0278-6133.27.2(Suppl.).S136; Waller E, 2006, INT REV PSYCHIATR, V18, P13, DOI 10.1080/09540260500466774; WALLHAUSSERFRANKE, 2017, FRONT NEUROL, V8, DOI DOI 10.3389/FNEUR.2017.00605; Weidt S, 2016, PSYCHIAT RES, V237, P114, DOI 10.1016/j.psychres.2016.01.065; Weise C, 2013, INT J AUDIOL, V52, P177, DOI 10.3109/14992027.2012.752111; Wells A, 2001, BEHAV THER, V32, P85, DOI 10.1016/S0005-7894(01)80045-9; Widiger TA, 2005, J ABNORM PSYCHOL, V114, P494, DOI 10.1037/0021-843X.114.4.494; Wielopolski J, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00223; WILSON PH, 1993, AUST PSYCHOL, V28, P172, DOI 10.1080/00050069308258898; Wolff S, 2007, BRIT J CLIN PSYCHOL, V46, P347, DOI 10.1348/014466507X173736; World Health Organization, 1993, ICD 10 CLASS MENT BE, V10th ed.; Zirke N, 2013, QUAL LIFE RES, V22, P263, DOI 10.1007/s11136-012-0156-0; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	121	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0234807	10.1371/journal.pone.0234807	http://dx.doi.org/10.1371/journal.pone.0234807			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MG0TI	32584841	gold, Green Published			2022-12-27	WOS:000545747200026
J	Byun, YM; Iida, T; Yamada, K; Abumi, K; Kokabu, T; Iwata, A; Iwasaki, N; Sudo, H				Byun, Young Man; Iida, Takahiro; Yamada, Katsuhisa; Abumi, Kuniyoshi; Kokabu, Terufumi; Iwata, Akira; Iwasaki, Norimasa; Sudo, Hideki			Long-term pulmonary function after posterior spinal fusion in main thoracic adolescent idiopathic scoliosis	PLOS ONE			English	Article							FOLLOW-UP; OUTCOMES; CURVES	Background Adolescent idiopathic scoliosis (AIS) patients typically undergo surgical treatment as teenagers, follow-ups of >5 years are necessary to evaluate effects on peak pulmonary reserves. However, limited data is available regarding the long-term (>10 years) effects of surgical intervention on pulmonary function (PF) in patients with thoracic AIS. Objective To provide long-term (>10 years) information on the PF after posterior spinal fusion for treating main thoracic AIS. We especially investigated whether surgical correction for AIS led to impairment of the PF. Methods A total of 35 patients with main thoracic AIS treated with posterior spinal fusion were included. Radiographs and PF tests, which included measurements of absolute and percent-predicted values of forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1), were evaluated. Results Mean age at surgery was 14.9 years (12-19 years). Mean follow-up period was 15.1 years (10-24 years). Although the final postoperative FVC and FEV(1)absolute values were higher than the preoperative values, the differences were not statistically significant (p = 0.22 and p = 0.08, respectively). Percent-predicted FVC and FEV(1)values between preoperative and final postoperative measurements were not statistically different (p = 0.63 and p = 0.29, respectively). However, for the patients who presented with pulmonary impairment preoperatively, both the FVC and FEV(1)significantly increased at the final follow-up (p = 0.01 and p = 0.01, respectively). Conclusions Long-term results of AIS patients who underwent posterior spinal fusion in main thoracic curves demonstrated absolute and percent-predicted PF test values similar to preoperative measurements; thus, indicating that posterior spinal fusion did not decrease PF 15 years after the initial surgery. Instead, patients with severe preoperative pulmonary impairment might show some degree of improvement after surgery.	[Byun, Young Man; Yamada, Katsuhisa; Abumi, Kuniyoshi; Kokabu, Terufumi; Iwata, Akira; Iwasaki, Norimasa; Sudo, Hideki] Hokkaido Univ Hosp, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan; [Iida, Takahiro] Dokkyo Med Univ, Saitama Med Ctr, Dept Orthopaed Surg 1, Koshigaya, Saitama, Japan	Hokkaido University; Dokkyo Medical University	Sudo, H (corresponding author), Hokkaido Univ Hosp, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan.	hidekisudo@yahoo.co.jp		Iwata, Akira/0000-0002-2376-8827; Sudo, Hideki/0000-0002-8635-4648				Akazawa T, 2018, J ORTHOP SCI, V23, P45, DOI 10.1016/j.jos.2017.08.016; Gitelman Y, 2011, SPINE, V36, P1665, DOI 10.1097/BRS.0b013e31821bcf4c; Huh Seokwon, 2015, Korean J Pediatr, V58, P218, DOI 10.3345/kjp.2015.58.6.218; Johnston CE, 2011, SPINE, V36, P1096, DOI 10.1097/BRS.0b013e3181f8c931; Newton PO, 2005, J BONE JOINT SURG AM, V87A, P1937, DOI 10.2106/JBJS.D.02209; Nohara A, 2015, SPINE, V40, P1681, DOI 10.1097/BRS.0000000000001121; RENZETTI AD, 1986, AM REV RESPIR DIS, V133, P1205; Ruiz-Juretschke C, 2017, SPINE, V42, P1241, DOI 10.1097/BRS.0000000000002062; Sudo HS, 2016, BONE JOINT J, V98B, P997, DOI 10.1302/0301-620X.98B7.37587; Sudo H, 2018, SPINE, V43, pE1135, DOI 10.1097/BRS.0000000000002628; Sudo Hideki, 2013, J Bone Joint Surg Am, V95, pe49, DOI 10.2106/JBJS.L.00781; Sudo H, 2013, SPINE, V38, P819, DOI 10.1097/BRS.0b013e31827ddc60; THURLBECK WM, 1982, THORAX, V37, P564, DOI 10.1136/thx.37.8.564; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; WANG XB, 1993, AM REV RESPIR DIS, V148, P1502, DOI 10.1164/ajrccm/148.6_Pt_1.1502; WEINSTEIN SL, 1981, J BONE JOINT SURG AM, V63, P702, DOI 10.2106/00004623-198163050-00003	16	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235123	10.1371/journal.pone.0235123	http://dx.doi.org/10.1371/journal.pone.0235123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584916	Green Published, gold			2022-12-27	WOS:000545747200013
J	Dalla Libera, LS; de Siqueira, T; Santos, IL; Ramos, JEP; Milhomen, AX; de Alencar, RDG; Santos, SHR; Carneiro, MAD; Alves, RRF; Saddi, VA				Dalla Libera, Larisse Silva; de Siqueira, Thalita; Santos, Igor Lopes; Porto Ramos, Jessica Enocencio; Milhomen, Amanda Xavier; Goncalves de Alencar, Rita de Cassia; Rabelo Santos, Silvia Helena; dos Santos Carneiro, Megmar Aparecida; Figueiredo Alves, Rosane Ribeiro; Saddi, Vera Aparecida			Detection of Human papillomavirus and the role of p16(INK4a)in colorectal carcinomas	PLOS ONE			English	Article							DNA EXTRACTION; MICROSATELLITE INSTABILITY; MOLECULAR-BIOLOGY; CANCER SAMPLES; GLOBAL BURDEN; INFECTION; ASSOCIATION; RISK; PREVALENCE; VIRUS	Introduction Human papillomavirus (HPV) infection is associated with the development of anogenital and head and neck cancers. In recent years a potential role of HPV in colorectal cancer (CRC) has been suggested. Objective To investigate the presence of HPV in colorectal carcinomas and to study the role of p16(INK4a)as a marker of transcriptionally active HPV infection. In addition, to investigate the correlation between these findings and the CRC prognostic factors. Methods Case control study with 92 cases of colorectal cancers, 75 controls of normal tissue adjacent to the tumor, and 30 controls of precursor lesions, including polyps and colorectal adenomas. Paraffinized samples were used, HPV detection and genotyping were performed by PCR and reverse hybridization by using the INNO LIPA kit, with SPF10 plus primers. The expression of the p16(INK4a)protein was investigated using immunohistochemistry. Data analysis was performed using descriptive, univariate statistics and survival curves were calculated by using the Kaplan Meier and log-rank method. Results HPV was detected in 13% of the cases and the most prevalent genotype was HPV 16. HPV DNA was not detected in either control groups. The high expression of p16(INK4a)was observed in 30% of the cases, but it was not associated to the presence of HPV. The overall survival was 53.3% and was influenced by prognostic factors such as later stage, lymph node and distant metastasis. Conclusions Based on these results, HPV is unlikely to be involved in colorectal carcinogenesis and p16(INK4a)expression is not a relevant marker of transcriptionally active HPV infection in CRC.	[Dalla Libera, Larisse Silva; Rabelo Santos, Silvia Helena; dos Santos Carneiro, Megmar Aparecida; Figueiredo Alves, Rosane Ribeiro; Saddi, Vera Aparecida] Univ Fed Goias UFG, Programa Posgrad Ciencias Saude PPGCS, Fac Med FM, Goiania, Go, Brazil; [Dalla Libera, Larisse Silva; Rabelo Santos, Silvia Helena; dos Santos Carneiro, Megmar Aparecida; Figueiredo Alves, Rosane Ribeiro; Saddi, Vera Aparecida] Inst Patol Trop & Saude Publ IPTSP, Goiania, Go, Brazil; [de Siqueira, Thalita; Santos, Igor Lopes; Porto Ramos, Jessica Enocencio; Milhomen, Amanda Xavier; Saddi, Vera Aparecida] Pontificia Univ Catolica Goias PUC GO, Programa Posgrad Ciencias Ambientais & Saude MCAS, Goiania, Go, Brazil; [de Siqueira, Thalita; Santos, Igor Lopes; Porto Ramos, Jessica Enocencio; Milhomen, Amanda Xavier; Saddi, Vera Aparecida] Escola Ciencias Med Farmaceut & Biomed ECMFB, Goiania, Go, Brazil; [Goncalves de Alencar, Rita de Cassia] Assoc Combate Canc Goias ACCG, Hosp Araujo Jorge HAJ, Dept Patol, Goiania, Go, Brazil	Universidade Federal de Goias; Pontificia Universidade Catolica de Goias	Dalla Libera, LS (corresponding author), Univ Fed Goias UFG, Programa Posgrad Ciencias Saude PPGCS, Fac Med FM, Goiania, Go, Brazil.; Dalla Libera, LS (corresponding author), Inst Patol Trop & Saude Publ IPTSP, Goiania, Go, Brazil.	larisse.dalla@gmail.com	Rabelo-Santos, Silvia Helena/S-1912-2017; Carneiro, Megmar/O-6482-2018	Carneiro, Megmar/0000-0003-0569-477X; Lopes dos Santos, Igor/0000-0001-9199-9603; SADDI, VERA/0000-0001-9949-9988	Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG); Programa Pesquisa para o Sistema Unico de Saude (PPSUS), Ministerio da Saude (MS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); Programa Pesquisa para o Sistema Unico de Saude (PPSUS), Ministerio da Saude (MS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG); Programa Pesquisa para o Sistema Unico de Saude (PPSUS), Ministerio da Saude (MS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberizzi P, 2014, J CLIN VIROL, V61, P535, DOI 10.1016/j.jcv.2014.10.016; [Anonymous], 2018, NAT REV GENET, V19, P1, DOI 10.1038/nrg.2017.141; [Anonymous], 2018, MED BALTIMORE, V97, pe9654; [Anonymous], 2013, POLAR GEOPOLITICS NE, V3, P1, DOI DOI 10.4236/NJGC.2013.31001; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; [Anonymous], 2019, DTBI S, V1, P1, DOI DOI 10.36811/RJCSE.2019.110001; [Anonymous], 2016, CIRE ANTILLES GUYANE; [Anonymous], 2009, SHADOW PHENOMENOLOGY; [Anonymous], 2018, CONTROL ENG PRACT, V73, P1; Baandrup L, 2014, EUR J CANCER, V50, P1446, DOI 10.1016/j.ejca.2014.01.019; Bardhan Kankana, 2013, Cancers (Basel), V5, P676, DOI 10.3390/cancers5020676; Biesaga B, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152513; Biesaga B, 2016, J VIROL METHODS, V236, P157, DOI 10.1016/j.jviromet.2016.07.021; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Bodaghi S, 2005, CLIN CANCER RES, V11, P2862, DOI 10.1158/1078-0432.CCR-04-1680; Brunelli L, 2014, ONCOTARGET, V5, P4722, DOI 10.18632/oncotarget.1958; Bucchi D, 2016, WORLD J GASTROENTERO, V22, P7415, DOI 10.3748/wjg.v22.i33.7415; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386; Burnett-Hartman AN, 2008, CANCER EPIDEM BIOMAR, V17, P2970, DOI 10.1158/1055-9965.EPI-08-0571; Burnett-Hartman AN, 2013, CANCER EPIDEM BIOMAR, V22, P317, DOI 10.1158/1055-9965.EPI-12-1170; Burnett-Hartman AN, 2011, CANCER EPIDEM BIOMAR, V20, P2288, DOI 10.1158/1055-9965.EPI-11-0450; Chen HD, 2015, INT J CANCER, V137, P12, DOI 10.1002/ijc.29180; Chen TH, 2012, WORLD J GASTROENTERO, V18, P4051, DOI 10.3748/wjg.v18.i30.4051; Chung CH, 2014, J CLIN ONCOL, V32, P3930, DOI 10.1200/JCO.2013.54.5228; Cricca M, 2007, GYNECOL ONCOL, V106, P549, DOI 10.1016/j.ygyno.2007.05.004; Cutait G, 2000, REV MED SAO PAULO, V79, P45; D Damayanti D., 2018, BULLWHIP EFFECT SUPP, V1, P1, DOI DOI 10.1080/09593330.2018.1526217; Damin DC, 2007, EJSO-EUR J SURG ONC, V33, P569, DOI 10.1016/j.ejso.2007.01.014; Damin DC, 2013, COLORECTAL DIS, V15, pe420, DOI 10.1111/codi.12257; Darragh TM, 2013, INT J GYNECOL PATHOL, V32, P76, DOI 10.1097/PGP.0b013e31826916c7; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Depuydt CE, 2007, J CELL MOL MED, V11, P881, DOI 10.1111/j.1582-4934.2007.00073.x; Deschoolmeester V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-117; Dieguez Christine, 2017, ESTIMATIVA 2018 BRAS; Doorbar J, 2018, BEST PRACT RES CL OB, V47, P27, DOI 10.1016/j.bpobgyn.2017.08.001; Doorbar J, 2015, REV MED VIROL, V25, P2, DOI 10.1002/rmv.1822; Edge SB, 2010, AJCC CANC STAGING MA; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Gautam A, 2019, CURR MOL MED, V19, P237, DOI 10.2174/1566524019666190405120441; Gazzaz F, 2016, SAUDI MED J, V37, P256, DOI 10.15537/smj.2016.3.13514; Ghabreau L, 2012, CLIN CANCER INVESTIG, V1, P26, DOI 10.4103/2278-0513.95016; Goel A, 2012, GASTROENTEROLOGY, V143, P1442, DOI 10.1053/j.gastro.2012.09.032; Gornick MC, 2010, CANCER CAUSE CONTROL, V21, P737, DOI 10.1007/s10552-010-9502-0; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hellman K, 2014, BRIT J CANCER, V110, P1561, DOI 10.1038/bjc.2014.32; International Agency for Research on Cancer(IARC), 2018, GLOBAL CANC OBSERVAT; Jalilvand S, 2014, ASIAN PAC J CANCER P, V15, P7029, DOI 10.7314/APJCP.2014.15.17.7029; Jansma AL, 2014, J MOL BIOL, V426, P4030, DOI 10.1016/j.jmb.2014.10.021; Karbasi A, 2015, PATHOL RES PRACT, V211, P444, DOI 10.1016/j.prp.2015.02.001; Karpinski P, 2011, TUMOR BIOL, V32, P653, DOI 10.1007/s13277-011-0165-6; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Kocjan BJ, 2011, J VIROL METHODS, V175, P117, DOI 10.1016/j.jviromet.2011.04.006; Koerber SA, 2014, RADIOTHER ONCOL, V113, P331, DOI 10.1016/j.radonc.2014.11.013; Liu F, 2011, COLORECTAL DIS, V13, P865, DOI 10.1111/j.1463-1318.2010.02335.x; Lorenzon L, 2015, WORLD J GASTROENTERO, V21, P342, DOI 10.3748/wjg.v21.i1.342; Lorenzon L, 2011, INT J COLORECTAL DIS, V26, P135, DOI 10.1007/s00384-010-1049-8; Loukola A, 1999, AM J PATHOL, V155, P1849, DOI 10.1016/S0002-9440(10)65503-4; Picanco-Junior OM, 2014, ABCD-ARQ BRAS CIR DI, V27, P172, DOI 10.1590/S0102-67202014000300003; Mahajan A, 2016, HUM PATHOL, V51, P64, DOI 10.1016/j.humpath.2015.12.021; Mahmoudvand Shahab, 2015, Asian Pac J Cancer Prev, V16, P7883; Malekpour Afshar Reza, 2018, Asian Pac J Cancer Prev, V19, P193, DOI 10.22034/APJCP.2018.19.1.193; Menter DG, 2019, CURR GASTROENTEROL R, V21, P1, DOI [10.1007/s11894-019-0669-6, DOI 10.1007/S11894-019-0669-6]; Meshkat M, 2014, TURK J MED SCI, V44, P501, DOI 10.3906/sag-1303-81; Militello V, 2009, INT J CANCER, V124, P2501, DOI 10.1002/ijc.24224; Ministero delle Infrastrutture e dei Trasporti, 2019, CIRC 21 GENN 2019 N, P1; Moran A, 2010, WORLD J GASTRO ONCOL, V2, P151, DOI 10.4251/wjgo.v2.i3.151; Muller MF, 2016, VIRCHOWS ARCH, V469, P125, DOI 10.1007/s00428-016-1956-3; Nowak Jonathan A, 2016, Surg Pathol Clin, V9, P427, DOI 10.1016/j.path.2016.04.007; Perez LO, 2010, PATHOL ONCOL RES, V16, P461, DOI 10.1007/s12253-010-9246-x; Pelizzer Thaisa, 2016, Rev. bras. epidemiol., V19, P791, DOI 10.1590/1980-5497201600040009; Leto MDP, 2011, AN BRAS DERMATOL, V86, P306, DOI 10.1590/S0365-05962011000200014; Perez LO, 2005, COLORECTAL DIS, V7, P492, DOI 10.1111/j.1463-1318.2005.00774.x; Perin DMP, 2015, PREV MED, V81, P373, DOI 10.1016/j.ypmed.2015.09.021; Phaeton R, 2015, IMMUNOTHERAPY-UK, V7, P631, DOI [10.2217/IMT.15.18, 10.2217/imt.15.18]; Plummer M, 2016, LANCET GLOB HEALTH, V4, pE609, DOI 10.1016/S2214-109X(16)30143-7; Ranjbar R, 2014, ASIAN PAC J CANCER P, V15, P1521, DOI 10.7314/APJCP.2014.15.4.1521; Rogler G, 2014, CANCER LETT, V345, P235, DOI 10.1016/j.canlet.2013.07.032; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Ruas M, 2007, MOL CELL BIOL, V27, P4273, DOI 10.1128/MCB.02286-06; Salepci T, 2009, J BUON, V14, P495; Schiffman M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.86; SEER, 2019, CANC STAT FACTS COL; Serra S, 2018, J CLIN PATHOL, V71, P853, DOI 10.1136/jclinpath-2018-205216; Serup-Hansen E, 2014, J CLIN ONCOL, V32, P1812, DOI 10.1200/JCO.2013.52.3464; Shamir ER, 2019, MODERN PATHOL, V32, P290, DOI 10.1038/s41379-018-0131-6; Shi SR, 2004, HISTOCHEM CELL BIOL, V122, P211, DOI 10.1007/s00418-004-0693-x; Shi SR, 2002, J HISTOCHEM CYTOCHEM, V50, P1005, DOI 10.1177/002215540205000802; Siegel RL, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw322; Snietura M, 2012, J BIOL REG HOMEOS AG, V26, P757; Sohrabi A, 2016, CLIN LAB, V62, P615, DOI 10.7754/Clin.Lab.2015.150808; Soto Y, 2016, MEM I OSWALDO CRUZ, V111, P731, DOI 10.1590/0074-02760160217; Steinau M, 2011, J MOL DIAGN, V13, P377, DOI 10.1016/j.jmoldx.2011.03.007; Taherian H, 2014, PRZ GASTROENTEROL, V9, P280, DOI 10.5114/pg.2014.46163; Tanaka Takako Imai, 2018, Dent Clin North Am, V62, P111, DOI 10.1016/j.cden.2017.08.008; Tanzi E, 2015, J GEN VIROL, V96, P206, DOI 10.1099/vir.0.070672-0; Vuitton L, 2017, DIGEST LIVER DIS, V49, P446, DOI 10.1016/j.dld.2016.11.003; Westra WH, 2015, SEMIN DIAGN PATHOL, V32, P42, DOI 10.1053/j.semdp.2015.02.023; Wlodarczyk M, 2018, CURR DRUG TARGETS, V19, P1731, DOI 10.2174/1389450119666180803122744; Yang SY, 2018, EXPERT REV ANTICANC, V18, P351, DOI 10.1080/14737140.2018.1442217; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Yavuzer D, 2011, MED ONCOL, V28, P127, DOI 10.1007/s12032-010-9416-4; Zhang XH, 2018, COLORECTAL DIS, V20, P961, DOI 10.1111/codi.14416	103	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2020	15	6							e0235065	10.1371/journal.pone.0235065	http://dx.doi.org/10.1371/journal.pone.0235065			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG0TI	32584870	Green Published, gold			2022-12-27	WOS:000545747200035
J	Roque-Jimenez, JA; Oviedo-Ojeda, MF; Whalin, M; Lee-Rangel, HA; Relling, AE				Roque-Jimenez, Jose Alejandro; Oviedo-Ojeda, Mario Francisco; Whalin, Megan; Lee-Rangel, Hector Aaron; Relling, Alejandro Enrique			Eicosapentaenoic and docosahexaenoic acid supplementation during early gestation modified relative abundance on placenta and fetal liver tissue mRNA and concentration pattern of fatty acids in fetal liver and fetal central nervous system of sheep	PLOS ONE			English	Article							PREGNANCY; GROWTH; GPR120	In sheep, polyunsaturated fatty acid (PUFA) supplementations in late gestation increases the growth of offspring; however, there is a lack of evidence on the effect of PUFA supplementation during early gestation. Thus, the objective of this study was to evaluate the effect of dietary supplementation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in early gestation pregnant ewes on fatty acid concentration of fetal liver (FL) and fetal central nervous system (FCNS), and relative abundance of the mRNA for genes associated with transport and metabolism of fatty acids in FL and placenta. A total of 12 ewes, block for stage of gestation were fed a diet containing 1.6% (dry matter basis) monounsaturated fatty acids (MUFA) or EPA+DHA during the first 45 days of gestation. A cesarean section was conducted on day 45 of gestation to collect placenta (caruncle and cotyledon), FL, and FCNS. Relative abundance of mRNA in FL and FCNS and fatty acid concentration were analyzed using a 2x2 factorial arrangement of treatments considering fatty acid supplementation and tissue as the main factors. Concentrations of C18:1 isomers increase (P < 0.05) in FL and FCNS with MUFA supplementation; the FL and FCNS had a greater concentration of C20:3(n-6), C20:3(n-3), C22:1, C22:5 and C22:6 (P < 0.05) with EPA+DHA supplementation. In FL, the relative abundance ofLPLmRNA was greater(P = 0.02) as a result of MUFA supplementation. In placenta, there was a FA x tissue interaction for relative abundance ofDNMT3bandFFAR-4mRNA (P < 0.05). Fetus from MUFA-supplemented dams had a greater relative abundance ofFABP-4mRNA (P < 0.05). Results indicate supplementation with EPA+DHA during early gestation increases the total EPA and DHA in FL. For the placenta, EPA+DHA supplementation led to an increase in the relative abundance of lipid mRNA for transport genes.	[Roque-Jimenez, Jose Alejandro; Oviedo-Ojeda, Mario Francisco; Lee-Rangel, Hector Aaron] Univ Autonoma San Luis Potosi, Fac Agron, San Luis Potosi, San Luis Potosi, Mexico; [Roque-Jimenez, Jose Alejandro; Oviedo-Ojeda, Mario Francisco; Whalin, Megan; Relling, Alejandro Enrique] Ohio State Univ, Ohio Agr Res & Dev Ctr OARDC, Dept Anim Sci, Wooster, OH 44691 USA	Universidad Autonoma de San Luis Potosi; University System of Ohio; Ohio State University	Relling, AE (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr OARDC, Dept Anim Sci, Wooster, OH 44691 USA.	relling.1@osu.edu	Relling, Alejandro/AAV-5281-2020	Relling, Alejandro/0000-0002-1288-3037				Amusquivar E, 2003, BIOL NEONATE, V83, P136, DOI 10.1159/000067963; AOAC, 2007, OFFICIAL METHODS ANA, V18th; Botelho AP, 2009, REV NUTR, V22, P767, DOI 10.1590/S1415-52732009000500017; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Campbell FM, 1998, LIFE SCI, V63, P235, DOI 10.1016/S0024-3205(98)00267-7; Coleman DN, 2018, J ANIM SCI, V96, P1181, DOI 10.1093/jas/skx013; Desantadina R, 2018, BIOSCI J, DOI [10.14393/BJ-v34n1a2018-36825, DOI 10.14393/BJ-V34N1A2018-36825]; Duttaroy AK, 2016, EUR J LIPID SCI TECH, V118, P1439, DOI 10.1002/ejlt.201500496; Gil-Sanchez A, 2012, CURR OPIN CLIN NUTR, V15, P265, DOI 10.1097/MCO.0b013e3283523b6e; Greenberg James A, 2008, Rev Obstet Gynecol, V1, P162; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; INNIS SM, 2004, BIOL METABOLISM GROW; Knipp GT, 2000, PLACENTA, V21, P367, DOI 10.1053/plac.1999.0484; Kulkarni A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017706; Lager S, 2014, PLACENTA, V35, P523, DOI 10.1016/j.placenta.2014.04.017; Larque E, 2006, AM J CLIN NUTR, V84, P853, DOI 10.1093/ajcn/84.4.853; Larque E, 2011, AM J CLIN NUTR, V94, p1908S, DOI 10.3945/ajcn.110.001230; Maillard V, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0357-7; Maktoobian Baharanchi Ehsan, 2018, Avicenna J Med Biotechnol, V10, P214; Malcolm CA, 2003, ARCH DIS CHILD-FETAL, V88, pF383, DOI 10.1136/fn.88.5.F383; Markhus MW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136409; Meher A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147359; Nickles KR, 2019, J ANIM SCI, V97, P2631, DOI 10.1093/jas/skz141; Niculescu MD, 2013, FASEB J, V27, P350, DOI 10.1096/fj.12-210724; Nitert MD, 2013, J NUTR SCI, V2, DOI 10.1017/jns.2013.36; NRC, 2007, NUTR REQ SMALL RUM S, DOI [10.17226/11654, DOI 10.17226/11654]; O'Fallon JV, 2007, J ANIM SCI, V85, P1511, DOI 10.2527/jas.2006-491; Palmquist D. L., 2009, Professional Animal Scientist, V25, P207; Parry SA, 2017, J INVEST MED, V65, P1102, DOI 10.1136/jim-2017-000524; Song YP, 2018, LIFE SCI, V212, P241, DOI 10.1016/j.lfs.2018.10.008; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; VATNICK I, 1991, J DEV PHYSIOL, V15, P351; Weiss WP, 2003, J DAIRY SCI, V86, P3582, DOI 10.3168/jds.S0022-0302(03)73964-2; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhou YH, 2008, LIPIDS, V43, P525, DOI 10.1007/s11745-008-3186-1	35	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235217	10.1371/journal.pone.0235217	http://dx.doi.org/10.1371/journal.pone.0235217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574225	Green Published, gold			2022-12-27	WOS:000544972400024
J	Sisay, BG; Haile, D; Hassen, HY; Gebreyesus, SH				Sisay, Binyam Girma; Haile, Demewoz; Hassen, Hamid Yimam; Gebreyesus, Seifu Hagos			Performance of mid-upper arm circumference as a screening tool for identifying adolescents with overweight and obesity	PLOS ONE			English	Article							HEIGHT RATIO; CHILDREN; MORBIDITY; GROWTH; BMI	Background Adolescent overweight and obesity is a global public health problem, associated with an increased risk of metabolic syndrome. Recently, mid-upper arm circumference (MUAC) has been suggested as a screening tool to identify overweight and obesity among school-age children and early adolescents (5-14 years). However, little is known about the potential use of MUAC in the late adolescence period (15-19 years). Therefore, the present study aimed to evaluate the performance of MUAC to identify overweight (including obesity) in the late adolescence period in Ethiopia. Methods We conducted a cross-sectional study among 851 adolescents aged 15 to 19 years. We collected anthropometric data including MUAC, weight and height with the help of trained field workers. The receiver operating characteristic (ROC) curve analysis was used to examine the validity of MUAC compared to BMI Z score in identifying adolescents with overweight or obesity. Furthermore, we calculated the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), proportion of correctly classified, positive, and negative likelihood ratio for the proposed optimal cut-offs. Results MUAC was strongly correlated with BMI Z score with a correlation coefficient (r) of 0.81 (95% CI; 0.79-0.84). The optimal MUAC cut-off for identifying adolescents with overweight or obesity was 27.7 cm for males and 27.9 cm for females. The area under the ROC curve (AUC) was 0.96 (95% CI; 0.93-0.98) for males and 0.96 (95% CI; 0.94-0.98) for females. The accuracy level of MUAC to identify adolescents with overweight (including obesity) was high for both sexes (overall a sensitivity of 91.1% and a specificity of 90.3%). Conclusions MUAC has relatively equivalent accuracy with BMI Z score to identify overweight and obesity in adolescents. Hence, MUAC could be used as an alternative tool for surveillance and screening of overweight in adolescents aged 15-19 years.	[Sisay, Binyam Girma; Haile, Demewoz; Gebreyesus, Seifu Hagos] Addis Ababa Univ, Sch Publ Hlth, Dept Nutr & Dietet, Addis Ababa, Ethiopia; [Hassen, Hamid Yimam] Univ Antwerp, Fac Med & Hlth Sci, Dept Primary & Interdisciplinary Care, Antwerp, Belgium	Addis Ababa University; University of Antwerp	Gebreyesus, SH (corresponding author), Addis Ababa Univ, Sch Publ Hlth, Dept Nutr & Dietet, Addis Ababa, Ethiopia.	seif_h23@yahoo.com	; Hassen, Hamid/A-1105-2019	Sisay, Binyam/0000-0002-9310-8170; Hassen, Hamid/0000-0001-6485-4193	Addis Ababa University	Addis Ababa University	BGS have received financial support from Addis Ababa University for data collection. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2010, ENDNOTES, V2, P144; [Anonymous], 2008, SUMM STAT REP 2007 P; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; CHAPUT J-P, 2017, PEDIAT OBES, V12, P439, DOI DOI 10.1111/IJP0.12162; Craig E, 2014, ARCH DIS CHILD, V99, P763, DOI 10.1136/archdischild-2013-305137; Almeida Carlos A.N. de, 2003, J. Pediatr. (Rio J.), V79, P455, DOI 10.1590/S0021-75572003000500014; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Souza MFC., 2016, J HUM GROWTH DEV, V26, P260, DOI [DOI 10.7322/jhgd.119302, 10.7322/jhgd.119302, DOI 10.7322/JHGD.119302]; Efron B., 1994, INTRO BOOTSTRAP; Fakier A, 2017, SAMJ S AFR MED J, V107, P606, DOI [10.7196/SAMJ.2017.v107i7.12255, 10.7196/samj.2017.vi7.12255]; Freedman DS, 2013, AM J CLIN NUTR, V98, P1417, DOI 10.3945/ajcn.113.065961; Inge TH, 2013, PEDIATRICS, ppeds 2013; Jaiswal M, 2017, J CLIN DIAGN RES, V11, pSC5, DOI 10.7860/JCDR/2017/27442.10422; JAMES WPT, 1994, EUR J CLIN NUTR, V48, P883; Kumar S, 2017, MAYO CLIN P; Levin A, 2010, PEDIATR INT, V52, P347, DOI 10.1111/j.1442-200X.2009.02972.x; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lu Q, 2014, PEDIATR NEONATOL, V55, P14, DOI 10.1016/j.pedneo.2013.05.004; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Neovius M, 2004, Obes Rev, V5, P105, DOI 10.1111/j.1467-789X.2004.00136.x; O'Donohue WT., 2013, HDB ADOLESCENT HLTH; Rerksuppaphol S, 2017, CLIN MED RES, V15, P53, DOI 10.3121/cmr.2017.1365; Shegaze M, 2015, J FOOD NUTR SCI, V3, P166; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Talma H, 2019, ARCH DIS CHILD, V104, P159, DOI 10.1136/archdischild-2017-313528; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; Wohlfahrt-Veje C, 2014, EUR J CLIN NUTR, V68, P664, DOI 10.1038/ejcn.2013.282; World Health Organization, 2020, GROWTH REF 5 19 YEAR; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zaidi SMH, 2016, SAMPL SIZ EST DIAGN; 2006, CLIN BIOCH REV, V27, pS7	31	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235063	10.1371/journal.pone.0235063	http://dx.doi.org/10.1371/journal.pone.0235063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574192	Green Published, gold			2022-12-27	WOS:000544972400035
J	Dzurendova, S; Zimmermann, B; Kohler, A; Tafintseva, V; Slany, O; Certik, M; Shapaval, V				Dzurendova, Simona; Zimmermann, Boris; Kohler, Achim; Tafintseva, Valeria; Slany, Ondrej; Certik, Milan; Shapaval, Volha			Microcultivation and FTIR spectroscopy-based screening revealed a nutrient-induced co-production of high-value metabolites in oleaginous Mucoromycota fungi	PLOS ONE			English	Article							GAMMA-LINOLENIC ACID; MULTIPLICATIVE SIGNAL CORRECTION; FILAMENTOUS FUNGI; VIBRATIONAL SPECTROSCOPY; SACCHAROMYCES-CEREVISIAE; BIOCHEMICAL-COMPOSITION; COMPONENT ANALYSIS; ARACHIDONIC-ACID; LIPID PRODUCTION; CARBON SOURCE	Mucoromycotafungi possess a versatile metabolism and can utilize various substrates for production of industrially important products, such as lipids, chitin/chitosan, polyphosphates, pigments, alcohols and organic acids. However, as far as commercialisation is concerned, establishing industrial biotechnological processes based onMucoromycotafungi is still challenging due to the high production costs compared to the final product value. Therefore, the development of co-production concept is highly desired since more than one valuable product could be produced at the time and the process has a potentially higher viability. To develop such biotechnological strategy, we applied a high throughput approach consisting of micro-titre cultivation and FTIR spectroscopy. This approach allows single-step biochemical fingerprinting of either fungal biomass or growth media without tedious extraction of metabolites. The influence of two types of nitrogen sources and different levels of inorganic phosphorus on the co-production of lipids, chitin/chitosan and polyphosphates for nine different oleaginousMucoromycotafungi was evaluated. FTIR analysis of biochemical composition ofMucoromycotafungi and biomass yield showed that variation in inorganic phosphorus had higher effect when inorganic nitrogen source-ammonium sulphate-was used. It was observed that: (1)Umbelopsis vinaceareached almost double biomass yield compared to other strains when yeast extract was used as nitrogen source while phosphorus limitation had little effect on the biomass yield; (2)Mucor circinelloides,Rhizopus stolonifer,Amylomyces rouxii,Absidia glaucaandLichtheimia corymbiferaoverproduced chitin/chitosan under the low pH caused by the limitation of inorganic phosphorus; (3)Mucor circinelloides,Amylomyces rouxii,Rhizopus stoloniferandAbsidia glaucawere able to store polyphosphates in addition to lipids when high concentration of inorganic phosphorus was used; (4) the biomass and lipid yield of high-value lipid producersMortierella alpinaandMortierella hyalinawere significantly increased when high concentrations of inorganic phosphorus were combined with ammonium sulphate, while the same amount of inorganic phosphorus combined with yeast extract showed negative impact on the growth and lipid accumulation. FTIR spectroscopy revealed the co-production potential of several oleaginousMucoromycotafungi forming lipids, chitin/chitosan and polyphosphates in a single cultivation process.	[Dzurendova, Simona; Zimmermann, Boris; Kohler, Achim; Tafintseva, Valeria; Shapaval, Volha] Norwegian Univ Life Sci, Fac Sci & Technol, As, Norway; [Slany, Ondrej; Certik, Milan] Slovak Tech Univ, Fac Chem & Food Technol, Bratislava, Slovakia	Norwegian University of Life Sciences; Slovak University of Technology Bratislava	Dzurendova, S (corresponding author), Norwegian Univ Life Sci, Fac Sci & Technol, As, Norway.	simona.dzurendova@gmail.com	Zimmermann, Boris/N-8297-2014; Zimmermann, Boris/GVS-6235-2022	Zimmermann, Boris/0000-0001-5046-520X; Zimmermann, Boris/0000-0001-5046-520X; Kohler, Achim/0000-0001-5759-1989	Research Council of Norway - FMETEKN Grant [257622]; BIONAER Grant [268305, 305215]; DAAD Grant [309220]; Slovak Ministry of Education, Science, Research and Sport [VEGA 1/0323/19]	Research Council of Norway - FMETEKN Grant(Research Council of Norway); BIONAER Grant; DAAD Grant; Slovak Ministry of Education, Science, Research and Sport	The study was funded by the Research Council of Norway - FMETEKN Grant, project number 257622; BIONAER Grant, project numbers 268305, 305215; DAAD Grant, project number 309220 and by the Slovak Ministry of Education, Science, Research and Sport-grant VEGA 1/0323/19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Afseth NK, 2012, CHEMOMETR INTELL LAB, V117, P92, DOI 10.1016/j.chemolab.2012.03.004; Ami D, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-12; Andre A, 2010, IND CROP PROD, V31, P407, DOI 10.1016/j.indcrop.2009.12.011; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2008, SIDRA, V23, P83; [Anonymous], 2001, INTENSIVE CARE MED; Appels L, 2010, BIORESOURCE TECHNOL, V101, P5743, DOI 10.1016/j.biortech.2010.02.068; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; BARTNICKIGARCIA S, 1969, SCIENCE, V165, P302, DOI 10.1126/science.165.3890.302; Beever R. E., 1980, Advances in Botanical Research, V8, P127, DOI 10.1016/S0065-2296(08)60034-8; Bignell E, 2012, ADV APPL MICROBIOL, V79, P1, DOI 10.1016/B978-0-12-394318-7.00001-2; Botha A, 1997, SYST APPL MICROBIOL, V20, P165, DOI 10.1016/S0723-2020(97)80062-8; Brar KK, 2017, BIORESOURCE TECHNOL, V242, P161, DOI 10.1016/j.biortech.2017.03.155; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Cardenas G, 2004, J APPL POLYM SCI, V93, P1876, DOI 10.1002/app.20647; Cardoso A, 2012, MOLECULES, V17, P4904, DOI 10.3390/molecules17054904; Cherubini F, 2010, ENERG CONVERS MANAGE, V51, P1412, DOI 10.1016/j.enconman.2010.01.015; Correa-Garcia S, 2014, ANAL METHODS-UK, V6, P1855, DOI 10.1039/c3ay42322k; Corte L, 2014, COLLOID SURFACE B, V116, P761, DOI 10.1016/j.colsurfb.2014.01.054; de Lima MAB, 2003, BRAZ J MICROBIOL, V34, P363, DOI 10.1590/S1517-83822003000400016; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Di Mario F, 2008, INT J BIOL MACROMOL, V43, P8, DOI 10.1016/j.ijbiomac.2007.10.005; El Wali M, 2019, CHINESE J CHEM ENG, V27, P1219, DOI 10.1016/j.cjche.2018.09.004; Enshaeieh M., 2012, J BIOL TODAYS WORLD, V1, P82, DOI DOI 10.15412/J.JBTW.01010203; Erukhimovitch V, 2005, J PHARMACEUT BIOMED, V37, P1105, DOI 10.1016/j.jpba.2004.08.010; Ferreira JA, 2013, BIORESOURCE TECHNOL, V135, P523, DOI 10.1016/j.biortech.2012.09.064; Forfang K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170611; Guillen MD, 1998, J AGR FOOD CHEM, V46, P1788, DOI 10.1021/jf9705274; Gupta VK, 2016, TRENDS BIOCHEM SCI, V41, P633, DOI 10.1016/j.tibs.2016.04.006; Harrington PD, 2005, ANAL CHIM ACTA, V544, P118, DOI 10.1016/j.aca.2005.02.042; Hu KJ, 2004, CARBOHYD POLYM, V58, P45, DOI 10.1016/j.carbpol.2004.06.015; Jebsen C, 2012, PHYSIOL PLANTARUM, V146, P427, DOI 10.1111/j.1399-3054.2012.01636.x; Karimi S, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10093296; Kavadia A, 2001, J AM OIL CHEM SOC, V78, P341, DOI 10.1007/s11746-001-0266-3; Khoshmanesh A, 2012, ANALYST, V137, P3704, DOI 10.1039/c2an35289c; Khot M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-71; Kim W.J., 2001, BIOTECHNOLOGY BIOPRO, V6, P6, DOI DOI 10.1007/BF02942243; Kohler A, 2005, APPL SPECTROSC, V59, P707, DOI 10.1366/0003702054280649; Kosa G, 2018, APPL MICROBIOL BIOT, V102, P4915, DOI 10.1007/s00253-018-8920-x; Kosa G, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1070-7; Kosa G, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0817-3; Kosa G, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0716-7; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1; Lecellier A, 2015, FOOD MICROBIOL, V45, P126, DOI 10.1016/j.fm.2014.01.002; Li JC, 2016, MECH MACH SCI, V36, P769; Liao W, 2008, BIORESOURCE TECHNOL, V99, P5859, DOI 10.1016/j.biortech.2007.10.006; LINDBERG AM, 1991, APPL MICROBIOL BIOT, V36, P26, DOI 10.1007/BF00164693; Liu JY, 2013, J CHEM TECHNOL BIOT, V88, P1807, DOI 10.1002/jctb.4027; Liu Y, 2008, J APPL MICROBIOL, V105, P1521, DOI 10.1111/j.1365-2672.2008.03913.x; Lu JM, 2011, APPL BIOCHEM BIOTECH, V164, P979, DOI 10.1007/s12010-011-9189-z; Mayers JJ, 2013, BIORESOURCE TECHNOL, V148, P215, DOI 10.1016/j.biortech.2013.08.133; Meyer Vera, 2016, Fungal Biol Biotechnol, V3, P6, DOI 10.1186/s40694-016-0024-8; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Ojeda Jesus J, 2012, Methods Mol Biol, V881, P187, DOI 10.1007/978-1-61779-827-6_8; Papanikolaou S, 2007, EUR J LIPID SCI TECH, V109, P1060, DOI 10.1002/ejlt.200700169; Raghukumar S., 2017, FUNGI COASTAL OCEANI; Ratledge C, 2004, BIOCHIMIE, V86, P807, DOI 10.1016/j.biochi.2004.09.017; Ratledge C., 2010, Single cell oils: microbial and algal oils, P3; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Safaei Z, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091429; Sakuradani E, 2009, J BIOTECHNOL, V144, P31, DOI 10.1016/j.jbiotec.2009.04.012; Salman A, 2010, SPECTROSC-INT J, V24, P261, DOI 10.1155/2010/723489; Santek M.I., 2018, ADV BIOFUELS BIOENER, P137; Santos C, 2010, RES MICROBIOL, V161, P168, DOI 10.1016/j.resmic.2009.12.007; Satari B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030302; Schmitt J, 1998, INT BIODETER BIODEGR, V41, P1, DOI 10.1016/S0964-8305(98)80002-4; Seufferheld MJ, 2008, APPL ENVIRON MICROB, V74, P5867, DOI 10.1128/AEM.00501-08; Shaligram NS, 2009, PROCESS BIOCHEM, V44, P939, DOI 10.1016/j.procbio.2009.04.009; Shapaval V, 2013, ANALYST, V138, P4129, DOI 10.1039/c3an00304c; Shapaval V, 2013, J APPL MICROBIOL, V114, P788, DOI 10.1111/jam.12092; Shapaval V, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1481-0; Shapaval V, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-86; Shapaval V, 2010, J BIOPHOTONICS, V3, P512, DOI 10.1002/jbio.201000014; SHINMEN Y, 1989, APPL MICROBIOL BIOT, V31, P11, DOI 10.1007/BF00252518; Signori L, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0467-x; Smilde AK, 2005, BIOINFORMATICS, V21, P3043, DOI 10.1093/bioinformatics/bti476; Tan SC, 1996, CARBOHYD POLYM, V30, P239, DOI 10.1016/S0144-8617(96)00052-5; Tang MJ, 2013, ANAL BIOANAL CHEM, V405, P1577, DOI 10.1007/s00216-012-6556-8; Teng WL, 2001, CARBOHYD RES, V332, P305, DOI 10.1016/S0008-6215(01)00084-2; Toplak M., 2017, Synchrotron Radiation News, V30, P40, DOI 10.1080/08940886.2017.1338424; Veale EL, 2007, BIOTECHNOL PROGR, V23, P494, DOI 10.1021/bp060306v; Vongsangnak W, 2013, GENE, V521, P180, DOI 10.1016/j.gene.2013.03.012; Vongsvivut J, 2013, ANALYST, V138, P6016, DOI 10.1039/c3an00485f; Wagner H, 2010, J BIOPHOTONICS, V3, P557, DOI 10.1002/jbio.201000019; Walther G, 2019, J FUNGI, V5, DOI 10.3390/jof5040106; Wang LP, 2005, BIOTECHNOL ADV, V23, P115, DOI 10.1016/j.biotechadv.2004.11.001; Werner TP, 2007, FUNGAL GENET BIOL, V44, P845, DOI 10.1016/j.fgb.2007.01.008; WHITE SA, 1979, APPL ENVIRON MICROB, V38, P323, DOI 10.1128/AEM.38.2.323-328.1979; Wu T, 2005, J AGR FOOD CHEM, V53, P3888, DOI 10.1021/jf048202s; Xiong Y, 2019, IEEE ACCESS, V7, P132763, DOI 10.1109/ACCESS.2019.2941704; Xiong Y, 2019, SLAS TECHNOL, V24, P583, DOI 10.1177/2472630319861361; Yadav A.N., 2019, RECENT ADVANCEMENT W; Ye YL, 2015, APPL BIOCHEM BIOTECH, V177, P1127, DOI 10.1007/s12010-015-1801-1; Yehia RS, 2017, APPL BIOCHEM MICRO+, V53, P94, DOI 10.1134/S0003683817010045; Zeng Y, 2012, BIOPROC BIOSYST ENG, V35, P683, DOI 10.1007/s00449-011-0648-2; Zimmermann B, 2013, APPL SPECTROSC, V67, P892, DOI 10.1366/12-06723; Zininga JT, 2019, BIORESOURCE TECHNOL, V272, P545, DOI 10.1016/j.biortech.2018.10.035	99	21	21	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234870	10.1371/journal.pone.0234870	http://dx.doi.org/10.1371/journal.pone.0234870			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569317	Green Published, gold			2022-12-27	WOS:000543547900010
J	Foster, CE; Kok, M; Flores, AR; Minard, CG; Luna, RA; Lamberth, LB; Kaplan, SL; Hulten, KG				Foster, Catherine E.; Kok, Melissa; Flores, Anthony R.; Minard, Charles G.; Luna, Ruth A.; Lamberth, Linda B.; Kaplan, Sheldon L.; Hulten, Kristina G.			Adhesin genes and biofilm formation among pediatricStaphylococcus aureus isolates from implant-associated infections	PLOS ONE			English	Article							QUANTIFICATION; EPIDEMIOLOGY; SURVEILLANCE; PROTEINS; CRITERIA; PLATES	Background Microbial surface component recognizing adhesive matrix molecules (MSCRAMMs) facilitateStaphylococcus aureusadherence to host tissue. We hypothesized thatS.aureusisolates from implant-associated infections (IAIs) would differ in MSCRAMM profile and biofilm formationin vitrocompared to skin and soft tissue infection (SSTI) isolates. Methods Pediatric patients and their isolates were identified retrospectively. IAI and SSTI isolates were matched (1:4). Pulsed field gel electrophoresis was performed to group isolates as USA300 vs. non-USA300. Whole genome sequencing was performed and raw sequence data were interrogated for presence of MSCRAMMs (clfA,clfB,cna,ebh,efb,fnbpA,fnbpB,isdA,isdB,sdrC,sdrD,sdrE), biofilm-associated (icaA,D,B,C), and Panton-Valentine leukocidin (lukSF-PV) genes, accessory gene regulator group, and multilocus sequence types.In vitrobiofilm formation was assessed for 47 IAI and 47 SSTI isolates using a microtiter plate assay. Conditional logistic regression was performed for analysis of matched data (STATA11, College Station, TX). Results Forty-seven IAI and 188 SSTI isolates were studied. IAI isolates were more often methicillin susceptibleS.aureusand non-USA300 vs. SSTI isolates [34 (72%) vs. 79 (42%), p = 0.001 and 38 (81%) vs. 57 (30%) p <0.001, respectively]. Greater than 98% of isolates carriedclfA,clfB,efb,isdA,isdB, andicaA,D,B,Cwhilecnawas more frequently found among IAI vs. SSTI isolates (p = 0.003). Most isolates were strong biofilm producers. Conclusions S.aureusIAI isolates were significantly more likely to be MSSA and non-USA300 than SSTI isolates. Carriage of MSCRAMMs and biofilm formation did not differ significantly between isolates. Evaluation of genetic polymorphisms and gene expression profiles are needed to further delineate the role of adhesins in the pathogenesis of IAIs.	[Foster, Catherine E.; Kok, Melissa; Lamberth, Linda B.; Kaplan, Sheldon L.; Hulten, Kristina G.] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA; [Foster, Catherine E.; Kok, Melissa; Minard, Charles G.; Luna, Ruth A.; Lamberth, Linda B.; Kaplan, Sheldon L.; Hulten, Kristina G.] Texas Childrens Hosp, Houston, TX 77030 USA; [Flores, Anthony R.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Ctr Antimicrobial Resistance & Microbial Genom, Div Infect Dis,McGovern Med Sch, Houston, TX 77030 USA; [Minard, Charles G.] Baylor Coll Med, Inst Clin & Translat Res, Houston, TX 77030 USA; [Luna, Ruth A.] Baylor Coll Med, Dept Pediat, Sect Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine	Foster, CE (corresponding author), Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA.; Foster, CE (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.	catherine.foster@bcm.edu	Flores, Anthony/W-3797-2017	Flores, Anthony/0000-0002-6402-4269; Foster, Catherine/0000-0002-2657-039X; Minard, Charles/0000-0003-4631-6943; Kok, Melissa/0000-0002-4635-4459				Arciola CR, 2018, NAT REV MICROBIOL, V16, P397, DOI 10.1038/s41579-018-0019-y; Arciola CR, 2005, FEMS MICROBIOL LETT, V246, P81, DOI 10.1016/j.femsle.2005.03.035; Bartlett AH, 2010, PEDIATR INFECT DIS J, V29, P860, DOI 10.1097/INF.0b013e3181ef2477; Bocchini CE, 2006, PEDIATRICS, V117, P433, DOI 10.1542/peds.2005-0566; Carrillo-Marquez MA, 2010, PEDIATR INFECT DIS J, V29, P410, DOI 10.1097/INF.0b013e3181c767b6; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130; Deny A, 2016, ORTHOP TRAUMATOL-SUR, V102, P919, DOI 10.1016/j.otsr.2016.08.012; Foster CE, 2019, PEDIATR INFECT DIS J, V38, P808, DOI 10.1097/INF.0000000000002349; Foster T, 2016, EUR J CLIN MICROBIOL, V35, P1923, DOI 10.1007/s10096-016-2763-0; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Ghasemian Abdolmajid, 2015, Iran J Pathol, V10, P258; Gonzalez BE, 2005, CLIN INFECT DIS, V41, P583, DOI 10.1086/432475; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hulten KG, 2006, PEDIATR INFECT DIS J, V25, P349, DOI 10.1097/01.inf.0000207404.50143.1e; Hulten KG, 2020, PEDIATR INFECT DIS J, V39, P30, DOI 10.1097/INF.0000000000002499; Hulten KG, 2018, PEDIATR INFECT DIS J, V37, P235, DOI 10.1097/INF.0000000000001753; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Lamberet A, 2018, PEDIATR INFECT DIS J, V37, P511, DOI [10.1097/INF.0000000000001812, 10.1097/inf.0000000000001812]; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; McCarthy H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00001; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Robinson DA, 2005, J BACTERIOL, V187, P8312, DOI 10.1128/JB.187.24.8312-8321.2005; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Tan T, 2019, FEIGIN CHERRYS TXB P, P725; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Von Eiff C, 2006, INT J ARTIF ORGANS, V29, P360, DOI 10.1177/039139880602900405; Zapotoczna M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005671	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235115	10.1371/journal.pone.0235115	http://dx.doi.org/10.1371/journal.pone.0235115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569268	Green Published, gold			2022-12-27	WOS:000543547900054
J	Lysholm, S; Wensman, JJ; Munyeme, M; Fischer, K				Lysholm, Sara; Johansson Wensman, Jonas; Munyeme, Musso; Fischer, Klara			Perceptions and practices among Zambian sheep and goat traders concerning small ruminant health and disease	PLOS ONE			English	Article							AFRICAN-SWINE-FEVER; DES-PETITS RUMINANTS; AVIAN INFLUENZA; FARMERS; INFECTION; KNOWLEDGE; ATTITUDES; SPREAD	Trade in animals and animal products is a key factor in the transmission of infectious diseases. Livestock traders play an important role in this process, yet there is little knowledge of traders' perceptions of animal disease or their associated actions. The aim of this study was to investigate perceptions and practices of Zambian small ruminant traders with regard to sheep and goat health and disease. It also analysed how existing perceptions and practices might affect risks of disease transmission through trade. A case study was performed at the two largest small livestock markets in Zambia: the Lusaka market in the capital and the Kasumbalesa market near the border with the Democratic Republic of Congo. Semi-structured interviews with 47 traders performed in April-May and September 2018 represent the core material. Zambian small ruminant traders frequently trade animals that have clinical signs of disease, either because they appear unaware or indifferent to the associated risks, experience financial constraints or assign responsibility for disease prevention to other value chain actors. In their decision about whether or not to sell a visibly sick small ruminant, traders appear to consider whether the clinical sign is perceived as 'natural' or the result of an illness, whether the buyer is aware of the animal's health condition, and whether the animal is sold for consumption or breeding purposes. Traders appear to regard the veterinary certificate required to transport small ruminants in Zambia as proof of health, placing the responsibility for potential disease in traded animals on the veterinary authorities. In their description of a model trader, taking good care of and being sensitive to customer needs was emphasized, indicating that an efficient way to encourage traders to change their behaviour is to influence customer demands. In contrast to the focus in previous studies on identifying and filling knowledge gaps, the present study show that lack of knowledge is not central to why traders engage in disease-transmitting behaviour. Greater awareness of other reasons for certain perceptions and practices could lead to the formulation of risk communication strategies and mitigation measures that are relevant for the local context, as well as alternative strategies for changing trader behaviour.	[Lysholm, Sara; Johansson Wensman, Jonas] Swedish Univ Agr Sci SLU, Sect Ruminant Med, Dept Clin Sci, Uppsala, Sweden; [Munyeme, Musso] Univ Zambia, Dept Dis Control, Lusaka, Zambia; [Fischer, Klara] Swedish Univ Agr Sci SLU, Div Rural Dev, Dept Urban & Rural Dev, Uppsala, Sweden	Swedish University of Agricultural Sciences; University of Zambia; Swedish University of Agricultural Sciences	Lysholm, S (corresponding author), Swedish Univ Agr Sci SLU, Sect Ruminant Med, Dept Clin Sci, Uppsala, Sweden.	sara.lysholm@slu.se	MUNYEME, MUSSO/AAJ-2469-2021; Fischer, Klara/I-2962-2019	Fischer, Klara/0000-0001-6590-4025; Johansson Wensman, Jonas/0000-0002-6957-7110; Lysholm, Sara/0000-0002-0392-1572	Swedish Research Council [201803956, 2016-05667, 348-2014-4293]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by the Swedish Research Council (www.vr.se), grant no 201803956 awarded to JJW and MM, 2016-05667 awarded to JJW and 348-2014-4293 awarded to JJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, CANC DISCOVERY, V7, pOF12; Birindwa BA, 2017, J ADV VET ANIM RES, V4, P348, DOI 10.5455/javar.2017.d233; Bowen GA, 2006, INT J QUAL METH, V5, P12, DOI [DOI 10.1177/160940690600500304, 10.1177/160940690600500304]; Burton RJF, 2004, SOCIOL RURALIS, V44, P195, DOI 10.1111/j.1467-9523.2004.00270.x; Chenais E, 2017, TRANSBOUND EMERG DIS, V64, P101, DOI 10.1111/tbed.12347; Chipasha H., 2017, African Journal of Food, Agriculture, Nutrition and Development, V17, P11691, DOI 10.18697/ajfand.77.16175; Chota A, 2019, TROP ANIM HLTH PROD; Delgado C, 1999, 28 IFPRI AGR ENV; Dione M, 2016, PREV VET MED, V135, P102, DOI 10.1016/j.prevetmed.2016.11.001; Elelu N, 2017, INT J VET SCI MED, V5, P47, DOI 10.1016/j.ijvsm.2017.03.002; FAO, 2012, VET RECORD, V171; Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; Fischer K, 2019, J DAIRY SCI, V102, P2724, DOI 10.3168/jds.2018-15015; Garforth CJ, 2013, PREV VET MED, V110, P456, DOI 10.1016/j.prevetmed.2013.02.018; Gillham B., 2000, CONTINUUM-J MEDIA CU; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Hamilton L., 2018, Food Ethics, V1, P221, DOI 10.1007/s41055-017-0011-7; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; ILRI, 2002, ILR STRAT 2010; Jansen J, 2009, PREV VET MED, V92, P210, DOI 10.1016/j.prevetmed.2009.08.015; Karimuribo E. D., 2011, RES OPIN ANIM VET SC, V1, P184; Kgotlele T., 2019, Comparative Clinical Pathology, V28, P755, DOI 10.1007/s00580-018-2848-5; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kivaria FM, 2013, ONDERSTEPOORT J VET, V80, DOI 10.4102/ojvr.v80i1.593; Leslie EEC, 2016, ACTA TROP, V155, P95, DOI 10.1016/j.actatropica.2015.12.014; Lichoti JK, 2017, PREV VET MED, V140, P87, DOI 10.1016/j.prevetmed.2017.03.005; MILES M, 1994, NEW YORK TIMES BK R, P26; Muhangi D., 2014, LIVESTOCK RES RURAL, V26, P5; Muse EA, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.457; Namonje-Kapembwa N, 2016, 117 IAPRI; Naylor R, 2016, SOCIOL RURALIS, V58, P3; Neupane D, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-76; OIE, 2013, EV SUMM PEST PET RUM; Parida S, 2016, SMALL RUMINANT RES, V142, P16, DOI 10.1016/j.smallrumres.2016.02.018; Porten K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-147; Saunders FP, 2016, SOCIOL RURALIS, V56, P391, DOI 10.1111/soru.12115; Shortall O, 2018, SOCIOL RURALIS, V58, P583, DOI 10.1111/soru.12205; Siamupa C, 2018, TROP ANIM HEALTH PRO, V50, P177, DOI 10.1007/s11250-017-1419-0; Southwold-Llewellyn S, 2002, METHODS TECHNIQUES F; Sutherland LA, 2012, J RURAL STUD, V28, P232, DOI 10.1016/j.jrurstud.2012.03.003; Swai ES, 2013, TROP ANIM HEALTH PRO, V45, P1603, DOI 10.1007/s11250-013-0405-4; Yin R. K., 1994, CASE STUDY RES DESIG; Yu Q, 2013, EMERG INFECT DIS, V19, P313, DOI 10.3201/eid1902.120251	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0233611	10.1371/journal.pone.0233611	http://dx.doi.org/10.1371/journal.pone.0233611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569297	Green Published, gold			2022-12-27	WOS:000543547900045
J	Ortiz-Barrios, M; Alfaro-Saiz, JJ				Ortiz-Barrios, Miguel; Alfaro-Saiz, Juan-Jose			An integrated approach for designing in-time and economically sustainable emergency care networks: A case study in the public sector	PLOS ONE			English	Article							DISCRETE-EVENT SIMULATION; WAITING TIME; 6 SIGMA; SYSTEMS	Emergency Care Networks (ECNs) were created as a response to the increased demand for emergency services and the ever-increasing waiting times experienced by patients in emergency rooms. In this sense, ECNs are called to provide a rapid diagnosis and early intervention so that poor patient outcomes, patient dissatisfaction, and cost overruns can be avoided. Nevertheless, ECNs, as nodal systems, are often inefficient due to the lack of coordination between emergency departments (EDs) and the presence of non-value added activities within each ED. This situation is even more complex in the public healthcare sector of low-income countries where emergency care is provided under constraint resources and limited innovation. Notwithstanding the tremendous efforts made by healthcare clusters and government agencies to tackle this problem, most of ECNs do not yet provide nimble and efficient care to patients. Additionally, little progress has been evidenced regarding the creation of methodological approaches that assist policymakers in solving this problem. In an attempt to address these shortcomings, this paper presents a three-phase methodology based on Discrete-event simulation, payment collateral models, and lean six sigma to support the design of in-time and economically sustainable ECNs. The proposed approach is validated in a public ECN consisting of 2 hospitals and 8 POCs (Point of Care). The results of this study evidenced that the average waiting time in an ECN can be substantially diminished by optimizing the cooperation flows between EDs.	[Ortiz-Barrios, Miguel] Univ Costa CUC, Dept Ind Management Agroind & Operat, Barranquilla, Colombia; [Alfaro-Saiz, Juan-Jose] Univ Politecn Valencia, Res Ctr Prod Management & Engn, Valencia, Spain	Universidad de la Costa; Universitat Politecnica de Valencia	Ortiz-Barrios, M (corresponding author), Univ Costa CUC, Dept Ind Management Agroind & Operat, Barranquilla, Colombia.	mortiz1@cuc.edu.co	Barrios, Miguel Ángel Ortíz/AAW-2705-2021	Ortiz Barrios, Miguel Angel/0000-0001-6890-7547				Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Ahmed Selim, 2013, Reviews on Environmental Health, V28, P189, DOI 10.1515/reveh-2013-0015; Al Owad A, 2014, ADV MATER RES-SWITZ, V835-836, P1893, DOI 10.4028/www.scientific.net/AMR.834-836.1893; Ortiz-Barrios MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082664; [Anonymous], 2015, PS-POLIT SCI POLIT, V48, P557, DOI 10.1017/S1049096515000694; [Anonymous], 2017, ARTIFICIAL ORGANS, V41, pE141; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2016, UNCERTAINTY MODELLIN; [Anonymous], 2016, AIP C P; [Anonymous], 2015, 6 INT C MOD SIM APPL; [Anonymous], 2018, IEEE INT C IND ENG E; Baier N, 2019, HEALTH POLICY, V123, P1, DOI 10.1016/j.healthpol.2018.11.001; Baril C, 2019, J OPER RES SOC, V70, P2019, DOI 10.1080/01605682.2018.1510805; Barrios MAO, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0577-3; Becker JB, 2015, REV ESC ENFERM USP, V49, P779, DOI 10.1590/S0080-623420150000500011; Bedoya-Valencia L, 2016, SIMUL-T SOC MOD SIM, V92, P1041, DOI 10.1177/0037549716673150; Calvello EJB, 2013, ACAD EMERG MED, V20, P1278, DOI 10.1111/acem.12266; Furterer SL, 2018, QUAL ENG, V30, P389, DOI 10.1080/08982112.2018.1464657; Gartner D, 2020, J OPER RES SOC, V71, P1087, DOI 10.1080/01605682.2019.1571005; Gaviria A, 2015, INFORM NACL CALIDAD; Gillespie J, 2016, J OPER RES SOC, V67, P1239, DOI 10.1057/jors.2015.114; Glickman SW, 2010, ACAD EMERG MED, V17, P1297, DOI 10.1111/j.1553-2712.2010.00930.x; Gul M, 2020, J OPER RES SOC, V71, P733, DOI 10.1080/01605682.2019.1582588; Habidin NF, 2015, INT J PHARM SCI REV, V35, P151; Harrop Nick, 2005, Inform Prim Care, V13, P223; Hawkins Robert C, 2007, Clin Biochem Rev, V28, P179; Hussein NA, 2017, OPER RES HEALTH CARE, V15, P1, DOI 10.1016/j.orhc.2017.06.003; Ibrahim I.M., 2018, INDIAN J PUBLIC HLTH, V9, P1558, DOI [10.5958/0976-5506.2018.01670.4, DOI 10.5958/0976-5506.2018.01670.4]; Isfahani HM, 2019, INT J LEAN SIX SIG, V10, P161, DOI 10.1108/IJLSS-05-2017-0051; Karnon J, 2012, VALUE HEALTH, V15, P821, DOI 10.1016/j.jval.2012.04.013; Kaushal A, 2015, SOCIO-ECON PLAN SCI, V50, P18, DOI 10.1016/j.seps.2015.02.002; Konder MT, 2016, INTERFACE-BOTUCATU, V20, P879, DOI 10.1590/1807-57622015.0519; Kuo YH, 2016, FLEX SERV MANUF J, V28, P120, DOI 10.1007/s10696-014-9198-7; Mandahawi N, 2017, J IND PROD ENG, V34, P495, DOI 10.1080/21681015.2017.1367728; Martinez R, 2010, ACAD EMERG MED, V17, P1346, DOI 10.1111/j.1553-2712.2010.00945.x; Modeling the Healthcare Services in Hilla Emergency Department, 2018, ICOASE 2018 INT C AD; Morley C, 2018, INT EMERG NURS, V38, P34, DOI 10.1016/j.ienj.2017.09.001; Navein J, 2003, EMERG MED J, V20, P192, DOI 10.1136/emj.20.2.192; NNDSS Annual Report Working Group, 2016, COMMUN DIS INTELL, V40, pE48; Nunez-Perez N, 2017, LECT NOTES COMPUT SC, V10586, P352, DOI 10.1007/978-3-319-67585-5_37; Ortiz Barrios Miguel, 2014, Ambient Assisted Living and Daily Activities. 6th International Work-Conference, IWAAL 2014. Proceedings: LNCS 8868, P413, DOI 10.1007/978-3-319-13105-4_62; Ortiz Barrios M.A., 2014, PROSPECTIVA, V12, P73, DOI [10.15665/RP.V12I2.291, DOI 10.15665/RP.V12I2.291]; Barrios MAO, 2015, LECT NOTES COMPUT SC, V9456, P247, DOI 10.1007/978-3-319-26508-7_24; Ortiz-Barrios MA, 2018, MANAGE DECIS, V56, P2187, DOI 10.1108/MD-09-2017-0917; Porter ME, 2019, MANAGING SUSTAINABLE, P323, DOI DOI 10.1007/978-94-024-1144-7_16; Regione Umbria, 2009, B UFFICIALE, V25, P1; Romero-Conrado Alfonso R., 2017, Dyna rev.fac.nac.minas, V84, P129, DOI 10.15446/dyna.v84n201.57504; s NA, 2018, LANCET INFECT DIS, V18, pe228; Salisbury C, 2010, EMERG MED J, V27, P186, DOI 10.1136/emj.2009.073056; Sheard S, 2018, HEALTH ECON POLICY L, V13, P226, DOI 10.1017/S1744133117000366; Steventon A, 2018, BRIEFING EMERGENCY H; Stoner MJ, 2018, ACAD EMERG MED, V25, P1336, DOI 10.1111/acem.13656; Turner J., 2015, WHAT EVIDENCE IS THE; Wilson KJ, 2013, QUAL MANAG HEALTH CA, V22, P2, DOI 10.1097/QMH.0b013e31827dea50; 2017, BEHAV SOC NETW, V15, P91	56	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234984	10.1371/journal.pone.0234984	http://dx.doi.org/10.1371/journal.pone.0234984			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569319	Green Published, gold			2022-12-27	WOS:000543547900046
J	Shaban, M; Ogur, Z; Mahmoud, A; Switala, A; Shalaby, A; Abu Khalifeh, H; Ghazal, M; Fraiwan, L; Giridharan, G; Sandhu, H; El-Baz, AS				Shaban, Mohamed; Ogur, Zeliha; Mahmoud, Ali; Switala, Andrew; Shalaby, Ahmed; Abu Khalifeh, Hadil; Ghazal, Mohammed; Fraiwan, Luay; Giridharan, Guruprasad; Sandhu, Harpal; El-Baz, Ayman S.			A convolutional neural network for the screening and staging of diabetic retinopathy	PLOS ONE			English	Article							DIAGNOSIS	Diabetic retinopathy (DR) is a serious retinal disease and is considered as a leading cause of blindness in the world. Ophthalmologists use optical coherence tomography (OCT) and fundus photography for the purpose of assessing the retinal thickness, and structure, in addition to detecting edema, hemorrhage, and scars. Deep learning models are mainly used to analyze OCT or fundus images, extract unique features for each stage of DR and therefore classify images and stage the disease. Throughout this paper, a deep Convolutional Neural Network (CNN) with 18 convolutional layers and 3 fully connected layers is proposed to analyze fundus images and automatically distinguish between controls (i.e. no DR), moderate DR (i.e. a combination of mild and moderate Non Proliferative DR (NPDR)) and severe DR (i.e. a group of severe NPDR, and Proliferative DR (PDR)) with a validation accuracy of 88%-89%, a sensitivity of 87%-89%, a specificity of 94%-95%, and a Quadratic Weighted Kappa Score of 0.91-0.92 when both 5-fold, and 10-fold cross validation methods were used respectively. A prior pre-processing stage was deployed where image resizing and a class-specific data augmentation were used. The proposed approach is considerably accurate in objectively diagnosing and grading diabetic retinopathy, which obviates the need for a retina specialist and expands access to retinal care. This technology enables both early diagnosis and objective tracking of disease progression which may help optimize medical therapy to minimize vision loss.	[Shaban, Mohamed] Univ S Alabama, Elect & Comp Engn, Mobile, AL 36688 USA; [Ogur, Zeliha; Mahmoud, Ali; Switala, Andrew; Shalaby, Ahmed; Giridharan, Guruprasad; El-Baz, Ayman S.] Univ Louisville, Bioengn Dept, Louisville, KY 40292 USA; [Abu Khalifeh, Hadil; Ghazal, Mohammed; Fraiwan, Luay] Abu Dhabi Univ, Abu Dhabi, U Arab Emirates; [Sandhu, Harpal] Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40292 USA	University of South Alabama; University of Louisville; Abu Dhabi University; University of Louisville	El-Baz, AS (corresponding author), Univ Louisville, Bioengn Dept, Louisville, KY 40292 USA.	ayman.elbaz@louisville.edu	El-Baz, Ayman/AAC-6689-2019	El-Baz, Ayman/0000-0001-7264-1323; Ghazal, Mohammed/0000-0002-9045-6698; Abu Khalifeh, Hadil/0000-0003-1133-3647				Acharya UR, 2009, P I MECH ENG H, V223, P545, DOI 10.1243/09544119JEIM486; Asia Pacific Tele-Ophthalmology Society, 2019, APTOS 2019 BLINDN DE; Ben-David A, 2008, EXPERT SYST APPL, V34, P825, DOI 10.1016/j.eswa.2006.10.022; Boucher MC, 2003, CAN J OPHTHALMOL, V38, P557, DOI 10.1016/S0008-4182(03)80109-6; Dekhil Omar, 2019, IEEE INT C IM SYST T; Deng Jia, 2009, IEEE C COMP VIS PATT; Gao ZT, 2019, IEEE ACCESS, V7, P3360, DOI 10.1109/ACCESS.2018.2888639; Hu JJ, 2019, IEEE T MED IMAGING, V38, P269, DOI 10.1109/TMI.2018.2863562; Jaafar HF, 2010, EUR SIGNAL PR CONF, P1622; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Mizutani A., 2009, P SPIE; Molina-Fernández E., 2008, Arch Soc Esp Oftalmol, V83, P23; Mookiah MRK, 2013, COMPUT BIOL MED, V43, P2136, DOI 10.1016/j.compbiomed.2013.10.007; Nayak J, 2008, J MED SYST, V32, P107, DOI 10.1007/s10916-007-9113-9; O'Shea K., 2016, NEURAL EVOLUTIONARY; Pachiyappan A, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-73; Pratt H., 2016, INT C MED IM UND AN INT C MED IM UND AN; Sabour S., 2017, NIPS P; Shaban M., 2018, IEEE INT S SIGN PROC; Tan JH, 2016, MED PHYS, V43, DOI 10.1118/1.4945413; U RA, 2008, J MED SYST, V32, P481, DOI 10.1007/s10916-008-9154-8	21	27	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0233514	10.1371/journal.pone.0233514	http://dx.doi.org/10.1371/journal.pone.0233514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569310	Green Published, gold			2022-12-27	WOS:000543547900021
J	Nguyen, Q; Babanezhad, M; Nakhjiri, AT; Rezakazemi, M; Shirazian, S				Quyen Nguyen; Babanezhad, Meisam; Nakhjiri, Ali Taghvaie; Rezakazemi, Mashallah; Shirazian, Saeed			Prediction of thermal distribution and fluid flow in the domain with multi-solid structures using Cubic-Interpolated Pseudo-Particle model	PLOS ONE			English	Article							LATTICE BOLTZMANN SIMULATION; CONVECTIVE HEAT-TRANSFER; NATURAL-CONVECTION; NUMERICAL-SIMULATION; TRANSFER ENHANCEMENT; CO2 SEPARATION; NANOFLUIDS; ENCLOSURES; ABSORBENTS	A nanofluid is a suspension of very small solid particles in a continuous fluid with significant improvement of heat transfer characteristics in the main liquid. In general, in industrial equipment, the heat transfer rate can be improved with optimization of equipment including the domain structure and using the different types of nanofluids. Still, there is a big challenge to analyze the heat transfer and fluid circulation in the domain. Having nanofluids with experimental observation as using sensors and probes are destructive for the liquid stream and they are costly to observe the details of particles and the original fluid. Over the 20 years, different numerical methods have been implemented in the modeling of the heat and fluid distribution in industrial equipment containing nanofluids. Among all mathematical and numerical methods, Cubic-Interpolated Pseudo-Particle (CIP) model provides a strong potential in the prediction of the fluid structure and heat analysis, when there is a complex structure of thermal walls and high concentration of nanoparticles. However, this method is not frequently used by researchers in nanofluids analysis. In this study, the Cubic-Interpolated Pseudo-Particle model is applied to predict the flow in the square domain. different thermal walls (multi-solid structure) and hot cylindrical wall are specifically used to observe the fluid flow and heat distribution in the domain. Additionally, for a better understanding of the flow in the domain, different numbers of cylinders are used and also different amounts of nanofluid in the continuous fluid are added. The results show that adding more walls in the domain causes the change in the vortex structure. Furthermore, using nanofluid results in better heat transfer rate in the system. The CIP method is also a capable tool to predict the heat and fluid flow in the multi-solid structure domain.	[Quyen Nguyen] Duy Tan Univ, Inst Res & Dev, Danang, Vietnam; [Babanezhad, Meisam] Islamic Azad Univ, Fac Mech Engn, Dept Energy, South Tehran Branch, Tehran, Iran; [Nakhjiri, Ali Taghvaie] Islamic Azad Univ, Dept Petr & Chem Engn, Sci & Res Branch, Tehran, Iran; [Rezakazemi, Mashallah] Shahrood Univ Technol, Fac Chem & Mat Engn, Shahrood, Iran; [Shirazian, Saeed] Ton Duc Thang Univ, Dept Management Sci & Technol Dev, Ho Chi Minh City, Vietnam; [Shirazian, Saeed] Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam	Duy Tan University; Islamic Azad University; Islamic Azad University; Shahrood University of Technology; Ton Duc Thang University; Ton Duc Thang University	Shirazian, S (corresponding author), Ton Duc Thang Univ, Dept Management Sci & Technol Dev, Ho Chi Minh City, Vietnam.; Shirazian, S (corresponding author), Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam.	saeed.shirazian@tdtu.edu.vn	Taghvaie Nakhjiri, Ali/ABG-2176-2021; babanezhad, Meisam/ABB-2400-2020; Rezakazemi, Mashallah/H-4046-2017	Taghvaie Nakhjiri, Ali/0000-0001-6244-3446; babanezhad, Meisam/0000-0003-4303-7412; Rezakazemi, Mashallah/0000-0002-9980-6682				Abu-Nada E, 2009, INT J HEAT FLUID FL, V30, P679, DOI 10.1016/j.ijheatfluidflow.2009.02.003; [Anonymous], 2011, WORLD APPL SCI J; [Anonymous], 2012, DIABETES CARE S1, V35, pS11; Aydin O, 2000, INT J NUMER METHOD H, V10, P518, DOI 10.1108/09615530010338196; Azwadi CSN, 2013, INT J MECH MAT ENG, V8, P58; Bararnia H, 2011, INT COMMUN HEAT MASS, V38, P1436, DOI 10.1016/j.icheatmasstransfer.2011.07.012; Dagtekin I, 2007, INT COMMUN HEAT MASS, V34, P502, DOI 10.1016/j.icheatmasstransfer.2007.01.003; Das S, 2002, INT J NUMER METHOD H, V12, P126, DOI 10.1108/09615530210418294; Daungthongsuk W, 2007, RENEW SUST ENERG REV, V11, P797, DOI 10.1016/j.rser.2005.06.005; DAVIS GD, 1983, INT J NUMER METH FL, V3, P249; Delavar MA, 2010, INT J HYDROGEN ENERG, V35, P9306, DOI 10.1016/j.ijhydene.2010.02.126; Ding YL, 2007, KONA, V25, P23, DOI 10.14356/kona.2007006; Eastman JA, 1997, MATER RES SOC SYMP P, V457, P3, DOI 10.1557/PROC-457-3; Fard MH, 2010, INT COMMUN HEAT MASS, V37, P91, DOI 10.1016/j.icheatmasstransfer.2009.08.003; Fattahi E, 2012, INT J THERM SCI, V52, P137, DOI 10.1016/j.ijthermalsci.2011.09.001; He YR, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-184; Kefayati GHR, 2012, INT J THERM SCI, V52, P91, DOI 10.1016/j.ijthermalsci.2011.09.005; Kefayati GR, 2011, INT COMMUN HEAT MASS, V38, P798, DOI 10.1016/j.icheatmasstransfer.2011.03.005; Khanafer K, 2003, INT J HEAT MASS TRAN, V46, P3639, DOI 10.1016/S0017-9310(03)00156-X; Khodadadi JM, 2007, INT COMMUN HEAT MASS, V34, P534, DOI 10.1016/j.icheatmasstransfer.2007.02.005; Khodadai J, 2013, NANOSTRUCTURE ENHANC; Lai FH, 2011, INT J THERM SCI, V50, P1930, DOI 10.1016/j.ijthermalsci.2011.04.015; Mahmoodi M, 2011, INT J THERM SCI, V50, P1731, DOI 10.1016/j.ijthermalsci.2011.04.009; Mohammed HA, 2011, RENEW SUST ENERG REV, V15, P2921, DOI 10.1016/j.rser.2011.02.019; Nabavitabatabayi M, 2011, INT COMMUN HEAT MASS, V38, P128, DOI 10.1016/j.icheatmasstransfer.2010.09.008; Nakhjiri AT, 2019, J IND ENG CHEM, V78, P106, DOI 10.1016/j.jiec.2019.06.031; Nakhjiri AT, 2018, J MEMBRANE SCI, V565, P1, DOI 10.1016/j.memsci.2018.07.095; Nakhjiri AT, 2018, J ENVIRON CHEM ENG, V6, P1500, DOI 10.1016/j.jece.2018.01.068; Nemati H, 2010, INT COMMUN HEAT MASS, V37, P1528, DOI 10.1016/j.icheatmasstransfer.2010.08.004; Oztop HF, 2008, INT J HEAT FLUID FL, V29, P1326, DOI 10.1016/j.ijheatfluidflow.2008.04.009; Poliseno L, 2012, SCI SIGNAL, V5, pre5; Pourtousi M, 2012, SIMULATION PARTICLE; Safdari A, 2018, COMPUT FLUIDS, V164, P102, DOI 10.1016/j.compfluid.2017.05.029; Schmid G., 2011, NANOPARTICLES THEORY; Shi Y, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066310; Shirazian S, 2012, ENG COMPUT-GERMANY, V28, P189, DOI 10.1007/s00366-011-0237-7; Shirazian S, 2009, SIMUL MODEL PRACT TH, V17, P708, DOI 10.1016/j.simpat.2008.12.002; Taherri-Garavand A., 2010, INT J CHEM ENG APPL, V1, P1; Wang XQ, 2008, BRAZ J CHEM ENG, V25, P613, DOI 10.1590/S0104-66322008000400001; Xuan YM, 2005, HEAT MASS TRANSFER, V41, P199, DOI 10.1007/s00231-004-0539-z; Xuan YM, 2000, INT J HEAT FLUID FL, V21, P58, DOI 10.1016/S0142-727X(99)00067-3; Yan YY, 2008, INT J HEAT MASS TRAN, V51, P2519, DOI 10.1016/j.ijheatmasstransfer.2007.07.053; Zhou LJ, 2010, INT J MULTIPHAS FLOW, V36, P364, DOI 10.1016/j.ijmultiphaseflow.2010.01.005	43	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0233850	10.1371/journal.pone.0233850	http://dx.doi.org/10.1371/journal.pone.0233850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555730	Green Published, gold			2022-12-27	WOS:000543273200081
J	Xie, LH; Varathan, P; Nho, K; Saykin, AJ; Salama, P; Yan, JW				Xie, Linhui; Varathan, Pradeep; Nho, Kwangsik; Saykin, Andrew J.; Salama, Paul; Yan, Jingwen			Identification of functionally connected multi-omic biomarkers for Alzheimer's disease using modularity-constrained Lasso	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; SHC ADAPTER PROTEINS; MINI-MENTAL STATE; INSULIN-RESISTANCE; REGRESSION; SHRINKAGE; CYTOSCAPE; PATHWAYS; GENES; ROLES	Large-scale genome wide association studies (GWASs) have led to discovery of many genetic risk factors in Alzheimer's disease (AD), such asAPOE,TOMM40andCLU. Despite the significant progress, it remains a major challenge to functionally validate these genetic findings and translate them into targetable mechanisms. Integration of multiple types of molecular data is increasingly used to address this problem. In this paper, we proposed a modularity-constrained Lasso model to jointly analyze the genotype, gene expression and protein expression data for discovery of functionally connected multi-omic biomarkers in AD. With a prior network capturing the functional relationship between SNPs, genes and proteins, the newly introduced penalty term maximizes the global modularity of the subnetwork involving selected markers and encourages the selection of multi-omic markers with dense functional connectivity, instead of individual markers. We applied this new model to the real data collected in the ROS/MAP cohort where the cognitive performance was used as disease quantitative trait. A functionally connected subnetwork involving 276 multi-omic biomarkers, including SNPs, genes and proteins, were identified to bear predictive power. Within this subnetwork, multiple trans-omic paths from SNPs to genes and then proteins were observed. This suggests that cognitive performance deterioration in AD patients can be potentially a result of genetic variations due to their cascade effect on the downstream transcriptome and proteome level.	[Xie, Linhui; Salama, Paul] Indiana Univ Purdue Univ, Dept Elect & Comp Engn, Indianapolis, IN 46202 USA; [Nho, Kwangsik; Saykin, Andrew J.; Yan, Jingwen] Indiana Univ Sch Med, Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Varathan, Pradeep; Yan, Jingwen] Indiana Univ Purdue Univ, Dept BioHlth Informat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Yan, JW (corresponding author), Indiana Univ Sch Med, Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA.; Yan, JW (corresponding author), Indiana Univ Purdue Univ, Dept BioHlth Informat, Indianapolis, IN 46202 USA.	jingyan@iupui.edu	Xie, Linhui/AAA-3577-2022	Xie, Linhui/0000-0003-1238-8789; Salama, Paul/0000-0002-7643-3879	NIH [R21 AG066135, R01 EB022574, R01 AG019771, P30 AG010133]; NSF CRII [1755836]; Indiana University Collaborative Research Grant (IUCRG); Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [UL1TR001108]; NIA [P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152]; Illinois Department of Public Health; Translational Genomics Research Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CRII(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Indiana University Collaborative Research Grant (IUCRG); Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; Translational Genomics Research Institute	This research was supported by NIH grants R21 AG066135, R01 EB022574, R01 AG019771, P30 AG010133, NSF CRII 1755836 and Indiana University Collaborative Research Grant (IUCRG). This project was also funded, in part, with support from the Indiana Clinical and Translational Sciences Institute funded, in part by Grant Number UL1TR001108 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. The results published here are in whole or in part based on data obtained from the AMP-AD Knowledge Portal (doi:10.7303/syn2580853). Study data were provided by the Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago. Data collection was supported through funding by NIA grants P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152, the Illinois Department of Public Health, and the Translational Genomics Research Institute.	Ali-Rahmani F, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.014; Andreev VP, 2012, J PROTEOME RES, V11, P3053, DOI 10.1021/pr3001546; Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Caltagarone J, 2007, BBA-MOL BASIS DIS, V1772, P438, DOI 10.1016/j.bbadis.2006.11.007; Cattaneo E, 1998, TRENDS NEUROSCI, V21, P476, DOI 10.1016/S0166-2236(98)01282-X; Chan YK, 2011, 22 INT JOINT C ART I; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; De Jager PL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.033; Dumbacher M, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0283-3; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Ekblad LL, 2018, NEUROLOGY, V90, pE1150, DOI 10.1212/WNL.0000000000005214; Engelman CD, 2013, J ALZHEIMERS DIS, V36, P749, DOI 10.3233/JAD-130482; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkz1031, 10.1093/nar/gkx1132]; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Gabbouj S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00629; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Global Health Estimates 2016, 2018, GLOBAL HLTH ESTIMATE; Grosenick L, 2013, NEUROIMAGE, V72, P304, DOI 10.1016/j.neuroimage.2012.12.062; Hasin Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1215-1; Hedges D, 2016, CLIN EEG NEUROSCI, V47, P48, DOI 10.1177/1550059414550567; Hildebrand R, 2008, ARXIV08061896; Horgusluoglu-Moloch E, 2017, NEUROBIOL AGING, V60, P92, DOI 10.1016/j.neurobiolaging.2017.08.010; Huang J, 2016, FRONT GENET, V7, DOI [10.3389/fgene.2016.00084, 10.3389/fgene.2017.00084]; Jacob L., 2009, P 26 ANN INT C MACH, P26, DOI DOI 10.1145/1553374.1553431; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kerrisk ME, 2014, PROG BRAIN RES, V214, P101, DOI 10.1016/B978-0-444-63486-3.00005-0; Kim S, 2012, ANN APPL STAT, V6, P1095, DOI 10.1214/12-AOAS549; Kirouac L, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0149-16.2017; Kumar S, 2017, NUCLEIC ACIDS RES, V45, pD139, DOI 10.1093/nar/gkw1064; Meng XZ, 2011, PROCEEDINGS OF THE 16TH INTERNATIONAL SYMPOSIUM ON ADVANCEMENT OF CONSTRUCTION MANAGEMENT AND REAL ESTATE (CRIOCM2011), P352; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nho K, 2013, MOL PSYCHIATR, V18, P781, DOI [10.1038/mp.2013.24, 10.1038/mp.2013.81]; Perez-Canamas A, 2016, NEUROBIOL AGING, V48, P1, DOI 10.1016/j.neurobiolaging.2016.08.009; Petyuk VA, 2010, METHODS, V50, P77, DOI 10.1016/j.ymeth.2009.07.009; POLICH J, 1990, ELECTROEN CLIN NEURO, V77, P179, DOI 10.1016/0168-5597(90)90036-D; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Saucier C, 2002, ONCOGENE, V21, P1800, DOI 10.1038/sj.onc.1205261; Schneider T, 2001, J CLIMATE, V14, P853, DOI 10.1175/1520-0442(2001)014<0853:AOICDE>2.0.CO;2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Thung KH, 2014, NEUROIMAGE, V91, P386, DOI 10.1016/j.neuroimage.2014.01.033; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Willette AA, 2015, ALZHEIMERS DEMENT, V11, P504, DOI 10.1016/j.jalz.2014.03.011; Wu CC, 2013, BIOINFORMATICS, V29, P1174, DOI 10.1093/bioinformatics/btt131; YOKOTE K, 1994, J BIOL CHEM, V269, P15337; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	53	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234748	10.1371/journal.pone.0234748	http://dx.doi.org/10.1371/journal.pone.0234748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555747	Green Published, Green Submitted, gold			2022-12-27	WOS:000542759600052
J	Yu, J; Hu, B				Yu, Jie; Hu, Bo			Influence of the combination of big data technology on the Spark platform with deep learning on elevator safety monitoring efficiency	PLOS ONE			English	Article								To effectively minimize elevator safety accidents, big data technology is combined with deep learning technology based on the Spark platform. This study first introduces the relevant theories of elevator safety monitoring technology, namely big data technology and deep learning technology. Then, the fault types that occur in the running state of the elevator are identified, and a finite state machine model is established. An elevator fault monitoring method based on the Spark platform is proposed, namely finite state machine (FSM), and the results of elevator safety fault monitoring are evaluated. Based on deep learning, an elevator fault warning model is constructed and its early warning performance is evaluated. The results show that the study can realize real-time and effective monitoring in the operation state of the elevator, and can determine the fault type of the elevator by binding the abnormal operation state with the corresponding fault. The feasibility of the elevator safety monitoring efficiency is evaluated based on three indexes: mutual information, accuracy, and false positives. Compared with other algorithms, the proposed FSM algorithm has the largest mutual information (0.1337), the highest accuracy (0.9899), the lowest false positive rate (0.0624), and the lowest false negative rate (0.1126); compared with other models, the elevator fault warning model proposed in this study has the lowest root mean-square error (RMSE) value (0.0201), the highest accuracy (0.9834), the lowest Loss value (0.0012), and the shortest convergence time (88.2608s), indicating that the elevator safety monitoring system and elevator fault warning model are feasible. This study establishes a good direction for elevator safety monitoring efficiency in China.	[Yu, Jie; Hu, Bo] Fudan Univ, Inst Informat Sci & Technol, Shanghai, Peoples R China	Fudan University	Yu, J (corresponding author), Fudan Univ, Inst Informat Sci & Technol, Shanghai, Peoples R China.	yujienuaa@163.com						Bertini JR, 2019, INFORM FUSION, V45, P66, DOI 10.1016/j.inffus.2018.01.003; Davila Delgado J M, 2019, J CONSTR ENG M ASCE, V146; Dou Y., 2019, INT WORKSH ADV MAN A, P309; El Mazouri FZ, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-018-0165-0; Garcia O, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040826; Ham S, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19235160; Jabari SE, 2020, TRANSPORT SCI, V54, P1, DOI 10.1287/trsc.2019.0920; Jesse N, 2018, AI SOC, V33, P229, DOI 10.1007/s00146-018-0807-y; Lin J, 2019, DESTECH T COMPUTER S, P22; Liu C, 2017, AUTOMATION CONTROL I, V5, P50; Loukas G, 2018, IEEE ACCESS, V6, P3491, DOI 10.1109/ACCESS.2017.2782159; Ming ZH, 2018, INT J ONLINE ENG, V14, P121, DOI 10.3991/ijoe.v14i08.9179; Olalere IO, 2018, S AFR J IND ENG, V29, P17, DOI 10.7166/29-4-1947; Skog I, 2017, IEEE SENS J, V17, P5198, DOI 10.1109/JSEN.2017.2719630; Subbu KP, 2017, BIG DATA RES, V10, P33, DOI 10.1016/j.bdr.2017.10.002; Wang HM, 2017, CHINA COMMUN, V14, P39, DOI 10.1109/CC.2017.8233649; Wang YQ, 2019, INT J OCCUP SAF ERGO, V25, P362, DOI 10.1080/10803548.2017.1371408; Waseem HM, 2019, APPL PHYS B-LASERS O, V125, DOI 10.1007/s00340-019-7142-y; Wen P., 2016, ENGINEERING, V8, P761, DOI 10.4236/eng.2016.811068; You Zhou, 2018, Procedia Computer Science, V131, P541, DOI 10.1016/j.procs.2018.04.262; Zhong BT, 2020, AUTOMAT CONSTR, V113, DOI 10.1016/j.autcon.2020.103089	21	2	3	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234824	10.1371/journal.pone.0234824	http://dx.doi.org/10.1371/journal.pone.0234824			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555687	gold, Green Published			2022-12-27	WOS:000542759600056
